Citrus Sinensis ID: 006277
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 652 | 2.2.26 [Sep-21-2011] | |||||||
| Q8S8Y8 | 567 | Probable serine/threonine | no | no | 0.726 | 0.835 | 0.707 | 0.0 | |
| Q8LST2 | 557 | Probable serine/threonine | yes | no | 0.687 | 0.804 | 0.714 | 0.0 | |
| Q6EU49 | 612 | Probable serine/threonine | yes | no | 0.588 | 0.627 | 0.644 | 1e-147 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.592 | 0.621 | 0.570 | 1e-130 | |
| Q944Q0 | 563 | Serine/threonine-protein | no | no | 0.647 | 0.749 | 0.543 | 1e-126 | |
| Q0D598 | 704 | Probable serine/threonine | no | no | 0.585 | 0.542 | 0.543 | 1e-125 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.585 | 0.542 | 0.543 | 1e-125 | |
| Q9STK6 | 516 | Probable serine/threonine | no | no | 0.542 | 0.686 | 0.555 | 1e-125 | |
| Q9CAV6 | 700 | Serine/threonine-protein | no | no | 0.608 | 0.567 | 0.531 | 1e-125 | |
| Q8RXE5 | 524 | Probable serine/threonine | no | no | 0.588 | 0.732 | 0.563 | 1e-119 |
| >sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 696 bits (1797), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/496 (70%), Positives = 398/496 (80%), Gaps = 22/496 (4%)
Query: 13 YLRLIQLVDTSG----YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 68
Y+R +++ YKAFDEV+G+EVAW QVRIDDVLQSP LERLYSEV LLKSLKH
Sbjct: 27 YIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEVRLLKSLKH 86
Query: 69 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 128
NNIIRFYNSWIDD+NKTVNIITELFTSGSLR YRKKH+KV+MKAVK WARQIL GL YLH
Sbjct: 87 NNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLH 146
Query: 129 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENY 188
+PPIIHRDLKCDNIFINGN GEVKIGDLGLAT+MEQANAKSVIGTPEFMAPELYDENY
Sbjct: 147 GQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENY 206
Query: 189 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248
NELADIYSFGMCMLEMVTF+YPY EC+NSAQIYKKVSSGIKPA+LS+VKDPEVK FIEKC
Sbjct: 207 NELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKC 266
Query: 249 LVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVR-NK 307
L+PAS+RLSAKELL+DPFLQ+NG T N PLPLPDIV+P+ GAFGDRCLMSEGP + R +K
Sbjct: 267 LLPASERLSAKELLLDPFLQLNGLTMNNPLPLPDIVMPKEGAFGDRCLMSEGPPTTRPSK 326
Query: 308 HPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRI 367
S+D D D+ LP++T DNSG S IEVRR+KRGNFF+LKGE NDE SVSLILRI
Sbjct: 327 TLSIDLDEDSNLPIVTFSDNSG-----SRCIEVRRAKRGNFFVLKGEENDEQSVSLILRI 381
Query: 368 ADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPGWKPC 427
D++GR+RNIHFLFY + DTA VSSEMVEQLEL DQNVTFIAELID+LL+N+IP WK
Sbjct: 382 VDENGRVRNIHFLFYQEGDTASKVSSEMVEQLELTDQNVTFIAELIDILLVNMIPTWKTD 441
Query: 428 VRIDHLIPQKSRRQSPEDHE--KDALSLERV--DNSSGLSH-------RSYEADNHS-RS 475
V +DHLI + + S H K E V D +SH RS E D +
Sbjct: 442 VTVDHLIHSQLNQNSRSHHNEAKPQKQEETVFHDTCELVSHSCNSDCPRSDEEDKQCVDA 501
Query: 476 SDGQDSTSLKEGIQTT 491
+ G+D +S++E + T
Sbjct: 502 TKGEDKSSIQEVEEAT 517
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8LST2|WNK7_ARATH Probable serine/threonine-protein kinase WNK7 OS=Arabidopsis thaliana GN=WNK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 690 bits (1781), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/469 (71%), Positives = 388/469 (82%), Gaps = 21/469 (4%)
Query: 13 YLRLIQLVDTSG----YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 68
Y+R +++ +K FDEV+G+EVAW QVRIDD+LQSP+ LERLYSEV LLKSLKH
Sbjct: 27 YIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYSEVRLLKSLKH 86
Query: 69 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 128
NIIRFYNSWIDD+NKTVNIITELFTSGSLRQYRKKH+KV+MKAVK WARQIL+GL YLH
Sbjct: 87 KNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLKYLH 146
Query: 129 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENY 188
S DPPIIHRD+KCDNIFINGN GEVKIGDLGLAT+MEQANAKSVIGTPEFMAPELYDENY
Sbjct: 147 SQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENY 206
Query: 189 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248
NELADIYSFGMCMLEMVTFEYPY ECRNSAQIYKKVSSGIKPA+LSKVKDPEV FIEKC
Sbjct: 207 NELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFIEKC 266
Query: 249 LVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKH 308
L+PAS+RLSA+ELL+D FL VNG N PLPLPDIV+P+ G+FG+RCLMSEGP + RN+
Sbjct: 267 LLPASERLSAEELLLDSFLNVNGLVMNNPLPLPDIVMPKEGSFGERCLMSEGPPNARNRT 326
Query: 309 PSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRIA 368
SM+ D D LP++ S +NSG + IEVRR+KRGNFF+LKGE NDE SVSLILRI
Sbjct: 327 MSMNLDEDNNLPIVISSNNSG-----TNCIEVRRAKRGNFFVLKGEENDENSVSLILRIV 381
Query: 369 DQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPGWKPCV 428
D++GR+RNIHFLF+ + DTA +VSSEMVEQLEL D+NV FIAELID+LL+NLIP WK V
Sbjct: 382 DENGRVRNIHFLFFQEGDTASNVSSEMVEQLELTDKNVKFIAELIDVLLVNLIPNWKTDV 441
Query: 429 RIDHLIPQKSRRQSPEDHEKDALSLERVDNSSGLSHRSYEADNHSRSSD 477
+DHLI + + S ++H+ +G S ++ E+ +HS SSD
Sbjct: 442 AVDHLIHPQQNQSSKDNHQ------------NGASSQAGESISHSLSSD 478
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6EU49|WNK4_ORYSJ Probable serine/threonine-protein kinase WNK4 OS=Oryza sativa subsp. japonica GN=WNK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 523 bits (1346), Expect = e-147, Method: Compositional matrix adjust.
Identities = 257/399 (64%), Positives = 306/399 (76%), Gaps = 15/399 (3%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKAFDEV G+EVAW QV ID+V+QSP++LERLYSEVHLLKSLKH N+++FYN W+DDQ K
Sbjct: 40 YKAFDEVEGIEVAWSQVEIDEVMQSPDNLERLYSEVHLLKSLKHENVMKFYNYWVDDQKK 99
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
T+N+ITELFTSGSLRQYR+KH +VD+KA+K WARQ+L GL YLH+H PPIIHRDLKCDNI
Sbjct: 100 TINVITELFTSGSLRQYRQKHPRVDLKAIKNWARQVLRGLDYLHTHQPPIIHRDLKCDNI 159
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 204
F+NGN GEVKIGDLGLAT+M AKSVIGTPEFMAPELYDENY+EL DIYSFGMCMLEM
Sbjct: 160 FVNGNHGEVKIGDLGLATVMLTPRAKSVIGTPEFMAPELYDENYDELVDIYSFGMCMLEM 219
Query: 205 VTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMD 264
T EYPYSEC N+AQI+KKVS G+KPAAL+K+ + + K FI+KCLVPAS+RLSAKELL D
Sbjct: 220 FTLEYPYSECTNAAQIFKKVSKGVKPAALAKITNIQAKQFIDKCLVPASERLSAKELLQD 279
Query: 265 PFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITS 324
PFL + ++ VL VG L S+ H MD D++ + T
Sbjct: 280 PFLCSDNSS----------VL--VGTKFPSSLPKSVDVSLEALH--MDVDTNESMCTSTC 325
Query: 325 LDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLD 384
N GG + +E R+ + L GE D+ SVSL+LRIAD G RNIHFLFYLD
Sbjct: 326 KRNDLGG-PHRSVLEFTRTNKNTELKLTGEKLDDNSVSLVLRIADLCGHARNIHFLFYLD 384
Query: 385 SDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPG 423
SDTA SV++EMVEQLELAD +VTFIA+ IDLL++NL+PG
Sbjct: 385 SDTAMSVAAEMVEQLELADCDVTFIADFIDLLIVNLVPG 423
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 466 bits (1198), Expect = e-130, Method: Compositional matrix adjust.
Identities = 231/405 (57%), Positives = 293/405 (72%), Gaps = 19/405 (4%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKAFD++ GLEVAW Q+++ D+L++ +DLERL SEV LLK+LKH NII+FYNSW+D +N
Sbjct: 43 YKAFDQLEGLEVAWNQIKVGDILRNNDDLERLRSEVRLLKTLKHKNIIKFYNSWLDKKNN 102
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+N ITE+FTSG+LRQYR KHKKVD++A+K W+RQILSGL+YLHSHDPP+IHRDLKCDNI
Sbjct: 103 NINFITEVFTSGTLRQYRIKHKKVDVRALKKWSRQILSGLVYLHSHDPPVIHRDLKCDNI 162
Query: 145 FINGNQGEVKIGDLGLATIMEQA-NAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLE 203
F+NGNQGEVKIGDLGLATI++ A +A S+IGTPEFMAPELYDE YNEL DIY+FGMC+LE
Sbjct: 163 FVNGNQGEVKIGDLGLATILDNARSAHSIIGTPEFMAPELYDEEYNELVDIYAFGMCLLE 222
Query: 204 MVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLM 263
+VTFEYPY EC N+AQIYKKVS G KP++L+K++DPEV+ FIEKC+ ASQRLSA+ELLM
Sbjct: 223 LVTFEYPYCECSNAAQIYKKVSDGEKPSSLAKIEDPEVRFFIEKCIAKASQRLSAQELLM 282
Query: 264 DPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVIT 323
DPFL+ +G PL S+G S N +D DA I
Sbjct: 283 DPFLRDDGEKIFYPL-------------QSNTKASDGAGS-SNSSMGYKYDRDASSMAIR 328
Query: 324 ----SLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHF 379
S D Y S ++ G ++ + D ++ L LRIAD +G +NIHF
Sbjct: 329 EHTGSFAEEHPSDRYIHSTMDPQAAAGRIITVESQMKDLNTIFLKLRIADSTGHAQNIHF 388
Query: 380 LFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPGW 424
F +++DT+ SV++EMV QL+L DQ+VT IAE+ID + IP W
Sbjct: 389 PFDIEADTSISVATEMVVQLDLTDQDVTAIAEMIDAEIRAHIPDW 433
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q944Q0|WNK8_ARATH Serine/threonine-protein kinase WNK8 OS=Arabidopsis thaliana GN=WNK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1161), Expect = e-126, Method: Compositional matrix adjust.
Identities = 246/453 (54%), Positives = 308/453 (67%), Gaps = 31/453 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKAFDEV+G+EVAW V I+DV+Q P LERLYSEVHLLK+LKH NII+ + SW+D++NK
Sbjct: 44 YKAFDEVDGIEVAWNLVSIEDVMQMPGQLERLYSEVHLLKALKHENIIKLFYSWVDEKNK 103
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
T+N+ITELFTSGSLR YRKKH+KVD KA+K WARQIL GL YLHS +PP+IHRDLKCDNI
Sbjct: 104 TINMITELFTSGSLRVYRKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNI 163
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 204
F+NGN GEVKIGDLGLAT+++Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMCMLEM
Sbjct: 164 FVNGNTGEVKIGDLGLATVLQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEM 223
Query: 205 VTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMD 264
VT EYPY+ECRN AQIYKKV+S IKP +L KV DP+V+ FIEKCL+PAS R +A EL D
Sbjct: 224 VTCEYPYNECRNQAQIYKKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKD 283
Query: 265 PFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITS 324
PFL +G + L V P + +H MD D + V ++
Sbjct: 284 PFLARDGGKDSALLASSSTSSKYV-----------RPPQL--EHLPMDVDHNENKSVSSN 330
Query: 325 LDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLD 384
D +S +IE++R F L+GE +D+ + S++LRIAD SG+ R +HF FYL+
Sbjct: 331 EDY-----PWSQTIELQRIAENKEFRLRGERSDDVTASMVLRIADPSGKCRIVHFAFYLE 385
Query: 385 SDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPGWKPCVRIDHLIPQKSRRQSPE 444
SDTA +++ EMVE+L L Q V IA++ID ++ L+ R Q S R + E
Sbjct: 386 SDTATAIAEEMVEELHLTSQEVVVIADMIDDFIMQLLSD-----RTSSHHNQNSPRLTHE 440
Query: 445 DHEKDALSLERVDNSSGLSHRSYEADNHSRSSD 477
DHE N ++ + EA S SD
Sbjct: 441 DHE--------AANQQTVNSKDEEAAGQSMKSD 465
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates the vacuolar ATPase subunit C (VATC). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 450 bits (1157), Expect = e-125, Method: Compositional matrix adjust.
Identities = 229/421 (54%), Positives = 293/421 (69%), Gaps = 39/421 (9%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y+AFDE G+EVAW QV++ D LQSPEDLERLY E+HLLK+LKH NI++FY SW+D +
Sbjct: 42 YRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDVSRR 101
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+N ITE+FTSG+LRQYR+KH +V++ AVK W RQILSGL+YLHSHDPPIIHRDLKCDNI
Sbjct: 102 NINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNI 161
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 204
F+NGNQGEVKIGDLGLA I+ +++A +GTPEFMAPE+Y+E YNEL DIYSFGMC+LEM
Sbjct: 162 FVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEM 221
Query: 205 VTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMD 264
VTFEYPYSEC + QIYKKV SG KP AL KVKDP V+ F+EKCL AS+RLSA+ELL D
Sbjct: 222 VTFEYPYSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKD 281
Query: 265 PFLQVNGTTKNRPLPLPDIVL-PRVG---------------AFGDRCLMSEGPA-SVRNK 307
PFLQV+ D+V P G A+ + +MS G + S+
Sbjct: 282 PFLQVD-----------DLVFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLSESIDED 330
Query: 308 HPSMD-FDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNF-FLLKGESNDEYSVSLIL 365
P+ D +D + + +D G + GN +KG +++ S+ L L
Sbjct: 331 TPTEDRWDCEDDDIKADGIDLFNGHED---------EPLGNVDITIKGRKSEDGSIFLRL 381
Query: 366 RIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPGWK 425
RIAD G +RNI+F F +++DTA SV++EMV +L++ D VT IAE+ID + L+P W+
Sbjct: 382 RIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWR 441
Query: 426 P 426
P
Sbjct: 442 P 442
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 450 bits (1157), Expect = e-125, Method: Compositional matrix adjust.
Identities = 229/421 (54%), Positives = 293/421 (69%), Gaps = 39/421 (9%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y+AFDE G+EVAW QV++ D LQSPEDLERLY E+HLLK+LKH NI++FY SW+D +
Sbjct: 42 YRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDVSRR 101
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+N ITE+FTSG+LRQYR+KH +V++ AVK W RQILSGL+YLHSHDPPIIHRDLKCDNI
Sbjct: 102 NINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNI 161
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 204
F+NGNQGEVKIGDLGLA I+ +++A +GTPEFMAPE+Y+E YNEL DIYSFGMC+LEM
Sbjct: 162 FVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEM 221
Query: 205 VTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMD 264
VTFEYPYSEC + QIYKKV SG KP AL KVKDP V+ F+EKCL AS+RLSA+ELL D
Sbjct: 222 VTFEYPYSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKD 281
Query: 265 PFLQVNGTTKNRPLPLPDIVL-PRVG---------------AFGDRCLMSEGPA-SVRNK 307
PFLQV+ D+V P G A+ + +MS G + S+
Sbjct: 282 PFLQVD-----------DLVFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLSESIDED 330
Query: 308 HPSMD-FDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNF-FLLKGESNDEYSVSLIL 365
P+ D +D + + +D G + GN +KG +++ S+ L L
Sbjct: 331 TPTEDRWDCEDDDIKADGIDLFNGHED---------EPLGNVDITIKGRKSEDGSIFLRL 381
Query: 366 RIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPGWK 425
RIAD G +RNI+F F +++DTA SV++EMV +L++ D VT IAE+ID + L+P W+
Sbjct: 382 RIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWR 441
Query: 426 P 426
P
Sbjct: 442 P 442
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 448 bits (1152), Expect = e-125, Method: Compositional matrix adjust.
Identities = 225/405 (55%), Positives = 292/405 (72%), Gaps = 51/405 (12%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y+AFD++ G+EVAW QV++DD S EDL+RLYSEVHLLK+LKH +II+FY SWID Q+
Sbjct: 37 YRAFDQLEGIEVAWNQVKLDDKFCSSEDLDRLYSEVHLLKTLKHKSIIKFYTSWIDHQHM 96
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
T+N+ITE+FTSG+LRQYRKKHK VD++A+K W+RQIL GL+YLHSHDPP+IHRDLKCDNI
Sbjct: 97 TINLITEVFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNI 156
Query: 145 FINGNQGEVKIGDLGLATIMEQA-NAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLE 203
FINGNQGEVKIGDLGLA I+ +A +A SVIGTPEFMAPELY+E+YN L DIY+FGMC+LE
Sbjct: 157 FINGNQGEVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLE 216
Query: 204 MVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLM 263
+VTFEYPYSEC N+AQIY+KV+SGIKPAAL V DP+V++FIEKC+ SQRLSAKELL
Sbjct: 217 LVTFEYPYSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCIAKVSQRLSAKELLD 276
Query: 264 DPFLQV-NGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVI 322
DPFL+ T+N +S + N + +D SD+E+ ++
Sbjct: 277 DPFLKCYKENTEN---------------------VSSHKENGYNGNGIVDKLSDSEVGLL 315
Query: 323 TSLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFY 382
T ++G+ D ++ L LRI D G++RNIHF F
Sbjct: 316 T---------------------------VEGQRKDLNTIFLKLRITDSKGQIRNIHFPFN 348
Query: 383 LDSDTAFSVSSEMVEQLELA-DQNVTFIAELIDLLLLNLIPGWKP 426
+++DT+FSV+ EMVE+L+L DQ+++ IA++ID + + IP W P
Sbjct: 349 IETDTSFSVAIEMVEELDLTDDQDISTIAKMIDTEIHSHIPDWTP 393
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 448 bits (1152), Expect = e-125, Method: Compositional matrix adjust.
Identities = 231/435 (53%), Positives = 305/435 (70%), Gaps = 38/435 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y+AFDE G+EVAW QV++ D LQSPEDLERLY E+HLLK+LKH NI++FY SW+D N+
Sbjct: 39 YRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+N +TELFTSG+LRQYR +HK+V+++A+K W RQIL GL YLHSHDPP+IHRDLKCDNI
Sbjct: 99 NINFVTELFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNI 158
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 204
F+NGNQGEVKIGDLGLA I+ +++A +GTPEFMAPE+Y+E YNEL DIYSFGMC+LEM
Sbjct: 159 FVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEM 218
Query: 205 VTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMD 264
VTF+YPYSEC + AQIYKKV SG KP AL KVKDPEVK FIEKCL S R+SA+ELL D
Sbjct: 219 VTFDYPYSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDD 278
Query: 265 PFLQV-NGTTKNRPLPLPDIVLP---RVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELP 320
PFL++ +G R + + D V P + D +S+ ++ + ++ S++
Sbjct: 279 PFLRIDDGEFDLRSVDMEDSVGPLYRQPHHLPDYYNYPSNSSSLNRQYSNGNYPSNS--- 335
Query: 321 VITSLDN--SGG---------GDSYSPS-------IEVRRS----------KRGNF-FLL 351
+SL+ S G G +Y+P+ IE+ S K GN +
Sbjct: 336 --SSLNRQYSNGYNSHHEYQNGWAYNPAETEETHGIELFESRNNDDQEEEKKSGNVDITI 393
Query: 352 KGESNDEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAE 411
KG+ D+ + L LRIAD+ GR+RNI+F F +++DTA SV++EMV +L++ D VT IA
Sbjct: 394 KGKRRDDGGLFLRLRIADKEGRVRNIYFPFDIETDTALSVATEMVAELDMDDHGVTKIAN 453
Query: 412 LIDLLLLNLIPGWKP 426
+ID + +L+P W+P
Sbjct: 454 MIDGEISSLVPSWRP 468
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXE5|WNK10_ARATH Probable serine/threonine-protein kinase WNK10 OS=Arabidopsis thaliana GN=WNK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 431 bits (1107), Expect = e-119, Method: Compositional matrix adjust.
Identities = 223/396 (56%), Positives = 279/396 (70%), Gaps = 12/396 (3%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKAFDEV G+EVAW + I+DVLQ P L+RLYSEVHLL SLKH+NII+ + SW+DD NK
Sbjct: 31 YKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRLYSEVHLLNSLKHDNIIKLFYSWVDDHNK 90
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
++N+ITELFTSGSL YRKKH+KVD KA+ WARQIL GL YLHS PP+IHRDLKCDNI
Sbjct: 91 SINMITELFTSGSLTLYRKKHRKVDPKAIMNWARQILKGLHYLHSQTPPVIHRDLKCDNI 150
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 204
F+NGN G+VKIGDLGLA +M+Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMCMLEM
Sbjct: 151 FVNGNTGKVKIGDLGLAAVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEM 210
Query: 205 VTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMD 264
VT EYPY ECRN AQIYKKV+SGIKP +LSKV DP+VK FIEKCL+PA R +A ELL D
Sbjct: 211 VTCEYPYRECRNQAQIYKKVTSGIKPQSLSKVDDPQVKQFIEKCLLPAPSRPTALELLKD 270
Query: 265 PFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITS 324
L V+G + + A + P + +++ + + + +S
Sbjct: 271 QLLAVDGAKDS-----------TLTASSNTTFKPAMPPQCEYRPMDVEYKKNTSVSICSS 319
Query: 325 LDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLD 384
+S + ++EV+R F L GE D+ + S+ LRIA SG+ R + F F L
Sbjct: 320 AKSSQEC-ALLQTMEVQRVAESTEFKLSGERRDDVAASMALRIAGSSGQARKVDFDFNLK 378
Query: 385 SDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNL 420
+DTA +V+ EMVE+L+L+ VT IAE+ID L++ L
Sbjct: 379 TDTARAVTGEMVEELDLSSHEVTVIAEMIDELIMKL 414
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 652 | ||||||
| 225431547 | 677 | PREDICTED: probable serine/threonine-pro | 0.953 | 0.918 | 0.660 | 0.0 | |
| 255585425 | 662 | kinase, putative [Ricinus communis] gi|2 | 0.955 | 0.941 | 0.638 | 0.0 | |
| 10241605 | 666 | protein kinase [Fagus sylvatica] | 0.875 | 0.857 | 0.586 | 0.0 | |
| 18402506 | 539 | putative serine/threonine-protein kinase | 0.705 | 0.853 | 0.716 | 0.0 | |
| 224131198 | 583 | predicted protein [Populus trichocarpa] | 0.763 | 0.854 | 0.715 | 0.0 | |
| 357464557 | 675 | Protein kinase [Medicago truncatula] gi| | 0.940 | 0.908 | 0.590 | 0.0 | |
| 297834790 | 571 | hypothetical protein ARALYDRAFT_318635 [ | 0.680 | 0.777 | 0.753 | 0.0 | |
| 15230184 | 567 | putative serine/threonine-protein kinase | 0.726 | 0.835 | 0.707 | 0.0 | |
| 357519861 | 676 | Protein kinase [Medicago truncatula] gi| | 0.883 | 0.852 | 0.588 | 0.0 | |
| 9293898 | 571 | MAP (mitogen activated protein) kinase-l | 0.708 | 0.809 | 0.727 | 0.0 |
| >gi|225431547|ref|XP_002275565.1| PREDICTED: probable serine/threonine-protein kinase WNK6-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 793 bits (2047), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/625 (66%), Positives = 484/625 (77%), Gaps = 3/625 (0%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKAFD+V+G+EVAW QVRID+VLQSP++LERLYSEVHLLKSLKH NII+FYNSWIDD NK
Sbjct: 48 YKAFDQVDGIEVAWNQVRIDEVLQSPDELERLYSEVHLLKSLKHKNIIKFYNSWIDDGNK 107
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQIL GL YLH+H+PPIIHRDLKCDNI
Sbjct: 108 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILMGLNYLHNHNPPIIHRDLKCDNI 167
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 204
FINGNQGEVKIGDLGLAT+M+QANA++VIGTPEFMAPELYDENYNELADIYSFGMCMLEM
Sbjct: 168 FINGNQGEVKIGDLGLATVMQQANARTVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 227
Query: 205 VTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMD 264
VT EYPYSECRNSAQIYKKVS+GIKPAALSK+KD EVK FIEKCLVPASQRLSAK+LL D
Sbjct: 228 VTLEYPYSECRNSAQIYKKVSNGIKPAALSKIKDLEVKMFIEKCLVPASQRLSAKKLLND 287
Query: 265 PFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKHPSMDFDS--DAELPVI 322
PF QV+G TKN PL LPDIV+P+ GAFGDRCL+SEGP S++N+ +MD D+ D ELP+I
Sbjct: 288 PFFQVDGLTKNHPLQLPDIVIPKTGAFGDRCLLSEGPTSLQNRPLAMDLDAVDDDELPII 347
Query: 323 TSLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFY 382
TS+DNS G YS +EV+R+K GNFFLLKGE NDE S+SLILRIADQ+GRLRNIHF+FY
Sbjct: 348 TSMDNSVDGGPYSLCMEVQRAKGGNFFLLKGEGNDENSISLILRIADQNGRLRNIHFMFY 407
Query: 383 LDSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPGWKPCVRIDHLIPQKSRRQS 442
LDSDTA SVSSEMVEQLELADQNVTFIAELIDLLL+ LIP WKPCV IDHL+ +R Q+
Sbjct: 408 LDSDTALSVSSEMVEQLELADQNVTFIAELIDLLLIMLIPTWKPCVPIDHLVAL-NRMQT 466
Query: 443 PEDHEKDALSLERVDNSSGLSHRSYEADNHSRSSDGQDSTSLKEGIQTTVLGPDFMKPDE 502
H +D E + G E DN +STS + I+T P + DE
Sbjct: 467 SNGHHEDLQCPEHGECLVGSFEGVCETDNLLSPHVYPNSTSFEGYIETMQENPKHLSLDE 526
Query: 503 KRSHNDFSCQGKATADDQTSEKSNVSASSSEQNEKKYCFSSDIFPEPGTMDFDGHAFVVR 562
++H D AT +D S+ S VSA+S+E ++KKY ++ + E G MD++ +
Sbjct: 527 IKTHADLGLPSSATVEDHGSDMSYVSATSNEGSDKKYSHNAYLSAESGCMDYNEYGSKRG 586
Query: 563 TSESPARMGLGETPDEKSNIMDICSNGVVDTSSGLTISSLSDLEIDEEIRMKLEMIDLQY 622
+S + + +K DI SNG V +S SSLSD E + ++LEMI+LQY
Sbjct: 587 VRQSLSAVQTSSCNLDKGKATDIGSNGAVTSSDYPIDSSLSDQVESENMILELEMIELQY 646
Query: 623 QEEFKAISKRRHDAILDTKKSMKKK 647
E K I+KRR +AI +TKK + +K
Sbjct: 647 HEAVKEIAKRRQEAIRETKKRLSQK 671
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585425|ref|XP_002533407.1| kinase, putative [Ricinus communis] gi|223526752|gb|EEF28980.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 770 bits (1987), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/644 (63%), Positives = 482/644 (74%), Gaps = 21/644 (3%)
Query: 13 YLRLIQLVDTSG----YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 68
Y+R +++ YKAFDEVNGLEVAW QVRID+VLQSPEDLERLYSEVHLLKSLKH
Sbjct: 27 YIRYKEMLGKGAFKRVYKAFDEVNGLEVAWNQVRIDEVLQSPEDLERLYSEVHLLKSLKH 86
Query: 69 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 128
NI+RFYNSWIDD+NKTVNIITELFTSG+LR+Y KK++ V+MKAVKGWARQIL GL YLH
Sbjct: 87 GNIVRFYNSWIDDKNKTVNIITELFTSGNLREYCKKYRNVEMKAVKGWARQILMGLSYLH 146
Query: 129 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENY 188
H PP+IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ+NAKSVIGTPEFMAPELYDE+Y
Sbjct: 147 GHKPPVIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQSNAKSVIGTPEFMAPELYDEDY 206
Query: 189 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248
NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK FI+KC
Sbjct: 207 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKLFIQKC 266
Query: 249 LVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKH 308
+V ASQRLSAKELLMDPFL+VNG KNRPL LPDIV+P++ AFGDRCLMSEGPA+ RNK
Sbjct: 267 IVSASQRLSAKELLMDPFLEVNGLAKNRPLSLPDIVMPKLSAFGDRCLMSEGPANARNKP 326
Query: 309 PSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRIA 368
PSMD D+D E+P+I + NS G S +EVRR+K+GN F LKGE +DE SVSLILRIA
Sbjct: 327 PSMDLDNDPEMPIIKAFKNSFGRHFNSTFVEVRRAKKGNIFFLKGEKHDENSVSLILRIA 386
Query: 369 DQSG-RLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPGWKPC 427
DQ+G R+RNIHFLFYLD DTA VSSEMVEQLEL DQN+TFIAELIDLLLL LIP WKPC
Sbjct: 387 DQNGSRVRNIHFLFYLDGDTALLVSSEMVEQLELEDQNITFIAELIDLLLLKLIPNWKPC 446
Query: 428 VRIDHLIPQKSRRQSPEDHEKDALSLERVDN--SSGLSHRSYEADNHSRSSDGQDSTSLK 485
VRI+HL+P+ + S + + S D +G + + +SR+S DS S
Sbjct: 447 VRIEHLVPRNATNSSKGNLKSHKSSENYKDQIVVAGSAQDIRQIATYSRTSSCLDSCSQG 506
Query: 486 EGIQTTVLGPD----FMKPDEKRSHNDFSCQGK-ATADDQTSEKSNVSASSSEQNEKKYC 540
I + D +K + S + S + A +D SEKS SA+SSE N+K+
Sbjct: 507 GSIPRSEADQDGSAGIIKLSDMPSQTNESGNYRMAMVEDLVSEKSYTSAASSEWNDKRLS 566
Query: 541 FSSDIFPEPGTMDFDGHAFVVRTSESPARMGLGETPDEKSNIMDICSNGVVDTSSGLTIS 600
F+S + E G ++FDGH F + A M G+ PD M+I S+ +IS
Sbjct: 567 FNSCVTAESGLVNFDGHGFKGSQGDLLASMEAGQPPDSH---MEISSDYPT------SIS 617
Query: 601 SLSDLEIDEEIRMKLEMIDLQYQEEFKAISKRRHDAILDTKKSM 644
LS+ E+R +LE I+LQYQE K I ++RH AI++T K +
Sbjct: 618 FLSNKNESNELREELEKIELQYQEAIKEIIRQRHKAIIETTKRL 661
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|10241605|emb|CAC09581.1| protein kinase [Fagus sylvatica] | Back alignment and taxonomy information |
|---|
Score = 714 bits (1843), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/656 (58%), Positives = 447/656 (68%), Gaps = 85/656 (12%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+KAFDE +GLEVAW QVRIDDVLQSP+DLERLYSEVHLLKSLKH+NI++FYNSWIDD+NK
Sbjct: 48 FKAFDEADGLEVAWNQVRIDDVLQSPDDLERLYSEVHLLKSLKHSNIVKFYNSWIDDKNK 107
Query: 85 TVNIITELFTSGSLRQYR--------------------------------KKHKKVDMKA 112
TVNIITELFTSG+LRQY KKHKKVDMKA
Sbjct: 108 TVNIITELFTSGNLRQYVSFLLIALLKFLILFYGDISLVVSGCNPWFRYCKKHKKVDMKA 167
Query: 113 VKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172
+KGWARQIL+GL YLHSH PPIIHRDLKCDNIFINGNQGEVKIGDLGLAT+MEQANAKSV
Sbjct: 168 LKGWARQILTGLNYLHSHSPPIIHRDLKCDNIFINGNQGEVKIGDLGLATVMEQANAKSV 227
Query: 173 IGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA 232
IGTPEFMAPELYDE+YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP A
Sbjct: 228 IGTPEFMAPELYDEDYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPVA 287
Query: 233 LSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFG 292
LSKVKDP +K FIEKCLVPASQRLSAKELLMDPFLQVN KNRPLPLPDIVLP++GAF
Sbjct: 288 LSKVKDPAMKQFIEKCLVPASQRLSAKELLMDPFLQVNRLAKNRPLPLPDIVLPKMGAF- 346
Query: 293 DRCLMSEGPASVRNKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFLLK 352
DNS G SY +E++R+K+GNFF +K
Sbjct: 347 ---------------------------------DNSVYGGSYPVCVEIQRAKKGNFFWIK 373
Query: 353 GESNDEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAEL 412
GE NDE SVSLILRIADQ+GR RNIHFLFYL SDTA SVSSEMVEQLELADQNV FIAEL
Sbjct: 374 GEGNDEDSVSLILRIADQNGRARNIHFLFYLVSDTAISVSSEMVEQLELADQNVMFIAEL 433
Query: 413 IDLLLLNLIPGWKPCVRIDHLIPQKSRRQSPEDHEKDALS------LERVDNSSGLSHRS 466
IDLLL+NL+P WKPCVRIDHL+ R E L ++ N ++H S
Sbjct: 434 IDLLLMNLVPKWKPCVRIDHLVAPNGIRTHEAHQEASQLPKHGEKLVKSHQNVCAVAHPS 493
Query: 467 YEADNHSRSSDGQDSTSLKEGIQTTVL---------GPDFMKPDEKRSHNDFSCQGKATA 517
+ + S G + + PD +K +E SH++F Q
Sbjct: 494 SPPSSTNSISSGGSIQPVPSSTNSISSGGSIQSVRESPDNVKLEEIMSHDNFGLQSATVT 553
Query: 518 DDQTSEKSNVSASSSEQNEKKYCFSSDIFPEPGTMDFDGHAFVVRTSESPARMGLGETPD 577
+DQ SE S +SA+S+E ++K S + E G +D + + ESP++ +G +PD
Sbjct: 554 EDQCSEMSYISATSTEFDDKNSSIDSYMSAEMGPVDLNRYRLDRGVRESPSKAEMGASPD 613
Query: 578 EKSNIMDICSNGVVDTSSGLTISSLSDLEIDEEIRMKLEMIDLQYQEEFKAISKRR 633
S MD+ S+ V T S I+ +D EE+RM+LE+I+LQYQE K +S+ +
Sbjct: 614 YNSKDMDLESSLV--TFSAYPIN--ADQGGVEELRMELEVIELQYQEAIKEMSQEK 665
|
Source: Fagus sylvatica Species: Fagus sylvatica Genus: Fagus Family: Fagaceae Order: Fagales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18402506|ref|NP_564541.1| putative serine/threonine-protein kinase WNK7 [Arabidopsis thaliana] gi|13430448|gb|AAK25846.1|AF360136_1 putative serine/threonine protein kinase [Arabidopsis thaliana] gi|332194276|gb|AEE32397.1| putative serine/threonine-protein kinase WNK7 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1817), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/477 (71%), Positives = 395/477 (82%), Gaps = 17/477 (3%)
Query: 1 MVRQKWSLLILMYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEV 60
M+ Q + L +L+ QLVD G+K FDEV+G+EVAW QVRIDD+LQSP+ LERLYSEV
Sbjct: 1 MLLQLLNHLTQKFLKSTQLVDIFGFKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYSEV 60
Query: 61 HLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQI 120
LLKSLKH NIIRFYNSWIDD+NKTVNIITELFTSGSLRQYRKKH+KV+MKAVK WARQI
Sbjct: 61 RLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQI 120
Query: 121 LSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMA 180
L+GL YLHS DPPIIHRD+KCDNIFINGN GEVKIGDLGLAT+MEQANAKSVIGTPEFMA
Sbjct: 121 LTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMA 180
Query: 181 PELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 240
PELYDENYNELADIYSFGMCMLEMVTFEYPY ECRNSAQIYKKVSSGIKPA+LSKVKDPE
Sbjct: 181 PELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDPE 240
Query: 241 VKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEG 300
V FIEKCL+PAS+RLSA+ELL+D FL VNG N PLPLPDIV+P+ G+FG+RCLMSEG
Sbjct: 241 VMKFIEKCLLPASERLSAEELLLDSFLNVNGLVMNNPLPLPDIVMPKEGSFGERCLMSEG 300
Query: 301 PASVRNKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYS 360
P + RN+ SM+ D D LP++ S +NSG + IEVRR+KRGNFF+LKGE NDE S
Sbjct: 301 PPNARNRTMSMNLDEDNNLPIVISSNNSG-----TNCIEVRRAKRGNFFVLKGEENDENS 355
Query: 361 VSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNL 420
VSLILRI D++GR+RNIHFLF+ + DTA +VSSEMVEQLEL D+NV FIAELID+LL+NL
Sbjct: 356 VSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELTDKNVKFIAELIDVLLVNL 415
Query: 421 IPGWKPCVRIDHLIPQKSRRQSPEDHEKDALSLERVDNSSGLSHRSYEADNHSRSSD 477
IP WK V +DHLI + + S ++H+ +G S ++ E+ +HS SSD
Sbjct: 416 IPNWKTDVAVDHLIHPQQNQSSKDNHQ------------NGASSQAGESISHSLSSD 460
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224131198|ref|XP_002328479.1| predicted protein [Populus trichocarpa] gi|222838194|gb|EEE76559.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 701 bits (1810), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/503 (71%), Positives = 411/503 (81%), Gaps = 5/503 (0%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKAFDEVNG+EVAW QVRID+VLQSP+DLERLYSE+HLLK+LK++NI+RFYNSWIDD+ K
Sbjct: 43 YKAFDEVNGIEVAWNQVRIDEVLQSPDDLERLYSEMHLLKTLKNSNIVRFYNSWIDDKKK 102
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
TVNIITELFTSGSLRQY KKH+K++MKAVKGWARQIL+GL YLH+HDPPIIHRDLKCDNI
Sbjct: 103 TVNIITELFTSGSLRQYCKKHRKIEMKAVKGWARQILNGLNYLHNHDPPIIHRDLKCDNI 162
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 204
FINGNQGEVKIGDLGLAT+MEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM
Sbjct: 163 FINGNQGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 222
Query: 205 VTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMD 264
VTFEYPYSECRNSAQIYKKVSSGIKPA+LSKVKDP++K FIEKCL+PAS+RL AKELLMD
Sbjct: 223 VTFEYPYSECRNSAQIYKKVSSGIKPASLSKVKDPDLKQFIEKCLLPASERLPAKELLMD 282
Query: 265 PFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITS 324
PFL VNG +N +P DI++ ++ A GDRCLMSEGPA+ RNK PSMD D E+P ITS
Sbjct: 283 PFLDVNGFARNSSIPRSDILMSKMTAIGDRCLMSEGPATARNKPPSMDLSHDPEMPTITS 342
Query: 325 LDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRIADQSG-RLRNIHFLFYL 383
+NS D++S +EVRR+KRGN FLL+GE NDE SVSLILR+ADQ+G R+RNIHFLFYL
Sbjct: 343 FNNSVDEDTHSLCLEVRRAKRGNVFLLRGEGNDENSVSLILRMADQNGARVRNIHFLFYL 402
Query: 384 DSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPGWKPCVRIDHLIPQKSRRQSP 443
D DTA SVSSEMVEQLEL +NV FIAELIDLLLL LIP WKP V I+HL+P SR Q+P
Sbjct: 403 DGDTALSVSSEMVEQLELEVENVKFIAELIDLLLLKLIPNWKPGVHIEHLVP-PSREQTP 461
Query: 444 EDHEKDALSLERVDNSSGLSHRSYEADNHSRSSDGQDSTSLKEGIQTTVLGPDFMKPDEK 503
KD SL + +++A NHSR S SL I T P +K D+
Sbjct: 462 RVQSKDFHSLGNGKMAVAPFQNAHDAANHSRCS--SRPNSLGGSIPTVGESPSTVKLDDL 519
Query: 504 RSH-NDFSCQGKATADDQTSEKS 525
S+ +DF Q A+D+ SE S
Sbjct: 520 MSNLDDFDSQNPPAAEDRHSEMS 542
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357464557|ref|XP_003602560.1| Protein kinase [Medicago truncatula] gi|355491608|gb|AES72811.1| Protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 700 bits (1807), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/643 (59%), Positives = 455/643 (70%), Gaps = 30/643 (4%)
Query: 13 YLRLIQLVDTSG----YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 68
YLR +++ YKAFDEV GLEVAW QVRID+VLQSP DLERLYSEVHLL+SLKH
Sbjct: 50 YLRYKEVIGKGAFKTVYKAFDEVTGLEVAWSQVRIDEVLQSPGDLERLYSEVHLLRSLKH 109
Query: 69 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 128
+NIIRFYNSWIDD++ VN+ITELFTSGSLRQYRKKHKKVD+KAVKGWARQIL GL+YLH
Sbjct: 110 SNIIRFYNSWIDDKHGNVNMITELFTSGSLRQYRKKHKKVDVKAVKGWARQILMGLVYLH 169
Query: 129 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENY 188
+H+PPIIHRD+KCDNIFING+QGEVKIGDLGLAT+++Q NAKSVIGTPEFMAPELYDE+Y
Sbjct: 170 NHNPPIIHRDVKCDNIFINGHQGEVKIGDLGLATLLKQNNAKSVIGTPEFMAPELYDEDY 229
Query: 189 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248
NELADIYSFGMCMLE+ T +YPY ECRNSAQIYKKVSSGIKP +LS +KDPE+KSFIEKC
Sbjct: 230 NELADIYSFGMCMLELATSQYPYRECRNSAQIYKKVSSGIKPVSLSTIKDPEIKSFIEKC 289
Query: 249 LVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKH 308
LVPASQRLSAKELLMDPFL+VN + KNRPLPLPDIVLP+ G F +RCLMSEGPAS R
Sbjct: 290 LVPASQRLSAKELLMDPFLEVNFSVKNRPLPLPDIVLPKFGGFENRCLMSEGPASARIGS 349
Query: 309 PSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRIA 368
SM+ E PVIT NS SP +E+RR + F LKGE+ND S+SL+LRI
Sbjct: 350 SSMELGDTNEQPVITVSYNSVDDAPPSPCVEIRRLMGVDRFFLKGEANDTNSISLVLRII 409
Query: 369 DQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPGWKPCV 428
DQ GR RNIHF+FYLDSDTA SVSSEMVEQLELA+ NV FIAELIDLLL LIP WKPCV
Sbjct: 410 DQGGRARNIHFIFYLDSDTAMSVSSEMVEQLELAEHNVKFIAELIDLLLTTLIPDWKPCV 469
Query: 429 RIDHLIPQKSRR----QSPEDHEKDALSLERVDNSSGLSHRSYEADNHSRSSDGQDSTSL 484
IDHLI RR Q + + +D+S + + +H R ++
Sbjct: 470 AIDHLISPNGRRTHMSQQKQLSQLAKYKQNSIDSSQIMREYVGPSTSHERLAE------- 522
Query: 485 KEGIQTTVLGPDFMKPDEKRSHNDFSCQGKATADDQTSEKSNVSASSSEQNEKKYCFSSD 544
KE I D M ++ SH Q DD S S SA +S+ N+K + S
Sbjct: 523 KENI-------DNMNFEDVFSHASIGLQRTTKTDDLYSMTSYTSA-TSDYNDKNFSTVSF 574
Query: 545 IFPEPGTMDFDGHAFVVRTSESPARMGLGETPDEKSNIMDICSNGVVDTSSGLTISSLSD 604
+ G DF+ S+S +G + D+KS + +N +S+ S
Sbjct: 575 MSARSGFTDFNFPTVNGWGSQSSLASEIGASYDKKSKFPCMENN-------NYPLSTSSF 627
Query: 605 LEIDEEIRMKLEMIDLQYQEEFKAISKRRHDAILDTKKSMKKK 647
E ++E+R++LE I+ QYQE K + KRRHDA+++T+K + +K
Sbjct: 628 HEAEDELRIELEKIERQYQEAMKDLCKRRHDAMMETRKRLSQK 670
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297834790|ref|XP_002885277.1| hypothetical protein ARALYDRAFT_318635 [Arabidopsis lyrata subsp. lyrata] gi|297331117|gb|EFH61536.1| hypothetical protein ARALYDRAFT_318635 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1800), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/454 (75%), Positives = 384/454 (84%), Gaps = 10/454 (2%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKAFDEV+G+EVAW QVRIDDVLQSP LERLYSEV LLKSLKHNNIIRFYNSWIDD+NK
Sbjct: 47 YKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNK 106
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
TVNIITELFTSGSLR YRKKH+KV+MKAVK WARQIL GL YLH +PPIIHRDLKCDNI
Sbjct: 107 TVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNI 166
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 204
FINGN GEVKIGDLGLAT+MEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM
Sbjct: 167 FINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 226
Query: 205 VTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMD 264
VTFEYPY EC+NSAQIYKKVSSGIKPA+LS+VKDPEVK FIEKCL+PAS+RLSAKELL+D
Sbjct: 227 VTFEYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLD 286
Query: 265 PFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVR-NKHPSMDFDSDAELPVIT 323
PFLQ+NG T N PLPLPDIV+P+ GAFGDRCLMSEGP + R +K S+D D D+ LP++T
Sbjct: 287 PFLQLNGLTMNNPLPLPDIVMPKEGAFGDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVT 346
Query: 324 SLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYL 383
DNSG S IEVRR+KRGNFF+LKGE NDE SVSLILRI D++GR+RNIHFLFY
Sbjct: 347 FSDNSG-----SRCIEVRRAKRGNFFVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQ 401
Query: 384 DSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPGWKPCVRIDHLIPQKSRRQSP 443
+ DTA VSSEMVEQLEL DQNVTFIAELID+LL+N+IP WK V +DHLI Q+
Sbjct: 402 EGDTASKVSSEMVEQLELTDQNVTFIAELIDILLVNMIPTWKTDVTVDHLI-HSQLNQNS 460
Query: 444 EDHEKDALSLERVDNSSGLSHRSYEADNHSRSSD 477
H +A ++ + + H + E+ +HS +SD
Sbjct: 461 RSHHNEAKPQKQEETT---FHDACESVSHSWNSD 491
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15230184|ref|NP_188505.1| putative serine/threonine-protein kinase WNK6 [Arabidopsis thaliana] gi|334185446|ref|NP_001189928.1| putative serine/threonine-protein kinase WNK6 [Arabidopsis thaliana] gi|75248034|sp|Q8S8Y8.1|WNK6_ARATH RecName: Full=Probable serine/threonine-protein kinase WNK6; Short=AtWNK6; AltName: Full=Protein kinase with no lysine 6 gi|20302604|dbj|BAB91129.1| Ser/Thr kinase [Arabidopsis thaliana] gi|51970136|dbj|BAD43760.1| putative mitogen activated protein kinase kinase [Arabidopsis thaliana] gi|133778828|gb|ABO38754.1| At3g18750 [Arabidopsis thaliana] gi|332642618|gb|AEE76139.1| putative serine/threonine-protein kinase WNK6 [Arabidopsis thaliana] gi|332642620|gb|AEE76141.1| putative serine/threonine-protein kinase WNK6 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 696 bits (1797), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/496 (70%), Positives = 398/496 (80%), Gaps = 22/496 (4%)
Query: 13 YLRLIQLVDTSG----YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 68
Y+R +++ YKAFDEV+G+EVAW QVRIDDVLQSP LERLYSEV LLKSLKH
Sbjct: 27 YIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEVRLLKSLKH 86
Query: 69 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 128
NNIIRFYNSWIDD+NKTVNIITELFTSGSLR YRKKH+KV+MKAVK WARQIL GL YLH
Sbjct: 87 NNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLH 146
Query: 129 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENY 188
+PPIIHRDLKCDNIFINGN GEVKIGDLGLAT+MEQANAKSVIGTPEFMAPELYDENY
Sbjct: 147 GQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENY 206
Query: 189 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248
NELADIYSFGMCMLEMVTF+YPY EC+NSAQIYKKVSSGIKPA+LS+VKDPEVK FIEKC
Sbjct: 207 NELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKC 266
Query: 249 LVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVR-NK 307
L+PAS+RLSAKELL+DPFLQ+NG T N PLPLPDIV+P+ GAFGDRCLMSEGP + R +K
Sbjct: 267 LLPASERLSAKELLLDPFLQLNGLTMNNPLPLPDIVMPKEGAFGDRCLMSEGPPTTRPSK 326
Query: 308 HPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRI 367
S+D D D+ LP++T DNSG S IEVRR+KRGNFF+LKGE NDE SVSLILRI
Sbjct: 327 TLSIDLDEDSNLPIVTFSDNSG-----SRCIEVRRAKRGNFFVLKGEENDEQSVSLILRI 381
Query: 368 ADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPGWKPC 427
D++GR+RNIHFLFY + DTA VSSEMVEQLEL DQNVTFIAELID+LL+N+IP WK
Sbjct: 382 VDENGRVRNIHFLFYQEGDTASKVSSEMVEQLELTDQNVTFIAELIDILLVNMIPTWKTD 441
Query: 428 VRIDHLIPQKSRRQSPEDHE--KDALSLERV--DNSSGLSH-------RSYEADNHS-RS 475
V +DHLI + + S H K E V D +SH RS E D +
Sbjct: 442 VTVDHLIHSQLNQNSRSHHNEAKPQKQEETVFHDTCELVSHSCNSDCPRSDEEDKQCVDA 501
Query: 476 SDGQDSTSLKEGIQTT 491
+ G+D +S++E + T
Sbjct: 502 TKGEDKSSIQEVEEAT 517
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357519861|ref|XP_003630219.1| Protein kinase [Medicago truncatula] gi|355524241|gb|AET04695.1| Protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 696 bits (1797), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/636 (58%), Positives = 450/636 (70%), Gaps = 60/636 (9%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y+AFDEVNG+EVAW QV+ID+VLQSP+DL+RLYSE+HLLKSL+HNNI+RFYNSWIDD+ +
Sbjct: 85 YRAFDEVNGIEVAWGQVQIDEVLQSPDDLDRLYSEMHLLKSLRHNNIVRFYNSWIDDKRR 144
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
TVN+ITELFTSGSL+QYRKKHKKVD+KAV+GWA+QIL GL YLH+H+PPIIHRDLKCDNI
Sbjct: 145 TVNMITELFTSGSLKQYRKKHKKVDLKAVRGWAKQILMGLNYLHTHNPPIIHRDLKCDNI 204
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 204
FING+QGEVKIGDLGLAT + QANAK+VIGTPEFMAPE+YDENYNELADIYSFGMCMLE+
Sbjct: 205 FINGHQGEVKIGDLGLATFLMQANAKTVIGTPEFMAPEMYDENYNELADIYSFGMCMLEL 264
Query: 205 VTFEYPYSECRNSAQIYKK------------VSSGIKPAALSKVKDPEVKSFIEKCLVPA 252
VT EYPYSECRNSAQIYKK + GIKPAALSKV DP++KSFIEKC+VPA
Sbjct: 265 VTAEYPYSECRNSAQIYKKDITGLHGHSQYIILQGIKPAALSKVIDPKIKSFIEKCIVPA 324
Query: 253 SQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKHPSMD 312
S+RLSAKELLMDPF+QVNG+TKN LPLPDIVLP++GA +RC+MSEGPAS R SMD
Sbjct: 325 SERLSAKELLMDPFVQVNGSTKNISLPLPDIVLPKLGASKNRCMMSEGPASARIGAISMD 384
Query: 313 FDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRIADQSG 372
ELPVIT LDNS S S +E+RR K G+ F LKG NDE SVSL+LRIADQ G
Sbjct: 385 IGDTNELPVITVLDNSTVDASSSACVEIRRLKGGDTFFLKGGLNDENSVSLVLRIADQRG 444
Query: 373 RLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPGWKPCVRIDH 432
+ + IHF+FYLDSDTA SVS EMVEQLELADQNV FIAELIDLLL+ L+P WKPCV IDH
Sbjct: 445 QAKYIHFIFYLDSDTAVSVSKEMVEQLELADQNVKFIAELIDLLLIKLVPEWKPCVAIDH 504
Query: 433 LIPQKSRRQSPEDHEKDALSLERVDNSSGLSHRSYEADNHSRSSDGQDSTSLKEGIQTTV 492
L+ + S L+ ++G S + Y D +S G+ +S KE +
Sbjct: 505 LVSANDKWTSASQQTDSELA-----KNNG-SSKHYTEDAGPSTSFGR--SSAKENVDNM- 555
Query: 493 LGPDFMKPDEKRSHNDFSCQGKATADDQTSEKSNVSASSSEQNEKKYCFSSDIFPEPGTM 552
D SE S SA +S+ N+K S F +
Sbjct: 556 --------------------------DLYSEMSYASA-TSDINDKLSMVS---FMSAELL 585
Query: 553 DFDGHAFVVRTSESPARMGLGETPDEKSNIMDICSNGVVDTSS-GLTISSLSDLEIDEEI 611
F G + SE +G + D S + SN + SS +++SSLS D+E+
Sbjct: 586 GFGGGSRSSFASE------IGASSDHVSKFLHTGSNSMASLSSYPISVSSLS--YPDDEL 637
Query: 612 RMKLEMIDLQYQEEFKAISKRRHDAILDTKKSMKKK 647
R++LEMI+ +Y+E + +SKRR+ AI + KK M K
Sbjct: 638 RVELEMIEQKYEEAIRDLSKRRNLAIEEIKKRMSDK 673
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|9293898|dbj|BAB01801.1| MAP (mitogen activated protein) kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 695 bits (1794), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/480 (72%), Positives = 392/480 (81%), Gaps = 18/480 (3%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKAFDEV+G+EVAW QVRIDDVLQSP LERLYSEV LLKSLKHNNIIRFYNSWIDD+NK
Sbjct: 47 YKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNK 106
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
TVNIITELFTSGSLR YRKKH+KV+MKAVK WARQIL GL YLH +PPIIHRDLKCDNI
Sbjct: 107 TVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNI 166
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 204
FINGN GEVKIGDLGLAT+MEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM
Sbjct: 167 FINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 226
Query: 205 VTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMD 264
VTF+YPY EC+NSAQIYKKVSSGIKPA+LS+VKDPEVK FIEKCL+PAS+RLSAKELL+D
Sbjct: 227 VTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLD 286
Query: 265 PFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVR-NKHPSMDFDSDAELPVIT 323
PFLQ+NG T N PLPLPDIV+P+ GAFGDRCLMSEGP + R +K S+D D D+ LP++T
Sbjct: 287 PFLQLNGLTMNNPLPLPDIVMPKEGAFGDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVT 346
Query: 324 SLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYL 383
DNSG S IEVRR+KRGNFF+LKGE NDE SVSLILRI D++GR+RNIHFLFY
Sbjct: 347 FSDNSG-----SRCIEVRRAKRGNFFVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQ 401
Query: 384 DSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPGWKPCVRIDHLIPQKSRRQSP 443
+ DTA VSSEMVEQLEL DQNVTFIAELID+LL+N+IP WK V +DHLI + + S
Sbjct: 402 EGDTASKVSSEMVEQLELTDQNVTFIAELIDILLVNMIPTWKTDVTVDHLIHSQLNQNSR 461
Query: 444 EDHE--KDALSLERV--DNSSGLSH-------RSYEADNHS-RSSDGQDSTSLKEGIQTT 491
H K E V D +SH RS E D ++ G+D +S++E + T
Sbjct: 462 SHHNEAKPQKQEETVFHDTCELVSHSCNSDCPRSDEEDKQCVDATKGEDKSSIQEVEEAT 521
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 652 | ||||||
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.680 | 0.783 | 0.713 | 7.4e-176 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.687 | 0.804 | 0.692 | 4.7e-172 | |
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.378 | 0.438 | 0.704 | 1.7e-121 | |
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.401 | 0.374 | 0.661 | 1.7e-113 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.374 | 0.472 | 0.706 | 1.5e-110 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.575 | 0.715 | 0.550 | 1.9e-108 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.601 | 0.796 | 0.498 | 2e-97 | |
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.411 | 0.488 | 0.605 | 3e-95 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.372 | 0.425 | 0.651 | 7e-92 | |
| TAIR|locus:2176135 | 314 | AT5G55560 [Arabidopsis thalian | 0.371 | 0.770 | 0.588 | 3.5e-75 |
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1631 (579.2 bits), Expect = 7.4e-176, Sum P(2) = 7.4e-176
Identities = 324/454 (71%), Positives = 361/454 (79%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKAFDEV+G+EVAW QVRIDDVLQSP LERLYSEV LLKSLKHNNIIRFYNSWIDD+NK
Sbjct: 43 YKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNK 102
Query: 85 TVNIITELFTSGSLRQYRXXXXXXXXXXXXGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
TVNIITELFTSGSLR YR WARQIL GL YLH +PPIIHRDLKCDNI
Sbjct: 103 TVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNI 162
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 204
FINGN GEVKIGDLGLAT+MEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM
Sbjct: 163 FINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 222
Query: 205 VTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMD 264
VTF+YPY EC+NSAQIYKKVSSGIKPA+LS+VKDPEVK FIEKCL+PAS+RLSAKELL+D
Sbjct: 223 VTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLD 282
Query: 265 PFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVR-NKHPSMDFDSDAELPVIT 323
PFLQ+NG T N PLPLPDIV+P+ GAFGDRCLMSEGP + R +K S+D D D+ LP++T
Sbjct: 283 PFLQLNGLTMNNPLPLPDIVMPKEGAFGDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVT 342
Query: 324 SLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYL 383
DNSG S IEVRR+KRGNFF+LKGE NDE SVSLILRI D++GR+RNIHFLFY
Sbjct: 343 FSDNSG-----SRCIEVRRAKRGNFFVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQ 397
Query: 384 DSDTAFSVSSEMVEQLELADQNVTFIAEXXXXXXXXXXPGWKPCVRIDHLIPQKSRRQSP 443
+ DTA VSSEMVEQLEL DQNVTFIAE P WK V +DHLI Q+
Sbjct: 398 EGDTASKVSSEMVEQLELTDQNVTFIAELIDILLVNMIPTWKTDVTVDHLI-HSQLNQNS 456
Query: 444 EDHEKDALSLERVDNSSGLSHRSYEADNHSRSSD 477
H +A ++ + + H + E +HS +SD
Sbjct: 457 RSHHNEAKPQKQEET---VFHDTCELVSHSCNSD 487
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1602 (569.0 bits), Expect = 4.7e-172, Sum P(2) = 4.7e-172
Identities = 317/458 (69%), Positives = 360/458 (78%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+K FDEV+G+EVAW QVRIDD+LQSP+ LERLYSEV LLKSLKH NIIRFYNSWIDD+NK
Sbjct: 43 FKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNK 102
Query: 85 TVNIITELFTSGSLRQYRXXXXXXXXXXXXGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
TVNIITELFTSGSLRQYR WARQIL+GL YLHS DPPIIHRD+KCDNI
Sbjct: 103 TVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNI 162
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 204
FINGN GEVKIGDLGLAT+MEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM
Sbjct: 163 FINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 222
Query: 205 VTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMD 264
VTFEYPY ECRNSAQIYKKVSSGIKPA+LSKVKDPEV FIEKCL+PAS+RLSA+ELL+D
Sbjct: 223 VTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLD 282
Query: 265 PFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITS 324
FL VNG N PLPLPDIV+P+ G+FG+RCLMSEGP + RN+ SM+ D D LP++ S
Sbjct: 283 SFLNVNGLVMNNPLPLPDIVMPKEGSFGERCLMSEGPPNARNRTMSMNLDEDNNLPIVIS 342
Query: 325 LDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLD 384
+NSG + IEVRR+KRGNFF+LKGE NDE SVSLILRI D++GR+RNIHFLF+ +
Sbjct: 343 SNNSG-----TNCIEVRRAKRGNFFVLKGEENDENSVSLILRIVDENGRVRNIHFLFFQE 397
Query: 385 SDTAFSVSSEMVEQLELADQNVTFIAEXXXXXXXXXXPGWKPCVRIDHLIPQKSRRQSPE 444
DTA +VSSEMVEQLEL D+NV FIAE P WK V +DHLI + + S +
Sbjct: 398 GDTASNVSSEMVEQLELTDKNVKFIAELIDVLLVNLIPNWKTDVAVDHLIHPQQNQSSKD 457
Query: 445 DHEKDALSLERVDNSSGLSHRSYEADNHSRSSDGQDST 482
+H+ A S +SH S +D RS D + T
Sbjct: 458 NHQNGASS----QAGESISH-SLSSDYCPRSDDEANPT 490
|
|
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 933 (333.5 bits), Expect = 1.7e-121, Sum P(3) = 1.7e-121
Identities = 174/247 (70%), Positives = 202/247 (81%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKAFDEV+G+EVAW V I+DV+Q P LERLYSEVHLLK+LKH NII+ + SW+D++NK
Sbjct: 44 YKAFDEVDGIEVAWNLVSIEDVMQMPGQLERLYSEVHLLKALKHENIIKLFYSWVDEKNK 103
Query: 85 TVNIITELFTSGSLRQYRXXXXXXXXXXXXGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
T+N+ITELFTSGSLR YR WARQIL GL YLHS +PP+IHRDLKCDNI
Sbjct: 104 TINMITELFTSGSLRVYRKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNI 163
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 204
F+NGN GEVKIGDLGLAT+++Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMCMLEM
Sbjct: 164 FVNGNTGEVKIGDLGLATVLQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEM 223
Query: 205 VTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMD 264
VT EYPY+ECRN AQIYKKV+S IKP +L KV DP+V+ FIEKCL+PAS R +A EL D
Sbjct: 224 VTCEYPYNECRNQAQIYKKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKD 283
Query: 265 PFLQVNG 271
PFL +G
Sbjct: 284 PFLARDG 290
|
|
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 929 (332.1 bits), Expect = 1.7e-113, Sum P(3) = 1.7e-113
Identities = 174/263 (66%), Positives = 206/263 (78%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y+AFDE G+EVAW QV++ D LQSPEDLERLY E+HLLK+LKH NI++FY SW+D N+
Sbjct: 39 YRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98
Query: 85 TVNIITELFTSGSLRQYRXXXXXXXXXXXXGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+N +TELFTSG+LRQYR W RQIL GL YLHSHDPP+IHRDLKCDNI
Sbjct: 99 NINFVTELFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNI 158
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 204
F+NGNQGEVKIGDLGLA I+ +++A +GTPEFMAPE+Y+E YNEL DIYSFGMC+LEM
Sbjct: 159 FVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEM 218
Query: 205 VTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMD 264
VTF+YPYSEC + AQIYKKV SG KP AL KVKDPEVK FIEKCL S R+SA+ELL D
Sbjct: 219 VTFDYPYSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDD 278
Query: 265 PFLQVN-GTTKNRPLPLPDIVLP 286
PFL+++ G R + + D V P
Sbjct: 279 PFLRIDDGEFDLRSVDMEDSVGP 301
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 936 (334.5 bits), Expect = 1.5e-110, Sum P(2) = 1.5e-110
Identities = 173/245 (70%), Positives = 207/245 (84%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y+AFD++ G+EVAW QV++DD S EDL+RLYSEVHLLK+LKH +II+FY SWID Q+
Sbjct: 37 YRAFDQLEGIEVAWNQVKLDDKFCSSEDLDRLYSEVHLLKTLKHKSIIKFYTSWIDHQHM 96
Query: 85 TVNIITELFTSGSLRQYRXXXXXXXXXXXXGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
T+N+ITE+FTSG+LRQYR W+RQIL GL+YLHSHDPP+IHRDLKCDNI
Sbjct: 97 TINLITEVFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNI 156
Query: 145 FINGNQGEVKIGDLGLATIMEQA-NAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLE 203
FINGNQGEVKIGDLGLA I+ +A +A SVIGTPEFMAPELY+E+YN L DIY+FGMC+LE
Sbjct: 157 FINGNQGEVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLE 216
Query: 204 MVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLM 263
+VTFEYPYSEC N+AQIY+KV+SGIKPAAL V DP+V++FIEKC+ SQRLSAKELL
Sbjct: 217 LVTFEYPYSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCIAKVSQRLSAKELLD 276
Query: 264 DPFLQ 268
DPFL+
Sbjct: 277 DPFLK 281
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1037 (370.1 bits), Expect = 1.9e-108, Sum P(2) = 1.9e-108
Identities = 213/387 (55%), Positives = 263/387 (67%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKAFDEV G+EVAW + I+DVLQ P L+RLYSEVHLL SLKH+NII+ + SW+DD NK
Sbjct: 31 YKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRLYSEVHLLNSLKHDNIIKLFYSWVDDHNK 90
Query: 85 TVNIITELFTSGSLRQYRXXXXXXXXXXXXGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
++N+ITELFTSGSL YR WARQIL GL YLHS PP+IHRDLKCDNI
Sbjct: 91 SINMITELFTSGSLTLYRKKHRKVDPKAIMNWARQILKGLHYLHSQTPPVIHRDLKCDNI 150
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 204
F+NGN G+VKIGDLGLA +M+Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMCMLEM
Sbjct: 151 FVNGNTGKVKIGDLGLAAVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEM 210
Query: 205 VTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMD 264
VT EYPY ECRN AQIYKKV+SGIKP +LSKV DP+VK FIEKCL+PA R +A ELL D
Sbjct: 211 VTCEYPYRECRNQAQIYKKVTSGIKPQSLSKVDDPQVKQFIEKCLLPAPSRPTALELLKD 270
Query: 265 PFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITS 324
L V+G K+ L A + P + +++ + + + +S
Sbjct: 271 QLLAVDGA-KDSTLT----------ASSNTTFKPAMPPQCEYRPMDVEYKKNTSVSICSS 319
Query: 325 LDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLD 384
+S + ++EV+R F L GE D+ + S+ LRIA SG+ R + F F L
Sbjct: 320 AKSSQEC-ALLQTMEVQRVAESTEFKLSGERRDDVAASMALRIAGSSGQARKVDFDFNLK 378
Query: 385 SDTAFSVSSEMVEQLELADQNVTFIAE 411
+DTA +V+ EMVE+L+L+ VT IAE
Sbjct: 379 TDTARAVTGEMVEELDLSSHEVTVIAE 405
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 968 (345.8 bits), Expect = 2.0e-97, P = 2.0e-97
Identities = 204/409 (49%), Positives = 265/409 (64%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y+ FDE G+EVAW QV++ D LQSP++LERLY E+HLLK+LKH +I++FY SW+D N+
Sbjct: 40 YRGFDEYQGIEVAWNQVKLYDFLQSPQELERLYCEIHLLKTLKHKSIMKFYASWVDTDNR 99
Query: 85 TVNIITELFTSGSLRQYRXXXXXXXXXXXXGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+N +TE+FTSG+LRQYR W RQIL GL YLH+HDPP+IHRDLKCDNI
Sbjct: 100 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNI 159
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 204
FINGNQGEVKIGDLGLA ++ ++A +GTPEFMAPE+Y E YN+L DIYSFGMC+LEM
Sbjct: 160 FINGNQGEVKIGDLGLAACLQHSHAAHCVGTPEFMAPEVYKEEYNQLVDIYSFGMCVLEM 219
Query: 205 VTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMD 264
VTF+YPYSEC + AQIYK+V SG KP L KVKDPEV+ FIEKCL S RLSA ELL D
Sbjct: 220 VTFDYPYSECSHPAQIYKRVISGKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDD 279
Query: 265 PFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCL----MSEGPASVRNKHPSMDFDSD--AE 318
FL ++ + R + ++ G S G S+ N++ D++ D E
Sbjct: 280 HFLCIDESDMRR-VESEKGLIDEAGTPLRHSYHIPHYSNGYYSLYNQN-QWDYNGDETVE 337
Query: 319 LPVITSLDNSGGGDSYSPSIEVRRSKR-GNFFL-LKGESNDEYS-VSLILRIADQSGRLR 375
I L+ D E KR G+ + +KG+ D + L L+ ++ G +R
Sbjct: 338 SHEIDLLEFQNDDD------EEEEDKRFGSVDISIKGKRRDNGDGLFLRLKTVNKEGCVR 391
Query: 376 NIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAEXXXXXXXXXXPGW 424
NI+F F +++DTA SV+ EMVE+LE+ D++VT IA P W
Sbjct: 392 NIYFPFDIETDTAISVAREMVEELEMDDRDVTKIANMIDGEIASLVPNW 440
|
|
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 841 (301.1 bits), Expect = 3.0e-95, Sum P(2) = 3.0e-95
Identities = 164/271 (60%), Positives = 199/271 (73%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKAFD+V G+EVAW QV++++V +SPE L+RLYSEVHLLK+L H +IIR+ SWID +
Sbjct: 40 YKAFDQVLGMEVAWNQVKLNEVFRSPEPLQRLYSEVHLLKNLNHESIIRYCTSWIDVNRR 99
Query: 85 TVNIITELFTSGSLRQYRXXXXXXXXXXXXGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
T N ITELFTSG+LR+YR WARQIL+GL YLH HDPP+IHRDLKCDNI
Sbjct: 100 TFNFITELFTSGTLREYRRKYQKVDIRAIKSWARQILNGLAYLHGHDPPVIHRDLKCDNI 159
Query: 145 FINGNQGEVKIGDLGLATIMEQA-NAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLE 203
F+NG+ G+VKIGDLGLA I+ + NA SVIGTPEFMAPELY+E+YNEL DIYSFGMC+LE
Sbjct: 160 FVNGHLGQVKIGDLGLAAILRGSQNAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLE 219
Query: 204 MVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLM 263
M+T EYPYSEC N AQIYKKV+SG P + ++ E + F+ KCL S+RL AKELL
Sbjct: 220 MLTGEYPYSECTNPAQIYKKVTSGKLPDSFHLIQHTEAQRFVGKCLETVSRRLPAKELLA 279
Query: 264 DPFLQVNGTTKNRPL-PLPD-IVLPRVGAFG 292
DPFL PL LP + + + A G
Sbjct: 280 DPFLAATDERDLAPLFRLPQQLAIQNLAANG 310
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 845 (302.5 bits), Expect = 7.0e-92, Sum P(2) = 7.0e-92
Identities = 159/244 (65%), Positives = 188/244 (77%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKA DE G+EVAW QV++ +VL+S DL+RLYSEVHLL +L H +IIRFY SWID N
Sbjct: 34 YKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLYSEVHLLSTLNHKSIIRFYTSWIDVHNH 93
Query: 85 TVNIITELFTSGSLRQYRXXXXXXXXXXXXGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
T+N ITELFTSG+LRQY+ WARQIL GL+YLH HDPP+IHRDLKCDNI
Sbjct: 94 TLNFITELFTSGTLRQYKNKYLRIDIRAIKSWARQILEGLVYLHEHDPPVIHRDLKCDNI 153
Query: 145 FINGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLE 203
F+NG+ G+VKIGDLGLA ++ + A S+IGTPEFMAPELY+ENYNEL D+YSFGMC LE
Sbjct: 154 FVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTPEFMAPELYEENYNELIDVYSFGMCFLE 213
Query: 204 MVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLM 263
M+T E+PYSEC + AQIYKKV G P A +V D E + FI KCLV AS+R+SAKELL
Sbjct: 214 MITSEFPYSECNHPAQIYKKVVGGKLPGAFYRVGDIEAQRFIGKCLVSASKRVSAKELLQ 273
Query: 264 DPFL 267
DPFL
Sbjct: 274 DPFL 277
|
|
| TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 758 (271.9 bits), Expect = 3.5e-75, P = 3.5e-75
Identities = 143/243 (58%), Positives = 180/243 (74%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y+AFD+ G+EVAW QV++ P ERLYSEV LLK+LK++NII Y W D++N
Sbjct: 46 YRAFDQEEGIEVAWNQVKLRCFSDDPAMTERLYSEVRLLKNLKNSNIITLYKVWRDERNN 105
Query: 85 TVNIITELFTSGSLRQYRXXXXXXXXXXXXGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
T+N ITE+ TSG+LR+YR W++QIL GL YLH+HDP IIHRDL C NI
Sbjct: 106 TLNFITEICTSGNLREYRKKHRHVSMRALKKWSKQILKGLDYLHTHDPCIIHRDLNCSNI 165
Query: 145 FINGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLE 203
F+NGN G+VKIGDLGLA I+ + + A S++GTPEFMAPELY+ENY E+ DIYS+GMC+LE
Sbjct: 166 FVNGNIGQVKIGDLGLAAIVGKNHLAHSILGTPEFMAPELYEENYTEMVDIYSYGMCVLE 225
Query: 204 MVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLM 263
+V+ E PYSEC + A+IYK+VS G+KP AL+KV DPE K+FIEKC+ R SA ELL
Sbjct: 226 LVSLEIPYSECDSVAKIYKRVSKGLKPEALNKVNDPEAKAFIEKCIAQPRARPSAAELLC 285
Query: 264 DPF 266
DPF
Sbjct: 286 DPF 288
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8LST2 | WNK7_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7142 | 0.6871 | 0.8043 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 652 | |||
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-68 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-62 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-48 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-48 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-47 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-47 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-43 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-43 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-41 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-40 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-39 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-37 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-37 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-36 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-35 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-34 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-33 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-33 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-32 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-29 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-28 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-28 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-27 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-27 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-26 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-23 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-23 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-23 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-22 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-18 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-17 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 0.003 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.003 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 6e-68
Identities = 95/249 (38%), Positives = 134/249 (53%), Gaps = 11/249 (4%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y A D+ G +A V + S E+LE L E+ +L SL+H NI+R+Y S D++
Sbjct: 17 YLALDKDTGELMAVKSVELSG--DSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
T+NI E + GSL KK K+ ++ + RQIL GL YLHS+ I+HRD+K NI
Sbjct: 75 TLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANI 132
Query: 145 FINGNQGEVKIGDLGLATIMEQANA----KSVIGTPEFMAPELY-DENYNELADIYSFGM 199
++ + G VK+ D G A + SV GTP +MAPE+ E Y ADI+S G
Sbjct: 133 LVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGC 191
Query: 200 CMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSA 258
++EM T + P+SE N K+ S +P + + E K F+ KCL +R +A
Sbjct: 192 TVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTA 251
Query: 259 KELLMDPFL 267
ELL PFL
Sbjct: 252 DELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 206 bits (528), Expect = 3e-62
Identities = 82/247 (33%), Positives = 128/247 (51%), Gaps = 12/247 (4%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y A D+ G VA ++ + + E + R E+ +LK LKH NI+R Y+ + D+
Sbjct: 16 YLARDKKTGKLVAIKVIKKKKIKKDRERILR---EIKILKKLKHPNIVRLYDVFEDEDK- 71
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ ++ E G L KK ++ + + RQILS L YLHS I+HRDLK +NI
Sbjct: 72 -LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG--IVHRDLKPENI 128
Query: 145 FINGNQGEVKIGDLGLATIM-EQANAKSVIGTPEFMAPELYDEN-YNELADIYSFGMCML 202
++ + G VK+ D GLA + + +GTPE+MAPE+ Y + DI+S G+ +
Sbjct: 129 LLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILY 187
Query: 203 EMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK-DPEVKSFIEKCLVP-ASQRLSAKE 260
E++T + P+ +++KK+ P + PE K I K LV +RL+A+E
Sbjct: 188 ELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEE 247
Query: 261 LLMDPFL 267
L PF
Sbjct: 248 ALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 6e-54
Identities = 77/252 (30%), Positives = 125/252 (49%), Gaps = 16/252 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKA + G VA ++ + + + E+ +L+ L H NI+R +++ D +
Sbjct: 16 YKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDH- 72
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ ++ E G L Y + + K A QIL GL YLHS+ IIHRDLK +NI
Sbjct: 73 -LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG--IIHRDLKPENI 129
Query: 145 FINGNQGEVKIGDLGLATIME--QANAKSVIGTPEFMAPE--LYDENYNELADIYSFGMC 200
++ N G VKI D GLA + ++ + +GTP +MAPE L Y D++S G+
Sbjct: 130 LLDEN-GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVI 188
Query: 201 MLEMVTFEYPYSEC--RNSAQIYKKVSSGIKPAALSKV--KDPEVKSFIEKCLVP-ASQR 255
+ E++T + P+S + Q+ +++ K E K I+KCL S+R
Sbjct: 189 LYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKR 248
Query: 256 LSAKELLMDPFL 267
+A+E+L P+
Sbjct: 249 PTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 2e-51
Identities = 76/244 (31%), Positives = 120/244 (49%), Gaps = 47/244 (19%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y A D+ G +VA ++ +D S LE L E+ +LK L H NI++ Y + D+ +
Sbjct: 10 YLARDKKTGKKVAIKIIKKED---SSSLLEELLREIEILKKLNHPNIVKLYGVFEDENH- 65
Query: 85 TVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ ++ E GSL+ ++ K+ + QIL GL YLHS+ IIHRDLK +N
Sbjct: 66 -LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN--GIIHRDLKPEN 122
Query: 144 IFINGNQGEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPELYDEN--YNELADIYSFGM 199
I ++ + G+VK+ D GL+ ++ K+++GTP +MAPE+ Y+E +DI+S G+
Sbjct: 123 ILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGV 182
Query: 200 CMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSA 258
+ E+ PE+K I K L +R SA
Sbjct: 183 ILYEL----------------------------------PELKDLIRKMLQKDPEKRPSA 208
Query: 259 KELL 262
KE+L
Sbjct: 209 KEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 3e-48
Identities = 82/247 (33%), Positives = 139/247 (56%), Gaps = 15/247 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKA + G EVA +++ L+S E E++ +E+ +LK KH NI+++Y S++
Sbjct: 17 YKARHKRTGKEVA---IKVIK-LESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK--KD 70
Query: 85 TVNIITELFTSGSLRQ-YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ I+ E + GSL+ + ++ + + +++L GL YLHS+ IIHRD+K N
Sbjct: 71 ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAAN 128
Query: 144 IFINGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LYDENYNELADIYSFGMCM 201
I + + GEVK+ D GL+ + A +++GTP +MAPE + + Y+ ADI+S G+
Sbjct: 129 ILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITA 187
Query: 202 LEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK-DPEVKSFIEKCLVPA-SQRLSAK 259
+E+ + PYSE ++K ++G P + K E K F++KCL +R +A+
Sbjct: 188 IELAEGKPPYSELPPMKALFKIATNGP-PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAE 246
Query: 260 ELLMDPF 266
+LL PF
Sbjct: 247 QLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 6e-48
Identities = 89/251 (35%), Positives = 134/251 (53%), Gaps = 17/251 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRI-DDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
Y+ + +G A +V + DD E +++L E+ LL L+H NI+++ + ++ N
Sbjct: 17 YEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN 76
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ I EL GSL + KK+ ++ + RQIL GL YLH + +HRD+K N
Sbjct: 77 --LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGAN 132
Query: 144 IFINGNQGEVKIGDLGLAT-IMEQANAKSVIGTPEFMAPELYDE--NYNELADIYSFGMC 200
I ++ N G VK+ D G+A ++E + AKS G+P +MAPE+ + Y ADI+S G
Sbjct: 133 ILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCT 191
Query: 201 MLEMVTFEYPYSECRNSAQIYKKVSSGIKPA---ALSKVKDPEVKSFIEKCL-VPASQRL 256
+LEM T + P+S+ A ++K S P LS E K FI KCL S R
Sbjct: 192 VLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLS----DEAKDFILKCLQRDPSLRP 247
Query: 257 SAKELLMDPFL 267
+A ELL PF+
Sbjct: 248 TAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 5e-47
Identities = 88/253 (34%), Positives = 134/253 (52%), Gaps = 23/253 (9%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKA D G EVA ++R+ ++ E + +E+ ++K KH NI+ +Y+S++
Sbjct: 36 YKATDRATGKEVAIKKMRLRK-----QNKELIINEILIMKDCKHPNIVDYYDSYLVG--D 88
Query: 85 TVNIITELFTSGSL----RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 140
+ ++ E GSL Q + + + V R++L GL YLHS +IHRD+K
Sbjct: 89 ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV---CREVLQGLEYLHSQ--NVIHRDIK 143
Query: 141 CDNIFINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPELY-DENYNELADIYSF 197
DNI ++ G VK+ D G A + E++ SV+GTP +MAPE+ ++Y DI+S
Sbjct: 144 SDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSL 202
Query: 198 G-MCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQR 255
G MC+ EM E PY ++ + GI P + PE K F+ KCLV +R
Sbjct: 203 GIMCI-EMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKR 261
Query: 256 LSAKELLMDPFLQ 268
SA+ELL PFL+
Sbjct: 262 PSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 7e-47
Identities = 75/251 (29%), Positives = 129/251 (51%), Gaps = 17/251 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y + +G ++ + + S ++ E +EV +LK L H NII++Y S+ +
Sbjct: 17 YLVRRKSDGKLYVLKEIDLSN--MSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KG 72
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDM----KAVKGWARQILSGLIYLHSHDPPIIHRDLK 140
+ I+ E G L Q KK KK + + W Q+ L YLHS I+HRD+K
Sbjct: 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIK 130
Query: 141 CDNIFINGNQGEVKIGDLGLATIME--QANAKSVIGTPEFMAPELY-DENYNELADIYSF 197
NIF+ N G VK+GD G++ ++ AK+V+GTP +++PEL ++ YN +DI+S
Sbjct: 131 PQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSL 189
Query: 198 GMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRL 256
G + E+ T ++P+ E N ++ K+ G + + E+++ + L +R
Sbjct: 190 GCVLYELCTLKHPF-EGENLLELALKILKG-QYPPIPSQYSSELRNLVSSLLQKDPEERP 247
Query: 257 SAKELLMDPFL 267
S ++L PF+
Sbjct: 248 SIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-43
Identities = 77/250 (30%), Positives = 127/250 (50%), Gaps = 13/250 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YK + G A ++ V E ++L E+ L+S + +++ Y ++
Sbjct: 18 YKVRHKPTGKIYA---LKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK--EG 72
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
++I+ E GSL KK K+ + ARQIL GL YLH IIHRD+K N+
Sbjct: 73 EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH-TKRHIIHRDIKPSNL 131
Query: 145 FINGNQGEVKIGDLGLATIMEQ--ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCM 201
IN ++GEVKI D G++ ++E + +GT +M+PE E+Y+ ADI+S G+ +
Sbjct: 132 LIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTL 190
Query: 202 LEMVTFEYPYS--ECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSA 258
LE ++P+ + ++ + + G P+ ++ PE + FI CL +R SA
Sbjct: 191 LECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSA 250
Query: 259 KELLMDPFLQ 268
ELL PF++
Sbjct: 251 AELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 6e-43
Identities = 83/247 (33%), Positives = 132/247 (53%), Gaps = 13/247 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YK + G VA Q+ ++ + E L+ + E+ LLK+LKH NI+++ S I+ +
Sbjct: 17 YKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGS-IETSD- 72
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
++ II E +GSLRQ KK V + Q+L GL YLH +IHRD+K NI
Sbjct: 73 SLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANI 130
Query: 145 FINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCM 201
+ G VK+ D G+AT + + SV+GTP +MAPE + + +DI+S G +
Sbjct: 131 LTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTV 189
Query: 202 LEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKE 260
+E++T PY + A +++ V P L + PE+K F+ +C + R +AK+
Sbjct: 190 IELLTGNPPYYDLNPMAALFRIVQDDHPP--LPEGISPELKDFLMQCFQKDPNLRPTAKQ 247
Query: 261 LLMDPFL 267
LL P++
Sbjct: 248 LLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 6e-41
Identities = 76/225 (33%), Positives = 123/225 (54%), Gaps = 14/225 (6%)
Query: 54 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL----RQYRKKHKKVD 109
++L SEV++L+ LKH NI+R+Y+ ID N+T+ I+ E G L ++ +K+ K ++
Sbjct: 44 QQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIE 103
Query: 110 MKAVKGWARQILSGLIYLHSHDPP---IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166
+ + Q+L L H+ P ++HRDLK NIF++ N VK+GD GLA I+
Sbjct: 104 EEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKILGH 162
Query: 167 AN--AKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKK 223
+ AK+ +GTP +M+PE L +Y+E +DI+S G + E+ P+ RN Q+ K
Sbjct: 163 DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQLASK 221
Query: 224 VSSGIKPAALSKVKDPEVKSFIEKCL-VPASQRLSAKELLMDPFL 267
+ G + E+ I+ L V +R S +ELL P +
Sbjct: 222 IKEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 7e-40
Identities = 86/253 (33%), Positives = 128/253 (50%), Gaps = 26/253 (10%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKA + G VA V ++ EDL+ + E+ +LK I+++Y S+ +N
Sbjct: 20 YKAIHKETGQVVAIKVVPVE------EDLQEIIKEISILKQCDSPYIVKYYGSYF--KNT 71
Query: 85 TVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ I+ E +GS+ K K + + Q L GL YLHS+ IHRD+K N
Sbjct: 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGN 129
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPELYDE-NYNELADIYSFGMC 200
I +N +G+ K+ D G++ + AK +VIGTP +MAPE+ E YN ADI+S G+
Sbjct: 130 ILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGIT 188
Query: 201 MLEMVTFEYPYSECRNSAQIYKKVSSGIK---PAALSKVKD--PEVKSFIEKCLV-PASQ 254
+EM + PYS+ I+ I P LS + PE F++KCLV +
Sbjct: 189 AIEMAEGKPPYSDIHPMRAIFM-----IPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEE 243
Query: 255 RLSAKELLMDPFL 267
R SA +LL PF+
Sbjct: 244 RPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 88/256 (34%), Positives = 138/256 (53%), Gaps = 21/256 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y A + G +A ++RI D P+ ++ + E+ +L+ LKH N++++Y ++ +
Sbjct: 17 YTAVNLDTGELMAVKEIRIQD--NDPKTIKEIADEMKVLELLKHPNLVKYYG--VEVHRE 72
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
V I E + G+L + + + +D ++ + Q+L GL YLHSH I+HRD+K NI
Sbjct: 73 KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANI 130
Query: 145 FINGNQGEVKIGDLGLA------TIMEQANAKSVIGTPEFMAPELYDEN----YNELADI 194
F++ N G +K+GD G A T +S+ GTP +MAPE+ + ADI
Sbjct: 131 FLDHN-GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADI 189
Query: 195 YSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA-LSKVKDPEVKSFIEKCLV--P 251
+S G +LEM T + P+SE N QI V +G KP S PE K F+++CL P
Sbjct: 190 WSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDP 249
Query: 252 ASQRLSAKELLMDPFL 267
+R +A ELL PF+
Sbjct: 250 -KKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 88/250 (35%), Positives = 136/250 (54%), Gaps = 14/250 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRID-DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
Y +D G E+A QV D D ++ +++ L E+ LLK+L+H I+++Y DD+
Sbjct: 19 YLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE- 77
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
T++I E GS++ K + + + + RQIL G+ YLHS+ I+HRD+K N
Sbjct: 78 -TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGAN 134
Query: 144 IFINGNQGEVKIGDLG----LATI-MEQANAKSVIGTPEFMAPELYD-ENYNELADIYSF 197
I + G VK+GD G L TI KSV GTP +M+PE+ E Y AD++S
Sbjct: 135 ILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSV 193
Query: 198 GMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRL 256
G ++EM+T + P++E A I+K + P S V P+ ++F+ + V A +R
Sbjct: 194 GCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV-SPDARNFLRRTFVENAKKRP 252
Query: 257 SAKELLMDPF 266
SA+ELL F
Sbjct: 253 SAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 8e-37
Identities = 87/252 (34%), Positives = 136/252 (53%), Gaps = 11/252 (4%)
Query: 25 YKAFDEVNGLEVAWCQVRID-DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
Y +D G E+A QV+ D + ++ +++ L E+ LLK+L+H I+++Y D
Sbjct: 19 YLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
KT+ I E GS++ K + + + + RQIL G+ YLHS+ I+HRD+K N
Sbjct: 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN--MIVHRDIKGAN 136
Query: 144 IFINGNQGEVKIGDLG----LATI-MEQANAKSVIGTPEFMAPELYD-ENYNELADIYSF 197
I + + G VK+GD G L TI M +SV GTP +M+PE+ E Y AD++S
Sbjct: 137 I-LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSL 195
Query: 198 GMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLS 257
G ++EM+T + P++E A I+K + P S + + + F+ V A R S
Sbjct: 196 GCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARDFLGCIFVEARHRPS 254
Query: 258 AKELLMDPFLQV 269
A+ELL PF Q+
Sbjct: 255 AEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 4e-36
Identities = 89/253 (35%), Positives = 134/253 (52%), Gaps = 15/253 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPE---DLERLYSEVHLLKSLKHNNIIRFYNSWIDD 81
Y +D G E+A QV+ D +SPE ++ L E+ LLK+L H I+++Y D
Sbjct: 19 YLCYDADTGRELAVKQVQFDP--ESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP 76
Query: 82 QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 141
+T++I E GS++ K + + + + RQIL G+ YLHS+ I+HRD+K
Sbjct: 77 MERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN--MIVHRDIKG 134
Query: 142 DNIFINGNQGEVKIGDLG----LATI-MEQANAKSVIGTPEFMAPELYD-ENYNELADIY 195
NI + + G VK+GD G L TI + KSV GTP +M+PE+ E Y ADI+
Sbjct: 135 ANI-LRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIW 193
Query: 196 SFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQR 255
S G ++EM+T + P++E A I+K + P V D + F+++ V A R
Sbjct: 194 SVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD-HCRDFLKRIFVEAKLR 252
Query: 256 LSAKELLMDPFLQ 268
SA ELL F+
Sbjct: 253 PSADELLRHTFVH 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 78/247 (31%), Positives = 128/247 (51%), Gaps = 15/247 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKA ++G VA +V+I +++ + + E+ LLK L H N+I++ S+I+ N
Sbjct: 19 YKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NN 75
Query: 85 TVNIITELFTSGSLRQYRKKHKK----VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 140
+NI+ EL +G L + K KK + + + + Q+ S L ++HS I+HRD+K
Sbjct: 76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIK 133
Query: 141 CDNIFINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPELYDEN-YNELADIYSF 197
N+FI G VK+GDLGL + A S++GTP +M+PE EN YN +DI+S
Sbjct: 134 PANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192
Query: 198 GMCMLEMVTFEYP-YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQR 255
G + EM + P Y + N + KK+ P + E++ + +C+ P +R
Sbjct: 193 GCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKR 252
Query: 256 LSAKELL 262
+L
Sbjct: 253 PDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 2e-34
Identities = 73/249 (29%), Positives = 131/249 (52%), Gaps = 15/249 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+K + + A Q+ + + + + E E +L L + IIR+Y S++D
Sbjct: 17 FKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGK- 73
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWAR--QILSGLIYLHSHDPPIIHRDLKCD 142
+NI+ E +G L + K + + + W QIL GL +LHS I+HRD+K
Sbjct: 74 -LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSL 130
Query: 143 NIFINGNQGEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPEL-YDENYNELADIYSFGM 199
N+F++ VKIGDLG+A ++ A +++GTP +++PEL D+ YNE +D+++ G+
Sbjct: 131 NLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGV 189
Query: 200 CMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL-VPASQRLSA 258
+ E T ++P+ + N + K+ G+ P +S++ ++ I++CL QR
Sbjct: 190 VLYECCTGKHPF-DANNQGALILKIIRGVFP-PVSQMYSQQLAQLIDQCLTKDYRQRPDT 247
Query: 259 KELLMDPFL 267
+LL +P L
Sbjct: 248 FQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 84/249 (33%), Positives = 135/249 (54%), Gaps = 11/249 (4%)
Query: 25 YKAFDEVNGLEVAWCQVRID-DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
Y +D G E+A QV D D ++ +++ L E+ LLK+L+H+ I+++Y D +
Sbjct: 19 YLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
K ++I E GS++ K + + + + RQIL G+ YLHS+ I+HRD+K N
Sbjct: 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN--MIVHRDIKGAN 136
Query: 144 IFINGNQGEVKIGDLG----LATI-MEQANAKSVIGTPEFMAPELYD-ENYNELADIYSF 197
I + + G VK+GD G + TI M KSV GTP +M+PE+ E Y AD++S
Sbjct: 137 I-LRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSV 195
Query: 198 GMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLS 257
++EM+T + P++E A I+K + KP V D + F+++ V +R +
Sbjct: 196 ACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRDFLKQIFVEEKRRPT 254
Query: 258 AKELLMDPF 266
A+ LL PF
Sbjct: 255 AEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 9e-33
Identities = 79/263 (30%), Positives = 126/263 (47%), Gaps = 24/263 (9%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKA D+ VA +++ D+ ++ +++E + E+ L + I ++Y S++
Sbjct: 18 YKAIDKRTNQVVA---IKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK- 73
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ II E GS K K +D + R++L GL YLH IHRD+K NI
Sbjct: 74 -LWIIMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEEGK--IHRDIKAANI 129
Query: 145 FINGNQGEVKIGDLGLATIME--QANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCM 201
++ +G+VK+ D G++ + + + +GTP +MAPE+ Y+E ADI+S G+
Sbjct: 130 LLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITA 188
Query: 202 LEMVTFEYPYSE---CRNSAQIYKKVSSGIKPAALSKVK-DPEVKSFIEKCLV--PASQR 255
+E+ E P S+ R I K P +L K K F+ CL P +R
Sbjct: 189 IELAKGEPPLSDLHPMRVLFLIPKN-----NPPSLEGNKFSKPFKDFVSLCLNKDPK-ER 242
Query: 256 LSAKELLMDPFLQVNGTTKNRPL 278
SAKELL F++ T L
Sbjct: 243 PSAKELLKHKFIKKAKKTSYLTL 265
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 87/246 (35%), Positives = 127/246 (51%), Gaps = 28/246 (11%)
Query: 40 QVRIDDVLQSPE----DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 95
QVRI + + PE ++ L+ E+ L LKH NI+++ S D +N I E
Sbjct: 33 QVRIA-IKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGS--DSENGFFKIFMEQVPG 89
Query: 96 GSLRQY-RKKHKKVDMK--AVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE 152
GSL R K + + + +QIL GL YLH + I+HRD+K DN+ +N G
Sbjct: 90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGV 147
Query: 153 VKIGDLGLATIMEQAN--AKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTF 207
VKI D G + + N ++ GT ++MAPE+ D+ Y ADI+S G ++EM T
Sbjct: 148 VKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207
Query: 208 EYPYSECRN-SAQIYK----KVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKEL 261
+ P+ E A ++K K+ I P +LS E K+FI +C P +R SA +L
Sbjct: 208 KPPFIELGEPQAAMFKVGMFKIHPEI-PESLSA----EAKNFILRCFEPDPDKRASAHDL 262
Query: 262 LMDPFL 267
L DPFL
Sbjct: 263 LQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 75/229 (32%), Positives = 118/229 (51%), Gaps = 15/229 (6%)
Query: 47 LQSPEDLERLYS--EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK 104
L S ER + E+ +L S+ H NII + +++D NK I+ E G L + K
Sbjct: 35 LGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-NKLC-IVMEYAPFGDLSKAISK 92
Query: 105 HKK----VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160
KK + + + Q+L GL LH I+HRDLK NI + N VKIGDLG+
Sbjct: 93 RKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVAN-DLVKIGDLGI 149
Query: 161 ATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ 219
+ ++++ AK+ IGTP +MAPE++ Y+ +DI+S G + EM TF P+ E R+
Sbjct: 150 SKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQD 208
Query: 220 IYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFL 267
+ KV G P + + ++++FI L R + ++L P +
Sbjct: 209 LRYKVQRGKYP-PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 55/213 (25%), Positives = 107/213 (50%), Gaps = 12/213 (5%)
Query: 52 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMK 111
++E +E ++L + H I++ + ++ ++ + ++ E G L + K + +
Sbjct: 36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEK--LYLVLEYAPGGELFSHLSKEGRFSEE 93
Query: 112 AVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK- 170
+ +A +I+ L YLHS II+RDLK +NI ++ G +K+ D GLA + ++
Sbjct: 94 RARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRT 150
Query: 171 -SVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI 228
+ GTPE++APE+ Y + D +S G+ + EM+T + P+ + +IY+K+
Sbjct: 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKILK-- 207
Query: 229 KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKE 260
P + PE + I L ++RL +
Sbjct: 208 DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 75/253 (29%), Positives = 121/253 (47%), Gaps = 21/253 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKA D G VA ++++ +D E + E+ +LK +H NI+ ++ S++ +
Sbjct: 20 YKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYL--RRD 73
Query: 85 TVNIITELFTSGSLRQ-YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ I+ E GSL+ Y+ + + R+ L GL YLH IHRD+K N
Sbjct: 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGAN 131
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPELYDEN----YNELADIYSF 197
I + G+VK+ D G++ + AK S IGTP +MAPE+ Y+ DI++
Sbjct: 132 ILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWAL 190
Query: 198 GMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD---PEVKSFIEKCLVPA-S 253
G+ +E+ + P + ++ S P L K K+ P FI+KCL
Sbjct: 191 GITAIELAELQPPMFDLHPMRALFLISKSNFPPPKL-KDKEKWSPVFHDFIKKCLTKDPK 249
Query: 254 QRLSAKELLMDPF 266
+R +A +LL PF
Sbjct: 250 KRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 20/224 (8%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKK 107
S + +E E +++ L H N+++ +++ I+ E G L Y RK K
Sbjct: 41 SEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLY--IVMEYMEGGDLLSYLRKNRPK 98
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA------ 161
+ + + +A QI G+ YL S IHRDL N + N VKI D GL+
Sbjct: 99 LSLSDLLSFALQIARGMEYLESK--NFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDD 155
Query: 162 TIMEQANAKSVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTF-EYPYSECRNSAQ 219
+ K I +MAPE E + +D++SFG+ + E+ T E PY N +
Sbjct: 156 DYYRKRGGKLPI---RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EE 211
Query: 220 IYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELL 262
+ + + +G + PE+ + +C R + EL+
Sbjct: 212 VLEYLKNGYRL-PQPPNCPPELYDLMLQCWAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 25/227 (11%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK- 107
S + +E E +++ L H NI++ +++ I+ E G L Y +K++
Sbjct: 41 SEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM--IVMEYMPGGDLLDYLRKNRPK 98
Query: 108 -VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA----- 161
+ + + +A QI G+ YL S IHRDL N + N VKI D GL+
Sbjct: 99 ELSLSDLLSFALQIARGMEYLESK--NFIHRDLAARNCLVGENLV-VKISDFGLSRDLYD 155
Query: 162 -TIMEQANAKSVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTF-EYPYSECRNSA 218
+ K I +MAPE E + +D++SFG+ + E+ T E PY N A
Sbjct: 156 DDYYKVKGGKLPI---RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-A 211
Query: 219 QIYKKVSSGIKPAALSKVKD--PEVKSFIEKCLVP-ASQRLSAKELL 262
++ + + G + L K + PE+ + +C R + EL+
Sbjct: 212 EVLEYLKKGYR---LPKPPNCPPELYKLMLQCWAEDPEDRPTFSELV 255
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 8e-31
Identities = 84/260 (32%), Positives = 132/260 (50%), Gaps = 22/260 (8%)
Query: 23 SGYKAFDEVNGLEVAWCQVRIDDVLQSPED-----LERLYSEVHLLKSLKHNNIIRFYNS 77
S Y + +G +A QV + V S +D L+ L E+ LLK L+H NI+++ S
Sbjct: 15 SVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGS 74
Query: 78 WIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHR 137
+D + +NI E GS+ + + V+ + RQIL GL YLH+ IIHR
Sbjct: 75 SLDADH--LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHR 130
Query: 138 DLKCDNIFINGNQGEVKIGDLGLATIME--------QANAKSVIGTPEFMAPELYDEN-Y 188
D+K NI ++ N+G +KI D G++ +E S+ G+ +MAPE+ + Y
Sbjct: 131 DIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSY 189
Query: 189 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248
ADI+S G ++EM+T ++P+ +C I+ K+ P S + E F+EK
Sbjct: 190 TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENASPEIPSNISS-EAIDFLEKT 247
Query: 249 LVP-ASQRLSAKELLMDPFL 267
++R +A ELL PFL
Sbjct: 248 FEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 65/236 (27%), Positives = 124/236 (52%), Gaps = 16/236 (6%)
Query: 40 QVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLR 99
++ I++ +Q +++ E+ +L I+ FY ++ + N ++I E GSL
Sbjct: 35 RLEINEAIQ-----KQILRELDILHKCNSPYIVGFYGAFYN--NGDISICMEYMDGGSLD 87
Query: 100 QYRKKHKK-VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 158
+ K+ + + + + A +L GL YLH IIHRD+K NI +N ++G++K+ D
Sbjct: 88 KILKEVQGRIPERILGKIAVAVLKGLTYLH-EKHKIIHRDVKPSNILVN-SRGQIKLCDF 145
Query: 159 GLATIMEQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNS 217
G++ + + AK+ +GT +MAPE +Y+ +DI+S G+ ++E+ T +PY +
Sbjct: 146 GVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP 205
Query: 218 A----QIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 268
++ + + + P S P+ + F+ CL+ +R S KELL PF++
Sbjct: 206 PDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 65/248 (26%), Positives = 104/248 (41%), Gaps = 18/248 (7%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
K E +VA ++ S E+ E E ++K L H NI+R +
Sbjct: 20 LKGDGEGTETKVAVKTLKEGA---SEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGE-- 74
Query: 85 TVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ I+TE G L + +KH K+ +K + A QI G+ YL S +HRDL N
Sbjct: 75 PLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK--NFVHRDLAARN 132
Query: 144 IFINGNQGEVKIGDLGLA-TIMEQANAKSVIGTPE---FMAPELYDEN-YNELADIYSFG 198
+ VKI D GL+ I E + G +MAPE + + +D++SFG
Sbjct: 133 CLV-TENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFG 191
Query: 199 MCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRL 256
+ + E+ T E PY N ++ + + G + E+ + +C R
Sbjct: 192 VLLWEIFTLGEQPYPGMSNE-EVLELLEDGYRLPRPENC-PDELYELMLQCWAYDPEDRP 249
Query: 257 SAKELLMD 264
+ EL+ D
Sbjct: 250 TFSELVED 257
|
Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 70/257 (27%), Positives = 118/257 (45%), Gaps = 23/257 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y A N +VA ++ D+ + ++ L EV + H N++++Y S++
Sbjct: 18 YAAICLPNNEKVA---IKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD-- 72
Query: 85 TVNIITELFTSGSLR---QYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 141
+ ++ + GSL + +D + +++L GL YLHS+ IHRD+K
Sbjct: 73 ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKA 130
Query: 142 DNIFINGNQGEVKIGDLGLA------TIMEQANAKSVIGTPEFMAPELY--DENYNELAD 193
NI + G G VKI D G++ + K+ +GTP +MAPE+ Y+ AD
Sbjct: 131 GNILL-GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKAD 189
Query: 194 IYSFGMCMLEMVTFEYPYSECRNSAQIYKKV---SSGIKPAALSKVKDPEVKSFIEKCLV 250
I+SFG+ +E+ T PYS+ + + ++ A K + I CL
Sbjct: 190 IWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQ 249
Query: 251 P-ASQRLSAKELLMDPF 266
S+R +A+ELL F
Sbjct: 250 KDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 86/284 (30%), Positives = 128/284 (45%), Gaps = 58/284 (20%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS----EVHLLKSLKHNNIIRFYNSWID 80
YKA D+ G VA ++R+D + E + S E+ LLK LKH NI++ + +
Sbjct: 16 YKARDKKTGEIVALKKIRLD------NEEEGIPSTALREISLLKELKHPNIVKLLD--VI 67
Query: 81 DQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL 139
+ + ++ E + L++Y K+ + +K Q+L GL Y HSH I+HRDL
Sbjct: 68 HTERKLYLVFE-YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDL 124
Query: 140 KCDNIFINGNQGEVKIGDLGLA---TIMEQANAKSVIGTPEFMAPELY--DENYNELADI 194
K NI IN + G +K+ D GLA I + V+ T + APE+ ++Y+ DI
Sbjct: 125 KPQNILINRD-GVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHYSTAVDI 182
Query: 195 YSFGMCMLEMVTFEYPY---SECRNSAQI-----------------------YKKVSSGI 228
+S G EM+T + + SE Q+ YK
Sbjct: 183 WSVGCIFAEMITGKPLFPGDSE---IDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF 239
Query: 229 KPAALSKV---KDPEVKSFIEKCLV--PASQRLSAKELLMDPFL 267
P L KV DPE + K L PA +R+SAKE L P+
Sbjct: 240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPA-KRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 73/259 (28%), Positives = 120/259 (46%), Gaps = 22/259 (8%)
Query: 22 TSGYKAFDEVNGLEVAWCQVRIDDVLQSPED--LERLYSEVHLLKSLKHNNIIRFYNSWI 79
+S Y+A D G +A QV S ++ +E L E+ L+ L H +IIR +
Sbjct: 14 SSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC 73
Query: 80 DDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL 139
+D + N+ E GS+ K+ + + Q+L GL YLH + IIHRD+
Sbjct: 74 EDSH--FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH--ENQIIHRDV 129
Query: 140 KCDNIFINGNQGEVKIGDLGLATIMEQANAK---------SVIGTPEFMAPE-LYDENYN 189
K N+ I+ ++I D G A + AK ++GT FMAPE L E Y
Sbjct: 130 KGANLLIDSTGQRLRIADFGAAA---RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYG 186
Query: 190 ELADIYSFGMCMLEMVTFEYPYS--ECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247
D++S G ++EM T + P++ + N + K++S ++ + P ++ +
Sbjct: 187 RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLR 246
Query: 248 CL-VPASQRLSAKELLMDP 265
CL + R ++ELL P
Sbjct: 247 CLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (292), Expect = 2e-28
Identities = 70/312 (22%), Positives = 122/312 (39%), Gaps = 31/312 (9%)
Query: 45 DVLQSPEDLERLYSEVHLLKSLKH-NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRK 103
+ +++ER E+ +L SL H NI++ Y+ + D+ + + ++ E GSL K
Sbjct: 33 KLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS--LYLVMEYVDGGSLEDLLK 90
Query: 104 KH---KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160
K + QILS L YLHS IIHRD+K +NI ++ + VK+ D GL
Sbjct: 91 KIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGL 148
Query: 161 ATIMEQAN--------AKSVIGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFE 208
A ++ + +GTP +MAPE+ + +DI+S G+ + E++T
Sbjct: 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
Query: 209 YPY---SECRNSAQIYKKVSSGIKPAALSKVK-------DPEVKSFIEKCLVP-ASQRLS 257
P+ ++Q K + P+ S + ++K L RLS
Sbjct: 209 PPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS 268
Query: 258 AKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDA 317
+ L L ++ L + +S+ + S
Sbjct: 269 SSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLD 328
Query: 318 ELPVITSLDNSG 329
+ L +G
Sbjct: 329 DSNFSKELAPNG 340
|
Length = 384 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 78/245 (31%), Positives = 125/245 (51%), Gaps = 19/245 (7%)
Query: 36 VAWCQVRID--DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93
+A QV +D +VL + ++ E+L EV LLKSLKH NI+++ + +DD T++I E
Sbjct: 27 IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN--TISIFMEFV 84
Query: 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 153
GS+ + + + +QIL G+ YLH++ ++HRD+K +N+ + N G +
Sbjct: 85 PGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPN-GII 141
Query: 154 KIGDLGLATIMEQANA--------KSVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEM 204
K+ D G A + KS+ GTP +MAPE+ +E+ Y +DI+S G + EM
Sbjct: 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEM 201
Query: 205 VTFEYPYSEC-RNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELL 262
T + P + R +A Y G+ P + F+ CL +R SA +LL
Sbjct: 202 ATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI-DFVTSCLTRDQHERPSALQLL 260
Query: 263 MDPFL 267
FL
Sbjct: 261 RHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 72/239 (30%), Positives = 114/239 (47%), Gaps = 17/239 (7%)
Query: 47 LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK 106
++S E+LE E+ +L KH NI+ Y ++ + I+ E G+L + +
Sbjct: 40 IESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW--ILIEFCDGGALDSIMLELE 97
Query: 107 KV-DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165
+ ++ RQ+L L +LHSH +IHRDLK NI + G+VK+ D G++ +
Sbjct: 98 RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSAKNK 154
Query: 166 QANAK--SVIGTPEFMAPELY------DENYNELADIYSFGMCMLEMVTFEYPYSECRNS 217
K + IGTP +MAPE+ D Y+ ADI+S G+ ++E+ E P+ E N
Sbjct: 155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NP 213
Query: 218 AQIYKKVSSGIKPAALSKVK-DPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTK 274
++ K+ P K F++ CLV R +A ELL PF+ K
Sbjct: 214 MRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNK 272
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-28
Identities = 76/233 (32%), Positives = 120/233 (51%), Gaps = 20/233 (8%)
Query: 47 LQSPED-LERLYSEVHLLKSLKHN---NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR 102
L +P+D + + EV LL L+ + NI ++Y S++ + II E GS+R
Sbjct: 36 LDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR--LWIIMEYAEGGSVRTLM 93
Query: 103 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162
K + K + R++L L Y+H +IHRD+K NI + N G VK+ D G+A
Sbjct: 94 KA-GPIAEKYISVIIREVLVALKYIHKV--GVIHRDIKAANILVT-NTGNVKLCDFGVAA 149
Query: 163 IMEQANAK--SVIGTPEFMAPELYDEN--YNELADIYSFGMCMLEMVTFEYPYSECRNSA 218
++ Q ++K + +GTP +MAPE+ E Y+ ADI+S G+ + EM T PYS+
Sbjct: 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209
Query: 219 QIYKKVSSGIKPAALS-KVKDPEVKSFIEKCL--VPASQRLSAKELLMDPFLQ 268
+ S KP L ++ F+ CL P +RLSA+ELL +++
Sbjct: 210 AMMLIPKS--KPPRLEDNGYSKLLREFVAACLDEEPK-ERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 28/218 (12%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV 108
S E+ + E ++K L H N++R +++ + ++ E G L Y +K + V
Sbjct: 36 SEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPV 93
Query: 109 DMKAVKG---------WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 159
K +A QI G+ YL S +HRDL N + + VKI D G
Sbjct: 94 FPSPEKSTLSLKDLLSFAIQIAKGMEYLASK--KFVHRDLAARNCLVGED-LVVKISDFG 150
Query: 160 LA-------TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYP 210
L+ ++ K I +MAPE L D + +D++SFG+ + E+ T P
Sbjct: 151 LSRDVYDDDYYRKKTGGKLPI---RWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
Query: 211 YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248
Y N ++ + + G + D E+ + C
Sbjct: 208 YPGLSNE-EVLEYLRKGYRLPKPEYCPD-ELYELMLSC 243
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 77/239 (32%), Positives = 129/239 (53%), Gaps = 14/239 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y+A ++G+ VA +V+I D++ + + + E+ LLK L H N+I++Y S+I+D
Sbjct: 19 YRATCLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLNHPNVIKYYASFIEDNE- 76
Query: 85 TVNIITELFTSGSL----RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 140
+NI+ EL +G L + ++K+ + + K V + Q+ S L ++HS ++HRD+K
Sbjct: 77 -LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIK 133
Query: 141 CDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPELYDEN-YNELADIYSF 197
N+FI G VK+GDLGL A S++GTP +M+PE EN YN +DI+S
Sbjct: 134 PANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192
Query: 198 GMCMLEMVTFEYP-YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQR 255
G + EM + P Y + N + KK+ P S E++ + C+ P ++
Sbjct: 193 GCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEK 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 73/238 (30%), Positives = 126/238 (52%), Gaps = 15/238 (6%)
Query: 36 VAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 95
V W +V + + S ++ +E+ +L L+H NII +YN ++DD T+ I E
Sbjct: 28 VVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN--TLLIEMEYANG 83
Query: 96 GSLRQ--YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 153
G+L R+K + + + V + QI+S + Y+H I+HRD+K NIF+ G +
Sbjct: 84 GTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLI 140
Query: 154 KIGDLGLATIM--EQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYP 210
K+GD G++ I+ E + A++V+GTP +M+PEL YN +DI++ G + E++T +
Sbjct: 141 KLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT 200
Query: 211 YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL-VPASQRLSAKELLMDPFL 267
+ + N + K+ G +S V E+ S + L +R +A E+L P L
Sbjct: 201 F-DATNPLNLVVKIVQGNYTPVVS-VYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 18/218 (8%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWAR 118
E +L+ L H ++ + S+ D++N + ++ +L G LR + + K + VK W
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC 107
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME-QANAKSVIGTPE 177
+I+ L YLHS IIHRD+K DNI ++ QG V I D +AT + S GTP
Sbjct: 108 EIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPG 164
Query: 178 FMAPELY-DENYNELADIYSFGMCMLEMVTFEYPY---SECRNSAQIYKKVSSGIK-PAA 232
+MAPE+ + Y+ D +S G+ E + + PY S K+ ++ + PA
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPAT 224
Query: 233 LSKVKDPEVKSFIEKCL-VPASQRLS--AKELLMDPFL 267
S E I K L +RL K+L P+
Sbjct: 225 WST----EAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 69/220 (31%), Positives = 117/220 (53%), Gaps = 14/220 (6%)
Query: 54 ERLYSEVHLLKSLKHNNIIRFYNSW-IDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA 112
E L++EV +++ +H NI+ Y+S+ + D+ + ++ E G+L H +++ +
Sbjct: 61 ELLFNEVVIMRDYQHPNIVEMYSSYLVGDE---LWVVMEFLEGGALTDI-VTHTRMNEEQ 116
Query: 113 VKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAK 170
+ +L L +LH+ +IHRD+K D+I + + G VK+ D G E K
Sbjct: 117 IATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRK 173
Query: 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK 229
S++GTP +MAPE+ Y DI+S G+ ++EMV E PY Q K++ +
Sbjct: 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLP 232
Query: 230 PAALSKVK-DPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267
P + K P ++SF+++ LV +QR +A ELL PFL
Sbjct: 233 PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-27
Identities = 65/213 (30%), Positives = 120/213 (56%), Gaps = 11/213 (5%)
Query: 58 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK--VDMKAVKG 115
+E +LK L H NII +Y ++++D K + I+ E G+L +Y +K +D +
Sbjct: 48 NECQVLKLLSHPNIIEYYENFLED--KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILH 105
Query: 116 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM-EQANAKSVIG 174
+ QIL L ++H+ I+HRDLK NI ++ ++ VKIGD G++ I+ ++ A +V+G
Sbjct: 106 FFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVG 163
Query: 175 TPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL 233
TP +++PEL + + YN+ +DI++ G + E+ + + + E N + K+ SG A +
Sbjct: 164 TPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAF-EAANLPALVLKIMSG-TFAPI 221
Query: 234 SKVKDPEVKSFIEKCL-VPASQRLSAKELLMDP 265
S P+++ I L + S+R +++ P
Sbjct: 222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 70/235 (29%), Positives = 127/235 (54%), Gaps = 14/235 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y+A ++ VA +V+I +++ + + + E+ LLK L H N+I++ +S+I+D
Sbjct: 19 YRATCLLDRKPVALKKVQIFEMMDA-KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE- 76
Query: 85 TVNIITELFTSGSLRQ----YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 140
+NI+ EL +G L Q ++K+ + + + V + Q+ S + ++HS ++HRD+K
Sbjct: 77 -LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIK 133
Query: 141 CDNIFINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPELYDEN-YNELADIYSF 197
N+FI G VK+GDLGL + A S++GTP +M+PE EN YN +DI+S
Sbjct: 134 PANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192
Query: 198 GMCMLEMVTFEYP-YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP 251
G + EM + P Y + N + +K+ P ++ +++ + C+ P
Sbjct: 193 GCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 67/215 (31%), Positives = 114/215 (53%), Gaps = 12/215 (5%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL--RQYRKKHKKVDMKAVKGW 116
E LL LKH NI+ + SW + ++ + I+ G L + +K K + V W
Sbjct: 49 EAQLLSQLKHPNIVAYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107
Query: 117 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVIG 174
QI L YLH + I+HRDLK N+F+ +K+GDLG+A ++E A ++IG
Sbjct: 108 FVQIAMALQYLH--EKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIG 164
Query: 175 TPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL 233
TP +M+PEL+ ++ YN +D+++ G C+ EM T ++ ++ ++ +Y+ + + P +
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP--M 222
Query: 234 SKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFL 267
K PE+ I L +R S K +L P++
Sbjct: 223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 65/235 (27%), Positives = 123/235 (52%), Gaps = 22/235 (9%)
Query: 50 PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL----RQYRKKH 105
P+ +++ E+ + KS K I+++Y +++D+ + ++ I E GSL ++ +K+
Sbjct: 40 PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRG 99
Query: 106 KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165
++ K + A +L GL YLHS IIHRD+K NI + +G+VK+ D G++ +
Sbjct: 100 GRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELV 156
Query: 166 QANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVT--FEYPYSECRNSAQIYK 222
+ A + GT +MAPE + + Y+ +D++S G+ +LE+ F +P I
Sbjct: 157 NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI-- 214
Query: 223 KVSSGIKPAALSKVKD-PEV--------KSFIEKCL-VPASQRLSAKELLMDPFL 267
++ S I ++KD P K FI++CL ++R + ++L P++
Sbjct: 215 ELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 64/225 (28%), Positives = 107/225 (47%), Gaps = 16/225 (7%)
Query: 53 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA 112
++ L SE+ LK L H NI+++ + + ++I E GS+ + + + + +
Sbjct: 52 VKALRSEIETLKDLDHLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL 109
Query: 113 VKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL----ATIMEQAN 168
V+ + Q+L GL YLHS I+HRDLK DN+ ++ G KI D G+ I +
Sbjct: 110 VRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQ 166
Query: 169 AKSVIGTPEFMAPE---LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK--- 222
S+ G+ +MAPE Y + Y+ DI+S G +LEM P+S+ A ++K
Sbjct: 167 NMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN 226
Query: 223 -KVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPF 266
+ + I P + + + R +A+ELL PF
Sbjct: 227 KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 4e-25
Identities = 69/237 (29%), Positives = 111/237 (46%), Gaps = 44/237 (18%)
Query: 62 LLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQIL 121
L + H II+ Y ++ D++N + + E +G L QY +K+ +D K + +A +IL
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEEN--LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEIL 112
Query: 122 SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM----------------- 164
L YLHS IIHRDLK +NI ++ + +KI D G A ++
Sbjct: 113 LALEYLHSKG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 165 -----EQANAKSVIGTPEFMAPELYDENY-NELADIYSFGMCML-EMVTFEYPYSECRNS 217
+ S +GT E+++PEL +E + +D+++ G C++ +M+T + P+ N
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALG-CIIYQMLTGKPPFR-GSNE 227
Query: 218 AQIYKKVSSGIKPAALS--KVKDPEVKSFIEKCLV--PASQRLSAK----ELLMDPF 266
++K I S P+ K IEK LV P RL EL PF
Sbjct: 228 YLTFQK----ILKLEYSFPPNFPPDAKDLIEKLLVLDP-QDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 79/249 (31%), Positives = 127/249 (51%), Gaps = 14/249 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y A D G EVA Q+ + Q P+ E + +E+ +++ KH NI+ + +S++
Sbjct: 36 YTAIDVATGQEVAIKQMNLQ---QQPKK-ELIINEILVMRENKHPNIVNYLDSYL--VGD 89
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ ++ E GSL + +D + R+ L L +LHS+ +IHRD+K DNI
Sbjct: 90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNI 146
Query: 145 FINGNQGEVKIGDLGL-ATIM-EQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCM 201
+ G G VK+ D G A I EQ+ +++GTP +MAPE+ + Y DI+S G+
Sbjct: 147 LL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205
Query: 202 LEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL-VPASQRLSAKE 260
+EMV E PY +Y ++G + + F+ +CL + +R SAKE
Sbjct: 206 IEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 265
Query: 261 LLMDPFLQV 269
LL PFL++
Sbjct: 266 LLQHPFLKI 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 80/279 (28%), Positives = 136/279 (48%), Gaps = 41/279 (14%)
Query: 18 QLVDTSG-------YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHN 69
+LV+ G YKA + G VA ++I D++ ++ E + E ++L+ H
Sbjct: 9 ELVEVIGEGTYGKVYKARHKKTGQLVA---IKIMDII--EDEEEEIKEEYNILRKYSNHP 63
Query: 70 NIIRFYNSWI--DDQNKTVNI--ITELFTSGS----LRQYRKKHKKVDMKAVKGWARQIL 121
NI FY ++I + + + EL GS ++ RKK K++ + + R+ L
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123
Query: 122 SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFM 179
GL YLH + +IHRD+K NI + N EVK+ D G++ ++ + + IGTP +M
Sbjct: 124 RGLAYLHENK--VIHRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 180 APEL------YDENYNELADIYSFGMCMLEMVTFEYPYSE---CRNSAQIYKKVSSGIK- 229
APE+ D +Y+ +D++S G+ +E+ + P + R +I + +K
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS 240
Query: 230 PAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFL 267
P SK + FI +CL+ QR +ELL PF+
Sbjct: 241 PENWSK----KFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 14/261 (5%)
Query: 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 72
Y ++ Q + + A D G EVA Q+ LQ E + +E+ ++K LK+ NI+
Sbjct: 24 YEKIGQGASGTVFTAIDVATGQEVAIKQIN----LQKQPKKELIINEILVMKELKNPNIV 79
Query: 73 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 132
F +S++ + ++ E GSL + +D + R+ L L +LH++
Sbjct: 80 NFLDSFL--VGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ- 135
Query: 133 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPELYDEN-YN 189
+IHRD+K DN+ + G G VK+ D G + EQ+ +++GTP +MAPE+ Y
Sbjct: 136 -VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 190 ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249
DI+S G+ +EMV E PY +Y ++G + P + F+ +CL
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCL 253
Query: 250 -VPASQRLSAKELLMDPFLQV 269
+ +R SAKELL PFL++
Sbjct: 254 EMDVEKRGSAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 11/208 (5%)
Query: 54 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAV 113
E ++SE +L+ H I++ Y ++ D K + ++ E G L + D
Sbjct: 38 EHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTA 95
Query: 114 KGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKSV 172
+ + ++ YLH+ II+RDLK +N+ ++ + G VK+ D G A ++ +
Sbjct: 96 RFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTF 152
Query: 173 IGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ-IYKKVSSGIKP 230
GTPE++APE + ++ Y+ D +S G+ + E++T P+ E IY + G
Sbjct: 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK 212
Query: 231 AALSKVKDPEVKSFIEK--CLVPASQRL 256
D K I++ P +RL
Sbjct: 213 LEFPNYIDKAAKDLIKQLLRRNPE-ERL 239
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 63/247 (25%), Positives = 102/247 (41%), Gaps = 47/247 (19%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT---SGSLRQYRKKHKKVDMKAVKG 115
E+ LL+ L+H NI+R ++ ++ E +G L K +K
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS---PEVKFTESQIKC 104
Query: 116 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS---- 171
+ +Q+L GL YLHS+ I+HRD+K NI IN N G +K+ D GLA + N+
Sbjct: 105 YMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNR 161
Query: 172 VIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTFEYPY---SECRNSAQIYKKVSS 226
VI T + PEL Y D++S G + E+ + + +E +I++ S
Sbjct: 162 VI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGS 220
Query: 227 ----------------GIKPAA---------LSKVKDPEVKSFIEK--CLVPASQRLSAK 259
+KP + DP ++K L P +R+SA
Sbjct: 221 PTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDP-KKRISAD 279
Query: 260 ELLMDPF 266
+ L +
Sbjct: 280 QALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 69/215 (32%), Positives = 109/215 (50%), Gaps = 12/215 (5%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV--DMKAVKGW 116
EV LL +KH NI+ F+ S+ +N + I+ E G L + + + V + W
Sbjct: 49 EVILLAKMKHPNIVTFFASF--QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW 106
Query: 117 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVIG 174
QI GL H HD I+HRD+K NIF++ N K+GD G+A + + A + +G
Sbjct: 107 FVQISLGL--KHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVG 164
Query: 175 TPEFMAPEL-YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL 233
TP +++PE+ + YN DI+S G + E+ T ++P+ E N Q+ K+ G A +
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQG-YFAPI 222
Query: 234 SKVKDPEVKSFIEKCL-VPASQRLSAKELLMDPFL 267
S +++S I + V R S +L PFL
Sbjct: 223 SPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 61/208 (29%), Positives = 108/208 (51%), Gaps = 25/208 (12%)
Query: 58 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWA 117
+E +L+S++H ++ Y S+ DD N + ++ E G L + +K + + +A
Sbjct: 50 NEKRILQSIRHPFLVNLYGSFQDDSN--LYLVMEYVPGGELFSHLRKSGRFPEPVARFYA 107
Query: 118 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE 177
Q++ L YLHS D I++RDLK +N+ + + G +KI D G A ++ ++ GTPE
Sbjct: 108 AQVVLALEYLHSLD--IVYRDLKPENLLL-DSDGYIKITDFGFAKRVKG-RTYTLCGTPE 163
Query: 178 FMAPE-LYDENYNELADIYSFGMCMLEMVTFEYP--YSECRNSAQIYKKVSSGIKPAALS 234
++APE + + Y + D ++ G+ + EM+ YP + + N QIY+K+ G
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLA-GYPPFFDD--NPIQIYEKILEG------- 213
Query: 235 KVK-----DPEVKSFIEKCLVP-ASQRL 256
KV+ P+ K I L ++RL
Sbjct: 214 KVRFPSFFSPDAKDLIRNLLQVDLTKRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 82/289 (28%), Positives = 120/289 (41%), Gaps = 59/289 (20%)
Query: 26 KAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN- 83
A D+ G +VA + +I +V D +R+ E+ LL+ L+H NII +
Sbjct: 18 SAVDKRTGRKVA---IKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE 74
Query: 84 --KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 141
V I+TEL + L + K + + ++ + QIL GL YLHS + +IHRDLK
Sbjct: 75 DFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKP 131
Query: 142 DNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFM----------APE--LYDENYN 189
NI +N N ++KI D GLA ++ F+ APE L Y
Sbjct: 132 SNILVNSNC-DLKICDFGLARGVDPDED-----EKGFLTEYVVTRWYRAPELLLSSSRYT 185
Query: 190 ELADIYSFGMCMLEMVT----F---------------------EYPYSECRNSAQIYKKV 224
+ DI+S G E++T F E A+ Y K
Sbjct: 186 KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKS 245
Query: 225 SSGIKPAALSKV---KDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQ 268
LSK+ PE +EK LV P +R++A E L P+L
Sbjct: 246 LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPK-KRITADEALAHPYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 72/240 (30%), Positives = 115/240 (47%), Gaps = 23/240 (9%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWAR 118
E+ +L+ + H N+++ ++ + D N + ++ E GSL ++ + AR
Sbjct: 122 EIEILRDVNHPNVVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADEQ----FLADVAR 175
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAKSVIGTP 176
QILSG+ YLH I+HRD+K N+ IN + VKI D G++ I+ Q S +GT
Sbjct: 176 QILSGIAYLHRRH--IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSVGTI 232
Query: 177 EFMAPE-----LYDENYNELA-DIYSFGMCMLEMVTFEYPYSECRNS--AQIYKKVSSGI 228
+M+PE L Y+ A DI+S G+ +LE +P+ R A + +
Sbjct: 233 AYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ 292
Query: 229 KPAALSKVKDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLP 286
P A + E + FI CL PA +R SA +LL PF+ + + P +LP
Sbjct: 293 PPEAPATAS-REFRHFISCCLQREPA-KRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLP 350
|
Length = 353 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 6e-23
Identities = 80/253 (31%), Positives = 126/253 (49%), Gaps = 22/253 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y A D G EVA Q+ LQ E + +E+ +++ K+ NI+ + +S++
Sbjct: 36 YTAIDIATGQEVAIKQMN----LQQQPKKELIINEILVMRENKNPNIVNYLDSYL--VGD 89
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ ++ E GSL + +D + R+ L L +LHS+ +IHRD+K DNI
Sbjct: 90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNI 146
Query: 145 FINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPELYDEN-YNELADIYSFGMCM 201
+ G G VK+ D G + EQ+ +++GTP +MAPE+ Y DI+S G+
Sbjct: 147 LL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205
Query: 202 LEMVTFEYPYSECRNSAQIYKKVSSGI----KPAALSKVKDPEVKSFIEKCL-VPASQRL 256
+EMV E PY +Y ++G P LS V + F+ +CL + +R
Sbjct: 206 IEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV----FRDFLNRCLEMDVDRRG 261
Query: 257 SAKELLMDPFLQV 269
SAKELL PFL++
Sbjct: 262 SAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 6e-23
Identities = 72/231 (31%), Positives = 118/231 (51%), Gaps = 14/231 (6%)
Query: 47 LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK 106
L+ + E L++EV +++ +H N++ YNS++ + ++ E G+L H
Sbjct: 55 LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDI-VTHT 111
Query: 107 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM-- 164
+++ + + +L L LH+ +IHRD+K D+I + + G VK+ D G +
Sbjct: 112 RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSK 168
Query: 165 EQANAKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKK 223
E KS++GTP +MAPEL Y DI+S G+ ++EMV E PY + K
Sbjct: 169 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKM 227
Query: 224 VSSGIKP--AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 271
+ + P L KV P +K F+++ LV +QR +A ELL PFL G
Sbjct: 228 IRDNLPPKLKNLHKVS-PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 8e-23
Identities = 72/240 (30%), Positives = 115/240 (47%), Gaps = 28/240 (11%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 107
QS E + + EV L+ L+H N I + ++ + T ++ E + GS + HKK
Sbjct: 54 QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH--TAWLVME-YCLGSASDILEVHKK 110
Query: 108 ----VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163
V++ A+ L GL YLHSH+ IHRD+K NI + G VK+ D G A++
Sbjct: 111 PLQEVEIAAI---CHGALQGLAYLHSHE--RIHRDIKAGNILLTEP-GTVKLADFGSASL 164
Query: 164 MEQANAKSVIGTPEFMAPEL---YDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ 219
+ AN S +GTP +MAPE+ DE Y+ D++S G+ +E+ + P +
Sbjct: 165 VSPAN--SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222
Query: 220 IYKKVSSGIKPAALSKVK-DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGTTKNRP 277
+Y + LS ++F++ CL R S++ELL F+ + RP
Sbjct: 223 LYHIAQN--DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV-----LRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 71/242 (29%), Positives = 121/242 (50%), Gaps = 20/242 (8%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK-HK 106
+S E+LE E+ +L S H NI++ +++ + N + I+ E G++ + +
Sbjct: 41 KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELER 98
Query: 107 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166
+ ++ +Q L L YLH + IIHRDLK NI + G++K+ D G++ +
Sbjct: 99 PLTEPQIRVVCKQTLEALNYLH--ENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTR 155
Query: 167 ANAK--SVIGTPEFMAPELY------DENYNELADIYSFGMCMLEMVTFEYPYSECRNSA 218
+ S IGTP +MAPE+ D Y+ AD++S G+ ++EM E P+ E N
Sbjct: 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL-NPM 214
Query: 219 QIYKKVSSGIKPAALSKVK-DPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNR 276
++ K++ P + E K F++KCL R + +LL PF+ VN N+
Sbjct: 215 RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN---SNK 271
Query: 277 PL 278
P+
Sbjct: 272 PI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 3e-22
Identities = 67/218 (30%), Positives = 111/218 (50%), Gaps = 18/218 (8%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSG-----SLRQYRKKHKKVDMKAV 113
E LL L H I++F+ S++ + IITE + G L + + K + V
Sbjct: 52 EAQLLSKLDHPAIVKFHASFL--ERDAFCIITE-YCEGRDLDCKLEELKHTGKTLSENQV 108
Query: 114 KGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKS 171
W Q+L G+ Y+H I+HRDLK NIF+ N +KIGD G++ ++ + A +
Sbjct: 109 CEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATT 164
Query: 172 VIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP 230
GTP +M+PE L + Y+ +DI+S G + EM + + E +N + ++ G P
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRIVEGPTP 223
Query: 231 AALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFL 267
+L + ++ S ++ L S R SA E+L +PF+
Sbjct: 224 -SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 68/230 (29%), Positives = 118/230 (51%), Gaps = 12/230 (5%)
Query: 47 LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK 106
L+ + E L++EV +++ H N++ YNS++ + ++ E G+L H
Sbjct: 57 LRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL--VGDELWVVMEFLEGGALTDI-VTHT 113
Query: 107 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM-- 164
+++ + + +L L YLH+ +IHRD+K D+I + + G +K+ D G +
Sbjct: 114 RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSK 170
Query: 165 EQANAKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKK 223
E KS++GTP +MAPE+ Y DI+S G+ ++EM+ E PY Q ++
Sbjct: 171 EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRR 229
Query: 224 VSSGIKPAALSKVKDPEV-KSFIEKCLV-PASQRLSAKELLMDPFLQVNG 271
+ + P K V + F++ LV SQR +A+ELL PFL++ G
Sbjct: 230 IRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 57/229 (24%), Positives = 107/229 (46%), Gaps = 21/229 (9%)
Query: 54 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAV 113
+++ +E +L + +++ Y S+ +N + ++ E G L + +D
Sbjct: 38 DQVLTERDILSQAQSPYVVKLYYSFQGKKN--LYLVMEYLPGGDLASLLENVGSLDEDVA 95
Query: 114 KGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI--------ME 165
+ + +I+ L YLHS+ IIHRDLK DNI I+ N G +K+ D GL+ + +
Sbjct: 96 RIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLN 152
Query: 166 QANAKS--VIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 222
+ ++GTP+++APE + + +++ D +S G + E + P+ +I++
Sbjct: 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQ 211
Query: 223 KVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRL---SAKELLMDPFL 267
+ +G E I K LVP +RL S +E+ PF
Sbjct: 212 NILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 95.6 bits (237), Expect = 1e-21
Identities = 77/253 (30%), Positives = 128/253 (50%), Gaps = 22/253 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y A D G EVA +R ++ Q P+ E + +E+ +++ K+ NI+ + +S++
Sbjct: 37 YTAMDVATGQEVA---IRQMNLQQQPKK-ELIINEILVMRENKNPNIVNYLDSYL--VGD 90
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ ++ E GSL + +D + R+ L L +LHS+ +IHRD+K DNI
Sbjct: 91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNI 147
Query: 145 FINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPELYDEN-YNELADIYSFGMCM 201
+ G G VK+ D G + EQ+ +++GTP +MAPE+ Y DI+S G+
Sbjct: 148 LL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 202 LEMVTFEYPYSECRNSAQIYKKVSSGI----KPAALSKVKDPEVKSFIEKCL-VPASQRL 256
+EM+ E PY +Y ++G P LS + + F+ +CL + +R
Sbjct: 207 IEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI----FRDFLNRCLDMDVEKRG 262
Query: 257 SAKELLMDPFLQV 269
SAKELL FL++
Sbjct: 263 SAKELLQHQFLKI 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-20
Identities = 82/275 (29%), Positives = 138/275 (50%), Gaps = 32/275 (11%)
Query: 16 LIQLVDTSGYKAFDEV-NGLEVAWCQ---VRIDDVLQSPEDLERLYSEVHLLKSLKHN-N 70
+ +LV+ G + +V G V Q +++ DV E E + E+++LK H+ N
Sbjct: 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE--EEIKQEINMLKKYSHHRN 64
Query: 71 IIRFYNSWI-------DDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA--VKGWARQIL 121
I +Y ++I DDQ + ++ E +GS+ K K +K + R+IL
Sbjct: 65 IATYYGAFIKKNPPGMDDQ---LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 122 SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFM 179
GL +LH H +IHRD+K N+ + N EVK+ D G++ +++ + + IGTP +M
Sbjct: 122 RGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178
Query: 180 APELY--DEN----YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL 233
APE+ DEN Y+ +D++S G+ +EM P + ++ + P
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLK 237
Query: 234 SKVKDPEVKSFIEKCLVPA-SQRLSAKELLMDPFL 267
SK + +SFIE CLV SQR + ++L+ PF+
Sbjct: 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 70/247 (28%), Positives = 125/247 (50%), Gaps = 20/247 (8%)
Query: 47 LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK 106
L+ + E L++EV +++ +H N++ Y S++ + + ++ E G+L +
Sbjct: 56 LRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL--VGEELWVLMEFLQGGALTDIVSQ-T 112
Query: 107 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166
+++ + + +L L YLHS +IHRD+K D+I + + G VK+ D G + +
Sbjct: 113 RLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISK 169
Query: 167 --ANAKSVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKK 223
KS++GTP +MAPE+ Y DI+S G+ ++EMV E PY + Q K+
Sbjct: 170 DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKR 228
Query: 224 VSSGIKPAALSKVK-DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGTTKNRPLPLP 281
+ P + K P ++ F+E+ L +R +A+ELL PFL G LP
Sbjct: 229 LRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG--------LP 280
Query: 282 DIVLPRV 288
+ ++P +
Sbjct: 281 ECLVPLI 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 73/242 (30%), Positives = 119/242 (49%), Gaps = 19/242 (7%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK-HK 106
+S E+LE E+ +L + H I++ ++ D + I+ E G++ + +
Sbjct: 48 KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGK--LWIMIEFCPGGAVDAIMLELDR 105
Query: 107 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166
+ ++ RQ+L L YLHS IIHRDLK N+ + G++K+ D G++ +
Sbjct: 106 GLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVK 162
Query: 167 ANAK--SVIGTPEFMAPE------LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSA 218
+ S IGTP +MAPE + D Y+ ADI+S G+ ++EM E P+ E N
Sbjct: 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPM 221
Query: 219 QIYKKVSSGIKPAALSKVK-DPEVKSFIEKCLVPASQ-RLSAKELLMDPFLQVNGTTKNR 276
++ K++ P K E + F++ L + R SA +LL PF V+ T NR
Sbjct: 222 RVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF--VSSVTSNR 279
Query: 277 PL 278
PL
Sbjct: 280 PL 281
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 70/235 (29%), Positives = 116/235 (49%), Gaps = 12/235 (5%)
Query: 41 VRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQ 100
++I D+ ++ +++E + E+ +L + ++Y S++ D + II E GS
Sbjct: 34 IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK--LWIIMEYLGGGSALD 91
Query: 101 YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160
+ +D + R+IL GL YLHS IHRD+K N+ ++ GEVK+ D G+
Sbjct: 92 LLEP-GPLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGV 147
Query: 161 ATIMEQANAKS--VIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEYPYSECRNS 217
A + K +GTP +MAPE+ ++ Y+ ADI+S G+ +E+ E P+SE
Sbjct: 148 AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM 207
Query: 218 AQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL-VPASQRLSAKELLMDPFLQVNG 271
++ + P L +K F+E CL S R +AKELL F+
Sbjct: 208 KVLFLIPKN--NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 7e-20
Identities = 67/229 (29%), Positives = 112/229 (48%), Gaps = 14/229 (6%)
Query: 47 LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK 106
L+ ED + E+ ++K KH+NI+ ++ S++ + + I E GSL+
Sbjct: 44 LEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL--RRDKLWICMEFCGGGSLQDIYHVTG 101
Query: 107 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166
+ + +R+ L GL YLHS +HRD+K NI + N G VK+ D G++ +
Sbjct: 102 PLSESQIAYVSRETLQGLYYLHSKGK--MHRDIKGANILLTDN-GHVKLADFGVSAQITA 158
Query: 167 --ANAKSVIGTPEFMAPEL----YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI 220
A KS IGTP +MAPE+ YN+L DI++ G+ +E+ + P + +
Sbjct: 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
Query: 221 YKKVSSGIKPAALS-KVK-DPEVKSFIEKCLVP-ASQRLSAKELLMDPF 266
+ S +P L K+K F++ L +R +A++LL PF
Sbjct: 219 FLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 15 RLIQLVDTSGYKAFDEV-NGLEVAWCQV---RIDDVLQSPEDLERLYSEVHLLKSLKHNN 70
L ++ G +F EV G++ +V +I D+ ++ +++E + E+ +L
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 71 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH 130
I R+Y S++ + + II E GS K ++ + R+IL GL YLHS
Sbjct: 64 ITRYYGSYL--KGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSE 120
Query: 131 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPELYDEN- 187
IHRD+K N+ ++ QG+VK+ D G+A + K + +GTP +MAPE+ ++
Sbjct: 121 RK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 188 YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247
Y+ ADI+S G+ +E+ E P S+ ++ + P L K F+E
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--SPPTLEGQYSKPFKEFVEA 235
Query: 248 CLVPASQ-RLSAKELLMDPFL 267
CL + R +AKELL F+
Sbjct: 236 CLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 83/277 (29%), Positives = 137/277 (49%), Gaps = 36/277 (12%)
Query: 16 LIQLVDTSGYKAFDEV-NGLEVAWCQ---VRIDDVLQSPEDLERLYSEVHLLKSLKHN-N 70
+ +LV+ G + +V G V Q +++ DV + E E + E+++LK H+ N
Sbjct: 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE--EEIKLEINMLKKYSHHRN 74
Query: 71 IIRFYNSWI-------DDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGW----ARQ 119
I +Y ++I DDQ + ++ E +GS+ K K +K + W R+
Sbjct: 75 IATYYGAFIKKSPPGHDDQ---LWLVMEFCGAGSVTDLVKNTKGNALK--EDWIAYICRE 129
Query: 120 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPE 177
IL GL +LH+H +IHRD+K N+ + N EVK+ D G++ +++ + + IGTP
Sbjct: 130 ILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186
Query: 178 FMAPELY--DEN----YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA 231
+MAPE+ DEN Y+ +DI+S G+ +EM P + ++ + P
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPPPK 245
Query: 232 ALSKVKDPEVKSFIEKCLVPAS-QRLSAKELLMDPFL 267
SK + FIE CLV R S ++LL PF+
Sbjct: 246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 57/229 (24%), Positives = 118/229 (51%), Gaps = 21/229 (9%)
Query: 55 RLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVK 114
++ E+ ++ + I+ FY +++++ N + + E GSL + KK + ++ +
Sbjct: 49 QILRELQIMHECRSPYIVSFYGAFLNENN--ICMCMEFMDCGSLDRIYKKGGPIPVEILG 106
Query: 115 GWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI 173
A ++ GL YL++ H I+HRD+K NI +N +G++K+ D G++ + + A + +
Sbjct: 107 KIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIADTFV 163
Query: 174 GTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI---- 228
GT +M+PE + Y +D++S G+ ++E+ ++P++ N + GI
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF-SNIDDDGQDDPMGILDLL 222
Query: 229 ------KPAALSKVKDPEV-KSFIEKCLV-PASQRLSAKELL-MDPFLQ 268
P L PE + F++ CL+ ++R + ++L M PF+Q
Sbjct: 223 QQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 52/159 (32%), Positives = 88/159 (55%), Gaps = 10/159 (6%)
Query: 56 LYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVK 114
L E+ +L++L H NI+++ +D + +I E SGSL++Y ++K K+++K
Sbjct: 53 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL 112
Query: 115 GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA----TIMEQANAK 170
+A QI G+ YL S +HRDL N+ + ++ +VKIGD GL T E K
Sbjct: 113 KYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVK 169
Query: 171 SVIGTPEF-MAPE-LYDENYNELADIYSFGMCMLEMVTF 207
+ +P F APE L + +D++SFG+ + E++T+
Sbjct: 170 DDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 57/183 (31%), Positives = 97/183 (53%), Gaps = 15/183 (8%)
Query: 33 GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN-KTVNIITE 91
G +VA + Q D ER E+ +L++L H NI++ Y + +++ +I E
Sbjct: 33 GEQVAVKSLNHSGEEQHRSDFER---EIEILRTLDHENIVK-YKGVCEKPGGRSLRLIME 88
Query: 92 LFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 150
SGSLR Y ++H+ ++++K + ++ QI G+ YL S IHRDL NI + ++
Sbjct: 89 YLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVE-SE 145
Query: 151 GEVKIGDLGLATIMEQAN----AKSVIGTPEF-MAPE-LYDENYNELADIYSFGMCMLEM 204
VKI D GLA ++ + K +P F APE L ++ +D++SFG+ + E+
Sbjct: 146 DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205
Query: 205 VTF 207
T+
Sbjct: 206 FTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 43/236 (18%)
Query: 71 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS- 129
I+ FY ++ D ++I E GSL Q KK ++ + + +L GL YL
Sbjct: 61 IVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118
Query: 130 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENY 188
H I+HRD+K NI +N GE+K+ D G++ + + A S +GT +M+PE L +Y
Sbjct: 119 HK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 189 NELADIYSFGMCMLEMVTFEYP---------------YSECRNSAQIYKKVSSGI----K 229
+DI+S G+ ++EM YP + + ++ VS +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235
Query: 230 PAAL----------------SKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 268
P A+ S E + F++KCL +R KEL PF++
Sbjct: 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 73/240 (30%), Positives = 118/240 (49%), Gaps = 26/240 (10%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 107
Q+ E + + EV L+ LKH N I + ++ + T ++ E + GS + HKK
Sbjct: 60 QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH--TAWLVME-YCLGSASDLLEVHKK 116
Query: 108 ----VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163
V++ A+ A L GL YLHSH+ +IHRD+K NI + G+VK+ D G A+
Sbjct: 117 PLQEVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASK 170
Query: 164 MEQANAKSVIGTPEFMAPEL---YDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ 219
AN S +GTP +MAPE+ DE Y+ D++S G+ +E+ + P +
Sbjct: 171 SSPAN--SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 228
Query: 220 IYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQ-RLSAKELLMDPFLQVNGTTKNRPL 278
+Y ++ P S + F++ CL Q R ++ ELL F++ ++RP
Sbjct: 229 LY-HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR-----RDRPA 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 13/168 (7%)
Query: 47 LQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH 105
S E+ L EV L+ L H NI++ + + N + + E + G+L Q K
Sbjct: 36 FYSWEECMNL-REVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE-YMEGNLYQLMKDR 91
Query: 106 KKVDM--KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-T 162
K ++ QIL GL ++H H HRDLK +N+ ++G VKI D GLA
Sbjct: 92 KGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLARE 148
Query: 163 IMEQANAKSVIGTPEFMAPE--LYDENYNELADIYSFGMCMLEMVTFE 208
I + + T + APE L +Y+ DI++ G M E+ T
Sbjct: 149 IRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-19
Identities = 76/240 (31%), Positives = 121/240 (50%), Gaps = 26/240 (10%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 107
QS E + + EV L+ L+H N I++ ++ + T ++ E + GS + HKK
Sbjct: 54 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAWLVME-YCLGSASDLLEVHKK 110
Query: 108 ----VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163
V++ AV A L GL YLHSH+ +IHRD+K NI ++ G VK+GD G A+I
Sbjct: 111 PLQEVEIAAVTHGA---LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASI 164
Query: 164 MEQANAKSVIGTPEFMAPEL---YDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ 219
M AN +GTP +MAPE+ DE Y+ D++S G+ +E+ + P +
Sbjct: 165 MAPAN--XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222
Query: 220 IYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQ-RLSAKELLMDPFLQVNGTTKNRPL 278
+Y ++ PA S ++F++ CL Q R +++ LL F+ + RP
Sbjct: 223 LY-HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL-----RERPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 6e-19
Identities = 79/296 (26%), Positives = 132/296 (44%), Gaps = 48/296 (16%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLER-LYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
YKA D+ G VA ++++ + ++ + + E+ LL+ LKH NII + + N
Sbjct: 17 YKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN 76
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMKA-VKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+N++ E F L + K V A +K + L GL YLHS+ I+HRDLK +
Sbjct: 77 --INLVFE-FMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPN 131
Query: 143 NIFINGNQGEVKIGDLGLATIMEQANAK---SVIGTPEFMAPELY--DENYNELADIYSF 197
N+ I + G +K+ D GLA N K V+ T + APEL +Y D++S
Sbjct: 132 NLLIASD-GVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGARHYGVGVDMWSV 189
Query: 198 GMCMLEM---VTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDP-EVKSF------- 244
G E+ V F S+ +I++ + + + ++ + D E K F
Sbjct: 190 GCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQ 249
Query: 245 ------------IEKCLV--PASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLP 286
+++ L P ++R++A++ L P+ N P P P LP
Sbjct: 250 IFPAASDDALDLLQRLLTLNP-NKRITARQALEHPYF------SNDPAPTPPSQLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 7e-19
Identities = 71/257 (27%), Positives = 124/257 (48%), Gaps = 32/257 (12%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKA+ + +A V++ + + E +++ SE+ +L II FY ++ +
Sbjct: 18 YKAYHLLTRRILA---VKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR- 73
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
++I TE GSL YRK + V + A ++ GL YL S I+HRD+K N+
Sbjct: 74 -ISICTEFMDGGSLDVYRKIPEHVLGRI----AVAVVKGLTYLWSLK--ILHRDVKPSNM 126
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLE 203
+N +G+VK+ D G++T + + AK+ +GT +MAPE + E Y +D++S G+ +E
Sbjct: 127 LVN-TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFME 185
Query: 204 MVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD------------PEVKSFIEKCL-V 250
+ +PY QI K S + L + D + FI +C+
Sbjct: 186 LALGRFPY------PQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRK 239
Query: 251 PASQRLSAKELLMDPFL 267
+R + + L+ PF+
Sbjct: 240 QPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 14/229 (6%)
Query: 47 LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK 106
L+ +D + E+ ++K KH NI+ ++ S++ + + I E GSL+
Sbjct: 44 LEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREK--LWICMEYCGGGSLQDIYHVTG 101
Query: 107 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166
+ + R+ L GL YLHS +HRD+K NI + N G+VK+ D G+A +
Sbjct: 102 PLSELQIAYVCRETLQGLAYLHSKGK--MHRDIKGANILLTDN-GDVKLADFGVAAKITA 158
Query: 167 --ANAKSVIGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI 220
A KS IGTP +MAPE+ + YN+L DI++ G+ +E+ + P + +
Sbjct: 159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
Query: 221 YKKVSSGIKPAALS-KVK-DPEVKSFIEKCLVP-ASQRLSAKELLMDPF 266
+ S +P L K K +F++ L +R +A+ LL F
Sbjct: 219 FLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 16/211 (7%)
Query: 70 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMK----AVKGWARQILSGLI 125
+ FY + + V I E+ + SL ++ KK + + A I+ L
Sbjct: 61 YTVTFYGALF--REGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 126 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV-IGTPEFMAPELY 184
YLHS +IHRD+K N+ IN G+VK+ D G++ + + AK++ G +MAPE
Sbjct: 118 YLHSK-LSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERI 175
Query: 185 D-----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 239
+ + Y+ +D++S G+ M+E+ T +PY + Q K+V P ++ P
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSP 235
Query: 240 EVKSFIEKCLVP-ASQRLSAKELLMDPFLQV 269
E + F+ KCL +R + ELL PF ++
Sbjct: 236 EFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 57/187 (30%), Positives = 98/187 (52%), Gaps = 11/187 (5%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV 108
SP++ E EV +L ++KH NI+++ S+ ++N + I+ + G L + + V
Sbjct: 39 SPKEREESRKEVAVLSNMKHPNIVQYQESF--EENGNLYIVMDYCEGGDLYKKINAQRGV 96
Query: 109 --DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166
+ W QI L H HD I+HRD+K NIF+ G +K+GD G+A ++
Sbjct: 97 LFPEDQILDWFVQICLAL--KHVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNS 153
Query: 167 AN--AKSVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKK 223
A++ IGTP +++PE+ + YN +DI++ G + EM T ++ + E N + K
Sbjct: 154 TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLK 212
Query: 224 VSSGIKP 230
+ G P
Sbjct: 213 IIRGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 53/188 (28%), Positives = 94/188 (50%), Gaps = 20/188 (10%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY--RKKHK 106
P+D E ++K L+H +I+ Y ++ + I+TEL GSL +Y +
Sbjct: 44 DPKDFLA---EAQIMKKLRHPKLIQLYAVCTLEE--PIYIVTELMKYGSLLEYLQGGAGR 98
Query: 107 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166
+ + + A Q+ SG+ YL + + IHRDL N+ + G K+ D GLA ++++
Sbjct: 99 ALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLV-GENNICKVADFGLARVIKE 155
Query: 167 ANAKSVIGTP---EFMAPELYDENYNEL---ADIYSFGMCMLEMVTF-EYPYSECRNSAQ 219
++ G ++ APE YN +D++SFG+ + E+VT+ PY N A+
Sbjct: 156 DIYEAREGAKFPIKWTAPEA--ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AE 212
Query: 220 IYKKVSSG 227
+ ++V G
Sbjct: 213 VLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 12/214 (5%)
Query: 45 DVLQSPEDLERLYSEVHLLK-SLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-- 101
D + + + + SEV ++K L+H NI+R+Y +++ +N + I+ +L L ++
Sbjct: 44 DKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL--ENDRLYIVMDLIEGAPLGEHFN 101
Query: 102 RKKHKKVDMKAVKGWAR--QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 159
K KK + W Q++ L YLH + I+HRDL +NI + G +V I D G
Sbjct: 102 SLKEKKQRFTEERIWNIFVQMVLALRYLHK-EKRIVHRDLTPNNIML-GEDDKVTITDFG 159
Query: 160 LA-TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNS 217
LA ++ SV+GT + PE + +E Y E AD+++FG + +M T + P+ N
Sbjct: 160 LAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNM 218
Query: 218 AQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP 251
+ K+ + + +V I CL P
Sbjct: 219 LSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTP 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 51/166 (30%), Positives = 89/166 (53%), Gaps = 10/166 (6%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-K 107
+ E L E+ +LKSL+H+NI+++ + + ++ E GSLR Y +KH+ +
Sbjct: 45 TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER 104
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167
+D + + +A QI G+ YL S +HRDL NI + ++ VKIGD GL ++ Q
Sbjct: 105 LDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLPQD 161
Query: 168 NAKSVIGTPE-----FMAPE-LYDENYNELADIYSFGMCMLEMVTF 207
+ P + APE L + ++ +D++SFG+ + E+ T+
Sbjct: 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 77/283 (27%), Positives = 114/283 (40%), Gaps = 51/283 (18%)
Query: 25 YKAFDEVNGLEVAWCQVRI----DDVLQSPEDLERLYSEVHLLKSLK---HNNIIRFYN- 76
YKA D G VA +VR+ + + S E+ LLK L+ H NI+R +
Sbjct: 16 YKARDLNTGRFVALKKVRVPLSEEGIPLS------TLREIALLKQLESFEHPNIVRLLDV 69
Query: 77 --SWIDDQNKTVNIITELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDP 132
D+ + ++ E L Y K K + + +K RQ+L G+ +LHSH
Sbjct: 70 CHGPRTDRELKLTLVFE-HVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR- 127
Query: 133 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LYDENYNE 190
I+HRDLK NI + + G+VKI D GLA I A SV+ T + APE L +Y
Sbjct: 128 -IVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYAT 185
Query: 191 LADIYSFGMCMLEMVTFE---YPYSECRNSAQIYKKV---------------------SS 226
D++S G E+ SE +I+ + +
Sbjct: 186 PVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYT 245
Query: 227 GIKPAALSKVKDPEVKSFIEKCLV--PASQRLSAKELLMDPFL 267
+ E ++K L P R+SA E L P+
Sbjct: 246 PRSFKSFVPEICEEGLDLLKKMLTFNPHK-RISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 61/189 (32%), Positives = 95/189 (50%), Gaps = 12/189 (6%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRK--KH 105
+S +E E LL +KH NI+ F S+ D + + I+ E G L Q K +
Sbjct: 37 KSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGH--LYIVMEYCDGGDLMQKIKLQRG 94
Query: 106 KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165
K + W Q+ G+ H H+ ++HRD+K NIF+ N G+VK+GD G A ++
Sbjct: 95 KLFPEDTILQWFVQMCLGV--QHIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLT 151
Query: 166 Q--ANAKSVIGTPEFMAPELYDEN--YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIY 221
A A + +GTP ++ PE++ EN YN +DI+S G + E+ T ++P+ I
Sbjct: 152 SPGAYACTYVGTPYYVPPEIW-ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL 210
Query: 222 KKVSSGIKP 230
K KP
Sbjct: 211 KVCQGSYKP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.9 bits (217), Expect = 6e-18
Identities = 71/238 (29%), Positives = 125/238 (52%), Gaps = 32/238 (13%)
Query: 55 RLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL-RQYRKKHK---KVDM 110
+L EV++++ LKH NI+R+ + +++ N+ + I+ E +G L R +K +K K++
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 111 KAVKGWARQILSGLIYLHS-HDPP----IIHRDLKCDNIFI--------------NGNQG 151
A+ RQ+L L Y H+ D P ++HRDLK NIF+ N G
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 152 E--VKIGDLGLA-TIMEQANAKSVIGTPEFMAPELY---DENYNELADIYSFGMCMLEMV 205
KIGD GL+ I ++ A S +GTP + +PEL ++Y++ +D+++ G + E+
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 206 TFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL-VPASQRLSAKELL 262
+ + P+ + N +Q+ ++ G P K K E+ I+ L + A +R SA + L
Sbjct: 238 SGKTPFHKANNFSQLISELKRG--PDLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 75/257 (29%), Positives = 117/257 (45%), Gaps = 45/257 (17%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN----KTVNIITELFTSGSLRQYRK 103
QS +R Y E+ LLK + H N+I + + + + V ++T L + L
Sbjct: 53 QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNI-V 110
Query: 104 KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163
K +K+ ++ QIL GL Y+HS IIHRDLK NI +N + E+KI D GLA
Sbjct: 111 KCQKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNED-CELKILDFGLA-- 165
Query: 164 MEQANAK--SVIGTPEFMAPE--LYDENYNELADIYSFGMCMLEMVTFE--YPYSECRN- 216
+ + + T + APE L +YN+ DI+S G M E++T + +P S+ +
Sbjct: 166 -RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ 224
Query: 217 -----------SAQIYKKVSSG-----IKPAALSKVKD---------PEVKSFIEKCLV- 250
++ +K+SS I+ KD P +EK LV
Sbjct: 225 LKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVL 284
Query: 251 PASQRLSAKELLMDPFL 267
+R++A E L P+L
Sbjct: 285 DPDKRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 8e-18
Identities = 72/229 (31%), Positives = 116/229 (50%), Gaps = 21/229 (9%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 107
QS E + + EV L+ +KH N I + ++ + T ++ E + GS + HKK
Sbjct: 64 QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH--TAWLVME-YCLGSASDLLEVHKK 120
Query: 108 ----VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163
V++ A+ A L GL YLHSH+ +IHRD+K NI + G+VK+ D G A+I
Sbjct: 121 PLQEVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASI 174
Query: 164 MEQANAKSVIGTPEFMAPEL---YDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ 219
AN S +GTP +MAPE+ DE Y+ D++S G+ +E+ + P +
Sbjct: 175 ASPAN--SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 232
Query: 220 IYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQ-RLSAKELLMDPFL 267
+Y ++ P S ++F++ CL Q R +++ELL F+
Sbjct: 233 LY-HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 62/239 (25%), Positives = 121/239 (50%), Gaps = 22/239 (9%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+ D ++ A + I +V++ ++ + +++E +LK + H IIR + + D +
Sbjct: 18 HLVRDRISEHYYALKVMAIPEVIRLKQE-QHVHNEKRVLKEVSHPFIIRLFWTEHDQRF- 75
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ ++ E G L Y + + +A +I+ L YLHS + I++RDLK +NI
Sbjct: 76 -LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENI 132
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLE 203
++ +G +K+ D G A + ++ GTPE++APE + + +N+ D ++ G+ + E
Sbjct: 133 LLD-KEGHIKLTDFGFAKKLRD-RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYE 190
Query: 204 MVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK-----DPEVKSFIEKCLV-PASQRL 256
M+ P+ + N IY+K+ +G K++ D K I+K LV ++RL
Sbjct: 191 MLVGYPPFFD-DNPFGIYEKILAG-------KLEFPRHLDLYAKDLIKKLLVVDRTRRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 59/181 (32%), Positives = 93/181 (51%), Gaps = 20/181 (11%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQ-----YRKKHKKVDMKAV 113
E+ LL+ LKH N++ +++ +K+V ++ + + L Q + K + V
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFD-YAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 114 KGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN---QGEVKIGDLGLATIMEQ---- 166
K QIL+G+ YLHS+ ++HRDLK NI + G +G VKIGDLGLA +
Sbjct: 111 KSLLWQILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 167 -ANAKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKK 223
A+ V+ T + APEL +Y + DI++ G E++T E P + R A+I K
Sbjct: 169 LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE-PIFKGRE-AKIKKS 226
Query: 224 V 224
Sbjct: 227 N 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 67/231 (29%), Positives = 116/231 (50%), Gaps = 12/231 (5%)
Query: 41 VRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQ 100
++I D+ ++ +++E + E+ +L + ++Y S++ + + II E GS
Sbjct: 34 IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KGTKLWIIMEYLGGGSALD 91
Query: 101 YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160
+ D + ++IL GL YLHS IHRD+K N+ ++ QG+VK+ D G+
Sbjct: 92 LLRA-GPFDEFQIATMLKEILKGLDYLHSEKK--IHRDIKAANVLLS-EQGDVKLADFGV 147
Query: 161 ATIMEQANAK--SVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEYPYSECRNS 217
A + K + +GTP +MAPE+ ++ Y+ ADI+S G+ +E+ E P S+
Sbjct: 148 AGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM 207
Query: 218 AQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL-VPASQRLSAKELLMDPFL 267
++ + P L+ K FI+ CL S R +AKELL F+
Sbjct: 208 RVLF--LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 53/164 (32%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV 108
++ E+++LK+L H NI+++ + K + +I E GSLR Y KH K+
Sbjct: 46 GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KL 104
Query: 109 DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168
++ + +A+QI G+ YLHS IHRDL N+ ++ N VKIGD GLA + + +
Sbjct: 105 NLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH 161
Query: 169 AKSVIG----TPEF-MAPELYDEN-YNELADIYSFGMCMLEMVT 206
+ +P F A E EN ++ +D++SFG+ + E++T
Sbjct: 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 23/257 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YK G+ +A ++R++ ++ E+ +L I+ FY ++
Sbjct: 18 YKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAVSPYIVDFYGAFF--IEG 72
Query: 85 TVNIITELFTSGSLRQY---RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 141
V + E +GSL + + + ++ ++ GL +L + IIHRD+K
Sbjct: 73 AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL-KEEHNIIHRDVKP 131
Query: 142 DNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDEN------YNELADI 194
N+ +NGN G+VK+ D G++ + + AK+ IG +MAPE + Y +D+
Sbjct: 132 TNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDV 190
Query: 195 YSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKSFIEKCL--V 250
+S G+ +LEM YPY A I+ ++S+ + P L + + F+ KCL +
Sbjct: 191 WSLGLSILEMALGRYPYPP-ETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKI 249
Query: 251 PASQRLSAKELLMDPFL 267
P ++R + +LL P+L
Sbjct: 250 P-NRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 48/174 (27%), Positives = 88/174 (50%), Gaps = 9/174 (5%)
Query: 45 DVLQSPEDLERLYSEVHLLK-SLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRK 103
DV+ +D+E E +L + +H + + ++ + + + E G L + +
Sbjct: 31 DVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF--QTKEHLFFVMEYLNGGDLMFHIQ 88
Query: 104 KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-- 161
+ D + +A +I+ GL +LH II+RDLK DN+ ++ G +KI D G+
Sbjct: 89 SSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKE 145
Query: 162 TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSEC 214
+ + A + GTP+++APE L + YNE D +SFG+ + EM+ + P+
Sbjct: 146 NMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 27/194 (13%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKA D++ G VA ++++ +S + E+ LLK L H NII+ + + +
Sbjct: 16 YKARDKLTGEIVAIKKIKLRF--ESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGD- 72
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ ++ E + + + + + + +K + Q+L GL + HSH I+HRDLK +N+
Sbjct: 73 -LYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENL 129
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFM----------APELY--DENYNELA 192
IN G +K+ D GL A+S APEL D+ Y+
Sbjct: 130 LINTE-GVLKLADFGL--------ARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 193 DIYSFGMCMLEMVT 206
DI+S G E+++
Sbjct: 181 DIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 61/190 (32%), Positives = 97/190 (51%), Gaps = 18/190 (9%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YK + G VA ++ +D +P R E+ L+K LKH NI+R ++ I +NK
Sbjct: 17 YKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVRLHDV-IHTENK 72
Query: 85 TVNIITELFTSGSLRQYRKKH---KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 141
+ ++ E + L++Y H +D VK + Q+L G+ + H + ++HRDLK
Sbjct: 73 LM-LVFE-YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKP 128
Query: 142 DNIFINGNQGEVKIGDLGLAT---IMEQANAKSVIGTPEFMAPE--LYDENYNELADIYS 196
N+ IN +GE+K+ D GLA I + V+ T + AP+ L Y+ DI+S
Sbjct: 129 QNLLINK-RGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTSIDIWS 186
Query: 197 FGMCMLEMVT 206
G M EM+T
Sbjct: 187 VGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 66/269 (24%), Positives = 117/269 (43%), Gaps = 47/269 (17%)
Query: 46 VLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID---DQNKTVNIITELFTSGSLRQYR 102
VL P+ ++ E+ +++ L H+NI++ Y D + V +TEL + +++Y
Sbjct: 39 VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM 98
Query: 103 K-------KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKI 155
+ + + + + + Q+L GL Y+HS + ++HRDLK N+FIN +KI
Sbjct: 99 ETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKI 156
Query: 156 GDLGLATIMEQANAKS-----VIGTPEFMAPE--LYDENYNELADIYSFGMCMLEMVT-- 206
GD GLA I++ + + T + +P L NY + D+++ G EM+T
Sbjct: 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
Query: 207 ----------------------FEYPYSECRNSAQIYKKVSSGIKPAALSKV---KDPEV 241
E +E N + + G L + +PE
Sbjct: 217 PLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEA 276
Query: 242 KSFIEKCLVPA-SQRLSAKELLMDPFLQV 269
F+E+ L RL+A+E LM P++
Sbjct: 277 LDFLEQILTFNPMDRLTAEEALMHPYMSC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 61/193 (31%), Positives = 95/193 (49%), Gaps = 24/193 (12%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS----EVHLLKSLKHNNIIRFYNSWID 80
YKA D++ G VA ++R++ ED E + S E+ LLK L H NI+R +
Sbjct: 16 YKARDKLTGEIVALKKIRLET-----ED-EGVPSTAIREISLLKELNHPNIVRLLDVVHS 69
Query: 81 DQNKTVNIITELFTSGSLRQY--RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRD 138
+ + ++ E F L++Y +D +K + Q+L G+ Y HSH ++HRD
Sbjct: 70 ENK--LYLVFE-FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRD 124
Query: 139 LKCDNIFINGNQGEVKIGDLGLAT---IMEQANAKSVIGTPEFMAPE--LYDENYNELAD 193
LK N+ I+ +G +K+ D GLA + + V+ T + APE L Y+ D
Sbjct: 125 LKPQNLLID-REGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYSTPVD 182
Query: 194 IYSFGMCMLEMVT 206
I+S G EMV
Sbjct: 183 IWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 71/286 (24%), Positives = 121/286 (42%), Gaps = 56/286 (19%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 107
S EDL+ L E+ + L+H NI+ + S+I D + +++ L GS K H
Sbjct: 38 CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE--LYVVSPLMAYGSCEDLLKTHFP 95
Query: 108 VDMK--AVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-TIM 164
+ A+ + +L+ L Y+HS IHR +K +I ++G+ G+V + L + +++
Sbjct: 96 EGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMI 152
Query: 165 EQANAKSVI-GTPEF-------MAPELYDEN---YNELADIYSFGMCMLEMVTFEYPYSE 213
+ + V+ P+ ++PE+ +N YNE +DIYS G+ E+ P+ +
Sbjct: 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212
Query: 214 CRNSAQIYKKV------------------------SSGIKPAALSKVKDPEVKSF----- 244
+ + +KV SS P V P ++F
Sbjct: 213 MPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFH 272
Query: 245 --IEKCL-VPASQRLSAKELLMDPFL-QVNGTTKNRPLPLPDIVLP 286
+E CL R SA +LL F Q K R L D++ P
Sbjct: 273 QFVELCLQRDPESRPSASQLLNHSFFKQC----KRRNTSLLDLLKP 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 52/142 (36%), Positives = 80/142 (56%), Gaps = 17/142 (11%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS----EVHLLKSLKHNNIIRFYNSWID 80
+KA + VA +VR+DD D E + S E+ LLK LKH NI+R Y+ +
Sbjct: 17 FKAKNRETHEIVALKRVRLDD------DDEGVPSSALREICLLKELKHKNIVRLYD--VL 68
Query: 81 DQNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL 139
+K + ++ E + L++Y + +D + VK + Q+L GL + HSH+ ++HRDL
Sbjct: 69 HSDKKLTLVFE-YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDL 125
Query: 140 KCDNIFINGNQGEVKIGDLGLA 161
K N+ IN N GE+K+ D GLA
Sbjct: 126 KPQNLLINKN-GELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 57/188 (30%), Positives = 96/188 (51%), Gaps = 20/188 (10%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--K 106
SPE + E ++K L+H+ +++ Y + + + + I+TE + GSL + K K
Sbjct: 44 SPEAFLQ---EAQIMKKLRHDKLVQLYA--VCSEEEPIYIVTEYMSKGSLLDFLKSGEGK 98
Query: 107 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME- 165
K+ + + A QI G+ YL S + IHRDL NI + G KI D GLA ++E
Sbjct: 99 KLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILV-GENLVCKIADFGLARLIED 155
Query: 166 -QANAKSVIGTP-EFMAPELYDENYNEL---ADIYSFGMCMLEMVTF-EYPYSECRNSAQ 219
+ A+ P ++ APE NY +D++SFG+ + E+VT+ PY + +
Sbjct: 156 DEYTAREGAKFPIKWTAPEA--ANYGRFTIKSDVWSFGILLTEIVTYGRVPY-PGMTNRE 212
Query: 220 IYKKVSSG 227
+ ++V G
Sbjct: 213 VLEQVERG 220
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 34 LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93
+ VA ++ D + +D + E ++ SL H N+IR Y + V TEL
Sbjct: 24 IPVAVKCLKSDKLSDIMDDFLK---EAAIMHSLDHENLIRLYGVVLTHPLMMV---TELA 77
Query: 94 TSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 151
GSL +K + + +A QI +G+ YL S IHRDL NI + +
Sbjct: 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDD- 134
Query: 152 EVKIGDLGLAT---------IMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCM 201
+VKIGD GL +M + + K + APE L ++ +D++ FG+ +
Sbjct: 135 KVKIGDFGLMRALPQNEDHYVM-EEHLKVPFA---WCAPESLRTRTFSHASDVWMFGVTL 190
Query: 202 LEMVTF-EYPYSECRNSAQIYKKV 224
EM T+ E P++ + +QI KK+
Sbjct: 191 WEMFTYGEEPWAGL-SGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 65/243 (26%), Positives = 115/243 (47%), Gaps = 35/243 (14%)
Query: 23 SGYKAFDEV------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYN 76
SGY F EV N + VA ++ DD+L+ + EV LK L+H ++I +
Sbjct: 16 SGY--FGEVWEGLWKNRVRVAIKILKSDDLLK----QQDFQKEVQALKRLRHKHLISLFA 69
Query: 77 SWIDDQNKTVNIITELFTSGSLRQYRK--KHKKVDMKAVKGWARQILSGLIYLHSHDPPI 134
+ + V IITEL GSL + + + + + + ++ A Q+ G+ YL +
Sbjct: 70 --VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--S 125
Query: 135 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE-------FMAPE-LYDE 186
IHRDL NI + G K+ D GLA ++ K + + APE
Sbjct: 126 IHRDLAARNILV-GEDLVCKVADFGLARLI-----KEDVYLSSDKKIPYKWTAPEAASHG 179
Query: 187 NYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245
++ +D++SFG+ + EM T+ + PY N+ ++Y ++++G + +K E+ +
Sbjct: 180 TFSTKSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITAGYRMPCPAKCP-QEIYKIM 237
Query: 246 EKC 248
+C
Sbjct: 238 LEC 240
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 7e-16
Identities = 50/139 (35%), Positives = 71/139 (51%), Gaps = 9/139 (6%)
Query: 116 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANAKSVI 173
+ QI+SGL +LH II+RDLK +N+ ++ N G V+I DLGLA ++ Q+ K
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYA 158
Query: 174 GTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KP 230
GTP FMAPE L E Y+ D ++ G+ + EM+ P+ R K++ I
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF-RARGEKVENKELKQRILNDS 217
Query: 231 AALSKVKDPEVKSFIEKCL 249
P KSF E L
Sbjct: 218 VTYPDKFSPASKSFCEALL 236
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-16
Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 11/181 (6%)
Query: 27 AFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 86
A D++ G VA +I +P +R Y E+ LLK L+H NII + +I + +
Sbjct: 29 ARDQLTGQNVA--IKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-EDI 85
Query: 87 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI 146
+TEL + R + ++ + ++ + QIL GL Y+HS ++HRDLK NI I
Sbjct: 86 YFVTELLGTDLHRLL--TSRPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILI 141
Query: 147 NGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE--LYDENYNELADIYSFGMCMLEM 204
N N ++KI D GLA I + + T + APE L + Y+ DI+S G EM
Sbjct: 142 NEN-CDLKICDFGLARIQD-PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEM 199
Query: 205 V 205
+
Sbjct: 200 L 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 48/161 (29%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 120 ILSGLIYL---HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--EQANAKSVIG 174
I+ L YL H +IHRD+K NI ++ + G VK+ D G++ + +A +S G
Sbjct: 123 IVKALHYLKEKHG----VIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTRSA-G 176
Query: 175 TPEFMAPELYD-----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK 229
+MAPE D Y+ AD++S G+ ++E+ T ++PY C+ ++ K+
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP 236
Query: 230 PA-ALSKVKDPEVKSFIEKCLVPASQ-RLSAKELLMDPFLQ 268
P+ ++ P+ SF++ CL + R +ELL PF++
Sbjct: 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 61/190 (32%), Positives = 98/190 (51%), Gaps = 18/190 (9%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQS-PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
YKA +++ G VA ++R+D + P R E+ LLK L H NI++ + I +N
Sbjct: 17 YKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKLLDV-IHTEN 72
Query: 84 KTVNIITELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 141
K + ++ E F L+++ + + +K + Q+L GL + HSH ++HRDLK
Sbjct: 73 K-LYLVFE-FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKP 128
Query: 142 DNIFINGNQGEVKIGDLGLAT---IMEQANAKSVIGTPEFMAPE--LYDENYNELADIYS 196
N+ IN +G +K+ D GLA + + V+ T + APE L + Y+ DI+S
Sbjct: 129 QNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWS 186
Query: 197 FGMCMLEMVT 206
G EMVT
Sbjct: 187 LGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 69/228 (30%), Positives = 108/228 (47%), Gaps = 16/228 (7%)
Query: 27 AFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID----DQ 82
AFD GL VA ++ QS +R Y E+ LLK +KH N+I + + ++
Sbjct: 36 AFDTKTGLRVA--VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93
Query: 83 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
V ++T L L K K D V+ QIL GL Y+HS D IIHRDLK
Sbjct: 94 FNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGLKYIHSAD--IIHRDLKPS 149
Query: 143 NIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDE--NYNELADIYSFGMC 200
N+ +N E+KI D GLA + + T + APE+ +YN+ DI+S G
Sbjct: 150 NLAVN-EDCELKILDFGLARHTDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 207
Query: 201 MLEMVTFE--YPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246
M E++T +P ++ + ++ ++ L K+ +++I+
Sbjct: 208 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 255
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 52/192 (27%), Positives = 99/192 (51%), Gaps = 16/192 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLK-SLKHNNIIRFYNSWIDDQN 83
K DE+ ++V ++ D +LQ +D+E +E +L + KH + + ++ + Q
Sbjct: 16 LKGTDELYAVKV----LKKDVILQD-DDVECTMTEKRVLALAGKHPFLTQLHSCF---QT 67
Query: 84 KT-VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
K + + E G L + ++ + D + +A +I+ GL +LH II+RDLK D
Sbjct: 68 KDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLD 125
Query: 143 NIFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGM 199
N+ ++ +G +KI D G+ I+ + GTP+++APE L + Y D ++ G+
Sbjct: 126 NVLLDS-EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGV 184
Query: 200 CMLEMVTFEYPY 211
+ EM+ + P+
Sbjct: 185 LLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 49/162 (30%), Positives = 86/162 (53%), Gaps = 5/162 (3%)
Query: 50 PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVD 109
P ++ E+ +L I+ FY ++ D ++I E GSL Q KK ++
Sbjct: 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIP 101
Query: 110 MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169
+ + + ++ GL YL I+HRD+K NI +N ++GE+K+ D G++ + + A
Sbjct: 102 EQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 159
Query: 170 KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYP 210
S +GT +M+PE L +Y+ +DI+S G+ ++EM YP
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWA 117
E ++ L H N+++ Y + + + I+TE +G L Y ++ K + +
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCT--KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106
Query: 118 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP- 176
+ + YL S+ IHRDL N + G VK+ D GLA + S GT
Sbjct: 107 SDVCEAMEYLESNG--FIHRDLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTKF 163
Query: 177 --EFMAPELYDEN-YNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGI---K 229
++ PE++D + ++ +D++SFG+ M E+ + + PY NS ++ + VS+G +
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-EVVESVSAGYRLYR 222
Query: 230 PAALSKVKDPEVKSFIEKCLVPASQ-RLSAKELL 262
P K+ EV + + C + R + K+LL
Sbjct: 223 P----KLAPTEVYTIMYSCWHEKPEDRPAFKKLL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 43/176 (24%), Positives = 79/176 (44%), Gaps = 10/176 (5%)
Query: 88 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN 147
++ E G K + K + +++ G+ LH IIHRD+K +N+ I+
Sbjct: 74 LVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH--QRGIIHRDIKPENLLID 131
Query: 148 GNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVT 206
G +K+ D GL+ + K +GTP+++APE + ++++D +S G + E +
Sbjct: 132 -QTGHLKLTDFGLSRNGLE--NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFL- 187
Query: 207 FEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKSFIEKCLVP-ASQRLSAK 259
F YP ++ + S P + + PE I + L ++RL A
Sbjct: 188 FGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGAN 243
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 49/162 (30%), Positives = 87/162 (53%), Gaps = 5/162 (3%)
Query: 50 PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVD 109
P ++ E+ +L I+ FY ++ D ++I E GSL Q K+ K++
Sbjct: 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKEAKRIP 101
Query: 110 MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169
+ + + +L GL YL I+HRD+K NI +N ++GE+K+ D G++ + + A
Sbjct: 102 EEILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 159
Query: 170 KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYP 210
S +GT +M+PE L +Y+ +DI+S G+ ++E+ YP
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 15/171 (8%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-K 107
SP+ + + E +++ S+ H +++R + + V +IT+L G L Y + HK
Sbjct: 49 SPKANKEILDEAYVMASVDHPHVVRLLGICL---SSQVQLITQLMPLGCLLDYVRNHKDN 105
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167
+ + + W QI G+ YL ++HRDL N+ + Q VKI D GLA +++
Sbjct: 106 IGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLD-V 161
Query: 168 NAKSVIGT----P-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPY 211
+ K P ++MA E + Y +D++S+G+ + E++TF PY
Sbjct: 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 9e-15
Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 23/189 (12%)
Query: 41 VRIDDVLQSPEDLERL--YSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL 98
V I V ++ ER+ +E ++K ++++R + T+ ++ EL G L
Sbjct: 39 VAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGV-VSTGQPTL-VVMELMAKGDL 96
Query: 99 RQYRKKHKKVDMKAVKG----------WARQILSGLIYLHSHDPPIIHRDLKCDNIFING 148
+ Y + + A +I G+ YL + +HRDL N +
Sbjct: 97 KSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAE 154
Query: 149 NQGEVKIGDLGLATIMEQANAKSVIGT---P-EFMAPE-LYDENYNELADIYSFGMCMLE 203
+ VKIGD G+ + + + G P +MAPE L D + +D++SFG+ + E
Sbjct: 155 D-LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWE 213
Query: 204 MVTF-EYPY 211
M T E PY
Sbjct: 214 MATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 10/153 (6%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWAR 118
EV +L+ L+H NI+ ++ + ++ E L + AV+ +
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRK--GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIW 107
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK---SVIGT 175
Q+L + Y HSH+ IIHRD+K +NI ++ + G +K+ D G A + A + T
Sbjct: 108 QLLQAIAYCHSHN--IIHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYVAT 164
Query: 176 PEFMAPELY--DENYNELADIYSFGMCMLEMVT 206
+ APEL D NY + D+++ G M E++
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 67/265 (25%), Positives = 128/265 (48%), Gaps = 35/265 (13%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQN 83
+K ++ NG + A V+I D + + E + +E ++LK+L H N+++FY +
Sbjct: 35 FKVLNKKNGSKAA---VKILDPIHDID--EEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89
Query: 84 KTVN---IITELFTSGSL----RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIH 136
K + ++ EL GS+ + + K+ ++++ + + L GL +LH + IH
Sbjct: 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIH 147
Query: 137 RDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPEL------YDENY 188
RD+K +NI + +G VK+ D G++ + + + +GTP +MAPE+ D Y
Sbjct: 148 RDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTY 206
Query: 189 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS----- 243
+ D++S G+ +E+ + P ++ ++K I + PE+ S
Sbjct: 207 DARCDVWSLGITAIELGDGDPPLADLHPMRALFK-----IPRNPPPTLHQPELWSNEFND 261
Query: 244 FIEKCLVPA-SQRLSAKELLMDPFL 267
FI KCL +R + +LL F+
Sbjct: 262 FIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 26/193 (13%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YK ++ G VA ++R++ +P R E LLK LKH NI+ ++ I K
Sbjct: 22 YKGRSKLTGQLVALKEIRLEHEEGAPFTAIR---EASLLKDLKHANIVTLHD--IIHTKK 76
Query: 85 TVNIITELFTSGSLRQYRKKHKK-VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
T+ ++ E + L+QY + M V+ + Q+L GL Y H ++HRDLK N
Sbjct: 77 TLTLVFE-YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQN 133
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAKSV--------IGTPEFMAPE--LYDENYNELAD 193
+ I+ +GE+K+ D GL A AKSV + T + P+ L Y+ D
Sbjct: 134 LLIS-ERGELKLADFGL------ARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLD 186
Query: 194 IYSFGMCMLEMVT 206
++ G EM T
Sbjct: 187 MWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 40/206 (19%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQS-PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
YKA D+ G VA +VR+D+ + P R E+ +L+ L H NI+ D Q+
Sbjct: 24 YKARDKDTGELVALKKVRLDNEKEGFPITAIR---EIKILRQLNHRNIVNLKEIVTDKQD 80
Query: 84 KT--------VNIITE--------LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYL 127
++ E L SG L + + H K MK Q+L GL Y
Sbjct: 81 ALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDHIKSFMK-------QLLEGLNYC 132
Query: 128 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK----SVIGTPEFMAPEL 183
H + +HRD+KC NI +N N+G++K+ D GLA + ++ VI T + PEL
Sbjct: 133 HKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYRPPEL 188
Query: 184 Y--DENYNELADIYSFGMCML-EMVT 206
+E Y D++S G C+L E+ T
Sbjct: 189 LLGEERYGPAIDVWSCG-CILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 11/164 (6%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-K 107
SP E+ E ++++ H +I++ ++ V I+ EL G LR Y + +K
Sbjct: 47 SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---PVWIVMELAPLGELRSYLQVNKYS 103
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167
+D+ ++ ++ Q+ + L YL S +HRD+ N+ ++ VK+GD GL+ +E
Sbjct: 104 LDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDC-VKLGDFGLSRYLEDE 160
Query: 168 N--AKSVIGTP-EFMAPELYD-ENYNELADIYSFGMCMLEMVTF 207
+ S P ++MAPE + + +D++ FG+CM E++
Sbjct: 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILML 204
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 47/172 (27%), Positives = 74/172 (43%), Gaps = 30/172 (17%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT---------SGSLRQYRKKHKKVD 109
E+ +LK LKH N++ + ++ +K+ ++ SG L K +
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LT 113
Query: 110 MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI------ 163
+K + Q+L G+ YLH + I+HRD+K NI I+ NQG +KI D GLA
Sbjct: 114 ESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPP 170
Query: 164 -------MEQANAKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVT 206
+++ T + PEL + Y DI+ G EM T
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 69/260 (26%), Positives = 121/260 (46%), Gaps = 23/260 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQN 83
YK ++ +G A V+I D + + E + +E ++L+SL H N+++FY +
Sbjct: 39 YKVTNKKDGSLAA---VKILDPISDVD--EEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93
Query: 84 KT---VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSG--LIYLHSHDPPIIHRD 138
+ ++ EL GS+ + K + + IL G L H H+ IIHRD
Sbjct: 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRD 153
Query: 139 LKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPEL------YDENYNE 190
+K +NI + +G VK+ D G++ + + + +GTP +MAPE+ YD +Y+
Sbjct: 154 VKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDA 212
Query: 191 LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK-DPEVKSFIEKCL 249
D++S G+ +E+ + P + ++ K+ P L K FI +CL
Sbjct: 213 RCDVWSLGITAIELGDGDPPLFDMHPVKTLF-KIPRNPPPTLLHPEKWCRSFNHFISQCL 271
Query: 250 VPA-SQRLSAKELLMDPFLQ 268
+ R S LL PF++
Sbjct: 272 IKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 42/126 (33%), Positives = 69/126 (54%), Gaps = 6/126 (4%)
Query: 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 148
+ E G L + + K D+ +A +I+ GL +LHS I++RDLK DNI ++
Sbjct: 74 VMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLD- 130
Query: 149 NQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMV 205
G +KI D G+ ++ A + GTP+++APE L + YN D +SFG+ + EM+
Sbjct: 131 TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEML 190
Query: 206 TFEYPY 211
+ P+
Sbjct: 191 IGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 76/245 (31%), Positives = 113/245 (46%), Gaps = 44/245 (17%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR---KKHKKVDMKAVKG 115
E+ LLK L+H NI+ + + Q + +I E F S L++Y K + +D + VK
Sbjct: 49 EISLLKELQHPNIVCLQDVLM--QESRLYLIFE-FLSMDLKKYLDSLPKGQYMDAELVKS 105
Query: 116 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT---IMEQANAKSV 172
+ QIL G+++ HS ++HRDLK N+ I+ N+G +K+ D GLA I + V
Sbjct: 106 YLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEV 162
Query: 173 IGTPEFMAPE--LYDENYNELADIYSFGMCMLEMVT-----------------FEY---P 210
+ T + APE L Y+ DI+S G EM T F P
Sbjct: 163 V-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTP 221
Query: 211 YSECRN---SAQIYKKVSSGIKPAAL-SKVK--DPEVKSFIEKCLV--PASQRLSAKELL 262
+ S YK K +L S VK D + +EK L+ PA +R+SAK+ L
Sbjct: 222 TEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPA-KRISAKKAL 280
Query: 263 MDPFL 267
P+
Sbjct: 281 NHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 24/217 (11%)
Query: 17 IQLVDTSGYKAFDEV-NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 75
++LV G F EV G +V I + Q E +E +L+K L+H ++R Y
Sbjct: 8 LKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLY 67
Query: 76 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVK--GWARQILSGLIYLHSHDPP 133
+ + IITE +GSL + K + + + K A QI G+ ++ +
Sbjct: 68 AVV---TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN-- 122
Query: 134 IIHRDLKCDNIFINGNQGEVKIGDLGLATIME------QANAKSVIGTPEFMAPELYDEN 187
IHRDL+ NI ++ KI D GLA ++E + AK I ++ APE N
Sbjct: 123 YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPI---KWTAPEAI--N 176
Query: 188 YNEL---ADIYSFGMCMLEMVTF-EYPYSECRNSAQI 220
Y +D++SFG+ + E+VT+ PY N I
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 20/203 (9%)
Query: 18 QLVDTSGYKAFDEV-------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HN 69
+++ G F EV G A + + +S E + L E+ L+ L H
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYA-IK-CMKKHFKSLEQVNNL-REIQALRRLSPHP 58
Query: 70 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK-VDMKAVKGWARQILSGLIYLH 128
NI+R D + + ++ EL +L + K K+ + K VK + Q+L L ++H
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 129 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLG-LATIMEQANAKSVIGTPEFMAPE--LYD 185
+ I HRD+K +NI I +K+ D G I + I T + APE L D
Sbjct: 118 RNG--IFHRDIKPENILI--KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTD 173
Query: 186 ENYNELADIYSFGMCMLEMVTFE 208
Y DI++ G E+++
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 52/156 (33%), Positives = 82/156 (52%), Gaps = 9/156 (5%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWAR 118
E LL+++ H ++IR ++ + ++ ++S K+ + + + +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV--SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI-MEQANAKSVIGTPE 177
QIL GL YLH+ IIHRD+K +NIFIN + +V IGDLG A + + GT E
Sbjct: 165 QILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVE 221
Query: 178 FMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYS 212
APE L + YN ADI+S G+ + EM+ YP +
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPST 255
|
Length = 357 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 38/100 (38%), Positives = 57/100 (57%), Gaps = 6/100 (6%)
Query: 116 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI-MEQANAKSVI- 173
+A ++ GL YLH + I++RDLK DN+ ++ +G VKI D GL M + S
Sbjct: 106 YAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTSTFC 162
Query: 174 GTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYS 212
GTPEF+APE L + +Y D + G+ + EM+ E P+
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 55/233 (23%), Positives = 94/233 (40%), Gaps = 45/233 (19%)
Query: 71 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH 130
I++ Y S+ D+++ + ++ E G L + + + + +++ L +H
Sbjct: 63 IVKLYYSFQDEEH--LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 131 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----------------------- 167
IHRD+K DNI I G +K+ D GL M +A
Sbjct: 121 G--FIHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 168 --------NAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYP--YSECRN 216
A S +GTP+++APE L Y D +S G+ + EM+ + +P YS+
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML-YGFPPFYSD--T 234
Query: 217 SAQIYKKVSSGIKPAALSKVKD--PEVKSFIEKCLVPASQRL-SAKELLMDPF 266
+ Y K+ + + PE I + L RL S +E+ PF
Sbjct: 235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 61/229 (26%), Positives = 113/229 (49%), Gaps = 19/229 (8%)
Query: 26 KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLK-SLKHNNIIRFYNSWIDDQNK 84
K DEV ++V ++ D +LQ +D++ +E +L + KH + + + Q K
Sbjct: 17 KGTDEVYAIKV----LKKDVILQD-DDVDCTMTEKRILALAAKHPFLTALHCCF---QTK 68
Query: 85 T-VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ + E G L ++ +K D + +A ++ L++LH H +I+RDLK DN
Sbjct: 69 DRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDN 126
Query: 144 IFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFMAPELYDE-NYNELADIYSFGMC 200
I ++ +G K+ D G+ I+ + GTP+++APE+ E Y D ++ G+
Sbjct: 127 ILLDA-EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVL 185
Query: 201 MLEMVTFEYPYSECRNSAQIYKKV--SSGIKPAALSKVKDPEVKSFIEK 247
M EM+ + P+ E N +++ + + P LSK +K+F+ K
Sbjct: 186 MYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 53/194 (27%), Positives = 80/194 (41%), Gaps = 18/194 (9%)
Query: 88 IITELFTSGSLRQ--YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIF 145
++ L G L+ Y +A QI+ GL H H I++RDLK +N+
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGL--EHLHQRRIVYRDLKPENVL 127
Query: 146 INGNQGEVKIGDLGLATIM-EQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLE 203
++ + G V+I DLGLA + K GTP +MAPE L E Y+ D ++ G + E
Sbjct: 128 LD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYE 186
Query: 204 MVTFEYP---YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRL--- 256
M+ P E ++ ++ PE K E L +RL
Sbjct: 187 MIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCR 244
Query: 257 --SAKELLMDPFLQ 268
SA E+ P +
Sbjct: 245 GGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 45/144 (31%), Positives = 76/144 (52%), Gaps = 10/144 (6%)
Query: 134 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV-IGTPEFMAPELYDEN----Y 188
IIHRD+K NI ++ N G +K+ D G++ + + AK+ G +MAPE D + Y
Sbjct: 129 IIHRDVKPSNILLDRN-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGY 187
Query: 189 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG---IKPAALSKVKDPEVKSFI 245
+ +D++S G+ + E+ T ++PY + + +V G I + + P +FI
Sbjct: 188 DVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFI 247
Query: 246 EKCLVP-ASQRLSAKELLMDPFLQ 268
CL+ S+R KELL PF++
Sbjct: 248 NLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 61/233 (26%), Positives = 115/233 (49%), Gaps = 21/233 (9%)
Query: 45 DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK 104
+V+ + +++ +E +L++ +H + S+ + + + E G L + +
Sbjct: 31 EVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF--QTHDRLCFVMEYANGGELFFHLSR 88
Query: 105 HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT-- 162
+ + + +I+S L YLHS D +++RDLK +N+ ++ + G +KI D GL
Sbjct: 89 ERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEG 145
Query: 163 IMEQANAKSVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIY 221
I + A K+ GTPE++APE+ ++N Y D + G+ M EM+ P+ ++ +++
Sbjct: 146 ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLF 204
Query: 222 KKVSSG-IK-PAALSKVKDPEVKSFIEKCLVP-ASQRL-----SAKELLMDPF 266
+ + I+ P LS PE KS + L QRL AKE++ F
Sbjct: 205 ELILMEEIRFPRTLS----PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 53/162 (32%), Positives = 80/162 (49%), Gaps = 17/162 (10%)
Query: 116 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT--IMEQANAKSVI 173
+ +I+S L YLHS D +++RD+K +N+ ++ G +KI D GL I + A K+
Sbjct: 100 YGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFC 156
Query: 174 GTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-PA 231
GTPE++APE L D +Y D + G+ M EM+ P+ + + I+ P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR 216
Query: 232 ALSKVKDPEVKSFIEKCLVP-ASQRL-----SAKELLMDPFL 267
LS PE KS + L QRL AKE++ F
Sbjct: 217 TLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 22/194 (11%)
Query: 51 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK--- 107
++ + E HL+ + H NI++ + N+ II EL G L Y + +
Sbjct: 41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIMELMEGGDLLSYLRDARVERF 98
Query: 108 ----VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE----VKIGDLG 159
+ +K + + G +YL IHRDL N ++ + VKIGD G
Sbjct: 99 GPPLLTLKELLDICLDVAKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156
Query: 160 LATIMEQANAKSVIGTP----EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSE 213
LA + +++ G +MAPE L D + +D++SFG+ M E++T + PY
Sbjct: 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP- 215
Query: 214 CRNSAQIYKKVSSG 227
N+ ++ + V++G
Sbjct: 216 ALNNQEVLQHVTAG 229
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 150
ELFT R++ + V+ + +I+ L +LH II+RD+K +NI ++
Sbjct: 91 ELFTHLYQREHFTES------EVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE- 141
Query: 151 GEVKIGDLGLATIM---EQANAKSVIGTPEFMAPELY---DENYNELADIYSFGMCMLEM 204
G V + D GL+ E+ A S GT E+MAPE+ +++ D +S G+ E+
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 205 VTFEYPYS---ECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRL---S 257
+T P++ E + ++I +++ P K E + FI+K L +RL
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQKLLEKDPKKRLGANG 259
Query: 258 AKELLMDPFLQ----VNGTTKNRPLP 279
A E+ PF Q + K P P
Sbjct: 260 ADEIKNHPFFQGIDWDDLAAKRIPAP 285
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 58/241 (24%), Positives = 102/241 (42%), Gaps = 38/241 (15%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWAR 118
E+ +LK LKH N++ + + + ++++ E L + K + V +K
Sbjct: 50 EIRMLKQLKHPNLVNLIEVF--RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIW 107
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANAKSVIGTP 176
Q L + + H H+ IHRD+K +NI I QG++K+ D G A I+ + + T
Sbjct: 108 QTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATR 164
Query: 177 EFMAPELY--DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK------------ 222
+ APEL D Y D+++ G E++T + + + Q+Y
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH 224
Query: 223 -------KVSSGIKPAALSKVKDPEVK---------SFIEKCLVP-ASQRLSAKELLMDP 265
+ G+ + E K SF++ CL ++RLS +ELL P
Sbjct: 225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP 284
Query: 266 F 266
+
Sbjct: 285 Y 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 56/202 (27%), Positives = 86/202 (42%), Gaps = 37/202 (18%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLER----LYS--EVHLLKSLKHNNIIRFYNSW 78
Y+A D +G VA +VR+D+ ER + S E+ LL +L+H NI+
Sbjct: 24 YRARDTTSGEIVALKKVRMDN--------ERDGIPISSLREITLLLNLRHPNIVELKEVV 75
Query: 79 IDDQNKTVNIITELFTS--GSLRQYRKKHKKVDMKA------VKGWARQILSGLIYLHSH 130
+ ++ ++ E SL +M VK Q+L GL YLH +
Sbjct: 76 VGKHLDSIFLVMEYCEQDLASLLD--------NMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 131 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANAKSVIGTPEFMAPELY--DE 186
IIHRDLK N+ + G +KI D GLA + T + APEL
Sbjct: 128 --FIIHRDLKVSNLLLTDK-GCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCT 184
Query: 187 NYNELADIYSFGMCMLEMVTFE 208
Y D+++ G + E++ +
Sbjct: 185 TYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 17/211 (8%)
Query: 17 IQLVDTSGYKAFDEV-NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 75
I+LV G F EV G +V + + ++ E +L+K+L+H+ ++R Y
Sbjct: 8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 67
Query: 76 NSWIDDQNKTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPP 133
+ + + + IITE GSL + K + KV + + ++ QI G+ Y+ +
Sbjct: 68 A--VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 123
Query: 134 IIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANAKSVIGTP-EFMAPELYDENYNE 190
IHRDL+ N+ ++ KI D GLA ++E + A+ P ++ APE N+
Sbjct: 124 YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI--NFGS 180
Query: 191 L---ADIYSFGMCMLEMVTF-EYPYSECRNS 217
+D++SFG+ + E+VT+ + PY NS
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNS 211
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 15/185 (8%)
Query: 58 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGW 116
SE ++ H+NIIR + + K IITE +G+L +Y + H + + G
Sbjct: 55 SEASIMGQFSHHNIIRLEG--VVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGM 112
Query: 117 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP 176
R I +G+ YL D +HRDL NI +N + E K+ D GL+ ++E + +
Sbjct: 113 LRGIAAGMKYLS--DMNYVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSG 169
Query: 177 -----EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIK 229
+ APE + + +D++SFG+ M E+++F E PY + N ++ K ++ G +
Sbjct: 170 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-EVMKAINDGFR 228
Query: 230 -PAAL 233
PA +
Sbjct: 229 LPAPM 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 9e-13
Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 50/284 (17%)
Query: 25 YKAFDEVNGLEVAWCQVRI--DDVLQSPEDLERLYSEVHLLKSLKHNN-IIRFYN--SWI 79
YKA D+ G VA + R+ D+ P L E+ LL+ L + I+R +
Sbjct: 18 YKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQMLSESIYIVRLLDVEHVE 73
Query: 80 DDQNKTVNIITELFTSGSLRQY-----RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 134
+ K + + L+++ R + + K +K + Q+L G+ + H H +
Sbjct: 74 EKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--V 131
Query: 135 IHRDLKCDNIFINGNQGEVKIGDLGLA---TIMEQANAKSVIGTPEFMAPE--LYDENYN 189
+HRDLK N+ ++ +G +KI DLGL +I ++ ++ T + APE L +Y+
Sbjct: 132 MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRAPEVLLGSTHYS 190
Query: 190 ELADIYSFGMCMLEMVTFEYPY---SECRNSAQIYK-------KVSSGI----------- 228
DI+S G EM + + SE + I+K +V G+
Sbjct: 191 TPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQ 250
Query: 229 -KPAALSKV---KDPEVKSFIEKCLV--PASQRLSAKELLMDPF 266
KP LS+ PE ++K L PA +R+SAK L P+
Sbjct: 251 WKPQDLSRAVPDLSPEGLDLLQKMLRYDPA-KRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 76/294 (25%), Positives = 123/294 (41%), Gaps = 59/294 (20%)
Query: 24 GYKAF-------DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYN 76
GY AF D +G VA ++ +V Q+ +R++ E+ +L KH+N++
Sbjct: 9 GYGAFGVVWSVTDPRDGKRVAL--KKMPNVFQNLVSCKRVFRELKMLCFFKHDNVL---- 62
Query: 77 SWID-------DQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS 129
S +D D + + ++TEL S L + + + VK + QIL GL YLHS
Sbjct: 63 SALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121
Query: 130 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV---IGTPEFMAPELY-- 184
I+HRD+K N+ +N N +KI D GLA + E +K + + T + APE+
Sbjct: 122 AG--ILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 185 DENYNELADIYSFGMCMLEMV-------------------------TFEYPYSECRNS-A 218
+Y DI+S G E++ + E S C + A
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238
Query: 219 QIYKKVSSGIKPAALSKVKDP---EVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268
I + L + E + + LV +R+SA + L P+L
Sbjct: 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 44/187 (23%), Positives = 87/187 (46%), Gaps = 14/187 (7%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 107
+ E ++ L H I+R + + ++ EL G L +Y KK ++
Sbjct: 35 HIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP---LMLVMELAPLGPLLKYLKKRRE 91
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167
+ + +K A Q+ G+ YL S +HRDL N+ + N+ + KI D G++ +
Sbjct: 92 IPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAG 148
Query: 168 N----AKSVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQI 220
+ A + P ++ APE + ++ +D++S+G+ + E ++ PY E + A++
Sbjct: 149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEV 207
Query: 221 YKKVSSG 227
+ SG
Sbjct: 208 IAMLESG 214
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 67/192 (34%), Positives = 94/192 (48%), Gaps = 20/192 (10%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS--EVHLLKSLK---HNNIIRFYN--- 76
YKA D +G VA VR+ Q+ ED L + EV LLK L+ H NI+R +
Sbjct: 17 YKARDPHSGHFVALKSVRV----QTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCA 72
Query: 77 SWIDDQNKTVNIITELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPI 134
+ D+ V ++ E LR Y K + + +K RQ L GL +LH++ I
Sbjct: 73 TSRTDRETKVTLVFE-HVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN--CI 129
Query: 135 IHRDLKCDNIFINGNQGEVKIGDLGLATIME-QANAKSVIGTPEFMAPE-LYDENYNELA 192
+HRDLK +NI + + G+VK+ D GLA I Q V+ T + APE L Y
Sbjct: 130 VHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPV 188
Query: 193 DIYSFGMCMLEM 204
D++S G EM
Sbjct: 189 DMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 47/170 (27%), Positives = 85/170 (50%), Gaps = 8/170 (4%)
Query: 45 DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK 104
+V+ + +++ +E +LK+ +H + S+ + + E G L + +
Sbjct: 31 EVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF--QTKDRLCFVMEYVNGGELFFHLSR 88
Query: 105 HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT-- 162
+ + + +I+S L YLHS I++RDLK +N+ ++ + G +KI D GL
Sbjct: 89 ERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKD-GHIKITDFGLCKEG 145
Query: 163 IMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPY 211
I + A K+ GTPE++APE L D +Y D + G+ M EM+ P+
Sbjct: 146 ITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 47/175 (26%), Positives = 88/175 (50%), Gaps = 8/175 (4%)
Query: 54 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAV 113
+ + E +L L H I+ S+ D+ V + E G L + +K +
Sbjct: 63 QHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVA 120
Query: 114 KGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI 173
K + +++ YLHS D II+RDLK +N+ ++ N+G VK+ D G A + ++
Sbjct: 121 KFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPD-RTFTLC 176
Query: 174 GTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG 227
GTPE++APE + + + + D ++ G+ + E + P+ + +IY+K+ +G
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAG 230
|
Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 40/126 (31%), Positives = 67/126 (53%), Gaps = 6/126 (4%)
Query: 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 148
+ E G L + + + D+ +A +I+ GL +LHS II+RDLK DN+ ++
Sbjct: 74 VMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDR 131
Query: 149 NQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMV 205
+ G +KI D G+ + A + GTP+++APE L Y D +SFG+ + EM+
Sbjct: 132 D-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
Query: 206 TFEYPY 211
+ P+
Sbjct: 191 IGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/223 (26%), Positives = 109/223 (48%), Gaps = 12/223 (5%)
Query: 46 VLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH 105
+L+ E+ + LLK++KH ++ + S+ + + + G L + ++
Sbjct: 33 ILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF--QTADKLYFVLDYINGGELFYHLQRE 90
Query: 106 KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TI 163
+ + +A +I S L YLHS + I++RDLK +NI ++ +QG + + D GL I
Sbjct: 91 RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENI 147
Query: 164 MEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 222
+ GTPE++APE L+ + Y+ D + G + EM+ + P RN+A++Y
Sbjct: 148 EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEMYD 206
Query: 223 KVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMD 264
+ + KP L + +E L ++RL AK+ M+
Sbjct: 207 NILN--KPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 47/182 (25%), Positives = 90/182 (49%), Gaps = 12/182 (6%)
Query: 54 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH-KKVDMKA 112
+ E ++ L H +++ Y + + + + I+TE ++G L Y ++H K+
Sbjct: 44 DEFIEEAKVMMKLSHEKLVQLYG--VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ 101
Query: 113 VKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172
+ + + G+ YL S IHRDL N ++ +QG VK+ D GL+ + S
Sbjct: 102 LLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSS 158
Query: 173 IGTP---EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 227
+G+ + PE L ++ +D+++FG+ M E+ + + PY NS + +KVS G
Sbjct: 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-ETVEKVSQG 217
Query: 228 IK 229
++
Sbjct: 218 LR 219
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 37/151 (24%), Positives = 70/151 (46%), Gaps = 10/151 (6%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWAR 118
E+ L++ +H +++ + + ++ E S R + + + VK + R
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSG--FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMR 106
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV---IGT 175
+L G+ Y+H++ I+HRDLK N+ I G +KI D GLA + + + + T
Sbjct: 107 MLLKGVAYMHANG--IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLYSHQVAT 163
Query: 176 PEFMAPELY--DENYNELADIYSFGMCMLEM 204
+ APEL Y+ D+++ G E+
Sbjct: 164 RWYRAPELLYGARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 54/166 (32%), Positives = 83/166 (50%), Gaps = 12/166 (7%)
Query: 47 LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT----SGSLRQYR 102
QS +R Y E+ LLK +KH N+I + + D + ++ + + G+
Sbjct: 52 FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS--LDRFHDFYLVMPFMGTDLGKL 109
Query: 103 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162
KH+K+ ++ Q+L GL Y+H+ IIHRDLK N+ +N E+KI D GLA
Sbjct: 110 MKHEKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLAR 166
Query: 163 IMEQANAKSVIGTPEFMAPE--LYDENYNELADIYSFGMCMLEMVT 206
+ V+ T + APE L +Y + DI+S G M EM+T
Sbjct: 167 QTDSEMTGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 59/194 (30%), Positives = 91/194 (46%), Gaps = 25/194 (12%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDL-ERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
YKA D V +A ++R++ Q E + E+ LLK ++H NI+R + +
Sbjct: 19 YKARDRVTNETIALKKIRLE---QEDEGVPSTAIREISLLKEMQHGNIVRLQD--VVHSE 73
Query: 84 KTVNIITELFTSGSLRQYRKKHKKV------DMKAVKGWARQILSGLIYLHSHDPPIIHR 137
K + ++ E L KKH + + +K + QIL G+ Y HSH ++HR
Sbjct: 74 KRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHR 126
Query: 138 DLKCDNIFINGNQGEVKIGDLGLAT---IMEQANAKSVIGTPEFMAPE--LYDENYNELA 192
DLK N+ I+ +K+ D GLA I + V+ T + APE L +Y+
Sbjct: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRHYSTPV 185
Query: 193 DIYSFGMCMLEMVT 206
DI+S G EMV
Sbjct: 186 DIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 35/100 (35%), Positives = 59/100 (59%), Gaps = 8/100 (8%)
Query: 116 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVI 173
+A +I GL +LHS II+RDLK DN+ ++ +G +KI D G+ I ++
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFC 162
Query: 174 GTPEFMAPE--LYDENYNELADIYSFGMCMLEMVTFEYPY 211
GTP+++APE Y + Y + D ++FG+ + EM+ + P+
Sbjct: 163 GTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 62 LLKSLKHNNIIRFYNSWIDDQNK-TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQI 120
LLK++KH ++ + S+ Q + + + G L + ++ + + +A +I
Sbjct: 49 LLKNVKHPFLVGLHYSF---QTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEI 105
Query: 121 LSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEF 178
S L YLHS + II+RDLK +NI ++ +QG V + D GL I + GTPE+
Sbjct: 106 ASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEY 162
Query: 179 MAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK 237
+APE L + Y+ D + G + EM+ + P R++A++Y + + KP L
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRDTAEMYDNILN--KPLRLKPNI 219
Query: 238 DPEVKSFIEKCLVP-ASQRLSAKELLMD 264
+ +E L ++RL AK+ ++
Sbjct: 220 SVSARHLLEGLLQKDRTKRLGAKDDFLE 247
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 20/143 (13%)
Query: 130 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT-IMEQANAKSVIGTPEFMAPE-LYDEN 187
H+ IHRDLK +N F+ G +K+ D GL+ I+ AN SV+G+P++MAPE L +
Sbjct: 118 HELGYIHRDLKPEN-FLIDASGHIKLTDFGLSKGIVTYAN--SVVGSPDYMAPEVLRGKG 174
Query: 188 YNELADIYSFGMCMLEMVTFEYP----------YSECRNSAQIYKKVSSGIKPAALSKVK 237
Y+ D +S G CML +P + + + ++ LS
Sbjct: 175 YDFTVDYWSLG-CMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD-- 231
Query: 238 DPEVKSFIEKCLVPASQRLSAKE 260
E I K + S+R + E
Sbjct: 232 --EAWDLITKLINDPSRRFGSLE 252
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 14/210 (6%)
Query: 45 DVLQSPEDLERLYSEVHLLKSLKHNN--IIRFYNSWIDDQNKTVNIITELFTSGSLRQYR 102
DV+ +D+E +E +L SL N+ + + Y + + + E G L +
Sbjct: 31 DVILQDDDVECTMTEKRIL-SLARNHPFLTQLYCCF--QTPDRLFFVMEFVNGGDLMFHI 87
Query: 103 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162
+K ++ D + +A +I S L++LH D II+RDLK DN+ ++ ++G K+ D G+
Sbjct: 88 QKSRRFDEARARFYAAEITSALMFLH--DKGIIYRDLKLDNVLLD-HEGHCKLADFGMCK 144
Query: 163 --IMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ 219
I + GTP+++APE L + Y D ++ G+ + EM+ P+ E N
Sbjct: 145 EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF-EAENEDD 203
Query: 220 IYKKVSSG--IKPAALSKVKDPEVKSFIEK 247
+++ + + + P LS+ +K+F+ K
Sbjct: 204 LFEAILNDEVVYPTWLSQDAVDILKAFMTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 67/259 (25%), Positives = 121/259 (46%), Gaps = 37/259 (14%)
Query: 17 IQLVDTSGYKAFDEV-NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 75
+QL+ G F EV G +V + + E E ++K L+H+ +++ Y
Sbjct: 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLY 67
Query: 76 NSWIDDQNKTVNIITELFTSGSLRQYRK--KHKKVDMKAVKGWARQILSGLIYLHSHDPP 133
+ + I+TE + GSL + K + + + + + A Q+ +G+ Y+ +
Sbjct: 68 AVV---SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN-- 122
Query: 134 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP---EFMAPE--LYDENY 188
IHRDL+ NI + G+ KI D GLA ++E + G ++ APE LY +
Sbjct: 123 YIHRDLRSANILV-GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-F 180
Query: 189 NELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIK-------PAALSKV---- 236
+D++SFG+ + E+VT PY N+ ++ ++V G + P +L ++
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPG-MNNREVLEQVERGYRMPCPQDCPISLHELMLQC 239
Query: 237 --KDPE-------VKSFIE 246
KDPE ++SF+E
Sbjct: 240 WKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 69/243 (28%), Positives = 111/243 (45%), Gaps = 37/243 (15%)
Query: 49 SPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 107
+ +DL L SE+ ++K + KH NII + Q+ + +I E + G+LR+Y + +
Sbjct: 60 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRP 117
Query: 108 VDMKAVKGWAR----------------QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 151
M+ AR Q+ G+ YL S IHRDL N+ + N
Sbjct: 118 PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENN- 174
Query: 152 EVKIGDLGLATIMEQAN--AKSVIG--TPEFMAPE-LYDENYNELADIYSFGMCMLEMVT 206
+KI D GLA + + K+ G ++MAPE L+D Y +D++SFG+ M E+ T
Sbjct: 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
Query: 207 F---EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC--LVPASQRLSAKEL 261
YP ++ K+ KPA + E+ + C +P S R + K+L
Sbjct: 235 LGGSPYPGIPVEELFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAIP-SHRPTFKQL 289
Query: 262 LMD 264
+ D
Sbjct: 290 VED 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 47/166 (28%), Positives = 86/166 (51%), Gaps = 9/166 (5%)
Query: 62 LLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQIL 121
LLK+LKH ++ + S+ + + + + G L + ++ + + +A ++
Sbjct: 49 LLKNLKHPFLVGLHYSF--QTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVA 106
Query: 122 SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFM 179
S + YLHS + II+RDLK +NI ++ +QG V + D GL + + + GTPE++
Sbjct: 107 SAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYL 163
Query: 180 APE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 224
APE L E Y+ D + G + EM+ + P R+ +Q+Y +
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEML-YGLPPFYSRDVSQMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 22/217 (10%)
Query: 24 GYKAFDEV------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNS 77
G F +V EVA R P+ + E +LK H NI++
Sbjct: 4 GKGNFGDVYKGVLKGNTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIG- 59
Query: 78 WIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIH 136
+ Q + + I+ EL GSL + RKK ++ +K + + +G+ YL S + IH
Sbjct: 60 -VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIH 116
Query: 137 RDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE----FMAPE-LYDENYNEL 191
RDL N + G +KI D G++ E G + + APE L Y
Sbjct: 117 RDLAARNCLV-GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 192 ADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 227
+D++S+G+ + E + + PY N Q +++ SG
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQ-QTRERIESG 211
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 54 ERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY--RKKHKKVDM 110
E L SE+ ++ L H NI+ + + +ITE G L + RK+ + +
Sbjct: 83 EALMSELKIMSHLGNHENIVNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTL 140
Query: 111 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV-KIGDLGLA-TIMEQAN 168
+ + ++ Q+ G+ +L S + IHRDL N+ + G++ KI D GLA IM +N
Sbjct: 141 EDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT--HGKIVKICDFGLARDIMNDSN 196
Query: 169 --AKSVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKK 223
K P ++MAPE +++ Y +D++S+G+ + E+ + PY ++ YK
Sbjct: 197 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL 256
Query: 224 VSSGI---KPAALSKVKDPEVKSFIEKC 248
+ G +P E+ ++ C
Sbjct: 257 IKEGYRMAQPEHAPA----EIYDIMKTC 280
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 58/192 (30%), Positives = 94/192 (48%), Gaps = 23/192 (11%)
Query: 58 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGW 116
SE ++ H NII + ++K V I+TE +GSL + +KH + + + G
Sbjct: 54 SEASIMGQFDHPNIIHLEG--VVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGM 111
Query: 117 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP 176
R I SG+ YL D +HRDL NI +N N K+ D GL+ ++E + ++ T
Sbjct: 112 LRGIASGMKYL--SDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLED-DPEAAYTTR 167
Query: 177 ------EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGI 228
+ APE + + +D++S+G+ M E++++ E PY E N I K + G
Sbjct: 168 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI-KAIEEGY 226
Query: 229 K-------PAAL 233
+ PAAL
Sbjct: 227 RLPAPMDCPAAL 238
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 49/175 (28%), Positives = 84/175 (48%), Gaps = 9/175 (5%)
Query: 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 148
I +L G L + +H K ++ +A +I+ GL H H+ +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGL--EHMHNRFVVYRDLKPANILLD- 131
Query: 149 NQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDEN--YNELADIYSFGMCMLEMVT 206
G V+I DLGLA + + +GT +MAPE+ + Y+ AD +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191
Query: 207 FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKEL 261
P+ + + + + L PE+KS +E L QR +K L
Sbjct: 192 GHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLL----QRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 37/194 (19%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV 108
S +L L SE +LLK + H ++I+ Y + Q+ + +I E GSLR + ++ +KV
Sbjct: 43 SSSELRDLLSEFNLLKQVNHPHVIKLYGAC--SQDGPLLLIVEYAKYGSLRSFLRESRKV 100
Query: 109 D------------------------MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
M + +A QI G+ YL + ++HRDL N+
Sbjct: 101 GPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNV 158
Query: 145 FINGNQGEVKIGDLGLATIMEQANA---KSVIGTP-EFMAPE-LYDENYNELADIYSFGM 199
+ + ++KI D GL+ + + ++ +S P ++MA E L+D Y +D++SFG+
Sbjct: 159 LVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV 217
Query: 200 CMLEMVTF---EYP 210
+ E+VT YP
Sbjct: 218 LLWEIVTLGGNPYP 231
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 53/189 (28%), Positives = 92/189 (48%), Gaps = 23/189 (12%)
Query: 53 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA 112
+E E ++K +KH N+++ + + IITE T G+L Y ++ + ++ A
Sbjct: 46 VEEFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA 103
Query: 113 VK--GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME----- 165
V A QI S + YL + IHRDL N + G VK+ D GL+ +M
Sbjct: 104 VVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYT 160
Query: 166 -QANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF---EYPYSECRNSAQI 220
A AK I ++ APE L ++ +D+++FG+ + E+ T+ YP + +Q+
Sbjct: 161 AHAGAKFPI---KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQV 214
Query: 221 YKKVSSGIK 229
Y+ + G +
Sbjct: 215 YELLEKGYR 223
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 20/192 (10%)
Query: 26 KAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN- 83
A D +G +VA ++ DV + R E+ +L+ KH+NII +
Sbjct: 23 SAIDTRSGKKVAIKKIPHAFDVPTLAK---RTLRELKILRHFKHDNIIAIRDILRPPGAD 79
Query: 84 -KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
K V ++ +L S L + + + ++ + Q+L GL Y+HS + +IHRDLK
Sbjct: 80 FKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPS 136
Query: 143 NIFINGNQGEVKIGDLGLATIMEQANAK------SVIGTPEFMAPEL---YDENYNELAD 193
N+ +N + E++IGD G+A + + + + T + APEL E Y D
Sbjct: 137 NLLVNED-CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPE-YTTAID 194
Query: 194 IYSFGMCMLEMV 205
++S G EM+
Sbjct: 195 MWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 50/200 (25%), Positives = 101/200 (50%), Gaps = 10/200 (5%)
Query: 51 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM 110
+ ++ ++SE +L + H + Y S+ D+ + ++ E G + +++K+
Sbjct: 73 KQVDHVFSERKILNYINHPFCVNLYGSFKDES--YLYLVLEFVIGGEFFTFLRRNKRFPN 130
Query: 111 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 170
+A QI+ YL S + I++RDLK +N+ ++ + G +K+ D G A +++
Sbjct: 131 DVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKVVD-TRTY 186
Query: 171 SVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK 229
++ GTPE++APE L + + + AD ++ G+ + E++ P+ IY+K+ GI
Sbjct: 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY-ANEPLLIYQKILEGI- 244
Query: 230 PAALSKVKDPEVKSFIEKCL 249
K D K ++K L
Sbjct: 245 -IYFPKFLDNNCKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 20/215 (9%)
Query: 59 EVHLLKSLKHNNIIRFYNSWID--DQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGW 116
E+ L+ + NNI++ Y ID D +++I E T G LR+ K K + K
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDM 127
Query: 117 ARQILSGLIYLHSHD--PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG 174
A GL L+ + P +++L + + N ++KI GL I+ K+V
Sbjct: 128 AIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTEN-YKLKIICHGLEKILSSPPFKNV-- 181
Query: 175 TPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI 228
FM Y Y DIYS G+ + E+ T + P+ E + +IY + +
Sbjct: 182 --NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF-ENLTTKEIYDLIINKN 238
Query: 229 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELL 262
L E+K +E C + +R + KE+L
Sbjct: 239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 57/232 (24%), Positives = 112/232 (48%), Gaps = 16/232 (6%)
Query: 45 DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK 104
+V+ + +++ +E +L++ +H + S+ + + + E G L + +
Sbjct: 31 EVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF--QTHDRLCFVMEYANGGELFFHLSR 88
Query: 105 HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT-- 162
+ + + +I+S L YLHS + +++RDLK +N+ ++ + G +KI D GL
Sbjct: 89 ERVFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEG 146
Query: 163 IMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIY 221
I + A K+ GTPE++APE L D +Y D + G+ M EM+ P+ ++ +++
Sbjct: 147 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLF 205
Query: 222 KKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRL-----SAKELLMDPFL 267
+ + ++ + PE KS + L QRL AKE++ F
Sbjct: 206 ELIL--MEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 61/237 (25%), Positives = 111/237 (46%), Gaps = 29/237 (12%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWI--DDQNK----TVNIITELFTSGSLRQYR 102
S D R +EV L + +I++ + + D +N + ++ + +G LRQ
Sbjct: 71 SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEI 130
Query: 103 KKHKKVDMKAVKGWARQILSGLIYL-------HSHDPPIIHRDLKCDNIFINGNQGEVKI 155
K K + + A GL+++ H H +IHRD+K NI + N G VK+
Sbjct: 131 KSRAKTNRTFREHEA-----GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKL 184
Query: 156 GDLGL-----ATIMEQANAKSVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEY 209
GD G AT+ + ++ GTP ++APE++ Y++ AD++S G+ + E++T +
Sbjct: 185 GDFGFSKMYAATVSDDV-GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
Query: 210 PYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDP 265
P+ ++K ++ P L PE++ + L +R S+ +LL P
Sbjct: 244 PFDGENMEEVMHKTLAGRYDP--LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 50/163 (30%), Positives = 85/163 (52%), Gaps = 14/163 (8%)
Query: 58 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL----RQYRKKHKKVDMKAV 113
SE+H L + H I++ ++ + D + +I E + G L +Q K+H V
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDK--LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV 171
Query: 114 KGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----NA 169
QI+ L +HS ++HRDLK NIF+ G +K+GD G + + A
Sbjct: 172 GLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSVSLDVA 228
Query: 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPY 211
S GTP ++APEL++ + Y++ AD++S G+ + E++T P+
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 78/294 (26%), Positives = 131/294 (44%), Gaps = 37/294 (12%)
Query: 62 LLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQIL 121
LLK++KH ++ + S+ + + + + G L + ++ + + +A +I
Sbjct: 49 LLKNVKHPFLVGLHYSF--QTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIA 106
Query: 122 SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFM 179
S L YLHS + I++RDLK +NI ++ +QG V + D GL I + + GTPE++
Sbjct: 107 SALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYL 163
Query: 180 APE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 238
APE + + Y+ D + G + EM+ + P CR+ A++Y + KP L
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEML-YGLPPFYCRDVAEMYDNILH--KPLVLRPGAS 220
Query: 239 PEVKSFIEKCLVPASQ-RLSAKELLMD----PFLQVNGTTKNRPLPLPDIVLPRVGAFGD 293
S +E+ L Q RL AKE ++ PF + T +P P V
Sbjct: 221 LTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNV----- 275
Query: 294 RCLMSEGPASVRNKHP---------SMDFDSDAEL--PVITSLDNSGGGDSYSP 336
EGP + N S+ F SD + + D++ G SY+P
Sbjct: 276 -----EGPDDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEADDAFVGFSYAP 324
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 52/175 (29%), Positives = 83/175 (47%), Gaps = 12/175 (6%)
Query: 41 VRIDDVLQSPEDLER---LYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGS 97
V I L+S +D E+ +LK L+H N++ + + K + ++ E
Sbjct: 29 VAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE--VFRRKKRLYLVFEFVDHTV 86
Query: 98 LRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 157
L K +D V+ + QIL G+ + HSH+ IIHRD+K +NI ++ + G VK+ D
Sbjct: 87 LDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCD 143
Query: 158 LGLATIMEQANA--KSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTFE 208
G A + + T + APEL D Y DI++ G + EM+T E
Sbjct: 144 FGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 58/188 (30%), Positives = 90/188 (47%), Gaps = 11/188 (5%)
Query: 25 YKAFDEVNGLE-VAWCQVRIDDVLQS-PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 82
+KA D NG VA +VR+ + P R + + L++ +H N++R ++ +
Sbjct: 18 FKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77
Query: 83 NKTVNIITELF--TSGSLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRD 138
+T +F L Y K V + +K Q+L GL +LHSH ++HRD
Sbjct: 78 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRD 135
Query: 139 LKCDNIFINGNQGEVKIGDLGLATIME-QANAKSVIGTPEFMAPE-LYDENYNELADIYS 196
LK NI + + G++K+ D GLA I Q SV+ T + APE L +Y D++S
Sbjct: 136 LKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWS 194
Query: 197 FGMCMLEM 204
G EM
Sbjct: 195 VGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 51/154 (33%), Positives = 80/154 (51%), Gaps = 13/154 (8%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWA 117
EV LLK LKH NI+ ++ I K++ ++ E + L+QY ++M VK +
Sbjct: 54 EVSLLKDLKHANIVTLHD--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNSINMHNVKLFL 110
Query: 118 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA---TIMEQANAKSVIG 174
Q+L GL Y H ++HRDLK N+ IN +GE+K+ D GLA +I + + V+
Sbjct: 111 FQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVV- 166
Query: 175 TPEFMAPE--LYDENYNELADIYSFGMCMLEMVT 206
T + P+ L +Y+ D++ G EM T
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 44/173 (25%), Positives = 87/173 (50%), Gaps = 12/173 (6%)
Query: 41 VRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQ 100
++I + P+ E ++ S+ H +++R + + T+ ++T+L G L
Sbjct: 41 IKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL---SPTIQLVTQLMPHGCLLD 97
Query: 101 YRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 159
Y +HK + + + W QI G++YL ++HRDL N+ + + VKI D G
Sbjct: 98 YVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVK-SPNHVKITDFG 154
Query: 160 LATIME----QANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF 207
LA ++E + NA ++MA E ++ + +D++S+G+ + E++TF
Sbjct: 155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 34/210 (16%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS----------EVHLLKSLKHNNIIRF 74
KA+D + G VA +V+I ++ +L E+ ++ +KH NI+
Sbjct: 26 EKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85
Query: 75 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 134
+ ++ + +N++ ++ + L++ + ++ VK QIL+GL LH
Sbjct: 86 VDVYV--EGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--F 140
Query: 135 IHRDLKCDNIFINGNQGEVKIGDLGLA-----------TIMEQANAKSVIGTPE-----F 178
+HRDL NIFIN ++G KI D GLA ++ + T + +
Sbjct: 141 MHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWY 199
Query: 179 MAPELY--DENYNELADIYSFGMCMLEMVT 206
APEL E Y+ D++S G E++T
Sbjct: 200 RAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 72/295 (24%), Positives = 120/295 (40%), Gaps = 70/295 (23%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQN 83
+KA D VA +I D ++ D +R + E+ L+ L H NI++ N + +
Sbjct: 24 WKAIDRRTKEVVAL--KKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81
Query: 84 KTVNIITELFTSGSLRQYRKK-----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRD 138
K + ++ E + R HK+ M Q+L L Y+HS + +IHRD
Sbjct: 82 KDIYLVFEYMETDLHAVIRANILEDVHKRYIM-------YQLLKALKYIHSGN--VIHRD 132
Query: 139 LKCDNIFINGNQGEVKIGDLGLA---TIMEQANAKSV----IGTPEFMAPE--LYDENYN 189
LK NI +N + VK+ D GLA + +E+ V + T + APE L Y
Sbjct: 133 LKPSNILLNSD-CRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYT 191
Query: 190 ELADIYSFGMCML-EMVT----F-----------------------------EYPYSECR 215
+ D++S G C+L EM+ F + +
Sbjct: 192 KGVDMWSVG-CILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLD 250
Query: 216 NSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQ 268
+ +K + P A + ++K LV P ++RL+A+E L P++
Sbjct: 251 SLPSRPRKPLDELLPKA-----SDDALDLLKKLLVFNP-NKRLTAEEALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 48/191 (25%), Positives = 92/191 (48%), Gaps = 15/191 (7%)
Query: 54 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKA 112
E E ++ L H +++ Y + + + ++ E G L Y R + K +
Sbjct: 44 EDFIEEAQVMMKLSHPKLVQLYG--VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQET 101
Query: 113 VKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172
+ G + G+ YL S + +IHRDL N + NQ VK+ D G+ + S
Sbjct: 102 LLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQYTSS 158
Query: 173 IGTP---EFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSG 227
GT ++ +PE++ Y+ +D++SFG+ M E+ + + PY E R+++++ + +++G
Sbjct: 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY-ENRSNSEVVETINAG 217
Query: 228 ---IKPAALSK 235
KP S+
Sbjct: 218 FRLYKPRLASQ 228
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 40/145 (27%), Positives = 78/145 (53%), Gaps = 10/145 (6%)
Query: 88 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN 147
++T+ + G L + +K + K + +++ L +LH +D I++RDLK +NI ++
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD 130
Query: 148 GNQGEVKIGDLGL--ATIMEQANAKSVIGTPEFMAPE--LYDENYNELADIYSFGMCMLE 203
G + + D GL A + + + GT E++APE L ++ Y + D +S G+ + E
Sbjct: 131 AT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
Query: 204 MVTFEYP-YSECRNSAQIYKKVSSG 227
M P Y+E ++ Q+Y+ ++ G
Sbjct: 190 MCCGWSPFYAE--DTQQMYRNIAFG 212
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 30/199 (15%)
Query: 44 DDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRK 103
D L + +D +R E LL +L+H +I++FY D + ++ E G L ++ +
Sbjct: 45 DPTLAARKDFQR---EAELLTNLQHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLR 99
Query: 104 KHKKVDMKAVKGW----------------ARQILSGLIYLHSHDPPIIHRDLKCDNIFIN 147
H M V G A QI SG++YL S +HRDL N +
Sbjct: 100 AHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV- 156
Query: 148 GNQGEVKIGDLGLATIMEQANAKSVIGTP----EFMAPE-LYDENYNELADIYSFGMCML 202
G VKIGD G++ + + V G +M PE + + +D++SFG+ +
Sbjct: 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILW 216
Query: 203 EMVTF-EYPYSECRNSAQI 220
E+ T+ + P+ + N+ I
Sbjct: 217 EIFTYGKQPWFQLSNTEVI 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 19/180 (10%)
Query: 58 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGW 116
+E ++ H NIIR + +++ V IITE +GSL ++ R+ K + + G
Sbjct: 54 TEASIMGQFDHPNIIRLEG--VVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGM 111
Query: 117 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA------- 169
R I SG+ YL + +HRDL NI +N + K+ D GL+ +E + A
Sbjct: 112 LRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGG 168
Query: 170 KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 227
K I + APE + + +D++SFG+ M E++++ E PY + N + K V G
Sbjct: 169 KIPI---RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-DVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 21/175 (12%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE--------LFTSGSLRQYRKKHKKVDM 110
E+ LL+ LKH N+I ++ ++ V ++ + + + KK ++
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 111 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING---NQGEVKIGDLGLATIMEQ- 166
VK QIL G+ YLH++ ++HRDLK NI + G +G VKI D+G A +
Sbjct: 108 SMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 167 ----ANAKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTFEYPYSECR 215
A+ V+ T + APEL +Y + DI++ G E++T E P CR
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 17/245 (6%)
Query: 27 AFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--- 83
AFD V G+ VA ++ Q+ +R Y E+ LLK + H NII N + ++
Sbjct: 40 AFDTVLGINVA--VKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97
Query: 84 -KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+ V ++ EL + + H ++D + + Q+L G+ +LHS IIHRDLK
Sbjct: 98 FQDVYLVMELMDANLCQVI---HMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPS 152
Query: 143 NIFINGNQGEVKIGDLGLA-TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMC 200
NI + + +KI D GLA T + T + APE + Y E DI+S G
Sbjct: 153 NIVVKSD-CTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 211
Query: 201 MLEMVTFEYPYSECRNSAQIYKKVSS-GIKPAALSKVKDPEVKSFIEKCLVPASQRLSAK 259
M E+V + + Q K + G A P V++++E P +S +
Sbjct: 212 MGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVEN--RPQYPGISFE 269
Query: 260 ELLMD 264
EL D
Sbjct: 270 ELFPD 274
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 47 LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSG-SLRQYRK-- 103
QS +R Y E+ LLK ++H N+I +D +FTS S +++
Sbjct: 52 FQSEIFAKRAYRELTLLKHMQHENVIG----LLD-----------VFTSAVSGDEFQDFY 96
Query: 104 ---KHKKVDMKAVKGW----------ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 150
+ + D++ + G Q+L GL Y+HS IIHRDLK N+ +N
Sbjct: 97 LVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-ED 153
Query: 151 GEVKIGDLGLATIMEQANAKSVIGTPEFMAPE--LYDENYNELADIYSFGMCMLEMVTFE 208
E+KI D GLA + A + T + APE L +YN+ DI+S G M EM+T +
Sbjct: 154 CELKILDFGLARHAD-AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
Query: 209 YPYSECRNSAQIYK--KVSSGIKPAALSKVKDPEVKSFIE 246
+ Q+ + KV+ P + K++D KS+I+
Sbjct: 213 TLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIK 252
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 49/188 (26%), Positives = 90/188 (47%), Gaps = 11/188 (5%)
Query: 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 148
I +L G L + +H ++ +A +I+ GL H H+ +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGL--EHMHNRFVVYRDLKPANILLDE 132
Query: 149 NQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDEN--YNELADIYSFGMCMLEMVT 206
+ G V+I DLGLA + + +GT +MAPE+ + Y+ AD +S G + +++
Sbjct: 133 H-GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 191
Query: 207 FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL-VPASQRL-----SAKE 260
P+ + + + + L PE++S +E L ++RL A+E
Sbjct: 192 GHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 251
Query: 261 LLMDPFLQ 268
+ PF +
Sbjct: 252 VKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 52/184 (28%), Positives = 83/184 (45%), Gaps = 30/184 (16%)
Query: 52 DLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM 110
DL L SE+ ++K + KH NII + Q + ++ E G+LR + + +
Sbjct: 58 DLSDLVSEMEMMKMIGKHKNIINLLG--VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGE 115
Query: 111 KAVK----------------GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVK 154
A +A Q+ G+ +L S IHRDL N+ + +K
Sbjct: 116 YASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLV-TEDHVMK 172
Query: 155 IGDLGLATIMEQAN--AKSVIGT-P-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-- 207
I D GLA + + K+ G P ++MAPE L+D Y +D++SFG+ + E+ T
Sbjct: 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 232
Query: 208 -EYP 210
YP
Sbjct: 233 SPYP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 54/175 (30%), Positives = 86/175 (49%), Gaps = 21/175 (12%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNII-----TELFTSGSLRQYRKKHKK---VDM 110
E+ LL+ LKH N+I ++ ++ V ++ +L+ + K +KK +
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107
Query: 111 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING---NQGEVKIGDLGLATIMEQ- 166
VK QIL G+ YLH++ ++HRDLK NI + G +G VKI D+G A +
Sbjct: 108 GMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 167 ----ANAKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTFEYPYSECR 215
A+ V+ T + APEL +Y + DI++ G E++T E P CR
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 34/99 (34%), Positives = 61/99 (61%), Gaps = 6/99 (6%)
Query: 116 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVI 173
+A +I GL +LHS II+RDLK DN+ ++ ++G +KI D G+ + + K+
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFC 162
Query: 174 GTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPY 211
GTP+++APE+ + Y + D ++FG+ + EM+ + P+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 20/211 (9%)
Query: 47 LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSW-----IDDQNKTVNIITELFTSGSLRQY 101
QS R Y E+ LLK +KH N+I + + I++ N+ V ++T L G+
Sbjct: 52 FQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE-VYLVTNLM--GADLNN 108
Query: 102 RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 161
K +K+ + V+ Q+L GL Y+HS IIHRDLK N+ +N E++I D GLA
Sbjct: 109 IVKCQKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLA 165
Query: 162 TIMEQANAK--SVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFE--YPYSECR 215
QA+ + + T + APE+ +YN+ DI+S G M E++ + +P ++
Sbjct: 166 ---RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI 222
Query: 216 NSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246
+ + +V P L K+ + +I+
Sbjct: 223 DQLKRIMEVVGTPSPEVLKKISSEHARKYIQ 253
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 47/186 (25%), Positives = 96/186 (51%), Gaps = 18/186 (9%)
Query: 53 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK--KVDM 110
+E +E +++K+L+H+ +++ ++ + + + IITE GSL + K + K +
Sbjct: 45 VEAFLAEANVMKTLQHDKLVKL-HAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL 101
Query: 111 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 170
+ ++ QI G+ ++ + IHRDL+ NI ++ + KI D GLA ++E
Sbjct: 102 PKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT 158
Query: 171 SVIGTP---EFMAPELYDENYNEL---ADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKK 223
+ G ++ APE N+ +D++SFG+ ++E+VT+ PY N ++ +
Sbjct: 159 AREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVIRA 215
Query: 224 VSSGIK 229
+ G +
Sbjct: 216 LERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 16/156 (10%)
Query: 58 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV---DMKAVK 114
+E H+L+++ H +II+ ++ NK +I + + L Y + + D+ A++
Sbjct: 132 TEAHILRAINHPSIIQLKGTFT--YNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIE 188
Query: 115 GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV-- 172
R +L + YLH + IIHRD+K +NIFIN + G+V +GD G A NA
Sbjct: 189 ---RSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINANKYYG 242
Query: 173 -IGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVT 206
GT APEL + Y DI+S G+ + EM T
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 54/159 (33%), Positives = 78/159 (49%), Gaps = 23/159 (14%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWA 117
EV LLK+LKH NI+ ++ I + + ++ E S L+QY + M VK +
Sbjct: 53 EVSLLKNLKHANIVTLHD--IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM 109
Query: 118 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV----- 172
Q+L GL Y H I+HRDLK N+ IN +GE+K+ D GL A AKSV
Sbjct: 110 FQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGL------ARAKSVPTKTY 160
Query: 173 ---IGTPEFMAPE--LYDENYNELADIYSFGMCMLEMVT 206
+ T + P+ L Y+ D++ G + EM T
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 6e-11
Identities = 59/187 (31%), Positives = 94/187 (50%), Gaps = 16/187 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YK +VNG VA +R+ + +P R E LLK LKH NI+ ++ I +
Sbjct: 22 YKGKSKVNGKLVALKVIRLQEEEGTPFTAIR---EASLLKGLKHANIVLLHD--IIHTKE 76
Query: 85 TVNIITELFTSGSLRQYRKKHKK-VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
T+ ++ E + L QY KH + + VK + Q+L GL Y+H I+HRDLK N
Sbjct: 77 TLTLVFE-YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR--YILHRDLKPQN 133
Query: 144 IFINGNQGEVKIGDLGLA---TIMEQANAKSVIGTPEFMAPE--LYDENYNELADIYSFG 198
+ I+ + GE+K+ D GLA ++ + V+ T + P+ L Y+ D++ G
Sbjct: 134 LLIS-DTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYSTCLDMWGVG 191
Query: 199 MCMLEMV 205
+EM+
Sbjct: 192 CIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-11
Identities = 82/338 (24%), Positives = 141/338 (41%), Gaps = 51/338 (15%)
Query: 40 QVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI------DDQNKTVNIITELF 93
+V I VLQ P+ R E+ ++K+L H NII + + +++N +N++ E
Sbjct: 93 KVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFI 149
Query: 94 ---TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 150
++ Y + + + + VK ++ Q+ L Y+HS I HRDLK N+ I+ N
Sbjct: 150 PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNT 207
Query: 151 GEVKIGDLGLA-TIMEQANAKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTF 207
+K+ D G A ++ + S I + + APEL NY D++S G + EM+
Sbjct: 208 HTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI-L 266
Query: 208 EYPYSECRNSA-QIYKKVSSGIKPAA---------LSKVKDPEVKSFIEKCLVPAS---- 253
YP ++S Q+ + + P + +K P+VK K + P
Sbjct: 267 GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDD 326
Query: 254 --------------QRLSAKELLMDPFLQVNGTTKNRPLPLPDIV--LPRVGAFGDRCLM 297
+RL+ E L DPF ++ + LP + LP + F D +
Sbjct: 327 AINFISQFLKYEPLKRLNPIEALADPFFD---DLRDPCIKLPKYIDKLPDLFNFCDAEIK 383
Query: 298 SEGPASVRNKHPSMDFDSDAELPVITSLDNSGGGDSYS 335
A R P +++ E + D + D S
Sbjct: 384 EMSDACRRKIIPKCTYEAYKEFLMSDENDANIIADKIS 421
|
Length = 440 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 47/137 (34%), Positives = 68/137 (49%), Gaps = 12/137 (8%)
Query: 128 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LY 184
H H II+RDLK +NI ++ QG VK+ D GL +I E + GT E+MAPE L
Sbjct: 115 HLHQQGIIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 185 DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IKPAALSKVKDPEVK 242
+ + D +S G M +M+T P++ N + K+ G P L+ PE +
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKLNLPPYLT----PEAR 228
Query: 243 SFIEKCLV-PASQRLSA 258
++K L S RL A
Sbjct: 229 DLLKKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 35/87 (40%), Positives = 54/87 (62%), Gaps = 4/87 (4%)
Query: 128 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPELYD 185
H H II+RDLK +NI ++ +G +K+ D GL+ +I + A S GT E+MAPE+ +
Sbjct: 113 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 186 -ENYNELADIYSFGMCMLEMVTFEYPY 211
+ + AD +SFG+ M EM+T P+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 30/187 (16%)
Query: 49 SPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY------ 101
+ +DL L SE+ L+K + KH NII + Q + +I E G+LR++
Sbjct: 57 TDKDLADLISEMELMKLIGKHKNIINLLG--VCTQEGPLYVIVEYAAKGNLREFLRARRP 114
Query: 102 ----------RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 151
+ +++ K + A Q+ G+ YL S IHRDL N+ + +
Sbjct: 115 PGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDN- 171
Query: 152 EVKIGDLGLATIMEQAN--AKSVIG--TPEFMAPE-LYDENYNELADIYSFGMCMLEMVT 206
+KI D GLA + + K+ G ++MAPE L+D Y +D++SFG+ M E+ T
Sbjct: 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
Query: 207 F---EYP 210
YP
Sbjct: 232 LGGSPYP 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 42/132 (31%), Positives = 76/132 (57%), Gaps = 11/132 (8%)
Query: 88 IITELFTSGSLRQ--YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIF 145
++ L G L+ Y + ++M+ V ++ QI G+++LHS D I++RD+K +N+
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVL 127
Query: 146 INGNQGEVKIGDLGLATIMEQANAKSVI---GTPEFMAPE-LYDENYNELADIYSFGMCM 201
++ +QG ++ DLGLA +E + K++ GT +MAPE L +E Y+ D ++ G +
Sbjct: 128 LD-DQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSI 184
Query: 202 LEMVTFEYPYSE 213
EMV P+ +
Sbjct: 185 YEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 50 PEDLE-RLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKK 107
P++L+ + SE +LK H NI++ + Q + + I+ EL G + RKK +
Sbjct: 32 PQELKIKFLSEARILKQYDHPNIVKLIG--VCTQRQPIYIVMELVPGGDFLSFLRKKKDE 89
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167
+ K + +A +G+ YL S + IHRDL N + G +KI D G++ E
Sbjct: 90 LKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLV-GENNVLKISDFGMSR-QEDD 145
Query: 168 NAKSVIGTPE----FMAPE-LYDENYNELADIYSFGMCMLEMVTFEY-PYSECRNSAQIY 221
S G + + APE L Y+ +D++S+G+ + E + PY N Q
Sbjct: 146 GIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-QAR 204
Query: 222 KKVSSGIKPAALSKVKDPEVKSFIEKC 248
++V G + + K D +V +++C
Sbjct: 205 EQVEKGYRMSCPQKCPD-DVYKVMQRC 230
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 35/104 (33%), Positives = 62/104 (59%), Gaps = 7/104 (6%)
Query: 110 MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--- 166
+K + +Q+L + Y+H D +IHRD+K +NIF+N + G++ +GD G A E+
Sbjct: 266 LKQTRAIMKQLLCAVEYIH--DKKLIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKERE 322
Query: 167 ANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEY 209
A +GT +PE L + Y E+ DI+S G+ +L+M++ ++
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
|
Length = 501 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 15/162 (9%)
Query: 55 RLYSEVHLLKSLKHNNIIRFYNSWID---DQNKTVNIITELFTSGSLRQYRKKHKKVDMK 111
R E+ +L+ KH NII + + V I+ EL + + + +H D
Sbjct: 49 RTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH- 107
Query: 112 AVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 171
++ + QIL GL Y+HS + ++HRDLK N+ +N N ++KI D GLA I + + +
Sbjct: 108 -IQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLARIADPEHDHT 163
Query: 172 -----VIGTPEFMAPE--LYDENYNELADIYSFGMCMLEMVT 206
+ T + APE L + Y + DI+S G + EM++
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 48/170 (28%), Positives = 86/170 (50%), Gaps = 13/170 (7%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-K 107
SP+ + + E +++ S+ + ++ R + TV +IT+L G L Y ++HK
Sbjct: 49 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDN 105
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--- 164
+ + + W QI G+ YL + ++HRDL N+ + Q VKI D GLA ++
Sbjct: 106 IGSQYLLNWCVQIAKGMNYLE--ERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAD 162
Query: 165 EQANAKSVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPY 211
E+ P ++MA E + Y +D++S+G+ + E++TF PY
Sbjct: 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 56/241 (23%), Positives = 104/241 (43%), Gaps = 39/241 (16%)
Query: 42 RIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID-------DQNKTVNIITELFT 94
+I + + D +R E+ LL+ L H N+I + D + V I+ EL
Sbjct: 37 KIANAFDNRIDAKRTLREIKLLRHLDHENVI----AIKDIMPPPHREAFNDVYIVYELMD 92
Query: 95 SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVK 154
+ L Q + + + + + Q+L GL Y+HS + ++HRDLK N+ +N N ++K
Sbjct: 93 T-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNAN-CDLK 148
Query: 155 IGDLGLATIMEQANAKSVIGTPEFM----------APELY--DENYNELADIYSFGMCML 202
I D GL A++ +FM APEL Y D++S G
Sbjct: 149 ICDFGL--------ARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFA 200
Query: 203 EMVTFE--YPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKE 260
E++ + +P + + ++ ++ L +++ + + +I +P + R S
Sbjct: 201 ELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRS--LPYTPRQSFAR 258
Query: 261 L 261
L
Sbjct: 259 L 259
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 59/189 (31%), Positives = 90/189 (47%), Gaps = 22/189 (11%)
Query: 27 AFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--- 83
A+D V G VA ++ Q+ +R Y E+ L+K + H NII N + ++
Sbjct: 35 AYDTVTGQNVAI--KKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92
Query: 84 -KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+ V ++ EL + +L Q +D + + Q+L G+ +LHS IIHRDLK
Sbjct: 93 FQDVYLVMELMDA-NLCQV--IQMDLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPS 147
Query: 143 NIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE-----FMAPE-LYDENYNELADIYS 196
NI + + +KI D GLA + S + TP + APE + Y E DI+S
Sbjct: 148 NIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 202
Query: 197 FGMCMLEMV 205
G M EM+
Sbjct: 203 VGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 35/98 (35%), Positives = 55/98 (56%), Gaps = 5/98 (5%)
Query: 116 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT-IMEQANAKSVIG 174
+A +I GL LH I++RDLK +NI ++ + G ++I DLGLA I E + +G
Sbjct: 107 YAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVG 163
Query: 175 TPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPY 211
T +MAPE + +E Y D + G + EM+ + P+
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 48/179 (26%), Positives = 90/179 (50%), Gaps = 13/179 (7%)
Query: 96 GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKI 155
G L + ++ + D+ + + ++L L LH + +I+RDLK +NI ++ QG + +
Sbjct: 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIAL 134
Query: 156 GDLGLATI-MEQAN-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYS 212
D GL + M+ + + GTPE++APEL Y + D ++ G+ + EM+T P+
Sbjct: 135 CDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194
Query: 213 ECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPA-SQRL---SAKELLMDPFL 267
+ N ++Y+K+ +P D + K + L ++RL A+E+ PF
Sbjct: 195 D-ENVNEMYRKILQ--EPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 73/260 (28%), Positives = 119/260 (45%), Gaps = 39/260 (15%)
Query: 51 EDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVD 109
+DL L SE+ ++K + KH NII + Q+ + ++ E + G+LR+Y + +
Sbjct: 59 KDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVLVEYASKGNLREYLRARRPPG 116
Query: 110 M----------------KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 153
M K + A Q+ G+ YL S IHRDL N+ + +
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVT-EDNVM 173
Query: 154 KIGDLGLATIMEQAN--AKSVIG--TPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF- 207
KI D GLA + + K+ G ++MAPE L+D Y +D++SFG+ + E+ T
Sbjct: 174 KIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 233
Query: 208 --EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC--LVPASQRLSAKELL- 262
YP ++ K+ KPA + E+ + +C VP SQR + K+L+
Sbjct: 234 GSPYPGIPVEELFKLLKEGHRMDKPANCTH----ELYMIMRECWHAVP-SQRPTFKQLVE 288
Query: 263 -MDPFLQVNGTTKNRPLPLP 281
+D L V T + L +P
Sbjct: 289 DLDRVLTVTSTDEYLDLSVP 308
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 43/170 (25%), Positives = 84/170 (49%), Gaps = 7/170 (4%)
Query: 45 DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK 104
+++ ED++ + +E H+ + N + +S ++ +I E G L + ++
Sbjct: 31 ELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI-EYVNGGDLMFHMQR 89
Query: 105 HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT-- 162
+K+ + + +A +I L +LH II+RDLK DN+ ++ + G +K+ D G+
Sbjct: 90 QRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDAD-GHIKLTDYGMCKEG 146
Query: 163 IMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPY 211
+ + GTP ++APE L E Y D ++ G+ M EM+ P+
Sbjct: 147 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 47/164 (28%), Positives = 85/164 (51%), Gaps = 15/164 (9%)
Query: 61 HLLK--SLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWA 117
H+L SL H I+R ++ ++T+L GSL + ++H+ +D + + W
Sbjct: 59 HMLAMGSLDHAYIVRLLGIC---PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC 115
Query: 118 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK---SVIG 174
QI G+ YL H ++HR+L NI + + V+I D G+A ++ + K S
Sbjct: 116 VQIAKGMYYLEEHR--MVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHK 172
Query: 175 TP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECR 215
TP ++MA E + Y +D++S+G+ + EM+++ PY+ R
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 59/258 (22%)
Query: 59 EVHLLKSLKHNNIIRFY---NSWIDDQNK---TVNIITELFTSGSLRQYRKKHKKVDMKA 112
E+ +L+ LKH N++ + N+ + ++ E K+ K +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE 120
Query: 113 VKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-----TIMEQA 167
+K + +L+GL Y+H + I+HRD+K NI I + G +K+ D GLA + +
Sbjct: 121 IKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKP 177
Query: 168 NAKS--VIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTFEYP------------- 210
N + V+ T + PEL + +Y D++ G M EM T P
Sbjct: 178 NRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLTL 235
Query: 211 ---------------------YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249
+ + +KV +KP VKDP I+K L
Sbjct: 236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP----YVKDPHALDLIDKLL 291
Query: 250 V-PASQRLSAKELLMDPF 266
V ++R+ A L F
Sbjct: 292 VLDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 53/159 (33%), Positives = 78/159 (49%), Gaps = 23/159 (14%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWA 117
EV LLK LKH NI+ ++ I +K++ ++ E + L+QY + M VK +
Sbjct: 54 EVSLLKDLKHANIVTLHD--IVHTDKSLTLVFE-YLDKDLKQYMDDCGNIMSMHNVKIFL 110
Query: 118 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV----- 172
QIL GL Y H ++HRDLK N+ IN +GE+K+ D GL A AKSV
Sbjct: 111 YQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGL------ARAKSVPTKTY 161
Query: 173 ---IGTPEFMAPE--LYDENYNELADIYSFGMCMLEMVT 206
+ T + P+ L Y+ D++ G EM +
Sbjct: 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 13 YLRLIQLVDTSG---YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 69
YL L +L + S YK +NG VA + + P R E LLK LKH
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR---EASLLKGLKHA 63
Query: 70 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK-VDMKAVKGWARQILSGLIYLH 128
NI+ ++ I +T+ + E + L QY +H + V+ + Q+L GL Y+H
Sbjct: 64 NIVLLHD--IIHTKETLTFVFE-YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH 120
Query: 129 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA---TIMEQANAKSVIGTPEFMAPE--L 183
I+HRDLK N+ I+ GE+K+ D GLA +I Q + V+ T + P+ L
Sbjct: 121 GQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLL 176
Query: 184 YDENYNELADIYSFGMCMLEMV 205
+Y+ DI+ G +EM+
Sbjct: 177 GATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 19/155 (12%)
Query: 127 LHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM---EQANAKSVIGTPEFMAPE 182
+HS H +HRD+K +N+ I+ G +K+ D G A + + N+K +GTP+++APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 183 LY-------DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 235
+ Y D +S G+ EM+ P+ E SA+ Y + + L
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMN--FQRFLKF 230
Query: 236 VKDPEVKS----FIEKCLVPASQRLSAKELLMDPF 266
+DP+V S I+ L +RL + L PF
Sbjct: 231 PEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 45/160 (28%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 54 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--KKVDMK 111
E E ++K L+H +++ Y ++ + I+TE + GSL + K K + +
Sbjct: 46 EAFLQEAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLP 102
Query: 112 AVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 171
+ A QI SG+ Y+ + +HRDL+ NI + G K+ D GLA ++E +
Sbjct: 103 QLVDMAAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTA 159
Query: 172 VIGTP---EFMAPE--LYDENYNELADIYSFGMCMLEMVT 206
G ++ APE LY + +D++SFG+ + E+ T
Sbjct: 160 RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 67/243 (27%), Positives = 113/243 (46%), Gaps = 37/243 (15%)
Query: 49 SPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK- 106
+ +DL L SE+ ++K + KH NII + Q+ + +I E + G+LR+Y + +
Sbjct: 63 TEKDLSDLISEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRP 120
Query: 107 ---------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 151
++ K + A Q+ G+ YL S IHRDL N+ + +
Sbjct: 121 PGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN- 177
Query: 152 EVKIGDLGLATIMEQAN--AKSVIG--TPEFMAPE-LYDENYNELADIYSFGMCMLEMVT 206
+KI D GLA + + K+ G ++MAPE L+D Y +D++SFG+ + E+ T
Sbjct: 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
Query: 207 F---EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC--LVPASQRLSAKEL 261
YP ++ K+ KP+ + E+ + C VP SQR + K+L
Sbjct: 238 LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTN----ELYMMMRDCWHAVP-SQRPTFKQL 292
Query: 262 LMD 264
+ D
Sbjct: 293 VED 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 46/189 (24%), Positives = 95/189 (50%), Gaps = 12/189 (6%)
Query: 26 KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 85
K + + ++V ++ DD ED++ + +E H+ + ++ + +S +++
Sbjct: 17 KKTERIYAMKVVKKELVNDD-----EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71
Query: 86 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIF 145
+I E G L + ++ +K+ + + ++ +I L YLH II+RDLK DN+
Sbjct: 72 FFVI-EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVL 128
Query: 146 INGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCML 202
++ ++G +K+ D G+ + + GTP ++APE L E+Y D ++ G+ M
Sbjct: 129 LD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 187
Query: 203 EMVTFEYPY 211
EM+ P+
Sbjct: 188 EMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 31/99 (31%), Positives = 61/99 (61%), Gaps = 6/99 (6%)
Query: 116 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVI 173
+A +I GL +LH II+RDLK DN+ ++ ++G +KI D G+ +++ ++
Sbjct: 106 YAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTTRTFC 162
Query: 174 GTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPY 211
GTP+++APE+ + Y + D +++G+ + EM+ + P+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 5e-10
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 54 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--KKVDMK 111
E E ++K L+H+ ++ Y ++ + I+TE GSL + K+ K + +
Sbjct: 46 EAFLQEAQIMKKLRHDKLVPLYAVVSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLP 102
Query: 112 AVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 171
+ A QI G+ Y+ + IHRDL+ NI + N KI D GLA ++E +
Sbjct: 103 QLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYTA 159
Query: 172 VIGTP---EFMAPE--LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVS 225
G ++ APE LY + +D++SFG+ + E+VT PY N ++ ++V
Sbjct: 160 RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNR-EVLEQVE 217
Query: 226 SGIK-------PAALSKV------KDPE-------VKSFIE 246
G + P +L ++ KDP+ ++SF+E
Sbjct: 218 RGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 62/201 (30%)
Query: 135 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-------------------------- 168
IHRD+K DN+ ++ +G +K+ D GL T +++++
Sbjct: 123 IHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181
Query: 169 --------------AKSVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEYP--Y 211
A S +GTP+++APE++ + YN+ D +S G+ M EM+ YP
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV-GYPPFC 240
Query: 212 SECRNSAQIYKKV----SSGIKP--AALSKVKDPEVKSFIEKCLVPASQRL---SAKELL 262
S+ N + Y+K+ + P LS PE K I++ A +RL E+
Sbjct: 241 SD--NPQETYRKIINWKETLQFPDEVPLS----PEAKDLIKRLCCEAERRLGNNGVNEIK 294
Query: 263 MDPFLQ-VN-GTTKNRPLPLP 281
PF + V+ + RP P+
Sbjct: 295 SHPFFKGVDWEHIRERPAPII 315
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 6e-10
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 12/157 (7%)
Query: 60 VHLLKSLKHN-NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWAR 118
VH L +K N N I+ Y S K +I + G L KK K+ VK R
Sbjct: 61 VHQL--MKDNPNFIKLYYSV--TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIR 116
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI-GTPE 177
Q++ L LH H+ IIH D+K +N+ + + + + D GL I+ S GT +
Sbjct: 117 QLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKII---GTPSCYDGTLD 171
Query: 178 FMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSE 213
+ +PE + NY+ D ++ G+ E++T ++P+ E
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208
|
Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-10
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 38/219 (17%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y A+D V VA ++R +D+ ++P +R E + L H I+ Y+ I
Sbjct: 19 YLAYDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLIHPGIVPVYS--ICSDGD 75
Query: 85 TVNIITELFTSGSLRQYRKK-----------HKKVDMKAVKGWARQILSGLIYLHSHDPP 133
V +L+ K +K + A +I + + Y+HS
Sbjct: 76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG-- 133
Query: 134 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ---------ANAKS-----------VI 173
++HRDLK DNI + G GEV I D G A + + ++ ++
Sbjct: 134 VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIV 192
Query: 174 GTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPY 211
GTP++MAPE L +E DIY+ G+ + +M+T +PY
Sbjct: 193 GTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 59/196 (30%), Positives = 92/196 (46%), Gaps = 32/196 (16%)
Query: 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYL---HSHDPPIIHRDLKCDNIFIN 147
ELFT S R+ K+ + QI SG I L H H II+RD+K +NI ++
Sbjct: 91 ELFTHLSQRERFKEQEV-----------QIYSGEIVLALEHLHKLGIIYRDIKLENILLD 139
Query: 148 GNQGEVKIGDLGLAT---IMEQANAKSVIGTPEFMAPELY---DENYNELADIYSFGMCM 201
N G V + D GL+ E A S GT E+MAP++ D +++ D +S G+ M
Sbjct: 140 SN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLM 198
Query: 202 LEMVTFEYPYS---ECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRL- 256
E++T P++ E + A+I +++ P + K I++ L+ +RL
Sbjct: 199 YELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDIIQRLLMKDPKKRLG 256
Query: 257 ----SAKELLMDPFLQ 268
A E+ PF Q
Sbjct: 257 CGPSDADEIKKHPFFQ 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 64/259 (24%), Positives = 118/259 (45%), Gaps = 23/259 (8%)
Query: 27 AFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 86
A D G +VA +I+DV + D R+ E+ LL+ L+H +I+ + + +
Sbjct: 19 AIDTHTGEKVAI--KKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 76
Query: 87 N---IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
++ EL S L Q K + + + + + Q+L L Y+H+ + + HRDLK N
Sbjct: 77 KDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKN 133
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAKSV-----IGTPEFMAPEL---YDENYNELADIY 195
I N + ++KI D GLA + ++ + T + APEL + Y DI+
Sbjct: 134 ILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 192
Query: 196 SFGMCMLEMVTFE--YPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI----EKCL 249
S G E++T + +P + + + P +S+V++ + + ++ +K
Sbjct: 193 SIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQP 252
Query: 250 VPASQRLSAKELLMDPFLQ 268
VP SQ+ + L L+
Sbjct: 253 VPFSQKFPNADPLALRLLE 271
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 16/192 (8%)
Query: 35 EVAWCQVRIDDVLQSPEDLE--RLYSEVHLLKSLKHNNIIRFYNS-------WIDDQNKT 85
EV CQVR + + + LE R+ +L I+ NS + +
Sbjct: 15 EVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA 74
Query: 86 VNIITELFTSGSLR--QYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ ++ L G L+ Y + +A +I GL LH I++RDLK +N
Sbjct: 75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPEN 132
Query: 144 IFINGNQGEVKIGDLGLAT-IMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCM 201
I ++ + G ++I DLGLA + E K +GT +MAPE+ +E Y D ++ G +
Sbjct: 133 ILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLL 191
Query: 202 LEMVTFEYPYSE 213
EM+ + P+ +
Sbjct: 192 YEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 47/194 (24%), Positives = 96/194 (49%), Gaps = 12/194 (6%)
Query: 40 QVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLR 99
+V I + + E E ++ L H +++ Y Q K + I+TE +G L
Sbjct: 30 KVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT--QQKPLYIVTEFMENGCLL 87
Query: 100 QY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 158
Y R++ K+ + + + G+ YL + IHRDL N ++ + G VK+ D
Sbjct: 88 NYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDF 144
Query: 159 GLA--TIMEQANAKSVIGTP-EFMAPELYDEN-YNELADIYSFGMCMLEMVT-FEYPYSE 213
G+ + ++ + S P ++ PE+++ + Y+ +D++SFG+ M E+ T + P+ E
Sbjct: 145 GMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF-E 203
Query: 214 CRNSAQIYKKVSSG 227
+++ ++ + +S G
Sbjct: 204 KKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 47/169 (27%), Positives = 83/169 (49%), Gaps = 15/169 (8%)
Query: 58 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGW 116
SE ++ H NII + +++ V IITE +G+L + R+ + + + G
Sbjct: 54 SEASIMGQFDHPNIIHLEG--VVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGM 111
Query: 117 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK----SV 172
R I +G+ YL + +HRDL NI +N N K+ D GL+ +E + S
Sbjct: 112 LRGIAAGMKYLS--EMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSS 168
Query: 173 IGTP---EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRN 216
+G + APE + + +D++S+G+ M E++++ E PY + N
Sbjct: 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 47/179 (26%), Positives = 74/179 (41%), Gaps = 23/179 (12%)
Query: 53 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA 112
E EV +L L NI R D + +I E +G L Q+ +KH
Sbjct: 63 REDFLKEVKILSRLSDPNIARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 113 VKG-----------WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 161
A QI SG+ YL S + +HRDL N + N +KI D G++
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNY-TIKIADFGMS 177
Query: 162 TIMEQANAKSVIGTP----EFMAPE-LYDENYNELADIYSFGMCMLEMVTF--EYPYSE 213
+ ++ V G +MA E + + +D+++FG+ + E++T E PY
Sbjct: 178 RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 4e-09
Identities = 36/99 (36%), Positives = 55/99 (55%), Gaps = 9/99 (9%)
Query: 113 VKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK-- 170
VK Q+LSG+ +LH + I+HRDLK N+ +N N+G +KI D GLA + K
Sbjct: 108 VKCLMLQLLSGVAHLHDN--WILHRDLKTSNLLLN-NRGILKICDFGLAREY-GSPLKPY 163
Query: 171 -SVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVT 206
++ T + APEL + Y+ D++S G E++T
Sbjct: 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 35/194 (18%)
Query: 51 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM 110
+D +R E LL L+H +I+RFY + + + ++ E G L ++ + H D
Sbjct: 52 QDFQR---EAELLTVLQHQHIVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGP-DA 105
Query: 111 KAVKGW----------------ARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEV 153
K + G A QI SG++YL S H +HRDL N + G V
Sbjct: 106 KILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLV-GQGLVV 161
Query: 154 KIGDLGLATIMEQANAKSVIGTP----EFMAPE--LYDENYNELADIYSFGMCMLEMVTF 207
KIGD G++ + + V G +M PE LY + E +DI+SFG+ + E+ T+
Sbjct: 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTY 220
Query: 208 -EYPYSECRNSAQI 220
+ P+ + N+ I
Sbjct: 221 GKQPWYQLSNTEAI 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 43/205 (20%)
Query: 51 EDLERLYSEVHLLKSLKHNNIIRFY------NSWIDDQNKTVNIITELFTSGSLRQYRKK 104
+D ER E LL + +H NI++FY + I ++ E G L ++ +
Sbjct: 53 KDFER---EAELLTNFQHENIVKFYGVCTEGDPPI--------MVFEYMEHGDLNKFLRS 101
Query: 105 HKK-----VDMKAVKG---------WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 150
H + G A QI SG++YL S +HRDL N + G
Sbjct: 102 HGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYD 158
Query: 151 GEVKIGDLGLATIMEQANAKSVIGTP----EFMAPE--LYDENYNELADIYSFGMCMLEM 204
VKIGD G++ + + V G +M PE +Y + E +D++SFG+ + E+
Sbjct: 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEI 217
Query: 205 VTF-EYPYSECRNSAQIYKKVSSGI 228
T+ + P+ N I + ++ G
Sbjct: 218 FTYGKQPWYGLSNEEVI-ECITQGR 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 47/141 (33%), Positives = 78/141 (55%), Gaps = 12/141 (8%)
Query: 115 GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE-VKIGDLGLA-TIMEQAN--AK 170
G++ Q+ +G+ +L S + +HRDL N+ I +G+ VKI D GLA IM +N +K
Sbjct: 243 GFSYQVANGMEFLASKN--CVHRDLAARNVLIC--EGKLVKICDFGLARDIMRDSNYISK 298
Query: 171 SVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 227
P ++MAPE +++ Y L+D++SFG+ + E+ T PY E + Q Y + G
Sbjct: 299 GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRG 358
Query: 228 IKPAALSKVKDPEVKSFIEKC 248
+ A + D E+ ++KC
Sbjct: 359 YRMAKPAHASD-EIYEIMQKC 378
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 14/165 (8%)
Query: 53 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMK 111
+ +E ++ +L+H N+++ + + I+TE GSL Y R + + V
Sbjct: 44 AQAFLAEASVMTTLRHPNLVQLLGVVLQGNP--LYIVTEYMAKGSLVDYLRSRGRAVITL 101
Query: 112 A-VKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQAN 168
A G+A + G+ YL + +HRDL N+ ++ K+ D GLA Q +
Sbjct: 102 AQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQDS 158
Query: 169 AKSVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTF-EYPY 211
K + ++ APE E ++ +D++SFG+ + E+ +F PY
Sbjct: 159 GKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-09
Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 27/208 (12%)
Query: 33 GLEVAWCQVRIDDVLQSPED---LERLYSEVHLLKSLKHNNIIRFYNSWI--DDQNKTVN 87
G EVA +R D +PE+ R E L L H NI+ +S V
Sbjct: 3 GHEVAIKLLRTD----APEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAV- 57
Query: 88 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN 147
E +LR+ + Q+L L +H+ I+HRDLK NI ++
Sbjct: 58 --FEYVPGRTLREVLAADGALPAGETGRLMLQVLDALA--CAHNQGIVHRDLKPQNIMVS 113
Query: 148 GNQGE--VKIGDLGLATIMEQANAK---------SVIGTPEFMAPE-LYDENYNELADIY 195
K+ D G+ T++ V+GTP + APE L E +D+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 196 SFGMCMLEMVTFEYPYSECRNSAQIYKK 223
++G+ LE +T + + + A+I +
Sbjct: 174 AWGLIFLECLTGQ-RVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 35/98 (35%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 116 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT-IMEQANAKSVIG 174
+A +IL GL LH + ++RDLK +NI ++ + G ++I DLGLA I E + + +G
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVG 163
Query: 175 TPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPY 211
T +MAPE L ++ Y D + G + EM+ + P+
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 42/170 (24%), Positives = 89/170 (52%), Gaps = 7/170 (4%)
Query: 45 DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK 104
+++ ED++ + +E H+ ++ ++ + +S +++ +I E + G L + ++
Sbjct: 31 ELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVI-EFVSGGDLMFHMQR 89
Query: 105 HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT-- 162
+K+ + + ++ +I L +LH II+RDLK DN+ ++ +G +K+ D G+
Sbjct: 90 QRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDA-EGHIKLTDYGMCKEG 146
Query: 163 IMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPY 211
I + GTP ++APE L E+Y D ++ G+ M EM+ P+
Sbjct: 147 IRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 37/131 (28%), Positives = 70/131 (53%), Gaps = 13/131 (9%)
Query: 85 TVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
TV ++T+L G L Y +++K ++ + + W QI G+ YL + ++HRDL N
Sbjct: 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL--EEVRLVHRDLAARN 139
Query: 144 IFINGNQGEVKIGDLGLATIME------QANAKSVIGTPEFMAPE-LYDENYNELADIYS 196
+ + + VKI D GLA +++ A+ V ++MA E + + +D++S
Sbjct: 140 VLVK-SPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALESILHRRFTHQSDVWS 196
Query: 197 FGMCMLEMVTF 207
+G+ + E++TF
Sbjct: 197 YGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 59/250 (23%), Positives = 111/250 (44%), Gaps = 57/250 (22%)
Query: 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 73
+RL+Q DT V +++ +R D+L+ E + + +E +L +++
Sbjct: 17 VRLVQKKDTG------HVYAMKI----LRKADMLEK-EQVGHIRAERDILVEADSLWVVK 65
Query: 74 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 133
+ S+ D N + +I E G + K + + + + + + + +H
Sbjct: 66 MFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG-- 121
Query: 134 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN------------------------- 168
IHRD+K DN+ ++ ++G VK+ D GL T +++A+
Sbjct: 122 FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 169 ------------AKSVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEYPYSECR 215
A S +GTP+++APE++ + YN+L D +S G+ M EM+ P+ C
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF--CS 238
Query: 216 NSAQ-IYKKV 224
+ Q YKKV
Sbjct: 239 ETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 13/153 (8%)
Query: 58 SEVHLLKSLKHNNIIRFYNSWIDDQNK-TVNIITELFTSGSLRQYRKKHKKVDMKAVKGW 116
E+ +LK++ H II +++ + K TV ++ + L Y + + ++
Sbjct: 135 REIDILKTISHRAIINLIHAY---RWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITI 190
Query: 117 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV---- 172
R++L L YLH IIHRD+K +NIF++ +GD G A ++
Sbjct: 191 QRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGW 247
Query: 173 IGTPEFMAPELYD-ENYNELADIYSFGMCMLEM 204
GT E +PEL + Y DI+S G+ + EM
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 53/223 (23%), Positives = 101/223 (45%), Gaps = 47/223 (21%)
Query: 41 VRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQ 100
+R D+L+ E + + +E +L +++ + S+ D +N + +I E G +
Sbjct: 34 LRKADMLEK-EQVAHIRAERDILVEADGAWVVKMFYSFQDKRN--LYLIMEFLPGGDMMT 90
Query: 101 YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160
K + +A + + + + + +H IHRD+K DN+ ++ +G VK+ D GL
Sbjct: 91 LLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDA-KGHVKLSDFGL 147
Query: 161 ATIMEQAN-------------------------------------AKSVIGTPEFMAPEL 183
T +++A+ A S +GTP+++APE+
Sbjct: 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEV 207
Query: 184 YDEN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQ-IYKKV 224
+ + YN+L D +S G+ M EM+ P+ C + Q Y+KV
Sbjct: 208 FMQTGYNKLCDWWSLGVIMYEMLIGYPPF--CSETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 12/92 (13%)
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA------TIMEQANAKSV 172
QIL GL Y+HS + ++HRDLK N+ +N + E+KI D GLA
Sbjct: 113 QILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENAGFMTEY 169
Query: 173 IGTPEFMAPE--LYDENYNELADIYSFGMCML 202
+ T + APE L ++Y + D++S G C+L
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVG-CIL 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 24/184 (13%)
Query: 56 LYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKG 115
+ E LL +L+H +I++FY + + + ++ E G L ++ + H + +G
Sbjct: 54 FHREAELLTNLQHEHIVKFYGVCV--EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 116 -------------WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162
A+QI +G++YL S +HRDL N + G VKIGD G++
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV-GENLLVKIGDFGMSR 168
Query: 163 IMEQANAKSVIGTP----EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRN 216
+ + V G +M PE + + +D++S G+ + E+ T+ + P+ + N
Sbjct: 169 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228
Query: 217 SAQI 220
+ I
Sbjct: 229 NEVI 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 48/210 (22%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 12 MYLRLIQLVDTSGYKAFDEV-----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL 66
+ ++ ++L+ T G F +V G +VA ++ D Q+ +E ++ L
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA------FLAEASVMTQL 56
Query: 67 KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKV-DMKAVKGWARQILSGL 124
+H+N+++ +++ + I+TE GSL Y R + + V + ++ + +
Sbjct: 57 RHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 125 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP-EFMAPE- 182
YL +++ +HRDL N+ ++ K+ D GL E ++ + P ++ APE
Sbjct: 116 EYLEANN--FVHRDLAARNVLVS-EDNVAKVSDFGLTK--EASSTQDTGKLPVKWTAPEA 170
Query: 183 LYDENYNELADIYSFGMCMLEMVTF-EYPY 211
L ++ ++ +D++SFG+ + E+ +F PY
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 63/231 (27%), Positives = 103/231 (44%), Gaps = 23/231 (9%)
Query: 27 AFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--- 83
A+D + LE ++ Q+ +R Y E+ L+K + H NII N + ++
Sbjct: 43 AYDAI--LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100
Query: 84 -KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+ V I+ EL + + + + +D + + Q+L G+ +LHS IIHRDLK
Sbjct: 101 FQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPS 155
Query: 143 NIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE-----FMAPE-LYDENYNELADIYS 196
NI + + +KI D GLA + S + TP + APE + Y E DI+S
Sbjct: 156 NIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 210
Query: 197 FGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIKPAALSKVKDPEVKSFIE 246
G M EM+ + + Q K + G K P V++++E
Sbjct: 211 VGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 33/106 (31%), Positives = 56/106 (52%), Gaps = 8/106 (7%)
Query: 103 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162
+ + + + V ARQ+LS + Y+H IIHRD+K +N+ +NG + ++ +GD G A
Sbjct: 252 ARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAAC 308
Query: 163 IMEQANAK----SVIGTPEFMAPE-LYDENYNELADIYSFGMCMLE 203
+ + + GT + APE L + Y DI+S G+ + E
Sbjct: 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 5/98 (5%)
Query: 116 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT-IMEQANAKSVIG 174
+A ++ GL L I++RDLK +NI ++ ++G ++I DLGLA I E + +G
Sbjct: 107 YAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVG 163
Query: 175 TPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPY 211
T +MAPE + +E Y D + G + EM+ + P+
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 47 LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN----KTVNIITELFTSGSLRQYR 102
Q+ +R Y E+ L+K + H NII N + ++ + V ++ EL + + +
Sbjct: 54 FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ 113
Query: 103 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162
+ +D + + Q+L G+ +LHS IIHRDLK NI + + +KI D GLA
Sbjct: 114 ME---LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA- 166
Query: 163 IMEQANAKSVIGTP-----EFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRN 216
+ S + TP + APE + Y E DI+S G M EMV + + R+
Sbjct: 167 ---RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RD 222
Query: 217 SAQIYKKVSSGIK---PAALSKVKDPEVKSFIE 246
+ KV + P + K++ P V++++E
Sbjct: 223 YIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVE 254
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 16/140 (11%)
Query: 130 HDPPIIHRDLKCDNIFINGNQGEVKIGDLG-LATIMEQANAKS--VIGTPEFMAPELYDE 186
H +HRD+K DNI ++ N G +++ D G +ME +S +GTP++++PE+
Sbjct: 119 HQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 187 ------NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK----PAALSKV 236
Y D +S G+CM EM+ E P+ + + Y K+ + + PA ++ V
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKERFQFPAQVTDV 236
Query: 237 KDPEVKSFIEKCLVPASQRL 256
+ + K I + + RL
Sbjct: 237 SE-DAKDLIRRLICSREHRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 41/148 (27%), Positives = 76/148 (51%), Gaps = 19/148 (12%)
Query: 124 LIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ---ANAKSVIGTPEFM 179
++ +HS H +HRD+K DN+ ++ N G +++ D G M Q + +GTP+++
Sbjct: 112 VLAIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYI 170
Query: 180 APELYDE------NYNELADIYSFGMCMLEMVTFEYP-YSECRNSAQIYKKVSSGIK--- 229
+PE+ Y D +S G+CM EM+ E P Y+E + + Y K+ + +
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHEERFQ 228
Query: 230 -PAALSKVKDPEVKSFIEKCLVPASQRL 256
P+ ++ V + E K I++ + +RL
Sbjct: 229 FPSHITDVSE-EAKDLIQRLICSRERRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 48/192 (25%), Positives = 87/192 (45%), Gaps = 22/192 (11%)
Query: 39 CQVRIDDVLQ--SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSG 96
+V + V S + L E LL L H NI+ + I+D ++ G
Sbjct: 36 EEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF-VLYPYMNWG 94
Query: 97 SLRQYRKKHKKVDMKAVKG--------WARQILSGLIYLHSHDPPIIHRDLKCDNIFING 148
+L+ + ++ + + + A QI G+ YLH +IH+D+ N I+
Sbjct: 95 NLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID- 151
Query: 149 NQGEVKIGDLGLATIMEQANAKSVIGTPE-----FMAPE-LYDENYNELADIYSFGMCML 202
+ +VKI D L+ + + +G E +MA E L ++ Y+ +D++SFG+ +
Sbjct: 152 EELQVKITDNALSRDLFPMDYHC-LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLW 210
Query: 203 EMVTF-EYPYSE 213
E++T + PY E
Sbjct: 211 ELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 31/183 (16%)
Query: 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 150
E+FT R + V+ ++ +I+ L +LH I++RD+K +NI ++ ++
Sbjct: 91 EMFTHLYQRDNFSE------DEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SE 141
Query: 151 GEVKIGDLGLATIM---EQANAKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMV 205
G V + D GL+ E+ S GT E+MAPE+ + + D +S G+ + E++
Sbjct: 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
Query: 206 TFEYPYS---ECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELL 262
T P++ E +++ +++ DP SFI P +Q L K L
Sbjct: 202 TGASPFTLEGERNTQSEVSRRILK----------CDPPFPSFIG----PEAQDLLHKLLR 247
Query: 263 MDP 265
DP
Sbjct: 248 KDP 250
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-----------K 107
E+ ++ LK NIIR I + +ITE +G L Q+ +H+
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167
+ + A QI SG+ YL S + +HRDL N + G +KI D G++ +
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLV-GKNYTIKIADFGMSRNLYSG 183
Query: 168 NAKSVIGTP----EFMAPE-LYDENYNELADIYSFGMCMLEMVTF--EYPYSE 213
+ + G +M+ E + + +D+++FG+ + E++T E PYS+
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 15/207 (7%)
Query: 50 PEDLE-RLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKK 107
P DL+ + E +LK H NI+R + Q + + I+ EL G + R + +
Sbjct: 33 PPDLKAKFLQEARILKQYSHPNIVRLIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGPR 90
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167
+ +K + +G+ YL S IHRDL N + + +KI D G++ E
Sbjct: 91 LKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVT-EKNVLKISDFGMSREEEDG 147
Query: 168 NAKSVIGTPE----FMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIY 221
S G + + APE L Y+ +D++SFG+ + E + PY+ N Q
Sbjct: 148 VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-QTR 206
Query: 222 KKVSSGIKPAALSKVKDPEVKSFIEKC 248
+ + G++ D V +E+C
Sbjct: 207 EAIEQGVRLPCPELCPD-AVYRLMERC 232
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 21/96 (21%)
Query: 126 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI-----------------MEQAN 168
YLH++ I+HRDLK DN+ I + G +K+ D GL+ I +
Sbjct: 116 YLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 169 AKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLE 203
K V GTPE++APE + + Y + D ++ G+ + E
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 29/184 (15%)
Query: 47 LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY---RK 103
+ +P+ E L+ L H NI+ + Q + V ++ E G L ++ R
Sbjct: 45 INNPQQWGEFQQEASLMAELHHPNIVCLLG--VVTQEQPVCMLFEYLNQGDLHEFLIMRS 102
Query: 104 KHKKVDMKA-----VKG---------WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN 149
H V + VK A QI +G+ YL SH +H+DL NI I G
Sbjct: 103 PHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI-GE 159
Query: 150 QGEVKIGDLGLATIMEQANAKSVIGTP----EFMAPE--LYDENYNELADIYSFGMCMLE 203
Q VKI DLGL+ + A+ V +M PE +Y + ++ +DI+SFG+ + E
Sbjct: 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWE 218
Query: 204 MVTF 207
+ +F
Sbjct: 219 IFSF 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 40 QVRIDDVLQSPEDLERL--YSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGS 97
+V I V ++ ER+ +E ++K ++++R + Q + +I EL T G
Sbjct: 38 RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGD 95
Query: 98 LRQYRKKHKKVD----------MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN 147
L+ Y + + +K + A +I G+ YL+++ +HRDL N +
Sbjct: 96 LKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV- 152
Query: 148 GNQGEVKIGDLGLATIMEQANAKSVIGTP----EFMAPE-LYDENYNELADIYSFGMCML 202
VKIGD G+ + + + G +M+PE L D + +D++SFG+ +
Sbjct: 153 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 212
Query: 203 EMVTF-EYPYSECRNSAQIYKKVSSG 227
E+ T E PY N Q+ + V G
Sbjct: 213 EIATLAEQPYQGMSNE-QVLRFVMEG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 61/257 (23%), Positives = 107/257 (41%), Gaps = 33/257 (12%)
Query: 30 EVN-GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88
EVN G A V+ V S ++ + E +SL+H+N+++ + +
Sbjct: 15 EVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT--EVTPYLL 72
Query: 89 ITELFTSGSLRQYRKKHKKV-----DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ E G L+ Y + +K D ++ A +I GL++LH ++ IH DL N
Sbjct: 73 VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRN 130
Query: 144 IFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELYDENYNEL-------- 191
+ + VKIGD GL+ + + + ++APEL DE + L
Sbjct: 131 CLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKE 189
Query: 192 ADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAALSKVKDP------EVKSF 244
++++S G+ + E+ PY + + V ++K P EV F
Sbjct: 190 SNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQF 249
Query: 245 IEKCLVPASQRLSAKEL 261
C + QR SA+E+
Sbjct: 250 ---CWLQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 37/149 (24%), Positives = 74/149 (49%), Gaps = 14/149 (9%)
Query: 71 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH 130
+++ + ++ DD K + ++ E G L + V K K + +++ L +HS
Sbjct: 105 VVQLFCAFQDD--KYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSM 161
Query: 131 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA---NAKSVIGTPEFMAPELY--- 184
+IHRD+K DN+ ++ G +K+ D G M++ + +GTP++++PE+
Sbjct: 162 G--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 185 --DENYNELADIYSFGMCMLEMVTFEYPY 211
D Y D +S G+ + EM+ + P+
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 44/186 (23%), Positives = 88/186 (47%), Gaps = 17/186 (9%)
Query: 30 EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89
E G +VA ++ D Q+ E ++ L H N++R + + + I+
Sbjct: 26 EYTGQKVAVKNIKCDVTAQA------FLEETAVMTKLHHKNLVRLLGVIL---HNGLYIV 76
Query: 90 TELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN 147
EL + G+L + + + V + + ++ + G+ YL S ++HRDL NI ++
Sbjct: 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVS 134
Query: 148 GNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVT 206
G K+ D GLA + S + ++ APE L + ++ +D++S+G+ + E+ +
Sbjct: 135 -EDGVAKVSDFGLARVGSMGVDNSKLPV-KWTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192
Query: 207 F-EYPY 211
+ PY
Sbjct: 193 YGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 33/182 (18%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGW-- 116
EV +L LK NIIR +D+ + +ITE +G L Q+ H +D K G
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSH-HLDDKEENGNDA 125
Query: 117 ------------------ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 158
A QI SG+ YL S + +HRDL N + N +KI D
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENL-TIKIADF 182
Query: 159 GLATIMEQANAKSVIGTP----EFMAPE-LYDENYNELADIYSFGMCMLEMVTF--EYPY 211
G++ + + + G +MA E + + +D+++FG+ + E++ E PY
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 212 SE 213
E
Sbjct: 243 GE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 45/137 (32%), Positives = 70/137 (51%), Gaps = 12/137 (8%)
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE-VKIGDLGLA-TIMEQANAKSVIGT- 175
Q+ G+ +L S + +HRDL N+ + QG+ VKI D GLA IM +N S T
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLLA--QGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 176 --PEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPA 231
++MAPE ++D Y L+D++S+G+ + E+ + PY + Y K+ SG + A
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA 360
Query: 232 ALSKVKDPEVKSFIEKC 248
EV + KC
Sbjct: 361 KPDHATQ-EVYDIMVKC 376
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 54/226 (23%), Positives = 96/226 (42%), Gaps = 32/226 (14%)
Query: 17 IQLVDTSGYKAFDEV--------NGLEVAWCQVRIDDV--LQSPEDLERLYSEVHLLKSL 66
I L+ G+ AF EV +G V QV + + S +D E ++
Sbjct: 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVE-LQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 67 KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-------KVDMKAVKGWARQ 119
H NI+R + + I+ EL G L+ + ++++ + MK + AR
Sbjct: 67 NHQNIVRLIG--VSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 120 ILSGLIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGLATIMEQA-----NAKSV 172
+ G YL + IHRD+ N + G KI D G+A + +A +++
Sbjct: 125 VAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM 182
Query: 173 IGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEY-PYSECRN 216
+ ++M PE + + + D++SFG+ + E+ + Y PY N
Sbjct: 183 LPI-KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 34/222 (15%)
Query: 17 IQLVDTSGYKAFDEVNGLE-------VAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 69
+ L + G F E VA +R D + D + E+ ++ LK+
Sbjct: 21 VHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLK---EIKIMSRLKNP 77
Query: 70 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK------------KVDMKAVKGWA 117
NIIR + D + +ITE +G L Q+ + + V + + A
Sbjct: 78 NIIRLLGVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMA 135
Query: 118 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP- 176
QI SG+ YL S + +HRDL N + GN +KI D G++ + + + G
Sbjct: 136 VQIASGMKYLASLN--FVHRDLATRNCLV-GNHYTIKIADFGMSRNLYSGDYYRIQGRAV 192
Query: 177 ---EFMAPE-LYDENYNELADIYSFGMCMLEMVTF--EYPYS 212
+MA E + + +D+++FG+ + EM T E PYS
Sbjct: 193 LPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 40/151 (26%), Positives = 58/151 (38%), Gaps = 19/151 (12%)
Query: 116 WA--RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI 173
WA Q L L LH K NI + + G +K+ G +
Sbjct: 20 WAVCLQCLGALRELHRQA--------KSGNILLTWD-GLLKLD--GSVAFKTPEQS---R 65
Query: 174 GTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA 232
P FMAPE+ +Y E ADIYS G+ + E + +E PY+E R + I + + +G A
Sbjct: 66 PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG--MPA 123
Query: 233 LSKVKDPEVKSFIEKCLVPASQRLSAKELLM 263
++ RL A L
Sbjct: 124 DDPRDRSNLEGVSAARSFEDFMRLCASRLPQ 154
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 41/172 (23%), Positives = 80/172 (46%), Gaps = 19/172 (11%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVD--------- 109
E+ + + L H N++R + + +I E G L+Q+ + K D
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 110 MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM---EQ 166
K QI G+ +L + +HRDL N ++ +Q EVK+ L L+ + E
Sbjct: 116 TKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVS-SQREVKVSLLSLSKDVYNSEY 172
Query: 167 ANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRN 216
++ + ++APE + +++++ +D++SFG+ M E+ T E P+ +
Sbjct: 173 YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 37/136 (27%), Positives = 68/136 (50%), Gaps = 18/136 (13%)
Query: 135 IHRDLKCDNIFINGNQGEVKIGDLG-LATIMEQANAKS--VIGTPEFMAPELYDE----- 186
+HRD+K DN+ ++ N G +++ D G ++ +S +GTP++++PE+
Sbjct: 124 VHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 187 -NYNELADIYSFGMCMLEMVTFEYP-YSECRNSAQIYKKVSSGIK----PAALSKVKDPE 240
Y D +S G+CM EM+ E P Y+E + + Y K+ + + P ++ V + E
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQFPPDVTDVSE-E 239
Query: 241 VKSFIEKCLVPASQRL 256
K I + + RL
Sbjct: 240 AKDLIRRLICSPETRL 255
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 52/207 (25%), Positives = 82/207 (39%), Gaps = 56/207 (27%)
Query: 130 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT--------------------IMEQAN- 168
H IHRD+K DNI I+ + G +K+ D GL T ME ++
Sbjct: 118 HKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176
Query: 169 ----------------------------AKSVIGTPEFMAPE-LYDENYNELADIYSFGM 199
A S++GTP ++APE L + Y +L D +S G+
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236
Query: 200 CMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK-DPEVKSFIEKCLVPASQRL-- 256
+ EM+ + P+ + K ++ +VK PE I K A +RL
Sbjct: 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGR 296
Query: 257 -SAKELLMDPFL-QVNGTTKNRPLPLP 281
A ++ PF +V+ ++ R P P
Sbjct: 297 NGADDIKAHPFFSEVDFSSDIRTQPAP 323
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 34/128 (26%), Positives = 51/128 (39%), Gaps = 47/128 (36%)
Query: 130 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT--------------------------- 162
H IHRD+K DNI I+ G +K+ D GL T
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 163 ----------IMEQAN--------AKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLE 203
+E+ A S++GTP ++APE L Y +L D +S G+ + E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 204 MVTFEYPY 211
M+ + P+
Sbjct: 237 MLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 30/182 (16%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY---RKKH 105
P+ + E L+ L+H NI+ + + + ++ E G L ++ H
Sbjct: 48 EPKVQQEFRQEAELMSDLQHPNIVCLLG--VCTKEQPTCMLFEYLAHGDLHEFLVRNSPH 105
Query: 106 KKVDMKAVKGW-------------ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE 152
V ++ A QI +G+ YL SH +HRDL N + G
Sbjct: 106 SDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLT 162
Query: 153 VKIGDLGLATIMEQAN-----AKSVIGTPEFMAPE--LYDENYNELADIYSFGMCMLEMV 205
VKI D GL+ + A+ +KS++ +M PE LY + E +DI+SFG+ + E+
Sbjct: 163 VKISDFGLSRDIYSADYYRVQSKSLLPV-RWMPPEAILYGKFTTE-SDIWSFGVVLWEIF 220
Query: 206 TF 207
++
Sbjct: 221 SY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 31/210 (14%)
Query: 54 ERLYSEVHLLKSLKHNNIIRFY-----NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV 108
+ L E ++++ L + I+R SW+ ++ EL G L ++ +K+K V
Sbjct: 41 DELLREANVMQQLDNPYIVRMIGICEAESWM--------LVMELAELGPLNKFLQKNKHV 92
Query: 109 DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-TIMEQA 167
K + Q+ G+ YL + +HRDL N+ + Q KI D GL+ +
Sbjct: 93 TEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALGADE 149
Query: 168 N---AKSVIGTP-EFMAPELYD-ENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIY 221
N AK+ P ++ APE + ++ +D++SFG+ M E ++ + PY + + ++
Sbjct: 150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-EVT 208
Query: 222 KKVSSGIK---PAALSKVKDPEVKSFIEKC 248
+ + SG + P PE+ ++ C
Sbjct: 209 QMIESGERMECPQRCP----PEMYDLMKLC 234
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 43/176 (24%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 42 RIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY 101
RI D+ E++E+ E ++K H N++ + + + ++ G LR +
Sbjct: 33 RITDL----EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPL-VVLPYMKHGDLRNF 87
Query: 102 -RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160
R + +K + G+ Q+ G+ YL S +HRDL N ++ + VK+ D GL
Sbjct: 88 IRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESF-TVKVADFGL 144
Query: 161 A---------TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVT 206
A ++ AK + ++MA E L + + +D++SFG+ + E++T
Sbjct: 145 ARDIYDKEYYSVHNHTGAKLPV---KWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 31/108 (28%), Positives = 56/108 (51%), Gaps = 15/108 (13%)
Query: 116 WAR----QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME---QAN 168
WAR +++ L +HS IHRD+K DN+ ++ + G +K+ D G M+
Sbjct: 143 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGMVR 199
Query: 169 AKSVIGTPEFMAPEL-----YDENYNELADIYSFGMCMLEMVTFEYPY 211
+ +GTP++++PE+ D Y D +S G+ + EM+ + P+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 116 WAR----QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ---AN 168
WAR +++ L +HS IHRD+K DN+ ++ G +K+ D G M +
Sbjct: 143 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVR 199
Query: 169 AKSVIGTPEFMAPELY-----DENYNELADIYSFGMCMLEMVTFEYPY 211
+ +GTP++++PE+ D Y D +S G+ + EM+ + P+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 37/225 (16%)
Query: 22 TSGYKAFDEVNGLEVAWCQVRIDDVLQ-SPEDLERLYSEVHLLKSLKHNNIIRFYN---- 76
TS Y A G V VRI D+ + E L+ L +EV L +H NI+ +
Sbjct: 14 TSVYLARHTPTGTLVT---VRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT 70
Query: 77 -SWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLI----YLHSHD 131
SW+ +I+ GS K + M + IL G + YLH +
Sbjct: 71 GSWL-------WVISPFMAYGSANSLLKTYFPEGMS--EALIGNILFGALRGLNYLHQNG 121
Query: 132 PPIIHRDLKCDNIFINGNQGEVKIGDLG--LATIMEQANAKSVIGTPEF-------MAPE 182
IHR++K +I I+G+ G V + L + + AK V P+F ++PE
Sbjct: 122 --YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 183 LYDEN---YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 224
L ++ YN +DIYS G+ E+ T P+ + + + +K+
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKL 223
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 30/197 (15%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKK 107
+P++ EV + L H N+++ I ++ ++ E G L+ Y R
Sbjct: 35 TPDEQLLFLQEVQPYRELNHPNVLQCLGQCI--ESIPYLLVLEFCPLGDLKNYLRSNRGM 92
Query: 108 VDMKAVKG----WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-- 161
V A K A ++ SGL++LH D IH DL N + + VKIGD GLA
Sbjct: 93 VAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADL-SVKIGDYGLALE 149
Query: 162 ----TIMEQANAKSVIGTP-EFMAPELYDENYNEL--------ADIYSFGMCMLEMVTF- 207
+ +V P ++APEL + +L ++I+S G+ M E+ T
Sbjct: 150 QYPEDYYITKDCHAV---PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAA 206
Query: 208 EYPYSECRNSAQIYKKV 224
+ PY + + Q+ K+V
Sbjct: 207 DQPYPDLSDE-QVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 54/217 (24%), Positives = 75/217 (34%), Gaps = 57/217 (26%)
Query: 118 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME---QANAKSVIG 174
RQIL L LHS I+HRD+K NI + G KI DLG A + K +
Sbjct: 262 RQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL 319
Query: 175 TPEFMAPE-----------------------LYDENYNELADIYSFGMCMLEM------- 204
P + APE L+ N + DIYS G+ L+M
Sbjct: 320 DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRS 379
Query: 205 ----VTFEYPYSECRNSAQIYKKVSSGIKPAALSK---VKDPE-------VKSFIEKCLV 250
+ F ++K+ L + V D + +KS +
Sbjct: 380 DSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF--- 436
Query: 251 PASQRLSAKELLMDPFLQVNG-----TTKNRPLPLPD 282
QR+SAK L P+ G +N L L
Sbjct: 437 KGRQRISAKAALAHPYFDREGLLGLSVMQNLRLQLFR 473
|
Length = 566 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 42/181 (23%), Positives = 83/181 (45%), Gaps = 18/181 (9%)
Query: 58 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGW 116
+E L H+NI+R + + T+ I+TE ++G+L + +KH+ ++ + G
Sbjct: 55 AEALTLGQFDHSNIVRLEG--VITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGM 112
Query: 117 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG------LATIMEQANAK 170
+ SG+ YL +H+ L + +N + KI I + K
Sbjct: 113 LPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLV-CKISGFRRLQEDKSEAIYTTMSGK 169
Query: 171 SVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGI 228
S + + APE + +++ +D++SFG+ M E++++ E PY + + K V G
Sbjct: 170 SPV---LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-DVIKAVEDGF 225
Query: 229 K 229
+
Sbjct: 226 R 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 26/60 (43%), Positives = 36/60 (60%), Gaps = 5/60 (8%)
Query: 124 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAP 181
L YLH H IIHRDLK DN+ I+ N+G +K+ D GL+ T+ + N ++ TP P
Sbjct: 117 LDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 48/203 (23%), Positives = 90/203 (44%), Gaps = 34/203 (16%)
Query: 52 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDM 110
+ + E ++ L + I+R + + + ++ E+ + G L ++ K ++ +
Sbjct: 38 VRDEMMREAEIMHQLDNPYIVRMIGVC---EAEALMLVMEMASGGPLNKFLSGKKDEITV 94
Query: 111 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168
V Q+ G+ YL + +HRDL N+ + NQ KI D GL+ + +
Sbjct: 95 SNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSY 151
Query: 169 --AKSVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 224
A+S P ++ APE + ++ +D++S+G+ M E ++
Sbjct: 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSY----------------- 194
Query: 225 SSGIKPAALSKVKDPEVKSFIEK 247
G KP K+K PEV SFIE+
Sbjct: 195 --GQKP--YKKMKGPEVMSFIEQ 213
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 40/165 (24%), Positives = 79/165 (47%), Gaps = 10/165 (6%)
Query: 42 RIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY 101
+ D ++ E E E+ +L++LK NI+ ++ + + ++ E L
Sbjct: 33 KFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF--RRRGKLYLVFEYVEKNMLELL 90
Query: 102 RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 161
+ V + V+ + Q++ + + H +D I+HRD+K +N+ I+ N +K+ D G A
Sbjct: 91 EEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHND-VLKLCDFGFA 147
Query: 162 TIMEQ---ANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCML 202
+ + AN + T + +PE L Y + D++S G C+L
Sbjct: 148 RNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVG-CIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 38/139 (27%), Positives = 70/139 (50%), Gaps = 16/139 (11%)
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-------TIMEQANAKS 171
Q+ G+ +L S IHRDL NI ++ N VKI D GLA + + +A+
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 172 VIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIK 229
+ ++MAPE ++D+ Y +D++SFG+ + E+ + PY + + + +++ G +
Sbjct: 239 PL---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR 295
Query: 230 PAALSKVKDPEVKSFIEKC 248
A + PE+ + C
Sbjct: 296 MRA-PENATPEIYRIMLAC 313
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 25/60 (41%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 105 HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 164
K D+ +KG RQ+L+GL LH I+HRD+K +N+ + + G+VKI D G A M
Sbjct: 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVD-GQVKIIDFGAAVDM 359
|
Length = 507 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 17/103 (16%)
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-------TIMEQANAKS 171
Q+ G+ +L S IHRDL NI ++ N VKI D GLA + + +A+
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 172 VIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF---EYP 210
+ ++MAPE ++D+ Y +D++SFG+ + E+ + YP
Sbjct: 238 PL---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 31/113 (27%), Positives = 54/113 (47%), Gaps = 13/113 (11%)
Query: 117 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL-----ATIMEQANAKS 171
A+Q+ +G+ YL + +HRDL N + N VKI D GL + +A+
Sbjct: 136 AKQVAAGMAYLS--ERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKASEND 192
Query: 172 VIGTPEFMAPE--LYDENYNELADIYSFGMCMLEMVTFEY-PYSECRNSAQIY 221
I +M PE Y+ Y +D++++G+ + E+ ++ PY + IY
Sbjct: 193 AIPI-RWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 48/195 (24%), Positives = 77/195 (39%), Gaps = 63/195 (32%)
Query: 130 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT-------------IMEQANAK------ 170
H IHRD+K DNI I+ G +K+ D GL+T +++ + K
Sbjct: 118 HKLGFIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 171 ------------------------------SVIGTPEFMAPELY-DENYNELADIYSFGM 199
S +GTP+++APE++ + Y + D +S G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236
Query: 200 CMLEMVTFEYPY-SECRNSAQIYKKVSSGIKPAALSKVKD----PEVKSFIEKCLVPASQ 254
M E + P+ SE NS + Y+K+ + + L D E + I + + A
Sbjct: 237 IMFECLIGWPPFCSE--NSHETYRKIINWRE--TLYFPDDIHLSVEAEDLIRRLITNAEN 292
Query: 255 RL---SAKELLMDPF 266
RL A E+ PF
Sbjct: 293 RLGRGGAHEIKSHPF 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 40/138 (28%), Positives = 69/138 (50%), Gaps = 12/138 (8%)
Query: 116 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGT 175
+A + +G+ YL + IHRDL N+ + G KI D GL+ E K++
Sbjct: 124 FASDVATGMQYLS--EKQFIHRDLAARNVLV-GENLASKIADFGLSRGEEVYVKKTMGRL 180
Query: 176 P-EFMAPELYDEN-YNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAA 232
P +MA E + + Y +D++SFG+ + E+V+ PY A++Y+K+ G +
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYR--- 236
Query: 233 LSKVK--DPEVKSFIEKC 248
+ K + D EV + +C
Sbjct: 237 MEKPRNCDDEVYELMRQC 254
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 21/147 (14%)
Query: 120 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---AKSVIGTP 176
I SG+ YL S + IHRDL N +N N V + D GL+ + + P
Sbjct: 122 IASGMEYLSSKN--FIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGDYYRQGCASKLP 178
Query: 177 -EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAAL 233
+++A E L D Y +D+++FG+ M E++T + PY+ NS +IY + G
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-EIYNYLIKG------ 231
Query: 234 SKVKDP-----EVKSFIEKCLVPASQR 255
+++K P +V + +C P +
Sbjct: 232 NRLKQPPDCLEDVYELMCQCWSPEPKC 258
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 42/189 (22%), Positives = 85/189 (44%), Gaps = 43/189 (22%)
Query: 53 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSG----SLRQYRKKHKKV 108
++R+ +E +L +L H + Y S+ + ++ + + G L Q R+ K +
Sbjct: 45 VKRVLTEQEILATLDHPFLPTLYASF--QTETYLCLVMD-YCPGGELFRLLQ-RQPGKCL 100
Query: 109 DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA------- 161
+ + +A ++L L YLH I++RDLK +NI ++ + G + + D L+
Sbjct: 101 SEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEP 157
Query: 162 ----------------------TIMEQANAK--SVIGTPEFMAPELYDENYNELA-DIYS 196
T E+ + + S +GT E++APE+ + + A D ++
Sbjct: 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWT 217
Query: 197 FGMCMLEMV 205
G+ + EM+
Sbjct: 218 LGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 19/164 (11%)
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-------TIMEQANAKS 171
Q+ G+ +L S IHRDL NI ++ N VKI D GLA + + +A+
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 172 VIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIK 229
+ ++MAPE ++D Y +D++SFG+ + E+ + PY + + +++ G +
Sbjct: 244 PL---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 300
Query: 230 PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELL--MDPFLQVN 270
A PE+ + C SQR + EL+ + LQ N
Sbjct: 301 MRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 38/114 (33%), Positives = 56/114 (49%), Gaps = 10/114 (8%)
Query: 120 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---AKSVIGTP 176
I SG+ YL S IHRDL N +N N V + D GL+ + + + P
Sbjct: 121 IASGMEYLSSKS--FIHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 177 -EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 227
+++A E L D Y +D++SFG+ M E+ T + PY NS +IY + G
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-EIYDYLRQG 230
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 35/132 (26%), Positives = 52/132 (39%), Gaps = 51/132 (38%)
Query: 130 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT--------------------IMEQAN- 168
H IHRD+K DNI I+ G +K+ D GL T M+ +N
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 169 ----------------------------AKSVIGTPEFMAPE-LYDENYNELADIYSFGM 199
A S++GTP ++APE L Y +L D +S G+
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 200 CMLEMVTFEYPY 211
+ EM+ + P+
Sbjct: 237 ILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 53/231 (22%), Positives = 99/231 (42%), Gaps = 34/231 (14%)
Query: 29 DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID--DQNKTV 86
D+ + L+VA +++D S ++E SE +K H N+++ + K
Sbjct: 23 DDGSQLKVAVKTMKLDIHTYS--EIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80
Query: 87 N--IITELFTSGSLRQY------RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRD 138
+I G L + +K+ ++ + + I G+ YL + + IHRD
Sbjct: 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRD 138
Query: 139 LKCDNIFINGNQGEVKIGDLGLATIMEQAN-------AKSVIGTPEFMAPE-LYDENYNE 190
L N + + V + D GL+ + + AK + +++A E L D Y
Sbjct: 139 LAARNCMLREDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPV---KWIAIESLADRVYTS 194
Query: 191 LADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 240
+D+++FG+ M E+ T + PY N +IY + G +++K PE
Sbjct: 195 KSDVWAFGVTMWEIATRGQTPYPGVENH-EIYDYLRHG------NRLKQPE 238
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 8/136 (5%)
Query: 116 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGT 175
+A + G+ YL IHRDL NI + N KI D GL+ E K++
Sbjct: 117 FAADVARGMDYLS--QKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRL 173
Query: 176 P-EFMAPELYDEN-YNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAA 232
P +MA E + + Y +D++S+G+ + E+V+ PY A++Y+K+ G +
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRLEK 232
Query: 233 LSKVKDPEVKSFIEKC 248
D EV + +C
Sbjct: 233 PLNCDD-EVYDLMRQC 247
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 35/129 (27%), Positives = 65/129 (50%), Gaps = 11/129 (8%)
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV-KIGDLGLATIMEQ 166
+D + + ++ Q+ G+ +L S + IHRDL NI + G + KI D GLA +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILL--THGRITKICDFGLARDIRN 266
Query: 167 ANAKSVIGTP----EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQI 220
+ V G ++MAPE +++ Y +D++S+G+ + E+ + PY ++
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326
Query: 221 YKKVSSGIK 229
YK + G +
Sbjct: 327 YKMIKEGYR 335
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 41/139 (29%), Positives = 65/139 (46%), Gaps = 14/139 (10%)
Query: 116 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGT 175
+A + G+ YL IHRDL NI + G KI D GL+ E K++
Sbjct: 129 FAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMGRL 185
Query: 176 P-EFMAPELYDEN-YNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGI---K 229
P +MA E + + Y +D++S+G+ + E+V+ PY A++Y+K+ G K
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRLEK 244
Query: 230 PAALSKVKDPEVKSFIEKC 248
P D EV + +C
Sbjct: 245 PLNC----DDEVYDLMRQC 259
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 19/172 (11%)
Query: 56 LYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMK--AV 113
L E+H+ K H NI+ + ++I D V +T GS + H M A+
Sbjct: 46 LQGELHVSKLFNHPNIVPYRATFIADNELWV--VTSFMAYGSAKDLICTHFMDGMSELAI 103
Query: 114 KGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL--GLATIMEQANAKS 171
+ +L L Y+H +HR +K +I I+ + G+V + L L+ I +
Sbjct: 104 AYILQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQRLRV 160
Query: 172 VIGTPEF-------MAPELYDEN---YNELADIYSFGMCMLEMVTFEYPYSE 213
V P++ ++PE+ +N Y+ +DIYS G+ E+ P+ +
Sbjct: 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 652 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.94 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.66 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.57 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.54 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.51 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.49 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.12 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.07 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.04 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.03 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.95 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.9 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.84 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.78 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.61 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.54 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.53 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.46 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.39 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.34 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.12 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.03 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.84 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.84 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.83 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.72 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.71 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.7 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.36 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.3 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.29 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.24 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.24 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.17 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.09 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.74 | |
| PLN02236 | 344 | choline kinase | 96.65 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.55 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.42 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.41 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.38 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.27 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 96.27 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.14 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.12 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 95.94 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.82 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 95.78 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.61 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.1 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.08 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.95 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.9 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.82 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.76 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.38 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.14 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.55 | |
| KOG4720 | 391 | consensus Ethanolamine kinase [Lipid transport and | 92.15 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 91.32 | |
| PTZ00296 | 442 | choline kinase; Provisional | 91.16 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 90.14 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 89.75 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 89.13 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 88.35 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 87.03 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-87 Score=730.52 Aligned_cols=427 Identities=58% Similarity=0.901 Sum_probs=361.0
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 95 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~g 95 (652)
||++...|||+|+|..+|.+|||+++++.++.++++.++|++.|+++|+.|+|||||+||++|++..+.++++|+|+|++
T Consensus 48 LGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TS 127 (632)
T KOG0584|consen 48 LGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTS 127 (632)
T ss_pred cccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccC
Confidence 34444479999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccccCC
Q 006277 96 GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGT 175 (652)
Q Consensus 96 GsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~vGT 175 (652)
|+|+.|++++++++.+.++.|++|||+||.|||++.||||||||||+||||+++.|.|||+|+|||+.++...+.+++||
T Consensus 128 GtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksvIGT 207 (632)
T KOG0584|consen 128 GTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSVIGT 207 (632)
T ss_pred CcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccceeccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCCCCCCC
Q 006277 176 PEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQR 255 (652)
Q Consensus 176 p~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~~P~~R 255 (652)
|.|||||++.+.|++.+|||||||||+||+|+++||++|.+++|||++|.+|++|..+.++.+|++++||.+||...+.|
T Consensus 208 PEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~~~~R 287 (632)
T KOG0584|consen 208 PEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLATKSER 287 (632)
T ss_pred ccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcCchhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999889999
Q ss_pred CCHHHHhcCccccccCCCCCCCCCCCCCcCCCCC-cccccccccCCCCcccCCCCCCCCCCCCCCccccccCCCCCCCCC
Q 006277 256 LSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVG-AFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITSLDNSGGGDSY 334 (652)
Q Consensus 256 pSa~elL~hpf~~~~~~~~~~~~~~p~~~lp~~~-~~~~~~~~~~~~~~~~~~~~~~d~d~d~~~~~~~~~~~~~~~~~~ 334 (652)
|||.|||+||||+.++... ...+......+.+. .+.........+...+.....++...|...++....... +....
T Consensus 288 ~sa~eLL~d~Ff~~d~g~~-~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~-~~~~e 365 (632)
T KOG0584|consen 288 LSAKELLKDPFFDEDGGIV-ELAPEDDMSDPALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEE-EIVSE 365 (632)
T ss_pred cCHHHHhhChhhccccccc-cccchhhcccccccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHh-ccCCc
Confidence 9999999999999876653 33333333333333 122222111111111111122233332222211111101 01112
Q ss_pred CCcchhhhcccCcceeccCCcCCcc-cceeeeeeecCCCceeeeecccccCCCCcCcchHHHHhccccCCcChHHHHHHH
Q 006277 335 SPSIEVRRSKRGNFFLLKGESNDEY-SVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAELI 413 (652)
Q Consensus 335 ~~~i~~~~l~~~~~~~~~G~~~~~~-~I~liLri~D~~g~i~~ieF~f~~d~Dta~~Va~EmV~~l~l~~~d~~~iA~~I 413 (652)
..+.+++++.+...+.++|++.++. .++|.|||+|.+|+.++|+|+|++..|||..||.|||++|+++++++..||+||
T Consensus 366 dd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta~~Va~eMv~el~~~dq~v~~ia~mi 445 (632)
T KOG0584|consen 366 DDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTAPSVAHEMVEELEITDQPVVNIAEMI 445 (632)
T ss_pred chHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCcchhHHHHHHHhhcCCcccchhhHHHHH
Confidence 2346777888888899999999877 999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCccccccccCCCCCCCcc
Q 006277 414 DLLLLNLIPGWKPCVRIDHLIPQKSRRQSPE 444 (652)
Q Consensus 414 d~~i~~l~~~~~~~~~~~~~~~~~~~~~~~~ 444 (652)
|.+|..|+|.|+.....++.++..-...+.+
T Consensus 446 d~~i~~L~p~~~~~~~~~~s~~~~~~~~~~s 476 (632)
T KOG0584|consen 446 DGEISALVPNWKASTPNDESPHEQHTDNSVS 476 (632)
T ss_pred hchhhhcCCccCCCCCccccchhccCccccc
Confidence 9999999999999876666655544444433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-52 Score=438.98 Aligned_cols=254 Identities=25% Similarity=0.332 Sum_probs=221.6
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCH---HHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSP---EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~---e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
+-..||.+..+.|-+|+.+.||+.||||++.+....... .....+++|++||++|+|||||+++++|.+.. ..|+
T Consensus 176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d--s~Ym 253 (475)
T KOG0615|consen 176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD--SSYM 253 (475)
T ss_pred eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC--ceEE
Confidence 345677777799999999999999999999876654321 12345789999999999999999999998766 7899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC--CCcEEEeccCchhhhhc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~--~g~VKL~DFGla~~l~~ 166 (652)
||||+.||+|++++..++.+.+..-+.+++|++.||.|||++| |+||||||+|||++.+ +..+||+|||+|+....
T Consensus 254 VlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~ 331 (475)
T KOG0615|consen 254 VLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE 331 (475)
T ss_pred EEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence 9999999999999999999999999999999999999999999 9999999999999832 35799999999999875
Q ss_pred c-ccccccCCCCccCcccccc----CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcc--ccCCCCh
Q 006277 167 A-NAKSVIGTPEFMAPELYDE----NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA--LSKVKDP 239 (652)
Q Consensus 167 ~-~~~~~vGTp~YmAPEvl~~----~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~--l~~~~s~ 239 (652)
. ..++.||||.|.|||++.. .|..++|+||+||++|.+++|.+||++......+++.|.+|..+.. .+...+.
T Consensus 332 ~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Ise 411 (475)
T KOG0615|consen 332 GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISE 411 (475)
T ss_pred ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhH
Confidence 4 4689999999999998843 3556899999999999999999999997666668999999986433 3455789
Q ss_pred HHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 240 EVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 240 ~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
++++||.+||+ ||++|||+.|+|+||||+.
T Consensus 412 ea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 412 EALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred HHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 99999999997 9999999999999999974
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-51 Score=427.20 Aligned_cols=251 Identities=29% Similarity=0.486 Sum_probs=227.6
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
....||.+.+|+||||.|+.||+.+|+|+|... .++...+++.+|+++++.++||+||++|+.|+.... .++|+||
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mE 158 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICME 158 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehh
Confidence 456788888899999999999999999999533 347788999999999999999999999999998764 6999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 170 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~ 170 (652)
||.||+|.++++..++++|..+..++++|++||.|||. ++ ||||||||.|||+| ..|+|||||||.++.+....+.
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvN-skGeVKicDFGVS~~lvnS~a~ 235 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVN-SKGEVKICDFGVSGILVNSIAN 235 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeec-cCCCEEeccccccHHhhhhhcc
Confidence 99999999999999999999999999999999999996 77 99999999999999 5799999999999999888889
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCC----CCCHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSE----CRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~----~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
+++||..|||||.+. +.|+.++||||||+.++||++|++||.. ......++..|..+..|.......++++++||
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV 315 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFV 315 (364)
T ss_pred cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence 999999999999775 4799999999999999999999999976 24677888888887655444446999999999
Q ss_pred HHhCC-CCCCCCCHHHHhcCccccc
Q 006277 246 EKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.+||+ +|.+|+|++|||+|||++.
T Consensus 316 ~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 316 SCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred HHHhcCCcccCCCHHHHhcCHHHhh
Confidence 99998 8999999999999999974
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=423.35 Aligned_cols=272 Identities=23% Similarity=0.372 Sum_probs=240.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...+|++..|.||+++.+.||+.||+|+++++.... .........|..||.+++||+||+++.+|++.. .+|||+||
T Consensus 30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~-~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~--kLylVld~ 106 (357)
T KOG0598|consen 30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE-KKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE--KLYLVLDY 106 (357)
T ss_pred eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh-hhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC--eEEEEEec
Confidence 456788888999999999999999999999777654 367889999999999999999999999998876 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--ccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~ 170 (652)
+.||+|+.++++.+.|+|..++.|+.+|+.||.|||++| ||||||||+|||++ .+|+|+|+||||++..-.. ...
T Consensus 107 ~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd-~~GHi~LtDFgL~k~~~~~~~~t~ 183 (357)
T KOG0598|consen 107 LNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLD-EQGHIKLTDFGLCKEDLKDGDATR 183 (357)
T ss_pred cCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeec-CCCcEEEeccccchhcccCCCccc
Confidence 999999999999999999999999999999999999999 99999999999999 7899999999999965433 467
Q ss_pred cccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 171 SVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 171 ~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
++|||+.|||||++ +.+|+..+||||||+++|+|++|.+||.+ .+...++++|..+.. ...+...+.++++||+++|
T Consensus 184 tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~-~~~p~~ls~~ardll~~LL 261 (357)
T KOG0598|consen 184 TFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKL-PLPPGYLSEEARDLLKKLL 261 (357)
T ss_pred cccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcC-CCCCccCCHHHHHHHHHHh
Confidence 89999999999976 66899999999999999999999999988 788899999998863 2345667899999999999
Q ss_pred C-CCCCCC----CHHHHhcCccccccCCCCCCCCCCCCCcCCCCCccc
Q 006277 250 V-PASQRL----SAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFG 292 (652)
Q Consensus 250 ~-~P~~Rp----Sa~elL~hpf~~~~~~~~~~~~~~p~~~lp~~~~~~ 292 (652)
. +|.+|+ ++.++-.||||...+|.......+.+++.|......
T Consensus 262 ~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~ 309 (357)
T KOG0598|consen 262 KRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLE 309 (357)
T ss_pred ccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCcc
Confidence 7 899996 699999999999888866554455556777665443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=440.88 Aligned_cols=247 Identities=34% Similarity=0.501 Sum_probs=224.6
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
-||+++...+|.+.+..+|..||+|+|.++.+ ..+...+++.+||+|.++|+|||||+||++|+|.+ ++|||+|+|.
T Consensus 25 ~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l-~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~--nVYivLELC~ 101 (592)
T KOG0575|consen 25 FLGKGGFARCYEARDLDTGEVVAVKVVPKKLL-KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN--NVYIVLELCH 101 (592)
T ss_pred eeccCcceEEEEEEEcCCCcEEEEEEeehHHh-cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC--ceEEEEEecC
Confidence 46667778999999999999999999986554 45678999999999999999999999999999877 7999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--cccccc
Q 006277 95 SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKSV 172 (652)
Q Consensus 95 gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~~~~ 172 (652)
.|+|..++++++.++|.+++.+++||+.||.|||+++ |||||||..|||++ ..-+|||+|||||+.+.. .+..+.
T Consensus 102 ~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~-~~~~VKIgDFGLAt~le~~~Erk~Tl 178 (592)
T KOG0575|consen 102 RGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLN-ENMNVKIGDFGLATQLEYDGERKKTL 178 (592)
T ss_pred CccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeec-CcCcEEecccceeeeecCccccccee
Confidence 9999999999999999999999999999999999999 99999999999999 456999999999999874 346789
Q ss_pred cCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-
Q 006277 173 IGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV- 250 (652)
Q Consensus 173 vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~- 250 (652)
||||.|+||||+. .+++..+||||+||+||.||+|.|||.. .+..++|.+|..... ..|...+.++++||.+||.
T Consensus 179 CGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y--~~P~~ls~~A~dLI~~lL~~ 255 (592)
T KOG0575|consen 179 CGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEY--SMPSHLSAEAKDLIRKLLRP 255 (592)
T ss_pred cCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCc--ccccccCHHHHHHHHHHhcC
Confidence 9999999999874 5799999999999999999999999987 778999999988653 3455788999999999998
Q ss_pred CCCCCCCHHHHhcCcccccc
Q 006277 251 PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 251 ~P~~RpSa~elL~hpf~~~~ 270 (652)
+|.+|||+.++|.|+||...
T Consensus 256 ~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 256 NPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred CcccCCCHHHHhcCHhhhCC
Confidence 89999999999999999543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=396.39 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=227.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.-||.+-.|.|.++.++.+|..+|+|++.+.++.. -.+++....|.++|+.+.||++++++++|.|.. .+|+||||+
T Consensus 50 ~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk-lKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~--~lymvmeyv 126 (355)
T KOG0616|consen 50 KTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK-LKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS--NLYMVMEYV 126 (355)
T ss_pred eeeccCccceEEEEEEccCCceeehhhcCHHHHHH-HHHHHHHhhHHHHHhhccCceeEEEEEeeccCC--eEEEEEecc
Confidence 34555556899999999999999999999877654 467889999999999999999999999998766 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI 173 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~v 173 (652)
+||.|+.++++.++|++..++.|+.||+.||+|||+++ |++|||||+|||+| ..|++||+|||+|+.+... +.+.|
T Consensus 127 ~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD-~~G~iKitDFGFAK~v~~r-T~TlC 202 (355)
T KOG0616|consen 127 PGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLD-QNGHIKITDFGFAKRVSGR-TWTLC 202 (355)
T ss_pred CCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeec-cCCcEEEEeccceEEecCc-EEEec
Confidence 99999999999999999999999999999999999999 99999999999999 7799999999999988765 77899
Q ss_pred CCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-C
Q 006277 174 GTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-P 251 (652)
Q Consensus 174 GTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~ 251 (652)
|||.|+|||++ ..+|+.++|||||||++|||++|.+||.. .++.++|.+|..|.. .+|...++++++||+++|+ |
T Consensus 203 GTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD 279 (355)
T KOG0616|consen 203 GTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKV--KFPSYFSSDAKDLLKKLLQVD 279 (355)
T ss_pred CCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCcc--cCCcccCHHHHHHHHHHHhhh
Confidence 99999999976 57899999999999999999999999988 677999999999863 4677889999999999997 7
Q ss_pred CCCCC-----CHHHHhcCccccccCCCC
Q 006277 252 ASQRL-----SAKELLMDPFLQVNGTTK 274 (652)
Q Consensus 252 P~~Rp-----Sa~elL~hpf~~~~~~~~ 274 (652)
-.+|. ...++..||||+...|..
T Consensus 280 ~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 280 LTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred hHhhhcCcCCCccccccCcccccccHHH
Confidence 78884 688999999999877754
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-48 Score=416.79 Aligned_cols=278 Identities=22% Similarity=0.359 Sum_probs=240.2
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
....+++++.|.||+|.-+.||..+|+|++++.+++ ..++++.++.|..+|...++|+||++|.+|+|.. ++|||||
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~--~LYLiME 221 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE--YLYLIME 221 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHH-hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC--eeEEEEE
Confidence 446788888899999999999999999999987765 4688999999999999999999999999999877 8999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc-----
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ----- 166 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~----- 166 (652)
|++||++..++.+.+.|++..+++|+.+++.|++.||.+| +|||||||+|+||| ..|+|||+||||++-+..
T Consensus 222 ylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD-~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 222 YLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLID-AKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred ecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeec-CCCCEeeccccccchhhhhhhhh
Confidence 9999999999999999999999999999999999999999 99999999999999 789999999999854310
Q ss_pred --------------------c-----c-------------------cccccCCCCccCcccc-ccCCCccccchhhHHHH
Q 006277 167 --------------------A-----N-------------------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCM 201 (652)
Q Consensus 167 --------------------~-----~-------------------~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvil 201 (652)
. . +.+.+|||.||||||+ ..+|+..|||||||||+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM 378 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence 0 0 1146899999999977 55799999999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc--CCCChHHHHHHHHhCCCCCCCC---CHHHHhcCccccccCCCCCC
Q 006277 202 LEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS--KVKDPEVKSFIEKCLVPASQRL---SAKELLMDPFLQVNGTTKNR 276 (652)
Q Consensus 202 yeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~--~~~s~~~kdlI~kcL~~P~~Rp---Sa~elL~hpf~~~~~~~~~~ 276 (652)
||||.|.+||.+ .++.+.|++|........++ ...+++++|||.+||.+|.+|+ +++|+.+||||+...|....
T Consensus 379 yEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~l~ 457 (550)
T KOG0605|consen 379 YEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDHLR 457 (550)
T ss_pred HHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcchhh
Confidence 999999999998 78899999998765322222 3456899999999999999998 49999999999988887665
Q ss_pred CCCCCCCcCCCCCccccccccc
Q 006277 277 PLPLPDIVLPRVGAFGDRCLMS 298 (652)
Q Consensus 277 ~~~~p~~~lp~~~~~~~~~~~~ 298 (652)
..+ ++++|.+....+...+.
T Consensus 458 ~~~--apfvP~v~~~~DT~yFd 477 (550)
T KOG0605|consen 458 EMP--APFVPQVNSELDTQYFD 477 (550)
T ss_pred cCC--CCCCCCCCCcccccccc
Confidence 543 55778877666655443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=400.73 Aligned_cols=250 Identities=26% Similarity=0.461 Sum_probs=221.5
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.++|.+..++||+|.++++|.+||||.|.++.+ .++..+-+..||.+|+.++|||||.++++..+.+ ++|||||||
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~--~i~lVMEyC 91 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD--FIYLVMEYC 91 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC--eEEEEEEeC
Confidence 356777778999999999999999999987765 4678899999999999999999999999887665 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC-C----CcEEEeccCchhhhhccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN-Q----GEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~-~----g~VKL~DFGla~~l~~~~ 168 (652)
.||+|.+|+++++.++|..++.++.||+.||++||+++ ||||||||+|||++.. . -.+||+|||+|+.+....
T Consensus 92 ~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~ 169 (429)
T KOG0595|consen 92 NGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS 169 (429)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh
Confidence 99999999999999999999999999999999999999 9999999999999843 1 358999999999998654
Q ss_pred -cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC-CccccCCCChHHHHHH
Q 006277 169 -AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-PAALSKVKDPEVKSFI 245 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~-p~~l~~~~s~~~kdlI 245 (652)
..+.||+|.|||||++ .++|+.|+|+||+|+|+|+|++|.+||.. .+..+++..+.++.. ...++...+....+++
T Consensus 170 ~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll 248 (429)
T KOG0595|consen 170 MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPAELSNPLRELL 248 (429)
T ss_pred HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhhhccCchhhhh
Confidence 6789999999999988 68999999999999999999999999987 577778778887753 3344555667777888
Q ss_pred HHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 246 EKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
-..|. +|..|.+..+-+.|+|+...
T Consensus 249 ~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 249 ISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred hHHHhcCccccCchHHhhhhhhcccC
Confidence 88886 89999999999999999643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=412.26 Aligned_cols=251 Identities=26% Similarity=0.421 Sum_probs=223.0
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
+|++-.++|++|.++.++++||||++.++-+++ ...++-+..|..+|.+| .||.|+++|..|+|+. .+|+|+||++
T Consensus 81 lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik-e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~--sLYFvLe~A~ 157 (604)
T KOG0592|consen 81 LGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK-EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE--SLYFVLEYAP 157 (604)
T ss_pred eccccceeEEEeeecCCCceeeHhhhhHHHHHh-hcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc--ceEEEEEecC
Confidence 445556899999999999999999998655443 45667888999999999 9999999999999887 7999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc------
Q 006277 95 SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN------ 168 (652)
Q Consensus 95 gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~------ 168 (652)
+|+|.++|++.+.|++..++.|+.||+.||+|||++| ||||||||+|||++ .+|++||+|||.|+.+....
T Consensus 158 nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd-~dmhikITDFGsAK~l~~~~~~~~~~ 234 (604)
T KOG0592|consen 158 NGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLD-KDGHIKITDFGSAKILSPSQKSQENP 234 (604)
T ss_pred CCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEc-CCCcEEEeeccccccCChhhccccCc
Confidence 9999999999999999999999999999999999999 99999999999999 67999999999999884311
Q ss_pred ---------cccccCCCCccCcccccc-CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCC
Q 006277 169 ---------AKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 238 (652)
Q Consensus 169 ---------~~~~vGTp~YmAPEvl~~-~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 238 (652)
..+++||..|++||++.. ..+..+|||+||||+|.|+.|.+||.+ .+.-.++++|+.-. ..++...+
T Consensus 235 ~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l~--y~fp~~fp 311 (604)
T KOG0592|consen 235 VDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQALD--YEFPEGFP 311 (604)
T ss_pred cCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHhc--ccCCCCCC
Confidence 145899999999998854 568899999999999999999999988 78888999998743 45666778
Q ss_pred hHHHHHHHHhCC-CCCCCCCHHHHhcCccccccCCCCC
Q 006277 239 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGTTKN 275 (652)
Q Consensus 239 ~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~~~~~~ 275 (652)
+.+++||+++|+ +|++|+|+.||.+||||...+|...
T Consensus 312 ~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl 349 (604)
T KOG0592|consen 312 EDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL 349 (604)
T ss_pred HHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence 999999999998 9999999999999999998777553
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=417.01 Aligned_cols=248 Identities=32% Similarity=0.535 Sum_probs=224.1
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.|.+++++..|.||.|....+++.||+|++.+... ...+-+..|+.+|+.++|+|||.|+++|...+ .+|+|||
T Consensus 277 ~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d--eLWVVME 350 (550)
T KOG0578|consen 277 DFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ----PKKELLLNEILVMRDLHHPNIVNFLDSYLVGD--ELWVVME 350 (550)
T ss_pred chhhhccccccceeeeeeccCCceEEEEEEEeccC----CchhhhHHHHHHHHhccchHHHHHHHHhcccc--eeEEEEe
Confidence 46678888889999999999999999999987653 24567899999999999999999999998764 7999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
|+.||+|.+.+... .++|.+++.++++++.||+|||.+| |+|||||.+|||++ .+|.|||+|||++..+... ..
T Consensus 351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~-~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLT-MDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEec-cCCcEEEeeeeeeeccccccCcc
Confidence 99999999988754 5999999999999999999999999 99999999999998 7889999999999988654 45
Q ss_pred ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
.+.+|||+|||||++ +..|++++||||||++++||+-|++||........+|.....|......+...++++++|+.+|
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~c 506 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRC 506 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHH
Confidence 789999999999987 4589999999999999999999999998767777788888888877777888999999999999
Q ss_pred CC-CCCCCCCHHHHhcCccccc
Q 006277 249 LV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~~~ 269 (652)
|+ |+.+|++|.|||+||||+.
T Consensus 507 L~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 507 LVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred hhcchhcCCCHHHHhcChhhhh
Confidence 97 9999999999999999963
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=406.31 Aligned_cols=250 Identities=29% Similarity=0.491 Sum_probs=218.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCH-HHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSP-EDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~-e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
..|+++..|+|++|.+..+|..||+|.+......... ...+.+.+|+.+++.+. ||||+++++++.... .+|+|||
T Consensus 23 ~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~--~~~ivmE 100 (370)
T KOG0583|consen 23 RTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT--KIYIVME 100 (370)
T ss_pred eeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC--eEEEEEE
Confidence 4555555689999999999999999977654332122 34567789999999998 999999999987765 5999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh--cccc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~--~~~~ 169 (652)
||.||+|++++..++++.|..++.+++||++|++|||++| |+||||||+|||++.+.+++||+|||++.... ....
T Consensus 101 y~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l 178 (370)
T KOG0583|consen 101 YCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLL 178 (370)
T ss_pred ecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcc
Confidence 9999999999999999999999999999999999999999 99999999999999554899999999999883 3456
Q ss_pred ccccCCCCccCcccccc-C-CC-ccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCC-ChHHHHHH
Q 006277 170 KSVIGTPEFMAPELYDE-N-YN-ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK-DPEVKSFI 245 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~-~-y~-~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~-s~~~kdlI 245 (652)
++.+|||.|+|||++.+ . |+ .++||||+||++|.|++|..||.+ .+...++.+|..+.. .++... ++++++||
T Consensus 179 ~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~--~~p~~~~S~~~~~Li 255 (370)
T KOG0583|consen 179 KTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEF--KIPSYLLSPEARSLI 255 (370)
T ss_pred cCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCc--cCCCCcCCHHHHHHH
Confidence 89999999999998865 4 75 789999999999999999999988 677788888888754 345555 99999999
Q ss_pred HHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 246 EKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.+||+ +|.+|+++.+++.||||+..
T Consensus 256 ~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 256 EKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred HHHcCCCcccCCCHHHHhhChhhccC
Confidence 99998 89999999999999999863
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=411.62 Aligned_cols=248 Identities=25% Similarity=0.441 Sum_probs=220.5
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 95 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~g 95 (652)
||.+..|.|.+|.|-.||+.+|||+|.+...+ +......+.+||-||+-+.||||+.+|++|.+.. .+|+|+||+.|
T Consensus 20 LG~Gstg~vrlakh~~TGqlaaiKii~k~~~~-s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~--~lylvlEyv~g 96 (786)
T KOG0588|consen 20 LGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL-SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ--HLYLVLEYVPG 96 (786)
T ss_pred ccCCCCceehhhhcccccceeEEEeecccccc-ccccccchhhhhHHHHHhcCCCeeeeeeeeccCc--eEEEEEEecCC
Confidence 44455589999999999999999999866332 2345677888999999999999999999997654 89999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-ccccccC
Q 006277 96 GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKSVIG 174 (652)
Q Consensus 96 GsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~~~vG 174 (652)
|.|++|+.++|++++.+++.+++||+.|+.|||..+ |+||||||+|+|++. .++|||+|||+|...... ...+.||
T Consensus 97 GELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~-~~nIKIADFGMAsLe~~gklLeTSCG 173 (786)
T KOG0588|consen 97 GELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDV-KNNIKIADFGMASLEVPGKLLETSCG 173 (786)
T ss_pred chhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhc-ccCEeeeccceeecccCCccccccCC
Confidence 999999999999999999999999999999999999 999999999999994 456999999999876544 3588999
Q ss_pred CCCccCccccc-cCC-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-C
Q 006277 175 TPEFMAPELYD-ENY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-P 251 (652)
Q Consensus 175 Tp~YmAPEvl~-~~y-~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~ 251 (652)
+|.|.|||++. ..| +.++||||+|||+|.||||..||.+ ++...++.+|.+|.+ .++..+++++++||.+||. |
T Consensus 174 SPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f--~MPs~Is~eaQdLLr~ml~VD 250 (786)
T KOG0588|consen 174 SPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVF--EMPSNISSEAQDLLRRMLDVD 250 (786)
T ss_pred CcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCcc--cCCCcCCHHHHHHHHHHhccC
Confidence 99999999875 456 5789999999999999999999986 899999999999975 4567889999999999996 9
Q ss_pred CCCCCCHHHHhcCccccccCC
Q 006277 252 ASQRLSAKELLMDPFLQVNGT 272 (652)
Q Consensus 252 P~~RpSa~elL~hpf~~~~~~ 272 (652)
|++|+|.+|+++|||+.....
T Consensus 251 p~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 251 PSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred ccccccHHHHhhCchhhcCCC
Confidence 999999999999999986544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=393.10 Aligned_cols=250 Identities=35% Similarity=0.519 Sum_probs=213.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..|+||+|.++.+|...|+|.+.... ++. .+.+.+|+++|++|+|||||++|+......+..++++|||+
T Consensus 23 ~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 23 KLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred ccccCccceEEEEEEecCCCcceeeeeeeccc---chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 45677777999999999999999999998652 222 78899999999999999999999964333223799999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc-----c
Q 006277 94 TSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ-----A 167 (652)
Q Consensus 94 ~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~-----~ 167 (652)
++|+|.+++++.+ .+++..++.+.+||+.||.|||++| ||||||||+|||++...|.+||+|||+++.... .
T Consensus 99 ~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 9999999999987 7999999999999999999999999 999999999999994368999999999998763 1
Q ss_pred ccccccCCCCccCccccccCCC--ccccchhhHHHHHHHhhccCCCCC-CCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 168 NAKSVIGTPEFMAPELYDENYN--ELADIYSFGMCMLEMVTFEYPYSE-CRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 168 ~~~~~vGTp~YmAPEvl~~~y~--~~sDIWSlGvilyeLltG~~Pf~~-~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
....+.|||.|||||++...+. .++|||||||++.||+||.+||.. ......++........| .++...++++++|
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ls~~a~~F 255 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSLSDEAKDF 255 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCcccCHHHHHH
Confidence 2456899999999998874433 499999999999999999999987 34455556555555444 7788899999999
Q ss_pred HHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 245 IEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
|.+|++ +|.+||||.+||.|||++..
T Consensus 256 l~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 256 LRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred HHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 999997 89999999999999999754
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=383.93 Aligned_cols=245 Identities=29% Similarity=0.488 Sum_probs=215.4
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
.+|.+-.|+||++.+..+|..||+|.+....+ +....+.+..|+.+|++|+|||||++|+.-..+++..+|||||||.
T Consensus 26 ~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m--d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~ 103 (375)
T KOG0591|consen 26 KIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM--DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCD 103 (375)
T ss_pred HHcCCcchheEEeeeccCcchhhhhhcchhhc--cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhc
Confidence 34555568999999999999999999985443 4577888999999999999999999999434445557999999999
Q ss_pred CCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCC--eeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 95 SGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPP--IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 95 gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~--IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
+|+|.+.++. ++.++|+.++.++.|++.||..||++-+. |+||||||.|||++ ..|.|||+||||++.+....
T Consensus 104 ~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDfGL~r~l~s~~ 182 (375)
T KOG0591|consen 104 AGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGDFGLGRFLSSKT 182 (375)
T ss_pred ccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-CCCceeeccchhHhHhcchh
Confidence 9999998763 46799999999999999999999995444 99999999999999 67899999999999997654
Q ss_pred --cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 169 --AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
+++.+|||+||+||++ +.+|+.++||||+||++|||+...+||.+ .+..++.++|.+|..|+.+...+|.+++.+|
T Consensus 183 tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li 261 (375)
T KOG0591|consen 183 TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEHYSTDLRELI 261 (375)
T ss_pred HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHHhhhHHHHHH
Confidence 5889999999999976 56899999999999999999999999998 6899999999999877666688999999999
Q ss_pred HHhCC-CCCCCCCHHHHhcCcccc
Q 006277 246 EKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
..|+. +|..||+. +|+++
T Consensus 262 ~~ci~vd~~~RP~t-----~~~v~ 280 (375)
T KOG0591|consen 262 NMCIAVDPEQRPDT-----VPYVQ 280 (375)
T ss_pred HHHccCCcccCCCc-----chHHH
Confidence 99997 89999987 55554
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=387.21 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=219.6
Q ss_pred cceeeeeeEEE---EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 006277 5 KWSLLILMYLR---LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 81 (652)
Q Consensus 5 ~W~~~~~~~~r---L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 81 (652)
.|....-.|.- +|.+...+||+|+...++..||||++.+++. ...++.+++|++.|+.++||||+++|.+|+.+
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc---~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC---NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh---hhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 34444444443 3444446899999999999999999998764 34589999999999999999999999999987
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccC
Q 006277 82 QNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 159 (652)
Q Consensus 82 ~~~~~~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFG 159 (652)
. .+|+||.|+.+|++.+.++.. ..++|..++.+++++++||.|||.+| .||||||+.||||+ .+|.|||+|||
T Consensus 97 ~--~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~-~dG~VkLadFg 171 (516)
T KOG0582|consen 97 S--ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILID-SDGTVKLADFG 171 (516)
T ss_pred c--eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEc-CCCcEEEcCce
Confidence 6 799999999999999998865 45999999999999999999999999 99999999999998 78999999999
Q ss_pred chhhhhccc-----c-ccccCCCCccCccccc---cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC-
Q 006277 160 LATIMEQAN-----A-KSVIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK- 229 (652)
Q Consensus 160 la~~l~~~~-----~-~~~vGTp~YmAPEvl~---~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~- 229 (652)
.+..+.... . .+++|||+|||||++. .+|+.|+||||||+...||.+|..||........+..++.....
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~ 251 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT 251 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC
Confidence 887664322 2 6789999999999853 47999999999999999999999999997777778777766442
Q ss_pred ------CccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 230 ------PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 230 ------p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+..-.+..+..++.||..||+ ||.+||||.+||+|+||+..
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 222234456789999999998 89999999999999999854
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=408.90 Aligned_cols=272 Identities=21% Similarity=0.347 Sum_probs=237.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...||++-.|.|++|..+.+++.+|||++++..++++ ++++.++.|.+|+... +||.++.+|.+|+... .+|+|||
T Consensus 373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~-d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~--~l~fvme 449 (694)
T KOG0694|consen 373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQR-DEVESLMCEKRIFELANRHPFLVNLFSCFQTKE--HLFFVME 449 (694)
T ss_pred EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecc-ccHHHHHHHHHHHHHhccCCeEeecccccccCC--eEEEEEE
Confidence 3556666679999999999999999999998887764 8899999999999988 6999999999998766 8999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh--cccc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~--~~~~ 169 (652)
|+.||++. ++...+.|++..++.|+..|+.||.|||++| |||||||.+|||+| .+|++||+|||+++.-- ...+
T Consensus 450 y~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~m~~g~~T 525 (694)
T KOG0694|consen 450 YVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLD-TEGHVKIADFGLCKEGMGQGDRT 525 (694)
T ss_pred ecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEc-ccCcEEecccccccccCCCCCcc
Confidence 99999944 3445578999999999999999999999999 99999999999999 78999999999998653 3457
Q ss_pred ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
.++||||.|||||++ +..|+..+|||||||+|||||.|+.||.+ ++.++++..|.... ..+|...+.++.++++++
T Consensus 526 sTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d~--~~yP~~ls~ea~~il~~l 602 (694)
T KOG0694|consen 526 STFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVNDE--VRYPRFLSKEAIAIMRRL 602 (694)
T ss_pred ccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCC--CCCCCcccHHHHHHHHHH
Confidence 899999999999988 45799999999999999999999999998 78899999998753 345677889999999999
Q ss_pred CC-CCCCCCC-----HHHHhcCccccccCCCCCCCCCCCCCcCCCCCccccc
Q 006277 249 LV-PASQRLS-----AKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDR 294 (652)
Q Consensus 249 L~-~P~~RpS-----a~elL~hpf~~~~~~~~~~~~~~p~~~lp~~~~~~~~ 294 (652)
|. +|.+|+. +.++.+||||+..+|.........+++.|.++...+.
T Consensus 603 l~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~ 654 (694)
T KOG0694|consen 603 LRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDV 654 (694)
T ss_pred hccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhh
Confidence 97 8999995 6899999999998887655555667788887754443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=369.89 Aligned_cols=248 Identities=25% Similarity=0.428 Sum_probs=219.7
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
.++++..+.||++.+..||+.+|+|.|..+.+.+. ..+.+.+|++|-+.|+|||||++++++.... +.|+|+|+++
T Consensus 18 ~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~--~~ylvFe~m~ 93 (355)
T KOG0033|consen 18 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKLEREARICRKLQHPNIVRLHDSIQEES--FHYLVFDLVT 93 (355)
T ss_pred HHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHHHHHHHHHHhcCCCcEeehhhhhcccc--eeEEEEeccc
Confidence 46677778999999999999999999987766443 7888999999999999999999999886544 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC--CCcEEEeccCchhhhhccc-ccc
Q 006277 95 SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLGLATIMEQAN-AKS 171 (652)
Q Consensus 95 gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~--~g~VKL~DFGla~~l~~~~-~~~ 171 (652)
||+|..-|.++-.++|..+-.+++||+.+|.|||.+| |||||+||+|+|+-++ ...+||+|||+|..+..+. ...
T Consensus 94 G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G 171 (355)
T KOG0033|consen 94 GGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHG 171 (355)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCCcccccc
Confidence 9999887777778899999999999999999999999 9999999999999743 3459999999999887543 467
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--CccccCCCChHHHHHHHHh
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~~kdlI~kc 248 (652)
++|||.|||||++. ..|+..+|||+.|||+|.|+.|.+||++ .+...+|+.|..|.. +...+...++++++||++|
T Consensus 172 ~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrM 250 (355)
T KOG0033|consen 172 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRM 250 (355)
T ss_pred ccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHH
Confidence 89999999999885 5799999999999999999999999998 677889999999873 3334456789999999999
Q ss_pred CC-CCCCCCCHHHHhcCccccc
Q 006277 249 LV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~~~ 269 (652)
|. ||.+|+||.|+|+|||++.
T Consensus 251 L~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 251 LTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred hccChhhhccHHHHhCCchhcc
Confidence 97 9999999999999999974
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=373.46 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=217.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...++++..|+||+|.++.+|+.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.. .+|+||||
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~ 82 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR--FLYMLMEY 82 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC--eEEEEEeC
Confidence 35678888899999999999999999999754332 2345677899999999999999999999887654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
+.+|+|.+++...+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++..+... ....
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~-~~~~ 158 (291)
T cd05612 83 VPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDR-TWTL 158 (291)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEEecCcchhccCC-cccc
Confidence 999999999999899999999999999999999999998 99999999999998 6789999999999876543 3456
Q ss_pred cCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-
Q 006277 173 IGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV- 250 (652)
Q Consensus 173 vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~- 250 (652)
+||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .+...++..+..+.. .++...++.+++||.+||.
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~ 235 (291)
T cd05612 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKL--EFPRHLDLYAKDLIKKLLVV 235 (291)
T ss_pred cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCc--CCCccCCHHHHHHHHHHcCC
Confidence 8999999999774 4689999999999999999999999987 566777777777642 3455668999999999998
Q ss_pred CCCCCCC-----HHHHhcCccccccCCC
Q 006277 251 PASQRLS-----AKELLMDPFLQVNGTT 273 (652)
Q Consensus 251 ~P~~RpS-----a~elL~hpf~~~~~~~ 273 (652)
+|.+|++ +.+++.||||+...+.
T Consensus 236 dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 236 DRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred CHHHccCCccCCHHHHhcCccccCCCHH
Confidence 8999995 9999999999865554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=377.84 Aligned_cols=259 Identities=23% Similarity=0.361 Sum_probs=221.5
Q ss_pred Ccceeeee-eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 006277 4 QKWSLLIL-MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 82 (652)
Q Consensus 4 ~~W~~~~~-~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 82 (652)
..|....+ ....++++..|.||+|.++.+|+.||+|++...... .....+++.+|+.+|++++||||++++++|.+..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 91 (329)
T PTZ00263 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN 91 (329)
T ss_pred CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence 34544443 345677777899999999999999999999754332 2345678999999999999999999999987654
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 83 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 83 ~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
.+|+|||||.+|+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++.
T Consensus 92 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~ 166 (329)
T PTZ00263 92 --RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAK 166 (329)
T ss_pred --EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEC-CCCCEEEeeccCce
Confidence 89999999999999999999899999999999999999999999998 99999999999998 67899999999998
Q ss_pred hhhccccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHH
Q 006277 163 IMEQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 163 ~l~~~~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~ 241 (652)
..... ..+.+||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .....++..+..+.. .++...+..+
T Consensus 167 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~ 242 (329)
T PTZ00263 167 KVPDR-TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRL--KFPNWFDGRA 242 (329)
T ss_pred EcCCC-cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCc--CCCCCCCHHH
Confidence 66433 34568999999999874 5689999999999999999999999977 566777888877653 3456678999
Q ss_pred HHHHHHhCC-CCCCCCC-----HHHHhcCccccccCC
Q 006277 242 KSFIEKCLV-PASQRLS-----AKELLMDPFLQVNGT 272 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpS-----a~elL~hpf~~~~~~ 272 (652)
++||.+||. +|.+|++ +++++.||||....+
T Consensus 243 ~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~ 279 (329)
T PTZ00263 243 RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW 279 (329)
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence 999999997 8999997 799999999986544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=371.14 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=209.5
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
+++|++-.|+||+|.++.||+.||||.+.-.+ .++...+-.++||++|++|+|||+|.+.++|.. .+.++||+|||
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese--dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhLVFE~~ 83 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE--DDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHLVFEYC 83 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCC--ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEEEeeec
Confidence 56777778999999999999999999986432 346667888999999999999999999998854 45899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~~ 171 (652)
...-|.++-.....++...++.|++|++.|+.|||+++ +|||||||+|||++ ..|.+||||||+|+.+... ..+.
T Consensus 84 dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit-~~gvvKLCDFGFAR~L~~pgd~YTD 160 (396)
T KOG0593|consen 84 DHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILIT-QNGVVKLCDFGFARTLSAPGDNYTD 160 (396)
T ss_pred chHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEe-cCCcEEeccchhhHhhcCCcchhhh
Confidence 77555544444457999999999999999999999999 99999999999999 6789999999999998743 3466
Q ss_pred ccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-------------------CCC-
Q 006277 172 VIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-------------------GIK- 229 (652)
Q Consensus 172 ~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-------------------g~~- 229 (652)
.+.|.+|.|||++- -+|+..+||||+||++.||++|++-|++..+.+|+|..+.. |..
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l 240 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL 240 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence 88999999999774 47999999999999999999999999999999999866543 111
Q ss_pred -----Ccccc---CCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 230 -----PAALS---KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 230 -----p~~l~---~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
+..+. ...+..+.+|+.+||. ||.+|++.+|+|.||||.
T Consensus 241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 11111 1234578999999997 999999999999999994
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=376.20 Aligned_cols=250 Identities=22% Similarity=0.367 Sum_probs=216.1
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
.|+++..|.||+|.++.+|+.||+|+++.... .......++.+|+.+++.++||||+++++++.+.. .+|+||||+.
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~e~~~ 78 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD--RLCFVMEYAN 78 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC--EEEEEEeCCC
Confidence 47888899999999999999999999975432 23456678889999999999999999999887654 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--ccccc
Q 006277 95 SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAKSV 172 (652)
Q Consensus 95 gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~~~ 172 (652)
+|+|.+++...+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+++..... .....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCcccce
Confidence 9999999998889999999999999999999999999 99999999999998 6789999999998754322 23457
Q ss_pred cCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-
Q 006277 173 IGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV- 250 (652)
Q Consensus 173 vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~- 250 (652)
+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+...++..+..+. ..++...++++++||.+||.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHccC
Confidence 8999999999874 5699999999999999999999999977 55666666666543 23456678999999999997
Q ss_pred CCCCCC-----CHHHHhcCccccccCCC
Q 006277 251 PASQRL-----SAKELLMDPFLQVNGTT 273 (652)
Q Consensus 251 ~P~~Rp-----Sa~elL~hpf~~~~~~~ 273 (652)
+|.+|| ++.++++||||+...+.
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 899999 89999999999875543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=385.78 Aligned_cols=253 Identities=27% Similarity=0.441 Sum_probs=220.9
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.||.+..|.||+|.++.||..||+|.+.+... ......+.+.+|+++|++|. |||||.++++|.+.. .+++|||+|
T Consensus 42 ~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~-~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~--~~~lvmEL~ 118 (382)
T KOG0032|consen 42 ELGRGQFGVVYLCREKSTGKEVACKVIPKRKL-RGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD--SVYLVMELC 118 (382)
T ss_pred hhCCCCceEEEEEEecCCCceeEEEEeehhhc-cccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC--eEEEEEEec
Confidence 55555568999999999999999999986654 33446788999999999997 999999999998776 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC---CCcEEEeccCchhhhhcc-cc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN---QGEVKIGDLGLATIMEQA-NA 169 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~---~g~VKL~DFGla~~l~~~-~~ 169 (652)
.||+|++++.+. .++|..+..+++||+.|+.|||+.| |+||||||+|+|+... .+.+|++|||++...... ..
T Consensus 119 ~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~ 195 (382)
T KOG0032|consen 119 EGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERL 195 (382)
T ss_pred CCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceE
Confidence 999999999887 5999999999999999999999998 9999999999999743 247999999999988763 45
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--CccccCCCChHHHHHHH
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKSFIE 246 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~~kdlI~ 246 (652)
..++|||+|+|||++. ..|+..+||||+||++|.|++|.+||.+ ......+..|..+.. +...+..++..+++||.
T Consensus 196 ~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~ 274 (382)
T KOG0032|consen 196 HTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILRGDFDFTSEPWDDISESAKDFIR 274 (382)
T ss_pred eeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHcCCCCCCCCCccccCHHHHHHHH
Confidence 7899999999999987 7899999999999999999999999998 566667778888764 33334456899999999
Q ss_pred HhCC-CCCCCCCHHHHhcCccccccCCCC
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQVNGTTK 274 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~~~~~~~ 274 (652)
+||. +|.+|+||.++|+|||++......
T Consensus 275 ~ll~~dp~~R~ta~~~L~HpWi~~~~~~~ 303 (382)
T KOG0032|consen 275 KLLEFDPRKRLTAAQALQHPWIKSIGEAT 303 (382)
T ss_pred HhcccCcccCCCHHHHhcCccccCCcccc
Confidence 9997 899999999999999998654433
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=375.50 Aligned_cols=257 Identities=26% Similarity=0.340 Sum_probs=218.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+||.+.-|+||+|....++..+|+|++.+..+ ...+.+.|++.|.+||+.++||.++.+|..|..+. +.|++||||
T Consensus 83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l-~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~--~~cl~meyC 159 (459)
T KOG0610|consen 83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL-ASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK--YSCLVMEYC 159 (459)
T ss_pred HHcCCCCceeEEEEEecCCCceEEEEEecHHHH-hhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc--eeEEEEecC
Confidence 456666669999999999999999999986554 34678899999999999999999999999997665 899999999
Q ss_pred CCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh------
Q 006277 94 TSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME------ 165 (652)
Q Consensus 94 ~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~------ 165 (652)
+||+|..+++++ +.|++..+++|+.+|+.||+|||..| ||+|||||+||||. ++|+|.|+||.|+....
T Consensus 160 pGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvr-edGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 160 PGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVR-EDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred CCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEe-cCCcEEeeeccccccCCCCCeee
Confidence 999999998876 57999999999999999999999999 99999999999998 78999999999863210
Q ss_pred ----------------------------c-c-----------------------ccccccCCCCccCcccccc-CCCccc
Q 006277 166 ----------------------------Q-A-----------------------NAKSVIGTPEFMAPELYDE-NYNELA 192 (652)
Q Consensus 166 ----------------------------~-~-----------------------~~~~~vGTp~YmAPEvl~~-~y~~~s 192 (652)
. . ...+++||-+|+|||++.+ +.+.++
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAV 316 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAV 316 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchh
Confidence 0 0 0125789999999999854 799999
Q ss_pred cchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCC----HHHHhcCccc
Q 006277 193 DIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLS----AKELLMDPFL 267 (652)
Q Consensus 193 DIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpS----a~elL~hpf~ 267 (652)
|||+|||++|||+.|..||.+..+.+.++..+.+...-+.. ...+..++|||+++|+ ||++|+. |.|+.+||||
T Consensus 317 DWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~-~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF 395 (459)
T KOG0610|consen 317 DWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE-PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFF 395 (459)
T ss_pred hHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC-CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccc
Confidence 99999999999999999999966666666655554322222 2456799999999998 8999997 9999999999
Q ss_pred cccCCCCCCC
Q 006277 268 QVNGTTKNRP 277 (652)
Q Consensus 268 ~~~~~~~~~~ 277 (652)
+..+|+..+.
T Consensus 396 ~gVnWaLir~ 405 (459)
T KOG0610|consen 396 EGVNWALIRC 405 (459)
T ss_pred cCCChhheec
Confidence 9988875443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=391.18 Aligned_cols=255 Identities=30% Similarity=0.449 Sum_probs=222.4
Q ss_pred cceeeeeeEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 006277 5 KWSLLILMYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84 (652)
Q Consensus 5 ~W~~~~~~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 84 (652)
.|..+-....+++++-.|.||+|+|..+++.||+|++.+.. ..+.++.+++|+.+|.+++++||.++|++|....
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-- 84 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-- 84 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhheeecc--
Confidence 34444333345566666899999999999999999998765 3578899999999999999999999999998766
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhh
Q 006277 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 164 (652)
Q Consensus 85 ~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l 164 (652)
.++++||||.||++.+.++..+.++|..+..++++++.||.|||+++ .+|||||+.|||+. .+|.|||+|||.+..+
T Consensus 85 ~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s-~~g~vkl~DfgVa~ql 161 (467)
T KOG0201|consen 85 KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLS-ESGDVKLADFGVAGQL 161 (467)
T ss_pred cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEe-ccCcEEEEecceeeee
Confidence 79999999999999999998888899999999999999999999999 99999999999998 5599999999999988
Q ss_pred hccc--cccccCCCCccCcccccc-CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHH
Q 006277 165 EQAN--AKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 165 ~~~~--~~~~vGTp~YmAPEvl~~-~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~ 241 (652)
.... ..+++|||.||||||+.+ .|+.++||||||+++|||++|.+||.++.....++..- ...|+.+....++.+
T Consensus 162 ~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp--k~~PP~L~~~~S~~~ 239 (467)
T KOG0201|consen 162 TNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP--KSAPPRLDGDFSPPF 239 (467)
T ss_pred echhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc--CCCCCccccccCHHH
Confidence 7543 478999999999998865 89999999999999999999999999877644443222 224666777889999
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 242 KSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
++||..||. +|+.||||.+||+|+|++.
T Consensus 240 kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 240 KEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 999999998 8999999999999999975
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=369.73 Aligned_cols=247 Identities=21% Similarity=0.353 Sum_probs=213.6
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 95 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~g 95 (652)
|++++.|+||+|.+..+|+.||+|++..... .......++.+|+.+|++++||||+++++++.+.. .+|+|||||.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE--KLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC--eEEEEEcCCCC
Confidence 4677889999999999999999999875432 23456778899999999999999999999887654 89999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cccccc
Q 006277 96 GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAKSVI 173 (652)
Q Consensus 96 GsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~~~v 173 (652)
|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++..... .....+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCcccccc
Confidence 999999998889999999999999999999999998 99999999999998 6789999999998764322 234578
Q ss_pred CCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-C
Q 006277 174 GTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-P 251 (652)
Q Consensus 174 GTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~ 251 (652)
||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+ .+..+.+..+..+. ..++...++++++||.+||. +
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEP--LRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCC--CCCCCcCCHHHHHHHHHHcCCC
Confidence 999999999774 5699999999999999999999999987 56667777776653 34556678999999999998 8
Q ss_pred CCCCC---CHHHHhcCccccccC
Q 006277 252 ASQRL---SAKELLMDPFLQVNG 271 (652)
Q Consensus 252 P~~Rp---Sa~elL~hpf~~~~~ 271 (652)
|.+|| ++.++|.||||....
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCCCC
Confidence 99997 589999999998653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=376.16 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=214.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.+..+|+.||+|++...... .......+.+|+.+|+.++||||++++++|.+.. .+|+||||
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~--~~~lv~E~ 82 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN--YLYLIMEY 82 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--eEEEEECC
Confidence 46788888899999999999999999999865432 2356678899999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc----
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---- 168 (652)
|.+|+|.+++...+.+++..++.|+.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++..+....
T Consensus 83 ~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 83 LPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEeecccceeccccccccc
Confidence 999999999998889999999999999999999999998 99999999999998 67899999999987543211
Q ss_pred ------------------------------------cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCC
Q 006277 169 ------------------------------------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPY 211 (652)
Q Consensus 169 ------------------------------------~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf 211 (652)
..+.+||+.|+|||++ ...|+.++|||||||++|+|++|.+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 1135799999999977 457999999999999999999999999
Q ss_pred CCCCCHHHHHHHHhcCCCCcccc--CCCChHHHHHHHHhCCCCCCCCC---HHHHhcCccccccCC
Q 006277 212 SECRNSAQIYKKVSSGIKPAALS--KVKDPEVKSFIEKCLVPASQRLS---AKELLMDPFLQVNGT 272 (652)
Q Consensus 212 ~~~~~~~~i~~~I~~g~~p~~l~--~~~s~~~kdlI~kcL~~P~~RpS---a~elL~hpf~~~~~~ 272 (652)
.. .+..+.+..+.........+ ...++++++||.+||.+|.+|++ +.++|.||||+...+
T Consensus 240 ~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 240 CS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred CC-CCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 87 45566666666544322222 24588999999999998999987 999999999986554
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=376.20 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=214.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.++.+|+.||+|++...... .......+.+|+.+++.++||||+++++++.+.. .+|+||||
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~--~~~lv~E~ 82 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL--NLYLIMEF 82 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--eEEEEEcC
Confidence 46788888899999999999999999999754332 2355678899999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc----
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---- 168 (652)
|+||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+++.+....
T Consensus 83 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~-~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 83 LPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCCEEEeeccCcccccccccccc
Confidence 999999999998899999999999999999999999998 99999999999998 67899999999987543210
Q ss_pred ---------------------------------cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCC
Q 006277 169 ---------------------------------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSEC 214 (652)
Q Consensus 169 ---------------------------------~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~ 214 (652)
....+||+.|+|||++ ...|+.++|||||||++|+|++|.+||.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~- 238 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS- 238 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC-
Confidence 1246899999999977 45799999999999999999999999987
Q ss_pred CCHHHHHHHHhcCCCCcccc--CCCChHHHHHHHHhCCCC---CCCCCHHHHhcCccccccCCCC
Q 006277 215 RNSAQIYKKVSSGIKPAALS--KVKDPEVKSFIEKCLVPA---SQRLSAKELLMDPFLQVNGTTK 274 (652)
Q Consensus 215 ~~~~~i~~~I~~g~~p~~l~--~~~s~~~kdlI~kcL~~P---~~RpSa~elL~hpf~~~~~~~~ 274 (652)
.+....+..+........++ ...++++++||.+|+.+| ..||++.|+++||||+...+..
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 239 ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence 55667777777643222222 235789999999987644 4578999999999998766543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=386.79 Aligned_cols=246 Identities=29% Similarity=0.447 Sum_probs=220.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
|-.+|++-.|.||||+.+.|++.||+|.+.+.. +...++..+++|++|++.|+|||||.++++|+... .+|+|+||
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~--~~~vVte~ 82 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA--HLWVVTEY 82 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc--eEEEEehh
Confidence 445777778999999999999999999987544 34678899999999999999999999999997654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
|.| +|+.++...+.++|+.++.++.++++||.|||+++ |+|||+||.|||+. ..|.+|+||||+|+.+.... .+
T Consensus 83 a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 83 AVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeec-CCCceeechhhhhhhcccCceeee
Confidence 988 99999999999999999999999999999999999 99999999999998 67899999999999887543 46
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
++-|||.|||||++. +.|+..+|+||+|||+|||.+|++||.. ....++.+.|... |..++...+..++.|+..+|
T Consensus 159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d--~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKD--PVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcC--CCCCcccccHHHHHHHHHHh
Confidence 789999999999875 5799999999999999999999999987 6667777777764 44556678899999999999
Q ss_pred C-CCCCCCCHHHHhcCccccc
Q 006277 250 V-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 250 ~-~P~~RpSa~elL~hpf~~~ 269 (652)
. ||.+|+|..+|+.|||.+.
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred hcChhhcccHHHHhcChHHhh
Confidence 7 8999999999999999874
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=362.32 Aligned_cols=247 Identities=26% Similarity=0.421 Sum_probs=213.0
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCC----HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQS----PEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s----~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
++.++.++|.++.++.+|.++|+|++.....-.+ .+.++.-.+|+.||+++ .||+|+++.++|+... ++++|+
T Consensus 25 lgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s--F~FlVF 102 (411)
T KOG0599|consen 25 LGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA--FVFLVF 102 (411)
T ss_pred hcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc--hhhhhh
Confidence 5566678999999999999999999876432222 23456667899999999 8999999999997554 899999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-c
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~ 169 (652)
|+|+.|.|++|+...-.++|+..+.+++|++.|++|||..+ |+||||||+|||++ ++-+|||+|||+|..+..+. .
T Consensus 103 dl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILld-dn~~i~isDFGFa~~l~~GekL 179 (411)
T KOG0599|consen 103 DLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLD-DNMNIKISDFGFACQLEPGEKL 179 (411)
T ss_pred hhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeec-cccceEEeccceeeccCCchhH
Confidence 99999999999999999999999999999999999999999 99999999999998 45589999999999987764 5
Q ss_pred ccccCCCCccCccccc-------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc--CCCChH
Q 006277 170 KSVIGTPEFMAPELYD-------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS--KVKDPE 240 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~--~~~s~~ 240 (652)
...||||.|+|||.+. .+|+..+|+||+|||||.|+.|.+||+. .......+.|++|......+ ...+..
T Consensus 180 relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-RkQmlMLR~ImeGkyqF~speWadis~~ 258 (411)
T KOG0599|consen 180 RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-RKQMLMLRMIMEGKYQFRSPEWADISAT 258 (411)
T ss_pred HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-HHHHHHHHHHHhcccccCCcchhhcccc
Confidence 7899999999999763 4699999999999999999999999986 33334567788887544332 345789
Q ss_pred HHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 241 VKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 241 ~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
+++||++||+ ||.+|+|++|+|.||||.
T Consensus 259 ~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 259 VKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred HHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 9999999997 999999999999999995
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=366.41 Aligned_cols=250 Identities=22% Similarity=0.370 Sum_probs=214.1
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
.+++++.|.||+|.+..+|..||+|+++.... .......++.+|+.+++.++||||++++++|.+.. .+|+||||+.
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~E~~~ 78 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFVMEYAN 78 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--EEEEEEeCCC
Confidence 47888899999999999999999999975432 23456778889999999999999999999987654 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--ccccc
Q 006277 95 SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAKSV 172 (652)
Q Consensus 95 gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~~~ 172 (652)
+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...... .....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEc-CCCCEEecccHHhccccCCCCccccc
Confidence 9999999988889999999999999999999999998 99999999999998 6789999999998754222 23457
Q ss_pred cCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-
Q 006277 173 IGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV- 250 (652)
Q Consensus 173 vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~- 250 (652)
+||+.|+|||++ .+.|+.++|||||||++|+|++|..||.. .+....+..+.... ..++...++++++||.+||.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHccC
Confidence 899999999987 45789999999999999999999999977 45555665555433 23455678999999999997
Q ss_pred CCCCCC-----CHHHHhcCccccccCCC
Q 006277 251 PASQRL-----SAKELLMDPFLQVNGTT 273 (652)
Q Consensus 251 ~P~~Rp-----Sa~elL~hpf~~~~~~~ 273 (652)
+|.+|+ ++.++++||||....+.
T Consensus 233 dP~~R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 899998 89999999999865543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=374.24 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=212.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+.+..|+||+|.++.+|+.||+|++...... ..+..+++.+|+++++.++|||||+++++|.+.. .+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--~~~lv~E~ 82 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ--YLYLIMEF 82 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--eeEEEEeC
Confidence 46788888899999999999999999998754332 2456778999999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-----
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----- 167 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~----- 167 (652)
|.||+|.+++...+.+++..++.|+.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+++.+...
T Consensus 83 ~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 83 LPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEEeeccccccccccccccc
Confidence 999999999998889999999999999999999999998 99999999999998 6789999999998633110
Q ss_pred --------------------------------------------ccccccCCCCccCcccc-ccCCCccccchhhHHHHH
Q 006277 168 --------------------------------------------NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCML 202 (652)
Q Consensus 168 --------------------------------------------~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvily 202 (652)
.....+||+.|+|||++ ...|+.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 00135799999999977 457999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHhcCCCCccccC--CCChHHHHHHHHhCCCCCC---CCCHHHHhcCccccccCCC
Q 006277 203 EMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK--VKDPEVKSFIEKCLVPASQ---RLSAKELLMDPFLQVNGTT 273 (652)
Q Consensus 203 eLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~--~~s~~~kdlI~kcL~~P~~---RpSa~elL~hpf~~~~~~~ 273 (652)
||++|.+||.. ......+..+........++. ..++++++||.+||.+|.+ |+++.+++.||||+...+.
T Consensus 240 elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~~ 314 (377)
T cd05629 240 ECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWD 314 (377)
T ss_pred hhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 99999999977 455566666665332223332 4678999999999986654 5699999999999865543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=368.42 Aligned_cols=252 Identities=20% Similarity=0.302 Sum_probs=214.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+++++..|.||+|.+..+|+.||+|++..... ........+.+|+.+++.++||||+++++++.+.. .+|+||||
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~~lv~e~ 82 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE--YLYLAMEY 82 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC--EEEEEEeC
Confidence 4678888889999999999999999999975432 22345678899999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
|.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..... .....
T Consensus 83 ~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~-~~~~~ 158 (333)
T cd05600 83 VPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLID-ASGHIKLTDFGLSKGIVT-YANSV 158 (333)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEEEeCcCCccccc-ccCCc
Confidence 999999999998889999999999999999999999998 99999999999998 678999999999986644 34567
Q ss_pred cCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc------CCCChHHHHHH
Q 006277 173 IGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS------KVKDPEVKSFI 245 (652)
Q Consensus 173 vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~------~~~s~~~kdlI 245 (652)
+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.. .+....+..+.........+ ...++++++||
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li 237 (333)
T cd05600 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI 237 (333)
T ss_pred ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence 8999999999774 5789999999999999999999999987 55666666665432211111 13478999999
Q ss_pred HHhCC-CCCCCCCHHHHhcCccccccCC
Q 006277 246 EKCLV-PASQRLSAKELLMDPFLQVNGT 272 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~hpf~~~~~~ 272 (652)
.+||. +|.+||++.++++||||....+
T Consensus 238 ~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 238 TKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 99998 6899999999999999986543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=368.11 Aligned_cols=249 Identities=22% Similarity=0.369 Sum_probs=214.4
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
.|+++..|.||+|.+..+|+.||+|++..... .......++.+|+++++.++||||+++++++.+.. .+|+||||+.
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~Ey~~ 78 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD--RLCFVMEYVN 78 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--EEEEEEeCCC
Confidence 57888899999999999999999999975432 23456778899999999999999999999887654 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--cccccc
Q 006277 95 SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKSV 172 (652)
Q Consensus 95 gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~~~~ 172 (652)
+|+|..++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+++.... ......
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEEC-CCCcEEEecCcCCccCCCcccccccc
Confidence 9999999988889999999999999999999999998 99999999999998 678999999999875432 223457
Q ss_pred cCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-
Q 006277 173 IGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV- 250 (652)
Q Consensus 173 vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~- 250 (652)
+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+...+...+..+. ..++...++++++||.+||.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMED--IKFPRTLSADAKSLLSGLLIK 232 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccCC--ccCCCCCCHHHHHHHHHHcCC
Confidence 8999999999874 5789999999999999999999999977 45556666665443 23556678999999999998
Q ss_pred CCCCCC-----CHHHHhcCccccccCC
Q 006277 251 PASQRL-----SAKELLMDPFLQVNGT 272 (652)
Q Consensus 251 ~P~~Rp-----Sa~elL~hpf~~~~~~ 272 (652)
+|.+|+ ++.++++||||....+
T Consensus 233 dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 899997 8999999999986544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=380.28 Aligned_cols=252 Identities=29% Similarity=0.367 Sum_probs=215.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.++||.+-.|.||+|..+.+|..||||.++.+.. +-++.-+ ++|++.|++|+ |||||++++++.|..+ .+|||||
T Consensus 15 i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~--s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~-~L~fVfE 90 (538)
T KOG0661|consen 15 IRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY--SWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYFVFE 90 (538)
T ss_pred HHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc--cHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCc-eEeeeHH
Confidence 4678888889999999999999999999875433 3444444 57999999998 9999999999987765 8999999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-c
Q 006277 92 LFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~ 169 (652)
||. .+|.++++.+ +.|++..++.|+.||++||+|+|.|| +.||||||+|||+.+. ..|||+|||+|+...... .
T Consensus 91 ~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~-~~iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 91 FMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGN-DVIKIADFGLAREVRSKPPY 166 (538)
T ss_pred hhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEeccc-ceeEecccccccccccCCCc
Confidence 994 5999999866 56999999999999999999999999 9999999999999854 489999999999887654 5
Q ss_pred ccccCCCCccCcccc--ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC-------------------
Q 006277 170 KSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI------------------- 228 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl--~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~------------------- 228 (652)
+..+.|.+|.|||++ .+.|+.++|+||+|||++|+.+.++-|.|....+|+|+...--.
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf 246 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF 246 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence 778999999999976 46799999999999999999999999999999999987654200
Q ss_pred -CC----c---cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccccCC
Q 006277 229 -KP----A---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGT 272 (652)
Q Consensus 229 -~p----~---~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~~~ 272 (652)
.| . .+-...++++.++|.+||. ||.+||||.|+|+||||+....
T Consensus 247 ~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 247 RFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred CCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 01 0 1112267899999999998 9999999999999999986543
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=368.27 Aligned_cols=250 Identities=21% Similarity=0.345 Sum_probs=214.6
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.|+++..|+||+|.++.+|+.||+|++...... .....+.+..|+.+++.+ +||||+++++++.+.. .+|+|||||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~--~~~iv~Ey~ 78 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD--RLFFVMEFV 78 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC--EEEEEEcCC
Confidence 478888899999999999999999998754322 234567788899999877 7999999999987654 799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--ccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~~~ 171 (652)
.+|+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..... .....
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcCCCcccc
Confidence 99999999998889999999999999999999999998 99999999999998 678999999999875422 22345
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+...++..+..+.. ..+...++++++||.+||.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~L~ 232 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLSQDAVDILKAFMT 232 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHcc
Confidence 78999999999875 5689999999999999999999999987 566777777776542 3445678999999999998
Q ss_pred -CCCCCCCH------HHHhcCccccccCCC
Q 006277 251 -PASQRLSA------KELLMDPFLQVNGTT 273 (652)
Q Consensus 251 -~P~~RpSa------~elL~hpf~~~~~~~ 273 (652)
+|.+|+++ +++++||||+...+.
T Consensus 233 ~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~ 262 (320)
T cd05590 233 KNPTMRLGSLTLGGEEAILRHPFFKELDWE 262 (320)
T ss_pred cCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence 89999998 999999999865543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=371.01 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=216.5
Q ss_pred EEEEEEecCcEEEEEEEccCC-eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNG-LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG-~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...++++..|.||+|.+..++ ..||+|++...... .....+.+.+|+.+++.++||||+++++++.+.. .+|+|||
T Consensus 35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~--~~~lv~E 111 (340)
T PTZ00426 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKDES--YLYLVLE 111 (340)
T ss_pred EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC--EEEEEEe
Confidence 457788888999999977665 78999998754432 2345678899999999999999999999987654 8999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 171 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~ 171 (652)
||.+|+|.+++.+.+.+++..+..++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..+.. ...+
T Consensus 112 y~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~~~-~~~~ 187 (340)
T PTZ00426 112 FVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVVDT-RTYT 187 (340)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEecCCCCeecCC-Ccce
Confidence 9999999999999889999999999999999999999998 99999999999998 678999999999986643 2346
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
.+||+.|||||++. ..++.++|||||||++|+|++|.+||.+ .+...+++.+..+.. .++...++.+++||++||.
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~l~ 264 (340)
T PTZ00426 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGII--YFPKFLDNNCKHLMKKLLS 264 (340)
T ss_pred ecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHcc
Confidence 78999999999874 4689999999999999999999999987 566677788877653 3455678899999999997
Q ss_pred -CCCCCC-----CHHHHhcCccccccCCC
Q 006277 251 -PASQRL-----SAKELLMDPFLQVNGTT 273 (652)
Q Consensus 251 -~P~~Rp-----Sa~elL~hpf~~~~~~~ 273 (652)
+|.+|+ +++++++||||+...|.
T Consensus 265 ~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 265 HDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred cCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 899995 89999999999865554
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=372.61 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=210.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+|++++.|+||+|.++.+|+.||+|++...... ......++.+|+.+++.++||||+++++++.+.. .+|+||||
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~--~~~lv~E~ 82 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD--NLYFVMDY 82 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC--EEEEEEec
Confidence 46788889999999999999999999999865433 3456778999999999999999999999998654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-----
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----- 167 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~----- 167 (652)
|+||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|++||+|||++..+...
T Consensus 83 ~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 83 IPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEEC-CCCCEEEeeCcCCccccccccccc
Confidence 999999999998889999999999999999999999998 99999999999998 6789999999997543100
Q ss_pred --------------------------------------------ccccccCCCCccCcccc-ccCCCccccchhhHHHHH
Q 006277 168 --------------------------------------------NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCML 202 (652)
Q Consensus 168 --------------------------------------------~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvily 202 (652)
...+.+||+.|+|||++ ...|+.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 01346899999999977 456999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHhcCCCCccc--cCCCChHHHHHHHHhCC---CCCCCCCHHHHhcCccccccCCC
Q 006277 203 EMVTFEYPYSECRNSAQIYKKVSSGIKPAAL--SKVKDPEVKSFIEKCLV---PASQRLSAKELLMDPFLQVNGTT 273 (652)
Q Consensus 203 eLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l--~~~~s~~~kdlI~kcL~---~P~~RpSa~elL~hpf~~~~~~~ 273 (652)
||++|..||.... .......+......... ....++++++||.+||. ++..|+++.+++.||||+...+.
T Consensus 240 elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 240 EMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred HHHhCCCCCcCCC-HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 9999999998744 33444444432211122 23468999999999764 35569999999999999865543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=371.21 Aligned_cols=255 Identities=23% Similarity=0.374 Sum_probs=215.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.++.+|+.||+|++...... ..+...++.+|+.++..++||||++++++|.+.. .+|+||||
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~--~~~lv~E~ 82 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR--NLYLIMEF 82 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--EEEEEEeC
Confidence 46788888999999999999999999999754332 2356778999999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc----
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---- 168 (652)
|+||+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++..+....
T Consensus 83 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 83 LPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred CCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEeeccCCccccccccccc
Confidence 999999999998889999999999999999999999998 99999999999998 67899999999987543210
Q ss_pred ---------------------------------cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCC
Q 006277 169 ---------------------------------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSEC 214 (652)
Q Consensus 169 ---------------------------------~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~ 214 (652)
..+.+||+.|+|||++ ...|+.++|||||||++|+|++|.+||.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~- 238 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS- 238 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC-
Confidence 1245899999999977 45799999999999999999999999987
Q ss_pred CCHHHHHHHHhcCCCCcccc--CCCChHHHHHHHHhCCCCCCCC---CHHHHhcCccccccCCCC
Q 006277 215 RNSAQIYKKVSSGIKPAALS--KVKDPEVKSFIEKCLVPASQRL---SAKELLMDPFLQVNGTTK 274 (652)
Q Consensus 215 ~~~~~i~~~I~~g~~p~~l~--~~~s~~~kdlI~kcL~~P~~Rp---Sa~elL~hpf~~~~~~~~ 274 (652)
.+....+..+........++ ...++++++||.+|+.+|.+|+ ++.++++||||+...|..
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 239 ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGH 303 (360)
T ss_pred CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHH
Confidence 55666777776543222222 2367899999999888898888 589999999998766543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=368.93 Aligned_cols=253 Identities=23% Similarity=0.362 Sum_probs=215.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.+..+|+.||+|++...... .......+.+|+.+++.++||||++++++|.+.. .+|+||||
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv~e~ 82 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQDEE--HLYLVMEY 82 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheecCC--eEEEEEcC
Confidence 46788888899999999999999999999865432 2345678899999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc----
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---- 168 (652)
|.+|+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++..+....
T Consensus 83 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 83 MPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILID-ADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEeecCCCCccCcccCcccc
Confidence 999999999998889999999999999999999999998 99999999999998 67899999999998764332
Q ss_pred ---------------------------cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHH
Q 006277 169 ---------------------------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI 220 (652)
Q Consensus 169 ---------------------------~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i 220 (652)
....+||+.|+|||++. ..|+.++|||||||++|+|++|..||... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-~~~~~ 238 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD-TLQET 238 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC-CHHHH
Confidence 23567999999999774 56999999999999999999999999874 45556
Q ss_pred HHHHhcCCCCcccc--CCCChHHHHHHHHhCCCCCCCCC-HHHHhcCccccccCC
Q 006277 221 YKKVSSGIKPAALS--KVKDPEVKSFIEKCLVPASQRLS-AKELLMDPFLQVNGT 272 (652)
Q Consensus 221 ~~~I~~g~~p~~l~--~~~s~~~kdlI~kcL~~P~~RpS-a~elL~hpf~~~~~~ 272 (652)
+..+........++ ...++++++||.+||.+|.+|++ +.++|+||||+...+
T Consensus 239 ~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred HHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCH
Confidence 66666522222222 23589999999999999999999 999999999986544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=372.95 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=212.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.+..+|+.||+|++...... .......+.+|+.+++.++|||||+++++|.+.. .+|+||||
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~--~~~lv~E~ 82 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NLYFVMDY 82 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--EEEEEEeC
Confidence 46788888999999999999999999999754432 2356778999999999999999999999998654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc------
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ------ 166 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~------ 166 (652)
|++|+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++..+..
T Consensus 83 ~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 83 IPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEeECCCCccccccccccc
Confidence 999999999988888999999999999999999999998 99999999999998 678999999999753210
Q ss_pred -------------------------------------------cccccccCCCCccCcccc-ccCCCccccchhhHHHHH
Q 006277 167 -------------------------------------------ANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCML 202 (652)
Q Consensus 167 -------------------------------------------~~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvily 202 (652)
....+.+||+.|+|||++ ...|+.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 001245899999999977 457999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHhcCCCCccc--cCCCChHHHHHHHHhCCCCCCCCC---HHHHhcCccccccCC
Q 006277 203 EMVTFEYPYSECRNSAQIYKKVSSGIKPAAL--SKVKDPEVKSFIEKCLVPASQRLS---AKELLMDPFLQVNGT 272 (652)
Q Consensus 203 eLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l--~~~~s~~~kdlI~kcL~~P~~RpS---a~elL~hpf~~~~~~ 272 (652)
||++|.+||.+. +..+....+......... ....++++++||.+|+.+|.+|++ +.++++||||+...+
T Consensus 240 elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 240 EMLVGQPPFLAQ-TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred HHHhCCCCCCCC-CHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 999999999874 444444445443222222 235689999999999889999987 999999999986544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=348.49 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=209.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..++|++..+.||+|.|.+||+.||||.|+..+.. ...-....+||+.|+.++||||+.+.++|-... .+.||+||
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k--dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~--~l~lVfEf 82 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK--DGINRTALREIKLLQELKHPNIIELIDVFPHKS--NLSLVFEF 82 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc--cCccHHHHHHHHHHHHccCcchhhhhhhccCCC--ceEEEEEe
Confidence 35788888899999999999999999999987542 123456889999999999999999999997655 69999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~ 169 (652)
++. +|...++.. ..++...++.|+.++++||+|||++. |+||||||.|+|++ .+|.+||+|||+|+.+.... .
T Consensus 83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLIS-SDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEc-CCCcEEeecccchhccCCCCccc
Confidence 965 899888765 46899999999999999999999999 99999999999998 67999999999999987543 2
Q ss_pred ccccCCCCccCcccc--ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC--CCcc-------------
Q 006277 170 KSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAA------------- 232 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl--~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~--~p~~------------- 232 (652)
...+-|.+|.|||++ .+.|+..+|+||.|||+.||+-|.+-|.+.++.+|+-.....-. .+..
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 334789999999976 45799999999999999999999999999888888754443211 1111
Q ss_pred ----------ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 233 ----------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 233 ----------l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+....+.++.+|+.+||. +|.+|++|.|+|+|+||..
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 112245678999999998 9999999999999999973
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=364.69 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=213.4
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
.++++..|.||+|.+..+|..||+|++..... .......++..|+++++.++||||+++++++.+.. .+|+||||+.
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~--~~~lv~E~~~ 78 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RLCFVMEYAN 78 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC--EEEEEEeCCC
Confidence 47888899999999999999999999975432 23456678889999999999999999999887654 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--ccccc
Q 006277 95 SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKS 171 (652)
Q Consensus 95 gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~~~ 171 (652)
+|+|..++...+.+++..++.++.||+.||.|||+ +| |+||||||+|||++ .+|.+||+|||++..... .....
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCCccccc
Confidence 99999999888899999999999999999999997 67 99999999999998 678999999999875432 22345
Q ss_pred ccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
.+||+.|||||++ ...|+.++|||||||++|+|++|..||.+ .+...++..+..+. ..++...++++++||.+||+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLSPEAKSLLSGLLK 232 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhh
Confidence 6899999999987 45789999999999999999999999977 45566666665543 23456678999999999997
Q ss_pred -CCCCCC-----CHHHHhcCccccccCC
Q 006277 251 -PASQRL-----SAKELLMDPFLQVNGT 272 (652)
Q Consensus 251 -~P~~Rp-----Sa~elL~hpf~~~~~~ 272 (652)
+|.+|+ ++.++++||||....+
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 899997 8999999999986544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=373.99 Aligned_cols=249 Identities=25% Similarity=0.309 Sum_probs=210.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.++|++..|.||+|.+..||+.||+|.|++... .++......+||.||++|+||||+++.+...+...+.+|||+|||
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM 200 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM 200 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc
Confidence 355666668899999999999999999997643 245677888999999999999999999998887667999999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---c
Q 006277 94 TSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---A 169 (652)
Q Consensus 94 ~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---~ 169 (652)
.. +|.-++... -+|++.+++.|++||+.||+|||++| |+|||||+.||||| +.|.+||+|||||+++.... .
T Consensus 201 dh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~~~~~~~ 276 (560)
T KOG0600|consen 201 DH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILID-NNGVLKIADFGLARFYTPSGSAPY 276 (560)
T ss_pred cc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEc-CCCCEEeccccceeeccCCCCccc
Confidence 66 887777653 47999999999999999999999999 99999999999999 78999999999999876543 4
Q ss_pred ccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CCCC-cc-------------
Q 006277 170 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIKP-AA------------- 232 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~~p-~~------------- 232 (652)
+..+-|.+|.|||++- ..|+.++|+||+||||.||++|++.|.+....+|+.+...- |... ..
T Consensus 277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~k 356 (560)
T KOG0600|consen 277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFK 356 (560)
T ss_pred ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccC
Confidence 6677899999999763 47999999999999999999999999997777776544332 1000 00
Q ss_pred -----------ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 233 -----------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 233 -----------l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
..+..++.+.+|+.+||. ||.+|.||.++|+|+||.
T Consensus 357 p~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 357 PQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred CCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 112356788999999997 999999999999999994
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=369.81 Aligned_cols=253 Identities=19% Similarity=0.306 Sum_probs=212.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+|+++..|+||+|.++.+|..||+|++...... .......+.+|+.+++.++||||+++++++.+.. .+|+||||
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~--~~~lv~Ey 124 (370)
T cd05596 48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK--YLYMVMEY 124 (370)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--EEEEEEcC
Confidence 45678888899999999999999999999754332 2344566889999999999999999999887654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---~ 169 (652)
|.||+|.+++... .+++..+..++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++..+.... .
T Consensus 125 ~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~~kL~DfG~~~~~~~~~~~~~ 200 (370)
T cd05596 125 MPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVRC 200 (370)
T ss_pred CCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEc-CCCCEEEEeccceeeccCCCcccC
Confidence 9999999988654 6899999999999999999999998 99999999999998 67899999999998764322 2
Q ss_pred ccccCCCCccCcccccc-----CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccC--CCChHHH
Q 006277 170 KSVIGTPEFMAPELYDE-----NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK--VKDPEVK 242 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~-----~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~--~~s~~~k 242 (652)
...+||+.|||||++.. .|+.++|||||||++|+|++|.+||.+ .+....+..+..+.....++. ..+.+++
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 279 (370)
T cd05596 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPDDIEISKQAK 279 (370)
T ss_pred CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCCcCCCCHHHH
Confidence 45689999999998742 488999999999999999999999987 555667777776543333333 4689999
Q ss_pred HHHHHhCC-CCCC--CCCHHHHhcCccccccCCC
Q 006277 243 SFIEKCLV-PASQ--RLSAKELLMDPFLQVNGTT 273 (652)
Q Consensus 243 dlI~kcL~-~P~~--RpSa~elL~hpf~~~~~~~ 273 (652)
+||.+||. +|.+ |+++.+++.||||+...+.
T Consensus 280 ~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 280 DLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred HHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 99999998 5766 9999999999999875543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=371.00 Aligned_cols=253 Identities=22% Similarity=0.299 Sum_probs=210.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.+..+|+.||+|++...... .......+.+|+.+|+.++||||+++++.|.+.. .+|+||||
T Consensus 6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~--~~~lv~E~ 82 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD--NLYFVMDY 82 (376)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--EEEEEEeC
Confidence 46788888899999999999999999998754332 2345677889999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-----
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----- 167 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~----- 167 (652)
|++|+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 83 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 83 IPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEEC-CCCCEEEEeCCCCccccccccccc
Confidence 999999999998889999999999999999999999998 99999999999998 6789999999997533100
Q ss_pred ----------------------------------------ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh
Q 006277 168 ----------------------------------------NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT 206 (652)
Q Consensus 168 ----------------------------------------~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt 206 (652)
.....+||+.|||||++. ..|+.++|||||||++|+|++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 012458999999999874 568999999999999999999
Q ss_pred ccCCCCCCCCHHHHHHHHhcCCCC--ccccCCCChHHHHHHHHhCCCCCCCC---CHHHHhcCccccccCC
Q 006277 207 FEYPYSECRNSAQIYKKVSSGIKP--AALSKVKDPEVKSFIEKCLVPASQRL---SAKELLMDPFLQVNGT 272 (652)
Q Consensus 207 G~~Pf~~~~~~~~i~~~I~~g~~p--~~l~~~~s~~~kdlI~kcL~~P~~Rp---Sa~elL~hpf~~~~~~ 272 (652)
|..||.+. ........+...... .......++++++||.+|+.+|.+|+ ++.++++||||+...+
T Consensus 240 G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 240 GQPPFLAD-TPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred CCCCCCCC-CHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 99999874 444444444433221 12223468899999999888999999 9999999999986443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=356.14 Aligned_cols=253 Identities=19% Similarity=0.299 Sum_probs=210.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
+..|++++.|+||+|.+..+|+.||+|.+...... .......+.+|+++++.++|+||++++++|.+.. .+++||||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~--~~~lv~e~ 81 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD--ALCLVLTI 81 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--eEEEEEEe
Confidence 56788888999999999999999999998755432 2334556789999999999999999999887654 79999999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-c
Q 006277 93 FTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~ 169 (652)
|.+|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++....... .
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcCCCCee
Confidence 9999998887643 36899999999999999999999998 99999999999998 67899999999998764332 3
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCH---HHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNS---AQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~---~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
...+||+.|||||++. ..|+.++|||||||++|+|++|..||...... ..+...+... ...++...++++.+||
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li 236 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED--QEEYSEKFSEDAKSIC 236 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc--cccCCccCCHHHHHHH
Confidence 4568999999999874 57999999999999999999999999764332 2233333322 2334556788999999
Q ss_pred HHhCC-CCCCCCC-----HHHHhcCccccccCCC
Q 006277 246 EKCLV-PASQRLS-----AKELLMDPFLQVNGTT 273 (652)
Q Consensus 246 ~kcL~-~P~~RpS-----a~elL~hpf~~~~~~~ 273 (652)
.+||. +|.+||+ ++++++||||....+.
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence 99998 8999997 9999999999876553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=361.77 Aligned_cols=250 Identities=19% Similarity=0.325 Sum_probs=211.2
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.|+++..|.||+|.+..+|+.||+|+++.... ...+....+.+|+.+++.+ +||||++++++|.+.. .+|+|||||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~--~~~lv~e~~ 78 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELV-NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES--RLFFVIEFV 78 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC--EEEEEEeCC
Confidence 47888899999999999999999999985432 3345677889999999999 7999999999987654 799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh--cccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~--~~~~~~ 171 (652)
++|+|..++.+.+++++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++... ......
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEECcCccccccccCCCcccc
Confidence 99999999988889999999999999999999999998 99999999999998 67899999999987532 222356
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCC--------CCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSEC--------RNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~--------~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
.+||+.|+|||++. ..|+.++|||||||++|+|++|..||... .....+++.+..+. ..++...++.++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~ 233 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKAS 233 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--CCCCCCCCHHHH
Confidence 78999999999874 56899999999999999999999999531 12233455555543 234566788999
Q ss_pred HHHHHhCC-CCCCCCC------HHHHhcCccccccCC
Q 006277 243 SFIEKCLV-PASQRLS------AKELLMDPFLQVNGT 272 (652)
Q Consensus 243 dlI~kcL~-~P~~RpS------a~elL~hpf~~~~~~ 272 (652)
+||.+||+ +|.+|++ +.++++||||....+
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 99999998 8999987 789999999976544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=360.45 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=211.8
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.|++++.|.||+|.++.+|..||+|+++..... .......+..|+.++..+ +||||++++++|.+.. .+|+|||||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~lv~E~~ 78 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE--HLFFVMEFL 78 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC--EEEEEECCC
Confidence 578888999999999999999999999854322 123456677888888765 9999999999987654 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh--cccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~--~~~~~~ 171 (652)
.+|+|..++...+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++.... ......
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEeCccCCCeecccCCCceec
Confidence 99999999998889999999999999999999999998 99999999999998 66899999999987432 223456
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+...++..+..+. ..++...+.++++||.+||.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDT--PHYPRWITKESKDILEKLFE 232 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHcc
Confidence 78999999999874 5799999999999999999999999987 55667777776543 23455678999999999997
Q ss_pred -CCCCCCCH-HHHhcCccccccCC
Q 006277 251 -PASQRLSA-KELLMDPFLQVNGT 272 (652)
Q Consensus 251 -~P~~RpSa-~elL~hpf~~~~~~ 272 (652)
+|.+|+++ .++++||||+...+
T Consensus 233 ~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 233 RDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred CCHHHcCCChHHHHcCCCcCCCCH
Confidence 89999997 58999999986544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=361.82 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=209.8
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHH-HHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~-iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.|++++.|+||+|.++.+|+.||+|++....... .....++..|.. +++.++||||++++++|.+.. .+|+|||||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~--~~~lv~e~~ 78 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD--KLYFVLDYV 78 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC--EEEEEEcCC
Confidence 4788889999999999999999999997544322 233445555554 568899999999999987654 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--ccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~~~ 171 (652)
.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..... .....
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeccCCCcccccCCCcccc
Confidence 99999999998889999999999999999999999998 99999999999998 678999999999875432 22345
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+..+++..+..+. ..++...++.+.+||.+||+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKP--LRLKPNISVSARHLLEGLLQ 232 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhh
Confidence 68999999999774 5689999999999999999999999987 56677777777653 23344568999999999998
Q ss_pred -CCCCCCCH----HHHhcCccccccCC
Q 006277 251 -PASQRLSA----KELLMDPFLQVNGT 272 (652)
Q Consensus 251 -~P~~RpSa----~elL~hpf~~~~~~ 272 (652)
+|.+||++ .+++.||||....+
T Consensus 233 ~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred cCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 89999987 69999999986544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=361.35 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=214.7
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.|++++.|.||+|.+..+|+.||+|++..... ...+..+.+..|+.+++.+ +||||++++++|.+.. .+|+|||||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~--~~~lv~E~~ 78 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD--RLFFVMEYV 78 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--eEEEEEeCC
Confidence 47788889999999999999999999975433 2345667788899999876 8999999999997654 799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--ccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~~~ 171 (652)
.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..... .....
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeecccceecccCCccccc
Confidence 99999999998889999999999999999999999998 99999999999998 678999999999875432 22345
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+...++..+..+.. ..+...++++++||.+||.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~L~ 232 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDV--LYPVWLSKEAVSILKAFMT 232 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhc
Confidence 68999999999875 4799999999999999999999999987 566777777776542 2345578899999999998
Q ss_pred -CCCCCC-------CHHHHhcCccccccCCC
Q 006277 251 -PASQRL-------SAKELLMDPFLQVNGTT 273 (652)
Q Consensus 251 -~P~~Rp-------Sa~elL~hpf~~~~~~~ 273 (652)
+|.+|+ ++.++++||||....+.
T Consensus 233 ~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 233 KNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred cCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 899999 99999999999765543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=367.24 Aligned_cols=252 Identities=19% Similarity=0.311 Sum_probs=210.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|.||+|.++.+|+.||+|++...... .......+.+|+.+++.++||||++++++|.+.. .+|+||||
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~--~~~lv~Ey 124 (370)
T cd05621 48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK--YLYMVMEY 124 (370)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--EEEEEEcC
Confidence 45788888899999999999999999999754332 2345567889999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---~ 169 (652)
|.||+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..+.... .
T Consensus 125 ~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~~~~~~~~~ 200 (370)
T cd05621 125 MPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRC 200 (370)
T ss_pred CCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEEecccceecccCCceec
Confidence 9999999998754 6899999999999999999999998 99999999999998 67899999999998764322 2
Q ss_pred ccccCCCCccCcccccc-----CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccC--CCChHHH
Q 006277 170 KSVIGTPEFMAPELYDE-----NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK--VKDPEVK 242 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~-----~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~--~~s~~~k 242 (652)
.+.+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.. .+....+..+........++. ..+..++
T Consensus 201 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 279 (370)
T cd05621 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPEDVEISKHAK 279 (370)
T ss_pred ccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCCcccCCHHHH
Confidence 46789999999998743 378999999999999999999999987 455666777765443333332 4578999
Q ss_pred HHHHHhCCC-C--CCCCCHHHHhcCccccccCC
Q 006277 243 SFIEKCLVP-A--SQRLSAKELLMDPFLQVNGT 272 (652)
Q Consensus 243 dlI~kcL~~-P--~~RpSa~elL~hpf~~~~~~ 272 (652)
+||.+||.+ + ..|+++.|+++||||+...+
T Consensus 280 ~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 280 NLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred HHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 999999974 3 34889999999999986543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.60 Aligned_cols=249 Identities=23% Similarity=0.375 Sum_probs=211.1
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.|+++..|.||+|.+..+|+.||+|+++..... .....+.+..|..++..+ +||||+++++++.... .+|+||||+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--~~~lv~e~~ 78 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE--HLFFVMEYL 78 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEEEEcCC
Confidence 578889999999999999999999999854322 234556667777777765 8999999999987654 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--ccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~~~ 171 (652)
.||+|..++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... .....
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCCCCcccc
Confidence 99999999998889999999999999999999999998 99999999999998 678999999999976432 22356
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+..+++..+.... ..++...+.++++||.+||.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~ll~~~l~ 232 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDR--PHFPRWISKEAKDCLSKLFE 232 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHcc
Confidence 78999999999774 4689999999999999999999999987 55666777766543 23456678899999999997
Q ss_pred -CCCCCCCH-HHHhcCccccccCC
Q 006277 251 -PASQRLSA-KELLMDPFLQVNGT 272 (652)
Q Consensus 251 -~P~~RpSa-~elL~hpf~~~~~~ 272 (652)
+|.+||++ .+++.||||+...+
T Consensus 233 ~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 233 RDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred CCHHHcCCChHHHHcCcccCCCCH
Confidence 89999985 58999999986554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=361.68 Aligned_cols=254 Identities=19% Similarity=0.274 Sum_probs=215.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+++++..|+||+|.++.+|+.||+|+++.... ...+....+.+|+.+++.++||||+++++++.+.. .+|+||||
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~--~~~lv~e~ 82 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD--NLYLVMEY 82 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--eEEEEECC
Confidence 4678888899999999999999999999985432 23456678899999999999999999999887654 79999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
|.+|+|.+++.+. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+....
T Consensus 83 ~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEEC-CCCCEEeccCCCCeECCCCCcee
Confidence 9999999999876 68999999999999999999999998 99999999999998 67899999999998765332
Q ss_pred cccccCCCCccCccccc-------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc--CCCCh
Q 006277 169 AKSVIGTPEFMAPELYD-------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS--KVKDP 239 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~--~~~s~ 239 (652)
.....||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+....+..+........++ ...++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC-CCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 23457999999999874 3578999999999999999999999987 45555666666544322222 24678
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHhcCccccccCCC
Q 006277 240 EVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTT 273 (652)
Q Consensus 240 ~~kdlI~kcL~~P~~RpSa~elL~hpf~~~~~~~ 273 (652)
++++||.+||.+|.+||++.+++.||||+...+.
T Consensus 239 ~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 239 DFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred HHHHHHHHHccChhhCCCHHHHhCCCCcCCCCHH
Confidence 9999999999999999999999999999865543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=358.89 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=213.8
Q ss_pred EEEEEecCcEEEEEEEc---cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~---~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
..|++++.|.||+|.+. .+|+.||+|++..............+..|+.+|+.++||||++++++|.+.. .+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG--KLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC--eEEEEE
Confidence 36888999999999874 5789999999986544333445667889999999999999999999987654 799999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--c
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--N 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~ 168 (652)
||+.+|+|.+++.+.+.+.+..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++..... .
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEeeCcCCeecccCCCc
Confidence 99999999999998889999999999999999999999998 99999999999998 6789999999998754322 2
Q ss_pred cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~k 247 (652)
....+||+.|+|||++. ..++.++|||||||++|+|++|.+||.. .+....+..+..+.. .++...++.+++||.+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~ 233 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKL--NLPPYLTPEARDLLKK 233 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence 34568999999999874 4688999999999999999999999987 455566666666543 3455678999999999
Q ss_pred hCC-CCCCCC-----CHHHHhcCccccccCC
Q 006277 248 CLV-PASQRL-----SAKELLMDPFLQVNGT 272 (652)
Q Consensus 248 cL~-~P~~Rp-----Sa~elL~hpf~~~~~~ 272 (652)
||. +|.+|| ++.+++.||||....+
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 997 899999 8999999999976443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=367.27 Aligned_cols=243 Identities=33% Similarity=0.479 Sum_probs=206.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeE-EEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLE-VAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~-VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
..+++.+..|+||+|.. .|.. ||+|.+...+. +....+.+.+|+.+|.+|+|||||+|++++..... .+++|||
T Consensus 46 ~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~--~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iVtE 120 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDF--DDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIVTE 120 (362)
T ss_pred hhhcccCCceeEEEEEe--CCceeEEEEEecchhc--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEEEE
Confidence 44577888899999975 5566 99999986553 23348899999999999999999999998865542 6899999
Q ss_pred cCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCC-cEEEeccCchhhhhcc-
Q 006277 92 LFTSGSLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG-EVKIGDLGLATIMEQA- 167 (652)
Q Consensus 92 y~~gGsL~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g-~VKL~DFGla~~l~~~- 167 (652)
|+++|+|.+++.+ .+.++...+..|+.||+.|+.|||++++ ||||||||+|||++ .++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~-~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVD-LKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEc-CCCCEEEECCCccceeecccc
Confidence 9999999999987 6789999999999999999999999986 99999999999999 555 9999999999887653
Q ss_pred -ccccccCCCCccCcccccc---CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHH
Q 006277 168 -NAKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 243 (652)
Q Consensus 168 -~~~~~vGTp~YmAPEvl~~---~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kd 243 (652)
......||+.|||||++++ .|+.++|||||||++|||+||+.||.+... .++...+..+...+.++...++.+..
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~l~~ 277 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPHLSS 277 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 3344799999999999985 499999999999999999999999998666 55555554444444566668899999
Q ss_pred HHHHhCC-CCCCCCCHHHHhc
Q 006277 244 FIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~ 263 (652)
+|..||. +|.+||+..+++.
T Consensus 278 l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 278 LMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHhCCCCCCcCCCHHHHHH
Confidence 9999997 8999999998874
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=356.83 Aligned_cols=251 Identities=21% Similarity=0.307 Sum_probs=214.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC-CeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN-NIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hp-nIVkl~~~~~d~~~~~~~LVmE 91 (652)
...|++++.|.||+|.++.+++.||+|++..... ......+.+..|+++++.++|+ +|+++++++.+.. .+|+|||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~lv~E 81 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--RLYFVME 81 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC--EEEEEEc
Confidence 3578888889999999999999999999985433 2345677888999999999765 6888998887654 7999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh--cccc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~--~~~~ 169 (652)
||.+|+|.+++...+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++.... ....
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTT 158 (324)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEc-CCCCEEEeecCcceecCCCCCce
Confidence 9999999999998889999999999999999999999998 99999999999998 67899999999987532 2223
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
...+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .....++..+.... ..++...++++++||.+|
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~ 235 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHN--VSYPKSLSKEAVSICKGL 235 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHH
Confidence 4568999999999875 4689999999999999999999999987 55667777776654 234566789999999999
Q ss_pred CC-CCCCCCCH-----HHHhcCccccccCC
Q 006277 249 LV-PASQRLSA-----KELLMDPFLQVNGT 272 (652)
Q Consensus 249 L~-~P~~RpSa-----~elL~hpf~~~~~~ 272 (652)
|. +|.+|+++ .+++.||||+...+
T Consensus 236 l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 236 LTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred hhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 98 89999976 89999999986554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=356.79 Aligned_cols=253 Identities=19% Similarity=0.303 Sum_probs=211.5
Q ss_pred EEEEEEecCcEEEEEEEc---cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~---~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~L 88 (652)
..+|++++.|+||+|.+. .+|..||+|++............+++..|+.+++.+ +||||+++++++.+.. .+|+
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--~~~l 82 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA--KLHL 82 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC--EEEE
Confidence 467888999999998874 589999999997654433345567889999999999 5999999999887554 7999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 167 (652)
|||||.+|+|.+++.+++.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 83 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 83 ILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEEC-CCCCEEEeeCcCCccccccC
Confidence 9999999999999998889999999999999999999999998 99999999999998 6689999999999865332
Q ss_pred --ccccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCC---CCHHHHHHHHhcCCCCccccCCCChH
Q 006277 168 --NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSEC---RNSAQIYKKVSSGIKPAALSKVKDPE 240 (652)
Q Consensus 168 --~~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~---~~~~~i~~~I~~g~~p~~l~~~~s~~ 240 (652)
.....+||+.|||||++.+ .++.++|||||||++|+|++|..||... .....+...+.... ..++...++.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 237 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--PPFPSFIGPE 237 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHH
Confidence 2335689999999998754 4788999999999999999999999642 23344445554432 2345567899
Q ss_pred HHHHHHHhCC-CCCCCC-----CHHHHhcCccccccCC
Q 006277 241 VKSFIEKCLV-PASQRL-----SAKELLMDPFLQVNGT 272 (652)
Q Consensus 241 ~kdlI~kcL~-~P~~Rp-----Sa~elL~hpf~~~~~~ 272 (652)
+++||.+||. +|.+|| ++.++++||||+...+
T Consensus 238 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 9999999997 899999 8899999999986544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=359.20 Aligned_cols=253 Identities=28% Similarity=0.385 Sum_probs=213.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe---CCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID---DQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d---~~~~~~~LVm 90 (652)
..+|.+..|.|..|.++.+|..||+|++. +..++.-..+|.++|+.+|+.++|+||+.+++.+.. ..-..+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~--~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKIL--NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhh--hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence 34777778999999999999999999886 233456788999999999999999999999999865 2334799999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh----c
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME----Q 166 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~----~ 166 (652)
|++ +.+|.+.++.++.+++..+..++.|||.||.|+|+.| |+||||||.|+|+| .+..+||+|||+|+... .
T Consensus 106 elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n-~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 106 ELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLN-ADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred hHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeec-cCCCEEeccccceeeccccCcc
Confidence 999 6699999998888999999999999999999999999 99999999999999 66789999999999885 3
Q ss_pred cccccccCCCCccCcccc--ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHh-------------------
Q 006277 167 ANAKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS------------------- 225 (652)
Q Consensus 167 ~~~~~~vGTp~YmAPEvl--~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~------------------- 225 (652)
...+..+-|.+|.|||++ ...|+..+||||+|||+.||++|++-|.+.....|+...+.
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 334667889999999976 45799999999999999999999999998666665532211
Q ss_pred ----c-CC-CCc---cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccccCC
Q 006277 226 ----S-GI-KPA---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGT 272 (652)
Q Consensus 226 ----~-g~-~p~---~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~~~ 272 (652)
+ +. .+. ......++.+.+|+++||+ ||.+|+||+|+|.||||.....
T Consensus 262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 1 11 111 1223568999999999998 9999999999999999975443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=357.44 Aligned_cols=249 Identities=26% Similarity=0.440 Sum_probs=208.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+++++..|.||+|.+..+|..||+|.+.... .+...+++.+|+++|++++||||+++++++.+.. .+++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 84 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISICMEH 84 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--EEEEEeec
Confidence 356777778999999999999999999987542 3456778999999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
+.+|+|.+++...+.+++..+..++.|++.||.|||+.+ +|+||||||+|||++ .++.+||+|||++..+........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (331)
T cd06649 85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSF 162 (331)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEc-CCCcEEEccCcccccccccccccC
Confidence 999999999998888999999999999999999999852 399999999999998 678999999999987765555667
Q ss_pred cCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHH---------------------------
Q 006277 173 IGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV--------------------------- 224 (652)
Q Consensus 173 vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I--------------------------- 224 (652)
.||+.|+|||++. ..++.++|||||||++|+|++|..||... ....+...+
T Consensus 163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (331)
T cd06649 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP-DAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVS 241 (331)
T ss_pred CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccccCCccccCccccccccccc
Confidence 8999999999875 46899999999999999999999999653 222222211
Q ss_pred -------------------hcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 225 -------------------SSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 225 -------------------~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.....+.......++++++||.+||+ +|++|||+.++|+||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 242 GHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred ccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 11111111123467899999999998 8999999999999999974
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=357.41 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=211.9
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+++++.|+||+|.+..+|+.||+|+++..... ..........|+.+++.+ +||||+++++++.+.. .+|+||||+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~--~~~lv~ey~ 78 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE--NLFFVMEYL 78 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC--EEEEEEeCC
Confidence 578899999999999999999999999854321 123456677788888765 9999999999987654 799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh--cccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~--~~~~~~ 171 (652)
++|+|..++.....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.... ......
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEccCCcceECCCCCCceee
Confidence 99999999988888999999999999999999999998 99999999999998 66899999999987532 223356
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+..+++..+..+. ..++...+.++++||.+||.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDN--PCYPRWLTREAKDILVKLFV 232 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHhc
Confidence 78999999999874 5789999999999999999999999987 45666777666543 23445678899999999997
Q ss_pred -CCCCCCCHH-HHhcCccccccCCC
Q 006277 251 -PASQRLSAK-ELLMDPFLQVNGTT 273 (652)
Q Consensus 251 -~P~~RpSa~-elL~hpf~~~~~~~ 273 (652)
+|.+||++. ++++||||+...+.
T Consensus 233 ~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 233 REPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred cCHhhcCCChHHHHcCcccCCCCHH
Confidence 899999996 99999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=348.73 Aligned_cols=248 Identities=19% Similarity=0.271 Sum_probs=202.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...+++++.|+||+|.++.+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.... .+|+||||
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 81 (287)
T cd07848 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRRRG--KLYLVFEY 81 (287)
T ss_pred EEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEecCC--EEEEEEec
Confidence 3567888889999999999999999999875432 2345678889999999999999999999887554 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---~ 169 (652)
+.++.|..+......+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..+.... .
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccCcccccccccccc
Confidence 999887766665668999999999999999999999998 99999999999998 67899999999998764322 2
Q ss_pred ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CC-------------------
Q 006277 170 KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GI------------------- 228 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~------------------- 228 (652)
....||+.|+|||++ ...|+.++|||||||++|+|++|.+||.+............. +.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 346799999999976 457899999999999999999999999875443333221110 00
Q ss_pred CCc---------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 229 KPA---------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 229 ~p~---------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
.+. ......+.++++||.+||. +|.+|||++|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 0112357789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=356.51 Aligned_cols=249 Identities=21% Similarity=0.337 Sum_probs=214.1
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.|++++.|+||+|.+..+|+.||+|+++.... ...+....+..|+.+++.+ +||||+++++++.+.. .+|+|||||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~--~~~lv~e~~ 78 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVI-LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD--RLFFVMEYV 78 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEEEEcCC
Confidence 57888899999999999999999999985432 2335567788999999988 7999999999987654 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--ccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~~~ 171 (652)
.||+|..++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... .....
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEEC-CCCcEEecccCCCeecCcCCCcccc
Confidence 99999999998889999999999999999999999998 99999999999998 678999999999875322 22345
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+...++..+..... ..+...+..+++||.+||.
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~ 232 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEV--RYPRWLSKEAKSILKSFLT 232 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHcc
Confidence 68999999999774 5789999999999999999999999976 556667776665432 3455678999999999997
Q ss_pred -CCCCCCCH-----HHHhcCccccccCC
Q 006277 251 -PASQRLSA-----KELLMDPFLQVNGT 272 (652)
Q Consensus 251 -~P~~RpSa-----~elL~hpf~~~~~~ 272 (652)
+|.+|||+ .+++.||||+...+
T Consensus 233 ~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 233 KNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 89999999 99999999987554
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=354.53 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=202.4
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---CeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN---KTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~---~~~~LVm 90 (652)
..++++..|.||+|.+..+|..||+|++.... .......++.+|+.+++.++||||+++++++..... ..+|+||
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~ 83 (338)
T cd07859 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83 (338)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEE
Confidence 57888888999999999999999999986432 123445678999999999999999999998865432 3589999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
||| +++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++......
T Consensus 84 e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 84 ELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred ecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEccCccccccccccCc
Confidence 999 5699999988889999999999999999999999998 99999999999998 67899999999998653221
Q ss_pred ---cccccCCCCccCccccc---cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHH--------------HHHHhc--
Q 006277 169 ---AKSVIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI--------------YKKVSS-- 226 (652)
Q Consensus 169 ---~~~~vGTp~YmAPEvl~---~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i--------------~~~I~~-- 226 (652)
....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.....++ ...+..
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 23468999999999874 46899999999999999999999999764332211 111110
Q ss_pred ---------CCCCcc---ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 227 ---------GIKPAA---LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 227 ---------g~~p~~---l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
...+.. .....++.+.+||.+||. +|.+|||+.|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 001111 112356789999999997 89999999999999999743
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=351.99 Aligned_cols=263 Identities=23% Similarity=0.302 Sum_probs=217.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
-|+.++-.|.||+|.|+.|+..||+|.++...- ....--.-++||.+|.+++|||||.+.++.+...-..+|+|||||
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmeke--k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~ 159 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE--KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV 159 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccc--cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH
Confidence 467788889999999999999999999986541 111223567899999999999999999999888778899999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 94 TSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 94 ~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
+. +|..++...+ +|.+.+++.++.|+|+||.|||.+. |+|||||++|+|++ +.|.+||+|||+|+.+.... .+
T Consensus 160 Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~-~~G~lKiaDFGLAR~ygsp~k~~T 235 (419)
T KOG0663|consen 160 EH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLS-HKGILKIADFGLAREYGSPLKPYT 235 (419)
T ss_pred Hh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeec-cCCcEEecccchhhhhcCCcccCc
Confidence 66 8999888765 8999999999999999999999999 99999999999998 78999999999999987653 35
Q ss_pred cccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC----------------c-
Q 006277 171 SVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP----------------A- 231 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p----------------~- 231 (652)
..+-|.+|.|||++- ..|+.++|+||+|||+.||+++.+-|.+....+|+.+...--..| .
T Consensus 236 ~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~ 315 (419)
T KOG0663|consen 236 PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMT 315 (419)
T ss_pred ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccc
Confidence 567799999999763 469999999999999999999999999988888877655421000 0
Q ss_pred -----------cccCC-CChHHHHHHHHhCC-CCCCCCCHHHHhcCccccccCCCCCCCCCCCCCcCCCC
Q 006277 232 -----------ALSKV-KDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRV 288 (652)
Q Consensus 232 -----------~l~~~-~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~~~~~~~~~~~p~~~lp~~ 288 (652)
.+... .+....+|+..+|. ||.+|.||.|.|+|.||.. .|++.++..+|..
T Consensus 316 f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e------~P~p~~P~~~Pt~ 379 (419)
T KOG0663|consen 316 FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE------TPLPIDPSMFPTW 379 (419)
T ss_pred cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc------CCCCCChhhcCCC
Confidence 01111 34678899999998 9999999999999999974 3444444455543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=366.16 Aligned_cols=255 Identities=22% Similarity=0.402 Sum_probs=211.7
Q ss_pred eEEEEEEec---CcEEEEEEEccCCeEEEEEEEeecccCCC----------HHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Q 006277 12 MYLRLIQLV---DTSGYKAFDEVNGLEVAWCQVRIDDVLQS----------PEDLERLYSEVHLLKSLKHNNIIRFYNSW 78 (652)
Q Consensus 12 ~~~rL~~l~---~gtVykA~d~~tG~~VAiK~v~~~~~~~s----------~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~ 78 (652)
.|..+.++| .|.|-+|++..+|+.||||++.+.++.+. ...++++++||.||++|.|||||+++++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 454444444 47999999999999999999987654321 12357999999999999999999999998
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEecc
Q 006277 79 IDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 158 (652)
Q Consensus 79 ~d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DF 158 (652)
-|.....+|||+|||..|.+...-....-+++.+++.|++.++.||+|||.+| ||||||||.|+|++ .+|+|||+||
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~-~~g~VKIsDF 254 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLS-SDGTVKISDF 254 (576)
T ss_pred cCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEc-CCCcEEeecc
Confidence 88888899999999999987654322223999999999999999999999999 99999999999998 5699999999
Q ss_pred Cchhhhhcc-------ccccccCCCCccCcccccc----C-CCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc
Q 006277 159 GLATIMEQA-------NAKSVIGTPEFMAPELYDE----N-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS 226 (652)
Q Consensus 159 Gla~~l~~~-------~~~~~vGTp~YmAPEvl~~----~-y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~ 226 (652)
|.+..+..+ .....+|||.|||||.+.+ . -+.+.||||+||++|.|+.|++||.+ .....+|.+|..
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIvn 333 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIVN 333 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHhc
Confidence 998866322 1234799999999997743 1 35789999999999999999999988 677889999988
Q ss_pred CCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 227 GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 227 g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
......-.....++++++|.+||. ||.+|++..++..|||...+
T Consensus 334 ~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 334 DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 654333334467899999999997 89999999999999999654
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=355.30 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=209.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHH---HhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL---KSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iL---k~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
...|+++..|.||+|.+..+|+.||+|+++..... .....+++.+|++++ +.++||||+++++++.+.. .+|+|
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~--~~~lv 80 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED--HVCFV 80 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC--EEEEE
Confidence 35788888899999999999999999999855432 234566777777765 4668999999999987654 89999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--c
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--A 167 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~ 167 (652)
|||+.||+|..++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..... .
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCcEEeCcccCCccCCCCCC
Confidence 999999999988754 57999999999999999999999998 99999999999998 678999999999875432 2
Q ss_pred ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 168 NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 168 ~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
.....+||+.|||||++. ..|+.++|||||||++|+|++|..||.+ .+...++..+..+.. .++...++.+.+||.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~ 233 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSREAISIMR 233 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHH
Confidence 234678999999999774 5689999999999999999999999987 455666666665532 244567889999999
Q ss_pred HhCC-CCCCCC-----CHHHHhcCccccccCC
Q 006277 247 KCLV-PASQRL-----SAKELLMDPFLQVNGT 272 (652)
Q Consensus 247 kcL~-~P~~Rp-----Sa~elL~hpf~~~~~~ 272 (652)
+||. +|.+|| ++.++++||||+...+
T Consensus 234 ~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 234 RLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred HHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 9998 899999 7999999999986543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=352.56 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=200.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+++++..|+||+|.++.+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+.. .+++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~ 84 (303)
T cd07869 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHTKE--TLTLVFEY 84 (303)
T ss_pred eeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEecCC--eEEEEEEC
Confidence 4678888889999999999999999999875432 123446778999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
+. ++|.+++..+ +.+++..++.++.||+.||+|||+++ |+||||||+|||++ ..|.+||+|||++...... ..
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECCCCcceeccCCCccC
Confidence 95 6788777654 57999999999999999999999998 99999999999998 6789999999998754322 23
Q ss_pred ccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC-CC----------------C
Q 006277 170 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG-IK----------------P 230 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g-~~----------------p 230 (652)
...+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+..+.......+... .. +
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 4567899999999874 358899999999999999999999998755544333322210 00 0
Q ss_pred ccc------------c-CCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 231 AAL------------S-KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 231 ~~l------------~-~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
..+ . ...++.+++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 000 0 0134678999999998 8999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=349.93 Aligned_cols=246 Identities=25% Similarity=0.355 Sum_probs=199.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+++.++.|+||+|.+..+|..||+|+++.... ......+.+|+++++.++||||+++++++.+.. .+++||||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~ 84 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHTER--CLTLVFEY 84 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC--eEEEEEeC
Confidence 3577788889999999999999999999875432 223456788999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 93 FTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
+.+ +|.+++...+ .+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||++...... ..
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEECcCcceeeccCCCccc
Confidence 975 8999887654 5799999999999999999999998 99999999999998 6789999999998765432 23
Q ss_pred ccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CCC-----------------
Q 006277 170 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIK----------------- 229 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~~----------------- 229 (652)
....||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+......+...+.. +..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 4567899999999774 35899999999999999999999999874433332221111 000
Q ss_pred --Cc-------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 230 --PA-------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 230 --p~-------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
+. ......++++++||.+||+ +|.+|||++|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00 0012356789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=349.35 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=205.8
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 95 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~g 95 (652)
|++++.|+||+|.++.+|+.||+|++..... ......+++..|+.+++.++||||+++++++.... .+|+||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL-KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT--DLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH-hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC--eEEEEEeCCCC
Confidence 3567789999999999999999999875432 22345577889999999999999999999886544 79999999999
Q ss_pred CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c
Q 006277 96 GSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 169 (652)
Q Consensus 96 GsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~ 169 (652)
|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..+.... .
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKT 154 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCccc
Confidence 999887743 356999999999999999999999998 99999999999998 57899999999997665432 3
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCH---HHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNS---AQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~---~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
....||+.|+|||++. ..++.++|||||||++|+|++|..||...... ..+...+..+ +...+...++.+++||
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 232 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFC 232 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHH
Confidence 4568999999999774 57899999999999999999999999763322 2233333322 2334456788999999
Q ss_pred HHhCC-CCCCCC-----CHHHHhcCccccccCCC
Q 006277 246 EKCLV-PASQRL-----SAKELLMDPFLQVNGTT 273 (652)
Q Consensus 246 ~kcL~-~P~~Rp-----Sa~elL~hpf~~~~~~~ 273 (652)
.+||. +|.+|| ++++++.||||+...+.
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 99997 899999 89999999999865443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=362.37 Aligned_cols=247 Identities=28% Similarity=0.463 Sum_probs=214.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+|+++-.|.||+|.|+.+|+.||+|+|... .+++.+.+||.||++|+.|++|++|++|.... .+|+||||
T Consensus 38 ~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s--DLWIVMEY 109 (502)
T KOG0574|consen 38 VGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS--DLWIVMEY 109 (502)
T ss_pred HHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCC--ceEeehhh
Confidence 36788888899999999999999999998753 46889999999999999999999999997544 79999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~ 169 (652)
|..|+..+.++. ++++++.++..+++..|+||+|||... -||||||..|||++ .+|+.||+|||.|..+.... .
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLN-T~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLN-TDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEc-ccchhhhhhccccchhhhhHHhh
Confidence 999999998774 468999999999999999999999987 89999999999999 77999999999999987764 4
Q ss_pred ccccCCCCccCcccccc-CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~-~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
.+++|||.|||||++.+ +|+.++||||||+...||..|++||.+-.....++..-........-+...+.++.+||++|
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 78999999999999865 89999999999999999999999998866655555333222211222345678999999999
Q ss_pred CC-CCCCCCCHHHHhcCcccccc
Q 006277 249 LV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~~~~ 270 (652)
|. +|++|-||.+|++|||++..
T Consensus 267 LiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred hcCCHHHHHHHHHHhhhhhhcCC
Confidence 98 79999999999999999854
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=354.70 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=215.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...|++++.|.||+|.++.+|+.||+|++..... ......+.+..|+.++..+ .||+|+++++++.+.. .+|+|||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~lv~E 81 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD--RLYFVME 81 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC--EEEEEEc
Confidence 4678888899999999999999999999985432 2334566778888998888 6899999999887654 7999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--ccc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~ 169 (652)
|+.+|+|..++...+.+++..+..++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+++.... ...
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTT 158 (323)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEEC-CCCcEEEccCCCceecCCCCCcc
Confidence 9999999999998889999999999999999999999998 99999999999998 678999999999875432 234
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
...+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+...++..+..+.. .++...+.++++||.+|
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~ 235 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICKGL 235 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCcCCHHHHHHHHHH
Confidence 5678999999999774 5699999999999999999999999987 556677777766542 34566789999999999
Q ss_pred CC-CCCCCCC-----HHHHhcCccccccCCC
Q 006277 249 LV-PASQRLS-----AKELLMDPFLQVNGTT 273 (652)
Q Consensus 249 L~-~P~~RpS-----a~elL~hpf~~~~~~~ 273 (652)
|. +|.+|++ ..+++.||||+...|.
T Consensus 236 l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~ 266 (323)
T cd05616 236 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 266 (323)
T ss_pred cccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 97 8999997 4899999999866553
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=357.53 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=208.6
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHH-HHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~-iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.|++++.|.||+|.+..+|+.||+|++...... ......++..|.. +++.++||||++++++|.... .+|+||||+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~--~~~lv~e~~ 78 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE--KLYFVLDFV 78 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC--EEEEEEcCC
Confidence 478888999999999999999999999754332 2334455566655 577889999999999887654 799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--ccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~~~ 171 (652)
.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..... .....
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEeecCCcccCCCCCCCccc
Confidence 99999999998889999999999999999999999998 99999999999998 678999999999875422 22346
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
.+||+.|||||++. ..|+.++|||||||++|+|++|.+||.. .+...++..+..+.. .+....+..+.++|.+||.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKPL--VLRPGASLTAWSILEELLE 232 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCCc--cCCCCCCHHHHHHHHHHhc
Confidence 78999999999874 5689999999999999999999999987 566667777766432 2334567899999999997
Q ss_pred -CCCCCCCH----HHHhcCccccccCC
Q 006277 251 -PASQRLSA----KELLMDPFLQVNGT 272 (652)
Q Consensus 251 -~P~~RpSa----~elL~hpf~~~~~~ 272 (652)
+|.+||++ .+++.||||....+
T Consensus 233 ~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred cCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 89999876 59999999986544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=356.67 Aligned_cols=250 Identities=20% Similarity=0.324 Sum_probs=210.6
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.|++++.|+||+|.+..+|+.||+|+++.... ........+.+|+.++.++ +||||+++++++.+.. .+|+||||+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~~~lv~E~~ 78 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RLFFVIEYV 78 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh-cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC--EEEEEEeCC
Confidence 57888999999999999999999999985432 3345677888999999887 8999999999987654 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--ccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~~~ 171 (652)
.+|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.... .....
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCCEEEeeCCccccccCCCCcccc
Confidence 99999999988889999999999999999999999998 99999999999998 678999999999875422 22345
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCC--------CCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSEC--------RNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~--------~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
.+||+.|+|||++. ..|+.++|||||||++|+|++|..||... .....+++.+.... ..++...+..++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~ 233 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKAA 233 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCCCCCCHHHH
Confidence 78999999999774 56899999999999999999999999521 12233455555433 234566788999
Q ss_pred HHHHHhCC-CCCCCCC------HHHHhcCccccccCC
Q 006277 243 SFIEKCLV-PASQRLS------AKELLMDPFLQVNGT 272 (652)
Q Consensus 243 dlI~kcL~-~P~~RpS------a~elL~hpf~~~~~~ 272 (652)
+||.+||+ +|.+||+ +.+++.||||+...|
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 99999998 8999998 579999999986544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=360.65 Aligned_cols=252 Identities=18% Similarity=0.293 Sum_probs=211.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...+++++.|.||+|.++.+++.||+|++...... .......+.+|+.+++.++||||+++++++.+.. .+|+||||
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~--~~~lv~Ey 124 (371)
T cd05622 48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR--YLYMVMEY 124 (371)
T ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC--EEEEEEcC
Confidence 46788888899999999999999999998754332 2344567889999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---~ 169 (652)
|.||+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+.... .
T Consensus 125 ~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~-~~~~ikL~DfG~a~~~~~~~~~~~ 200 (371)
T cd05622 125 MPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRC 200 (371)
T ss_pred CCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEC-CCCCEEEEeCCceeEcCcCCcccc
Confidence 9999999998754 6899999999999999999999998 99999999999998 67899999999998764322 2
Q ss_pred ccccCCCCccCcccccc-----CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc--CCCChHHH
Q 006277 170 KSVIGTPEFMAPELYDE-----NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS--KVKDPEVK 242 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~-----~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~--~~~s~~~k 242 (652)
...+||+.|||||++.. .|+.++|||||||++|+|++|.+||.. .+....+..+........++ ...+.+++
T Consensus 201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 279 (371)
T cd05622 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEAK 279 (371)
T ss_pred cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcCCCCHHHH
Confidence 46789999999998743 388999999999999999999999987 56677788887654333333 35688999
Q ss_pred HHHHHhCCCCC---CCCCHHHHhcCccccccCC
Q 006277 243 SFIEKCLVPAS---QRLSAKELLMDPFLQVNGT 272 (652)
Q Consensus 243 dlI~kcL~~P~---~RpSa~elL~hpf~~~~~~ 272 (652)
+||.+||.+|. .|+++.++++||||+...+
T Consensus 280 ~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 280 NLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred HHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 99999998543 3789999999999986543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=357.15 Aligned_cols=245 Identities=23% Similarity=0.446 Sum_probs=220.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..|+.+..|.|-+|++...|++||||.|++. .+.+++++-++++||+||..|+||||+.+|++|+..+ .+.|||||.
T Consensus 59 etLGkGTYGKVk~A~e~~sgR~VAiKsIrKd-kIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd--KIvivMEYa 135 (668)
T KOG0611|consen 59 ETLGKGTYGKVKLAYEHKSGREVAIKSIRKD-KIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD--KIVIVMEYA 135 (668)
T ss_pred HHhcCCcccceeehhhccCCcEeehhhhhhh-hcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc--eEEEEEEec
Confidence 3577778899999999999999999999854 4567899999999999999999999999999997554 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-cccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKSV 172 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~~~~ 172 (652)
.+|+|.+|+.+.+.++|.+++.+++||++|+.|||.++ |+|||||.+|||++ .++++||+||||+..+.... ..++
T Consensus 136 S~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD-~N~NiKIADFGLSNly~~~kfLqTF 212 (668)
T KOG0611|consen 136 SGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLD-QNNNIKIADFGLSNLYADKKFLQTF 212 (668)
T ss_pred CCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeec-CCCCeeeeccchhhhhccccHHHHh
Confidence 99999999999999999999999999999999999999 99999999999999 56899999999999887765 5899
Q ss_pred cCCCCccCcccccc-CC-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 173 IGTPEFMAPELYDE-NY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 173 vGTp~YmAPEvl~~-~y-~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
||+|.|.+||++++ .| ++.+|-|||||++|.|+.|..||.+ .+...+.+.|..|..... ..+..+.-||+.||.
T Consensus 213 CGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrEP---~~PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 213 CGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYREP---ETPSDASGLIRWMLM 288 (668)
T ss_pred cCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccCC---CCCchHHHHHHHHHh
Confidence 99999999999876 45 5789999999999999999999988 677778888888864332 234578999999995
Q ss_pred -CCCCCCCHHHHhcCcccc
Q 006277 251 -PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 251 -~P~~RpSa~elL~hpf~~ 268 (652)
+|.+|.|+.++..|=|+.
T Consensus 289 VNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 289 VNPERRATIEDIASHWWVN 307 (668)
T ss_pred cCcccchhHHHHhhhheee
Confidence 999999999999998885
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.26 Aligned_cols=251 Identities=19% Similarity=0.316 Sum_probs=212.7
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.|+++..|.||+|.+..+|+.||+|+++.... ...+..+.+.+|+.++.++ +||||+++++++.+.. .+|+|||||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~ 78 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS--RLFLVIEYV 78 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC--EEEEEEeCC
Confidence 57888999999999999999999999985432 2345677889999999998 7999999999987654 799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--ccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~~~ 171 (652)
++|+|..++...+.+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+++.... .....
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEe-CCCCEEEeccccceeccCCCCceec
Confidence 99999999988889999999999999999999999998 99999999999998 678999999999875322 22356
Q ss_pred ccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCC------CCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 172 VIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSEC------RNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 172 ~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~------~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
.+||+.|+|||++ ...|+.++|||||||++|+|++|..||... .....+++.+... +..++...++.++++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~l 233 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASHV 233 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHHH
Confidence 7899999999977 457899999999999999999999999532 2234455555543 334566778999999
Q ss_pred HHHhCC-CCCCCCC------HHHHhcCccccccCCC
Q 006277 245 IEKCLV-PASQRLS------AKELLMDPFLQVNGTT 273 (652)
Q Consensus 245 I~kcL~-~P~~RpS------a~elL~hpf~~~~~~~ 273 (652)
|.+||. +|.+|++ ..+++.||||+...|.
T Consensus 234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 999998 8999997 5799999999876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=354.20 Aligned_cols=249 Identities=24% Similarity=0.313 Sum_probs=209.4
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHH-HHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEV-HLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei-~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.|++++.|.||+|.+..+|+.||+|++....... .....++.+|+ .+++.++||||+++++++.+.. .+|+|||||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~--~~~lv~e~~ 78 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE--KLYFVLDYV 78 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--EEEEEEcCC
Confidence 5788889999999999999999999997544322 23344555565 4678899999999999887654 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--ccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~~~ 171 (652)
.+|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... .....
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEccCCCCccCCCCCCcccc
Confidence 99999999988888999999999999999999999998 99999999999998 678999999999875322 22345
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
.+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.. .+..+++..+..+. ..++...+..+.++|.+||+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKP--LQLPGGKTVAACDLLVGLLH 232 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHcc
Confidence 68999999999874 5689999999999999999999999987 56667777776653 34455677899999999998
Q ss_pred -CCCCCCCH----HHHhcCccccccCC
Q 006277 251 -PASQRLSA----KELLMDPFLQVNGT 272 (652)
Q Consensus 251 -~P~~RpSa----~elL~hpf~~~~~~ 272 (652)
+|.+|+++ .++++||||....+
T Consensus 233 ~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 233 KDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred CCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 89999875 59999999976544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=354.72 Aligned_cols=274 Identities=21% Similarity=0.347 Sum_probs=235.3
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
.|+++..|.|.++..+.+|+.||+|++++ +++-.++.+..-+.|-++|+.++||.+..+..+|+... .+|+||||..
T Consensus 175 vLGkGTFGKVIL~rEKat~k~YAiKIlkK-eviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d--rlCFVMeyan 251 (516)
T KOG0690|consen 175 VLGKGTFGKVILCREKATGKLYAIKILKK-EVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD--RLCFVMEYAN 251 (516)
T ss_pred HhcCCccceEEEEeecccCceeehhhhhh-hheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc--eEEEEEEEcc
Confidence 35667779999999999999999999874 55556788888999999999999999999999997654 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--cccccc
Q 006277 95 SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKSV 172 (652)
Q Consensus 95 gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~~~~ 172 (652)
||+|+-++.+.+.|++..++.|-..|++||.|||+++ ||+||||.+|+|++ .+|+|||+|||+++.--. ...+++
T Consensus 252 GGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLD-kDGHIKitDFGLCKE~I~~g~t~kTF 328 (516)
T KOG0690|consen 252 GGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLD-KDGHIKITDFGLCKEEIKYGDTTKTF 328 (516)
T ss_pred CceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheec-cCCceEeeecccchhcccccceeccc
Confidence 9999999999999999999999999999999999999 99999999999999 789999999999985432 346789
Q ss_pred cCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-
Q 006277 173 IGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV- 250 (652)
Q Consensus 173 vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~- 250 (652)
||||.|+|||++. ..|+.++|||.+||+||||+||+.||+. .+...++..|..+. ..++...+++++.|+..+|.
T Consensus 329 CGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~ed--~kFPr~ls~eAktLLsGLL~k 405 (516)
T KOG0690|consen 329 CGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILMED--LKFPRTLSPEAKTLLSGLLKK 405 (516)
T ss_pred cCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhhh--ccCCccCCHHHHHHHHHHhhc
Confidence 9999999999995 5799999999999999999999999987 66777888777653 34677889999999999997
Q ss_pred CCCCCC-----CHHHHhcCccccccCCCCCCCCCCCCCcCCCCCcccccccc
Q 006277 251 PASQRL-----SAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLM 297 (652)
Q Consensus 251 ~P~~Rp-----Sa~elL~hpf~~~~~~~~~~~~~~p~~~lp~~~~~~~~~~~ 297 (652)
+|.+|+ .|+|+.+|+||...+|...-...+++++.|+...-.+...+
T Consensus 406 dP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryF 457 (516)
T KOG0690|consen 406 DPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYF 457 (516)
T ss_pred ChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhh
Confidence 899998 49999999999988775433233445566766555444443
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=355.24 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=208.1
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHH-HHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEV-HLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei-~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.|++++.|+||+|.+..+++.||+|++........ ....++..|. .+++.++||||+++++++.+.. .+|+||||+
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~--~~~lv~e~~ 78 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--KLYFVLDYI 78 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC--eEEEEEeCC
Confidence 57888899999999999999999999975443222 2333444444 4578899999999999987654 799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--ccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~~~ 171 (652)
.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..... .....
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEEccCCCCcccccCCCCccc
Confidence 99999999998888999999999999999999999998 99999999999998 678999999999875432 22456
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
.+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+ .+....+..+.... .......++.++++|.+||+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKP--LQLKPNITNSARHLLEGLLQ 232 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhCC--cCCCCCCCHHHHHHHHHHcc
Confidence 78999999999774 5689999999999999999999999987 55666666666543 23444578899999999998
Q ss_pred -CCCCCCCHH----HHhcCccccccCC
Q 006277 251 -PASQRLSAK----ELLMDPFLQVNGT 272 (652)
Q Consensus 251 -~P~~RpSa~----elL~hpf~~~~~~ 272 (652)
+|.+|+++. ++++|+||....|
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 899999866 8999999976544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=368.80 Aligned_cols=248 Identities=30% Similarity=0.505 Sum_probs=221.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
+.+|++..|.++++.++.++..|++|.|...... ........+|+.++++++|||||.++++|+..+ ..++|||+||
T Consensus 10 ~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t--~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l~Ivm~Y~ 86 (426)
T KOG0589|consen 10 RQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT--EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLLCIVMEYC 86 (426)
T ss_pred hhcCccccchhhhhhhccCCceEEEEEEeccccC--chhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceEEEEEeec
Confidence 4567777899999999999999999999987653 334447889999999999999999999998765 3599999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 94 TSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 94 ~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
.||+|.+.+++.+ .|+|+.+..|+.||+.|+.|||+++ |+|||||+.|||++ .++.|||+|||+|+.+... .+
T Consensus 87 eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Niflt-k~~~VkLgDfGlaK~l~~~~~~a 163 (426)
T KOG0589|consen 87 EGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLT-KDKKVKLGDFGLAKILNPEDSLA 163 (426)
T ss_pred CCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcc-ccCceeecchhhhhhcCCchhhh
Confidence 9999999988664 6899999999999999999999888 99999999999999 6678899999999999765 57
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
.+++|||.||.||++. ..|+.++||||||||+|||++-+++|.+ .+...+..+|..+. ..+++..++.+++.+|+.|
T Consensus 164 ~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~ 241 (426)
T KOG0589|consen 164 STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGL-YSPLPSMYSSELRSLVKSM 241 (426)
T ss_pred heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhcc-CCCCCccccHHHHHHHHHH
Confidence 8899999999999885 5899999999999999999999999988 67777777787776 3456777889999999999
Q ss_pred CC-CCCCCCCHHHHhcCccccc
Q 006277 249 LV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~~~ 269 (652)
|. +|..||+|.+||.+|.++.
T Consensus 242 l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 242 LRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred hhcCCccCCCHHHHhhChhhhh
Confidence 97 7999999999999998863
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=352.06 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=211.2
Q ss_pred EEEEEecCcEEEEEEEc---cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~---~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
..|++++.|.||++.+. .+|+.||+|++..... ......++.+|+++|++++||||+++++++.+.. .+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG--KLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--EEEEEE
Confidence 35788889999998874 5899999999975432 1234567788999999999999999999987654 899999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--c
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--N 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~ 168 (652)
|||.+|+|.+++.+...+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...... .
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEEC-CCCcEEEeeccCCcccCCCCCc
Confidence 99999999999988888999999999999999999999998 99999999999998 6789999999998865433 2
Q ss_pred cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~k 247 (652)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||.. ......+..+..+.. .++...++.+++||.+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~ 231 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAKL--GMPQFLSPEAQSLLRA 231 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence 34578999999999874 5688999999999999999999999987 455666666655432 3455678999999999
Q ss_pred hCC-CCCCCCC-----HHHHhcCccccccCC
Q 006277 248 CLV-PASQRLS-----AKELLMDPFLQVNGT 272 (652)
Q Consensus 248 cL~-~P~~RpS-----a~elL~hpf~~~~~~ 272 (652)
||+ +|.+||+ +.+++.||||+...+
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 997 8999999 788999999986543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=356.24 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=209.3
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC---CCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL---KHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L---~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
|++++.|+||+|.++.+|+.||+|++...... ......+...|..++..+ +||||++++++|.+.. .+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~--~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS--DLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC--eEEEEEcC
Confidence 46778899999999999999999999754432 223455666777777766 6999999999987654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--cccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~~ 170 (652)
+.+|+|..++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCCCCCcc
Confidence 999999999998889999999999999999999999998 99999999999998 678999999999875432 2235
Q ss_pred cccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 171 SVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
..+||+.|||||++.+ .|+.++|||||||++|+|++|..||.. .+..++++.+..+..... ....++++++||.+|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~-~~~~~~~~~~li~~~ 232 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRFP-KNVLSDEGRQFVKGL 232 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCCC-CccCCHHHHHHHHHH
Confidence 6789999999998743 489999999999999999999999987 566777777776643221 234678999999999
Q ss_pred CC-CCCCCC----CHHHHhcCccccccCC
Q 006277 249 LV-PASQRL----SAKELLMDPFLQVNGT 272 (652)
Q Consensus 249 L~-~P~~Rp----Sa~elL~hpf~~~~~~ 272 (652)
|. +|.+|| ++.++++||||....+
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~~~~~~~~ 261 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHPFFADIDW 261 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence 97 899998 7999999999986543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=349.75 Aligned_cols=252 Identities=20% Similarity=0.308 Sum_probs=213.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...|+++..|+||+|.++.+|+.||+|++...... .....+.+..|+.+++.+. |++|+++++++.+.. .+|+|||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~lv~E 81 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD--RLYFVME 81 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC--EEEEEEc
Confidence 35688888899999999999999999998754322 2345677888999999885 577888999887654 7999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
|++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...... ..
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeccccccccCCCCccc
Confidence 9999999999998889999999999999999999999998 99999999999998 6789999999998764322 23
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
...+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+ .....+++.+..+.. .++...+.++++||.+|
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~ 235 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSICKGL 235 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHH
Confidence 4567999999999774 5689999999999999999999999987 556667777766532 34556788999999999
Q ss_pred CC-CCCCCCC-----HHHHhcCccccccCCC
Q 006277 249 LV-PASQRLS-----AKELLMDPFLQVNGTT 273 (652)
Q Consensus 249 L~-~P~~RpS-----a~elL~hpf~~~~~~~ 273 (652)
|. +|.+|++ ..++++||||+...+.
T Consensus 236 l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~ 266 (323)
T cd05615 236 MTKHPSKRLGCGPEGERDIREHAFFRRIDWD 266 (323)
T ss_pred cccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence 97 8999997 5899999999876553
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=342.84 Aligned_cols=254 Identities=21% Similarity=0.325 Sum_probs=209.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
+..++++..|+||+|.+..+|..||+|++..... ........+.+|+.+++.++||||+++++++.+.. .+++||||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 81 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD--ALCLVLTL 81 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh-hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--eEEEEEec
Confidence 4678888889999999999999999999875433 22334566788999999999999999999886654 79999999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-c
Q 006277 93 FTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~ 169 (652)
+.+|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++ +++.++|+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETI 158 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEEC-CCCCEEEeeCCCceecCCCCcc
Confidence 9999999887654 46999999999999999999999998 99999999999998 66899999999988764332 2
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHH---HHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSA---QIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~---~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
...+||+.|+|||++. ..++.++||||+||++|+|++|..||.+..... .+...+..+ +...+...++.+++||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 236 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--QEEYSEKFSEAARSIC 236 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--ccccCcccCHHHHHHH
Confidence 4568999999999774 568999999999999999999999998643221 222333322 2334455788999999
Q ss_pred HHhCC-CCCCCC-----CHHHHhcCccccccCCCC
Q 006277 246 EKCLV-PASQRL-----SAKELLMDPFLQVNGTTK 274 (652)
Q Consensus 246 ~kcL~-~P~~Rp-----Sa~elL~hpf~~~~~~~~ 274 (652)
.+||. +|.+|| +++++++||||....+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~ 271 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence 99997 899999 999999999998755543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=350.45 Aligned_cols=248 Identities=26% Similarity=0.452 Sum_probs=206.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+++++..|.||+|.+..+|..||+|.+.... .....+++.+|+++++.++||||++++++|.+.. .+|+||||
T Consensus 10 ~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 84 (333)
T cd06650 10 ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISICMEH 84 (333)
T ss_pred eccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC--EEEEEEec
Confidence 356777888999999999999999999887542 2456678999999999999999999999998754 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 171 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~ 171 (652)
+.+|+|.+++...+.+++..+..++.||+.||.|||+. + |+||||||+|||++ .+|.+||+|||++..+.......
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~ 161 (333)
T cd06650 85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANS 161 (333)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEc-CCCCEEEeeCCcchhhhhhcccc
Confidence 99999999999888999999999999999999999974 5 99999999999998 67899999999998765544556
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHH----------------------------
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK---------------------------- 222 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~---------------------------- 222 (652)
..||+.|+|||++. ..++.++|||||||++|+|++|..||.... ..++..
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (333)
T cd06650 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD-AKELELMFGCPVEGDPAESETSPRPRPPGRPLSS 240 (333)
T ss_pred CCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc-hhHHHHHhcCcccCCccccccCcccCCccchhhh
Confidence 78999999999875 468899999999999999999999996522 222211
Q ss_pred ----------------HHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 223 ----------------KVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 223 ----------------~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.+.....+.......+.++++||.+||+ +|.+|||+.|++.||||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 241 YGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred hcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 1111111111122357889999999998 8999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=368.16 Aligned_cols=245 Identities=27% Similarity=0.328 Sum_probs=198.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC------CCCeEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD------QNKTVN 87 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~------~~~~~~ 87 (652)
..|++++.|.||+|.+..+|+.||+|++.... ....+|+.+|+.++|||||+++++|... ...+++
T Consensus 72 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 56777888999999999999999999886321 2235699999999999999999987542 223578
Q ss_pred EEEecCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 88 IITELFTSGSLRQYRK----KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~----~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
+||||+.+ +|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++..++.+||+|||+++.
T Consensus 144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 99999975 6766654 3467999999999999999999999998 999999999999986666899999999987
Q ss_pred hhcc-ccccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC----------
Q 006277 164 MEQA-NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP---------- 230 (652)
Q Consensus 164 l~~~-~~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p---------- 230 (652)
+... .....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.....++.+.+.....|
T Consensus 221 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 300 (440)
T PTZ00036 221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300 (440)
T ss_pred ccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhch
Confidence 6543 234568999999999764 369999999999999999999999998865555554443211000
Q ss_pred ----------------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 231 ----------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 231 ----------------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
..++...++++++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 301 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred hhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 01223356799999999998 8999999999999999974
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=349.28 Aligned_cols=253 Identities=17% Similarity=0.289 Sum_probs=209.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+|+++..|+||+|.++.+|+.||+|++...+.. .....+.+.+|+.+++.++||||++++++|.+.. .+|+||||
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv~e~ 82 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDEN--NLYLVMDY 82 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC--eEEEEEec
Confidence 46788889999999999999999999999754332 2345677889999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
+.||+|.+++.+ ...+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..+....
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEEC-CCCCEEEEECCceeecCCCCCcc
Confidence 999999999976 467999999999999999999999998 99999999999998 67899999999987654332
Q ss_pred cccccCCCCccCccccc------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccc---cCCCCh
Q 006277 169 AKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL---SKVKDP 239 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l---~~~~s~ 239 (652)
....+||+.|||||++. +.++.++|||||||++|+|++|..||.+ ....+.+..+........+ ....++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 12357999999999874 3578899999999999999999999987 4556666666553321111 233678
Q ss_pred HHHHHHHHhCCCC---CCCCCHHHHhcCccccccCC
Q 006277 240 EVKSFIEKCLVPA---SQRLSAKELLMDPFLQVNGT 272 (652)
Q Consensus 240 ~~kdlI~kcL~~P---~~RpSa~elL~hpf~~~~~~ 272 (652)
.+++||.+||..| ..|+++.+++.||||....+
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 9999999999633 34889999999999976544
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=337.07 Aligned_cols=257 Identities=23% Similarity=0.404 Sum_probs=226.9
Q ss_pred CcceeeeeeEEE-EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 006277 4 QKWSLLILMYLR-LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 82 (652)
Q Consensus 4 ~~W~~~~~~~~r-L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 82 (652)
..|+......+| |+++-.|.||+|+.++++-.||+|++-+..+. ..+...++.+|++|-..|+||||+++|++|.|..
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~-~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL-KTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH-HhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 567777665544 45555699999999999999999999876643 3355678999999999999999999999999876
Q ss_pred CCeEEEEEecCCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCc
Q 006277 83 NKTVNIITELFTSGSLRQYRK--KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160 (652)
Q Consensus 83 ~~~~~LVmEy~~gGsL~~~i~--~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGl 160 (652)
.+||++||.+.|+|...+. ...++++..++.|++|++.||.|||..+ ||||||||+|+|+. ..|.+||+|||-
T Consensus 96 --riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg-~~~~lkiAdfGw 170 (281)
T KOG0580|consen 96 --RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLG-SAGELKIADFGW 170 (281)
T ss_pred --eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccC-CCCCeeccCCCc
Confidence 7999999999999999998 6678999999999999999999999998 99999999999997 678999999999
Q ss_pred hhhhhccccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCCh
Q 006277 161 ATIMEQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 239 (652)
Q Consensus 161 a~~l~~~~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~ 239 (652)
+..-......+.|||..|.+||..+ ..++..+|+|++|++.||++.|.+||.. ......|++|.+-. ..++...+.
T Consensus 171 sV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes-~~~~etYkrI~k~~--~~~p~~is~ 247 (281)
T KOG0580|consen 171 SVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES-QSHSETYKRIRKVD--LKFPSTISG 247 (281)
T ss_pred eeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh-hhhHHHHHHHHHcc--ccCCcccCh
Confidence 9887767788999999999999775 5799999999999999999999999987 44888999998754 234477889
Q ss_pred HHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 240 EVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 240 ~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+++|+|.+||+ +|.+|++..|++.|||+..
T Consensus 248 ~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 248 GAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred hHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 99999999998 8999999999999999864
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=350.58 Aligned_cols=244 Identities=27% Similarity=0.452 Sum_probs=200.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+|+++..|+||+|.+..+|+.||+|++.... .......+.+|+.+++.++|+||++++++|.+.. .+|+|||||
T Consensus 80 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~ 154 (353)
T PLN00034 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG--EIQVLLEFM 154 (353)
T ss_pred hhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC--eEEEEEecC
Confidence 46788888999999999999999999986432 2455678999999999999999999999886544 799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--ccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~~ 171 (652)
.+|+|... ...++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+.... ...
T Consensus 155 ~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~ 227 (353)
T PLN00034 155 DGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDPCNS 227 (353)
T ss_pred CCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEcccccceecccccccccc
Confidence 99998653 34678889999999999999999998 99999999999998 67899999999998765432 345
Q ss_pred ccCCCCccCcccccc------CCCccccchhhHHHHHHHhhccCCCCCCC--CHHHHHHHHhcCCCCccccCCCChHHHH
Q 006277 172 VIGTPEFMAPELYDE------NYNELADIYSFGMCMLEMVTFEYPYSECR--NSAQIYKKVSSGIKPAALSKVKDPEVKS 243 (652)
Q Consensus 172 ~vGTp~YmAPEvl~~------~y~~~sDIWSlGvilyeLltG~~Pf~~~~--~~~~i~~~I~~g~~p~~l~~~~s~~~kd 243 (652)
.+||+.|+|||++.. .++.++|||||||++|+|++|..||.... ....+...+.... +.......+.++++
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 306 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-PPEAPATASREFRH 306 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-CCCCCCccCHHHHH
Confidence 689999999998732 23568999999999999999999997422 2222333333222 23344567889999
Q ss_pred HHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 244 FIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
||.+||. +|.+||++.|+|+||||...
T Consensus 307 li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 307 FISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccccC
Confidence 9999997 89999999999999999754
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=388.40 Aligned_cols=275 Identities=20% Similarity=0.292 Sum_probs=240.7
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..+|+++.|.|.++.++.|++.||+|.+.+-+++.. ..-.-|..|..+|..-+.+.||.++..|+|+. ++|+||||+
T Consensus 81 KvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr-~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~--~LYlVMdY~ 157 (1317)
T KOG0612|consen 81 KVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKR-AETACFREERDIMVFGNSEWIVQLHYAFQDER--YLYLVMDYM 157 (1317)
T ss_pred HHhcccccceeEEEEeeccccchhHHHhhHHHHhhc-hhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc--ceEEEEecc
Confidence 457888999999999999999999999987655532 34567899999999999999999999999876 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---cc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---AK 170 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---~~ 170 (652)
+||+|..++.+..+++++.+++|+..|+.||.-||+.| +|||||||+|||++ ..|+|||+|||.+..+...+ ..
T Consensus 158 pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld-~~GHikLADFGsClkm~~dG~V~s~ 234 (1317)
T KOG0612|consen 158 PGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLD-KSGHIKLADFGSCLKMDADGTVRSS 234 (1317)
T ss_pred cCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEec-ccCcEeeccchhHHhcCCCCcEEec
Confidence 99999999999999999999999999999999999999 99999999999999 78999999999988876432 35
Q ss_pred cccCCCCccCccccc------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc--CCCChHHH
Q 006277 171 SVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS--KVKDPEVK 242 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~--~~~s~~~k 242 (652)
..+|||-|++||++. +.|+..|||||+|||+|||+.|..||+. ......|.+|+.......+| ..+|++++
T Consensus 235 ~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~VSeeak 313 (1317)
T KOG0612|consen 235 VAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETDVSEEAK 313 (1317)
T ss_pred cccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccccCHHHH
Confidence 679999999999882 4699999999999999999999999988 77888999999876544555 44789999
Q ss_pred HHHHHhCCCCCCCCC---HHHHhcCccccccCCCCCCCCCCCCCcCCCCCcccccccc
Q 006277 243 SFIEKCLVPASQRLS---AKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLM 297 (652)
Q Consensus 243 dlI~kcL~~P~~RpS---a~elL~hpf~~~~~~~~~~~~~~p~~~lp~~~~~~~~~~~ 297 (652)
+||.++|.+|..|++ ++++..||||....|...+.. .++++|.+..-.+++.+
T Consensus 314 dLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~iR~~--~pP~vPevssd~DTsnF 369 (1317)
T KOG0612|consen 314 DLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDNIRES--VPPVVPEVSSDDDTSNF 369 (1317)
T ss_pred HHHHHHhcChhhhcccccHHHHHhCccccCCChhhhhhc--CCCCCCcCCCCCccccc
Confidence 999999999999998 999999999999999554443 45577888776666555
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=371.74 Aligned_cols=247 Identities=28% Similarity=0.446 Sum_probs=214.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
++.||.+..|.||+|..+.++..-|-|+|..+ +.+.++.+.-||.||..|+||+||++|+.|+-++ .+|++.||
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetk----seEELEDylVEIeILa~CdHP~ivkLl~ayy~en--kLwiliEF 110 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETK----SEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN--KLWILIEF 110 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhccc----chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC--ceEEEEee
Confidence 67888888899999999999999999998754 5788999999999999999999999999887665 69999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
|.||-....+-. ...+.+.++..+++|++.||.|||+++ |||||||..|||++ -+|.|+|+|||.+...... ..
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~T-ldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLT-LDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEE-ecCcEeeecccccccchhHHhhh
Confidence 999998887654 467999999999999999999999999 99999999999999 6799999999998766543 35
Q ss_pred ccccCCCCccCcccc------ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC-ccccCCCChHHH
Q 006277 170 KSVIGTPEFMAPELY------DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKVKDPEVK 242 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl------~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p-~~l~~~~s~~~k 242 (652)
.+++|||+|||||+. ...|+.++||||||+.+.||..+++|..+......+. +|.+..+| ...+..++..++
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll-KiaKSePPTLlqPS~Ws~~F~ 266 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-KIAKSEPPTLLQPSHWSRSFS 266 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH-HHhhcCCCcccCcchhhhHHH
Confidence 789999999999975 3579999999999999999999999998854444444 44444333 333566788999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 243 SFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
||+.+||+ +|..||++.+||+|||++.
T Consensus 267 DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 267 DFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred HHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 99999998 8999999999999999984
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=357.46 Aligned_cols=242 Identities=25% Similarity=0.406 Sum_probs=210.6
Q ss_pred cEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHH
Q 006277 22 TSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY 101 (652)
Q Consensus 22 gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~~~ 101 (652)
..|-+|.|.-||..||||+|.+.++ +.-....+.+|++.|+.++|||||++|++. |. ...+|||+|+-.+|+|++|
T Consensus 32 AVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEVi-DT-QTKlyLiLELGD~GDl~Dy 107 (864)
T KOG4717|consen 32 AVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-DT-QTKLYLILELGDGGDLFDY 107 (864)
T ss_pred ehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeehh-cc-cceEEEEEEecCCchHHHH
Confidence 4788999999999999999986554 233456899999999999999999999974 33 3489999999999999999
Q ss_pred HHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-cccccCCCCcc
Q 006277 102 RKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFM 179 (652)
Q Consensus 102 i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~~~~vGTp~Ym 179 (652)
|.++ ..+.|..++.|++||+.|+.|||+.. ||||||||+|+.+-...|-|||+|||++..+.++. ..+.||+..|-
T Consensus 108 ImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYS 185 (864)
T KOG4717|consen 108 IMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYS 185 (864)
T ss_pred HHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhcc
Confidence 9887 57999999999999999999999998 99999999999888788999999999999887664 58899999999
Q ss_pred Ccccc-ccCCC-ccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCC
Q 006277 180 APELY-DENYN-ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRL 256 (652)
Q Consensus 180 APEvl-~~~y~-~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~Rp 256 (652)
|||++ +..|+ +++||||||||+|.|+||++||... +..+..-.|+..+ ...+...+.++++||..||+ +|.+|.
T Consensus 186 APEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA-NDSETLTmImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRA 262 (864)
T KOG4717|consen 186 APEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA-NDSETLTMIMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRA 262 (864)
T ss_pred CchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc-cchhhhhhhhccc--ccCchhhhHHHHHHHHHHHhcCchhhc
Confidence 99976 55676 6799999999999999999999885 4455555666654 34567788999999999998 999999
Q ss_pred CHHHHhcCccccccCC
Q 006277 257 SAKELLMDPFLQVNGT 272 (652)
Q Consensus 257 Sa~elL~hpf~~~~~~ 272 (652)
+.+++..|+|++..+.
T Consensus 263 slEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 263 SLEEIVSTSWLQAGDR 278 (864)
T ss_pred cHHHHhccccccCCCC
Confidence 9999999999996543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=348.22 Aligned_cols=247 Identities=27% Similarity=0.375 Sum_probs=207.1
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC---eEEE
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK---TVNI 88 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~---~~~L 88 (652)
....++.+..|.||+|....++++||||++..+.... .+|+++|+.++|||||++..+|...... +.++
T Consensus 28 ~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 28 AVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred eeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 4456677777999999999999999999987544332 3599999999999999998888765544 5679
Q ss_pred EEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhh
Q 006277 89 ITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 164 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l 164 (652)
||||++- +|.++++. +..++.-.++-|+.||++||.|||++| |+||||||.|||+|.+.|.+||||||.|+.+
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 9999965 88888774 578999999999999999999999998 9999999999999988899999999999998
Q ss_pred hccc-cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc---------------
Q 006277 165 EQAN-AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--------------- 226 (652)
Q Consensus 165 ~~~~-~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~--------------- 226 (652)
.... ..+..-|.+|.|||++- ..|+.+.||||.|||+.||+-|.+-|.+.....|+...+.-
T Consensus 177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 6553 34566699999999763 47999999999999999999999999997777776544431
Q ss_pred -------CCCCcc----ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 227 -------GIKPAA----LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 227 -------g~~p~~----l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
...+.. +.+..++++.+|+.++|+ +|.+|.++.|+|.||||..
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 001112 345568999999999999 8999999999999999974
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=344.05 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=208.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCC--CCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQ--NKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~--~~~~~LVm 90 (652)
..||-++.|.|-.++++.||+.+|+|++. +.++.++|+++.-.. .|||||.+.++|...- ...+.+||
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~---------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLL---------DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHh---------cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 45677778999999999999999999865 235678899988777 7999999999986432 34678999
Q ss_pred ecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC--CCCcEEEeccCchhhhhc
Q 006277 91 ELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~--~~g~VKL~DFGla~~l~~ 166 (652)
|.++||+|+..++.++. |+|+++..|++||..|+.|||+.+ |.||||||+|+|+.+ .+..+||+|||+|+.-..
T Consensus 139 E~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred ecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 99999999999998875 999999999999999999999999 999999999999973 344699999999997663
Q ss_pred -cccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCC---HHHHHHHHhcCCC--CccccCCCCh
Q 006277 167 -ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRN---SAQIYKKVSSGIK--PAALSKVKDP 239 (652)
Q Consensus 167 -~~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~---~~~i~~~I~~g~~--p~~l~~~~s~ 239 (652)
....+.|-||+|.|||+++ ++|+..+|+||+||++|.|+||.+||+.... ......+|..|.. |..-+...|.
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe 296 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSE 296 (400)
T ss_pred CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHH
Confidence 3457888999999999995 5799999999999999999999999976432 2345667777763 3333445688
Q ss_pred HHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 240 EVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 240 ~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.++++|+++|. +|++|+|+.+++.|||+...
T Consensus 297 ~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 297 AAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred HHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 99999999997 89999999999999999644
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.56 Aligned_cols=242 Identities=22% Similarity=0.291 Sum_probs=206.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe--CCCCeEEEEEe
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID--DQNKTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d--~~~~~~~LVmE 91 (652)
..+++++.+.||+|.. +|+.||+|.++.... ......+.+.+|+.+|++++|||||++++++.+ .....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 4577888899999986 799999999875432 233446788999999999999999999999877 44457899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 170 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~ 170 (652)
||.+|+|.+++.+.+.+++.....++.|++.||.|||+. + ++||||||+|||++ +++.+||+|||++..+... ..
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~~-~~ 178 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVT-ENYKLKIICHGLEKILSSP-PF 178 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEEC-CCCcEEEcccchHhhhccc-cc
Confidence 999999999999888999999999999999999999985 6 88999999999998 6789999999999876543 23
Q ss_pred cccCCCCccCccccc---cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHH
Q 006277 171 SVIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~---~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~k 247 (652)
..+||+.|+|||++. ..|+.++|||||||++|||++|..||.+ .+..+++..+..+......+...++++++||.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 467899999999885 4789999999999999999999999987 456677777765444444555678899999999
Q ss_pred hCC-CCCCCCCHHHHhc
Q 006277 248 CLV-PASQRLSAKELLM 263 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~ 263 (652)
||+ +|.+|||+.++++
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 998 8999999999985
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=363.16 Aligned_cols=253 Identities=32% Similarity=0.490 Sum_probs=221.6
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
....||++..|+||-|.|..|....|||.|..++ ....+-+..||.+.++|+|.|||++.+++ ..++++-+.||
T Consensus 579 ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd----sr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFME 652 (1226)
T KOG4279|consen 579 ERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD----SREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFME 652 (1226)
T ss_pred ceEEeecCceeEEEeeccccceeEEEeeeccccc----chhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEee
Confidence 3457888888999999999999999999987443 46778899999999999999999999985 45669999999
Q ss_pred cCCCCCHHHHHHh-CCCC--CHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 92 LFTSGSLRQYRKK-HKKV--DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 92 y~~gGsL~~~i~~-~~~l--se~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
-++||+|..+++. .|++ .|.++..|.+||+.||.|||.+. |||||||-+|+|||.-.|.+||+|||-++.+...+
T Consensus 653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin 730 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN 730 (1226)
T ss_pred cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence 9999999998775 4788 89999999999999999999999 99999999999999778999999999999886543
Q ss_pred --cccccCCCCccCccccc---cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHH
Q 006277 169 --AKSVIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 243 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl~---~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kd 243 (652)
+.++.||..|||||++. ++|+.++|||||||.+.||.||++||.+..++...+-++---+.-+..+...+.+++.
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~ 810 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKN 810 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHH
Confidence 57899999999999985 3699999999999999999999999988777766655554444445567777899999
Q ss_pred HHHHhCC-CCCCCCCHHHHhcCccccccCC
Q 006277 244 FIEKCLV-PASQRLSAKELLMDPFLQVNGT 272 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~hpf~~~~~~ 272 (652)
||.+|.. +|..||+|.+||.+||++....
T Consensus 811 FilrcFepd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 811 FILRCFEPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred HHHHHcCCCcccCccHHHhccCcccccCCC
Confidence 9999998 7999999999999999986633
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=328.36 Aligned_cols=248 Identities=34% Similarity=0.538 Sum_probs=209.8
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQ-SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~-s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..++++..|.||+|.+..+|+.||+|.+....... .......+.+|+.++++++||||+++++++.+.. .+++||||
T Consensus 8 ~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~ 85 (263)
T cd06625 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE--TLSIFMEY 85 (263)
T ss_pred ceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC--eEEEEEEE
Confidence 46777778999999999999999999987543211 1234568899999999999999999999987655 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc---
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA--- 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~--- 169 (652)
+++++|.+++...+.+++..++.++.|++.||.|||+.| |+||||+|+||+++ .++.++|+|||++..+.....
T Consensus 86 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~~~~~~ 162 (263)
T cd06625 86 MPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGT 162 (263)
T ss_pred CCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceeccccccccc
Confidence 999999999998889999999999999999999999998 99999999999998 678999999999876543211
Q ss_pred --ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 170 --KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 170 --~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
....|++.|+|||++. ..++.++|||||||++|+|++|..||..........+ +........++...+..+++||.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~ 241 (263)
T cd06625 163 GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQPTNPQLPSHVSPDARNFLR 241 (263)
T ss_pred cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH-HhccCCCCCCCccCCHHHHHHHH
Confidence 3457889999999874 4588999999999999999999999977544444443 33333344566677899999999
Q ss_pred HhCC-CCCCCCCHHHHhcCccc
Q 006277 247 KCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~ 267 (652)
+||. +|.+|||+.++|+||||
T Consensus 242 ~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 242 RTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHhhcCcccCCCHHHHhhCCCC
Confidence 9998 89999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=364.36 Aligned_cols=280 Identities=21% Similarity=0.330 Sum_probs=248.0
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
-|+-++.|.|=++........+|+|++++..+.. ..+.+.+..|.+||..++.|.||++|..|.|.. ++|++||-|-
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k--yvYmLmEaCl 503 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK--YVYMLMEACL 503 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHHHHhHHHHHHhcCchHHHHHHHHhccch--hhhhhHHhhc
Confidence 3555666788887766655569999998777654 467889999999999999999999999998765 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-cccccc
Q 006277 95 SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKSVI 173 (652)
Q Consensus 95 gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~~~v 173 (652)
||+|+..++.++.|++..+++|+.-++.|++|||++| ||+|||||+|++++ +.|.+||.|||+|+.+... .+.++|
T Consensus 504 GGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd-~~Gy~KLVDFGFAKki~~g~KTwTFc 580 (732)
T KOG0614|consen 504 GGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLD-NRGYLKLVDFGFAKKIGSGRKTWTFC 580 (732)
T ss_pred CchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeec-cCCceEEeehhhHHHhccCCceeeec
Confidence 9999999999999999999999999999999999999 99999999999998 7899999999999999765 468999
Q ss_pred CCCCccCccc-cccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-C
Q 006277 174 GTPEFMAPEL-YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-P 251 (652)
Q Consensus 174 GTp~YmAPEv-l~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~ 251 (652)
|||.|+|||+ ++.+.+.++|.||||+++|||++|.+||++ .++...|..|.+|+....+|+.+...+.+||+++.. +
T Consensus 581 GTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~ 659 (732)
T KOG0614|consen 581 GTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDN 659 (732)
T ss_pred CCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcC
Confidence 9999999995 588899999999999999999999999998 788999999999999999999999999999999886 7
Q ss_pred CCCCCC-----HHHHhcCccccccCCCCCCCCCCCCCcCCCCCcccccccccCCC
Q 006277 252 ASQRLS-----AKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGP 301 (652)
Q Consensus 252 P~~RpS-----a~elL~hpf~~~~~~~~~~~~~~p~~~lp~~~~~~~~~~~~~~~ 301 (652)
|.+|+. +.++-+|.||...+|...+...++++++|.+....+.+.+...|
T Consensus 660 P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~p 714 (732)
T KOG0614|consen 660 PTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNFP 714 (732)
T ss_pred cHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCCC
Confidence 999985 89999999999988877666667777888777666555544433
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.41 Aligned_cols=255 Identities=16% Similarity=0.278 Sum_probs=210.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+|++++.|+||+|.++.+++.||+|++...... .......+.+|+.+++.++|+||+++++++.+.. .+|+||||
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~--~~~lv~Ey 82 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQDEN--YLYLVMDY 82 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--EEEEEEeC
Confidence 46789999999999999999999999998753322 2345567889999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
+.||+|.+++.+ ...+++..++.|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..+....
T Consensus 83 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 83 YVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEc-CCCCEEEEeccceeeccCCCcee
Confidence 999999999987 468999999999999999999999998 99999999999998 67899999999997664332
Q ss_pred cccccCCCCccCccccc------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc---CCCCh
Q 006277 169 AKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS---KVKDP 239 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~---~~~s~ 239 (652)
....+||+.|||||++. +.++.++|||||||++|+|++|..||.. .+....+..+........++ ...+.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 23467999999999875 3588999999999999999999999987 45566666666543222222 23578
Q ss_pred HHHHHHHHhCCCCCC---CCCHHHHhcCccccccCCCC
Q 006277 240 EVKSFIEKCLVPASQ---RLSAKELLMDPFLQVNGTTK 274 (652)
Q Consensus 240 ~~kdlI~kcL~~P~~---RpSa~elL~hpf~~~~~~~~ 274 (652)
++++||.+||..+.+ |++++++++||||+...|..
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~ 276 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence 999999999974323 57999999999998665543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.33 Aligned_cols=254 Identities=16% Similarity=0.276 Sum_probs=210.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.++.+++.||+|++...... .......+.+|+.++..++|+||+++++++.+.. .+|+||||
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv~ey 82 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDEN--NLYLVMDY 82 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC--EEEEEEec
Confidence 46788999999999999999999999998753322 2334556888999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
+.+|+|.+++.+ ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEeecchheecccCCcce
Confidence 999999999987 467999999999999999999999998 99999999999998 67899999999987653322
Q ss_pred cccccCCCCccCccccc------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc---CCCCh
Q 006277 169 AKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS---KVKDP 239 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~---~~~s~ 239 (652)
....+||+.|||||++. +.|+.++|||||||++|+|++|..||.. .+..+.+..+........++ ...++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCccccCCH
Confidence 23468999999999874 3588999999999999999999999987 45666677776544222222 34688
Q ss_pred HHHHHHHHhCCC-C--CCCCCHHHHhcCccccccCCC
Q 006277 240 EVKSFIEKCLVP-A--SQRLSAKELLMDPFLQVNGTT 273 (652)
Q Consensus 240 ~~kdlI~kcL~~-P--~~RpSa~elL~hpf~~~~~~~ 273 (652)
++++||.+||.. + ..|+++.++++||||+...+.
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~ 275 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD 275 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence 999999999963 3 347899999999999865543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=336.55 Aligned_cols=250 Identities=20% Similarity=0.294 Sum_probs=202.6
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 95 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~g 95 (652)
|++++.|+||+|.++.+|+.||+|.+...... .......+..|++++++++||||+++++++.+.. .+|+||||+.|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~--~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLK-KKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT--HLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhh-cchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC--eEEEEEecCCC
Confidence 45677899999999999999999998754332 1223445667999999999999999999887654 79999999999
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-cccc
Q 006277 96 GSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKSV 172 (652)
Q Consensus 96 GsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~~~~ 172 (652)
|+|.+++...+ .+++..+..++.||+.||+|||+.| |+||||||+|||++ .++.+||+|||++....... ....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEc-CCCCEEEeeceeeeecCCCceeecc
Confidence 99998876543 5899999999999999999999998 99999999999998 67899999999988765432 2346
Q ss_pred cCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCC---HHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 173 IGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRN---SAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 173 vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~---~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
.||+.|+|||++ ...++.++|||||||++|+|++|..||..... ..++...+.....+. .....++++++||.+|
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~ 233 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHH
Confidence 799999999977 45689999999999999999999999975332 233434433332221 1235688999999999
Q ss_pred CC-CCCCCCCH----HHHhcCccccccCC
Q 006277 249 LV-PASQRLSA----KELLMDPFLQVNGT 272 (652)
Q Consensus 249 L~-~P~~RpSa----~elL~hpf~~~~~~ 272 (652)
|+ +|.+||++ .+++.||||+...+
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 98 89999999 67889999986443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=346.54 Aligned_cols=248 Identities=29% Similarity=0.384 Sum_probs=198.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC----CeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN----KTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~----~~~~LV 89 (652)
..|++++.|.||+|.+..+|..||+|++.... .......++.+|+.+++.++||||++++++|..... ..+|+|
T Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 104 (359)
T cd07876 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104 (359)
T ss_pred EEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEE
Confidence 56777778999999999999999999986442 234566788899999999999999999998865432 358999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-c
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-N 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~ 168 (652)
|||+.+ +|.+++. ..+++..+..++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++...... .
T Consensus 105 ~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~ 178 (359)
T cd07876 105 MELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTACTNFM 178 (359)
T ss_pred EeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEecCCCccccccCcc
Confidence 999965 6666654 35899999999999999999999998 99999999999998 6789999999999765432 2
Q ss_pred cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc---------------------
Q 006277 169 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--------------------- 226 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~--------------------- 226 (652)
.....||+.|+|||++. ..|+.++|||||||++|+|++|..||.+..........+..
T Consensus 179 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (359)
T cd07876 179 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVE 258 (359)
T ss_pred CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHh
Confidence 34568999999999774 57999999999999999999999999875433222111110
Q ss_pred CC--CC----------------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 227 GI--KP----------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 227 g~--~p----------------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.. .+ .......++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 259 NRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred hCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 00 00 00112245789999999998 8999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=334.84 Aligned_cols=247 Identities=28% Similarity=0.382 Sum_probs=196.0
Q ss_pred EEEEEecCcEEEEEEEcc-CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC---CCCCeeeeeeEEEe---CCCCeE
Q 006277 14 LRLIQLVDTSGYKAFDEV-NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL---KHNNIIRFYNSWID---DQNKTV 86 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~-tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L---~HpnIVkl~~~~~d---~~~~~~ 86 (652)
..|+++..|.||+|.+.. +|..||+|.++..... ......+.+|+.+++.+ +||||+++++++.. .....+
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 84 (290)
T cd07862 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 84 (290)
T ss_pred eEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC--CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcE
Confidence 568888889999999865 5789999998754321 22334556677777766 69999999998753 223469
Q ss_pred EEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhh
Q 006277 87 NIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 164 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l 164 (652)
++||||+. ++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...
T Consensus 85 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 85 TLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIY 160 (290)
T ss_pred EEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEc-CCCCEEEccccceEec
Confidence 99999996 6899998764 45899999999999999999999998 99999999999998 6789999999999866
Q ss_pred hccc-cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC---Cc--------
Q 006277 165 EQAN-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK---PA-------- 231 (652)
Q Consensus 165 ~~~~-~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~---p~-------- 231 (652)
.... .....||+.|+|||++ ...|+.++|||||||++|+|++|.+||.+..... .+..+..... +.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 161 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred cCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhchhhhcc
Confidence 5432 3456899999999977 5578999999999999999999999998754433 3333332110 00
Q ss_pred --------------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 232 --------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 232 --------------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
.+....++.+++||.+||+ +|.+|||+.++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112356788999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=332.97 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=215.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...+++++.+.||+|.+..+++.||+|++...... .....+++.+|++++++++||||+++++++.+.. .+|+||||
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~ 82 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS--NLYLVMEY 82 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--eEEEEEec
Confidence 46778888899999999999999999998754332 2355778999999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
+.+++|.+++.+.+.+++..+..++.||+.||.|||++| |+||||+|.|||++ .+|.+||+|||++...... ....
T Consensus 83 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~-~~~~ 158 (290)
T cd05580 83 VPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGR-TYTL 158 (290)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEeeCCCccccCCC-CCCC
Confidence 999999999998899999999999999999999999998 99999999999998 5689999999999876544 4456
Q ss_pred cCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-
Q 006277 173 IGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV- 250 (652)
Q Consensus 173 vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~- 250 (652)
.|++.|+|||.+ ...++.++||||||+++|+|++|..||.. ......++.+..+.. .++...++.++++|.+||.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~ 235 (290)
T cd05580 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD-DNPIQIYEKILEGKV--RFPSFFSPDAKDLIRNLLQV 235 (290)
T ss_pred CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCc--cCCccCCHHHHHHHHHHccC
Confidence 799999999976 45688899999999999999999999977 345566666665542 3445568999999999997
Q ss_pred CCCCCC-----CHHHHhcCccccccCCC
Q 006277 251 PASQRL-----SAKELLMDPFLQVNGTT 273 (652)
Q Consensus 251 ~P~~Rp-----Sa~elL~hpf~~~~~~~ 273 (652)
+|.+|+ ++++++.||||+...|.
T Consensus 236 ~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 236 DLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred CHHHccCcccCCHHHHHcCcccccCCHH
Confidence 899999 99999999999865543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=339.60 Aligned_cols=245 Identities=25% Similarity=0.362 Sum_probs=192.6
Q ss_pred EEEEEecCcEEEEEEEc--cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 14 LRLIQLVDTSGYKAFDE--VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~--~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.+|++++.|+||+|.++ .+++.||+|++..... ...+.+|+.+|++++||||++++++|.+.....+|+|||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 47888999999999976 4789999998864322 245678999999999999999999998776678999999
Q ss_pred cCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEc---CCCCcEEEeccC
Q 006277 92 LFTSGSLRQYRKKH---------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN---GNQGEVKIGDLG 159 (652)
Q Consensus 92 y~~gGsL~~~i~~~---------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~---~~~g~VKL~DFG 159 (652)
|+. ++|.+++... ..+++..++.+++||+.||.|||++| |+||||||+|||++ ...+.+||+|||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 985 5888887532 25899999999999999999999998 99999999999994 245789999999
Q ss_pred chhhhhcc-----ccccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCH---------HHHHHH
Q 006277 160 LATIMEQA-----NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNS---------AQIYKK 223 (652)
Q Consensus 160 la~~l~~~-----~~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~---------~~i~~~ 223 (652)
++..+... .....+||+.|+|||++. ..|+.++||||+||++|+|++|.+||...... .++...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 99876432 124568999999999774 35899999999999999999999999643211 111111
Q ss_pred HhcCCCC-----------------------------------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 224 VSSGIKP-----------------------------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 224 I~~g~~p-----------------------------------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
+.....+ .......+..+.+||.+||. ||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1000000 00001235678999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.07 Aligned_cols=250 Identities=27% Similarity=0.386 Sum_probs=207.2
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC-eeeeeeEEEeCC----CCeEEEE
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN-IIRFYNSWIDDQ----NKTVNII 89 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hpn-IVkl~~~~~d~~----~~~~~LV 89 (652)
+++++..++||+|.++.+|+.||+|+++..... +..-....+|+.+|+.|+|+| ||.+++++.... .+.+++|
T Consensus 18 klGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 18 KLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 467777799999999999999999999976431 112345688999999999999 999999987654 2479999
Q ss_pred EecCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh
Q 006277 90 TELFTSGSLRQYRKKHK----KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~----~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~ 165 (652)
+||+. -+|..|+...+ .++...++.+++||+.||+|||+++ |+||||||+||||+ +.|.+||+|||+|+.+.
T Consensus 96 fe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~-~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 96 FEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLIS-SSGVLKLADFGLARAFS 171 (323)
T ss_pred EEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEEC-CCCcEeeeccchHHHhc
Confidence 99995 49999998765 5888999999999999999999999 99999999999999 58999999999999876
Q ss_pred cc-c-cccccCCCCccCcccc-c-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC--cc-------
Q 006277 166 QA-N-AKSVIGTPEFMAPELY-D-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AA------- 232 (652)
Q Consensus 166 ~~-~-~~~~vGTp~YmAPEvl-~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p--~~------- 232 (652)
-. . ....++|.+|.|||++ + ..|+..+||||+|||++||+++.+-|.+..+.+++......-..| ..
T Consensus 172 ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~ 251 (323)
T KOG0594|consen 172 IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSL 251 (323)
T ss_pred CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccc
Confidence 33 2 4667899999999976 3 369999999999999999999999999977777766554421100 00
Q ss_pred ------cc------------CCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 233 ------LS------------KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 233 ------l~------------~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
++ +..++...+++.+||. +|.+|.||+.+|.||||+..
T Consensus 252 ~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 252 PDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 10 1123588999999998 89999999999999999754
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=327.17 Aligned_cols=251 Identities=33% Similarity=0.520 Sum_probs=211.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVL-QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~-~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..++++..|.||+|.+..+|..||+|++...... ......+.+.+|++++++++||||+++++++.+.....+++||||
T Consensus 8 ~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~ 87 (265)
T cd06652 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEH 87 (265)
T ss_pred eEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEe
Confidence 4677788899999999999999999998754322 223457889999999999999999999999877655689999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-----
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----- 167 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~----- 167 (652)
+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+|+||||+||+++ .++.+||+|||++..+...
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~ 164 (265)
T cd06652 88 MPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGT 164 (265)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-CCCCEEECcCcccccccccccccc
Confidence 999999999988888999999999999999999999998 99999999999998 6789999999998765421
Q ss_pred ccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 168 NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 168 ~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
......|+..|+|||++ ...++.++|||||||++|+|++|..||........+.+ +.........+...+..+.++|.
T Consensus 165 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~ 243 (265)
T cd06652 165 GMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQPTNPVLPPHVSDHCRDFLK 243 (265)
T ss_pred ccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH-HhcCCCCCCCchhhCHHHHHHHH
Confidence 23346789999999977 45688999999999999999999999987544444443 33332233345556788999999
Q ss_pred HhCCCCCCCCCHHHHhcCcccc
Q 006277 247 KCLVPASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 247 kcL~~P~~RpSa~elL~hpf~~ 268 (652)
+||.+|.+||+++++++|||+.
T Consensus 244 ~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 244 RIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHhcChhhCCCHHHHhcCcccC
Confidence 9999999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=335.38 Aligned_cols=254 Identities=20% Similarity=0.318 Sum_probs=207.5
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.+..+++++.|+||+|.+..+|+.||+|.+..... ........+.+|+.+++.++|+||+++++.+.+.. .+|+|||
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~e 80 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD--ALCLVLT 80 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhc-cchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--EEEEEEE
Confidence 35678888889999999999999999999875433 22344566788999999999999999999887654 8999999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 92 LFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 92 y~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
|+.||+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeccceeecCCCcc
Confidence 99999999988654 35899999999999999999999998 99999999999998 56789999999987654322
Q ss_pred cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHH--HHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSA--QIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~--~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||....... .....+.... +...+...++++++||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-QEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-hhhcCccCCHHHHHHH
Confidence 24568999999999874 568999999999999999999999997633221 1122222211 2234456788999999
Q ss_pred HHhCC-CCCCCCC-----HHHHhcCccccccCC
Q 006277 246 EKCLV-PASQRLS-----AKELLMDPFLQVNGT 272 (652)
Q Consensus 246 ~kcL~-~P~~RpS-----a~elL~hpf~~~~~~ 272 (652)
.+||+ +|.+||| +.|+++||||+...+
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 99998 8999999 999999999975433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=360.31 Aligned_cols=246 Identities=26% Similarity=0.398 Sum_probs=208.6
Q ss_pred EEEEEEecCcEEEEEEEccC-CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVN-GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~t-G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...+++++.|.||+|.+..+ +..||+|.+... .......+.+|+.+|+.++|||||+++++|.... .+|+|||
T Consensus 72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~--~~~lv~E 145 (478)
T PTZ00267 72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDD--KLLLIME 145 (478)
T ss_pred EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC--EEEEEEE
Confidence 34667777799999999888 888999976533 3455677889999999999999999999987654 8999999
Q ss_pred cCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 92 LFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 92 y~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
|+.||+|.+++.. ..++++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEEC-CCCcEEEEeCcCceecCCc
Confidence 9999999987653 457999999999999999999999998 99999999999998 6789999999999876543
Q ss_pred c----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 168 N----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 168 ~----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
. ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .....++..+..+..+ ..+...+++++
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~-~~~~~~s~~~~ 300 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYD-PFPCPVSSGMK 300 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC-CCCccCCHHHH
Confidence 2 34568999999999874 5699999999999999999999999977 4556666666665433 23455678999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 243 SFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+||.+||. +|.+||++.++|.|||++.
T Consensus 301 ~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 301 ALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99999998 8999999999999999863
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=353.72 Aligned_cols=240 Identities=26% Similarity=0.357 Sum_probs=193.7
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+|++++.|.||+|.+..+++.||+|... ...+.+|+++|++|+|||||+++++|.... ..++|||++
T Consensus 98 ~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~lv~e~~ 165 (391)
T PHA03212 98 ETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTYNK--FTCLILPRY 165 (391)
T ss_pred EEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECC--eeEEEEecC
Confidence 56777778999999999999999999643 234678999999999999999999987654 799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc---ccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA---NAK 170 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~---~~~ 170 (652)
. ++|..++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++...... ...
T Consensus 166 ~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 166 K-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred C-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEc-CCCCEEEEeCCcccccccccccccc
Confidence 4 789999988888999999999999999999999998 99999999999998 6689999999999754322 234
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCC-------HHHHHHHHhc-CCCC-----------
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRN-------SAQIYKKVSS-GIKP----------- 230 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~-------~~~i~~~I~~-g~~p----------- 230 (652)
..+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+... ..++...+.. |..|
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 568999999999874 5799999999999999999999988754221 1111111110 1000
Q ss_pred ---------------cc---cc--CCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 231 ---------------AA---LS--KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 231 ---------------~~---l~--~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.. +. ...+.++++||.+||. +|.+||||.|+|+||||+.
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 00 00 1134578999999998 8999999999999999974
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=332.08 Aligned_cols=249 Identities=29% Similarity=0.378 Sum_probs=196.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC---CCCCeeeeeeEEEeC---CCCeE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL---KHNNIIRFYNSWIDD---QNKTV 86 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L---~HpnIVkl~~~~~d~---~~~~~ 86 (652)
...+++++.|+||+|.++.+|+.||+|.++..... ......+.+|+.+++.+ +||||+++++++.+. ....+
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~ 82 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE--DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC--CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence 36788888999999999999999999998754321 11223455677777665 799999999988653 23468
Q ss_pred EEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhh
Q 006277 87 NIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 164 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l 164 (652)
++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...
T Consensus 83 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 83 TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGLARIY 158 (288)
T ss_pred EEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccCccccc
Confidence 999999974 898888764 35899999999999999999999998 99999999999998 6789999999999876
Q ss_pred hccc-cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CC-C----C------
Q 006277 165 EQAN-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GI-K----P------ 230 (652)
Q Consensus 165 ~~~~-~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~-~----p------ 230 (652)
.... .....||+.|+|||++ ...++.++|||||||++|+|++|.+||.+......+.+.+.. +. . +
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238 (288)
T ss_pred cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence 5432 3456889999999977 457899999999999999999999999774443332222210 00 0 0
Q ss_pred ------------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 231 ------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 231 ------------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
..+....+..+++||.+||. +|.+|||+.|+|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01112356788999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=326.98 Aligned_cols=244 Identities=28% Similarity=0.472 Sum_probs=204.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..+++++.|.||+|.+..+++.||+|+++... ......+.+|+.+++.++||||+++++++.+.. .+|+||||+
T Consensus 15 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~--~~~lv~e~~ 88 (267)
T cd06645 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD--KLWICMEFC 88 (267)
T ss_pred HHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--EEEEEEecc
Confidence 35678888999999999999999999987543 244567889999999999999999999987654 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--ccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~~ 171 (652)
++++|.+++...+.+++..++.++.||+.||.|||++| ++||||||+||+++ ..+.+||+|||++..+.... ...
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKS 165 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECcceeeeEccCccccccc
Confidence 99999999998889999999999999999999999998 99999999999998 66899999999987654322 244
Q ss_pred ccCCCCccCcccc----ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc--CCCChHHHHHH
Q 006277 172 VIGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS--KVKDPEVKSFI 245 (652)
Q Consensus 172 ~vGTp~YmAPEvl----~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~--~~~s~~~kdlI 245 (652)
..|++.|+|||++ ...++.++|||||||++|+|++|..||........+.........+..+. ...+..+++||
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFV 245 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHH
Confidence 6799999999976 34588999999999999999999999976544444443333333332222 13567899999
Q ss_pred HHhCC-CCCCCCCHHHHhcCcc
Q 006277 246 EKCLV-PASQRLSAKELLMDPF 266 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~hpf 266 (652)
.+||. +|.+||++.++++|||
T Consensus 246 ~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 246 KMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHccCCchhCcCHHHHhcCCC
Confidence 99997 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=325.74 Aligned_cols=251 Identities=33% Similarity=0.523 Sum_probs=209.8
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVL-QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~-~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..++++..|.||+|.+..+|..||+|.+...... ...+....+.+|+.++++++||||+++++++.+.....++++|||
T Consensus 8 ~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~ 87 (266)
T cd06651 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEY 87 (266)
T ss_pred ceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeC
Confidence 4677778899999999999999999998754321 123456789999999999999999999999877655689999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-----
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----- 167 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~----- 167 (652)
+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..+...
T Consensus 88 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~ 164 (266)
T cd06651 88 MPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGT 164 (266)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCCCccccccccccCC
Confidence 999999999988888999999999999999999999998 99999999999998 6679999999998765431
Q ss_pred ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 168 NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 168 ~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
......|+..|+|||.+. ..++.++|||||||++|+|++|..||........+....... ....++...++.+++||.
T Consensus 165 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~ 243 (266)
T cd06651 165 GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-TNPQLPSHISEHARDFLG 243 (266)
T ss_pred ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC-CCCCCchhcCHHHHHHHH
Confidence 123456899999999774 468899999999999999999999998755555555443333 334455667889999996
Q ss_pred HhCCCCCCCCCHHHHhcCcccc
Q 006277 247 KCLVPASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 247 kcL~~P~~RpSa~elL~hpf~~ 268 (652)
.|+.+|.+||+++|++.||||+
T Consensus 244 ~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 244 CIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HhcCChhhCcCHHHHhcCcccc
Confidence 5556999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=330.43 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=203.3
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHH---HHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSE---VHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~E---i~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
++++..|.||+|.+..+|+.||+|++........ ........| +++++...||||+++++++.+.. .+|+||||
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~e~ 78 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KLSFILDL 78 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC--EEEEEEec
Confidence 5677889999999999999999999976543211 222223333 44555668999999999887654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
+.||+|..++...+.+++..++.|+.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++..+........
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~~ 155 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHAS 155 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEEC-CCCCEEEccCcCccccCccCCcCc
Confidence 999999999988889999999999999999999999998 99999999999998 568999999999987655455567
Q ss_pred cCCCCccCccccc-c-CCCccccchhhHHHHHHHhhccCCCCCCC--CHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 173 IGTPEFMAPELYD-E-NYNELADIYSFGMCMLEMVTFEYPYSECR--NSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 173 vGTp~YmAPEvl~-~-~y~~~sDIWSlGvilyeLltG~~Pf~~~~--~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
+|++.|+|||++. + .++.++||||+||++|+|++|..||.... ........+.. .+..++...++.+.++|.+|
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~~ 233 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLLEGL 233 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCCCcCCHHHHHHHHHH
Confidence 8999999999875 3 58999999999999999999999997642 22223222222 23345556689999999999
Q ss_pred CC-CCCCCC-----CHHHHhcCccccccCCC
Q 006277 249 LV-PASQRL-----SAKELLMDPFLQVNGTT 273 (652)
Q Consensus 249 L~-~P~~Rp-----Sa~elL~hpf~~~~~~~ 273 (652)
|. +|.+|| ++.++++||||+...+.
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 97 799999 99999999999865543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=343.67 Aligned_cols=248 Identities=29% Similarity=0.374 Sum_probs=198.5
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC----CCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ----NKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~----~~~~~LV 89 (652)
..+++++.|.||+|.+..+|+.||+|.+.... .......++.+|+.+++.++||||++++++|.... ...+|+|
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 100 (355)
T cd07874 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 100 (355)
T ss_pred EEeeecCCEEEEEEEecCCCceEEEEEeCCcc--cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEE
Confidence 56788888999999999999999999986432 23456678889999999999999999999886432 2358999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
|||+.+ +|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++......
T Consensus 101 ~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~ 174 (355)
T cd07874 101 MELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFM 174 (355)
T ss_pred hhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEC-CCCCEEEeeCcccccCCCccc
Confidence 999965 67776653 5899999999999999999999998 99999999999998 67899999999998765432
Q ss_pred cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC--------------------
Q 006277 169 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG-------------------- 227 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g-------------------- 227 (652)
.....||+.|+|||++. ..|+.++|||||||++|+|++|..||.+..........+..-
T Consensus 175 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (355)
T cd07874 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254 (355)
T ss_pred cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHh
Confidence 34568999999999774 568999999999999999999999998743322222111100
Q ss_pred --CC------C-----------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 228 --IK------P-----------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 228 --~~------p-----------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.. + .......+.++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred cCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 00 0 00112235678999999998 8999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=326.96 Aligned_cols=248 Identities=33% Similarity=0.542 Sum_probs=205.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.+..+|+.||+|++..... .........+|+.++++++||||+++++++.+.. .+++||||
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~~v~~~ 79 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQDDN--YLYIVMEY 79 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS--EEEEEEEE
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhccccccccccccccccccccc--cccccccc
Confidence 4688999999999999999999999999986543 1223334456999999999999999999998754 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhh--hccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--EQANAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l--~~~~~~ 170 (652)
+.+++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.++|+|||++... ......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTSEBS
T ss_pred ccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-cccccccccccccccccccccccc
Confidence 999999999998889999999999999999999999998 99999999999999 7789999999999753 223345
Q ss_pred cccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCC--CHHHHHHHHhcCCCCccccC--CCChHHHHH
Q 006277 171 SVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECR--NSAQIYKKVSSGIKPAALSK--VKDPEVKSF 244 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~--~~~~i~~~I~~g~~p~~l~~--~~s~~~kdl 244 (652)
...||+.|+|||++. ..++.++||||||+++|+|++|..||.... ..............+..... ...+.++++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL 236 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence 678999999999876 578999999999999999999999998752 22223333322211111111 113799999
Q ss_pred HHHhCC-CCCCCCCHHHHhcCccc
Q 006277 245 IEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
|.+||. +|.+||++.++++||||
T Consensus 237 i~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 237 IKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHccCChhHCcCHHHHhcCCCC
Confidence 999997 89999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=325.48 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=213.2
Q ss_pred EEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCC
Q 006277 17 IQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSG 96 (652)
Q Consensus 17 ~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~gG 96 (652)
+.+..|+||+|.+..+|+.||+|++..... ......+.+.+|+++++.++||||+++++++.+.. .+++||||+.++
T Consensus 2 g~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~ 78 (262)
T cd05572 2 GVGGFGRVELVKVKSKNRTFALKCVKKRHI-VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK--YIYMLMEYCLGG 78 (262)
T ss_pred CCCCceEEEEEEECCCCcEEEEEEEehhcc-hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC--ccEEEEecCCCC
Confidence 456678999999999999999999975443 23355678999999999999999999999887654 799999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-cccccCC
Q 006277 97 SLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKSVIGT 175 (652)
Q Consensus 97 sL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~~~~vGT 175 (652)
+|.+++.+...+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++....... .....|+
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEc-CCCCEEEeeCCcccccCcccccccccCC
Confidence 99999988888999999999999999999999998 99999999999998 57899999999998775442 3446789
Q ss_pred CCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCC-CHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CC
Q 006277 176 PEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECR-NSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PA 252 (652)
Q Consensus 176 p~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~-~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P 252 (652)
+.|+|||.+ ...++.++|+||||+++|+|++|..||.... +....+..+..+......+...++++++||.+||. +|
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 235 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP 235 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 999999976 4568999999999999999999999997643 25666677765544445555568899999999997 89
Q ss_pred CCCCC-----HHHHhcCccccccC
Q 006277 253 SQRLS-----AKELLMDPFLQVNG 271 (652)
Q Consensus 253 ~~RpS-----a~elL~hpf~~~~~ 271 (652)
.+||+ ++|+++||||....
T Consensus 236 ~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 236 EERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred hhCcCCcccCHHHHhcChhhhCCC
Confidence 99999 99999999998543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=331.04 Aligned_cols=249 Identities=23% Similarity=0.311 Sum_probs=200.6
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHH---HHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH---LLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~---iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
++++..|.||+|.+..+|+.||+|.+........ .......+|.. ++...+||||+.+++++...+ .+++||||
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~ 78 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD--KLCFILDL 78 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC--eEEEEEec
Confidence 5678889999999999999999999875543222 22233344443 344458999999999887654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
+.+|+|.+++..++.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...........
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~ 155 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHAS 155 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEEC-CCCCEEEccCCcceeccccCccCc
Confidence 999999999998889999999999999999999999998 99999999999998 668999999999876654444556
Q ss_pred cCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCH--HHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 173 IGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNS--AQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 173 vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~--~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
.||+.|+|||.+. ..++.++|||||||++|+|++|..||...... ..+..... ..+..++...++++++||.+|
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~ 233 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TVNVELPDSFSPELKSLLEGL 233 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh--cCCcCCccccCHHHHHHHHHH
Confidence 8999999999774 35899999999999999999999999753322 22222111 123344556788999999999
Q ss_pred CC-CCCCCC-----CHHHHhcCccccccCC
Q 006277 249 LV-PASQRL-----SAKELLMDPFLQVNGT 272 (652)
Q Consensus 249 L~-~P~~Rp-----Sa~elL~hpf~~~~~~ 272 (652)
|. +|.+|+ |++++++||||+...+
T Consensus 234 l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 234 LQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred hcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 97 899999 6999999999986544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.67 Aligned_cols=248 Identities=27% Similarity=0.446 Sum_probs=206.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
-.+++++..|.||+|.+..+|..||+|.+.... .+....++.+|++++++++||||+++++++.+.. .+|+||||
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ey 80 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG--EISICMEH 80 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--EEEEEeec
Confidence 356788888999999999999999999887432 2456678999999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 171 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~ 171 (652)
+++++|.+++.+.+.+++..+..++.||+.||.|||+ ++ ++||||||+|||++ .++.+||+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~ 157 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANS 157 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEe-cCCcEEEccCCCccccccccccc
Confidence 9999999999988899999999999999999999997 46 99999999999998 57899999999988765555566
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc------------------------
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS------------------------ 226 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~------------------------ 226 (652)
.+|++.|+|||++. ..++.++|||||||++|+|++|..||.... .......+..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCCCccch
Confidence 78999999999874 468899999999999999999999996532 2222222211
Q ss_pred ------------CCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 227 ------------GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 227 ------------g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
...|.......++++++||.+||. +|++||++.++++||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 111111112357789999999997 8999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.79 Aligned_cols=244 Identities=27% Similarity=0.456 Sum_probs=204.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..|.||+|.+..+|+.||+|.+.... ..+....+.+|+.++++++||||+++++++.+.. ..++||||+
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~ 81 (279)
T cd06619 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN--RISICTEFM 81 (279)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC--EEEEEEecC
Confidence 45777778999999999999999999987542 3455678999999999999999999999988764 789999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI 173 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~v 173 (652)
++|+|..+ ..+++..+..++.||+.||.|||+++ |+|+||||+|||++ .++.+||+|||++..+........+
T Consensus 82 ~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (279)
T cd06619 82 DGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTYV 154 (279)
T ss_pred CCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEEC-CCCCEEEeeCCcceecccccccCCC
Confidence 99999765 35789999999999999999999998 99999999999998 6789999999999876655556678
Q ss_pred CCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCC------HHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 174 GTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRN------SAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 174 GTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~------~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
||+.|+|||++ ...++.++|||||||++|+|++|..||..... .......+.....+.......++++++||.
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT 234 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHH
Confidence 99999999977 45689999999999999999999999964221 123333333333332223446789999999
Q ss_pred HhCC-CCCCCCCHHHHhcCccccc
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+||. +|.+||++++++.||||+.
T Consensus 235 ~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 235 QCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred HHhhCChhhCCCHHHHhcCccccc
Confidence 9997 8999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.78 Aligned_cols=247 Identities=29% Similarity=0.394 Sum_probs=198.4
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC----CCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ----NKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~----~~~~~LV 89 (652)
..+++++.|.||+|.+..+++.||+|++.... .......++.+|+.+++.++||||+++++++.... ...+|+|
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv 107 (364)
T cd07875 30 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 107 (364)
T ss_pred EEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEE
Confidence 46777777999999999999999999986432 23455678889999999999999999999875432 2368999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
|||+.+ +|..++.. .+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++......
T Consensus 108 ~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~ 181 (364)
T cd07875 108 MELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFM 181 (364)
T ss_pred EeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEEC-CCCcEEEEeCCCccccCCCCc
Confidence 999965 77777653 5889999999999999999999998 99999999999998 67899999999998765432
Q ss_pred cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC------------------
Q 006277 169 AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK------------------ 229 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~------------------ 229 (652)
.....||+.|+|||++ ...|+.++|||||||++|+|++|..||.+... ...+..+.....
T Consensus 182 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (364)
T cd07875 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 260 (364)
T ss_pred ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHhhhHHHHHHH
Confidence 3456899999999977 45789999999999999999999999987443 333333222100
Q ss_pred ---C-------------------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 230 ---P-------------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 230 ---p-------------------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+ .......+..+++||.+||+ +|.+|||+.|+|+||||..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0 00111234678999999998 9999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=345.74 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=204.3
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---CeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN---KTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~---~~~~LVm 90 (652)
..|++++.|+||+|.+..+|+.||+|++... ........++.+|+.+|+.++||||+++++++.+... ..+|+||
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNV--FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ceeeeCCCEEEEEEEECCCCCEEEEEecccc--ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 5788888999999999999999999988532 2234556789999999999999999999998875431 2689999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
||+. ++|..++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 84 e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 84 ELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred eccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEEC-CCCCEEeccccceeecccCccc
Confidence 9996 589998888888999999999999999999999998 99999999999998 67899999999998654322
Q ss_pred -cccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-------------------
Q 006277 169 -AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS------------------- 226 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~------------------- 226 (652)
....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.... .....+..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 234578999999997754 4889999999999999999999999874433 22222211
Q ss_pred -----CCCCc------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 227 -----GIKPA------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 227 -----g~~p~------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
...+. .+....++++.+||.+||. +|.+|||+.|+|.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 11111 1223347899999999998 89999999999999999754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=319.58 Aligned_cols=245 Identities=29% Similarity=0.516 Sum_probs=210.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..+++++.+.||+|.+..+|..|++|.+..... .......+.+|+++++.++||||+++++++.+.. .+|+||||+
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 81 (256)
T cd08529 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDKG--KLNIVMEYA 81 (256)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC--EEEEEEEeC
Confidence 567778889999999999999999999875443 2456778999999999999999999999987654 899999999
Q ss_pred CCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c
Q 006277 94 TSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 169 (652)
Q Consensus 94 ~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~ 169 (652)
++++|.+++... ..+++..+..++.||+.||.|||+.| ++||||||+||+++ .++.+||+|||++..+.... .
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~-~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEe-CCCCEEEcccccceeccCccchh
Confidence 999999998764 57899999999999999999999998 99999999999998 56899999999988765432 2
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
....|++.|+|||++. ..++.++|+|||||++|+|++|..||.. .+.......+..+..+. .+...+..++++|.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA-NNQGALILKIIRGVFPP-VSQMYSQQLAQLIDQC 236 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHHHHHHH
Confidence 4567899999999774 5688999999999999999999999976 44566666666665433 3346778999999999
Q ss_pred CC-CCCCCCCHHHHhcCccc
Q 006277 249 LV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~ 267 (652)
|+ +|++||++.++++|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 97 89999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=335.52 Aligned_cols=246 Identities=25% Similarity=0.355 Sum_probs=198.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.++++++.|+||+|.++.++..||+|+++.... ......+.+|+.+++.++||||+++++++.+.. .+++||||+
T Consensus 12 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~ 86 (309)
T cd07872 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK--SLTLVFEYL 86 (309)
T ss_pred EEecccCCEEEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC--eEEEEEeCC
Confidence 467777789999999999999999999875432 223446778999999999999999999987654 799999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 94 TSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 94 ~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
.+ +|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....... ..
T Consensus 87 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (309)
T cd07872 87 DK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYS 162 (309)
T ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECccccceecCCCccccc
Confidence 75 888887655 45899999999999999999999998 99999999999998 66899999999987654322 23
Q ss_pred cccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC---CC----------------
Q 006277 171 SVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG---IK---------------- 229 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g---~~---------------- 229 (652)
...||+.|+|||++. ..++.++|||||||++|+|+||.+||.+....+ ....+... ..
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 457899999999774 358899999999999999999999998744332 22222110 00
Q ss_pred --Cc-------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 230 --PA-------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 230 --p~-------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+. ......++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 00 0112357789999999998 8999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=355.81 Aligned_cols=245 Identities=19% Similarity=0.264 Sum_probs=192.5
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC------CCeeeeeeEEEeCCCCeEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH------NNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~H------pnIVkl~~~~~d~~~~~~~ 87 (652)
..|++++.|+||+|.+..+++.||+|+++.. .........|+++++.+.| ++|++++++|.... ..+|
T Consensus 135 ~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~-~~~~ 208 (467)
T PTZ00284 135 SLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET-GHMC 208 (467)
T ss_pred EEEEeccCEEEEEEEEcCCCeEEEEEEEecc-----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC-ceEE
Confidence 4678888899999999999999999998632 2233445667777777754 45899999887543 4789
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCcccEEEcCCC---------------C
Q 006277 88 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQ---------------G 151 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IiHRDLKp~NILl~~~~---------------g 151 (652)
+||+++ |++|.+++.+++.+++..++.++.||+.||+|||++ | ||||||||+|||++..+ +
T Consensus 209 iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 999998 789999998888999999999999999999999984 7 99999999999997432 1
Q ss_pred cEEEeccCchhhhhccccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc--CC
Q 006277 152 EVKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GI 228 (652)
Q Consensus 152 ~VKL~DFGla~~l~~~~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~--g~ 228 (652)
.+||+|||++..... .....+||+.|||||++ ...|+.++|||||||++|||++|.+||.+..+...+. .+.. |.
T Consensus 286 ~vkl~DfG~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~-~i~~~~g~ 363 (467)
T PTZ00284 286 RVRICDLGGCCDERH-SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH-LMEKTLGR 363 (467)
T ss_pred eEEECCCCccccCcc-ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHcCC
Confidence 599999998764322 23567899999999977 4579999999999999999999999998744433222 1111 11
Q ss_pred CCccc--------------------------------------cCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 229 KPAAL--------------------------------------SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 229 ~p~~l--------------------------------------~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.|..+ ....++.+.+||.+||+ ||.+|||++|+|+||||+.
T Consensus 364 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence 11000 01124668899999998 9999999999999999974
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=337.21 Aligned_cols=247 Identities=27% Similarity=0.381 Sum_probs=211.7
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
|+++..+.|-.|....+|.+||||+|.+.. .-...|+.+|++++.++ .|+||+.+.++|+|+. .+|||||-+.
T Consensus 86 LGeGAyasVqtcv~i~t~~EYAVKiidKq~----gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYLVfEKm~ 159 (463)
T KOG0607|consen 86 LGEGAYASVQTCVSIQTGKEYAVKIIDKQP----GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYLVFEKMR 159 (463)
T ss_pred hcCccceeeeeeeeeccchhhhhhhhhcCC----chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEEEEeccc
Confidence 566777899999999999999999987532 35678999999999999 7999999999998876 7999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCC--CcEEEeccCchhhhhcc-----
Q 006277 95 SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ--GEVKIGDLGLATIMEQA----- 167 (652)
Q Consensus 95 gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~--g~VKL~DFGla~~l~~~----- 167 (652)
||.|..+|.+++.|+|.++..+++.|++||.|||.+| |.||||||+|||....+ ..||||||.|..-+...
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9999999999999999999999999999999999999 99999999999987322 34899999987654321
Q ss_pred ----ccccccCCCCccCccccc------cCCCccccchhhHHHHHHHhhccCCCCCC-------------C-CHHHHHHH
Q 006277 168 ----NAKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSEC-------------R-NSAQIYKK 223 (652)
Q Consensus 168 ----~~~~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG~~Pf~~~-------------~-~~~~i~~~ 223 (652)
...+.+|+..|||||+.. ..|+.++|.||||||+|.||+|.+||.+. . -...++..
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 134678999999999652 35999999999999999999999999641 1 12457889
Q ss_pred HhcCCC--CccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 224 VSSGIK--PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 224 I~~g~~--p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
|+.|.. |..-+..++.+++++|+.+|+ ++.+|++|.++|+|||++..
T Consensus 318 IQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 318 IQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 999974 444445678899999999997 89999999999999999854
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=329.00 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=207.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
+..+++++.|+||+|.+..+|+.||+|++..... ........+.+|+++|+.++|+||+++++.+.+.. .+++||||
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~e~ 81 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI-KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD--ALCLVLTI 81 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh-hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC--EEEEEEEe
Confidence 5678888889999999999999999999875433 22334566788999999999999999999887654 89999999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-cc
Q 006277 93 FTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NA 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~ 169 (652)
+.+|+|..++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++...... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEC-CCCCEEEecCCcceecCCCCcc
Confidence 9999999887653 46999999999999999999999998 99999999999998 5679999999998765432 23
Q ss_pred ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHH---HHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 170 KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSA---QIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~---~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
....|++.|+|||++ ...++.++|+|||||++|+|++|..||....... .+...+..+. .......++++.+||
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li 236 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE--EVYSAKFSEEAKSIC 236 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc--cccCccCCHHHHHHH
Confidence 456899999999977 4578999999999999999999999997643322 2222232221 233445678999999
Q ss_pred HHhCC-CCCCCCC-----HHHHhcCccccccCCC
Q 006277 246 EKCLV-PASQRLS-----AKELLMDPFLQVNGTT 273 (652)
Q Consensus 246 ~kcL~-~P~~RpS-----a~elL~hpf~~~~~~~ 273 (652)
.+||+ +|.+||+ +.+++.|+||+...+.
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 99998 8999999 8999999999865443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=322.30 Aligned_cols=252 Identities=33% Similarity=0.508 Sum_probs=209.9
Q ss_pred cceeeeeeEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCC-----HHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 006277 5 KWSLLILMYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQS-----PEDLERLYSEVHLLKSLKHNNIIRFYNSWI 79 (652)
Q Consensus 5 ~W~~~~~~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s-----~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 79 (652)
+|... ..++.+..|.||+|.+..++..||+|.+........ .+..+.+.+|+.++++++||||+++++++.
T Consensus 1 ~~~~~----~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (267)
T cd06628 1 KWIKG----ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL 76 (267)
T ss_pred Ccccc----ceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Confidence 45553 467777889999999999999999999876543221 234567889999999999999999999987
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccC
Q 006277 80 DDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 159 (652)
Q Consensus 80 d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFG 159 (652)
+.. ..++||||+++++|.+++...+.+++..+..++.|++.||+|||++| ++||||+|+||+++ .++.+||+|||
T Consensus 77 ~~~--~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~-~~~~~~l~dfg 151 (267)
T cd06628 77 DAD--HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFG 151 (267)
T ss_pred eCC--ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEc-CCCCEEecccC
Confidence 654 78999999999999999998889999999999999999999999998 99999999999998 67899999999
Q ss_pred chhhhhccc--------cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC
Q 006277 160 LATIMEQAN--------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP 230 (652)
Q Consensus 160 la~~l~~~~--------~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p 230 (652)
++..+.... .....|++.|+|||.+. ..++.++|+|||||++|+|++|..||.+......+ ..+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~- 229 (267)
T cd06628 152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-FKIGENAS- 229 (267)
T ss_pred CCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-HHHhccCC-
Confidence 988765211 12346889999999774 56888999999999999999999999875544433 33333322
Q ss_pred ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 231 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 231 ~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
...+...+..+++||.+||. +|.+||++.++++||||
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 23445678899999999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=321.86 Aligned_cols=248 Identities=30% Similarity=0.442 Sum_probs=206.3
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccC--CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVL--QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~--~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
..++.+..+.||+|.+ .+|..||+|.+...... .......++.+|+++++.++|+||+++++++.+. ..+++|||
T Consensus 6 ~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e 82 (265)
T cd06631 6 EVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTISIFME 82 (265)
T ss_pred ceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeEEEEEe
Confidence 4677888899999986 58999999998754321 1234557799999999999999999999998765 48999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc----
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA---- 167 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~---- 167 (652)
|+.+++|.+++.+.+++++..+..++.||+.||+|||+.+ |+|+||+|+||+++ .++.+||+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 83 FVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEEC-CCCeEEeccchhhHhhhhccccc
Confidence 9999999999998888999999999999999999999998 99999999999998 6789999999998865321
Q ss_pred ----ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 168 ----NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 168 ----~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
......|++.|+|||++. ..++.++|||||||++|+|++|..||......................+...+.++.
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI 239 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHH
Confidence 123457899999999875 468899999999999999999999997754444443333221222335556788999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 243 SFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
+||.+||. +|.+||++.++|.||||
T Consensus 240 ~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 240 DFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999997 89999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=357.22 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=213.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC------CeE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN------KTV 86 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~------~~~ 86 (652)
...|++++.|+||+|.+..+|+.||+|++..... +.....++.+|+.++..++|+||+++++.+..... ..+
T Consensus 37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i 114 (496)
T PTZ00283 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMI 114 (496)
T ss_pred EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEE
Confidence 3567777889999999999999999999976543 35677889999999999999999999987754321 147
Q ss_pred EEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 87 NIITELFTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
++||||+.+|+|.+++..+ ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 115 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~-~~~~vkL~DFGls~ 191 (496)
T PTZ00283 115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLC-SNGLVKLGDFGFSK 191 (496)
T ss_pred EEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEe-CCCCEEEEecccCe
Confidence 8999999999999988653 46899999999999999999999998 99999999999998 56899999999998
Q ss_pred hhhcc----ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCC
Q 006277 163 IMEQA----NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK 237 (652)
Q Consensus 163 ~l~~~----~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 237 (652)
.+... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+...++..+..+..+ .++...
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~~~~-~~~~~~ 269 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGRYD-PLPPSI 269 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCC
Confidence 66432 234678999999999875 4699999999999999999999999987 5666677777666543 345667
Q ss_pred ChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 238 DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 238 s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
++++++||.+||. +|.+||++.++|.|||++.
T Consensus 270 ~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 270 SPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 8999999999998 8999999999999999863
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=318.48 Aligned_cols=247 Identities=30% Similarity=0.503 Sum_probs=213.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.++.++||+|.+..+|..||+|.+..... .....+++..|+++++.++||||+++++++....+..++++|||+
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~ 83 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC 83 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence 466777779999999999999999999875543 345678899999999999999999999988876667899999999
Q ss_pred CCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhh
Q 006277 94 TSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLH-----SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 164 (652)
Q Consensus 94 ~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLH-----s~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l 164 (652)
.+++|.+++.. ..++++..++.++.||+.||.||| +.+ ++||||||+||+++ .++.+||+|||++..+
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~-~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 84 EGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLD-ANNNVKLGDFGLAKIL 160 (265)
T ss_pred cCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEe-cCCCEEEecccccccc
Confidence 99999999875 367999999999999999999999 776 99999999999998 6789999999999877
Q ss_pred hccc--cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHH
Q 006277 165 EQAN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 165 ~~~~--~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~ 241 (652)
.... .....|++.|+|||++. ..++.++|+||||+++|+|++|..||... +...+.+.+..+..+ .++...+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~ 238 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKFR-RIPYRYSSEL 238 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-CHHHHHHHHhcCCCC-CCccccCHHH
Confidence 5443 34567999999999774 46889999999999999999999999874 466677777766543 3455677899
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 242 KSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
.+++.+||. +|.+||++.++|+|||+
T Consensus 239 ~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 239 NEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999997 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=322.86 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=207.8
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCC--CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQ--SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~--s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.+++++..|.||+|.+..+|..||+|++....... .....+++.+|+.++++++||||+++++++.+.. .+++|||
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~~v~e 83 (268)
T cd06630 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS--HFNLFVE 83 (268)
T ss_pred ceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC--eEEEEEe
Confidence 46788888999999999999999999987543211 1235678999999999999999999999987554 7999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
|+.+++|.+++.+.+++++..+..|+.||+.||.|||++| ++||||+|+||+++..+..+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (268)
T cd06630 84 WMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA 161 (268)
T ss_pred ccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccccccC
Confidence 9999999999998889999999999999999999999998 99999999999998555579999999987765321
Q ss_pred ---cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCC--HHHHHHHHhcCCCCccccCCCChHHH
Q 006277 169 ---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRN--SAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 169 ---~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~--~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||..... .......+.........+...+++++
T Consensus 162 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (268)
T cd06630 162 GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLR 241 (268)
T ss_pred CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHH
Confidence 12357899999999774 5688999999999999999999999965332 12222223233334445556788999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 243 SFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
+||.+||. +|.+||++.++++||||+
T Consensus 242 ~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 242 DVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999997 899999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=324.25 Aligned_cols=248 Identities=27% Similarity=0.476 Sum_probs=210.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.+..+.||+|.++.+|+.||+|.+.... ..+...++.+|+++++.++||||+++++++.+.. .+++++||+
T Consensus 7 ~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv~e~~ 81 (265)
T cd06605 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG--DISICMEYM 81 (265)
T ss_pred HHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC--EEEEEEEec
Confidence 45677788999999999999999999987542 2356678899999999999999999999987764 899999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccc
Q 006277 94 TSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs-~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~ 171 (652)
.+++|.+++... ..+++..+..++.|++.||+|||+ .+ ++||||||+||+++ +++.++|+|||++..+.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~~~ 158 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKT 158 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEEC-CCCCEEEeecccchhhHHHHhhc
Confidence 999999999876 789999999999999999999999 88 99999999999998 57899999999998775544444
Q ss_pred ccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCC----CCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 172 VIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSEC----RNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 172 ~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~----~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
..|++.|+|||.+ ...++.++|||||||++|+|++|..||... .......+.+..+..+.......++++++||.
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (265)
T cd06605 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN 238 (265)
T ss_pred ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHH
Confidence 7899999999976 456899999999999999999999999764 23334445555544333223337889999999
Q ss_pred HhCC-CCCCCCCHHHHhcCccccc
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+||. +|.+|||+.+++.||||+.
T Consensus 239 ~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 239 LCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHcCCCchhCcCHHHHhhCchhhc
Confidence 9997 8999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=318.85 Aligned_cols=246 Identities=28% Similarity=0.500 Sum_probs=206.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.+..+.||+|.++.+|+.||+|.+..... .....+.+.+|+.++++++||||+++++.+... ...+|+||||+
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~e~~ 82 (257)
T cd08223 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVMGFC 82 (257)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEeccc
Confidence 456667779999999999999999999875443 234567789999999999999999999987543 34789999999
Q ss_pred CCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 94 TSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 94 ~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
++++|.+++... ..+++..+..++.|++.||+|||++| ++||||||+||+++ .++.++|+|||++..+... ..
T Consensus 83 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 83 EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEe-cCCcEEEecccceEEecccCCcc
Confidence 999999998763 46899999999999999999999998 99999999999998 6789999999998866432 23
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
....|++.|+|||++. ..++.++|||||||++|+|++|..||... +.......+..+..+ ..+...++++.+||.+|
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 237 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-DMNSLVYRIIEGKLP-PMPKDYSPELGELIATM 237 (257)
T ss_pred ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCC-CCccccCHHHHHHHHHH
Confidence 4567899999999774 56889999999999999999999999763 444444455555433 24456789999999999
Q ss_pred CC-CCCCCCCHHHHhcCccc
Q 006277 249 LV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~ 267 (652)
|. +|.+||++.++++||||
T Consensus 238 l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 238 LSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred hccCcccCCCHHHHhcCCCC
Confidence 97 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=324.76 Aligned_cols=247 Identities=29% Similarity=0.470 Sum_probs=206.5
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..+++++.|.||+|.+..+|..+|+|.+... .....+.+.+|+++++.++||||+++++++.... ..|+||||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--~~~~v~e~~ 84 (282)
T cd06643 11 GELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--NLWILIEFC 84 (282)
T ss_pred hhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC--EEEEEEEec
Confidence 4678888899999999999999999988643 3456788899999999999999999999987654 799999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--ccc
Q 006277 94 TSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAK 170 (652)
Q Consensus 94 ~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~ 170 (652)
.+|+|..++.+ .+++++..+..++.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++...... ...
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-cCCCEEEccccccccccccccccc
Confidence 99999988764 467999999999999999999999998 99999999999998 6689999999998765432 234
Q ss_pred cccCCCCccCccccc------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC-CccccCCCChHHHH
Q 006277 171 SVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-PAALSKVKDPEVKS 243 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~-p~~l~~~~s~~~kd 243 (652)
...||+.|+|||++. ..++.++|||||||++|+|++|.+||.... .......+..+.. ....+...+.++++
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 567999999999762 347789999999999999999999998744 3334334433322 22334556789999
Q ss_pred HHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 244 FIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
||.+||. +|.+||++.++++||||...
T Consensus 241 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 241 FLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 9999997 89999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=373.36 Aligned_cols=254 Identities=25% Similarity=0.418 Sum_probs=213.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+.+..|+||+|.+..++..||+|++..... .......+..|+.+|+.|+|||||+++++|.+.....+||||||
T Consensus 18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY 95 (1021)
T PTZ00266 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEF 95 (1021)
T ss_pred EEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeC
Confidence 3456677778999999999999999999875543 34567789999999999999999999999988777789999999
Q ss_pred CCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCeeeccCCcccEEEcCC--------------
Q 006277 93 FTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHD-----PPIIHRDLKCDNIFINGN-------------- 149 (652)
Q Consensus 93 ~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g-----~~IiHRDLKp~NILl~~~-------------- 149 (652)
|.+|+|.+++.. .+.+++..++.|+.||+.||.|||+.+ .+||||||||+||||+..
T Consensus 96 ~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ 175 (1021)
T PTZ00266 96 CDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175 (1021)
T ss_pred CCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence 999999998875 357999999999999999999999854 349999999999999631
Q ss_pred --CCcEEEeccCchhhhhccc-cccccCCCCccCccccc---cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHH
Q 006277 150 --QGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKK 223 (652)
Q Consensus 150 --~g~VKL~DFGla~~l~~~~-~~~~vGTp~YmAPEvl~---~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~ 223 (652)
.+.+||+|||++..+.... ....+||+.|+|||++. ..|+.++||||||||+|+|+||..||.......++...
T Consensus 176 ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~ 255 (1021)
T PTZ00266 176 NGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISE 255 (1021)
T ss_pred CCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHH
Confidence 2348999999998765332 35678999999999773 35889999999999999999999999876777777777
Q ss_pred HhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 224 VSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 224 I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+..+... .....++++.+||.+||. +|.+||++.|+|.||||+..
T Consensus 256 lk~~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 256 LKRGPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HhcCCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 6655321 123457899999999997 89999999999999999744
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=328.98 Aligned_cols=247 Identities=28% Similarity=0.486 Sum_probs=207.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+++++..+.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++.|.+.. ..|+||||+
T Consensus 26 ~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~--~~~lv~e~~ 99 (296)
T cd06654 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGD--ELWVVMEYL 99 (296)
T ss_pred EEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC--EEEEeeccc
Confidence 467777779999999999999999999875442 34577889999999999999999999987654 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--ccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~~ 171 (652)
.+++|.+++.. ..+++..+..++.|++.||.|||+.| |+||||||+|||++ .++.+||+|||++....... ...
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEECccccchhccccccccCc
Confidence 99999999864 46899999999999999999999998 99999999999998 67899999999988654332 234
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
..|++.|+|||.+. ..++.++|||||||++|+|++|..||........++.....+..+...+...++.+.+||.+||.
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (296)
T cd06654 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255 (296)
T ss_pred ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCc
Confidence 57999999999774 45889999999999999999999999875544445544444433333445567889999999997
Q ss_pred -CCCCCCCHHHHhcCcccccc
Q 006277 251 -PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 251 -~P~~RpSa~elL~hpf~~~~ 270 (652)
+|.+||++.+++.||||...
T Consensus 256 ~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 256 MDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred CCcccCcCHHHHhhChhhhcc
Confidence 89999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.10 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=197.1
Q ss_pred EEEEec--CcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 15 RLIQLV--DTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 15 rL~~l~--~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
.++++. .++||+|.++.+|+.||+|.+..... .....+.+.+|+++++.++||||++++++|.... .+|+||||
T Consensus 5 ~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e~ 80 (327)
T cd08227 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--ELWVVTSF 80 (327)
T ss_pred hccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--EEEEEEec
Confidence 345553 36899999999999999999875432 2345677888999999999999999999998765 79999999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 93 FTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
+++|+|.+++..+ +.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.++++||+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEe-cCCcEEEcccchhhcccccccc
Confidence 9999999998753 45899999999999999999999998 99999999999998 66899999998654432111
Q ss_pred -------cccccCCCCccCcccccc---CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC--------
Q 006277 169 -------AKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-------- 230 (652)
Q Consensus 169 -------~~~~vGTp~YmAPEvl~~---~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p-------- 230 (652)
.....++..|+|||++.+ .|+.++|||||||++|+|++|..||............+ .+..+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-NGTVPCLLDTTTI 236 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh-cCCccccccccch
Confidence 123457788999998753 58999999999999999999999997643333222222 11111
Q ss_pred ------------------------------------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 231 ------------------------------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 231 ------------------------------------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.......++++++||.+||. +|++|||+.|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 00112346789999999998 8999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=322.87 Aligned_cols=245 Identities=27% Similarity=0.475 Sum_probs=202.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCC----CCeEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQ----NKTVNI 88 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~----~~~~~L 88 (652)
..++++..|.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.... ...+|+
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 86 (272)
T cd06637 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 86 (272)
T ss_pred HheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence 45778888999999999999999999987432 2346788899999999 7999999999987543 246899
Q ss_pred EEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 89 ITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
||||+.+|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++ .++.+||+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~-~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 87 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEEC-CCCCEEEccCCCceeccc
Confidence 99999999999998864 46899999999999999999999998 99999999999998 667999999999876543
Q ss_pred c--ccccccCCCCccCccccc------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCC
Q 006277 167 A--NAKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 238 (652)
Q Consensus 167 ~--~~~~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 238 (652)
. ......|++.|+|||++. ..|+.++|||||||++|+|++|..||.......... .+.....+.......+
T Consensus 164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 242 (272)
T cd06637 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLKSKKWS 242 (272)
T ss_pred ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-HHhcCCCCCCCCCCcC
Confidence 2 234568999999999773 358889999999999999999999997644333333 3333322333334567
Q ss_pred hHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 239 PEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 239 ~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
.++++||.+||. +|.+|||+.+++.||||
T Consensus 243 ~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 243 KKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 899999999998 89999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.22 Aligned_cols=242 Identities=22% Similarity=0.337 Sum_probs=198.3
Q ss_pred EEEEEecCcEEEEEEE-----ccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEE
Q 006277 14 LRLIQLVDTSGYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d-----~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~ 87 (652)
.+|++++.|.||+|.+ ..++..||+|+++... .......+.+|+.+|+.+ +||||+++++++.... ..++
T Consensus 13 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~~~~ 88 (338)
T cd05102 13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN-GPLM 88 (338)
T ss_pred eEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC-CceE
Confidence 5678888899999975 3456789999986432 234567899999999999 8999999999876543 4689
Q ss_pred EEEecCCCCCHHHHHHhC--------------------------------------------------------------
Q 006277 88 IITELFTSGSLRQYRKKH-------------------------------------------------------------- 105 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~-------------------------------------------------------------- 105 (652)
+|||||++|+|.+++...
T Consensus 89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd05102 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK 168 (338)
T ss_pred EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence 999999999999998753
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCc
Q 006277 106 KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAP 181 (652)
Q Consensus 106 ~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAP 181 (652)
.++++..+..++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+++.+.... .....+++.||||
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEc-CCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 24778899999999999999999998 99999999999998 56899999999998653221 2344567899999
Q ss_pred ccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCH
Q 006277 182 ELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSA 258 (652)
Q Consensus 182 Evl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa 258 (652)
|++ ...|+.++|||||||++|||++ |..||.+......+...+..+..+ ..+...++.+++||.+||. +|.+|||+
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~ 324 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-RAPENATPEIYRIMLACWQGDPKERPTF 324 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence 976 5679999999999999999997 999998755555555666555432 3455678899999999997 89999999
Q ss_pred HHHhc
Q 006277 259 KELLM 263 (652)
Q Consensus 259 ~elL~ 263 (652)
.++++
T Consensus 325 ~el~~ 329 (338)
T cd05102 325 SALVE 329 (338)
T ss_pred HHHHH
Confidence 99975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.21 Aligned_cols=247 Identities=29% Similarity=0.385 Sum_probs=197.8
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC----CeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN----KTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~----~~~~LV 89 (652)
..|+.+..|+||+|.+..+|..||+|++.... .......++.+|+.+|++++||||++++++|..... ..+|++
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 98 (343)
T cd07878 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLV 98 (343)
T ss_pred eecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEE
Confidence 45666777999999999999999999986432 123455678899999999999999999998764321 357899
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 169 (652)
|+++ +++|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...... .
T Consensus 99 ~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~-~ 172 (343)
T cd07878 99 TNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLARQADDE-M 172 (343)
T ss_pred eecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEEC-CCCCEEEcCCccceecCCC-c
Confidence 9998 789988775 457999999999999999999999998 99999999999998 6789999999999865432 3
Q ss_pred ccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC--CCC---------------
Q 006277 170 KSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IKP--------------- 230 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g--~~p--------------- 230 (652)
...+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+...... ...+... ..+
T Consensus 173 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (343)
T cd07878 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ-LKRIMEVVGTPSPEVLKKISSEHARKY 251 (343)
T ss_pred CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhcchhhHHHH
Confidence 45689999999998744 589999999999999999999999976433222 2222110 000
Q ss_pred ---------c---cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 231 ---------A---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 231 ---------~---~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
. ......++.+.+||.+||. +|.+|||+.|+|.||||..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 252 IQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred hhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 0 0012245678999999998 8999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=319.52 Aligned_cols=250 Identities=31% Similarity=0.510 Sum_probs=212.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeeccc-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDV-LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~-~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+++++.|.||+|.+..+|..||+|.+..... ....+....+.+|+.++++++||||+++++++.+.....++++|||
T Consensus 8 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~ 87 (264)
T cd06653 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEY 87 (264)
T ss_pred eeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEe
Confidence 477888889999999999999999999865322 1234567789999999999999999999999887666689999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-----
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----- 167 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~----- 167 (652)
+.+++|.+++...+.+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++......
T Consensus 88 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~ 164 (264)
T cd06653 88 MPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGT 164 (264)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECccccccccccccccCc
Confidence 999999999988888999999999999999999999998 99999999999998 5678999999999865421
Q ss_pred ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 168 NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 168 ~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
......|++.|+|||++. ..++.++|+|||||++|+|++|..||........+.+.. ....+..++...++.+++||.
T Consensus 165 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~i~ 243 (264)
T cd06653 165 GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA-TQPTKPMLPDGVSDACRDFLK 243 (264)
T ss_pred cccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH-cCCCCCCCCcccCHHHHHHHH
Confidence 123467899999999774 468899999999999999999999998755555554433 333344566677889999999
Q ss_pred HhCCCCCCCCCHHHHhcCccc
Q 006277 247 KCLVPASQRLSAKELLMDPFL 267 (652)
Q Consensus 247 kcL~~P~~RpSa~elL~hpf~ 267 (652)
+||++|.+||++.++|.|||.
T Consensus 244 ~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 244 QIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHhcCcccCccHHHHhcCCCC
Confidence 999988999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=353.26 Aligned_cols=245 Identities=29% Similarity=0.452 Sum_probs=212.0
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
.+|-+-.|.||-|+|+.+.+.||||.+..... ++.+.-+.+.+||..|++|+|||+|.|.++|..+. +.|||||||-
T Consensus 33 EIGHGSFGAVYfArd~~n~evVAIKKMsySGK-Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~--TaWLVMEYCl 109 (948)
T KOG0577|consen 33 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH--TAWLVMEYCL 109 (948)
T ss_pred HhcCCccceeEEeeccCccceeeeeecccccc-ccHHHHHHHHHHHHHHHhccCCCcccccceeeccc--hHHHHHHHHh
Confidence 44555568999999999999999999875443 45677789999999999999999999999998765 7999999995
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccccc
Q 006277 95 SGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI 173 (652)
Q Consensus 95 gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~v 173 (652)
| +..+++.-+ +++.+..++.|+.+.|.||+|||+++ .||||||..|||++ +.|.|||+|||.|.+..+ +.+++
T Consensus 110 G-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLs-e~g~VKLaDFGSAsi~~P--AnsFv 183 (948)
T KOG0577|consen 110 G-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLS-EPGLVKLADFGSASIMAP--ANSFV 183 (948)
T ss_pred c-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEec-CCCeeeeccccchhhcCc--hhccc
Confidence 5 777777644 58999999999999999999999999 99999999999998 779999999999987654 57899
Q ss_pred CCCCccCcccc----ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 174 GTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 174 GTp~YmAPEvl----~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
|||+||||||+ .+.|+-++||||||++..||.-.++|+...+....+|..... ..|.......+..++.||..||
T Consensus 184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPtLqs~eWS~~F~~Fvd~CL 262 (948)
T KOG0577|consen 184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTLQSNEWSDYFRNFVDSCL 262 (948)
T ss_pred CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCCCCCchhHHHHHHHHHHHH
Confidence 99999999976 578999999999999999999999998886666777765544 3344344566789999999999
Q ss_pred C-CCCCCCCHHHHhcCccccc
Q 006277 250 V-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 250 ~-~P~~RpSa~elL~hpf~~~ 269 (652)
+ .|.+|||++++|+|+|...
T Consensus 263 qKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 263 QKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred hhCcccCCcHHHHhhcchhcc
Confidence 8 5899999999999999863
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=320.92 Aligned_cols=247 Identities=31% Similarity=0.461 Sum_probs=204.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...+++++.|.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.. .+++|+||
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 86 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG--FFKIFMEQ 86 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC--EEEEEEec
Confidence 457888888999999999999999999886432 356678999999999999999999999887654 89999999
Q ss_pred CCCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 93 FTSGSLRQYRKKH-KKV--DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~l--se~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
+.+++|.+++... ..+ ++..+..++.||+.||.|||+++ |+||||||+||+++...+.+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 9999999998764 456 88999999999999999999998 99999999999998556799999999987654322
Q ss_pred -cccccCCCCccCcccccc---CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 169 -AKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl~~---~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
.....|++.|+|||++.. .++.++||||||+++|+|++|..||............+........++...++++++|
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence 234568999999998743 3789999999999999999999999764433332222221122234556678899999
Q ss_pred HHHhCC-CCCCCCCHHHHhcCccc
Q 006277 245 IEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
|.+||. +|.+|||+.+++.||||
T Consensus 245 i~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 245 ILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHcCCCchhCCCHHHHHhCCCC
Confidence 999997 79999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=329.22 Aligned_cols=254 Identities=21% Similarity=0.327 Sum_probs=208.8
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..|+||+|.+..+|+.||+|.+...... ......++..|+++++.++||||+++++.+.+.. .+|+||||+
T Consensus 7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~ 83 (316)
T cd05574 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHPFLPTLYASFQTET--YLCLVMDYC 83 (316)
T ss_pred eeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-hHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC--EEEEEEEec
Confidence 5677777899999999999999999999865432 2346678999999999999999999999886644 899999999
Q ss_pred CCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 94 TSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 94 ~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
.+++|.+++... ..+++..++.++.||+.||.|||+.| ++||||||+|||++ .+|.++|+|||++.......
T Consensus 84 ~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLH-ESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred CCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEc-CCCCEEEeecchhhccccccccc
Confidence 999999998764 57999999999999999999999998 99999999999998 56899999999987543211
Q ss_pred ----------------------------cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHH
Q 006277 169 ----------------------------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ 219 (652)
Q Consensus 169 ----------------------------~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~ 219 (652)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD-E 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH-H
Confidence 12357899999999764 56889999999999999999999999875444 3
Q ss_pred HHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCC----HHHHhcCccccccCCCC
Q 006277 220 IYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLS----AKELLMDPFLQVNGTTK 274 (652)
Q Consensus 220 i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpS----a~elL~hpf~~~~~~~~ 274 (652)
.+..+.............+..+++||.+||. +|.+||| +.++|.||||+...+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~ 299 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL 299 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence 4444443322222222367899999999997 8999999 99999999998765543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=324.75 Aligned_cols=246 Identities=27% Similarity=0.401 Sum_probs=199.4
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.+..++||+|.+..+|..||+|.+..... .......+.+|+.++++++||||+++++++.+.. .+|+||||+
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~~ 81 (285)
T cd07861 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQES--RLYLIFEFL 81 (285)
T ss_pred eEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC--eEEEEEecC
Confidence 467777789999999999999999999875432 1234467888999999999999999999987654 799999999
Q ss_pred CCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 94 TSGSLRQYRKKH---KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 94 ~gGsL~~~i~~~---~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.......
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEc-CCCcEEECcccceeecCCCccc
Confidence 7 6888887643 46899999999999999999999998 99999999999998 67899999999987654322
Q ss_pred cccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC----------------
Q 006277 169 AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP---------------- 230 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p---------------- 230 (652)
.....|++.|+|||++.+ .++.++|||||||++|+|+||.+||.+.......+..+.....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 234567899999997743 57889999999999999999999998755444443322211000
Q ss_pred ----------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 231 ----------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 231 ----------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
.......++++++||.+||. +|.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 01123367899999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=324.93 Aligned_cols=247 Identities=29% Similarity=0.432 Sum_probs=206.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+++.+..|.||+|.+..+|..||+|.+... +.+..+.+.+|+.+++.++||||+++++++.... .+|+||||+
T Consensus 18 ~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 91 (292)
T cd06644 18 GELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG--KLWIMIEFC 91 (292)
T ss_pred heecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC--eEEEEEecC
Confidence 4677777899999999999999999998743 3567888999999999999999999999987654 799999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--ccc
Q 006277 94 TSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAK 170 (652)
Q Consensus 94 ~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~ 170 (652)
.+++|..++.+ ...+++..+..++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++...... ...
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEc-CCCCEEEccCccceeccccccccc
Confidence 99999887754 457899999999999999999999998 99999999999998 5789999999998754332 234
Q ss_pred cccCCCCccCccccc------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC-ccccCCCChHHHH
Q 006277 171 SVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKVKDPEVKS 243 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p-~~l~~~~s~~~kd 243 (652)
...|++.|+|||++. ..++.++|||||||++|+|++|.+||... +....+..+.....+ ...+...+.++.+
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLSQPSKWSMEFRD 247 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc-cHHHHHHHHhcCCCccCCCCcccCHHHHH
Confidence 567899999999763 34788999999999999999999999774 344444455444332 2234456789999
Q ss_pred HHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 244 FIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
||.+||. +|.+||++.++++||||...
T Consensus 248 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 248 FLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred HHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 9999997 89999999999999999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=324.00 Aligned_cols=247 Identities=31% Similarity=0.496 Sum_probs=208.7
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+++.+..|+||+|.+..++..||+|++... .....+.+.+|+.++++++||||+++++++.... .+|+||||+
T Consensus 11 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 84 (280)
T cd06611 11 GELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN--KLWILIEFC 84 (280)
T ss_pred HHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC--eEEEEeecc
Confidence 4678888899999999999999999998754 3456788999999999999999999999987644 799999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 94 TSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 94 ~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
.+|+|..++.+. +.+++..++.++.|++.||.|||+++ |+||||||+||+++ .++.++|+|||++....... ..
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEC-CCCCEEEccCccchhhcccccccc
Confidence 999999998764 57999999999999999999999998 99999999999998 67899999999987654332 34
Q ss_pred cccCCCCccCccccc------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC-ccccCCCChHHHH
Q 006277 171 SVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKVKDPEVKS 243 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p-~~l~~~~s~~~kd 243 (652)
...||+.|+|||++. ..++.++|||||||++|+|++|.+||... ........+..+..+ ...+...+.++.+
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSSSFND 240 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence 567999999999763 34678999999999999999999999774 444445555554332 2233456789999
Q ss_pred HHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 244 FIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
||.+||. +|.+||++.++|+||||...
T Consensus 241 li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 241 FLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHhccChhhCcCHHHHhcChhhccc
Confidence 9999997 89999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=317.04 Aligned_cols=244 Identities=30% Similarity=0.499 Sum_probs=206.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.+..+.||+|.+..++..+|+|++.... .+..+.+.+|++++++++||||+++++++.+.. .+|++|||+
T Consensus 9 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~l~~e~~ 82 (262)
T cd06613 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD--KLWIVMEYC 82 (262)
T ss_pred EEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC--EEEEEEeCC
Confidence 56788888999999999999999999997543 346788999999999999999999999987654 799999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 94 TSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 94 ~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
.+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++..+.... ..
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEEC-CCCCEEECccccchhhhhhhhccc
Confidence 999999998876 78999999999999999999999998 99999999999998 67899999999998765432 34
Q ss_pred cccCCCCccCccccc-c---CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcc--ccCCCChHHHHH
Q 006277 171 SVIGTPEFMAPELYD-E---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA--LSKVKDPEVKSF 244 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~---~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~--l~~~~s~~~kdl 244 (652)
...|++.|+|||++. . .++.++|||||||++|+|++|.+||.........+........+.. .....+.++++|
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF 239 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHH
Confidence 568899999999764 3 6888999999999999999999999875554444443333222221 122346789999
Q ss_pred HHHhCC-CCCCCCCHHHHhcCcc
Q 006277 245 IEKCLV-PASQRLSAKELLMDPF 266 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~hpf 266 (652)
|.+||. +|.+|||+.+++.|+|
T Consensus 240 i~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 240 IKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHcCCChhhCCCHHHHhcCCC
Confidence 999997 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=327.18 Aligned_cols=248 Identities=30% Similarity=0.521 Sum_probs=207.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...++.+..|+||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.. .+|+|+||
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 97 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ----PKKELIINEILVMKELKNPNIVNFLDSFLVGD--ELFVVMEY 97 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC----chHHHHHHHHHHHHhcCCCceeeeeeeEecCc--eEEEEEEe
Confidence 4567777779999999999999999999875432 34577889999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
+.+++|..++... .+++..+..++.|++.||+|||++| ++||||||+||+++ .++.+||+|||++..+.... ..
T Consensus 98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 98 LAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred cCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccchhcccccccCC
Confidence 9999999988654 6899999999999999999999998 99999999999998 67899999999988764432 23
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
...|++.|+|||.+. ..++.++|||||||++|+|++|..||...............+..+...+...++.+++||.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 253 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCL 253 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHh
Confidence 457899999999774 5688999999999999999999999987544444433333332233344556789999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccc
Q 006277 250 V-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 250 ~-~P~~RpSa~elL~hpf~~~~ 270 (652)
. +|.+||++.+++.||||+..
T Consensus 254 ~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 254 EMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred hcChhhCCCHHHHhhChHhhhc
Confidence 7 89999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.61 Aligned_cols=246 Identities=27% Similarity=0.412 Sum_probs=198.4
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.+..+.||+|.+..+|..||+|.+..... .......+.+|+++++.++||||+++++++.+.. .+++|+||+
T Consensus 6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 81 (284)
T cd07839 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSDK--KLTLVFEYC 81 (284)
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccCC--ceEEEEecC
Confidence 567777789999999999999999999976432 1233456788999999999999999999987654 799999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 94 TSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 94 ~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
. ++|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..+.... ..
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 82 D-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEc-CCCcEEECccchhhccCCCCCCcC
Confidence 6 578887765 567999999999999999999999998 99999999999998 66899999999998664322 23
Q ss_pred cccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC-------------------
Q 006277 171 SVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK------------------- 229 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~------------------- 229 (652)
...+++.|+|||++.+ .++.++|||||||++|+|++|..||....+....++.+.....
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 4578999999997643 4789999999999999999999886544444444333321100
Q ss_pred C--------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 230 P--------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 230 p--------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
+ .......++++++||.+||. +|.+|||++++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 00112356889999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=321.48 Aligned_cols=245 Identities=27% Similarity=0.449 Sum_probs=202.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...++++..|.||+|.+..+|+.||+|++.... ......+.+|+.++++++||||+++++++.... .+|+||||
T Consensus 14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~--~~~iv~e~ 87 (267)
T cd06646 14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE--KLWICMEY 87 (267)
T ss_pred hheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC--EEEEEEeC
Confidence 357778888999999999999999999987442 234567889999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
+.+|+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++ ..+.+||+|||++..+.... ..
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEECcCccceeecccccccC
Confidence 999999999988888999999999999999999999998 99999999999998 66789999999998664322 24
Q ss_pred cccCCCCccCccccc----cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccc--cCCCChHHHHH
Q 006277 171 SVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL--SKVKDPEVKSF 244 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~----~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l--~~~~s~~~kdl 244 (652)
...|++.|+|||.+. ..++.++|||||||++|+|++|..||..................+..+ ....+..+.+|
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF 244 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence 567899999999762 347889999999999999999999997643333222222222222222 12357899999
Q ss_pred HHHhCC-CCCCCCCHHHHhcCcc
Q 006277 245 IEKCLV-PASQRLSAKELLMDPF 266 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~hpf 266 (652)
|.+||. +|.+||+++++|+|+|
T Consensus 245 i~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 245 VKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHhhCChhhCcCHHHHhcCCC
Confidence 999997 8999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=321.93 Aligned_cols=247 Identities=28% Similarity=0.463 Sum_probs=209.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.++.+.||+|.+..+|..||+|.+.... .......+.+|+++++.++||||+++++++.+.. .+|+|+||+
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~~ 81 (274)
T cd06609 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS--KLWIIMEYC 81 (274)
T ss_pred hhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC--eEEEEEEee
Confidence 46777888999999999999999999987543 2345677889999999999999999999988664 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~~ 171 (652)
.+++|.+++... ++++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++..+... ....
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 82 GGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEcccccceeeccccccccc
Confidence 999999998765 8999999999999999999999998 99999999999998 5789999999999877543 2345
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
..|++.|+|||.+. ..++.++|||||||++|+|++|..||... +.......+..+..+.......++.+.++|.+||.
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 236 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLN 236 (274)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhh
Confidence 68899999999774 46899999999999999999999999763 34444455555543332222277899999999997
Q ss_pred -CCCCCCCHHHHhcCcccccc
Q 006277 251 -PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 251 -~P~~RpSa~elL~hpf~~~~ 270 (652)
+|.+|||++++++||||+..
T Consensus 237 ~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 237 KDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred CChhhCcCHHHHhhChhhcCC
Confidence 89999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=328.69 Aligned_cols=245 Identities=27% Similarity=0.363 Sum_probs=191.3
Q ss_pred EEEEEecCcEEEEEEEcc--CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 14 LRLIQLVDTSGYKAFDEV--NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~--tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.++++++.|+||+|.++. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++.......+++|||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 478899999999999654 67899999886432 2345778999999999999999999998766678999999
Q ss_pred cCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEc---CCCCcEEEeccC
Q 006277 92 LFTSGSLRQYRKKH---------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN---GNQGEVKIGDLG 159 (652)
Q Consensus 92 y~~gGsL~~~i~~~---------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~---~~~g~VKL~DFG 159 (652)
|+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ...+.+||+|||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 986 4787776532 24889999999999999999999998 99999999999994 245789999999
Q ss_pred chhhhhccc-----cccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCH---------HHHHHH
Q 006277 160 LATIMEQAN-----AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNS---------AQIYKK 223 (652)
Q Consensus 160 la~~l~~~~-----~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~---------~~i~~~ 223 (652)
+++.+.... ....+||+.|+|||++.+ .++.++|||||||++|+|+||.+||...... .++.+.
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 998764321 245688999999998743 5889999999999999999999999642211 111110
Q ss_pred Hhc-C--------------------------CC-C-------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 224 VSS-G--------------------------IK-P-------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 224 I~~-g--------------------------~~-p-------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
+.. + .. . .......+..+++||.+||+ ||.+|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0 00 0 00011234578899999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=319.40 Aligned_cols=246 Identities=28% Similarity=0.473 Sum_probs=202.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCC----CCeEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQ----NKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~----~~~~~ 87 (652)
...++++..++||+|.++.+++.|++|++.... ...+++.+|+.+++++ +||||+++++++.+.. ...+|
T Consensus 11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 467777778999999999999999999887432 2456789999999999 7999999999987643 45689
Q ss_pred EEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 88 IITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
+||||+.+++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~-~~~~~~l~d~~~~~~ 162 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEc-cCCeEEECCCcccee
Confidence 99999999999998764 357999999999999999999999998 99999999999998 568999999999876
Q ss_pred hhccc--cccccCCCCccCccccc------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc-ccc
Q 006277 164 MEQAN--AKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA-ALS 234 (652)
Q Consensus 164 l~~~~--~~~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~-~l~ 234 (652)
..... .....|++.|+|||++. ..++.++|||||||++|+|++|.+||........+.+ +..+..+. ...
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (275)
T cd06608 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK-IPRNPPPTLKSP 241 (275)
T ss_pred cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH-hhccCCCCCCch
Confidence 54322 34567899999999763 2477899999999999999999999976444444443 33333222 112
Q ss_pred CCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 235 KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 235 ~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
...+.++++||.+||. +|.+|||+.++++|||+
T Consensus 242 ~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 242 ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2356789999999997 89999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.45 Aligned_cols=248 Identities=33% Similarity=0.492 Sum_probs=209.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeeccc-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDV-LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~-~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+++++.|.||+|.+..+|..|++|.+..... ....+..+.+.+|+.+++.++||||+++++++.+.. .+|++|||
T Consensus 6 ~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~e~ 83 (258)
T cd06632 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED--NLYIFLEL 83 (258)
T ss_pred ceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC--eEEEEEEe
Confidence 467888889999999999999999999876542 223456788999999999999999999999886554 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-ccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKS 171 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~~~ 171 (652)
+++++|.+++.+.+.+++..+..++.||+.||.|||+.+ |+|+||+|+||+++ .++.+||+|||++....... ...
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~~~~~~~ 160 (258)
T cd06632 84 VPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFSFAKS 160 (258)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccceeccccccccc
Confidence 999999999998888999999999999999999999998 99999999999998 67899999999988765433 355
Q ss_pred ccCCCCccCccccc-cC-CCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 172 VIGTPEFMAPELYD-EN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~-y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
..|++.|+|||.+. .. ++.++|+|||||++|+|++|..||........... +.........+...++.+++||.+||
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELPPIPDHLSDEAKDFILKCL 239 (258)
T ss_pred cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-HHhcccCCCcCCCcCHHHHHHHHHHh
Confidence 67899999999764 34 89999999999999999999999977554343433 33322233445567899999999999
Q ss_pred C-CCCCCCCHHHHhcCccc
Q 006277 250 V-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 250 ~-~P~~RpSa~elL~hpf~ 267 (652)
. +|.+||++.++|.|||+
T Consensus 240 ~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 240 QRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hcCcccCcCHHHHhcCCCC
Confidence 7 89999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=321.61 Aligned_cols=245 Identities=27% Similarity=0.459 Sum_probs=203.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeC----CCCeEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDD----QNKTVNI 88 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~----~~~~~~L 88 (652)
..++.++.+.||+|.+..+++.||+|++... ......+..|+.+++.+ +||||++++++|... ....+|+
T Consensus 22 ~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 96 (282)
T cd06636 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL 96 (282)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence 5778888899999999999999999988643 23456788899999999 799999999998643 2357899
Q ss_pred EEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 89 ITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
+|||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.++|+|||++.....
T Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~-~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 97 VMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCcchhhhhc
Confidence 99999999999998764 45889999999999999999999998 99999999999998 678999999999886643
Q ss_pred c--ccccccCCCCccCccccc------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCC
Q 006277 167 A--NAKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 238 (652)
Q Consensus 167 ~--~~~~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 238 (652)
. ......|++.|+|||++. ..|+.++|||||||++|+|++|.+||........+.. +.....+.......+
T Consensus 174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 252 (282)
T cd06636 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-IPRNPPPKLKSKKWS 252 (282)
T ss_pred cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-HhhCCCCCCcccccC
Confidence 2 234567999999999763 3588899999999999999999999977544444433 333333333344578
Q ss_pred hHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 239 PEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 239 ~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
.++.+||.+||. +|.+||++.|+|+||||
T Consensus 253 ~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 253 KKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 899999999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=327.03 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=199.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+|+.+..|.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++.+.. .+++||||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~--~~~lv~e~ 85 (301)
T cd07873 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK--SLTLVFEY 85 (301)
T ss_pred eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc---cCchhHHHHHHHHHHhcCCCCcceEEEEEecCC--eEEEEEec
Confidence 3567777779999999999999999999875432 223456778999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~ 169 (652)
+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....... .
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEEC-CCCcEEECcCcchhccCCCCCcc
Confidence 96 5898887654 56899999999999999999999998 99999999999998 67899999999997654322 2
Q ss_pred ccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC---C---------------
Q 006277 170 KSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI---K--------------- 229 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~---~--------------- 229 (652)
....+++.|+|||++.+ .++.++|||||||++|+|++|.+||...... .....+.... .
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChhhchhhhccccccc
Confidence 34567999999997743 5788999999999999999999999874433 2222221100 0
Q ss_pred ---C-------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccccC
Q 006277 230 ---P-------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 271 (652)
Q Consensus 230 ---p-------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~~ 271 (652)
+ .......++.+++||.+||. +|.+|||+.|+|+||||+..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0 00112357789999999998 899999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=318.59 Aligned_cols=248 Identities=21% Similarity=0.358 Sum_probs=203.0
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHH-HhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL-KSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iL-k~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.++.+..|.||+|.+..+|+.||+|.+....... ......+..|..++ ..++||||+++++++.... .+|+||||+
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~ 79 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD--YLYLVMEYL 79 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC--eEEEEEecc
Confidence 4677788999999999999999999987543321 23334455565554 4559999999999987544 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI 173 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~v 173 (652)
.+++|.+++...+.+++..+..++.||+.||.|||+++ ++||||+|+|||++ .++.+||+|||++..... .....
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~--~~~~~ 154 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE--NKKFV 154 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEeecccceeccc--cccCC
Confidence 99999999998889999999999999999999999998 99999999999998 678999999999876433 34567
Q ss_pred CCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--CccccCCCChHHHHHHHHhCC
Q 006277 174 GTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 174 GTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~~kdlI~kcL~ 250 (652)
|++.|+|||.+. ..++.++||||||+++|+|++|..||.. .+..+.+..+..+.. +.......++.+.+||.+||.
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 233 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC 233 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence 899999999774 4578999999999999999999999976 455666666554432 233334568899999999997
Q ss_pred -CCCCCCC---HHHHhcCccccccC
Q 006277 251 -PASQRLS---AKELLMDPFLQVNG 271 (652)
Q Consensus 251 -~P~~RpS---a~elL~hpf~~~~~ 271 (652)
+|.+||+ +.|+|.||||+...
T Consensus 234 ~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 234 MDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred CCHHHccCCCcHHHHHcChHhhcCC
Confidence 8999995 47999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=321.95 Aligned_cols=245 Identities=24% Similarity=0.423 Sum_probs=199.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeC---CCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDD---QNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~---~~~~~~LV 89 (652)
..++++..+.||+|.++.+|..||+|++.... .....+.+|+.+++.+ +||||+++++++... .+..+++|
T Consensus 24 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred eeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 57788888999999999999999999875321 2235678899999999 799999999987532 23479999
Q ss_pred EecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh
Q 006277 90 TELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 90 mEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~ 165 (652)
|||+.+|+|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++..+.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT-TEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEEC-CCCCEEEccCCceeecc
Confidence 999999999988653 356899999999999999999999998 99999999999998 56789999999987664
Q ss_pred cc--ccccccCCCCccCccccc------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC-CCccccCC
Q 006277 166 QA--NAKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI-KPAALSKV 236 (652)
Q Consensus 166 ~~--~~~~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~-~p~~l~~~ 236 (652)
.. ......|++.|+|||++. ..|+.++|||||||++|+|++|..||........+.. +..+. .....+..
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~ 254 (286)
T cd06638 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-IPRNPPPTLHQPEL 254 (286)
T ss_pred cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-ccccCCCcccCCCC
Confidence 32 234567999999999763 3488999999999999999999999987544444333 22222 22223445
Q ss_pred CChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 237 KDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 237 ~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
.+..+++||.+||. +|.+|||+.++|+|+||
T Consensus 255 ~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 255 WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 67789999999997 89999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=309.95 Aligned_cols=249 Identities=39% Similarity=0.568 Sum_probs=215.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..+++++.|.||+|.+..+|..|++|++..... .+...+.+.+|+.++++++||||+++++.+.+.....+++|+||+
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 567888889999999999999999999876543 246778999999999999999999999998766335899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc----c
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----A 169 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~----~ 169 (652)
.+++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++ .++.++|+|||.+....... .
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 84 SGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEcccccEEecccccccccc
Confidence 99999999998889999999999999999999999998 99999999999998 56899999999988776543 3
Q ss_pred ccccCCCCccCcccccc-CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~-~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
....+++.|+|||.+.. .++.++||||||+++|+|++|..||....+.......+..+......+...+..+++||.+|
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 240 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHh
Confidence 45678999999997754 58999999999999999999999998755455555555543444455566689999999999
Q ss_pred CC-CCCCCCCHHHHhcCccc
Q 006277 249 LV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~ 267 (652)
|. +|.+||++.+++.||||
T Consensus 241 l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 241 LRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CcCChhhCCCHHHHhhCCCC
Confidence 98 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=321.54 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=205.9
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 95 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~g 95 (652)
+++++.|+||+|.+..+|+.||+|.+..... ........+..|+.+|+.++||||+++++++.... .+|+||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL-KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD--DLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh-hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC--eEEEEEecCCC
Confidence 3567789999999999999999999875432 22234566788999999999999999999886554 79999999999
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-ccccc
Q 006277 96 GSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKSV 172 (652)
Q Consensus 96 GsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~~~ 172 (652)
++|.+++.+.+ .+++..+..++.|++.||.|||++| ++||||+|+||+++ +++.+||+|||++...... .....
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCccccc
Confidence 99999987765 7999999999999999999999998 99999999999998 6789999999998876532 23445
Q ss_pred cCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCC---HHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 173 IGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRN---SAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 173 vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~---~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
.|++.|+|||++ .+.++.++|||||||++|+|++|..||..... ...+...+.. .+...+...++.+++||.+|
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHH
Confidence 788999999976 44688999999999999999999999966332 2223222222 23344556789999999999
Q ss_pred CC-CCCCCC-----CHHHHhcCccccccCCC
Q 006277 249 LV-PASQRL-----SAKELLMDPFLQVNGTT 273 (652)
Q Consensus 249 L~-~P~~Rp-----Sa~elL~hpf~~~~~~~ 273 (652)
|+ +|.+|| ++.+++.||||....+.
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 97 899999 89999999999765553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.83 Aligned_cols=255 Identities=20% Similarity=0.310 Sum_probs=211.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...++++..+.||+|.+..+++.||+|.+..... ........+.+|+.+++.++||||+++++++.... .+++||||
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv~e~ 82 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR--HLCMVMEY 82 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC--EEEEEEec
Confidence 3567777889999999999999999999875432 22345678889999999999999999999886543 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-----
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----- 167 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~----- 167 (652)
+.||+|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+||+++ ..|.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 83 VEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEEC-CCCCEEEeeCCCccccCcCccccc
Confidence 999999999998889999999999999999999999998 99999999999998 6789999999988642100
Q ss_pred ------------ccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC-ccc
Q 006277 168 ------------NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AAL 233 (652)
Q Consensus 168 ------------~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p-~~l 233 (652)
......|++.|+|||.+ ...++.++|+|||||++|+|++|..||.+ ....+++..+..+..+ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~ 238 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPEG 238 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCCCCc
Confidence 01235688899999976 55789999999999999999999999987 4556666666554322 122
Q ss_pred cCCCChHHHHHHHHhCC-CCCCCCC---HHHHhcCccccccCCCC
Q 006277 234 SKVKDPEVKSFIEKCLV-PASQRLS---AKELLMDPFLQVNGTTK 274 (652)
Q Consensus 234 ~~~~s~~~kdlI~kcL~-~P~~RpS---a~elL~hpf~~~~~~~~ 274 (652)
....++++++||.+||. +|.+||+ +.++|.||||...+++.
T Consensus 239 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 239 DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 23567899999999998 8999997 89999999997665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=320.38 Aligned_cols=251 Identities=27% Similarity=0.467 Sum_probs=208.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+++.+..|.||+|.+..+++.||+|.+.... ......++.+|+++++.++||||++++++|.+.....+|+||||
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 467888888999999999999999999987542 23556789999999999999999999999987766689999999
Q ss_pred CCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 93 FTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 93 ~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ .++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe-cCCeEEEeeccccccccccc
Confidence 999999887653 356899999999999999999999998 99999999999998 56789999999987665444
Q ss_pred cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCC----CCHHHHHHHHhcCCCCcccc------CCC
Q 006277 169 AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSEC----RNSAQIYKKVSSGIKPAALS------KVK 237 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~----~~~~~i~~~I~~g~~p~~l~------~~~ 237 (652)
.....++..|+|||.+ ...++.++|||||||++|+|++|..||... ....+....+.....+ .+. ...
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (287)
T cd06621 160 AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP-ELKDEPGNGIKW 238 (287)
T ss_pred cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch-hhccCCCCCCch
Confidence 4456788999999976 457899999999999999999999999764 2334444444432211 111 123
Q ss_pred ChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 238 DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 238 s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
++.+++||.+||. +|.+|||+.|++.||||+..
T Consensus 239 ~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred HHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 5789999999997 89999999999999999643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=314.64 Aligned_cols=244 Identities=29% Similarity=0.485 Sum_probs=204.4
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.++.|+||+|....+|..||+|++..... ......+.+|+.+++.++|+||+++++.+.+.. .+++|||++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~iv~e~~ 81 (267)
T cd06610 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD--ELWLVMPYL 81 (267)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC--EEEEEEecc
Confidence 467777789999999999999999999875433 236788999999999999999999999887654 899999999
Q ss_pred CCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 94 TSGSLRQYRKKH---KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 94 ~gGsL~~~i~~~---~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
.+++|.+++... ..+++..++.++.||+.||.|||++| ++||||+|+||+++ +++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~-~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccchHHHhccCccc
Confidence 999999998764 45899999999999999999999998 99999999999998 56899999999998775432
Q ss_pred ----cccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc-----CCC
Q 006277 169 ----AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS-----KVK 237 (652)
Q Consensus 169 ----~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~-----~~~ 237 (652)
....+|++.|+|||++.. .++.++|+|||||++|+|++|..||..... ...+..+.....+ .+. ...
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-MKVLMLTLQNDPP-SLETGADYKKY 236 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-hhhHHHHhcCCCC-CcCCccccccc
Confidence 134579999999997743 588999999999999999999999977444 3344444333221 111 245
Q ss_pred ChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 238 DPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 238 s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
++.+++||.+||. +|.+||++.+++.||||
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 6889999999998 89999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=314.07 Aligned_cols=248 Identities=32% Similarity=0.515 Sum_probs=214.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+++.++.+.||+|.+..+|+.||+|++..... +.....+.+|+.+++.++||||+++++++.... .+++||||
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~ 80 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG--EISIVLEY 80 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC--eEEEEEEe
Confidence 4678888889999999999999999999875432 255788999999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc--
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-- 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~-- 169 (652)
+.+++|.+++.....+++..+..++.||+.||.|||+ .+ ++||||+|+||+++ .++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEEC-CCCCEEEccCccceecccCCCcc
Confidence 9999999999988899999999999999999999999 88 99999999999998 578999999999987654332
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCC--CHHHHHHHHhcCCCCccccCC-CChHHHHHH
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECR--NSAQIYKKVSSGIKPAALSKV-KDPEVKSFI 245 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~--~~~~i~~~I~~g~~p~~l~~~-~s~~~kdlI 245 (652)
....|++.|+|||.+. ..++.++|+||||+++|+|++|..||.... ...+..+.+.....+. ++.. .+..+.++|
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 236 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS-LPAEEFSPEFRDFI 236 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC-CCcccCCHHHHHHH
Confidence 2567899999999774 468889999999999999999999997764 5566666666554433 3333 778999999
Q ss_pred HHhCC-CCCCCCCHHHHhcCccccc
Q 006277 246 EKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.+||. +|.+||++.+++.|||++.
T Consensus 237 ~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 237 SACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHccCChhhCCCHHHHHhCHHHHh
Confidence 99997 7999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=322.46 Aligned_cols=247 Identities=27% Similarity=0.471 Sum_probs=207.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..|.||+|.+..+|..||+|.+.... .......+.+|+.++++++||||+++++++.... .+|+||||+
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv~e~~ 81 (286)
T cd06622 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG--AVYMCMEYM 81 (286)
T ss_pred hhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC--eEEEEEeec
Confidence 56788888999999999999999999887431 3455678999999999999999999999887654 899999999
Q ss_pred CCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc
Q 006277 94 TSGSLRQYRKKH---KKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169 (652)
Q Consensus 94 ~gGsL~~~i~~~---~~lse~~i~~i~~QIl~aL~yLHs-~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 169 (652)
++++|..++... ..+++..+..++.||+.||.|||+ ++ |+||||||+||+++ .++.+||+|||++..+.....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVN-GNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEEC-CCCCEEEeecCCcccccCCcc
Confidence 999999988763 379999999999999999999996 46 99999999999998 578999999999987755555
Q ss_pred ccccCCCCccCcccccc-------CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHH---HHhcCCCCccccCCCCh
Q 006277 170 KSVIGTPEFMAPELYDE-------NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK---KVSSGIKPAALSKVKDP 239 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~-------~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~---~I~~g~~p~~l~~~~s~ 239 (652)
....|++.|+|||++.+ .++.++|||||||++|+|++|..||.... ....+. .+..+. +..++...++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDGD-PPTLPSGYSD 236 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhcC-CCCCCcccCH
Confidence 66788999999997732 35789999999999999999999996532 233332 333333 3344555789
Q ss_pred HHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 240 EVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 240 ~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
++++||.+||. +|.+||++.+++.||||...
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 99999999998 89999999999999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=342.89 Aligned_cols=270 Identities=23% Similarity=0.332 Sum_probs=227.8
Q ss_pred eeEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 11 LMYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 11 ~~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
..|+.|++++.|.||-+.-..||+-||+|.+.++++. .+....-.+.|.+||..++.+.||.+-..|...+ .+||||
T Consensus 188 ~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiK-kr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd--~LClVL 264 (591)
T KOG0986|consen 188 RVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIK-KRKGETMALNEKQILEKVSSPFIVSLAYAFETKD--ALCLVL 264 (591)
T ss_pred eeeEEEecccccceeEEEEecchhhHHHHHHHHHHHH-HhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC--ceEEEE
Confidence 3689999999999999999999999999999876643 3455566788999999999999999988887655 799999
Q ss_pred ecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 91 ELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
.+|+||+|.-+|.+.+ .|++..+..|+.+|+.||++||..+ ||+|||||+|||+| +.|+|.|+|+|||..+....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccceEEecCCCC
Confidence 9999999999888876 7999999999999999999999998 99999999999999 78999999999999887765
Q ss_pred c-ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCC---HHHHHHHHhcCCCCccccCCCChHHHH
Q 006277 169 A-KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRN---SAQIYKKVSSGIKPAALSKVKDPEVKS 243 (652)
Q Consensus 169 ~-~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~---~~~i~~~I~~g~~p~~l~~~~s~~~kd 243 (652)
. ...+||..|||||++ ++.|+..+|||||||++|||+.|+.||..... .+++-+.+.. .+..++...++++++
T Consensus 342 ~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS~eaks 419 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFSEEAKS 419 (591)
T ss_pred ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccCHHHHH
Confidence 4 556999999999987 45799999999999999999999999965322 2334444444 356677788999999
Q ss_pred HHHHhCC-CCCCCC-----CHHHHhcCccccccCCCCCCCCCCCCCcCCCC
Q 006277 244 FIEKCLV-PASQRL-----SAKELLMDPFLQVNGTTKNRPLPLPDIVLPRV 288 (652)
Q Consensus 244 lI~kcL~-~P~~Rp-----Sa~elL~hpf~~~~~~~~~~~~~~p~~~lp~~ 288 (652)
|.+.+|. +|++|+ ++.++.+||||+..+|.....--++|++.|..
T Consensus 420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp 470 (591)
T KOG0986|consen 420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDP 470 (591)
T ss_pred HHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCc
Confidence 9999997 899998 47799999999987775433333444455543
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=320.21 Aligned_cols=249 Identities=22% Similarity=0.409 Sum_probs=207.7
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..|+||+|.+..+|+.||+|++.... .+....++.+|+++++.++||||+++++++.+.. .+++||||+
T Consensus 11 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 85 (284)
T cd06620 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN--NICMCMEFM 85 (284)
T ss_pred HHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC--EEEEEEecC
Confidence 45777888999999999999999999887543 2455678999999999999999999999988764 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
++|+|..++.+.+.+++..+..++.|++.||.|||+ ++ ++||||||+||+++ +++.++|+|||++...........
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~~~~~~~~ 162 (284)
T cd06620 86 DCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVN-SRGQIKLCDFGVSGELINSIADTF 162 (284)
T ss_pred CCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEEC-CCCcEEEccCCcccchhhhccCcc
Confidence 999999999888889999999999999999999997 56 99999999999998 678999999999876654444567
Q ss_pred cCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCH----------HHHHHHHhcCCCCccccCCCChHH
Q 006277 173 IGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNS----------AQIYKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 173 vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~----------~~i~~~I~~g~~p~~l~~~~s~~~ 241 (652)
+|++.|+|||++ ...++.++|||||||++|+|++|..||...... ......+.....+.......+.++
T Consensus 163 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd06620 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDL 242 (284)
T ss_pred ccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHH
Confidence 899999999976 567889999999999999999999999753321 122333333222221122366789
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 242 KSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.+||.+||. +|.+|||+.|+++||||...
T Consensus 243 ~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 243 RDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 999999998 89999999999999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=311.94 Aligned_cols=246 Identities=26% Similarity=0.446 Sum_probs=207.8
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..+++++.|.||+|.+..+++.||+|.+..... +.+....+.+|+++|+.++||||+++++.+.... .+++||||+
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv~e~~ 81 (256)
T cd08220 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK--ALMIVMEYA 81 (256)
T ss_pred EEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC--EEEEEEecC
Confidence 567777889999999999999999999975543 2356788999999999999999999999886543 899999999
Q ss_pred CCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-cc
Q 006277 94 TSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AK 170 (652)
Q Consensus 94 ~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~~ 170 (652)
++++|.+++... ..+++..+..++.|++.||.|||++| ++||||||+||+++..++.+||+|||++....... ..
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 999999998764 35899999999999999999999998 99999999999998666678999999998765432 23
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
...|++.|+|||.+. ..++.++||||||+++|+|++|..||... +.......+..+... ..+...++.+++||.+||
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l 237 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-NLPALVLKIMSGTFA-PISDRYSPDLRQLILSML 237 (256)
T ss_pred ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC-chHHHHHHHHhcCCC-CCCCCcCHHHHHHHHHHc
Confidence 467899999999875 45788999999999999999999999774 444455555544322 344456789999999999
Q ss_pred C-CCCCCCCHHHHhcCccc
Q 006277 250 V-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 250 ~-~P~~RpSa~elL~hpf~ 267 (652)
. +|.+|||+.|+++||||
T Consensus 238 ~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 238 NLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred cCChhhCCCHHHHhhCCCC
Confidence 7 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=315.82 Aligned_cols=247 Identities=24% Similarity=0.405 Sum_probs=208.0
Q ss_pred EEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCC
Q 006277 17 IQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSG 96 (652)
Q Consensus 17 ~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~gG 96 (652)
+.+..|.||+|.+..+|+.||+|.+..... ......+.+.+|++++++++||||+++++.+... ..+|+||||+.++
T Consensus 2 g~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~ 78 (265)
T cd05579 2 SKGAYGRVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK--KNLYLVMEYLPGG 78 (265)
T ss_pred CCCCceEEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC--cEEEEEEecCCCC
Confidence 456678999999999999999999875433 2245678899999999999999999999988654 3899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc---------
Q 006277 97 SLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--------- 167 (652)
Q Consensus 97 sL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--------- 167 (652)
+|.+++.+.+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++......
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEc-CCCCEEEEecccchhcccCccccccccc
Confidence 99999998889999999999999999999999998 99999999999998 6789999999998765332
Q ss_pred -ccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 168 -NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 168 -~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
......+++.|+|||.+ ...++.++||||||+++|+|++|..||.. ......+..+..+..+.......+..+.+||
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 234 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDLI 234 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCccccCCHHHHHHH
Confidence 22345788999999976 44588899999999999999999999976 4566666666664433222222478999999
Q ss_pred HHhCC-CCCCCCCH---HHHhcCcccccc
Q 006277 246 EKCLV-PASQRLSA---KELLMDPFLQVN 270 (652)
Q Consensus 246 ~kcL~-~P~~RpSa---~elL~hpf~~~~ 270 (652)
.+||. +|.+|||+ .++|+||||...
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 99997 89999999 999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=326.25 Aligned_cols=246 Identities=29% Similarity=0.496 Sum_probs=205.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+++++..|.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||+++++++.... .+|+||||+
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~e~~ 98 (297)
T cd06656 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGD--ELWVVMEYL 98 (297)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--EEEEeeccc
Confidence 567777779999999999999999999875432 34567889999999999999999999987654 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--ccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~~ 171 (652)
++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+|||++ .++.+||+|||++....... ...
T Consensus 99 ~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEECcCccceEccCCccCcCc
Confidence 99999999865 46899999999999999999999998 99999999999998 67899999999987654332 234
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
..|++.|+|||.+. ..++.++|+|||||++|+|++|..||........++.....+..+...+...++.+++||.+||.
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 254 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLE 254 (297)
T ss_pred ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHcc
Confidence 67899999999764 56889999999999999999999999775444444433333333333445567889999999997
Q ss_pred -CCCCCCCHHHHhcCccccc
Q 006277 251 -PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 251 -~P~~RpSa~elL~hpf~~~ 269 (652)
+|.+||++.++++||||+.
T Consensus 255 ~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 255 MDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred CChhhCcCHHHHhcCchhcc
Confidence 8999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.36 Aligned_cols=250 Identities=24% Similarity=0.298 Sum_probs=200.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...++++..+.||+|.+..+|..||+|+++..... ......+.+|+.++++++|+||+++++++.+.....+++||||
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY 89 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence 34567777799999999999999999998765421 1223356679999999999999999999887665679999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~ 169 (652)
+.+ +|.+++.. ...+++..+..++.||+.||.|||++| ++||||||+||+++ ..+.+||+|||++..+.... .
T Consensus 90 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~kL~dfg~~~~~~~~~~~~ 165 (309)
T cd07845 90 CEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAKPM 165 (309)
T ss_pred CCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccceeeecCCccCCC
Confidence 965 78888765 367999999999999999999999998 99999999999998 67899999999998765431 2
Q ss_pred ccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC-C----------------
Q 006277 170 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-P---------------- 230 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~-p---------------- 230 (652)
....+++.|+|||++. ..++.++|||||||++|+|++|.+||.... ....+..+..... +
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS-EIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence 3345688999999874 358899999999999999999999998744 4444433332100 0
Q ss_pred ccc-----------cCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 231 AAL-----------SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 231 ~~l-----------~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
... ....++.+.+||.+||. +|++|||+.++|.||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 000 01247889999999998 8999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=318.29 Aligned_cols=249 Identities=27% Similarity=0.433 Sum_probs=199.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHH-HHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHL-LKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~i-Lk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...++++..|.||+|.++.+|..||+|++..... .+...++..|+.+ ++.++||||+++++++.... .+|++||
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~--~~~lv~e 80 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN---SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG--DVWICME 80 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC---cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC--cEEEEhh
Confidence 3567888889999999999999999999875422 1233455556665 66779999999999987654 7999999
Q ss_pred cCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 92 LFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 92 y~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
|+. |+|.+++.. ...+++..++.++.||+.||.|||++ + ++||||||+|||++ .++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~-~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeeccccccccc
Confidence 996 688777653 34689999999999999999999997 7 99999999999998 678999999999987654
Q ss_pred ccc-ccccCCCCccCccccc-----cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChH
Q 006277 167 ANA-KSVIGTPEFMAPELYD-----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 240 (652)
Q Consensus 167 ~~~-~~~vGTp~YmAPEvl~-----~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 240 (652)
... ....|++.|+|||++. ..++.++|+|||||++|+|++|..||.......+....+..+..+.......+.+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd06617 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE 236 (283)
T ss_pred ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHH
Confidence 332 3367899999999774 3478899999999999999999999976444433344444443333223446789
Q ss_pred HHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 241 VKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 241 ~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+++||.+||. +|.+||++.+++.||||+..
T Consensus 237 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 237 FQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 9999999997 89999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=311.80 Aligned_cols=246 Identities=33% Similarity=0.570 Sum_probs=208.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..+.||+|.+..+|+.||+|.+..... .+.....+.+|+.+++.++|+||+++++++... ..+++|+||+
T Consensus 6 ~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~lv~e~~ 81 (264)
T cd06626 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR--EKVYIFMEYC 81 (264)
T ss_pred eEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeEecC--CEEEEEEecC
Confidence 577888889999999999999999999876543 246788999999999999999999999987654 4899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc----
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA---- 169 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~---- 169 (652)
.+++|.+++...+.+++..++.++.|++.||.|||+++ |+||||+|+||+++ .++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 82 SGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEcccccccccCCCCCcccc
Confidence 99999999988888999999999999999999999998 99999999999998 578999999999887653321
Q ss_pred --ccccCCCCccCcccccc-C---CCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccC--CCChHH
Q 006277 170 --KSVIGTPEFMAPELYDE-N---YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK--VKDPEV 241 (652)
Q Consensus 170 --~~~vGTp~YmAPEvl~~-~---y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~--~~s~~~ 241 (652)
....|++.|+|||++.. . ++.++||||||+++|+|++|..||....+.......+..+. +..++. ..++.+
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPIPDSLQLSPEG 237 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCC-CCCCCcccccCHHH
Confidence 23568899999998753 3 78899999999999999999999977555444444444433 222333 348899
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 242 KSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
.+||.+||+ +|.+||++.+++.|||+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 999999997 89999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=318.16 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=201.3
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..|.||+|.+..+|..||+|++..... .......+.+|+.++++++||||+++++++.+.. .+++||||+
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~~v~e~~ 81 (286)
T cd07832 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPHGS--GFVLVMEYM 81 (286)
T ss_pred eecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC--eeEEEeccc
Confidence 567777789999999999999999999876543 1344678899999999999999999999987644 899999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---c
Q 006277 94 TSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---A 169 (652)
Q Consensus 94 ~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---~ 169 (652)
+++|.+++.. .+.+++..++.++.||+.||.|||+++ ++|+||||+||+++ ..+.++|+|||++....... .
T Consensus 82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEc-CCCcEEEeeeeecccccCCCCCcc
Confidence 9999999865 457999999999999999999999998 99999999999998 56899999999998765433 3
Q ss_pred ccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC-----------------
Q 006277 170 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP----------------- 230 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p----------------- 230 (652)
....|++.|+|||.+. ..++.++|||||||++|+|++|.+||.+..+...+...+..-..+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 4567899999999763 347899999999999999999988887644433332222110000
Q ss_pred ----------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 231 ----------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 231 ----------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
.......+..+.+||.+||. +|.+|||++++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence 00112346789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=317.29 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=209.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...++.++.+.||+|.+..+|..||+|++..... ......+++.+|++++++++||||+++++++.+.. .+++|+||
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 81 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE--NMYLVVDL 81 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC--eEEEEEeC
Confidence 4677888889999999999999999999975443 23356788999999999999999999999886544 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-cccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKS 171 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~~ 171 (652)
+.|++|..++.....+++..+..|+.||+.||.|||.++ ++|+||+|+||+++ .++.++|+|||++...... ....
T Consensus 82 ~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 82 LLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEc-CCCCEEEeecccccccCCCccccc
Confidence 999999999988888999999999999999999999998 99999999999998 6789999999998876543 2345
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCC--HHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRN--SAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~--~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
..|+..|+|||++. ..++.++|+||||+++|+|++|..||..... ...+...... .....+...+..+.+||.+|
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHHHH
Confidence 67899999999774 4579999999999999999999999987543 4444443332 22334455678999999999
Q ss_pred CC-CCCCCCCH--HHHhcCccc
Q 006277 249 LV-PASQRLSA--KELLMDPFL 267 (652)
Q Consensus 249 L~-~P~~RpSa--~elL~hpf~ 267 (652)
|. +|.+||++ .|++.||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 97 89999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=319.93 Aligned_cols=246 Identities=25% Similarity=0.412 Sum_probs=200.7
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCC---CCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQ---NKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~---~~~~~LV 89 (652)
.+++++..+.||+|.++.+|+.||+|++.... .....+.+|+.+++++ +||||+++++++.... ...+|+|
T Consensus 28 ~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 46777777999999999999999999886432 2345678899999999 8999999999987543 2468999
Q ss_pred EecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh
Q 006277 90 TELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 90 mEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~ 165 (652)
|||+.+|+|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++..+.
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~-~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT-TEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEeecccchhcc
Confidence 999999999998753 457899999999999999999999998 99999999999998 67889999999988765
Q ss_pred ccc--cccccCCCCccCcccccc------CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC-ccccCC
Q 006277 166 QAN--AKSVIGTPEFMAPELYDE------NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKV 236 (652)
Q Consensus 166 ~~~--~~~~vGTp~YmAPEvl~~------~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p-~~l~~~ 236 (652)
... .....|++.|+|||++.. .++.++|||||||++|+|++|.+||........+. .+..+..+ ...+..
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 258 (291)
T cd06639 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF-KIPRNPPPTLLHPEK 258 (291)
T ss_pred cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH-HHhcCCCCCCCcccc
Confidence 332 245678999999998742 36789999999999999999999998744333333 34333222 112233
Q ss_pred CChHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 237 KDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 237 ~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
....+++||.+||. +|.+||++.++++||||+
T Consensus 259 ~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 259 WCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 56789999999997 899999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.55 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=202.8
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..+.||+|.+..+|+.||+|.+..... .....+.+.+|++++++++||||+++++++.+.. .+++||||+
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~v~e~~ 82 (286)
T cd07847 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR--KLHLVFEYC 82 (286)
T ss_pred eeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC--EEEEEEecc
Confidence 567778889999999999999999999875432 1223456789999999999999999999987654 799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--ccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~~ 171 (652)
+++.|..++.....+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++..+.... ...
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 83 DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred CccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEc-CCCcEEECccccceecCCCcccccC
Confidence 99999888877778999999999999999999999998 99999999999998 66899999999998765432 234
Q ss_pred ccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC-------------------C-C
Q 006277 172 VIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG-------------------I-K 229 (652)
Q Consensus 172 ~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g-------------------~-~ 229 (652)
..++..|+|||++. ..++.++|||||||++|+|++|.+||.+..+.+.++...... . .
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence 56889999999764 358899999999999999999999998755554444322110 0 0
Q ss_pred Cc--------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 230 PA--------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 230 p~--------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
+. ......+..+.+||.+||. +|.+||++.|++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00 0012346789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=310.96 Aligned_cols=246 Identities=28% Similarity=0.463 Sum_probs=210.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...++++..|.||.+.+..+|..|++|.+..... ++....++.+|+.++++++|+||+++++++.+.. .++++|||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~~~e~ 80 (256)
T cd08221 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN--TLLIEMEY 80 (256)
T ss_pred eeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC--eEEEEEEe
Confidence 3456777778999999999999999999876543 2456678899999999999999999999997654 89999999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 93 FTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
|.+|+|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++ .++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEe-CCCCEEECcCcceEEccccccc
Confidence 9999999998765 46899999999999999999999998 99999999999998 56899999999987664332
Q ss_pred cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~k 247 (652)
.....|++.|+|||++. ..++.++|||||||++|+|++|..||.. .+.......+..+..+. .....+.++.+||.+
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~ 235 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTP-VVSVYSSELISLVHS 235 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHHHHHH
Confidence 34567999999999764 4688899999999999999999999977 55566666666655433 335567899999999
Q ss_pred hCC-CCCCCCCHHHHhcCccc
Q 006277 248 CLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~ 267 (652)
||. +|.+||++.++|+|||+
T Consensus 236 ~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 236 LLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HcccCcccCCCHHHHhhCcCC
Confidence 997 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.42 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=199.8
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+++.++.|.||+|.++.+|+.||+|.+..... .......+.+|++++++++||||+++++++.+.. ..++||||+
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~~ 81 (284)
T cd07860 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN--KLYLVFEFL 81 (284)
T ss_pred eeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhcccCC--cEEEEeecc
Confidence 466777779999999999999999998875432 2334567889999999999999999999986544 799999999
Q ss_pred CCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c
Q 006277 94 TSGSLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 169 (652)
Q Consensus 94 ~gGsL~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~ 169 (652)
. ++|..++.. ...+++..++.++.||+.||+|||+++ ++||||+|+||+++ .++.+||+|||++..+.... .
T Consensus 82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEeeccchhhcccCcccc
Confidence 5 689888865 356899999999999999999999998 99999999999998 67899999999987664332 2
Q ss_pred ccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc----------------
Q 006277 170 KSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA---------------- 231 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~---------------- 231 (652)
....+++.|+|||++.+ .++.++|||||||++|+|+||..||..........+.+.....+.
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 34567899999997743 368899999999999999999999987555444444332211110
Q ss_pred ----------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 232 ----------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 232 ----------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
......++++++||.+||. +|.+|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0112357889999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=338.55 Aligned_cols=243 Identities=23% Similarity=0.328 Sum_probs=193.7
Q ss_pred EEEEEEecCcEEEEEEEc--cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDE--VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~--~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
...|+++..|.||+|... .++..||+|.+... ....+|+.+|+.|+|||||+++++|.... .+|+||
T Consensus 97 ~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~~~--~~~lv~ 165 (392)
T PHA03207 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRWKS--TVCMVM 165 (392)
T ss_pred EEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEeeCC--EEEEEe
Confidence 345666667899999754 46788999987532 13457999999999999999999987654 799999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
|++. ++|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++..+....
T Consensus 166 e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~-~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 166 PKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEccCccccccCccccc
Confidence 9995 689999987889999999999999999999999998 99999999999998 67899999999997664332
Q ss_pred --cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCH--HHHHHHHhc-----------------
Q 006277 169 --AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNS--AQIYKKVSS----------------- 226 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~--~~i~~~I~~----------------- 226 (652)
....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.... ...+..+..
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 23568999999999875 56999999999999999999999999764321 111111111
Q ss_pred ---------CCCC-cccc-----CCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 227 ---------GIKP-AALS-----KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 227 ---------g~~p-~~l~-----~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
...+ ...+ ...+.++++||.+||. +|.+|||+.++|.||||+..
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0000 0111 1245688999999998 89999999999999999753
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.87 Aligned_cols=247 Identities=27% Similarity=0.519 Sum_probs=206.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
+.++++++.|.||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||+++++.+.... ..|+||||
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--~~~lv~e~ 100 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD--ELWVVMEF 100 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecch----HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC--eEEEEEeC
Confidence 456788888999999999999999999886432 355677899999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
+.+++|.+++.. +.+++..+..++.||+.||.|||+++ |+||||||+||+++ +++.+||+|||++....... ..
T Consensus 101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEccCcchhhcccccccCc
Confidence 999999998754 57999999999999999999999998 99999999999998 66899999999987654322 24
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc-cccCCCChHHHHHHHHh
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA-ALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~-~l~~~~s~~~kdlI~kc 248 (652)
...|++.|+|||.+. ..++.++|||||||++|+|++|..||.. ......+..+.....+. ......+..+++||.+|
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 567899999999774 4688999999999999999999999976 34444444444433221 12234678999999999
Q ss_pred CC-CCCCCCCHHHHhcCcccccc
Q 006277 249 LV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~~~~ 270 (652)
|. +|.+|||++++++||||+..
T Consensus 256 l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 256 LVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred ccCChhHCcCHHHHhhChhhhcc
Confidence 97 89999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=314.53 Aligned_cols=254 Identities=29% Similarity=0.462 Sum_probs=207.5
Q ss_pred cceeeeeeEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCC------CHHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Q 006277 5 KWSLLILMYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQ------SPEDLERLYSEVHLLKSLKHNNIIRFYNSW 78 (652)
Q Consensus 5 ~W~~~~~~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~------s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~ 78 (652)
+|... ..++.+..|.||+|.+..+|+.||+|.++...... .....+.+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~----~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 77 (272)
T cd06629 2 KWVKG----ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE 77 (272)
T ss_pred ceeec----ceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe
Confidence 56664 47888888999999999999999999987532211 112346788999999999999999999987
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEecc
Q 006277 79 IDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 158 (652)
Q Consensus 79 ~d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DF 158 (652)
... ..+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+||
T Consensus 78 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~d~ 152 (272)
T cd06629 78 TTE--EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDF 152 (272)
T ss_pred ccC--CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEc-CCCeEEEeec
Confidence 654 379999999999999999998889999999999999999999999998 99999999999998 6789999999
Q ss_pred Cchhhhhcc----ccccccCCCCccCcccccc---CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC---
Q 006277 159 GLATIMEQA----NAKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--- 228 (652)
Q Consensus 159 Gla~~l~~~----~~~~~vGTp~YmAPEvl~~---~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~--- 228 (652)
|++...... ......|++.|+|||++.. .++.++|+||||+++|+|++|..||........+........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (272)
T cd06629 153 GISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP 232 (272)
T ss_pred cccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCc
Confidence 998765432 1234568999999997742 378999999999999999999999976444444433322221
Q ss_pred CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 229 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 229 ~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
.+.......+..+++||.+||. +|.+||++.++|+|||+
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 233 IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 1222333457899999999997 89999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=312.44 Aligned_cols=242 Identities=33% Similarity=0.538 Sum_probs=201.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.+..+.||+|.+..++..||+|.+... ...+.+.+|+++++.++||||+++++++.+.. .+|+++||+
T Consensus 9 ~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~l~~e~~ 80 (256)
T cd06612 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVE------EDLQEIIKEISILKQCDSPYIVKYYGSYFKNT--DLWIVMEYC 80 (256)
T ss_pred hhhcCCCCeEEEEEEEcCCCcEEEEEEeecH------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC--cEEEEEecC
Confidence 3566667789999999999999999998643 22678999999999999999999999987664 799999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 94 TSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 94 ~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
.+++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||+|+||+++ .++.+||+|||++....... ..
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEC-CCCcEEEcccccchhcccCccccc
Confidence 99999999875 457899999999999999999999998 99999999999998 57899999999998775443 24
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC-CCccccCCCChHHHHHHHHh
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI-KPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~-~p~~l~~~~s~~~kdlI~kc 248 (652)
...|++.|+|||++. ..++.++|||||||++|+|++|..||.......... .+.... .....+...+.++.+||.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-hhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 456899999999774 468899999999999999999999997643333222 222211 11222344678999999999
Q ss_pred CC-CCCCCCCHHHHhcCccc
Q 006277 249 LV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~ 267 (652)
|. +|.+|||+.|+|.||||
T Consensus 237 l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 237 LVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HhcChhhCcCHHHHhcCCCC
Confidence 97 89999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.66 Aligned_cols=250 Identities=25% Similarity=0.394 Sum_probs=202.1
Q ss_pred EEEEEec--CcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 14 LRLIQLV--DTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~--~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
+.++++. ++.||++.++.+|+.||+|++..... ..+...++.+|+++++.++||||++++++|.+.. ..+++||
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~--~~~~~~e 79 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS--ELYVVSP 79 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecCC--eEEEEEe
Confidence 3455553 47899999999999999999986532 3467789999999999999999999999997654 7999999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 92 LFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 92 y~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
||.+|+|.+++... ..+++..++.+++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||.+..+....
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~ 156 (314)
T cd08216 80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGK 156 (314)
T ss_pred ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEe-cCCceEEecCccceeeccccc
Confidence 99999999998764 46899999999999999999999998 99999999999998 66899999999886543211
Q ss_pred --------cccccCCCCccCcccccc---CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--------
Q 006277 169 --------AKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-------- 229 (652)
Q Consensus 169 --------~~~~vGTp~YmAPEvl~~---~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~-------- 229 (652)
.....+++.|+|||++.. .|+.++|||||||++|+|++|..||........+...+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCch
Confidence 234567889999998743 5889999999999999999999999875554444444332110
Q ss_pred -----------------------CccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 230 -----------------------PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 230 -----------------------p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+.......+.++.+||.+||. +|.+|||+.++|.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 000111224578899999997 89999999999999999744
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=316.35 Aligned_cols=248 Identities=28% Similarity=0.515 Sum_probs=209.2
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.|..++++..|.||+|.+..+|..||+|++.... ....+.+.+|+.+++.++||||+++++++.... ..++|+|
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~--~~~~v~e 96 (285)
T cd06648 23 NFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD--ELWVVME 96 (285)
T ss_pred cceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC--eEEEEEe
Confidence 4667888888999999999999999999886432 344567889999999999999999999887654 7899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~ 169 (652)
|+.+++|.+++.. +++++..+..++.||+.||+|||++| ++||||+|+||+++ .++.++|+|||++....... .
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEc-CCCcEEEcccccchhhccCCccc
Confidence 9999999999877 67999999999999999999999998 99999999999998 67899999999887654322 2
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcc-ccCCCChHHHHHHHH
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA-LSKVKDPEVKSFIEK 247 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~-l~~~~s~~~kdlI~k 247 (652)
....|++.|+|||.+. ..++.++|||||||++|+|++|..||.. .+....+..+..+..+.. .....+..+.+||.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR 251 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence 3467999999999774 4689999999999999999999999977 455555666665532221 122367899999999
Q ss_pred hCC-CCCCCCCHHHHhcCcccccc
Q 006277 248 CLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
||. +|.+||++.+++.||||+..
T Consensus 252 ~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 252 MLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred HcccChhhCcCHHHHccCcccccC
Confidence 997 89999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=332.78 Aligned_cols=241 Identities=28% Similarity=0.382 Sum_probs=188.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+++++..|.||+|.+..++..||+|+.... ....|+.++++++||||+++++++.... ..++|||+
T Consensus 71 ~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 138 (357)
T PHA03209 71 IKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSGA--ITCMVLPH 138 (357)
T ss_pred EEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeCC--eeEEEEEc
Confidence 35677777799999999999999999974322 2356999999999999999999987654 78999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-ccc
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~ 170 (652)
+. |+|.+++.. .+.+++..+..|+.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++...... ...
T Consensus 139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEecCccccccccCcccc
Confidence 95 588887765 467999999999999999999999998 99999999999998 6679999999999754332 234
Q ss_pred cccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCC----------HHHHHHHHhc-CCCCcccc----
Q 006277 171 SVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRN----------SAQIYKKVSS-GIKPAALS---- 234 (652)
Q Consensus 171 ~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~----------~~~i~~~I~~-g~~p~~l~---- 234 (652)
...||+.|+|||++ ...|+.++|||||||++|||+++..|+..... ...+...+.. +..+..++
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 56799999999977 45799999999999999999986555422111 1112222211 11111111
Q ss_pred --------------------------CCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 235 --------------------------KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 235 --------------------------~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
...+.++.+||.+||+ +|.+||||.|+|+||||+.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1235677889999998 8999999999999999973
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.55 Aligned_cols=246 Identities=24% Similarity=0.463 Sum_probs=207.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+++++..|+||++.+..+|+.||+|.+..... .......+.+|+.++++++||||+++++++.+.. ..++||||
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~ 80 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEENG--NLYIVMDY 80 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC--eEEEEEec
Confidence 3577777789999999999999999999875433 2345678899999999999999999999886543 89999999
Q ss_pred CCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 93 FTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
+.+++|.+++.... .+++..+..|+.|++.||.|||+++ ++|+||+|+|||++ .++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEEeeccceeecCcchhh
Confidence 99999999987643 5899999999999999999999998 99999999999998 56799999999997664332
Q ss_pred cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~k 247 (652)
.....|++.|+|||++. +.++.++|+|||||++|+|++|..||.. .....+...+..+..+. .+...+.+++++|.+
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ 235 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGSYPP-VSSHYSYDLRNLVSQ 235 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC-CCHHHHHHHHhcCCCCC-CcccCCHHHHHHHHH
Confidence 23457899999999764 5678899999999999999999999976 45555666666555432 344567899999999
Q ss_pred hCC-CCCCCCCHHHHhcCccc
Q 006277 248 CLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~ 267 (652)
||. +|.+||++.++++||||
T Consensus 236 ~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 236 LFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HhhCChhhCcCHHHHhhCcCC
Confidence 997 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=344.48 Aligned_cols=273 Identities=22% Similarity=0.331 Sum_probs=225.9
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 95 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~g 95 (652)
||-+..|.|-++....|...||+|.+++.+++. +.++..+..|..||..-+.+.||++|.+|.|.. .+||||+|++|
T Consensus 637 iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-rnQvaHVKAERDILAEADn~WVVrLyySFQDkd--nLYFVMdYIPG 713 (1034)
T KOG0608|consen 637 IGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-RNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NLYFVMDYIPG 713 (1034)
T ss_pred ecccccceeEEEeecchhhHHHHhhhHHHHHHh-hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC--ceEEEEeccCC
Confidence 344445899999999999999999999998874 578889999999999999999999999999877 79999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh----------
Q 006277 96 GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME---------- 165 (652)
Q Consensus 96 GsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~---------- 165 (652)
|++-.++.+.+.|.|..+++|+.++..|+++.|..| +|||||||+||||| .+|+|||+||||++-+.
T Consensus 714 GDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILID-rdGHIKLTDFGLCTGfRWTHdskYYq~ 790 (1034)
T KOG0608|consen 714 GDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQE 790 (1034)
T ss_pred ccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEc-cCCceeeeeccccccceeccccccccC
Confidence 999999999999999999999999999999999999 99999999999999 78999999999985431
Q ss_pred ----------------------------------ccccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCC
Q 006277 166 ----------------------------------QANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYP 210 (652)
Q Consensus 166 ----------------------------------~~~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~P 210 (652)
...++..+||+.|+|||++ ..+|+..|||||.|||||||+.|++|
T Consensus 791 gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~p 870 (1034)
T KOG0608|consen 791 GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPP 870 (1034)
T ss_pred CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCC
Confidence 0012357899999999987 56899999999999999999999999
Q ss_pred CCCCCCHHHHHHHHh-cCCCCccccCCCChHHHHHHHHhCCCCCCCC---CHHHHhcCccccccCCCCCCCCCCCCCcCC
Q 006277 211 YSECRNSAQIYKKVS-SGIKPAALSKVKDPEVKSFIEKCLVPASQRL---SAKELLMDPFLQVNGTTKNRPLPLPDIVLP 286 (652)
Q Consensus 211 f~~~~~~~~i~~~I~-~g~~p~~l~~~~s~~~kdlI~kcL~~P~~Rp---Sa~elL~hpf~~~~~~~~~~~~~~p~~~lp 286 (652)
|.........++.+. +...-.......++++.++|.++...++.|+ .++|+..||||+..++...+....+ .+|
T Consensus 871 f~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfsslRkq~Ap--YIP 948 (1034)
T KOG0608|consen 871 FLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAP--YIP 948 (1034)
T ss_pred ccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHhhhhccCC--cCc
Confidence 987544433332221 1111222335578999999999998999998 4888999999998887765554443 667
Q ss_pred CCCccccccc
Q 006277 287 RVGAFGDRCL 296 (652)
Q Consensus 287 ~~~~~~~~~~ 296 (652)
++..-.+++.
T Consensus 949 ~ItHptDTSN 958 (1034)
T KOG0608|consen 949 RITHPTDTSN 958 (1034)
T ss_pred cccCCCcccc
Confidence 7766555543
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=317.19 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=202.4
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQS-PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s-~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..++++..+.||+|.+..+|+.||+|.+........ ......+..|+++++.++||||+++++++.+. ..+++||||
T Consensus 6 ~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~ 83 (298)
T cd07841 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK--SNINLVFEF 83 (298)
T ss_pred eeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC--CEEEEEEcc
Confidence 467778889999999999999999999986543211 22345678899999999999999999999774 389999999
Q ss_pred CCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c
Q 006277 93 FTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~ 169 (652)
+ +|+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++....... .
T Consensus 84 ~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 84 M-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred c-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEc-CCCCEEEccceeeeeccCCCccc
Confidence 9 999999998776 7999999999999999999999998 99999999999998 67899999999998765432 2
Q ss_pred ccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC-CC----------------
Q 006277 170 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI-KP---------------- 230 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~-~p---------------- 230 (652)
....+++.|+|||.+. ..++.++|||||||++|+|++|.+||.+..... .+.++.... .+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTSLPDYVE 238 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhccccccccc
Confidence 3446788999999763 357899999999999999999988887644333 232322110 00
Q ss_pred ---------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 231 ---------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 231 ---------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.......+..+.+||.+||. +|.+|||+.|+|.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 00112346789999999998 89999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=343.13 Aligned_cols=240 Identities=23% Similarity=0.332 Sum_probs=192.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|.||+|.+..+++.||+|... ...+.+|+++|++|+|||||++++++.... ..++||++
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~--~~~lv~e~ 241 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPDYPQRVVVKAGW----------YASSVHEARLLRRLSHPAVLALLDVRVVGG--LTCLVLPK 241 (461)
T ss_pred EEEEccCCCeEEEEEEECCCCCEEEEeccc----------ccCHHHHHHHHHHCCCCCCCcEEEEEEECC--EEEEEEEc
Confidence 356677777999999999999999999543 123567999999999999999999887654 78999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
+. ++|..++... +.+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVN-GPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEEC-CCCCEEEcccCCceecccccccc
Confidence 95 6888887664 56999999999999999999999998 99999999999998 56799999999998764322
Q ss_pred -cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCC-------CHHHHHHHHhcCCCC---------
Q 006277 169 -AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECR-------NSAQIYKKVSSGIKP--------- 230 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~-------~~~~i~~~I~~g~~p--------- 230 (652)
....+||+.|||||++. ..|+.++|||||||++|||++|..|+.... ...++.+.+......
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 22467999999999774 569999999999999999999876653211 123444444432210
Q ss_pred ---------------------cccc--CCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 231 ---------------------AALS--KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 231 ---------------------~~l~--~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
..|. ...+..+++||.+||. ||.+|||+.|+|+||||+
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~ 459 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ 459 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence 0011 1235689999999998 999999999999999996
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=343.64 Aligned_cols=246 Identities=27% Similarity=0.437 Sum_probs=214.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.+-.++|.+|++..||.+||+|.+.+... ++..++.+.+|+++|+.|+|||||++|.+.+.+. .+|+||||+
T Consensus 62 ~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~--~lylV~eya 137 (596)
T KOG0586|consen 62 KTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA--TLYLVMEYA 137 (596)
T ss_pred eeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc--eeEEEEEec
Confidence 344445557999999999999999998875543 4556677999999999999999999999887655 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-cccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKSV 172 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~~~~ 172 (652)
.+|++++|+.++++..+..++.++.|+++|++|||+++ |+|||||.+|||++.+ -++||+|||++.++.... ..+.
T Consensus 138 ~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~-mnikIaDfgfS~~~~~~~~lqt~ 214 (596)
T KOG0586|consen 138 SGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDEN-MNIKIADFGFSTFFDYGLMLQTF 214 (596)
T ss_pred cCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccc-cceeeeccccceeeccccccccc
Confidence 99999999999999999999999999999999999999 9999999999999954 469999999999987553 5889
Q ss_pred cCCCCccCcccccc-CC-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 173 IGTPEFMAPELYDE-NY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 173 vGTp~YmAPEvl~~-~y-~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
||+|.|.|||++.+ .| ++.+|+||+|+++|-|++|..||.+ .+...+...+..|.... +...+-+++++|+++|+
T Consensus 215 cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~rI--p~~ms~dce~lLrk~lv 291 (596)
T KOG0586|consen 215 CGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKYRI--PFYMSCDCEDLLRKFLV 291 (596)
T ss_pred CCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeeecc--cceeechhHHHHHHhhc
Confidence 99999999999865 45 5789999999999999999999988 56666666677766443 34456799999999998
Q ss_pred -CCCCCCCHHHHhcCccccc
Q 006277 251 -PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 251 -~P~~RpSa~elL~hpf~~~ 269 (652)
+|.+|++..++..|.|...
T Consensus 292 l~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 292 LNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred cCccccCCHHHhhhhcccch
Confidence 8999999999999999853
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=316.69 Aligned_cols=247 Identities=24% Similarity=0.319 Sum_probs=200.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.+..|.||+|.+..+|..||+|.++..... ......+.+|+.++++++||||+++++++.+.....+|+||||+
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~ 88 (293)
T cd07843 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV 88 (293)
T ss_pred hhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhc
Confidence 4567777899999999999999999999865432 23345677899999999999999999998877556899999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--ccc
Q 006277 94 TSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAK 170 (652)
Q Consensus 94 ~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~ 170 (652)
.+ +|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+|||++ ..+.+||+|||++..+... ...
T Consensus 89 ~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 164 (293)
T cd07843 89 EH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYT 164 (293)
T ss_pred Cc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCcEEEeecCceeeccCCccccc
Confidence 74 9998887654 5899999999999999999999998 99999999999998 6689999999998876543 233
Q ss_pred cccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC-------------------
Q 006277 171 SVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK------------------- 229 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~------------------- 229 (652)
...+++.|+|||++.+ .++.++|||||||++|+|++|.+||........ +.++.....
T Consensus 165 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd07843 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSELPGAKKK 243 (293)
T ss_pred cccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhccchhccc
Confidence 4568899999997743 468899999999999999999999987544332 222211000
Q ss_pred ----------CccccCC-CChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 230 ----------PAALSKV-KDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 230 ----------p~~l~~~-~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
...++.. .++.+++||.+||+ +|++|||+.|+|.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0111222 47789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=321.22 Aligned_cols=248 Identities=28% Similarity=0.506 Sum_probs=206.5
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.+.++++++.|.||+|.+..+|..||+|++..... ...+.+.+|+.+++.++||||+++++++.... .+|+|||
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~iv~e 98 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE--ELWVLME 98 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheeeCC--eEEEEEe
Confidence 35578888889999999999999999999875432 34567889999999999999999999887654 7999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~ 169 (652)
|+++++|..++.. ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++..+.... .
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEc-cCCcEEEeechhHhhcccccccc
Confidence 9999999987754 57899999999999999999999998 99999999999998 67899999999987654332 3
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC-ccccCCCChHHHHHHHH
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKVKDPEVKSFIEK 247 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p-~~l~~~~s~~~kdlI~k 247 (652)
....|++.|+|||++. ..++.++|||||||++|+|++|..||... ........+.....+ .......+..+.+||.+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 253 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER 253 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence 4567999999999774 46899999999999999999999999763 444444444443221 11223457889999999
Q ss_pred hCC-CCCCCCCHHHHhcCcccccc
Q 006277 248 CLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
||. +|.+||++.++++||||...
T Consensus 254 ~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 254 MLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HhcCCcccCcCHHHHhhChhhccC
Confidence 998 89999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=303.95 Aligned_cols=245 Identities=29% Similarity=0.516 Sum_probs=210.7
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.++.+.||+|.+..+|..||+|++..... .......+.+|+++++.++|||++++++.+.+. ..+++|+||+
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~e~~ 81 (258)
T cd08215 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVMEYA 81 (258)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEEEec
Confidence 567777789999999999999999999876443 245677899999999999999999999998766 4899999999
Q ss_pred CCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 94 TSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 94 ~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
++++|.+++... ..+++..+..++.||+.||.|||++| ++|+||+|+||+++ .++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEc-CCCcEEECCccceeecccCcc
Confidence 999999998764 67999999999999999999999998 99999999999998 56899999999998765432
Q ss_pred -cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 169 -AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
.....|++.|+|||.+ ...++.++|+||+|+++|+|++|..||.. .....+...+.... ...++...+..+.++|.
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG-ENLLELALKILKGQ-YPPIPSQYSSELRNLVS 236 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCC-CcHHHHHHHHhcCC-CCCCCCCCCHHHHHHHH
Confidence 3456889999999976 45688999999999999999999999976 44566666665543 33445567789999999
Q ss_pred HhCC-CCCCCCCHHHHhcCccc
Q 006277 247 KCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~ 267 (652)
+||. +|.+||++.++|.||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9997 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=313.25 Aligned_cols=246 Identities=31% Similarity=0.512 Sum_probs=204.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC---CCCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK---HNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~---HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
..++.++.|.||+|.+..+|..||+|.+.... .....+++.+|+.+++.++ ||||+++++++.+.. .+++||
T Consensus 7 ~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~--~~~lv~ 81 (277)
T cd06917 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP--RLWIIM 81 (277)
T ss_pred hheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC--EEEEEE
Confidence 45778888999999999999999999987532 2456678889999999996 999999999987654 799999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
||+.+++|.+++.. +.+++..+..++.||+.||.|||+.| |+||||+|+||+++ .++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEc-CCCCEEEccCCceeecCCCccc
Confidence 99999999999865 47999999999999999999999998 99999999999998 57899999999998765432
Q ss_pred cccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccC-CCChHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK-VKDPEVKSFI 245 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~-~~s~~~kdlI 245 (652)
.....|++.|+|||.+.+ .++.++|+|||||++|+|++|..||.+.. .......+... .+..+.. ..+.++.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-AFRAMMLIPKS-KPPRLEDNGYSKLLREFV 235 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC-hhhhhhccccC-CCCCCCcccCCHHHHHHH
Confidence 244579999999997743 47889999999999999999999997643 33333333332 2223332 3678999999
Q ss_pred HHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 246 EKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.+||. +|.+||++.+++.||||+..
T Consensus 236 ~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 236 AACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred HHHcCCCcccCcCHHHHhhChHhhcc
Confidence 99997 89999999999999999753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=315.52 Aligned_cols=247 Identities=24% Similarity=0.386 Sum_probs=198.7
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..++++..|.||++.+..+|+.||+|++..... .....++.+|+.++.++. ||||+++++++.+.. ..+++|||
T Consensus 10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~--~~~~~~e~ 84 (288)
T cd06616 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG--DCWICMEL 84 (288)
T ss_pred HHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC--cEEEEEec
Confidence 356777779999999999999999999875432 255678899999999995 999999999887654 68999999
Q ss_pred CCCCCHHHH---HH--hCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 93 FTSGSLRQY---RK--KHKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 93 ~~gGsL~~~---i~--~~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
+.+ +|.++ +. ..+.+++..+..++.|++.||+|||+. + ++||||||+||+++ .++.+||+|||++..+..
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLD-RNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEc-cCCcEEEeecchhHHhcc
Confidence 864 55443 22 346799999999999999999999975 7 99999999999998 568999999999987654
Q ss_pred cc-cccccCCCCccCcccccc----CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccc---cCCCC
Q 006277 167 AN-AKSVIGTPEFMAPELYDE----NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL---SKVKD 238 (652)
Q Consensus 167 ~~-~~~~vGTp~YmAPEvl~~----~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l---~~~~s 238 (652)
.. .....|++.|+|||++.. .++.++|||||||++|+|++|.+||.......+....+..+..+... ....+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS 240 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccC
Confidence 32 344578999999998753 58999999999999999999999997754333333333333322211 12367
Q ss_pred hHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 239 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 239 ~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.++.+||.+||. +|.+|||+++++.||||+.
T Consensus 241 ~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 241 PSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 899999999998 8999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.85 Aligned_cols=246 Identities=26% Similarity=0.447 Sum_probs=203.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.++.+.||+|.++.+|..||+|.+..... .....+.+.+|+++++.++||||+++++.+.+.. .+++|+||+
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~e~~ 81 (257)
T cd08225 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQENG--RLFIVMEYC 81 (257)
T ss_pred EEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheeccCC--eEEEEEecC
Confidence 456777779999999999999999999876432 2234567889999999999999999999886544 899999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c
Q 006277 94 TSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 169 (652)
Q Consensus 94 ~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~ 169 (652)
.+++|.+++.... .+++..+..|+.||+.||.|||+++ ++|+||||+||+++.++..+||+|||++....... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 9999999987653 4799999999999999999999998 99999999999998554467999999998765432 2
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
....|++.|+|||++. ..++.++|+|||||++|+|++|..||... +.......+..+..+ ......+..++++|.+|
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~ 237 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFA-PISPNFSRDLRSLISQL 237 (257)
T ss_pred cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhcccCC-CCCCCCCHHHHHHHHHH
Confidence 3457899999999764 56889999999999999999999999764 444444444444322 22344567999999999
Q ss_pred CC-CCCCCCCHHHHhcCccc
Q 006277 249 LV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~ 267 (652)
|. +|++|||+.++++||||
T Consensus 238 l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 238 FKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred hccChhhCcCHHHHhhCCCC
Confidence 97 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.85 Aligned_cols=248 Identities=28% Similarity=0.399 Sum_probs=197.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC----CeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN----KTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~----~~~~L 88 (652)
...+++++.|.||+|.+..+|..||+|.+.... .......++.+|+.+++.++||||++++++|..... ..+|+
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 98 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL 98 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccc--cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEE
Confidence 356777777999999999999999999886432 234556778899999999999999999998864421 35799
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
||||+. ++|.+++... +++..+..++.||+.||+|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 99 v~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 99 VMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSF 172 (353)
T ss_pred EEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCccceeCCCCC
Confidence 999995 5888887654 899999999999999999999998 99999999999998 56899999999998764432
Q ss_pred -cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC-CC---------------
Q 006277 169 -AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI-KP--------------- 230 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~-~p--------------- 230 (652)
.....||+.|+|||++ ...++.++|||||||++|+|++|..||....... .+..+.... .|
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (353)
T cd07850 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPSDEFMSRLQPTVRNY 251 (353)
T ss_pred CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhhhhhhHH
Confidence 2446789999999976 4579999999999999999999999997643322 222221100 00
Q ss_pred ---------ccc----------------cCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 231 ---------AAL----------------SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 231 ---------~~l----------------~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
..+ ....+..+++||.+||. +|.+|||+.|+|.||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 252 VENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 000 11345678999999998 8999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=314.15 Aligned_cols=248 Identities=24% Similarity=0.390 Sum_probs=203.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...++++..+.||+|.+..+|+.||+|.++.... .....+.+.+|+++++.++||||+++++++.+.. .+++||||
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~iv~e~ 81 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG--RLYLVFEY 81 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEECC--EEEEEEec
Confidence 3567777779999999999999999998865432 3345678999999999999999999999997644 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---~ 169 (652)
+.++.|..+..+...+++..+..++.||+.||.|||.++ ++||||+|+||+++ .++.+||+|||++....... .
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEEeeecccccCCCccccc
Confidence 998888777776677999999999999999999999998 99999999999998 57899999999988765432 3
Q ss_pred ccccCCCCccCcccc-cc-CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-------------------CC
Q 006277 170 KSVIGTPEFMAPELY-DE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-------------------GI 228 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl-~~-~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-------------------g~ 228 (652)
...+|++.|+|||++ .. .++.++|||||||++|+|++|.+||.+......+...... +.
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 456789999999976 34 6789999999999999999999999875544433322110 00
Q ss_pred C-C---------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 229 K-P---------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 229 ~-p---------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
. + ..++...++++++||.+||. +|.+||++.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 0 01223347889999999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.03 Aligned_cols=246 Identities=26% Similarity=0.391 Sum_probs=194.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...++++..+.||+|.+..+|..||+|.+..... ......+.+|+++++.++|+||+++++++.+.. ..|+||||
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~lv~e~ 84 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHTKE--TLTFVFEY 84 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC--eEEEEEec
Confidence 3567777789999999999999999999875432 122345678999999999999999999987554 79999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
+. ++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++..... ..
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEc-CCCcEEEeccccccccCCCCCCC
Confidence 95 677776654 356889999999999999999999998 99999999999998 6789999999998765332 22
Q ss_pred ccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc--CCC----------------
Q 006277 170 KSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GIK---------------- 229 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~--g~~---------------- 229 (652)
....+++.|+|||++.+ .++.++|||||||++|+|++|..||.+..........+.. +..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 34568999999998743 5788999999999999999999999765444333322211 000
Q ss_pred -------Cccc----c-CCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 230 -------PAAL----S-KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 230 -------p~~l----~-~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
+..+ . ...++.+.+||.+||+ +|++|||+.|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 0 0125689999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.63 Aligned_cols=246 Identities=28% Similarity=0.474 Sum_probs=207.4
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+++.+..|.||+|.+..++..||+|.+.... .......+.+|+.+++++.||||+++++++.+.. .+|+||||+
T Consensus 10 ~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 84 (277)
T cd06640 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT--KLWIIMEYL 84 (277)
T ss_pred hhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--EEEEEEecC
Confidence 46777888999999999999999999987543 2456788999999999999999999999987754 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--ccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~~ 171 (652)
.||+|.+++.. +++++..+..++.|++.||+|||+.+ ++|+||+|+||+++ .++.++|+|||++..+.... ...
T Consensus 85 ~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 85 GGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEc-CCCCEEEcccccceeccCCcccccc
Confidence 99999999865 57899999999999999999999998 99999999999998 67899999999997664432 234
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
..|+..|+|||++. ..++.++|+|||||++|+|++|..||.... .......+..+. +.......+..+.+||.+||.
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLIPKNN-PPTLTGEFSKPFKEFIDACLN 238 (277)
T ss_pred ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC-hHhHhhhhhcCC-CCCCchhhhHHHHHHHHHHcc
Confidence 57899999999774 468899999999999999999999998743 333333343332 334445567889999999997
Q ss_pred -CCCCCCCHHHHhcCcccccc
Q 006277 251 -PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 251 -~P~~RpSa~elL~hpf~~~~ 270 (652)
+|.+||++.++++||||...
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 239 KDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred cCcccCcCHHHHHhChHhhhc
Confidence 89999999999999999743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.93 Aligned_cols=242 Identities=22% Similarity=0.307 Sum_probs=203.6
Q ss_pred EEEEEEecCcEEEEEEEccCC-----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNG-----LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG-----~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~ 87 (652)
..++++++.|.||+|.+...+ ..||+|.+.... ......++.+|+++++.++||||+++++++.+.. ..|
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--~~~ 84 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ--PTC 84 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC--ceE
Confidence 456778888999999987665 789999876432 3456678999999999999999999999887554 789
Q ss_pred EEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCC
Q 006277 88 IITELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 151 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g 151 (652)
++|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+|||++ +++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~-~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG-EGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc-CCC
Confidence 999999999999999765 45788999999999999999999998 99999999999998 678
Q ss_pred cEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHh
Q 006277 152 EVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVS 225 (652)
Q Consensus 152 ~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~ 225 (652)
.+||+|||++....... .....+++.|+|||.+ ...++.++|||||||++|||++ |..||.+ ....++...+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHH
Confidence 99999999987653221 2345678899999976 5679999999999999999998 9999987 45667777777
Q ss_pred cCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 226 SGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 226 ~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.+..+ ..+...++++.+|+.+||. +|.+||++.+++++
T Consensus 241 ~~~~~-~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLL-PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcC-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 66543 3445678999999999998 89999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.18 Aligned_cols=236 Identities=23% Similarity=0.337 Sum_probs=192.1
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
+++++..|.||++.++.+|..+|+|.+...... .. |+.....+ +||||++++++|.... .+|+||||+
T Consensus 23 ~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~~-----e~~~~~~~~~h~~iv~~~~~~~~~~--~~~iv~e~~ 91 (267)
T PHA03390 23 KLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN----AI-----EPMVHQLMKDNPNFIKLYYSVTTLK--GHVLIMDYI 91 (267)
T ss_pred eecCCCceEEEEEEEcCCCcEEEEEEEehhhcc----hh-----hHHHHHHhhcCCCEEEEEEEEecCC--eeEEEEEcC
Confidence 357888899999999999999999998754321 11 22222222 7999999999987655 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI 173 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~v 173 (652)
++|+|.+++...+.+++..++.++.||++||.|||+.+ ++||||||+||+++...+.++|+|||++...... ....
T Consensus 92 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~ 167 (267)
T PHA03390 92 KDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--SCYD 167 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--ccCC
Confidence 99999999998889999999999999999999999998 9999999999999854448999999998765432 3457
Q ss_pred CCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHH----HHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 174 GTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSA----QIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 174 GTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~----~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
|++.|+|||++. ..++.++|||||||++|+|++|..||....... .+.... ..+....+..++.+++||.+|
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~ 244 (267)
T PHA03390 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSKNANDFVQSM 244 (267)
T ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccCCcccccCHHHHHHHHHH
Confidence 899999999874 578999999999999999999999997533221 122222 223344456889999999999
Q ss_pred CC-CCCCCCC-HHHHhcCcccc
Q 006277 249 LV-PASQRLS-AKELLMDPFLQ 268 (652)
Q Consensus 249 L~-~P~~RpS-a~elL~hpf~~ 268 (652)
|+ +|.+|++ ++++|+||||.
T Consensus 245 l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 245 LKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred hccChhhCCchHHHHhcCCccc
Confidence 98 8999996 59999999996
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=300.87 Aligned_cols=244 Identities=32% Similarity=0.551 Sum_probs=205.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+++.++.+.||+|.+..+|..|++|++..... .....+.+|+.+++.++||||+++++++.... ..++++||+
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~l~~e~~ 79 (253)
T cd05122 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKD--ELWIVMEFC 79 (253)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--eEEEEEecC
Confidence 567777789999999999999999999875432 46778999999999999999999999987654 799999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-ccc
Q 006277 94 TSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~~~ 171 (652)
.+++|.+++... +.+++..+..++.|++.||.|||.+| ++||||+|+||+++ .++.++|+|||++....... ...
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEc-cCCeEEEeeccccccccccccccc
Confidence 999999998876 68999999999999999999999988 99999999999998 57899999999998776543 356
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
..|+..|+|||.+. ..++.++|+||||+++|+|++|..||........+.................+..+.+||.+||.
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHcc
Confidence 68899999999764 45788999999999999999999999875444444433332221111222237899999999997
Q ss_pred -CCCCCCCHHHHhcCcc
Q 006277 251 -PASQRLSAKELLMDPF 266 (652)
Q Consensus 251 -~P~~RpSa~elL~hpf 266 (652)
+|.+|||+.++|.|||
T Consensus 237 ~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 237 KNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CChhhCCCHHHHhcCCC
Confidence 8999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.26 Aligned_cols=245 Identities=23% Similarity=0.289 Sum_probs=195.5
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..++++..|.||+|.+..+|..||+|+++.... +... ....+|+.+++++ +||||+++++++.+..++.+++||||
T Consensus 5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred eeccccccceEEEEEEcCCCcEEEEEEehhccC--Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 467778889999999999999999998864321 2222 2345789999999 59999999999987755689999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-cc
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~~ 170 (652)
+. |+|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||||+||+++. +.+||+|||++..+.... ..
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 82 MD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD--DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred CC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC--CCeEEEecccccccccCCCcC
Confidence 96 578777765 357899999999999999999999998 999999999999984 899999999998765432 24
Q ss_pred cccCCCCccCcccc-c-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC--C--------------CCc-
Q 006277 171 SVIGTPEFMAPELY-D-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--I--------------KPA- 231 (652)
Q Consensus 171 ~~vGTp~YmAPEvl-~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g--~--------------~p~- 231 (652)
...+++.|+|||++ . +.++.++|||||||++|+|++|.+||.+... ...+..+... . ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-LDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN 235 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-HHHHHHHHHHcCCCCHHHHHhhccccccccc
Confidence 45789999999965 3 4578899999999999999999999977433 2222222210 0 000
Q ss_pred ----------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 232 ----------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 232 ----------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
.+....+..+++||.+||. +|.+||++.++|.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred CcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0112356899999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=340.80 Aligned_cols=231 Identities=31% Similarity=0.438 Sum_probs=194.7
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
=|+.+.+|.||+|.- .++.||||+|+- .-..+|+-|++|+||||+.|.+++. +...+|||||||.
T Consensus 131 WlGSGaQGAVF~Grl--~netVAVKKV~e-----------lkETdIKHLRkLkH~NII~FkGVCt--qsPcyCIiMEfCa 195 (904)
T KOG4721|consen 131 WLGSGAQGAVFLGRL--HNETVAVKKVRE-----------LKETDIKHLRKLKHPNIITFKGVCT--QSPCYCIIMEFCA 195 (904)
T ss_pred hhccCcccceeeeec--cCceehhHHHhh-----------hhhhhHHHHHhccCcceeeEeeeec--CCceeEEeeeccc
Confidence 356677899999975 468999998751 1124788899999999999999764 4458999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-cccccc
Q 006277 95 SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKSVI 173 (652)
Q Consensus 95 gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~~~v 173 (652)
.|.|...++..+.+.......|..+|+.|+.|||.|. |||||||.-||||+ .+..|||+|||-++.+... ...+++
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs-~~d~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILIS-YDDVVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEee-ccceEEeccccchHhhhhhhhhhhhh
Confidence 9999999999999999999999999999999999999 99999999999998 4558999999999988654 356899
Q ss_pred CCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-C
Q 006277 174 GTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-P 251 (652)
Q Consensus 174 GTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~ 251 (652)
||..|||||+++ +..++++|||||||+|||||||+.||.+-...+-|+ -|-........+...+..++-||++||. +
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw-GVGsNsL~LpvPstcP~GfklL~Kqcw~sK 351 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW-GVGSNSLHLPVPSTCPDGFKLLLKQCWNSK 351 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE-eccCCcccccCcccCchHHHHHHHHHHhcC
Confidence 999999999885 578999999999999999999999997744333222 1222223344566677899999999997 8
Q ss_pred CCCCCCHHHHhcC
Q 006277 252 ASQRLSAKELLMD 264 (652)
Q Consensus 252 P~~RpSa~elL~h 264 (652)
|..||+..++|.|
T Consensus 352 pRNRPSFrqil~H 364 (904)
T KOG4721|consen 352 PRNRPSFRQILLH 364 (904)
T ss_pred CCCCccHHHHHHH
Confidence 9999999999998
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.00 Aligned_cols=246 Identities=27% Similarity=0.410 Sum_probs=198.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+++.++.+.||+|.+..+|..||+|++..... ......+.+|+.+++.++||||+++++++.+.. ..++||||
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 79 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTEN--KLMLVFEY 79 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--cEEEEEec
Confidence 3577777789999999999999999999976432 233566778999999999999999999998765 78999999
Q ss_pred CCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 93 FTSGSLRQYRKKH---KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~---~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
+.+ +|.+++... ..+++..+..++.||+.||.|||++| ++||||||+||+++ .++.+||+|||++..+....
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLIN-KRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCcEEEeecchhhhhcCCcc
Confidence 975 888887654 36899999999999999999999998 99999999999998 67899999999997664322
Q ss_pred -cccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC---------------
Q 006277 169 -AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--------------- 230 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p--------------- 230 (652)
.....+++.|+|||++.+ .++.++|||||||++|+|++|.+||.+........+.+.....|
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 234567899999997643 57889999999999999999999998755443322221110000
Q ss_pred -----------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 231 -----------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 231 -----------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
..+....++.+++||.+||+ +|.+||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00112346789999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.51 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=198.3
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCC---CeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQN---KTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~---~~~~LV 89 (652)
..++++..|.||+|.+..+|+.||+|++..... .......+.+|+.+++.+ +||||+++++++..... ..+|+|
T Consensus 7 ~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred eEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 567888889999999999999999998865422 223446788899999999 56999999998875442 248999
Q ss_pred EecCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhh
Q 006277 90 TELFTSGSLRQYRKKH-----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 164 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~-----~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l 164 (652)
|||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++..++.+||+|||++..+
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecccceec
Confidence 999975 888887643 35899999999999999999999998 9999999999999954789999999998765
Q ss_pred hccc--cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC----------
Q 006277 165 EQAN--AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP---------- 230 (652)
Q Consensus 165 ~~~~--~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p---------- 230 (652)
.... .....+++.|+|||++. ..++.++|||||||++|+|++|.+||.+........+....-..+
T Consensus 162 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T cd07837 162 SIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK 241 (295)
T ss_pred CCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhh
Confidence 4321 23346789999999764 357899999999999999999999998755544443322210000
Q ss_pred ------------c---cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 231 ------------A---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 231 ------------~---~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
. ......++++.+||.+||. +|.+||++.|+|.||||+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 242 LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred ccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0 0012357889999999997 899999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.72 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=199.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+++++..++||+|.++.+|+.||+|.+..... .......+.+|++++++++||||+++++++.+.. .+|+||||+
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 83 (294)
T PLN00009 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK--RLYLVFEYL 83 (294)
T ss_pred EEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecCC--eEEEEEecc
Confidence 567777779999999999999999999865432 1234567888999999999999999999987654 799999999
Q ss_pred CCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c
Q 006277 94 TSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 169 (652)
Q Consensus 94 ~gGsL~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~ 169 (652)
. ++|.+++..... +++..++.++.||+.||+|||+++ ++||||+|+||+++..++.+||+|||++....... .
T Consensus 84 ~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 84 D-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred c-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 5 588888765543 588999999999999999999998 99999999999998556689999999997654322 2
Q ss_pred ccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC-----------------
Q 006277 170 KSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP----------------- 230 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p----------------- 230 (652)
....|++.|+|||++.+ .++.++|||||||++|+|+||.+||........+.+.+..-..+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA 240 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence 34578899999997743 57899999999999999999999998754444444332210000
Q ss_pred ------c---cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 231 ------A---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 231 ------~---~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
. ......++.+++||.+||. +|.+||++.+++.||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 0112357889999999997 89999999999999999754
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=316.33 Aligned_cols=246 Identities=28% Similarity=0.443 Sum_probs=202.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..|+||+|.+..+|+.||+|++..... ...+..+++.+|+.+++.++||||+++++++.+.. ..|+||||+
T Consensus 21 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~ 97 (307)
T cd06607 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH--TAWLVMEYC 97 (307)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC--eEEEEHHhh
Confidence 456777779999999999999999999864432 23456678999999999999999999999988655 789999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 94 TSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 94 ~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
. |+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||+|+||+++ .++.+||+|||++..... ....
T Consensus 98 ~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~-~~~~~kL~dfg~~~~~~~--~~~~ 171 (307)
T cd06607 98 L-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSASLVSP--ANSF 171 (307)
T ss_pred C-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEC-CCCCEEEeecCcceecCC--CCCc
Confidence 6 577676653 457999999999999999999999998 99999999999998 668999999999876543 2456
Q ss_pred cCCCCccCcccc----ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 173 IGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 173 vGTp~YmAPEvl----~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
.|++.|+|||++ .+.++.++||||||+++|+|++|.+||........++ .+.....+.......+..+++||.+|
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~ 250 (307)
T cd06607 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLSSNDWSDYFRNFVDSC 250 (307)
T ss_pred cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-HHhcCCCCCCCchhhCHHHHHHHHHH
Confidence 789999999976 2468899999999999999999999997644333333 33333333322334577899999999
Q ss_pred CC-CCCCCCCHHHHhcCccccc
Q 006277 249 LV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~~~ 269 (652)
|. +|.+||++.+++.||||..
T Consensus 251 l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 251 LQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred hcCChhhCcCHHHHhcChhhcc
Confidence 97 8999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=315.48 Aligned_cols=244 Identities=30% Similarity=0.478 Sum_probs=204.2
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
.++++..+.||+|.+..+|..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.. .+|+||||+.
T Consensus 11 ~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~ 85 (277)
T cd06642 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT--KLWIIMEYLG 85 (277)
T ss_pred HhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccCC--ceEEEEEccC
Confidence 4567777999999999999999999887442 2345678999999999999999999999987654 7999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cccc
Q 006277 95 SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSV 172 (652)
Q Consensus 95 gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~~~ 172 (652)
+++|.+++.. +.+++..++.++.||+.||.|||+++ ++|+||+|+||+++ .++.+||+|||++..+.... ....
T Consensus 86 ~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06642 86 GGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEe-CCCCEEEccccccccccCcchhhhcc
Confidence 9999998864 57899999999999999999999998 99999999999998 67899999999998765432 2345
Q ss_pred cCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-
Q 006277 173 IGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV- 250 (652)
Q Consensus 173 vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~- 250 (652)
.|+..|+|||.+. ..++.++|+|||||++|+|++|..||... ........+..+. +..+....+..+.+||.+||.
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06642 162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNS-PPTLEGQYSKPFKEFVEACLNK 239 (277)
T ss_pred cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc-chhhHHhhhhcCC-CCCCCcccCHHHHHHHHHHccC
Confidence 7899999999774 46889999999999999999999999763 3333333343333 233444567889999999997
Q ss_pred CCCCCCCHHHHhcCccccc
Q 006277 251 PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 251 ~P~~RpSa~elL~hpf~~~ 269 (652)
+|.+||++.++++||||..
T Consensus 240 ~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 240 DPRFRPTAKELLKHKFITR 258 (277)
T ss_pred CcccCcCHHHHHHhHHHHH
Confidence 8999999999999999964
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=314.86 Aligned_cols=248 Identities=25% Similarity=0.424 Sum_probs=211.3
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
.-++.+-.|+|+++....+|...|||++.... +.+..+|++..+.++... +.|+||+.|++|+... .+++.||+
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~--dV~IcMel 172 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT--DVFICMEL 172 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccC---CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc--hHHHHHHH
Confidence 44555666899999999999999999998654 478889999999988777 5899999999998755 68999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccc
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 171 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~ 171 (652)
+. ..+..++++ .++++|..+-.+...+++||.||-.+. +|||||+||.|||+| ..|+|||||||++..+-...+++
T Consensus 173 Ms-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlD-e~GniKlCDFGIsGrlvdSkAht 249 (391)
T KOG0983|consen 173 MS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKAHT 249 (391)
T ss_pred HH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEc-cCCCEEeecccccceeecccccc
Confidence 83 344444443 468999999999999999999997553 399999999999999 77999999999999887776654
Q ss_pred -ccCCCCccCccccc----cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc--CCCChHHHHH
Q 006277 172 -VIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS--KVKDPEVKSF 244 (652)
Q Consensus 172 -~vGTp~YmAPEvl~----~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~--~~~s~~~kdl 244 (652)
..|-|.|||||.+. ..|+.++||||||+.++||+||.+||.+|...-+...+|..... +.++ ...++.+++|
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L~~~~gFSp~F~~f 328 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLLPGHMGFSPDFQSF 328 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCCCcccCcCHHHHHH
Confidence 58999999999874 36999999999999999999999999999988888888888544 4444 2379999999
Q ss_pred HHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 245 IEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+..||. |+.+||-..+||+|||+...
T Consensus 329 v~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 329 VKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHHhhcCcccCcchHHHhcCcceeec
Confidence 999997 89999999999999999754
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=339.51 Aligned_cols=243 Identities=27% Similarity=0.412 Sum_probs=201.6
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-C-----CCeeeeeeEEEeCCCCeEEEE
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-H-----NNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-H-----pnIVkl~~~~~d~~~~~~~LV 89 (652)
||++-.|.|.+|+|..||+.||||+|+.. +....+...|+.||..|+ | -|||++|++|...+ .+|||
T Consensus 194 LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~--HlciV 266 (586)
T KOG0667|consen 194 LGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN--HLCIV 266 (586)
T ss_pred ecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc--ceeee
Confidence 34444588999999999999999999843 567888899999999996 3 48999999998765 79999
Q ss_pred EecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEc-CCCCcEEEeccCchhhhhc
Q 006277 90 TELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN-GNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~-~~~g~VKL~DFGla~~l~~ 166 (652)
+|++ +-+|.++++.+ ..|+...++.+++||+.||.+||+.+ |||+||||+|||+. .....|||+|||.|....+
T Consensus 267 fELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred ehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 9999 66999999976 46999999999999999999999999 99999999999997 3345799999999998776
Q ss_pred cccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CC----------------
Q 006277 167 ANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GI---------------- 228 (652)
Q Consensus 167 ~~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~---------------- 228 (652)
... +.+-+..|.|||++ +..|+.+.||||||||++||++|.+-|.+....+|+...+.- |.
T Consensus 344 ~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff 422 (586)
T KOG0667|consen 344 RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFF 422 (586)
T ss_pred cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceeh
Confidence 655 77889999999965 678999999999999999999999999986666665433221 00
Q ss_pred ------------------------------------CCcc-------ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 229 ------------------------------------KPAA-------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 229 ------------------------------------~p~~-------l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.|.. +....+..+.+||.+||. ||.+|+|+.|+|+|
T Consensus 423 ~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 423 TSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred hccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000 001123467999999998 99999999999999
Q ss_pred ccccc
Q 006277 265 PFLQV 269 (652)
Q Consensus 265 pf~~~ 269 (652)
|||..
T Consensus 503 pfl~~ 507 (586)
T KOG0667|consen 503 PFLTG 507 (586)
T ss_pred ccccc
Confidence 99974
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=312.95 Aligned_cols=245 Identities=25% Similarity=0.378 Sum_probs=194.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..|+||+|.++.+|+.||+|.+..... ......+.+|+.+++.++||||+++++++.+.. ..++||||+
T Consensus 11 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 85 (291)
T cd07844 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE---EGAPFTAIREASLLKDLKHANIVTLHDIIHTKK--TLTLVFEYL 85 (291)
T ss_pred EEEeecCCeEEEEEEEcCCCcEEEEEEEecccc---cCCchhHHHHHHHHhhCCCcceeeEEEEEecCC--eEEEEEecC
Confidence 567777779999999999999999999875432 112345678999999999999999999987554 899999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--ccc
Q 006277 94 TSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAK 170 (652)
Q Consensus 94 ~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~ 170 (652)
.+ +|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++...... ...
T Consensus 86 ~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~ 161 (291)
T cd07844 86 DT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYS 161 (291)
T ss_pred CC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEc-CCCCEEECccccccccCCCCcccc
Confidence 75 999988764 46899999999999999999999998 99999999999998 6689999999998754322 123
Q ss_pred cccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC---CC---------------
Q 006277 171 SVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI---KP--------------- 230 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~---~p--------------- 230 (652)
...+++.|+|||++. ..++.++||||+||++|+|++|..||.+..........+.... .+
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY 241 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccc
Confidence 345789999999774 3588999999999999999999999976543333222221100 00
Q ss_pred -------ccc---cCCCC--hHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 231 -------AAL---SKVKD--PEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 231 -------~~l---~~~~s--~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
... ....+ ..+.+||.+||. +|.+|||+.++|.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 01123 788999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=307.30 Aligned_cols=245 Identities=28% Similarity=0.444 Sum_probs=205.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..+.||+|.+..+|..||+|.+..... .......++.+|+.+++.++||||+++++++.+.. ..++||||+
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~~ 84 (267)
T cd08228 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN--ELNIVLELA 84 (267)
T ss_pred eeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC--eEEEEEEec
Confidence 467777789999999999999999998875443 23456678899999999999999999999988654 799999999
Q ss_pred CCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 94 TSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 94 ~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
.+|+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++..+....
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEc-CCCCEEECccccceeccchhH
Confidence 99999988753 345899999999999999999999998 99999999999998 67899999999988764322
Q ss_pred -cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCC-CHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 169 -AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECR-NSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~-~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
.....|++.|+|||.+ ...++.++|+||||+++|+|++|..||.... +...+...+..+..+.......+..+++||
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELV 241 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence 2456789999999976 4568899999999999999999999986533 345566666665555444455678899999
Q ss_pred HHhCC-CCCCCCCHHHHhcC
Q 006277 246 EKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~h 264 (652)
.+||. +|.+||++.++++.
T Consensus 242 ~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 242 SMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHCCCCcccCcCHHHHHHH
Confidence 99997 89999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=305.77 Aligned_cols=242 Identities=27% Similarity=0.418 Sum_probs=205.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..|.||+|.++.+|+.||+|.++... .....+++.+|+.+++.++||||++++++|.+.. .+|+||||+
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 80 (255)
T cd08219 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG--HLYIVMEYC 80 (255)
T ss_pred EEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--EEEEEEeeC
Confidence 57788888999999999999999999987543 2346778899999999999999999999987654 899999999
Q ss_pred CCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c
Q 006277 94 TSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 169 (652)
Q Consensus 94 ~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~ 169 (652)
++|+|.+++... ..+++..++.|+.||+.||.|||++| |+|+||||+||+++ .++.++|+|||++..+.... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEC-CCCcEEEcccCcceeeccccccc
Confidence 999999988653 45899999999999999999999998 99999999999998 67899999999987664332 3
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
....|++.|+|||++. ..++.++|+||||+++|+|++|..||.. .+.......+..+..+ ..+...+..+++||.+|
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYK-PLPSHYSYELRSLIKQM 235 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCC-CCCcccCHHHHHHHHHH
Confidence 4567999999999875 4688999999999999999999999976 4555556666655433 24455678999999999
Q ss_pred CC-CCCCCCCHHHHhcCc
Q 006277 249 LV-PASQRLSAKELLMDP 265 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hp 265 (652)
|. +|.+||++.+++.--
T Consensus 236 l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 236 FKRNPRSRPSATTILSRG 253 (255)
T ss_pred HhCCcccCCCHHHHhhcc
Confidence 97 899999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=306.22 Aligned_cols=239 Identities=22% Similarity=0.341 Sum_probs=197.2
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
+++++..|+||+|.+..+|..||+|.+... ...+...++.+|+.+++.++||||+++++++.+.. .+++||||+.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~ 76 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIYIVMELVQ 76 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--CeEEEEeecc
Confidence 467788899999999999999999987532 13456778999999999999999999999887654 7999999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccc---
Q 006277 95 SGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--- 170 (652)
Q Consensus 95 gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~--- 170 (652)
+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.........
T Consensus 77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEc-CCCcEEECccccCcccccccccccC
Confidence 99999998764 46899999999999999999999998 99999999999998 6789999999998765432211
Q ss_pred -cccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHH
Q 006277 171 -SVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 171 -~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~k 247 (652)
...++..|+|||.+ .+.++.++|||||||++|+|++ |.+||.. .........+..+.. ...+...+..+.+||.+
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 231 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN-LSNQQTREAIEQGVR-LPCPELCPDAVYRLMER 231 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc-cCHHHHHHHHHcCCC-CCCcccCCHHHHHHHHH
Confidence 11234569999976 4568999999999999999998 8888866 344555555555433 23455668899999999
Q ss_pred hCC-CCCCCCCHHHHhc
Q 006277 248 CLV-PASQRLSAKELLM 263 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~ 263 (652)
||+ +|.+|||+.++++
T Consensus 232 ~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 232 CWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 998 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=330.74 Aligned_cols=269 Identities=21% Similarity=0.335 Sum_probs=233.4
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
....|+++-.|.|.+|..+.|.+.||||+++++-++++ ++++--..|.++|... +-|.+++++.+|+.-+ .+|+||
T Consensus 353 Fl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHScFQTmD--RLyFVM 429 (683)
T KOG0696|consen 353 FLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD--RLYFVM 429 (683)
T ss_pred eEEEeccCccceeeeecccCcchhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHHHhhhhh--heeeEE
Confidence 34567777779999999999999999999986555554 6677777788888877 6789999999998765 799999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhh--hhccc
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI--MEQAN 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~--l~~~~ 168 (652)
||++||+|-..+++-+++.|..+..|+.+|+.||-+||++| ||+||||.+||+++ .+|+|||+|||+++. +....
T Consensus 430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd-~eGHiKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIFDGVT 506 (683)
T ss_pred EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEec-cCCceEeeecccccccccCCcc
Confidence 99999999999999999999999999999999999999999 99999999999999 679999999999874 34455
Q ss_pred cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~k 247 (652)
++++||||.|+|||++ -+.|+..+||||+||++|||+.|++||.+ .+..++++.|... ...+++..|.++.+++..
T Consensus 507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~eh--nvsyPKslSkEAv~ickg 583 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEH--NVSYPKSLSKEAVAICKG 583 (683)
T ss_pred eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHc--cCcCcccccHHHHHHHHH
Confidence 7899999999999976 57899999999999999999999999988 7788899999875 356778889999999999
Q ss_pred hCC-CCCCCCC-----HHHHhcCccccccCCCCCCCCCCCCCcCCCCC
Q 006277 248 CLV-PASQRLS-----AKELLMDPFLQVNGTTKNRPLPLPDIVLPRVG 289 (652)
Q Consensus 248 cL~-~P~~RpS-----a~elL~hpf~~~~~~~~~~~~~~p~~~lp~~~ 289 (652)
+|. .|.+|+. -.++-.||||+..+|.+......++++.|+++
T Consensus 584 ~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k 631 (683)
T KOG0696|consen 584 LLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIK 631 (683)
T ss_pred HhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccc
Confidence 997 6999985 46899999999888876655555666667664
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=373.30 Aligned_cols=246 Identities=31% Similarity=0.481 Sum_probs=217.4
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
.++++-.|.||.|.+..||...|+|.+++.... ......+.+|..+|..|+|||+|++|++=++.+ .+||.||||.
T Consensus 1242 ~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe--kv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1242 FIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE--KVYIFMEYCE 1317 (1509)
T ss_pred ccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHH--HHHHHHHHhc
Confidence 345555589999999999999999999876543 345677889999999999999999999766554 7999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc------
Q 006277 95 SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN------ 168 (652)
Q Consensus 95 gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~------ 168 (652)
||+|.+.+...+..+|...+.|..|++.||.|||++| ||||||||.|||++ ..|.+|++|||.|..+....
T Consensus 1318 ~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld-~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1318 GGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLD-FNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred cCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeee-cCCcEEeecccceeEecCchhcCCHH
Confidence 9999999998888999999999999999999999999 99999999999999 66899999999998875432
Q ss_pred cccccCCCCccCcccccc----CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 169 AKSVIGTPEFMAPELYDE----NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~~----~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
....+|||.|||||++.+ +...++|||||||+++||+||+.||...++.-+|+-+|..|..|.. |...+++.++|
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~-P~~ls~~g~dF 1473 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI-PERLSSEGRDF 1473 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC-chhhhHhHHHH
Confidence 245789999999998843 4667899999999999999999999998899999999999987754 44488999999
Q ss_pred HHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 245 IEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
|..||. ||++|.++.|||.|.|-+
T Consensus 1474 le~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1474 LEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred HHHHHhcCchhhhHHHHHHHhhccc
Confidence 999997 999999999999999865
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=310.98 Aligned_cols=247 Identities=34% Similarity=0.575 Sum_probs=206.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..+++++.+.||+|.+..++..||+|++..... ..+.+.+|+++++.++|+||+++++++.... ..|+|+||+
T Consensus 25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~ 97 (286)
T cd06614 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVGD--ELWVVMEYM 97 (286)
T ss_pred HhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC--EEEEEEecc
Confidence 456777779999999999999999999875432 5677889999999999999999999988764 899999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 94 TSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 94 ~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
.+++|.+++..++ .+++..+..++.||+.||.|||+.| ++|+||+|+||+++ .++.++|+|||++....... ..
T Consensus 98 ~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~ 174 (286)
T cd06614 98 DGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRN 174 (286)
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEc-CCCCEEECccchhhhhccchhhhc
Confidence 9999999999877 8999999999999999999999998 99999999999998 67899999999987654322 24
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CCCCccccCCCChHHHHHHHHh
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~~p~~l~~~~s~~~kdlI~kc 248 (652)
...|++.|+|||++. ..++.++|+|||||++|+|++|..||..... ......+.. +..+.......+..+++||.+|
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 253 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-LRALFLITTKGIPPLKNPEKWSPEFKDFLNKC 253 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCcchhhCCHHHHHHHHHH
Confidence 557899999999764 4689999999999999999999999976433 333333333 3222222333678999999999
Q ss_pred CC-CCCCCCCHHHHhcCccccccC
Q 006277 249 LV-PASQRLSAKELLMDPFLQVNG 271 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~~~~~ 271 (652)
|. +|.+||++.++|.||||....
T Consensus 254 l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 254 LVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred hccChhhCcCHHHHhhChHhhccC
Confidence 98 899999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=316.88 Aligned_cols=250 Identities=29% Similarity=0.404 Sum_probs=196.4
Q ss_pred EEEEEecCcEEEEEEEcc--CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 14 LRLIQLVDTSGYKAFDEV--NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~--tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
..+++++.|.||+|.+.. +|..||+|.+..... ......+.+.+|+.+++.++||||+++++++.+.....+++|||
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 84 (316)
T cd07842 6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFD 84 (316)
T ss_pred EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEe
Confidence 457777889999999999 899999999885331 12234567788999999999999999999998875568999999
Q ss_pred cCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC---CCCcEEEeccCchhh
Q 006277 92 LFTSGSLRQYRKKH-----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING---NQGEVKIGDLGLATI 163 (652)
Q Consensus 92 y~~gGsL~~~i~~~-----~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~---~~g~VKL~DFGla~~ 163 (652)
|+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++. ..+.+||+|||++..
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~ 161 (316)
T cd07842 85 YAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161 (316)
T ss_pred CCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCccccc
Confidence 9965 677666432 36899999999999999999999998 999999999999983 168999999999987
Q ss_pred hhccc-----cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHH--------HHHHHHhc--
Q 006277 164 MEQAN-----AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSA--------QIYKKVSS-- 226 (652)
Q Consensus 164 l~~~~-----~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~--------~i~~~I~~-- 226 (652)
+.... ....++|+.|+|||++. ..++.++|||||||++|+|++|.+||.+..... .....+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (316)
T cd07842 162 FNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241 (316)
T ss_pred cCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHh
Confidence 64322 23457899999999764 358899999999999999999999997533221 00000000
Q ss_pred ----------------------CCCCcccc-----------CCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 227 ----------------------GIKPAALS-----------KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 227 ----------------------g~~p~~l~-----------~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
.......+ ...+..+.+||.+||. +|++|||+.|++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred CCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00000000 1456789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=319.94 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=199.1
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCH----------HHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSP----------EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~----------e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 84 (652)
.++.++.|+||+|.+..+|+.||+|+++........ .....+.+|+.++++++||||+++++++....
T Consensus 16 ~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 93 (335)
T PTZ00024 16 HLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD-- 93 (335)
T ss_pred cccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC--
Confidence 367777799999999999999999998754432110 01125788999999999999999999987654
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhh
Q 006277 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 164 (652)
Q Consensus 85 ~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l 164 (652)
.+++||||+. |+|.+++.....+++..+..++.||+.||.|||++| |+||||+|+|||++ .++.+||+|||++...
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~-~~~~~kl~dfg~~~~~ 169 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLARRY 169 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEEC-CCCCEEECCccceeec
Confidence 8999999996 699999988888999999999999999999999998 99999999999998 6789999999998765
Q ss_pred hc----------------cccccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc
Q 006277 165 EQ----------------ANAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS 226 (652)
Q Consensus 165 ~~----------------~~~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~ 226 (652)
.. .......+++.|+|||.+.+ .++.++|||||||++|+|++|.+||.+...... +..+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-~~~i~~ 248 (335)
T PTZ00024 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ-LGRIFE 248 (335)
T ss_pred ccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH
Confidence 41 11123457889999997743 478999999999999999999999987444333 322221
Q ss_pred CC---CCc-----------------------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 227 GI---KPA-----------------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 227 g~---~p~-----------------------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.. .+. ......+..+.+||.+||. +|.+|||+.|+|.||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 00 000 0012346789999999998 89999999999999999854
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.23 Aligned_cols=246 Identities=27% Similarity=0.409 Sum_probs=199.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.+..+.||+|.++.+|..||+|.+..... .......+.+|+++++.++||||+++++++.+. ...|++|||+
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~e~~ 80 (283)
T cd07835 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVFEFL 80 (283)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEEecc
Confidence 456777779999999999999999999876532 123346778899999999999999999998765 4899999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c
Q 006277 94 TSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 169 (652)
Q Consensus 94 ~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~ 169 (652)
. ++|.+++.... .+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++..+.... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCcEEEeecccccccCCCcccc
Confidence 5 69999988766 7999999999999999999999998 99999999999998 57899999999987654322 2
Q ss_pred ccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC-----------------
Q 006277 170 KSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP----------------- 230 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p----------------- 230 (652)
....+++.|+|||++.+ .++.++|||||||++|+|++|.+||.......+.++.+.....+
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 34467899999997643 47889999999999999999999998754444433322211000
Q ss_pred ---------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 231 ---------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 231 ---------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
.......+..+.+||.+||. +|.+|||++|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01123456789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=308.82 Aligned_cols=245 Identities=29% Similarity=0.479 Sum_probs=207.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+++.++.|.||+|.+..+|..||+|++.... .......+.+|+.++++++||||+++++++.+.. .+|+||||+
T Consensus 10 ~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~ 84 (277)
T cd06641 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT--KLWIIMEYL 84 (277)
T ss_pred eeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC--eEEEEEEeC
Confidence 56788888999999999999999999876443 2345678899999999999999999999987654 799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--ccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~~ 171 (652)
.+|+|.+++.. +.+++..+..++.|++.||.|||+++ ++|+||||+||+++ .++.++|+|||++..+.... ...
T Consensus 85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEEC-CCCCEEEeecccceecccchhhhcc
Confidence 99999998864 47899999999999999999999998 99999999999998 66899999999987664332 234
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
..|+..|+|||.+. ..++.++|+|||||++|+|++|..||.. .........+..+. +..+....+.++.+||.+||.
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHHhcCC-CCCCCcccCHHHHHHHHHHcc
Confidence 67899999999774 4678899999999999999999999976 34444444454433 334455678899999999997
Q ss_pred -CCCCCCCHHHHhcCccccc
Q 006277 251 -PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 251 -~P~~RpSa~elL~hpf~~~ 269 (652)
+|.+||++.++++||||..
T Consensus 239 ~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 239 KEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred CChhhCcCHHHHHhCHHHhh
Confidence 8999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.38 Aligned_cols=244 Identities=25% Similarity=0.368 Sum_probs=194.7
Q ss_pred cCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHH
Q 006277 20 VDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLR 99 (652)
Q Consensus 20 ~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~ 99 (652)
..++||+|.+..+|+.||+|++..... ..+..+.+.+|+.+++.++||||++++++|.... .+++||||+.+|+|.
T Consensus 12 ~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~~~v~e~~~~~~l~ 87 (328)
T cd08226 12 NLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--WLWVISPFMAYGSAN 87 (328)
T ss_pred CceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC--ceEEEEecccCCCHH
Confidence 457899999999999999999875432 2456688999999999999999999999997654 789999999999999
Q ss_pred HHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c------
Q 006277 100 QYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A------ 169 (652)
Q Consensus 100 ~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~------ 169 (652)
+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+|++||+.+....... .
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (328)
T cd08226 88 SLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRNGQKAKVVYDF 164 (328)
T ss_pred HHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEe-CCCcEEEechHHHhhhhccCccccccccc
Confidence 998764 35899999999999999999999998 99999999999998 66899999998654432211 1
Q ss_pred -ccccCCCCccCcccccc---CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC-C--------------
Q 006277 170 -KSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-P-------------- 230 (652)
Q Consensus 170 -~~~vGTp~YmAPEvl~~---~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~-p-------------- 230 (652)
....++..|||||++.+ .|+.++|||||||++|+|++|.+||............+..... +
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (328)
T cd08226 165 PQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMK 244 (328)
T ss_pred cccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhc
Confidence 11235667999998753 4789999999999999999999999875444433333221100 0
Q ss_pred -----------------------------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 231 -----------------------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 231 -----------------------------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.......++.+++||.+||. +|.+|||+.|+|+||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 245 NSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred cchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00112245689999999997 89999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=348.36 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=202.7
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeeee-EEEeC--C--CCe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYN-SWIDD--Q--NKT 85 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~~-~~~d~--~--~~~ 85 (652)
.-.-|.++|.+.||+|.+...|..||+|.+-.. ++..++.+.+||.+|+.|+ |+|||.|++ +.... . ...
T Consensus 41 V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 41 VEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 345678888999999999999999999987643 5788999999999999995 999999999 33222 1 246
Q ss_pred EEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 86 VNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 86 ~~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
++|+||||.||.|-++++.+ .+|+|.+++.|+.+++.|+.+||...|||||||||-+||||+ .+|+.||||||.|.-
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-CCCCEEeCccccccc
Confidence 88999999999999999843 569999999999999999999999999999999999999998 678999999998864
Q ss_pred hhccc--c---------ccccCCCCccCcccc---c-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC
Q 006277 164 MEQAN--A---------KSVIGTPEFMAPELY---D-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI 228 (652)
Q Consensus 164 l~~~~--~---------~~~vGTp~YmAPEvl---~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~ 228 (652)
..... . -...-||.|.|||.+ . ...++|+|||+|||+||-|+.+..||.+.... .|..|.
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----aIlng~ 270 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----AILNGN 270 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----eEEecc
Confidence 32111 1 123569999999965 3 36899999999999999999999999774232 255565
Q ss_pred CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcc
Q 006277 229 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPF 266 (652)
Q Consensus 229 ~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf 266 (652)
...+....++..+++||..||+ +|.+||++-|++.+-+
T Consensus 271 Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 271 YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 5444445677899999999998 8999999999997644
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=303.11 Aligned_cols=240 Identities=23% Similarity=0.361 Sum_probs=205.6
Q ss_pred EEEEecCcEEEEEEEccC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 15 RLIQLVDTSGYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~t---G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.+++++.|.||+|.+... +..||+|.+..... ....+.+.+|+.+++.++|+||+++++++.+. ..+++|||
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e 76 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCTEE--EPLYLVLE 76 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeecCC--CceEEEEE
Confidence 467778899999999876 99999999875432 22578899999999999999999999988763 48999999
Q ss_pred cCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 92 LFTSGSLRQYRKKH---------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 92 y~~gGsL~~~i~~~---------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
|+.+|+|.+++... ..+++..+..++.||+.||+|||+++ ++||||||+||+++ .++.+||+|||.+.
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~-~~~~~~l~dfg~~~ 153 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVG-EDLVVKISDFGLSR 153 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEEC-CCCcEEEccccccc
Confidence 99999999999875 78999999999999999999999998 99999999999998 56899999999998
Q ss_pred hhhccc----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCC
Q 006277 163 IMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKV 236 (652)
Q Consensus 163 ~l~~~~----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~ 236 (652)
...... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.. ....++...+..+... ..+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~ 231 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG-LSNEEVLEYLRKGYRL-PKPEY 231 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCcc
Confidence 775432 34567889999999774 478999999999999999999 5999987 4667777777765432 34455
Q ss_pred CChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 237 KDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 237 ~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.++++.++|.+||. +|.+|||+.|++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 68899999999997 89999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.23 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=201.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...+++++.|.||+|.+..+|+.||+|++..... .....+.+.+|+++++.++||||+++++++.+.. .+|+||||
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 81 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK--RLYLVFEF 81 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC--eEEEEEec
Confidence 3577888889999999999999999998764332 2234567889999999999999999999986544 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
+.++.|..+......+++..++.++.||+.||.|||+.+ ++||||+|+||+++ .++.++|+|||++..+.... ..
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 82 VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred CCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCcEEEEeeeeeeeccCCccccC
Confidence 999999888777777999999999999999999999998 99999999999998 67899999999988764432 23
Q ss_pred cccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-------------------CCC
Q 006277 171 SVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-------------------GIK 229 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-------------------g~~ 229 (652)
...|++.|+|||++. ..++.++|||||||++|+|++|.+||............... +..
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 457899999999774 35788999999999999999999999764433332222110 000
Q ss_pred -Cc--------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 230 -PA--------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 230 -p~--------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
+. ......+..+++||.+||. +|.+||++.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 0112346789999999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=335.41 Aligned_cols=245 Identities=25% Similarity=0.382 Sum_probs=208.6
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 95 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~g 95 (652)
|+.+-.|+||-|.+..+|+.||||+|.+-+.- +.....++.|+.||+++.||.||.+--.|+..+ .+++|||-+.|
T Consensus 572 LGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp--~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e--rvFVVMEKl~G 647 (888)
T KOG4236|consen 572 LGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP--TKQESQLRNEVAILQNLHHPGIVNLECMFETPE--RVFVVMEKLHG 647 (888)
T ss_pred ccCCcceeeecceecccCceeeeeeeecccCC--CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc--eEEEEehhhcc
Confidence 45555689999999999999999999866553 345588999999999999999999998876655 89999999955
Q ss_pred CCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCC--CcEEEeccCchhhhhcc-ccc
Q 006277 96 GSLRQYRK--KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ--GEVKIGDLGLATIMEQA-NAK 170 (652)
Q Consensus 96 GsL~~~i~--~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~--g~VKL~DFGla~~l~~~-~~~ 170 (652)
++.+.|- +.++++++..++++.||+-||.|||-+| |+|+||||+|||+...+ -++||||||+|+++... ..+
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr 724 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR 724 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence 6666554 4578999999999999999999999999 99999999999998432 36999999999999765 468
Q ss_pred cccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC--CCCccccCCCChHHHHHHHH
Q 006277 171 SVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 171 ~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g--~~p~~l~~~~s~~~kdlI~k 247 (652)
+++|||.|+|||++ +.+|+..-|+||+|||+|.-+.|..||.+..+ |...|+.. ..|+..++.+++++.+||..
T Consensus 725 sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---IndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---INDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---hhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 89999999999988 46899999999999999999999999976444 44445443 34555566678999999999
Q ss_pred hCC-CCCCCCCHHHHhcCcccccc
Q 006277 248 CLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+|+ +-.+|.|..+.|.|||+|..
T Consensus 802 LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHhcchHhhccchhhhcc
Confidence 997 78999999999999999864
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=328.96 Aligned_cols=242 Identities=24% Similarity=0.358 Sum_probs=197.2
Q ss_pred EEEEEEecCcEEEEEEEccCC-----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNG-----LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTV 86 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG-----~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~ 86 (652)
...|++++.|.||+|.+..+| ..||+|.++... ..+..+.+.+|+++++.+ +|||||++++++.... .+
T Consensus 43 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~--~~ 117 (374)
T cd05106 43 GKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGACTHGG--PV 117 (374)
T ss_pred hheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC--Ce
Confidence 456777778999999965544 579999987432 245577899999999999 8999999999887654 79
Q ss_pred EEEEecCCCCCHHHHHHhC-------------------------------------------------------------
Q 006277 87 NIITELFTSGSLRQYRKKH------------------------------------------------------------- 105 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~~------------------------------------------------------------- 105 (652)
++|||||.+|+|.+++.+.
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999999999988643
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc----ccc
Q 006277 106 ---------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA----KSV 172 (652)
Q Consensus 106 ---------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~----~~~ 172 (652)
.++++..++.++.||+.||.|||++| |+||||||+|||++ +++.+||+|||+++.+..... ...
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEe-CCCeEEEeeceeeeeccCCcceeeccCC
Confidence 24788899999999999999999998 99999999999998 678999999999986543221 223
Q ss_pred cCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 173 IGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 173 vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
.+++.|||||++ ...|+.++|||||||++|+|++ |..||........++..+..+. ....+...+++++++|.+||+
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~ 353 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-QMSRPDFAPPEIYSIMKMCWN 353 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc-CccCCCCCCHHHHHHHHHHcC
Confidence 456789999976 5679999999999999999997 9999987554445555555443 333445568999999999998
Q ss_pred -CCCCCCCHHHHhc
Q 006277 251 -PASQRLSAKELLM 263 (652)
Q Consensus 251 -~P~~RpSa~elL~ 263 (652)
+|.+|||+.++++
T Consensus 354 ~dp~~RPs~~~l~~ 367 (374)
T cd05106 354 LEPTERPTFSQISQ 367 (374)
T ss_pred CChhhCcCHHHHHH
Confidence 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.62 Aligned_cols=247 Identities=30% Similarity=0.504 Sum_probs=203.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.+..|+||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.. ..|+|+||+
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~e~~ 98 (293)
T cd06647 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLVGD--ELWVVMEYL 98 (293)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeeeCC--cEEEEEecC
Confidence 46777778999999999999999999986432 234577899999999999999999999987754 799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--ccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~~ 171 (652)
.+++|.+++.+. .+++..+..++.|++.||.|||++| ++||||||+||+++ .++.+||+|||++..+.... ...
T Consensus 99 ~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~-~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 99 AGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEc-CCCCEEEccCcceeccccccccccc
Confidence 999999998754 5889999999999999999999998 99999999999998 66899999999887654332 234
Q ss_pred ccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
..|++.|+|||.+ ...++.++|+|||||++|+|++|..||.......++......+......+...+..+++||.+||.
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 254 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 254 (293)
T ss_pred ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHcc
Confidence 5789999999976 456889999999999999999999999774443333322222222222233456789999999997
Q ss_pred -CCCCCCCHHHHhcCcccccc
Q 006277 251 -PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 251 -~P~~RpSa~elL~hpf~~~~ 270 (652)
+|.+||++.+++.||||+..
T Consensus 255 ~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 255 MDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred CChhhCcCHHHHhcCHHHhcC
Confidence 89999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=313.55 Aligned_cols=240 Identities=23% Similarity=0.302 Sum_probs=191.1
Q ss_pred EEEEEecCcEEEEEEEcc----------------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeE
Q 006277 14 LRLIQLVDTSGYKAFDEV----------------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNS 77 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~----------------tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~ 77 (652)
.++++++.|.||+|.+.. ++..||+|++.... ......++.+|+.+|++++||||++++++
T Consensus 11 ~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 87 (304)
T cd05096 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPNIIRLLGV 87 (304)
T ss_pred eEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCCeeEEEEE
Confidence 578888889999998532 45689999886432 34567789999999999999999999999
Q ss_pred EEeCCCCeEEEEEecCCCCCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeecc
Q 006277 78 WIDDQNKTVNIITELFTSGSLRQYRKKHK-------------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRD 138 (652)
Q Consensus 78 ~~d~~~~~~~LVmEy~~gGsL~~~i~~~~-------------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRD 138 (652)
+.+.. .+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||++| |+|||
T Consensus 88 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH~d 163 (304)
T cd05096 88 CVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRD 163 (304)
T ss_pred EecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--ccccC
Confidence 87654 6999999999999999986532 3677889999999999999999998 99999
Q ss_pred CCcccEEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh--ccCCC
Q 006277 139 LKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT--FEYPY 211 (652)
Q Consensus 139 LKp~NILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt--G~~Pf 211 (652)
|||+|||++ .++.+||+|||++..+.... .....+++.|||||++ .+.++.++|||||||++|+|++ +..||
T Consensus 164 lkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 164 LATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred cchhheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 999999998 67899999999998664322 2334568899999976 5679999999999999999986 56788
Q ss_pred CCCCCHHHHHHHHhc----CC--CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHh
Q 006277 212 SECRNSAQIYKKVSS----GI--KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELL 262 (652)
Q Consensus 212 ~~~~~~~~i~~~I~~----g~--~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL 262 (652)
.... ..+....+.. .. .....+...+..+.+||.+||. +|.+|||+.++.
T Consensus 243 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 243 GELT-DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CcCC-HHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 7643 3333333221 11 1111233456889999999998 899999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=327.54 Aligned_cols=242 Identities=22% Similarity=0.323 Sum_probs=198.5
Q ss_pred EEEEEecCcEEEEEEE-----ccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEE
Q 006277 14 LRLIQLVDTSGYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d-----~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~ 87 (652)
.+|++++.|+||+|.+ ..++..||+|+++... .....+.+.+|+++|+.+ +|||||++++++.+.. ..+
T Consensus 41 ~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~--~~~ 115 (375)
T cd05104 41 KTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGACTVGG--PTL 115 (375)
T ss_pred heecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC--cce
Confidence 4677778899999974 4577899999886432 234567889999999999 8999999999887654 789
Q ss_pred EEEecCCCCCHHHHHHhCC-------------------------------------------------------------
Q 006277 88 IITELFTSGSLRQYRKKHK------------------------------------------------------------- 106 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~------------------------------------------------------------- 106 (652)
+|||||++|+|.+++...+
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 9999999999999886432
Q ss_pred --------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc---
Q 006277 107 --------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA--- 169 (652)
Q Consensus 107 --------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~--- 169 (652)
.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+.....
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEE-CCCcEEEecCccceeccCcccccc
Confidence 4788899999999999999999998 99999999999998 567899999999986643221
Q ss_pred -ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 170 -KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 170 -~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
....+++.|+|||++ ...|+.++|||||||++|+|++ |..||........+++.+..+..+ ..+...+.++++||.
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 351 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-LSPECAPSEMYDIMK 351 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-CCCCCCCHHHHHHHH
Confidence 223456789999977 4579999999999999999998 899998765566677777666433 234456789999999
Q ss_pred HhCC-CCCCCCCHHHHhcC
Q 006277 247 KCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~h 264 (652)
+||. +|.+|||+.++++.
T Consensus 352 ~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 352 SCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHccCChhHCcCHHHHHHH
Confidence 9998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.66 Aligned_cols=253 Identities=22% Similarity=0.322 Sum_probs=208.6
Q ss_pred EEEEEEecCcEEEEEEEc---cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~---~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~L 88 (652)
..++++++.|.||+|.+. .+|..||+|++............+++.+|+++++++ +||||+++++++.... .+|+
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--~~~l 82 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT--KLHL 82 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC--eEEE
Confidence 357788888999999985 489999999987544333334567888999999999 6999999999887543 7999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
||||+.+++|.+++...+++++..+..++.||+.||.|||+.+ ++||||+|+|||++ .++.+||+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 83 ILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEC-CCCCEEEeeCccceeccccc
Confidence 9999999999999998888999999999999999999999998 99999999999998 67899999999987664322
Q ss_pred ---cccccCCCCccCccccc---cCCCccccchhhHHHHHHHhhccCCCCCCC---CHHHHHHHHhcCCCCccccCCCCh
Q 006277 169 ---AKSVIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYSECR---NSAQIYKKVSSGIKPAALSKVKDP 239 (652)
Q Consensus 169 ---~~~~vGTp~YmAPEvl~---~~y~~~sDIWSlGvilyeLltG~~Pf~~~~---~~~~i~~~I~~g~~p~~l~~~~s~ 239 (652)
.....|++.|+|||.+. ..++.++||||||+++|+|++|..||.... ....+...+..... .++...++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 237 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSA 237 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCccCCH
Confidence 23567999999999774 357889999999999999999999996422 22333344433322 24556788
Q ss_pred HHHHHHHHhCC-CCCCCC-----CHHHHhcCccccccCC
Q 006277 240 EVKSFIEKCLV-PASQRL-----SAKELLMDPFLQVNGT 272 (652)
Q Consensus 240 ~~kdlI~kcL~-~P~~Rp-----Sa~elL~hpf~~~~~~ 272 (652)
.+.+|+.+||. +|.+|| ++.+++.||||+...|
T Consensus 238 ~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 99999999998 899997 8999999999986554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=318.65 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=197.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC---CCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ---NKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~---~~~~~LV 89 (652)
...+++++.|+||+|.+..+|+.||+|++.... ......++.+|+.+++.++||||+++++++.... ...+|+|
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 357888888999999999999999999986322 2345677889999999999999999999775432 2358999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
+||+. ++|..++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 87 ~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 87 QELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred ehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEECcccceeecccccc
Confidence 99996 58888775 457999999999999999999999998 99999999999998 67899999999987654321
Q ss_pred ----cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc---------------C
Q 006277 169 ----AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS---------------G 227 (652)
Q Consensus 169 ----~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~---------------g 227 (652)
....+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+...... ...+.. .
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-LNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCCHHHHHHhhch
Confidence 13457899999999753 3688999999999999999999999976432221 111110 0
Q ss_pred C-----------CCcc---ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 228 I-----------KPAA---LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 228 ~-----------~p~~---l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
. .... .....++++.+||.+||. +|.+|||+.+++.||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0 0000 112346789999999998 89999999999999999743
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=306.81 Aligned_cols=240 Identities=20% Similarity=0.276 Sum_probs=198.0
Q ss_pred EEEEEecCcEEEEEEEc---cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~---~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
..++++..|.||+|.++ ..+..||+|.++... +......+.+|+.++++++||||+++++++... ..+++||
T Consensus 11 ~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 85 (266)
T cd05064 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG--NTMMIVT 85 (266)
T ss_pred eeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--CCcEEEE
Confidence 56788888999999875 467799999987432 244567789999999999999999999988654 3799999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 91 ELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
||+.+|+|.+++... +.+++..+..++.||+.||+|||+++ ++||||||+|||++ .++.+|++|||.+.......
T Consensus 86 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~-~~~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 86 EYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVN-SDLVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred EeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEc-CCCcEEECCCcccccccccch
Confidence 999999999998774 57899999999999999999999998 99999999999998 57899999999876543221
Q ss_pred --cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 169 --AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
.....+++.|+|||++ .+.++.++|||||||++|+|++ |..||.. .....+.+.+..+..+ ..+...+..+.++
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 240 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD-MSGQDVIKAVEDGFRL-PAPRNCPNLLHQL 240 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHH
Confidence 1223456789999976 4678999999999999999775 9999987 4455566666665433 3455678899999
Q ss_pred HHHhCC-CCCCCCCHHHHhc
Q 006277 245 IEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~ 263 (652)
+.+||. +|.+||++.++++
T Consensus 241 i~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 241 MLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHcCCCchhCCCHHHHHH
Confidence 999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=314.36 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=205.2
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...+++++..|+||+|.+..+|..||+|++..... ........+.+|+++++.++||||+++++++.+.. ..|+|||
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 101 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH--TAWLVME 101 (313)
T ss_pred cceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--EEEEEEe
Confidence 34568888889999999999999999999875433 23456678899999999999999999999988764 7999999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccc
Q 006277 92 LFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 170 (652)
Q Consensus 92 y~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~ 170 (652)
|+. |+|.+++.. ..++++..+..++.||+.||.|||++| ++||||+|+||+++ .++.+||+|||++.... ...
T Consensus 102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~-~~~~~kL~dfg~~~~~~--~~~ 175 (313)
T cd06633 102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKSS--PAN 175 (313)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEEC-CCCCEEEeecCCCcccC--CCC
Confidence 996 577776654 457899999999999999999999998 99999999999998 66899999999886432 234
Q ss_pred cccCCCCccCccccc----cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 171 SVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~----~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
...|++.|+|||++. +.++.++|||||||++|+|++|.+||.........+... ....+.......+..+++||.
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~ 254 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSPTLQSNEWTDSFRGFVD 254 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-hcCCCCCCccccCHHHHHHHH
Confidence 568899999999762 458889999999999999999999998755444454443 333333334456678999999
Q ss_pred HhCC-CCCCCCCHHHHhcCccccc
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+||. +|.+||++.+++.||||+.
T Consensus 255 ~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 255 YCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred HHccCChhhCcCHHHHhcCcccCC
Confidence 9997 8999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=299.64 Aligned_cols=245 Identities=33% Similarity=0.523 Sum_probs=209.4
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..+.||+|.+..+|+.||+|.+..... .....+.+.+|++++++++||||+++++++.+.. .++++|||+
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~~ 81 (254)
T cd06627 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD--SLYIILEYA 81 (254)
T ss_pred eEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC--EEEEEEecC
Confidence 467777789999999999999999999976543 2356788999999999999999999999887653 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc--cc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA--KS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~--~~ 171 (652)
.+++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+||+++ .++.++|+|||++........ ..
T Consensus 82 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 82 ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTT-KDGVVKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEC-CCCCEEEeccccceecCCCcccccc
Confidence 99999999998889999999999999999999999998 99999999999998 578999999999987755432 45
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
..|++.|+|||.+. ..++.++||||||+++|+|++|..||..........+.. .... ..++...+..+++||.+||.
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDH-PPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCC-CCCCCCCCHHHHHHHHHHHh
Confidence 67899999999764 457889999999999999999999997755434444433 3222 23455678899999999997
Q ss_pred -CCCCCCCHHHHhcCccc
Q 006277 251 -PASQRLSAKELLMDPFL 267 (652)
Q Consensus 251 -~P~~RpSa~elL~hpf~ 267 (652)
+|++||++.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 89999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=312.19 Aligned_cols=247 Identities=25% Similarity=0.340 Sum_probs=193.4
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC------CCeEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ------NKTVN 87 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~------~~~~~ 87 (652)
..++++..+.||+|.+..+|+.||+|.+..... .......+.+|+.++++++||||+++++++.+.. ....+
T Consensus 18 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 95 (310)
T cd07865 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFY 95 (310)
T ss_pred EEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEE
Confidence 466667778999999999999999999875432 1223445678999999999999999999876543 23579
Q ss_pred EEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 88 IITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||++| ++||||||+||+++ .++.+||+|||++..+..
T Consensus 96 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~ 171 (310)
T cd07865 96 LVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGILKLADFGLARAFSL 171 (310)
T ss_pred EEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-CCCcEEECcCCCcccccC
Confidence 9999996 4888777654 37899999999999999999999998 99999999999998 678999999999986643
Q ss_pred cc------cccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc--CC-CCc----
Q 006277 167 AN------AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GI-KPA---- 231 (652)
Q Consensus 167 ~~------~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~--g~-~p~---- 231 (652)
.. .....+++.|+|||++.+ .++.++||||||+++|+|++|.+||.+... ......+.. +. .+.
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-QHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhhccc
Confidence 22 124567889999997643 478899999999999999999999976432 222111111 10 000
Q ss_pred -----------------------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 232 -----------------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 232 -----------------------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
......++.+++||.+||. +|.+|||+.++|+||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0012235678899999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=308.67 Aligned_cols=246 Identities=28% Similarity=0.427 Sum_probs=207.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...++.++.+.||+|.+..+|+.||+|++...... .......+.+|+.+++++. ||||+++++++.+.. .+++|||
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~--~~~lv~e 82 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE--NLYFVLE 82 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc--eEEEEEc
Confidence 35677778899999999999999999998754332 3345578899999999998 999999999886554 7999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
|+.+++|.+++.+.+.+++..+..++.||+.||.|||++| ++|+||+|+||+++ .+|.++|+|||++.......
T Consensus 83 ~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 83 YAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEecCCccccccCCccccc
Confidence 9999999999999889999999999999999999999998 99999999999998 67899999999988664321
Q ss_pred -------------------cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC
Q 006277 169 -------------------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI 228 (652)
Q Consensus 169 -------------------~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~ 228 (652)
.....|++.|+|||++ ...++.++|+||||+++++|++|..||... ...+.++.+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~ 238 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS-NEYLTFQKILKLE 238 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHhcC
Confidence 2345788999999976 456888999999999999999999999874 3445555554432
Q ss_pred CCccccCCCChHHHHHHHHhCC-CCCCCCCH----HHHhcCccc
Q 006277 229 KPAALSKVKDPEVKSFIEKCLV-PASQRLSA----KELLMDPFL 267 (652)
Q Consensus 229 ~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa----~elL~hpf~ 267 (652)
. .++...++.+.+||.+||. +|.+||++ +++|+||||
T Consensus 239 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 Y--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred C--CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 2 2344557899999999997 89999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=307.42 Aligned_cols=240 Identities=22% Similarity=0.337 Sum_probs=200.3
Q ss_pred EEEEEecCcEEEEEEEc-----cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 14 LRLIQLVDTSGYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~-----~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
..+++++.|.||+|.+. .++..||+|.+.... ..+..+.+.+|+++|+.++||||+++++++.... ..++
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~l 85 (280)
T cd05049 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD--PPIM 85 (280)
T ss_pred hhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC--CeEE
Confidence 46788888999999875 347899999886432 2345688999999999999999999999987654 7999
Q ss_pred EEecCCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEE
Q 006277 89 ITELFTSGSLRQYRKKHK--------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVK 154 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~--------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VK 154 (652)
||||+.+|+|.+++...+ .+++..+..++.||+.||.|||++| ++||||||+||+++ .++.+|
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~~k 162 (280)
T cd05049 86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVG-YDLVVK 162 (280)
T ss_pred EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEc-CCCeEE
Confidence 999999999999987643 4788999999999999999999998 99999999999998 668999
Q ss_pred EeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCC
Q 006277 155 IGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGI 228 (652)
Q Consensus 155 L~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~ 228 (652)
|+|||++....... .....+++.|+|||++ .+.++.++|||||||++|+|++ |..||.+ .........+..+.
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~-~~~~~~~~~~~~~~ 241 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG-LSNEEVIECITQGR 241 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCC
Confidence 99999987653221 2344567899999977 4578999999999999999998 9999977 44556667777665
Q ss_pred CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 229 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 229 ~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
.+. .+...+..+++||.+||. +|.+||++.|++.
T Consensus 242 ~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 242 LLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 433 334577899999999997 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=301.35 Aligned_cols=246 Identities=30% Similarity=0.476 Sum_probs=209.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...++++..+.||+|.+..+|+.||+|.+..... ......++.+|+.+++.++||||+++++++.+. ...|+||||
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~ 80 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVMEY 80 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEehh
Confidence 3567777779999999999999999999875443 234567888999999999999999999998765 489999999
Q ss_pred CCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 93 FTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 93 ~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
+++++|.+++.+ ...+++..+..++.|++.||.|||++| ++||||+|+||+++ .++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~-~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLV-ANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEe-cCCcEEEeeccchhhhccCC
Confidence 999999998866 356899999999999999999999998 99999999999998 56899999999998876654
Q ss_pred cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~k 247 (652)
.....|++.|+|||.+ ...++.++|+||||+++|+|++|..||.. .+...+...+..+..+. .+...+.+++++|.+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ 235 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQDLRYKVQRGKYPP-IPPIYSQDLQNFIRS 235 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCC-CchhhCHHHHHHHHH
Confidence 4556789999999976 45688899999999999999999999977 44555555665554332 334677899999999
Q ss_pred hCC-CCCCCCCHHHHhcCccc
Q 006277 248 CLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~ 267 (652)
||. +|.+||++.++++||++
T Consensus 236 ~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 236 MLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HcCCCcccCCCHHHHhcCCCC
Confidence 997 89999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=301.77 Aligned_cols=244 Identities=29% Similarity=0.484 Sum_probs=203.8
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..+.||+|.+..+|++||+|.++..... .....+++.+|+.++++++|+||+++++++.+.. ..++||||+
T Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~--~~~lv~e~~ 84 (267)
T cd08224 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN--ELNIVLELA 84 (267)
T ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeeccccc-chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC--eEEEEEecC
Confidence 4667777799999999999999999998754432 3455788999999999999999999999997654 799999999
Q ss_pred CCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 94 TSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 94 ~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
++|+|..++.. ...+++..+..|+.||+.||.|||++| |+||||+|+||+++ .++.++|+|||++..+....
T Consensus 85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 85 DAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEEC-CCCcEEEeccceeeeccCCCc
Confidence 99999998864 345899999999999999999999998 99999999999998 56899999999987654322
Q ss_pred -cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCC-CHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 169 -AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECR-NSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~-~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
.....|++.|+|||.+ ...++.++|||||||++|+|++|..||.... +.......+..+..+.......+..++++|
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 241 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV 241 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHH
Confidence 2446789999999976 4568999999999999999999999996533 344555666665544333335678999999
Q ss_pred HHhCC-CCCCCCCHHHHhc
Q 006277 246 EKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~ 263 (652)
.+||. +|.+|||+.++++
T Consensus 242 ~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 242 SRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHcCCCcccCCCHHHHHH
Confidence 99997 8999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=332.18 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=199.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
.+||.+|.+.||++..... +.||+|.+... ..+.+.+.-+..||.+|.+| .|.+||++|+|-+.+ +++|+||||
T Consensus 367 k~iG~GGSSkV~kV~~s~~-~iyalkkv~~~--~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d--~~lYmvmE~ 441 (677)
T KOG0596|consen 367 KQIGSGGSSKVFKVLNSDK-QIYALKKVVLL--EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD--GYLYMVMEC 441 (677)
T ss_pred HhhcCCCcceeeeeecCCC-cchhhhHHHHh--hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC--ceEEEEeec
Confidence 4566666689999997554 45556655433 34678899999999999999 699999999976654 499999997
Q ss_pred CCCCCHHHHHHhCCCCCH-HHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKKHKKVDM-KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse-~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
- ..+|...++++....+ -.++.|..|||.|+.++|.+| |||.||||.|+|+- .|.+||+|||+|..+....
T Consensus 442 G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV--kG~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 442 G-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV--KGRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred c-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE--eeeEEeeeechhcccCccccce
Confidence 5 5699999988765444 589999999999999999999 99999999999985 5899999999999887654
Q ss_pred -cccccCCCCccCccccc-c-----------CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccC
Q 006277 169 -AKSVIGTPEFMAPELYD-E-----------NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 235 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl~-~-----------~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~ 235 (652)
..+.+||+.||+||.+. . +.+.++||||||||+|+|+.|++||....+....+..|...-....++.
T Consensus 517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~ 596 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPD 596 (677)
T ss_pred eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccC
Confidence 35679999999999651 1 1567899999999999999999999775555555666665433344555
Q ss_pred CCChH-HHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 236 VKDPE-VKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 236 ~~s~~-~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
..... +.++++.||+ ||.+|+|+.+||+|||++
T Consensus 597 ~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~ 631 (677)
T KOG0596|consen 597 IPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQ 631 (677)
T ss_pred CCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccc
Confidence 54444 9999999997 999999999999999997
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=320.50 Aligned_cols=249 Identities=26% Similarity=0.383 Sum_probs=198.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---------
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--------- 83 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~--------- 83 (652)
...|+.++.|.||+|.++.+|..||+|++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 3566777779999999999999999999876542 456778899999999999999999987755432
Q ss_pred ---CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCc
Q 006277 84 ---KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160 (652)
Q Consensus 84 ---~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGl 160 (652)
..+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++..++.+||+|||+
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEECCccc
Confidence 25799999996 589888764 57999999999999999999999998 999999999999986667899999999
Q ss_pred hhhhhccc-----cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC------
Q 006277 161 ATIMEQAN-----AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG------ 227 (652)
Q Consensus 161 a~~l~~~~-----~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g------ 227 (652)
+..+.... .....|++.|+|||++. ..++.++|||||||++|+|++|..||.+..........+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241 (342)
T ss_pred ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 97654321 12346889999999653 458889999999999999999999997754333322221110
Q ss_pred ----------------CCC-----ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 228 ----------------IKP-----AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 228 ----------------~~p-----~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
... ..+....+.++++||.+||+ +|.+|||+.++|.||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 242 DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 000 01112456889999999998 8999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.32 Aligned_cols=248 Identities=22% Similarity=0.315 Sum_probs=200.4
Q ss_pred EEEEEEecCcEEEEEEEcc-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 006277 13 YLRLIQLVDTSGYKAFDEV-----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~-----tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~ 87 (652)
..++++++.|.||+|.++. .+..||+|.+.... ......++.+|+.+++.++||||+++++++.+.. ..|
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~ 85 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ--PTL 85 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC--CcE
Confidence 4678888889999998653 46689999876332 2344567889999999999999999999876544 789
Q ss_pred EEEecCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEec
Q 006277 88 IITELFTSGSLRQYRKKH----------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 157 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~----------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~D 157 (652)
+||||+.+|+|.+++.+. ..++...+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~-~~~~~~L~D 162 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVA-HDFTVKIGD 162 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEc-CCCcEEECc
Confidence 999999999999999753 23466788999999999999999998 99999999999998 578999999
Q ss_pred cCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCc
Q 006277 158 LGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPA 231 (652)
Q Consensus 158 FGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~ 231 (652)
||+++...... .....++..|+|||.+ .+.++.++|||||||++|+|++ |.+||.+ ....++++.+..+..+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~~~~ 241 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFVMDGGYLD 241 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC
Confidence 99987653321 1233557789999976 4578999999999999999998 7889976 45566666666554332
Q ss_pred cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc------Ccccccc
Q 006277 232 ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM------DPFLQVN 270 (652)
Q Consensus 232 ~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~------hpf~~~~ 270 (652)
.+...++.++++|.+||. +|.+|||+.++++ ||||+..
T Consensus 242 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 242 -QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 334457899999999997 8999999999986 8998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=303.51 Aligned_cols=239 Identities=21% Similarity=0.326 Sum_probs=200.4
Q ss_pred EEEEecCcEEEEEEE--ccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 15 RLIQLVDTSGYKAFD--EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 15 rL~~l~~gtVykA~d--~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
.+++++.|.||+|.+ +.++..||+|+++... ..+...+.+..|+.+++.++||||+++++++.. ...++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEec
Confidence 467788899999964 5678999999886443 234567889999999999999999999997643 257999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc----
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---- 168 (652)
+.+|+|.+++...+.+++..+..++.||+.||.|||++| |+||||||.|||++ .++.+||+|||++..+....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEc-CCCeEEECCCccccccCCCCCeee
Confidence 999999999988888999999999999999999999998 99999999999998 56789999999998764322
Q ss_pred -cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 169 -AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
.....+++.|+|||.+. ..++.++|||||||++|||++ |..||.. .....+...+..+..+ ..+...++++++||
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li 231 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERM-ECPQRCPPEMYDLM 231 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence 12234467899999774 468889999999999999998 9999976 4556777777776543 35566789999999
Q ss_pred HHhCC-CCCCCCCHHHHhc
Q 006277 246 EKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~ 263 (652)
.+||+ +|.+||++.++.+
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 232 KLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHhccCchhCcCHHHHHH
Confidence 99997 8999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=319.67 Aligned_cols=250 Identities=25% Similarity=0.374 Sum_probs=201.4
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC--CCCeEEEEEe
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD--QNKTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~--~~~~~~LVmE 91 (652)
..+++++.|.||+|.++.+|..||+|++..... ......++.+|+.+|+.++||||+++++++... ....+++|||
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence 567888889999999999999999999875422 224567788899999999999999999987543 2347899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
|+. |+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.......
T Consensus 89 ~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 164 (334)
T cd07855 89 LME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSSPTEH 164 (334)
T ss_pred hhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEecccccceeecccCcCC
Confidence 995 689999988888999999999999999999999998 99999999999998 67899999999987654321
Q ss_pred ---cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CC--------------
Q 006277 169 ---AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GI-------------- 228 (652)
Q Consensus 169 ---~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~-------------- 228 (652)
....+|++.|+|||.+. ..++.++|||||||++|+|++|.+||.+.....++...+.. |.
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~ 244 (334)
T cd07855 165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRV 244 (334)
T ss_pred CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhH
Confidence 13457899999999774 35899999999999999999999999764433222111110 00
Q ss_pred ----------CCcc---ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 229 ----------KPAA---LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 229 ----------~p~~---l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.+.. +....++.+++||.+||+ +|.+||++.+++.||||..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 245 RKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299 (334)
T ss_pred HHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence 0000 113357899999999997 8999999999999999973
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=301.43 Aligned_cols=243 Identities=25% Similarity=0.415 Sum_probs=208.6
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 95 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~g 95 (652)
+++++.+.||+|.+..+|+.||+|++..... .......++..|+.+++.++||||+++++.+.+.. .+|+||||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE--KLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC--eeEEEEecCCC
Confidence 3566778999999999999999999875543 33456778999999999999999999999886544 89999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cccccc
Q 006277 96 GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAKSVI 173 (652)
Q Consensus 96 GsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~~~v 173 (652)
++|.+++...+.+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ .++.++|+|||++...... ......
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEc-CCCcEEEeecCcceecccCCCcccCCc
Confidence 999999998888999999999999999999999988 99999999999998 6789999999998876543 244567
Q ss_pred CCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-C
Q 006277 174 GTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-P 251 (652)
Q Consensus 174 GTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~ 251 (652)
|+..|+|||... ..++.++|+||||+++|+|++|..||.. ......+..+..+. ..++...+..+.+||.+||. +
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDP--LRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhcCC
Confidence 899999999764 4578899999999999999999999976 44466666666533 33555567899999999997 8
Q ss_pred CCCCCCH---HHHhcCccc
Q 006277 252 ASQRLSA---KELLMDPFL 267 (652)
Q Consensus 252 P~~RpSa---~elL~hpf~ 267 (652)
|.+||++ ++++.||||
T Consensus 232 p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhhCCCcccHHHHHhCCCC
Confidence 9999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=306.19 Aligned_cols=242 Identities=22% Similarity=0.323 Sum_probs=195.9
Q ss_pred EEEEEEecCcEEEEEEEc-----cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 006277 13 YLRLIQLVDTSGYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~-----~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~ 87 (652)
..++++++.|.||+|.+. .++..||+|.+.... ......++.+|+.+++.++||||+++++++.+. ...+
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~ 85 (277)
T cd05062 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG--QPTL 85 (277)
T ss_pred eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCeE
Confidence 467788888999999875 346789999875322 234556788999999999999999999987644 3799
Q ss_pred EEEecCCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEec
Q 006277 88 IITELFTSGSLRQYRKKHK----------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 157 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~----------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~D 157 (652)
+||||+.+|+|.+++...+ .++...+..++.|++.||.|||+.+ ++||||||+||+++ .++.+||+|
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~-~~~~~~l~d 162 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEc-CCCCEEECC
Confidence 9999999999999987532 3577889999999999999999998 99999999999998 578999999
Q ss_pred cCchhhhhccc----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCc
Q 006277 158 LGLATIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPA 231 (652)
Q Consensus 158 FGla~~l~~~~----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~ 231 (652)
||++..+.... .....+++.|||||++. +.++.++|||||||++|+|++ |..||.+ .+.....+.+..+..+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~~~- 240 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-MSNEQVLRFVMEGGLL- 240 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCcC-
Confidence 99987654321 12345678899999874 568999999999999999999 6889976 4555666655554432
Q ss_pred cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 232 ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 232 ~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
..+...+..+++||.+||. +|.+|||+.+++.+
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3345567889999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=319.05 Aligned_cols=249 Identities=25% Similarity=0.336 Sum_probs=199.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---CeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN---KTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~---~~~~LVm 90 (652)
..+++++.|+||+|.+..+|..||+|++.... .......++.+|+.+++.++||||+++++++..... ..+|+||
T Consensus 11 ~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07858 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88 (337)
T ss_pred EEeccCCCeEEEEEEecCCCCeEEEEEecccc--cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence 45666667899999999999999999987432 123445677889999999999999999998764422 3589999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--c
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--N 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~ 168 (652)
||+. ++|.+++...+.+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++...... .
T Consensus 89 e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~ 164 (337)
T cd07858 89 ELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLN-ANCDLKICDFGLARTTSEKGDF 164 (337)
T ss_pred eCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcCccccccCCCccc
Confidence 9995 689999988889999999999999999999999998 99999999999998 5689999999999876433 2
Q ss_pred cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc---C----------------
Q 006277 169 AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS---G---------------- 227 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~---g---------------- 227 (652)
.....|+..|+|||.+. ..++.++|||||||++|+|++|.+||.+.. ....+..+.. .
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07858 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD-YVHQLKLITELLGSPSEEDLGFIRNEKARR 243 (337)
T ss_pred ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHHhCCCChHHhhhcCchhhhH
Confidence 24557899999999764 458899999999999999999999997632 2211111110 0
Q ss_pred --------CCC--ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 228 --------IKP--AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 228 --------~~p--~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
..+ .......++++++||.+||+ +|.+|||+.++|+||||..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 244 YIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred HHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 000 01123467889999999998 8999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=303.82 Aligned_cols=244 Identities=30% Similarity=0.491 Sum_probs=203.3
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.+..|.||+|.+..+|..||+|.+...+.. ......++.+|+.+++.++||||++++++|.+.. .++++|||+
T Consensus 8 ~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~v~e~~ 84 (267)
T cd08229 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELNIVLELA 84 (267)
T ss_pred hhhcccCCeEEEEEeecCCCceEEEEeeeehhhh-hHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC--eEEEEEEec
Confidence 3567777799999999999999999988754432 3345678899999999999999999999987654 799999999
Q ss_pred CCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 94 TSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 94 ~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
.+++|.+++.. ...+++..+..++.||+.||.|||++| ++|+||||+||+++ .++.++|+|||++..+....
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 85 DAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEECcchhhhccccCCc
Confidence 99999998763 356899999999999999999999998 99999999999998 56899999999988765432
Q ss_pred -cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCC-CHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 169 -AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECR-NSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~-~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
.....|++.|+|||.+ ...++.++|+||||+++|+|++|..||.+.. ......+.+.....+.......++.+++||
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 241 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHH
Confidence 2356799999999977 4568889999999999999999999996533 234555556555444444456788999999
Q ss_pred HHhCC-CCCCCCCHHHHhc
Q 006277 246 EKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~ 263 (652)
.+||. +|.+|||+.++++
T Consensus 242 ~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 242 NMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHhcCCCcccCCCHHHHHH
Confidence 99997 8999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.82 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=202.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+++++.+.||+|.+..+|..||+|.+.... ........+.+|+.+++++ +||||+++++++.......+|+||||
T Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07852 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF--RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY 90 (337)
T ss_pred HhhcCCCCeeEEEEEEcCCCeEEEEEeecccc--CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecc
Confidence 46777778999999999999999999885321 2334566788899999999 99999999999876655679999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc----
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---- 168 (652)
+. ++|..++... .+++..+..++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..+....
T Consensus 91 ~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~-~~~~~kl~d~g~~~~~~~~~~~~~ 165 (337)
T cd07852 91 ME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSLSELEENPE 165 (337)
T ss_pred cc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccchhcccccccccc
Confidence 96 5999988765 7899999999999999999999998 99999999999998 67899999999998664321
Q ss_pred ---cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC---------------
Q 006277 169 ---AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--------------- 228 (652)
Q Consensus 169 ---~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~--------------- 228 (652)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||.+........+.+....
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (337)
T cd07852 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFA 245 (337)
T ss_pred CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhH
Confidence 23457899999999763 4578999999999999999999999976544433222111110
Q ss_pred -------------CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 229 -------------KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 229 -------------~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.........+.++.+||.+||+ +|.+|||+.+++.||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 246 ATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0011122357889999999998 89999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.24 Aligned_cols=239 Identities=25% Similarity=0.367 Sum_probs=200.8
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+++++..+.||+|.++.++..||+|.+... ......+.+|+.+++.++||||+++++++.... .+++||||+
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 84 (263)
T cd05052 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYIITEFM 84 (263)
T ss_pred eecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCC--CcEEEEEeC
Confidence 4567777799999999999999999987632 234567889999999999999999999886544 789999999
Q ss_pred CCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccc-
Q 006277 94 TSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK- 170 (652)
Q Consensus 94 ~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~- 170 (652)
.+|+|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+|||++ +++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCcEEeCCCccccccccceeec
Confidence 999999998754 35899999999999999999999998 99999999999998 6789999999999876543221
Q ss_pred --cccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 171 --SVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 171 --~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
...+++.|+|||.+ ...++.++|||||||++|+|++ |..||.+ ......+..+..+..+ ..+...++++.++|.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 239 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRM-ERPEGCPPKVYELMR 239 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHHH
Confidence 22346689999976 4578899999999999999998 8999977 5667777777765433 345567889999999
Q ss_pred HhCC-CCCCCCCHHHHhcC
Q 006277 247 KCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~h 264 (652)
+||. +|++||++.++++.
T Consensus 240 ~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 240 ACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHccCCcccCCCHHHHHHH
Confidence 9997 89999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.81 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=201.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...++.++.|.||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||+++++++.+......++||||
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 356777888999999999999999999998653 223445678889999999999999999999877633589999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
+.+ +|..++... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++ +++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEc-CCCCEEEccccceeeccCCCccc
Confidence 974 898888765 57999999999999999999999998 99999999999998 67899999999998775443
Q ss_pred cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC---CCc------------
Q 006277 169 AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI---KPA------------ 231 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~---~p~------------ 231 (652)
.....+++.|+|||.+. ..++.++||||||+++|+|++|..||...... .....+.... .+.
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccchhhh
Confidence 33456788999999664 35789999999999999999999999874433 3333322210 000
Q ss_pred --------------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 232 --------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 232 --------------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
.+....++.+.+||.+||. +|.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0111237889999999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=309.88 Aligned_cols=248 Identities=25% Similarity=0.330 Sum_probs=194.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC------CeE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN------KTV 86 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~------~~~ 86 (652)
...++.++.+.||+|.+..+|+.||+|++...... ......+.+|+++++.++||||+++++++.+... ..+
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 90 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV 90 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC--CCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence 45678888899999999999999999998754321 1223456789999999999999999998765432 358
Q ss_pred EEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh
Q 006277 87 NIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~ 165 (652)
++||+|+.+ +|..++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 91 ~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 91 YMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYD 166 (311)
T ss_pred EEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECcCccchhcc
Confidence 999999965 67666654 457999999999999999999999998 99999999999998 67899999999998654
Q ss_pred ccc-------------cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC---
Q 006277 166 QAN-------------AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--- 227 (652)
Q Consensus 166 ~~~-------------~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g--- 227 (652)
... .....|++.|+|||++. ..++.++|||||||++|+|++|.+||.+..... ....+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~~~~~~ 245 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIFKLCGT 245 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCC
Confidence 221 12346789999999764 358899999999999999999999997744333 22222210
Q ss_pred CCC----------------------ccc---cCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 228 IKP----------------------AAL---SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 228 ~~p----------------------~~l---~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
..+ ..+ ....++.+.+||.+||. +|.+|||+.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000 000 01234678999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.77 Aligned_cols=241 Identities=24% Similarity=0.399 Sum_probs=198.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeE----EEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLE----VAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~----VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
...+++++.|+||+|.+..+|.. ||+|.+... ......+++.+|+.+++.++||||+++++++... ..++
T Consensus 12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~---~~~~ 85 (316)
T cd05108 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---TVQL 85 (316)
T ss_pred eeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---Ccee
Confidence 35788888899999998776664 899987632 2345677899999999999999999999988653 4789
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 89 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
|++|+.+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~-~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEec-CCCcEEEccccccccccCC
Confidence 99999999999998875 46899999999999999999999998 99999999999998 6679999999999876532
Q ss_pred cc----ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHH
Q 006277 168 NA----KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 168 ~~----~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~ 241 (652)
.. ....+++.|+|||.+ ...++.++|||||||++|||++ |..||.+ ....++...+..+..+ ..+...+..+
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 240 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICTIDV 240 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhCCCCC-CCCCCCCHHH
Confidence 21 223346789999976 4578999999999999999997 9999976 4555565555554432 2345567899
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 242 KSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.++|.+||. +|.+||++.+++.+
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999997 89999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=310.99 Aligned_cols=246 Identities=28% Similarity=0.502 Sum_probs=204.4
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..|.||+|.+..+|..||+|++... .......+.+|+.+++.++||||+++++++.+.. ..++||||+
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~ 99 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELWVVMEFL 99 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC--EEEEEEecC
Confidence 4578888899999999999999999987533 2345677999999999999999999999987654 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--ccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~~ 171 (652)
++++|.+++. .+.+++..+..++.|++.||+|||++| ++||||+|.||+++ .++.++|+|||++....... ...
T Consensus 100 ~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 100 EGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEcccccceecccccccccc
Confidence 9999999875 457899999999999999999999998 99999999999998 66899999999887654321 234
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc-cccCCCChHHHHHHHHhC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA-ALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~-~l~~~~s~~~kdlI~kcL 249 (652)
..|++.|+|||.+. ..++.++|+|||||++|+|++|..||.. .........+..+..+. ......++.+.+||.+||
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL 254 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence 67899999999764 5688999999999999999999999976 34344444444433221 122346789999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccc
Q 006277 250 V-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 250 ~-~P~~RpSa~elL~hpf~~~~ 270 (652)
. +|.+||++.++|.||||...
T Consensus 255 ~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 255 VRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred hCCcccCcCHHHHhcChHHhcc
Confidence 7 89999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=310.16 Aligned_cols=246 Identities=27% Similarity=0.440 Sum_probs=203.7
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..+.||+|.+..+|..||+|.+..... ...+...++.+|+++++.++||||+++++++.+.. ..++||||+
T Consensus 31 ~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~ 107 (317)
T cd06635 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH--TAWLVMEYC 107 (317)
T ss_pred heeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--eEEEEEeCC
Confidence 467777889999999999999999999875433 23456678999999999999999999999987654 789999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 94 TSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 94 ~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
.| +|.+++.. ..++++..+..++.||+.||.|||+++ |+||||+|+||+++ .++.+||+|||++..... ....
T Consensus 108 ~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~-~~~~~kl~dfg~~~~~~~--~~~~ 181 (317)
T cd06635 108 LG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASIASP--ANSF 181 (317)
T ss_pred CC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEEC-CCCCEEEecCCCccccCC--cccc
Confidence 75 77776654 467999999999999999999999998 99999999999998 578999999998875432 2456
Q ss_pred cCCCCccCcccc----ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 173 IGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 173 vGTp~YmAPEvl----~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
.|++.|+|||++ .+.++.++|||||||++|+|++|.+||........++. +..+..+.......++.+++||.+|
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~ 260 (317)
T cd06635 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNESPTLQSNEWSDYFRNFVDSC 260 (317)
T ss_pred cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HHhccCCCCCCccccHHHHHHHHHH
Confidence 789999999976 24688999999999999999999999977444444444 4443333333445678899999999
Q ss_pred CC-CCCCCCCHHHHhcCccccc
Q 006277 249 LV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~~~ 269 (652)
|+ +|.+||++.++++|+|+..
T Consensus 261 l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 261 LQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ccCCcccCcCHHHHHhChhhhc
Confidence 97 8999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.20 Aligned_cols=241 Identities=25% Similarity=0.324 Sum_probs=199.6
Q ss_pred EEEEEecCcEEEEEEEc----cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDE----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~----~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
.+|++++.|+||+|... .++..||+|.+.... ..+....+.+|+.+++.++||||+++++++.... ..|+|
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv 85 (283)
T cd05090 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ--PVCML 85 (283)
T ss_pred eeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC--ceEEE
Confidence 67888888999999853 456889999886432 3456678999999999999999999999887654 78999
Q ss_pred EecCCCCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCc
Q 006277 90 TELFTSGSLRQYRKKH-----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE 152 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~-----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~ 152 (652)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~-~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG-EQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc-CCCc
Confidence 9999999999998633 24788899999999999999999998 99999999999998 6678
Q ss_pred EEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhc
Q 006277 153 VKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSS 226 (652)
Q Consensus 153 VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~ 226 (652)
+||+|||+++...... .....++..|+|||.+ .+.++.++|||||||++|+|++ |.+||.+ .....+...+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~ 241 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEVIEMVRK 241 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHc
Confidence 9999999998764321 2345567789999976 4568999999999999999998 9999976 455566666665
Q ss_pred CCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 227 GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 227 g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
+..+ ..+...++.+++||.+||+ +|.+||++.+++++
T Consensus 242 ~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 242 RQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5433 3455678999999999998 89999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=306.41 Aligned_cols=239 Identities=22% Similarity=0.359 Sum_probs=198.8
Q ss_pred EEEEEecCcEEEEEEE-----ccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 14 LRLIQLVDTSGYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d-----~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
..+++++.|+||+|.+ ..++..||+|.+... .....+.+.+|+.++++++||||+++++++.... .+++
T Consensus 11 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 84 (288)
T cd05093 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD--PLIM 84 (288)
T ss_pred cccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--ccEE
Confidence 4677777899999985 345678999987632 2456778999999999999999999999987544 7999
Q ss_pred EEecCCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEE
Q 006277 89 ITELFTSGSLRQYRKKHK-------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKI 155 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~-------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL 155 (652)
||||+.+|+|.+++..++ .+++..+..++.||+.||+|||++| ++||||||+|||++ .++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~-~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-cCCcEEe
Confidence 999999999999997654 4899999999999999999999998 99999999999998 6789999
Q ss_pred eccCchhhhhccc----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCC
Q 006277 156 GDLGLATIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIK 229 (652)
Q Consensus 156 ~DFGla~~l~~~~----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~ 229 (652)
+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |.+||.. .........+..+..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~-~~~~~~~~~i~~~~~ 240 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVIECITQGRV 240 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCc
Confidence 9999998654321 23345678899999775 568999999999999999998 8999976 455566677777653
Q ss_pred CccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 230 PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 230 p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
+ ..+...++++.+||.+||. +|.+|||+.+++.
T Consensus 241 ~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 241 L-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred C-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3 3345577899999999998 8999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=315.47 Aligned_cols=251 Identities=28% Similarity=0.365 Sum_probs=205.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC---CCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ---NKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~---~~~~~LV 89 (652)
...++.++.|.||+|.+..+|..||+|++.... ......+.+.+|+.+++.++||||+++++++.+.. ...+|+|
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 356777888999999999999999999987432 22456678999999999999999999999887653 2368999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
|+|+. ++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.++|+|||++.......
T Consensus 83 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~-~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 83 TELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred ecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccCceEeeccccc
Confidence 99997 589999988889999999999999999999999998 99999999999998 56899999999998765432
Q ss_pred ----cccccCCCCccCccccc-c-CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--Cc---------
Q 006277 169 ----AKSVIGTPEFMAPELYD-E-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PA--------- 231 (652)
Q Consensus 169 ----~~~~vGTp~YmAPEvl~-~-~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~--p~--------- 231 (652)
.....||+.|+|||++. . .++.++|+|||||++|+|++|.+||.+.. ....+..+..... +.
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD-YIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHhcCCCChhHhhhcccc
Confidence 34567899999999774 3 68899999999999999999999998743 3333443332110 00
Q ss_pred ---------------c---ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 232 ---------------A---LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 232 ---------------~---l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
. .....++.+.+||.+||. +|.+||++.++|.||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0 012246789999999998 89999999999999999743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.77 Aligned_cols=246 Identities=28% Similarity=0.448 Sum_probs=203.5
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..|+||+|.++.+|..||+|.+..... .......++.+|+++++.++||||+++++++.+.. ..++||||+
T Consensus 21 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 97 (308)
T cd06634 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAWLVMEYC 97 (308)
T ss_pred HheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--eeEEEEEcc
Confidence 467888889999999999999999999874322 23455678889999999999999999999987654 799999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 94 TSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 94 ~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
. |+|.+++.. ..++++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++..... ....
T Consensus 98 ~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~--~~~~ 171 (308)
T cd06634 98 L-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANXF 171 (308)
T ss_pred C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEEC-CCCcEEECCcccceeecC--cccc
Confidence 6 577776653 456899999999999999999999998 99999999999998 568999999999876543 2346
Q ss_pred cCCCCccCccccc----cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 173 IGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 173 vGTp~YmAPEvl~----~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
.|++.|+|||.+. +.++.++|||||||++|+|++|..||.........+. +..+..+.......+..+++||.+|
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~c 250 (308)
T cd06634 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNESPALQSGHWSEYFRNFVDSC 250 (308)
T ss_pred cCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH-HhhcCCCCcCcccccHHHHHHHHHH
Confidence 7899999999762 4588899999999999999999999977444444443 3344434333446778999999999
Q ss_pred CC-CCCCCCCHHHHhcCccccc
Q 006277 249 LV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~~~ 269 (652)
|. +|.+||++.+++.|||+..
T Consensus 251 l~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 251 LQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred hhCCcccCCCHHHHhhCccccc
Confidence 97 8999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=300.16 Aligned_cols=244 Identities=20% Similarity=0.294 Sum_probs=200.2
Q ss_pred EEEEEecCcEEEEEEEccC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC----CeE
Q 006277 14 LRLIQLVDTSGYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN----KTV 86 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~t---G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~----~~~ 86 (652)
..+++++.|.||+|....+ +..||+|.++.... .......+.+|+.+++.++||||+++++++..... ...
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 4678888899999997654 48899999875432 34567789999999999999999999998755332 247
Q ss_pred EEEEecCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCc
Q 006277 87 NIITELFTSGSLRQYRKKH------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~~------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGl 160 (652)
++||||+.+|+|..++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++ +++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEEC-CCCeEEECCccc
Confidence 9999999999999987543 36899999999999999999999998 99999999999998 668999999999
Q ss_pred hhhhhccc----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCcccc
Q 006277 161 ATIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALS 234 (652)
Q Consensus 161 a~~l~~~~----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 234 (652)
++.+.... .....+++.|+|||.+. ..++.++|||||||++|||++ |.+||.+ ....++++.+..+..+ ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~ 237 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHEIYDYLRHGNRL-KQP 237 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCC
Confidence 98664322 11234567899999774 568999999999999999999 8899976 4556677777766433 345
Q ss_pred CCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 235 KVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 235 ~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
...+..+.++|.+||+ +|.+||++.+++++
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5678899999999998 89999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=299.39 Aligned_cols=238 Identities=23% Similarity=0.355 Sum_probs=198.3
Q ss_pred EEEEecCcEEEEEEEccCC---eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 15 RLIQLVDTSGYKAFDEVNG---LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG---~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
++++++.|.||+|....++ ..||+|.+..... ....+++.+|+.+++.++||||+++++++.. ..+++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e 75 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVME 75 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEE
Confidence 5778888999999877765 8999999875443 2456788999999999999999999997653 25899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc--
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-- 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~-- 169 (652)
|+.+|+|.+++...+.+++..+..++.|++.||.|||.++ ++||||||+|||++ .++.+||+|||++..+.....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEc-CCCcEEeccccccceeecCCccc
Confidence 9999999999998888999999999999999999999998 99999999999998 678999999999986643321
Q ss_pred ---ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 170 ---KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 170 ---~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
....++..|+|||.+ ...++.++|||||||++|+|++ |.+||... +..++...+..+.. ...+...++.++++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 230 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESGER-LPRPEECPQEIYSI 230 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCc-CCCCCCCCHHHHHH
Confidence 112234679999976 4568999999999999999998 99999774 45566666666543 33455677899999
Q ss_pred HHHhCC-CCCCCCCHHHHhc
Q 006277 245 IEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~ 263 (652)
|.+||. +|.+||++.++++
T Consensus 231 i~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 231 MLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 999997 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.35 Aligned_cols=249 Identities=29% Similarity=0.401 Sum_probs=200.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC----CeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN----KTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~----~~~~L 88 (652)
...++++..|.||+|.+..+|..||+|++.... .+.....++.+|+.+++.++||||+++++++..... ..+++
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL 97 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEE
Confidence 355666666899999999999999999876432 234456778899999999999999999987764431 34899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
|+||+ +++|.+++.. .++++..++.++.||+.||.|||+.| |+||||||+||+++ .++.+||+|||++......
T Consensus 98 v~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 98 VTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN-EDCELKILDFGLARHTDDE- 171 (343)
T ss_pred EEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEcccccccccccc-
Confidence 99999 6799998875 57999999999999999999999998 99999999999998 5789999999999876432
Q ss_pred cccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--Cc-------------
Q 006277 169 AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PA------------- 231 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~--p~------------- 231 (652)
.....+++.|+|||++.+ .++.++|||||||++|+|++|..||.+... ...+..+..... +.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07851 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNLVGTPDEELLQKISSESARN 250 (343)
T ss_pred ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhhccchhHHH
Confidence 345678999999997643 578999999999999999999999977443 333333322110 00
Q ss_pred --------------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 232 --------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 232 --------------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
......++.+.+||.+||. +|.+|||+.+++.||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 251 YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred HHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 0112347899999999997 89999999999999999753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=323.70 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=202.3
Q ss_pred cceeeeeeE---EEEEEecCcEEEEEEEcc-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeee
Q 006277 5 KWSLLILMY---LRLIQLVDTSGYKAFDEV-----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFY 75 (652)
Q Consensus 5 ~W~~~~~~~---~rL~~l~~gtVykA~d~~-----tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~ 75 (652)
+|......| .+|++++.|.||+|.+.. ++..||+|++.... .....+.+.+|+++|++|. |||||+++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 677666544 356777779999998754 34579999886432 2345678999999999996 99999999
Q ss_pred eEEEeCCCCeEEEEEecCCCCCHHHHHHhC--------------------------------------------------
Q 006277 76 NSWIDDQNKTVNIITELFTSGSLRQYRKKH-------------------------------------------------- 105 (652)
Q Consensus 76 ~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~-------------------------------------------------- 105 (652)
++|.+.. .+|+|||||.+|+|.+++.+.
T Consensus 108 ~~~~~~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (400)
T cd05105 108 GACTKSG--PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT 185 (400)
T ss_pred EEEccCC--ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence 9986554 799999999999999987642
Q ss_pred ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccC
Q 006277 106 ----------------------------------------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL 139 (652)
Q Consensus 106 ----------------------------------------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDL 139 (652)
..+++..+..++.||+.||.|||+++ |+||||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~di 263 (400)
T cd05105 186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDL 263 (400)
T ss_pred cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCC
Confidence 24778888999999999999999998 999999
Q ss_pred CcccEEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCC
Q 006277 140 KCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSE 213 (652)
Q Consensus 140 Kp~NILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~ 213 (652)
||+|||++ .++.+||+|||+++.+.... .....+++.|+|||++ ...++.++|||||||++|+|++ |..||..
T Consensus 264 kp~Nill~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 264 AARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred ChHhEEEe-CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 99999998 56789999999998654322 2334678899999976 4578999999999999999997 8999987
Q ss_pred CCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 214 CRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 214 ~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
......++..+..+..+ ..+...+.+++++|.+||. +|.+||++.++.+
T Consensus 343 ~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 343 MIVDSTFYNKIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred cchhHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 55556666777666433 3445567899999999998 8999999988875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=301.31 Aligned_cols=227 Identities=19% Similarity=0.254 Sum_probs=186.9
Q ss_pred ecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCH
Q 006277 19 LVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL 98 (652)
Q Consensus 19 l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL 98 (652)
+..+.||+|.++.+|+.||+|++.... ...+|...+....||||+++++++.+.. .+++||||+.||+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSED--SVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecCC--eEEEEEecCCCCCH
Confidence 445789999999999999999987532 1233555566678999999999987654 79999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccccCCCCc
Q 006277 99 RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEF 178 (652)
Q Consensus 99 ~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~vGTp~Y 178 (652)
.+++.+...+++..+..++.|++.||.|||+.+ |+||||||+||+++ .++.++++|||++..+... .....+++.|
T Consensus 73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~-~~~~~~~~~y 148 (237)
T cd05576 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDS-CDGEAVENMY 148 (237)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEecccchhccccc-cccCCcCccc
Confidence 999988888999999999999999999999998 99999999999998 5678999999988766543 2344567889
Q ss_pred cCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCC
Q 006277 179 MAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRL 256 (652)
Q Consensus 179 mAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~Rp 256 (652)
+|||.+. +.++.++||||+||++|+|++|..||..... .+ .......++...++.+++||.+||. +|.+|+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~--~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS--GI-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch--hc-----ccccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence 9999875 5688999999999999999999988754211 11 1111223445678899999999997 899999
Q ss_pred CH-----HHHhcCccc
Q 006277 257 SA-----KELLMDPFL 267 (652)
Q Consensus 257 Sa-----~elL~hpf~ 267 (652)
++ .+++.||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 86 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.38 Aligned_cols=243 Identities=22% Similarity=0.333 Sum_probs=198.3
Q ss_pred EEEEEEecCcEEEEEEEcc-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 006277 13 YLRLIQLVDTSGYKAFDEV-----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~-----tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~ 87 (652)
...+++++.|.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+.. ..+
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~ 85 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL--PRF 85 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--CcE
Confidence 4577888889999999987 78999999875322 2344567899999999999999999999887654 689
Q ss_pred EEEecCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC--CCcEEEecc
Q 006277 88 IITELFTSGSLRQYRKKHK-------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDL 158 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~-------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~--~g~VKL~DF 158 (652)
+||||+.||+|.+++...+ .+++..+..++.||+.||+|||+++ ++||||||+|||++.. ...+||+||
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEeccC
Confidence 9999999999999987654 4899999999999999999999998 9999999999999733 235999999
Q ss_pred Cchhhhhcccc----ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCcc
Q 006277 159 GLATIMEQANA----KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAA 232 (652)
Q Consensus 159 Gla~~l~~~~~----~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~ 232 (652)
|+++.+..... ....+++.|+|||++ ...++.++|||||||++|+|++ |..||.+ .....+...+..+.. ..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~-~~ 241 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG-RTNQEVMEFVTGGGR-LD 241 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCc-CC
Confidence 99987633211 122345689999976 4579999999999999999997 9999987 444556666655432 23
Q ss_pred ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 233 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 233 l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.+...+..+.+||.+||+ +|.+|||+.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 445567899999999998 89999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=301.25 Aligned_cols=244 Identities=21% Similarity=0.302 Sum_probs=199.7
Q ss_pred EEEEEecCcEEEEEEEccCCe--EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC----CCeEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGL--EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ----NKTVN 87 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~--~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~----~~~~~ 87 (652)
..+++++.|.||+|.+..++. .||+|.++... .+....+.+.+|+.+++.++||||+++++++.... ....+
T Consensus 5 ~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 467888889999999988775 69999876532 24566788999999999999999999999765322 12578
Q ss_pred EEEecCCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCch
Q 006277 88 IITELFTSGSLRQYRKK------HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 161 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~------~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla 161 (652)
+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEc-CCCCEEECCCCcc
Confidence 99999999999988742 234899999999999999999999998 99999999999998 6789999999999
Q ss_pred hhhhccc----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccC
Q 006277 162 TIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSK 235 (652)
Q Consensus 162 ~~l~~~~----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~ 235 (652)
+.+.... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+ ....+++..+..+..+. .+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 237 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK-QPP 237 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC-CCC
Confidence 8764322 12335677899999774 568999999999999999999 8899976 45667777777765432 234
Q ss_pred CCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 236 VKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 236 ~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
..+..++++|.+||+ +|.+|||+.+++++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 466789999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.87 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=205.5
Q ss_pred EEEEEEecCcEEEEEEEc---cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~---~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~L 88 (652)
...+++++.|+||+|.+. .++..||+|+++...........+++.+|+++++++ +||||+++++++.... .+|+
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~--~~~l 82 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT--KLHL 82 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC--EEEE
Confidence 356788888999999864 478899999987544333334567788999999999 6999999999886543 7999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
||||+.+|+|.+++.....+++..++.++.|++.||.|||+.+ ++||||||+||+++ .++.++|+|||++..+....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 83 ILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLD-SEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEEECcccccccccc
Confidence 9999999999999988888999999999999999999999988 99999999999998 56899999999987654322
Q ss_pred ---cccccCCCCccCcccccc---CCCccccchhhHHHHHHHhhccCCCCCCC---CHHHHHHHHhcCCCCccccCCCCh
Q 006277 169 ---AKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECR---NSAQIYKKVSSGIKPAALSKVKDP 239 (652)
Q Consensus 169 ---~~~~vGTp~YmAPEvl~~---~y~~~sDIWSlGvilyeLltG~~Pf~~~~---~~~~i~~~I~~g~~p~~l~~~~s~ 239 (652)
.....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.... ....+.+.+..... ..+...++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 237 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTMSA 237 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcccCH
Confidence 234578999999997743 36889999999999999999999996422 12333344433322 33455678
Q ss_pred HHHHHHHHhCC-CCCCCCC---HHHHhcCccccccCC
Q 006277 240 EVKSFIEKCLV-PASQRLS---AKELLMDPFLQVNGT 272 (652)
Q Consensus 240 ~~kdlI~kcL~-~P~~RpS---a~elL~hpf~~~~~~ 272 (652)
.+++||.+||. +|++||| +.++|+||||+...|
T Consensus 238 ~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 238 EARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred HHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 99999999997 8999998 678899999986655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.19 Aligned_cols=243 Identities=22% Similarity=0.338 Sum_probs=197.8
Q ss_pred EEEEEecCcEEEEEEEc-----cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEE
Q 006277 14 LRLIQLVDTSGYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~-----~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~ 87 (652)
..|++++.|.||+|.+. .+++.||+|+++... .....+.+.+|+++++++ +||||+++++++.... ..++
T Consensus 13 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~-~~~~ 88 (337)
T cd05054 13 KPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG-GPLM 88 (337)
T ss_pred cccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC-CCEE
Confidence 46777778999999754 356899999886432 234567788999999999 8999999999886543 4789
Q ss_pred EEEecCCCCCHHHHHHhC-------------------------------------------------------------C
Q 006277 88 IITELFTSGSLRQYRKKH-------------------------------------------------------------K 106 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~-------------------------------------------------------------~ 106 (652)
++|||+.+|+|.+++... .
T Consensus 89 ~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (337)
T cd05054 89 VIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKE 168 (337)
T ss_pred EEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhc
Confidence 999999999999988642 2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCcc
Q 006277 107 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPE 182 (652)
Q Consensus 107 ~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPE 182 (652)
.+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..+.... .....+++.|+|||
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~-~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEe-CCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 6789999999999999999999998 99999999999998 57899999999998764321 23455678899999
Q ss_pred cc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHH
Q 006277 183 LY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAK 259 (652)
Q Consensus 183 vl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~ 259 (652)
++ ...|+.++|||||||++|+|++ |..||.+......+...+..+..+ ..+...++++.+++.+||+ +|.+||++.
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 324 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHNNPEDRPTFS 324 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 66 5679999999999999999998 999998744444455555554432 3345667899999999997 899999999
Q ss_pred HHhcC
Q 006277 260 ELLMD 264 (652)
Q Consensus 260 elL~h 264 (652)
|+++|
T Consensus 325 ell~~ 329 (337)
T cd05054 325 ELVEI 329 (337)
T ss_pred HHHHH
Confidence 99976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=301.81 Aligned_cols=241 Identities=21% Similarity=0.295 Sum_probs=190.4
Q ss_pred EEEEecCcEEEEEEEc--cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 15 RLIQLVDTSGYKAFDE--VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 15 rL~~l~~gtVykA~d~--~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
.+++++.|.||+|... .++..+|+|.++... .......+.+|+.++++++||||+++++++.+.. .+++||||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 76 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT--PYLLVMEF 76 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--CcEEEEEC
Confidence 4678888999999754 466789999876443 2334557888999999999999999999886554 68999999
Q ss_pred CCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 93 FTSGSLRQYRKKHK-----KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 93 ~~gGsL~~~i~~~~-----~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
+++|+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++ .++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEECCccccccccCc
Confidence 99999999987532 4567788899999999999999998 99999999999998 5689999999998754322
Q ss_pred c----cccccCCCCccCcccccc--------CCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCC---Cc
Q 006277 168 N----AKSVIGTPEFMAPELYDE--------NYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIK---PA 231 (652)
Q Consensus 168 ~----~~~~vGTp~YmAPEvl~~--------~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~---p~ 231 (652)
. .....|++.|+|||++.+ .++.++|||||||++|+|++ |..||............+..... .+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 1 223567889999998743 35789999999999999996 99999775444433333333221 12
Q ss_pred cccCCCChHHHHHHHHhCCCCCCCCCHHHHhc
Q 006277 232 ALSKVKDPEVKSFIEKCLVPASQRLSAKELLM 263 (652)
Q Consensus 232 ~l~~~~s~~~kdlI~kcL~~P~~RpSa~elL~ 263 (652)
.+....+..+++++.+|+.+|.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred ccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 22334567899999999988999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=300.70 Aligned_cols=240 Identities=22% Similarity=0.341 Sum_probs=198.6
Q ss_pred EEEEEecCcEEEEEEEccCC-----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNG-----LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG-----~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
..+++++.|.||+|.++..+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ...++
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~ 86 (277)
T cd05032 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG--QPTLV 86 (277)
T ss_pred eEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--CCcEE
Confidence 56777788999999987544 899999976432 234566788999999999999999999988765 47999
Q ss_pred EEecCCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEecc
Q 006277 89 ITELFTSGSLRQYRKKHK----------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 158 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~----------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DF 158 (652)
||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~-~~~~~kl~df 163 (277)
T cd05032 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVA-EDLTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEc-CCCCEEECCc
Confidence 999999999999986532 3678899999999999999999998 99999999999998 6789999999
Q ss_pred Cchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCcc
Q 006277 159 GLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAA 232 (652)
Q Consensus 159 Gla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~ 232 (652)
|+++.+.... .....+++.|+|||.+ .+.++.++|||||||++|+|++ |..||.+ .......+.+..+.. ..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~-~~ 241 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKFVIDGGH-LD 241 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHHHhcCCC-CC
Confidence 9998664332 2344678899999976 4578999999999999999998 9999976 456666666665433 23
Q ss_pred ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 233 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 233 l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
.+...+..+.+||.+||. +|.+|||+.+++.
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 242 LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 444568899999999998 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=304.87 Aligned_cols=241 Identities=26% Similarity=0.383 Sum_probs=199.3
Q ss_pred EEEEEecCcEEEEEEEccCC-----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNG-----LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG-----~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~ 87 (652)
..+++++.|.||+|.+...+ ..||+|.+.... ......++.+|+.+++.+ +||||+++++++.... .++
T Consensus 18 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--~~~ 92 (293)
T cd05053 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG--PLY 92 (293)
T ss_pred eEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC--CeE
Confidence 45677777999999987544 789999887432 245567899999999999 8999999999886543 799
Q ss_pred EEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCC
Q 006277 88 IITELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 151 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g 151 (652)
+||||+.+|+|..++..+ +.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++
T Consensus 93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~-~~~ 169 (293)
T cd05053 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVT-EDH 169 (293)
T ss_pred EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEc-CCC
Confidence 999999999999998642 46889999999999999999999998 99999999999998 678
Q ss_pred cEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHh
Q 006277 152 EVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVS 225 (652)
Q Consensus 152 ~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~ 225 (652)
.+||+|||++..+.... .....+++.|+|||++ ...++.++|||||||++|+|++ |..||.. ....+.++.+.
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~ 248 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFKLLK 248 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC-CCHHHHHHHHH
Confidence 99999999998765432 1223356789999976 4578999999999999999997 9999976 55667777777
Q ss_pred cCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 226 SGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 226 ~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.+..+. .+...+..+.+||.+||. +|.+|||+.+++++
T Consensus 249 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 249 EGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred cCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 665432 344567899999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=298.49 Aligned_cols=239 Identities=25% Similarity=0.381 Sum_probs=197.9
Q ss_pred EEEEecCcEEEEEEEcc-CC--eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 15 RLIQLVDTSGYKAFDEV-NG--LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~-tG--~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.+++++.|.||+|.+.. .| ..||+|.+..... ....+++.+|+.++++++||||+++++++.+ ..+++|||
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e 75 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL---SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTE 75 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCccc---HHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEE
Confidence 46778889999999866 33 4799999875443 1667889999999999999999999999876 47999999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 92 LFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 92 y~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
|+.+|+|.+++.... .+++..+..++.||+.||+|||+++ ++||||||+||+++ .++.+||+|||++..+....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~-~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLA-SDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEe-cCCEEEecccccccccccccc
Confidence 999999999987764 6899999999999999999999998 99999999999998 56899999999998764421
Q ss_pred ----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 169 ----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 169 ----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
.....++..|+|||.+. ..++.++|||||||++|+|++ |..||.. .+..++.+.+.........+...+..+.
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG-LSGSQILKKIDKEGERLERPEACPQDIY 231 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhcCCcCCCCccCCHHHH
Confidence 12345778999999774 578999999999999999998 9999976 3445555555542222233445678999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhc
Q 006277 243 SFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~ 263 (652)
++|.+||. +|.+||++.+++.
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 99999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.09 Aligned_cols=246 Identities=26% Similarity=0.399 Sum_probs=201.3
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.++.+.||+|.+..+|+.||+|++..... .+....++.+|+++++.++||||+++++++.+.. .+++||||+
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~~ 80 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG--DLYLVFEFM 80 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC--CEEEEEecc
Confidence 567888889999999999999999999875432 2345678889999999999999999999887654 799999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 94 TSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 94 ~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
.+ +|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||||+||+++ .++.+||+|||++....... ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEEC-CCCcEEEeeeeeeEecCCCccccc
Confidence 75 88887766 468999999999999999999999998 99999999999998 56899999999987765432 23
Q ss_pred cccCCCCccCccccc-c-CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC--c---------------
Q 006277 171 SVIGTPEFMAPELYD-E-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--A--------------- 231 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~-~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p--~--------------- 231 (652)
...+++.|+|||.+. . .++.++|+|||||++|+|++|..||.......++...+.....+ .
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 456889999999764 3 68899999999999999999999998755544443332221110 0
Q ss_pred ----------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 232 ----------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 232 ----------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
......+.++++||.+||. +|.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0112356789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=313.40 Aligned_cols=250 Identities=28% Similarity=0.363 Sum_probs=201.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC----CeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN----KTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~----~~~~L 88 (652)
...|+++..|+||+|.+..+|..||+|++.... .......++.+|+.+|+.++||||+++++++..... ..+++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL 97 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEE
Confidence 356777888999999999999999999886432 234456678899999999999999999998865432 24689
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
||+|+ +++|..++.. ..+++..++.++.||+.||+|||++| |+||||||+||+++ .++.+||+|||++..... .
T Consensus 98 v~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~-~ 171 (343)
T cd07880 98 VMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDS-E 171 (343)
T ss_pred EEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeeccccccccc-C
Confidence 99999 7799888764 57999999999999999999999998 99999999999998 578999999999876543 2
Q ss_pred cccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC-----------------
Q 006277 169 AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK----------------- 229 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~----------------- 229 (652)
.....+++.|+|||.+.+ .++.++|+|||||++|+|++|.+||.+..........+.....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (343)
T cd07880 172 MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNY 251 (343)
T ss_pred ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHH
Confidence 344578999999997743 5889999999999999999999999875433332221111000
Q ss_pred --------C---ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 230 --------P---AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 230 --------p---~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+ ..+....++.+.++|.+||. +|.+|||+.+++.||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 252 VKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0 01123457789999999998 89999999999999999854
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=301.68 Aligned_cols=241 Identities=21% Similarity=0.311 Sum_probs=190.2
Q ss_pred EEEEecCcEEEEEEEcc--CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 15 RLIQLVDTSGYKAFDEV--NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~--tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
+|+++..|.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++++.+.. .+|+||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~--~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI--PYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC--ceEEEEEe
Confidence 47788889999996433 45678888765322 2445667889999999999999999999887554 79999999
Q ss_pred CCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 93 FTSGSLRQYRKKHK-----KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 93 ~~gGsL~~~i~~~~-----~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
+.+|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLT-ADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEec-CCCcEEEeccccccccccc
Confidence 99999999987643 2467888999999999999999998 99999999999998 5789999999998654221
Q ss_pred c----cccccCCCCccCccccc--------cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCC---Cc
Q 006277 168 N----AKSVIGTPEFMAPELYD--------ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIK---PA 231 (652)
Q Consensus 168 ~----~~~~vGTp~YmAPEvl~--------~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~---p~ 231 (652)
. .....+++.|+|||++. ..++.++|||||||++|+|++ |..||....+...+...+..+.. .+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 1 22345677899999763 246789999999999999999 78899775444444444444332 22
Q ss_pred cccCCCChHHHHHHHHhCCCCCCCCCHHHHhc
Q 006277 232 ALSKVKDPEVKSFIEKCLVPASQRLSAKELLM 263 (652)
Q Consensus 232 ~l~~~~s~~~kdlI~kcL~~P~~RpSa~elL~ 263 (652)
.+....++.+++++..|+.+|.+|||+++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred cccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 33445678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=307.72 Aligned_cols=252 Identities=27% Similarity=0.389 Sum_probs=203.4
Q ss_pred CCcceeeeeeE---EEEEEecCcEEEEEEEcc-------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCe
Q 006277 3 RQKWSLLILMY---LRLIQLVDTSGYKAFDEV-------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNI 71 (652)
Q Consensus 3 ~~~W~~~~~~~---~rL~~l~~gtVykA~d~~-------tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnI 71 (652)
.|+|......| ..+++++.|.||+|.+.. ++..||+|.+.... ......++.+|+.+++.+ +||||
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i 86 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNI 86 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCE
Confidence 46777755444 455666678999998643 34579999886432 245567889999999999 89999
Q ss_pred eeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCee
Q 006277 72 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPII 135 (652)
Q Consensus 72 Vkl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~Ii 135 (652)
+++++++.... .+|+||||+.+|+|.+++..++ .++...+..++.||+.||+|||++| ++
T Consensus 87 ~~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~ 162 (307)
T cd05098 87 INLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CI 162 (307)
T ss_pred eeEEEEEecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cc
Confidence 99999886554 7999999999999999997643 4788999999999999999999998 99
Q ss_pred eccCCcccEEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccC
Q 006277 136 HRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEY 209 (652)
Q Consensus 136 HRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~ 209 (652)
||||||+|||++ .++.+||+|||++..+.... .....+++.|+|||++ ...++.++|||||||++|+|++ |..
T Consensus 163 H~dlkp~Nill~-~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~ 241 (307)
T cd05098 163 HRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 241 (307)
T ss_pred cccccHHheEEc-CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 999999999998 56899999999987654321 1122345789999976 4568999999999999999998 888
Q ss_pred CCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 210 PYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 210 Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
||.+ .+..+++..+..+..+ ..+...+.++++||.+||. +|.+|||+.+++++
T Consensus 242 p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 242 PYPG-VPVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CCCc-CCHHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 9876 6667777777766532 3445567899999999997 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=296.48 Aligned_cols=238 Identities=21% Similarity=0.356 Sum_probs=196.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..++++++.|.||+|..+ .+..+|+|.+..... ....+.+|+.+|+.++||||+++++++.+.. .+++||||
T Consensus 9 ~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~iv~e~ 80 (256)
T cd05114 9 MKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM-----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK--PLYIVTEF 80 (256)
T ss_pred eeEecCCcCceEEEEEec-cCceEEEEecccCCc-----cHHHHHHHHHHHHHCCCCCceeEEEEEccCC--CEEEEEEc
Confidence 457888888999999875 456899998764332 2356888999999999999999999886544 79999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc--
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-- 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~-- 169 (652)
+++|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEc-CCCeEEECCCCCccccCCCceec
Confidence 9999999998754 56899999999999999999999998 99999999999998 567999999999886543221
Q ss_pred -ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 170 -KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 170 -~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
....++..|+|||++. ..++.++|||||||++|+|++ |.+||.. .+..+....+..+..+ ..+...+..+.+||.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~ 235 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFRL-YRPKLASMTVYEVMY 235 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHHH
Confidence 2234566899999774 578999999999999999999 8999976 4556667777766533 234556789999999
Q ss_pred HhCC-CCCCCCCHHHHhc
Q 006277 247 KCLV-PASQRLSAKELLM 263 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~ 263 (652)
+||. +|.+||++.++++
T Consensus 236 ~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 236 SCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 9997 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=324.74 Aligned_cols=247 Identities=23% Similarity=0.390 Sum_probs=204.5
Q ss_pred CCcceeeee---eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 006277 3 RQKWSLLIL---MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 79 (652)
Q Consensus 3 ~~~W~~~~~---~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 79 (652)
+.+|+..+. ..++||.+-.|.||.|.... ...||+|.++...+ ..+.+.+|+++|++|+|+|||++|+++.
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m-----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM-----SPEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc-----ChhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 567777664 34567777779999997632 23899999985532 2356779999999999999999999876
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEec
Q 006277 80 DDQNKTVNIITELFTSGSLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 157 (652)
Q Consensus 80 d~~~~~~~LVmEy~~gGsL~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~D 157 (652)
.+. .+||||||++.|+|.+|++. ++.+.......++.||+.|++||++++ +|||||-..||||+ +++.+||+|
T Consensus 272 ~~~--piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~-~~~~vKIsD 346 (468)
T KOG0197|consen 272 KQE--PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVD-EDLVVKISD 346 (468)
T ss_pred cCC--ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeec-cCceEEEcc
Confidence 544 79999999999999999997 567999999999999999999999999 99999999999998 678999999
Q ss_pred cCchhhhhccccccccC---CCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCcc
Q 006277 158 LGLATIMEQANAKSVIG---TPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAA 232 (652)
Q Consensus 158 FGla~~l~~~~~~~~vG---Tp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~ 232 (652)
||||+...........| ...|.|||.+ .+.++.++|||||||+|+||+| |+.||.+ ....+....|.+|..- .
T Consensus 347 FGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-msn~ev~~~le~GyRl-p 424 (468)
T KOG0197|consen 347 FGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-MSNEEVLELLERGYRL-P 424 (468)
T ss_pred cccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-CCHHHHHHHHhccCcC-C
Confidence 99999655443332222 3479999977 5689999999999999999998 7888887 5667788888888643 3
Q ss_pred ccCCCChHHHHHHHHhCC-CCCCCCCHHHHh
Q 006277 233 LSKVKDPEVKSFIEKCLV-PASQRLSAKELL 262 (652)
Q Consensus 233 l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL 262 (652)
.|..+++++-+++..|+. +|++|||.+.+.
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 455688999999999997 899999998664
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=297.89 Aligned_cols=238 Identities=24% Similarity=0.402 Sum_probs=196.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..++++++.|.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.. ..+++|||
T Consensus 11 ~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 82 (261)
T cd05072 11 VKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE--PIYIITEY 82 (261)
T ss_pred eeecCCcCCceEEEEEec-CCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC--CcEEEEec
Confidence 457777777999999964 56789999876432 34678899999999999999999999886544 78999999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 93 FTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
+.+|+|.+++... ..+++..+..++.||+.||+|||+++ ++||||||+||+++ .++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEec-CCCcEEECCCccceecCCCcee
Confidence 9999999998753 56889999999999999999999998 99999999999998 67899999999998765432
Q ss_pred -cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 169 -AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
.....++..|+|||.+. +.++.++|||||||++|+|++ |..||.. .........+..+... ......+.++.+||
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 237 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYRM-PRMENCPDELYDIM 237 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHH
Confidence 12334567899999764 568899999999999999998 9999976 4555566666655433 23345678999999
Q ss_pred HHhCC-CCCCCCCHHHHhc
Q 006277 246 EKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~ 263 (652)
.+||. +|.+||++.++++
T Consensus 238 ~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 238 KTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 99997 8999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=303.68 Aligned_cols=241 Identities=23% Similarity=0.345 Sum_probs=198.5
Q ss_pred EEEEEEecCcEEEEEEEc-----cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 006277 13 YLRLIQLVDTSGYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~-----~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~ 87 (652)
...+++++.|.||+|.+. .++..|++|.+.... ....+.+.+|++++++++||||+++++++.... ..+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 83 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT----LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD--PLI 83 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc----HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC--ceE
Confidence 357888888999999853 456779998875332 345567899999999999999999999887544 799
Q ss_pred EEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCC
Q 006277 88 IITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 151 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g 151 (652)
+||||+.+++|.+++..++ .+++..++.++.||+.||+|||+++ |+||||||+|||++ .++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~-~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG-ANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-cCC
Confidence 9999999999999997653 3889999999999999999999998 99999999999998 668
Q ss_pred cEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHh
Q 006277 152 EVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVS 225 (652)
Q Consensus 152 ~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~ 225 (652)
.+||+|||++....... .....|++.|+|||.+ ...++.++|||||||++|+|+| |..||.. .........+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ-LSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHh
Confidence 99999999997654321 2345678899999976 4578899999999999999998 9999976 44555666666
Q ss_pred cCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 226 SGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 226 ~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.+..+ ..+...+..+.+||.+||. +|.+||++.++++.
T Consensus 240 ~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~ 278 (291)
T cd05094 240 QGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278 (291)
T ss_pred CCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 65433 3345567899999999998 89999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=300.95 Aligned_cols=240 Identities=23% Similarity=0.366 Sum_probs=198.3
Q ss_pred EEEEEEecCcEEEEEEEccCCe----EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGL----EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~----~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
...+++++.|+||+|.+..+|. .||+|+++... .......+.+|+.+++.++||||+++++++... ..++
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~l 85 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS---TVQL 85 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---CcEE
Confidence 4577888889999999887776 48999876432 345567889999999999999999999988643 4789
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 89 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
+|+|+++|+|.+++..+ +.+++..+..++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||+++.+...
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~-~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc-CCCcEEECCCCceeecccc
Confidence 99999999999998764 56999999999999999999999998 99999999999997 6678999999999876532
Q ss_pred cc----ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHH
Q 006277 168 NA----KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 168 ~~----~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~ 241 (652)
.. ....+++.|+|||.+ ...++.++|||||||++|||++ |..||.. .....+...+..+..+ ..+...+..+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 240 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERL-PQPPICTIDV 240 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcC-CCCccCCHHH
Confidence 21 123456789999976 5579999999999999999998 8999876 4555566666665433 2344567899
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhc
Q 006277 242 KSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
.++|.+||. +|.+||++.+++.
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 999999997 8999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=305.73 Aligned_cols=241 Identities=22% Similarity=0.340 Sum_probs=198.4
Q ss_pred EEEEEecCcEEEEEEE-----ccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEE
Q 006277 14 LRLIQLVDTSGYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d-----~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~ 87 (652)
..+++++.|.||+|.+ ..++..||+|.++... .....+.+.+|+.+++++ +||||+++++++.+.. .+|
T Consensus 41 ~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~ 115 (302)
T cd05055 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG--PIL 115 (302)
T ss_pred ceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC--ceE
Confidence 3567777799999985 3466789999876432 245567899999999999 8999999999887654 799
Q ss_pred EEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh
Q 006277 88 IITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~ 165 (652)
+||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+.
T Consensus 116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT-HGKIVKICDFGLARDIM 192 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEc-CCCeEEECCCccccccc
Confidence 9999999999999987643 3899999999999999999999998 99999999999998 66789999999998664
Q ss_pred ccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCCh
Q 006277 166 QAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 239 (652)
Q Consensus 166 ~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~ 239 (652)
... .....+++.|+|||.+ ...++.++|||||||++|+|++ |..||..........+.+..+..+ ..+...++
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 271 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-AQPEHAPA 271 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-CCCCCCCH
Confidence 322 1234567889999976 4568999999999999999998 999998755555566666555433 34455678
Q ss_pred HHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 240 EVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 240 ~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
++.+||.+||. +|.+|||+.|+++
T Consensus 272 ~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 272 EIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999997 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=303.15 Aligned_cols=247 Identities=22% Similarity=0.282 Sum_probs=200.2
Q ss_pred CcceeeeeeEEEEEEecCcEEEEEEEccCC----------------eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC
Q 006277 4 QKWSLLILMYLRLIQLVDTSGYKAFDEVNG----------------LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 67 (652)
Q Consensus 4 ~~W~~~~~~~~rL~~l~~gtVykA~d~~tG----------------~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~ 67 (652)
.+|.+ ..++++++.|.||+|.+..++ ..||+|.+.... .....+.+.+|++++++++
T Consensus 5 ~~~~~----~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~ 77 (296)
T cd05051 5 QPLNF----VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLS 77 (296)
T ss_pred hhCcc----cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcC
Confidence 45555 368888888999999887654 568999887442 2456788999999999999
Q ss_pred CCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 006277 68 HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-----------KVDMKAVKGWARQILSGLIYLHSHDPPIIH 136 (652)
Q Consensus 68 HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~-----------~lse~~i~~i~~QIl~aL~yLHs~g~~IiH 136 (652)
||||+++++++.+.. .++++|||+.+++|.+++.... .+++..++.++.||+.||.|||+++ |+|
T Consensus 78 ~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H 153 (296)
T cd05051 78 DPNIARLLGVCTVDP--PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVH 153 (296)
T ss_pred CCCEeEEEEEEecCC--CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccc
Confidence 999999999987653 7999999999999999998766 6899999999999999999999998 999
Q ss_pred ccCCcccEEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh--ccC
Q 006277 137 RDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT--FEY 209 (652)
Q Consensus 137 RDLKp~NILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt--G~~ 209 (652)
|||||+||+++ .++.++|+|||++..+.... .....+++.|+|||.+. +.++.++|||||||++|+|++ +..
T Consensus 154 ~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 232 (296)
T cd05051 154 RDLATRNCLVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232 (296)
T ss_pred cccchhceeec-CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCC
Confidence 99999999998 56899999999987654321 23456788999999764 578999999999999999998 678
Q ss_pred CCCCCCCHHHHHHHHhcC------CCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 210 PYSECRNSAQIYKKVSSG------IKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 210 Pf~~~~~~~~i~~~I~~g------~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
||... +..+++..+... ......+...+.++.+||.+||. +|.+|||+.++++
T Consensus 233 p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 233 PYEHL-TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCCc-ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 88663 344444444432 11112233456899999999998 8999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=296.48 Aligned_cols=235 Identities=20% Similarity=0.329 Sum_probs=196.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..+++++.|.||+|.. .|..||+|.++.. ...+.+.+|+.+++.++|+||+++++++.... ..+++||||+
T Consensus 12 ~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~lv~e~~ 82 (256)
T cd05082 12 QTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEYM 82 (256)
T ss_pred eeecccCCCeEEEEEE--cCCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC-CceEEEEECC
Confidence 5778888899999965 4889999987532 23567889999999999999999999765443 3689999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccc
Q 006277 94 TSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~ 171 (652)
.+|+|.+++.+.+ .+++..+..++.||+.||+|||++| ++||||||+||+++ .++.+||+|||++...... ...
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~-~~~ 158 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST-QDT 158 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEc-CCCcEEecCCccceecccc-CCC
Confidence 9999999987654 4889999999999999999999998 99999999999998 6789999999998765432 233
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
..++..|+|||++. ..++.++|||||||++|+|++ |.+||.. ....++...+..+..+ ..+...++.+++||.+||
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l 236 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVYDVMKQCW 236 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHh
Confidence 44567899999774 468899999999999999997 9999976 5666677777666433 345567889999999999
Q ss_pred C-CCCCCCCHHHHhc
Q 006277 250 V-PASQRLSAKELLM 263 (652)
Q Consensus 250 ~-~P~~RpSa~elL~ 263 (652)
. +|.+|||+.++++
T Consensus 237 ~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 237 HLDAATRPSFLQLRE 251 (256)
T ss_pred cCChhhCcCHHHHHH
Confidence 7 8999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=302.09 Aligned_cols=241 Identities=28% Similarity=0.470 Sum_probs=197.6
Q ss_pred EEEEEEecCcEEEEEEEc----cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDE----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~----~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
..+++.+..|.||+|... ..+..|+||.++.. ...+..+.+.+|++++++++||||+++++++.... .+++
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~--~~~l 78 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE--PLFL 78 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS--SEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeecccccccccccccccccccccccc--cccc
Confidence 468899999999999988 46789999998532 24566899999999999999999999999988443 5999
Q ss_pred EEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 89 ITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
|||||++|+|.+++... ..+++..+..|+.||+.||.|||+++ ++|++|+|.|||++ .++.+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~-~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLD-SNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEE-TTTEEEEESTTTGEETTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-cccccccccccccccccc
Confidence 99999999999999987 78999999999999999999999998 99999999999999 567999999999987632
Q ss_pred c----ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChH
Q 006277 167 A----NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 240 (652)
Q Consensus 167 ~----~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 240 (652)
. ......+...|+|||.+. ..++.++||||||+++|||++ |..||... ...++...+..+..+ ..+...+..
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 233 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRL-PIPDNCPKD 233 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEET-TSBTTSBHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccc-eeccchhHH
Confidence 1 123445678899999874 458999999999999999999 78999874 667777777666543 345556789
Q ss_pred HHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 241 VKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 241 ~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
+.++|.+||. +|.+|||+.++++
T Consensus 234 ~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 234 IYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999999997 8999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=298.36 Aligned_cols=239 Identities=23% Similarity=0.364 Sum_probs=197.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...++++..|.||+|.++ ++..+|+|.+..... ....+.+|+.+++.++||||+++++++.... ..|+||||
T Consensus 9 ~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~ 80 (256)
T cd05059 9 LKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR--PIFIVTEY 80 (256)
T ss_pred hhhhccCCCceEEEeEec-CCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--ceEEEEec
Confidence 457788888999999876 567899998764332 2346788999999999999999999876543 79999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccc
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 171 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~ 171 (652)
+++++|.+++..+ +.+++..+..++.||+.||.|||+++ ++||||||+|||++ ++|.+||+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEEC-CCCcEEECCcccceecccccccc
Confidence 9999999998764 46899999999999999999999998 99999999999998 67899999999987664433222
Q ss_pred cc---CCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 172 VI---GTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 172 ~v---GTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
.. ++..|+|||.+. ..++.++|||||||++|+|++ |.+||.. .....+...+..+.. ...+...++++.+++.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 235 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER-FSNSEVVESVSAGYR-LYRPKLAPTEVYTIMY 235 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHcCCc-CCCCCCCCHHHHHHHH
Confidence 22 345799999764 578999999999999999999 8999976 445666677766543 2344567899999999
Q ss_pred HhCC-CCCCCCCHHHHhcC
Q 006277 247 KCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~h 264 (652)
+||. +|.+|||+.++++.
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHhcCChhhCcCHHHHHHH
Confidence 9997 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=303.74 Aligned_cols=248 Identities=26% Similarity=0.441 Sum_probs=199.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...++++..+.||+|.+..+|+.||+|.++.... .....++.+|+.++..+ .||||+++++++.+.. .+|+|||
T Consensus 20 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~e 94 (296)
T cd06618 20 LGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS--DVFICME 94 (296)
T ss_pred eeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC---hHHHHHHHHHHHHHHhccCCCchHhhheeeecCC--eEEEEee
Confidence 3567777779999999999999999999875432 33456677788777666 5999999999987654 7999999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 92 LFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 92 y~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
|+. ++|..++.. .+.+++..+..++.||+.||.|||+ ++ |+||||+|+||+++ +++.+||+|||++..+....
T Consensus 95 ~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~-~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 95 LMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred ccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEc-CCCCEEECccccchhccCCCc
Confidence 985 577776655 4579999999999999999999997 46 99999999999998 67899999999988765432
Q ss_pred cccccCCCCccCcccccc-----CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc-cccCCCChHHH
Q 006277 169 AKSVIGTPEFMAPELYDE-----NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA-ALSKVKDPEVK 242 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~~-----~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~-~l~~~~s~~~k 242 (652)
.....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.......+.+..+.....+. ......+.+++
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFC 250 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHH
Confidence 233468889999998743 378899999999999999999999976544444555555443222 12224678999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 243 SFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+||.+||. +|.+||++.+++.||||+.
T Consensus 251 ~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 251 SFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred HHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 99999997 8999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=297.42 Aligned_cols=238 Identities=18% Similarity=0.326 Sum_probs=195.7
Q ss_pred EEEEecCcEEEEEEEc--cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 15 RLIQLVDTSGYKAFDE--VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 15 rL~~l~~gtVykA~d~--~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
.+++++.|.||+|... ..+..||+|++.... .+...+.+.+|+.++++++||||+++++++.. ..+++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEe
Confidence 3677888999999775 456789999886432 24556789999999999999999999998743 368999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
+++|+|.+++.. ...+++..++.++.||+.||.|||++| ++||||||+|||++ .++.+||+|||++..+....
T Consensus 76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEc-CCCcEEeccCCccccccCCccce
Confidence 999999999875 457999999999999999999999998 99999999999998 66799999999997654321
Q ss_pred --cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 169 --AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
.....+++.|+|||.+. +.++.++|||||||++|+|++ |..||... ....+...+..+..+ ..+...++++.++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 230 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRL-DCPAECPPEMYAL 230 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHHHHH
Confidence 11123357899999764 568999999999999999996 99999874 455566677666543 4555678999999
Q ss_pred HHHhCC-CCCCCCCHHHHhc
Q 006277 245 IEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~ 263 (652)
|.+||. +|.+||++.++++
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999998 8999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=311.76 Aligned_cols=247 Identities=30% Similarity=0.375 Sum_probs=196.7
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC----CCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ----NKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~----~~~~~LV 89 (652)
..++++..|.||+|.+..+|+.||+|++.... .+....+++.+|+.++++++||||+++++++.... ...+|++
T Consensus 23 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 100 (345)
T cd07877 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100 (345)
T ss_pred EEeeecCCeEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEE
Confidence 45777777999999999999999999886432 22344677889999999999999999999886432 1347889
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 169 (652)
++++ +++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++..... ..
T Consensus 101 ~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~dfg~~~~~~~-~~ 174 (345)
T cd07877 101 THLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDD-EM 174 (345)
T ss_pred ehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEc-CCCCEEEecccccccccc-cc
Confidence 9887 7899887764 46999999999999999999999998 99999999999998 678999999999876533 23
Q ss_pred ccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC--CC----------------
Q 006277 170 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IK---------------- 229 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g--~~---------------- 229 (652)
....||+.|+|||++. ..++.++|||||||++|+|++|.+||....... ....+... ..
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (345)
T cd07877 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKISSESARNY 253 (345)
T ss_pred cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHhhcccHhHHHH
Confidence 4567899999999764 358889999999999999999999997633322 22222110 00
Q ss_pred --------Cc---cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 230 --------PA---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 230 --------p~---~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.. ......++++++||.+||. +|.+||++.++|.||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 254 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred HHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 00 0111357789999999998 8999999999999999974
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=332.83 Aligned_cols=234 Identities=22% Similarity=0.353 Sum_probs=200.7
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
++.+..+.|-.+.+..+++..++|.+.... ....+|+.++... +||||+++++.+.+.. .+|+|||++.
T Consensus 330 ~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~--~~~~v~e~l~ 399 (612)
T KOG0603|consen 330 LGEGSFSAVKYCESSPTDQEPAVKIISKRA--------DDNQDEIPISLLVRDHPNIVKSHDVYEDGK--EIYLVMELLD 399 (612)
T ss_pred cCCCCccceeeeeccccccchhheeccccc--------cccccccchhhhhcCCCcceeecceecCCc--eeeeeehhcc
Confidence 344444899999999999999999987541 2344577666666 8999999999887655 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccccC
Q 006277 95 SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG 174 (652)
Q Consensus 95 gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~vG 174 (652)
||.|.+.+...+.+. ..+..|++||+.|+.|||++| |+||||||+|||++++.|+++|+|||.++..... ..+.+-
T Consensus 400 g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-~~tp~~ 475 (612)
T KOG0603|consen 400 GGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-CDTPAL 475 (612)
T ss_pred ccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh-hcccch
Confidence 999999888776666 888899999999999999998 9999999999999657889999999999887655 445566
Q ss_pred CCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CC
Q 006277 175 TPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PA 252 (652)
Q Consensus 175 Tp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P 252 (652)
|..|.|||++. ..|+++|||||||+++|+||+|..||.......+++..|..+.. ....|.++++||++||+ +|
T Consensus 476 t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~----s~~vS~~AKdLl~~LL~~dP 551 (612)
T KOG0603|consen 476 TLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF----SECVSDEAKDLLQQLLQVDP 551 (612)
T ss_pred hhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc----ccccCHHHHHHHHHhccCCh
Confidence 88999999885 57999999999999999999999999876666688888876643 36778999999999998 99
Q ss_pred CCCCCHHHHhcCccc
Q 006277 253 SQRLSAKELLMDPFL 267 (652)
Q Consensus 253 ~~RpSa~elL~hpf~ 267 (652)
.+||++.+++.||||
T Consensus 552 ~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 552 ALRLGADEIGAHPWF 566 (612)
T ss_pred hhCcChhhhccCcch
Confidence 999999999999999
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=312.84 Aligned_cols=249 Identities=27% Similarity=0.342 Sum_probs=196.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC----CeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN----KTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~----~~~~L 88 (652)
...++++..|.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++..... ..+|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 97 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYL 97 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEE
Confidence 3566667779999999999999999999875322 22345678899999999999999999998865432 25799
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
||||+. ++|..++ ...+++..+..++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..... .
T Consensus 98 v~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~-~~~~~kL~dfg~~~~~~~-~ 170 (342)
T cd07879 98 VMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLARHADA-E 170 (342)
T ss_pred Eecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCCCCcCCCC-C
Confidence 999995 4777665 346899999999999999999999998 99999999999998 578999999999876532 2
Q ss_pred cccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC-C----------------
Q 006277 169 AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI-K---------------- 229 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~-~---------------- 229 (652)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..... .+..+.... .
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (342)
T cd07879 171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQKLEDKAAKS 249 (342)
T ss_pred CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhcccchHH
Confidence 344578999999997743 58899999999999999999999998743333 222222110 0
Q ss_pred -----C----cc---ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccccC
Q 006277 230 -----P----AA---LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 271 (652)
Q Consensus 230 -----p----~~---l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~~ 271 (652)
+ .. .....++.+.+||.+||+ +|.+||++.++|.||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0 00 012356789999999997 899999999999999997543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=298.26 Aligned_cols=238 Identities=25% Similarity=0.381 Sum_probs=199.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.++.|+||+|.++. +..||+|++.... ......+.+|+.+++.++||||+++++++.+.. .+++||||+
T Consensus 12 ~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~ 84 (261)
T cd05148 12 RKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE--PVYIITELM 84 (261)
T ss_pred hhhccCCCccEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEecCC--CeEEEEeec
Confidence 456777789999999988 9999999987543 234667889999999999999999999886654 799999999
Q ss_pred CCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c
Q 006277 94 TSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 169 (652)
Q Consensus 94 ~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~ 169 (652)
.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++ +++.+||+|||++....... .
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~-~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVG-EDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEc-CCceEEEccccchhhcCCccccc
Confidence 999999999753 46899999999999999999999998 99999999999998 67899999999998764432 2
Q ss_pred ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHH
Q 006277 170 KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~k 247 (652)
....+++.|+|||++ .+.++.++||||||+++|+|++ |..||.. .+..+.+..+..+..+ ..+...++.+.++|.+
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~ 239 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-PCPAKCPQEIYKIMLE 239 (261)
T ss_pred cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC-CCCCCCCHHHHHHHHH
Confidence 234567789999976 4568899999999999999998 8999976 4556666666655432 3345677899999999
Q ss_pred hCC-CCCCCCCHHHHhc
Q 006277 248 CLV-PASQRLSAKELLM 263 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~ 263 (652)
||. +|.+|||+.++++
T Consensus 240 ~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 240 CWAAEPEDRPSFKALRE 256 (261)
T ss_pred HcCCCchhCcCHHHHHH
Confidence 997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=294.35 Aligned_cols=238 Identities=23% Similarity=0.350 Sum_probs=197.2
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
.+++++.|.||+|.+.. |+.||+|.+..... .+....+.+|+.++++++||||+++++++.+.. ..++||||+.
T Consensus 2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~~~ 75 (251)
T cd05041 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ--PIYIVMELVP 75 (251)
T ss_pred ccccCCCceEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--CeEEEEEcCC
Confidence 46778889999999988 99999998875432 346678999999999999999999999887654 7899999999
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc----
Q 006277 95 SGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA---- 169 (652)
Q Consensus 95 gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~---- 169 (652)
+++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+|||++ .++.+||+|||++........
T Consensus 76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEc-CCCcEEEeeccccccccCCcceecc
Confidence 9999999865 356899999999999999999999998 99999999999998 668999999999976542211
Q ss_pred ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHH
Q 006277 170 KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~k 247 (652)
....++..|+|||.+ .+.++.++|||||||++|+|++ |..||.. .........+..+. ....+...+.++.+||.+
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ 230 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG-MSNQQTRERIESGY-RMPAPQLCPEEIYRLMLQ 230 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc-CCHHHHHHHHhcCC-CCCCCccCCHHHHHHHHH
Confidence 122345679999976 4578999999999999999999 8889976 34455555555543 223345667899999999
Q ss_pred hCC-CCCCCCCHHHHhc
Q 006277 248 CLV-PASQRLSAKELLM 263 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~ 263 (652)
||. +|.+||++.|+|+
T Consensus 231 ~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 231 CWAYDPENRPSFSEIYN 247 (251)
T ss_pred HhccChhhCcCHHHHHH
Confidence 997 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=343.62 Aligned_cols=246 Identities=26% Similarity=0.358 Sum_probs=195.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..++++++.|.||+|.+..+|+.||+|++... ....+...+++.+|+++++.++||||+++++++.+.. ..|+||||
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~-l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~--~lyLVMEY 83 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD--PVYYTMPY 83 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcc-cccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC--EEEEEEEc
Confidence 46888888999999999999999999998743 2334456678999999999999999999999887654 79999999
Q ss_pred CCCCCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCch
Q 006277 93 FTSGSLRQYRKKH-----------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 161 (652)
Q Consensus 93 ~~gGsL~~~i~~~-----------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla 161 (652)
++||+|.+++... ..++...+..++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd-~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLG-LFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEc-CCCCEEEEecCcc
Confidence 9999999988642 23566778899999999999999998 99999999999998 6789999999999
Q ss_pred hhhhcc--------------------ccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHH
Q 006277 162 TIMEQA--------------------NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI 220 (652)
Q Consensus 162 ~~l~~~--------------------~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i 220 (652)
...... .....+||+.|||||++ ...++.++|||||||++|+|+||.+||.........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 865210 01235799999999976 457899999999999999999999999764333322
Q ss_pred HHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 221 YKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 221 ~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
+................++.+.+++.+||. +|.+|+++.+.|.+
T Consensus 241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 222221111111123467889999999998 89999876665544
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.65 Aligned_cols=238 Identities=24% Similarity=0.388 Sum_probs=195.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..++++++.|.||+|.+. ++..||+|.++.... ..+.+.+|+.++++++||||+++++++.... .+|+||||
T Consensus 11 ~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 82 (261)
T cd05068 11 LRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE--PIYIVTEL 82 (261)
T ss_pred EEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecCC--Ceeeeeec
Confidence 467788888999999975 457899999874332 2456888999999999999999999876544 78999999
Q ss_pred CCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccc
Q 006277 93 FTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~ 170 (652)
+.+++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVG-ENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEc-CCCCEEECCcceEEEccCCccc
Confidence 99999999987654 6899999999999999999999998 99999999999998 6789999999999876543222
Q ss_pred cccC---CCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 171 SVIG---TPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 171 ~~vG---Tp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
...| +..|+|||++. ..++.++||||||+++|+|++ |..||.+ .....++..+..+... ..+...+..+.++|
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 237 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG-MTNAEVLQQVDQGYRM-PCPPGCPKELYDIM 237 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCcCCHHHHHHH
Confidence 2233 35799999764 568999999999999999999 9999977 4555666666555322 23445678999999
Q ss_pred HHhCC-CCCCCCCHHHHhc
Q 006277 246 EKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~ 263 (652)
.+||. +|.+||++.+++.
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHhhcCcccCCCHHHHHH
Confidence 99997 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=294.44 Aligned_cols=235 Identities=22% Similarity=0.359 Sum_probs=198.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.+..|.||+|... |+.||+|.+.... ...+++.+|+.+++.++|+||+++++++.+. ...++||||+
T Consensus 12 ~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~ 82 (256)
T cd05039 12 ATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQG--NPLYIVTEYM 82 (256)
T ss_pred eeeecCCCceEEEEEec--CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCC--CCeEEEEEec
Confidence 46777777999999864 8999999987432 2567899999999999999999999988764 3799999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccc
Q 006277 94 TSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~ 171 (652)
.+++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~-~~~~~~l~d~g~~~~~~~~~~-~ 158 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQD-S 158 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEe-CCCCEEEcccccccccccccc-c
Confidence 9999999998765 7999999999999999999999998 99999999999998 678999999999987643322 3
Q ss_pred ccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 172 VIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 172 ~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
..++..|+|||.+ .+.++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ..+...++.+.+||.+||
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l 236 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCPPEVYKVMKDCW 236 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCCHHHHHHHHHHh
Confidence 3446679999976 4578899999999999999997 9999976 4566666666665432 344556889999999999
Q ss_pred C-CCCCCCCHHHHhc
Q 006277 250 V-PASQRLSAKELLM 263 (652)
Q Consensus 250 ~-~P~~RpSa~elL~ 263 (652)
. +|.+||++.+++.
T Consensus 237 ~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 237 ELDPAKRPTFKQLRE 251 (256)
T ss_pred ccChhhCcCHHHHHH
Confidence 7 8999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=303.44 Aligned_cols=247 Identities=26% Similarity=0.376 Sum_probs=196.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC--------CCe
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ--------NKT 85 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~--------~~~ 85 (652)
..++++..|+||+|.++.+|+.||+|.++..... ......+.+|+++++.++||||+++++++.+.. +..
T Consensus 13 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 90 (302)
T cd07864 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGA 90 (302)
T ss_pred eeecccCCEEEEEEEECCCCcEEEEEEEeecccc--cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCc
Confidence 4667777799999999999999999998765321 223456778999999999999999999886543 347
Q ss_pred EEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhh
Q 006277 86 VNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 164 (652)
Q Consensus 86 ~~LVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l 164 (652)
+++|+||+.+ +|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++ +.+.+||+|||++..+
T Consensus 91 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~ 166 (302)
T cd07864 91 FYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLY 166 (302)
T ss_pred EEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCcEEeCcccccccc
Confidence 9999999976 677766654 47999999999999999999999998 99999999999998 6789999999999876
Q ss_pred hccc---cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc---CCCCcc----
Q 006277 165 EQAN---AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS---GIKPAA---- 232 (652)
Q Consensus 165 ~~~~---~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~---g~~p~~---- 232 (652)
.... .....+++.|+|||++. ..++.++|||||||++|+|++|.+||....... ....+.. +..+..
T Consensus 167 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 245 (302)
T cd07864 167 NSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-QLELISRLCGSPCPAVWPDV 245 (302)
T ss_pred cCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhhcccc
Confidence 4332 12345688999999774 347889999999999999999999997643332 2222222 111110
Q ss_pred ---------------------ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 233 ---------------------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 233 ---------------------l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
.....++.+.+||.+||. +|.+||++.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 246 IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 112357899999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=316.41 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=210.8
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCH---HHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSP---EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~---e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.|++++.+.||+|+|....+.||+|+-.+.+.+.++ ...+...+|..|.+.|+||.||++|++|--+ +..+|-|+|
T Consensus 470 LLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-tdsFCTVLE 548 (775)
T KOG1151|consen 470 LLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-TDSFCTVLE 548 (775)
T ss_pred HhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-cccceeeee
Confidence 467888899999999999999999987766544432 3456788999999999999999999998543 347999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC--CCCcEEEeccCchhhhhccc-
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~--~~g~VKL~DFGla~~l~~~~- 168 (652)
||+|.+|.-|++.++.+++++++.|+.||+.||.||....|||||-||||.|||+-. ..|.|||+||||++++....
T Consensus 549 YceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy 628 (775)
T KOG1151|consen 549 YCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSY 628 (775)
T ss_pred ecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCcc
Confidence 999999999999999999999999999999999999999999999999999999852 34689999999999986432
Q ss_pred --------cccccCCCCccCcccc--c---cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHH--HHHhcCC-CCcc
Q 006277 169 --------AKSVIGTPEFMAPELY--D---ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIY--KKVSSGI-KPAA 232 (652)
Q Consensus 169 --------~~~~vGTp~YmAPEvl--~---~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~--~~I~~g~-~p~~ 232 (652)
+....||.+|++||.+ . ...+.++||||+|||+|.++.|+-||........|. ..|.... ...+
T Consensus 629 ~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP 708 (775)
T KOG1151|consen 629 NSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFP 708 (775)
T ss_pred CcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCC
Confidence 2346899999999955 2 247889999999999999999999997644333332 2222221 1223
Q ss_pred ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 233 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 233 l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
...+.++++++||++||+ .-..|....+|..||||..
T Consensus 709 ~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 709 PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 345678999999999998 6899999999999999964
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=306.19 Aligned_cols=243 Identities=23% Similarity=0.322 Sum_probs=195.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEE--EEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEV--AWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~V--AiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
...+++++.|.||+|.+..+|..+ |+|.+. .. .......++.+|+.++.++ +||||+++++++.+.. .+|+|
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~--~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~--~~~lv 86 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLYLA 86 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEec--cc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC--CceEE
Confidence 356777888999999998888655 655543 22 2345667889999999999 8999999999886554 79999
Q ss_pred EecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcE
Q 006277 90 TELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 153 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~V 153 (652)
|||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~-~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEec-CCCcE
Confidence 99999999999987543 5789999999999999999999998 99999999999998 66799
Q ss_pred EEeccCchhhhhccc-cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCC
Q 006277 154 KIGDLGLATIMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKP 230 (652)
Q Consensus 154 KL~DFGla~~l~~~~-~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p 230 (652)
||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|+| |.+||.. .+..+.++.+..+..+
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~ 242 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL 242 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHhcCCcC
Confidence 999999986432211 11223467899999774 468899999999999999998 9999976 4555666666554322
Q ss_pred ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCc
Q 006277 231 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDP 265 (652)
Q Consensus 231 ~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hp 265 (652)
..+...++.+.+||.+||. +|.+||++.++|.+.
T Consensus 243 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 243 -EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2333467899999999998 899999999999873
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=300.50 Aligned_cols=245 Identities=27% Similarity=0.358 Sum_probs=198.3
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..++.++.++||+|.+..+|+.||+|++..... . .......+|+..+++++ ||||+++++++.+. ...++||||
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~--~~~~lv~e~ 79 (283)
T cd07830 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--S-WEECMNLREVKSLRKLNEHPNIVKLKEVFREN--DELYFVFEY 79 (283)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEehhhcc--c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcC--CcEEEEEec
Confidence 467778889999999999999999998864322 1 22334457999999998 99999999998764 479999999
Q ss_pred CCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-c
Q 006277 93 FTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~ 169 (652)
+ +|+|.+++.... .+++..+..++.|++.+|.|||+++ ++|+||+|+||+++ ..+.++|+|||++....... .
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCCEEEeecccceeccCCCCc
Confidence 9 889999887764 7899999999999999999999998 99999999999998 57899999999998765432 2
Q ss_pred ccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC-----------------
Q 006277 170 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP----------------- 230 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p----------------- 230 (652)
....|+..|+|||++. ..++.++|+||||+++++|++|.+||.........++...-...+
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 4467899999999773 357899999999999999999999998755544443332211000
Q ss_pred ----------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 231 ----------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 231 ----------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
.......+..+++||.+||. +|.+|||++|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00111235789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=300.06 Aligned_cols=241 Identities=20% Similarity=0.237 Sum_probs=199.0
Q ss_pred EEEEEecCcEEEEEEEcc-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 14 LRLIQLVDTSGYKAFDEV-----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~-----tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
..+++++.|.||+|.+.. +++.||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.. ..++
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~~ 85 (283)
T cd05091 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ--PLSM 85 (283)
T ss_pred HHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC--ceEE
Confidence 356777789999998764 36889999987432 2345678899999999999999999999886654 6899
Q ss_pred EEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCc
Q 006277 89 ITELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE 152 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~ 152 (652)
++||+.+++|.+++... ..+++..+..++.|++.||.|||++| |+||||||+|||++ +++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF-DKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec-CCCc
Confidence 99999999999998532 35788899999999999999999998 99999999999998 6678
Q ss_pred EEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhc
Q 006277 153 VKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSS 226 (652)
Q Consensus 153 VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~ 226 (652)
+||+|||+++.+.... .....+++.|+|||.+ .+.++.++|||||||++|||++ |..||.+ .....+...+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~i~~ 241 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVIEMIRN 241 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHc
Confidence 9999999988654322 2344567899999976 5678999999999999999998 8888876 455677777776
Q ss_pred CCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 227 GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 227 g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
+... ..+...+..+.+||.+||+ +|.+||++.+++..
T Consensus 242 ~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 242 RQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 6532 2345577899999999997 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.73 Aligned_cols=242 Identities=23% Similarity=0.346 Sum_probs=199.6
Q ss_pred EEEEEEecCcEEEEEEEccC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~t---G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
...+++++.|+||+|..+.+ ...||+|.+.... ......++.+|+.+++.++||||+++++++.... .+++|
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~iv 83 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR--PVMII 83 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC--ceEEE
Confidence 45678888899999998754 4689999876432 3455678899999999999999999999886543 79999
Q ss_pred EecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 90 TELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
|||+.+|+|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++..+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~-~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCCEEECccchhhcccccc
Confidence 9999999999998764 47899999999999999999999998 99999999999998 66899999999998875211
Q ss_pred ----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 169 ----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 169 ----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
.....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. .....+...+..+... ..+...++.+.
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 238 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD-MSNQDVIKAVEDGYRL-PPPMDCPSALY 238 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHH
Confidence 11234567899999774 578999999999999999998 9999976 3455566666665432 23345678999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcC
Q 006277 243 SFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~h 264 (652)
+|+.+||. +|.+||++.+++++
T Consensus 239 ~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 239 QLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHcCCCcccCcCHHHHHHH
Confidence 99999997 89999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=299.74 Aligned_cols=242 Identities=25% Similarity=0.367 Sum_probs=192.2
Q ss_pred EEEEEecCcEEEEEE----EccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~----d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
..+++++.|+||++. ...+|..||+|.+.... .......+.+|+++|+.++||||+++++++.......+++|
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 567777789997764 44578899999986432 23456778899999999999999999998876666679999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 169 (652)
|||+.+|+|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++........
T Consensus 87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEc-CCCcEEEeecccccccCCcch
Confidence 9999999999998764 5999999999999999999999998 99999999999998 568999999999987643221
Q ss_pred -----ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHH--------------HHHHHHhcCCC
Q 006277 170 -----KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSA--------------QIYKKVSSGIK 229 (652)
Q Consensus 170 -----~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~--------------~i~~~I~~g~~ 229 (652)
....++..|+|||.+. ..++.++|||||||++|+|++|..||....... .+...+..+..
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence 2234567799999764 568999999999999999999999985422110 11111111211
Q ss_pred CccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 230 PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 230 p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
...+...+.++++|+.+||. +|++|||+.+++.
T Consensus 243 -~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 243 -LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred -CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 12234567899999999998 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.90 Aligned_cols=238 Identities=22% Similarity=0.374 Sum_probs=195.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.++++++.|+||+|.... +..||+|.+..... ..+.+.+|+.++++++||||+++++++.+.. .+++||||+
T Consensus 10 ~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 81 (256)
T cd05113 10 KELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR--PIYIVTEYM 81 (256)
T ss_pred eEecCcccceEEEEEecC-CCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC--CcEEEEEcC
Confidence 567777889999997653 45699998864322 2356889999999999999999999886543 689999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccc-
Q 006277 94 TSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS- 171 (652)
Q Consensus 94 ~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~- 171 (652)
.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||+++.........
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCCEEECCCccceecCCCceeec
Confidence 999999998764 46899999999999999999999998 99999999999998 67899999999987654332222
Q ss_pred --ccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHH
Q 006277 172 --VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 172 --~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~k 247 (652)
..++..|+|||.+. ..++.++|||||||++|+|++ |..||.. .+...+...+..+..+ ..+...+..+++++.+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 236 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER-FNNSETVEKVSQGLRL-YRPHLASEKVYAIMYS 236 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHH
Confidence 23456799999874 578999999999999999998 9999976 4455666667666433 2344567899999999
Q ss_pred hCC-CCCCCCCHHHHhcC
Q 006277 248 CLV-PASQRLSAKELLMD 264 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~h 264 (652)
||. +|.+||++.+++.+
T Consensus 237 cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 237 CWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HcCCCcccCCCHHHHHHh
Confidence 998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=337.21 Aligned_cols=144 Identities=25% Similarity=0.322 Sum_probs=130.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+|+.+..|+||+|.+..+|+.||+|+++.... .......++..|+.+++.++||||+++++++.... .+|+||||
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~--~~~lVmEy 85 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN--NVYLVMEY 85 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC--EEEEEEeC
Confidence 4678888889999999999999999999986543 34566788999999999999999999999887654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
+.|++|.+++...+.+++..++.|+.||+.||.|||.++ |+||||||+|||++ .++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~-~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEc-CCCCEEEEeCCCCc
Confidence 999999999998889999999999999999999999998 99999999999998 67899999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=291.78 Aligned_cols=240 Identities=25% Similarity=0.413 Sum_probs=202.8
Q ss_pred EEEEEecCcEEEEEEEccCC----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNG----LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG----~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
..++.++.|.||+|.+..++ ..||+|++.... ..+....+.+|+.+++.++||||+++++++.+.. ..+++
T Consensus 5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~i 79 (258)
T smart00219 5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE--PLMIV 79 (258)
T ss_pred ceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--eeEEE
Confidence 56777888999999999877 999999986432 2336788999999999999999999999887654 79999
Q ss_pred EecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 90 TELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
|||+.+++|.+++..... +++..+..++.||+.||+|||+++ ++||||||+||+++ .++.++|+|||++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEc-cCCeEEEcccCCceecccc
Confidence 999999999999876554 999999999999999999999998 99999999999998 6679999999999876543
Q ss_pred cc---ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 168 NA---KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 168 ~~---~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
.. ....+++.|+|||.+ ...++.++|||||||++|+|++ |.+||.. .....++..+..+..+. .+...+.++.
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 234 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLP-KPENCPPEIY 234 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCHHHH
Confidence 21 122367899999977 4568999999999999999998 7888876 56677777777665433 3445788999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhc
Q 006277 243 SFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~ 263 (652)
+++.+||. +|.+|||+.|+++
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 235 KLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHCcCChhhCcCHHHHHh
Confidence 99999998 8999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.71 Aligned_cols=251 Identities=26% Similarity=0.393 Sum_probs=203.0
Q ss_pred CcceeeeeeE---EEEEEecCcEEEEEEEc-------cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCee
Q 006277 4 QKWSLLILMY---LRLIQLVDTSGYKAFDE-------VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNII 72 (652)
Q Consensus 4 ~~W~~~~~~~---~rL~~l~~gtVykA~d~-------~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIV 72 (652)
++|.+....| ..+++++.|.||+|.+. .++..||+|.+.... ......++.+|+.+++.+ +||||+
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~ 84 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNII 84 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCch
Confidence 4565554433 45667777999999753 345689999876321 235567899999999999 899999
Q ss_pred eeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 006277 73 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIH 136 (652)
Q Consensus 73 kl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiH 136 (652)
++++++.... .+|+||||+.+|+|.+++.+.+ .++...+..++.||+.||.|||++| |+|
T Consensus 85 ~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH 160 (304)
T cd05101 85 NLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIH 160 (304)
T ss_pred heeEEEecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eee
Confidence 9999887654 7899999999999999987642 4678889999999999999999998 999
Q ss_pred ccCCcccEEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCC
Q 006277 137 RDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYP 210 (652)
Q Consensus 137 RDLKp~NILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~P 210 (652)
|||||+|||++ .++.+||+|||+++.+.... .....+++.|+|||++ ...|+.++||||||+++|+|++ |..|
T Consensus 161 ~dlkp~Nili~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 239 (304)
T cd05101 161 RDLAARNVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239 (304)
T ss_pred cccccceEEEc-CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 99999999998 66899999999998764321 2234567889999976 4568999999999999999998 7888
Q ss_pred CCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 211 YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 211 f~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
|.+ .+...++..+..+... ..+...+..+++||.+||. +|.+|||+.++++.
T Consensus 240 ~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 240 YPG-IPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred ccc-CCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 876 5677777777766533 2344567899999999997 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=302.78 Aligned_cols=242 Identities=23% Similarity=0.318 Sum_probs=196.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeE--EEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLE--VAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~--VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
...+++++.|.||+|.++.+|.. +++|.++.. ......+.+.+|+++++++ +||||+++++++.+.. .+|+|
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--~~~lv 81 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF---ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG--YLYIA 81 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEcccc---CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC--cceEE
Confidence 34677778899999999888764 677766521 2345567899999999999 7999999999886544 79999
Q ss_pred EecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcE
Q 006277 90 TELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 153 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~V 153 (652)
|||+++|+|.+++.+.+ .+++..+..++.||+.||+|||++| |+||||||+|||++ .++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVG-ENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEEC-CCCeE
Confidence 99999999999987643 4888999999999999999999998 99999999999998 56799
Q ss_pred EEeccCchhhhhcccccc-ccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCC
Q 006277 154 KIGDLGLATIMEQANAKS-VIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKP 230 (652)
Q Consensus 154 KL~DFGla~~l~~~~~~~-~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p 230 (652)
||+|||++.......... ...+..|+|||++ ...++.++|||||||++|+|++ |..||.. ......+..+..+..+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~~~~~ 237 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRM 237 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCC
Confidence 999999986443221222 2234579999976 4568999999999999999997 9999977 4556667777665432
Q ss_pred ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 231 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 231 ~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
..+...+..+++||.+||. +|.+||++.++++.
T Consensus 238 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 238 -EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3345678899999999997 89999999999866
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.21 Aligned_cols=247 Identities=29% Similarity=0.369 Sum_probs=194.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC---CCCCeeeeeeEEEeCCC---CeEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL---KHNNIIRFYNSWIDDQN---KTVN 87 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L---~HpnIVkl~~~~~d~~~---~~~~ 87 (652)
..++.+..|.||+|.+..+|..||+|.++.... .......+.+|+.+++++ +||||+++++++.+... ..++
T Consensus 5 ~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 567778889999999999999999999975432 122334566788877766 59999999999876542 2389
Q ss_pred EEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh
Q 006277 88 IITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~ 165 (652)
++|||+.+ +|.+++.... .+++..++.++.||+.||.|||+++ ++|+||+|+||+++ .++.+||+|||++..+.
T Consensus 83 l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~-~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 83 LVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLARIYS 158 (287)
T ss_pred EEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEc-cCCCEEEeccCcceecc
Confidence 99999974 8988887643 5899999999999999999999998 99999999999998 55899999999987764
Q ss_pred ccc-cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC-C-------------
Q 006277 166 QAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI-K------------- 229 (652)
Q Consensus 166 ~~~-~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~-~------------- 229 (652)
... .....+++.|+|||++. ..++.++|||||||++|+|++|.+||.+..... .+.++.... .
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCCCcccc
Confidence 332 23456889999999764 568899999999999999999999998744333 333332210 0
Q ss_pred --------C---ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 230 --------P---AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 230 --------p---~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
+ .......++.+.+||.+||. +|.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 00011235678999999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=293.97 Aligned_cols=241 Identities=20% Similarity=0.292 Sum_probs=194.1
Q ss_pred EEEEecCcEEEEEEEcc---CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 15 RLIQLVDTSGYKAFDEV---NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~---tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.+++++.|.||+|.+.. .+..||+|.+... ......+.+.+|+.+++.++||||+++++++.... +..++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~e 77 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVLP 77 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCcc---CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEEe
Confidence 46778889999999754 4568999987532 23456788899999999999999999999765443 36889999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 92 LFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 92 y~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
|+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||||+|||++ .++.+||+|||++..+....
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCccccccccCCcce
Confidence 99999999998764 45678888999999999999999998 99999999999998 67899999999987653221
Q ss_pred ----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhc-cCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 169 ----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 169 ----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG-~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
.....+++.|+|||.+ ...++.++|||||||++|+|++| .+||.. .+...+...+..+..+ ..+...+..+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 232 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRL-LQPEYCPDPLY 232 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCcCCHHHH
Confidence 1234567889999976 45789999999999999999995 566655 4555666666665433 23445578899
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcC
Q 006277 243 SFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~h 264 (652)
+++.+||. +|.+||++.+++..
T Consensus 233 ~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 233 EVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHHHH
Confidence 99999997 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.79 Aligned_cols=242 Identities=26% Similarity=0.376 Sum_probs=197.4
Q ss_pred EEEEEEecCcEEEEEEEcc-------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCC
Q 006277 13 YLRLIQLVDTSGYKAFDEV-------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNK 84 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~-------tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~ 84 (652)
-.++++++.|.||+|.+.. .+..||+|.++... ......++.+|+++++++ +||||+++++++.+..
T Consensus 17 ~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-- 91 (314)
T cd05099 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG-- 91 (314)
T ss_pred eeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC--
Confidence 3677777789999998642 45679999876432 245677899999999999 6999999999886543
Q ss_pred eEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC
Q 006277 85 TVNIITELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 148 (652)
Q Consensus 85 ~~~LVmEy~~gGsL~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~ 148 (652)
.+|+||||+.+|+|.+++... ..++...+..++.||+.||.|||++| |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~- 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVT- 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEEc-
Confidence 799999999999999999764 24888999999999999999999998 99999999999998
Q ss_pred CCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHH
Q 006277 149 NQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYK 222 (652)
Q Consensus 149 ~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~ 222 (652)
.++.+||+|||+++...... .....+++.|||||++ .+.++.++|||||||++|+|++ |..||.. .+...++.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-~~~~~~~~ 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG-IPVEELFK 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC-CCHHHHHH
Confidence 67899999999998664321 1122345689999976 4568999999999999999999 8899976 56667777
Q ss_pred HHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 223 KVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 223 ~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.+..+..+ ..+...+.++++||.+||. +|.+|||+.++++.
T Consensus 248 ~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 248 LLREGHRM-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHHcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 77765432 2344567789999999997 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=298.94 Aligned_cols=239 Identities=23% Similarity=0.339 Sum_probs=194.6
Q ss_pred EEEEEecCcEEEEEEEccCCeE----EEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLE----VAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~----VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
.++++++.|+||+|....+|.. |++|.+... .......++..|+.++++++||||+++++++.. ...+++
T Consensus 13 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~~~~i 86 (279)
T cd05111 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---ASLQLV 86 (279)
T ss_pred cccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---CccEEE
Confidence 4677888899999999888875 566655321 123455778889999999999999999998643 257899
Q ss_pred EecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 90 TELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
+||+.+|+|.+++... +.+++..+..|+.||+.||.|||+++ ++||||||+|||++ .++.+||+|||+++.+....
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~-~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLK-SDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEEcCCccceeccCCC
Confidence 9999999999999764 57899999999999999999999998 99999999999998 67899999999998654321
Q ss_pred ----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 169 ----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 169 ----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
.....|++.|+|||.+ .+.|+.++|||||||++|||++ |..||.+ .....+...+..+..+ ..+...+..+.
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 241 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG-MRPHEVPDLLEKGERL-AQPQICTIDVY 241 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcC-CCCCCCCHHHH
Confidence 2334577889999977 4679999999999999999998 9999977 3445555556555433 33445677899
Q ss_pred HHHHHhCC-CCCCCCCHHHHhc
Q 006277 243 SFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~ 263 (652)
+++.+||. +|.+|||+.|+++
T Consensus 242 ~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 99999997 8999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.38 Aligned_cols=240 Identities=24% Similarity=0.382 Sum_probs=197.2
Q ss_pred EEEEEEecCcEEEEEEE-----ccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 006277 13 YLRLIQLVDTSGYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d-----~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~ 87 (652)
..++++++.|.||+|.. ..++..||+|.+... .....+.+.+|+++++.++||||+++++++.+.. .++
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 83 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR--PLL 83 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC--ceE
Confidence 45778888899999964 346788999987632 2456778999999999999999999999887654 789
Q ss_pred EEEecCCCCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCc
Q 006277 88 IITELFTSGSLRQYRKKHK---------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE 152 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~---------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~ 152 (652)
++|||+.+|+|.+++...+ .+++..+..++.||+.||+|||++| ++||||||+|||++ +++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~-~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVG-QGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEc-CCCC
Confidence 9999999999999987653 4889999999999999999999998 99999999999998 6789
Q ss_pred EEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhc
Q 006277 153 VKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSS 226 (652)
Q Consensus 153 VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~ 226 (652)
+||+|||++....... .....+++.|+|||.+ ...++.++|||||||++|+|++ |.+||... ........+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL-SNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC-CHHHHHHHHHc
Confidence 9999999987553221 1233457889999976 4578999999999999999998 89999763 44455555655
Q ss_pred CCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 227 GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 227 g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
+..+ ..+...++.+.+||.+||. +|.+||++.+++.
T Consensus 240 ~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GREL-ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 5433 3345567899999999997 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.42 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=198.1
Q ss_pred EEEEEecCcEEEEEEEccC--CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeC--CCCeEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVN--GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDD--QNKTVNI 88 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~t--G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~--~~~~~~L 88 (652)
..++++..|.||+|.+..+ |..||+|.+.... ......+++.+|+.+++++ +||||+++++.+... ....+|+
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 83 (332)
T cd07857 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYL 83 (332)
T ss_pred EEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEE
Confidence 5678888899999999988 9999999886422 2234466788999999999 699999999875432 2236889
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
+|+|+. ++|.+++.....+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+....
T Consensus 84 ~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 84 YEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVN-ADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEc-CCCCEEeCcCCCceeccccc
Confidence 999985 699999988889999999999999999999999998 99999999999998 67899999999998654321
Q ss_pred ------cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc--------------
Q 006277 169 ------AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-------------- 226 (652)
Q Consensus 169 ------~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-------------- 226 (652)
.....||+.|+|||++. ..++.++|||||||++|+|++|.+||....... ....+..
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHHHHhhh
Confidence 23457999999999764 368999999999999999999999997633221 1111110
Q ss_pred ------------CCCCc---cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 227 ------------GIKPA---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 227 ------------g~~p~---~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
..... ......+..+++||.+||+ +|.+|||+.+++.||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 00001 1112347889999999998 8999999999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.69 Aligned_cols=238 Identities=24% Similarity=0.323 Sum_probs=193.4
Q ss_pred EEEecCcEEEEEEEccCCeE--EEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 16 LIQLVDTSGYKAFDEVNGLE--VAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~--VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
+++++.|.||+|.++.+|.. +|+|.+... ......+.+.+|+++++++ +||||+++++++.... .+|+||||
T Consensus 3 lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~lv~e~ 77 (270)
T cd05047 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLYLAIEY 77 (270)
T ss_pred CCCCCCceEEEEEEcCCCCeeEEEEEEcccc---CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC--CceEEEEe
Confidence 57788899999999888864 577776521 2345667899999999999 8999999999886544 78999999
Q ss_pred CCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEe
Q 006277 93 FTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 156 (652)
Q Consensus 93 ~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~ 156 (652)
+++|+|.+++...+ .+++..+..++.|++.||+|||+++ ++||||||+|||++ .++.+||+
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~-~~~~~kl~ 154 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAKIA 154 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEc-CCCeEEEC
Confidence 99999999987643 4789999999999999999999998 99999999999998 66899999
Q ss_pred ccCchhhhhcccc-ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccc
Q 006277 157 DLGLATIMEQANA-KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAAL 233 (652)
Q Consensus 157 DFGla~~l~~~~~-~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l 233 (652)
|||++........ .....++.|+|||++ ...++.++|||||||++|+|++ |..||.+ .+....++.+..+... ..
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~-~~ 232 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL-EK 232 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCCC-CC
Confidence 9999864322111 122345679999976 4568899999999999999997 9999976 4555666666655432 23
Q ss_pred cCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 234 SKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 234 ~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
+...+.++.+++.+||. +|.+|||+.+++.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 44567899999999998 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=294.36 Aligned_cols=237 Identities=22% Similarity=0.373 Sum_probs=194.1
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...++++++.+.||+|.+. .+..||+|.+..... ..+.+.+|+.++++++||||+++++++.. ...|++||
T Consensus 10 ~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~e 80 (260)
T cd05070 10 LIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-----SPESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIVTE 80 (260)
T ss_pred hhheeccccCceEEEEEec-CCceeEEEEecCCCC-----CHHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEEEE
Confidence 3567888888999999875 567799999875432 23568899999999999999999997643 25899999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc
Q 006277 92 LFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 169 (652)
|+.+++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++..+.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~-~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVG-DGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEe-CCceEEeCCceeeeeccCccc
Confidence 99999999998764 45899999999999999999999998 99999999999998 567999999999976643221
Q ss_pred ---ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 170 ---KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 170 ---~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
....++..|+|||++ ...++.++||||||+++|+|++ |.+||.+ .+.......+..+.. ...+...+..+++|
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 235 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG-MNNREVLEQVERGYR-MPCPQDCPISLHEL 235 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC-CCCCCcCCHHHHHH
Confidence 223456679999976 4568899999999999999999 8999977 344555566655433 23445677899999
Q ss_pred HHHhCC-CCCCCCCHHHHh
Q 006277 245 IEKCLV-PASQRLSAKELL 262 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL 262 (652)
|.+||. +|.+|||+.+++
T Consensus 236 i~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred HHHHcccCcccCcCHHHHH
Confidence 999997 899999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=309.99 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=197.3
Q ss_pred EEEEEecCcEEEEEEE-----ccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEE
Q 006277 14 LRLIQLVDTSGYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d-----~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~ 87 (652)
..|++++.|+||+|.+ ..+++.||+|+++... .......+.+|+.+|+++ +||||+++++++.... ..++
T Consensus 13 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~~~~ 88 (343)
T cd05103 13 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-GPLM 88 (343)
T ss_pred ccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC-CceE
Confidence 4567777799999984 4578999999987432 234567889999999999 7899999999886544 4789
Q ss_pred EEEecCCCCCHHHHHHhC--------------------------------------------------------------
Q 006277 88 IITELFTSGSLRQYRKKH-------------------------------------------------------------- 105 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~-------------------------------------------------------------- 105 (652)
+|||||.+|+|.+++...
T Consensus 89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (343)
T cd05103 89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ 168 (343)
T ss_pred EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence 999999999999998643
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc----cccccCCC
Q 006277 106 -----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTP 176 (652)
Q Consensus 106 -----~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp 176 (652)
..++...+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..+.... .....+++
T Consensus 169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 169 EDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEc-CCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 23677888999999999999999998 99999999999998 66899999999998653321 12344567
Q ss_pred CccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCC
Q 006277 177 EFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PAS 253 (652)
Q Consensus 177 ~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~ 253 (652)
.|+|||++ ...|+.++|||||||++|+|++ |..||........+...+..+..+ ..+...++++.+++.+||. +|.
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~cl~~~p~ 324 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPS 324 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CCCCCCCHHHHHHHHHHccCChh
Confidence 89999976 5578999999999999999997 999998755555555555555432 2344567899999999997 899
Q ss_pred CCCCHHHHhcC
Q 006277 254 QRLSAKELLMD 264 (652)
Q Consensus 254 ~RpSa~elL~h 264 (652)
+|||+.++++|
T Consensus 325 ~Rps~~eil~~ 335 (343)
T cd05103 325 QRPTFSELVEH 335 (343)
T ss_pred hCcCHHHHHHH
Confidence 99999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.73 Aligned_cols=245 Identities=24% Similarity=0.392 Sum_probs=196.2
Q ss_pred EEEEEEecCcEEEEEEE----ccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFD----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d----~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
...+++++.|.||+|.. ..++..||+|.+.... .......+.+|+++++.++||||+++++++.+.....+++
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred ceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 35678888899999974 5678999999986432 2455678999999999999999999999988765567999
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 89 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
||||++|++|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+||+++ .++.+||+|||++..+...
T Consensus 86 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred EEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEc-CCCCEEECCCccccccccC
Confidence 99999999999998765 36899999999999999999999998 99999999999998 5789999999999876432
Q ss_pred c-----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCC--------------CHHHHHHHHhcC
Q 006277 168 N-----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECR--------------NSAQIYKKVSSG 227 (652)
Q Consensus 168 ~-----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~--------------~~~~i~~~I~~g 227 (652)
. .....|+..|+|||++ ...++.++|||||||++|+|+++..|+.... ........+..+
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 2 2345677889999976 4568999999999999999999876653211 111222223333
Q ss_pred CCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 228 IKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 228 ~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
... ..+...+..+.+||.+||. +|.+|||+.+++++
T Consensus 243 ~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 322 2334567899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.17 Aligned_cols=240 Identities=24% Similarity=0.357 Sum_probs=197.1
Q ss_pred EEEEEecCcEEEEEEEcc-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 14 LRLIQLVDTSGYKAFDEV-----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~-----tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
..+++++.|+||+|.+.. .+..||+|.+.... .....+++.+|+++++.++||||+++++.+.... ..++
T Consensus 6 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 80 (290)
T cd05045 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG--PLLL 80 (290)
T ss_pred ccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC--CcEE
Confidence 577888889999999764 33578888776332 2345678999999999999999999999886554 6899
Q ss_pred EEecCCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccE
Q 006277 89 ITELFTSGSLRQYRKKH------------------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~------------------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NI 144 (652)
+|||+.+|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~ni 158 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNV 158 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhheE
Confidence 99999999999998643 24788999999999999999999998 99999999999
Q ss_pred EEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHH
Q 006277 145 FINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSA 218 (652)
Q Consensus 145 Ll~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~ 218 (652)
|++ +++.+||+|||++....... .....++..|+|||.+ ...++.++|||||||++|+|++ |..||.+ ..+.
T Consensus 159 ll~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~ 236 (290)
T cd05045 159 LVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-IAPE 236 (290)
T ss_pred EEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-CCHH
Confidence 998 67899999999997653321 1233557789999965 5568999999999999999998 9999976 5667
Q ss_pred HHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 219 QIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 219 ~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
.++..+..+..+. .+...+.++++||.+||. +|.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 237 RLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 7777776654332 345567899999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=289.84 Aligned_cols=239 Identities=22% Similarity=0.328 Sum_probs=195.4
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
.+++++.|.||+|.+. ++..||+|.+.... ..+....+.+|+++++.++||||+++++++.... ..++||||+.
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~ 75 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ--PIYIVMELVP 75 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC--ccEEEEECCC
Confidence 3677888999999864 78899999876321 2345567899999999999999999999887654 7899999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc---c
Q 006277 95 SGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA---K 170 (652)
Q Consensus 95 gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~---~ 170 (652)
+|+|.+++... ..+++..+..++.|++.||.|||++| ++||||||+||+++ .++.+||+|||++........ .
T Consensus 76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEc-CCCeEEECCCccceeccccccccCC
Confidence 99999998754 46899999999999999999999998 99999999999998 678999999999875433221 1
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
...+++.|+|||++. +.++.++|||||||++|+|++ |..||... ........+..+... ..+...+..+.+||.+|
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 230 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVMQRC 230 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHH
Confidence 234467799999774 568899999999999999998 99999874 455555666655432 33445678999999999
Q ss_pred CC-CCCCCCCHHHHhcC
Q 006277 249 LV-PASQRLSAKELLMD 264 (652)
Q Consensus 249 L~-~P~~RpSa~elL~h 264 (652)
|. +|.+||++.++++.
T Consensus 231 l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 231 WDYKPENRPKFSELQKE 247 (250)
T ss_pred cccCcccCCCHHHHHHH
Confidence 97 89999999999753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=305.58 Aligned_cols=246 Identities=29% Similarity=0.422 Sum_probs=196.3
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.++.|.||+|.++.+|..||+|.+..... .....+.+.+|+.+++.++||||++++++|.... ..+|+||||+
T Consensus 16 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~lv~e~~ 92 (328)
T cd07856 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-EDIYFVTELL 92 (328)
T ss_pred EeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-CcEEEEeehh
Confidence 456666679999999999999999998864322 2345577889999999999999999999987543 3689999998
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI 173 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~v 173 (652)
+++|..+++. ..+++..+..++.||+.||.|||+++ |+||||+|+|||++ .++.+||+|||++..... ......
T Consensus 93 -~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~~~-~~~~~~ 166 (328)
T cd07856 93 -GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARIQDP-QMTGYV 166 (328)
T ss_pred -ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeEC-CCCCEEeCccccccccCC-CcCCCc
Confidence 6689888764 46899999999999999999999998 99999999999998 678999999999876533 234457
Q ss_pred CCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc---------------C---------
Q 006277 174 GTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS---------------G--------- 227 (652)
Q Consensus 174 GTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~---------------g--------- 227 (652)
+++.|+|||++. ..++.++|||||||++|+|++|.+||..... ...+..+.. +
T Consensus 167 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (328)
T cd07856 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-VNQFSIITDLLGTPPDDVINTICSENTLRFVQSL 245 (328)
T ss_pred ccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhc
Confidence 899999999764 3689999999999999999999999976332 211111110 0
Q ss_pred --CCCc---cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 228 --IKPA---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 228 --~~p~---~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
..+. ......++.+++||.+||+ +|.+||++.+++.||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 0000 1112356889999999997 8999999999999999974
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.15 Aligned_cols=232 Identities=22% Similarity=0.339 Sum_probs=187.6
Q ss_pred EEEEecCcEEEEEEEccCC----------eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 006277 15 RLIQLVDTSGYKAFDEVNG----------LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG----------~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 84 (652)
.+++++.+.||+|.+..++ ..|++|.+.... .....+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-- 73 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-D-- 73 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec-C--
Confidence 4678888999999998887 457777665332 126788899999999999999999998876 3
Q ss_pred eEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCC-------cEEEe
Q 006277 85 TVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG-------EVKIG 156 (652)
Q Consensus 85 ~~~LVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g-------~VKL~ 156 (652)
..++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++ .+||+
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~-~~~~~~~~~~~~kl~ 150 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVA-RYGLNEGYVPFIKLS 150 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEe-cCccccCCceeEEeC
Confidence 5799999999999999998776 7999999999999999999999998 99999999999998 444 69999
Q ss_pred ccCchhhhhccccccccCCCCccCcccccc---CCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCcc
Q 006277 157 DLGLATIMEQANAKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAA 232 (652)
Q Consensus 157 DFGla~~l~~~~~~~~vGTp~YmAPEvl~~---~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~ 232 (652)
|||++..... .....+++.|+|||++.. .++.++|||||||++|+|++ |..||.... ........... ..
T Consensus 151 Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~---~~ 224 (259)
T cd05037 151 DPGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQ---HR 224 (259)
T ss_pred CCCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcC---CC
Confidence 9999987543 334567888999998754 58899999999999999999 588886643 22222222211 11
Q ss_pred ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 233 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 233 l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
.+......+.+||.+||. +|.+|||+.++++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 225 LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 122223789999999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=331.97 Aligned_cols=248 Identities=26% Similarity=0.411 Sum_probs=212.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeC---CCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDD---QNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~---~~~~~~L 88 (652)
+.-++++.+|.||++.++.+|+.+|+|+.... .+.-+.+..|..+|+.+ .|||++.+|++|.-. .++.+||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-----~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-----EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCC-----ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 56888888999999999999999999987643 24456677789999998 899999999998632 3458999
Q ss_pred EEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 89 ITELFTSGSLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
|||||.||+..++++. ..++.|..++.|++.++.||.+||.+. ++|||+|-.|||++ ..|.|||+|||.+..+..
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT-~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEe-ccCcEEEeeeeeeeeeec
Confidence 9999999999999875 357999999999999999999999998 99999999999999 678999999999998876
Q ss_pred c--ccccccCCCCccCccccc------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCC
Q 006277 167 A--NAKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 238 (652)
Q Consensus 167 ~--~~~~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 238 (652)
. +..+++|||+|||||++. -.|+..+|+||||++..||.-|.+|+.+......+++..........-+...+
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs 255 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWS 255 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHH
Confidence 5 357899999999999873 24788999999999999999999999887777777765544322222245667
Q ss_pred hHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 239 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 239 ~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
.++.+||..||. +-.+||+..++|+|||+.
T Consensus 256 ~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 256 KKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred HHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 899999999998 789999999999999997
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=294.01 Aligned_cols=240 Identities=22% Similarity=0.355 Sum_probs=197.0
Q ss_pred EEEEEecCcEEEEEEEccCC---eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNG---LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG---~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
..+++++.|.||+|.++.++ ..||+|.++... .....+.+.+|+.++++++||||+++++++.... .+|+||
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 84 (267)
T cd05066 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK--PVMIVT 84 (267)
T ss_pred eeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--ccEEEE
Confidence 57788888999999987554 479999876432 2345678999999999999999999999886543 799999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc
Q 006277 91 ELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 169 (652)
||+++|+|.+++.+. +.+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++..+.....
T Consensus 85 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 85 EYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEEC-CCCeEEeCCCCcccccccccc
Confidence 999999999998765 46899999999999999999999998 99999999999998 568999999999987653221
Q ss_pred -----ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 170 -----KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 170 -----~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
....+++.|+|||.+. +.++.++|+|||||++|++++ |..||.+. ...+....+..+..+ ..+...++.++
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~ 239 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEGYRL-PAPMDCPAALH 239 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCCCcC-CCCCCCCHHHH
Confidence 1123356899999775 578999999999999999886 99999773 445566666665432 23345678999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhc
Q 006277 243 SFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~ 263 (652)
+|+.+||. +|.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 99999998 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=293.11 Aligned_cols=240 Identities=23% Similarity=0.364 Sum_probs=196.8
Q ss_pred EEEEEecCcEEEEEEEccCCe---EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGL---EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~---~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
..+++++.|.||+|.++.++. .||+|.+.... .....+++.+|+.+++.++||||+++++++.+.. ..|+||
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 85 (268)
T cd05063 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK--PAMIIT 85 (268)
T ss_pred eEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC--CcEEEE
Confidence 467777789999999987665 79999876432 2455678999999999999999999999887554 789999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc
Q 006277 91 ELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 169 (652)
||+.+++|.+++..+ +.+++..+..++.|++.||+|||+.+ ++||||||+||+++ .++.+||+|||++........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 86 EYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEc-CCCcEEECCCccceecccccc
Confidence 999999999998764 57899999999999999999999998 99999999999998 678999999999876643221
Q ss_pred c-----cccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 170 K-----SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 170 ~-----~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
. ....++.|+|||++. ..++.++|||||||++|+|++ |..||.. .....+...+..+... ......+..+.
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~~ 240 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD-MSNHEVMKAINDGFRL-PAPMDCPSAVY 240 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc-CCHHHHHHHHhcCCCC-CCCCCCCHHHH
Confidence 1 122345799999774 568999999999999999997 9999977 3455666666655332 23344678999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhc
Q 006277 243 SFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~ 263 (652)
+||.+||. +|.+||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 99999997 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=295.50 Aligned_cols=240 Identities=17% Similarity=0.279 Sum_probs=187.0
Q ss_pred EEEEecCcEEEEEEEccC--CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 15 RLIQLVDTSGYKAFDEVN--GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~t--G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
.|+++..|+||+|..... ...+++|.+... ......+.+.+|+.+++.++||||+++++.+.+.. .+|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN---ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI--PYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC---CChHHHHHHHHHHHHHhccCCcchhheEEEecCCC--ccEEEEec
Confidence 467788899999975433 234556655432 23456778999999999999999999999987654 78999999
Q ss_pred CCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-
Q 006277 93 FTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 167 (652)
Q Consensus 93 ~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 167 (652)
+.+|+|.+++.+. ..+++..++.++.||+.||+|||+++ ++||||||+|||++ .++.+||+|||++......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEc-CCccEEecccccccccCcch
Confidence 9999999998754 34677888999999999999999998 99999999999998 5689999999998643211
Q ss_pred ---ccccccCCCCccCcccccc--------CCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCC----CCc
Q 006277 168 ---NAKSVIGTPEFMAPELYDE--------NYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGI----KPA 231 (652)
Q Consensus 168 ---~~~~~vGTp~YmAPEvl~~--------~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~----~p~ 231 (652)
.....+|++.|+|||++.. .++.++|||||||++|+|++ |..||..... ...+..+..+. ...
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~ 232 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKDQQVKLFKP 232 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhhcccccCCC
Confidence 1235678899999998632 35778999999999999997 5778876444 34444433322 122
Q ss_pred cccCCCChHHHHHHHHhCCCCCCCCCHHHHhc
Q 006277 232 ALSKVKDPEVKSFIEKCLVPASQRLSAKELLM 263 (652)
Q Consensus 232 ~l~~~~s~~~kdlI~kcL~~P~~RpSa~elL~ 263 (652)
.+....++.+.+++..|+.+|.+||+++++++
T Consensus 233 ~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 233 QLELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred ccCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 33345678899999999989999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=295.54 Aligned_cols=246 Identities=28% Similarity=0.455 Sum_probs=202.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQ-SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~-s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+++++.|+||+|.+..++..+++|.++...... .+....++..|+.+++.++||||+++++++.+.. ..++||||
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 83 (260)
T cd08222 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD--AFCIITEY 83 (260)
T ss_pred eeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--ceEEEEEe
Confidence 56788888999999999888888777765422211 2234556778999999999999999999887654 68999999
Q ss_pred CCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 93 FTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 93 ~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
+.+++|.+++.. ...+++..++.++.|++.||.|||++| ++|+||||+||+++ ++.+||+|||++.......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~--~~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 84 CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred CCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEee--cCCEeecccCceeecCCCc
Confidence 999999988753 357999999999999999999999998 99999999999997 3579999999987664322
Q ss_pred --cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 169 --AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
.....|++.|+|||.+. ..++.++|+||||+++|+|++|..||.. .........+..+..+ .++...+.++.+||
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 237 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTP-SLPETYSRQLNSIM 237 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCCCC-CCcchhcHHHHHHH
Confidence 23567899999999764 5688899999999999999999999976 4445555555555433 34556778999999
Q ss_pred HHhCC-CCCCCCCHHHHhcCccc
Q 006277 246 EKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
.+||. +|.+||++.++++||||
T Consensus 238 ~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 238 QSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHhcCChhhCcCHHHHhhCCCC
Confidence 99997 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.49 Aligned_cols=243 Identities=20% Similarity=0.293 Sum_probs=199.5
Q ss_pred EEEEEEecCcEEEEEEEccC-----CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVN-----GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~t-----G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~ 87 (652)
...++.++.|+||+|..+.+ .+.||+|.+.... .....+.+.+|++++++++||||+++++++.+.. ..|
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 84 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE--PHY 84 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC--cce
Confidence 45677888899999997653 4678888765332 2335678999999999999999999999876543 789
Q ss_pred EEEecCCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEecc
Q 006277 88 IITELFTSGSLRQYRKKHK---------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 158 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~---------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DF 158 (652)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVS-SQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEe-CCCcEEEccc
Confidence 9999999999999998766 7999999999999999999999998 99999999999998 6789999999
Q ss_pred Cchhhhhcc---ccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccc
Q 006277 159 GLATIMEQA---NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAAL 233 (652)
Q Consensus 159 Gla~~l~~~---~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l 233 (652)
|++...... ......+++.|+|||.+ ...++.++||||||+++|+|++ |..||.. .........+..+..+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG-LSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cchHHHHHHHHcCCcCCCC
Confidence 998754322 12345677889999976 4568899999999999999998 8889976 3445566666655444334
Q ss_pred cCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 234 SKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 234 ~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
....+..+.++|.+||. +|.+|||+.+++.+
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 45567899999999997 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=297.93 Aligned_cols=236 Identities=20% Similarity=0.291 Sum_probs=188.1
Q ss_pred EEEEecCcEEEEEEEccCCe-------EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 006277 15 RLIQLVDTSGYKAFDEVNGL-------EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~-------~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~ 87 (652)
+++.++.|+||+|.+..++. .||+|.+... .....+.+.+|+.+++.++||||+++++++.+.. ..+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~~ 75 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD--ESI 75 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--CcE
Confidence 46778889999999876554 3888876532 2345678889999999999999999999988654 689
Q ss_pred EEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCC-------cEEEeccC
Q 006277 88 IITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG-------EVKIGDLG 159 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g-------~VKL~DFG 159 (652)
+||||+.+|+|..++...+ .+++..++.++.||+.||+|||+++ |+||||||+||+++.+.. .++++|||
T Consensus 76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999999997654 5899999999999999999999998 999999999999974322 27999999
Q ss_pred chhhhhccccccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhc-cCCCCCCCCHHHHHHHHhcCCCCccccCC
Q 006277 160 LATIMEQANAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAALSKV 236 (652)
Q Consensus 160 la~~l~~~~~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG-~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~ 236 (652)
++..... .....|++.|+|||++.+ .++.++|||||||++|+|++| .+||.. ............ ...++..
T Consensus 154 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~-~~~~~~~~~~~~---~~~~~~~ 227 (258)
T cd05078 154 ISITVLP--KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA-LDSQKKLQFYED---RHQLPAP 227 (258)
T ss_pred cccccCC--chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh-ccHHHHHHHHHc---cccCCCC
Confidence 8865533 234678999999998854 588999999999999999999 466655 333322222222 1223444
Q ss_pred CChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 237 KDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 237 ~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.+.++.+||.+||+ +|.+|||++++++.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 228 KWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 56789999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.88 Aligned_cols=276 Identities=17% Similarity=0.286 Sum_probs=225.2
Q ss_pred cceeeeeeEEEEEEecC---cEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEe
Q 006277 5 KWSLLILMYLRLIQLVD---TSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWID 80 (652)
Q Consensus 5 ~W~~~~~~~~rL~~l~~---gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d 80 (652)
.|.+-...|..|.-++. ..|.++.+++|.+.||+|++++ ++....+++.-++.|.++..+- +||.+|.++.+|+.
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkk-el~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKK-ELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHH-HhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 46666666655554444 4789999999999999999985 4555668888999999999888 89999999999987
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCc
Q 006277 81 DQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160 (652)
Q Consensus 81 ~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGl 160 (652)
+. .+++|.||++||+|.-+++++++++++.++.|...|..||.|||+.| ||+||||.+|+|++ ..|+|||+|+|+
T Consensus 323 es--rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlld-aeghikltdygm 397 (593)
T KOG0695|consen 323 ES--RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGM 397 (593)
T ss_pred cc--eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEc-cCCceeecccch
Confidence 66 79999999999999999999999999999999999999999999999 99999999999999 678999999999
Q ss_pred hhhh-hc-cccccccCCCCccCcccccc-CCCccccchhhHHHHHHHhhccCCCC-------CCCCHHHHHHHHhcCCCC
Q 006277 161 ATIM-EQ-ANAKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYS-------ECRNSAQIYKKVSSGIKP 230 (652)
Q Consensus 161 a~~l-~~-~~~~~~vGTp~YmAPEvl~~-~y~~~sDIWSlGvilyeLltG~~Pf~-------~~~~~~~i~~~I~~g~~p 230 (652)
.+.- .. ..+.++||||.|+|||++++ .|+..+|||+|||+|+||+.|+.||. +.+..+-+++.|....
T Consensus 398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq-- 475 (593)
T KOG0695|consen 398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ-- 475 (593)
T ss_pred hhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--
Confidence 8753 22 24678999999999999965 79999999999999999999999994 2233445677776543
Q ss_pred ccccCCCChHHHHHHHHhCC-CCCCCCC------HHHHhcCccccccCCCCCCCCCCCCCcCCCC
Q 006277 231 AALSKVKDPEVKSFIEKCLV-PASQRLS------AKELLMDPFLQVNGTTKNRPLPLPDIVLPRV 288 (652)
Q Consensus 231 ~~l~~~~s~~~kdlI~kcL~-~P~~RpS------a~elL~hpf~~~~~~~~~~~~~~p~~~lp~~ 288 (652)
...+...+-.+..+++..|+ ||.+|+. ..++..|+||+..+|.......+.+++.|.+
T Consensus 476 iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i 540 (593)
T KOG0695|consen 476 IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQI 540 (593)
T ss_pred ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCcc
Confidence 23444555667778888887 8999974 7799999999987775543333334455554
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=297.71 Aligned_cols=240 Identities=19% Similarity=0.264 Sum_probs=196.4
Q ss_pred EEEEEecCcEEEEEEEc-----cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 14 LRLIQLVDTSGYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~-----~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
.++++++.|.||+|.+. .++..||+|++.... ..+....+.+|+.++++++||||+++++++.+.. .+++
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~--~~~l 85 (288)
T cd05050 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK--PMCL 85 (288)
T ss_pred ccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--ccEE
Confidence 46777778999999875 378899999886432 2455677999999999999999999999887654 6899
Q ss_pred EEecCCCCCHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEE
Q 006277 89 ITELFTSGSLRQYRKKHK----------------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI 146 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~----------------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl 146 (652)
||||+.+|+|.+++.... .+++..+..++.||+.||+|||+++ ++||||||+|||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~nil~ 163 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLV 163 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhheEe
Confidence 999999999999987532 3778889999999999999999998 9999999999999
Q ss_pred cCCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHH
Q 006277 147 NGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQI 220 (652)
Q Consensus 147 ~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i 220 (652)
+ .++.+||+|||++..+.... .....+++.|+|||++ ...++.++|||||||++|+|++ |..||.+ .....+
T Consensus 164 ~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~-~~~~~~ 241 (288)
T cd05050 164 G-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG-MAHEEV 241 (288)
T ss_pred c-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHH
Confidence 8 67899999999987653221 1223456789999976 4679999999999999999997 8889876 455666
Q ss_pred HHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 221 YKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 221 ~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
...+..+... ..+...+.++.+||.+||+ +|.+|||+.|+++
T Consensus 242 ~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 242 IYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6666665432 2334567899999999997 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=295.45 Aligned_cols=244 Identities=25% Similarity=0.390 Sum_probs=192.6
Q ss_pred EEEEEEecCcEEEEEE----EccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~----d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
...+++++.|+||+|. +..+|..||+|.+... .....+.+.+|+++++.++||||+++++++.......+++
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 3567888889999997 5568999999997643 2456778999999999999999999999876655557999
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 89 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
||||+.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++..+...
T Consensus 85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEEC-CCCeEEECCCcccccccCC
Confidence 99999999999998764 46899999999999999999999998 99999999999998 6789999999999876433
Q ss_pred cc-----ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCH---------------HHHHHHHhc
Q 006277 168 NA-----KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNS---------------AQIYKKVSS 226 (652)
Q Consensus 168 ~~-----~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~---------------~~i~~~I~~ 226 (652)
.. ....++..|+|||++. ..++.++|||||||++|||++|..|+...... ..+...+..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence 21 1123345699999774 56899999999999999999987765331110 011112222
Q ss_pred CCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 227 GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 227 g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
+. ........+.++.+||.+||. +|.+|||+.++++.
T Consensus 242 ~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 242 NG-RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred CC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 22 122334567899999999997 89999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=325.57 Aligned_cols=239 Identities=32% Similarity=0.458 Sum_probs=204.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
-.|+|++..|+||+|+.-. .||||++..... +++.++.|+.|+.+|++=+|.||+=|-+++.... +.||+.+
T Consensus 397 ~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~---~AIiTqw 468 (678)
T KOG0193|consen 397 GERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP---LAIITQW 468 (678)
T ss_pred cceeccccccceeeccccc---ceEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---eeeeehh
Confidence 3578888889999999875 699999987664 5789999999999999999999999999886543 5999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh----cc
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME----QA 167 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~----~~ 167 (652)
|.|.+|..++.-. .+|+......|++||++|+.|||.++ |||||||..|||+. +++.|||+||||+..-. ..
T Consensus 469 CeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~-~~~kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLH-EDLKVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred ccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEc-cCCcEEEecccceeeeeeecccc
Confidence 9999999987543 57999999999999999999999999 99999999999998 67999999999987542 22
Q ss_pred ccccccCCCCccCccccc----cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC---CccccCCCChH
Q 006277 168 NAKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK---PAALSKVKDPE 240 (652)
Q Consensus 168 ~~~~~vGTp~YmAPEvl~----~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~---p~~l~~~~s~~ 240 (652)
.....-|...|||||+++ ..|++.+||||||||+|||+||..||. ..+.++|.=.|.+|.. ..........+
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~pk~ 624 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCPKA 624 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCHHH
Confidence 345567888999999884 359999999999999999999999999 5888888878888843 22333445569
Q ss_pred HHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 241 VKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 241 ~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
+++|+..||. ++++||...+||.
T Consensus 625 mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 625 MKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHhcCcccCccHHHHHH
Confidence 9999999998 8999999999986
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=292.55 Aligned_cols=240 Identities=23% Similarity=0.405 Sum_probs=196.4
Q ss_pred EEEEEecCcEEEEEEEccC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~t---G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
..+++++.|.||+|.+... ...||+|.+.... ..+..+.+.+|+.+++.++||||+++++++.+. ..|+||
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~~~lv~ 85 (270)
T cd05056 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---PVWIVM 85 (270)
T ss_pred eeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC---CcEEEE
Confidence 5778888899999998654 4578999876432 245677899999999999999999999988653 478999
Q ss_pred ecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 91 ELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
||+++|+|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+|||++ ..+.+||+|||++.......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVS-SPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEe-cCCCeEEccCceeeecccccc
Confidence 9999999999997654 5899999999999999999999998 99999999999998 56799999999987664432
Q ss_pred --cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 169 --AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
.....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+.. .......+..+..+ ..+...++.+++|
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~l 240 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK-NNDVIGRIENGERL-PMPPNCPPTLYSL 240 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCcC-CCCCCCCHHHHHH
Confidence 12233456899999764 568999999999999999986 999998744 34455556555433 3345567899999
Q ss_pred HHHhCC-CCCCCCCHHHHhcC
Q 006277 245 IEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~h 264 (652)
|.+||. +|.+|||+.+++..
T Consensus 241 i~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 241 MTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999997 89999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=344.03 Aligned_cols=253 Identities=32% Similarity=0.490 Sum_probs=210.8
Q ss_pred eeeeeeEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC-----
Q 006277 7 SLLILMYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD----- 81 (652)
Q Consensus 7 ~~~~~~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~----- 81 (652)
......+.-||++|.|.||++.++-+|++||||+|.... +.....++.+|+.+|.+|+|||||+||..|+..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 333445667999999999999999999999999998653 346678899999999999999999999887530
Q ss_pred -------------------------------------------------C------------------------------
Q 006277 82 -------------------------------------------------Q------------------------------ 82 (652)
Q Consensus 82 -------------------------------------------------~------------------------------ 82 (652)
.
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred -------------------------C--------CeEEEEEecCCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHH
Q 006277 83 -------------------------N--------KTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWARQILSGLIYLH 128 (652)
Q Consensus 83 -------------------------~--------~~~~LVmEy~~gGsL~~~i~~~~~l-se~~i~~i~~QIl~aL~yLH 128 (652)
. ..+||=||||+..+|++++..+... ....++++++||+.||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 2578999999997788777765544 57889999999999999999
Q ss_pred hCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh--------------------ccccccccCCCCccCcccccc--
Q 006277 129 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--------------------QANAKSVIGTPEFMAPELYDE-- 186 (652)
Q Consensus 129 s~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~--------------------~~~~~~~vGTp~YmAPEvl~~-- 186 (652)
++| ||||||||.|||++ .++.|||+|||+|+... ....++.+||.-|+|||++.+
T Consensus 715 ~~g--iIHRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG--IIHRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc--eeeccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 99999999999999 67899999999998721 011245799999999998842
Q ss_pred --CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcc--ccCCCChHHHHHHHHhCC-CCCCCCCHHHH
Q 006277 187 --NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA--LSKVKDPEVKSFIEKCLV-PASQRLSAKEL 261 (652)
Q Consensus 187 --~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~--l~~~~s~~~kdlI~kcL~-~P~~RpSa~el 261 (652)
.|+.++|+||||||++||+ +||........+...+++|..|.. +....-+.-..+|..||. ||++||||.||
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL 868 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL 868 (1351)
T ss_pred cccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence 5999999999999999999 679887778888888888877765 122223567889999998 99999999999
Q ss_pred hcCcccc
Q 006277 262 LMDPFLQ 268 (652)
Q Consensus 262 L~hpf~~ 268 (652)
|++.||.
T Consensus 869 L~s~llp 875 (1351)
T KOG1035|consen 869 LNSELLP 875 (1351)
T ss_pred hhccCCC
Confidence 9999996
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=293.39 Aligned_cols=236 Identities=22% Similarity=0.355 Sum_probs=192.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.++++++.|+||+|.+..++ .||+|.+..... ..+++.+|+++++.++||||+++++.+.. ...++||||+
T Consensus 12 ~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~e~~ 82 (262)
T cd05071 12 VKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYM 82 (262)
T ss_pred eecCCCCCCcEEEEEecCCc-eEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEEEEEcC
Confidence 46666777899999987664 599999874332 23578889999999999999999997643 2579999999
Q ss_pred CCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc--
Q 006277 94 TSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-- 169 (652)
Q Consensus 94 ~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~-- 169 (652)
.+|+|.+++.+. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++ .++.+||+|||++..+.....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~-~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEc-CCCcEEeccCCceeecccccccc
Confidence 999999999764 35899999999999999999999998 99999999999998 678999999999976643321
Q ss_pred -ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 170 -KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 170 -~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
....++..|+|||+. ...++.++|||||||++|+|++ |..||.+ .....++..+..+... ......+..+.+||.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 237 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-PCPPECPESLHDLMC 237 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CChHHHHHHHhcCCCC-CCccccCHHHHHHHH
Confidence 234566789999976 4578999999999999999999 8889976 4455566666554322 233456789999999
Q ss_pred HhCC-CCCCCCCHHHHhc
Q 006277 247 KCLV-PASQRLSAKELLM 263 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~ 263 (652)
+||. +|.+||++.+++.
T Consensus 238 ~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 238 QCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHccCCcccCCCHHHHHH
Confidence 9998 8999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.22 Aligned_cols=246 Identities=30% Similarity=0.415 Sum_probs=198.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++++..+.||+|.+..+|+.||+|.+.... ......+.+..|+.+++.++||||+++++++.+. ..+++||||+
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~e~~ 80 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVFEYC 80 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEecCc
Confidence 45677777999999999999999999988653 1233456778899999999999999999988765 4799999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 94 TSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 94 ~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
. ++|.+++.+. ..+++..+..++.|++.||.|||+++ |+||||+|+||+++ +++.+||+|||++....... ..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~~~~ 156 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRTYT 156 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEc-CCCCEEEecCCcccccCCCccccC
Confidence 7 5899999876 58999999999999999999999998 99999999999998 57899999999998764432 23
Q ss_pred cccCCCCccCccccc-c-CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC-------------------CC
Q 006277 171 SVIGTPEFMAPELYD-E-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG-------------------IK 229 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~-~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g-------------------~~ 229 (652)
...+++.|+|||.+. . .++.++|||||||++|+|++|.+||........+.+..... ..
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 456688999999763 3 68899999999999999999999997744333322211100 00
Q ss_pred Cc-------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 230 PA-------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 230 p~-------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
+. ......+..+.+||.+||. +|.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00 0011236789999999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=290.70 Aligned_cols=236 Identities=22% Similarity=0.355 Sum_probs=192.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.++.|+||+|.+..++ .||+|.+..... ..+++.+|+.+++.++||||+++++++.. ...++||||+
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e~~ 82 (260)
T cd05069 12 VKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIVTEFM 82 (260)
T ss_pred eeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc-----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEEEEcC
Confidence 56777777999999886654 599998764332 24568889999999999999999997743 2588999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc--
Q 006277 94 TSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-- 169 (652)
Q Consensus 94 ~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~-- 169 (652)
.+|+|.+++.... .+++..+..++.||+.||.|||+.| ++||||||+||+++ .++.+||+|||++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~-~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVG-DNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCeEEECCCccceEccCCcccc
Confidence 9999999997643 4889999999999999999999998 99999999999998 678999999999976643221
Q ss_pred -ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 170 -KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 170 -~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
....++..|+|||... ..++.++|||||||++|+|++ |..||.+ .........+..+..+ ..+...+..+++||.
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 237 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG-MVNREVLEQVERGYRM-PCPQGCPESLHELMK 237 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCHHHHHHHH
Confidence 2334567899999764 568999999999999999999 8999987 4445555666555332 334456789999999
Q ss_pred HhCC-CCCCCCCHHHHhc
Q 006277 247 KCLV-PASQRLSAKELLM 263 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~ 263 (652)
+||. +|.+||++.++++
T Consensus 238 ~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 238 LCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 9998 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=304.51 Aligned_cols=252 Identities=27% Similarity=0.387 Sum_probs=201.8
Q ss_pred Ccceeeeee---EEEEEEecCcEEEEEEEcc-------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCee
Q 006277 4 QKWSLLILM---YLRLIQLVDTSGYKAFDEV-------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNII 72 (652)
Q Consensus 4 ~~W~~~~~~---~~rL~~l~~gtVykA~d~~-------tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIV 72 (652)
|+|.+.... -.++++++.|.||+|.+.. .+..||+|.+... ......+.+.+|+.+++++ +||||+
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv 81 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGKHKNII 81 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHHHHHHHHHHhhcCCCCee
Confidence 566665432 3457777779999998643 2347999987632 1245678899999999999 899999
Q ss_pred eeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 006277 73 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIH 136 (652)
Q Consensus 73 kl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiH 136 (652)
++++++.... .++++|||+.+|+|.+++.+.+ .++...+..++.||+.||.|||++| |+|
T Consensus 82 ~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH 157 (334)
T cd05100 82 NLLGACTQDG--PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIH 157 (334)
T ss_pred eeeEEEccCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eec
Confidence 9999886543 7999999999999999987642 3678889999999999999999998 999
Q ss_pred ccCCcccEEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCC
Q 006277 137 RDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYP 210 (652)
Q Consensus 137 RDLKp~NILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~P 210 (652)
|||||+|||++ .++.+||+|||+++...... .....+++.|+|||++ ...++.++|||||||++|+|++ |..|
T Consensus 158 ~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 236 (334)
T cd05100 158 RDLAARNVLVT-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236 (334)
T ss_pred cccccceEEEc-CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCC
Confidence 99999999998 56899999999997664322 1223345789999977 4578999999999999999998 8899
Q ss_pred CCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCc
Q 006277 211 YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDP 265 (652)
Q Consensus 211 f~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hp 265 (652)
|.+ .+...++..+..+..+ ..+...+.++.+||.+||. +|.+||++.+++.+-
T Consensus 237 ~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 237 YPG-IPVEELFKLLKEGHRM-DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred CCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 977 5667777777665433 2334567899999999998 899999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=290.23 Aligned_cols=237 Identities=23% Similarity=0.380 Sum_probs=194.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+++.++.|+||+|..+ +++.||+|.+..... ...++.+|+.++++++||||+++++++.+ ..++++|||
T Consensus 11 ~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e~ 81 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYIITEY 81 (260)
T ss_pred eeeeccCccceEEeeecC-CCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEEEEEc
Confidence 357788888999999864 678899998864332 24578889999999999999999998643 258999999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 93 FTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
+.+|+|.+++... ..+++..+..++.|++.||+|||++| ++||||||+||+++ .++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEc-CCCCEEEccCcceeecCCCCcc
Confidence 9999999998753 46899999999999999999999998 99999999999998 67899999999997665222
Q ss_pred -cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 169 -AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
.....++..|+|||++. ..++.++||||||+++|+|++ |.+||.+. +...+...+..+..+ ..+...+.++++||
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 236 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRM-PRPDNCPEELYELM 236 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCCC-CCCCCCCHHHHHHH
Confidence 12345677899999774 568899999999999999999 99999874 445556666555432 34455678999999
Q ss_pred HHhCC-CCCCCCCHHHHhc
Q 006277 246 EKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~ 263 (652)
.+||. +|.+||++.+++.
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 237 RLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHccCChhhCCCHHHHHH
Confidence 99997 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=327.56 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=184.0
Q ss_pred EEEEEEecCcEEEEEEEccCC-eEEEEEEE-------------eecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNG-LEVAWCQV-------------RIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSW 78 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG-~~VAiK~v-------------~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~ 78 (652)
..+|++++.|+||+|..+... ..++.|.+ ..+..........++.+|+.+|++|+|||||++++++
T Consensus 153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 232 (501)
T PHA03210 153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232 (501)
T ss_pred EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEEE
Confidence 356777777999998765432 22222211 0011112234566788999999999999999999998
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcE
Q 006277 79 IDDQNKTVNIITELFTSGSLRQYRKKH-----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 153 (652)
Q Consensus 79 ~d~~~~~~~LVmEy~~gGsL~~~i~~~-----~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~V 153 (652)
.+.. ..|+||+++. ++|..++... .......++.++.||+.||.|||++| |+||||||+|||++ .+|.+
T Consensus 233 ~~~~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~-~~~~v 306 (501)
T PHA03210 233 RSEA--NTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN-CDGKI 306 (501)
T ss_pred EECC--eeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCE
Confidence 7765 7899999994 5777776532 23446778899999999999999998 99999999999998 67899
Q ss_pred EEeccCchhhhhccc---cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCC-CCCCC-C-HHHHHHHHhc
Q 006277 154 KIGDLGLATIMEQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYP-YSECR-N-SAQIYKKVSS 226 (652)
Q Consensus 154 KL~DFGla~~l~~~~---~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~P-f~~~~-~-~~~i~~~I~~ 226 (652)
||+|||++..+.... ....+||+.|+|||++. ..|+.++|||||||++|||++|..| |.... . ..++.+.+..
T Consensus 307 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~ 386 (501)
T PHA03210 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS 386 (501)
T ss_pred EEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHh
Confidence 999999998765432 23568999999999874 5799999999999999999998764 43221 2 2233322221
Q ss_pred CC-----CC-------------------ccc-----cCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 227 GI-----KP-------------------AAL-----SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 227 g~-----~p-------------------~~l-----~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.. .| ..+ ....+..+.++|.+||. ||.+||||.|+|.||||..
T Consensus 387 ~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 387 LSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred cccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 00 00 000 01234577889999998 8999999999999999974
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=292.31 Aligned_cols=239 Identities=25% Similarity=0.401 Sum_probs=199.1
Q ss_pred EEEEEecCcEEEEEEEccCCe----EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGL----EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~----~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
..+++++.|+||+|.++.+|. .||+|...... .+.....+.+|+.+++.++||||+++++++.. ...++|
T Consensus 13 ~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~v 86 (279)
T cd05057 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQVQLI 86 (279)
T ss_pred ceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---CceEEE
Confidence 567888889999999887765 58888776432 25667889999999999999999999998875 368999
Q ss_pred EecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 90 TELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
|||+.+|+|.+++... ..+++..+..|+.||+.||+|||+++ ++||||||+||+++ .++.+||+|||+++.+....
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEc-CCCeEEECCCcccccccCcc
Confidence 9999999999998764 46999999999999999999999988 99999999999998 66799999999998765322
Q ss_pred c----ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 169 A----KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 169 ~----~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
. ....+++.|+|||.+ ...++.++|||||||++|+|++ |..||.+ .....+...+..+.. ...+...+..+.
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG-IPAVEIPDLLEKGER-LPQPPICTIDVY 241 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhCCCC-CCCCCCCCHHHH
Confidence 1 112345689999976 4678999999999999999998 9999977 456667777776542 334456778999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhc
Q 006277 243 SFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~ 263 (652)
+++.+||. +|.+||++.++++
T Consensus 242 ~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 242 MVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHcCCChhhCCCHHHHHH
Confidence 99999997 8999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=292.51 Aligned_cols=241 Identities=22% Similarity=0.280 Sum_probs=199.1
Q ss_pred EEEEEecCcEEEEEEEcc----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEV----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~----tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
..+++++.|.||+|.+.. ++..||+|.+... ......+.+.+|+.+++.++||||+++++++... +...+++
T Consensus 12 ~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~~~~ 87 (280)
T cd05043 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GEPPFVL 87 (280)
T ss_pred eeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CCCCEEE
Confidence 456777779999999887 3688999987532 2356678899999999999999999999987654 3478999
Q ss_pred EecCCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCch
Q 006277 90 TELFTSGSLRQYRKKH--------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 161 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~--------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla 161 (652)
++|+.+|+|..++... ..+++..+..++.||+.||+|||+++ ++||||||+||+++ .++.+||+|||++
T Consensus 88 ~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kl~d~g~~ 164 (280)
T cd05043 88 YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDNALS 164 (280)
T ss_pred EEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEc-CCCcEEECCCCCc
Confidence 9999999999998764 45899999999999999999999998 99999999999998 5689999999999
Q ss_pred hhhhcccc----ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccC
Q 006277 162 TIMEQANA----KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSK 235 (652)
Q Consensus 162 ~~l~~~~~----~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~ 235 (652)
+.+..... ....++..|+|||++. ..++.++|||||||++|++++ |.+||.. .+...+...+..+..+. ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 242 (280)
T cd05043 165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKDGYRLA-QPI 242 (280)
T ss_pred ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHHcCCCCC-CCC
Confidence 86643221 2334567899999774 568999999999999999999 9999977 46666777776654332 334
Q ss_pred CCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 236 VKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 236 ~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
..++++.+++.+||. +|++|||+.++++
T Consensus 243 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 243 NCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 467899999999997 8999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=289.19 Aligned_cols=237 Identities=24% Similarity=0.376 Sum_probs=194.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+++.++.|+||+|.+. .++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.. ..++||||+
T Consensus 12 ~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~~ 83 (261)
T cd05034 12 RKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE--PIYIVTEYM 83 (261)
T ss_pred eeeccCcceEEEEEEEc-CCceEEEEEecCCc-----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCC--ceEEEEecc
Confidence 45677777999999975 56789999887433 23467889999999999999999999876543 799999999
Q ss_pred CCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 94 TSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 94 ~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
.+++|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++..+....
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVG-ENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEc-CCCCEEECccccceeccchhhhh
Confidence 999999999765 36899999999999999999999998 99999999999998 67899999999987664321
Q ss_pred cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
.....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+ .........+..+... ..+...+.++++++.
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~ 238 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG-MTNREVLEQVERGYRM-PRPPNCPEELYDLML 238 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHH
Confidence 12233467899999774 568899999999999999998 9999977 4555566666655322 223345789999999
Q ss_pred HhCC-CCCCCCCHHHHhc
Q 006277 247 KCLV-PASQRLSAKELLM 263 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~ 263 (652)
+||. +|.+||++++++.
T Consensus 239 ~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 239 QCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHcccCcccCCCHHHHHH
Confidence 9997 8999999999873
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=293.49 Aligned_cols=235 Identities=19% Similarity=0.307 Sum_probs=185.2
Q ss_pred EEEEecCcEEEEEEEcc------------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 006277 15 RLIQLVDTSGYKAFDEV------------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 82 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~------------tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 82 (652)
+++++..|.||+|.... ....||+|++... .......+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 57788889999998432 2346888876532 2345567888999999999999999999887654
Q ss_pred CCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCC-------cEE
Q 006277 83 NKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG-------EVK 154 (652)
Q Consensus 83 ~~~~~LVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g-------~VK 154 (652)
..++||||+++|+|..++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++ .+|
T Consensus 78 --~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~~~~~~~~~ 152 (262)
T cd05077 78 --ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLA-REGIDGECGPFIK 152 (262)
T ss_pred --CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEe-cCCccCCCCceeE
Confidence 679999999999999988754 57999999999999999999999998 99999999999997 333 289
Q ss_pred EeccCchhhhhccccccccCCCCccCccccc--cCCCccccchhhHHHHHHHh-hccCCCCCCCCHHHHHHHHhcCCCCc
Q 006277 155 IGDLGLATIMEQANAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMV-TFEYPYSECRNSAQIYKKVSSGIKPA 231 (652)
Q Consensus 155 L~DFGla~~l~~~~~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLl-tG~~Pf~~~~~~~~i~~~I~~g~~p~ 231 (652)
++|||++..... .....|++.|+|||++. ..++.++|||||||++|+|+ +|..||... ...... ....+...
T Consensus 153 l~d~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~-~~~~~~~~- 227 (262)
T cd05077 153 LSDPGIPITVLS--RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKE-RFYEGQCM- 227 (262)
T ss_pred eCCCCCCccccC--cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-chhHHH-HHHhcCcc-
Confidence 999999865532 23457889999999774 46899999999999999997 588888663 322222 22222211
Q ss_pred cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 232 ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 232 ~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.....+.++++||.+||. +|.+||++.+++++
T Consensus 228 -~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 228 -LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 122235789999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=288.17 Aligned_cols=239 Identities=20% Similarity=0.383 Sum_probs=197.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...+++++.|.||+|.+. .+..+|+|.+..... ....+.+|++++++++||||+++++++.+.. .+++||||
T Consensus 9 ~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~ 80 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS--PICLVFEF 80 (256)
T ss_pred EeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC--ceEEEEEc
Confidence 467888888999999885 477899998864332 2346788999999999999999999886554 78999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc--
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-- 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~-- 169 (652)
+.+|+|.+++... +.+++..++.++.|++.||+|||+++ ++||||||+||+++ .++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEc-CCCeEEECCCcceeecccCcccc
Confidence 9999999998764 56899999999999999999999998 99999999999998 667999999999876543221
Q ss_pred -ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 170 -KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 170 -~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
....++..|+|||.+. +.++.++|||||||++|+|++ |..||.. .....+...+..+..+ ..+...+..+.+|+.
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 235 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRL-YKPRLASQSVYELMQ 235 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCC-CCCCCCCHHHHHHHH
Confidence 1233567899999774 578899999999999999998 9999976 4556666666665433 234556789999999
Q ss_pred HhCC-CCCCCCCHHHHhcC
Q 006277 247 KCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~h 264 (652)
+||. +|.+|||+.+++++
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHcccChhhCCCHHHHHHh
Confidence 9998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=297.88 Aligned_cols=241 Identities=24% Similarity=0.323 Sum_probs=191.8
Q ss_pred EEEEEecCcEEEEEEEccCC--------------eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNG--------------LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 79 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG--------------~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 79 (652)
.+|++++.|.||+|.+..++ ..||+|.++... .....+.+.+|++++++++||||+++++++.
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 87 (295)
T cd05097 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNIIRLLGVCV 87 (295)
T ss_pred hccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEc
Confidence 57889999999999886532 358999886431 3456778999999999999999999999987
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEc
Q 006277 80 DDQNKTVNIITELFTSGSLRQYRKKHK------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN 147 (652)
Q Consensus 80 d~~~~~~~LVmEy~~gGsL~~~i~~~~------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~ 147 (652)
... .+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+|||++
T Consensus 88 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nill~ 163 (295)
T cd05097 88 SDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVG 163 (295)
T ss_pred CCC--ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEEEc
Confidence 554 7899999999999999986532 3688899999999999999999998 99999999999998
Q ss_pred CCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh--ccCCCCCCCCHHHH
Q 006277 148 GNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT--FEYPYSECRNSAQI 220 (652)
Q Consensus 148 ~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt--G~~Pf~~~~~~~~i 220 (652)
.++.+||+|||++..+.... .....+++.|+|||++ .+.++.++|||||||++|+|++ +..||... ...++
T Consensus 164 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~-~~~~~ 241 (295)
T cd05097 164 -NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL-SDEQV 241 (295)
T ss_pred -CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc-ChHHH
Confidence 66799999999997654322 1234557789999976 5678999999999999999988 67788763 33333
Q ss_pred HHHHhc-----CC-CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 221 YKKVSS-----GI-KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 221 ~~~I~~-----g~-~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
...+.. +. .....+...++.+++||.+||. +|.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 333221 11 1122234567899999999998 8999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=313.64 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=202.1
Q ss_pred cceeeeeeE---EEEEEecCcEEEEEEE-----ccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeee
Q 006277 5 KWSLLILMY---LRLIQLVDTSGYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFY 75 (652)
Q Consensus 5 ~W~~~~~~~---~rL~~l~~gtVykA~d-----~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~ 75 (652)
.|......| .+|+++..|.||+|.+ ..++.+||+|+++... .....+.+.+|+.+|..+. |||||+++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 455544322 4677788899999995 3466899999987432 2344567899999999997 99999999
Q ss_pred eEEEeCCCCeEEEEEecCCCCCHHHHHHhCC-------------------------------------------------
Q 006277 76 NSWIDDQNKTVNIITELFTSGSLRQYRKKHK------------------------------------------------- 106 (652)
Q Consensus 76 ~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~------------------------------------------------- 106 (652)
+++.... .+++|||||.+|+|.+++.+.+
T Consensus 108 ~~~~~~~--~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (401)
T cd05107 108 GACTKGG--PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDE 185 (401)
T ss_pred EEEccCC--CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcc
Confidence 9987654 7999999999999999986532
Q ss_pred -------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 006277 107 -------------------------------------------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHR 137 (652)
Q Consensus 107 -------------------------------------------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHR 137 (652)
.+++..+..++.||+.||.|||+.+ |+||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHr 263 (401)
T cd05107 186 SADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHR 263 (401)
T ss_pred ccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcc
Confidence 3567778899999999999999988 9999
Q ss_pred cCCcccEEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCC
Q 006277 138 DLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPY 211 (652)
Q Consensus 138 DLKp~NILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf 211 (652)
||||+|||++ ..+.+||+|||+++.+.... .....|++.|||||.+. ..++.++|||||||++|||++ |..||
T Consensus 264 dlkp~NiLl~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 264 DLAARNVLIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred cCCcceEEEe-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 9999999998 56799999999998653221 23346788999999764 568999999999999999998 89999
Q ss_pred CCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 212 SECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 212 ~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
............+..+..+ ..+...+.++.+||.+||. +|.+||++.++++.
T Consensus 343 ~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 343 PELPMNEQFYNAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCCchHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8755566666666666433 3445568899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=290.78 Aligned_cols=240 Identities=20% Similarity=0.322 Sum_probs=196.1
Q ss_pred EEEEEecCcEEEEEEEccCCe---EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGL---EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~---~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
..+++++.|.||+|.++.+|. .||+|.+.... ......++..|+.+++.++||||+++++++.+.. .+++||
T Consensus 10 ~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~lv~ 84 (269)
T cd05065 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR--PVMIIT 84 (269)
T ss_pred eEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC--ceEEEE
Confidence 567778889999999988765 69999886431 3566788999999999999999999999886544 789999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc
Q 006277 91 ELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 169 (652)
||+.+|+|.+++... +.+++..++.++.|++.||.|||++| ++||||||+||+++ .++.+||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEc-CCCcEEECCCccccccccCcc
Confidence 999999999998764 56899999999999999999999998 99999999999998 567999999999876543221
Q ss_pred ----c-ccc--CCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChH
Q 006277 170 ----K-SVI--GTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 240 (652)
Q Consensus 170 ----~-~~v--GTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 240 (652)
. ... ++..|+|||.+. ..++.++|||||||++|||++ |..||.. .........+..... ...+...+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~-~~~~~~~~~i~~~~~-~~~~~~~~~~ 239 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MSNQDVINAIEQDYR-LPPPMDCPTA 239 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC-CCHHHHHHHHHcCCc-CCCcccCCHH
Confidence 1 111 245799999774 578999999999999999886 9999977 444556666655432 2233456789
Q ss_pred HHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 241 VKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 241 ~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
+.+++.+||. +|.+||++.+++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999998 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=295.13 Aligned_cols=248 Identities=22% Similarity=0.233 Sum_probs=200.1
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC---CCCeEEE
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD---QNKTVNI 88 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~---~~~~~~L 88 (652)
+.++|+++|.+.||++.+..++..||+|.|.... .++.+..++|+...++++|||+++++++...+ .....|+
T Consensus 25 i~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 25 IQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred EeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 5567888888999999999999999999998654 57899999999999999999999999876543 2357999
Q ss_pred EEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhh
Q 006277 89 ITELFTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 164 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l 164 (652)
++.|+..|+|.+++... ..++|.++..|+.+|++||.+||+..||.+||||||.|||+. ..+.++|.|||.+...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls-~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS-DSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec-CCCceEEEeccCcccc
Confidence 99999999999987643 369999999999999999999999999999999999999998 5789999999998765
Q ss_pred hccc-----------cccccCCCCccCcccccc----CCCccccchhhHHHHHHHhhccCCCCCCCC-HHHHHHHHhcCC
Q 006277 165 EQAN-----------AKSVIGTPEFMAPELYDE----NYNELADIYSFGMCMLEMVTFEYPYSECRN-SAQIYKKVSSGI 228 (652)
Q Consensus 165 ~~~~-----------~~~~vGTp~YmAPEvl~~----~y~~~sDIWSlGvilyeLltG~~Pf~~~~~-~~~i~~~I~~g~ 228 (652)
.-.- ...-..|..|.|||++.- ..++++|||||||++|.|+.|.-||...-. -..+--.+..+.
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q 259 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQ 259 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccc
Confidence 3110 012235889999998853 478999999999999999999999953110 000111222333
Q ss_pred CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 229 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 229 ~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
...+-...++..+.+||+.||+ ||.+||++.+++.+
T Consensus 260 ~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 260 ISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2222234478899999999997 99999999999864
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=292.51 Aligned_cols=239 Identities=24% Similarity=0.387 Sum_probs=194.3
Q ss_pred EEEEecCcEEEEEEEccCC------eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 15 RLIQLVDTSGYKAFDEVNG------LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG------~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
.+++++.|.||+|.++..+ +.||+|.+.... .......+.+|+.+++.++||||+++++++.+.. ..++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 76 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE--PQYI 76 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC--CeEE
Confidence 4677888999999987544 789999876432 1345678889999999999999999999887654 7999
Q ss_pred EEecCCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCC-----cEEEe
Q 006277 89 ITELFTSGSLRQYRKKH-------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG-----EVKIG 156 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~-------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g-----~VKL~ 156 (652)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+|||++. ++ .+||+
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~-~~~~~~~~~~l~ 153 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSE-KGYDADRVVKIG 153 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEec-CCCCCCcceEEC
Confidence 99999999999998643 34788999999999999999999998 999999999999984 44 79999
Q ss_pred ccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCC
Q 006277 157 DLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKP 230 (652)
Q Consensus 157 DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p 230 (652)
|||++..+.... .....+++.|+|||++ .+.++.++|||||||++|+|++ |..||.. .+.......+..+..+
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~ 232 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA-LNNQEVLQHVTAGGRL 232 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc-cCHHHHHHHHhcCCcc
Confidence 999987654321 1234567889999976 4578999999999999999998 9999976 3445566666554322
Q ss_pred ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 231 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 231 ~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
..+...+..+.+||.+||. +|.+||++.++++
T Consensus 233 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 -QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2334567899999999997 8999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=295.45 Aligned_cols=246 Identities=23% Similarity=0.327 Sum_probs=192.9
Q ss_pred cceeeeeeEEEEEEecCcEEEEEEEcc----------------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC
Q 006277 5 KWSLLILMYLRLIQLVDTSGYKAFDEV----------------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 68 (652)
Q Consensus 5 ~W~~~~~~~~rL~~l~~gtVykA~d~~----------------tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~H 68 (652)
+|.+. .++++++.|+||+|.+.. ++..||+|.+.... .....+++.+|+.+|+.++|
T Consensus 6 ~~~~~----~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~ 78 (296)
T cd05095 6 RLTFK----EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKD 78 (296)
T ss_pred hceee----eeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCC
Confidence 45553 578888899999986543 45579999886432 24566789999999999999
Q ss_pred CCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 006277 69 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-----------KVDMKAVKGWARQILSGLIYLHSHDPPIIHR 137 (652)
Q Consensus 69 pnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~-----------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHR 137 (652)
|||+++++++.+.. .+++||||+.+|+|.+++.... .+++..+..++.||+.||+|||++| ++||
T Consensus 79 ~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~ 154 (296)
T cd05095 79 PNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHR 154 (296)
T ss_pred CCcceEEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecc
Confidence 99999999987654 7899999999999999987643 3677899999999999999999998 9999
Q ss_pred cCCcccEEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh--ccCC
Q 006277 138 DLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT--FEYP 210 (652)
Q Consensus 138 DLKp~NILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt--G~~P 210 (652)
||||+|||++ .++.+||+|||++..+.... .....+++.|+|||+. .+.++.++|||||||++|||++ |..|
T Consensus 155 dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 155 DLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred cCChheEEEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 9999999998 57899999999998654322 1233456789999954 5679999999999999999998 7788
Q ss_pred CCCCCCHHHHHHHHhc-----CC-CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 211 YSECRNSAQIYKKVSS-----GI-KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 211 f~~~~~~~~i~~~I~~-----g~-~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
|... ...++...+.. +. .....+...++.+++||.+||. +|.+||++.++++
T Consensus 234 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 234 YSQL-SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cccc-ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8763 33333322211 00 1111233456899999999998 8999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=293.12 Aligned_cols=236 Identities=21% Similarity=0.270 Sum_probs=185.1
Q ss_pred EEEEecCcEEEEEEEccC------------------------CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC
Q 006277 15 RLIQLVDTSGYKAFDEVN------------------------GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 70 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~t------------------------G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hpn 70 (652)
.|+++..|.||+|....+ ...||+|.+... ..+....+.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS----HRDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH----HHHHHHHHHHHHHHHhcCCCCC
Confidence 367888899999985432 245888877532 1344567889999999999999
Q ss_pred eeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC
Q 006277 71 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN 149 (652)
Q Consensus 71 IVkl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~ 149 (652)
|+++++++.+.. ..++||||+++|+|..++.+ .+.+++..+..++.||+.||+|||+++ |+||||||+|||++..
T Consensus 78 iv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~ 153 (274)
T cd05076 78 LAFVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARL 153 (274)
T ss_pred eeeEEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEecc
Confidence 999999987654 78999999999999998865 467899999999999999999999998 9999999999999732
Q ss_pred ------CCcEEEeccCchhhhhccccccccCCCCccCccccc--cCCCccccchhhHHHHHHHh-hccCCCCCCCCHHHH
Q 006277 150 ------QGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMV-TFEYPYSECRNSAQI 220 (652)
Q Consensus 150 ------~g~VKL~DFGla~~l~~~~~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLl-tG~~Pf~~~~~~~~i 220 (652)
.+.+|++|||++..... .....+++.|+|||.+. ..++.++|||||||++|||+ +|..||.... ....
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~--~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALS--REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT-PSEK 230 (274)
T ss_pred CcccCccceeeecCCcccccccc--ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC-hHHH
Confidence 22489999998764422 23346788999999774 35899999999999999984 7899997643 3332
Q ss_pred HHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 221 YKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 221 ~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
...+.... ..+....+.+.++|.+||. +|.+|||+.++|++
T Consensus 231 ~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ERFYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22222211 1223345789999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=279.35 Aligned_cols=239 Identities=35% Similarity=0.577 Sum_probs=205.4
Q ss_pred CcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHH
Q 006277 21 DTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQ 100 (652)
Q Consensus 21 ~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~~ 100 (652)
.|.||+|.+..+|..||+|++...... ...+.+.+|++.+++++|+||+++++++.... ..++++||+.+++|..
T Consensus 2 ~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 2 FGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDED--KLYLVMEYCDGGDLFD 76 (244)
T ss_pred ceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC--EEEEEEeCCCCCCHHH
Confidence 478999999999999999998754321 11688999999999999999999999887654 7999999999999999
Q ss_pred HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-ccccccCCCCcc
Q 006277 101 YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKSVIGTPEFM 179 (652)
Q Consensus 101 ~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~~~vGTp~Ym 179 (652)
++.....++...+..++.+++.+|.|||+.+ ++|+||+|.||+++ .++.++|+|||++...... ......|++.|+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 77 LLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLD-EDGHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred HHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEEC-CCCcEEEccccceeeeccccccccccCCcCCC
Confidence 9987777999999999999999999999998 99999999999998 5589999999999877654 345677899999
Q ss_pred Cccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCC-CChHHHHHHHHhCC-CCCCCC
Q 006277 180 APELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKV-KDPEVKSFIEKCLV-PASQRL 256 (652)
Q Consensus 180 APEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~-~s~~~kdlI~kcL~-~P~~Rp 256 (652)
+||.+. ..++.++||||||+++++|++|..||........+...+..+......... .+.++.+|+.+||. +|.+||
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence 999764 678899999999999999999999997756667777777665544322222 67899999999997 899999
Q ss_pred CHHHHhcCccc
Q 006277 257 SAKELLMDPFL 267 (652)
Q Consensus 257 Sa~elL~hpf~ 267 (652)
++.++++||||
T Consensus 234 ~~~~~~~~~~~ 244 (244)
T smart00220 234 TAEEALQHPFF 244 (244)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=285.26 Aligned_cols=236 Identities=22% Similarity=0.373 Sum_probs=192.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.++++++.+.||+|.+. .+..||+|.+... ....+.+.+|+.+++.++|+||+++++++.+ ...+++|||+
T Consensus 12 ~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v~e~~ 82 (260)
T cd05073 12 KKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIITEFM 82 (260)
T ss_pred eEecCccceEEEEEEec-CCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEEEEeC
Confidence 56777777999999864 4567999987632 2346788899999999999999999998865 3689999999
Q ss_pred CCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc--
Q 006277 94 TSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-- 169 (652)
Q Consensus 94 ~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~-- 169 (652)
.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++..+.....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCCcceeeccCCCccc
Confidence 999999998764 45788999999999999999999998 99999999999998 678999999999876643221
Q ss_pred -ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 170 -KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 170 -~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
....++..|+|||++. +.++.++|+|||||++|+|++ |..||.+ .....+...+..+... ......+.++.+++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~ 237 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-MSNPEVIRALERGYRM-PRPENCPEELYNIMM 237 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCCC-CCcccCCHHHHHHHH
Confidence 2234567799999774 468889999999999999999 8999987 4445555566555432 334556789999999
Q ss_pred HhCC-CCCCCCCHHHHhc
Q 006277 247 KCLV-PASQRLSAKELLM 263 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~ 263 (652)
+||. +|.+||++.+++.
T Consensus 238 ~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 238 RCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHcccCcccCcCHHHHHH
Confidence 9997 8999999998763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.75 Aligned_cols=241 Identities=24% Similarity=0.402 Sum_probs=195.6
Q ss_pred EEEEEEecCcEEEEEEEccCCe----EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGL----EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~----~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
...+++++.|.||+|.+..+|. .||+|.+.... .+.....+.+|+.+++.++||||+++++++... ..++
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---~~~~ 85 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---TIQL 85 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---Ccee
Confidence 3467888889999999988886 46777765322 234455788999999999999999999988643 4679
Q ss_pred EEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 89 ITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
+++|+++|+|.+++..+. .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+...
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~-~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeec-CCCceEEccccccccccCc
Confidence 999999999999987754 6899999999999999999999998 99999999999997 5678999999999876432
Q ss_pred c----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHH
Q 006277 168 N----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 168 ~----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~ 241 (652)
. .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+ .........+..+..+ ..+...+..+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 240 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG-IPTREIPDLLEKGERL-PQPPICTIDV 240 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHH
Confidence 2 12344577899999764 568999999999999999997 8899976 3445555555554432 2344567899
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 242 KSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.++|.+||. +|.+||++.++++.
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999997 89999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=285.67 Aligned_cols=233 Identities=20% Similarity=0.356 Sum_probs=193.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.++++++.|.||+|. .+|..||+|.+... ...+.+.+|+.+++.++||||+++++++... ..++||||+
T Consensus 12 ~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~~v~e~~ 80 (254)
T cd05083 12 EIIGEGEFGAVLQGE--YTGQKVAVKNIKCD------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN---GLYIVMELM 80 (254)
T ss_pred eeeccCCCCceEecc--cCCCceEEEeecCc------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---CcEEEEECC
Confidence 567777789999985 57889999988642 2346788999999999999999999988643 479999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccc
Q 006277 94 TSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~ 171 (652)
.+|+|.+++.... .+++..+..++.|++.||.|||++| ++||||||+||+++ .++.+||+|||++...... ...
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~~~~-~~~ 156 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVS-EDGVAKVSDFGLARVGSMG-VDN 156 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCcEEECCCccceecccc-CCC
Confidence 9999999987654 5899999999999999999999998 99999999999998 5689999999998754332 223
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
...++.|+|||.+. +.++.++|+|||||++|+|++ |.+||.. .........+..+..+. .....++.+++||.+||
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l 234 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK-MSLKEVKECVEKGYRME-PPEGCPADVYVLMTSCW 234 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhCCCCCC-CCCcCCHHHHHHHHHHc
Confidence 34467899999764 578999999999999999997 9999977 44556666666664333 34556789999999999
Q ss_pred C-CCCCCCCHHHHhc
Q 006277 250 V-PASQRLSAKELLM 263 (652)
Q Consensus 250 ~-~P~~RpSa~elL~ 263 (652)
. +|.+||++.+++.
T Consensus 235 ~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 235 ETEPKKRPSFHKLRE 249 (254)
T ss_pred CCChhhCcCHHHHHH
Confidence 7 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=285.99 Aligned_cols=245 Identities=24% Similarity=0.407 Sum_probs=199.5
Q ss_pred EEEEEecCcEEEEEEEcc-CCeEEEEEEEeecccC------CCHHHHHHHHHHHHHHHh-CCCCCeeeeeeEEEeCCCCe
Q 006277 14 LRLIQLVDTSGYKAFDEV-NGLEVAWCQVRIDDVL------QSPEDLERLYSEVHLLKS-LKHNNIIRFYNSWIDDQNKT 85 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~-tG~~VAiK~v~~~~~~------~s~e~~~~l~~Ei~iLk~-L~HpnIVkl~~~~~d~~~~~ 85 (652)
..++++..+.||+|.++. ++..||+|.+...... .......++.+|+.++.+ ++||||+++++++.+.. .
T Consensus 6 ~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~--~ 83 (269)
T cd08528 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND--R 83 (269)
T ss_pred hhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC--e
Confidence 356777889999999988 7899999998654321 223456778889998876 69999999999887644 8
Q ss_pred EEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCcccEEEcCCCCcEEEeccCc
Q 006277 86 VNIITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160 (652)
Q Consensus 86 ~~LVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IiHRDLKp~NILl~~~~g~VKL~DFGl 160 (652)
.++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++||||+|+|||++ .++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~ 160 (269)
T cd08528 84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLG-EDDKVTITDFGL 160 (269)
T ss_pred EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEEC-CCCcEEEecccc
Confidence 9999999999999988643 3568999999999999999999996 55 99999999999998 678999999999
Q ss_pred hhhhhcc-ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCC
Q 006277 161 ATIMEQA-NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 238 (652)
Q Consensus 161 a~~l~~~-~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 238 (652)
+...... ......|+..|+|||.+. +.++.++||||||+++|+|++|.+||.. .........+..+..........+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhccCCcCCcccCC
Confidence 9876543 234567899999999764 4688999999999999999999999976 444555555555543333334567
Q ss_pred hHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 239 PEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 239 ~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
+.+.+||.+||. +|.+||++.|+..+
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 899999999997 89999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=313.45 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=211.2
Q ss_pred CCCcceeeee---eEEEEEEecCcEEEEEEEccCCe---E-EEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeee
Q 006277 2 VRQKWSLLIL---MYLRLIQLVDTSGYKAFDEVNGL---E-VAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 74 (652)
Q Consensus 2 ~~~~W~~~~~---~~~rL~~l~~gtVykA~d~~tG~---~-VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl 74 (652)
.++.|...-. .-.+||++..|.||+|.-+..+. . ||+|..+.... ...+.+..+.+|+++|++++|||||+|
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~-~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE-LTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc-ccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 3566765432 33789999999999999887533 3 89999875332 247889999999999999999999999
Q ss_pred eeEEEeCCCCeEEEEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcE
Q 006277 75 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK-VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 153 (652)
Q Consensus 75 ~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~~-lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~V 153 (652)
|++..+.. .+++|||+|.||+|.+|+++.+. ++..+...++.+.+.||+|||+++ +|||||-..|+|++ .++.+
T Consensus 227 yGVa~~~~--Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~-~~~~v 301 (474)
T KOG0194|consen 227 YGVAVLEE--PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYS-KKGVV 301 (474)
T ss_pred EEEEcCCC--ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheec-CCCeE
Confidence 99887766 79999999999999999999874 999999999999999999999999 99999999999998 55678
Q ss_pred EEeccCchhhhhcccc-c-cccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCC
Q 006277 154 KIGDLGLATIMEQANA-K-SVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIK 229 (652)
Q Consensus 154 KL~DFGla~~l~~~~~-~-~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~ 229 (652)
||+|||+++.-..... . ..--...|+|||.+ .+-|+.++|||||||++||+.+ |..||.+ ....++..+|.....
T Consensus 302 KISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~~~~~ 380 (474)
T KOG0194|consen 302 KISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIVKNGY 380 (474)
T ss_pred EeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHHhcCc
Confidence 9999999876542211 1 11234689999977 4579999999999999999998 7889998 566788888855444
Q ss_pred CccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 230 PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 230 p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
+...+...+.++..++.+|+. +|+.||+..++.+
T Consensus 381 r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 381 RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 555566777899999999997 8999999988764
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=287.77 Aligned_cols=243 Identities=23% Similarity=0.386 Sum_probs=195.6
Q ss_pred EEEEEecCcEEEEEEEc----cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDE----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~----~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
.++++++.|.||+|... .++..||+|++..... ....+.+.+|+.+++.+.||||+++++++.+..+...++|
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 86 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEE
Confidence 56788888999999864 3589999999875432 1457789999999999999999999998877556689999
Q ss_pred EecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 90 TELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
|||+.+++|.+++...+ .+++..+..++.||+.||+|||++| ++||||||+|||++ .++.+||+|||++.......
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 87 MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred EecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccccccccccCC
Confidence 99999999999997754 6999999999999999999999998 99999999999998 56899999999998775321
Q ss_pred c-----ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCC--------------HHHHHHHHhcCC
Q 006277 169 A-----KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRN--------------SAQIYKKVSSGI 228 (652)
Q Consensus 169 ~-----~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~--------------~~~i~~~I~~g~ 228 (652)
. ....++..|+|||.+ ...++.++|||||||++|+|++|..||..... ...+...+..+.
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243 (284)
T ss_pred cceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC
Confidence 1 123445679999966 45788999999999999999999999865321 111222333332
Q ss_pred CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 229 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 229 ~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
. ...+...+.++.+|+.+||. +|.+|||+.+++.
T Consensus 244 ~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 244 R-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred c-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2 22234456789999999998 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=285.85 Aligned_cols=244 Identities=22% Similarity=0.282 Sum_probs=196.7
Q ss_pred EEEEEecCcEEEEEEEcc---CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC----CeE
Q 006277 14 LRLIQLVDTSGYKAFDEV---NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN----KTV 86 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~---tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~----~~~ 86 (652)
..+++++.|+||+|.+.. +|+.||+|++.... ......+++.+|+++++.++||||+++++++..... ...
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred hcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 357788889999998654 68999999986432 234567889999999999999999999998865432 135
Q ss_pred EEEEecCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCc
Q 006277 87 NIITELFTSGSLRQYRKKH------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~~------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGl 160 (652)
+++++|+.+|+|..++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++ .++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~-~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEc-CCCCEEECcccc
Confidence 7899999999998886432 24789999999999999999999998 99999999999998 678999999999
Q ss_pred hhhhhccc----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCcccc
Q 006277 161 ATIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALS 234 (652)
Q Consensus 161 a~~l~~~~----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 234 (652)
+..+.... .....+++.|++||.+. ..++.++|||||||++|+|++ |.+||.+ .+...++..+..+... ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~ 237 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRL-KQP 237 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcC-CCC
Confidence 88664321 12334567899999764 568899999999999999999 8899976 5556677776665432 233
Q ss_pred CCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 235 KVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 235 ~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
...+..+.+++.+||. +|.+|||+.+++.+
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4466899999999997 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=323.20 Aligned_cols=201 Identities=28% Similarity=0.440 Sum_probs=175.7
Q ss_pred cceeeeeeEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC--
Q 006277 5 KWSLLILMYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ-- 82 (652)
Q Consensus 5 ~W~~~~~~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~-- 82 (652)
.|... .+||+++.|.||++.++.+|+.||||.++... +....++.-+|+++|++|+|||||+++++=.+..
T Consensus 14 ~W~~~----e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~ 86 (732)
T KOG4250|consen 14 LWEMD----ERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG 86 (732)
T ss_pred ceeeh----hhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence 36665 59999999999999999999999999988644 3456788899999999999999999999755444
Q ss_pred --CCeEEEEEecCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEc-CCCCc--EE
Q 006277 83 --NKTVNIITELFTSGSLRQYRKK---HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN-GNQGE--VK 154 (652)
Q Consensus 83 --~~~~~LVmEy~~gGsL~~~i~~---~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~-~~~g~--VK 154 (652)
.....+|||||.||+|+.++++ ...+++.++..++..+..||.|||.+| |+||||||+||++- +.+|+ -|
T Consensus 87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyK 164 (732)
T KOG4250|consen 87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYK 164 (732)
T ss_pred cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEe
Confidence 4456799999999999999875 357999999999999999999999999 99999999999875 44454 59
Q ss_pred EeccCchhhhhcc-ccccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCC
Q 006277 155 IGDLGLATIMEQA-NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSEC 214 (652)
Q Consensus 155 L~DFGla~~l~~~-~~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~ 214 (652)
|+|||.|+.+.+. ...+++||+.|.|||++. +.|+.-+|.|||||++|+++||..||-..
T Consensus 165 LtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 165 LTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred eecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9999999998765 468899999999999997 57999999999999999999999999543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=272.56 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=198.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+++++..||||+|.+..+++.||+|.++..+- +..--....+||-+|+.|+|.|||++++....+. .+-+|+|||
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvlhsdk--kltlvfe~c 83 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLTLVFEFC 83 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc--eeEEeHHHh
Confidence 367788889999999999999999999998753 2223457889999999999999999999765443 799999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 94 TSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 94 ~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
. .+|..|... ++.++...++.++.|++.||.|+|+++ ++||||||.|+|++ .+|++||+|||+++.+.-.. ..
T Consensus 84 d-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin-~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 84 D-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred h-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEec-cCCcEEecccchhhhcCCceEeee
Confidence 4 478777654 578999999999999999999999999 99999999999999 67899999999999886543 23
Q ss_pred cccCCCCccCccccc--cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhc-CC-CCcccc-----------
Q 006277 171 SVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSS-GI-KPAALS----------- 234 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~-g~-~p~~l~----------- 234 (652)
.-+-|.+|.+|.++- .-|+...|+||.|||+.|+.. |.+.|.+..-.+|+.+.... |. ....|+
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 345699999999874 359999999999999999985 66678875555555443332 10 000111
Q ss_pred -------------CCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 235 -------------KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 235 -------------~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
...+..-++++.++|. +|.+|++|+++|+||||..
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 0122356899999997 8999999999999999963
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=300.07 Aligned_cols=243 Identities=25% Similarity=0.373 Sum_probs=187.7
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.++++++.|+||+|.-. +|..||||.+...... . ...|.+|+.+|.+++|||+|+++++|.+... ..+||+||+
T Consensus 81 ~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~---~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LVYEym 154 (361)
T KOG1187|consen 81 NLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQ---G-EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLVYEYM 154 (361)
T ss_pred cceecCCCeEEEEEEEC-CCCEEEEEEecCCCCc---c-hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEEEEcc
Confidence 47899999999999864 4599999976533211 1 4459999999999999999999999886653 589999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc-ccc
Q 006277 94 TSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ-ANA 169 (652)
Q Consensus 94 ~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~-g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~-~~~ 169 (652)
+.|+|.+++.... .+++.....|+.++++||+|||.. .|+|||||||+.|||+| .+.+.||+|||+|+.... ...
T Consensus 155 ~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFGLa~~~~~~~~~ 233 (361)
T KOG1187|consen 155 PNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFGLAKLGPEGDTS 233 (361)
T ss_pred CCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCccCcccCCccccc
Confidence 9999999987665 899999999999999999999996 45899999999999999 778999999999976654 322
Q ss_pred -ccc-cCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCC--CH---HHH-HHHHhcCCCC----cccc-C
Q 006277 170 -KSV-IGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECR--NS---AQI-YKKVSSGIKP----AALS-K 235 (652)
Q Consensus 170 -~~~-vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~--~~---~~i-~~~I~~g~~p----~~l~-~ 235 (652)
.+. .||..|+|||.+ .+..+.++|||||||+++||+||+.|..... .. ... ...+..+... +.+. .
T Consensus 234 ~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~ 313 (361)
T KOG1187|consen 234 VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEG 313 (361)
T ss_pred eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCC
Confidence 223 899999999977 4689999999999999999999998876422 11 111 1233332211 1111 2
Q ss_pred CCC--hHH---HHHHHHhCC-CCCCCCCHHHHhc
Q 006277 236 VKD--PEV---KSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 236 ~~s--~~~---kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
..+ .++ ..+..+|+. +|..||+..|+++
T Consensus 314 ~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 314 EYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 222 233 445667997 7899999998743
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=294.71 Aligned_cols=253 Identities=28% Similarity=0.405 Sum_probs=196.8
Q ss_pred eEEEEEEecCcEEEEEEEccCCe----EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGL----EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~----~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~ 87 (652)
..+.++++..|.||+|..+.++- ++|+|+++-.+- ....-....+|+.+++.|+||||+.+..+|... ...++
T Consensus 28 ~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd--~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~v~ 104 (438)
T KOG0666|consen 28 GIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD--GTGISMSACREIALLRELKHPNVISLVKVFLSH-DKKVW 104 (438)
T ss_pred ccceecccccceeeEeeeccCCcccchhhHHHHHhccCC--CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-CceEE
Confidence 34556677778999997776543 789998875421 112345678899999999999999999998764 35899
Q ss_pred EEEecCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC---CCcEEEeccC
Q 006277 88 IITELFTSGSLRQYRKKH-----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN---QGEVKIGDLG 159 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~-----~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~---~g~VKL~DFG 159 (652)
+++||.+. +|.+.|+-+ +.++...++.++.||+.|+.|||++- |+||||||.||||.++ .|.|||+|||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeeccc
Confidence 99999966 898888744 35899999999999999999999999 9999999999999843 4899999999
Q ss_pred chhhhhccc-----cccccCCCCccCcccc--ccCCCccccchhhHHHHHHHhhccCCCCCCCC---------HHH---H
Q 006277 160 LATIMEQAN-----AKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTFEYPYSECRN---------SAQ---I 220 (652)
Q Consensus 160 la~~l~~~~-----~~~~vGTp~YmAPEvl--~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~---------~~~---i 220 (652)
+++.+...- ...++-|.+|.|||++ ...|+.++||||+|||+.||+|.++-|.+... ..| |
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 999987643 2456779999999976 34799999999999999999999988854211 111 1
Q ss_pred HHHHhcC-------------------------CCCc------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 221 YKKVSSG-------------------------IKPA------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 221 ~~~I~~g-------------------------~~p~------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
+..+-.. ..+. ...+..++.+.+|+.+||. ||-+|+||+|+|+|+||.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 1111000 0000 0112346678999999998 999999999999999998
Q ss_pred cc
Q 006277 269 VN 270 (652)
Q Consensus 269 ~~ 270 (652)
.+
T Consensus 342 ~d 343 (438)
T KOG0666|consen 342 ED 343 (438)
T ss_pred cC
Confidence 65
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=290.83 Aligned_cols=248 Identities=25% Similarity=0.370 Sum_probs=207.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
+.+|.+..|+|+|-.++.+|+..|||+++..- ......+++.|.....+- +.||||+||+....++ ..|+.||+
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n---~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG--dcWiCMEL 144 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN---IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG--DCWICMEL 144 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeecc---chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC--ceeeeHHH
Confidence 45666777999999999999999999998543 246678888998876555 8999999999887655 79999999
Q ss_pred CCCCCHHHHH-----HhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 93 FTSGSLRQYR-----KKHKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 93 ~~gGsL~~~i-----~~~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
+ ..+|..+. .+...++|..+..+..-.+.||.||-.. . |||||+||+|||++ ..|.|||||||++..+..
T Consensus 145 M-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILld-r~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 145 M-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLD-RHGDVKLCDFGICGQLVD 220 (361)
T ss_pred H-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEe-cCCCEeeecccchHhHHH
Confidence 9 44665432 3456899999999999999999999654 5 99999999999999 678999999999998877
Q ss_pred ccccc-ccCCCCccCccccc---cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccC----CCC
Q 006277 167 ANAKS-VIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK----VKD 238 (652)
Q Consensus 167 ~~~~~-~vGTp~YmAPEvl~---~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~----~~s 238 (652)
.-+.+ -.|-..|||||.+. .+|+.++||||||++|||+.||.+||.+..+.-+....|..|..|..... ..+
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s 300 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS 300 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence 66544 48899999999873 36999999999999999999999999988777666667777766654432 257
Q ss_pred hHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 239 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 239 ~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
..+..||.-||. +-+.||...+|+++||++..
T Consensus 301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred HHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 899999999997 78999999999999999743
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=314.11 Aligned_cols=247 Identities=23% Similarity=0.242 Sum_probs=172.3
Q ss_pred EEEEEEecCcEEEEEEEccC----CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEE----eCCCC
Q 006277 13 YLRLIQLVDTSGYKAFDEVN----GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI----DDQNK 84 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~t----G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~----d~~~~ 84 (652)
-.+|++++.|.||+|.+..+ |..||+|++.... ..+....| .++...+.+++.+...|. .....
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 35678888899999999999 9999999875321 11111111 122223333333332221 12345
Q ss_pred eEEEEEecCCCCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccE
Q 006277 85 TVNIITELFTSGSLRQYRKKHKK--------------------VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144 (652)
Q Consensus 85 ~~~LVmEy~~gGsL~~~i~~~~~--------------------lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NI 144 (652)
.+++||||+.+++|.+++..... ..+..+..++.||+.||.|||+++ |+||||||+||
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLKP~NI 286 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVKPQNI 286 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCCHHHE
Confidence 79999999999999998875421 123457789999999999999998 99999999999
Q ss_pred EEcCCCCcEEEeccCchhhhhcc---ccccccCCCCccCccccc-----------------------cCCCccccchhhH
Q 006277 145 FINGNQGEVKIGDLGLATIMEQA---NAKSVIGTPEFMAPELYD-----------------------ENYNELADIYSFG 198 (652)
Q Consensus 145 Ll~~~~g~VKL~DFGla~~l~~~---~~~~~vGTp~YmAPEvl~-----------------------~~y~~~sDIWSlG 198 (652)
|++...+.+||+|||+|+.+... .....+|||.|||||.+. ..|+.++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 99865689999999999876432 235678999999999542 1245567999999
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHHHhcCCC-------------Ccc------ccCCCChHHHHHHHHhCC-CCCCCCCH
Q 006277 199 MCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-------------PAA------LSKVKDPEVKSFIEKCLV-PASQRLSA 258 (652)
Q Consensus 199 vilyeLltG~~Pf~~~~~~~~i~~~I~~g~~-------------p~~------l~~~~s~~~kdlI~kcL~-~P~~RpSa 258 (652)
|++|||+++..|+.. ...+....+..... ... .....+...++||.+||+ ||.+|||+
T Consensus 367 viL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 367 LIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 999999997766532 23333322222110 000 011123346699999998 89999999
Q ss_pred HHHhcCccccccC
Q 006277 259 KELLMDPFLQVNG 271 (652)
Q Consensus 259 ~elL~hpf~~~~~ 271 (652)
.|+|+||||+...
T Consensus 445 ~e~L~Hpff~~~~ 457 (566)
T PLN03225 445 KAALAHPYFDREG 457 (566)
T ss_pred HHHhCCcCcCCCC
Confidence 9999999997543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=284.02 Aligned_cols=243 Identities=17% Similarity=0.176 Sum_probs=181.6
Q ss_pred EEEEEecCcEEEEEEEccC---CeEEEEEEEeecccCCCHHH-------HHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 006277 14 LRLIQLVDTSGYKAFDEVN---GLEVAWCQVRIDDVLQSPED-------LERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~t---G~~VAiK~v~~~~~~~s~e~-------~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 83 (652)
.+|++++.|+||+|.+..+ +..+|+|...........+. ......+...++.+.|+||+++++++.....
T Consensus 18 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 97 (294)
T PHA02882 18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRC 97 (294)
T ss_pred eEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecC
Confidence 5788888999999999887 67788876543321100000 0112234455667799999999987654432
Q ss_pred --CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCch
Q 006277 84 --KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 161 (652)
Q Consensus 84 --~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla 161 (652)
...+++++++. .++.+.+......++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 98 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~-~~~~~~l~DFGla 173 (294)
T PHA02882 98 RMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVD-GNNRGYIIDYGIA 173 (294)
T ss_pred CceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCcEEEEEcCCc
Confidence 24578888874 477777776666789999999999999999999998 99999999999998 5679999999999
Q ss_pred hhhhcc---------ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHH--------HHH
Q 006277 162 TIMEQA---------NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI--------YKK 223 (652)
Q Consensus 162 ~~l~~~---------~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i--------~~~ 223 (652)
+.+... ......||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+....... ...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~ 253 (294)
T PHA02882 174 SHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKR 253 (294)
T ss_pred eeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHH
Confidence 866321 123357999999999774 56999999999999999999999999875333222 233
Q ss_pred HhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 224 VSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 224 I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
+..+.. .....++++.+|+..|+. +|.+||+..++++
T Consensus 254 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 254 LHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 333221 123346889999999997 8999999999874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=275.95 Aligned_cols=246 Identities=22% Similarity=0.356 Sum_probs=207.0
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEEEE
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
+++++|++-.+.||.|....+.+.++||.++ |-..+.+.+|+.||+.|. ||||++++++..|.......||+
T Consensus 42 ivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-------PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 42 IVRKVGRGKYSEVFEGINITNNEKCVIKILK-------PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred HHHHHcCccHhhHhcccccCCCceEEEeeec-------hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 5677888888999999999999999999887 455678999999999995 99999999999998888899999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-c
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~ 169 (652)
||+.+.+...+ .+.++...++.++.|+++||.|||+.| |+|||+||.|++++.....++|+|+|+|.+..... .
T Consensus 115 E~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 115 EYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred hhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCCCcee
Confidence 99988776654 346888899999999999999999999 99999999999999777789999999999987765 3
Q ss_pred ccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCC-CCCCCHHHHHHHHhc--------------------
Q 006277 170 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPY-SECRNSAQIYKKVSS-------------------- 226 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf-~~~~~~~~i~~~I~~-------------------- 226 (652)
.-.+.+.+|.-||++- +.|+..-|+|||||++..|+..+-|| .+..+.+|+.+...-
T Consensus 190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~ 269 (338)
T KOG0668|consen 190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQ 269 (338)
T ss_pred eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChh
Confidence 5567788999999773 56999999999999999999998886 555677776543221
Q ss_pred -----CC-CC--------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 227 -----GI-KP--------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 227 -----g~-~p--------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
|. .. ..-....++++.||+.++|. |-.+|+||+|++.||||..
T Consensus 270 ~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 270 FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 00 00 11112356899999999998 8999999999999999973
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=313.53 Aligned_cols=248 Identities=28% Similarity=0.482 Sum_probs=218.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..|++.+-.|.||||+|+.+|...|+|+|++.- .+...-+++||-+++.++|||||.|+++|.... .+|++|||
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~gsylr~d--klwicMEy 93 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD--KLWICMEY 93 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccC----CccccccccceeeeecCCCcChHHHHhhhhhhc--CcEEEEEe
Confidence 356666667899999999999999999998753 356778899999999999999999999997655 69999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--ccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~ 170 (652)
|.||+|.+.-.--+++++.++..+++..+.||.|||+.| -+|||||-.|||++ +.|.||++|||.+..+... ..+
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanillt-d~gDvklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT-DEGDVKLADFGVSAQITATIAKRK 170 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeec-ccCceeecccCchhhhhhhhhhhh
Confidence 999999998777789999999999999999999999998 89999999999998 6789999999999888654 357
Q ss_pred cccCCCCccCcccc----ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc--CCCChHHHHH
Q 006277 171 SVIGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS--KVKDPEVKSF 244 (652)
Q Consensus 171 ~~vGTp~YmAPEvl----~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~--~~~s~~~kdl 244 (652)
+++|||+|||||+. .+.|+.++|||++|+...|+--.++|.........++..-.++..|+.+. ...++.+-+|
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f 250 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF 250 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence 89999999999975 46899999999999999999999999777566667777777777777665 3467899999
Q ss_pred HHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 245 IEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
++.+|. +|++||+++.+|.|||...
T Consensus 251 vK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 251 VKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHhcCCCccCCChhhheeceeecc
Confidence 999997 7999999999999999853
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-33 Score=284.51 Aligned_cols=238 Identities=30% Similarity=0.395 Sum_probs=196.6
Q ss_pred EEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC----CeEEEEEecCCCCCH
Q 006277 23 SGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN----KTVNIITELFTSGSL 98 (652)
Q Consensus 23 tVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~----~~~~LVmEy~~gGsL 98 (652)
.|--|+|..++++||+|.+..+. ++.....|.++|..++..++|+||++++.+|.-... ..+|+||||+ ..+|
T Consensus 31 ~v~~a~D~v~~~~v~ikk~~~pf--~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl 107 (369)
T KOG0665|consen 31 IVVAAFDQVLGRPVAIKKLSRPF--QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANL 107 (369)
T ss_pred eEEecchhhccCceehhhhcCcc--ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHH
Confidence 78999999999999999987663 334567899999999999999999999998853321 2589999999 5589
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-ccccccCCCC
Q 006277 99 RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKSVIGTPE 177 (652)
Q Consensus 99 ~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~~~vGTp~ 177 (652)
.+.+. -.++-..+..++.|++.|+.|||+.| |+||||||+||+++ .++.+||.|||+|+..... ..+..+.|.+
T Consensus 108 ~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~-~~~~lKi~dfg~ar~e~~~~~mtpyVvtRy 182 (369)
T KOG0665|consen 108 CQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVN-SDCTLKILDFGLARTEDTDFMMTPYVVTRY 182 (369)
T ss_pred HHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceec-chhheeeccchhhcccCcccccCchhheee
Confidence 88876 35788899999999999999999999 99999999999998 6789999999999876655 4566788999
Q ss_pred ccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC----------------------------
Q 006277 178 FMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI---------------------------- 228 (652)
Q Consensus 178 YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~---------------------------- 228 (652)
|.|||++ +.+|.+.+||||+||++.||++|..-|.+....+|..+.+..-.
T Consensus 183 yrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~ 262 (369)
T KOG0665|consen 183 YRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAIS 262 (369)
T ss_pred ccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccc
Confidence 9999965 66799999999999999999999999988666665544433200
Q ss_pred ----CCc-----cc--cCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 229 ----KPA-----AL--SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 229 ----~p~-----~l--~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
.|. .. .+.....+++++.+||+ +|++|.|++++|+|||++
T Consensus 263 f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 263 FSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 011 00 11223578999999998 999999999999999997
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=305.96 Aligned_cols=240 Identities=22% Similarity=0.314 Sum_probs=201.1
Q ss_pred EEEEEEecCcEEEEEEEcc-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 006277 13 YLRLIQLVDTSGYKAFDEV-----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~-----tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~ 87 (652)
...|+++..|.||+|.--. +.+.||||.++.+. +.+..+.|++|+.+|..|+|||||+|++++...+ .+|
T Consensus 491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~--P~~ 565 (774)
T KOG1026|consen 491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVCREGD--PLC 565 (774)
T ss_pred hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC--eeE
Confidence 4568888889999997432 45779999987443 3457889999999999999999999999886554 899
Q ss_pred EEEecCCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcE
Q 006277 88 IITELFTSGSLRQYRKKHK--------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 153 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~--------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~V 153 (652)
+|+|||..|+|.++++.+. +++..+...++.||+.|++||-++. +|||||-..|+||. ++-.|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVg-e~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVG-ENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceec-cceEE
Confidence 9999999999999987532 2788999999999999999999998 99999999999997 66789
Q ss_pred EEeccCchhhhhcccccc----ccCCCCccCcc-ccccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcC
Q 006277 154 KIGDLGLATIMEQANAKS----VIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSG 227 (652)
Q Consensus 154 KL~DFGla~~l~~~~~~~----~vGTp~YmAPE-vl~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g 227 (652)
||+|||+++..-...... -.-..+||||| ++.++|+.++||||+||+|+|+++ |..||.+. ..++..+.|+.|
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl-Sn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL-SNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc-chHHHHHHHHcC
Confidence 999999998764332111 12246899999 668899999999999999999997 78899884 456667778888
Q ss_pred CCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHh
Q 006277 228 IKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELL 262 (652)
Q Consensus 228 ~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL 262 (652)
.. -..+...+.++.+|+..|++ .|.+||+.+|+-
T Consensus 722 ~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 722 QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 75 55677888999999999998 799999999873
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-33 Score=280.23 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=194.9
Q ss_pred EEEEEEecC---cEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe------CCC
Q 006277 13 YLRLIQLVD---TSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID------DQN 83 (652)
Q Consensus 13 ~~rL~~l~~---gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d------~~~ 83 (652)
|.++..+++ |.||+|..+.+|+.||+|.+-...- ....-....+|+.+|..|+|+|++.+.+.+.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene--KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc--ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 444444444 5699999999999999987654211 11233567889999999999999998876532 123
Q ss_pred CeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 84 KTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 84 ~~~~LVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
..+|+|+.+|+. +|.-++... .+++..+++.++++++.||.|+|... |+|||+|+.|+||+ .+|.+||+|||+++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt-~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLIT-KDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEc-CCceEEeecccccc
Confidence 469999999966 888877665 68999999999999999999999999 99999999999999 67899999999998
Q ss_pred hhhccc------cccccCCCCccCcccc--ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHh---cCCCCc
Q 006277 163 IMEQAN------AKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS---SGIKPA 231 (652)
Q Consensus 163 ~l~~~~------~~~~vGTp~YmAPEvl--~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~---~g~~p~ 231 (652)
.+.... .+..+-|.+|.+||.+ ...|+.+.|||..|||+.||.|+.+-|.+..+..++. .|. ....+.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~-~Is~LcGs~tke 251 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLH-LISQLCGSITKE 251 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHH-HHHHHhccCCcc
Confidence 775332 2345569999999965 4579999999999999999999999998855444432 221 111111
Q ss_pred cc------------------------------cCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 232 AL------------------------------SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 232 ~l------------------------------~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.| +-+.++++.+|+.++|. ||.+|+++.++|.|-||..+
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 11 12235689999999998 99999999999999999643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=294.09 Aligned_cols=242 Identities=24% Similarity=0.387 Sum_probs=195.8
Q ss_pred EEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC------CCCeeeeeeEEEeCCCCeEEEEE
Q 006277 17 IQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK------HNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 17 ~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~------HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
|+++.++|-.|.|...|+.||||+|+..+++ .+.-+.|++||++|. .-|+++|+..|...+ .+|||+
T Consensus 441 GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-----~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn--HLClVF 513 (752)
T KOG0670|consen 441 GKGVFSTVVRARDQARGQEVAIKIIRNNEVM-----HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN--HLCLVF 513 (752)
T ss_pred ccceeeeeeeccccCCCCeeEEEEeecchHH-----hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc--eeEEEe
Confidence 4455578999999999999999999866543 456788999999994 468999999887655 799999
Q ss_pred ecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 91 ELFTSGSLRQYRKKHK---KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
|-+ ..+|++.+++.| .|...+++.|+.|++.||..|-..| |+|.||||+||||+.....+||||||.|......
T Consensus 514 E~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en 590 (752)
T KOG0670|consen 514 EPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDFGSASFASEN 590 (752)
T ss_pred hhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccCccccccccc
Confidence 988 669999999876 4889999999999999999999998 9999999999999977778999999999887665
Q ss_pred ccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHH-----------HHHhcCC-------
Q 006277 168 NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIY-----------KKVSSGI------- 228 (652)
Q Consensus 168 ~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~-----------~~I~~g~------- 228 (652)
..+...-+..|.|||++ +-.|+...|+||+||+||||.||..-|++.++...+. +.+..|.
T Consensus 591 eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD 670 (752)
T KOG0670|consen 591 EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFD 670 (752)
T ss_pred cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcc
Confidence 54444556789999965 6689999999999999999999999999976655432 1111111
Q ss_pred -------------------------CC-cc----------ccC---CCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 229 -------------------------KP-AA----------LSK---VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 229 -------------------------~p-~~----------l~~---~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
+| .. ++. ..-..+++|+.+||. ||.+|+|..|+|+||||+
T Consensus 671 ~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~ 750 (752)
T KOG0670|consen 671 QDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFIT 750 (752)
T ss_pred cccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCccc
Confidence 11 00 000 000267899999997 999999999999999996
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=307.95 Aligned_cols=240 Identities=20% Similarity=0.309 Sum_probs=197.6
Q ss_pred EEEEEecCcEEEEEEEccCCe-----EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGL-----EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~-----~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
+-|+.+..|.||.|....-.. .||+|.++.. .+.+....|++|..+|+.++|||||++.++..+. ...++
T Consensus 698 ~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~---~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--~~~~i 772 (1025)
T KOG1095|consen 698 RVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL---SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--GPPLI 772 (1025)
T ss_pred eeeccccccceEEEEEecCCCCccceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--CCcEE
Confidence 356777789999999776332 3888877632 3578899999999999999999999999998874 47999
Q ss_pred EEecCCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCch
Q 006277 89 ITELFTSGSLRQYRKKH-------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 161 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~-------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla 161 (652)
++|||.||+|..|+++. ..++...+..++.+|++|..||++++ +|||||-+.|+|++ ....|||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~-~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLD-ERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeec-ccCcEEEcccchh
Confidence 99999999999999876 35899999999999999999999998 99999999999999 4579999999999
Q ss_pred hhhhccccccc----cCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccC
Q 006277 162 TIMEQANAKSV----IGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSK 235 (652)
Q Consensus 162 ~~l~~~~~~~~----vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~ 235 (652)
+.+-....... .-...|||||.+ ++.++.++|||||||++||++| |..||.+. +..+++..+..|. ....+.
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~-~n~~v~~~~~~gg-RL~~P~ 927 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR-SNFEVLLDVLEGG-RLDPPS 927 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc-chHHHHHHHHhCC-ccCCCC
Confidence 96543322111 123579999976 5889999999999999999998 78899884 4455555455444 344556
Q ss_pred CCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 236 VKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 236 ~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
.++..+.+++.+||. +|.+||+...+++
T Consensus 928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 677788899999997 8999999999997
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=304.84 Aligned_cols=230 Identities=29% Similarity=0.369 Sum_probs=182.6
Q ss_pred CcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHH
Q 006277 21 DTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLR 99 (652)
Q Consensus 21 ~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~ 99 (652)
|+.||+|.. .|++||||.+. ++....+++||++|+.. .|||||++|..=. ...+.|+..|+|.. +|.
T Consensus 523 Gt~Vf~G~y--e~R~VAVKrll-------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~--d~qF~YIalELC~~-sL~ 590 (903)
T KOG1027|consen 523 GTVVFRGVY--EGREVAVKRLL-------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQ--DRQFLYIALELCAC-SLQ 590 (903)
T ss_pred CcEEEEEee--CCceehHHHHh-------hHhHHHHHHHHHHHHhccCCCceEEEEeecc--CCceEEEEehHhhh-hHH
Confidence 357899974 67999999765 45677889999999999 7999999998544 44599999999955 999
Q ss_pred HHHHhCCC-CC---HHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC----CCcEEEeccCchhhhhccc---
Q 006277 100 QYRKKHKK-VD---MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN----QGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 100 ~~i~~~~~-ls---e~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~----~g~VKL~DFGla~~l~~~~--- 168 (652)
+++...+. +. --....++.|+++||++||+.+ ||||||||.||||+.. ...++|+|||+++.+....
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~ 668 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF 668 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence 99987511 11 1345788999999999999998 9999999999999852 2468999999999986543
Q ss_pred --cccccCCCCccCcccccc-CCCccccchhhHHHHHHHhhc-cCCCCCCCCHHHHHHHHhcCCC-CccccCCCChHHHH
Q 006277 169 --AKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIK-PAALSKVKDPEVKS 243 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl~~-~y~~~sDIWSlGvilyeLltG-~~Pf~~~~~~~~i~~~I~~g~~-p~~l~~~~s~~~kd 243 (652)
..+..||-.|+|||++.+ .-..++||+||||++|+.++| ..||.+ . .+....|..|.. -..+....+.++++
T Consensus 669 ~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd--~-~~R~~NIl~~~~~L~~L~~~~d~eA~d 745 (903)
T KOG1027|consen 669 SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD--S-LERQANILTGNYTLVHLEPLPDCEAKD 745 (903)
T ss_pred hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc--h-HHhhhhhhcCccceeeeccCchHHHHH
Confidence 356789999999998864 455689999999999999987 889965 2 222234555443 22233333338999
Q ss_pred HHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 244 FIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
||.+||. +|..||+|.++|.||||
T Consensus 746 LI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 746 LISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred HHHHhcCCCcccCCCHHHHhCCCcc
Confidence 9999998 89999999999999999
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=292.17 Aligned_cols=263 Identities=22% Similarity=0.271 Sum_probs=186.4
Q ss_pred CCcceeeee-eEEEEEEecCcEEEEEEEc----------------cCCeEEEEEEEeecccCCCHH----------HHHH
Q 006277 3 RQKWSLLIL-MYLRLIQLVDTSGYKAFDE----------------VNGLEVAWCQVRIDDVLQSPE----------DLER 55 (652)
Q Consensus 3 ~~~W~~~~~-~~~rL~~l~~gtVykA~d~----------------~tG~~VAiK~v~~~~~~~s~e----------~~~~ 55 (652)
+++|....+ ...+|++++.|+||+|.+. ..++.||+|.+.........+ ..+.
T Consensus 139 ~~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~ 218 (507)
T PLN03224 139 NSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAET 218 (507)
T ss_pred CCCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccch
Confidence 467776664 5667888888999999753 345789999986532110000 1123
Q ss_pred HHHHHHHHHhCCCCCe-----eeeeeEEEeC------CCCeEEEEEecCCCCCHHHHHHhC-------------------
Q 006277 56 LYSEVHLLKSLKHNNI-----IRFYNSWIDD------QNKTVNIITELFTSGSLRQYRKKH------------------- 105 (652)
Q Consensus 56 l~~Ei~iLk~L~HpnI-----Vkl~~~~~d~------~~~~~~LVmEy~~gGsL~~~i~~~------------------- 105 (652)
...|+.++.+++|.++ ++++++|... ..+..++||||+.+|+|.+++...
T Consensus 219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~ 298 (507)
T PLN03224 219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP 298 (507)
T ss_pred hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence 3447777788866654 6666665431 123689999999999999887632
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-cc--cccCCCC
Q 006277 106 -----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AK--SVIGTPE 177 (652)
Q Consensus 106 -----~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~~--~~vGTp~ 177 (652)
..+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++..+.... .. ...+||.
T Consensus 299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~ 375 (507)
T PLN03224 299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPR 375 (507)
T ss_pred hhcccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEEC-CCCcEEEEeCcCccccccCCccCccccCCCcc
Confidence 12356788999999999999999998 99999999999998 56799999999997654322 12 2345899
Q ss_pred ccCccccccC---------------------CC--ccccchhhHHHHHHHhhccC-CCCCCC----------CHHHHHHH
Q 006277 178 FMAPELYDEN---------------------YN--ELADIYSFGMCMLEMVTFEY-PYSECR----------NSAQIYKK 223 (652)
Q Consensus 178 YmAPEvl~~~---------------------y~--~~sDIWSlGvilyeLltG~~-Pf~~~~----------~~~~i~~~ 223 (652)
|+|||++... |+ .+.||||+||++|+|++|.. ||.... +....++.
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~ 455 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM 455 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh
Confidence 9999976321 22 24799999999999999976 775321 11112222
Q ss_pred HhcCCCCccccCCCChHHHHHHHHhCC-CC---CCCCCHHHHhcCcccc
Q 006277 224 VSSGIKPAALSKVKDPEVKSFIEKCLV-PA---SQRLSAKELLMDPFLQ 268 (652)
Q Consensus 224 I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P---~~RpSa~elL~hpf~~ 268 (652)
+.............++.+++||.+||. +| .+|+|+.|+|.||||.
T Consensus 456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 222332333344567899999999996 43 6899999999999995
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=281.48 Aligned_cols=246 Identities=20% Similarity=0.303 Sum_probs=194.7
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC--CCC----eeeeeeEEEeCCCCe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK--HNN----IIRFYNSWIDDQNKT 85 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~--Hpn----IVkl~~~~~d~~~~~ 85 (652)
++..++++..|.|-.+.|..++..||+|+++.- ....+..+-|+++|+++. .|+ +|.+.++|. - .+.
T Consensus 93 i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd-y-rgh 165 (415)
T KOG0671|consen 93 IVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD-Y-RGH 165 (415)
T ss_pred hhhhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh-c-cCc
Confidence 556677788899999999999999999998632 345667778999999993 233 677776553 2 347
Q ss_pred EEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC----------C----
Q 006277 86 VNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING----------N---- 149 (652)
Q Consensus 86 ~~LVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~----------~---- 149 (652)
+|+|+|.+ |-+++++++.++ +++...++.+.+|++.+++|||+.+ ++|-||||+|||+.. .
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCccce
Confidence 99999998 679999998764 6899999999999999999999999 999999999999831 1
Q ss_pred -----CCcEEEeccCchhhhhccccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHH--H
Q 006277 150 -----QGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI--Y 221 (652)
Q Consensus 150 -----~g~VKL~DFGla~~l~~~~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i--~ 221 (652)
...|+|+|||.|+.-... ..+++.|..|.|||++ +-+++.++||||+|||++||.||...|....+.+.+ +
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~-hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMM 321 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEH-HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMM 321 (415)
T ss_pred eccCCCcceEEEecCCcceeccC-cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHH
Confidence 225899999999875544 3778999999999976 558999999999999999999999999886665543 3
Q ss_pred HHHhcCCC----------------CccccCC----------------------CC---hHHHHHHHHhCC-CCCCCCCHH
Q 006277 222 KKVSSGIK----------------PAALSKV----------------------KD---PEVKSFIEKCLV-PASQRLSAK 259 (652)
Q Consensus 222 ~~I~~g~~----------------p~~l~~~----------------------~s---~~~kdlI~kcL~-~P~~RpSa~ 259 (652)
+.|....+ ...|+.. .+ .++.|||++||. ||.+|+|+.
T Consensus 322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~ 401 (415)
T KOG0671|consen 322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR 401 (415)
T ss_pred HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence 33332110 0001100 11 257899999998 999999999
Q ss_pred HHhcCcccc
Q 006277 260 ELLMDPFLQ 268 (652)
Q Consensus 260 elL~hpf~~ 268 (652)
|+|.||||.
T Consensus 402 EAL~HpFF~ 410 (415)
T KOG0671|consen 402 EALSHPFFA 410 (415)
T ss_pred HHhcCHHhh
Confidence 999999996
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=256.38 Aligned_cols=211 Identities=27% Similarity=0.393 Sum_probs=181.5
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
...+|++++.|.|-+-.+..+|+..|+|.++..- +.+...++++|+.+..+. ..|.+|.||+.+.++. .+|+.|
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg--dvwIcM 124 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG--DVWICM 124 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc--cEEEeH
Confidence 3457888888999999999999999999987432 246677888999887776 8999999999988765 799999
Q ss_pred ecCCCCCHHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 91 ELFTSGSLRQY----RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 91 Ey~~gGsL~~~----i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
|.+ ..+|..+ +++.+.++|..+-.++..++.||.|||++= .|||||+||.|||+| .+|+||+||||++..+.+
T Consensus 125 E~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILIN-YDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEc-cCCcEEEcccccceeehh
Confidence 999 5577654 456788999999999999999999999982 499999999999999 779999999999999888
Q ss_pred ccccc-ccCCCCccCccccc-----cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC
Q 006277 167 ANAKS-VIGTPEFMAPELYD-----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP 230 (652)
Q Consensus 167 ~~~~~-~vGTp~YmAPEvl~-----~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p 230 (652)
.-+.+ -.|-..|||||.+. .+|+.++||||||+.+.||.++++||.....+-+..+.+.....|
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P 271 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP 271 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence 77666 67889999999773 369999999999999999999999999888888888888776544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=308.71 Aligned_cols=233 Identities=19% Similarity=0.299 Sum_probs=176.0
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
.++++..|.||+|.+..+|..||+|.+..... ....|++++++++|||||++++++.+.. ..|+||||++
T Consensus 697 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~~~--~~~lv~Ey~~ 766 (968)
T PLN00113 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRSEK--GAYLIHEYIE 766 (968)
T ss_pred EEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEcCC--CCEEEEeCCC
Confidence 57788889999999999999999998763221 1234688999999999999999987654 6899999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccccc
Q 006277 95 SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI 173 (652)
Q Consensus 95 gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~v 173 (652)
+|+|.+++. .+++..+..++.||+.||+|||.+ .++|+||||||+||+++ .++..++. ||.+..... .....
T Consensus 767 ~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~-~~~~~~~~-~~~~~~~~~--~~~~~ 839 (968)
T PLN00113 767 GKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID-GKDEPHLR-LSLPGLLCT--DTKCF 839 (968)
T ss_pred CCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC-CCCceEEE-ecccccccc--CCCcc
Confidence 999999986 488999999999999999999954 34499999999999998 44566664 555443321 23447
Q ss_pred CCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCC-HHHHHHHHh---cCC-----CCcccc------CCC
Q 006277 174 GTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRN-SAQIYKKVS---SGI-----KPAALS------KVK 237 (652)
Q Consensus 174 GTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~-~~~i~~~I~---~g~-----~p~~l~------~~~ 237 (652)
||+.|||||++. ..|+.++|||||||++|||+||+.||..... ...+..... ... ..+.+. ...
T Consensus 840 ~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (968)
T PLN00113 840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNE 919 (968)
T ss_pred ccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHH
Confidence 899999999774 5799999999999999999999999853211 111111111 100 000010 011
Q ss_pred ChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 238 DPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 238 s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
..++.+++.+||. +|.+|||+.|+++.
T Consensus 920 ~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 920 IVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 1256788999997 89999999999876
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=281.43 Aligned_cols=237 Identities=25% Similarity=0.443 Sum_probs=195.1
Q ss_pred EEEEecCcEEEEEEEcc----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 15 RLIQLVDTSGYKAFDEV----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~----tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
.+|++-.|.||+|.... ...-||||.-+.+. .++..+.|++|..+|++++|||||++.+++.+. ..|+||
T Consensus 396 ~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphIikLIGv~~e~---P~Wivm 469 (974)
T KOG4257|consen 396 LIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ---PMWIVM 469 (974)
T ss_pred hhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc---ceeEEE
Confidence 34555568999998654 34569999876543 367799999999999999999999999988754 599999
Q ss_pred ecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc
Q 006277 91 ELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 169 (652)
|+++-|.|+.|++.++ .++...+..|+.||..||.|||+.+ .|||||-..||||.+.+ -|||+|||+++.+.....
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~-CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQ-CVKLADFGLSRYLEDDAY 546 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcc-eeeecccchhhhccccch
Confidence 9999999999998764 6899999999999999999999998 99999999999998543 699999999999876532
Q ss_pred ---ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 170 ---KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 170 ---~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
....-...|||||-++ +.++.++|||-||||+||++. |.-||.+-.+.+.| ..+.+|.. .+.+..++|.+-.+
T Consensus 547 YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iEnGeR-lP~P~nCPp~LYsl 624 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIENGER-LPCPPNCPPALYSL 624 (974)
T ss_pred hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEecCCCC-CCCCCCCChHHHHH
Confidence 2222345799999774 679999999999999999875 88899886665443 34555543 34567788999999
Q ss_pred HHHhCC-CCCCCCCHHHHh
Q 006277 245 IEKCLV-PASQRLSAKELL 262 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL 262 (652)
+.+||+ +|.+||...++.
T Consensus 625 mskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 625 MSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHhccCcccCCcHHHHH
Confidence 999998 999999877764
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=275.36 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=207.5
Q ss_pred Ccceeeee---eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 006277 4 QKWSLLIL---MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 80 (652)
Q Consensus 4 ~~W~~~~~---~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 80 (652)
.+|...+. |--+|+.+-.|.||.|+.++-.-.||||.++-+ ...++.|+.|+.+|+.++|||+|++.++|..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-----chhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 57887765 444555555589999999999999999988632 3568999999999999999999999998765
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEecc
Q 006277 81 DQNKTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 158 (652)
Q Consensus 81 ~~~~~~~LVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DF 158 (652)
+- .+|||+|||..|+|.+|+++.. -++.-.+..++.||.+|++||..++ +|||||-..|+||. ++..||++||
T Consensus 335 Ep--PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVg-EnhiVKvADF 409 (1157)
T KOG4278|consen 335 EP--PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHIVKVADF 409 (1157)
T ss_pred CC--CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccc-ccceEEeecc
Confidence 54 7999999999999999998653 4677788889999999999999999 99999999999997 5668999999
Q ss_pred CchhhhhccccccccC---CCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccc
Q 006277 159 GLATIMEQANAKSVIG---TPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAAL 233 (652)
Q Consensus 159 Gla~~l~~~~~~~~vG---Tp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l 233 (652)
||++.+.....+.-.| ...|.|||-+ -..++.++|||+|||+|||+.| |-.||.+ .+..+.|..+.+|.. ..-
T Consensus 410 GLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyR-M~~ 487 (1157)
T KOG4278|consen 410 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYR-MDG 487 (1157)
T ss_pred chhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhcccc-ccC
Confidence 9999997655433333 3579999966 4678999999999999999987 6679988 788999999988764 344
Q ss_pred cCCCChHHHHHHHHhCC-CCCCCCCHHHHh
Q 006277 234 SKVKDPEVKSFIEKCLV-PASQRLSAKELL 262 (652)
Q Consensus 234 ~~~~s~~~kdlI~kcL~-~P~~RpSa~elL 262 (652)
+..+++.+.+|+..||+ .|+.||+..|+-
T Consensus 488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 488 PEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 56678999999999998 999999988764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=272.59 Aligned_cols=242 Identities=22% Similarity=0.330 Sum_probs=195.2
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
+..+|+++-.|.|.+|.-.. +..||+|.++... .......|.+||++|.+|+|||||.+++++..++ .+++|||
T Consensus 542 ~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a---~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De--PicmI~E 615 (807)
T KOG1094|consen 542 FKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA---TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD--PLCMITE 615 (807)
T ss_pred hhhhhcCcccceeEEEEecC-ceEEEEeecCccc---chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC--chHHHHH
Confidence 45688888899999997543 6999999987543 2455788999999999999999999999987655 7999999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc
Q 006277 92 LFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 169 (652)
|++.|+|.+|+.++. .+.-.....++.||++|++||.+.+ ++||||.+.|+|++ ..+++||+|||+++-+-.+..
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~-~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVD-GEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeec-CcccEEecCcccccccccCCc
Confidence 999999999999883 3345566779999999999999999 99999999999999 457999999999986644332
Q ss_pred ----ccccCCCCccCcc-ccccCCCccccchhhHHHHHHHh--hccCCCCCCCCHHHHHHHHhc---CCC---CccccCC
Q 006277 170 ----KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMV--TFEYPYSECRNSAQIYKKVSS---GIK---PAALSKV 236 (652)
Q Consensus 170 ----~~~vGTp~YmAPE-vl~~~y~~~sDIWSlGvilyeLl--tG~~Pf~~~~~~~~i~~~I~~---g~~---p~~l~~~ 236 (652)
...+-...||||| ++.++++.++|+|+||+++||++ |.+.||+.. ..+++...... +.. -...+..
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l-t~e~vven~~~~~~~~~~~~~l~~P~~ 771 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL-TDEQVVENAGEFFRDQGRQVVLSRPPA 771 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh-hHHHHHHhhhhhcCCCCcceeccCCCc
Confidence 2345567999999 66899999999999999999975 568899874 44444443322 111 1233456
Q ss_pred CChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 237 KDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 237 ~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
.+..+-+++-+|+. +.++|||.+++-.
T Consensus 772 cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 772 CPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 67788999999997 8899999999843
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=231.94 Aligned_cols=208 Identities=37% Similarity=0.588 Sum_probs=181.8
Q ss_pred EEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCC
Q 006277 17 IQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSG 96 (652)
Q Consensus 17 ~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~gG 96 (652)
+++..+.||++.+..+|+++++|.+..... ....+.+.+|+++++.+.|++|+++++++... ...+++||++.|+
T Consensus 2 ~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~~ 76 (215)
T cd00180 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDS---SSLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEGG 76 (215)
T ss_pred CcCCceEEEEEEecCCCcEEEEEEeccccc---hhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCCC
Confidence 456668999999998999999999875432 11467899999999999999999999988765 4799999999999
Q ss_pred CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--ccccc
Q 006277 97 SLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVI 173 (652)
Q Consensus 97 sL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~~~v 173 (652)
+|.+++... ..++...+..++.+++.+|.|||+++ ++|+||+|.||+++..++.++|+|||.+....... .....
T Consensus 77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 999998876 57899999999999999999999998 99999999999998426799999999998776543 44567
Q ss_pred CCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-
Q 006277 174 GTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV- 250 (652)
Q Consensus 174 GTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~- 250 (652)
+...|++||.+.. .++.+.|+|++|+++++| ..+.+++.+||.
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQK 200 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhhC
Confidence 8899999998755 788999999999999999 578999999997
Q ss_pred CCCCCCCHHHHhcCc
Q 006277 251 PASQRLSAKELLMDP 265 (652)
Q Consensus 251 ~P~~RpSa~elL~hp 265 (652)
+|.+||++.++++|+
T Consensus 201 ~p~~R~~~~~l~~~~ 215 (215)
T cd00180 201 DPEKRPSAKEILEHL 215 (215)
T ss_pred CcccCcCHHHHhhCC
Confidence 899999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=259.91 Aligned_cols=250 Identities=25% Similarity=0.397 Sum_probs=199.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC---eEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK---TVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~---~~~LVm 90 (652)
+.++-+..|.||.+.|..+|+.||+|++. .+.++-..-+++.+|+.+|...+|.|++...+...-..-. .+|+|+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~p--nvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMP--NVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcc--hHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 34566778999999999999999999864 3444455678999999999999999999988865433221 468899
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
|++.+ +|...|..-..++.+.++-++.||+.||.|||+.+ |+||||||.|+|+| .+..+||||||+++......
T Consensus 137 ELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVN-SNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 137 ELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVN-SNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEec-cCceEEecccccccccchhhhh
Confidence 99966 89888888889999999999999999999999998 99999999999999 55789999999999765432
Q ss_pred -cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHh--------------------
Q 006277 169 -AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS-------------------- 225 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~-------------------- 225 (652)
.+.-+-|.+|.|||++- +.|+.++||||+|||+.||+..+..|......+++- .|.
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~-lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQ-MIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHH-HHHHHhCCCcHHHHHHHhhhhHH
Confidence 23345689999999874 479999999999999999999999998755544432 221
Q ss_pred ----cCCCCcccc---CCC-----ChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 226 ----SGIKPAALS---KVK-----DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 226 ----~g~~p~~l~---~~~-----s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.+.+++.++ ... ..+...++.++|. +|.+|.+..+++.|+++...
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 122333322 222 2467788888887 89999999999999998643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=259.51 Aligned_cols=126 Identities=25% Similarity=0.358 Sum_probs=106.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-----C---CCeeeeeeEEEeC--CC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-----H---NNIIRFYNSWIDD--QN 83 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-----H---pnIVkl~~~~~d~--~~ 83 (652)
++||=+-.+|||+|+|..+.+.||+|+++-. ....+....||.+|++++ | .+||+|++.|... ++
T Consensus 84 rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG 158 (590)
T KOG1290|consen 84 RKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNG 158 (590)
T ss_pred EeccccccceeEEEeeccCCeEEEEEEEehh-----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCC
Confidence 4444444589999999999999999998743 345678889999999992 3 3699999999653 34
Q ss_pred CeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEE
Q 006277 84 KTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI 146 (652)
Q Consensus 84 ~~~~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl 146 (652)
..+|+|+|++ |.+|..+|++. +.++...++.|++|||.||.|||.. .+|||-||||+|||+
T Consensus 159 ~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 159 QHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLL 221 (590)
T ss_pred cEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeee
Confidence 5899999998 77999988864 6799999999999999999999988 359999999999998
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=272.24 Aligned_cols=245 Identities=23% Similarity=0.342 Sum_probs=203.5
Q ss_pred EEEEEEecCcEEEEEEEccC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~t---G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
|..|+++-.|.|++|..+.. -..||||+++..... .....|++|+.+|.+|+|||++++|++..+. .+.+|
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~q---p~mMV 188 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLDQ---PAMMV 188 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeeccc---hhhHH
Confidence 34566666789999987763 257999999865442 2788999999999999999999999988763 58999
Q ss_pred EecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 90 TELFTSGSLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 90 mEy~~gGsL~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
||+++.|+|.+.+.+ ...|-...+..|+.||+.|+.||.+++ +|||||-..|+|+-. ...|||+||||.+.+...
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllas-prtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLAS-PRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecc-cceeeeecccceeccCCC
Confidence 999999999999886 356889999999999999999999998 999999999999974 558999999999988765
Q ss_pred ccccccC-----CCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChH
Q 006277 168 NAKSVIG-----TPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 240 (652)
Q Consensus 168 ~~~~~vG-----Tp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 240 (652)
....+.+ ...|.|||.++ ..++.++|||++||++|||+| |+.||.++ ...+|.++|..+. ...-++.++.+
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD~~e-rLpRPk~csed 343 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNIDAGE-RLPRPKYCSED 343 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhccccc-cCCCCCCChHH
Confidence 4333322 34699999775 689999999999999999997 68899984 6778888888554 33456778899
Q ss_pred HHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 241 VKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 241 ~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
+.+++..||. +|.+|||...|...-+++
T Consensus 344 IY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 344 IYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 9999999998 899999999886554443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=260.48 Aligned_cols=238 Identities=25% Similarity=0.340 Sum_probs=184.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC--CCCCeeeeeeEEEeCC--CCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL--KHNNIIRFYNSWIDDQ--NKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L--~HpnIVkl~~~~~d~~--~~~~~L 88 (652)
...++++..|.||||.- +++.||||++. .+..+.++.|..|.+.. +|+||++|++.=.... ...++|
T Consensus 215 ~eli~~Grfg~V~KaqL--~~~~VAVKifp-------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQL--DNRLVAVKIFP-------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred HHHhhcCccceeehhhc--cCceeEEEecC-------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34567778899999974 56999999886 46778888998888776 8999999998432111 226999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCeeeccCCcccEEEcCCCCcEEEeccCch
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH-------DPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 161 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~-------g~~IiHRDLKp~NILl~~~~g~VKL~DFGla 161 (652)
|++|.+.|+|.+|++.+ .++.....+++..|+.||+|||+- .|+|+|||||..||||. ++++.-|+|||||
T Consensus 286 Vt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIaDFGLA 363 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIADFGLA 363 (534)
T ss_pred EeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEeecccee
Confidence 99999999999999876 689999999999999999999963 46799999999999997 7899999999999
Q ss_pred hhhhccc----cccccCCCCccCccccccCCCc-------cccchhhHHHHHHHhhcc------------CCCCC----C
Q 006277 162 TIMEQAN----AKSVIGTPEFMAPELYDENYNE-------LADIYSFGMCMLEMVTFE------------YPYSE----C 214 (652)
Q Consensus 162 ~~l~~~~----~~~~vGTp~YmAPEvl~~~y~~-------~sDIWSlGvilyeLltG~------------~Pf~~----~ 214 (652)
..+.... ....+||.+|||||++++..+. +.||||+|.+++||++.. +||.. .
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 9886543 3457999999999999775443 489999999999998742 23321 1
Q ss_pred CCHHHHHHHHhcCCCCcccc----CC-CChHHHHHHHHhCC-CCCCCCCHHHH
Q 006277 215 RNSAQIYKKVSSGIKPAALS----KV-KDPEVKSFIEKCLV-PASQRLSAKEL 261 (652)
Q Consensus 215 ~~~~~i~~~I~~g~~p~~l~----~~-~s~~~kdlI~kcL~-~P~~RpSa~el 261 (652)
...++....+.+.+..+.++ +. .-..+++.|.-|+. ||+.|+||.=+
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 12344444454443333232 22 23467899999997 89999997643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=271.67 Aligned_cols=241 Identities=25% Similarity=0.347 Sum_probs=199.6
Q ss_pred EEEEEecCcEEEEEEEcc-------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 006277 14 LRLIQLVDTSGYKAFDEV-------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 85 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~-------tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~ 85 (652)
..++.+..|.|++|.-.. ....||+|..+... ...+.+.+..|+.+|+.+ +||||+.+.+++.. .+.
T Consensus 302 ~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--~~~ 376 (609)
T KOG0200|consen 302 KYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--DGP 376 (609)
T ss_pred ceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--CCc
Confidence 378888889999987432 25679999876432 236788999999999999 79999999998765 458
Q ss_pred EEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC
Q 006277 86 VNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN 149 (652)
Q Consensus 86 ~~LVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~ 149 (652)
+++|+|||..|+|..|++..+ .++...+..++.||+.|++||++.. ++||||-..|||+. .
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi~-~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLIT-K 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEec-C
Confidence 999999999999999998776 3889999999999999999999998 99999999999998 5
Q ss_pred CCcEEEeccCchhhhhcccc---ccccC--CCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHH
Q 006277 150 QGEVKIGDLGLATIMEQANA---KSVIG--TPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYK 222 (652)
Q Consensus 150 ~g~VKL~DFGla~~l~~~~~---~~~vG--Tp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~ 222 (652)
+..+||+|||+|+....... ....| ...|||||.+. ..|+.++|||||||++|||++ |..||.+......+++
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~ 533 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE 533 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence 56899999999986544322 22223 23599999764 579999999999999999998 6889988665777788
Q ss_pred HHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 223 KVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 223 ~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
.+..|.+. ..+...++++.+++..|+. +|.+||+..++..
T Consensus 534 ~l~~G~r~-~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 534 FLKEGNRM-EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHhcCCCC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 88888754 3456668999999999997 8999999888764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=268.28 Aligned_cols=197 Identities=25% Similarity=0.386 Sum_probs=175.6
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHH----HHHHHHHHHHHHHhCC---CCCeeeeeeEEEeCCCC
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPE----DLERLYSEVHLLKSLK---HNNIIRFYNSWIDDQNK 84 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e----~~~~l~~Ei~iLk~L~---HpnIVkl~~~~~d~~~~ 84 (652)
+...+|++..|.|++|.|+....+|++|.|.+.+++.+.- .+-.+-.||+||..|+ |+||+++.++|+|.+
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd-- 642 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD-- 642 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC--
Confidence 4567788888999999999999999999998877654322 2345778999999997 999999999998765
Q ss_pred eEEEEEecCC-CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 85 TVNIITELFT-SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 85 ~~~LVmEy~~-gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
++||+||--. |-+|+++|..++.++|..++.+++||+.|+++||++| |||||||-+|+.++ ..|-+||+|||.|..
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd-~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVD-SNGFVKLIDFGSAAY 719 (772)
T ss_pred eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEe-cCCeEEEeeccchhh
Confidence 8999999865 4489999999999999999999999999999999999 99999999999999 458999999999999
Q ss_pred hhccccccccCCCCccCcccccc-CC-CccccchhhHHHHHHHhhccCCCCC
Q 006277 164 MEQANAKSVIGTPEFMAPELYDE-NY-NELADIYSFGMCMLEMVTFEYPYSE 213 (652)
Q Consensus 164 l~~~~~~~~vGTp~YmAPEvl~~-~y-~~~sDIWSlGvilyeLltG~~Pf~~ 213 (652)
...+....++||..|.|||++++ .| +..-|||++|+++|.++..+.||+.
T Consensus 720 ~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 88888899999999999999976 44 6789999999999999999999964
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=290.11 Aligned_cols=199 Identities=21% Similarity=0.240 Sum_probs=148.3
Q ss_pred HhCCC-CCeeeeeeEEE----eC-CCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 006277 64 KSLKH-NNIIRFYNSWI----DD-QNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIH 136 (652)
Q Consensus 64 k~L~H-pnIVkl~~~~~----d~-~~~~~~LVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiH 136 (652)
+.+.| +||++++++|. +. ....++++|||+ +++|.+++... +.+++..++.+++||+.||+|||++| |+|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvH 103 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVV 103 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 34455 58888888761 11 123577888987 66999999753 56999999999999999999999998 999
Q ss_pred ccCCcccEEEcC------------------CCCcEEEeccCchhhhhcc------------------ccccccCCCCccC
Q 006277 137 RDLKCDNIFING------------------NQGEVKIGDLGLATIMEQA------------------NAKSVIGTPEFMA 180 (652)
Q Consensus 137 RDLKp~NILl~~------------------~~g~VKL~DFGla~~l~~~------------------~~~~~vGTp~YmA 180 (652)
|||||+||||+. .++.+|++|||+++..... .....+||++|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999952 3456778888877642110 0112468999999
Q ss_pred cccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCH
Q 006277 181 PELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSA 258 (652)
Q Consensus 181 PEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa 258 (652)
||++ ...|+.++|||||||++|||++|.+|+... ......+.....+.... ...+.+.+++.+||. +|.+||++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCChhhCcCh
Confidence 9976 567999999999999999999998887542 22222332222222211 124567899999998 89999999
Q ss_pred HHHhcCccccc
Q 006277 259 KELLMDPFLQV 269 (652)
Q Consensus 259 ~elL~hpf~~~ 269 (652)
.|+|+||||..
T Consensus 260 ~eil~h~~~~~ 270 (793)
T PLN00181 260 SELLQSEFINE 270 (793)
T ss_pred HHHhhchhhhh
Confidence 99999999964
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=253.70 Aligned_cols=240 Identities=28% Similarity=0.451 Sum_probs=182.5
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC--CCCCeeeeeeEEEeCCC--CeEE
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL--KHNNIIRFYNSWIDDQN--KTVN 87 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L--~HpnIVkl~~~~~d~~~--~~~~ 87 (652)
....+|++..|.||+|. ..|..||||++.-. +.....+|.+|.+.. +|+||+.|.++=....+ ..+|
T Consensus 215 L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~sr-------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSR-------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred EEEEecCccccceeecc--ccCCceEEEEeccc-------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 45678888889999996 57899999998632 345677788888776 99999999885332222 3699
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeeeccCCcccEEEcCCCCcEEEeccCch
Q 006277 88 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH------DPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 161 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~------g~~IiHRDLKp~NILl~~~~g~VKL~DFGla 161 (652)
||++|.+.|+|++|+.+ ..++......++..+++||++||.. .|.|.|||||..||||. ++|.+-|+|+|||
T Consensus 286 LvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-kn~~C~IADLGLA 363 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLA 363 (513)
T ss_pred EeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc-cCCcEEEeeceee
Confidence 99999999999999987 5799999999999999999999952 36799999999999997 7789999999999
Q ss_pred hhhhcc------ccccccCCCCccCccccccCCC-------ccccchhhHHHHHHHhhc----------cCCCCCCCCHH
Q 006277 162 TIMEQA------NAKSVIGTPEFMAPELYDENYN-------ELADIYSFGMCMLEMVTF----------EYPYSECRNSA 218 (652)
Q Consensus 162 ~~l~~~------~~~~~vGTp~YmAPEvl~~~y~-------~~sDIWSlGvilyeLltG----------~~Pf~~~~~~~ 218 (652)
...... .....+||.+|||||++.+..+ ..+||||||.+++|++.. .+||.+..+.+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 876543 2457899999999999976433 358999999999999752 58887643332
Q ss_pred ---HHHHHHh-cC-CCCccccCC-CChH---HHHHHHHhCC-CCCCCCCHHHHh
Q 006277 219 ---QIYKKVS-SG-IKPAALSKV-KDPE---VKSFIEKCLV-PASQRLSAKELL 262 (652)
Q Consensus 219 ---~i~~~I~-~g-~~p~~l~~~-~s~~---~kdlI~kcL~-~P~~RpSa~elL 262 (652)
+-++++. -. ..|.....+ .++. +-.+++.|+. +|.-|+||--+.
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 2222222 11 122222222 2343 3456888996 899999986554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=255.81 Aligned_cols=243 Identities=25% Similarity=0.404 Sum_probs=192.5
Q ss_pred EEEEEecCcEEEEEEEcc---CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEV---NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~---tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
-+++++-.++||+|++.. ....||+|.+..-. .-.++..|+++|..+ .+.||+++.+++- .++.+.+|
T Consensus 42 ~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~r--nnd~v~iv 113 (418)
T KOG1167|consen 42 NKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCFR--NNDQVAIV 113 (418)
T ss_pred ccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhhc--cCCeeEEE
Confidence 356667778999999988 88999999987432 346799999999999 7999999999875 34589999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc---
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--- 166 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--- 166 (652)
|||++..+..++.. .++...++.|++.++.||.++|.+| ||||||||.|+|++...+.-.|.|||+|.....
T Consensus 114 lp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred ecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 99999999888876 5778999999999999999999999 999999999999998888999999999973210
Q ss_pred -----c-------c-------------------------------cccccCCCCccCccccc--cCCCccccchhhHHHH
Q 006277 167 -----A-------N-------------------------------AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCM 201 (652)
Q Consensus 167 -----~-------~-------------------------------~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvil 201 (652)
. . .....|||.|.|||++- ...+.++||||.|||+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 0 00246999999999874 3578899999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHh--------------cCC-----------------------------------CCcc
Q 006277 202 LEMVTFEYPYSECRNSAQIYKKVS--------------SGI-----------------------------------KPAA 232 (652)
Q Consensus 202 yeLltG~~Pf~~~~~~~~i~~~I~--------------~g~-----------------------------------~p~~ 232 (652)
+-++++.+||..+.+.......+. .|. .+..
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 999999999965433211110000 010 0111
Q ss_pred ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 233 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 233 l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+....+..+.+|+.+||. +|.+|+||+++|+||||..
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 223345588999999997 9999999999999999973
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=226.81 Aligned_cols=207 Identities=32% Similarity=0.482 Sum_probs=178.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..++.+..++||+|.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++++.... ..++++|++
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~e~~ 79 (225)
T smart00221 5 KKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPE--PLYLVMEYC 79 (225)
T ss_pred eEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCC--ceEEEEecc
Confidence 3556666789999999999999999998754321 36788999999999999999999999887654 799999999
Q ss_pred CCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc---cc
Q 006277 94 TSGSLRQYRKKHKK-VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA---NA 169 (652)
Q Consensus 94 ~gGsL~~~i~~~~~-lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~---~~ 169 (652)
.+++|.+++..... +++..+..++.|++.+|.|||+++ ++|+||+|.||+++ ..+.++|+|||++...... ..
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~-~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLG-MDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeeCceeeEecCcccccc
Confidence 99999999988776 899999999999999999999998 99999999999998 4589999999998877543 23
Q ss_pred ccccCCCCccCcccc-c-cCCCccccchhhHHHHHHHhhccCCCCC-CCCHHHHHHHHhcCC
Q 006277 170 KSVIGTPEFMAPELY-D-ENYNELADIYSFGMCMLEMVTFEYPYSE-CRNSAQIYKKVSSGI 228 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl-~-~~y~~~sDIWSlGvilyeLltG~~Pf~~-~~~~~~i~~~I~~g~ 228 (652)
....++..|++||.+ . ..++.++|+|+||+++++|++|..||.. ..+...+++.+..+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 456788999999976 3 4577899999999999999999999977 566678888888775
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=263.40 Aligned_cols=239 Identities=26% Similarity=0.386 Sum_probs=201.0
Q ss_pred EEEEEecCcEEEEEEEccCC----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNG----LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG----~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
..|+.+..|+||+|...-.| .+||+|++.... .++.-..++.|+-+|.+|+|||++++.+++... .+.||
T Consensus 702 kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t---~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~qlv 775 (1177)
T KOG1025|consen 702 KVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT---SPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TLQLV 775 (1177)
T ss_pred ceeccccceeEEeeeEecCCceecceeEEEEeeccC---CchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hHHHH
Confidence 46777888999999876655 578888876432 355678899999999999999999999987644 48899
Q ss_pred EecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 90 TELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
++|+++|.|.+|++.+ .++-.+....|+.||++|+.|||.+. ++||||-..|+||. .-.+|||.|||+++.+....
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVk-sP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVK-SPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeec-CCCeEEEEecchhhccCccc
Confidence 9999999999998876 57999999999999999999999998 99999999999998 55699999999999886533
Q ss_pred c--c--cccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 169 A--K--SVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 169 ~--~--~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
. . ...-.+.|||-|.+ ...|+.++|||||||.+||++| |.-||.+ ...++|-+.+..|.+ ...+.+.+-++.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCtiDVy 930 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICTIDVY 930 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCccHHHH
Confidence 1 1 22224678999966 5689999999999999999987 6789877 677888888888765 566778889999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhc
Q 006277 243 SFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~ 263 (652)
-++.+||. |+..||+++++..
T Consensus 931 ~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 931 MVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHhccCcccCccHHHHHH
Confidence 99999997 8999999988753
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=264.04 Aligned_cols=240 Identities=23% Similarity=0.370 Sum_probs=198.4
Q ss_pred EEEEecCcEEEEEEEccCC---eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 15 RLIQLVDTSGYKAFDEVNG---LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG---~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.++.+-.|.|++|.-+..| ..||||.++..- .+.+...|+.|+.||-+++||||+++.++.. ....+.||+|
T Consensus 636 VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy---tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT--ks~PvMIiTE 710 (996)
T KOG0196|consen 636 VIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT--KSKPVMIITE 710 (996)
T ss_pred EEecccccceecccccCCCCcceeEEEeeeccCc---cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe--cCceeEEEhh
Confidence 3444455899999998877 469999987543 3567788999999999999999999999653 4458999999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 92 LFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 92 y~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
||++|+|..+++++ +.|..-++..+++.|++|+.||-..| .|||||-..||||| .+-.+|++||||++.+.+..
T Consensus 711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVN-snLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeec-cceEEEeccccceeecccCCCc
Confidence 99999999998876 67999999999999999999999999 99999999999999 45689999999999886543
Q ss_pred c-ccccC--CCCccCcccc-ccCCCccccchhhHHHHHHHh-hccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHH
Q 006277 169 A-KSVIG--TPEFMAPELY-DENYNELADIYSFGMCMLEMV-TFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 243 (652)
Q Consensus 169 ~-~~~vG--Tp~YmAPEvl-~~~y~~~sDIWSlGvilyeLl-tG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kd 243 (652)
. .+.-| ...|.|||.+ -++++.++||||+|++|+|.+ .|+.||++..+ .+..+.|.+|..-+ .+-..+..+-+
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-QdVIkaIe~gyRLP-pPmDCP~aL~q 865 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEQGYRLP-PPMDCPAALYQ 865 (996)
T ss_pred cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-HHHHHHHHhccCCC-CCCCCcHHHHH
Confidence 2 22222 3589999966 578999999999999999965 59999999555 55667787776422 23346788999
Q ss_pred HHHHhCC-CCCCCCCHHHHhcC
Q 006277 244 FIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~h 264 (652)
|+..|++ +-..||...|++.+
T Consensus 866 LMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 866 LMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHhhcCCCHHHHHHH
Confidence 9999998 67999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=227.39 Aligned_cols=159 Identities=25% Similarity=0.366 Sum_probs=128.6
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccccC
Q 006277 96 GSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG 174 (652)
Q Consensus 96 GsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~vG 174 (652)
|+|.+++..+ +++++..++.|+.||+.||.|||+++ ||+|||++ .++.+|+ ||++...... ...|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~-~~~~~~~--fG~~~~~~~~---~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLT-WDGLLKL--DGSVAFKTPE---QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEc-Cccceee--ccceEeeccc---cCCC
Confidence 7899999874 56999999999999999999999986 99999998 6688999 9998765432 2378
Q ss_pred CCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcc-----ccCCCCh--HHHHHHH
Q 006277 175 TPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA-----LSKVKDP--EVKSFIE 246 (652)
Q Consensus 175 Tp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~-----l~~~~s~--~~kdlI~ 246 (652)
|+.|||||++ .+.|+.++|||||||++|||++|..||.........+..+..+..+.. .....+. .+++||.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 9999999977 457999999999999999999999999765554555555544332221 1111222 6999999
Q ss_pred HhCC-CCCCCCCHHHHhcCcccc
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
+||. +|.+||++.|++.|+|+.
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHH
Confidence 9997 899999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-23 Score=205.26 Aligned_cols=248 Identities=29% Similarity=0.396 Sum_probs=199.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC-CeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN-NIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hp-nIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..++.+..+.||++.+. ..+++|.+...... .......+.+|+.+++.+.|+ +|+++++.+.... ..++++++
T Consensus 6 ~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~ 79 (384)
T COG0515 6 RKLGEGSFGEVYLARDR---KLVALKVLAKKLES-KSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG--SLYLVMEY 79 (384)
T ss_pred EeecCCCCeEEEEEEec---cEEEEEeechhhcc-chhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC--EEEEEEec
Confidence 35555666899999988 78999988755432 223678899999999999988 7999999985443 58999999
Q ss_pred CCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 93 FTSGSLRQYRKKHK---KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
+.+++|.+++.... .+.+..+..++.|++.++.|+|..+ ++|||+||+||+++.....++++|||++..+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999998877765 7999999999999999999999999 99999999999998443379999999998654332
Q ss_pred -------cccccCCCCccCccccc----cCCCccccchhhHHHHHHHhhccCCCCCCCC---HHHHHHHHhcCCCC-ccc
Q 006277 169 -------AKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRN---SAQIYKKVSSGIKP-AAL 233 (652)
Q Consensus 169 -------~~~~vGTp~YmAPEvl~----~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~---~~~i~~~I~~g~~p-~~l 233 (652)
....+||+.|+|||++. ..+....|+||+|++++++++|..||..... ..+....+.....+ ...
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 36779999999999775 3688899999999999999999999877543 45666666655433 111
Q ss_pred cCCC------ChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 234 SKVK------DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 234 ~~~~------s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.... ...+.+++.+|+. +|..|.+..+...++|...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 1111 1478999999997 7999999999998877653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=249.15 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=193.8
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeec--ccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRID--DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~--~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
.++.+.+|.|+.+........+++|.++.+ ......+....+..|.-+-..|.||||+.....+.+.. ..+-+|||
T Consensus 325 ~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~--~~~~~mE~ 402 (601)
T KOG0590|consen 325 VLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID--GILQSMEY 402 (601)
T ss_pred eeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--cchhhhhc
Confidence 445555567888888877787888876632 11122233344788888889999999988777655443 34444999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc----
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---- 168 (652)
|++ +|+.++...+.+....+..+++|++.||.|||++| |.||||||+|++++ ..|.+||+|||.+..+....
T Consensus 403 ~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~-~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 403 CPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVT-ENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred ccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEe-cCCceEEeecCcceeeccCcchhh
Confidence 999 99999998889999999999999999999999999 99999999999998 67899999999998775332
Q ss_pred --cccccCCCCccCccccc-cCCCc-cccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHh-cCC-----CCccccCCCC
Q 006277 169 --AKSVIGTPEFMAPELYD-ENYNE-LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS-SGI-----KPAALSKVKD 238 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl~-~~y~~-~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~-~g~-----~p~~l~~~~s 238 (652)
...++|+..|+|||++. ..|+. .+||||.|+++..|++|+.||......++.+.... .+. .+..+....+
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp 558 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP 558 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence 35679999999999885 46775 58999999999999999999966444433321111 111 1223334456
Q ss_pred hHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 239 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 239 ~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.+.+.+|.+||+ +|.+|.|++++++++||+..
T Consensus 559 ~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 559 RETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred hhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 788999999998 89999999999999999854
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-24 Score=215.73 Aligned_cols=245 Identities=22% Similarity=0.266 Sum_probs=187.4
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..++++-.|.+-+|.|+.++..+++|.+.... .....+.+|.+.--.| .|.||+.-|+.-.... +++.+++||
T Consensus 30 k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~-d~YvF~qE~ 103 (378)
T KOG1345|consen 30 KQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS-DAYVFVQEF 103 (378)
T ss_pred HHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhhcC-ceEEEeecc
Confidence 45677777899999999999999999987542 3567899999988888 6999999988644333 388999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEc-CCCCcEEEeccCchhhhhcccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN-GNQGEVKIGDLGLATIMEQANAKS 171 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~-~~~g~VKL~DFGla~~l~~~~~~~ 171 (652)
++-|+|..-+.. ..+-|...+.++.|+++||.|+|+++ +||||||.+||||- .+.-+|||||||+.+..... .+.
T Consensus 104 aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-V~~ 179 (378)
T KOG1345|consen 104 APRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-VKY 179 (378)
T ss_pred CccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCce-ehh
Confidence 999999987765 45889999999999999999999999 99999999999985 44558999999988764432 223
Q ss_pred ccCCCCccCccccc----cC--CCccccchhhHHHHHHHhhccCCCCCCCCHHH---HHHHHhcCCCC--ccccCCCChH
Q 006277 172 VIGTPEFMAPELYD----EN--YNELADIYSFGMCMLEMVTFEYPYSECRNSAQ---IYKKVSSGIKP--AALSKVKDPE 240 (652)
Q Consensus 172 ~vGTp~YmAPEvl~----~~--y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~---i~~~I~~g~~p--~~l~~~~s~~ 240 (652)
.--+..|.|||++. +. .++..|||.||+++|.++||.+||.......+ -+.+-..+..+ +...+..++.
T Consensus 180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~ 259 (378)
T KOG1345|consen 180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEK 259 (378)
T ss_pred hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHH
Confidence 33466789999663 32 46789999999999999999999975332222 23333333322 1223446788
Q ss_pred HHHHHHHhCC-CCCCC---CCHHHHhcCcccc
Q 006277 241 VKSFIEKCLV-PASQR---LSAKELLMDPFLQ 268 (652)
Q Consensus 241 ~kdlI~kcL~-~P~~R---pSa~elL~hpf~~ 268 (652)
+..+.++-|. ++++| -+++.....-|..
T Consensus 260 a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 260 ALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred HHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 8889999997 67888 4666666677764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-24 Score=238.62 Aligned_cols=255 Identities=20% Similarity=0.240 Sum_probs=206.1
Q ss_pred EEecCcEEE---EEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 17 IQLVDTSGY---KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 17 ~~l~~gtVy---kA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
+++..|.|+ ++.....|.-+|+|+.++....... . .+-..|.+++..++ ||.+|+++..|+.+. .+++++++
T Consensus 3 g~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~-~-~~t~~er~il~~~~~~~f~v~lhyafqt~~--kl~l~ld~ 78 (612)
T KOG0603|consen 3 GQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD-R-THTKQERIILAFVHNTPFLVKLHYAFQTDG--KLYLILDF 78 (612)
T ss_pred CcCCCcchHHHHHhccccccchhhhhccccccccccc-c-cccccHHHHHhhccCCCceeeeeeeecccc--chhHhhhh
Confidence 344445544 4445567888999998876554332 2 26777899999996 999999999987665 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
..||+|+..+.+...+++...+.+...++.+++.+|+.+ |+|||+|++||+++ ..|++|+.|||+++..-.....
T Consensus 79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld-~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLL-LEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeec-ccCccccCCchhhhHhHhhhhc--
Confidence 999999999999999999999999999999999999999 99999999999999 6799999999999987554433
Q ss_pred cCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-C
Q 006277 173 IGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-P 251 (652)
Q Consensus 173 vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~ 251 (652)
|||..|||||+.+ .....+|+||||+++++|+||..||.+ .+...|.... ...+...++.+++++..++. +
T Consensus 154 cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~r~ 225 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAE--LEMPRELSAEARSLFRQLFKRN 225 (612)
T ss_pred ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhc--cCCchhhhHHHHHHHHHHHhhC
Confidence 9999999999998 678899999999999999999999976 4555555432 23456667899999999996 8
Q ss_pred CCCCCC-----HHHHhcCccccccCCCCCCCCCCCCCcCCCC
Q 006277 252 ASQRLS-----AKELLMDPFLQVNGTTKNRPLPLPDIVLPRV 288 (652)
Q Consensus 252 P~~RpS-----a~elL~hpf~~~~~~~~~~~~~~p~~~lp~~ 288 (652)
|..|+. +.++++|+||+...|........++.+.|..
T Consensus 226 p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~ 267 (612)
T KOG0603|consen 226 PENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGS 267 (612)
T ss_pred HHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcc
Confidence 999984 5799999999988776433333333344443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=206.38 Aligned_cols=238 Identities=21% Similarity=0.280 Sum_probs=191.6
Q ss_pred EEecCcEEEEEEEccCC-----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 17 IQLVDTSGYKAFDEVNG-----LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 17 ~~l~~gtVykA~d~~tG-----~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.++..|.||.|...... +.|-+|.++.. .++-++..+++|--+|..+.|||+..+.++.... ..+.++++.
T Consensus 293 qEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~---AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~-~~~P~V~y~ 368 (563)
T KOG1024|consen 293 QEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH---ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED-YATPFVLYP 368 (563)
T ss_pred hcCchhheeeeeecccCCcchHHHHHHHHHHhc---ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-cCcceEEEe
Confidence 34555788888655433 34555655422 2456788999999999999999999999987654 347889999
Q ss_pred cCCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 92 LFTSGSLRQYRKKH--------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 92 y~~gGsL~~~i~~~--------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
+..-|+|..++..- +.++..++..++.|+..|++|||+++ |||.||-..|++|+ +.-+|||+|=.+++.
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId-d~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID-DQLQVKLTDSALSRD 445 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh-hheeEEeccchhccc
Confidence 99999999998721 24667788899999999999999999 99999999999998 668999999999988
Q ss_pred hhcccccc----ccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCC
Q 006277 164 MEQANAKS----VIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVK 237 (652)
Q Consensus 164 l~~~~~~~----~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 237 (652)
+-+...+. -.....||+||.+ ...|+.++|+|||||++|||+| |+.||.+ .++.+.+..+..|.+ ...+-..
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdGyR-laQP~NC 523 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDGYR-LAQPFNC 523 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhccce-ecCCCCC
Confidence 75543221 1224579999966 6689999999999999999997 7889977 788888888888864 3445567
Q ss_pred ChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 238 DPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 238 s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
+.++..++..||+ .|++||+..|+..
T Consensus 524 PDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 524 PDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 7899999999998 8999999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-22 Score=230.35 Aligned_cols=216 Identities=24% Similarity=0.345 Sum_probs=165.5
Q ss_pred eeeEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 10 ILMYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 10 ~~~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
..+++-+..+.+|.||...|+.+.+++|+| +.+..++ .+- +|.....|.+|
T Consensus 85 f~~IklisngAygavylvrh~~trqrfa~k-iNkq~li---------lRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 85 FNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI---------LRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cceeEeeccCCCCceeeeeccccccchhhc-ccccchh---------hhc--cccccCCccee-----------------
Confidence 345666677778999999999999999994 4432211 000 22222333333
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc---
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--- 166 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--- 166 (652)
|+-...++.-++++.+. +.+++|||+.| |+|||+||+|++|+ .-|++|++|||+++.--.
T Consensus 136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT-~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ------chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceee-ecccccccchhhhhhhhhhcc
Confidence 56666667666666443 78999999988 99999999999999 679999999999875311
Q ss_pred --------------cccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC--C
Q 006277 167 --------------ANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--K 229 (652)
Q Consensus 167 --------------~~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~--~ 229 (652)
...+.++|||+|+||||+ .++|+..+|||++|+|+||.+.|..||.+ +.+++++..+.... .
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEW 277 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhhhhccc
Confidence 112457999999999965 77899999999999999999999999988 77888888777643 2
Q ss_pred CccccCCCChHHHHHHHHhCC-CCCCCC---CHHHHhcCccccccCCC
Q 006277 230 PAALSKVKDPEVKSFIEKCLV-PASQRL---SAKELLMDPFLQVNGTT 273 (652)
Q Consensus 230 p~~l~~~~s~~~kdlI~kcL~-~P~~Rp---Sa~elL~hpf~~~~~~~ 273 (652)
|.. ..-..++++++|.++|+ +|..|. ++-++.+|+||+.-+|.
T Consensus 278 pE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 278 PEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred ccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 333 33456899999999997 898886 58899999999987776
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-21 Score=207.47 Aligned_cols=156 Identities=17% Similarity=0.197 Sum_probs=122.9
Q ss_pred EEEEEecCcEEEEEEEcc-CCeEEEEEEEeeccc-CCCHHHHHHHHHHHHHHHhCCCCCeee-eeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEV-NGLEVAWCQVRIDDV-LQSPEDLERLYSEVHLLKSLKHNNIIR-FYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~-tG~~VAiK~v~~~~~-~~s~e~~~~l~~Ei~iLk~L~HpnIVk-l~~~~~d~~~~~~~LVm 90 (652)
..+++++.|+||+|++.. +|+.||+|++..... .......+.+.+|+++|++|+|+||++ +++. +..|+||
T Consensus 24 ~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~------~~~~LVm 97 (365)
T PRK09188 24 AVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT------GKDGLVR 97 (365)
T ss_pred cEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc------CCcEEEE
Confidence 568888889999999887 788899998752211 113345678999999999999999985 5431 2479999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccC-CcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL-KCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDL-Kp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
|||.|++|... . ... ...++.|++.+|.|||++| |+|||| ||+|||++ .++.+||+|||+|+.+....
T Consensus 98 E~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~-~~~~ikLiDFGlA~~~~~~~~ 167 (365)
T PRK09188 98 GWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMG-PDGEAAVIDFQLASVFRRRGA 167 (365)
T ss_pred EccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEc-CCCCEEEEECccceecccCcc
Confidence 99999999632 1 111 2578999999999999998 999999 99999997 56799999999998664322
Q ss_pred ---------cccccCCCCccCccccc
Q 006277 169 ---------AKSVIGTPEFMAPELYD 185 (652)
Q Consensus 169 ---------~~~~vGTp~YmAPEvl~ 185 (652)
..+.+|++.|+|||.+.
T Consensus 168 ~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 168 LYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred hhhhhhhhhhhhhhccCccCCcccCC
Confidence 14568899999999884
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-19 Score=188.49 Aligned_cols=248 Identities=19% Similarity=0.183 Sum_probs=182.4
Q ss_pred cceeeeeeEEEEEEecCcEEEEEEEccCC-eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC----CCeeeeeeEEE
Q 006277 5 KWSLLILMYLRLIQLVDTSGYKAFDEVNG-LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH----NNIIRFYNSWI 79 (652)
Q Consensus 5 ~W~~~~~~~~rL~~l~~gtVykA~d~~tG-~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~H----pnIVkl~~~~~ 79 (652)
+|.+ ..++++++.|.||+|.+..++ ..+|+|......... ...+..|+.++..+.. +++..+++...
T Consensus 19 ~~~i----~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~----~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKL----GKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK----PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEE----eeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC----CccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 5666 478999999999999998885 789999877543211 1267789999999963 68999988774
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCC----CcE
Q 006277 80 DDQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ----GEV 153 (652)
Q Consensus 80 d~~~~~~~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~----g~V 153 (652)
....+-|+||+++ |-+|.++.+.. +.++...+..++.|++.+|++||+.| ++||||||+|+++.... ..+
T Consensus 91 -~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 91 -STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred -CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceE
Confidence 2344789999998 88999988655 57999999999999999999999999 99999999999997432 469
Q ss_pred EEeccCchhhhh---cc--------c-cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHH-
Q 006277 154 KIGDLGLATIME---QA--------N-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ- 219 (652)
Q Consensus 154 KL~DFGla~~l~---~~--------~-~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~- 219 (652)
.|.|||+++... .. . ...+.||..|.++..- +...+.+.|+||++.++.+|+.|..||........
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 999999998332 11 0 1235699999999965 55788999999999999999999999976443222
Q ss_pred -HHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 220 -IYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 220 -i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.+..................++..+...+-. +...+|....+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 2222222111111222233455555555444 56788876665543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=178.10 Aligned_cols=143 Identities=16% Similarity=0.110 Sum_probs=112.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHH----------------------HHHHHHHHHHHHHhCCCCCe
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPE----------------------DLERLYSEVHLLKSLKHNNI 71 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e----------------------~~~~l~~Ei~iLk~L~HpnI 71 (652)
..++++..+.||+|.+. +|+.||+|+++......... .......|+++|+.|.++++
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46788888999999997 99999999998643211000 01233459999999988887
Q ss_pred eeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeeeccCCcccEEEcCCC
Q 006277 72 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYL-HSHDPPIIHRDLKCDNIFINGNQ 150 (652)
Q Consensus 72 Vkl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yL-Hs~g~~IiHRDLKp~NILl~~~~ 150 (652)
...+.... . ..+|||||+.|++|...+...+.+++..++.++.||+.+|.|| |+.| |+||||||+|||++ +
T Consensus 82 ~~p~~~~~-~---~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~--~ 153 (190)
T cd05147 82 PCPEPILL-K---SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH--D 153 (190)
T ss_pred CCCcEEEe-c---CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE--C
Confidence 54443322 1 2389999999988876655567899999999999999999999 6888 99999999999998 3
Q ss_pred CcEEEeccCchhhhh
Q 006277 151 GEVKIGDLGLATIME 165 (652)
Q Consensus 151 g~VKL~DFGla~~l~ 165 (652)
+.++|+|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 689999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6e-21 Score=197.35 Aligned_cols=241 Identities=36% Similarity=0.579 Sum_probs=176.1
Q ss_pred EEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---CeEEEEEecCCCCCHH
Q 006277 23 SGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN---KTVNIITELFTSGSLR 99 (652)
Q Consensus 23 tVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~---~~~~LVmEy~~gGsL~ 99 (652)
.||+|.+...|.+|.|..|+......-+++-+....-.+.|-+|.|.|||+++.+|-+.+. ..+.|++||+..|+|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 5899999999999999988654332222333444445677778899999999999976542 3578999999999999
Q ss_pred HHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh------cccc
Q 006277 100 QYRKKH----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME------QANA 169 (652)
Q Consensus 100 ~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~------~~~~ 169 (652)
+++++. ..+.....++|+.||++||.|||+..|||+|++|.|+.|++. ..|-||++--....... ....
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq-~ngLIkig~~ap~s~h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ-HNGLIKIGSVAPDSTHPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec-CCceEEecccCccccchhhhhhhHhhh
Confidence 998753 468899999999999999999999999999999999999998 67788875422211110 0111
Q ss_pred ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
....|-|+|.|||.- ..+-+.++|||+||+|.++|..++.--.........-..+..-+ .......-+++|.+|
T Consensus 240 ~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i-----~~len~lqr~~i~kc 314 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI-----IGLENGLQRGSITKC 314 (458)
T ss_pred hccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe-----eeccCccccCcCccc
Confidence 223467899999954 34567789999999999999998875432222111111111111 112234557899999
Q ss_pred CC-CCCCCCCHHHHhcCccccc
Q 006277 249 LV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~~~ 269 (652)
|. .|..||+++++|.||.+-.
T Consensus 315 l~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 315 LEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred ccCCCCCCcchhhhhcCceeee
Confidence 98 7999999999999998753
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.5e-19 Score=172.62 Aligned_cols=144 Identities=17% Similarity=0.147 Sum_probs=113.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccC--------------------CCHH--HHHHHHHHHHHHHhCCCCCe
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVL--------------------QSPE--DLERLYSEVHLLKSLKHNNI 71 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~--------------------~s~e--~~~~l~~Ei~iLk~L~HpnI 71 (652)
+.++++..|.||+|.+. +|+.||+|+++..... .++. ....+..|...+.++.|++|
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 3 GCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred ceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46788888999999987 9999999999864210 0011 12345689999999999988
Q ss_pred eeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCcccEEEcCCC
Q 006277 72 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQ 150 (652)
Q Consensus 72 Vkl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IiHRDLKp~NILl~~~~ 150 (652)
.....++.. ..+|||||++|+++.........+++..+..++.|++.+|.+||+ +| |+||||||+|||++ +
T Consensus 82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~--~ 153 (190)
T cd05145 82 PVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH--D 153 (190)
T ss_pred CCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE--C
Confidence 655544332 247999999998665443345678899999999999999999999 88 99999999999997 5
Q ss_pred CcEEEeccCchhhhhc
Q 006277 151 GEVKIGDLGLATIMEQ 166 (652)
Q Consensus 151 g~VKL~DFGla~~l~~ 166 (652)
+.++|+|||++..+..
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 7999999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.6e-19 Score=180.12 Aligned_cols=168 Identities=14% Similarity=0.143 Sum_probs=127.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHH------HHHHHHHHHhCCCCCeeeeeeEEEeCCC----
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLER------LYSEVHLLKSLKHNNIIRFYNSWIDDQN---- 83 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~------l~~Ei~iLk~L~HpnIVkl~~~~~d~~~---- 83 (652)
..+++++.|.||++.+ ++..+|+|+++.. ....+...++ +.+|++.+.+|.||+|..+++++.+...
T Consensus 37 ~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~-~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~ 113 (232)
T PRK10359 37 KVFRNIDDTKVSLIDT--DYGKYILKVFAPK-VKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLR 113 (232)
T ss_pred EEecCCCceEEEEEec--CCCcEEEEEechh-cCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccc
Confidence 4455556689999654 5778999998743 3334445555 5799999999999999999998775432
Q ss_pred --CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCch
Q 006277 84 --KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 161 (652)
Q Consensus 84 --~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla 161 (652)
...++||||++|.+|.++. .+++ ..+.+|+.+|..||.+| ++|||+||.||+++ .+| ++|+|||..
T Consensus 114 ~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~-~~g-i~liDfg~~ 181 (232)
T PRK10359 114 YAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVS-KNG-LRIIDLSGK 181 (232)
T ss_pred ccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEe-CCC-EEEEECCCc
Confidence 3578999999999998873 2333 34669999999999999 99999999999998 566 999999988
Q ss_pred hhhhccccccccCCCCccCccccccCCCccccchhhHHHHHHHh
Q 006277 162 TIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMV 205 (652)
Q Consensus 162 ~~l~~~~~~~~vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLl 205 (652)
.......+... | ++...|+.++|+||||+.+..+.
T Consensus 182 ~~~~e~~a~d~-----~----vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 182 RCTAQRKAKDR-----I----DLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ccccchhhHHH-----H----HHHhHhcccccccceeEeehHHH
Confidence 76533222110 0 23556888999999999877654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.1e-20 Score=212.60 Aligned_cols=229 Identities=21% Similarity=0.254 Sum_probs=169.2
Q ss_pred EEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHH
Q 006277 23 SGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR 102 (652)
Q Consensus 23 tVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~~~i 102 (652)
.|.+|.|. .|. |++|++-+.+-.-+-....+...|++ ...++|||+++|.-.-+. .+..|||-+|+.. +|.+++
T Consensus 38 Kv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAylvRqyvkh-nLyDRl 111 (1431)
T KOG1240|consen 38 KVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYLVRQYVKH-NLYDRL 111 (1431)
T ss_pred hhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHHHHHHHhh-hhhhhh
Confidence 56777764 455 88999877663333344555556666 677799999999875433 3478899999966 999999
Q ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhh--hccc---c----cccc
Q 006277 103 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--EQAN---A----KSVI 173 (652)
Q Consensus 103 ~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l--~~~~---~----~~~v 173 (652)
.-++.+..-+-+.|+.||+.||..||..| |+|+|||++||||+ .-+.+.|+||..-+.. ...+ . .+..
T Consensus 112 STRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiT-SWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSr 188 (1431)
T KOG1240|consen 112 STRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILIT-SWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSR 188 (1431)
T ss_pred ccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEe-eechhhhhcccccCCccCCCCCcccceEEEecCC
Confidence 98888899999999999999999999999 99999999999998 5678999999765432 1111 1 1222
Q ss_pred CCCCccCcccccc-----------C-CCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCC-CC-ccccCCCC
Q 006277 174 GTPEFMAPELYDE-----------N-YNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGI-KP-AALSKVKD 238 (652)
Q Consensus 174 GTp~YmAPEvl~~-----------~-y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~-~p-~~l~~~~s 238 (652)
-.-+|+|||.+.. . ..++-||||+||+++||++ |.+||. ..|++.--..+. .+ ..+.++.+
T Consensus 189 RRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~~~~~e~~Le~Ied 264 (1431)
T KOG1240|consen 189 RRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGNADDPEQLLEKIED 264 (1431)
T ss_pred ceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccCccCHHHHHHhCcC
Confidence 2348999996621 1 4567899999999999987 678883 344443322211 11 12345567
Q ss_pred hHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 239 PEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 239 ~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
...+.||..|++ +|++|++|++.|+.
T Consensus 265 ~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 265 VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 789999999998 99999999999986
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=182.35 Aligned_cols=229 Identities=16% Similarity=0.132 Sum_probs=144.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC----------CCeeeeeeEEE----
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH----------NNIIRFYNSWI---- 79 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~H----------pnIVkl~~~~~---- 79 (652)
..|+.+..+.||.+.|..||+++|+|++.... .......+.+.+|......+.+ -.++.-++...
T Consensus 18 ~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 18 RIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred cccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 45566667899999999999999999998776 3445678888888766665432 12222222111
Q ss_pred -----eCC-CC-----eEEEEEecCCCCCHHHHHH---hCCCC----CHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCc
Q 006277 80 -----DDQ-NK-----TVNIITELFTSGSLRQYRK---KHKKV----DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 141 (652)
Q Consensus 80 -----d~~-~~-----~~~LVmEy~~gGsL~~~i~---~~~~l----se~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp 141 (652)
... .. ..+++|+-. .++|.+.+. ..... .......+..|+++.+++||++| |+|+||||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHgdi~~ 173 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHGDIKP 173 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEEST-SG
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEecccce
Confidence 111 11 236777777 558877654 22222 22233455599999999999999 99999999
Q ss_pred ccEEEcCCCCcEEEeccCchhhhhccccccccCCCCccCcccccc---------CCCccccchhhHHHHHHHhhccCCCC
Q 006277 142 DNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDE---------NYNELADIYSFGMCMLEMVTFEYPYS 212 (652)
Q Consensus 142 ~NILl~~~~g~VKL~DFGla~~l~~~~~~~~vGTp~YmAPEvl~~---------~y~~~sDIWSlGvilyeLltG~~Pf~ 212 (652)
+|+|++ .+|.++|+||+........... ...++.|.+||+... .|+.+.|.|+||+++|.|.|+..||.
T Consensus 174 ~nfll~-~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 174 ENFLLD-QDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp GGEEE--TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred eeEEEc-CCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence 999999 6799999999876655443222 345678999996632 37889999999999999999999997
Q ss_pred CCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCC
Q 006277 213 ECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQR 255 (652)
Q Consensus 213 ~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~R 255 (652)
...... .... ....-...+..+++||.++|+ +|.+|
T Consensus 252 ~~~~~~-~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 252 LSSPEA-DPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCGGGS-TSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCccc-cccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 522111 0000 011112567889999999998 78777
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-18 Score=184.39 Aligned_cols=193 Identities=24% Similarity=0.362 Sum_probs=143.8
Q ss_pred CCCCeeeeeeEEEeC-------------------------CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHH
Q 006277 67 KHNNIIRFYNSWIDD-------------------------QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQIL 121 (652)
Q Consensus 67 ~HpnIVkl~~~~~d~-------------------------~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl 121 (652)
+|||||+++..|.|+ .+.++|+||.-+.. +|++|+-.+ ..+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 699999999988762 34579999998854 999998654 567788889999999
Q ss_pred HHHHHHHhCCCCeeeccCCcccEEEcC-CCC--cEEEeccCchhhhhccc--------cccccCCCCccCccccccCCC-
Q 006277 122 SGLIYLHSHDPPIIHRDLKCDNIFING-NQG--EVKIGDLGLATIMEQAN--------AKSVIGTPEFMAPELYDENYN- 189 (652)
Q Consensus 122 ~aL~yLHs~g~~IiHRDLKp~NILl~~-~~g--~VKL~DFGla~~l~~~~--------~~~~vGTp~YmAPEvl~~~y~- 189 (652)
.|+.|||.|| |.|||||.+|||+.- +++ .+.|+|||++-.-.... .-..-|.-..||||+.....+
T Consensus 352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999 999999999999852 222 47899999874432211 123457788999998853211
Q ss_pred ------ccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCH---H
Q 006277 190 ------ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSA---K 259 (652)
Q Consensus 190 ------~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa---~ 259 (652)
.++|.|+.|.+.||+++...||++......-...-++. .-+.++...++.++++|..+|+ +|++|+++ .
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~-qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES-QLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh-hCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 47999999999999999999998722211111111122 2345667788999999999998 89999984 4
Q ss_pred HHhcC
Q 006277 260 ELLMD 264 (652)
Q Consensus 260 elL~h 264 (652)
.+|+-
T Consensus 509 Nvl~L 513 (598)
T KOG4158|consen 509 NVLNL 513 (598)
T ss_pred hHHHH
Confidence 55543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.1e-18 Score=170.56 Aligned_cols=182 Identities=14% Similarity=0.019 Sum_probs=136.7
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..|...+.|+||.+.. .+..++.+.+.........-....+.+|+++|++| .|++|++++++ . ..+++|+|
T Consensus 8 ~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~--~~~lvmey 79 (218)
T PRK12274 8 EPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D--GRHLDRSY 79 (218)
T ss_pred eeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c--CEEEEEee
Confidence 5788888899997765 67788766655333221112233688999999999 45889999884 1 36999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccC-CcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL-KCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDL-Kp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
+.|.+|.+.+.. . ...++.|++.+|.+||.+| |+|||| ||+|||++ .+|.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEc-CCCCEEEEECCCceecCCcchHH
Confidence 999999754321 1 2457899999999999999 999999 79999998 67899999999998543221
Q ss_pred ------------cccccCCCCccCccc---cccCCCccccchhhHHHHHHHhhccCCCCC
Q 006277 169 ------------AKSVIGTPEFMAPEL---YDENYNELADIYSFGMCMLEMVTFEYPYSE 213 (652)
Q Consensus 169 ------------~~~~vGTp~YmAPEv---l~~~y~~~sDIWSlGvilyeLltG~~Pf~~ 213 (652)
..-...+|.|+.|+. +...--...++++.|+-+|.++|+..|+.+
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 011246889999983 333333677899999999999999999765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-18 Score=171.98 Aligned_cols=224 Identities=21% Similarity=0.257 Sum_probs=171.7
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC-CCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH-NNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~H-pnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
+++.+-.|.+|+|....+|.+||+|+-... ....++..|..+.+.|++ ..|..++.+... ..+-.+||+++
T Consensus 22 kiGsGSFGdIy~~~~i~~ge~VAiK~Es~~------a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynvlVMdLL 93 (341)
T KOG1163|consen 22 KIGSGSFGDIYLGISITSGEEVAIKLESSK------AKHPQLLYESKVYRILQGGVGIPHIRHYGTE--KDYNVLVMDLL 93 (341)
T ss_pred eecCCchhheeeeeeccCCceEEEEeeccc------CCCcchhHHHHHHHHhccCCCCchhhhhccc--cccceeeeecc
Confidence 333333478999999999999999976532 223467889999999954 567666665433 33678999998
Q ss_pred CCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEc--CCCCcEEEeccCchhhhhccc--
Q 006277 94 TSGSLRQYRK-KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 94 ~gGsL~~~i~-~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~--~~~g~VKL~DFGla~~l~~~~-- 168 (652)
|-+|.++.. ..+.|+.+++.-++-|++.-++|+|.++ .|||||||+|+|.. .....+.|+|||+|+.+.+..
T Consensus 94 -GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 94 -GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred -CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 779988765 3468999999999999999999999999 99999999999974 234569999999999886532
Q ss_pred -------cccccCCCCccCccc-cccCCCccccchhhHHHHHHHhhccCCCCCCC--CHHHHHHHHhcCCC---CccccC
Q 006277 169 -------AKSVIGTPEFMAPEL-YDENYNELADIYSFGMCMLEMVTFEYPYSECR--NSAQIYKKVSSGIK---PAALSK 235 (652)
Q Consensus 169 -------~~~~vGTp~YmAPEv-l~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~--~~~~i~~~I~~g~~---p~~l~~ 235 (652)
.+...||..|.+--. +.-..+.+-|+-|+|.++..+..|..||.+-. +..|.|.+|.+.+. +..+-+
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~ 250 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK 250 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence 234679999987663 33456778899999999999999999998743 45677888876442 233445
Q ss_pred CCChHHHHHHHHhC
Q 006277 236 VKDPEVKSFIEKCL 249 (652)
Q Consensus 236 ~~s~~~kdlI~kcL 249 (652)
..+.++--.+.-|-
T Consensus 251 G~P~EF~myl~Y~R 264 (341)
T KOG1163|consen 251 GFPAEFAMYLNYCR 264 (341)
T ss_pred CCcHHHHHHHHHHh
Confidence 56778877777775
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.5e-18 Score=176.35 Aligned_cols=203 Identities=20% Similarity=0.263 Sum_probs=166.0
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
+++++-.|..|.|.+.-++++||||.-..+ ....++..|.+..+.| ..++|..+|.+-.+ +.+-.||||++
T Consensus 35 KIGeGsFG~lf~G~Nl~nne~VAIKfEPrk------S~APQLrdEYr~YKlL~g~~GIP~vYYFGqe--G~~NiLVidLL 106 (449)
T KOG1165|consen 35 KIGEGSFGVLFLGKNLYNNEPVAIKFEPRK------SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQE--GKYNILVIDLL 106 (449)
T ss_pred ccccCcceeeecccccccCceEEEEecccc------CCcchHHHHHHHHHHHcCCCCCCceeeeccc--cchhhhhhhhh
Confidence 444555589999999999999999975432 3456788899999999 67999999875443 33566999998
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEc----CCCCcEEEeccCchhhhhccc
Q 006277 94 TSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN----GNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 94 ~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~----~~~g~VKL~DFGla~~l~~~~ 168 (652)
|-+|.++..- .++|+.++++.++.|++.-++|+|+++ +|+|||||+|+||. .+.+.|-|+|||+|+...+..
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 7788887664 467999999999999999999999999 99999999999995 233458999999999886543
Q ss_pred ---------cccccCCCCccCcc-ccccCCCccccchhhHHHHHHHhhccCCCCCC--CCHHHHHHHHhcCC
Q 006277 169 ---------AKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSEC--RNSAQIYKKVSSGI 228 (652)
Q Consensus 169 ---------~~~~vGTp~YmAPE-vl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~--~~~~~i~~~I~~g~ 228 (652)
.++..||..||+-- -++..-+.+-|+=|||-++...|.|..||.+- .+..+.|++|-..+
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 24678999999977 56777888999999999999999999999763 45677888886654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=168.52 Aligned_cols=136 Identities=18% Similarity=0.156 Sum_probs=108.4
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-----CCCCeeeeeeEEEeCCC-CeEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-----KHNNIIRFYNSWIDDQN-KTVN 87 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-----~HpnIVkl~~~~~d~~~-~~~~ 87 (652)
..|+++..+.||. +..++.. +||++..... ...+.+.+|+.+++.| +||||+++|+++.+..+ +.++
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred ceecCCCceEEEE--CCCCcCe-EEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 5688888899995 7777776 6898875432 3456789999999999 67999999999987642 3434
Q ss_pred -EEEec--CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCeeeccCCcccEEEcC---CCCcEEEeccCc
Q 006277 88 -IITEL--FTSGSLRQYRKKHKKVDMKAVKGWARQILSGL-IYLHSHDPPIIHRDLKCDNIFING---NQGEVKIGDLGL 160 (652)
Q Consensus 88 -LVmEy--~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL-~yLHs~g~~IiHRDLKp~NILl~~---~~g~VKL~DFGl 160 (652)
+|||| +.+|+|.+++++. .+++. +.+++|++.++ +|||+++ |+||||||+|||++. ..+.++|+||+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 5589999999764 57766 46788999888 9999999 999999999999973 223799999554
Q ss_pred h
Q 006277 161 A 161 (652)
Q Consensus 161 a 161 (652)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-18 Score=190.34 Aligned_cols=173 Identities=28% Similarity=0.512 Sum_probs=141.4
Q ss_pred eEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCch
Q 006277 85 TVNIITELFTSGSLRQYRKKHK---KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 161 (652)
Q Consensus 85 ~~~LVmEy~~gGsL~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla 161 (652)
++|+.|++|...+|.+++..+. ..+....+.|+.|+..|++| ++ .+|||+||.||++. .+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~-~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFS-DDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccc-cchhhhhhhhhhe
Confidence 5899999999999999997654 35667889999999999999 66 99999999999997 6678999999998
Q ss_pred hhhhccc--------cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCc
Q 006277 162 TIMEQAN--------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPA 231 (652)
Q Consensus 162 ~~l~~~~--------~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~ 231 (652)
....... ....+||+.||+||.+. +.|+.++||||||+|++||+. ...+|. ....+..+..|..|+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~~d~r~g~ip~ 479 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----RIATLTDIRDGIIPP 479 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----HHHhhhhhhcCCCCh
Confidence 7765432 34578999999999775 689999999999999999997 444443 344556677787775
Q ss_pred cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 232 ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 232 ~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
.+... .|+-.+|+.+||- .|.+||++.+.-.|+|++
T Consensus 480 ~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 480 EFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred HHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 44433 3677899999997 799999999988888864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.8e-16 Score=159.23 Aligned_cols=143 Identities=18% Similarity=0.132 Sum_probs=110.8
Q ss_pred EEEEEecCcEEEEEE-EccCCeEEEEEEEeecccCC------------------CHH--HHHHHHHHHHHHHhCCCC--C
Q 006277 14 LRLIQLVDTSGYKAF-DEVNGLEVAWCQVRIDDVLQ------------------SPE--DLERLYSEVHLLKSLKHN--N 70 (652)
Q Consensus 14 ~rL~~l~~gtVykA~-d~~tG~~VAiK~v~~~~~~~------------------s~e--~~~~l~~Ei~iLk~L~Hp--n 70 (652)
..++++..|.||+|. +..+|+.||+|+++...... .+. ....+..|+++++++.+. .
T Consensus 34 ~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~ 113 (237)
T smart00090 34 GCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVP 113 (237)
T ss_pred CeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 467777889999999 77899999999997543100 011 123567899999999753 3
Q ss_pred eeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCC
Q 006277 71 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 150 (652)
Q Consensus 71 IVkl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~ 150 (652)
+.++++. . ..++||||+.|++|..+......+....+..++.||+.+|.+||.+| +|+||||||+||+++ +
T Consensus 114 ~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli~--~ 184 (237)
T smart00090 114 VPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILVH--D 184 (237)
T ss_pred CCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEEE--C
Confidence 4455542 2 24899999999888776545556777788899999999999999986 499999999999998 5
Q ss_pred CcEEEeccCchhhhh
Q 006277 151 GEVKIGDLGLATIME 165 (652)
Q Consensus 151 g~VKL~DFGla~~l~ 165 (652)
+.++|+|||++....
T Consensus 185 ~~i~LiDFg~a~~~~ 199 (237)
T smart00090 185 GKVVIIDVSQSVELD 199 (237)
T ss_pred CCEEEEEChhhhccC
Confidence 789999999987544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.5e-17 Score=162.92 Aligned_cols=235 Identities=18% Similarity=0.270 Sum_probs=179.3
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.++.+.-.|..|+|.. .|-.++.|++...+.. +..-..|..|.-.|+-+.||||+.+.+.+.... .+.+|..|+
T Consensus 196 tkl~e~hsgelwrgrw--qgndivakil~vr~~t--~risrdfneefp~lrifshpnilpvlgacnspp--nlv~isq~m 269 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRW--QGNDIVAKILNVREVT--ARISRDFNEEFPALRIFSHPNILPVLGACNSPP--NLVIISQYM 269 (448)
T ss_pred hhhccCCCcccccccc--cCcchhhhhhhhhhcc--hhhcchhhhhCcceeeecCCchhhhhhhccCCC--CceEeeeec
Confidence 3455555678888864 4556667777765542 334456788888999999999999999886554 689999999
Q ss_pred CCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCc--EEEeccCchhhhhcccc
Q 006277 94 TSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE--VKIGDLGLATIMEQANA 169 (652)
Q Consensus 94 ~gGsL~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~--VKL~DFGla~~l~~~~~ 169 (652)
+-|+|+..+..... ++..++..++..|+.|++|||+..|-|.---|....++++ ++-+ +-.+|--++.. .
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid-edltarismad~kfsfq-----e 343 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID-EDLTARISMADTKFSFQ-----E 343 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec-chhhhheecccceeeee-----c
Confidence 99999999876654 6788999999999999999999986555567888899998 4434 33444332221 2
Q ss_pred ccccCCCCccCccccccC----CCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 170 KSVIGTPEFMAPELYDEN----YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~~----y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
....-.|.||+||.+... --.++|+|||.++++||.|.+.||.+..+.+.-++....|..+ ..+...++.+..|+
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv-~ippgis~hm~klm 422 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV-HIPPGISRHMNKLM 422 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc-cCCCCccHHHHHHH
Confidence 233457999999977543 2357999999999999999999999987777777777777654 34555678999999
Q ss_pred HHhCC-CCCCCCCHHHH
Q 006277 246 EKCLV-PASQRLSAKEL 261 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~el 261 (652)
+-|+. ||.+||....+
T Consensus 423 ~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 423 NICMNEDPGKRPKFDMI 439 (448)
T ss_pred HHHhcCCCCcCCCccee
Confidence 99997 89999976654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.8e-16 Score=172.16 Aligned_cols=197 Identities=25% Similarity=0.405 Sum_probs=152.1
Q ss_pred HHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCc
Q 006277 63 LKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 141 (652)
Q Consensus 63 Lk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp 141 (652)
|+.+.|.|+.+|++...+.. .++.|.+||.-|+|.+.+.. ...++.-....+++.|+.||.|||..- --.|+.|++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~--~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP--EMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCC--ceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeecc
Confidence 46789999999999998874 79999999999999999887 356888889999999999999999874 239999999
Q ss_pred ccEEEcCCCCcEEEeccCchhhhhcc----ccccccCCCCccCccccccC--------CCccccchhhHHHHHHHhhccC
Q 006277 142 DNIFINGNQGEVKIGDLGLATIMEQA----NAKSVIGTPEFMAPELYDEN--------YNELADIYSFGMCMLEMVTFEY 209 (652)
Q Consensus 142 ~NILl~~~~g~VKL~DFGla~~l~~~----~~~~~vGTp~YmAPEvl~~~--------y~~~sDIWSlGvilyeLltG~~ 209 (652)
.|++++. .=.+||+|||+....... ......-...|.|||+++.. -+.+.||||||++++|+++..-
T Consensus 78 ~nClvd~-~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 78 SNCLVDS-RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred ccceeee-eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 9999984 347999999998876421 11111123468999988642 4567999999999999999999
Q ss_pred CCCCCC---CHHHHHHHHhcCCCCccccC-----CCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 210 PYSECR---NSAQIYKKVSSGIKPAALSK-----VKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 210 Pf~~~~---~~~~i~~~I~~g~~p~~l~~-----~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
||.... .+.++...+..+..+...+. ...+++..++..|+. +|.+||+++++-.
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 996522 23456666666332211111 234578999999997 8999999888753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-15 Score=150.35 Aligned_cols=136 Identities=20% Similarity=0.220 Sum_probs=111.0
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHH-----HHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPE-----DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e-----~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
.|+++..|.||+|.+ +|..|++|+...... ..++ ...++.+|+.++..+.|++|+....++.+.. ..++|
T Consensus 3 ~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~-~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv 77 (211)
T PRK14879 3 LIKRGAEAEIYLGDF--LGIKAVIKWRIPKRY-RHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIV 77 (211)
T ss_pred ccccCceEEEEEEee--CCCceEEEEeCCcCC-cChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEE
Confidence 567888899999986 788999997653221 1111 2356888999999999999877766665544 57899
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
|||+.|++|.+++..... ....++.+++.+|.+||+++ ++|||++|.|||++ .+.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 999999999999875432 78899999999999999998 99999999999998 57899999998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-17 Score=190.75 Aligned_cols=247 Identities=24% Similarity=0.302 Sum_probs=192.0
Q ss_pred EEEecCcEEEEEEEcc-CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 16 LIQLVDTSGYKAFDEV-NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 16 L~~l~~gtVykA~d~~-tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
++++..+.|-.+.... +...+|.|.+.... .+.....+...|..+-+.+. |+|++.+++.+.... ..+++++|.
T Consensus 28 ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~--~~~~~~~~s 103 (601)
T KOG0590|consen 28 IGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR--SYLLSLSYS 103 (601)
T ss_pred ccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCCc--ccccccCcc
Confidence 4445555666655432 34456666655443 34566778888999999996 999999999876554 789999999
Q ss_pred CCCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCeeeccCCcccEEEcCCCC-cEEEeccCchhhhhc-cc
Q 006277 94 TSGSLRQYR-KKHK-KVDMKAVKGWARQILSGLIYLH-SHDPPIIHRDLKCDNIFINGNQG-EVKIGDLGLATIMEQ-AN 168 (652)
Q Consensus 94 ~gGsL~~~i-~~~~-~lse~~i~~i~~QIl~aL~yLH-s~g~~IiHRDLKp~NILl~~~~g-~VKL~DFGla~~l~~-~~ 168 (652)
.||+++.-+ .... ..+...+..++.|+..+|.|+| ..+ +.|||+||+|.+++ ..+ .+|+.|||+|..+.. ..
T Consensus 104 ~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~-~s~~~l~~~df~~At~~~~~~g 180 (601)
T KOG0590|consen 104 DGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLD-ESGSALKIADFGLATAYRNKNG 180 (601)
T ss_pred cccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhc-cCCCcccCCCchhhccccccCC
Confidence 999999988 5554 6788899999999999999999 777 99999999999998 455 899999999998866 32
Q ss_pred ----cccccC-CCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--CccccCCCCh
Q 006277 169 ----AKSVIG-TPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDP 239 (652)
Q Consensus 169 ----~~~~vG-Tp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~ 239 (652)
....+| ++.|+|||+..+ ......|+||+|+++.-+++|..|+.........|........ ........+.
T Consensus 181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (601)
T KOG0590|consen 181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISD 260 (601)
T ss_pred cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCCh
Confidence 245688 999999998755 4567899999999999999999998654444433333332221 1233455677
Q ss_pred HHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 240 EVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 240 ~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
...+++.++|. +|..|.+.+++-.+||+..
T Consensus 261 ~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 261 QAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred hhhhcccccccCCchhccccccccccccccc
Confidence 89999999996 8999999999999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.2e-15 Score=147.21 Aligned_cols=133 Identities=19% Similarity=0.191 Sum_probs=104.2
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCC----HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQS----PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s----~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
++++..|.||+|. .+|..|++|+......... .....++.+|+++++.+.|+++.....++.+.. ..++|||
T Consensus 2 ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~e 77 (199)
T TIGR03724 2 IAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVME 77 (199)
T ss_pred CCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEEE
Confidence 4667789999998 5788999998653322111 123477889999999998887654444444443 4689999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
|++|++|.+++..... .++.|++.+|.+||+.| ++|||++|.||+++ ++.++++|||++..
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 9999999988765321 88999999999999998 99999999999998 57999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.1e-15 Score=176.15 Aligned_cols=187 Identities=20% Similarity=0.215 Sum_probs=148.2
Q ss_pred eeEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC---CCCeeeeeeEEEeCCCCeEE
Q 006277 11 LMYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK---HNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 11 ~~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~---HpnIVkl~~~~~d~~~~~~~ 87 (652)
.+-..+|+++.++||+|.+.. |+.||+|+-+..-.. .++==.+++.+|+ -+.|+.++..++-.+ .-+
T Consensus 701 ~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W-------EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~--~S~ 770 (974)
T KOG1166|consen 701 CISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW-------EFYICLQVMERLKPQMLPSIMHISSAHVFQN--ASV 770 (974)
T ss_pred EEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce-------eeeehHHHHHhhchhhhcchHHHHHHHccCC--cce
Confidence 356778889999999999887 999999986543221 1222223344443 355666666554433 568
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC------CCCcEEEeccCch
Q 006277 88 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING------NQGEVKIGDLGLA 161 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~------~~g~VKL~DFGla 161 (652)
||+||.+-|+|.++++..+.+++..+..++.|++..++.||.++ |||+||||+|+||.. ..--++|+|||.+
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 99999999999999998899999999999999999999999999 999999999999951 1224899999998
Q ss_pred hhhh---cc-ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccC
Q 006277 162 TIME---QA-NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEY 209 (652)
Q Consensus 162 ~~l~---~~-~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~ 209 (652)
-.+. .. ....+++|-.|--+|... ..++..+|.|.|.-+++.||.|++
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 7664 22 346778999999999775 568999999999999999999975
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.8e-14 Score=162.52 Aligned_cols=135 Identities=16% Similarity=0.134 Sum_probs=106.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccC----CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVL----QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~----~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
..++++..++||+|... +..+++|+...+... ......+++.+|+++++.++|++|+..+.++.+.. ..++|
T Consensus 339 ~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv 414 (535)
T PRK09605 339 HLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--EKTIV 414 (535)
T ss_pred ceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--CCEEE
Confidence 46788888999998764 344555543322111 11123567899999999999999988777666543 57899
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhh
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 164 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l 164 (652)
|||+.|++|.+++. ....++.|++.+|.|||+++ ++||||||+|||++ ++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~--~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR--DDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE--CCcEEEEeCcccccC
Confidence 99999999999875 35779999999999999998 99999999999994 568999999998753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.9e-14 Score=143.48 Aligned_cols=139 Identities=14% Similarity=0.176 Sum_probs=105.2
Q ss_pred EEE-EecCcEEEEEEEccCCeEEEEEEEeeccc----CC-----CHHHHHHHHHHHHHHHhCCCCCe--eeeeeEEEeCC
Q 006277 15 RLI-QLVDTSGYKAFDEVNGLEVAWCQVRIDDV----LQ-----SPEDLERLYSEVHLLKSLKHNNI--IRFYNSWIDDQ 82 (652)
Q Consensus 15 rL~-~l~~gtVykA~d~~tG~~VAiK~v~~~~~----~~-----s~e~~~~l~~Ei~iLk~L~HpnI--Vkl~~~~~d~~ 82 (652)
.++ .++.++||.+... |..+++|.+....+ .. +.....++.+|+.++..|.|++| ++.+++.....
T Consensus 38 ~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred eeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 454 5666999999764 78899998865332 11 12345688999999999998875 66666543332
Q ss_pred CC--eEEEEEecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccC
Q 006277 83 NK--TVNIITELFTS-GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 159 (652)
Q Consensus 83 ~~--~~~LVmEy~~g-GsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFG 159 (652)
.. ..++|||+++| .+|.+++.. ..+++.. +.||+.+|.+||.+| |+||||||.|||++ .++.++|+|||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~-~~~~v~LIDfg 187 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLD-PDGKFWLIDFD 187 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEc-CCCCEEEEECC
Confidence 21 23599999997 689888765 4566543 578999999999999 99999999999998 45789999999
Q ss_pred chhh
Q 006277 160 LATI 163 (652)
Q Consensus 160 la~~ 163 (652)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.6e-14 Score=141.46 Aligned_cols=136 Identities=19% Similarity=0.177 Sum_probs=103.4
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCC-----CH-------------HHHHHHHHHHHHHHhCCCCC--eeee
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQ-----SP-------------EDLERLYSEVHLLKSLKHNN--IIRF 74 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~-----s~-------------e~~~~l~~Ei~iLk~L~Hpn--IVkl 74 (652)
.++++..+.||+|.+. +|+.||+|++....... .. ........|+.++..+.|++ ++..
T Consensus 22 ~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~ 100 (198)
T cd05144 22 QIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKP 100 (198)
T ss_pred ccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCce
Confidence 4666677899999875 89999999987543100 00 01224678999999998874 4444
Q ss_pred eeEEEeCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEE
Q 006277 75 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVK 154 (652)
Q Consensus 75 ~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VK 154 (652)
++ . ...++||||+.|++|..... ......++.+|+.++.++|.+| |+||||||+||+++ .++.++
T Consensus 101 ~~----~--~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~-~~~~~~ 165 (198)
T cd05144 101 ID----W--NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVD-DDEKIY 165 (198)
T ss_pred ee----c--CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEc-CCCcEE
Confidence 43 1 24689999999999876532 1456788999999999999998 99999999999998 578999
Q ss_pred EeccCchhhhhc
Q 006277 155 IGDLGLATIMEQ 166 (652)
Q Consensus 155 L~DFGla~~l~~ 166 (652)
|+|||++..+..
T Consensus 166 liDfg~~~~~~~ 177 (198)
T cd05144 166 IIDWPQMVSTDH 177 (198)
T ss_pred EEECCccccCCC
Confidence 999999976554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.5e-15 Score=172.20 Aligned_cols=246 Identities=22% Similarity=0.337 Sum_probs=196.5
Q ss_pred cEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHH
Q 006277 22 TSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY 101 (652)
Q Consensus 22 gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~~~ 101 (652)
+.++.+.-..+|...+.|+..+...+.. .+.+..+++-.++-...+|-++.....+... ...+|+++|..+++|...
T Consensus 818 ~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r--sP~~L~~~~~~~~~~~Sk 894 (1205)
T KOG0606|consen 818 SSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYESIRSKSNILITPRSPAVVRSFPSFPCR--SPLPLVGHYLNGGDLPSK 894 (1205)
T ss_pred cccccCCccccccccchhhhccchhhcc-ccccccCCccCccccCCCCceecccCCCCCC--CCcchhhHHhccCCchhh
Confidence 5667776666777777777665554432 3556667777777777788888887765433 368999999999999999
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh----------------
Q 006277 102 RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME---------------- 165 (652)
Q Consensus 102 i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~---------------- 165 (652)
+...+..++..++.++..+..+++|||+.. +.|||++|.|+|.. ..|+.+++|||......
T Consensus 895 l~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~-~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~ 971 (1205)
T KOG0606|consen 895 LHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIA-YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGT 971 (1205)
T ss_pred hhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhc-ccCCcccCccccccccccccCcCCcccccccCc
Confidence 988888999999999999999999999987 89999999999997 77899999998432210
Q ss_pred --------------c---cccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC
Q 006277 166 --------------Q---ANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG 227 (652)
Q Consensus 166 --------------~---~~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g 227 (652)
. ......+||+.|.|||.. .......+|+|++|++++|.++|.+||.. ..+.++++.+..+
T Consensus 972 ~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na-~tpq~~f~ni~~~ 1050 (1205)
T KOG0606|consen 972 PRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA-ETPQQIFENILNR 1050 (1205)
T ss_pred cccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC-cchhhhhhccccC
Confidence 0 002346899999999965 55678899999999999999999999987 7788899888877
Q ss_pred CCCc-cccCCCChHHHHHHHHhCC-CCCCCCCHH---HHhcCccccccCCCC
Q 006277 228 IKPA-ALSKVKDPEVKSFIEKCLV-PASQRLSAK---ELLMDPFLQVNGTTK 274 (652)
Q Consensus 228 ~~p~-~l~~~~s~~~kdlI~kcL~-~P~~RpSa~---elL~hpf~~~~~~~~ 274 (652)
..+- ..+...++++++++.++|. +|.+|..+. ++-.||||+...|..
T Consensus 1051 ~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1051 DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred CCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence 6432 2344568899999999997 899999877 999999999777654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.2e-13 Score=134.46 Aligned_cols=139 Identities=20% Similarity=0.161 Sum_probs=98.0
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHH---------------------HHHHHHHHHHhCCCC--Ce
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLE---------------------RLYSEVHLLKSLKHN--NI 71 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~---------------------~l~~Ei~iLk~L~Hp--nI 71 (652)
.++++..|+||+|.+. +|++||+|+++..... ...... ....|...+..+.+. .+
T Consensus 4 ~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 4 PIGTGKEADVYLALDG-DGEPVAVKIYRTGRTS-FKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred ccccccceeEEEEECC-CCCEEEEEEEecCccc-hhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5778888999999987 8999999998753221 111111 114567777777444 34
Q ss_pred eeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCcccEEEcCCC
Q 006277 72 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQ 150 (652)
Q Consensus 72 Vkl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IiHRDLKp~NILl~~~~ 150 (652)
.+.+.+. ..++||||++++.+....-...... ..++.++.+++.++.++|. ++ |+||||||+||+++ +
T Consensus 82 ~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~--~ 150 (187)
T cd05119 82 PKPIDLN------RHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD--D 150 (187)
T ss_pred CceEecC------CCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE--C
Confidence 5555421 3589999999954322111110111 6778999999999999999 87 99999999999998 6
Q ss_pred CcEEEeccCchhhhhc
Q 006277 151 GEVKIGDLGLATIMEQ 166 (652)
Q Consensus 151 g~VKL~DFGla~~l~~ 166 (652)
+.++|+|||.+.....
T Consensus 151 ~~~~liDfg~a~~~~~ 166 (187)
T cd05119 151 GKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcEEEEECcccccccC
Confidence 7999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.2e-13 Score=121.16 Aligned_cols=132 Identities=17% Similarity=0.069 Sum_probs=106.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC--CCeeeeeeEEEeCCCCeEEEEEe
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH--NNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~H--pnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.+++++..+.||++.+.. ..+++|.+..... ...+.+|+.+++.+.| +++++++.++... +..+++||
T Consensus 4 ~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~e 73 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD--EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLME 73 (155)
T ss_pred eecccccccceEEEEecC--CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEEE
Confidence 567778889999999754 7899998754321 4578889999999976 5889988866543 47899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD-PPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g-~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
|+.|+.+..+ +......++.+++.+|.+||... .+++|+||+|+||+++ ..+.++++|||++..
T Consensus 74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~-~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-CCcEEEEEecccccC
Confidence 9999877654 55677888999999999999852 2499999999999998 467899999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.3e-13 Score=151.30 Aligned_cols=248 Identities=25% Similarity=0.251 Sum_probs=190.7
Q ss_pred EEEEEE--ecCcEEEEEEE--ccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEE
Q 006277 13 YLRLIQ--LVDTSGYKAFD--EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 13 ~~rL~~--l~~gtVykA~d--~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~ 87 (652)
-.+++. +..+.||.+.- ..++..+|+|.-+... ..+..-.+=++|+...+.+ .|+|.++.+..|...+ ..|
T Consensus 119 ~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~--s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~--~lf 194 (524)
T KOG0601|consen 119 SSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF--SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG--ILF 194 (524)
T ss_pred ccccccCCCCCceeecccCCcccCCcccccccccCCC--CCccccccccchhhcccccCccccccccCcccccCC--cce
Confidence 345666 66688999888 8899999998743322 2233444556677777777 6999999999887654 789
Q ss_pred EEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 88 IITELFTSGSLRQYRKKHKK-VDMKAVKGWARQILS----GLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~~-lse~~i~~i~~QIl~----aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
+-+|+| +.+|..|...... ++...++..+.+... ||.++|+.+ ++|-|+||+||+...+...++++|||+..
T Consensus 195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcceeE
Confidence 999999 5788888766554 889999999999999 999999998 99999999999998554789999999998
Q ss_pred hhhccccc-------cccCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccC
Q 006277 163 IMEQANAK-------SVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 235 (652)
Q Consensus 163 ~l~~~~~~-------~~vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~ 235 (652)
.+...... ...|...|++||+.++-|+...|||++|.+.++-.++-.++....+. -+..+..+..+..+-.
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS--SWSQLRQGYIPLEFCE 349 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC--CccccccccCchhhhc
Confidence 88665421 12577899999999999999999999999999999887665442111 1112233334444444
Q ss_pred CCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 236 VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 236 ~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
..+..+...+..|+. +|..|+++..++.|+++..
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 455667778888887 7899999999999999873
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.4e-10 Score=128.80 Aligned_cols=172 Identities=25% Similarity=0.302 Sum_probs=129.9
Q ss_pred cEEE-EEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHH
Q 006277 22 TSGY-KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQ 100 (652)
Q Consensus 22 gtVy-kA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~~ 100 (652)
-.+| .|..+.+|.+|.+...+... .+..+.+.+-++-|+.|+||||++|++.++.+. .+|||+|-+. .|..
T Consensus 25 ~a~~~~~t~k~~~~~vsVF~~~~~~----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--~~ylvTErV~--Pl~~ 96 (690)
T KOG1243|consen 25 EALWPDGTRKADGGPVSVFVYKRSN----GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG--TLYLVTERVR--PLET 96 (690)
T ss_pred cccccccceeccCCceEEEEEeCCC----chhhHHHHHHHHHhhhccCchhhhhhhhhcccC--ceEEEeeccc--cHHH
Confidence 3566 57888999999999877432 244567788899999999999999999987655 8999999985 4666
Q ss_pred HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc--ccccCCCCc
Q 006277 101 YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA--KSVIGTPEF 178 (652)
Q Consensus 101 ~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~--~~~vGTp~Y 178 (652)
++++.+ ...+..-+.||+.||.|||..+ .++|++|.-+.|+|+ ..|+.||++|-++........ +...---.|
T Consensus 97 ~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~ 171 (690)
T KOG1243|consen 97 VLKELG---KEEVCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESF 171 (690)
T ss_pred HHHHhH---HHHHHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhcc
Confidence 776544 6777888999999999998542 399999999999999 779999999988765443321 111111234
Q ss_pred cCccccccCCCccccchhhHHHHHHHhhc
Q 006277 179 MAPELYDENYNELADIYSFGMCMLEMVTF 207 (652)
Q Consensus 179 mAPEvl~~~y~~~sDIWSlGvilyeLltG 207 (652)
..|+.+... .-..|.|-|||++++++.|
T Consensus 172 ~~P~~~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 172 DDPEEIDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cChhhcCcc-ccchhhhhHHHHHHHHhCc
Confidence 455533211 1346999999999999998
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.6e-10 Score=112.76 Aligned_cols=142 Identities=15% Similarity=0.092 Sum_probs=101.2
Q ss_pred EEEEecCcEEEEEEEcc------CCeEEEEEEEeeccc--------C-CC---------HHHHHHHH----HHHHHHHhC
Q 006277 15 RLIQLVDTSGYKAFDEV------NGLEVAWCQVRIDDV--------L-QS---------PEDLERLY----SEVHLLKSL 66 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~------tG~~VAiK~v~~~~~--------~-~s---------~e~~~~l~----~Ei~iLk~L 66 (652)
.++.+-.+.||.|.... .+..+|+|+.+.... + ++ ..-...+. +|++.|++|
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34455557999998654 368999998875211 1 00 01122333 899999999
Q ss_pred C--CCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeeeccCCccc
Q 006277 67 K--HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYL-HSHDPPIIHRDLKCDN 143 (652)
Q Consensus 67 ~--HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yL-Hs~g~~IiHRDLKp~N 143 (652)
. .-++.+.+++ . .-+|||||+.++.+..-.-+...+++..+..++.|++.+|..| |..| |+|+||++.|
T Consensus 84 ~~~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~N 155 (197)
T cd05146 84 QKAGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEYN 155 (197)
T ss_pred HHcCCCCCeEEEe--c----CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHH
Confidence 4 3567777764 1 3589999997754433222333566677788899999999999 8888 9999999999
Q ss_pred EEEcCCCCcEEEeccCchhhhhc
Q 006277 144 IFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 144 ILl~~~~g~VKL~DFGla~~l~~ 166 (652)
|++. +|.+.|+|||.+.....
T Consensus 156 IL~~--~~~v~iIDF~qav~~~h 176 (197)
T cd05146 156 MLWH--DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred EEEE--CCcEEEEECCCceeCCC
Confidence 9996 46899999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.6e-10 Score=110.24 Aligned_cols=129 Identities=19% Similarity=0.069 Sum_probs=92.5
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCee-eeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII-RFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIV-kl~~~~~d~~~~~~~LVmEy 92 (652)
..+..+..+.||++... |..|++|+...... ....+..|+.+++.+.+.+++ +++.+ +.. ..++||||
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~--~~~lv~e~ 72 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYF--DPE--TGVLITEF 72 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEE--eCC--CCeEEEEe
Confidence 45566667899998754 78999998653211 122457899999998655544 45543 232 24799999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC---CeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP---PIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~---~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
+.|.++... ......++.+++.+|..||..+. .++|+|++|.||+++ ++.++++|||.+..
T Consensus 73 i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~~ 136 (170)
T cd05151 73 IEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAGM 136 (170)
T ss_pred cCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE--CCeEEEEecccccC
Confidence 999887643 11123567899999999999862 259999999999998 45799999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.4e-10 Score=123.86 Aligned_cols=142 Identities=20% Similarity=0.176 Sum_probs=91.4
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCC--------------------------C-HHH----HH------HHHH
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQ--------------------------S-PED----LE------RLYS 58 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~--------------------------s-~e~----~~------~l~~ 58 (652)
++...-|.||+|.. .+|+.||||+.+.. ... + .+. .. .+.+
T Consensus 125 lasaSigQVh~A~l-~~G~~VaVKv~rp~-i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 125 LAAASIAQVHRARL-VDGKEVAVKVLRPG-IEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred eeeeehhheEEEEe-cCCCEEEEEeeCCC-cHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 44444578999986 48999999987632 100 0 000 00 2444
Q ss_pred HHHHHHhC----CCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 006277 59 EVHLLKSL----KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILS-GLIYLHSHDP 132 (652)
Q Consensus 59 Ei~iLk~L----~HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~-aL~yLHs~g~ 132 (652)
|.+.+.++ +|.+-+.+-..|.+.. ...+|||||+.|++|.++.... ..++ ...++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g- 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG- 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC-
Confidence 55555555 2333333333332222 2468999999999998876432 1222 2345555555 467889988
Q ss_pred CeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 133 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 133 ~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
++|+|+||.||+++ .+|.++++|||++..+..
T Consensus 278 -~~H~D~hPgNilv~-~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 -FFHADLHPGNIFVL-KDGKIIALDFGIVGRLSE 309 (437)
T ss_pred -ceeCCCCcccEEEC-CCCcEEEEeCCCeeECCH
Confidence 99999999999997 678999999999876643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.7e-10 Score=127.27 Aligned_cols=140 Identities=17% Similarity=0.155 Sum_probs=91.0
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeeccc--------------------------CCCH----HHHHH------HHHH
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDV--------------------------LQSP----EDLER------LYSE 59 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~--------------------------~~s~----e~~~~------l~~E 59 (652)
++..--+.||+|..+.+|+.||||+++..-. +.-. +..+. +.+|
T Consensus 127 lasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~E 206 (537)
T PRK04750 127 LASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMRE 206 (537)
T ss_pred hcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHH
Confidence 3333347999999988899999999974310 0001 11222 3344
Q ss_pred HHHHHhC----CCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHH--HHhCC----CCCHHHHHHHHHHHHHHHHHHHh
Q 006277 60 VHLLKSL----KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY--RKKHK----KVDMKAVKGWARQILSGLIYLHS 129 (652)
Q Consensus 60 i~iLk~L----~HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~~~--i~~~~----~lse~~i~~i~~QIl~aL~yLHs 129 (652)
+..+.++ .+.+.+.+-.+|.+-. ...+|||||+.|+.|.++ +...+ .+.+..+..++.||+ .
T Consensus 207 a~N~~~~~~~f~~~~~v~VP~v~~d~s-t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~ 278 (537)
T PRK04750 207 AANASQLRRNFEDSDMLYVPEVYWDYC-SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------R 278 (537)
T ss_pred HHHHHHHHHHccCCCCeecceeecccC-CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------h
Confidence 4444444 2444444444443322 246899999999999874 33333 355666666777765 3
Q ss_pred CCCCeeeccCCcccEEEcCCCC----cEEEeccCchhhhhc
Q 006277 130 HDPPIIHRDLKCDNIFINGNQG----EVKIGDLGLATIMEQ 166 (652)
Q Consensus 130 ~g~~IiHRDLKp~NILl~~~~g----~VKL~DFGla~~l~~ 166 (652)
.| ++|+|+||.||+++ .+| .++++|||+...+..
T Consensus 279 ~G--ffHaDpHPGNIlv~-~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 279 DG--FFHADMHPGNIFVS-YDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred CC--eeeCCCChHHeEEe-cCCCCCCeEEEEecceEEECCH
Confidence 66 99999999999998 445 899999999876643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.9e-10 Score=128.38 Aligned_cols=243 Identities=21% Similarity=0.162 Sum_probs=171.7
Q ss_pred eEEEEEEecC---cEEEEEEEc-cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeE
Q 006277 12 MYLRLIQLVD---TSGYKAFDE-VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTV 86 (652)
Q Consensus 12 ~~~rL~~l~~---gtVykA~d~-~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~ 86 (652)
.|..+.+++. +.||...-. .++..|++|.+...- ... .....-..|+.+...| .|.++++++..|..-. ..
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~-~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r--~~ 341 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATF-ASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR--QG 341 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cch-HhhhcchhhhhHhhHhhcccccCCCCCCccccc--cc
Confidence 4455555554 345554433 578889998776432 222 2333445678888877 7999999999997554 56
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 87 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
|+=.|||.++++...+.-...+++...+....|++.++.++|+.. ++|+|+||+||++...++.-+++|||+++.+..
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccccce
Confidence 799999999998887766668899999999999999999999988 999999999999984447889999999875322
Q ss_pred cccccccCCCCcc-Ccccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHH
Q 006277 167 ANAKSVIGTPEFM-APELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 243 (652)
Q Consensus 167 ~~~~~~vGTp~Ym-APEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kd 243 (652)
.. ....++-.++ ++|++.+ .+..++|++|||.-+.+.+++..--.. ......|..+..+. .+... .+++.
T Consensus 420 ~~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~----~~~~~~i~~~~~p~-~~~~~-~~~q~ 492 (524)
T KOG0601|consen 420 SS-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES----GVQSLTIRSGDTPN-LPGLK-LQLQV 492 (524)
T ss_pred ec-ccccccccccccchhhccccccccccccccccccccccccCcccCcc----cccceeeecccccC-CCchH-Hhhhh
Confidence 11 2223344455 3565543 567899999999999999998643222 11222344444332 22222 67777
Q ss_pred HHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 244 FIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
+.+.++. ++..|+.+.++..|.-|
T Consensus 493 ~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 493 LLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hhhhhcCCccccchhhhhhcccchh
Confidence 8888876 68899999999988755
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.3e-08 Score=112.02 Aligned_cols=213 Identities=16% Similarity=0.274 Sum_probs=152.4
Q ss_pred CcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC--CCeEEEEEecCCC-CC
Q 006277 21 DTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ--NKTVNIITELFTS-GS 97 (652)
Q Consensus 21 ~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~--~~~~~LVmEy~~g-Gs 97 (652)
..+.|+|+...+|-.|++|.+...+.. ++ .....-+++++++.|+|||+|.++|.... ...++||++|.++ ++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~-~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQ-ST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccccc-Cc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 478999999999999999999654432 21 23344688999999999999999887332 2368999999886 47
Q ss_pred HHHHHH---------------hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 98 LRQYRK---------------KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 98 L~~~i~---------------~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
|.++-- .....+|..+|.|+.|+..||.++|+.| +.-+-|.|.+||++++. +|+|...|+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~-RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKM-RIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcc-eEEEeccccee
Confidence 766531 2245788999999999999999999999 88899999999999654 78888777665
Q ss_pred hhhccccccccCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHH-HHHHhcCCCCccccCCCChHH
Q 006277 163 IMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI-YKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 163 ~l~~~~~~~~vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i-~~~I~~g~~p~~l~~~~s~~~ 241 (652)
.+..... |-+++ -.+-|.=.||.+++.|.||..--.......+. ...| ...++.++
T Consensus 442 vl~~d~~------------~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I---------~~~yS~D~ 498 (655)
T KOG3741|consen 442 VLQEDPT------------EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI---------TTTYSTDL 498 (655)
T ss_pred eecCCCC------------cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh---------hhhhhHHH
Confidence 5443221 11111 12457778999999999996432221222222 1222 23567889
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 242 KSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
+++|.-+.. .+.+ .++.+++.+
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHH
Confidence 999988876 4554 678888866
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.90 E-value=6.1e-09 Score=103.20 Aligned_cols=146 Identities=19% Similarity=0.197 Sum_probs=104.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC--CCeeeeeeEEEeCC-CCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH--NNIIRFYNSWIDDQ-NKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~H--pnIVkl~~~~~d~~-~~~~~LV 89 (652)
+..++.+..+.||++... +|..+++|........ .....+.+|+.+++.+.+ .++.+++.+..... .+..++|
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v 78 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV 78 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence 355666777899999764 3689999987643321 134578889999999965 34566666543221 1256899
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD-------------------------------------- 131 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g-------------------------------------- 131 (652)
|||++|++|...+.. ..+++.....++.+++..|..||+..
T Consensus 79 ~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 79 MERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999999888765432 45777788888888888888888521
Q ss_pred ----------------CCeeeccCCcccEEEcCC-CCcEEEeccCchhh
Q 006277 132 ----------------PPIIHRDLKCDNIFINGN-QGEVKIGDLGLATI 163 (652)
Q Consensus 132 ----------------~~IiHRDLKp~NILl~~~-~g~VKL~DFGla~~ 163 (652)
..++|+|++|+||+++.+ ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 237999999999999853 45689999987753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.9e-08 Score=97.34 Aligned_cols=129 Identities=24% Similarity=0.283 Sum_probs=95.3
Q ss_pred EEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHH-----HHHHHHHHHHHHhCCCCC--eeeeeeEEEeCCCCeEEEE
Q 006277 17 IQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPED-----LERLYSEVHLLKSLKHNN--IIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 17 ~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~-----~~~l~~Ei~iLk~L~Hpn--IVkl~~~~~d~~~~~~~LV 89 (652)
.++....+|.+.. -|.++.+| .++++....|+. .+|-.+|+.++..+.--. ...+|+ +|.. ...|+
T Consensus 5 ~~GAEa~i~~~~~--~g~~av~K-~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d--vD~~--~~~I~ 77 (204)
T COG3642 5 KQGAEAIIYLTDF--LGLPAVVK-ERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD--VDPD--NGLIV 77 (204)
T ss_pred hCCcceeEEeeec--cCcceEEE-eecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE--EcCC--CCEEE
Confidence 4556677887743 44555555 445555555543 456778999999996444 444555 5555 45799
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
|||++|-.|.+++... ...+++.+-.-+.-||..| |+|+||.++||++.+ +.+.++||||+.+
T Consensus 78 me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~--~~i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSG--GRIYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeC--CcEEEEECCcccc
Confidence 9999999999888765 2567778888888899999 999999999999973 4599999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=7.6e-08 Score=94.30 Aligned_cols=143 Identities=20% Similarity=0.233 Sum_probs=105.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHH-----HHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPE-----DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e-----~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
.-+.|+..+.|+++. ..|+...||.=- .+..+.|. ...|..+|+++|.+|.--.|.----+|+|..+ -.|
T Consensus 13 ~likQGAEArv~~~~--~~Ge~~iIK~Rf-~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~--~~i 87 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGS--FSGEAAIIKERF-SKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG--GQI 87 (229)
T ss_pred eeeeccceeeEeeec--cCCceeEEeecc-cccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC--CeE
Confidence 456677778888886 467777777533 23333343 35688999999999965555444445566653 578
Q ss_pred EEecCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcE--EEeccCchhh
Q 006277 89 ITELFTS-GSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV--KIGDLGLATI 163 (652)
Q Consensus 89 VmEy~~g-GsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~V--KL~DFGla~~ 163 (652)
+|||+.| -++.+++.... .........++++|-..+.-||.++ |||+||..+||++..+++.+ .++|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence 8999977 47888877652 2333344789999999999999999 99999999999998666654 8999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.5e-07 Score=96.79 Aligned_cols=138 Identities=17% Similarity=0.091 Sum_probs=94.4
Q ss_pred cEEEEEEEccCCeEEEEEEEeecccC---CC----HHHHHHHHHHHHHHHhCCCCCe--eeeeeEEEeCC---CCeEEEE
Q 006277 22 TSGYKAFDEVNGLEVAWCQVRIDDVL---QS----PEDLERLYSEVHLLKSLKHNNI--IRFYNSWIDDQ---NKTVNII 89 (652)
Q Consensus 22 gtVykA~d~~tG~~VAiK~v~~~~~~---~s----~e~~~~l~~Ei~iLk~L~HpnI--Vkl~~~~~d~~---~~~~~LV 89 (652)
..|++. ...|+.|.+|........ .+ ..-...+.+|...+..|..-+| +....+.+... ....+||
T Consensus 36 rrvvr~--~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRF--ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEE--EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 345554 457889999976432210 00 0011137788888888833222 22322333221 2357899
Q ss_pred EecCCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC------CCCcEEEeccCc
Q 006277 90 TELFTSG-SLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING------NQGEVKIGDLGL 160 (652)
Q Consensus 90 mEy~~gG-sL~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~------~~g~VKL~DFGl 160 (652)
||++.+. +|.+++.. ....+......++++++..+.-||.+| |+|+||++.|||++. ..+.+.|+||+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 9999886 89998764 345667788899999999999999999 999999999999973 245799999997
Q ss_pred hhh
Q 006277 161 ATI 163 (652)
Q Consensus 161 a~~ 163 (652)
+..
T Consensus 192 ~~~ 194 (268)
T PRK15123 192 AQI 194 (268)
T ss_pred ccc
Confidence 753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.8e-07 Score=92.81 Aligned_cols=130 Identities=27% Similarity=0.270 Sum_probs=84.4
Q ss_pred EEEEEEEccCCeEEEEEEEeecccC----------------------CCHHHHHHHHHHHHHHHhCCCC--CeeeeeeEE
Q 006277 23 SGYKAFDEVNGLEVAWCQVRIDDVL----------------------QSPEDLERLYSEVHLLKSLKHN--NIIRFYNSW 78 (652)
Q Consensus 23 tVykA~d~~tG~~VAiK~v~~~~~~----------------------~s~e~~~~l~~Ei~iLk~L~Hp--nIVkl~~~~ 78 (652)
.||.|.. ..|.++|+|..+..... ..........+|.+.|..|..- ++.+.+++
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4899986 57889999988763110 0011245778899999999655 56777753
Q ss_pred EeCCCCeEEEEEecCC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCeeeccCCcccEEEcCCCCcEEE
Q 006277 79 IDDQNKTVNIITELFT--SGSLRQYRKKHKKVDMKAVKGWARQILSGLIY-LHSHDPPIIHRDLKCDNIFINGNQGEVKI 155 (652)
Q Consensus 79 ~d~~~~~~~LVmEy~~--gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~y-LHs~g~~IiHRDLKp~NILl~~~~g~VKL 155 (652)
.. -.|||||+. |..+..+... .++......++.+++..+.. +|..| |+|+||.+.|||++. +.+.|
T Consensus 79 -~~----~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~--~~~~i 147 (188)
T PF01163_consen 79 -NR----NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDD--GKVYI 147 (188)
T ss_dssp -ET----TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEET--TCEEE
T ss_pred -eC----CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeec--ceEEE
Confidence 22 369999998 6555443322 12245567788888886655 57888 999999999999983 48999
Q ss_pred eccCchhhhh
Q 006277 156 GDLGLATIME 165 (652)
Q Consensus 156 ~DFGla~~l~ 165 (652)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999886544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.5e-08 Score=110.47 Aligned_cols=150 Identities=18% Similarity=0.297 Sum_probs=107.5
Q ss_pred HHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc-----------ccccCCCCccCcccccc-
Q 006277 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-----------KSVIGTPEFMAPELYDE- 186 (652)
Q Consensus 119 QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~-----------~~~vGTp~YmAPEvl~~- 186 (652)
++..||.|+|.+ +++||++|.|++|.++ ..|.+||+.|+++........ ....-...|.|||++..
T Consensus 107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~n-a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS-AKVVHGNIQPEAIVVN-ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC-cceeecccchhheeec-cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 344899999998 5799999999999999 668999999998876544211 01123457999997754
Q ss_pred CCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhc--CCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHh
Q 006277 187 NYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSS--GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELL 262 (652)
Q Consensus 187 ~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~--g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL 262 (652)
..+.++|++|+||++|.+.. |..-+.. ......+..... +..........++++++=+.++|. ++..||++.+++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a-~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAA-NGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhc-cCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 56788999999999999984 4444433 222222222111 111222335567899999999996 899999999999
Q ss_pred cCccccccC
Q 006277 263 MDPFLQVNG 271 (652)
Q Consensus 263 ~hpf~~~~~ 271 (652)
..|||....
T Consensus 264 ~~~ff~D~~ 272 (700)
T KOG2137|consen 264 SIPFFSDPG 272 (700)
T ss_pred cccccCCch
Confidence 999998543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=8.3e-07 Score=89.03 Aligned_cols=110 Identities=19% Similarity=0.186 Sum_probs=84.1
Q ss_pred HHHHHHHHHHHHHhCCCC--CeeeeeeEEEeCCC--CeEEEEEecCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 006277 52 DLERLYSEVHLLKSLKHN--NIIRFYNSWIDDQN--KTVNIITELFTSG-SLRQYRKKHKKVDMKAVKGWARQILSGLIY 126 (652)
Q Consensus 52 ~~~~l~~Ei~iLk~L~Hp--nIVkl~~~~~d~~~--~~~~LVmEy~~gG-sL~~~i~~~~~lse~~i~~i~~QIl~aL~y 126 (652)
...+..+|...+..|..- .+.+.+.+.....+ ...+||||++++. +|.+++......+......++.++...+.-
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 345788888888888432 23444444333221 3468999999884 799998875557888889999999999999
Q ss_pred HHhCCCCeeeccCCcccEEEcCCC--CcEEEeccCchhh
Q 006277 127 LHSHDPPIIHRDLKCDNIFINGNQ--GEVKIGDLGLATI 163 (652)
Q Consensus 127 LHs~g~~IiHRDLKp~NILl~~~~--g~VKL~DFGla~~ 163 (652)
||.+| |+|+|+++.|||++..+ ..+.++||+-+..
T Consensus 134 lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 99999999999998432 2689999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.1e-06 Score=93.05 Aligned_cols=172 Identities=18% Similarity=0.314 Sum_probs=123.0
Q ss_pred eEEEEEecCCCCC-HHH------HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEec
Q 006277 85 TVNIITELFTSGS-LRQ------YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 157 (652)
Q Consensus 85 ~~~LVmEy~~gGs-L~~------~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~D 157 (652)
.+.|+|..+.|-. ... .++.....++..+.++++.++.+.+-||.+| .+-+|+.++|+|+. +++.|.|.|
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVs-d~~~V~LVd 160 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVS-DDSKVVLVD 160 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeee-cCceEEEEc
Confidence 4889999988752 111 2233356788999999999999999999999 88899999999998 778999988
Q ss_pred cCchhhhh-ccccccccCCCCccCccccc------cCCCccccchhhHHHHHHHhhc-cCCCCCCC------CHHHHHHH
Q 006277 158 LGLATIME-QANAKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTF-EYPYSECR------NSAQIYKK 223 (652)
Q Consensus 158 FGla~~l~-~~~~~~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG-~~Pf~~~~------~~~~i~~~ 223 (652)
-..-.... .......+|.++|.+||... -.-+...|.|.||+++++++.| ..||++-. ++.+ ..
T Consensus 161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~ 238 (637)
T COG4248 161 SDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TD 238 (637)
T ss_pred ccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hh
Confidence 54322222 22245678999999999654 2345678999999999999887 89997621 1111 11
Q ss_pred Hhc-----------CCC--Ccccc-CCCChHHHHHHHHhCCC---CCCCCCHHHH
Q 006277 224 VSS-----------GIK--PAALS-KVKDPEVKSFIEKCLVP---ASQRLSAKEL 261 (652)
Q Consensus 224 I~~-----------g~~--p~~l~-~~~s~~~kdlI~kcL~~---P~~RpSa~el 261 (652)
|.. |.+ |..++ ....+.++.|..+|..+ +.-|||++-.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW 293 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW 293 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence 222 222 22232 34678999999999964 5689997643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.9e-08 Score=111.65 Aligned_cols=231 Identities=19% Similarity=0.198 Sum_probs=157.3
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC-eeeeeeEEEeCCCCeEEEEEecCC
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN-IIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hpn-IVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
++++.-+.++|++...+...+ .+.|... ....-++++|.+++||| .+.+++.+..+ .+.+++|++|.
T Consensus 250 fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E--~~~~i~~~i~s 317 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDYDGE--DYLWIPMRICS 317 (829)
T ss_pred HHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccCCcc--cccchhhhhhc
Confidence 344455778888887776666 6665422 33455899999999999 66666654333 47899999998
Q ss_pred CC-CHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-cccc
Q 006277 95 SG-SLRQYR-KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKS 171 (652)
Q Consensus 95 gG-sL~~~i-~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~~ 171 (652)
+| +-...+ ...-.+.+-+....++.-+.+|+|||+.. -+||| ||+.. .+..|.+||+....+... ..++
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s--~~~~~~~~~~v~~~L~~~~~~~t 389 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGS--EEEVKLLDFAVPPQLTRTMKPRT 389 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----ccccc--ccccccccccCCcccCccccccc
Confidence 87 221111 01112344456667778889999999974 58998 88775 368999999998887654 3567
Q ss_pred ccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc---CCCChHHHHHHHH
Q 006277 172 VIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS---KVKDPEVKSFIEK 247 (652)
Q Consensus 172 ~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~---~~~s~~~kdlI~k 247 (652)
..+|+.++|||+. ++.|....|.|++|+-..+|.-|.+|-.. .+.... .+-.+.....+. ......-++|...
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~-~~g~~p~s~~L~~~~aw~~~~~~~~~~~ 466 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLP-MIGNGPNSPMLTDKSAWSPVFHRDFPAP 466 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--CccccC-CCCCCCCccccchhhhcCcccccCCccc
Confidence 8999999999965 56799999999999988888888877543 111111 111111000010 0111122358889
Q ss_pred hCC-CCCCCCCHHHHhcCccccc
Q 006277 248 CLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~~~ 269 (652)
|+. -|..|+.+..++.|.+|..
T Consensus 467 ~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 467 CLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred ccCCCCCCCcchhhHHHHHHhcc
Confidence 998 6999999999999999853
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.3e-06 Score=104.22 Aligned_cols=204 Identities=22% Similarity=0.341 Sum_probs=144.7
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC--eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 006277 52 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK--TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS 129 (652)
Q Consensus 52 ~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~--~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs 129 (652)
.+....-|+..+....|+|++.++.+-...... ...+..++|+.-++...+..-+.++...++.|..+++.||.|+|+
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 445555677778888999999999876543321 234567899999999999998999999999999999999999999
Q ss_pred CCCCeeeccCCcc---cEEEcCCCCcEEEe--ccCchhhhhcccc-ccccCCCCccCccccccC-C--CccccchhhHHH
Q 006277 130 HDPPIIHRDLKCD---NIFINGNQGEVKIG--DLGLATIMEQANA-KSVIGTPEFMAPELYDEN-Y--NELADIYSFGMC 200 (652)
Q Consensus 130 ~g~~IiHRDLKp~---NILl~~~~g~VKL~--DFGla~~l~~~~~-~~~vGTp~YmAPEvl~~~-y--~~~sDIWSlGvi 200 (652)
+. ..|.-|... +--.+ ..+.+.++ ||+.++.+..... ....-+..+.|||....+ + ....|+|.+|..
T Consensus 305 ~~--l~~v~L~~s~~~~~~~~-~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 305 LS--LEHVVLSASSSKESTVD-GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred hc--cceeEEecccccccccC-ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 86 666655444 22223 23456666 8888776654332 334456678888877543 3 334699999999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 201 MLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 201 lyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
...+..|..+-.....+. . .+.........+++.+|+. ++++|+++.+++.|||++..
T Consensus 382 ~~~~~~~~~i~~~~~~~~----~--------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAVPV----S--------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred HhhhhhcCcccccccchh----h--------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 999998865532211100 1 1111122268889999997 79999999999999999754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.12 E-value=4.5e-05 Score=77.05 Aligned_cols=139 Identities=13% Similarity=0.109 Sum_probs=97.3
Q ss_pred ecCcEEEEEEEccCCeEEEEEEEe--ecccCCCHHHHHHHHHHHHHHHhCCCC--Ceeeee--eEEEeCCCCeEEEEEec
Q 006277 19 LVDTSGYKAFDEVNGLEVAWCQVR--IDDVLQSPEDLERLYSEVHLLKSLKHN--NIIRFY--NSWIDDQNKTVNIITEL 92 (652)
Q Consensus 19 l~~gtVykA~d~~tG~~VAiK~v~--~~~~~~s~e~~~~l~~Ei~iLk~L~Hp--nIVkl~--~~~~d~~~~~~~LVmEy 92 (652)
+|.+.|+.... .|..+-+|+-. ....+.-|-....+.+|+..|+.|..- .+.+.. +.-........+||+|-
T Consensus 29 gG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 29 NGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 46678888643 34467788754 122222245678899999999999432 233333 21112223357899997
Q ss_pred CCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCc--EEEeccCchh
Q 006277 93 FTS-GSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE--VKIGDLGLAT 162 (652)
Q Consensus 93 ~~g-GsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~--VKL~DFGla~ 162 (652)
+.| -+|.+++... .+.++.....++.+|...|.-||..| +.|+|+-+.|||++. +|. |+++||--++
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~-~g~~~v~lIDlEk~r 178 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKT-EGKAEAGFLDLEKSR 178 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecC-CCCeeEEEEEhhccc
Confidence 754 5888887653 35677888899999999999999999 999999999999973 345 9999997554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.9e-05 Score=81.98 Aligned_cols=133 Identities=19% Similarity=0.174 Sum_probs=92.3
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccC-----CCH-------------HHHHHHHHHHHHHHhCCCC--Ceeeee
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVL-----QSP-------------EDLERLYSEVHLLKSLKHN--NIIRFY 75 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~-----~s~-------------e~~~~l~~Ei~iLk~L~Hp--nIVkl~ 75 (652)
+|.+-.+.||.|.+. .|.++|+|.-+..... ... -.....++|.++|..|.-. .+.+.+
T Consensus 99 IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~ 177 (304)
T COG0478 99 IGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPI 177 (304)
T ss_pred cccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcc
Confidence 333334899999986 7999999976543210 001 1233567899999999544 788887
Q ss_pred eEEEeCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEE
Q 006277 76 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKI 155 (652)
Q Consensus 76 ~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL 155 (652)
+. + .-.+||||+.|-.|.... ++...+..++..|+.-+.-+-..| |||+|+.+=||+++ ++|.+.+
T Consensus 178 ~~----n--RHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~-~dg~~~v 243 (304)
T COG0478 178 AW----N--RHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVT-EDGDIVV 243 (304)
T ss_pred cc----c--cceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEe-cCCCEEE
Confidence 62 1 467999999998776542 234445555566666555555666 99999999999998 6789999
Q ss_pred eccCchhh
Q 006277 156 GDLGLATI 163 (652)
Q Consensus 156 ~DFGla~~ 163 (652)
+||--+..
T Consensus 244 IDwPQ~v~ 251 (304)
T COG0478 244 IDWPQAVP 251 (304)
T ss_pred EeCccccc
Confidence 99965543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00011 Score=74.67 Aligned_cols=128 Identities=17% Similarity=0.232 Sum_probs=81.2
Q ss_pred EEEEEEEccCCeEEEEEEEeecccCCCHH---------HHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---CeEEEEE
Q 006277 23 SGYKAFDEVNGLEVAWCQVRIDDVLQSPE---------DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN---KTVNIIT 90 (652)
Q Consensus 23 tVykA~d~~tG~~VAiK~v~~~~~~~s~e---------~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~---~~~~LVm 90 (652)
.-|.+.-..+|..+.+|..+..... ... ...++...+..++...--.+..+|-+..-... ...+|||
T Consensus 44 r~~ValIei~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~ 122 (229)
T PF06176_consen 44 RNYVALIEIDGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLM 122 (229)
T ss_pred ccEEEEEEECCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEE
Confidence 4566666788999999987643321 111 12233333333333333444444433222111 2456899
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
||++|..|.++.. +++ .+...|..++.-||.+| +.|+|..|.|++++ + +.++++||+..+.
T Consensus 123 EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~-~-~~i~iID~~~k~~ 183 (229)
T PF06176_consen 123 EYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVS-N-NGIRIIDTQGKRM 183 (229)
T ss_pred EEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEE-C-CcEEEEECccccc
Confidence 9999988876532 333 24456777889999999 99999999999998 3 4699999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.84 E-value=2.1e-06 Score=104.13 Aligned_cols=214 Identities=16% Similarity=0.038 Sum_probs=151.2
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHH
Q 006277 52 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYL 127 (652)
Q Consensus 52 ~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yL 127 (652)
..+-+..|+.-++...|++++..+.-..+..+..-|.+++||.+|.++..+.++ .++++.-+.....+.+.+..-+
T Consensus 1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred HHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence 345566677777888999999998877666667789999999999999988754 3455555555555547777766
Q ss_pred HhC---CCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--ccccccCCCCccCcccccc-CCCccccchhhHHHH
Q 006277 128 HSH---DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAKSVIGTPEFMAPELYDE-NYNELADIYSFGMCM 201 (652)
Q Consensus 128 Hs~---g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~~~vGTp~YmAPEvl~~-~y~~~sDIWSlGvil 201 (652)
|+. |.-.+|++||+-|.++..+. .||++++|+.++..+. ..+..+++|.|++|++.++ .++.++|+|..|+-+
T Consensus 1352 ls~tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred hhcccCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 654 22379999999999998554 7999999999954433 2467788999999998865 688889999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC-CCCCCCCCHHHHhcCcccc
Q 006277 202 LEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL-VPASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 202 yeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL-~~P~~RpSa~elL~hpf~~ 268 (652)
|++..|..||-. ......+.+.........+...+.++-.....+| .+-..||.-...+.-+.+.
T Consensus 1431 y~rs~~n~~fi~--flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1431 YLRSDGNAYFIF--FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHhcccHHHHH--HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 999999888743 1122222222222333444444444444434444 3667888888888777664
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.0006 Score=67.53 Aligned_cols=141 Identities=20% Similarity=0.209 Sum_probs=80.7
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC--CeeeeeeEEEe-CCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN--NIIRFYNSWID-DQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hp--nIVkl~~~~~d-~~~~~~~LVm 90 (652)
.++..+..+.||+..... ..+++|.... ......+.+|+.+++.|... .+.+++..... ......+++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRP------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEESS------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeCC------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 566777778999998765 4888887542 24567788899999888433 35566653322 2234679999
Q ss_pred ecCCCCCHHH----------------HHH---hC----CCCCHH---------HHHHH------------HHHHHH-HHH
Q 006277 91 ELFTSGSLRQ----------------YRK---KH----KKVDMK---------AVKGW------------ARQILS-GLI 125 (652)
Q Consensus 91 Ey~~gGsL~~----------------~i~---~~----~~lse~---------~i~~i------------~~QIl~-aL~ 125 (652)
++++|..+.. .+. .. ..+... ....+ ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988777 111 11 011100 00000 111222 333
Q ss_pred HHHh-----CCCCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 126 YLHS-----HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 126 yLHs-----~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
.++. ....++|+|+.|.|||++..++.|-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3332 223499999999999998555677899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00027 Score=72.03 Aligned_cols=75 Identities=12% Similarity=0.003 Sum_probs=48.7
Q ss_pred EEEEecC-cEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 15 RLIQLVD-TSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 15 rL~~l~~-gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
++..+.. ..||+.... +..+.+|...... ...+.+|+++++.| .+--+.+++.+.... +..++||++
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~ 73 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSA 73 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEe
Confidence 3433333 688999653 4567777654221 34567799999888 344466777765443 357899999
Q ss_pred CCCCCHHH
Q 006277 93 FTSGSLRQ 100 (652)
Q Consensus 93 ~~gGsL~~ 100 (652)
++|.+|..
T Consensus 74 i~G~~l~~ 81 (244)
T cd05150 74 VPGVPAAA 81 (244)
T ss_pred eCCccHhH
Confidence 99987753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00014 Score=82.70 Aligned_cols=76 Identities=16% Similarity=0.228 Sum_probs=53.7
Q ss_pred eEEEEEecCCCCCHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 85 TVNIITELFTSGSLRQY--RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 85 ~~~LVmEy~~gGsL~~~--i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
.-.|+|||+.|-.+.+. ++. ..++.+.+...+.++.- ..+-..| +.|.|.+|.||+++ .+|++-+.|||+..
T Consensus 240 ~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~--~q~~~dg--ffHaDpHpGNi~v~-~~g~i~~lDfGi~g 313 (517)
T COG0661 240 RRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFL--RQLLRDG--FFHADPHPGNILVR-SDGRIVLLDFGIVG 313 (517)
T ss_pred CcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHH--HHHHhcC--ccccCCCccceEEe-cCCcEEEEcCccee
Confidence 45899999999988777 444 45664444433333221 2222355 99999999999999 56899999999987
Q ss_pred hhhc
Q 006277 163 IMEQ 166 (652)
Q Consensus 163 ~l~~ 166 (652)
.+..
T Consensus 314 ~l~~ 317 (517)
T COG0661 314 RLDP 317 (517)
T ss_pred cCCH
Confidence 6643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00038 Score=71.01 Aligned_cols=135 Identities=12% Similarity=0.081 Sum_probs=77.5
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC--eeeeeeEEEeCCCCeEEEEEe
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN--IIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hpn--IVkl~~~~~d~~~~~~~LVmE 91 (652)
..++++..+.||+. .|..+++|...... ....+.+|.++++.+..-. +.+.+.+..+. +...+|||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~--~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLVEDG--GRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecC--Ceeeeeee
Confidence 35677777889984 24567788765211 2345688999999985433 45666654333 35789999
Q ss_pred cCCCCC-HH--------------HHHH-----hCC----CCCHHH-HHHHHHH----------HHH-HHHHHH--hCCCC
Q 006277 92 LFTSGS-LR--------------QYRK-----KHK----KVDMKA-VKGWARQ----------ILS-GLIYLH--SHDPP 133 (652)
Q Consensus 92 y~~gGs-L~--------------~~i~-----~~~----~lse~~-i~~i~~Q----------Il~-aL~yLH--s~g~~ 133 (652)
++.|.+ +. ..+. -|. ...... ...+..+ +.. ...+|. ...+.
T Consensus 75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 999963 11 1000 010 111110 1111111 111 122222 22335
Q ss_pred eeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 134 IIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 134 IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
++|+|+.|.||+++ .++ +.++||+.+.
T Consensus 155 ~~HgD~~~~Nii~~-~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITS-GKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEc-CCC-cEEEechhcC
Confidence 89999999999998 455 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0013 Score=67.87 Aligned_cols=135 Identities=19% Similarity=0.173 Sum_probs=91.4
Q ss_pred CcEEEEEEEccCCeEEEEEEEeecccCC------------------CHHHH--HHHHHHHHHHHhC--CCCCeeeeeeEE
Q 006277 21 DTSGYKAFDEVNGLEVAWCQVRIDDVLQ------------------SPEDL--ERLYSEVHLLKSL--KHNNIIRFYNSW 78 (652)
Q Consensus 21 ~gtVykA~d~~tG~~VAiK~v~~~~~~~------------------s~e~~--~~l~~Ei~iLk~L--~HpnIVkl~~~~ 78 (652)
...||+|.. .++..||+|+++..-... ++..+ .=..+|+..|+++ -+-.+.+-+.+.
T Consensus 61 EA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~ 139 (268)
T COG1718 61 EANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR 139 (268)
T ss_pred ceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec
Confidence 368999975 678999999987532110 11111 1245688888888 355666666643
Q ss_pred EeCCCCeEEEEEecCCCCCHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCcccEEEcCCCCcEEEe
Q 006277 79 IDDQNKTVNIITELFTSGSLRQ-YRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIG 156 (652)
Q Consensus 79 ~d~~~~~~~LVmEy~~gGsL~~-~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IiHRDLKp~NILl~~~~g~VKL~ 156 (652)
.-.|||||+....+.. .++. -.+....+..+..+++..+.-|-. .+ +||+||..=|||+. +|.+.++
T Consensus 140 ------~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~--~~~p~iI 208 (268)
T COG1718 140 ------NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH--DGEPYII 208 (268)
T ss_pred ------CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE--CCeEEEE
Confidence 2469999996541110 1111 123334678888899998888876 56 99999999999997 5789999
Q ss_pred ccCchhhhhcc
Q 006277 157 DLGLATIMEQA 167 (652)
Q Consensus 157 DFGla~~l~~~ 167 (652)
|||-|......
T Consensus 209 D~~QaV~~~hp 219 (268)
T COG1718 209 DVSQAVTIDHP 219 (268)
T ss_pred ECccccccCCC
Confidence 99988766543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0039 Score=75.26 Aligned_cols=148 Identities=20% Similarity=0.256 Sum_probs=87.8
Q ss_pred EEEEEEecCcEEEEEEEccCC--eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCe--eeeeeEEEeCC-CCeE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNG--LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNI--IRFYNSWIDDQ-NKTV 86 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG--~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnI--Vkl~~~~~d~~-~~~~ 86 (652)
..++..+....+|+......+ ..+++|+........ ....+.+|+++|+.|. |++| .+++.++.+.. .+..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~---~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ---SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc---cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 345554555688887654332 466677644322221 2346788999999995 6665 67776554431 1357
Q ss_pred EEEEecCCCCCHHH--------------------HHH-hCC---------------CCCHHHHHHHHHH-----------
Q 006277 87 NIITELFTSGSLRQ--------------------YRK-KHK---------------KVDMKAVKGWARQ----------- 119 (652)
Q Consensus 87 ~LVmEy~~gGsL~~--------------------~i~-~~~---------------~lse~~i~~i~~Q----------- 119 (652)
|+||||+.|..+.+ .+. -|. .+-...+..|..|
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999998864321 010 010 0112344444333
Q ss_pred ----HHHHHHHHHhCCC---------CeeeccCCcccEEEcCCCCc-EEEeccCchhh
Q 006277 120 ----ILSGLIYLHSHDP---------PIIHRDLKCDNIFINGNQGE-VKIGDLGLATI 163 (652)
Q Consensus 120 ----Il~aL~yLHs~g~---------~IiHRDLKp~NILl~~~~g~-VKL~DFGla~~ 163 (652)
+...+.||..+-| .+||+|++++|||++..++. +-|.||.++..
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 2234667754322 39999999999999854444 57999998764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00084 Score=66.72 Aligned_cols=100 Identities=22% Similarity=0.156 Sum_probs=77.7
Q ss_pred HHHHHHHhCCC-CCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-
Q 006277 58 SEVHLLKSLKH-NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY---RKKHKKVDMKAVKGWARQILSGLIYLHSHDP- 132 (652)
Q Consensus 58 ~Ei~iLk~L~H-pnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~~~---i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~- 132 (652)
.|.-+|+.+.+ ++++++++++ .-++|+||...+++... +...-.-++..+..++.+++..+.+|+..-.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C------G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC------GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC------CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 47888899965 6999999987 13678999987765421 1122245789999999999999999987422
Q ss_pred CeeeccCCcccEEEcCCCCcEEEeccCchhhh
Q 006277 133 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 164 (652)
Q Consensus 133 ~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l 164 (652)
.+.-.|++++|+-++ ++|++|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~-~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVN-DDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEe-CCCcEEEEechhcchh
Confidence 277799999999998 6789999999876554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0012 Score=75.31 Aligned_cols=88 Identities=14% Similarity=0.165 Sum_probs=58.7
Q ss_pred eeeeeeEEEeCCCCeEEEEEecCCCCCHHH--HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC
Q 006277 71 IIRFYNSWIDDQNKTVNIITELFTSGSLRQ--YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 148 (652)
Q Consensus 71 IVkl~~~~~d~~~~~~~LVmEy~~gGsL~~--~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~ 148 (652)
|.++|..+. ..-.|+||||.|..+.+ ++.++ .++...+...+.+...-.- =.+| .+|.|=+|.||+++.
T Consensus 266 VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~~qI--f~~G--ffHaDPHPGNilv~~ 336 (538)
T KOG1235|consen 266 VPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYLEQI--FKTG--FFHADPHPGNILVRP 336 (538)
T ss_pred CCeehhhcC----cceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHHHHH--HhcC--CccCCCCCCcEEEec
Confidence 556665432 24689999999986644 45554 4555544444444332222 2345 899999999999983
Q ss_pred ---CCCcEEEeccCchhhhhcc
Q 006277 149 ---NQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 149 ---~~g~VKL~DFGla~~l~~~ 167 (652)
.++.+.+-|||+...+...
T Consensus 337 ~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 337 NPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CCCCCccEEEEcccccccccHH
Confidence 3678999999998876543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0023 Score=64.73 Aligned_cols=75 Identities=17% Similarity=0.164 Sum_probs=46.1
Q ss_pred EEEEEEecCcEEEEEEEcc-CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEV-NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~-tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
+.++..+....+|++.... .+..|++|...... ...-...+|+.+++.+. +.-.++++..+ .. .+||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-----~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~ 71 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-----ELIIDRERELRIHKLLSKHGLAPKLYATF--QN----GLIY 71 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-----cceecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEE
Confidence 4566667778899886443 35678888654221 11122346888999884 33345555432 22 3799
Q ss_pred ecCCCCCH
Q 006277 91 ELFTSGSL 98 (652)
Q Consensus 91 Ey~~gGsL 98 (652)
||++|.++
T Consensus 72 e~i~G~~l 79 (235)
T cd05157 72 EFIPGRTL 79 (235)
T ss_pred EeeCCCcC
Confidence 99998664
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0015 Score=66.45 Aligned_cols=30 Identities=20% Similarity=0.305 Sum_probs=23.9
Q ss_pred CeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 133 PIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 133 ~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
.++|+|+.+.||+++ +++..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~-~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQ-DGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEE-CCCEEEEEeCcccCc
Confidence 389999999999998 434456999997643
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0073 Score=60.66 Aligned_cols=121 Identities=23% Similarity=0.296 Sum_probs=77.7
Q ss_pred cCCeEEEEEEEeeccc------------CCCHHHHHHHHHHHHHHHhCC------CCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 31 VNGLEVAWCQVRIDDV------------LQSPEDLERLYSEVHLLKSLK------HNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 31 ~tG~~VAiK~v~~~~~------------~~s~e~~~~l~~Ei~iLk~L~------HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
-......||+...... ...........+|+.....+. +.+|.++|+...... .+.+|+|.
T Consensus 21 P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~--G~Glv~e~ 98 (199)
T PF10707_consen 21 PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNL--GLGLVVEL 98 (199)
T ss_pred CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCC--ceEEEEEE
Confidence 3445567887765440 000112455666766666665 889999999765544 57888888
Q ss_pred CCC------CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC-CC--cEEEec-cCc
Q 006277 93 FTS------GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN-QG--EVKIGD-LGL 160 (652)
Q Consensus 93 ~~g------GsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~-~g--~VKL~D-FGl 160 (652)
+.. -+|.++++. +.+++ .+...+ -.-..||-.++ |+.+||+|.||++... +| .+.|+| ||-
T Consensus 99 I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L---~~f~~~l~~~~--Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 99 IRDADGNISPTLEDYLKE-GGLTE-ELRQAL---DEFKRYLLDHH--IVIRDLNPHNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EECCCCCcCccHHHHHHc-CCccH-HHHHHH---HHHHHHHHHcC--CeecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence 654 368888854 45666 333333 34456777777 9999999999999732 22 467777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0074 Score=63.60 Aligned_cols=75 Identities=17% Similarity=0.088 Sum_probs=46.9
Q ss_pred EEEEEEecCcEEEEEEEcc------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC-eeeeeeEEEeCCCCe
Q 006277 13 YLRLIQLVDTSGYKAFDEV------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN-IIRFYNSWIDDQNKT 85 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~------tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hpn-IVkl~~~~~d~~~~~ 85 (652)
+.++..+....+|+..... ++..|++|...... .......+|+++++.+...+ ..+++.++ ..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~--- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-----ELLIDRERELVVFARLSERNLGPKLYGIF--PN--- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-----cceechHHHHHHHHHHHhCCCCCceEEEe--CC---
Confidence 3556666667899887543 25788888854321 12334577888888884333 34555543 22
Q ss_pred EEEEEecCCCCCH
Q 006277 86 VNIITELFTSGSL 98 (652)
Q Consensus 86 ~~LVmEy~~gGsL 98 (652)
.+|++|++|..+
T Consensus 73 -~~v~e~i~G~~l 84 (302)
T cd05156 73 -GRIEEFIPSRTL 84 (302)
T ss_pred -CchhheeCCCcC
Confidence 258999988765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.011 Score=64.27 Aligned_cols=149 Identities=15% Similarity=0.229 Sum_probs=85.7
Q ss_pred CCcceee----eeeEEEEEEecCcEEEEEEEcc----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCe-ee
Q 006277 3 RQKWSLL----ILMYLRLIQLVDTSGYKAFDEV----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-IR 73 (652)
Q Consensus 3 ~~~W~~~----~~~~~rL~~l~~gtVykA~d~~----tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnI-Vk 73 (652)
++.|... ...+.++..+....+|++.... ++..|.++..... ....+.| .+|+.+++.+..-++ .+
T Consensus 27 ~~~w~~~~~~~~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~----t~~~idR-~~E~~~~~~l~~~gl~P~ 101 (344)
T PLN02236 27 ASKWGDVVDDEALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEG----VELFFDR-DDEIRTFECMSRHGQGPR 101 (344)
T ss_pred cchhcCCCCcCcEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCC----CCeeech-HHHHHHHHHHHHcCCCCc
Confidence 4668642 3456666666777899986422 3467888866432 1223344 679999999854433 45
Q ss_pred eeeEEEeCCCCeEEEEEecCCCCCHHHH--------------HHh-CC--------CCCHHHHHHHHHHHH---------
Q 006277 74 FYNSWIDDQNKTVNIITELFTSGSLRQY--------------RKK-HK--------KVDMKAVKGWARQIL--------- 121 (652)
Q Consensus 74 l~~~~~d~~~~~~~LVmEy~~gGsL~~~--------------i~~-~~--------~lse~~i~~i~~QIl--------- 121 (652)
+++.+ .. + .|++|+.|.+|..- +.+ |. ....+.+..|+.++.
T Consensus 102 ~~~~~--~~-g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~ 175 (344)
T PLN02236 102 LLGRF--PN-G---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAK 175 (344)
T ss_pred eEEEE--CC-c---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhh
Confidence 55544 22 1 58999987665311 110 10 111233444443321
Q ss_pred --------HHHHHH----Hh--CCCCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 122 --------SGLIYL----HS--HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 122 --------~aL~yL----Hs--~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
..+..| .. ....++|+|+++.||+++..++.+.++||..+.
T Consensus 176 ~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 176 EFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 111122 21 112489999999999998545789999998775
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.053 Score=60.15 Aligned_cols=79 Identities=18% Similarity=0.113 Sum_probs=50.9
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccC--CC-HHHHHHHHHHHHHHHhCC---CCCeeeeeeEEEeCCCCeEEE
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVL--QS-PEDLERLYSEVHLLKSLK---HNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~--~s-~e~~~~l~~Ei~iLk~L~---HpnIVkl~~~~~d~~~~~~~L 88 (652)
.++.+.-..||++.+...++.|++|+....-.. .+ +-..++...|.+.|+.+. -.+++++|.+ +.. ..++
T Consensus 33 elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~--~~~l 108 (401)
T PRK09550 33 EIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEE--LAVT 108 (401)
T ss_pred EcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCC--CCEE
Confidence 333333357899988644468999985421110 01 234678888999999872 2467778874 443 4689
Q ss_pred EEecCCCCC
Q 006277 89 ITELFTSGS 97 (652)
Q Consensus 89 VmEy~~gGs 97 (652)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998754
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.01 Score=66.81 Aligned_cols=162 Identities=20% Similarity=0.267 Sum_probs=99.4
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 006277 55 RLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 134 (652)
Q Consensus 55 ~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~I 134 (652)
.+.-..++++.+.|+|...+.++-. .......+|||++ +.+|.++.+.+. +-.... + .++ +
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r-~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~----------~----~~~--~ 88 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSR-GKHERVIVVMEHY-TMSLEDILKTGN-LKDESL----------L----AHG--V 88 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeec-CccceEEEEehhh-ccchHHHHHhcc-cchhhh----------c----ccc--c
Confidence 4556678999999999999988643 3344688999999 669999887654 211111 0 222 3
Q ss_pred eeccCCcccEEEcCCCCcEEEeccCchhhhhccccccccCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCC
Q 006277 135 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSEC 214 (652)
Q Consensus 135 iHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~ 214 (652)
.|- +.++.+| -++ .. ..+..| +++||||+|.++.++.-|..-+...
T Consensus 89 ~~~-------------~~~~~td-~~~---t~--~~~~~~---------------pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 89 LHL-------------NIIYITD-HFL---TK--YPSPIG---------------PKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred cee-------------hhhhccc-ccc---cc--CCCCCC---------------cchhhhhHHHHHHHHHHhhHHHHHH
Confidence 332 1233444 000 00 011222 3899999999999999887666553
Q ss_pred CCHHHHHHHHhcCCCCcc---------ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 215 RNSAQIYKKVSSGIKPAA---------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 215 ~~~~~i~~~I~~g~~p~~---------l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.+.++......-+..+.. .....+..+..+..+|+- .|..||...++.+++-|..
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence 333332222211111111 112245567788889996 7999999999999988753
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.041 Score=58.46 Aligned_cols=76 Identities=13% Similarity=0.064 Sum_probs=46.4
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC---CCeeeeeeEEEeCC-CCeEEEEE
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH---NNIIRFYNSWIDDQ-NKTVNIIT 90 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~H---pnIVkl~~~~~d~~-~~~~~LVm 90 (652)
.++.+..+.||...+. +| .+.+|..+ .. .....+..|...|+.|.. ..+.++++++.+.. .+..+|||
T Consensus 21 ~i~~G~~~~vy~~~~~-~~-~~~~k~~~-~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 21 CISEQPYAALWALYDS-QG-NPMPLMAR-SF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred ecCCccceeEEEEEcC-CC-CEEEEEec-cc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 3343444566766432 23 45667643 11 012467889999998843 46788887665431 24589999
Q ss_pred ecCCCCCH
Q 006277 91 ELFTSGSL 98 (652)
Q Consensus 91 Ey~~gGsL 98 (652)
|++.|+++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.011 Score=60.91 Aligned_cols=134 Identities=15% Similarity=0.142 Sum_probs=73.6
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeEEEeCCCCeEEEEEecCC
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-IRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnI-Vkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
+..+....+|+.. .+|..+++|...... ....-...+|..+++.+....+ .+++.. +. -++||||++
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~----~~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~~----~~~v~e~i~ 71 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVC----KALGVDRQREYQILQALSALGLAPKPILV--NE----HWLLVEWLE 71 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCccc----ccccCcHHHHHHHHHHHHhcCCCCceEEE--eC----CEEEEEecc
Confidence 3445567888885 567788888643221 1110124678899998854333 334432 22 268999999
Q ss_pred CCCHHH-----------H---HHh-C------CCCCH-HHHHHHHHHH---------HHHHHHHHhC------CCCeeec
Q 006277 95 SGSLRQ-----------Y---RKK-H------KKVDM-KAVKGWARQI---------LSGLIYLHSH------DPPIIHR 137 (652)
Q Consensus 95 gGsL~~-----------~---i~~-~------~~lse-~~i~~i~~QI---------l~aL~yLHs~------g~~IiHR 137 (652)
|..+.. . +.+ | .+++. ..+..+..++ ...+..+-.. .+.++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 866531 1 111 1 11221 1222332222 1122222221 1248999
Q ss_pred cCCcccEEEcCCCCcEEEeccCchhh
Q 006277 138 DLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 138 DLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
|+.|.||++++ ++ +.|+||..+..
T Consensus 152 Dl~~~Nil~~~-~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 152 DVHAYNLVVTP-QG-LKLIDWEYASD 175 (256)
T ss_pred CCCcCcEEEeC-CC-CEEEeccccCc
Confidence 99999999984 44 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.026 Score=60.85 Aligned_cols=149 Identities=15% Similarity=0.189 Sum_probs=84.3
Q ss_pred CCcceee---eeeEEEEEEecCcEEEEEEEccC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCe-eeee
Q 006277 3 RQKWSLL---ILMYLRLIQLVDTSGYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-IRFY 75 (652)
Q Consensus 3 ~~~W~~~---~~~~~rL~~l~~gtVykA~d~~t---G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnI-Vkl~ 75 (652)
.|.|... ...+.++..+....+|+...... +..|.+++..... ...+.| .+|+.+++.+..-++ .+++
T Consensus 6 ~~~w~~~~~~~i~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t----~~~IdR-~~E~~il~~l~~~gl~P~~l 80 (330)
T PLN02421 6 FKGWSDLDDSDFSVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT----DYVIDR-ERELQAIKYLSAAGFGAKLL 80 (330)
T ss_pred CCccccCCcCceEEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc----CeEech-HHHHHHHHHHHhcCCCCcee
Confidence 5778654 44666676677778998864332 3478888664221 112232 568888888855444 4555
Q ss_pred eEEEeCCCCeEEEEEecCCCCCHHH-----------H---HHh-CC-C------C-CHHHHHHHHHHH------------
Q 006277 76 NSWIDDQNKTVNIITELFTSGSLRQ-----------Y---RKK-HK-K------V-DMKAVKGWARQI------------ 120 (652)
Q Consensus 76 ~~~~d~~~~~~~LVmEy~~gGsL~~-----------~---i~~-~~-~------l-se~~i~~i~~QI------------ 120 (652)
.++ .. + +|.+|++|..|.. . +++ |. . . -...+..|..++
T Consensus 81 ~~~--~~-G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~ 154 (330)
T PLN02421 81 GVF--GN-G---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQK 154 (330)
T ss_pred EEe--CC-c---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhh
Confidence 544 22 2 5899998765421 0 111 10 1 1 122333333322
Q ss_pred -------------HHHHH-HHHhCC--CCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 121 -------------LSGLI-YLHSHD--PPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 121 -------------l~aL~-yLHs~g--~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
+..+. ++...+ ...+|.||.+.|||++..++.++++||..|.
T Consensus 155 ~~~~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 155 KYETISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hhcccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11111 121212 1379999999999997556789999998775
|
|
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.0024 Score=46.56 Aligned_cols=32 Identities=38% Similarity=0.472 Sum_probs=25.6
Q ss_pred ceeeeeeecCCC------ceeeeecccccCCCCcCcch
Q 006277 361 VSLILRIADQSG------RLRNIHFLFYLDSDTAFSVS 392 (652)
Q Consensus 361 I~liLri~D~~g------~i~~ieF~f~~d~Dta~~Va 392 (652)
|.|+||+.|+.. ....|+|.|++++|++..||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 578999999766 88999999999999998876
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.025 Score=59.27 Aligned_cols=138 Identities=14% Similarity=0.143 Sum_probs=74.7
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC--CeeeeeeE----EEeCCCCeEEE
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN--NIIRFYNS----WIDDQNKTVNI 88 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hp--nIVkl~~~----~~d~~~~~~~L 88 (652)
.+..+....+|+... ++..+++|.... ....++..|+.+++.|.+. .+.+++.. +....++..++
T Consensus 21 ~i~~G~~n~~y~v~~--~~~~~vLr~~~~-------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 21 GISAGIENTNYFVTT--DSGRYVLTLFEK-------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred cccCccccceEEEEe--CCCcEEEEEcCC-------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 344344467888753 345688887642 1234567788888888432 24454432 11111235789
Q ss_pred EEecCCCCCHHH--------H---HHh-C---CCCC--------HHHH------------HHHHHHHHHHHHHHHh----
Q 006277 89 ITELFTSGSLRQ--------Y---RKK-H---KKVD--------MKAV------------KGWARQILSGLIYLHS---- 129 (652)
Q Consensus 89 VmEy~~gGsL~~--------~---i~~-~---~~ls--------e~~i------------~~i~~QIl~aL~yLHs---- 129 (652)
|+++++|..+.. . +.+ | ..+. .... ......+..++.++..
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999999866421 0 000 0 0000 0000 0011122334445443
Q ss_pred -CCCCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 130 -HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 130 -~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
...+++|+|+.|.||+++ .++.+.|+||+.+.
T Consensus 172 ~~~~~l~HgD~~~~Nil~~-~~~~~~iIDfe~a~ 204 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFD-GDELSGVIDFYFAC 204 (296)
T ss_pred cCCCcCCccCcCcccEEEe-CCceEEEeehhhhc
Confidence 112499999999999998 44556899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.049 Score=59.59 Aligned_cols=78 Identities=15% Similarity=0.076 Sum_probs=49.9
Q ss_pred cEEEEEEEccCCeEEEEEEEeecccC-C-C-HHHHHHHHHHHHHHHhCC--CC-CeeeeeeEEEeCCCCeEEEEEecCCC
Q 006277 22 TSGYKAFDEVNGLEVAWCQVRIDDVL-Q-S-PEDLERLYSEVHLLKSLK--HN-NIIRFYNSWIDDQNKTVNIITELFTS 95 (652)
Q Consensus 22 gtVykA~d~~tG~~VAiK~v~~~~~~-~-s-~e~~~~l~~Ei~iLk~L~--Hp-nIVkl~~~~~d~~~~~~~LVmEy~~g 95 (652)
..||++.+...+..|+||+-...-.. . + +-..+|..-|...|+.+. -| .++++|. .|.. ...+|||+++.
T Consensus 9 N~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e--~~~~vMEdL~~ 84 (370)
T TIGR01767 9 NLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTE--MAVTVMEDLSH 84 (370)
T ss_pred EEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccc--cceehHhhCcc
Confidence 47899987644478999986422111 1 1 345678888999998873 34 4666765 3444 46799999965
Q ss_pred C-CHHHHHH
Q 006277 96 G-SLRQYRK 103 (652)
Q Consensus 96 G-sL~~~i~ 103 (652)
. .|++.+.
T Consensus 85 ~~ilR~~Li 93 (370)
T TIGR01767 85 HKIARKGLI 93 (370)
T ss_pred chHHHHHHH
Confidence 4 3445443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.055 Score=53.57 Aligned_cols=125 Identities=24% Similarity=0.187 Sum_probs=82.4
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCee-eeeeEEEeCCCCeEEEEEecCC
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII-RFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIV-kl~~~~~d~~~~~~~LVmEy~~ 94 (652)
|+++..+.||++. ..|.++|+|+-+-+ .....+..|+++|..+..-++- ++|.+- ..++.|||..
T Consensus 30 L~KG~~s~Vyl~~--~~~~~~a~Kvrr~d------s~r~~l~kEakiLeil~g~~~~p~vy~yg------~~~i~me~i~ 95 (201)
T COG2112 30 LAKGTTSVVYLGE--WRGGEVALKVRRRD------SPRRNLEKEAKILEILAGEGVTPEVYFYG------EDFIRMEYID 95 (201)
T ss_pred hhcccccEEEEee--ccCceEEEEEecCC------cchhhHHHHHHHHHHhhhcCCCceEEEec------hhhhhhhhhc
Confidence 4555668899996 56789999975532 3466789999999999877764 455432 2456799999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCC-cc-cEEEcCCCCcEEEeccCchhhhh
Q 006277 95 SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK-CD-NIFINGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 95 gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLK-p~-NILl~~~~g~VKL~DFGla~~l~ 165 (652)
|-.|...-... +.+++ ..++..---|-..| |-|..|. |. ||+++ ++.+.|+||.-|++..
T Consensus 96 G~~L~~~~~~~---~rk~l----~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~--~~~~~iIDFd~At~k~ 157 (201)
T COG2112 96 GRPLGKLEIGG---DRKHL----LRVLEKAYKLDRLG--IEHGELSRPWKNVLVN--DRDVYIIDFDSATFKK 157 (201)
T ss_pred Ccchhhhhhcc---cHHHH----HHHHHHHHHHHHhc--cchhhhcCCceeEEec--CCcEEEEEccchhhcc
Confidence 98886653321 22222 23333322345556 8898884 44 55554 4589999999888543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.062 Score=56.55 Aligned_cols=30 Identities=23% Similarity=0.379 Sum_probs=24.3
Q ss_pred CeeeccCCcccEEEcCCCCc-EEEeccCchhh
Q 006277 133 PIIHRDLKCDNIFINGNQGE-VKIGDLGLATI 163 (652)
Q Consensus 133 ~IiHRDLKp~NILl~~~~g~-VKL~DFGla~~ 163 (652)
.++|+|++|.|||++.+ +. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~-~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDED-ARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCC-CCEEEEECcHhccc
Confidence 48999999999999843 44 56999997754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.081 Score=53.40 Aligned_cols=124 Identities=17% Similarity=0.152 Sum_probs=81.0
Q ss_pred EEEEecC-cEEEEEEEccCCeEEEEEEEeecccCC----------CH-------HHHHHHHHHHHHHHhC---CCCCe--
Q 006277 15 RLIQLVD-TSGYKAFDEVNGLEVAWCQVRIDDVLQ----------SP-------EDLERLYSEVHLLKSL---KHNNI-- 71 (652)
Q Consensus 15 rL~~l~~-gtVykA~d~~tG~~VAiK~v~~~~~~~----------s~-------e~~~~l~~Ei~iLk~L---~HpnI-- 71 (652)
.|+.+.. |.||++. -.|+.||+|.++.-.... .. -...-+..|-+...+| .+.++
T Consensus 44 fLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~A 121 (207)
T PF13095_consen 44 FLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWA 121 (207)
T ss_pred ecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceE
Confidence 4455555 7888885 578999999943311111 00 1233567777776666 45566
Q ss_pred eeeeeEEEeCC---------------C-CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCee
Q 006277 72 IRFYNSWIDDQ---------------N-KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPII 135 (652)
Q Consensus 72 Vkl~~~~~d~~---------------~-~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~Ii 135 (652)
|+.|++..-.. . ...-||.||..... .+.. .-+.+|++-|.-+|..| |+
T Consensus 122 vkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~k~g--I~ 186 (207)
T PF13095_consen 122 VKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILHKLG--IV 186 (207)
T ss_pred EEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHHHCC--ee
Confidence 99999763221 1 12357888876653 2232 33567888888999999 99
Q ss_pred eccCCcccEEEcCCCCcEEEeccCch
Q 006277 136 HRDLKCDNIFINGNQGEVKIGDLGLA 161 (652)
Q Consensus 136 HRDLKp~NILl~~~~g~VKL~DFGla 161 (652)
-+|+++.|.. + -||+|||.+
T Consensus 187 ~~Dv~~~ny~-~-----G~lvDfs~~ 206 (207)
T PF13095_consen 187 PRDVKPRNYR-G-----GKLVDFSSS 206 (207)
T ss_pred eccCcccccc-C-----CEEEecccC
Confidence 9999999986 2 379999854
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.0075 Score=64.54 Aligned_cols=123 Identities=19% Similarity=0.208 Sum_probs=83.2
Q ss_pred cEEEEEEEccCCeEEEEEEEeecccCC-----CH-----------HHHH--HHHHHHHHHHhCC-C-CCeeeeeeEEEeC
Q 006277 22 TSGYKAFDEVNGLEVAWCQVRIDDVLQ-----SP-----------EDLE--RLYSEVHLLKSLK-H-NNIIRFYNSWIDD 81 (652)
Q Consensus 22 gtVykA~d~~tG~~VAiK~v~~~~~~~-----s~-----------e~~~--~l~~Ei~iLk~L~-H-pnIVkl~~~~~d~ 81 (652)
+.+|.+-+ ..|.+.++|.-++.+... .. -.+. ...+|...|+.|. | --+.+.+++
T Consensus 106 SDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVPkpiD~---- 180 (465)
T KOG2268|consen 106 SDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVPKPIDH---- 180 (465)
T ss_pred cceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCCCcccc----
Confidence 68999986 468899998665533211 01 1122 3467999999993 3 334555552
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCc
Q 006277 82 QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160 (652)
Q Consensus 82 ~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGl 160 (652)
. ..++|||++.|-.|.+... ..+. ..+...+..-+--|-.+| +||+|..-=||++. +++.++++||--
T Consensus 181 ~--RH~Vvmelv~g~Pl~~v~~---v~d~---~~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~-dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 181 N--RHCVVMELVDGYPLRQVRH---VEDP---PTLYDDLMGLIVRLANHG--LIHGDFNEFNIMVK-DDDKIVVIDFPQ 248 (465)
T ss_pred c--ceeeHHHhhcccceeeeee---cCCh---HHHHHHHHHHHHHHHHcC--ceecccchheeEEe-cCCCEEEeechH
Confidence 2 5789999999988865432 1223 334444455556677888 99999999999998 678999999953
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.53 Score=49.91 Aligned_cols=29 Identities=28% Similarity=0.324 Sum_probs=23.6
Q ss_pred CeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 133 PIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 133 ~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
++||+|+.|+||+++ .+..+-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~-~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFE-GDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEE-CCceEEEEeccccc
Confidence 499999999999998 33344799998764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.13 Score=54.56 Aligned_cols=30 Identities=30% Similarity=0.418 Sum_probs=24.8
Q ss_pred CCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 132 PPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 132 ~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
.+++|+|+.+.||++++ ++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~-~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDG-DSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEEC-CceEEEeeccccc
Confidence 35999999999999984 4556899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.22 Score=53.64 Aligned_cols=135 Identities=15% Similarity=0.167 Sum_probs=79.7
Q ss_pred EEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC--CCeeeeeeEEEeCCCCeEEEEEecCCCCCH--
Q 006277 23 SGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH--NNIIRFYNSWIDDQNKTVNIITELFTSGSL-- 98 (652)
Q Consensus 23 tVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~H--pnIVkl~~~~~d~~~~~~~LVmEy~~gGsL-- 98 (652)
.+|...+. ++.+++. . ..............+|..+++.+.- .-+...+.++.+..-+..|.||+|+.|..+
T Consensus 40 ~t~~~~~~--~~~~vlR-~--P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~ 114 (321)
T COG3173 40 DTFRLGDT--GQKYVLR-K--PPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS 114 (321)
T ss_pred ceEEEecC--CceEEEe-c--CCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC
Confidence 44555443 7777766 1 2111223556777888888888843 233344554444332467999999998322
Q ss_pred -------H-HHHH--------h--------------CCCCCHHHHHHHHHHH--------------HHHHHHHHhCCC--
Q 006277 99 -------R-QYRK--------K--------------HKKVDMKAVKGWARQI--------------LSGLIYLHSHDP-- 132 (652)
Q Consensus 99 -------~-~~i~--------~--------------~~~lse~~i~~i~~QI--------------l~aL~yLHs~g~-- 132 (652)
. +++. . ...+....+..|..+. ..-..||+.+-|
T Consensus 115 ~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~ 194 (321)
T COG3173 115 ALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPW 194 (321)
T ss_pred cCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCc
Confidence 2 2221 0 0112233444444443 233556766543
Q ss_pred ----CeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 133 ----PIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 133 ----~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
.++|+|+.+.||+++. .+.+=+.||+++..
T Consensus 195 ~~~~~lvHGD~~~gNlii~~-~~~~gVlDwe~~~l 228 (321)
T COG3173 195 AGPPVLVHGDYRPGNLIIDP-GRPTGVLDWELATL 228 (321)
T ss_pred CCCceeeeCCcccCCEEEeC-CCeeEEEecccccc
Confidence 4999999999999984 44588999998764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.29 Score=54.46 Aligned_cols=68 Identities=15% Similarity=0.010 Sum_probs=44.2
Q ss_pred cEEEEEEEccCCeEEEEEEEeecccCCC---HHHHHHHHHHHHHHHhCC---CCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 006277 22 TSGYKAFDEVNGLEVAWCQVRIDDVLQS---PEDLERLYSEVHLLKSLK---HNNIIRFYNSWIDDQNKTVNIITELFTS 95 (652)
Q Consensus 22 gtVykA~d~~tG~~VAiK~v~~~~~~~s---~e~~~~l~~Ei~iLk~L~---HpnIVkl~~~~~d~~~~~~~LVmEy~~g 95 (652)
..||+..+ .+..|+||+-...-...+ +-...|...|...|+.+. -.++.++|.+.. . ..+++||++++
T Consensus 46 N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d--~~vlvME~L~~ 119 (418)
T PLN02756 46 NFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--T--MALIGMRYLEP 119 (418)
T ss_pred eeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--C--CCEEEEeecCC
Confidence 47888776 345688998652222111 124667777888888774 247888887543 2 35789999977
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.19 Score=54.97 Aligned_cols=136 Identities=17% Similarity=0.186 Sum_probs=89.6
Q ss_pred cEEEEEEEccCCeEEEEEEEeecccC--------------------CCHHHHHH--HHHHHHHHHhCCCCCeeeeeeEEE
Q 006277 22 TSGYKAFDEVNGLEVAWCQVRIDDVL--------------------QSPEDLER--LYSEVHLLKSLKHNNIIRFYNSWI 79 (652)
Q Consensus 22 gtVykA~d~~tG~~VAiK~v~~~~~~--------------------~s~e~~~~--l~~Ei~iLk~L~HpnIVkl~~~~~ 79 (652)
..||-|. ..+|..+|||+++-.-+. .+|...-+ ...|++.|++|....|.----+..
T Consensus 158 ANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~PePIlL 236 (520)
T KOG2270|consen 158 ANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCPEPILL 236 (520)
T ss_pred ceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCCCceee
Confidence 4799987 468999999988642110 11222222 345788888887666543332222
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccC
Q 006277 80 DDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 159 (652)
Q Consensus 80 d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFG 159 (652)
. .-.|||+|+....-..=.-+.-.++...+..+-.|++.-+.-|... .++||.||.-=|+|+- +|.+.|+|.+
T Consensus 237 k----~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~-c~LVHADLSEfN~Lyh--dG~lyiIDVS 309 (520)
T KOG2270|consen 237 K----NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQK-CRLVHADLSEFNLLYH--DGKLYIIDVS 309 (520)
T ss_pred e----cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHH-hceeccchhhhhheEE--CCEEEEEEcc
Confidence 1 2479999995322111112233577778888888888888887554 2499999999999995 6899999988
Q ss_pred chhhhh
Q 006277 160 LATIME 165 (652)
Q Consensus 160 la~~l~ 165 (652)
-+....
T Consensus 310 QSVE~D 315 (520)
T KOG2270|consen 310 QSVEHD 315 (520)
T ss_pred ccccCC
Confidence 766543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.18 Score=53.56 Aligned_cols=29 Identities=10% Similarity=0.161 Sum_probs=24.8
Q ss_pred CeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 133 PIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 133 ~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
++||+|+.++|+|++ .++.+-++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~-~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYD-ETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEc-CCCCEEEEEhhhcc
Confidence 499999999999998 45678999998664
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.38 E-value=0.19 Score=55.68 Aligned_cols=79 Identities=15% Similarity=0.130 Sum_probs=51.0
Q ss_pred cEEEEEEEccCCeEEEEEEEeecc-cCCC-HHHHHHHHHHHHHHHhCC--CC-CeeeeeeEEEeCCCCeEEEEEecCCCC
Q 006277 22 TSGYKAFDEVNGLEVAWCQVRIDD-VLQS-PEDLERLYSEVHLLKSLK--HN-NIIRFYNSWIDDQNKTVNIITELFTSG 96 (652)
Q Consensus 22 gtVykA~d~~tG~~VAiK~v~~~~-~~~s-~e~~~~l~~Ei~iLk~L~--Hp-nIVkl~~~~~d~~~~~~~LVmEy~~gG 96 (652)
..||++.+...+..|+||+-...- +-.+ +-..+|..-|..+|+.+. -| +++++|. .|+. ...+|||+++..
T Consensus 43 N~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e--~~~~vMEdL~~~ 118 (409)
T PRK12396 43 NYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSV--MNCCVMEDLSDH 118 (409)
T ss_pred EEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcH--HhhHHHHhCccc
Confidence 478999885446789999864211 1111 345788888999999883 34 5666776 3444 567999999653
Q ss_pred -CHHHHHHh
Q 006277 97 -SLRQYRKK 104 (652)
Q Consensus 97 -sL~~~i~~ 104 (652)
.|++.+.+
T Consensus 119 ~ilR~~Li~ 127 (409)
T PRK12396 119 TILRTALIN 127 (409)
T ss_pred HHHHHHHHc
Confidence 34554443
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.14 E-value=0.19 Score=55.46 Aligned_cols=90 Identities=12% Similarity=-0.006 Sum_probs=49.2
Q ss_pred CCcceeee---eeEEEEEEecCcEEEEEEEccC-CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC-eeeeeeE
Q 006277 3 RQKWSLLI---LMYLRLIQLVDTSGYKAFDEVN-GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN-IIRFYNS 77 (652)
Q Consensus 3 ~~~W~~~~---~~~~rL~~l~~gtVykA~d~~t-G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hpn-IVkl~~~ 77 (652)
.|.|.... ..+.++..++...+|++..... +..+.+|.|.....-...+..-.-.+|+++++.|...+ -.++++.
T Consensus 42 ~p~w~~~~~~~i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~ 121 (383)
T PTZ00384 42 VPFWNNVNPEFIEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGR 121 (383)
T ss_pred CCccccCCcccEEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEe
Confidence 35674332 3556666677788999864332 22332332211111011111112356899999995544 4566765
Q ss_pred EEeCCCCeEEEEEecCCCCCH
Q 006277 78 WIDDQNKTVNIITELFTSGSL 98 (652)
Q Consensus 78 ~~d~~~~~~~LVmEy~~gGsL 98 (652)
+. -++|.||++|.+|
T Consensus 122 f~------~g~l~efIeGr~l 136 (383)
T PTZ00384 122 FG------DFTIQEWVEGNTM 136 (383)
T ss_pred cC------CEEEEEEeccccC
Confidence 52 2599999998765
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.55 E-value=0.23 Score=54.24 Aligned_cols=95 Identities=18% Similarity=0.178 Sum_probs=66.2
Q ss_pred HHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccC
Q 006277 60 VHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL 139 (652)
Q Consensus 60 i~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDL 139 (652)
+...+...-++..+.+-+-.+ ++.+.|++|++- |+.|.- + ..-..+++..++.+.+..++-|..+ -+.=||+|
T Consensus 276 L~qw~~~g~~~~e~~~vv~~d-e~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekk-f~fehrnl 348 (488)
T COG5072 276 LRQWRECGSVFLETLKVVSLD-ETLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKK-FPFEHRNL 348 (488)
T ss_pred hhhhhhccchhhhcceEEecC-CceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhc-CCcccccc
Confidence 334444455555555543323 345888999986 555532 1 1234667788888888777777666 46899999
Q ss_pred CcccEEEcCCCCcEEEeccCchhh
Q 006277 140 KCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 140 Kp~NILl~~~~g~VKL~DFGla~~ 163 (652)
..+||||+ .|+|-|+||-+++.
T Consensus 349 t~~niLId--~GnvtLIDfklsRl 370 (488)
T COG5072 349 TLDNILID--EGNVTLIDFKLSRL 370 (488)
T ss_pred cccceeee--cCceEEEEeeeeec
Confidence 99999998 58999999999983
|
|
| >KOG4720 consensus Ethanolamine kinase [Lipid transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.15 E-value=0.26 Score=52.37 Aligned_cols=150 Identities=18% Similarity=0.239 Sum_probs=87.1
Q ss_pred CCCcceeeeeeEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEe
Q 006277 2 VRQKWSLLILMYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWID 80 (652)
Q Consensus 2 ~~~~W~~~~~~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d 80 (652)
.||.|.-....+.|+..++....+.+....+.+..++=.+-.. +.+.+-.-.+|+...+.| -|-.-.++|+.|.
T Consensus 75 Lrp~W~~~~v~~~~fs~gitNkL~~~~vg~~~e~~v~vrvyg~----~te~vIdre~Ev~afk~L~a~G~ap~Ly~tF~- 149 (391)
T KOG4720|consen 75 LRPHWKPPEVTFKRFSDGITNKLFSCYVGENMEDHVLVRVYGH----NTELVIDRENEVIAFKLLAAYGFAPKLYGTFN- 149 (391)
T ss_pred hcccCCccceeeeeeccchhHHHHHhhcccccceeEEEEeccC----CCceeeccHHHHHHHHHHHHcCcChhhhheec-
Confidence 4899999888887777666655555544333333332222111 112222234577777877 5788889999883
Q ss_pred CCCCeEEEEEecCCCCCHHH----------HHHh----------CCCCC----HHHHH----------------------
Q 006277 81 DQNKTVNIITELFTSGSLRQ----------YRKK----------HKKVD----MKAVK---------------------- 114 (652)
Q Consensus 81 ~~~~~~~LVmEy~~gGsL~~----------~i~~----------~~~ls----e~~i~---------------------- 114 (652)
+ .||.||++|.+|.- .+.+ .+..+ +....
T Consensus 150 --N---GLvyefi~g~tL~p~~mr~pki~~lIAr~mak~H~~~~~g~~pkp~lw~km~~f~~lv~~~f~de~~kq~~~~~ 224 (391)
T KOG4720|consen 150 --N---GLVYEFIQGKTLEPEHMREPKIFRLIARRMAKIHSIVATGGNPKPPLWEKMRKFLQLVPTSFEDEINKQNLFDE 224 (391)
T ss_pred --C---ceEEeeecCcccChhhccChHHHHHHHHHHHHhheeccCCCCCCCcHHHHHHHHHHhcCchhhcccchhhcccC
Confidence 2 38999999987732 1100 00000 01111
Q ss_pred ----HHHHHHHHHHHHHHhCCCC--eeeccCCcccEEEcCCCCcEEEeccCch
Q 006277 115 ----GWARQILSGLIYLHSHDPP--IIHRDLKCDNIFINGNQGEVKIGDLGLA 161 (652)
Q Consensus 115 ----~i~~QIl~aL~yLHs~g~~--IiHRDLKp~NILl~~~~g~VKL~DFGla 161 (652)
.+-..|..--++|-..+.| .+|.||=+.||++|...|.|..+||-.+
T Consensus 225 ~~~~~L~~Ei~~l~E~l~~L~sPVVFcHNDLL~~Niiy~~~~~~v~fIDYEYa 277 (391)
T KOG4720|consen 225 PSPEDLGEEISKLKEMLSMLKSPVVFCHNDLLCGNIIYDSEKGSVEFIDYEYA 277 (391)
T ss_pred CCHHHHHHHHHHHHHHHHhhCCCeEEeecchhhcceeeccccCcEEEEeeccc
Confidence 1112222222333334455 4799999999999998999999998755
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.32 E-value=3.1 Score=44.78 Aligned_cols=72 Identities=10% Similarity=0.005 Sum_probs=40.7
Q ss_pred cCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC--Ceeeee---eEEEeCCCCeEEEEEecCC
Q 006277 20 VDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN--NIIRFY---NSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 20 ~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hp--nIVkl~---~~~~d~~~~~~~LVmEy~~ 94 (652)
....||+... .+|..+++|+.+.... ....+..|+..+..|... .++... +-....-++..+.+++++.
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~-----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERW-----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccC-----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 4568999864 4566788887653221 245566788888777321 122211 1110111246788999988
Q ss_pred CCC
Q 006277 95 SGS 97 (652)
Q Consensus 95 gGs 97 (652)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 753
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.16 E-value=1.2 Score=50.21 Aligned_cols=85 Identities=14% Similarity=0.132 Sum_probs=49.6
Q ss_pred CCcceee---eeeEEEEEEecCcEEEEEEEcc--------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCe
Q 006277 3 RQKWSLL---ILMYLRLIQLVDTSGYKAFDEV--------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI 71 (652)
Q Consensus 3 ~~~W~~~---~~~~~rL~~l~~gtVykA~d~~--------tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnI 71 (652)
.|.|... ...+.++..+....+|++.... +++.|.+++.-... ...+ .-.+|..+++.+..-+|
T Consensus 97 vp~W~~~~~~~I~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t----e~lI-dR~~E~~v~~~ls~~gi 171 (442)
T PTZ00296 97 VPEWRRFTEDDVRVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV----DELY-NPISEFEVYKTMSKYRI 171 (442)
T ss_pred CCccccCCcccEEEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc----ccee-CHHHHHHHHHHHHHCCC
Confidence 4668632 2356666666677889887442 25678877653211 1222 23568888888854444
Q ss_pred -eeeeeEEEeCCCCeEEEEEecCCCCCH
Q 006277 72 -IRFYNSWIDDQNKTVNIITELFTSGSL 98 (652)
Q Consensus 72 -Vkl~~~~~d~~~~~~~LVmEy~~gGsL 98 (652)
.++++.+ .+ +.|.+|++|..|
T Consensus 172 ~P~l~~~f--~g----g~I~efi~g~~l 193 (442)
T PTZ00296 172 APQLLNTF--SG----GRIEEWLYGDPL 193 (442)
T ss_pred CCceEEEe--CC----CEEEEeeCCccC
Confidence 3456544 22 367899988643
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=90.14 E-value=1.3 Score=47.13 Aligned_cols=71 Identities=13% Similarity=0.075 Sum_probs=39.1
Q ss_pred EEEEecCc---EEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC---CCCeeeeeeEEEeCCCCeEEE
Q 006277 15 RLIQLVDT---SGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK---HNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 15 rL~~l~~g---tVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~---HpnIVkl~~~~~d~~~~~~~L 88 (652)
++..+.+| .+|+.. .++..+.+|+-. . .....+..|..-|+.|. --.+.+++.+..... .-+|
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~--~~fL 89 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNS-E------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD--DAFL 89 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-G------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS--CCEE
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecC-h------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC--CceE
Confidence 44444454 556654 678889999765 2 23346778888888883 345667777655443 4589
Q ss_pred EEecCCCC
Q 006277 89 ITELFTSG 96 (652)
Q Consensus 89 VmEy~~gG 96 (652)
||||++.+
T Consensus 90 lle~l~~~ 97 (288)
T PF03881_consen 90 LLEFLEMG 97 (288)
T ss_dssp EEE-----
T ss_pred EEEeecCC
Confidence 99999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=89.75 E-value=0.9 Score=46.79 Aligned_cols=85 Identities=21% Similarity=0.312 Sum_probs=60.0
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 006277 55 RLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 134 (652)
Q Consensus 55 ~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~I 134 (652)
-++.+.+++.++. .|+++.. | .+..+.+|.|+|-.-.. . ...++..=+++|.-.|+.++..
T Consensus 104 ~y~nky~v~Armh--GilrL~N---D-n~~~yGvIlE~Cy~~~i---------~----~~N~i~agi~~L~~fH~~~~~~ 164 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKN---D-NNYKYGVILERCYKIKI---------N----FSNFITAGIKDLMDFHSENQHC 164 (308)
T ss_pred hhhhhhhHHHHhh--heeEeec---C-CCceeEEEEeeccCccc---------c----hhHHHHHhHHHHHHhhccCCCe
Confidence 4466778887664 5777773 3 55578899999954211 0 1122222356788889766679
Q ss_pred eeccCCcccEEEcCCCCcEEEeccC
Q 006277 135 IHRDLKCDNIFINGNQGEVKIGDLG 159 (652)
Q Consensus 135 iHRDLKp~NILl~~~~g~VKL~DFG 159 (652)
+|+|-.|+||+-+ ..|.+||.|=+
T Consensus 165 lHGD~np~NiM~D-~~G~lKlVDP~ 188 (308)
T PF07387_consen 165 LHGDCNPDNIMCD-KFGYLKLVDPV 188 (308)
T ss_pred ecCCCChhheeec-CCCCEEecChh
Confidence 9999999999998 67899999854
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=89.13 E-value=1.9 Score=44.64 Aligned_cols=73 Identities=14% Similarity=0.150 Sum_probs=51.1
Q ss_pred EEecCcEEEEEEEccCCe-EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC---CeeeeeeEEEeCCCCeEEEEEec
Q 006277 17 IQLVDTSGYKAFDEVNGL-EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN---NIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 17 ~~l~~gtVykA~d~~tG~-~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hp---nIVkl~~~~~d~~~~~~~LVmEy 92 (652)
.++-+|.|..|+...+|. +|-+|+= ..+....+..|+.-|..|.-. .+.+++. ....+...|+||||
T Consensus 22 ~~v~gG~inea~~v~dg~~~~FvK~n-------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~--~G~~~~~sylVle~ 92 (286)
T COG3001 22 EEVSGGDINEAWRLRDGTDPFFVKCN-------QREQLSMFTAEADGLELLARSNTITVPKVIA--VGASRDHSYLVLEY 92 (286)
T ss_pred cccCCccccceeEeecCCcceEEEec-------chhhHHHHHHHHHHHHHHHhcCCccccceEE--ecCCCCeeEEEEee
Confidence 345568888888877765 5777752 245667888898888888444 4556665 34455689999999
Q ss_pred CCCCCH
Q 006277 93 FTSGSL 98 (652)
Q Consensus 93 ~~gGsL 98 (652)
++-|.+
T Consensus 93 L~~~~~ 98 (286)
T COG3001 93 LPTGPL 98 (286)
T ss_pred ccCCCC
Confidence 987654
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=88.35 E-value=7.8 Score=48.34 Aligned_cols=31 Identities=26% Similarity=0.440 Sum_probs=24.3
Q ss_pred CeeeccCCcccEEEcCCC-CcEE-EeccCchhh
Q 006277 133 PIIHRDLKCDNIFINGNQ-GEVK-IGDLGLATI 163 (652)
Q Consensus 133 ~IiHRDLKp~NILl~~~~-g~VK-L~DFGla~~ 163 (652)
.+||.|+.+.|||++++. +++. |+|||-+..
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 499999999999998432 2555 999997643
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=87.03 E-value=1.1 Score=46.95 Aligned_cols=29 Identities=28% Similarity=0.418 Sum_probs=24.3
Q ss_pred CCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 132 PPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 132 ~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECcccc
Confidence 35999999999999984 578999998553
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 652 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-68 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-24 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-23 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-23 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-19 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-18 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-18 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-15 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-15 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-15 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-15 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-14 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-14 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-14 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 404 bits (1041), Expect = e-138
Identities = 131/247 (53%), Positives = 172/247 (69%), Gaps = 5/247 (2%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID--DQ 82
YK D +EVAWC+++ + + +R E +LK L+H NI+RFY+SW
Sbjct: 43 YKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100
Query: 83 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
K + ++TEL TSG+L+ Y K+ K + +K ++ W RQIL GL +LH+ PPIIHRDLKCD
Sbjct: 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 160
Query: 143 NIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCML 202
NIFI G G VKIGDLGLAT+ + AK+VIGTPEFMAPE+Y+E Y+E D+Y+FGMCML
Sbjct: 161 NIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCML 220
Query: 203 EMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKEL 261
EM T EYPYSEC+N+AQIY++V+SG+KPA+ KV PEVK IE C+ +R S K+L
Sbjct: 221 EMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 280
Query: 262 LMDPFLQ 268
L F Q
Sbjct: 281 LNHAFFQ 287
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-62
Identities = 74/255 (29%), Positives = 119/255 (46%), Gaps = 16/255 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
K + +G + W ++ + + + L SEV+LL+ LKH NI+R+Y+ ID N
Sbjct: 23 QKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDM----KAVKGWARQILSGLIYLHSHDPP---IIHR 137
T+ I+ E G L K K + V Q+ L H ++HR
Sbjct: 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 140
Query: 138 DLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPELY-DENYNELADI 194
DLK N+F++G VK+GD GLA I+ AK+ +GTP +M+PE +YNE +DI
Sbjct: 141 DLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDI 199
Query: 195 YSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-AS 253
+S G + E+ P+ + ++ K+ G K + E+ I + L
Sbjct: 200 WSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKDY 257
Query: 254 QRLSAKELLMDPFLQ 268
R S +E+L +P +
Sbjct: 258 HRPSVEEILENPLIL 272
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-61
Identities = 60/250 (24%), Positives = 118/250 (47%), Gaps = 15/250 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+G + ++ I S ++ E EV +L ++KH NI+++ S+ ++ +
Sbjct: 41 ILVKSTEDGRQYVIKEINISR--MSSKEREESRREVAVLANMKHPNIVQYRESFEENGS- 97
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDM--KAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+ I+ + G L + K V + W QI L ++H I+HRD+K
Sbjct: 98 -LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQ 154
Query: 143 NIFINGNQGEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPELYDEN-YNELADIYSFGM 199
NIF+ + G V++GD G+A ++ A++ IGTP +++PE+ + YN +DI++ G
Sbjct: 155 NIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGC 213
Query: 200 CMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSA 258
+ E+ T ++ + E + + K+ SG +S +++S + + R S
Sbjct: 214 VLYELCTLKHAF-EAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSV 271
Query: 259 KELLMDPFLQ 268
+L F+
Sbjct: 272 NSILEKGFIA 281
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 8e-61
Identities = 65/248 (26%), Positives = 108/248 (43%), Gaps = 16/248 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQN 83
+K + +G A + + P+D R +EV + + +H +R +W +
Sbjct: 74 FKVRSKEDGRLYAVKRSMSPF--RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131
Query: 84 KTVNIITELFTSGSLRQYRKKHKK-VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+ + TE SL+Q+ + + V G+ R L L +LHS ++H D+K
Sbjct: 132 --LYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPA 186
Query: 143 NIFINGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPELYDENYNELADIYSFGMCM 201
NIF+ G K+GD GL + A + G P +MAPEL +Y AD++S G+ +
Sbjct: 187 NIFLGPR-GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTI 245
Query: 202 LEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKE 260
LE+ Q+ + A LS E++S + L P R +A+
Sbjct: 246 LEVACNMELPHGGEGWQQLRQGYLPPEFTAGLS----SELRSVLVMMLEPDPKLRATAEA 301
Query: 261 LLMDPFLQ 268
LL P L+
Sbjct: 302 LLALPVLR 309
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 2e-59
Identities = 79/262 (30%), Positives = 126/262 (48%), Gaps = 15/262 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y+A ++G+ VA +V+I D L + E+ LLK L H N+I++Y S+I+ +
Sbjct: 49 YRAACLLDGVPVALKKVQIFD-LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DN 105
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDM----KAVKGWARQILSGLIYLHSHDPPIIHRDLK 140
+NI+ EL +G L + K KK + V + Q+ S L ++HS ++HRD+K
Sbjct: 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIK 163
Query: 141 CDNIFINGNQGEVKIGDLGLATIME--QANAKSVIGTPEFMAPELYDEN-YNELADIYSF 197
N+FI G VK+GDLGL A S++GTP +M+PE EN YN +DI+S
Sbjct: 164 PANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 222
Query: 198 GMCMLEMVTFEYPY-SECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQR 255
G + EM + P+ + N + KK+ P S E++ + C+ P +R
Sbjct: 223 GCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 282
Query: 256 LSAKELLMDPFLQVNGTTKNRP 277
+ T +
Sbjct: 283 PDVTYVYDVAKRMHACTASSLE 304
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 5e-59
Identities = 81/263 (30%), Positives = 127/263 (48%), Gaps = 25/263 (9%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y D N + +A ++ + + L+ E+ L K LKH NI+++ S+ ++
Sbjct: 39 YAGRDLSNQVRIAIKEIP----ERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG-- 92
Query: 85 TVNIITELFTSGSLRQ-YRKKHKKVDMK--AVKGWARQILSGLIYLHSHDPPIIHRDLKC 141
+ I E GSL R K + + + +QIL GL YLH + I+HRD+K
Sbjct: 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKG 150
Query: 142 DNIFINGNQGEVKIGDLGLATIME--QANAKSVIGTPEFMAPELYDEN---YNELADIYS 196
DN+ IN G +KI D G + + ++ GT ++MAPE+ D+ Y + ADI+S
Sbjct: 151 DNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWS 210
Query: 197 FGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK----PAALSKVKDPEVKSFIEKCLVP- 251
G ++EM T + P+ E KV P ++S E K+FI KC P
Sbjct: 211 LGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS----AEAKAFILKCFEPD 266
Query: 252 ASQRLSAKELLMDPFLQVNGTTK 274
+R A +LL+D FL+V+ K
Sbjct: 267 PDKRACANDLLVDEFLKVSSKKK 289
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-58
Identities = 64/274 (23%), Positives = 114/274 (41%), Gaps = 37/274 (13%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD--- 81
+KA ++G +V+ ++ E+ EV L L H NI+ + W
Sbjct: 28 FKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79
Query: 82 -----------QNKTVNIITELFTSGSLRQY--RKKHKKVDMKAVKGWARQILSGLIYLH 128
+ K + I E G+L Q+ +++ +K+D QI G+ Y+H
Sbjct: 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH 139
Query: 129 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ-ANAKSVIGTPEFMAPELY-DE 186
S +I+RDLK NIF+ +VKIGD GL T ++ GT +M+PE +
Sbjct: 140 SKK--LINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ 196
Query: 187 NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246
+Y + D+Y+ G+ + E++ E +++ + + GI + K+ ++
Sbjct: 197 DYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGIISDIFD----KKEKTLLQ 249
Query: 247 KCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLP 279
K L R + E+L + KN
Sbjct: 250 KLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHT 283
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 7e-57
Identities = 64/273 (23%), Positives = 119/273 (43%), Gaps = 39/273 (14%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN- 83
++A ++V+ A ++R+ + E++ EV L L+H I+R++N+W++
Sbjct: 22 FEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78
Query: 84 ---------KTVNIITELFTSGSLRQY---RKKHKKVDMKAVKGWARQILSGLIYLHSHD 131
+ I +L +L+ + R ++ + QI + +LHS
Sbjct: 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG 138
Query: 132 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--------------ANAKSVIGTPE 177
++HRDLK NIF + VK+GD GL T M+Q A +GT
Sbjct: 139 --LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKL 195
Query: 178 FMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKV 236
+M+PE ++ +Y+ DI+S G+ + E++ YP+S + V + K L
Sbjct: 196 YMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRNL-KFPPLFTQ 251
Query: 237 KDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 268
K P ++ L P +R A ++ + +
Sbjct: 252 KYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-56
Identities = 83/279 (29%), Positives = 121/279 (43%), Gaps = 44/279 (15%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
KA + ++ A ++R + E L + SEV LL SL H ++R+Y +W++ +N
Sbjct: 23 VKARNALDSRYYAIKKIR-----HTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNF 77
Query: 85 TVN-----------IITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDP 132
I E +G+L ++ RQIL L Y+HS
Sbjct: 78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG- 136
Query: 133 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----------------NAKSVIGTP 176
IIHRDLK NIFI+ + VKIGD GLA + ++ N S IGT
Sbjct: 137 -IIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA 194
Query: 177 EFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAA 232
++A E+ D +YNE D+YS G+ EM+ YP+S I KK+ S P
Sbjct: 195 MYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKLRSVSIEFPPD 251
Query: 233 LSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVN 270
K K I + ++R A+ LL +L V
Sbjct: 252 FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-54
Identities = 57/270 (21%), Positives = 109/270 (40%), Gaps = 39/270 (14%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQN 83
+K ++G A + + D + EV+ L +H++++R++++W +D +
Sbjct: 28 FKCVKRLDGCIYAIKRSKKPL--AGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDM----KAVKGWARQILSGLIYLHSHDPPIIHRDL 139
+ I E GSL ++ ++ +K Q+ GL Y+HS ++H D+
Sbjct: 86 --MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDI 141
Query: 140 KCDNIFINGN------------------QGEVKIGDLGLATIMEQANAKSVIGTPEFMAP 181
K NIFI+ + KIGDLG T + + + G F+A
Sbjct: 142 KPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS--SPQVEEGDSRFLAN 199
Query: 182 ELYDEN--YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 239
E+ EN + ADI++ + ++ E + ++ G P + +V
Sbjct: 200 EVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----GDQWHEIRQGRLP-RIPQVLSQ 254
Query: 240 EVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 268
E ++ + P +R SA L+ L
Sbjct: 255 EFTELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-52
Identities = 58/252 (23%), Positives = 101/252 (40%), Gaps = 20/252 (7%)
Query: 25 YKAFDEVNGLEVA---WCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 81
+K + VA + + E + EV ++ +L H NI++ Y
Sbjct: 36 HKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH-- 93
Query: 82 QNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 140
++ E G L K + I G+ Y+ + +PPI+HRDL+
Sbjct: 94 --NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLR 151
Query: 141 CDNIFINGNQGE----VKIGDLGLATIMEQANAKSVIGTPEFMAPELY---DENYNELAD 193
NIF+ K+ D GL+ + ++G ++MAPE +E+Y E AD
Sbjct: 152 SPNIFLQSLDENAPVCAKVADFGLSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKAD 210
Query: 194 IYSFGMCMLEMVTFEYPYSECRNS--AQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP 251
YSF M + ++T E P+ E I G++P + + P +++ IE C
Sbjct: 211 TYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP-TIPEDCPPRLRNVIELCWSG 269
Query: 252 -ASQRLSAKELL 262
+R ++
Sbjct: 270 DPKKRPHFSYIV 281
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 2e-52
Identities = 59/258 (22%), Positives = 97/258 (37%), Gaps = 30/258 (11%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
++ D+ G + A +VR++ E+ L I+ Y + +
Sbjct: 75 HRMKDKQTGFQCAVKKVRLEVFRVE---------ELVACAGLSSPRIVPLYGAVREGP-- 123
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
VNI EL GSL Q K+ + + Q L GL YLH+ I+H D+K DN+
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNV 181
Query: 145 FINGNQGEVKIGDLGLATIMEQ-------ANAKSVIGTPEFMAPELYDEN-YNELADIYS 196
++ + + D G A ++ + GT MAPE+ + DI+S
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241
Query: 197 FGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI----KPAALSKVKDPEVKSFIEKCLVP- 251
ML M+ +P+++ K S P + + P I++ L
Sbjct: 242 SCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA----PLTAQAIQEGLRKE 297
Query: 252 ASQRLSAKELLMDPFLQV 269
R SA EL +
Sbjct: 298 PVHRASAMELRRKVGKAL 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-52
Identities = 66/223 (29%), Positives = 115/223 (51%), Gaps = 12/223 (5%)
Query: 32 NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91
+G +VA + D E + EV ++K L+H NI+ F + N ++I+TE
Sbjct: 59 HGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN--LSIVTE 114
Query: 92 LFTSGSLRQY---RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 148
+ GSL + +++D + A + G+ YLH+ +PPI+HR+LK N+ ++
Sbjct: 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK 174
Query: 149 NQGEVKIGDLGLATIMEQ--ANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMV 205
VK+ D GL+ + ++KS GTPE+MAPE+ DE NE +D+YSFG+ + E+
Sbjct: 175 K-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233
Query: 206 TFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248
T + P+ + + + + + +P+V + IE C
Sbjct: 234 TLQQPWGNLNPAQVVAAVGFKCKRL-EIPRNLNPQVAAIIEGC 275
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 6e-51
Identities = 60/274 (21%), Positives = 113/274 (41%), Gaps = 29/274 (10%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN--IIRFYNSWIDDQ 82
++ +E A V +++ + L+ +E+ L L+ ++ IIR Y+ I DQ
Sbjct: 26 FQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82
Query: 83 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+ ++ E + L + KK K +D K + + +L + +H H I+H DLK
Sbjct: 83 Y--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPA 137
Query: 143 NIFINGNQGEVKIGDLGLATIME----QANAKSVIGTPEFMAPEL------------YDE 186
N I G +K+ D G+A M+ S +GT +M PE
Sbjct: 138 NFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 195
Query: 187 NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246
+ +D++S G + M + P+ + N + + + +++ ++
Sbjct: 196 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK 255
Query: 247 KCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLP 279
CL QR+S ELL P++Q+ N+
Sbjct: 256 CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 289
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 6e-51
Identities = 63/226 (27%), Positives = 95/226 (42%), Gaps = 13/226 (5%)
Query: 32 NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91
G EVA R D + +E + E L LKH NII + + N + ++ E
Sbjct: 29 IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN--LCLVME 86
Query: 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP-PIIHRDLKCDNIFINGNQ 150
G L + K++ + WA QI G+ YLH PIIHRDLK NI I
Sbjct: 87 FARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKV 145
Query: 151 GE-------VKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCML 202
+KI D GLA + S G +MAPE + +++ +D++S+G+ +
Sbjct: 146 ENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLW 205
Query: 203 EMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248
E++T E P+ A Y + + S +E C
Sbjct: 206 ELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC-PEPFAKLMEDC 250
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 3e-50
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 12/209 (5%)
Query: 46 VLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY---R 102
++S + + E+ L + H NI++ Y + + V ++ E GSL
Sbjct: 38 QIESESERKAFIVELRQLSRVNHPNIVKLYGACL----NPVCLVMEYAEGGSLYNVLHGA 93
Query: 103 KKHKKVDMKAVKGWARQILSGLIYLHSHDP-PIIHRDLKCDNIFINGNQGEVKIGDLGLA 161
+ W Q G+ YLHS P +IHRDLK N+ + +KI D G A
Sbjct: 94 EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153
Query: 162 TIMEQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ- 219
+ Q + + G+ +MAPE+++ NY+E D++S+G+ + E++T P+ E A
Sbjct: 154 CDI-QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR 212
Query: 220 IYKKVSSGIKPAALSKVKDPEVKSFIEKC 248
I V +G +P L K ++S + +C
Sbjct: 213 IMWAVHNGTRP-PLIKNLPKPIESLMTRC 240
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 4e-50
Identities = 59/265 (22%), Positives = 111/265 (41%), Gaps = 29/265 (10%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN--IIRFYNSWIDDQ 82
++ +E A V +++ + L+ +E+ L L+ ++ IIR Y+ I DQ
Sbjct: 45 FQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101
Query: 83 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+ ++ E + L + KK K +D K + + +L + +H H I+H DLK
Sbjct: 102 Y--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPA 156
Query: 143 NIFINGNQGEVKIGDLGLATIMEQ----ANAKSVIGTPEFMAPEL------------YDE 186
N I G +K+ D G+A M+ S +GT +M PE
Sbjct: 157 NFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 214
Query: 187 NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246
+ +D++S G + M + P+ + N + + + +++ ++
Sbjct: 215 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK 274
Query: 247 KCLVP-ASQRLSAKELLMDPFLQVN 270
CL QR+S ELL P++Q+
Sbjct: 275 CCLKRDPKQRISIPELLAHPYVQIQ 299
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-49
Identities = 59/274 (21%), Positives = 112/274 (40%), Gaps = 29/274 (10%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN--IIRFYNSWIDDQ 82
++ +E A V +++ + L+ +E+ L L+ ++ IIR Y+ I DQ
Sbjct: 73 FQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129
Query: 83 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+ ++ E + L + KK K +D K + + +L + +H H I+H DLK
Sbjct: 130 Y--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPA 184
Query: 143 NIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPEL------------YDE 186
N I G +K+ D G+A M+ S +G +M PE
Sbjct: 185 NFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 187 NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246
+ +D++S G + M + P+ + N + + + +++ ++
Sbjct: 243 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK 302
Query: 247 KCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLP 279
CL QR+S ELL P++Q+ N+
Sbjct: 303 CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 336
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-48
Identities = 43/223 (19%), Positives = 84/223 (37%), Gaps = 13/223 (5%)
Query: 32 NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91
G ++ +++ D S E L+ H N++ + +IT
Sbjct: 32 QGNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89
Query: 92 LFTSGSLRQY--RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN 149
GSL + VD +A + G+ +LH+ +P I L ++ I+ +
Sbjct: 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED 149
Query: 150 QGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMV 205
+I + + + P ++APE + AD++SF + + E+V
Sbjct: 150 -MTARISMADVKFSFQS---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV 205
Query: 206 TFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248
T E P+++ N K G++P + P V ++ C
Sbjct: 206 TREVPFADLSNMEIGMKVALEGLRP-TIPPGISPHVSKLMKIC 247
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-48
Identities = 69/212 (32%), Positives = 109/212 (51%), Gaps = 18/212 (8%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKK 107
+P+ L+ +EV +L+ +H NI+ F Q + I+T+ SL + K
Sbjct: 60 TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETK 116
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ- 166
+MK + ARQ G+ YLH+ IIHRDLK +NIF++ + VKIGD GLAT +
Sbjct: 117 FEMKKLIDIARQTARGMDYLHAK--SIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRW 173
Query: 167 ---ANAKSVIGTPEFMAPEL----YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ 219
+ + G+ +MAPE+ Y+ +D+Y+FG+ + E++T + PYS N Q
Sbjct: 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233
Query: 220 IYKKVSSGIKPAALSKVK---DPEVKSFIEKC 248
I + V G LSKV+ +K + +C
Sbjct: 234 IIEMVGRGSLSPDLSKVRSNCPKRMKRLMAEC 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 7e-48
Identities = 49/218 (22%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKK 107
+ + L+ EV + +H N++ F + + + + IIT L +L R
Sbjct: 69 NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH--LAIITSLCKGRTLYSVVRDAKIV 126
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167
+D+ + A++I+ G+ YLH+ I+H+DLK N+F + G+V I D GL +I
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLHAK--GILHKDLKSKNVFYD--NGKVVITDFGLFSISGVL 182
Query: 168 NA-------KSVIGTPEFMAPEL----------YDENYNELADIYSFGMCMLEMVTFEYP 210
A + G +APE+ +++ +D+++ G E+ E+P
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
Query: 211 YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248
+ + I ++ +G+KP E+ + C
Sbjct: 243 FKTQ-PAEAIIWQMGTGMKPNLSQIGMGKEISDILLFC 279
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 3e-45
Identities = 54/250 (21%), Positives = 101/250 (40%), Gaps = 28/250 (11%)
Query: 38 WCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGS 97
D L SP ++ ++ + N + + I +L +
Sbjct: 90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVY--LYIQMQLCRKEN 147
Query: 98 LRQY---RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVK 154
L+ + R + + QI + +LHS ++HRDLK NIF + VK
Sbjct: 148 LKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVK 204
Query: 155 IGDLGLATIMEQANAK--------------SVIGTPEFMAPE-LYDENYNELADIYSFGM 199
+GD GL T M+Q + +GT +M+PE ++ NY+ DI+S G+
Sbjct: 205 VGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGL 264
Query: 200 CMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSA 258
+ E++ Y +S +I V + P ++ K P+ ++ L P ++R A
Sbjct: 265 ILFELL---YSFSTQMERVRIITDVRNLKFPLLFTQ-KYPQEHMMVQDMLSPSPTERPEA 320
Query: 259 KELLMDPFLQ 268
+++ + +
Sbjct: 321 TDIIENAIFE 330
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 2e-43
Identities = 76/270 (28%), Positives = 127/270 (47%), Gaps = 23/270 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDD--VLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 82
++ D A +I +L P E++ E+ + +SL H +++ F+ + +D
Sbjct: 32 FEISDADTKEVFA---GKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDN 87
Query: 83 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+ V ++ EL SL + K+ K + + + RQI+ G YLH + +IHRDLK
Sbjct: 88 DF-VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLG 144
Query: 143 NIFINGNQGEVKIGDLGLATIMEQANA--KSVIGTPEFMAPE-LYDENYNELADIYSFGM 199
N+F+N + EVKIGD GLAT +E K + GTP ++APE L + ++ D++S G
Sbjct: 145 NLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGC 203
Query: 200 CMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDPEVKSFIEKCLVP-ASQRL 256
M ++ P E + Y ++ P ++ P S I+K L + R
Sbjct: 204 IMYTLLV-GKPPFETSCLKETYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARP 258
Query: 257 SAKELLMDPFLQVNGTTKNRPLPLPDIVLP 286
+ ELL D F LP+ + +P
Sbjct: 259 TINELLNDEFFTSGYIPAR--LPITCLTIP 286
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 49/265 (18%), Positives = 85/265 (32%), Gaps = 33/265 (12%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+G A ++ +D E E + + H NI+R + ++
Sbjct: 46 DLVEGLHDGHFYALKRILC----HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101
Query: 85 T--VNIITELFTSGSLRQY----RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRD 138
++ F G+L + K + + I GL +H+ HRD
Sbjct: 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRD 159
Query: 139 LKCDNIFINGNQGEVKIGDLGLATIMEQANAKS-----------VIGTPEFMAPELYDEN 187
LK NI + G+ + DLG S T + APEL+
Sbjct: 160 LKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ 218
Query: 188 ----YNELADIYSFGMCML-EMVTFEYPY-SECRNSAQIYKKVSSGIKPAALSKVKDPEV 241
+E D++S G C+L M+ E PY + + V + + + +
Sbjct: 219 SHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH-SSAL 276
Query: 242 KSFIEKCLVP-ASQRLSAKELLMDP 265
+ + QR LL
Sbjct: 277 WQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-43
Identities = 80/292 (27%), Positives = 135/292 (46%), Gaps = 23/292 (7%)
Query: 25 YKAFDEVNGLEVAWCQVRID-DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
++ D A ++ + +L P E++ E+ + +SL H +++ F+ + +D +
Sbjct: 58 FEISDADTKEVFA-GKI-VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDND 114
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
V ++ EL SL + K+ K + + + RQI+ G YLH + +IHRDLK N
Sbjct: 115 F-VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGN 171
Query: 144 IFINGNQGEVKIGDLGLATIMEQANA--KSVIGTPEFMAPE-LYDENYNELADIYSFGMC 200
+F+N + EVKIGD GLAT +E K + GTP ++APE L + ++ D++S G
Sbjct: 172 LFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCI 230
Query: 201 MLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDPEVKSFIEKCLVP-ASQRLS 257
M ++ P E + Y ++ P ++ P S I+K L + R +
Sbjct: 231 MYTLLV-GKPPFETSCLKETYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPT 285
Query: 258 AKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEG--PASVRNK 307
ELL D F LP+ + +P + L P +V NK
Sbjct: 286 INELLNDEFFTSGYIPAR--LPITCLTIPPRFSIAPSSLDPSNRKPLTVLNK 335
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-42
Identities = 76/251 (30%), Positives = 122/251 (48%), Gaps = 21/251 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+K D VA ++I D+ ++ +++E + E+ +L + ++Y S++ D
Sbjct: 39 FKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK- 94
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ II E GS + +D + R+IL GL YLHS IHRD+K N+
Sbjct: 95 -LWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANV 150
Query: 145 FINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPELYDEN-YNELADIYSFGMCM 201
++ GEVK+ D G+A + K + +GTP +MAPE+ ++ Y+ ADI+S G+
Sbjct: 151 LLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITA 209
Query: 202 LEMVTFEYPYSEC---RNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLS 257
+E+ E P+SE + I K P L +K F+E CL S R +
Sbjct: 210 IELARGEPPHSELHPMKVLFLIPKN-----NPPTLEGNYSKPLKEFVEACLNKEPSFRPT 264
Query: 258 AKELLMDPFLQ 268
AKELL F+
Sbjct: 265 AKELLKHKFIL 275
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 59/254 (23%), Positives = 119/254 (46%), Gaps = 17/254 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNIIRFYNSWIDDQN 83
+K G +A Q+R + E+ +R+ ++ +LKS I++ + ++I + +
Sbjct: 42 WKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
V I EL + + + ++ + + + I+ L YL +IHRD+K N
Sbjct: 99 --VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSN 155
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAK-SVIGTPEFMAPE------LYDENYNELADIYS 196
I ++ +G++K+ D G++ + AK G +MAPE +Y+ AD++S
Sbjct: 156 ILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWS 214
Query: 197 FGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK-DPEVKSFIEKCLV-PASQ 254
G+ ++E+ T ++PY C+ ++ KV P + + +SF++ CL +
Sbjct: 215 LGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRK 274
Query: 255 RLSAKELLMDPFLQ 268
R +LL F++
Sbjct: 275 RPKYNKLLEHSFIK 288
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-41
Identities = 65/270 (24%), Positives = 113/270 (41%), Gaps = 35/270 (12%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
A+ +VA ++ ++ + ++ L E+ + H NI+ +Y S++
Sbjct: 32 QAAYCAPKKEKVA---IKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE- 87
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWA--------RQILSGLIYLHSHDPPIIH 136
+ ++ +L + GS+ K R++L GL YLH + IH
Sbjct: 88 -LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIH 144
Query: 137 RDLKCDNIFINGNQGEVKIGDLGLA-------TIMEQANAKSVIGTPEFMAPELYDEN-- 187
RD+K NI + G V+I D G++ I K+ +GTP +MAPE+ ++
Sbjct: 145 RDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG 203
Query: 188 YNELADIYSFGMCMLEMVTFEYPYSEC---RNSAQIYKKVSSGIKPAALSKVKD----PE 240
Y+ ADI+SFG+ +E+ T PY + + + ++ K
Sbjct: 204 YDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKS 263
Query: 241 VKSFIEKCLV--PASQRLSAKELLMDPFLQ 268
+ I CL P +R +A ELL F Q
Sbjct: 264 FRKMISLCLQKDP-EKRPTAAELLRHKFFQ 292
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 9e-41
Identities = 61/245 (24%), Positives = 99/245 (40%), Gaps = 43/245 (17%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVN--IITELFTSGSLRQYRKKHKKVDMKAVKGW 116
E++ ++H NI+ F + I +IT+ +GSL Y K +D K++
Sbjct: 81 EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKL 139
Query: 117 ARQILSGLIYLHS------HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168
A +SGL +LH+ P I HRDLK NI + N G I DLGLA
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNE 198
Query: 169 ----AKSVIGTPEFMAPELYDEN-------YNELADIYSFGMCMLEMVT----------F 207
+ +GT +M PE+ DE+ +AD+YSFG+ + E+ +
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258
Query: 208 EYPYSECRNS----AQIYKKVSSG-----IKPAALSKVKDPEVKSFIEKCLVP-ASQRLS 257
+ PY + S + + V S ++ + +C + RL+
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318
Query: 258 AKELL 262
A +
Sbjct: 319 ALRVK 323
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 73/264 (27%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKA ++ G A ++ + +S E+LE E+ +L + H I++ ++ D
Sbjct: 36 YKAKNKETGALAA---AKVIE-TKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91
Query: 85 TVNIITELFTSGSLRQ-YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
I+ E G++ + + + ++ RQ+L L +LHS IIHRDLK N
Sbjct: 92 W--IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGN 147
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPE------LYDENYNELADIY 195
+ + +G++++ D G++ + K S IGTP +MAPE + D Y+ ADI+
Sbjct: 148 VLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIW 206
Query: 196 SFGMCMLEMVTFEYPYSEC---RNSAQIYKKVSSGIK-PAALSKVKDPEVKSFIEKCLVP 251
S G+ ++EM E P+ E R +I K + P+ S E + F++ L
Sbjct: 207 SLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS----VEFRDFLKIALDK 262
Query: 252 -ASQRLSAKELLMDPFLQVNGTTK 274
R SA +LL PF+ + K
Sbjct: 263 NPETRPSAAQLLEHPFVSSITSNK 286
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 71/253 (28%), Positives = 116/253 (45%), Gaps = 22/253 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y A D N VA ++ QS E + + EV L+ L+H N I++ ++ +
Sbjct: 71 YFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-- 127
Query: 85 TVNIITELFTSGSLRQ-YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
T ++ E + GS K + + L GL YLHSH+ +IHRD+K N
Sbjct: 128 TAWLVME-YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGN 184
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE----LYDENYNELADIYSFGM 199
I ++ G VK+GD G A+IM AN S +GTP +MAPE + + Y+ D++S G+
Sbjct: 185 ILLS-EPGLVKLGDFGSASIMAPAN--SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241
Query: 200 CMLEMVTFEYPYSEC---RNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL-VPASQR 255
+E+ + P I + S ++ S ++F++ CL R
Sbjct: 242 TCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS----EYFRNFVDSCLQKIPQDR 297
Query: 256 LSAKELLMDPFLQ 268
+++ LL F+
Sbjct: 298 PTSEVLLKHRFVL 310
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 75/281 (26%), Positives = 130/281 (46%), Gaps = 35/281 (12%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQN 83
YK G A + + ++ E + E+++LK H NI +Y ++I
Sbjct: 41 YKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95
Query: 84 KTVN----IITELFTSGSLRQYRKKHKKVDMKAVKGW----ARQILSGLIYLHSHDPPII 135
++ ++ E +GS+ K K +K + W R+IL GL +LH H +I
Sbjct: 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK--EEWIAYICREILRGLSHLHQHK--VI 151
Query: 136 HRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPE------LYDEN 187
HRD+K N+ + EVK+ D G++ +++ + + IGTP +MAPE D
Sbjct: 152 HRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDAT 210
Query: 188 YNELADIYSFGMCMLEMVTFEYPYSEC---RNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244
Y+ +D++S G+ +EM P + R I + + +K SK + +SF
Sbjct: 211 YDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK----KFQSF 266
Query: 245 IEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIV 284
IE CLV SQR + ++L+ PF++ + + L D +
Sbjct: 267 IESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHI 307
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 60/245 (24%), Positives = 98/245 (40%), Gaps = 43/245 (17%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVN--IITELFTSGSLRQYRKKHKKVDMKAVKGW 116
E++ L+H NI+ F S + ++ + +IT GSL Y + +D +
Sbjct: 52 ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRI 110
Query: 117 ARQILSGLIYLHS------HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI------M 164
I SGL +LH P I HRDLK NI + N G+ I DLGLA +
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQ 169
Query: 165 EQANAKSVIGTPEFMAPELYDE-------NYNELADIYSFGMCMLEMVT----------F 207
+GT +MAPE+ DE + + DI++FG+ + E+ +
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
Query: 208 EYPYSECRNS----AQIYKKVSSG-----IKPAALSKVKDPEVKSFIEKCLVP-ASQRLS 257
+ P+ + + + K V I S + +++C S RL+
Sbjct: 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 258 AKELL 262
A +
Sbjct: 290 ALRIK 294
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-40
Identities = 75/258 (29%), Positives = 122/258 (47%), Gaps = 22/258 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y A D G EVA +R + LQ E + +E+ +++ K+ NI+ + +S++
Sbjct: 37 YTAMDVATGQEVA---IRQMN-LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-- 90
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ ++ E GSL +D + R+ L L +LHS+ +IHRD+K DNI
Sbjct: 91 ELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNI 147
Query: 145 FINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPELYDEN-YNELADIYSFGMCM 201
+ G VK+ D G + +K +++GTP +MAPE+ Y DI+S G+
Sbjct: 148 LLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 202 LEMVTFEYPYSEC---RNSAQIYKKVSSGIK-PAALSKVKDPEVKSFIEKCL-VPASQRL 256
+EM+ E PY R I + ++ P LS + F+ +CL + +R
Sbjct: 207 IEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS----AIFRDFLNRCLEMDVEKRG 262
Query: 257 SAKELLMDPFLQVNGTTK 274
SAKELL FL++
Sbjct: 263 SAKELLQHQFLKIAKPLS 280
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 8e-40
Identities = 47/290 (16%), Positives = 102/290 (35%), Gaps = 50/290 (17%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
++ + G A +++ + + ++ E +LK L H NI++ + + +
Sbjct: 26 FRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDM---KAVKGWARQILSGLIYLHSHDPPIIHRDLKC 141
+I E GSL ++ R ++ G+ +L + I+HR++K
Sbjct: 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKP 140
Query: 142 DNIFINGNQGE---VKIGDLGLATIMEQAN-AKSVIGTPEFMAPELYD---------ENY 188
NI + K+ D G A +E S+ GT E++ P++Y+ + Y
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY 200
Query: 189 NELADIYSFGMCMLEMVT----FEYPYSECRNSAQIYKKVSSG----------------- 227
D++S G+ T F P+ R + ++ K+ +G
Sbjct: 201 GATVDLWSIGVTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI 259
Query: 228 ------IKPAALSKVKDPEVKSFIEKCL-VPASQRLSAKELLMDPFLQVN 270
+LS+ + + L + + + ++
Sbjct: 260 DWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 23/219 (10%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHK 106
E EV +++ L+H N+++F D+ +N ITE G+LR +
Sbjct: 46 FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDS 103
Query: 107 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166
+ +A+ I SG+ YLHS + IIHRDL N + N V + D GLA +M
Sbjct: 104 QYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVREN-KNVVVADFGLARLMVD 160
Query: 167 ----------------ANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEY 209
+V+G P +MAPE + +Y+E D++SFG+ + E++
Sbjct: 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
Query: 210 PYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248
+ + G P +C
Sbjct: 221 ADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRC 259
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 60/245 (24%), Positives = 97/245 (39%), Gaps = 43/245 (17%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVN--IITELFTSGSLRQYRKKHKKVDMKAVKGW 116
E++ L+H NI+ F + D ++++ GSL Y ++ V ++ +
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKL 144
Query: 117 ARQILSGLIYLHS------HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--- 167
A SGL +LH P I HRDLK NI + N G I DLGLA + A
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDT 203
Query: 168 ---NAKSVIGTPEFMAPELYDEN-------YNELADIYSFGMCMLEMVT----------F 207
+GT +MAPE+ D++ + ADIY+ G+ E+ +
Sbjct: 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263
Query: 208 EYPYSECRNS----AQIYKKVSSG-----IKPAALSKVKDPEVKSFIEKCLVP-ASQRLS 257
+ PY + S ++ K V I S + + +C + RL+
Sbjct: 264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323
Query: 258 AKELL 262
A +
Sbjct: 324 ALRIK 328
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 73/257 (28%), Positives = 127/257 (49%), Gaps = 20/257 (7%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKA + G VA ++ V +++ + E+ +++ +++++Y S+ +N
Sbjct: 46 YKAIHKETGQIVA---IKQVPVESDLQEIIK---EISIMQQCDSPHVVKYYGSYF--KNT 97
Query: 85 TVNIITELFTSGSLRQ-YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ I+ E +GS+ R ++K + + + L GL YLH IHRD+K N
Sbjct: 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGN 155
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPELYDEN-YNELADIYSFGMC 200
I +N +G K+ D G+A + AK +VIGTP +MAPE+ E YN +ADI+S G+
Sbjct: 156 ILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGIT 214
Query: 201 MLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD--PEVKSFIEKCLVP-ASQRLS 257
+EM + PY++ I+ ++ P K + F+++CLV QR +
Sbjct: 215 AIEMAEGKPPYADIHPMRAIFMIPTNP--PPTFRKPELWSDNFTDFVKQCLVKSPEQRAT 272
Query: 258 AKELLMDPFLQVNGTTK 274
A +LL PF++
Sbjct: 273 ATQLLQHPFVRSAKGVS 289
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 71/258 (27%), Positives = 129/258 (50%), Gaps = 22/258 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
A ++ +G +VA V++ D L+ + E L++EV +++ +H N++ Y S++ +
Sbjct: 62 CLAREKHSGRQVA---VKMMD-LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE- 116
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ ++ E G+L +++ + + +L L YLH+ +IHRD+K D+I
Sbjct: 117 -LWVLMEFLQGGALTDIV-SQVRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSI 172
Query: 145 FINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPEL-YDENYNELADIYSFGMCM 201
+ G VK+ D G + + K S++GTP +MAPE+ Y DI+S G+ +
Sbjct: 173 LLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMV 231
Query: 202 LEMVTFEYPYSEC---RNSAQIYKKVSSGIK-PAALSKVKDPEVKSFIEKCLVP-ASQRL 256
+EMV E PY + ++ +K +S P ++ F+E+ LV +R
Sbjct: 232 IEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVS----PVLRDFLERMLVRDPQERA 287
Query: 257 SAKELLMDPFLQVNGTTK 274
+A+ELL PFL G +
Sbjct: 288 TAQELLDHPFLLQTGLPE 305
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 64/287 (22%), Positives = 120/287 (41%), Gaps = 50/287 (17%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+K + +GL +A + ++ P ++ E+ +L I+ FY ++ D
Sbjct: 50 FKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-- 104
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
++I E GSL Q KK ++ + + + ++ GL YL I+HRD+K NI
Sbjct: 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNI 163
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLE 203
+N ++GE+K+ D G++ + + A S +GT +M+PE L +Y+ +DI+S G+ ++E
Sbjct: 164 LVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
Query: 204 MVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD------------------------- 238
M YP AA + +
Sbjct: 223 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLD 282
Query: 239 ----------------PEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268
E + F+ KCL+ ++R K+L++ F++
Sbjct: 283 YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-39
Identities = 64/262 (24%), Positives = 114/262 (43%), Gaps = 20/262 (7%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNIIRFYNSWIDDQN 83
K +G +A V+ + ++ +RL ++ ++++ + FY + + +
Sbjct: 24 EKMRHVPSGQIMA---VKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80
Query: 84 KTVNIITELFTSGSL----RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL 139
V I E SL +Q K + + + A I+ L +LHS +IHRD+
Sbjct: 81 --VWICME-LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDV 136
Query: 140 KCDNIFINGNQGEVKIGDLGLATIMEQANAK-SVIGTPEFMAPE-----LYDENYNELAD 193
K N+ IN G+VK+ D G++ + AK G +MAPE L + Y+ +D
Sbjct: 137 KPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSD 195
Query: 194 IYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PA 252
I+S G+ M+E+ +PY Q K+V P + E F +CL +
Sbjct: 196 IWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNS 255
Query: 253 SQRLSAKELLMDPFLQVNGTTK 274
+R + EL+ PF ++ +
Sbjct: 256 KERPTYPELMQHPFFTLHESKG 277
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 55/265 (20%), Positives = 107/265 (40%), Gaps = 27/265 (10%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
++ + G A +++ + + ++ E +LK L H NI++ + + +
Sbjct: 26 FRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDM---KAVKGWARQILSGLIYLHSHDPPIIHRDLKC 141
+I E GSL ++ R ++ G+ +L + I+HR++K
Sbjct: 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKP 140
Query: 142 DNIFINGNQGE---VKIGDLGLATIMEQAN-AKSVIGTPEFMAPELYD---------ENY 188
NI + K+ D G A +E S+ GT E++ P++Y+ + Y
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY 200
Query: 189 NELADIYSFGMCMLEMVT----FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244
D++S G+ T F P+ R + ++ K+ +G A+S V+ E
Sbjct: 201 GATVDLWSIGVTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI 259
Query: 245 IEKCLVPASQRLSAK-ELLMDPFLQ 268
+P S LS ++L+ P L
Sbjct: 260 DWSGDMPVSCSLSRGLQVLLTPVLA 284
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 4e-38
Identities = 58/221 (26%), Positives = 107/221 (48%), Gaps = 14/221 (6%)
Query: 54 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAV 113
+L EV + L+H NI+R Y + D + V +I E G++ + +K K D +
Sbjct: 54 HQLRREVEIQSHLRHPNILRLYG-YFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 111
Query: 114 KGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI 173
+ ++ + L Y HS +IHRD+K +N+ + G+ GE+KI D G + + +
Sbjct: 112 ATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLC 168
Query: 174 GTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG-IK-P 230
GT +++ PE + ++E D++S G+ E + + P+ E + YK++S P
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFP 227
Query: 231 AALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVN 270
++ + I + L SQR +E+L P++ N
Sbjct: 228 DFVT----EGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 61/303 (20%), Positives = 105/303 (34%), Gaps = 67/303 (22%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDV-LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
A + G V VR ++ S E + L E+H+ K H NI+ + ++I D
Sbjct: 44 NLARYKPTGEYVT---VRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMK--AVKGWARQILSGLIYLHSHDPPIIHRDLKC 141
+ ++T GS + H M A+ + +L L Y+H +HR +K
Sbjct: 101 --LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKA 156
Query: 142 DNIFINGNQGEVKIGDLGLATIMEQANAK---------SVIGTPEFMAPELYDEN---YN 189
+I I+ + G+V + L M + + +++PE+ +N Y+
Sbjct: 157 SHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD 215
Query: 190 ELADIYSFGMCMLEMVTFEYPYSE------------------------------------ 213
+DIYS G+ E+ P+ +
Sbjct: 216 AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRS 275
Query: 214 CRNSAQIYKKVSSGIKPAALSKVKD-------PEVKSFIEKCLVP-ASQRLSAKELLMDP 265
NS +S +P+ P F+E+CL R SA LL
Sbjct: 276 VANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335
Query: 266 FLQ 268
F +
Sbjct: 336 FFK 338
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-38
Identities = 73/262 (27%), Positives = 129/262 (49%), Gaps = 22/262 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDD--VLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 82
Y+A GLEVA +++ D + ++R+ +EV + LKH +I+ YN + +D
Sbjct: 28 YRAESIHTGLEVA---IKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN-YFEDS 83
Query: 83 NKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 141
N V ++ E+ +G + +Y + + K + + QI++G++YLHSH I+HRDL
Sbjct: 84 NY-VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTL 140
Query: 142 DNIFINGNQGEVKIGDLGLATIMEQANA--KSVIGTPEFMAPE-LYDENYNELADIYSFG 198
N+ + N +KI D GLAT ++ + ++ GTP +++PE + +D++S G
Sbjct: 141 SNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLG 199
Query: 199 MCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDPEVKSFIEKCLVP-ASQR 255
++ P+ + KV P+ LS E K I + L + R
Sbjct: 200 CMFYTLLIGRPPF-DTDTVKNTLNKVVLADYEMPSFLS----IEAKDLIHQLLRRNPADR 254
Query: 256 LSAKELLMDPFLQVNGTTKNRP 277
LS +L PF+ N +TK++
Sbjct: 255 LSLSSVLDHPFMSRNSSTKSKD 276
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 58/259 (22%), Positives = 116/259 (44%), Gaps = 22/259 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNIIRFYNSWIDDQN 83
K + +G +A ++R ++ ++L ++ +++S I++FY + + +
Sbjct: 39 NKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGW----ARQILSGLIYLHSHDPPIIHRDL 139
I EL ++ + Y+ + +D + + L +L + IIHRD+
Sbjct: 96 --CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDI 152
Query: 140 KCDNIFINGNQGEVKIGDLGLATIMEQANAKSV-IGTPEFMAPE-----LYDENYNELAD 193
K NI ++ G +K+ D G++ + + AK+ G +MAPE + Y+ +D
Sbjct: 153 KPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSD 211
Query: 194 IYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD---PEVKSFIEKCLV 250
++S G+ + E+ T +PY + + +V G P + + P +F+ CL
Sbjct: 212 VWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLT 271
Query: 251 -PASQRLSAKELLMDPFLQ 268
S+R KELL PF+
Sbjct: 272 KDESKRPKYKELLKHPFIL 290
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 61/294 (20%), Positives = 110/294 (37%), Gaps = 40/294 (13%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQN 83
Y+A D +G E A R+ E + EV +K L H NI++F ++ +
Sbjct: 45 YEAQDVGSGREYAL--KRLL--SNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100
Query: 84 KTVN-----IITELFTSGSLRQY---RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPII 135
++ ++ G L ++ + + V Q + ++H PPII
Sbjct: 101 ESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPII 160
Query: 136 HRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV--------------IGTPEFMAP 181
HRDLK +N+ ++ G +K+ D G AT + S TP + P
Sbjct: 161 HRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP 219
Query: 182 ELYDEN----YNELADIYSFGMCML-EMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKV 236
E+ D E DI++ G C+L + ++P+ + ++ +G
Sbjct: 220 EIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPFED-----GAKLRIVNGKYSIPPHDT 273
Query: 237 KDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVG 289
+ S I L +RLS E++ N P+ +++ G
Sbjct: 274 QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGG 327
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-37
Identities = 72/276 (26%), Positives = 129/276 (46%), Gaps = 17/276 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
D+V +E A ++ I S +L EV +LK L H NI++ Y+ + D +N
Sbjct: 54 LLCRDKVTHVERA-IKI-IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN- 110
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
++ E + G L K + +Q+LSG+ YLH H+ I+HRDLK +N+
Sbjct: 111 -YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENL 167
Query: 145 -FINGNQG-EVKIGDLGLATIMEQANA-KSVIGTPEFMAPELYDENYNELADIYSFGMCM 201
+ + +KI D GL+ + E K +GT ++APE+ + Y+E D++S G+ +
Sbjct: 168 LLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVIL 227
Query: 202 LEMVTFEYPYSECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIEKCLVP-ASQRLS 257
++ P+ + +I +KV G V K I++ L + +R+S
Sbjct: 228 FILLAGYPPFG-GQTDQEILRKVEKGKYTFDSPEWKNV-SEGAKDLIKQMLQFDSQRRIS 285
Query: 258 AKELLMDPFLQVNGTTKNRPLPLP--DIVLPRVGAF 291
A++ L P+++ + K + LP + + F
Sbjct: 286 AQQALEHPWIKEMCSKKESGIELPSLANAIENMRKF 321
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-37
Identities = 78/275 (28%), Positives = 128/275 (46%), Gaps = 15/275 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
D++ G E A +V ++ D E L EV LLK L H NI++ Y + D
Sbjct: 43 ILCKDKITGQECA-VKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY- 100
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
++ E++T G L K+ RQ+LSG+ Y+H + I+HRDLK +N+
Sbjct: 101 -FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENL 157
Query: 145 -FINGNQG-EVKIGDLGLATIMEQANA-KSVIGTPEFMAPELYDENYNELADIYSFGMCM 201
+ ++ ++I D GL+T E + K IGT ++APE+ Y+E D++S G+ +
Sbjct: 158 LLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVIL 217
Query: 202 LEMVTFEYPYSECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIEKCLVP-ASQRLS 257
+++ P++ N I KKV G + KV K I K L S R+S
Sbjct: 218 YILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKV-SESAKDLIRKMLTYVPSMRIS 275
Query: 258 AKELLMDPFLQVNGTTKNRP-LPLPDIVLPRVGAF 291
A++ L ++Q + +P D + + F
Sbjct: 276 ARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQF 310
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 55/221 (24%), Positives = 110/221 (49%), Gaps = 14/221 (6%)
Query: 54 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAV 113
+L E+ + L+H NI+R YN + D+ + + ++ E G L + +KH + D +
Sbjct: 59 HQLRREIEIQSHLRHPNILRMYN-YFHDRKR-IYLMLEFAPRGELYKELQKHGRFDEQRS 116
Query: 114 KGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI 173
+ ++ L Y H +IHRD+K +N+ + G +GE+KI D G + +++
Sbjct: 117 ATFMEELADALHYCHERK--VIHRDIKPENLLM-GYKGELKIADFGWSVHAPSLRRRTMC 173
Query: 174 GTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG-IK-P 230
GT +++ PE + + ++E D++ G+ E + P+ + + + ++++ + +K P
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFP 232
Query: 231 AALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVN 270
LS K I K L QRL K ++ P+++ N
Sbjct: 233 PFLS----DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 56/237 (23%), Positives = 110/237 (46%), Gaps = 17/237 (7%)
Query: 51 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM 110
ED++R E+ ++KSL H NIIR Y ++ D+ + + ++ EL T G L + +
Sbjct: 48 EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD--IYLVMELCTGGELFERVVHKRVFRE 105
Query: 111 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE--VKIGDLGLATIMEQAN 168
+ +LS + Y H + + HRDLK +N + + +K+ D GLA +
Sbjct: 106 SDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163
Query: 169 A-KSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYP--YSECRNSAQIYKKVS 225
++ +GTP +++P++ + Y D +S G M+ ++ YP + +++ K+
Sbjct: 164 MMRTKVGTPYYVSPQVLEGLYGPECDEWSAG-VMMYVLLCGYPPFSAP--TDSEVMLKIR 220
Query: 226 SGI---KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPL 278
G V + +S I + L QR+++ + L + + ++ R L
Sbjct: 221 EGTFTFPEKDWLNVSP-QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-36
Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 23/284 (8%)
Query: 25 YKAFDEVNGLEVA---------WCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 75
++ E A DD + E +Y+E+ LLKSL H NII+ +
Sbjct: 53 LLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112
Query: 76 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPII 135
+ + D + ++TE + G L + K D +QILSG+ YLH H+ I+
Sbjct: 113 DVFEDKKY--FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IV 168
Query: 136 HRDLKCDNI-FINGNQG-EVKIGDLGLATIMEQANA-KSVIGTPEFMAPELYDENYNELA 192
HRD+K +NI N N +KI D GL++ + + +GT ++APE+ + YNE
Sbjct: 169 HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKC 228
Query: 193 DIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIEKCL 249
D++S G+ M ++ P+ +N I KKV G + E K I+ L
Sbjct: 229 DVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYFDFNDWKNI-SDEAKELIKLML 286
Query: 250 VP-ASQRLSAKELLMDPFLQVNGTTKNRPL-PLPDIVLPRVGAF 291
++R +A+E L +++ N+ L + F
Sbjct: 287 TYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKF 330
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 22/237 (9%)
Query: 49 SPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHK 106
PE EV LL+ +H N+IR++ + D Q I EL + +L++Y +K
Sbjct: 57 LPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQF--QYIAIEL-CAATLQEYVEQKDF 113
Query: 107 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE----VKIGDLGLAT 162
+Q SGL +LHS + I+HRDLK NI I+ I D GL
Sbjct: 114 AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 163 IMEQ-----ANAKSVIGTPEFMAPELYDE----NYNELADIYSFGMCMLEMVTFEY-PYS 212
+ + V GT ++APE+ E N DI+S G +++ P+
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 213 ECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 268
+ + + K +D + IEK + +R SAK +L PF
Sbjct: 232 KSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-36
Identities = 77/276 (27%), Positives = 128/276 (46%), Gaps = 17/276 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
K D + E A +V I+ +D + EV LLK L H NI++ + D +
Sbjct: 39 LKCKDRITQQEYA-VKV-INKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS- 95
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
I+ EL+T G L K K+ +Q+ SG+ Y+H H+ I+HRDLK +NI
Sbjct: 96 -FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENI 152
Query: 145 -FINGNQG-EVKIGDLGLATIMEQANA-KSVIGTPEFMAPELYDENYNELADIYSFGMCM 201
+ + ++KI D GL+T +Q K IGT ++APE+ Y+E D++S G+ +
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVIL 212
Query: 202 LEMVTFEYPYSECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIEKCLVP-ASQRLS 257
+++ P+ +N I K+V +G + + K I K L S R++
Sbjct: 213 YILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTI-SDDAKDLIRKMLTFHPSLRIT 270
Query: 258 AKELLMDPFLQVNGTTKNR--PLPLPDIVLPRVGAF 291
A + L P++Q + LP + + + F
Sbjct: 271 ATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQF 306
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-35
Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 19/256 (7%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+ + G +VA ++ SP++ ER E+ ++K L H N++ D K
Sbjct: 31 LRWIHQDTGEQVA---IKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV-PDGLQK 86
Query: 85 TVN-----IITELFTSGSLRQYRKKHKKVDM---KAVKGWARQILSGLIYLHSHDPPIIH 136
+ E G LR+Y + + ++ I S L YLH + IIH
Sbjct: 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIH 144
Query: 137 RDLKCDNIFI--NGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPELYD-ENYNELA 192
RDLK +NI + + KI DLG A ++Q +GT +++APEL + + Y
Sbjct: 145 RDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTV 204
Query: 193 DIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPA 252
D +SFG E +T P+ Q + KV + F P
Sbjct: 205 DYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTP- 263
Query: 253 SQRLSAKELLMDPFLQ 268
+ ++ +LQ
Sbjct: 264 NHLSGILAGKLERWLQ 279
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 58/259 (22%), Positives = 117/259 (45%), Gaps = 29/259 (11%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+ + +GLE ++ + +S +E++ +E+ +LKSL H NII+ + + D N
Sbjct: 39 HLVEERSSGLERV---IKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN- 94
Query: 85 TVNIITELFTSGSL----RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 140
+ I+ E G L + + K + V +Q+++ L Y HS ++H+DLK
Sbjct: 95 -MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLK 151
Query: 141 CDNI-FINGNQG-EVKIGDLGLATIMEQANA-KSVIGTPEFMAPELYDENYNELADIYSF 197
+NI F + + +KI D GLA + + + GT +MAPE++ + DI+S
Sbjct: 152 PENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSA 211
Query: 198 GMCMLEMVTFEYP--YSECRNSAQIYKKVSSGI-----KPAALSKVKDPEVKSFIEKCLV 250
G ++ + + ++ +K + + L+ P+ +++ L
Sbjct: 212 G-VVMYFLLTGCLPFTGT--SLEEVQQKATYKEPNYAVECRPLT----PQAVDLLKQMLT 264
Query: 251 P-ASQRLSAKELLMDPFLQ 268
+R SA ++L + +
Sbjct: 265 KDPERRPSAAQVLHHEWFK 283
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 7e-35
Identities = 37/245 (15%), Positives = 75/245 (30%), Gaps = 31/245 (12%)
Query: 55 RLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS------GSLRQYRKKHKKV 108
R L+K + +IR D + + S L + HK +
Sbjct: 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 203
Query: 109 DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168
A Q++ L LH + ++H L+ +I ++ G V + +
Sbjct: 204 VHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFLTGFEHL--VRDGA 258
Query: 169 AKSVIGTPEFMAPELYDEN------------YNELADIYSFGMCMLEMVTFEYPYSECRN 216
+ F PEL D ++ G+ + + + P ++
Sbjct: 259 RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK-DA 317
Query: 217 SAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKN 275
+ + + + V++ +E L RL + + P + T +
Sbjct: 318 ALGGSEWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS 371
Query: 276 RPLPL 280
LPL
Sbjct: 372 AALPL 376
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 77/259 (29%), Positives = 123/259 (47%), Gaps = 19/259 (7%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
K D + E A +V I+ +D + EV LLK L H NI++ + D +
Sbjct: 39 LKCKDRITQQEYA-VKV-INKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS- 95
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
I+ EL+T G L K K+ +Q+ SG+ Y+H H+ I+HRDLK +NI
Sbjct: 96 -FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENI 152
Query: 145 FINGNQGE--VKIGDLGLATIMEQANA-KSVIGTPEFMAPELYDENYNELADIYSFGMCM 201
+ + + +KI D GL+T +Q K IGT ++APE+ Y+E D++S G +
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAG-VI 211
Query: 202 LEMVTFEYP--YSECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIEKCLVP-ASQR 255
L ++ P Y + N I K+V +G + D + K I K L S R
Sbjct: 212 LYILLSGTPPFYGK--NEYDILKRVETGKYAFDLPQWRTISD-DAKDLIRKMLTFHPSLR 268
Query: 256 LSAKELLMDPFLQVNGTTK 274
++A + L P++Q + +
Sbjct: 269 ITATQCLEHPWIQKYSSEE 287
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 50/265 (18%), Positives = 99/265 (37%), Gaps = 33/265 (12%)
Query: 44 DDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRK 103
+D + + +E+ ++ +K+ + + V II E + S+ ++ +
Sbjct: 78 NDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDE 135
Query: 104 KHKKVDMKAVKGW--------ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKI 155
+D + +L+ Y+H+ I HRD+K NI ++ N G VK+
Sbjct: 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKN-GRVKL 193
Query: 156 GDLGLATIMEQANAKSVIGTPEFMAPELYDEN---YNELADIYSFGMCMLEMVTFEYPYS 212
D G + M K GT EFM PE + DI+S G+C+ M P+S
Sbjct: 194 SDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253
Query: 213 ECRNSAQIYKKVSSG-----------------IKPAALSKVKDPEVKSFIEKCLVP-ASQ 254
+ +++ + + K + E F++ L ++
Sbjct: 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313
Query: 255 RLSAKELLMDPFLQVNGTTKNRPLP 279
R+++++ L +L R
Sbjct: 314 RITSEDALKHEWLADTNIEDLREFS 338
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 58/245 (23%), Positives = 94/245 (38%), Gaps = 43/245 (17%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVN--IITELFTSGSLRQYRKKHKKVDMKAVKGW 116
EV+ L +KH NI++F + + V+ +IT GSL + K + V +
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHI 126
Query: 117 ARQILSGLIYLHS--------HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 167
A + GL YLH H P I HRD+K N+ + N I D GLA E
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGK 185
Query: 168 ---NAKSVIGTPEFMAPEL------YDENYNELADIYSFGMCMLEMVT-----------F 207
+ +GT +MAPE+ + + D+Y+ G+ + E+ + +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 208 EYPYSECRNS----AQIYKKVSSG-----IKPAALSKVKDPEVKSFIEKCLVP-ASQRLS 257
P+ E + + V ++ + IE+C A RLS
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 258 AKELL 262
A +
Sbjct: 306 AGCVG 310
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-33
Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 41/276 (14%)
Query: 25 YKAFDEVNGLEVAWCQVRI-------DDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNS 77
AF+ +VA +RI + + + +E+ +LK L H II+ N
Sbjct: 152 KLAFERKTCKKVA---IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 208
Query: 78 WIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHR 137
D ++ I+ EL G L +K++ K + Q+L + YLH + IIHR
Sbjct: 209 -FDAED--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHR 263
Query: 138 DLKCDNIFI--NGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE----LYDENYNE 190
DLK +N+ + +KI D G + I+ + + +++ GTP ++APE + YN
Sbjct: 264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR 323
Query: 191 LADIYSFGMCMLEMVTFEY-------PYSECRNSAQIYKKVSSGI---KPAALSKVKDPE 240
D +S G +L + P+SE R + +++SG P ++V +
Sbjct: 324 AVDCWSLG-VIL------FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV-SEK 375
Query: 241 VKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKN 275
++K LV R + +E L P+LQ +
Sbjct: 376 ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK 411
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 68/276 (24%), Positives = 125/276 (45%), Gaps = 41/276 (14%)
Query: 25 YKAFDEVNGLEVAWCQVRI-------DDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNS 77
AF+ +VA ++I + + + +E+ +LK L H II+ N
Sbjct: 27 KLAFERKTCKKVA---IKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN- 82
Query: 78 WIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHR 137
+ D ++ I+ EL G L +K++ K + Q+L + YLH + IIHR
Sbjct: 83 FFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHR 138
Query: 138 DLKCDNIFINGNQGE--VKIGDLGLATIMEQANA-KSVIGTPEFMAPE----LYDENYNE 190
DLK +N+ ++ + + +KI D G + I+ + + +++ GTP ++APE + YN
Sbjct: 139 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR 198
Query: 191 LADIYSFGMCMLEMVTFEY-------PYSECRNSAQIYKKVSSGI---KPAALSKVKDPE 240
D +S G +L + P+SE R + +++SG P ++V + +
Sbjct: 199 AVDCWSLG-VIL------FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE-K 250
Query: 241 VKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKN 275
++K LV R + +E L P+LQ +
Sbjct: 251 ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK 286
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 67/276 (24%), Positives = 123/276 (44%), Gaps = 33/276 (11%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+ + GLE A ++ I+ S D ++L E + + L+H NI+R ++S ++
Sbjct: 23 RRCVHKTTGLEFA-AKI-INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF- 79
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
++ +L T G L + + +QIL + Y HS+ I+HR+LK +N+
Sbjct: 80 -HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENL 136
Query: 145 -FINGNQG-EVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LYDENYNELADIYSFG-- 198
+ +G VK+ D GLA + + A GTP +++PE L + Y++ DI++ G
Sbjct: 137 LLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 196
Query: 199 ----MCMLEMVTFEYP--YSECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIEKCL 249
+ YP + E + ++Y ++ +G V E KS I+ L
Sbjct: 197 LYILLV-------GYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTP-EAKSLIDSML 246
Query: 250 VP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIV 284
+R++A + L P++ N + D V
Sbjct: 247 TVNPKKRITADQALKVPWIC-NRERVASAIHRQDTV 281
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 56/228 (24%), Positives = 115/228 (50%), Gaps = 16/228 (7%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV 108
+P L++L+ EV ++K L H NI++ + + KT+ +I E + G + Y H ++
Sbjct: 54 NPTSLQKLFREVRIMKILNHPNIVKLFEVI--ETEKTLYLIMEYASGGEVFDYLVAHGRM 111
Query: 109 DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168
K + RQI+S + Y H I+HRDLK +N+ ++ + +KI D G +
Sbjct: 112 KEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGG 168
Query: 169 A-KSVIGTPEFMAPELY-DENYN-ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS 225
+ G P + APEL+ + Y+ D++S G+ + +V+ P+ +N ++ ++V
Sbjct: 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVL 227
Query: 226 SGI--KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVN 270
G P +S + ++ +++ LV +R + ++++ D ++
Sbjct: 228 RGKYRIPFYMS----TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 65/303 (21%), Positives = 108/303 (35%), Gaps = 63/303 (20%)
Query: 25 YKAFDEVNGLEVAWCQV--RIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 82
A + A ++ + +P+D+ER+ +EV L+K L H NI R Y + D+Q
Sbjct: 43 RVAIENQTRAIRA-IKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101
Query: 83 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWA------------------------- 117
+ ++ EL G L
Sbjct: 102 Y--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRE 159
Query: 118 ---------------RQILSGLIYLHSHDPPIIHRDLKCDNI-FINGNQGEVKIGDLGLA 161
RQI S L YLH+ I HRD+K +N F E+K+ D GL+
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLS 217
Query: 162 TIMEQANA------KSVIGTPEFMAPEL---YDENYNELADIYSFGMCMLEMVTFEYPYS 212
+ N + GTP F+APE+ +E+Y D +S G+ + ++ P+
Sbjct: 218 KEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF- 276
Query: 213 ECRNSAQIYKKVSSG---IKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 268
N A +V + + + + P + + L +R A L P++
Sbjct: 277 PGVNDADTISQVLNKKLCFENPNYNVL-SPLARDLLSNLLNRNVDERFDAMRALQHPWIS 335
Query: 269 VNG 271
Sbjct: 336 QFS 338
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 9e-32
Identities = 39/296 (13%), Positives = 78/296 (26%), Gaps = 45/296 (15%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN-------------- 70
+ D + A +V S +LERL+ L +
Sbjct: 79 FLVRDVERLEDFA-LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137
Query: 71 ----------IIRFYNSWIDDQNKTVNIITELFTS------GSLRQYRKKHKKVDMKAVK 114
+ D ++ + +L + A+
Sbjct: 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALH 197
Query: 115 GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG 174
Q++ L S ++H DN+FI + G + +GD+ +
Sbjct: 198 ILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPD-GRLMLGDVSALWK-VGTRGPASSV 253
Query: 175 TPEFMAPELYDEN---YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA 231
+ E + + + + + G+ + + P+ + K S P
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPG 313
Query: 232 ALSKVKD------PEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPL 280
S VK+ I + L +RL E + P + L
Sbjct: 314 TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLST 369
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 20/243 (8%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL--RQYRKKH 105
P D + +E+ ++ L H +I ++++ D + +I E + G L R + +
Sbjct: 87 PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDY 144
Query: 106 KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI-FINGNQGEVKIGDLGLATIM 164
K + + + + RQ GL ++H H I+H D+K +NI VKI D GLAT +
Sbjct: 145 KMSEAEVIN-YMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKL 201
Query: 165 EQANA-KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYP--YSECRNSAQI 220
K T EF APE + E D+++ G + ++ E + +
Sbjct: 202 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLET 258
Query: 221 YKKVSSGI---KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNR 276
+ V A S V E K FI+ L +RL+ + L P+L+ + +
Sbjct: 259 LQNVKRCDWEFDEDAFSSVSP-EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTS 317
Query: 277 PLP 279
+P
Sbjct: 318 RIP 320
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 65/285 (22%), Positives = 125/285 (43%), Gaps = 32/285 (11%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+ + GLE A ++ I+ S D ++L E + + L+H NI+R ++S ++
Sbjct: 46 RRCVHKTTGLEFA-AKI-INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF- 102
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
++ +L T G L + + +QIL + Y HS+ I+HR+LK +N+
Sbjct: 103 -HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENL 159
Query: 145 -FINGNQG-EVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LYDENYNELADIYSFGMC 200
+ +G VK+ D GLA + + A GTP +++PE L + Y++ DI++ G+
Sbjct: 160 LLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219
Query: 201 MLEMVTFEY-------PYSECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIEKCLV 250
+ Y P+ + + ++Y ++ +G V E KS I+ L
Sbjct: 220 L-------YILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTP-EAKSLIDSMLT 270
Query: 251 P-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDR 294
+R++A + L P++ + + + F R
Sbjct: 271 VNPKKRITADQALKVPWICNRERVASA--IHRQDTVDCLKKFNAR 313
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 57/258 (22%), Positives = 95/258 (36%), Gaps = 43/258 (16%)
Query: 49 SPEDLERLYSEVHLL-KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 107
+ + E+ LL +S H N+IR+Y S D+ + I EL + +L+ +
Sbjct: 48 LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRF--LYIALEL-CNLNLQDLVESKNV 104
Query: 108 VDMKAVKGWA-------RQILSGLIYLHSHDPPIIHRDLKCDNIFIN------------G 148
D RQI SG+ +LHS IIHRDLK NI ++
Sbjct: 105 SDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGA 162
Query: 149 NQGEVKIGDLGLATIME------QANAKSVIGTPEFMAPEL--------YDENYNELADI 194
+ I D GL ++ + N + GT + APEL DI
Sbjct: 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI 222
Query: 195 YSFGMCMLEMVTFEYP--YSECRNSAQIYKKVSSGIKPAALS-KVKDPEVKSFIEKCLVP 251
+S G +++ + + I + + S + L + E I + +
Sbjct: 223 FSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH 282
Query: 252 -ASQRLSAKELLMDPFLQ 268
+R +A ++L P
Sbjct: 283 DPLKRPTAMKVLRHPLFW 300
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 51/254 (20%), Positives = 111/254 (43%), Gaps = 20/254 (7%)
Query: 26 KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 85
+ + +Q +E++Y E+ +LK L H N+++ D
Sbjct: 53 RQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH 112
Query: 86 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIF 145
+ ++ EL G + + + +A + + ++ G+ YLH IIHRD+K N+
Sbjct: 113 LYMVFELVNQGPVMEVPTLKPLSEDQARF-YFQDLIKGIEYLHYQK--IIHRDIKPSNLL 169
Query: 146 INGNQGEVKIGDLGLATIMEQANA--KSVIGTPEFMAPEL---YDENYN-ELADIYSFGM 199
+ + G +KI D G++ + ++A + +GTP FMAPE + ++ + D+++ G+
Sbjct: 170 VGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
Query: 200 CMLEMVTFEYPYSECRNSAQIYKKVSSGI----KPAALSKVKDPEVKSFIEKCLVP-ASQ 254
+ V + P+ + ++ K+ S ++ ++K I + L
Sbjct: 229 TLYCFVFGQCPFMD-ERIMCLHSKIKSQALEFPDQPDIA----EDLKDLITRMLDKNPES 283
Query: 255 RLSAKELLMDPFLQ 268
R+ E+ + P++
Sbjct: 284 RIVVPEIKLHPWVT 297
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 57/276 (20%), Positives = 115/276 (41%), Gaps = 29/276 (10%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQN 83
+ F G + A ++ + D + EV +I+ + + + +
Sbjct: 46 LECFHRRTGQKCA-LKL-LYDS----PKARQ---EVDHHWQASGGPHIVCILDVYENMHH 96
Query: 84 --KTVNIITELFTSGSL--RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL 139
+ + II E G L R + + + R I + + +LHSH+ I HRD+
Sbjct: 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDV 154
Query: 140 KCDNI-FINGNQG-EVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYS 196
K +N+ + + + +K+ D G A Q ++ TP ++APE L E Y++ D++S
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWS 214
Query: 197 FGMCMLEMVTFEYP--YSECRN--SAQIYKKVSSG---IKPAALSKVKDPEVKSFIEKCL 249
G+ M ++ +P YS S + +++ G S+V + + K I L
Sbjct: 215 LGVIMYILLC-GFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE-DAKQLIRLLL 272
Query: 250 VP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIV 284
++RL+ + + P++ + PL ++
Sbjct: 273 KTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVL 308
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 9e-31
Identities = 45/310 (14%), Positives = 90/310 (29%), Gaps = 54/310 (17%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL------------------ 66
+A D+ G V ++++ EV L+ L
Sbjct: 95 LEATDQETGESFE-VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153
Query: 67 ----KHNNIIRFYNSWIDDQNKTVNIITELFTS---------GSLRQYRKKHKKVDMKAV 113
K + +D+++ V L+ L + HK + A
Sbjct: 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 213
Query: 114 KGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---AK 170
Q++ L LH + ++H L+ +I ++ G V + +
Sbjct: 214 LQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGASAVSPIG 270
Query: 171 SVIGTPEFMAPELY------DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 224
PE A + D ++ G+ + + + P ++ + + +
Sbjct: 271 RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-DAALGGSEWI 329
Query: 225 SSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPL--P 281
K V++ +E L RL + + P + T + LPL
Sbjct: 330 FRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQT 383
Query: 282 DIVLPRVGAF 291
D R G
Sbjct: 384 DGEPTREGGA 393
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-31
Identities = 56/272 (20%), Positives = 105/272 (38%), Gaps = 29/272 (10%)
Query: 25 YKAFDEVNGLEVAWCQVRID---DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 81
+ + G + A ++ +D E L E + LKH +I+ ++ D
Sbjct: 41 RRCINRETGQQFA-VKI-VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98
Query: 82 QNKTVNIITELFTSGSL--RQYRKKHKKVDM--KAVKGWARQILSGLIYLHSHDPPIIHR 137
+ ++ E L ++ + RQIL L Y H ++ IIHR
Sbjct: 99 GM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHR 154
Query: 138 DLKCDNI-FIN-GNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPE-LYDENYNELA 192
D+K + + N VK+G G+A + A +GTP FMAPE + E Y +
Sbjct: 155 DVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPV 214
Query: 193 DIYSFGMCMLEMVTFEYP--YSECRNSAQIYKKVSSGIKPAALSKVKD---PEVKSFIEK 247
D++ G +L ++ Y ++++ + G K + K + +
Sbjct: 215 DVWGCG-VILFILLSGCLPFYGT---KERLFEGIIKG-KYKMNPRQWSHISESAKDLVRR 269
Query: 248 CLVP-ASQRLSAKELLMDPFLQVNGTTKNRPL 278
L+ ++R++ E L P+L+ +
Sbjct: 270 MLMLDPAERITVYEALNHPWLKERDRYAYKIH 301
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-30
Identities = 73/338 (21%), Positives = 138/338 (40%), Gaps = 44/338 (13%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+ + G E A + I+ S D ++L E + + LKH NI+R ++S ++ +
Sbjct: 28 RRCVKVLAGQEYA-AMI-INTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH- 84
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+I +L T G L + + +QIL +++ H ++HR+LK +N+
Sbjct: 85 -HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENL 141
Query: 145 -FINGNQG-EVKIGDLGLATIM--EQANAKSVIGTPEFMAPE-LYDENYNELADIYSFG- 198
+ +G VK+ D GLA + EQ GTP +++PE L + Y + D+++ G
Sbjct: 142 LLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGV 201
Query: 199 -----MCMLEMVTFEYP--YSECRNSAQIYKKVSSGIKPAALSKVKDP------EVKSFI 245
+ YP + E + ++Y+++ +G A E K I
Sbjct: 202 ILYILLV-------GYPPFWDE--DQHRLYQQIKAG----AYDFPSPEWDTVTPEAKDLI 248
Query: 246 EKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASV 304
K L S+R++A E L P++ T + + + F R + +V
Sbjct: 249 NKMLTINPSKRITAAEALKHPWISHRSTVASC--MHRQETVDCLKKFNARRKLKGAILTV 306
Query: 305 RNKHPSMDFDSDAELPVITSL---DNSGGGDSYSPSIE 339
+ + V L ++G +SY+ +
Sbjct: 307 MLATRNFSVRKQEIIKVTEQLIEAISNGDFESYTKMCD 344
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 44/176 (25%), Positives = 74/176 (42%), Gaps = 30/176 (17%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVN---IITELFTSGSLRQYRKKHKKVDMKAVKG 115
++ + ++H+NI RF ++ E + +GSL +Y H D +
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCR 115
Query: 116 WARQILSGLIYLHS-------HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM---- 164
A + GL YLH+ + P I HRDL N+ + + G I D GL+ +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNR 174
Query: 165 ------EQANAKSVIGTPEFMAPELYD--------ENYNELADIYSFGMCMLEMVT 206
E A S +GT +MAPE+ + E+ + D+Y+ G+ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 63/258 (24%), Positives = 112/258 (43%), Gaps = 19/258 (7%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 107
+ E + EV +L+ + H+N+I ++ + + + V +I EL + G L + + +
Sbjct: 54 RRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD--VVLILELVSGGELFDFLAQKES 111
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI---NGNQGEVKIGDLGLATIM 164
+ + + +QIL G+ YLH+ I H DLK +NI + N +K+ D GLA +
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 165 EQANA-KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYP--YSECRNSAQI 220
E K++ GTPEF+APE + E AD++S G + ++ + +
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQET 226
Query: 221 YKKVSSGI---KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNR 276
++S S + K FI K LV +RL+ +E L P++ +
Sbjct: 227 LANITSVSYDFDEEFFSHTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAM 285
Query: 277 PLPLPDIVLPRVGAFGDR 294
+ L R
Sbjct: 286 VRRESVVNLENFRKQYVR 303
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 50/262 (19%), Positives = 92/262 (35%), Gaps = 35/262 (13%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 107
+P + + LK + ++FY S QN +V ++ EL++ G+L +K
Sbjct: 106 ANPWEFYIGTQLMERLKPSMQHMFMKFY-SAHLFQNGSV-LVGELYSYGTLLNAINLYKN 163
Query: 108 -----VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING----------NQGE 152
+ V +A ++L + +H + IIH D+K DN +
Sbjct: 164 TPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 153 VKIGDLGLA----TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF 207
+ + DLG + + + T F E L ++ +N D + + M+
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
Query: 208 EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL-VPASQRLSAKELL---M 263
Y + + + + F L +P L + +LL +
Sbjct: 282 TYMKVKNEGGECKPEGLFRRLP-------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334
Query: 264 DPFLQVNGTTKNRPLPLPDIVL 285
Q + T K R L IVL
Sbjct: 335 KKVFQQHYTNKIRALRNRLIVL 356
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 58/271 (21%), Positives = 116/271 (42%), Gaps = 25/271 (9%)
Query: 25 YKAFDEVNGLEVAWCQVRI---DDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 81
+ D A V+I + + P + E+ LL+ L+H N+I+ + ++
Sbjct: 22 KEVLDSETLCRRA---VKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78
Query: 82 QNKTVNIITELFTSGSLRQYRK-KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 140
+ + + ++ E G K+ + G+ Q++ GL YLHS I+H+D+K
Sbjct: 79 EKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIK 136
Query: 141 CDNIFINGNQGEVKIGDLGLATIMEQANAKSVI----GTPEFMAPELY--DENYN-ELAD 193
N+ + G +KI LG+A + A G+P F PE+ + ++ D
Sbjct: 137 PGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVD 195
Query: 194 IYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDPEVKSFIEKCLVP 251
I+S G+ + + T YP+ E N ++++ + G P P + ++ L
Sbjct: 196 IWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSYAIPGDCG----PPLSDLLKGMLEY 250
Query: 252 -ASQRLSAKELLMDPFLQVNGTTKNRPLPLP 281
++R S +++ + + P+P+P
Sbjct: 251 EPAKRFSIRQIRQHSWFRKKHPPAEAPVPIP 281
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 60/259 (23%), Positives = 106/259 (40%), Gaps = 37/259 (14%)
Query: 51 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM 110
D + + +E+ +L L H NII+ + ++++ EL T G L +
Sbjct: 90 VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE--ISLVLELVTGGELFDRIVEKGYYSE 147
Query: 111 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI-FINGNQG-EVKIGDLGLATIMEQAN 168
+ +QIL + YLH + I+HRDLK +N+ + +KI D GL+ I+E
Sbjct: 148 RDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205
Query: 169 A-KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEY-------PYSECRNSAQ 219
K+V GTP + APE L Y D++S G+ Y P+ + R
Sbjct: 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT-------YILLCGFEPFYDERGDQF 258
Query: 220 IYKKVSSGIKPAALSKVKDP------EVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGT 272
+++++ + + K + K +V +RL+ + L P++ T
Sbjct: 259 MFRRILNC----EYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV----T 310
Query: 273 TKNRPLPLPDIVLPRVGAF 291
K D ++ F
Sbjct: 311 GKAANFVHMDTAQKKLQEF 329
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 69/275 (25%), Positives = 116/275 (42%), Gaps = 28/275 (10%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQN 83
K + + A ++ I E+ LK + H NI++ + + D +
Sbjct: 28 RKCVHKKSNQAFA-VKI-ISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLH 80
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
++ EL G L + KK K R+++S + ++H ++HRDLK +N
Sbjct: 81 --TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPEN 136
Query: 144 I-FINGNQG-EVKIGDLGLATIMEQANA--KSVIGTPEFMAPE-LYDENYNELADIYSFG 198
+ F + N E+KI D G A + N K+ T + APE L Y+E D++S G
Sbjct: 137 LLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLG 196
Query: 199 MCMLEMVT----F--EYPYSECRNSAQIYKKVSSG---IKPAALSKVKDPEVKSFIEKCL 249
+ + M++ F C ++ +I KK+ G + A V E K I+ L
Sbjct: 197 VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ-EAKDLIQGLL 255
Query: 250 VP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDI 283
++RL L + +LQ + PL PDI
Sbjct: 256 TVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDI 290
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 31/273 (11%)
Query: 25 YKAFDEVNGLEVAWCQV---RIDDVLQSPEDLERLYSEVHLLKSLKHN--NIIRFYNSWI 79
Y + L VA V RI D + P + R+ EV LLK + +IR + W
Sbjct: 60 YSGIRVSDNLPVAIKHVEKDRISDWGELP-NGTRVPMEVVLLKKVSSGFSGVIRLLD-WF 117
Query: 80 DDQNKTVNIITELFT-SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRD 138
+ + V +I E L + + + + + + Q+L + + H+ ++HRD
Sbjct: 118 ERPDSFV-LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRD 174
Query: 139 LKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYN-ELADIYS 196
+K +NI I+ N+GE+K+ D G +++ GT + PE + Y+ A ++S
Sbjct: 175 IKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWS 234
Query: 197 FGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDPEVKSFIEKCLVPA-S 253
G+ + +MV + P+ +++ G +S E + I CL S
Sbjct: 235 LGILLYDMVCGDIPFEH-------DEEIIRGQVFFRQRVS----SECQHLIRWCLALRPS 283
Query: 254 QRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLP 286
R + +E+ P++Q P +I L
Sbjct: 284 DRPTFEEIQNHPWMQDV----LLPQETAEIHLH 312
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 61/253 (24%), Positives = 112/253 (44%), Gaps = 15/253 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
A + V VA V+I D+ ++ + E + E+ + K L H N+++FY +
Sbjct: 24 QLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR--REGN 78
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ E + G L + + + + Q+++G++YLH I HRD+K +N+
Sbjct: 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENL 136
Query: 145 FINGNQGEVKIGDLGLATIMEQANA----KSVIGTPEFMAPE-LYDENYN-ELADIYSFG 198
++ +KI D GLAT+ N + GT ++APE L ++ E D++S G
Sbjct: 137 LLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 195
Query: 199 MCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLS 257
+ + M+ E P+ + +S Q Y K D + + K LV S R++
Sbjct: 196 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255
Query: 258 AKELLMDPFLQVN 270
++ D +
Sbjct: 256 IPDIKKDRWYNKP 268
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 61/285 (21%), Positives = 117/285 (41%), Gaps = 42/285 (14%)
Query: 25 YKAFDEVNGLEVAWCQVRID-DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
+ + G A + I LE E+ +LK +KH NI+ + +
Sbjct: 26 FLVKQRLTGKLFA-LKC-IKKSPAFRDSSLEN---EIAVLKKIKHENIVTLED-IYESTT 79
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
++ +L + G L + K +Q+LS + YLH + I+HRDLK +N
Sbjct: 80 H-YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPEN 136
Query: 144 I-FINGNQG-EVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMC 200
+ ++ + ++ I D GL+ + + + GTP ++APE L + Y++ D +S G
Sbjct: 137 LLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIG-V 195
Query: 201 MLEMVTFEYP--YSECRNSAQIYKKVSSG-----------IKPAALSKVKDPEVKSFIEK 247
+ ++ YP Y E +++++K+ G I +A K FI
Sbjct: 196 ITYILLCGYPPFYEE--TESKLFEKIKEGYYEFESPFWDDISESA---------KDFICH 244
Query: 248 CLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAF 291
L ++R + ++ L P++ N + V ++
Sbjct: 245 LLEKDPNERYTCEKALSHPWIDGNTALHR---DIYPSVSLQIQKN 286
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 65/280 (23%), Positives = 119/280 (42%), Gaps = 33/280 (11%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSP--EDLERLYSEVHLLKSL----KHNNIIRFYNSW 78
+ + L+VA + + VL D EV LL + H +IR + W
Sbjct: 48 FAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD-W 106
Query: 79 IDDQNKTVNIITELFTSGS-LRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHR 137
+ Q + ++ E L Y + + + + Q+++ + + HS ++HR
Sbjct: 107 FETQEGFM-LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHR 163
Query: 138 DLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYN-ELADIY 195
D+K +NI I+ +G K+ D G ++ GT + PE + Y+ A ++
Sbjct: 164 DIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVW 223
Query: 196 SFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDPEVKSFIEKCLVPA- 252
S G+ + +MV + P+ +++ PA +S P+ + I +CL P
Sbjct: 224 SLGILLYDMVCGDIPFER-------DQEILEAELHFPAHVS----PDCCALIRRCLAPKP 272
Query: 253 SQRLSAKELLMDPFLQVNGT------TKNRPLPLPDIVLP 286
S R S +E+L+DP++Q +K P PL +LP
Sbjct: 273 SSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWSLLP 312
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 61/282 (21%), Positives = 112/282 (39%), Gaps = 42/282 (14%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWID--D 81
+ F++ + A ++ + D R EV L + +I+R + + +
Sbjct: 79 LQIFNKRTQEKFA-LKM-LQDC----PKARR---EVELHWRASQCPHIVRIVDVYENLYA 129
Query: 82 QNKTVNIITELFTSGSL--RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL 139
K + I+ E G L R + + + + I + YLHS + I HRD+
Sbjct: 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDV 187
Query: 140 KCDNI-FINGNQG-EVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LYDENYNELADIY 195
K +N+ + + +K+ D G A N+ + TP ++APE L E Y++ D++
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 247
Query: 196 SFG------MCMLEMVTFEYP--YSECRNSAQ--IYKKVSSGI---KPAALSKVKDPEVK 242
S G +C YP YS + + ++ G S+V + EVK
Sbjct: 248 SLGVIMYILLC-------GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE-EVK 299
Query: 243 SFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDI 283
I L +QR++ E + P++ + PL +
Sbjct: 300 MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRV 341
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 60/253 (23%), Positives = 111/253 (43%), Gaps = 17/253 (6%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL-RQYRKKHK 106
D E + E+ + L+H ++ ++++ DD + +I E + G L + +H
Sbjct: 193 PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHN 250
Query: 107 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI-FINGNQGEVKIGDLGLATIME 165
K+ + RQ+ GL ++H ++ +H DLK +NI F E+K+ D GL ++
Sbjct: 251 KMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308
Query: 166 QANA-KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYP-YSECRNSAQIYK 222
+ K GT EF APE + D++S G+ +++ P E N + +
Sbjct: 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--NDDETLR 366
Query: 223 KVSSGI---KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPL 278
V S +A S + + + K FI K L+ + R++ + L P+L G R
Sbjct: 367 NVKSCDWNMDDSAFSGISE-DGKDFIRKLLLADPNTRMTIHQALEHPWLT-PGNAPGRDS 424
Query: 279 PLPDIVLPRVGAF 291
+P ++
Sbjct: 425 QIPSSRYTKIRDS 437
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 59/290 (20%), Positives = 110/290 (37%), Gaps = 36/290 (12%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN-NIIRFYNSWIDDQN 83
+ + G E A + + + + + E+ +L+ K +I + + +
Sbjct: 46 RQCISKSTGQEYA-AKF-LKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103
Query: 84 KTVNIITELFTSGSL--RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 141
+ +I E G + + + V V +QIL G+ YLH ++ I+H DLK
Sbjct: 104 --IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKP 159
Query: 142 DNI-FINGNQ-GEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LYDENYNELADIYSF 197
NI + G++KI D G++ + A + ++GTPE++APE L + D+++
Sbjct: 160 QNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNI 219
Query: 198 G------MCMLEMVTFEYP--YSECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIE 246
G + E ++ + Y +S S V FI+
Sbjct: 220 GIIAYMLLT-------HTSPFVGE--DNQETYLNISQVNVDYSEETFSSVSQ-LATDFIQ 269
Query: 247 KCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRC 295
LV +R +A+ L +LQ +N P + R
Sbjct: 270 SLLVKNPEKRPTAEICLSHSWLQ-QWDFENLFHPEETSSSSQTQDHSVRS 318
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 66/285 (23%), Positives = 121/285 (42%), Gaps = 32/285 (11%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 107
+ E + EV +LK ++H N+I + + + + V +I EL G L + + +
Sbjct: 53 RRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKES 110
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI---NGNQGEVKIGDLGLATIM 164
+ + + +QIL+G+ YLHS I H DLK +NI + N + +KI D GLA +
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
Query: 165 EQANA-KSVIGTPEFMAPE-LYDENYNELADIYSFG------MCMLEMVTFEYP--YSEC 214
+ N K++ GTPEF+APE + E AD++S G + +
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-------GASPFLGD- 220
Query: 215 RNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVN 270
+ VS+ + S K FI + LV +R++ ++ L P+++
Sbjct: 221 -TKQETLANVSAVNYEFEDEYFSNTSA-LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278
Query: 271 GTTKNRPLPLPDIVLPRVGAFGDRCLMSEGP-ASVRNKHPSMDFD 314
T + + + + F R + G + + + +
Sbjct: 279 DTQQALSRKASAVNMEKFKKFAARKKSNNGSGGGLNDIFEAQKIE 323
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 64/258 (24%), Positives = 113/258 (43%), Gaps = 19/258 (7%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 107
+ E + EV +L+ + H NII ++ + + + V +I EL + G L + + +
Sbjct: 54 RRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD--VVLILELVSGGELFDFLAQKES 111
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI---NGNQGEVKIGDLGLATIM 164
+ + + +QIL G+ YLH+ I H DLK +NI + N +K+ D GLA +
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 165 EQANA-KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYP--YSECRNSAQI 220
E K++ GTPEF+APE + E AD++S G + ++ + +
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQET 226
Query: 221 YKKVSSGI---KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNR 276
+++ S+ + K FI K LV +RL+ +E L P++ T +
Sbjct: 227 LANITAVSYDFDEEFFSQTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAM 285
Query: 277 PLPLPDIVLPRVGAFGDR 294
+ L R
Sbjct: 286 VRRESVVNLENFKKQYVR 303
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 59/254 (23%), Positives = 118/254 (46%), Gaps = 21/254 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDD--VLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 82
++ G +VA V+I + ++S + + ++ E+ LK +H +II+ Y
Sbjct: 28 KIGEHQLTGHKVA---VKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI--ST 82
Query: 83 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
++ E + G L Y KH +V+ + +QILS + Y H H ++HRDLK +
Sbjct: 83 PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPE 140
Query: 143 NIFINGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LYDENYN-ELADIYSFGM 199
N+ ++ + KI D GL+ +M ++ G+P + APE + Y DI+S G+
Sbjct: 141 NVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGV 199
Query: 200 CMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDPEVKSFIEKCLVP-ASQRL 256
+ ++ P+ + + ++KK+ G+ P L+ V + + L +R
Sbjct: 200 ILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLN----RSVATLLMHMLQVDPLKRA 254
Query: 257 SAKELLMDPFLQVN 270
+ K++ + + +
Sbjct: 255 TIKDIREHEWFKQD 268
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 64/305 (20%), Positives = 127/305 (41%), Gaps = 20/305 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
A + V VA V+I D+ ++ + E + E+ + K L H N+++FY +
Sbjct: 24 QLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR--REGN 78
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ E + G L + + + + Q+++G++YLH I HRD+K +N+
Sbjct: 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENL 136
Query: 145 FINGNQGEVKIGDLGLATIMEQANA----KSVIGTPEFMAPE-LYDENYN-ELADIYSFG 198
++ +KI D GLAT+ N + GT ++APE L ++ E D++S G
Sbjct: 137 LLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 195
Query: 199 MCMLEMVTFEYPYSECRNSAQIY-KKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRL 256
+ + M+ E P+ + +S Q Y K+ D + + K LV S R+
Sbjct: 196 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-DSAPLALLHKILVENPSARI 254
Query: 257 SAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSE---GPASVRNKHPSMDF 313
+ ++ D + + + + + + + S P + ++ P +
Sbjct: 255 TIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGW 314
Query: 314 DSDAE 318
+
Sbjct: 315 SKEHH 319
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 66/274 (24%), Positives = 114/274 (41%), Gaps = 35/274 (12%)
Query: 25 YKAFDEVNGLEVAWCQV---RIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 81
K + G E A + R + E + EV++L+ ++H NII ++ + +
Sbjct: 22 RKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK 80
Query: 82 QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 141
+ V +I EL + G L + + + + + +QIL G+ YLHS I H DLK
Sbjct: 81 TD--VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKP 136
Query: 142 DNIFI---NGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LYDENYNELADIYS 196
+NI + N +K+ D G+A +E N K++ GTPEF+APE + E AD++S
Sbjct: 137 ENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 196
Query: 197 FG------MCMLEMVTFEYP--YSECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSFI 245
G + E + +S+ S + K FI
Sbjct: 197 IGVITYILLS-------GASPFLGE--TKQETLTNISAVNYDFDEEYFSNTSE-LAKDFI 246
Query: 246 EKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPL 278
+ LV +R++ + L +++ R
Sbjct: 247 RRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGE 280
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 61/279 (21%), Positives = 108/279 (38%), Gaps = 41/279 (14%)
Query: 25 YKAFDEVNGLEVAWC------QVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNS 77
+ + E A + E E EV +L+ + H NII+ ++
Sbjct: 34 RRCIHKPTCKEYA-VKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92
Query: 78 WIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHR 137
+ + ++ +L G L Y + + K + R +L + LH + I+HR
Sbjct: 93 YETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHR 148
Query: 138 DLKCDNIFINGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-------LYDENYN 189
DLK +NI ++ + +K+ D G + ++ + V GTP ++APE Y
Sbjct: 149 DLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYG 207
Query: 190 ELADIYSFGMCMLEMVTFEY-------PYSECRNSAQIYKKVSSGI---KPAALSKVKDP 239
+ D++S G+ M Y P+ R + + + SG D
Sbjct: 208 KEVDMWSTGVIM-------YTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSD- 258
Query: 240 EVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRP 277
VK + + LV +R +A+E L PF Q + R
Sbjct: 259 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 58/238 (24%), Positives = 108/238 (45%), Gaps = 32/238 (13%)
Query: 48 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL--RQYRKKH 105
+ +D E + +E+ ++ L H N+I+ Y+++ + + ++ E G L R + +
Sbjct: 125 RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKND--IVLVMEYVDGGELFDRIIDESY 182
Query: 106 KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI-FINGNQGEVKIGDLGLATIM 164
++ + + +QI G+ ++H I+H DLK +NI +N + ++KI D GLA
Sbjct: 183 NLTELDTIL-FMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
Query: 165 EQANA-KSVIGTPEFMAPE-LYDENYNELADIYSFG------MCMLEMVTFEYP--YSEC 214
+ K GTPEF+APE + + + D++S G + +
Sbjct: 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS-------GLSPFLGD- 291
Query: 215 RNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 268
N A+ + + + + + E K FI K L+ S R+SA E L P+L
Sbjct: 292 -NDAETLNNILACRWDLEDEEFQDISE-EAKEFISKLLIKEKSWRISASEALKHPWLS 347
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 67/302 (22%), Positives = 115/302 (38%), Gaps = 54/302 (17%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQN 83
+ + E A ++ I+ Q R++ EV +L + H N++ + ++
Sbjct: 30 QTCINLITSQEYA-VKI-IEK--QPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
++ E GS+ + K + + + + S L +LH+ I HRDLK +N
Sbjct: 86 --FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPEN 141
Query: 144 I-FINGNQG-EVKIGDLGLATIMEQANAKSVI---------GTPEFMAPE------LYDE 186
I + NQ VKI D L + ++ S I G+ E+MAPE
Sbjct: 142 ILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEAS 201
Query: 187 NYNELADIYSFGMCM--------------LEMVTFEYPYSECRNSAQIYKKVSSGIKPAA 232
Y++ D++S G+ + ++ + +++ + G
Sbjct: 202 IYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG----K 257
Query: 233 LSKVKDP------EVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVL 285
K I K LV A QRLSA ++L P++Q G LP P VL
Sbjct: 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ--GCAPENTLPTPM-VL 314
Query: 286 PR 287
R
Sbjct: 315 QR 316
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 50/278 (17%), Positives = 113/278 (40%), Gaps = 31/278 (11%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
++ + + + V D + E+ +L +H NI+ + S+ +
Sbjct: 22 HRCVETSSKKTYM-AKF----VKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEE- 75
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDM--KAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+ +I E + + + R ++ + + + Q+ L +LHSH+ I H D++ +
Sbjct: 76 -LVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPE 131
Query: 143 NI-FINGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LYDENYNELADIYSFGM 199
NI + +KI + G A ++ + + + PE+ APE + + D++S G
Sbjct: 132 NIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLG- 190
Query: 200 CMLEMVTFEYP--YSECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIEKCLVP-AS 253
++ ++ +E + QI + + + A ++ E F+++ LV
Sbjct: 191 TLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDEEAFKEISI-EAMDFVDRLLVKERK 247
Query: 254 QRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAF 291
R++A E L P+L K + + V+ +
Sbjct: 248 SRMTASEALQHPWL------KQKIERVSTKVIRTLKHR 279
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 63/266 (23%), Positives = 120/266 (45%), Gaps = 26/266 (9%)
Query: 15 RLIQLVDTSG----YKAFDEVNGLEVAWCQVRI--DDVLQSPEDLERLYSEVHLLKSLKH 68
+++ + G Y A D + ++VA ++ + E L+R EVH L H
Sbjct: 14 KIVDKLGGGGMSTVYLAEDTILNIKVA---IKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 69 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 128
NI+ + +D+++ ++ E +L +Y + H + + + QIL G+ + H
Sbjct: 71 QNIVSMID--VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH 128
Query: 129 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA---NAKSVIGTPEFMAPEL-Y 184
I+HRD+K NI I + +KI D G+A + + V+GT ++ +PE
Sbjct: 129 DMR--IVHRDIKPQNILI-DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 185 DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI-YKKVSSGIKPAALSKVKD---PE 240
E +E DIYS G+ + EM+ E P++ + I K + + P + V+
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNG-ETAVSIAIKHIQDSV-PNVTTDVRKDIPQS 243
Query: 241 VKSFIEKCLV--PASQRLSAKELLMD 264
+ + I + A++ + +E+ D
Sbjct: 244 LSNVILRATEKDKANRYKTIQEMKDD 269
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 72/266 (27%), Positives = 127/266 (47%), Gaps = 22/266 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDD--VLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 82
A +VA ++ +L+ + R+ E+ LK L+H +II+ Y+
Sbjct: 26 KLATHYKTQQKVA---LKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI--TT 80
Query: 83 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+ ++ E + G L Y + K++ + + +QI+ + Y H H I+HRDLK +
Sbjct: 81 PTDIVMVIE-YAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPE 137
Query: 143 NIFINGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPE-LYDENYN-ELADIYSFGM 199
N+ ++ N VKI D GL+ IM N K+ G+P + APE + + Y D++S G+
Sbjct: 138 NLLLDDN-LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGI 196
Query: 200 CMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDPEVKSFIEKCLVP-ASQRL 256
+ M+ P+ + ++KKV+S + P LS P +S I + +V QR+
Sbjct: 197 VLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFLS----PGAQSLIRRMIVADPMQRI 251
Query: 257 SAKELLMDPFLQVNGTTKNRPLPLPD 282
+ +E+ DP+ VN RP+
Sbjct: 252 TIQEIRRDPWFNVNLPDYLRPMEEVQ 277
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 14/186 (7%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-K 107
SP+ + + E +++ S+ + ++ R + V +IT+L G L Y ++HK
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDN 113
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167
+ + + W QI G+ YL ++HRDL N+ + Q VKI D GLA ++
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAE 170
Query: 168 NAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIY 221
+ + MA E + Y +D++S+G+ + E++TF PY S +I
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EIS 229
Query: 222 KKVSSG 227
+ G
Sbjct: 230 SILEKG 235
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 46/188 (24%), Positives = 89/188 (47%), Gaps = 11/188 (5%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-K 107
P+ E+ +LK+L + I+++ +++ ++ E SG LR + ++H+ +
Sbjct: 64 GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR 123
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167
+D + ++ QI G+ YL S +HRDL NI + ++ VKI D GLA ++
Sbjct: 124 LDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILV-ESEAHVKIADFGLAKLLPLD 180
Query: 168 N----AKSVIGTPEF-MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQI 220
+ +P F APE L D ++ +D++SFG+ + E+ T+ + S ++
Sbjct: 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM 240
Query: 221 YKKVSSGI 228
Sbjct: 241 MGCERDVP 248
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 53/224 (23%), Positives = 109/224 (48%), Gaps = 24/224 (10%)
Query: 58 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWA 117
E+ +++ L+H ++ + S+ D+++ + ++ +L G LR + +++ + VK +
Sbjct: 64 KELQIMQGLEHPFLVNLWYSFQDEED--MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI 121
Query: 118 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKSVIGTP 176
+++ L YL + IIHRD+K DNI ++ G V I D +A ++ + ++ GT
Sbjct: 122 CELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMAGTK 178
Query: 177 EFMAPELYDEN----YNELADIYSFGMCMLEMVT----FEYPYSECRNSAQIYKKVSSGI 228
+MAPE++ Y+ D +S G+ E++ + S +S +I + +
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIVHTFETTV 236
Query: 229 K--PAALSKVKDPEVKSFIEKCLVP-ASQRL-SAKELLMDPFLQ 268
P+A S E+ S ++K L P QR ++ P++
Sbjct: 237 VTYPSAWS----QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-K 107
+ E L E+ +LKSL+H+NI+++ + + +I E GSLR Y +KHK +
Sbjct: 51 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 110
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME-- 165
+D + + QI G+ YL + IHRDL NI + N+ VKIGD GL ++
Sbjct: 111 IDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQD 167
Query: 166 ------QANAKSVIGTPEF-MAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNS 217
+ +S P F APE L + ++ +D++SFG+ + E+ T Y E S
Sbjct: 168 KEFFKVKEPGES----PIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKS 219
Query: 218 AQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247
G ++ + ++
Sbjct: 220 PPAEFMRMIGNDKQG--QMIVFHLIELLKN 247
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 69/272 (25%), Positives = 116/272 (42%), Gaps = 28/272 (10%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNIIRFYNSWIDDQN 83
+ + +E A V+I + +S D E+ LL+ +H NII + + D +
Sbjct: 39 KRCIHKATNMEFA---VKI--IDKSKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKY 90
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
V ++TEL G L + K + I + YLH+ ++HRDLK N
Sbjct: 91 --VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSN 146
Query: 144 I-FIN--GNQGEVKIGDLGLATIMEQANA--KSVIGTPEFMAPE-LYDENYNELADIYSF 197
I +++ GN ++I D G A + N + T F+APE L + Y+ DI+S
Sbjct: 147 ILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSL 206
Query: 198 GMCMLEMVTFEYP--YSECRNSAQ-IYKKVSSG---IKPAALSKVKDPEVKSFIEKCLVP 251
G+ + M+T Y + ++ + I ++ SG + + V D K + K L
Sbjct: 207 GVLLYTMLT-GYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD-TAKDLVSKMLHV 264
Query: 252 -ASQRLSAKELLMDPFLQVNGTTKNRPLPLPD 282
QRL+A +L P++ L D
Sbjct: 265 DPHQRLTAALVLRHPWIVHWDQLPQYQLNRQD 296
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 63/258 (24%), Positives = 115/258 (44%), Gaps = 33/258 (12%)
Query: 25 YKAFDEVNGLEVAWCQVRI-------DDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNS 77
+ A D+ EV V+ +D L ++ E+ +L ++H NII+ +
Sbjct: 41 WTAVDKEKNKEVV---VKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD- 96
Query: 78 WIDDQNKTVNIITELFTSGS-LRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIH 136
++Q ++ E SG L + +H ++D RQ++S + YL D IIH
Sbjct: 97 IFENQGFFQ-LVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIH 153
Query: 137 RDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPELY-DENYN-ELAD 193
RD+K +NI I + +K+ D G A +E+ + GT E+ APE+ Y +
Sbjct: 154 RDIKDENIVIAED-FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELE 212
Query: 194 IYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDPEVKSFIEKCLVP 251
++S G+ + +V E P+ E ++ P +S E+ S + L P
Sbjct: 213 MWSLGVTLYTLVFEENPFCE-------LEETVEAAIHPPYLVS----KELMSLVSGLLQP 261
Query: 252 -ASQRLSAKELLMDPFLQ 268
+R + ++L+ DP++
Sbjct: 262 VPERRTTLEKLVTDPWVT 279
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-27
Identities = 46/195 (23%), Positives = 78/195 (40%), Gaps = 21/195 (10%)
Query: 25 YKAFDE-VNGLEVAWCQVRIDDVLQSPED---LERLYSEVHLLKSLKHNNIIRFYNSWID 80
Y A D VNG V ++ L D +E L + H +I++ +N
Sbjct: 97 YLALDRNVNGRPVV---LK---GLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150
Query: 81 DQNKTVN---IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHR 137
I+ E SL++ + + + + + +IL L YLHS +++
Sbjct: 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEILPALSYLHSI--GLVYN 206
Query: 138 DLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSF 197
DLK +NI + Q +K+ DLG + + + GTP F APE+ DIY+
Sbjct: 207 DLKPENIMLTEEQ--LKLIDLGAVSRINSFGY--LYGTPGFQAPEIVRTGPTVATDIYTV 262
Query: 198 GMCMLEMVTFEYPYS 212
G + + +
Sbjct: 263 GRTLAALTLDLPTRN 277
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-K 107
+ E L E+ +LKSL+H+NI+++ + + +I E GSLR Y +KHK +
Sbjct: 82 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 141
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME-- 165
+D + + QI G+ YL + IHRDL NI + N+ VKIGD GL ++
Sbjct: 142 IDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQD 198
Query: 166 ------QANAKSVIGTPEF-MAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNS 217
+ +S P F APE L + ++ +D++SFG+ + E+ T Y E S
Sbjct: 199 KEYYKVKEPGES----PIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKS 250
Query: 218 AQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247
G ++ + ++
Sbjct: 251 PPAEFMRMIGNDKQG--QMIVFHLIELLKN 278
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 57/194 (29%), Positives = 100/194 (51%), Gaps = 21/194 (10%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y + G +VA ++ + DL++ E+ +L++L H NI+++ +D
Sbjct: 42 YDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGICTEDGGN 98
Query: 85 TVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ +I E SGSL++Y K+K K+++K +A QI G+ YL S +HRDL N
Sbjct: 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARN 156
Query: 144 IFINGNQGEVKIGDLGLATIME--------QANAKSVIGTPEF-MAPE-LYDENYNELAD 193
+ + ++ +VKIGD GL +E + + S P F APE L + +D
Sbjct: 157 VLV-ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS----PVFWYAPECLMQSKFYIASD 211
Query: 194 IYSFGMCMLEMVTF 207
++SFG+ + E++T+
Sbjct: 212 VWSFGVTLHELLTY 225
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 57/271 (21%), Positives = 113/271 (41%), Gaps = 44/271 (16%)
Query: 25 YKAFDEVNGLEVA-------WCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYN 76
+ G E A ++ + + + E R E H+L+ + H +II +
Sbjct: 111 RRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRR---ETHILRQVAGHPHIITLID 167
Query: 77 SWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIH 136
S+ + ++ +L G L Y + + K + R +L + +LH+++ I+H
Sbjct: 168 SYESSSF--MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVH 223
Query: 137 RDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-------LYDENY 188
RDLK +NI ++ N ++++ D G + +E + + GTP ++APE Y
Sbjct: 224 RDLKPENILLDDN-MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY 282
Query: 189 NELADIYSFGMCMLEMVTFEY-------PYSECRNSAQIYKKVSSGIKPAALSKVKD--- 238
+ D+++ G+ + + P+ R + + + G + S D
Sbjct: 283 GKEVDLWACGVIL-------FTLLAGSPPFWH-RRQILMLRMIMEG-QYQFSSPEWDDRS 333
Query: 239 PEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 268
VK I + L RL+A++ L PF +
Sbjct: 334 STVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 21/193 (10%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y ++ G VA ++ D Q ++ E+ +L++L H +II++ D
Sbjct: 52 YDPTNDGTGEMVAVKALKADAGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDAGAA 108
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
++ ++ E GSLR Y +H + + + +A+QI G+ YLH+ IHRDL N+
Sbjct: 109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNV 165
Query: 145 FINGNQGEVKIGDLGLATIME--------QANAKSVIGTPEF-MAPE-LYDENYNELADI 194
+ N VKIGD GLA + + + S P F APE L + + +D+
Sbjct: 166 LL-DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS----PVFWYAPECLKEYKFYYASDV 220
Query: 195 YSFGMCMLEMVTF 207
+SFG+ + E++T
Sbjct: 221 WSFGVTLYELLTH 233
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 66/300 (22%), Positives = 119/300 (39%), Gaps = 33/300 (11%)
Query: 15 RLIQLVDTSG----YKAFDEVNGLEVAWCQVRI--DDVLQSPEDLERLYSEVHLLKSLKH 68
L +++ G + A D + +VA V++ D+ + P R E +L H
Sbjct: 15 ELGEILGFGGMSEVHLARDLRDHRDVA---VKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 69 NNIIRFYNSWIDD--QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIY 126
I+ Y++ + I+ E +LR + K L +
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 127 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK-----SVIGTPEFMAP 181
H + IIHRD+K NI I VK+ D G+A + + +VIGT ++++P
Sbjct: 132 SHQNG--IIHRDVKPANIMI-SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 182 EL-YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI-YKKVSSGIKPAALSKVKD- 238
E ++ + +D+YS G + E++T E P++ + + Y+ V P S +
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVRE--DPIPPSARHEG 245
Query: 239 --PEVKSFIEKCLV--PASQRLSAKELLMDPFLQVNGTTKNRPLPLPD----IVLPRVGA 290
++ + + K L P ++ +A E+ D NG P L D +L
Sbjct: 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSLLSSAAG 305
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-26
Identities = 64/254 (25%), Positives = 123/254 (48%), Gaps = 21/254 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDD--VLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 82
E+ G +VA V+I + ++S + + ++ E+ LK +H +II+ Y
Sbjct: 33 KVGKHELTGHKVA---VKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI--ST 87
Query: 83 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+ ++ E + G L Y K+ ++D K + +QILSG+ Y H H ++HRDLK +
Sbjct: 88 PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPE 145
Query: 143 NIFINGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPE-LYDENYN-ELADIYSFGM 199
N+ ++ + KI D GL+ +M ++ G+P + APE + Y DI+S G+
Sbjct: 146 NVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGV 204
Query: 200 CMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDPEVKSFIEKCLVP-ASQRL 256
+ ++ P+ + + ++KK+ GI P L+ P V S ++ L +R
Sbjct: 205 ILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYLN----PSVISLLKHMLQVDPMKRA 259
Query: 257 SAKELLMDPFLQVN 270
+ K++ + + +
Sbjct: 260 TIKDIREHEWFKQD 273
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 39/186 (20%), Positives = 88/186 (47%), Gaps = 14/186 (7%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-K 107
+ + + + + SL H +I+R + ++T+ GSL + ++H+
Sbjct: 55 GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGA 111
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167
+ + + W QI G+ YL H ++HR+L N+ + +V++ D G+A ++
Sbjct: 112 LGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPS-QVQVADFGVADLLPPD 168
Query: 168 NAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIY 221
+ + + + MA E ++ Y +D++S+G+ + E++TF PY+ R + ++
Sbjct: 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-EVP 227
Query: 222 KKVSSG 227
+ G
Sbjct: 228 DLLEKG 233
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 13/186 (6%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKK 107
P+ + E +LK H NI+R + Q + + I+ EL G + R + +
Sbjct: 152 PPDLKAKFLQEARILKQYSHPNIVRLIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGAR 209
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167
+ +K + +G+ YL S IHRDL N + +KI D G++
Sbjct: 210 LRVKTLLQMVGDAAAGMEYLESK--CCIHRDLAARNCLVTEK-NVLKISDFGMSREEADG 266
Query: 168 NAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIY 221
+ G + APE L Y+ +D++SFG+ + E + PY N Q
Sbjct: 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTR 325
Query: 222 KKVSSG 227
+ V G
Sbjct: 326 EFVEKG 331
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 71/280 (25%), Positives = 121/280 (43%), Gaps = 26/280 (9%)
Query: 54 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAV 113
E + E+ +SL+H NI+RF + II E + G L + +
Sbjct: 61 ENVQREIINHRSLRHPNIVRFKEVI--LTPTHLAIIMEYASGGELYERICNAGRFSEDEA 118
Query: 114 KGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ-GEVKIGDLGLATIMEQANA-KS 171
+ + +Q+LSG+ Y HS I HRDLK +N ++G+ +KI D G + + KS
Sbjct: 119 RFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 176
Query: 172 VIGTPEFMAPE-LYDENYN-ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK 229
+GTP ++APE L + Y+ ++AD++S G+ + M+ YP+ E + Y+K I
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRIL 235
Query: 230 PAALSKVKD----PEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIV 284
S D PE I + V + R+S E+ + N LP +
Sbjct: 236 SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN---------LPADL 286
Query: 285 LPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITS 324
+ E +++ M S+A +P + +
Sbjct: 287 MNESNTGSQ---FQEPEQPMQSLDTIMQIISEATIPAVRN 323
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 14/186 (7%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-K 107
SP+ + + E +++ S+ + ++ R + V +IT+L G L Y ++HK
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDN 113
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167
+ + + W QI G+ YL ++HRDL N+ + Q VKI D GLA ++
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAE 170
Query: 168 NAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIY 221
+ + MA E + Y +D++S+G+ + E++TF PY S +I
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EIS 229
Query: 222 KKVSSG 227
+ G
Sbjct: 230 SILEKG 235
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 14/205 (6%)
Query: 58 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWA 117
E ++ L H ++ Y ++ DD+ + +G L +Y +K D + +
Sbjct: 79 RERDVMSRLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 136
Query: 118 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA----TIMEQANAKSVI 173
+I+S L YLH IIHRDLK +NI +N ++I D G A +QA A S +
Sbjct: 137 AEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFV 193
Query: 174 GTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA 232
GT ++++PE L +++ + +D+++ G + ++V P+ N I++K+
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKL--EYD 250
Query: 233 LSKVKDPEVKSFIEKCLVP-ASQRL 256
+ P+ + +EK LV A++RL
Sbjct: 251 FPEKFFPKARDLVEKLLVLDATKRL 275
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 14/183 (7%)
Query: 52 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDM 110
+ + E + L H +++FY + + + I+TE ++G L Y R K ++
Sbjct: 46 SEDEFFQEAQTMMKLSHPKLVKFYG--VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP 103
Query: 111 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 170
+ + G+ +L SH IHRDL N ++ + VK+ D G+ +
Sbjct: 104 SQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQYV 160
Query: 171 SVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKV 224
S +GT +F APE + Y+ +D+++FG+ M E+ + + PY NS ++ KV
Sbjct: 161 SSVGT-KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-EVVLKV 218
Query: 225 SSG 227
S G
Sbjct: 219 SQG 221
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 49/188 (26%), Positives = 91/188 (48%), Gaps = 19/188 (10%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-K 107
S E+ E ++ H +I++ ++ V II EL T G LR + + K
Sbjct: 56 SDSVREKFLQEALTMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYS 112
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME-- 165
+D+ ++ +A Q+ + L YL S +HRD+ N+ + + VK+GD GL+ ME
Sbjct: 113 LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV-SSNDCVKLGDFGLSRYMEDS 169
Query: 166 ----QANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQ 219
+ K I ++MAPE + + +D++ FG+CM E++ P+ +N+
Sbjct: 170 TYYKASKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-D 225
Query: 220 IYKKVSSG 227
+ ++ +G
Sbjct: 226 VIGRIENG 233
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 44/183 (24%), Positives = 80/183 (43%), Gaps = 14/183 (7%)
Query: 52 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDM 110
E E ++ L H +++ Y + + + ++TE G L Y R +
Sbjct: 46 SEEDFIEEAEVMMKLSHPKLVQLYG--VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA 103
Query: 111 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 170
+ + G + G+ YL +IHRDL N + G +K+ D G+ +
Sbjct: 104 ETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYT 160
Query: 171 SVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKV 224
S GT +F +PE Y+ +D++SFG+ M E+ + + PY NS ++ + +
Sbjct: 161 SSTGT-KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVEDI 218
Query: 225 SSG 227
S+G
Sbjct: 219 STG 221
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 42/189 (22%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV 108
P + L +E ++++ L + I+R + ++ ++ E+ G L +Y ++++ V
Sbjct: 58 DPALKDELLAEANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAELGPLNKYLQQNRHV 114
Query: 109 DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--- 165
K + Q+ G+ YL + +HRDL N+ + Q KI D GL+ +
Sbjct: 115 KDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL-VTQHYAKISDFGLSKALRADE 171
Query: 166 -----QANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSA 218
Q + K + ++ APE + ++ +D++SFG+ M E ++ + PY + S
Sbjct: 172 NYYKAQTHGKWPV---KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS- 227
Query: 219 QIYKKVSSG 227
++ + G
Sbjct: 228 EVTAMLEKG 236
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 75/308 (24%), Positives = 120/308 (38%), Gaps = 74/308 (24%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR----FYNSWID 80
++A + EVA I VLQ R E+ +++ +KH N++ FY++
Sbjct: 57 FQAKLVESD-EVA-----IKKVLQDKRFKNR---ELQIMRIVKHPNVVDLKAFFYSNGDK 107
Query: 81 DQNKTVNIITELFTS---GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHR 137
+N++ E + R Y K + + M +K + Q+L L Y+HS I HR
Sbjct: 108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHR 165
Query: 138 DLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFM---------APELY--DE 186
D+K N+ ++ G +K+ D G AK +I + APEL
Sbjct: 166 DIKPQNLLLDPPSGVLKLIDFGS--------AKILIAGEPNVSYICSRYYRAPELIFGAT 217
Query: 187 NYNELADIYSFGMCMLEMVTFE--YPYSECRN------------SAQIYKKVSSG----- 227
NY DI+S G M E++ + +P + S + K ++
Sbjct: 218 NYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHK 277
Query: 228 ---IKPAALSKV----KDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQVNGTTKNRPL 278
I+P SKV P+ I + L P S RL+A E L PF L
Sbjct: 278 FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTP-SARLTAIEALCHPFFD--------EL 328
Query: 279 PLPDIVLP 286
+ +P
Sbjct: 329 RTGEARMP 336
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 50/183 (27%), Positives = 89/183 (48%), Gaps = 13/183 (7%)
Query: 52 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMK 111
++E E ++K +KH N+++ + + IITE T G+L Y ++ + ++
Sbjct: 259 EVEEFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 316
Query: 112 AVK--GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QA 167
AV A QI S + YL + IHR+L N + N VK+ D GL+ +M
Sbjct: 317 AVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTY 373
Query: 168 NAKSVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKV 224
A + P ++ APE L ++ +D+++FG+ + E+ T+ PY S Q+Y+ +
Sbjct: 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELL 432
Query: 225 SSG 227
Sbjct: 433 EKD 435
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 43/188 (22%), Positives = 78/188 (41%), Gaps = 14/188 (7%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKK 107
++ + +E ++K H N++ + + + ++ G LR + R +
Sbjct: 66 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHN 124
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167
+K + G+ Q+ G+ YL S +HRDL N ++ VK+ D GLA M
Sbjct: 125 PTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDK 181
Query: 168 NAKSVIGTPEF------MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQ 219
SV MA E L + + +D++SFG+ + E++T PY +
Sbjct: 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FD 240
Query: 220 IYKKVSSG 227
I + G
Sbjct: 241 ITVYLLQG 248
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 44/183 (24%), Positives = 84/183 (45%), Gaps = 14/183 (7%)
Query: 52 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDM 110
+ E ++ +L H +++ Y + + + + IITE +G L Y R+ +
Sbjct: 62 SEDEFIEEAKVMMNLSHEKLVQLYG--VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 119
Query: 111 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 170
+ + + + + YL S +HRDL N +N G VK+ D GL+ +
Sbjct: 120 QQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYT 176
Query: 171 SVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKV 224
S +G+ +F PE L ++ +DI++FG+ M E+ + + PY NS + + +
Sbjct: 177 SSVGS-KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-ETAEHI 234
Query: 225 SSG 227
+ G
Sbjct: 235 AQG 237
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 37/191 (19%), Positives = 79/191 (41%), Gaps = 20/191 (10%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-K 107
E + ++ L H +++ Y + ++ E GSL Y KK+K
Sbjct: 52 HRNYSESFFEAASMMSKLSHKHLVLNYG--VCVCGDENILVQEFVKFGSLDTYLKKNKNC 109
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN-------GNQGEVKIGDLGL 160
+++ A+Q+ + + +L + +IH ++ NI + GN +K+ D G+
Sbjct: 110 INILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167
Query: 161 A-TIMEQANAKSVIGTPEFMAPE--LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRN 216
+ T++ + + I ++ PE +N N D +SFG + E+ + + P S +
Sbjct: 168 SITVLPKDILQERI---PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224
Query: 217 SAQIYKKVSSG 227
+ +
Sbjct: 225 -QRKLQFYEDR 234
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 66/310 (21%), Positives = 116/310 (37%), Gaps = 75/310 (24%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR----FYNSWID 80
Y+A +G VA I VLQ D E+ +++ L H NI+R FY+S
Sbjct: 71 YQAKLCDSGELVA-----IKKVLQ---DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEK 122
Query: 81 DQNKTVNIITELFTS---GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHR 137
+N++ + R Y + + + + VK + Q+ L Y+HS I HR
Sbjct: 123 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHR 180
Query: 138 DLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFM----------APELY--D 185
D+K N+ ++ + +K+ D G A + + E APEL
Sbjct: 181 DIKPQNLLLDPDTAVLKLCDFGSAKQLVR---------GEPNVSYICSRYYRAPELIFGA 231
Query: 186 ENYNELADIYSFGMCMLEMVTFE--YPYSECRN------------SAQIYKKVSSG---- 227
+Y D++S G + E++ + +P + + + ++++
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 291
Query: 228 ----IKPAALSKV----KDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQVNGTTKNRP 277
IK +KV PE + + L P + RL+ E F
Sbjct: 292 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP-TARLTPLEACAHSFFD--------E 342
Query: 278 LPLPDIVLPR 287
L P++ LP
Sbjct: 343 LRDPNVKLPN 352
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 39/190 (20%), Positives = 86/190 (45%), Gaps = 21/190 (11%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKK 107
D E + E ++ L + I+R Q + + ++ E+ G L ++ K ++
Sbjct: 50 EKADTEEMMREAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREE 106
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME-- 165
+ + V Q+ G+ YL + +HRDL N+ + N+ KI D GL+ +
Sbjct: 107 IPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLL-VNRHYAKISDFGLSKALGAD 163
Query: 166 ------QANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNS 217
++ K + ++ APE + ++ +D++S+G+ M E +++ + PY + +
Sbjct: 164 DSYYTARSAGKWPL---KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 220
Query: 218 AQIYKKVSSG 227
++ + G
Sbjct: 221 -EVMAFIEQG 229
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 49/184 (26%), Positives = 87/184 (47%), Gaps = 14/184 (7%)
Query: 51 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--KKV 108
E E ++K L+H +++ Y ++ + I+TE + GSL + K K +
Sbjct: 221 MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYL 277
Query: 109 DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--Q 166
+ + A QI SG+ Y+ + +HRDL+ NI + N K+ D GLA ++E +
Sbjct: 278 RLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE 334
Query: 167 ANAKSVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKK 223
A+ P ++ APE + +D++SFG+ + E+ T PY N ++ +
Sbjct: 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQ 393
Query: 224 VSSG 227
V G
Sbjct: 394 VERG 397
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 56/286 (19%), Positives = 111/286 (38%), Gaps = 56/286 (19%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQN 83
++A + N +V ++ P +++ E+ +L++L+ NII + D +
Sbjct: 53 FEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNIITLADIVKDPVS 105
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+T ++ E + +Q + D ++ + +IL L Y HS I+HRD+K N
Sbjct: 106 RTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMG--IMHRDVKPHN 160
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAKSV-IGTPEFMAPE--LYDENYNELADIYSFGMC 200
+ I+ ++++ D GLA +V + + F PE + + Y+ D++S G C
Sbjct: 161 VMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG-C 219
Query: 201 ML-EMVT---------------------------FEYPYSECRNSAQIY--------KKV 224
ML M+ ++Y + +K
Sbjct: 220 MLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR 279
Query: 225 SSGIKPAALSKVKDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQ 268
+ + PE F++K L RL+A+E + P+
Sbjct: 280 WERFVHSENQHLVSPEALDFLDKLLRYDHQ-SRLTAREAMEHPYFY 324
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 44/176 (25%), Positives = 85/176 (48%), Gaps = 13/176 (7%)
Query: 58 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGW 116
SE ++K+L H +I++ + + II EL+ G L Y + + + + +
Sbjct: 62 SEAVIMKNLDHPHIVKLIGII---EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 117 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGT- 175
+ QI + YL S + +HRD+ NI + + VK+GD GL+ +E + T
Sbjct: 119 SLQICKAMAYLESIN--CVHRDIAVRNILV-ASPECVKLGDFGLSRYIEDEDYYKASVTR 175
Query: 176 -P-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 227
P ++M+PE + + +D++ F +CM E+++F + P+ N + + G
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-DVIGVLEKG 230
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 49/184 (26%), Positives = 87/184 (47%), Gaps = 14/184 (7%)
Query: 51 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--KKV 108
E E ++K L+H +++ Y ++ + I+TE + GSL + K K +
Sbjct: 304 MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYL 360
Query: 109 DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--Q 166
+ + A QI SG+ Y+ + +HRDL+ NI + N K+ D GLA ++E +
Sbjct: 361 RLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE 417
Query: 167 ANAKSVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKK 223
A+ P ++ APE + +D++SFG+ + E+ T PY N ++ +
Sbjct: 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQ 476
Query: 224 VSSG 227
V G
Sbjct: 477 VERG 480
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 48/185 (25%), Positives = 90/185 (48%), Gaps = 13/185 (7%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-K 107
S E+ E ++ H +I++ ++ V II EL T G LR + + K
Sbjct: 431 SDSVREKFLQEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKFS 487
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167
+D+ ++ +A Q+ + L YL S +HRD+ N+ + + VK+GD GL+ ME +
Sbjct: 488 LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV-SSNDCVKLGDFGLSRYMEDS 544
Query: 168 NAKSVIGT--P-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYK 222
P ++MAPE + + +D++ FG+CM E++ P+ +N+ +
Sbjct: 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIG 603
Query: 223 KVSSG 227
++ +G
Sbjct: 604 RIENG 608
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 58/189 (30%), Positives = 89/189 (47%), Gaps = 15/189 (7%)
Query: 44 DDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRK 103
DVL PE ++ EV+ + SL H N+IR Y + + ++TEL GSL +
Sbjct: 56 PDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLR 112
Query: 104 KHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162
KH+ + + +A Q+ G+ YL S IHRDL N+ + VKIGD GL
Sbjct: 113 KHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRD-LVKIGDFGLMR 169
Query: 163 IMEQA----NAKSVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECR 215
+ Q + P + APE L ++ +D + FG+ + EM T+ + P+
Sbjct: 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229
Query: 216 NSAQIYKKV 224
S QI K+
Sbjct: 230 GS-QILHKI 237
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 3e-23
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 33/202 (16%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS----EVHLLKSLKHNNIIRFYNSWID 80
+KA + VA +VR+DD D E + S E+ LLK LKH NI+R ++ +
Sbjct: 19 FKAKNRETHEIVALKRVRLDD------DDEGVPSSALREICLLKELKHKNIVRLHD--VL 70
Query: 81 DQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWARQILSGLIYLHSHDPPIIHRDL 139
+K + ++ E F L++Y D + VK + Q+L GL + HS + ++HRDL
Sbjct: 71 HSDKKLTLVFE-FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDL 127
Query: 140 KCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG---TPEFM-----APELY--DENYN 189
K N+ IN GE+K+ + GLA A + + E + P++ + Y+
Sbjct: 128 KPQNLLIN-RNGELKLANFGLA------RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 190 ELADIYSFGMCMLEMVTFEYPY 211
D++S G E+ P
Sbjct: 181 TSIDMWSAGCIFAELANAGRPL 202
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 50/184 (27%), Positives = 88/184 (47%), Gaps = 15/184 (8%)
Query: 52 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMK 111
++E E ++K +KH N+++ + + IITE T G+L Y ++ + ++
Sbjct: 52 EVEEFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 109
Query: 112 AVK--GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169
AV A QI S + YL + IHRDL N + N VK+ D GL+ +M
Sbjct: 110 AVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY 166
Query: 170 KSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKK 223
+ G +F APE L ++ +D+++FG+ + E+ T+ PY +Q+Y+
Sbjct: 167 TAHAGA-KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYEL 224
Query: 224 VSSG 227
+
Sbjct: 225 LEKD 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 54/274 (19%), Positives = 102/274 (37%), Gaps = 47/274 (17%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWID--D 81
+ F++ + A ++ + D R EV L + +I+R + + +
Sbjct: 35 LQIFNKRTQEKFA-LKM-LQDC----PKARR---EVELHWRASQCPHIVRIVDVYENLYA 85
Query: 82 QNKTVNIITELFTSGSL--RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL 139
K + I+ E G L R + + + + I + YLHS + I HRD+
Sbjct: 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDV 143
Query: 140 KCDNI-FINGNQG-EVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSF 197
K +N+ + + +K+ D G A E E Y++ D++S
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFA-------------------KETTGEKYDKSCDMWSL 184
Query: 198 GMCMLEMVT----FEYPYSECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIEKCLV 250
G+ M ++ F Y S + ++ G S+V + EVK I L
Sbjct: 185 GVIMYILLCGYPPF-YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE-EVKMLIRNLLK 242
Query: 251 P-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDI 283
+QR++ E + P++ + PL +
Sbjct: 243 TEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRV 276
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 25 YKA--FDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 82
YKA D + + A Q+ + S E+ LL+ LKH N+I ++
Sbjct: 38 YKAKRKDGKDDKDYALKQIEGTGISMSA------CREIALLRELKHPNVISLQKVFLSHA 91
Query: 83 NKTVNIITE--------LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 134
++ V ++ + + + KK ++ VK QIL G+ YLH++ +
Sbjct: 92 DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--V 149
Query: 135 IHRDLKCDNIFING---NQGEVKIGDLGLATIMEQANAKSVIGTPEFM-----APELY-- 184
+HRDLK NI + G +G VKI D+G A + P + APEL
Sbjct: 150 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 209
Query: 185 DENYNELADIYSFGMCMLEMVT 206
+Y + DI++ G E++T
Sbjct: 210 ARHYTKAIDIWAIGCIFAELLT 231
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-23
Identities = 60/285 (21%), Positives = 104/285 (36%), Gaps = 48/285 (16%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR----FYNSWID 80
++ G+ VA I V+Q P R + L L H NI++ FY
Sbjct: 40 QLGKEKSTGMSVA-----IKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94
Query: 81 DQNKT-VNIITELFTS---GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIH 136
D+ +N++ E R Y ++ +K + Q++ + LH + H
Sbjct: 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCH 154
Query: 137 RDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK-SVIGTPEFMAPELY--DENYNELAD 193
RD+K N+ +N G +K+ D G A + + + I + + APEL +++Y D
Sbjct: 155 RDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVD 214
Query: 194 IYSFGMCMLEMVTFE--YPYSECRN------------SAQIYKKVSSG--------IKPA 231
I+S G EM+ E + S ++ +K++ K
Sbjct: 215 IWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGI 274
Query: 232 ALSKV-------KDPEVKSFIEKCLV--PASQRLSAKELLMDPFL 267
S V E + L P +R+ E L P+
Sbjct: 275 PWSNVFSDHSLKDAKEAYDLLSALLQYLP-EERMKPYEALCHPYF 318
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 9e-23
Identities = 42/188 (22%), Positives = 79/188 (42%), Gaps = 14/188 (7%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKK 107
++ + +E ++K H N++ + + + ++ G LR + R +
Sbjct: 130 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHN 188
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167
+K + G+ Q+ G+ +L S +HRDL N ++ VK+ D GLA M
Sbjct: 189 PTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDK 245
Query: 168 NAKSVIGTPE------FMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQ 219
SV +MA E L + + +D++SFG+ + E++T PY +
Sbjct: 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FD 304
Query: 220 IYKKVSSG 227
I + G
Sbjct: 305 ITVYLLQG 312
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-23
Identities = 53/209 (25%), Positives = 106/209 (50%), Gaps = 15/209 (7%)
Query: 52 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMK 111
+E +E +L+++ +++ S+ D+ N + ++ E G + + ++ +
Sbjct: 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 112 AVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 171
+ +A QI+ YLHS D +I+RDLK +N+ I+ QG +++ D G A ++ +
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKG-RTWT 197
Query: 172 VIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG-IK 229
+ GTPE +APE + + YN+ D ++ G+ + EM P+ QIY+K+ SG ++
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVR 256
Query: 230 -PAALSKVKDPEVKSFIEKCLVP-ASQRL 256
P+ S ++K + L ++R
Sbjct: 257 FPSHFS----SDLKDLLRNLLQVDLTKRF 281
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 40/188 (21%), Positives = 75/188 (39%), Gaps = 14/188 (7%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKK 107
+ +E E L++ L H N++ + + ++ G L Q+ R +
Sbjct: 62 EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIRSPQRN 120
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167
+K + + Q+ G+ YL +HRDL N ++ + VK+ D GLA +
Sbjct: 121 PTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDES-FTVKVADFGLARDILDR 177
Query: 168 NAKSVIGTPE------FMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQ 219
SV + A E L + +D++SFG+ + E++T PY
Sbjct: 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FD 236
Query: 220 IYKKVSSG 227
+ ++ G
Sbjct: 237 LTHFLAQG 244
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 16/184 (8%)
Query: 52 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMK 111
+E +E +++K+L+H+ +++ + + + IITE GSL + K +
Sbjct: 226 SVEAFLAEANVMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQP 282
Query: 112 AVK--GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169
K ++ QI G+ ++ + IHRDL+ NI ++ + KI D GLA ++E
Sbjct: 283 LPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEY 339
Query: 170 KSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKK 223
+ G +F APE + ++ +D++SFG+ ++E+VT+ PY N ++ +
Sbjct: 340 TAREGA-KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRA 397
Query: 224 VSSG 227
+ G
Sbjct: 398 LERG 401
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 47/190 (24%), Positives = 83/190 (43%), Gaps = 20/190 (10%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-K 107
+ SE ++ H NIIR + + + I+TE +GSL + + H +
Sbjct: 90 TERQRRDFLSEASIMGQFDHPNIIRLEG--VVTRGRLAMIVTEYMENGSLDTFLRTHDGQ 147
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME-- 165
+ + G R + +G+ YL +HRDL N+ ++ N K+ D GL+ ++E
Sbjct: 148 FTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSN-LVCKVSDFGLSRVLEDD 204
Query: 166 ------QANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNS 217
K I + APE + ++ +D++SFG+ M E++ + E PY N
Sbjct: 205 PDAAYTTTGGKIPI---RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR 261
Query: 218 AQIYKKVSSG 227
+ V G
Sbjct: 262 -DVISSVEEG 270
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 35/200 (17%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS----EVHLLKSLKHNNIIRFYNSWID 80
YKA D V VA ++R++ + E + EV LLK L+H NII + +
Sbjct: 51 YKAIDTVTNETVAIKRIRLE------HEEEGVPGTAIREVSLLKELQHRNIIELKS--VI 102
Query: 81 DQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 140
N +++I E + L++Y K+ V M+ +K + Q+++G+ + HS +HRDLK
Sbjct: 103 HHNHRLHLIFE-YAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLK 159
Query: 141 CDNIFIN----GNQGEVKIGDLGLATIMEQANAKSVIG---TPEFM-----APELY--DE 186
N+ ++ +KIGD GL A A + T E + PE+
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGL------ARAFGIPIRQFTHEIITLWYRPPEILLGSR 213
Query: 187 NYNELADIYSFGMCMLEMVT 206
+Y+ DI+S EM+
Sbjct: 214 HYSTSVDIWSIACIWAEMLM 233
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 42/195 (21%), Positives = 79/195 (40%), Gaps = 20/195 (10%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN----IITELFTSGSLRQYRKK 104
+ D+E E +K H ++ + + + K +I G L +
Sbjct: 65 ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA 124
Query: 105 HKKVD------MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 158
+ + ++ + + I G+ YL S + IHRDL N + + V + D
Sbjct: 125 SRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED-MTVCVADF 181
Query: 159 GLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYS 212
GL+ + + + +A E L D Y +D+++FG+ M E++T + PY+
Sbjct: 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241
Query: 213 ECRNSAQIYKKVSSG 227
N A+IY + G
Sbjct: 242 GIEN-AEIYNYLIGG 255
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 53/190 (27%), Positives = 87/190 (45%), Gaps = 20/190 (10%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-K 107
+ + E ++ H NIIR + ++K V I+TE +GSL + +KH +
Sbjct: 86 TEKQRRDFLGEASIMGQFDHPNIIRLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME-- 165
+ + G R I SG+ YL +HRDL NI IN N K+ D GL ++E
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSN-LVCKVSDFGLGRVLEDD 200
Query: 166 ------QANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNS 217
K I + +PE + + +D++S+G+ + E++++ E PY E N
Sbjct: 201 PEAAYTTRGGKIPI---RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN- 256
Query: 218 AQIYKKVSSG 227
+ K V G
Sbjct: 257 QDVIKAVDEG 266
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 50/184 (27%), Positives = 87/184 (47%), Gaps = 16/184 (8%)
Query: 52 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK--KVD 109
+ +E +L+K L+H ++R Y + + IITE +GSL + K K+
Sbjct: 51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLT 107
Query: 110 MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169
+ + A QI G+ ++ + IHRDL+ NI ++ KI D GLA ++E
Sbjct: 108 INKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY 164
Query: 170 KSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKK 223
+ G +F APE + + +D++SFG+ + E+VT PY N ++ +
Sbjct: 165 TAREGA-KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQN 222
Query: 224 VSSG 227
+ G
Sbjct: 223 LERG 226
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 51/190 (26%), Positives = 93/190 (48%), Gaps = 20/190 (10%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-K 107
+ + E ++ H+NIIR + + K + IITE +G+L ++ ++ +
Sbjct: 86 TEKQRVDFLGEAGIMGQFSHHNIIRLEG--VISKYKPMMIITEYMENGALDKFLREKDGE 143
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME-- 165
+ + G R I +G+ YL + + +HRDL NI +N N K+ D GL+ ++E
Sbjct: 144 FSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDD 200
Query: 166 ------QANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNS 217
+ K I + APE + + +D++SFG+ M E++T+ E PY E N
Sbjct: 201 PEATYTTSGGKIPI---RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 257
Query: 218 AQIYKKVSSG 227
++ K ++ G
Sbjct: 258 -EVMKAINDG 266
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 3e-22
Identities = 60/217 (27%), Positives = 109/217 (50%), Gaps = 12/217 (5%)
Query: 42 RIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY 101
+ + V++ + +E E +L + H IIR + ++ D Q + +I + G L
Sbjct: 40 KKEIVVRL-KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ--IFMIMDYIEGGELFSL 96
Query: 102 RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 161
+K ++ K +A ++ L YLHS D II+RDLK +NI ++ G +KI D G A
Sbjct: 97 LRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFA 153
Query: 162 TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI 220
+ ++ GTP+++APE + + YN+ D +SFG+ + EM+ P+ N+ +
Sbjct: 154 KYVPD-VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKT 211
Query: 221 YKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRL 256
Y+K+ + + +VK + + + SQRL
Sbjct: 212 YEKILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRL 246
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 49/188 (26%), Positives = 90/188 (47%), Gaps = 15/188 (7%)
Query: 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 148
I +L G L + +H ++ +A +I+ GL ++H+ +++RDLK NI ++
Sbjct: 270 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD- 326
Query: 149 NQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE--LYDENYNELADIYSFGMCMLEMVT 206
G V+I DLGLA + + +GT +MAPE Y+ AD +S G + +++
Sbjct: 327 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386
Query: 207 FEYPY--SECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRL-----SA 258
P+ + ++ +I + + L PE++S +E L ++RL A
Sbjct: 387 GHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 444
Query: 259 KELLMDPF 266
+E+ PF
Sbjct: 445 QEVKESPF 452
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 72/296 (24%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLE-------RLYSEVHLLKSLKHNNIIRFYNS 77
K ++ G VA + +D + R E+ LLK L+H N++
Sbjct: 42 MKCRNKDTGRIVAIKKFLES------DDDKMVKKIAMR---EIKLLKQLRHENLVNLLE- 91
Query: 78 WIDDQNKTVNIITELFTSGSLRQYRKKHKK-VDMKAVKGWARQILSGLIYLHSHDPPIIH 136
+ + K ++ E F ++ + +D + V+ + QI++G+ + HSH+ IIH
Sbjct: 92 -VCKKKKRWYLVFE-FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIH 147
Query: 137 RDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFM-----APELY--DENYN 189
RD+K +NI ++ G VK+ D G A + A + E APEL D Y
Sbjct: 148 RDIKPENILVS-QSGVVKLCDFGFARTL---AAPGEVYDDEVATRWYRAPELLVGDVKYG 203
Query: 190 ELADIYSFGMCMLEMVTFEYPY----SECRNSAQIYK--------------KVSS--GIK 229
+ D+++ G + EM E P S+ Q+Y +
Sbjct: 204 KAVDVWAIGCLVTEMFMGE-PLFPGDSD---IDQLYHIMMCLGNLIPRHQELFNKNPVFA 259
Query: 230 PAALSKVK------------DPEVKSFIEKCLV--PASQRLSAKELLMDPFLQVNG 271
L ++K V +KCL P +R ELL F Q++G
Sbjct: 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPD-KRPFCAELLHHDFFQMDG 314
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 4e-22
Identities = 48/226 (21%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 17 IQLVDTSGYKAFDEV-----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI 71
++L+ T G F +V G +VA V+ +++ + +E ++ L+H+N+
Sbjct: 23 LKLLQTIGKGEFGDVMLGDYRGNKVA---VK---CIKNDATAQAFLAEASVMTQLRHSNL 76
Query: 72 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVK--GWARQILSGLIYLHS 129
++ I ++ + I+TE GSL Y + + + ++ + + YL
Sbjct: 77 VQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 130 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEF----MAPE- 182
++ +HRDL N+ ++ + K+ D GL Q K APE
Sbjct: 136 NN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGK-------LPVKWTAPEA 185
Query: 183 LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 227
L ++ ++ +D++SFG+ + E+ +F PY + +V G
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 230
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 8e-22
Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 17/181 (9%)
Query: 98 LRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 157
+ + + + QI+SGL +LH + II+RDLK +N+ ++ + G V+I D
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISD 332
Query: 158 LGLA--TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPY--- 211
LGLA Q K GTP FMAPE L E Y+ D ++ G+ + EM+ P+
Sbjct: 333 LGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392
Query: 212 SECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRL-----SAKELLMDP 265
E + ++ ++V P K F E L +RL S L P
Sbjct: 393 GEKVENKELKQRVLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450
Query: 266 F 266
Sbjct: 451 L 451
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 8e-22
Identities = 37/190 (19%), Positives = 85/190 (44%), Gaps = 21/190 (11%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-K 107
D E + E ++ L + I+R Q + + ++ E+ G L ++ + +
Sbjct: 376 EKADTEEMMREAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREE 432
Query: 108 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME-- 165
+ + V Q+ G+ YL + +HR+L N+ + N+ KI D GL+ +
Sbjct: 433 IPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLL-VNRHYAKISDFGLSKALGAD 489
Query: 166 ------QANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNS 217
++ K + ++ APE + ++ +D++S+G+ M E +++ + PY + +
Sbjct: 490 DSYYTARSAGKWPL---KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546
Query: 218 AQIYKKVSSG 227
++ + G
Sbjct: 547 -EVMAFIEQG 555
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 9e-22
Identities = 47/222 (21%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 17 IQLVDTSGYKAFDEV-----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI 71
++L+ T G F +V G +VA V+ +++ + +E ++ L+H+N+
Sbjct: 195 LKLLQTIGKGEFGDVMLGDYRGNKVA---VK---CIKNDATAQAFLAEASVMTQLRHSNL 248
Query: 72 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHS 129
++ ++++ + I+TE GSL Y + + + ++ + + YL
Sbjct: 249 VQLLGVIVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 130 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LYDE 186
++ +HRDL N+ ++ + K+ D GL Q K + ++ APE L ++
Sbjct: 308 NN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREK 361
Query: 187 NYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 227
++ +D++SFG+ + E+ +F PY + +V G
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVEKG 402
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 52/266 (19%), Positives = 100/266 (37%), Gaps = 28/266 (10%)
Query: 15 RLIQLVDTSG----YKAFDEVNGLEVAWCQVRI--DDVLQSPEDLERLYSEVHLLKSLKH 68
RL +LV G Y+A D V VA +++ + + P R+ E L+
Sbjct: 37 RLRRLVGRGGMGDVYEAEDTVRERIVA---LKLMSETLSSDPVFRTRMQREARTAGRLQE 93
Query: 69 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 128
+++ ++ D + + L L ++ + RQI S L H
Sbjct: 94 PHVVPIHDFGEIDG--QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH 151
Query: 129 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---AKSVIGTPEFMAPE-LY 184
+ HRD+K +NI ++ + + D G+A+ + +GT +MAPE
Sbjct: 152 AAG--ATHRDVKPENILVSAD-DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 185 DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI-YKKVSSGIKPAALSKVKD---PE 240
+ + ADIY+ + E +T PY + + ++ S V+
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPPYQ--GDQLSVMGAHINQ--AIPRPSTVRPGIPVA 264
Query: 241 VKSFIEKCLV--PASQRLSAKELLMD 264
+ I + + P + ++ +L
Sbjct: 265 FDAVIARGMAKNPEDRYVTCGDLSAA 290
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 48/149 (32%), Positives = 78/149 (52%), Gaps = 12/149 (8%)
Query: 117 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIG 174
A +I S L YLHS + I++RDLK +NI ++ +QG + + D GL I + + G
Sbjct: 145 AAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFCG 201
Query: 175 TPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL 233
TPE++APE L+ + Y+ D + G + EM+ P+ RN+A++Y + + KP L
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILN--KPLQL 258
Query: 234 SKVKDPEVKSFIEKCLV--PASQRLSAKE 260
+ +E L +RL AK+
Sbjct: 259 KPNITNSARHLLEGLLQKDRT-KRLGAKD 286
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 69/299 (23%), Positives = 118/299 (39%), Gaps = 73/299 (24%)
Query: 26 KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYN--------- 76
A D VA ++ VL P+ ++ E+ +++ L H+NI++ +
Sbjct: 29 SAVDNDCDKRVAIKKI----VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84
Query: 77 ---SWIDDQNKTVNIITEL--------FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLI 125
+ +V I+ E G L ++H ++ M Q+L GL
Sbjct: 85 TDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL---EEHARLFM-------YQLLRGLK 134
Query: 126 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE-----FMA 180
Y+HS + ++HRDLK N+FIN +KIGD GLA IM+ + + + +
Sbjct: 135 YIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRS 192
Query: 181 PE--LYDENYNELADIYSFGMCMLEMVT----F--------------------EYPYSEC 214
P L NY + D+++ G EM+T F E E
Sbjct: 193 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQEL 252
Query: 215 RNSAQIYKKVSSGIKPAALSKV---KDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQ 268
+ +Y + L+++ E F+E+ L P RL+A+E L P++
Sbjct: 253 LSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP-MDRLTAEEALSHPYMS 310
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 47/195 (24%), Positives = 83/195 (42%), Gaps = 22/195 (11%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY------- 101
S + +E ++K ++++R + Q + +I EL T G L+ Y
Sbjct: 68 SMRERIEFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPA 125
Query: 102 ---RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 158
+ + A +I G+ YL+++ +HRDL N + + VKIGD
Sbjct: 126 MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDF-TVKIGDF 182
Query: 159 GLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYS 212
G+ + + + G M+PE L D + +D++SFG+ + E+ T E PY
Sbjct: 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242
Query: 213 ECRNSAQIYKKVSSG 227
N Q+ + V G
Sbjct: 243 GLSN-EQVLRFVMEG 256
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 23/159 (14%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWA 117
E+ LLK L H NI+ + + + + ++ E F L++ ++K +K +
Sbjct: 69 EISLLKELHHPNIVSLID--VIHSERCLTLVFE-FMEKDLKKVLDENKTGLQDSQIKIYL 125
Query: 118 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG--- 174
Q+L G+ + H H I+HRDLK N+ IN + G +K+ D GLA A +
Sbjct: 126 YQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLA------RAFGIPVRSY 176
Query: 175 TPEFM-----APELY--DENYNELADIYSFGMCMLEMVT 206
T E + AP++ + Y+ DI+S G EM+T
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 58/293 (19%), Positives = 106/293 (36%), Gaps = 72/293 (24%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLE-------RLYSEVHLLKSLKHNNIIRFYNS 77
+K + G VA + ED R E+ +LK LKH N++
Sbjct: 20 FKCRNRDTGQIVAIKKFLES------EDDPVIKKIALR---EIRMLKQLKHPNLVNLLE- 69
Query: 78 WIDDQNKTVNIITELFTSGSLRQYRKKHKK-VDMKAVKGWARQILSGLIYLHSHDPPIIH 136
+ + + ++++ E + ++ ++++ V VK Q L + + H H+ IH
Sbjct: 70 -VFRRKRRLHLVFE-YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIH 125
Query: 137 RDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFM-----APELY--DENYN 189
RD+K +NI I +K+ D G A ++ S E +PEL D Y
Sbjct: 126 RDVKPENILIT-KHSVIKLCDFGFARLL---TGPSDYYDDEVATRWYRSPELLVGDTQYG 181
Query: 190 ELADIYSFGMCMLEMVTFEYPY----SECRNSAQIYK----------------------- 222
D+++ G E+++ P S+ Q+Y
Sbjct: 182 PPVDVWAIGCVFAELLSGV-PLWPGKSD---VDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 223 --KVSSGIKPAALSKVK---DPEVKSFIEKCLV--PASQRLSAKELLMDPFLQ 268
K+ L ++ CL P +RL+ ++LL P+ +
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPT-ERLTCEQLLHHPYFE 289
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 48/195 (24%), Positives = 79/195 (40%), Gaps = 22/195 (11%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--- 105
S +D E ++ H NI+R + Q+ I+ EL G L+ + ++
Sbjct: 73 SEQDELDFLMEALIISKFNHQNIVRCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPR 130
Query: 106 ----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE---VKIGDL 158
+ M + AR I G YL + IHRD+ N + G KIGD
Sbjct: 131 PSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLT-CPGPGRVAKIGDF 187
Query: 159 GLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYS 212
G+A + +A+ G M PE + + D +SFG+ + E+ + PY
Sbjct: 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247
Query: 213 ECRNSAQIYKKVSSG 227
N ++ + V+SG
Sbjct: 248 SKSN-QEVLEFVTSG 261
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 43/194 (22%), Positives = 80/194 (41%), Gaps = 19/194 (9%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN---IITELFTSGSLRQYRKKH 105
S ++E SE +K H N+IR I+ ++ + +I G L Y
Sbjct: 76 SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135
Query: 106 K------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 159
+ + ++ + + I G+ YL + + +HRDL N + + V + D G
Sbjct: 136 RLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDD-MTVCVADFG 192
Query: 160 LATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSE 213
L+ + + + +A E L D Y +D+++FG+ M E+ T PY
Sbjct: 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG 252
Query: 214 CRNSAQIYKKVSSG 227
+N ++Y + G
Sbjct: 253 VQN-HEMYDYLLHG 265
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 2e-21
Identities = 39/180 (21%), Positives = 78/180 (43%), Gaps = 25/180 (13%)
Query: 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 150
+L T K ++ + + + +++ + +H +HRD+K DNI ++
Sbjct: 160 DLLT-----LLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MN 211
Query: 151 GEVKIGDLGLATIM---EQANAKSVIGTPEFMAPEL------YDENYNELADIYSFGMCM 201
G +++ D G + + +GTP++++PE+ Y D +S G+CM
Sbjct: 212 GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCM 271
Query: 202 LEMVTFEYP-YSECRNSAQIYKKVSSGIK----PAALSKVKDPEVKSFIEKCLVPASQRL 256
EM+ E P Y+E + + Y K+ + + P ++ V K I + + RL
Sbjct: 272 YEMLYGETPFYAE--SLVETYGKIMNHKERFQFPTQVTDV-SENAKDLIRRLICSREHRL 328
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 38/199 (19%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPED------LERLYSEVHLLKSLKHNNIIRFYNSW 78
YK ++ VA ++R++ E+ + R EV LLK LKH NI+ ++
Sbjct: 19 YKGKSKLTDNLVALKEIRLEH-----EEGAPCTAI-R---EVSLLKDLKHANIVTLHD-- 67
Query: 79 IDDQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWARQILSGLIYLHSHDPPIIHR 137
I K++ ++ E + L+QY + +M VK + Q+L GL Y H ++HR
Sbjct: 68 IIHTEKSLTLVFE-YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHR 124
Query: 138 DLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG---TPEFM-----APELY--DEN 187
DLK N+ IN +GE+K+ D GL A AKS+ E + P++ +
Sbjct: 125 DLKPQNLLIN-ERGELKLADFGL------ARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 188 YNELADIYSFGMCMLEMVT 206
Y+ D++ G EM T
Sbjct: 178 YSTQIDMWGVGCIFYEMAT 196
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 3e-21
Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 23/159 (14%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWA 117
E+ +LK LKH+NI++ Y+ + K + ++ E L++ + + K +
Sbjct: 50 EISILKELKHSNIVKLYD--VIHTKKRLVLVFE-HLDQDLKKLLDVCEGGLESVTAKSFL 106
Query: 118 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG--- 174
Q+L+G+ Y H ++HRDLK N+ IN +GE+KI D GL A A +
Sbjct: 107 LQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGL------ARAFGIPVRKY 157
Query: 175 TPEFM-----APELY--DENYNELADIYSFGMCMLEMVT 206
T E + AP++ + Y+ DI+S G EMV
Sbjct: 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 3e-21
Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 14/144 (9%)
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTP 176
++ L +LHS II+RDLK +NI ++ +G +K+ D GL+ +I + A S GT
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 177 EFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IKPAAL 233
E+MAPE + + + AD +SFG+ M EM+T P+ + ++ + + P L
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKAKLGMPQFL 249
Query: 234 SKVKDPEVKSFIEKCLVP-ASQRL 256
S PE +S + + RL
Sbjct: 250 S----PEAQSLLRMLFKRNPANRL 269
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 3e-21
Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 44 DDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT-VNIITELFTSGSLRQYR 102
++++ +D +E ++L+ +KH I+ ++ Q + +I E + G L
Sbjct: 56 AMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF---QTGGKLYLILEYLSGGELFMQL 112
Query: 103 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA- 161
++ + +I L +LH II+RDLK +NI +N +QG VK+ D GL
Sbjct: 113 EREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGLCK 169
Query: 162 -TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ 219
+I + + GT E+MAPE L +N D +S G M +M+T P+ N +
Sbjct: 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRKK 228
Query: 220 IYKKVSSG-IK-PAALSKVKDPEVKSFIEKCLV--PASQRL 256
K+ + P L+ E + ++K L + RL
Sbjct: 229 TIDKILKCKLNLPPYLT----QEARDLLKKLLKRNA-ASRL 264
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 43/204 (21%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPED------LERLYSEVHLLKSLKHNNIIRFYNSW 78
YK ++ G+ VA +V++D E+ + R E+ L+K LKH NI+R Y+
Sbjct: 22 YKGLNKTTGVYVALKEVKLDS-----EEGTPSTAI-R---EISLMKELKHENIVRLYD-- 70
Query: 79 IDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA------VKGWARQILSGLIYLHSHDP 132
+ + ++ E F L++Y + VK + Q+L GL + H +
Sbjct: 71 VIHTENKLTLVFE-FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK- 128
Query: 133 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG---TPEFM-----APELY 184
I+HRDLK N+ IN +G++K+GD GL A A + + E + AP++
Sbjct: 129 -ILHRDLKPQNLLIN-KRGQLKLGDFGL------ARAFGIPVNTFSSEVVTLWYRAPDVL 180
Query: 185 --DENYNELADIYSFGMCMLEMVT 206
Y+ DI+S G + EM+T
Sbjct: 181 MGSRTYSTSIDIWSCGCILAEMIT 204
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 68/286 (23%), Positives = 117/286 (40%), Gaps = 58/286 (20%)
Query: 25 YKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
A D+ +G +VA + ++ QS +R Y E+ LLK ++H N+I + + +
Sbjct: 41 CSAIDKRSGEKVA---IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 97
Query: 84 ----KTVNIITELFTSGSLRQYRKK-----HKKVDMKAVKGWARQILSGLIYLHSHDPPI 134
++ + L++ + + Q+L GL Y+HS +
Sbjct: 98 LRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLV-------YQMLKGLKYIHSAG--V 147
Query: 135 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE--LYDENYNELA 192
+HRDLK N+ +N + E+KI D GLA + V+ T + APE L +YN+
Sbjct: 148 VHRDLKPGNLAVNED-CELKILDFGLARHADAEMTGYVV-TRWYRAPEVILSWMHYNQTV 205
Query: 193 DIYSFGMCMLEMVT----F---------------------EYPYSECRNSAQIYKKVSSG 227
DI+S G M EM+T F E+ +A+ Y +
Sbjct: 206 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQ 265
Query: 228 IKPAALSKV---KDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQ 268
+++ P+ +EK L +RL+A + L PF +
Sbjct: 266 TPRKDFTQLFPRASPQAADLLEKMLELDV-DKRLTAAQALTHPFFE 310
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 59/205 (28%), Positives = 84/205 (40%), Gaps = 39/205 (19%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS----EVHLLKSLK---HNNIIRFYN- 76
YKA D +G VA VR+ L EV LL+ L+ H N++R +
Sbjct: 26 YKARDPHSGHFVALKSVRVP---NGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82
Query: 77 --SWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA--VKGWARQILSGLIYLHSHDP 132
+ D+ V ++ E LR Y K + A +K RQ L GL +LH++
Sbjct: 83 CATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC- 140
Query: 133 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFM----------APE 182
I+HRDLK +NI + + G VK+ D GLA + + APE
Sbjct: 141 -IVHRDLKPENILVT-SGGTVKLADFGLA---------RIYSYQMALTPVVVTLWYRAPE 189
Query: 183 -LYDENYNELADIYSFGMCMLEMVT 206
L Y D++S G EM
Sbjct: 190 VLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 62/235 (26%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 45 DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT-VNIITELFTSGSLRQYRK 103
+V+ + +++ +E +L++ +H + ++ Q + + E G L +
Sbjct: 41 EVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF---QTHDRLCFVMEYANGGELFFHLS 97
Query: 104 KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-- 161
+ + + + + +I+S L YLHS D +++RD+K +N+ ++ G +KI D GL
Sbjct: 98 RERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDK-DGHIKITDFGLCKE 154
Query: 162 TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI 220
I + A K+ GTPE++APE L D +Y D + G+ M EM+ P+ ++ ++
Sbjct: 155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERL 213
Query: 221 YKKVSSG-IK-PAALSKVKDPEVKSFIEKCLV--PASQRL-----SAKELLMDPF 266
++ + I+ P LS PE KS + L P QRL AKE++ F
Sbjct: 214 FELILMEEIRFPRTLS----PEAKSLLAGLLKKDPK-QRLGGGPSDAKEVMEHRF 263
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 67/309 (21%), Positives = 117/309 (37%), Gaps = 72/309 (23%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLE----RLYSEVHLLKSLKHNNIIRFYNSWID 80
YKA D+ VA ++++ ++ + + R E+ LL+ L H NII +
Sbjct: 27 YKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR---EIKLLQELSHPNIIGLLD--AF 81
Query: 81 DQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWARQILSGLIYLHSHDPPIIHRDL 139
++++ + F L K + V +K + L GL YLH H I+HRDL
Sbjct: 82 GHKSNISLVFD-FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDL 138
Query: 140 KCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG---TPEFM-----APELY--DENYN 189
K +N+ ++ G +K+ D GLA + T + + APEL Y
Sbjct: 139 KPNNLLLD-ENGVLKLADFGLAK------SFGSPNRAYTHQVVTRWYRAPELLFGARMYG 191
Query: 190 ELADIYSFGMCMLEMVTFEYPY----SECRNSAQIYK--------------KVSS----- 226
D+++ G + E++ P+ S+ Q+ + + S
Sbjct: 192 VGVDMWAVGCILAELLLRV-PFLPGDSD---LDQLTRIFETLGTPTEEQWPDMCSLPDYV 247
Query: 227 ---GIKPAALSKV---KDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQVNGTTKNRPL 278
L + ++ I+ + P R++A + L + NRP
Sbjct: 248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC-ARITATQALKMKYF------SNRPG 300
Query: 279 PLPDIVLPR 287
P P LPR
Sbjct: 301 PTPGCQLPR 309
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 6e-21
Identities = 51/177 (28%), Positives = 83/177 (46%), Gaps = 16/177 (9%)
Query: 101 YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160
Y +A +I GL LH I++RDLK +NI ++ + G ++I DLGL
Sbjct: 276 YHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGL 332
Query: 161 AT-IMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSA 218
A + E K +GT +MAPE + +E Y D ++ G + EM+ + P+ + R
Sbjct: 333 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF-QQRKKK 391
Query: 219 QIYKKVSSGI--KPAALSKVKDPEVKSFIEKCLV--PASQRL-----SAKELLMDPF 266
++V + P S+ P+ +S + L PA +RL SA+E+ P
Sbjct: 392 IKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPA-ERLGCRGGSAREVKEHPL 447
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 40/194 (20%), Positives = 84/194 (43%), Gaps = 28/194 (14%)
Query: 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 150
+L T K +++ + + + +I+ + +H +HRD+K DNI ++
Sbjct: 147 DLLT-----LLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RC 198
Query: 151 GEVKIGDLGLATIM---EQANAKSVIGTPEFMAPEL--------YDENYNELADIYSFGM 199
G +++ D G + + +GTP++++PE+ +Y D ++ G+
Sbjct: 199 GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGV 258
Query: 200 CMLEMVTFEYP-YSECRNSAQIYKKVSSG---IKPAALSKVKDPEVKSFIEKCLVPASQR 255
EM + P Y++ ++A+ Y K+ + + + E + FI++ L P R
Sbjct: 259 FAYEMFYGQTPFYAD--STAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETR 316
Query: 256 L---SAKELLMDPF 266
L A + PF
Sbjct: 317 LGRGGAGDFRTHPF 330
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 48/195 (24%), Positives = 79/195 (40%), Gaps = 22/195 (11%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-- 106
S +D E ++ H NI+R + Q+ I+ EL G L+ + ++ +
Sbjct: 114 SEQDELDFLMEALIISKFNHQNIVRCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPR 171
Query: 107 -----KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE---VKIGDL 158
+ M + AR I G YL + IHRD+ N + G KIGD
Sbjct: 172 PSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLT-CPGPGRVAKIGDF 228
Query: 159 GLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYS 212
G+A + +A G M PE + + D +SFG+ + E+ + PY
Sbjct: 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288
Query: 213 ECRNSAQIYKKVSSG 227
N ++ + V+SG
Sbjct: 289 SKSN-QEVLEFVTSG 302
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 72/294 (24%), Positives = 123/294 (41%), Gaps = 58/294 (19%)
Query: 24 GYKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 82
A+D + VA + ++ Q+ +R Y E+ L+K + H NII N + +
Sbjct: 41 VCAAYDAILERNVA---IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 97
Query: 83 N----KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRD 138
+ + V I+ EL + +L Q + ++D + + Q+L G+ +LHS IIHRD
Sbjct: 98 SLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRD 152
Query: 139 LKCDNIFINGNQGEVKIGDLGLA-TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYS 196
LK NI + + +KI D GLA T + T + APE + Y E DI+S
Sbjct: 153 LKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 211
Query: 197 FGMCMLEMVTFE--YPYSECRN------------SAQIYKKVSSGIK------------- 229
G M EM+ +P ++ + + KK+ ++
Sbjct: 212 VGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYS 271
Query: 230 ------------PAALSKVKDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQV 269
+ +K+K + + + K LV S+R+S E L P++ V
Sbjct: 272 FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA-SKRISVDEALQHPYINV 324
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 82/294 (27%), Positives = 124/294 (42%), Gaps = 49/294 (16%)
Query: 15 RLIQLVDTSGY----KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 70
+ + V + Y AFD GL VA ++ QS +R Y E+ LLK +KH N
Sbjct: 32 QNLSPVGSGAYGSVCAAFDTKTGLRVA--VKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 71 IIRFYNSWIDDQN----KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIY 126
+I + + ++ V ++T L + L K +K+ V+ QIL GL Y
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNI-VKCQKLTDDHVQFLIYQILRGLKY 147
Query: 127 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE--LY 184
+HS D IIHRDLK N+ +N + E+KI D GLA V T + APE L
Sbjct: 148 IHSAD--IIHRDLKPSNLAVNED-CELKILDFGLARHTADEMTGYVA-TRWYRAPEIMLN 203
Query: 185 DENYNELADIYSFGMCMLEMVT----F---------------------EYPYSECRNSAQ 219
+YN+ DI+S G M E++T F E SA+
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263
Query: 220 IYKKVSSGIKPAALSKV---KDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQ 268
Y + + + + V +P +EK LV +R++A + L +
Sbjct: 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS-DKRITAAQALAHAYFA 316
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 74/282 (26%), Positives = 120/282 (42%), Gaps = 47/282 (16%)
Query: 24 GYKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 82
A D G +VA + ++ QS +R Y E+ LLK ++H N+I + + D+
Sbjct: 41 VCSAVDGRTGAKVA---IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97
Query: 83 N----KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRD 138
++ + L + KH+K+ ++ Q+L GL Y+H+ IIHRD
Sbjct: 98 TLDDFTDFYLVMPFMGT-DLGKL-MKHEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRD 153
Query: 139 LKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE--LYDENYNELADIYS 196
LK N+ +N + E+KI D GLA + V+ T + APE L Y + DI+S
Sbjct: 154 LKPGNLAVNED-CELKILDFGLARQADSEMTGYVV-TRWYRAPEVILNWMRYTQTVDIWS 211
Query: 197 FGMCMLEMVT----F---------------------EYPYSECRNSAQIYKKVSSGIKPA 231
G M EM+T F E+ + A+ Y K ++
Sbjct: 212 VGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK 271
Query: 232 ALSKV---KDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQ 268
+ + P + +EK LV QR++A E L P+ +
Sbjct: 272 DFASILTNASPLAVNLLEKMLVLDA-EQRVTAGEALAHPYFE 312
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 43/200 (21%), Positives = 85/200 (42%), Gaps = 27/200 (13%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--- 105
S + E LL L+H +I+RF+ + + + + ++ E G L ++ + H
Sbjct: 83 SESARQDFQREAELLTMLQHQHIVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPD 140
Query: 106 ------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 153
+ + + A Q+ +G++YL +HRDL N + V
Sbjct: 141 AKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VV 197
Query: 154 KIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF- 207
KIGD G++ + + V G M PE + + +D++SFG+ + E+ T+
Sbjct: 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257
Query: 208 EYPYSECRNSAQIYKKVSSG 227
+ P+ + N + ++ G
Sbjct: 258 KQPWYQLSN-TEAIDCITQG 276
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 46/201 (22%), Positives = 89/201 (44%), Gaps = 28/201 (13%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--- 105
+ + E LL +L+H +I++FY + + ++ E G L ++ + H
Sbjct: 57 TLAARKDFQREAELLTNLQHEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPD 114
Query: 106 -------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE 152
++ + + A QI SG++YL S +HRDL N + N
Sbjct: 115 AMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-L 171
Query: 153 VKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF 207
VKIGD G++ + + V G M PE + + +D++SFG+ + E+ T+
Sbjct: 172 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 231
Query: 208 -EYPYSECRNSAQIYKKVSSG 227
+ P+ + N ++ + ++ G
Sbjct: 232 GKQPWFQLSN-TEVIECITQG 251
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 75/297 (25%), Positives = 113/297 (38%), Gaps = 69/297 (23%)
Query: 26 KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 85
A + G VA ++ P R E+ +LK KH NII +N D +
Sbjct: 29 SATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85
Query: 86 VN---IITELFTSGSLRQYRKK------HKKVDMKAVKGWARQILSGLIYLHSHDPPIIH 136
N II EL + L + H + + Q L + LH + +IH
Sbjct: 86 FNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFI-------YQTLRAVKVLHGSN--VIH 135
Query: 137 RDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFM----------APE-- 182
RDLK N+ IN N ++K+ D GLA A+ G M APE
Sbjct: 136 RDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVM 194
Query: 183 LYDENYNELADIYSFGMCMLEMVT-----------------FEY---PYSE------CRN 216
L Y+ D++S G + E+ F P+S+
Sbjct: 195 LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESP 254
Query: 217 SAQIYKKVSSGIKPAALSKV---KDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQ 268
A+ Y K A L K+ +P+ +++ LV P ++R++AKE L P+LQ
Sbjct: 255 RAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP-AKRITAKEALEHPYLQ 310
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 46/156 (29%), Positives = 78/156 (50%), Gaps = 17/156 (10%)
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTP 176
+I+ GL +LHS I++RDLK DNI ++ G +KI D G+ ++ A + GTP
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTP 182
Query: 177 EFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IKPAAL 233
+++APE L + YN D +SFG+ + EM+ + P+ ++ +++ + P L
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWL 241
Query: 234 SKVKDPEVKSFIEKCLV--PASQRLSAKELLMD-PF 266
E K + K V P +RL + + P
Sbjct: 242 E----KEAKDLLVKLFVREPE-KRLGVRGDIRQHPL 272
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 41/201 (20%), Positives = 82/201 (40%), Gaps = 28/201 (13%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--- 105
E E L L+H N++ + +++ +++I + G L ++
Sbjct: 52 EGPLREEFRHEAMLRARLQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 109
Query: 106 -------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE 152
++ QI +G+ YL SH ++H+DL N+ +
Sbjct: 110 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDK-LN 166
Query: 153 VKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF 207
VKI DLGL + A+ ++G MAPE + ++ +DI+S+G+ + E+ ++
Sbjct: 167 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY 226
Query: 208 -EYPYSECRNSAQIYKKVSSG 227
PY N + + + +
Sbjct: 227 GLQPYCGYSN-QDVVEMIRNR 246
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 6e-20
Identities = 48/225 (21%), Positives = 89/225 (39%), Gaps = 44/225 (19%)
Query: 25 YKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYN---SWID 80
+A+D++ VA + +I V + D +R+ E+ +L L H+++++ +
Sbjct: 70 CEAYDKLEKRVVA---IKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126
Query: 81 DQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 140
++ + ++ E+ S ++ + + +K +L G+ Y+HS I+HRDLK
Sbjct: 127 EKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLK 183
Query: 141 CDNIFINGNQGEVKIGDLGLA-------------------TIMEQANAKSVIGTPEFM-- 179
N +N + VK+ D GLA M +
Sbjct: 184 PANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242
Query: 180 --------APE--LYDENYNELADIYSFGMCML-EMVTFEYPYSE 213
APE L ENY E D++S G C+ E++
Sbjct: 243 HVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLNMIKENVA 286
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 38/149 (25%), Positives = 71/149 (47%), Gaps = 16/149 (10%)
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTP 176
+I+S L++LH II+RDLK DN+ ++ +G K+ D G+ I + GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDH-EGHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 177 EFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKK-VSSGIK-PAAL 233
+++APE L + Y D ++ G+ + EM+ P+ E N +++ ++ + P L
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWL 247
Query: 234 SKVKDPEVKSFIEKCLV--PASQRLSAKE 260
+ ++ + P RL +
Sbjct: 248 H----EDATGILKSFMTKNPT-MRLGSLT 271
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 8e-20
Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 20/156 (12%)
Query: 116 WAR----QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168
WAR +++ L +HS IHRD+K DN+ ++ G +K+ D G M +
Sbjct: 169 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVR 225
Query: 169 AKSVIGTPEFMAPEL-----YDENYNELADIYSFGMCMLEMVTFEYP-YSECRNSAQIYK 222
+ +GTP++++PE+ D Y D +S G+ + EM+ + P Y++ + Y
Sbjct: 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTYS 283
Query: 223 KVSSGIKPAALSKVKD--PEVKSFIEKCLVPASQRL 256
K+ + D E K+ I L RL
Sbjct: 284 KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRL 319
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 65/273 (23%), Positives = 104/273 (38%), Gaps = 68/273 (24%)
Query: 59 EVHLLKSLK---HNNIIRFYN---SWIDDQNKTVNIITELFTSGSLRQYRKKHKKV--DM 110
EV +L+ L+ H N++R ++ D+ + ++ E L Y K +
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPT 119
Query: 111 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 170
+ +K Q+L GL +LHSH ++HRDLK NI + + G++K+ D GLA
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLA--------- 167
Query: 171 SVIGTPEFM----------APE-LYDENYNELADIYSFGMCMLEMVTFEYPY----SECR 215
+ + APE L +Y D++S G EM + P S+
Sbjct: 168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK-PLFRGSSD-- 224
Query: 216 NSAQIYK--------------KVSS-------GIKPAALSKVK---DPEVKSFIEKCLV- 250
Q+ K + + + K D K + KCL
Sbjct: 225 -VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 283
Query: 251 -PASQRLSAKELLMDP-FLQVNGTTKNRPLPLP 281
PA +R+SA L P F + +N LP
Sbjct: 284 NPA-KRISAYSALSHPYFQDLERCKENLDSHLP 315
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 61/285 (21%), Positives = 113/285 (39%), Gaps = 49/285 (17%)
Query: 24 GYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
A+D +N + VA ++ + +R E+ +L +H NII +
Sbjct: 43 VCSAYDNLNKVRVA---IKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99
Query: 84 KTVN---IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 140
+ + I+ +L + L + K + + + QIL GL Y+HS + ++HRDLK
Sbjct: 100 EQMKDVYIVQDLMET-DLYKLLKTQHLSNDH-ICYFLYQILRGLKYIHSAN--VLHRDLK 155
Query: 141 CDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE-----FMAPE--LYDENYNELAD 193
N+ +N ++KI D GLA + + + + T + APE L + Y + D
Sbjct: 156 PSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 214
Query: 194 IYSFGMCMLEMVT----F---------------------EYPYSECRNSAQIYKKVSSGI 228
I+S G + EM++ F E A+ Y
Sbjct: 215 IWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHK 274
Query: 229 KPAALSKV---KDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQ 268
+++ D + ++K L P +R+ ++ L P+L+
Sbjct: 275 NKVPWNRLFPNADSKALDLLDKMLTFNP-HKRIEVEQALAHPYLE 318
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 62/235 (26%), Positives = 112/235 (47%), Gaps = 24/235 (10%)
Query: 45 DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT-VNIITELFTSGSLRQYRK 103
+V+ + +++ +E +L++ +H + S+ Q + + E G L +
Sbjct: 184 EVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF---QTHDRLCFVMEYANGGELFFHLS 240
Query: 104 KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-- 161
+ + + + +I+S L YLHS +++RDLK +N+ ++ G +KI D GL
Sbjct: 241 RERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDK-DGHIKITDFGLCKE 298
Query: 162 TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI 220
I + A K+ GTPE++APE L D +Y D + G+ M EM+ P+ ++ ++
Sbjct: 299 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKL 357
Query: 221 YKK-VSSGIK-PAALSKVKDPEVKSFIEKCLV--PASQRL-----SAKELLMDPF 266
++ + I+ P L PE KS + L P QRL AKE++ F
Sbjct: 358 FELILMEEIRFPRTLG----PEAKSLLSGLLKKDPK-QRLGGGSEDAKEIMQHRF 407
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 21/151 (13%)
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA---TIMEQANAKSVIGT 175
+I+ L +LH II+RD+K +NI ++ + G V + D GL+ E A GT
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 176 PEFMAPELYDEN---YNELADIYSFGMCMLEMVT----FEYPYSECRNSAQIYKKVSSG- 227
E+MAP++ +++ D +S G+ M E++T F E + A+I +++
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF-TVDGEKNSQAEISRRILKSE 282
Query: 228 IK-PAALSKVKDPEVKSFIEKCLVP-ASQRL 256
P +S K I++ L+ +RL
Sbjct: 283 PPYPQEMS----ALAKDLIQRLLMKDPKKRL 309
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 3e-19
Identities = 72/294 (24%), Positives = 117/294 (39%), Gaps = 60/294 (20%)
Query: 25 YKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
A+D V VA + ++ Q+ +R Y E+ L+K + H NII N + +
Sbjct: 79 CAAYDAVLDRNVA---IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 135
Query: 84 ----KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL 139
+ V ++ EL + +L Q + ++D + + Q+L G+ +LHS IIHRDL
Sbjct: 136 LEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDL 190
Query: 140 KCDNIFINGNQGEVKIGDLGLA-TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSF 197
K NI + + +KI D GLA T + T + APE + Y E DI+S
Sbjct: 191 KPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249
Query: 198 GMCMLEMVT----F------------------------------------EYPYSECRNS 217
G M EMV F P
Sbjct: 250 GCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTF 309
Query: 218 AQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQV 269
+++ + +K+K + + + K LV PA +R+S + L P++ V
Sbjct: 310 PKLFPDSLFP-ADSEHNKLKASQARDLLSKMLVIDPA-KRISVDDALQHPYINV 361
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 69/313 (22%), Positives = 117/313 (37%), Gaps = 69/313 (22%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQS-PEDLERLYSEVHLLKSLKHNNIIRFY------NS 77
+KA G +VA +V +++ + P R E+ +L+ LKH N++ S
Sbjct: 34 FKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQLLKHENVVNLIEICRTKAS 90
Query: 78 WIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIH 136
+ ++ ++ + F L K + +K + +L+GL Y+H + I+H
Sbjct: 91 PYNRCKGSIYLVFD-FCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILH 147
Query: 137 RDLKCDNIFINGNQGEVKIGDLGLATIM-EQANAKSVIGTPE-----FMAPELY--DENY 188
RD+K N+ I G +K+ D GLA N++ T + PEL + +Y
Sbjct: 148 RDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY 206
Query: 189 NELADIYSFGMCMLEMVT--------------------------------FEYP-YSECR 215
D++ G M EM T Y Y +
Sbjct: 207 GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLE 266
Query: 216 NSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQVNGTT 273
+KV +K V+DP I+K LV PA QR+ + + L F
Sbjct: 267 LVKGQKRKVKDRLKAY----VRDPYALDLIDKLLVLDPA-QRIDSDDALNHDFF------ 315
Query: 274 KNRPLPLPDIVLP 286
+ P+P +
Sbjct: 316 WSDPMPSDLKGML 328
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 40/159 (25%), Positives = 80/159 (50%), Gaps = 19/159 (11%)
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTP 176
+I GL +L S II+RDLK DN+ ++ ++G +KI D G+ I + K+ GTP
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 177 EFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IKPAAL 233
+++APE + + Y + D ++FG+ + EM+ + P+ E + ++++ + P ++
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSM 244
Query: 234 SKVKDPEVKSFIEKCLVP-ASQRL-----SAKELLMDPF 266
S E + + + +RL +++ F
Sbjct: 245 S----KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 47/206 (22%), Positives = 84/206 (40%), Gaps = 34/206 (16%)
Query: 49 SPEDLERLYSEVHLLKSL-KHNNIIRFYN--SWIDDQNKTVNIITELFTSGSLRQYRKKH 105
+ E L SE+ +L L H NI+ + +ITE G L + ++
Sbjct: 66 HLTEREALMSELKVLSYLGNHMNIVNLLGACT----IGGPTLVITEYCCYGDLLNFLRRK 121
Query: 106 KKVDMKAVKG------------------WARQILSGLIYLHSHDPPIIHRDLKCDNIFIN 147
+ + + ++ Q+ G+ +L S + IHRDL NI +
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL- 178
Query: 148 GNQGEVKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCML 202
+ KI D GLA ++ + V G MAPE +++ Y +D++S+G+ +
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 203 EMVTF-EYPYSECRNSAQIYKKVSSG 227
E+ + PY ++ YK + G
Sbjct: 239 ELFSLGSSPYPGMPVDSKFYKMIKEG 264
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 42/155 (27%), Positives = 69/155 (44%), Gaps = 23/155 (14%)
Query: 117 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIG 174
+ +I L YLH II+RDLK DN+ ++ +G +K+ D G+ + + G
Sbjct: 116 SAEISLALNYLHERG--IIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTFCG 172
Query: 175 TPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIY----KKVSSGIK 229
TP ++APE L E+Y D ++ G+ M EM+ P+ +S + I
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 232
Query: 230 ------PAALSKVKDPEVKSFIEKCLV--PASQRL 256
P +LS + S ++ L P +RL
Sbjct: 233 EKQIRIPRSLS----VKAASVLKSFLNKDPK-ERL 262
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-19
Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 39/212 (18%)
Query: 26 KAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
A+D+ VA + +++ + + D +R+ E+ +L LK + IIR Y+ I D
Sbjct: 44 LAYDKNTEKNVA---IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100
Query: 85 TVN---IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 141
+ I+ E+ S L++ K + + +K +L G ++H IIHRDLK
Sbjct: 101 KFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKP 157
Query: 142 DNIFINGNQGEVKIGDLGLA--------------TIMEQANAKSVIGTPEFM-------- 179
N +N + VK+ D GLA + + +
Sbjct: 158 ANCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRW 216
Query: 180 --APE--LYDENYNELADIYSFGMCML-EMVT 206
APE L ENY + DI+S G C+ E++
Sbjct: 217 YRAPELILLQENYTKSIDIWSTG-CIFAELLN 247
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 44/202 (21%), Positives = 81/202 (40%), Gaps = 27/202 (13%)
Query: 49 SPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 107
+ + L SE+ +L + H N++ + + +I E G+L Y + +
Sbjct: 70 THSEHRALMSELKILIHIGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRN 128
Query: 108 VDMKAVKG----------------WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 151
+ ++ Q+ G+ +L S IHRDL NI ++
Sbjct: 129 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-N 185
Query: 152 EVKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVT 206
VKI D GLA + + G MAPE ++D Y +D++SFG+ + E+ +
Sbjct: 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
Query: 207 F-EYPYSECRNSAQIYKKVSSG 227
PY + + +++ G
Sbjct: 246 LGASPYPGVKIDEEFCRRLKEG 267
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 7e-19
Identities = 42/162 (25%), Positives = 81/162 (50%), Gaps = 21/162 (12%)
Query: 117 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIG 174
A +I GL +L S II+RDLK DN+ ++ +G +KI D G+ I + K+ G
Sbjct: 448 AAEIAIGLFFLQSKG--IIYRDLKLDNVMLDS-EGHIKIADFGMCKENIWDGVTTKTFCG 504
Query: 175 TPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IKPA 231
TP+++APE + + Y + D ++FG+ + EM+ + P+ E + ++++ + P
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPK 563
Query: 232 ALSKVKDPEVKSFIEKCLV--PASQRL-----SAKELLMDPF 266
++S E + + + P +RL +++ F
Sbjct: 564 SMS----KEAVAICKGLMTKHPG-KRLGCGPEGERDIKEHAF 600
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 59/282 (20%), Positives = 99/282 (35%), Gaps = 61/282 (21%)
Query: 34 LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYN---SWIDDQNKTVNIIT 90
+ R ++L +R+ E+ LL H NI+ + + + + ++T
Sbjct: 54 VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVT 113
Query: 91 ELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN 149
EL + L Q + + + ++ + IL GL LH ++HRDL NI + N
Sbjct: 114 ELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN 170
Query: 150 QGEVKIGDLGLATIMEQANAKSVIGTPEFM----------APE--LYDENYNELADIYSF 197
++ I D LA APE + + + +L D++S
Sbjct: 171 -NDITICDFNLA---------REDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSA 220
Query: 198 GMCMLEMVT----F---------------------EYPYSECRNSAQIYKKVSSGIKP-- 230
G M EM F E SA+ Y + S P
Sbjct: 221 GCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPAR 280
Query: 231 --AALSKVKDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQ 268
A+ DP I K L P +R+S ++ L P+ +
Sbjct: 281 AWTAVVPTADPVALDLIAKMLEFNP-QRRISTEQALRHPYFE 321
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 55/322 (17%), Positives = 104/322 (32%), Gaps = 99/322 (30%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR----FYNSWID 80
+ FD +G A + VLQ D E+ ++K L H NII+ FY + +
Sbjct: 24 CEVFDIESGKRFA-----LKKVLQ---DPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75
Query: 81 DQNKT--------------------------------VNIITELFTS---GSLRQYRKKH 105
+ +N+I E L+ + +
Sbjct: 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSG 135
Query: 106 KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165
+ + M + + Q+ + ++HS I HRD+K N+ +N +K+ D G A +
Sbjct: 136 RSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI 193
Query: 166 QANAKSVIGTPEFM----------APELY--DENYNELADIYSFGMCMLEMVTFE--YPY 211
+ E APEL Y D++S G E++ + +
Sbjct: 194 PS---------EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG 244
Query: 212 SECRN------------SAQIYKKVSSG--------IKPAALSKV----KDPEVKSFIEK 247
+ + + +++ +K K+ +E+
Sbjct: 245 ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ 304
Query: 248 CLV--PASQRLSAKELLMDPFL 267
L P R++ E + PF
Sbjct: 305 ILRYEP-DLRINPYEAMAHPFF 325
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 53/217 (24%)
Query: 26 KAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQN 83
K+ D G VA V +I D Q+ D +R + E+ +L L H NI+ N D +
Sbjct: 27 KSIDRRTGEVVA---VKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83
Query: 84 KTVNIITEL--------FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPII 135
+ V ++ + + L HK+ + Q++ + YLHS ++
Sbjct: 84 RDVYLVFDYMETDLHAVIRANIL---EPVHKQYVV-------YQLIKVIKYLHSGG--LL 131
Query: 136 HRDLKCDNIFINGNQGEVKIGDLGLA-------------TIMEQANAKSVIGTPEFM--- 179
HRD+K NI +N VK+ D GL+ + N ++ +
Sbjct: 132 HRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDY 190
Query: 180 -------APE--LYDENYNELADIYSFGMCML-EMVT 206
APE L Y + D++S G C+L E++
Sbjct: 191 VATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILC 226
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 42/155 (27%), Positives = 69/155 (44%), Gaps = 23/155 (14%)
Query: 117 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIG 174
+ +I L YLH II+RDLK DN+ ++ +G +K+ D G+ + + G
Sbjct: 159 SAEISLALNYLHERG--IIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTFCG 215
Query: 175 TPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIY----KKVSSGIK 229
TP ++APE L E+Y D ++ G+ M EM+ P+ +S + I
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 275
Query: 230 ------PAALSKVKDPEVKSFIEKCLV--PASQRL 256
P +LS + S ++ L P +RL
Sbjct: 276 EKQIRIPRSLS----VKAASVLKSFLNKDP-KERL 305
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 51/202 (25%), Positives = 89/202 (44%), Gaps = 30/202 (14%)
Query: 49 SPEDLERLYSEVHLLKSL-KHNNIIRFYN--SWIDDQNKTVNIITELFTSGSLRQY-RKK 104
++ E L SE+ ++ L +H NI+ + V +ITE G L + R+K
Sbjct: 89 HADEKEALMSELKIMSHLGQHENIVNLLGACT----HGGPVLVITEYCCYGDLLNFLRRK 144
Query: 105 HKKVDMKAVKG-------------WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 151
+ ++ ++ Q+ G+ +L S + IHRD+ N+ + N
Sbjct: 145 SRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL-TNGH 201
Query: 152 EVKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVT 206
KIGD GLA + + V G MAPE ++D Y +D++S+G+ + E+ +
Sbjct: 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
Query: 207 F-EYPYSECRNSAQIYKKVSSG 227
PY +++ YK V G
Sbjct: 262 LGLNPYPGILVNSKFYKLVKDG 283
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 29/202 (14%)
Query: 49 SPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 107
+ +DL L SE+ ++K + KH NII Q+ + +I E + G+LR+Y + +
Sbjct: 80 TEKDLSDLVSEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRP 137
Query: 108 VDMKAVKG----------------WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 151
M+ Q+ G+ YL S IHRDL N+ +
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLV-TENN 194
Query: 152 EVKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVT 206
+KI D GLA + + MAPE L+D Y +D++SFG+ M E+ T
Sbjct: 195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
Query: 207 F-EYPYSECRNSAQIYKKVSSG 227
PY +++K + G
Sbjct: 255 LGGSPYPGIPV-EELFKLLKEG 275
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 9e-18
Identities = 75/353 (21%), Positives = 125/353 (35%), Gaps = 85/353 (24%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-----------HNNIIR 73
+ A D VN VA VR E E+ LL+ + N+I++
Sbjct: 36 WLAKDMVNNTHVAMKIVR-----GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90
Query: 74 FYNS--WIDDQNKTVNIITELFTSGSLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHS 129
+ V ++ E+ +L KK H+ + + VK ++Q+L GL Y+H
Sbjct: 91 LLDHFNHKGPNGVHVVMVFEV-LGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR 149
Query: 130 HDPPIIHRDLKCDNIFI-----NGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-L 183
IIH D+K +N+ + N ++KI DLG A ++ + + I T E+ +PE L
Sbjct: 150 RC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVL 207
Query: 184 YDENYNELADIYSFGMCMLEMVT----F--EYPYSECRNSAQI----------------- 220
+ ADI+S + E++T F + +S ++ I
Sbjct: 208 LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRN 267
Query: 221 --------------YKKVSSGIKP--------AALSKVKDPEVKSFIEKCLV--PASQRL 256
P SK + E+ F+ L P +R
Sbjct: 268 GKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP-RKRA 326
Query: 257 SAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKHP 309
A L+ P+L+ T + +PD L G+ G H
Sbjct: 327 DAGGLVNHPWLK--DTLGMEEIRVPDRELYGSGSD------IPGWFEEVRDHK 371
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 36/209 (17%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV 108
SP +L L SE ++LK + H ++I+ Y + D + +I E GSLR + ++ +KV
Sbjct: 66 SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG--PLLLIVEYAKYGSLRGFLRESRKV 123
Query: 109 DMKAVKG------------------------WARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ +A QI G+ YL ++HRDL NI
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNI 181
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGM 199
+ ++KI D GL+ + + ++ MA E L+D Y +D++SFG+
Sbjct: 182 LVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 200 CMLEMVTF-EYPYSECRNSAQIYKKVSSG 227
+ E+VT PY +++ + +G
Sbjct: 241 LLWEIVTLGGNPYPGIPP-ERLFNLLKTG 268
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 33/204 (16%)
Query: 49 SPEDLERLYSEVHLLKSL-KHNNIIRFYN--SWIDDQNKTVNIITELFTSGSLRQYRKKH 105
+ +DL L SE+ ++K + KH NII + Q+ + +I E + G+LR+Y +
Sbjct: 114 TEKDLSDLISEMEMMKMIGKHKNIINLLGACT----QDGPLYVIVEYASKGNLREYLQAR 169
Query: 106 KKVDMKAVKG----------------WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN 149
+ ++ A Q+ G+ YL S IHRDL N+ + +
Sbjct: 170 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED 227
Query: 150 QGEVKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEM 204
+KI D GLA + + MAPE L+D Y +D++SFG+ + E+
Sbjct: 228 N-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286
Query: 205 VTF-EYPYSECRNSAQIYKKVSSG 227
T PY +++K + G
Sbjct: 287 FTLGGSPYPGVPV-EELFKLLKEG 309
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 29/202 (14%)
Query: 49 SPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 107
+ +DL L SE+ ++K + KH NII + D + +I E + G+LR+Y + +
Sbjct: 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRP 183
Query: 108 VDMKAVKG----------------WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 151
M+ Q+ G+ YL S IHRDL N+ +
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLV-TENN 240
Query: 152 EVKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVT 206
+KI D GLA + + MAPE L+D Y +D++SFG+ M E+ T
Sbjct: 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
Query: 207 F-EYPYSECRNSAQIYKKVSSG 227
PY +++K + G
Sbjct: 301 LGGSPYPGIPV-EELFKLLKEG 321
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 41/211 (19%), Positives = 79/211 (37%), Gaps = 40/211 (18%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV 108
S + E L+ + NI++ + + ++ E G L ++ +
Sbjct: 90 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPH 147
Query: 109 DMKAVKGW------------------------ARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ ++ ARQ+ +G+ YL +HRDL N
Sbjct: 148 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNC 205
Query: 145 FINGNQGEVKIGDLGLA-TIMEQ----ANAKSVIGTP-EFMAPE-LYDENYNELADIYSF 197
+ N VKI D GL+ I A+ I P +M PE ++ Y +D++++
Sbjct: 206 LVGENM-VVKIADFGLSRNIYSADYYKADGNDAI--PIRWMPPESIFYNRYTTESDVWAY 262
Query: 198 GMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 227
G+ + E+ ++ PY + ++ V G
Sbjct: 263 GVVLWEIFSYGLQPYYGMAH-EEVIYYVRDG 292
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 49/199 (24%), Positives = 80/199 (40%), Gaps = 26/199 (13%)
Query: 49 SPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 107
S +D E+ +L L H NII + + + E G+L + +K +
Sbjct: 65 SKDDHRDFAGELEVLCKLGHHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRV 122
Query: 108 VDMKAVKGW----------------ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 151
++ A + G+ YL IHRDL NI + N
Sbjct: 123 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY- 179
Query: 152 EVKIGDLGLATIMEQANAKSVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-E 208
KI D GL+ E K++ P +MA E L Y +D++S+G+ + E+V+
Sbjct: 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 239
Query: 209 YPYSECRNSAQIYKKVSSG 227
PY A++Y+K+ G
Sbjct: 240 TPYCGMTC-AELYEKLPQG 257
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 47/209 (22%), Positives = 80/209 (38%), Gaps = 35/209 (16%)
Query: 49 SPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 107
+ E L SE+ ++ L H NI+ + + +I E G L Y + ++
Sbjct: 88 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKRE 145
Query: 108 VDMKAVKG-----------------------WARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ +A Q+ G+ +L +HRDL N+
Sbjct: 146 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNV 203
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGM 199
+ VKI D GLA + + V G MAPE L++ Y +D++S+G+
Sbjct: 204 LVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262
Query: 200 CMLEMVTF-EYPYSECRNSAQIYKKVSSG 227
+ E+ + PY A YK + +G
Sbjct: 263 LLWEIFSLGVNPYPGIPVDANFYKLIQNG 291
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 9e-16
Identities = 50/194 (25%), Positives = 86/194 (44%), Gaps = 24/194 (12%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YK + VN VA ++ + + E ++ E+ ++ +H N++ D +
Sbjct: 48 YKGY--VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL 105
Query: 85 TVNIITELFTSGSLRQY---RKKHKKVD----MKAVKGWARQILSGLIYLHSHDPPIIHR 137
++ +GSL + K +G A G+ +LH + IHR
Sbjct: 106 C--LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN----GINFLH--ENHHIHR 157
Query: 138 DLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS-----VIGTPEFMAPELYDENYNELA 192
D+K NI ++ KI D GLA E+ A++ ++GT +MAPE +
Sbjct: 158 DIKSANILLDEAF-TAKISDFGLARASEK-FAQTVMTSRIVGTTAYMAPEALRGEITPKS 215
Query: 193 DIYSFGMCMLEMVT 206
DIYSFG+ +LE++T
Sbjct: 216 DIYSFGVVLLEIIT 229
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 30/167 (17%)
Query: 58 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQ----YRKKHKKVD---- 109
+EV ++ H N++R + + ++ +GS+ + +D
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERL--LVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 110 MKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168
+ G AR GL YLH H DP IIHRD+K NI ++ E +GD GLA +M+ +
Sbjct: 134 QRIALGSAR----GLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKD 188
Query: 169 AK---SVIGTPEFMAPELYDENY------NELADIYSFGMCMLEMVT 206
+V GT +APE Y +E D++ +G+ +LE++T
Sbjct: 189 THVTTAVRGTIGHIAPE-----YLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 37/287 (12%), Positives = 80/287 (27%), Gaps = 48/287 (16%)
Query: 15 RLIQLVDTSG----YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 70
RL+ ++A D +VA V VL + L+ S L +
Sbjct: 34 RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL-PDDVLQETLSRTLRLSRIDKPG 92
Query: 71 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH 130
+ R + + ++ E GSL++ + + + H
Sbjct: 93 VARVLD--VVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA 148
Query: 131 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNE 190
+ + ++ + G+V + M AN +
Sbjct: 149 G--VALSIDHPSRVRVSID-GDVVLAYPA---TMPDANPQD------------------- 183
Query: 191 LADIYSFGMCMLEMVTFEYPYSECRNSAQI---YKKVSSGIKPAALSKVKD---PEVKSF 244
DI G + ++ +P E + + + + +P + + ++ +
Sbjct: 184 --DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAG--QPIEPADIDRDIPFQISAV 239
Query: 245 IEKCLV--PASQRLSAKELLMDPFLQVNGTTKNRP--LPLPDIVLPR 287
+ + + S LM V T+ P PR
Sbjct: 240 AARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAPVSAAPR 286
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 63/311 (20%), Positives = 108/311 (34%), Gaps = 78/311 (25%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN------NIIRFYNSW 78
KA+D VA +++ V + E+ +L+ L+ N+I
Sbjct: 114 VKAYDHKVHQHVA---LKM--VRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE-N 167
Query: 79 IDDQNKTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIH 136
+N + EL S +L + KK+K + V+ +A IL L LH + IIH
Sbjct: 168 FTFRNHIC-MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIH 223
Query: 137 RDLKCDNI-FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADI 194
DLK +NI + +K+ D G + Q + I + + APE + Y D+
Sbjct: 224 CDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-RVYTYIQSRFYRAPEVILGARYGMPIDM 282
Query: 195 YSFGMCMLEMVT--------------------------------------FE---YPYSE 213
+S G + E++T YP
Sbjct: 283 WSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYC 342
Query: 214 CRNSAQIYKKVSSGIKP---------------AALSKVKDPEVKSFIEKCLVP-ASQRLS 257
+ V +G + AL DP F+++CL + R++
Sbjct: 343 TVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402
Query: 258 AKELLMDPFLQ 268
+ L P+L+
Sbjct: 403 PGQALRHPWLR 413
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 40/161 (24%), Positives = 73/161 (45%), Gaps = 22/161 (13%)
Query: 59 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQ--YRKKHKKVD------M 110
E+ L +H +++ + +I + +G+L++ Y + +
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDERNEMI--LIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 111 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 170
+ G AR GL YLH+ IIHRD+K NI ++ N KI D G++ + +
Sbjct: 143 EICIGAAR----GLHYLHT--RAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQT 195
Query: 171 ----SVIGTPEFMAPELYDENY-NELADIYSFGMCMLEMVT 206
V GT ++ PE + + E +D+YSFG+ + E++
Sbjct: 196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 33/118 (27%), Positives = 56/118 (47%), Gaps = 9/118 (7%)
Query: 116 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGT 175
++ Q+ G+ +L S IHRDL NI ++ VKI D GLA + + G
Sbjct: 198 YSFQVAKGMEFLASR--KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGD 254
Query: 176 PEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 227
MAPE ++D Y +D++SFG+ + E+ + PY + + +++ G
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 39/158 (24%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 59 EVHLLKSLKH------NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK--VDM 110
EV LL+ + I+ +N ++ E+ S +L + V +
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKR-HFMFRNHLC-LVFEML-SYNLYDLLRNTNFRGVSL 156
Query: 111 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI-FINGNQGEVKIGDLGLATIMEQANA 169
+ +A+Q+ + L++L + + IIH DLK +NI N + +KI D G + + Q
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-RI 215
Query: 170 KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVT 206
I + + +PE L Y+ D++S G ++EM T
Sbjct: 216 YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 34/184 (18%), Positives = 66/184 (35%), Gaps = 39/184 (21%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y AF + A V+++ ++ L+SE+ + + + I WI+ +
Sbjct: 54 YLAFPTNKPEKDARHVVKVE-----YQENGPLFSELKFYQRVAKKDCI---KKWIERKQL 105
Query: 85 TVNIITELFTSG-------------------SLRQYRKKHKKVDMKAVKGWARQILSGLI 125
I + SG L++ ++ V ++L L
Sbjct: 106 DYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLE 165
Query: 126 YLHSHDPPIIHRDLKCDNIFIN-GNQGEVKIGDLGLATI---------MEQANAKSVIGT 175
Y+H ++ +H D+K N+ + N +V + D GL+ ++ K GT
Sbjct: 166 YIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT 223
Query: 176 PEFM 179
EF
Sbjct: 224 IEFT 227
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 48/278 (17%), Positives = 97/278 (34%), Gaps = 75/278 (26%)
Query: 59 EVHLLKSLKH------NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV--DM 110
E+ +L+ L ++ W + I+ EL S + K++ + +
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLE-WFEHHGHIC-IVFELL-GLSTYDFIKENGFLPFRL 117
Query: 111 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG------------------E 152
++ A QI + +LHS+ + H DLK +NI + +
Sbjct: 118 DHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 153 VKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVT----- 206
+K+ D G AT + + +++ T + APE + +++ D++S G ++E
Sbjct: 176 IKVVDFGSAT-YDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 207 --------------------------------FEYPYSECRNSAQIYKKVSSGIKP---- 230
F + + + + VS KP
Sbjct: 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEF 294
Query: 231 AALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFL 267
V+ + I+K L ++R++ +E L PF
Sbjct: 295 MLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 55/287 (19%), Positives = 99/287 (34%), Gaps = 84/287 (29%)
Query: 59 EVHLLKSLKH-----NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV--DMK 111
E +LK +++ NNI++++ + +I E SL + ++ ++
Sbjct: 81 EADILKKIQNDDINNNNIVKYHG-KFMYYDHMC-LIFEPL-GPSLYEIITRNNYNGFHIE 137
Query: 112 AVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG-------------------- 151
+K + +IL L YL + H DLK +NI ++
Sbjct: 138 DIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 152 ----EVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVT 206
+K+ D G AT + S+I T ++ APE + + ++ +D++SFG + E+ T
Sbjct: 196 TKSTGIKLIDFGCAT-FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
Query: 207 ----F---------------------------------------EYPYSECRNSAQI-YK 222
F E + N++ I
Sbjct: 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314
Query: 223 KVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 268
K P +K F+ L + R S ELL FL+
Sbjct: 315 KHVKKCLPLYK-IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 44/279 (15%), Positives = 96/279 (34%), Gaps = 75/279 (26%)
Query: 59 EVHLLKSLKH------NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV--DM 110
E+++LK +K + + W + I EL + ++ K++ +
Sbjct: 66 EINVLKKIKEKDKENKFLCVLMSD-WFNFHGHMC-IAFELL-GKNTFEFLKENNFQPYPL 122
Query: 111 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG------------------E 152
V+ A Q+ L +LH + + H DLK +NI ++
Sbjct: 123 PHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 153 VKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVT----F 207
+++ D G AT + + +++ T + PE + + + + D++S G + E F
Sbjct: 181 IRVADFGSAT-FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239
Query: 208 ------------------------------------EYPYSECRNSAQIYKKVSSGIKPA 231
+ E + + K+ +K
Sbjct: 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSY 299
Query: 232 ALSK-VKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 268
L ++ ++ + + L +QR++ E L+ PF
Sbjct: 300 MLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.0 bits (147), Expect = 1e-09
Identities = 79/580 (13%), Positives = 167/580 (28%), Gaps = 175/580 (30%)
Query: 43 IDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF--------YNSWIDDQNKTVNI----IT 90
ID ++ S + + L S + + +F Y ++ KT +T
Sbjct: 51 IDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK-FLMSPIKTEQRQPSMMT 109
Query: 91 ELFTSGSLRQYR-----KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIH--------- 136
++ R Y K+ ++ ++ L+ L +I
Sbjct: 110 RMYIEQRDRLYNDNQVFAKYNVSRLQPYL----KLRQALLELRPAKNVLIDGVLGSGKTW 165
Query: 137 ------RDLK-----CDNIF-IN-GNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE- 182
K IF +N N + T++E P + +
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWLNLKNCNSPE-------TVLEMLQKLLYQIDPNWTSRSD 218
Query: 183 -------------------LYDENYNE----LADIYS------FGM-CMLEMVTFEYPYS 212
L + Y L ++ + F + C + + T
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT------ 272
Query: 213 ECRN-------SAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDP 265
R SA +S L+ EVKS + K L Q L + L +P
Sbjct: 273 --RFKQVTDFLSAATTTHISLDHHSMTLTP---DEVKSLLLKYLDCRPQDLPREVLTTNP 327
Query: 266 F--------LQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKHPSMD-FDSD 316
++ + ++ + L PA R + F
Sbjct: 328 RRLSIIAESIRDG---LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPS 384
Query: 317 AELP--VITSL-DNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDE-YSV-SLILRIADQS 371
A +P +++ + + + V +K + L++ + + S+ S+ L + +
Sbjct: 385 AHIPTILLSLIWFDV---IKSDVMVVV--NKLHKYSLVEKQPKESTISIPSIYLELKVKL 439
Query: 372 GRLRNIH--------FLFYLDSDTAFSVSSEM---------VEQLELADQNVTFIAELID 414
+H DSD + ++ +E ++ L
Sbjct: 440 ENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPER-----MTLFR 494
Query: 415 LLLLNLIPGWKPCVRIDHLIPQKSRRQSPEDHEKDALS--LERVDNSSGLSHRSYEADNH 472
++ L+ + + QK R S + ++ L+++ ++ Y DN
Sbjct: 495 MVFLDF--RF---------LEQKIRHDSTAWNASGSILNTLQQLKF-----YKPYICDND 538
Query: 473 SRSSDGQDSTSLKEGIQTTVLGPDF-MKPDEKRSHNDFSC 511
+ E + +L DF K +E + ++
Sbjct: 539 PK----------YERLVNAIL--DFLPKIEENLICSKYTD 566
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 55/269 (20%), Positives = 88/269 (32%), Gaps = 101/269 (37%)
Query: 97 SLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI-------- 146
L ++ K ++ + + VK +Q+L GL YLH+ IIH D+K +NI +
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK-CRIIHTDIKPENILLSVNEQYIR 188
Query: 147 ----------------------------------------NGNQGEVKIGDLGLATIMEQ 166
N + +VKI DLG A + +
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK 248
Query: 167 ANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPY-------------- 211
I T ++ + E L YN ADI+S E+ T +Y +
Sbjct: 249 HFT-EDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307
Query: 212 ----------------SECRNSAQIYK-----KVSSGIKPAALSKV-------KDPEVK- 242
+ S + + K + +KP L +V E
Sbjct: 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367
Query: 243 --SFIEKCLV--PASQRLSAKELLMDPFL 267
F+ L P +R +A E L P+L
Sbjct: 368 FTDFLLPMLELIP-EKRATAAECLRHPWL 395
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 40/168 (23%), Positives = 61/168 (36%), Gaps = 24/168 (14%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH-NNIIRFYNSWIDDQN 83
Y D G EVA + L+ E + K ++ I W +
Sbjct: 26 YLGTDIAAGEEVAIKLECVKTKHPQ------LHIESKIYKMMQGGVGIPTIR--WCGAEG 77
Query: 84 KTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
++ EL SL +K +K V A Q++S + Y+HS + IHRD+K D
Sbjct: 78 DYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPD 134
Query: 143 NIFI--NGNQGEVKIGDLGLA---------TIMEQANAKSVIGTPEFM 179
N + V I D GLA + K++ GT +
Sbjct: 135 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 25/131 (19%), Positives = 49/131 (37%), Gaps = 20/131 (15%)
Query: 63 LKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSG-SLRQYRKK--HKKVDMKAVKGWARQ 119
L S I + ++ L G SL+ + ++V A +
Sbjct: 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL---GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 120 ILSGLIYLHSHDPPIIHRDLKCDNIFIN-GNQGEVKIGDLGLAT----------IMEQAN 168
+L L +LH ++ +H ++ +NIF++ +Q +V + G A +E +
Sbjct: 168 LLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSR 225
Query: 169 AKSVIGTPEFM 179
G EF+
Sbjct: 226 -SPHEGDLEFI 235
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 34/161 (21%), Positives = 57/161 (35%), Gaps = 35/161 (21%)
Query: 49 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSG------------ 96
P D L++E+ + I WI + + + + SG
Sbjct: 73 EPSDNGPLFTELKFYQRAAKPEQI---QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFM 129
Query: 97 -------SLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN- 147
L++ + K+ K V + +IL L Y+H H+ +H D+K N+ +N
Sbjct: 130 IMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNY 187
Query: 148 GNQGEVKIGDLGLATI---------MEQANAKSVIGTPEFM 179
N +V + D GLA + GT EF
Sbjct: 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 34/168 (20%), Positives = 60/168 (35%), Gaps = 24/168 (14%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQN 83
Y + EVA + L E + + L+ I W +
Sbjct: 24 YLGTNIQTNEEVAIKLENVKTKHPQ------LLYESKIYRILQGGTGIPNVR--WFGVEG 75
Query: 84 KTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
++ +L SL +K+ +K V A Q+++ + ++HS +HRD+K D
Sbjct: 76 DYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPD 132
Query: 143 NIFI--NGNQGEVKIGDLGLATI---------MEQANAKSVIGTPEFM 179
N + +V I D GLA + K++ GT +
Sbjct: 133 NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 31/170 (18%), Positives = 60/170 (35%), Gaps = 26/170 (15%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH-NNIIRFYNSWIDDQN 83
++ + +N +VA L E K L I Y + +
Sbjct: 27 FEGTNLLNNQQVAIKFEPRRSDAPQ------LRDEYRTYKLLAGCTGIPNVY--YFGQEG 78
Query: 84 KTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
++ +L SL +K +K V A+Q+L+ + +H +++RD+K D
Sbjct: 79 LHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPD 135
Query: 143 NIFINGNQGE----VKIGDLGLATI---------MEQANAKSVIGTPEFM 179
N I + + + D G+ + K++ GT +M
Sbjct: 136 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 38/170 (22%), Positives = 64/170 (37%), Gaps = 26/170 (15%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH-NNIIRFYNSWIDDQN 83
+ VA ++++ + L E K L + I + Y +
Sbjct: 26 RLGKNLYTNEYVA---IKLEPMKSRAPQLHL---EYRFYKQLGSGDGIPQVY--YFGPCG 77
Query: 84 KTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
K ++ EL SL + +K V A Q++S + Y+HS + +I+RD+K +
Sbjct: 78 KYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPE 134
Query: 143 NIFI----NGNQGEVKIGDLGLATI---------MEQANAKSVIGTPEFM 179
N I N Q + I D LA + KS+ GT +M
Sbjct: 135 NFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 2e-05
Identities = 42/244 (17%), Positives = 70/244 (28%), Gaps = 43/244 (17%)
Query: 50 PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL-FTSGSLRQYRKKHKKV 108
P L + + + K ++ F + + I+ E F L Q R K
Sbjct: 108 PPLLLKAWDHYNSTKGSANDRPDFFKDD-------QLFIVLEFEFGGIDLEQMRTKLS-- 158
Query: 109 DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG----------------- 151
+ K Q+ + L HRDL N+ +
Sbjct: 159 SLATAKSILHQLTASLAVAE-ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSC 217
Query: 152 --EVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEY 209
+V I D L+ + V+ M +L+ + + DIY EY
Sbjct: 218 GLQVSIIDYTLSRLERDGI---VVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEY 274
Query: 210 -PYSECR-----NSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLM 263
PYS + + K +++ F L + SA +LL
Sbjct: 275 HPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----SATDLLC 330
Query: 264 DPFL 267
L
Sbjct: 331 QHSL 334
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 652 | |||
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.45 | |
| 2lru_A | 98 | Serine/threonine-protein kinase WNK1; autoinhibito | 98.63 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.88 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.81 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.74 | |
| 2v3s_A | 96 | Serine/threonine-protein kinase OSR1; ATP-binding, | 98.58 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.39 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.34 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.6 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.55 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.49 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.37 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.97 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.93 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.89 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.41 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.38 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.3 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.22 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.1 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.9 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.82 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.68 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.23 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.48 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.2 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.24 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.24 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 87.26 |
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-60 Score=493.57 Aligned_cols=253 Identities=52% Similarity=0.932 Sum_probs=232.9
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC--CCCeEEEEEec
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD--QNKTVNIITEL 92 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~--~~~~~~LVmEy 92 (652)
+||+++.|+||+|.++.+|+.||+|++..... .....+++.+|+++|++|+|||||++|++|.+. ....+||||||
T Consensus 33 ~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred EEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 48888889999999999999999999986543 456788999999999999999999999999763 23478999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
|.||+|.+++.+.+.+++..++.|++||+.||+|||+++++||||||||+|||+++.+|.+||+|||+|+........+.
T Consensus 111 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~~~ 190 (290)
T 3fpq_A 111 MTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV 190 (290)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEES
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCccCCc
Confidence 99999999999999999999999999999999999999888999999999999986678999999999987766667788
Q ss_pred cCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-C
Q 006277 173 IGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-P 251 (652)
Q Consensus 173 vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~ 251 (652)
+|||.|||||++.+.|+.++|||||||++|||+||.+||.+..+..++++.+..+..|..++...++++++||.+||+ +
T Consensus 191 ~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~d 270 (290)
T 3fpq_A 191 IGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQN 270 (290)
T ss_dssp CSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSS
T ss_pred ccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCC
Confidence 999999999999989999999999999999999999999988888999999999988888888889999999999998 8
Q ss_pred CCCCCCHHHHhcCccccc
Q 006277 252 ASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 252 P~~RpSa~elL~hpf~~~ 269 (652)
|.+|||+.|+|+||||+.
T Consensus 271 P~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 271 KDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GGGSCCHHHHHTSGGGC-
T ss_pred hhHCcCHHHHhcCccccC
Confidence 999999999999999974
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-57 Score=478.56 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=224.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...||++..|+||+|.++.+|+.||+|++.+.... .....+++.+|+++|++|+|||||++|++|.+.. .+||||||
T Consensus 37 ~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~yivmEy 113 (311)
T 4aw0_A 37 GKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE--KLYFGLSY 113 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEEECC
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EEEEEEec
Confidence 45788888899999999999999999999865432 2345788999999999999999999999998765 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc----c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----N 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~----~ 168 (652)
|.||+|.+++++.+.+++..++.|++||+.||+|||++| |+||||||+|||++ .+|++||+|||+|+.+... .
T Consensus 114 ~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~-~~g~vKl~DFGla~~~~~~~~~~~ 190 (311)
T 4aw0_A 114 AKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQAR 190 (311)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECCTTTTCCC
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEc-CCCCEEEEEcCCceecCCCCCccc
Confidence 999999999999999999999999999999999999999 99999999999998 6789999999999987432 3
Q ss_pred cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~k 247 (652)
..+.+|||.|||||++. ..|+.++|||||||++|+|+||.+||.+ .+..+++.+|..+.. .++...++++++||.+
T Consensus 191 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 191 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIKLEY--DFPEKFFPKARDLVEK 267 (311)
T ss_dssp BCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTCCHHHHHHHHH
T ss_pred ccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCcccCHHHHHHHHH
Confidence 46789999999999885 5799999999999999999999999987 677888888888753 3556788999999999
Q ss_pred hCC-CCCCCCCHHH------HhcCccccccCCCC
Q 006277 248 CLV-PASQRLSAKE------LLMDPFLQVNGTTK 274 (652)
Q Consensus 248 cL~-~P~~RpSa~e------lL~hpf~~~~~~~~ 274 (652)
||+ ||.+|||++| +++||||+..+|..
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence 998 8999999987 68999999776654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-56 Score=475.73 Aligned_cols=247 Identities=28% Similarity=0.499 Sum_probs=218.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
+.+||++..|+||+|.++.+|+.||||++.+... ...+.+.+|+.+|++|+|||||++|++|.+.. .+||||||
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~~ivmEy 152 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELWVVMEF 152 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEECC
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCch----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEEeC
Confidence 5688999999999999999999999999986543 23466889999999999999999999998765 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--ccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~ 170 (652)
|.||+|.+++.+ +++++..++.|++||+.||+|||++| ||||||||+|||++ .+|+|||+|||+|+.+... ...
T Consensus 153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEC-CCCCEEEecCcCceecCCCCCccc
Confidence 999999999876 57999999999999999999999999 99999999999998 6789999999999887543 356
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC-ccccCCCChHHHHHHHHh
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p-~~l~~~~s~~~kdlI~kc 248 (652)
+.+|||.|||||++. ..|+.++|||||||++|||++|.+||.+ .+..+++..|..+..+ ...+...++++++||.+|
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 307 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 789999999999885 5799999999999999999999999987 5677777777776533 233345789999999999
Q ss_pred CC-CCCCCCCHHHHhcCcccccc
Q 006277 249 LV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~~~~ 270 (652)
|+ ||.+|||+.|+|+||||+..
T Consensus 308 L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 308 LVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGC
T ss_pred cCCChhHCcCHHHHhcCHhhcCC
Confidence 98 89999999999999999853
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-56 Score=460.02 Aligned_cols=247 Identities=26% Similarity=0.464 Sum_probs=205.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...||+++.|+||+|.++.+|+.||+|++.+... ...+..+++.+|+++|++|+|||||++|++|.+.. .+|+||||
T Consensus 18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~~ivmEy 94 (275)
T 3hyh_A 18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVL-AKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD--EIIMVIEY 94 (275)
T ss_dssp EEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEEEEC
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHc-CCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--EEEEEEeC
Confidence 3577888889999999999999999999985543 33456778999999999999999999999998765 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-ccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKS 171 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~~~ 171 (652)
| +|+|.+++.+++++++..++.|++||+.||+|||++| |+||||||+|||++ .+|++||+|||+|+...... ..+
T Consensus 95 ~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~~~~~~ 170 (275)
T 3hyh_A 95 A-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKT 170 (275)
T ss_dssp C-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTCCEEECCSSCC-----------
T ss_pred C-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEEC-CCCCEEEeecCCCeecCCCCccCC
Confidence 9 7899999999999999999999999999999999999 99999999999998 67899999999998776543 467
Q ss_pred ccCCCCccCcccccc-CC-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 172 VIGTPEFMAPELYDE-NY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 172 ~vGTp~YmAPEvl~~-~y-~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
.+|||.|||||++.+ .| +.++|||||||++|+|+||.+||.+ .+..++++.+..+.. .++...++++++||.+||
T Consensus 171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L 247 (275)
T 3hyh_A 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVY--TLPKFLSPGAAGLIKRML 247 (275)
T ss_dssp ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHHS
T ss_pred eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHc
Confidence 899999999998854 44 6899999999999999999999987 677888888888754 355678999999999999
Q ss_pred C-CCCCCCCHHHHhcCccccc
Q 006277 250 V-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 250 ~-~P~~RpSa~elL~hpf~~~ 269 (652)
+ +|.+|||+.|+|+||||+.
T Consensus 248 ~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 248 IVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp CSSGGGSCCHHHHHHCHHHHT
T ss_pred cCChhHCcCHHHHHcCccccc
Confidence 8 8999999999999999974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-56 Score=474.47 Aligned_cols=248 Identities=23% Similarity=0.432 Sum_probs=215.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+||+++.|+||+|.++.+|+.||+|++.+... +....+++.+|+++|++|+|||||++|++|.+.. .+||||||
T Consensus 29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~--~~yiVmEy 104 (350)
T 4b9d_A 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEENG--SLYIVMDY 104 (350)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC--EEEEEEeC
Confidence 3567777789999999999999999999986543 4567889999999999999999999999998765 89999999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--c
Q 006277 93 FTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--N 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~ 168 (652)
|.||+|.+++..+ ..+++..++.|++||+.||+|||++| ||||||||+|||++ .+|.|||+|||+|+.+... .
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEEC-TTCCEEECSTTEESCCCHHHHH
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCCEEEcccccceeecCCccc
Confidence 9999999999765 35799999999999999999999999 99999999999998 6789999999999987543 2
Q ss_pred cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~k 247 (652)
..+.+|||.|||||++. ..|+.++|||||||++|||+||.+||.+ .+..+++.++..+..+. .+...++++++||.+
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~~-~~~~~s~~~~~li~~ 259 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFPP-VSLHYSYDLRSLVSQ 259 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCTTSCHHHHHHHHH
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHH
Confidence 45789999999999885 4799999999999999999999999987 56777788888776543 445678999999999
Q ss_pred hCC-CCCCCCCHHHHhcCccccc
Q 006277 248 CLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~~~ 269 (652)
||+ ||.+|||+.|+|+||||+.
T Consensus 260 ~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 260 LFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp HTCSSGGGSCCHHHHHTSHHHHT
T ss_pred HccCChhHCcCHHHHhcCHHhhc
Confidence 998 8999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=478.00 Aligned_cols=248 Identities=28% Similarity=0.494 Sum_probs=218.8
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.+.+||++..|+||+|.++.+|+.||||++.+... ...+.+.+|+.+|+.|+|||||++|++|.+.. .+|||||
T Consensus 155 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~~iVmE 228 (423)
T 4fie_A 155 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELWVVME 228 (423)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEE
T ss_pred eeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCCCceEEEEEECC--EEEEEEe
Confidence 35688999999999999999999999999986542 33567889999999999999999999998765 8999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
||.||+|.++++. +++++..++.|++||+.||+|||++| ||||||||+||||+ .+|.|||+|||+|+.+... ..
T Consensus 229 y~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 229 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEEC-TTCCEEECCCTTCEECCSSCCCB
T ss_pred CCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEecCccceECCCCCccc
Confidence 9999999999875 57999999999999999999999999 99999999999998 6789999999999887543 35
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC-ccccCCCChHHHHHHHH
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKVKDPEVKSFIEK 247 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p-~~l~~~~s~~~kdlI~k 247 (652)
.+.+|||.|||||++. ..|+.++|||||||++|||++|.+||.+ .+..+++..|..+..+ .......++++++||.+
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 6789999999999885 5799999999999999999999999987 5667777777766533 23345678999999999
Q ss_pred hCC-CCCCCCCHHHHhcCcccccc
Q 006277 248 CLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
||+ ||.+||||.|+|+||||+..
T Consensus 384 ~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HcCCChhHCcCHHHHhcCHHhcCC
Confidence 998 89999999999999999853
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-56 Score=466.41 Aligned_cols=251 Identities=23% Similarity=0.295 Sum_probs=212.7
Q ss_pred EEEEEEecCcEEEEEEEc---cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~---~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
...||+++.|+||+|.+. .+|+.||+|+++..... .....++.+|+++|++|+|||||++|++|.+.. .+|||
T Consensus 29 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~iv 104 (304)
T 3ubd_A 29 LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK--VRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG--KLYLI 104 (304)
T ss_dssp EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE--EEECC------CCCCCCCCTTEECEEEEEEETT--EEEEE
T ss_pred EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC--hHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--EEEEE
Confidence 456777788999999984 47899999999754331 123446888999999999999999999998765 89999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--c
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--A 167 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~ 167 (652)
||||.||+|.+++.+.+.+++..++.|++||+.||+|||++| |+||||||+|||++ .+|++||+|||+|+.... .
T Consensus 105 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEK 181 (304)
T ss_dssp ECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTSCEEEESSEEEEC-----C
T ss_pred EEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEc-CCCCEEecccccceeccCCCc
Confidence 999999999999999999999999999999999999999999 99999999999998 678999999999987643 2
Q ss_pred ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 168 NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 168 ~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
...+.+|||.|||||++. ..|+.++|||||||++|||+||.+||.+ .+..+++..|.++.. .++...++++++||.
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 258 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKL--GMPQFLSPEAQSLLR 258 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCcCCHHHHHHHH
Confidence 356789999999999874 5799999999999999999999999987 677788888887653 345678999999999
Q ss_pred HhCC-CCCCCCC-----HHHHhcCccccccCCC
Q 006277 247 KCLV-PASQRLS-----AKELLMDPFLQVNGTT 273 (652)
Q Consensus 247 kcL~-~P~~RpS-----a~elL~hpf~~~~~~~ 273 (652)
+||+ ||.+||| ++|+|+||||+..+|.
T Consensus 259 ~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~ 291 (304)
T 3ubd_A 259 MLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291 (304)
T ss_dssp HHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence 9998 8999998 5899999999976654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-54 Score=457.94 Aligned_cols=243 Identities=26% Similarity=0.318 Sum_probs=208.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+||+++.|+||+|.++.+|+.||+|+++.... ..+|+.+|+.|+|||||++|++|.+.. .+||||||
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~~--~~~ivmEy 131 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREGP--WVNIFMEL 131 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEETT--EEEEEECC
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEEec
Confidence 3579999999999999999999999999986433 136999999999999999999998765 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc----
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---- 168 (652)
|+||+|.+++++.+.+++..++.|++||+.||+|||++| ||||||||+|||++.++.++||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 999999999999999999999999999999999999999 99999999999998443379999999998775321
Q ss_pred ---cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC-ccccCCCChHHHH
Q 006277 169 ---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKVKDPEVKS 243 (652)
Q Consensus 169 ---~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p-~~l~~~~s~~~kd 243 (652)
..+++|||.|||||++. ..|+.++|||||||++|||+||.+||.+. +...++.+|..+..+ ..++...++++++
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 288 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY-FRGPLCLKIASEPPPIREIPPSCAPLTAQ 288 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT-CCSCCHHHHHHSCCGGGGSCTTSCHHHHH
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC-CHHHHHHHHHcCCCCchhcCccCCHHHHH
Confidence 23578999999999875 57999999999999999999999999874 444455566655433 3456678999999
Q ss_pred HHHHhCC-CCCCCCCHHHH-------------hcCccccc
Q 006277 244 FIEKCLV-PASQRLSAKEL-------------LMDPFLQV 269 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~el-------------L~hpf~~~ 269 (652)
||.+||+ +|.+|||+.|+ |+|||++.
T Consensus 289 li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 289 AIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred HHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 9999998 89999999998 56888863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=439.30 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=201.4
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC--------
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN-------- 83 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~-------- 83 (652)
....||+++.|+||+|.++.+|+.||+|+++... .....+++.+|+++|++|+|||||++|++|.+.+.
T Consensus 9 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 9 PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp EEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred EeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 3467889999999999999999999999998653 35567889999999999999999999999986542
Q ss_pred --CeEEEEEecCCCCCHHHHHHhCCCC---CHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEecc
Q 006277 84 --KTVNIITELFTSGSLRQYRKKHKKV---DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 158 (652)
Q Consensus 84 --~~~~LVmEy~~gGsL~~~i~~~~~l---se~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DF 158 (652)
..+|+|||||.||+|.+++..++.+ ++..++.|+.||+.||+|||++| |+||||||+|||++ .+|.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~-~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEEC-CCCcEEEccC
Confidence 2479999999999999999887654 45678999999999999999999 99999999999998 6789999999
Q ss_pred Cchhhhhccc--------------cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHH
Q 006277 159 GLATIMEQAN--------------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKK 223 (652)
Q Consensus 159 Gla~~l~~~~--------------~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~ 223 (652)
|+|+.+.... ..+.+|||.|||||++. ..|+.++|||||||++|||++ ||....+.......
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~ 239 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence 9998775321 23468999999999875 579999999999999999996 88654444455566
Q ss_pred HhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 224 VSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 224 I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+.....|..+. ..++.+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 240 ~~~~~~p~~~~-~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 240 VRNLKFPPLFT-QKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHTTCCCHHHH-HHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HhcCCCCCCCc-ccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 66665554333 345788999999998 89999999999999999754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=450.36 Aligned_cols=251 Identities=26% Similarity=0.348 Sum_probs=209.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC----CCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD----QNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~----~~~~~~L 88 (652)
...||++..|+||+|.++.+|+.||||+++... ......+++.+|+++|+.|+|||||++|+++... ....+||
T Consensus 59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~i 136 (398)
T 4b99_A 59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 136 (398)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEETTTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEE
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEECccc--cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEE
Confidence 457888888999999999999999999986443 2456778899999999999999999999987643 2347999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 167 (652)
|||||. |+|.+++.+.+++++..++.|++||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|+.+...
T Consensus 137 vmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~-~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 137 VLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp EEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCBCC----
T ss_pred EEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccC-CCCCEEEeecceeeecccCc
Confidence 999995 689999999999999999999999999999999999 99999999999998 6789999999999876432
Q ss_pred -----ccccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc--CCCCc-------
Q 006277 168 -----NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GIKPA------- 231 (652)
Q Consensus 168 -----~~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~--g~~p~------- 231 (652)
...+.+|||.|||||++.+ .|+.++||||+||++|||++|.+||.+. +....+..|.. |..+.
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~-~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK-NYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS-SHHHHHHHHHHHHCCCCGGGTC---
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC-CHHHHHHHHHHhcCCCChHHhhhhh
Confidence 2457899999999998643 5799999999999999999999999884 44444444432 11110
Q ss_pred -----------------c---ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 232 -----------------A---LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 232 -----------------~---l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
. .....++++++||.+||+ ||.+||||.|+|+||||+..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 0 112357899999999998 99999999999999999753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=470.78 Aligned_cols=270 Identities=21% Similarity=0.280 Sum_probs=227.3
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCC--CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQ--SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~--s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
....||+++.|.||+|.++.+|+.||+|++.+..+.. ......+...++.+++.++|||||++|++|.+.. .+|||
T Consensus 193 i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~--~lylV 270 (689)
T 3v5w_A 193 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KLSFI 270 (689)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--EEEEE
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC--EEEEE
Confidence 4567888888999999999999999999998654321 1223334445577788889999999999998765 89999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 169 (652)
||||.||+|.+++.+.+.+++..++.|++||+.||+|||++| ||||||||+|||++ .+|+|||+|||+|+.+.....
T Consensus 271 mEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld-~~G~vKL~DFGlA~~~~~~~~ 347 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKP 347 (689)
T ss_dssp ECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSCCC
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEe-CCCCEEecccceeeecCCCCC
Confidence 999999999999999999999999999999999999999999 99999999999998 678999999999998877777
Q ss_pred ccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCC--CHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 170 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECR--NSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~--~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
.+.+|||.|||||++. ..|+.++|||||||++|||++|.+||.+.. +...++..+.... ..++...++++++||
T Consensus 348 ~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--~~~p~~~S~~a~dLI 425 (689)
T 3v5w_A 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPDSFSPELRSLL 425 (689)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--CCCCccCCHHHHHHH
Confidence 8899999999999884 369999999999999999999999997632 4456666666653 345667899999999
Q ss_pred HHhCC-CCCCCCC-----HHHHhcCccccccCCCCCCCCCCCCCcCCCC
Q 006277 246 EKCLV-PASQRLS-----AKELLMDPFLQVNGTTKNRPLPLPDIVLPRV 288 (652)
Q Consensus 246 ~kcL~-~P~~RpS-----a~elL~hpf~~~~~~~~~~~~~~p~~~lp~~ 288 (652)
.+||+ ||.+|++ |.|+++||||+..+|........+++++|..
T Consensus 426 ~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~ 474 (689)
T 3v5w_A 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR 474 (689)
T ss_dssp HHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCT
T ss_pred HHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCC
Confidence 99998 8999998 8999999999988775432223344455544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=431.36 Aligned_cols=244 Identities=20% Similarity=0.299 Sum_probs=199.9
Q ss_pred EEEEEEecCcEEEEEEEc---cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~---~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~L 88 (652)
..+||++..|+||+|.++ .+++.||+|++... ....++.+|+++|+.+ +|||||+++++|.+.. .+|+
T Consensus 26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~------~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~--~~~l 97 (361)
T 4f9c_A 26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT------SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND--HVVI 97 (361)
T ss_dssp EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT------SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT--EEEE
T ss_pred EEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc------cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC--EEEE
Confidence 467888889999999986 46899999988643 2345788999999999 7999999999998765 8999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 167 (652)
|||||.||+|.++++ .+++..++.|++||+.||+|||++| |+||||||+|||++.+.|.+||+|||+|+.....
T Consensus 98 vmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 98 AMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 999999999999984 6999999999999999999999999 9999999999999966689999999999754321
Q ss_pred -----------------------------ccccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCC
Q 006277 168 -----------------------------NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRN 216 (652)
Q Consensus 168 -----------------------------~~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~ 216 (652)
...+.+|||.|||||++.+ .|+.++||||+||++|||+||.+||....+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 1235689999999998743 589999999999999999999999976555
Q ss_pred HHHHHHHHhc--C--------------------------------------------------CCCccccCCCChHHHHH
Q 006277 217 SAQIYKKVSS--G--------------------------------------------------IKPAALSKVKDPEVKSF 244 (652)
Q Consensus 217 ~~~i~~~I~~--g--------------------------------------------------~~p~~l~~~~s~~~kdl 244 (652)
.......|.. | ..........++++++|
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 4443333221 0 00001123467899999
Q ss_pred HHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 245 IEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
|.+||+ ||.+|+||+|+|+||||+.
T Consensus 333 l~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHCcCChhHCcCHHHHhcCcccCC
Confidence 999998 9999999999999999974
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=422.19 Aligned_cols=242 Identities=30% Similarity=0.438 Sum_probs=203.8
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.-.+||+++.|+||+|.... .||||+++... .+++..+++.+|+.+|++|+|||||++|+++.+ . .+|||||
T Consensus 40 l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~--~~~iVmE 111 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D--NLAIVTQ 111 (307)
T ss_dssp EEEECCCCSSSEEEEEESSS---EEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S--SCEEEEE
T ss_pred EeeEEeeCCCcEEEEEEECC---cEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C--eEEEEEE
Confidence 34678888889999997543 59999986443 356788999999999999999999999997643 2 5899999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc---
Q 006277 92 LFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--- 167 (652)
Q Consensus 92 y~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--- 167 (652)
||+||+|.+++... +++++..+..|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLH-EGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEE-TTEEEEECCCSSCBC-------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEEC-CCCcEEEeeccCceecccCCcc
Confidence 99999999999765 57999999999999999999999998 99999999999998 6789999999999876432
Q ss_pred -ccccccCCCCccCccccc----cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc---cccCCCCh
Q 006277 168 -NAKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA---ALSKVKDP 239 (652)
Q Consensus 168 -~~~~~vGTp~YmAPEvl~----~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~---~l~~~~s~ 239 (652)
...+.+|||.|||||++. +.|+.++|||||||++|||+||..||.+..+...+...+..+..++ ..+...++
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 268 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPK 268 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCH
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchH
Confidence 235679999999999873 3599999999999999999999999998778888888888776443 33456788
Q ss_pred HHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 240 EVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 240 ~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
++++||.+||. +|.+|||+.|++.+
T Consensus 269 ~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 269 AMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999998 89999999987654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=418.96 Aligned_cols=244 Identities=21% Similarity=0.340 Sum_probs=209.6
Q ss_pred EEEEEEecCcEEEEEEEc-----cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 006277 13 YLRLIQLVDTSGYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~-----~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~ 87 (652)
-.+||+++.|+||+|.+. .+|..||||+++.. +.+..+++.+|+++|++|+|||||++|+++.+.. .+|
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~--~~~ 91 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD--PLI 91 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--SEE
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC--EEE
Confidence 467899999999999864 47899999998632 4567789999999999999999999999987654 799
Q ss_pred EEEecCCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEE
Q 006277 88 IITELFTSGSLRQYRKKHK-------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVK 154 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~-------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VK 154 (652)
||||||++|+|.+++.+++ .+++..+..|+.||+.||+|||+++ ||||||||+|||++ .++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~-~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEEC-CCCcEE
Confidence 9999999999999997653 6999999999999999999999998 99999999999998 678999
Q ss_pred EeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCC
Q 006277 155 IGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGI 228 (652)
Q Consensus 155 L~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~ 228 (652)
|+|||+|+...... ....+||+.|||||++ .+.|+.++|||||||++|||+| |..||.+ .+..+++..+..+.
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVIECITQGR 247 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHHTC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCC
Confidence 99999998775432 2346799999999977 5689999999999999999998 8999987 56778888888876
Q ss_pred CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 229 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 229 ~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.+ ..+...++++.+||.+||. +|.+|||+.|+ ++||+.
T Consensus 248 ~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 248 VL-QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred CC-CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 54 3556788999999999998 89999999999 567753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=450.94 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=220.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...||++..|+||+|.++.+|+.||+|++.... ....+.+.+|+++|+.|+|||||+++++|.+.. .+||||||
T Consensus 162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~iv~E~ 235 (573)
T 3uto_A 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN--EMVMIYEF 235 (573)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS--EEEEEEEC
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEeccc----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEEEEEee
Confidence 457888888999999999999999999997543 456788999999999999999999999998765 89999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC-CCcEEEeccCchhhhhccc-c
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN-QGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~-~g~VKL~DFGla~~l~~~~-~ 169 (652)
|.||+|.+++.. ++.+++..++.|++||+.||.|||++| |+||||||+|||++.+ .|.+||+|||+|+.+.... .
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 999999999864 468999999999999999999999999 9999999999999843 4799999999999876543 4
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--CccccCCCChHHHHHHH
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKSFIE 246 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~~kdlI~ 246 (652)
.+.+|||.|||||++. ..|+.++|||||||++|+|++|.+||.+ .+..+++..|..+.. +.......++++++||.
T Consensus 314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~ 392 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 392 (573)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHH
T ss_pred eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 6789999999999875 5799999999999999999999999987 566777778877643 33444567899999999
Q ss_pred HhCC-CCCCCCCHHHHhcCccccccCC
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQVNGT 272 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~~~~~ 272 (652)
+||+ ||.+|||+.|+|+||||+...+
T Consensus 393 ~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 393 KLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp TTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 9998 8999999999999999986443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=419.99 Aligned_cols=241 Identities=22% Similarity=0.355 Sum_probs=202.1
Q ss_pred EEEEEEecCcEEEEEEEc-----cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 006277 13 YLRLIQLVDTSGYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~-----~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~ 87 (652)
-.+||+++.|+||+|... .+|+.||||+++.. +....+++.+|+++|++|+|||||++|+++.+.. .+|
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~--~~~ 119 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR--PLL 119 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--SEE
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEE
Confidence 357999999999999864 47999999998632 4567889999999999999999999999987654 799
Q ss_pred EEEecCCCCCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCc
Q 006277 88 IITELFTSGSLRQYRKKH---------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE 152 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~---------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~ 152 (652)
||||||++|+|.+++.++ +++++..+..|+.||+.||+|||+++ ||||||||+|||++ .++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~-~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVG-QGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEEC-CCCc
Confidence 999999999999999764 35899999999999999999999998 99999999999998 6789
Q ss_pred EEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhc
Q 006277 153 VKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSS 226 (652)
Q Consensus 153 VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~ 226 (652)
+||+|||+|+.+.... ....+||+.|||||++ .+.|+.++|||||||++|||+| |+.||.+ .+..+++..+..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~i~~ 275 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ-LSNTEAIDCITQ 275 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-SCHHHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC-CCHHHHHHHHHc
Confidence 9999999998764332 2457899999999977 4579999999999999999999 8999987 566778888888
Q ss_pred CCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 227 GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 227 g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
+..+ ..+...++++++||.+||. +|.+|||+.|++.+
T Consensus 276 g~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 276 GREL-ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCCC-CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCC-CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 7643 4566788999999999998 89999999999865
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=413.75 Aligned_cols=242 Identities=21% Similarity=0.259 Sum_probs=206.6
Q ss_pred EEEEEEecCcEEEEEEE-----ccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 006277 13 YLRLIQLVDTSGYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d-----~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~ 87 (652)
..+||+++.|+||+|.. ..+++.||||+++... .....+++.+|+.+|++|+|||||++|+++.+.. .++
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~--~~~ 105 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ--PLS 105 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCE
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC--EEE
Confidence 45789999999999984 4578999999986432 2345678999999999999999999999986554 789
Q ss_pred EEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCC
Q 006277 88 IITELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 151 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g 151 (652)
||||||++|+|.+++..+ ..+++..+..|+.||+.||+|||+++ ||||||||+||||+ +++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~-~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVY-DKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEEC-CCC
Confidence 999999999999999753 35899999999999999999999998 99999999999998 678
Q ss_pred cEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHh
Q 006277 152 EVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVS 225 (652)
Q Consensus 152 ~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~ 225 (652)
.+||+|||+|+.+.... ....+||+.|||||++ .+.|+.++|||||||++|||+| |..||.+ .+..++...+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~-~~~~~~~~~i~ 261 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVVEMIR 261 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-CCHHHHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHH
Confidence 99999999998775432 3457899999999976 5689999999999999999998 8999987 56778888888
Q ss_pred cCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 226 SGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 226 ~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.+..+ ..+...++++.+||.+||. +|.+|||+.|++++
T Consensus 262 ~~~~~-~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 262 NRQVL-PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC-CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 87654 3456678999999999997 89999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=415.32 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=213.4
Q ss_pred cceeeee---eEEEEEEecCcEEEEEEEccC-----CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC-CCeeeee
Q 006277 5 KWSLLIL---MYLRLIQLVDTSGYKAFDEVN-----GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH-NNIIRFY 75 (652)
Q Consensus 5 ~W~~~~~---~~~rL~~l~~gtVykA~d~~t-----G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~H-pnIVkl~ 75 (652)
+|..... .-..||++..|+||+|.+..+ ++.||+|.+.... .....+.+.+|+.+|++|+| ||||+++
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 5765443 335788888899999997654 4789999886432 34567889999999999965 9999999
Q ss_pred eEEEeCCCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccC
Q 006277 76 NSWIDDQNKTVNIITELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL 139 (652)
Q Consensus 76 ~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDL 139 (652)
++|.... ..+|||||||++|+|.++++.. ..+++..+..|+.||+.||+|||+++ ||||||
T Consensus 135 g~~~~~~-~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDL 211 (353)
T 4ase_A 135 GACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 211 (353)
T ss_dssp EEECCTT-SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEEecC-CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCcc
Confidence 9876543 3689999999999999999763 34899999999999999999999998 999999
Q ss_pred CcccEEEcCCCCcEEEeccCchhhhhcc----ccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCC
Q 006277 140 KCDNIFINGNQGEVKIGDLGLATIMEQA----NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSE 213 (652)
Q Consensus 140 Kp~NILl~~~~g~VKL~DFGla~~l~~~----~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~ 213 (652)
||+|||++ .++.+||+|||+|+.+... ...+.+||+.|||||++ .+.|+.++|||||||++|||+| |..||.+
T Consensus 212 K~~NILl~-~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 212 AARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp SGGGEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CccceeeC-CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 99999998 6789999999999876432 23467899999999977 5689999999999999999998 8999998
Q ss_pred CCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 214 CRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 214 ~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
......+.+.+..+..+ ..+...++++.+||.+||. +|.+|||+.|+++|
T Consensus 291 ~~~~~~~~~~i~~g~~~-~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 291 VKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 77777788888887654 3556678999999999998 89999999999998
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=434.44 Aligned_cols=361 Identities=24% Similarity=0.359 Sum_probs=265.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+|++++.|+||+|.++.+|..||+|++...... ......+.+|+.+|+.|+|||||+++++|.+.. .+|+|||||
T Consensus 43 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e~~ 118 (494)
T 3lij_A 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS--TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR--NYYLVMECY 118 (494)
T ss_dssp EEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEEEECC
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EEEEEEecC
Confidence 4667777799999999999999999999865432 234577899999999999999999999997654 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC--CCcEEEeccCchhhhhccc-cc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLGLATIMEQAN-AK 170 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~--~g~VKL~DFGla~~l~~~~-~~ 170 (652)
.+|+|.+++...+.+++..++.+++||+.||.|||++| |+||||||+|||++.. ++.+||+|||++..+.... ..
T Consensus 119 ~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~ 196 (494)
T 3lij_A 119 KGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK 196 (494)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcccc
Confidence 99999999998899999999999999999999999998 9999999999999742 4569999999998775433 45
Q ss_pred cccCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc--cccCCCChHHHHHHHHh
Q 006277 171 SVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA--ALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~--~l~~~~s~~~kdlI~kc 248 (652)
..+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+ .....+...+..+.... ......++.+++||.+|
T Consensus 197 ~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 275 (494)
T 3lij_A 197 ERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQM 275 (494)
T ss_dssp CCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHH
T ss_pred ccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHH
Confidence 6789999999999988999999999999999999999999987 56677778887775433 23345789999999999
Q ss_pred CC-CCCCCCCHHHHhcCccccccCCCCC--CCCCCCCCcCCCCCcccccccc--------------cCCCCcccCCCCCC
Q 006277 249 LV-PASQRLSAKELLMDPFLQVNGTTKN--RPLPLPDIVLPRVGAFGDRCLM--------------SEGPASVRNKHPSM 311 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~~~~~~~~~--~~~~~p~~~lp~~~~~~~~~~~--------------~~~~~~~~~~~~~~ 311 (652)
|. +|.+|||+.|+|+||||+....... ...+.....+.++..+...... .+........|..+
T Consensus 276 L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~~~l~~~F~~~ 355 (494)
T 3lij_A 276 LQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELTDIFRHI 355 (494)
T ss_dssp TCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHHHHHHHHHHHH
T ss_pred CCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHHHHHHHHHHHh
Confidence 98 8999999999999999975322111 1111111112222222211100 00001111122223
Q ss_pred CCCCCCCCccccccCCCCCCCCCCCcchhhhcccCccee------ccCCcCCcccceeeeeeec--CCCceeeeecc---
Q 006277 312 DFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFL------LKGESNDEYSVSLILRIAD--QSGRLRNIHFL--- 380 (652)
Q Consensus 312 d~d~d~~~~~~~~~~~~~~~~~~~~~i~~~~l~~~~~~~------~~G~~~~~~~I~liLri~D--~~g~i~~ieF~--- 380 (652)
|.+.++ .++.+++....... ..|....+..+..+++..| .+|.|.+-||.
T Consensus 356 D~d~dG-------------------~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~EF~~~~ 416 (494)
T 3lij_A 356 DKNGDG-------------------QLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVTVA 416 (494)
T ss_dssp CTTCSS-------------------EECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred CcCCCC-------------------eEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 333333 35556655442110 0111233567788888888 46799999997
Q ss_pred ----------------cccCCCCcCcchHHHHhccc
Q 006277 381 ----------------FYLDSDTAFSVSSEMVEQLE 400 (652)
Q Consensus 381 ----------------f~~d~Dta~~Va~EmV~~l~ 400 (652)
..+|+|..|.|+.+++....
T Consensus 417 ~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l 452 (494)
T 3lij_A 417 MDRKSLLSKDKLESAFQKFDQDGNGKISVDELASVF 452 (494)
T ss_dssp SCHHHHTCHHHHHHHHHHHCTTCSSEECHHHHHHHC
T ss_pred HhhhccccHHHHHHHHHHHCCCCCCcCCHHHHHHHH
Confidence 35789999999999998853
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=435.77 Aligned_cols=363 Identities=26% Similarity=0.368 Sum_probs=270.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.++.+|+.||+|++..... ......+.+.+|+.+|++|+|||||+++++|.+.. .+|+||||
T Consensus 31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e~ 107 (484)
T 3nyv_A 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQV-KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG--YFYLVGEV 107 (484)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEEECC
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhc-ccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--EEEEEEec
Confidence 3568888889999999999999999999975543 22345788999999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEc--CCCCcEEEeccCchhhhhccc-c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~--~~~g~VKL~DFGla~~l~~~~-~ 169 (652)
|.+|+|.+++...+.+++..++.+++||+.||.|||++| |+||||||+|||++ ..++.+||+|||++..+.... .
T Consensus 108 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 185 (484)
T 3nyv_A 108 YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185 (484)
T ss_dssp CCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSH
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccccc
Confidence 999999999999999999999999999999999999999 99999999999995 256789999999998775443 3
Q ss_pred ccccCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcc--ccCCCChHHHHHHHH
Q 006277 170 KSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA--LSKVKDPEVKSFIEK 247 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~--l~~~~s~~~kdlI~k 247 (652)
...+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+ .+...+...+..+..... .....++++++||.+
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 264 (484)
T 3nyv_A 186 KDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264 (484)
T ss_dssp HHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHH
T ss_pred ccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHH
Confidence 56789999999999988999999999999999999999999987 566777778877764433 234578999999999
Q ss_pred hCC-CCCCCCCHHHHhcCccccccCCCCCC-CCCCCCCcCCCCCccccccc--------------ccCCCCcccCCCCCC
Q 006277 248 CLV-PASQRLSAKELLMDPFLQVNGTTKNR-PLPLPDIVLPRVGAFGDRCL--------------MSEGPASVRNKHPSM 311 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~~~~~~~~~~-~~~~p~~~lp~~~~~~~~~~--------------~~~~~~~~~~~~~~~ 311 (652)
||. +|.+|||+.|+|+||||+........ ..+.....+.++..+..... ..+........|..+
T Consensus 265 ~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l~~~F~~~ 344 (484)
T 3nyv_A 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTAIFHKM 344 (484)
T ss_dssp HTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHHHHHHHHh
Confidence 998 89999999999999999854321110 11100001111111111000 001111122223334
Q ss_pred CCCCCCCCccccccCCCCCCCCCCCcchhhhcccCcc--eeccCCcCC-------cccceeeeeeecC--CCceeeeecc
Q 006277 312 DFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNF--FLLKGESND-------EYSVSLILRIADQ--SGRLRNIHFL 380 (652)
Q Consensus 312 d~d~d~~~~~~~~~~~~~~~~~~~~~i~~~~l~~~~~--~~~~G~~~~-------~~~I~liLri~D~--~g~i~~ieF~ 380 (652)
|.+.++. ++.+++..... +...|.... +..+..+++..|. +|.|.+-||.
T Consensus 345 D~d~dG~-------------------I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i~~~Ef~ 405 (484)
T 3nyv_A 345 DKNGDGQ-------------------LDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYSEFV 405 (484)
T ss_dssp CTTCSSE-------------------EEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEEEHHHHH
T ss_pred CcCCCce-------------------EeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 4444432 55555532211 111233222 5667788888884 6799999996
Q ss_pred -------------------cccCCCCcCcchHHHHhccc
Q 006277 381 -------------------FYLDSDTAFSVSSEMVEQLE 400 (652)
Q Consensus 381 -------------------f~~d~Dta~~Va~EmV~~l~ 400 (652)
..+|+|..|.|+.+++..+.
T Consensus 406 ~~~~~~~~~~~~~~~~~~F~~~D~d~dG~I~~~El~~~l 444 (484)
T 3nyv_A 406 TVAMDRKTLLSRERLERAFRMFDSDNSGKISSTELATIF 444 (484)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHH
T ss_pred HHHHhccccCcHHHHHHHHHHHCCCCCCcCCHHHHHHHH
Confidence 45789999999999988743
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=385.42 Aligned_cols=254 Identities=52% Similarity=0.932 Sum_probs=230.8
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC--CCCeEEEEEe
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD--QNKTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~--~~~~~~LVmE 91 (652)
..|++++.|+||+|.+..++..||+|.+..... +....+++.+|+.+|+.++||||++++++|.+. ....+++|||
T Consensus 32 ~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 109 (290)
T 1t4h_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeccCCCCeEEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEE
Confidence 357888889999999999999999999875443 456788999999999999999999999998753 3357899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 171 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~ 171 (652)
|+.+|+|.+++...+.+++..++.|+.||+.||.|||+++++|+||||||+|||++..++.+||+|||++..........
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~ 189 (290)
T 1t4h_A 110 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA 189 (290)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEE
T ss_pred ecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccccccc
Confidence 99999999999988899999999999999999999999987799999999999998667899999999998766655667
Q ss_pred ccCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-
Q 006277 172 VIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV- 250 (652)
Q Consensus 172 ~vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~- 250 (652)
..||+.|+|||++.+.++.++|||||||++|+|++|..||........++..+..+..+..++...++++++||.+||.
T Consensus 190 ~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 269 (290)
T 1t4h_A 190 VIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ 269 (290)
T ss_dssp SCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCS
T ss_pred ccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccC
Confidence 7899999999999888999999999999999999999999998888999999999888888888888999999999998
Q ss_pred CCCCCCCHHHHhcCccccc
Q 006277 251 PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 251 ~P~~RpSa~elL~hpf~~~ 269 (652)
+|.+|||+.|+|+||||+.
T Consensus 270 dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 270 NKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp SGGGSCCHHHHHTSGGGC-
T ss_pred ChhhCCCHHHHhhCccccc
Confidence 8999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=432.57 Aligned_cols=363 Identities=25% Similarity=0.348 Sum_probs=267.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCC---------HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQS---------PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s---------~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 83 (652)
..+|+++..|+||+|.++.+|+.||+|++........ ....+.+.+|+.+|++|+|||||+++++|.+..
T Consensus 41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 119 (504)
T 3q5i_A 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK- 119 (504)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC-
Confidence 3577777789999999999999999999976442210 134678999999999999999999999997654
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCC--CcEEEeccCch
Q 006277 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ--GEVKIGDLGLA 161 (652)
Q Consensus 84 ~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~--g~VKL~DFGla 161 (652)
.+|+|||||.||+|.+++...+.+++..++.+++||+.||.|||++| |+||||||+|||++..+ ..+||+|||++
T Consensus 120 -~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 196 (504)
T 3q5i_A 120 -YFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLS 196 (504)
T ss_dssp -EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEECCCTTC
T ss_pred -EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEEECCCC
Confidence 89999999999999999998899999999999999999999999998 99999999999998432 26999999999
Q ss_pred hhhhcc-ccccccCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcc--ccCCCC
Q 006277 162 TIMEQA-NAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA--LSKVKD 238 (652)
Q Consensus 162 ~~l~~~-~~~~~vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~--l~~~~s 238 (652)
..+... .....+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+ .+...+...+..+..... .....+
T Consensus 197 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (504)
T 3q5i_A 197 SFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYFDFNDWKNIS 275 (504)
T ss_dssp EECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSC
T ss_pred EEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCccccCCCC
Confidence 877544 3456789999999999988999999999999999999999999987 667778888887764332 235678
Q ss_pred hHHHHHHHHhCC-CCCCCCCHHHHhcCccccccCCCCCCCC-CCCCCcCCCCCccccccc--------------ccCCCC
Q 006277 239 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGTTKNRPL-PLPDIVLPRVGAFGDRCL--------------MSEGPA 302 (652)
Q Consensus 239 ~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~~~~~~~~~-~~p~~~lp~~~~~~~~~~--------------~~~~~~ 302 (652)
+++++||.+||. +|.+|||+.|+|+||||+.......... ......+.++..|..... ..+...
T Consensus 276 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~~~~~~~~~~ 355 (504)
T 3q5i_A 276 DEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERK 355 (504)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHHHTSCHHHHH
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhccCCcHHHHH
Confidence 999999999998 8999999999999999975432111000 000001111111211110 000011
Q ss_pred cccCCCCCCCCCCCCCCccccccCCCCCCCCCCCcchhhhcccCccee------ccCCcCCcccceeeeeeecC--CCce
Q 006277 303 SVRNKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFL------LKGESNDEYSVSLILRIADQ--SGRL 374 (652)
Q Consensus 303 ~~~~~~~~~d~d~d~~~~~~~~~~~~~~~~~~~~~i~~~~l~~~~~~~------~~G~~~~~~~I~liLri~D~--~g~i 374 (652)
.....|..+|.+.++ .++.+++....... ..|....+..+..+++..|. +|.|
T Consensus 356 ~l~~~F~~~D~d~dG-------------------~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I 416 (504)
T 3q5i_A 356 ELTDIFKKLDKNGDG-------------------QLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYI 416 (504)
T ss_dssp HHHHHHHHHCTTCSS-------------------EECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSE
T ss_pred HHHHHHHeeCCCCCC-------------------eEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcE
Confidence 112223333444333 25555554321100 11334456778888888884 5799
Q ss_pred eeeecc-------------------cccCCCCcCcchHHHHhcc
Q 006277 375 RNIHFL-------------------FYLDSDTAFSVSSEMVEQL 399 (652)
Q Consensus 375 ~~ieF~-------------------f~~d~Dta~~Va~EmV~~l 399 (652)
.+-||. -.+|+|..|.|+.+++..+
T Consensus 417 ~~~EF~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~El~~~ 460 (504)
T 3q5i_A 417 EYSEFISVCMDKQILFSEERLRRAFNLFDTDKSGKITKEELANL 460 (504)
T ss_dssp EHHHHHHHHSCHHHHTCHHHHHHHHHHHCTTCCSEECHHHHHHH
T ss_pred eHHHHHHHHHhhhcccCHHHHHHHHHHhcCCCCCcCcHHHHHHH
Confidence 999997 3468999999999999885
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=398.47 Aligned_cols=252 Identities=22% Similarity=0.369 Sum_probs=220.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.++.+|+.||+|+++..... ......++.+|+.+|+.++||||++++++|.+.. .+|+||||
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~--~~~lv~E~ 86 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFVMEY 86 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS--EEEEEEEC
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC--EEEEEEeC
Confidence 46788888899999999999999999999754321 1235678899999999999999999999998765 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--cccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~~ 170 (652)
|.||+|..++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|++||+|||+++.... ....
T Consensus 87 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~ 163 (337)
T 1o6l_A 87 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMK 163 (337)
T ss_dssp CTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTCCBC
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEEC-CCCCEEEeeccchhhcccCCCccc
Confidence 999999999998889999999999999999999999998 99999999999998 678999999999986432 2346
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
+.+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+ .+...++..+..+.. .++...++++++||.+||
T Consensus 164 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL 240 (337)
T 1o6l_A 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSLLAGLL 240 (337)
T ss_dssp CCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHT
T ss_pred ccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence 789999999999874 5799999999999999999999999987 566777777776542 345667899999999999
Q ss_pred C-CCCCCC-----CHHHHhcCccccccCCC
Q 006277 250 V-PASQRL-----SAKELLMDPFLQVNGTT 273 (652)
Q Consensus 250 ~-~P~~Rp-----Sa~elL~hpf~~~~~~~ 273 (652)
. +|.+|| ++.|+++||||+...|.
T Consensus 241 ~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 241 KKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred hcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 7 899999 89999999999876664
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=404.95 Aligned_cols=268 Identities=20% Similarity=0.331 Sum_probs=223.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...|+++..|+||+|.++.+|+.||+|+++..... .....+.+.+|+.+|+.+ +||||++++++|.+.. .+|+|||
T Consensus 28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~--~~~lv~E 104 (353)
T 3txo_A 28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD--RLFFVME 104 (353)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEEEEEE
T ss_pred EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC--EEEEEEe
Confidence 46788888899999999999999999999854321 234567889999999998 7999999999998765 7999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--ccc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~ 169 (652)
||.||+|..++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++ .+|++||+|||+++.... ...
T Consensus 105 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~-~~g~ikL~DFG~a~~~~~~~~~~ 181 (353)
T 3txo_A 105 FVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTT 181 (353)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCC-----
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEEC-CCCCEEEccccceeecccCCccc
Confidence 9999999999999899999999999999999999999999 99999999999998 678999999999986432 234
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
.+.+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+ .+...++..+..+.. .++...++++++||.+|
T Consensus 182 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~l 258 (353)
T 3txo_A 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLHEDATGILKSF 258 (353)
T ss_dssp ----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred cccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 6789999999999874 4699999999999999999999999987 677778888877643 34556789999999999
Q ss_pred CC-CCCCCCCH------HHHhcCccccccCCCCCCCCCCCCCcCCCCC
Q 006277 249 LV-PASQRLSA------KELLMDPFLQVNGTTKNRPLPLPDIVLPRVG 289 (652)
Q Consensus 249 L~-~P~~RpSa------~elL~hpf~~~~~~~~~~~~~~p~~~lp~~~ 289 (652)
|. +|.+||++ .|+++||||+...|.........++..|.+.
T Consensus 259 L~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~ 306 (353)
T 3txo_A 259 MTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIK 306 (353)
T ss_dssp TCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred hhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCC
Confidence 98 89999998 9999999999776654322233344555554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=391.38 Aligned_cols=248 Identities=23% Similarity=0.440 Sum_probs=219.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...+++++.|.||+|.+..+|+.||+|++..... ++...+++.+|+++|+.++||||+++++++.+.. .+|+||||
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lv~e~ 95 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK--TLYLIMEY 95 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEEECC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--EEEEEEEC
Confidence 4577888889999999999999999999975543 4677889999999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-cccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKS 171 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~~ 171 (652)
|.||+|.+++..++.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...... ....
T Consensus 96 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~ 172 (328)
T 3fe3_A 96 ASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDA 172 (328)
T ss_dssp CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTCCGGGSSSCGGGT
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEc-CCCCEEEeeccCceecCCCCcccc
Confidence 999999999999899999999999999999999999998 99999999999998 6789999999999876543 3467
Q ss_pred ccCCCCccCcccccc-CC-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 172 VIGTPEFMAPELYDE-NY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 172 ~vGTp~YmAPEvl~~-~y-~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
.+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+ .+...+...+..+... .+...++++++||.+||
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L 249 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYR--IPFYMSTDCENLLKRFL 249 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHC
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHHC
Confidence 789999999998743 44 4799999999999999999999987 6777788888877543 34567899999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccc
Q 006277 250 V-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 250 ~-~P~~RpSa~elL~hpf~~~~ 270 (652)
. +|.+|||+.|+|+||||+..
T Consensus 250 ~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 250 VLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp CSSTTTSCCHHHHTTCTTTTTT
T ss_pred CCChhHCcCHHHHhcCHhhcCC
Confidence 8 89999999999999999753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=434.60 Aligned_cols=251 Identities=29% Similarity=0.446 Sum_probs=218.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.+..+|+.||+|++...... ......+.+|+.+|++|+|||||++++++.+.. .+|+||||
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e~ 102 (486)
T 3mwu_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDSS--SFYIVGEL 102 (486)
T ss_dssp EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEEECC
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC--EEEEEEEc
Confidence 45777888899999999999999999999754321 134678899999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC--CCCcEEEeccCchhhhhccc-c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~--~~g~VKL~DFGla~~l~~~~-~ 169 (652)
|.||+|.+++...+.+++..++.+++||+.||.|||++| |+||||||+|||++. .++.+||+|||++..+.... .
T Consensus 103 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 180 (486)
T 3mwu_A 103 YTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (486)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCcc
Confidence 999999999998899999999999999999999999999 999999999999963 45679999999998775443 4
Q ss_pred ccccCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccc--cCCCChHHHHHHHH
Q 006277 170 KSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL--SKVKDPEVKSFIEK 247 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l--~~~~s~~~kdlI~k 247 (652)
...+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+ .+...+...+..+..+... ....++++++||.+
T Consensus 181 ~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 259 (486)
T 3mwu_A 181 KDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259 (486)
T ss_dssp -CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHH
T ss_pred CCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHH
Confidence 56789999999999988999999999999999999999999987 5667777788777644332 34578999999999
Q ss_pred hCC-CCCCCCCHHHHhcCcccccc
Q 006277 248 CLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
||. +|.+|||+.|+|+||||+..
T Consensus 260 ~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 260 MLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp HTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred HcCCChhhCcCHHHHhcCHhhccC
Confidence 998 89999999999999999854
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=391.66 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=219.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.++.+|+.||+|++...... .....+.+.+|+.+++.++||||++++++|.+.. .+|+||||
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~--~~~lv~e~ 87 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ--QIFMIMDY 87 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS--EEEEEECC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC--EEEEEEeC
Confidence 46788888899999999999999999999754321 1134677889999999999999999999998654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
|.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|++||+|||+++.... ...+.
T Consensus 88 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~Dfg~a~~~~~-~~~~~ 163 (318)
T 1fot_A 88 IEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPD-VTYTL 163 (318)
T ss_dssp CCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSS-CBCCC
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEc-CCCCEEEeecCcceecCC-ccccc
Confidence 999999999999999999999999999999999999998 99999999999998 678999999999986543 34567
Q ss_pred cCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-
Q 006277 173 IGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV- 250 (652)
Q Consensus 173 vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~- 250 (652)
+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+....+..+..+.. .++...++++++||.+||.
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL~~ 240 (318)
T 1fot_A 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLITR 240 (318)
T ss_dssp CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCS
T ss_pred cCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhcc
Confidence 8999999999774 5799999999999999999999999987 566677777776542 3456678999999999998
Q ss_pred CCCCCC-----CHHHHhcCccccccCCC
Q 006277 251 PASQRL-----SAKELLMDPFLQVNGTT 273 (652)
Q Consensus 251 ~P~~Rp-----Sa~elL~hpf~~~~~~~ 273 (652)
+|.+|| +++++++||||+...|.
T Consensus 241 dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 241 DLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred CHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 899999 89999999999876654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=404.75 Aligned_cols=270 Identities=19% Similarity=0.301 Sum_probs=223.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...|+++..|+||+|.++.+|+.||+|++++... ...+..+.+.+|+.+|+++ +|||||+++++|.+.. .+|+|||
T Consensus 57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~-~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~--~~~lV~E 133 (396)
T 4dc2_A 57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RLFFVIE 133 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGT-C----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS--EEEEEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-cCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC--EEEEEEE
Confidence 4678888889999999999999999999986543 3345667889999999887 8999999999998654 8999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh--cccc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~--~~~~ 169 (652)
||.||+|..++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++ .+|++||+|||+++... ....
T Consensus 134 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~~~~~ 210 (396)
T 4dc2_A 134 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTT 210 (396)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCCB
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEC-CCCCEEEeecceeeecccCCCcc
Confidence 9999999999999899999999999999999999999999 99999999999998 67899999999998632 2335
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCC--------CCHHHHHHHHhcCCCCccccCCCChH
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSEC--------RNSAQIYKKVSSGIKPAALSKVKDPE 240 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~--------~~~~~i~~~I~~g~~p~~l~~~~s~~ 240 (652)
.+.+||+.|+|||++. ..|+.++|||||||++|+|++|.+||... .....++..+..+. ..++...+++
T Consensus 211 ~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~s~~ 288 (396)
T 4dc2_A 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVK 288 (396)
T ss_dssp CCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--CCCCTTSCHH
T ss_pred ccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--cCCCCcCCHH
Confidence 6789999999999774 57999999999999999999999999642 23345666776654 3355668899
Q ss_pred HHHHHHHhCC-CCCCCCCH------HHHhcCccccccCCCCCCCCCCCCCcCCCCCc
Q 006277 241 VKSFIEKCLV-PASQRLSA------KELLMDPFLQVNGTTKNRPLPLPDIVLPRVGA 290 (652)
Q Consensus 241 ~kdlI~kcL~-~P~~RpSa------~elL~hpf~~~~~~~~~~~~~~p~~~lp~~~~ 290 (652)
+++||.+||. +|.+||++ .|+++||||+...|.........+++.|.+..
T Consensus 289 ~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~ 345 (396)
T 4dc2_A 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISG 345 (396)
T ss_dssp HHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred HHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCC
Confidence 9999999998 89999985 89999999997766443222333445565543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=396.15 Aligned_cols=267 Identities=21% Similarity=0.322 Sum_probs=226.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|.||+|.++.+|+.||+|++...... .....+++.+|+.+|+.++||||++++++|.+.. .+|+||||
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~ 122 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEY 122 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEEEEC
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc-cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC--EEEEEEcC
Confidence 46777888899999999999999999999754321 1234678899999999999999999999998654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
|.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+++..... ..+.
T Consensus 123 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFg~a~~~~~~-~~~~ 198 (350)
T 1rdq_E 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGR-TWTL 198 (350)
T ss_dssp CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC-BCCC
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEEC-CCCCEEEcccccceeccCC-cccc
Confidence 999999999998889999999999999999999999999 99999999999998 6789999999999876443 4567
Q ss_pred cCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-
Q 006277 173 IGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV- 250 (652)
Q Consensus 173 vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~- 250 (652)
+||+.|+|||++ ...|+.++|||||||++|+|++|.+||.+ .+..+++..+..+.. .++...++++++||.+||.
T Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL~~ 275 (350)
T 1rdq_E 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLLRNLLQV 275 (350)
T ss_dssp EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHHHHHSCS
T ss_pred cCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhc
Confidence 899999999976 45799999999999999999999999987 567788888887753 3456678999999999998
Q ss_pred CCCCCCC-----HHHHhcCccccccCCCCCCCCCCCCCcCCCCC
Q 006277 251 PASQRLS-----AKELLMDPFLQVNGTTKNRPLPLPDIVLPRVG 289 (652)
Q Consensus 251 ~P~~RpS-----a~elL~hpf~~~~~~~~~~~~~~p~~~lp~~~ 289 (652)
+|.+||+ +.++++||||+...|........+++..|.+.
T Consensus 276 dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~ 319 (350)
T 1rdq_E 276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFK 319 (350)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred CHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCC
Confidence 8999998 99999999998776643222223334455543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=382.84 Aligned_cols=247 Identities=28% Similarity=0.494 Sum_probs=215.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+|++++.|+||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||++++++|.+.. .+|+||||
T Consensus 25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~ 98 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGD--ELWVVMEY 98 (297)
T ss_dssp CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred eeeeccCCCeEEEEEEECCCCcEEEEEEeecccc----cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC--EEEEEEEC
Confidence 4689999999999999999999999999975542 23567889999999999999999999998765 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
|.||+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++....... ..
T Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSTTCCBC
T ss_pred CCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEC-CCCCEEEeeCCCceecCCcccccC
Confidence 9999999998765 6999999999999999999999998 99999999999998 67899999999988765432 35
Q ss_pred cccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 171 SVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 171 ~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
..+||+.|+|||++ ...|+.++|||||||++|+|++|..||.+.......+.....+......+...++.+++||.+||
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 254 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHS
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHc
Confidence 67899999999977 55799999999999999999999999988555555555555554444555667899999999999
Q ss_pred C-CCCCCCCHHHHhcCccccc
Q 006277 250 V-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 250 ~-~P~~RpSa~elL~hpf~~~ 269 (652)
. +|.+|||+.|+|+||||+.
T Consensus 255 ~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 255 EMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp CSSTTTSCCHHHHTTCGGGGG
T ss_pred cCChhHCcCHHHHhhChhhcc
Confidence 8 8999999999999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=391.26 Aligned_cols=253 Identities=19% Similarity=0.319 Sum_probs=218.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...|+++..|.||+|.++.+|+.||+|++.... ....+..+.+.+|+.+++++ +||||++++++|.+.. .+|+|||
T Consensus 14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~--~~~lv~e 90 (345)
T 3a8x_A 14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKEL-VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RLFFVIE 90 (345)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGG-SCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEEEEEC
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHH-hcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC--EEEEEEe
Confidence 467888888999999999999999999998554 34567788899999999998 8999999999997754 8999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--ccc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~ 169 (652)
||.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|++||+|||+++.... ...
T Consensus 91 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFG~a~~~~~~~~~~ 167 (345)
T 3a8x_A 91 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTT 167 (345)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCGGGCBCSCCTTCCB
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEEeccccccccCCCCcc
Confidence 9999999999998889999999999999999999999999 99999999999998 678999999999986432 234
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCC--------CCHHHHHHHHhcCCCCccccCCCChH
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSEC--------RNSAQIYKKVSSGIKPAALSKVKDPE 240 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~--------~~~~~i~~~I~~g~~p~~l~~~~s~~ 240 (652)
.+.+||+.|+|||++. ..|+.++|||||||++|+|++|..||... .....++..+..+.. .++...+++
T Consensus 168 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~s~~ 245 (345)
T 3a8x_A 168 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSVK 245 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--CCCTTSCHH
T ss_pred cccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--CCCCCCCHH
Confidence 6779999999999774 57999999999999999999999999642 234456666666532 345667899
Q ss_pred HHHHHHHhCC-CCCCCCCH------HHHhcCccccccCCC
Q 006277 241 VKSFIEKCLV-PASQRLSA------KELLMDPFLQVNGTT 273 (652)
Q Consensus 241 ~kdlI~kcL~-~P~~RpSa------~elL~hpf~~~~~~~ 273 (652)
+++||.+||. +|.+||++ .|+++||||+...|.
T Consensus 246 ~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~ 285 (345)
T 3a8x_A 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 285 (345)
T ss_dssp HHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence 9999999998 89999995 899999999876654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=395.81 Aligned_cols=253 Identities=26% Similarity=0.366 Sum_probs=219.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCC--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQS--PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s--~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
...|+++..|+||+|.++.+|+.||+|++........ ....+.+.+|+.+|++|+||||++++++|.+.. .+|+||
T Consensus 17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~lv~ 94 (361)
T 2yab_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT--DVVLIL 94 (361)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEEE
T ss_pred eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC--EEEEEE
Confidence 3567888889999999999999999999986554221 123578899999999999999999999997654 899999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCC---cEEEeccCchhhhhcc
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG---EVKIGDLGLATIMEQA 167 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g---~VKL~DFGla~~l~~~ 167 (652)
|||.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++..++ .+||+|||++..+...
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~ 172 (361)
T 2yab_A 95 ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172 (361)
T ss_dssp ECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC
Confidence 99999999999998889999999999999999999999998 999999999999984432 7999999999877553
Q ss_pred -ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC--ccccCCCChHHHH
Q 006277 168 -NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AALSKVKDPEVKS 243 (652)
Q Consensus 168 -~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p--~~l~~~~s~~~kd 243 (652)
.....+|||.|+|||++. ..|+.++|||||||++|+|++|.+||.+ .+...++..+..+... .......++++++
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 251 (361)
T 2yab_A 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEFFSQTSELAKD 251 (361)
T ss_dssp CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHH
T ss_pred CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCchhccCCCHHHHH
Confidence 345678999999999875 4799999999999999999999999987 5667777788776532 2334567899999
Q ss_pred HHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 244 FIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
||.+||. +|.+|||+.|+|+||||+..
T Consensus 252 li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 252 FIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred HHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 9999998 89999999999999999754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=407.55 Aligned_cols=271 Identities=18% Similarity=0.267 Sum_probs=223.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.++.+|+.||+|++....... ....+.+.+|+.+++.++|||||+++++|.+.. .+|+||||
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~lV~E~ 150 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR--YLYMVMEY 150 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEEECC
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEEEEEeC
Confidence 467888888999999999999999999997533211 122345889999999999999999999998654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---~ 169 (652)
|.||+|.+++.. ..+++..++.|+.||+.||+|||++| |+||||||+|||++ .+|++||+|||+++.+.... .
T Consensus 151 ~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFG~a~~~~~~~~~~~ 226 (410)
T 3v8s_A 151 MPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRC 226 (410)
T ss_dssp CTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTSEEEC
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeEC-CCCCEEEeccceeEeeccCCcccc
Confidence 999999999876 47999999999999999999999999 99999999999998 67899999999998765432 3
Q ss_pred ccccCCCCccCcccccc-C----CCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--CccccCCCChHHH
Q 006277 170 KSVIGTPEFMAPELYDE-N----YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVK 242 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~-~----y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~~k 242 (652)
.+.+||+.|+|||++.+ . |+.++|||||||++|+|++|.+||.+ .+...++..|..+.. ........+++++
T Consensus 227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 305 (410)
T 3v8s_A 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305 (410)
T ss_dssp CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCTTCCCCHHHH
T ss_pred cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC-CChhhHHHHHHhccccccCCCcccccHHHH
Confidence 57899999999998743 2 88999999999999999999999987 667777877776432 1222245789999
Q ss_pred HHHHHhCC-CCCC--CCCHHHHhcCccccccCCCCCCCCCCCCCcCCCCCcc
Q 006277 243 SFIEKCLV-PASQ--RLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAF 291 (652)
Q Consensus 243 dlI~kcL~-~P~~--RpSa~elL~hpf~~~~~~~~~~~~~~p~~~lp~~~~~ 291 (652)
+||.+||. +|.+ |+++.|+++||||+...|.........++..|.+...
T Consensus 306 ~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~ 357 (410)
T 3v8s_A 306 NLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSD 357 (410)
T ss_dssp HHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSST
T ss_pred HHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCCcCCCc
Confidence 99999998 5777 9999999999999987665433333344556665443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=398.39 Aligned_cols=268 Identities=23% Similarity=0.361 Sum_probs=222.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...|+++..|.||+|.++.+|+.||+|+++...... .+..+.+..|+.+|+.+ +||||++++++|.+.. .+|+|||
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~--~~~lv~E 98 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE--NLFFVME 98 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS--EEEEEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC--EEEEEEe
Confidence 457888888999999999999999999998543211 23466788999999987 9999999999998755 7999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh--cccc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~--~~~~ 169 (652)
||.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|++||+|||+++... ....
T Consensus 99 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~ 175 (345)
T 1xjd_A 99 YLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKT 175 (345)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCCB
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEEC-CCCCEEEeEChhhhhcccCCCcc
Confidence 9999999999998889999999999999999999999999 99999999999998 67899999999998643 2335
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
.+.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+...++..+..+.. .++...++++++||.+|
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~l 252 (345)
T 1xjd_A 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAKDLLVKL 252 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred cCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCC--CCCcccCHHHHHHHHHH
Confidence 6789999999999774 5799999999999999999999999987 567778888877642 34566789999999999
Q ss_pred CC-CCCCCCCHH-HHhcCccccccCCCCCCCCCCCCCcCCCCC
Q 006277 249 LV-PASQRLSAK-ELLMDPFLQVNGTTKNRPLPLPDIVLPRVG 289 (652)
Q Consensus 249 L~-~P~~RpSa~-elL~hpf~~~~~~~~~~~~~~p~~~lp~~~ 289 (652)
|. +|.+||++. ++++||||+...|........+++..|.+.
T Consensus 253 L~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~ 295 (345)
T 1xjd_A 253 FVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVK 295 (345)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSCC-------
T ss_pred hcCCHhHcCCChHHHHcCccccCCCHHHHhhCCCCCCcCCCCC
Confidence 98 899999998 999999999776643322223333445443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=388.78 Aligned_cols=242 Identities=24% Similarity=0.295 Sum_probs=188.3
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC--CeEEEEEe
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--KTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~--~~~~LVmE 91 (652)
.+||+++.|+||+|.+ +|+.||||++.... ........|+..+.+|+|||||++++++.+... ..+|||||
T Consensus 9 ~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 9 ESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp EEEEECSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 5799999999999986 69999999986432 222233456777788999999999999876543 36899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH------DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~------g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~ 165 (652)
||++|+|.+++..+ ++++..+..++.|++.||+|||++ .++||||||||+|||++ .++++||+|||+|+...
T Consensus 82 y~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECCCTTCEEEE
T ss_pred CCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC-CCCCEEEEeCCCCcccc
Confidence 99999999999764 689999999999999999999987 23499999999999998 67899999999998764
Q ss_pred ccc------cccccCCCCccCcccccc-------CCCccccchhhHHHHHHHhhccCCCCCC--------------CCHH
Q 006277 166 QAN------AKSVIGTPEFMAPELYDE-------NYNELADIYSFGMCMLEMVTFEYPYSEC--------------RNSA 218 (652)
Q Consensus 166 ~~~------~~~~vGTp~YmAPEvl~~-------~y~~~sDIWSlGvilyeLltG~~Pf~~~--------------~~~~ 218 (652)
... ....+||+.|||||++.+ .|+.++|||||||++|||+||.+||... ....
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 332 234689999999998854 3778999999999999999997765321 1234
Q ss_pred HHHHHHhcCCCCccccCC-----CChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 219 QIYKKVSSGIKPAALSKV-----KDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 219 ~i~~~I~~g~~p~~l~~~-----~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
++.+.+......+.++.. ....+.+||.+||. +|.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 555555544333233321 12467899999997 89999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=393.53 Aligned_cols=267 Identities=20% Similarity=0.297 Sum_probs=225.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...|+++..|+||+|.++.+|+.||+|++....... ....+.+..|+.+|+.+ +||||++++++|.+.. .+|+|||
T Consensus 25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~--~~~lv~E 101 (353)
T 2i0e_A 25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--RLYFVME 101 (353)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS--EEEEEEE
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC--EEEEEEe
Confidence 467888888999999999999999999998643221 23567889999999998 8999999999998654 8999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh--cccc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~--~~~~ 169 (652)
||.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|++||+|||+++... ....
T Consensus 102 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~ 178 (353)
T 2i0e_A 102 YVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTT 178 (353)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCCB
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEc-CCCcEEEEeCCcccccccCCccc
Confidence 9999999999998889999999999999999999999998 99999999999998 67899999999998643 2235
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
.+.+||+.|+|||++. ..|+.++|||||||++|||++|.+||.+ .+...++..+..+.. .++...++++++||.+|
T Consensus 179 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~l 255 (353)
T 2i0e_A 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICKGL 255 (353)
T ss_dssp CCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred ccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHH
Confidence 6789999999999774 5799999999999999999999999987 567778888877643 34567789999999999
Q ss_pred CC-CCCCCC-----CHHHHhcCccccccCCCCCCCCCCCCCcCCCC
Q 006277 249 LV-PASQRL-----SAKELLMDPFLQVNGTTKNRPLPLPDIVLPRV 288 (652)
Q Consensus 249 L~-~P~~Rp-----Sa~elL~hpf~~~~~~~~~~~~~~p~~~lp~~ 288 (652)
|. +|.+|| ++.++++||||+...|........+++..|..
T Consensus 256 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~ 301 (353)
T 2i0e_A 256 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA 301 (353)
T ss_dssp TCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred hhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCC
Confidence 98 899999 47999999999876664332222333344544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=384.19 Aligned_cols=252 Identities=24% Similarity=0.299 Sum_probs=205.9
Q ss_pred EEEEEEecCcEEEEEEEc---cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~---~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
...|++++.|+||+|.+. .+|+.||+|+++.............+.+|+.+|+.++||||+++++++.+.. .+|+|
T Consensus 22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv 99 (327)
T 3a62_A 22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG--KLYLI 99 (327)
T ss_dssp EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS--CEEEE
T ss_pred EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC--EEEEE
Confidence 467888888999999986 6899999999986554444456677889999999999999999999987654 79999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-- 167 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 167 (652)
||||.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++.....
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~ 176 (327)
T 3a62_A 100 LEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGT 176 (327)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTSCEEECCCSCC--------
T ss_pred EeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEEC-CCCcEEEEeCCcccccccCCc
Confidence 999999999999998889999999999999999999999998 99999999999998 6789999999999865432
Q ss_pred ccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 168 NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 168 ~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
.....+||+.|+|||++ ...|+.++|||||||++|+|++|..||.+ .+....+..+..+.. .++...++++++||.
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~ 253 (327)
T 3a62_A 177 VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKL--NLPPYLTQEARDLLK 253 (327)
T ss_dssp --CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHHH
T ss_pred cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHH
Confidence 24567899999999977 45789999999999999999999999987 556666666666542 344567899999999
Q ss_pred HhCC-CCCCCC-----CHHHHhcCccccccCC
Q 006277 247 KCLV-PASQRL-----SAKELLMDPFLQVNGT 272 (652)
Q Consensus 247 kcL~-~P~~Rp-----Sa~elL~hpf~~~~~~ 272 (652)
+||. +|.+|| ++.|+|+||||+...|
T Consensus 254 ~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 254 KLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp HHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred HHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 9998 899999 8999999999986554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=389.01 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=218.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.++.+|+.||+|++..... .....+++.+|+.+|+.|+||||++++++|.+.. .+|+||||
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~lv~e~ 109 (362)
T 2bdw_A 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEES--FHYLVFDL 109 (362)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEEECC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EEEEEEec
Confidence 3578888889999999999999999999986543 4567788999999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC--CCcEEEeccCchhhhhccc-c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~--~g~VKL~DFGla~~l~~~~-~ 169 (652)
|.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.. ++.+||+|||++....... .
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~ 187 (362)
T 2bdw_A 110 VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187 (362)
T ss_dssp CCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence 999999999998889999999999999999999999998 9999999999999843 3469999999998776433 3
Q ss_pred ccccCCCCccCcccccc-CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC--ccccCCCChHHHHHHH
Q 006277 170 KSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AALSKVKDPEVKSFIE 246 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~-~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p--~~l~~~~s~~~kdlI~ 246 (652)
...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+ .+...++..+..+... .......++++++||.
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 266 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 266 (362)
T ss_dssp CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHH
T ss_pred ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 56789999999998754 799999999999999999999999987 5667777777776533 2223456899999999
Q ss_pred HhCC-CCCCCCCHHHHhcCccccc
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+||. +|.+|||+.|+|+||||+.
T Consensus 267 ~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 267 SMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHcCCChhhCcCHHHHhcCcccCC
Confidence 9998 8999999999999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=402.39 Aligned_cols=267 Identities=22% Similarity=0.341 Sum_probs=214.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|.||+|.+..+|+.||+|++..... .......++.+|+.+|+.++||||++++++|.+.. .+|+||||
T Consensus 153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~~~lv~e~ 229 (446)
T 4ejn_A 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RLCFVMEY 229 (446)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-C-------------CCCCCSCTTSCCEEEEEEETT--EEEEEECC
T ss_pred eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh-hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC--EEEEEEee
Confidence 4578888889999999999999999999975432 23456678899999999999999999999998765 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
|.+|+|.+++...+.+++..++.++.||+.||+|||+ +| |+||||||+|||++ .+|.+||+|||+++..... ..
T Consensus 230 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~ 306 (446)
T 4ejn_A 230 ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATM 306 (446)
T ss_dssp CSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEEC-SSSCEEECCCCCCCTTCC-----
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEEC-CCCCEEEccCCCceeccCCCccc
Confidence 9999999999988999999999999999999999998 88 99999999999998 6789999999999864332 34
Q ss_pred ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
...+||+.|+|||++ ...|+.++|||||||++|+|++|..||.+ .+...++..+..... .++...++++++||.+|
T Consensus 307 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~ 383 (446)
T 4ejn_A 307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLGPEAKSLLSGL 383 (446)
T ss_dssp CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred ccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHH
Confidence 668999999999987 46799999999999999999999999987 566677777766543 34566789999999999
Q ss_pred CC-CCCCCC-----CHHHHhcCccccccCCCCCCCCCCCCCcCCCC
Q 006277 249 LV-PASQRL-----SAKELLMDPFLQVNGTTKNRPLPLPDIVLPRV 288 (652)
Q Consensus 249 L~-~P~~Rp-----Sa~elL~hpf~~~~~~~~~~~~~~p~~~lp~~ 288 (652)
|. +|.+|| ++.|+|+||||+...|........++++.|..
T Consensus 384 L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~ 429 (446)
T 4ejn_A 384 LKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQV 429 (446)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSC
T ss_pred cccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCC
Confidence 98 899999 99999999999876554322222333344544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=400.39 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=218.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.++.+|+.||+|++..... +....+.+.+|+.+|+.|+|||||+++++|.+.. .+|+||||
T Consensus 16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~lv~E~ 91 (444)
T 3soa_A 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISEEG--HHYLIFDL 91 (444)
T ss_dssp EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS--EEEEEECC
T ss_pred EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC--EEEEEEEe
Confidence 4678888889999999999999999999986543 3456778999999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC--CCCcEEEeccCchhhhhccc--
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~--~~g~VKL~DFGla~~l~~~~-- 168 (652)
|.||+|.+++...+.+++..++.+++||+.||.|||++| |+||||||+|||++. .++.+||+|||++.......
T Consensus 92 ~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~ 169 (444)
T 3soa_A 92 VTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169 (444)
T ss_dssp CBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence 999999999999999999999999999999999999998 999999999999984 35789999999998765432
Q ss_pred cccccCCCCccCcccccc-CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc--cccCCCChHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA--ALSKVKDPEVKSFI 245 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~~-~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~--~l~~~~s~~~kdlI 245 (652)
....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+ .+...++..+..+.... ......++++++||
T Consensus 170 ~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 248 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 248 (444)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence 346789999999998854 699999999999999999999999987 56777788888775432 23346789999999
Q ss_pred HHhCC-CCCCCCCHHHHhcCccccc
Q 006277 246 EKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.+||. +|.+|||+.|+|+||||+.
T Consensus 249 ~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 249 NKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHcCCChhHCCCHHHHhcCccccC
Confidence 99998 8999999999999999974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=401.06 Aligned_cols=269 Identities=18% Similarity=0.275 Sum_probs=220.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.++.+|+.||+|++.+.... .....+.+.+|+.+|..++||||++++++|.+.. .+|+||||
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~--~~~lVmE~ 142 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN--YLYLVMEY 142 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS--EEEEEECC
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC--EEEEEEcC
Confidence 45788888899999999999999999999753321 1234456889999999999999999999998765 89999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
|.||+|.+++.+. ..+++..++.|+.||+.||+|||++| |+||||||+|||++ .+|++||+|||+++.+....
T Consensus 143 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld-~~g~vkL~DFGla~~~~~~~~~~ 219 (412)
T 2vd5_A 143 YVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTVR 219 (412)
T ss_dssp CCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTSCEE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeec-CCCCEEEeechhheeccCCCccc
Confidence 9999999999875 47999999999999999999999999 99999999999998 67899999999998765432
Q ss_pred cccccCCCCccCccccc--------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC---CCccccCCC
Q 006277 169 AKSVIGTPEFMAPELYD--------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI---KPAALSKVK 237 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~--------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~---~p~~l~~~~ 237 (652)
....+||+.|+|||++. +.|+.++|||||||++|||++|.+||.+ .+...++..|.... ..+......
T Consensus 220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~ 298 (412)
T 2vd5_A 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVDEGV 298 (412)
T ss_dssp CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCC----CC
T ss_pred cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCcCCCccccCC
Confidence 34579999999999874 4689999999999999999999999987 56677777776532 112233567
Q ss_pred ChHHHHHHHHhCCCCCCC---CCHHHHhcCccccccCCCCCCCCCCCCCcCCCCCc
Q 006277 238 DPEVKSFIEKCLVPASQR---LSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGA 290 (652)
Q Consensus 238 s~~~kdlI~kcL~~P~~R---pSa~elL~hpf~~~~~~~~~~~~~~p~~~lp~~~~ 290 (652)
++++++||.+||.+|.+| ++++|+++||||+..+|...... .++..|.+..
T Consensus 299 s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~--~~p~~p~~~~ 352 (412)
T 2vd5_A 299 PEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLRDS--VPPFTPDFEG 352 (412)
T ss_dssp CHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTSTTS--CCSCCCC---
T ss_pred CHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHHhhc--CCCCCCcCCC
Confidence 899999999999988777 59999999999998777654432 3345565543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=403.55 Aligned_cols=268 Identities=17% Similarity=0.274 Sum_probs=220.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.++.+|+.||+|++....... ......+.+|+.+++.++||||++++++|.+.. .+|+||||
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~--~~~lV~Ey 155 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQDDN--NLYLVMDY 155 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS--EEEEEECC
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--EEEEEEec
Confidence 467888888999999999999999999997533211 122345889999999999999999999998755 89999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
|.||+|.+++.+ .+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|++||+|||+++.+....
T Consensus 156 ~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~-~~g~vkL~DFGla~~~~~~~~~~ 232 (437)
T 4aw2_A 156 YVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQ 232 (437)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTSCEE
T ss_pred CCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEc-CCCCEEEcchhhhhhcccCCCcc
Confidence 999999999987 478999999999999999999999999 99999999999998 67899999999997664332
Q ss_pred cccccCCCCccCccccc------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC---CccccCCCCh
Q 006277 169 AKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK---PAALSKVKDP 239 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~---p~~l~~~~s~ 239 (652)
....+||+.|||||++. +.|+.++|||||||++|||++|.+||.+ .+..+.+..+..... .+......++
T Consensus 233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 311 (437)
T 4aw2_A 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQVTDVSE 311 (437)
T ss_dssp CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCSSCCCSCH
T ss_pred cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhhccccccCCcccccCCH
Confidence 34578999999999874 4689999999999999999999999987 566777777765321 1122234789
Q ss_pred HHHHHHHHhCC-CCCC--CCCHHHHhcCccccccCCCCCCCCCCCCCcCCCCC
Q 006277 240 EVKSFIEKCLV-PASQ--RLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVG 289 (652)
Q Consensus 240 ~~kdlI~kcL~-~P~~--RpSa~elL~hpf~~~~~~~~~~~~~~p~~~lp~~~ 289 (652)
++++||.+||. +|.+ |++++|+++||||+..+|...... .++..|.+.
T Consensus 312 ~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~~--~~p~~P~~~ 362 (437)
T 4aw2_A 312 NAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNC--EAPYIPEVS 362 (437)
T ss_dssp HHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGGS--CCSCCCCCS
T ss_pred HHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhhC--CCCCCCcCC
Confidence 99999999997 5666 999999999999998777654332 233455543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=383.00 Aligned_cols=248 Identities=19% Similarity=0.289 Sum_probs=215.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.+..+|+.||+|.+... ......+.+|+.+|+.++||||++++++|.+.. .+|+||||
T Consensus 10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~e~ 82 (321)
T 1tki_A 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESME--ELVMIFEF 82 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--EEEEEECC
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC--EEEEEEEe
Confidence 35788888899999999999999999998743 245677899999999999999999999998765 89999999
Q ss_pred CCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC-CCcEEEeccCchhhhhccc-c
Q 006277 93 FTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN-QGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~-~g~VKL~DFGla~~l~~~~-~ 169 (652)
|.||+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.. ++.+||+|||++..+.... .
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 99999999997654 7999999999999999999999998 9999999999999842 6899999999998775432 3
Q ss_pred ccccCCCCccCcccccc-CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc--cccCCCChHHHHHHH
Q 006277 170 KSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA--ALSKVKDPEVKSFIE 246 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~-~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~--~l~~~~s~~~kdlI~ 246 (652)
...+|||.|+|||++.+ .|+.++|||||||++|+|++|.+||.+ .+..+++..+..+.... ......++++++||.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 239 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHH
Confidence 56789999999998755 579999999999999999999999987 56667777777665432 223457899999999
Q ss_pred HhCC-CCCCCCCHHHHhcCcccccc
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+||. +|.+|||+.|+|+||||+..
T Consensus 240 ~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 240 RLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHcCCChhHCcCHHHHhcChhhccC
Confidence 9998 89999999999999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=393.72 Aligned_cols=254 Identities=20% Similarity=0.358 Sum_probs=218.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|.||+|.+..+|+.||+|++...... .......+.+|+++|+.++|||||+++++|.+.. .+|+||||
T Consensus 20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~lv~e~ 96 (384)
T 4fr4_A 20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV-ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE--DMFMVVDL 96 (384)
T ss_dssp EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEEEECC
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc-cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--EEEEEEec
Confidence 45777777899999999999999999999754321 1235678999999999999999999999998765 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-cccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKS 171 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~~ 171 (652)
|.||+|..++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|++||+|||++..+... ...+
T Consensus 97 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~ 173 (384)
T 4fr4_A 97 LLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITT 173 (384)
T ss_dssp CTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTCCBCC
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEC-CCCCEEEeccceeeeccCCCceec
Confidence 999999999999889999999999999999999999999 99999999999998 6789999999999876543 3567
Q ss_pred ccCCCCccCccccc----cCCCccccchhhHHHHHHHhhccCCCCCC--CCHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 172 VIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSEC--RNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 172 ~vGTp~YmAPEvl~----~~y~~~sDIWSlGvilyeLltG~~Pf~~~--~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
.+||+.|+|||++. ..|+.++|||||||++|+|++|..||... .....++..+.... ..++...++++++||
T Consensus 174 ~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~p~~~s~~~~~li 251 (384)
T 4fr4_A 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSAWSQEMVSLL 251 (384)
T ss_dssp CCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred cCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--cCCCCcCCHHHHHHH
Confidence 89999999999874 35899999999999999999999999642 34456666665543 234556789999999
Q ss_pred HHhCC-CCCCCCC-HHHHhcCccccccCCCC
Q 006277 246 EKCLV-PASQRLS-AKELLMDPFLQVNGTTK 274 (652)
Q Consensus 246 ~kcL~-~P~~RpS-a~elL~hpf~~~~~~~~ 274 (652)
.+||. +|.+||+ +.++++||||+...|..
T Consensus 252 ~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~ 282 (384)
T 4fr4_A 252 KKLLEPNPDQRFSQLSDVQNFPYMNDINWDA 282 (384)
T ss_dssp HHHSCSSGGGSCCSHHHHHTSGGGTTCCHHH
T ss_pred HHHhcCCHhHhcccHHHHHcChhhhcCCHHH
Confidence 99998 8999998 99999999998776643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=370.70 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=206.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+|+++..|+||+|.+..+|+.||+|++..... .......+.+|+.++++++||||+++++++.+.. .+++||||
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 82 (292)
T 3o0g_A 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLTLVFEF 82 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred eeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC--EEEEEEec
Confidence 4688888899999999999999999999986543 3455678899999999999999999999998765 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--ccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~ 170 (652)
|.++.+..+....+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++..+... ...
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCSCCSCCC
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecCCcccccc
Confidence 976444444444678999999999999999999999998 99999999999998 6789999999999876533 235
Q ss_pred cccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC--C-C---------------
Q 006277 171 SVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--K-P--------------- 230 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~--~-p--------------- 230 (652)
..+||+.|+|||++.+ .|+.++|||||||++|+|++|..||....+.......+.... . .
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence 5689999999997743 389999999999999999999888655566665555553310 0 0
Q ss_pred ---------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 231 ---------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 231 ---------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.......++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 01112367899999999998 8999999999999999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=374.58 Aligned_cols=251 Identities=21% Similarity=0.380 Sum_probs=208.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCC----------------------CHHHHHHHHHHHHHHHhCCCCC
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQ----------------------SPEDLERLYSEVHLLKSLKHNN 70 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~----------------------s~e~~~~l~~Ei~iLk~L~Hpn 70 (652)
...|+++..|+||+|.+..+|+.||+|++....... .....+++.+|+++|++|+|||
T Consensus 18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 97 (298)
T 2zv2_A 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN 97 (298)
T ss_dssp EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence 356777778999999999999999999997654321 1123567899999999999999
Q ss_pred eeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCC
Q 006277 71 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 150 (652)
Q Consensus 71 IVkl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~ 150 (652)
|+++++++.+.....+|+||||+.+|+|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+
T Consensus 98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~~ 173 (298)
T 2zv2_A 98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVG-ED 173 (298)
T ss_dssp BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TT
T ss_pred CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-CC
Confidence 999999998766668999999999999987643 457999999999999999999999998 99999999999998 67
Q ss_pred CcEEEeccCchhhhhccc--cccccCCCCccCccccccC----CCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 006277 151 GEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPELYDEN----YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 224 (652)
Q Consensus 151 g~VKL~DFGla~~l~~~~--~~~~vGTp~YmAPEvl~~~----y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I 224 (652)
|.+||+|||++..+.... ....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+ .....+...+
T Consensus 174 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~ 252 (298)
T 2zv2_A 174 GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKI 252 (298)
T ss_dssp SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHH
T ss_pred CCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccHHHHHHHH
Confidence 899999999998765432 3567899999999988543 47889999999999999999999987 4556666667
Q ss_pred hcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 225 SSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 225 ~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
.............++++++||.+||. +|.+|||+.|+|+||||+
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 253 KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred hcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 66554433445678999999999998 899999999999999995
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=388.10 Aligned_cols=252 Identities=22% Similarity=0.341 Sum_probs=207.9
Q ss_pred EEEEEEe--cCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 13 YLRLIQL--VDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 13 ~~rL~~l--~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
...|+++ +.|+||+|.++.+|+.||+|++..... ..+..+.+.+|+.+|+.++|||||+++++|.+.. .+|+||
T Consensus 30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 105 (389)
T 3gni_B 30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--ELWVVT 105 (389)
T ss_dssp EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEE
T ss_pred EecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC--EEEEEE
Confidence 4577777 778999999999999999999986543 4567888999999999999999999999998765 899999
Q ss_pred ecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-
Q 006277 91 ELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 167 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 167 (652)
|||.+|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp ECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCGGGCEECEETT
T ss_pred EccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccccceeecccc
Confidence 999999999999876 67999999999999999999999999 99999999999998 6789999999988654321
Q ss_pred --------ccccccCCCCccCcccccc---CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC-------
Q 006277 168 --------NAKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK------- 229 (652)
Q Consensus 168 --------~~~~~vGTp~YmAPEvl~~---~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~------- 229 (652)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+......+...+.....
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 1234589999999998754 6899999999999999999999999875554444332221100
Q ss_pred ------------------------------------CccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccccC
Q 006277 230 ------------------------------------PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 271 (652)
Q Consensus 230 ------------------------------------p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~~ 271 (652)
...++...++++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 112334567899999999998 899999999999999998543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=392.16 Aligned_cols=268 Identities=22% Similarity=0.307 Sum_probs=216.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHH-HHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHL-LKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~i-Lk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...|+++..|.||+|.++.+|+.||+|++.+.... ......++.+|..+ ++.++|||||+++++|.+.. .+|+|||
T Consensus 43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~--~~~lv~E 119 (373)
T 2r5t_A 43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL-KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--KLYFVLD 119 (373)
T ss_dssp EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSS--EEEEEEE
T ss_pred EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC--EEEEEEe
Confidence 45677777899999999999999999999866543 23456677788877 57789999999999998755 8999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc--ccc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~ 169 (652)
||.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|++||+|||+++.... ...
T Consensus 120 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~ikL~DFG~a~~~~~~~~~~ 196 (373)
T 2r5t_A 120 YINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTT 196 (373)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCBCGGGBCCCCCC
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEeeCccccccccCCCcc
Confidence 9999999999998889999999999999999999999999 99999999999998 678999999999986433 235
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
.+.+||+.|+|||++. ..|+.++|||||||++|||++|.+||.+ .+...++..+..+. ..++...++++++||.+|
T Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~l 273 (373)
T 2r5t_A 197 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKP--LQLKPNITNSARHLLEGL 273 (373)
T ss_dssp CSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHSC--CCCCSSSCHHHHHHHHHH
T ss_pred ccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcc--cCCCCCCCHHHHHHHHHH
Confidence 6789999999999874 5699999999999999999999999987 56777888877753 334566789999999999
Q ss_pred CC-CCCCCCCH----HHHhcCccccccCCCCCCCCCCCCCcCCCCC
Q 006277 249 LV-PASQRLSA----KELLMDPFLQVNGTTKNRPLPLPDIVLPRVG 289 (652)
Q Consensus 249 L~-~P~~RpSa----~elL~hpf~~~~~~~~~~~~~~p~~~lp~~~ 289 (652)
|. +|.+||++ .++++||||+..+|........+++..|.+.
T Consensus 274 L~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~ 319 (373)
T 2r5t_A 274 LQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVS 319 (373)
T ss_dssp TCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCC
T ss_pred cccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCC
Confidence 98 89999986 6999999999776643322223334455443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=379.16 Aligned_cols=252 Identities=26% Similarity=0.374 Sum_probs=214.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCC--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQS--PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s--~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
...|+++..|+||+|.++.+|..||+|++........ ....+.+.+|+.+|+.|+||||++++++|.+.. .+++||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~ 93 (326)
T 2y0a_A 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT--DVILIL 93 (326)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEEE
T ss_pred ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--EEEEEE
Confidence 3567777789999999999999999999986543221 123678899999999999999999999987654 899999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCC----cEEEeccCchhhhhc
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG----EVKIGDLGLATIMEQ 166 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g----~VKL~DFGla~~l~~ 166 (652)
|||.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++. ++ .+||+|||++..+..
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~-~~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 94 ELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLD-RNVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp ECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESC-SSSSSCCEEECCCTTCEECCT
T ss_pred EcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEec-CCCCCCCEEEEECCCCeECCC
Confidence 99999999999988889999999999999999999999998 999999999999983 44 799999999987653
Q ss_pred c-ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--CccccCCCChHHH
Q 006277 167 A-NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVK 242 (652)
Q Consensus 167 ~-~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~~k 242 (652)
. .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .........+..... +.......++.++
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (326)
T 2y0a_A 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAK 249 (326)
T ss_dssp TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHHhcCCCcCccccccCCHHHH
Confidence 3 345678999999999875 5799999999999999999999999987 455556555555432 2233356788999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 243 SFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+||.+||. +|.+|||+.|+|+||||+..
T Consensus 250 ~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 250 DFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 99999998 89999999999999999743
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=380.61 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=211.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.. ..|+||||
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~e~ 86 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGN--IQYLFLEY 86 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEEEEC
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--eEEEEEEc
Confidence 4688999999999999999999999999975543 234567889999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc----
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---- 168 (652)
|.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+....
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEETTEECC
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEe-CCCCEEEEEeeccceeccCCcccc
Confidence 999999999988888999999999999999999999998 99999999999998 66899999999998764322
Q ss_pred cccccCCCCccCcccccc-C-CCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYDE-N-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~~-~-y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
....+||+.|+|||++.+ . ++.++|||||||++|+|++|..||.........+................++.+++||.
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHH
Confidence 346789999999998743 4 47889999999999999999999987665555555555544333334557899999999
Q ss_pred HhCC-CCCCCCCHHHHhcCcccccc
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+||. +|.+|||+.|+|+||||+..
T Consensus 244 ~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 244 KILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHccCChhhCcCHHHHhhChhhccc
Confidence 9998 89999999999999999743
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=388.42 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=209.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.+..+|+.||+|++..... ...+...++.+|+.+|+.++||||+++++++.+.. .+++||||
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lv~E~ 90 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLL-KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT--DIVMVIEY 90 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEEECC
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc-cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EEEEEEEC
Confidence 4677888889999999999999999999874322 11123467899999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-ccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKS 171 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~~~ 171 (652)
+ +|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....... ..+
T Consensus 91 ~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~DFG~s~~~~~~~~~~~ 166 (336)
T 3h4j_B 91 A-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKT 166 (336)
T ss_dssp C-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEEC-TTCCEEECCSSCTBTTTTSBTTCC
T ss_pred C-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEc-CCCCEEEEEeccceeccCCccccc
Confidence 9 7899999998899999999999999999999999998 99999999999998 67899999999998776543 466
Q ss_pred ccCCCCccCcccccc-CC-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 172 VIGTPEFMAPELYDE-NY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 172 ~vGTp~YmAPEvl~~-~y-~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
.+||+.|+|||++.+ .| +.++|||||||++|+|++|..||.+. ....+++.+..+. ...+...++++++||.+||
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~-~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L 243 (336)
T 3h4j_B 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE-FIPNLFKKVNSCV--YVMPDFLSPGAQSLIRRMI 243 (336)
T ss_dssp CTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS-SSTTCBCCCCSSC--CCCCTTSCHHHHHHHHTTS
T ss_pred ccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHcCC--CCCcccCCHHHHHHHHHHc
Confidence 789999999998865 34 68999999999999999999999763 2233333333322 2345567899999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccc
Q 006277 250 V-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 250 ~-~P~~RpSa~elL~hpf~~~~ 270 (652)
. +|.+|||+.|+++||||+..
T Consensus 244 ~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 244 VADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp CSSGGGSCCHHHHTTCHHHHTT
T ss_pred CCChhHCcCHHHHHhChhhccC
Confidence 8 89999999999999999743
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=381.39 Aligned_cols=245 Identities=23% Similarity=0.328 Sum_probs=211.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...|+++..|+||+|.++.+|+.||+|++..... ...+|+++|.++ +||||++++++|.+.. .+|+|||
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~~~lv~E 96 (342)
T 2qr7_A 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDGK--YVYVVTE 96 (342)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECSS--EEEEEEC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcCC--EEEEEEe
Confidence 3577888889999999999999999999975432 234688888888 8999999999987654 8999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCC---CcEEEeccCchhhhhcc-
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ---GEVKIGDLGLATIMEQA- 167 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~---g~VKL~DFGla~~l~~~- 167 (652)
||.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||+...+ +.+||+|||++..+...
T Consensus 97 ~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 97 LMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 9999999999999999999999999999999999999999 99999999999986433 35999999999876543
Q ss_pred -ccccccCCCCccCcccccc-CCCccccchhhHHHHHHHhhccCCCCCC--CCHHHHHHHHhcCCCCc--cccCCCChHH
Q 006277 168 -NAKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSEC--RNSAQIYKKVSSGIKPA--ALSKVKDPEV 241 (652)
Q Consensus 168 -~~~~~vGTp~YmAPEvl~~-~y~~~sDIWSlGvilyeLltG~~Pf~~~--~~~~~i~~~I~~g~~p~--~l~~~~s~~~ 241 (652)
...+.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+. .....++..+..+..+. ..+...++++
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 254 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHH
T ss_pred CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHH
Confidence 2456789999999998854 5999999999999999999999999753 45677888888776432 2335678999
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 242 KSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
++||.+||. +|.+|||+.++|+||||..
T Consensus 255 ~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 255 KDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 999999997 8999999999999999964
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=386.31 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=199.8
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..|+++..|+||+|.+..+|+.||+|++... ........++.+|+.+|+.+. ||||+++++++.......+|+||||
T Consensus 15 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 92 (388)
T 3oz6_A 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY 92 (388)
T ss_dssp EC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEEC
T ss_pred EEeeeCCCeEEEEEEECCCCCEEEEEEeccc--ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecc
Confidence 5677777899999999999999999998633 334677889999999999996 9999999999987766689999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc------
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ------ 166 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~------ 166 (652)
|. |+|..++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.+..
T Consensus 93 ~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~ 167 (388)
T 3oz6_A 93 ME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTN 167 (388)
T ss_dssp CS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEESSSCCCCCC
T ss_pred cC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEc-CCCCEEecCCcccccccccccccc
Confidence 97 589998876 57999999999999999999999999 99999999999998 678999999999976532
Q ss_pred -----------------cccccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC
Q 006277 167 -----------------ANAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG 227 (652)
Q Consensus 167 -----------------~~~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g 227 (652)
......+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.....++...+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 247 (388)
T 3oz6_A 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVI 247 (388)
T ss_dssp CGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 1124568999999999774 469999999999999999999999998855444443332111
Q ss_pred CCCcc--------------------------------------------ccCCCChHHHHHHHHhCC-CCCCCCCHHHHh
Q 006277 228 IKPAA--------------------------------------------LSKVKDPEVKSFIEKCLV-PASQRLSAKELL 262 (652)
Q Consensus 228 ~~p~~--------------------------------------------l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL 262 (652)
..|.. .....++++++||.+||+ +|.+|||+.|+|
T Consensus 248 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l 327 (388)
T 3oz6_A 248 DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDAL 327 (388)
T ss_dssp CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHh
Confidence 11100 011457899999999998 899999999999
Q ss_pred cCcccccc
Q 006277 263 MDPFLQVN 270 (652)
Q Consensus 263 ~hpf~~~~ 270 (652)
+||||+..
T Consensus 328 ~Hp~~~~~ 335 (388)
T 3oz6_A 328 KHPFVSIF 335 (388)
T ss_dssp TSTTTTTT
T ss_pred CCHHHHHh
Confidence 99999753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=365.74 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=207.3
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...+|++++.|+||+|.+..+|..||+|.+..... ....+++.+|+++|++++||||+++++++.+.. .+++|||
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e 100 (285)
T 3is5_A 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS---QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH--NMYIVME 100 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEEEEC
T ss_pred ecceeccCCCeEEEEEEEccCCceEEEEEeecccc---chhHHHHHHHHHHHHhCCCchHHhHHHheecCC--eEEEEEE
Confidence 34678888889999999999999999999986542 234678899999999999999999999987654 7999999
Q ss_pred cCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC--CCCcEEEeccCchhhhh
Q 006277 92 LFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLATIME 165 (652)
Q Consensus 92 y~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~--~~g~VKL~DFGla~~l~ 165 (652)
||.+|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++..+.
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998754 368999999999999999999999998 999999999999953 34789999999998765
Q ss_pred ccc-cccccCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc-cccCCCChHHHH
Q 006277 166 QAN-AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA-ALSKVKDPEVKS 243 (652)
Q Consensus 166 ~~~-~~~~vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~-~l~~~~s~~~kd 243 (652)
... .....||+.|+|||++.+.++.++|||||||++|+|++|..||.+ .....+...+....... ......++++++
T Consensus 179 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (285)
T 3is5_A 179 SDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEVQQKATYKEPNYAVECRPLTPQAVD 257 (285)
T ss_dssp --------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCC--CCCCHHHHH
T ss_pred CcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCC-CCHHHHHhhhccCCcccccccCcCCHHHHH
Confidence 433 456789999999999988999999999999999999999999987 45555555554433222 222346789999
Q ss_pred HHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 244 FIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
||.+||. +|.+|||+.|+|+||||+.
T Consensus 258 li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 258 LLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 9999998 8999999999999999973
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=361.91 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=215.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.+..++..||+|.+..... ...+++.+|++++++++||||+++++++.+.. .+++||||
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 87 (277)
T 3f3z_A 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT--DIYLVMEL 87 (277)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEEEEEC
T ss_pred eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--eEEEEEec
Confidence 3578888889999999999999999999875432 34678899999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEc--CCCCcEEEeccCchhhhhccc-c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~--~~~g~VKL~DFGla~~l~~~~-~ 169 (652)
|.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||+. ..++.+||+|||++..+.... .
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 999999999998889999999999999999999999999 99999999999992 256789999999998765433 4
Q ss_pred ccccCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcc--ccCCCChHHHHHHHH
Q 006277 170 KSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA--LSKVKDPEVKSFIEK 247 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~--l~~~~s~~~kdlI~k 247 (652)
....||+.|+|||++.+.++.++|||||||++|+|++|..||.. .........+..+..... .....++.+++||.+
T Consensus 166 ~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244 (277)
T ss_dssp CCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHH
T ss_pred hccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHH
Confidence 56789999999999988899999999999999999999999987 455666666666643322 223568999999999
Q ss_pred hCC-CCCCCCCHHHHhcCccccc
Q 006277 248 CLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~~~ 269 (652)
||. +|.+|||+.++|+||||+.
T Consensus 245 ~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 245 LLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp HTCSSTTTSCCHHHHTTSHHHHH
T ss_pred HccCChhhCcCHHHHhcCHHHhc
Confidence 998 8999999999999999974
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=381.44 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=211.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQS-PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s-~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...|+++..|+||+|.++.+|+.||+|++........ ....+.+.+|+.+++.|+||||++++++|.+.. .+|+|||
T Consensus 29 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~e 106 (351)
T 3c0i_A 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG--MLYMVFE 106 (351)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEE
T ss_pred eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--EEEEEEe
Confidence 3567888889999999999999999999975432111 123578899999999999999999999998754 8999999
Q ss_pred cCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC--CCcEEEeccCchhhhh
Q 006277 92 LFTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLGLATIME 165 (652)
Q Consensus 92 y~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~--~g~VKL~DFGla~~l~ 165 (652)
||.||+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++..+.
T Consensus 107 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 184 (351)
T 3c0i_A 107 FMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184 (351)
T ss_dssp CCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcceeEec
Confidence 99999998887643 35899999999999999999999998 9999999999999732 2349999999998775
Q ss_pred ccc--cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc--cccCCCChH
Q 006277 166 QAN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA--ALSKVKDPE 240 (652)
Q Consensus 166 ~~~--~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~--~l~~~~s~~ 240 (652)
... ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ ....++..+..+.... ......+++
T Consensus 185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~ 262 (351)
T 3c0i_A 185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFEGIIKGKYKMNPRQWSHISES 262 (351)
T ss_dssp TTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS--SHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC--cHHHHHHHHHcCCCCCCccccccCCHH
Confidence 432 35678999999999874 5699999999999999999999999976 3456677776665332 222456889
Q ss_pred HHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 241 VKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 241 ~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+++||.+||. +|.+|||+.|+|+||||+.
T Consensus 263 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 263 AKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 9999999998 8999999999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=378.12 Aligned_cols=246 Identities=24% Similarity=0.315 Sum_probs=196.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..|++++.|+||+|.++.+|+.||+|++.. .....+.+|+.+++.+. ||||++++++|.+.. .+|+||||
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-------~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~--~~~lv~e~ 87 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK-------RMEANTQKEITALKLCEGHPNIVKLHEVFHDQL--HTFLVMEL 87 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEG-------GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEEEEECC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEECh-------hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC--EEEEEEEc
Confidence 358899999999999999999999999863 24567788999999996 999999999997654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCC--CcEEEeccCchhhhhcc--c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ--GEVKIGDLGLATIMEQA--N 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~--g~VKL~DFGla~~l~~~--~ 168 (652)
|.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++..+ ..+||+|||++...... .
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 88 LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 999999999999999999999999999999999999998 99999999999998432 27999999999865433 2
Q ss_pred cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCC------CCHHHHHHHHhcCCCCcc--ccCCCCh
Q 006277 169 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSEC------RNSAQIYKKVSSGIKPAA--LSKVKDP 239 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~------~~~~~i~~~I~~g~~p~~--l~~~~s~ 239 (652)
....+||+.|+|||++. ..|+.++|||||||++|+|++|..||... .....++..+..+..+.. .....++
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCH
Confidence 35678999999999874 56999999999999999999999999753 234567777777654322 2245789
Q ss_pred HHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 240 EVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 240 ~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 246 ~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 246 EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred HHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 99999999997 89999999999999999854
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=365.25 Aligned_cols=257 Identities=24% Similarity=0.381 Sum_probs=214.8
Q ss_pred cceeeee-eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 006277 5 KWSLLIL-MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83 (652)
Q Consensus 5 ~W~~~~~-~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 83 (652)
.|....+ ....|++++.|+||+|.+..+|..||+|++..... ........+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 82 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT- 82 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc-chhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC-
Confidence 4555444 34567788889999999999999999999875332 11233567899999999999999999999987654
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 84 ~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
.+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..
T Consensus 83 -~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 83 -RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVH 158 (279)
T ss_dssp -EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEEC-TTSCEEECSCCEESC
T ss_pred -EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEc-CCCCEEEEecccccc
Confidence 79999999999999999998889999999999999999999999998 99999999999998 678999999999977
Q ss_pred hhccccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 164 MEQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 164 l~~~~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
..........||+.|+|||++. ..++.++|||||||++|+|++|..||.. ......+..+..... .++...++.++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (279)
T 3fdn_A 159 APSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGAR 235 (279)
T ss_dssp C--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHHHH
T ss_pred CCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC-CcHHHHHHHHHhCCC--CCCCcCCHHHH
Confidence 6655556778999999999774 4688999999999999999999999987 566667666666432 34556789999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 243 SFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+||.+||. +|.+|||+.|+|+||||+..
T Consensus 236 ~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 236 DLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 99999998 89999999999999999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=358.54 Aligned_cols=252 Identities=23% Similarity=0.397 Sum_probs=217.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.+..+|+.||+|++..... +....+++.+|+.++++++||||+++++++.+.. ..++||||
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~ 86 (284)
T 3kk8_A 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEES--FHYLVFDL 86 (284)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEEECC
T ss_pred hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC--EEEEEEec
Confidence 4678888899999999999999999999976543 4567788999999999999999999999987654 78999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC--CCcEEEeccCchhhhhccc-c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~--~g~VKL~DFGla~~l~~~~-~ 169 (652)
+.+|+|.+++...+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++....... .
T Consensus 87 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (284)
T 3kk8_A 87 VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164 (284)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc
Confidence 999999999998889999999999999999999999998 9999999999999732 3349999999997765443 3
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC--ccccCCCChHHHHHHH
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AALSKVKDPEVKSFIE 246 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p--~~l~~~~s~~~kdlI~ 246 (652)
....||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .........+..+... .......++++++||.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243 (284)
T ss_dssp CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccccCCchhhcccCHHHHHHHH
Confidence 5578999999999774 4689999999999999999999999987 5566677777665432 2233467899999999
Q ss_pred HhCC-CCCCCCCHHHHhcCccccccC
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQVNG 271 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~~~~ 271 (652)
+||. +|.+|||+.|+|+||||+...
T Consensus 244 ~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 244 SMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHcccChhhCCCHHHHhcCccccCCh
Confidence 9998 899999999999999997543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=374.57 Aligned_cols=253 Identities=27% Similarity=0.359 Sum_probs=200.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+|+++..|+||+|.+..+|+.||+|++..... .....+.+.+|+.+|++++||||+++++++.+.. .+|+||||
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 114 (329)
T 3gbz_A 39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH--RLHLIFEY 114 (329)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred EEEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC--EEEEEEec
Confidence 4678888889999999999999999999875432 2345667889999999999999999999998765 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC----CCCcEEEeccCchhhhhcc-
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING----NQGEVKIGDLGLATIMEQA- 167 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~----~~g~VKL~DFGla~~l~~~- 167 (652)
|. |+|.+++...+.+++..++.+++||+.||.|||++| |+||||||+|||++. ..+.+||+|||++..+...
T Consensus 115 ~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~ 191 (329)
T 3gbz_A 115 AE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191 (329)
T ss_dssp CS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred CC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence 97 599999999999999999999999999999999998 999999999999962 3456999999999877533
Q ss_pred -ccccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC--cc----------
Q 006277 168 -NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AA---------- 232 (652)
Q Consensus 168 -~~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p--~~---------- 232 (652)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+......+...+.....+ ..
T Consensus 192 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (329)
T 3gbz_A 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW 271 (329)
T ss_dssp --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhh
Confidence 2355688999999998743 58999999999999999999999998855544444433321111 00
Q ss_pred ---------------ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccccCC
Q 006277 233 ---------------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGT 272 (652)
Q Consensus 233 ---------------l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~~~ 272 (652)
+....++++++||.+||. +|.+|||+.|+|+||||+...+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 272 KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 111257899999999998 8999999999999999986544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=363.74 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=214.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...++++..|+||+|.+..+|..||+|++...... ......++.+|+.+++.++||||+++++++.+.. .+|+||||
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 95 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK--RIYLMLEF 95 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEEEECC
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc-hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC--EEEEEEEe
Confidence 35677777899999999999999999998754221 1123567899999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++...........
T Consensus 96 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (284)
T 2vgo_A 96 APRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTM 172 (284)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECSSSCBCCC
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEc-CCCCEEEecccccccCcccccccc
Confidence 999999999998889999999999999999999999998 99999999999998 678999999999977665555677
Q ss_pred cCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-
Q 006277 173 IGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV- 250 (652)
Q Consensus 173 vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~- 250 (652)
.||+.|+|||++. ..++.++|||||||++|+|++|..||.. .........+..... .++...+..+++||.+||.
T Consensus 173 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~ 249 (284)
T 2vgo_A 173 CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVNVDL--KFPPFLSDGSKDLISKLLRY 249 (284)
T ss_dssp CSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHHHHSCS
T ss_pred cCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC-CCHhHHHHHHhcccc--CCCCcCCHHHHHHHHHHhhc
Confidence 8999999999775 4689999999999999999999999987 455556666665432 3445678999999999998
Q ss_pred CCCCCCCHHHHhcCcccccc
Q 006277 251 PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 251 ~P~~RpSa~elL~hpf~~~~ 270 (652)
+|.+|||+.++|+||||+..
T Consensus 250 ~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 250 HPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp SGGGSCCHHHHHTCHHHHHH
T ss_pred CHhhCCCHHHHhhCHHHHhh
Confidence 89999999999999999854
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=370.29 Aligned_cols=247 Identities=28% Similarity=0.511 Sum_probs=213.3
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.+.+|+++..|.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||++++++|.... .+++|||
T Consensus 49 ~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e 122 (321)
T 2c30_A 49 SYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE--ELWVLME 122 (321)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEEEC
T ss_pred ccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--EEEEEEe
Confidence 3568999999999999999999999999987543 234677889999999999999999999998765 7999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
|+.+|+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+... ..
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~ 198 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKR 198 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSSSCCB
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCcEEEeeeeeeeecccCcccc
Confidence 9999999998764 57999999999999999999999998 99999999999998 6789999999999876543 23
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc-cccCCCChHHHHHHHH
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA-ALSKVKDPEVKSFIEK 247 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~-~l~~~~s~~~kdlI~k 247 (652)
...+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. ....+....+.....+. ......++.+++||.+
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 277 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER 277 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHH
T ss_pred ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHH
Confidence 5678999999999774 5689999999999999999999999987 45566666666654332 2234568899999999
Q ss_pred hCC-CCCCCCCHHHHhcCccccc
Q 006277 248 CLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~~~ 269 (652)
||. +|.+|||+.|+|+||||..
T Consensus 278 ~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 278 MLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp HSCSSTTTSCCHHHHHTSGGGGG
T ss_pred HccCChhhCcCHHHHhcChhhcc
Confidence 998 8999999999999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=364.02 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=201.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.+ .+|+.||+|++..... .....+.+.+|+++++.++||||+++++++.+.. .+++||||
T Consensus 7 ~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 81 (288)
T 1ob3_A 7 LEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RLVLVFEH 81 (288)
T ss_dssp EEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CEEEEEEC
T ss_pred hhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC--eEEEEEEe
Confidence 36788888999999998 7899999999875432 1233467889999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
+.+ +|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++...... ..
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEeECccccccCcccccc
Confidence 975 999988764 67999999999999999999999998 99999999999998 6789999999999877532 23
Q ss_pred ccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CC-CC---------------
Q 006277 170 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GI-KP--------------- 230 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~-~p--------------- 230 (652)
...+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+......+...+.. +. ..
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 4568999999999874 35899999999999999999999999875444443332221 10 00
Q ss_pred ---------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 231 ---------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 231 ---------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.......++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 01123467899999999998 8999999999999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=369.93 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=200.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+|+++..|+||+|.+. +|+.||+|++..... .......+.+|+.+|++++||||+++++++.+.. .+++||||
T Consensus 26 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~ 100 (311)
T 3niz_A 26 LEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER--CLTLVFEF 100 (311)
T ss_dssp EEEEEECSSCEEEEEEET-TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS--CEEEEEEC
T ss_pred hhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC--EEEEEEcC
Confidence 467888888999999985 599999999875432 2345678899999999999999999999986554 79999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
|.+ +|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+... ..
T Consensus 101 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 101 MEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp CSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEETTSCCC--
T ss_pred CCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEEC-CCCCEEEccCcCceecCCCcccc
Confidence 975 788877665 45999999999999999999999998 99999999999998 6689999999999876533 23
Q ss_pred ccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHh--cCCCCccc------------
Q 006277 170 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS--SGIKPAAL------------ 233 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~--~g~~p~~l------------ 233 (652)
...+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+......+..... ....+..+
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence 4568999999999874 4689999999999999999999999987555444333222 11111111
Q ss_pred -------------cCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 234 -------------SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 234 -------------~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
....++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 12356789999999998 8999999999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=369.47 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=203.5
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.|+++..|+||+|.+..+|+.||+|++.... ....+++.+|+++|+++ +||||+++++++.+.. .+|+|||||
T Consensus 20 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~--~~~lv~e~~ 93 (316)
T 2ac3_A 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED--RFYLVFEKM 93 (316)
T ss_dssp CCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEEEECC
T ss_pred eecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC--EEEEEEEcC
Confidence 3677777999999999999999999997542 23467889999999996 7999999999998754 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCC--CcEEEeccCchhhhhcc----
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ--GEVKIGDLGLATIMEQA---- 167 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~--g~VKL~DFGla~~l~~~---- 167 (652)
.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.++ +.+||+|||++......
T Consensus 94 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 171 (316)
T 2ac3_A 94 RGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171 (316)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred CCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence 99999999998889999999999999999999999998 99999999999998432 23999999998765321
Q ss_pred -----ccccccCCCCccCccccc------cCCCccccchhhHHHHHHHhhccCCCCCCCC--------------HHHHHH
Q 006277 168 -----NAKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRN--------------SAQIYK 222 (652)
Q Consensus 168 -----~~~~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~--------------~~~i~~ 222 (652)
.....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+... ...++.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
T 2ac3_A 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251 (316)
T ss_dssp ----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHH
T ss_pred cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHH
Confidence 123457999999999874 4589999999999999999999999976432 244666
Q ss_pred HHhcCCCCcc--ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 223 KVSSGIKPAA--LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 223 ~I~~g~~p~~--l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.+..+..... .....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 252 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 252 SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 6666643222 224568899999999998 89999999999999999853
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=366.37 Aligned_cols=245 Identities=27% Similarity=0.372 Sum_probs=205.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
..+|++++.|+||+|.+..+|+.||+|++.... .......+...|+..+..+ +||||++++++|.+.. .+|+|||
T Consensus 62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~--~~~lv~e 137 (311)
T 3p1a_A 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF--RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG--ILYLQTE 137 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTSCEEEEEEESSSC--CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEE
T ss_pred eheeccCCCeEEEEEEECCCCeEEEEEEecccc--cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC--EEEEEEe
Confidence 457888889999999999999999999876432 2344555566666666555 9999999999987654 8999999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-c
Q 006277 92 LFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~ 169 (652)
|| +|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++....... .
T Consensus 138 ~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 138 LC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLG-PRGRCKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp CC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-GGGCEEECCCTTCEECC-----
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEccceeeeecccCCCC
Confidence 99 77898887764 46999999999999999999999998 99999999999998 67899999999988765433 3
Q ss_pred ccccCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 170 KSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
....||+.|+|||++.+.|+.++|||||||++|+|++|..||.. ...+..+..+..+..++...++++++||.+||
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 289 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG----GEGWQQLRQGYLPPEFTAGLSSELRSVLVMML 289 (311)
T ss_dssp -CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS----HHHHHHHTTTCCCHHHHTTSCHHHHHHHHHHS
T ss_pred cccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC----ccHHHHHhccCCCcccccCCCHHHHHHHHHHc
Confidence 45679999999999988999999999999999999999777654 23345566666666677778999999999999
Q ss_pred C-CCCCCCCHHHHhcCccccc
Q 006277 250 V-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 250 ~-~P~~RpSa~elL~hpf~~~ 269 (652)
. +|.+|||+.|+|+||||+.
T Consensus 290 ~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 290 EPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp CSSTTTSCCHHHHHTSGGGSC
T ss_pred CCChhhCcCHHHHHhCccccC
Confidence 8 8999999999999999973
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=381.21 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=213.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.++.+|+.||+|++.... ......+.+|+.+|+.|+||||++++++|.+.. .+++||||
T Consensus 56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~lv~E~ 129 (387)
T 1kob_A 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY--EMVLILEF 129 (387)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS--EEEEEEEC
T ss_pred EEEEecCCCEEEEEEEECCCCCEEEEEEecccc----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC--EEEEEEEc
Confidence 356888888999999999999999999987532 455678999999999999999999999997654 89999999
Q ss_pred CCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC-CCCcEEEeccCchhhhhccc-c
Q 006277 93 FTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING-NQGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~-~~g~VKL~DFGla~~l~~~~-~ 169 (652)
|.||+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++..+.... .
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 99999999987654 7999999999999999999999998 999999999999973 35689999999998765432 3
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--CccccCCCChHHHHHHH
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKSFIE 246 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~~kdlI~ 246 (652)
...+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+.......+..+.. +.......++++++||.
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 286 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 286 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence 4568999999999875 5699999999999999999999999987 455556666665442 22333457899999999
Q ss_pred HhCC-CCCCCCCHHHHhcCcccccc
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+||. +|.+|||+.|+|+||||+..
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 287 NLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp TTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHcCCChhHCcCHHHHhhCccccCC
Confidence 9998 89999999999999999854
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=374.52 Aligned_cols=249 Identities=26% Similarity=0.461 Sum_probs=211.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.+..+|..||+|++.... .....+++.+|+.+|+.++||||+++++++.+.. .+|+||||
T Consensus 38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 112 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISICMEH 112 (360)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT--EEEEEECC
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC--EEEEEEEC
Confidence 457888888999999999999999999987542 4567789999999999999999999999998754 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 171 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~ 171 (652)
|.+|+|.+++...+.+++..+..++.||+.||.|||+. | |+||||||+|||++ .++.+||+|||++..+.......
T Consensus 113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~ 189 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANS 189 (360)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHHHC---
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEEC-CCCCEEEEECCCCcccccccccC
Confidence 99999999999988999999999999999999999985 7 99999999999998 66899999999998876666677
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHH------------------------------
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI------------------------------ 220 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i------------------------------ 220 (652)
.+||+.|+|||++. ..|+.++|||||||++|+|++|..||... ....+
T Consensus 190 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (360)
T 3eqc_A 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP-DAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268 (360)
T ss_dssp -CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC-CHHHHHHHHC-------------------------
T ss_pred CCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence 89999999999774 56899999999999999999999999763 32222
Q ss_pred ------------HHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 221 ------------YKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 221 ------------~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
...+..+..+.......++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 222333333333334568899999999998 89999999999999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=375.99 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=199.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.+..+|+.||+|++... ...+.+.+|+.+|++|+||||++++++|.+.. .+++||||
T Consensus 58 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~ 129 (349)
T 2w4o_A 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKT------VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPT--EISLVLEL 129 (349)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECSS--EEEEEECC
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEeccc------hhHHHHHHHHHHHHhCCCCCCcceeeeEecCC--eEEEEEEe
Confidence 35788888899999999999999999998743 23466888999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC--CCCcEEEeccCchhhhhccc-c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~--~~g~VKL~DFGla~~l~~~~-~ 169 (652)
+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++. .++.+||+|||++....... .
T Consensus 130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 207 (349)
T 2w4o_A 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM 207 (349)
T ss_dssp CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccCccccc
Confidence 999999999998889999999999999999999999998 999999999999973 36789999999998765433 3
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC--ccccCCCChHHHHHHH
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AALSKVKDPEVKSFIE 246 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p--~~l~~~~s~~~kdlI~ 246 (652)
...+||+.|+|||++. ..|+.++|||||||++|+|++|..||........++..+..+... ..+....+.++++||.
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 287 (349)
T 2w4o_A 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR 287 (349)
T ss_dssp -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHH
Confidence 5678999999999875 469999999999999999999999998877777677777776432 2333557889999999
Q ss_pred HhCC-CCCCCCCHHHHhcCccccc
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+||. +|.+|||+.|+|+||||+.
T Consensus 288 ~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 288 KLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp TTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHccCChhhCcCHHHHhcCcccCC
Confidence 9998 8999999999999999974
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=376.91 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=197.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.++.+|+.||+|++..... ..+.+.+|+.+++.|+||||+++++++.+.. .+|+||||
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e~ 97 (361)
T 3uc3_A 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-----IDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIIMEY 97 (361)
T ss_dssp EEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEEEEC
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC--EEEEEEEe
Confidence 3567777779999999999999999999975432 2356889999999999999999999998654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC-CCcEEEeccCchhhhhcc-ccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN-QGEVKIGDLGLATIMEQA-NAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~-~g~VKL~DFGla~~l~~~-~~~ 170 (652)
|.+|+|.+++...+.+++..++.+++||+.||.|||++| |+||||||+|||++.+ .+.+||+|||+++..... ...
T Consensus 98 ~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (361)
T 3uc3_A 98 ASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175 (361)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence 999999999998889999999999999999999999999 9999999999999833 235999999999754332 345
Q ss_pred cccCCCCccCcccc-ccCCCcc-ccchhhHHHHHHHhhccCCCCCCCC---HHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 171 SVIGTPEFMAPELY-DENYNEL-ADIYSFGMCMLEMVTFEYPYSECRN---SAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 171 ~~vGTp~YmAPEvl-~~~y~~~-sDIWSlGvilyeLltG~~Pf~~~~~---~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
..+||+.|+|||++ ...|+.+ +|||||||++|+|++|.+||.+... ...+...+.............++++++||
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 255 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHH
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHH
Confidence 67899999999977 4456544 8999999999999999999976432 24445555554433333345689999999
Q ss_pred HHhCC-CCCCCCCHHHHhcCccccc
Q 006277 246 EKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.+||. +|.+|||+.|+|+||||..
T Consensus 256 ~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 256 SRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp HHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred HHHccCChhHCcCHHHHHhCcchhc
Confidence 99998 8999999999999999964
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=388.36 Aligned_cols=253 Identities=22% Similarity=0.331 Sum_probs=193.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC---CCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ---NKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~---~~~~~LVm 90 (652)
..|+++..|+||+|.++.+|+.||+|++... ..+....+++.+|+.+|+.|+|||||+++++|.... ...+|+||
T Consensus 59 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 136 (458)
T 3rp9_A 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136 (458)
T ss_dssp CC-------CEEEEEECC--CEEEEEEECST--TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred eEeeecCCeEEEEEEECCCCcEEEEEEechh--hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEE
Confidence 3566777799999999999999999998643 335667889999999999999999999999886542 24799999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc---
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--- 167 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--- 167 (652)
||+ +|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 137 e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~-~~~~~kl~DFGla~~~~~~~~~ 212 (458)
T 3rp9_A 137 EIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENG 212 (458)
T ss_dssp CCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCBCTTSCTTC
T ss_pred ecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEEC-CCCCEeecccccchhccCcccc
Confidence 998 5799999998889999999999999999999999998 99999999999998 6789999999999876421
Q ss_pred --------------------------ccccccCCCCccCcccc--ccCCCccccchhhHHHHHHHhh-----------cc
Q 006277 168 --------------------------NAKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVT-----------FE 208 (652)
Q Consensus 168 --------------------------~~~~~vGTp~YmAPEvl--~~~y~~~sDIWSlGvilyeLlt-----------G~ 208 (652)
.....+||+.|+|||++ ...|+.++|||||||++|||++ |.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~ 292 (458)
T 3rp9_A 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRG 292 (458)
T ss_dssp CCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCC
T ss_pred ccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccccc
Confidence 12456899999999965 4569999999999999999999 67
Q ss_pred CCCCCCCC--------------------HHHHHHHHhc--CCC---------------------------CccccCCCCh
Q 006277 209 YPYSECRN--------------------SAQIYKKVSS--GIK---------------------------PAALSKVKDP 239 (652)
Q Consensus 209 ~Pf~~~~~--------------------~~~i~~~I~~--g~~---------------------------p~~l~~~~s~ 239 (652)
++|.+... ..++. .+.. |.. ........++
T Consensus 293 p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 371 (458)
T 3rp9_A 293 PLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLN-VIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSA 371 (458)
T ss_dssp CSCC--------------------CHHHHHHHH-HHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCH
T ss_pred ccCCCCccccccccccccccccccccCCHHHHH-HHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCH
Confidence 77765321 11111 1100 000 0111234578
Q ss_pred HHHHHHHHhCC-CCCCCCCHHHHhcCccccccCCC
Q 006277 240 EVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGTT 273 (652)
Q Consensus 240 ~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~~~~ 273 (652)
++++||.+||+ ||.+|||+.|+|+||||+...+.
T Consensus 372 ~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 372 DAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred HHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence 99999999998 99999999999999999865443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=382.05 Aligned_cols=255 Identities=25% Similarity=0.320 Sum_probs=202.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---CeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN---KTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~---~~~~LV 89 (652)
...|+++..|+||+|.++.+|+.||+|++... .......+++.+|+.+|+.|+||||+++++++..... ..+|+|
T Consensus 31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 108 (432)
T 3n9x_A 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIV 108 (432)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECST--TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeCch--hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEE
Confidence 45778888899999999999999999998643 3356678899999999999999999999999876532 469999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-- 167 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 167 (652)
|||+. |+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.....
T Consensus 109 ~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~ 184 (432)
T 3n9x_A 109 LEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKD 184 (432)
T ss_dssp EECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEEC-----
T ss_pred EecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEEC-CCCCEEEccCCCccccccccc
Confidence 99985 599999998888999999999999999999999999 99999999999998 6789999999999876432
Q ss_pred ----------------------ccccccCCCCccCcccc--ccCCCccccchhhHHHHHHHhhc-----------cCCCC
Q 006277 168 ----------------------NAKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTF-----------EYPYS 212 (652)
Q Consensus 168 ----------------------~~~~~vGTp~YmAPEvl--~~~y~~~sDIWSlGvilyeLltG-----------~~Pf~ 212 (652)
.....+||+.|+|||++ ...|+.++|||||||++|||++| .++|.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~ 264 (432)
T 3n9x_A 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264 (432)
T ss_dssp --------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCC
T ss_pred ccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCC
Confidence 12567899999999975 45699999999999999999984 44443
Q ss_pred CCCC-----------------HHHHH-----------------------HHHhcCC--CCcc---ccCCCChHHHHHHHH
Q 006277 213 ECRN-----------------SAQIY-----------------------KKVSSGI--KPAA---LSKVKDPEVKSFIEK 247 (652)
Q Consensus 213 ~~~~-----------------~~~i~-----------------------~~I~~g~--~p~~---l~~~~s~~~kdlI~k 247 (652)
+... ..++. ..+.... .+.. .....++++++||.+
T Consensus 265 g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~ 344 (432)
T 3n9x_A 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLES 344 (432)
T ss_dssp CSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred CccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHH
Confidence 3210 11111 1111111 0100 113468999999999
Q ss_pred hCC-CCCCCCCHHHHhcCccccccCCC
Q 006277 248 CLV-PASQRLSAKELLMDPFLQVNGTT 273 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~~~~~~~ 273 (652)
||+ +|.+|||+.|+|+||||+...+.
T Consensus 345 mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 345 MLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HhcCCcccCCCHHHHhcChhhhhccCc
Confidence 998 89999999999999999865443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=403.23 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=218.8
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
....|++++.|.||+|.++.+|+.||+|++...... .......+.+|+++|+.++|||||+++++|.+.. .+|+|||
T Consensus 188 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~l~lVmE 264 (576)
T 2acx_A 188 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD--ALCLVLT 264 (576)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEEEC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh-hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC--EEEEEEE
Confidence 456788888999999999999999999999764331 1234567889999999999999999999997654 8999999
Q ss_pred cCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 92 LFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
||.||+|.+++...+. +++..++.|+.||+.||+|||++| |+||||||+|||++ .+|++||+|||+++.+....
T Consensus 265 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld-~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 265 LMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp CCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECCTTCC
T ss_pred cCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEe-CCCCeEEEecccceecccCcc
Confidence 9999999999987644 999999999999999999999998 99999999999998 67899999999998775433
Q ss_pred cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCC---CHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 169 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECR---NSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~---~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.... ....++..+... +..++...++++++|
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p~~~s~~~~dL 419 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYSERFSPQARSL 419 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cccCCccCCHHHHHH
Confidence 35679999999999875 469999999999999999999999997643 346677777654 334556788999999
Q ss_pred HHHhCC-CCCCCC-----CHHHHhcCccccccCCC
Q 006277 245 IEKCLV-PASQRL-----SAKELLMDPFLQVNGTT 273 (652)
Q Consensus 245 I~kcL~-~P~~Rp-----Sa~elL~hpf~~~~~~~ 273 (652)
|.+||. +|.+|| ++.|+++||||+..+|.
T Consensus 420 I~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454 (576)
T ss_dssp HHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred HHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence 999998 899999 89999999999976654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=410.63 Aligned_cols=268 Identities=20% Similarity=0.295 Sum_probs=227.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..|+++..|.||+|.++.+|+.||+|+++..... .....+.+..|+.+|..+ +||||++++++|.+.. .+||||||
T Consensus 347 ~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~--~~~lV~E~ 423 (674)
T 3pfq_A 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--RLYFVMEY 423 (674)
T ss_dssp EESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH-HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS--EEEEEEEC
T ss_pred EEEccCCCEEEEEEEECCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC--EEEEEEeC
Confidence 4566777799999999999999999999854322 124567888999999998 7999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh--ccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~--~~~~~ 170 (652)
+.||+|.+++...+.+++..++.|+.||+.||+|||++| |+||||||+|||++ .+|++||+|||+++... .....
T Consensus 424 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~~~~~~ 500 (674)
T 3pfq_A 424 VNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTK 500 (674)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEEC-SSSCEEECCCTTCEECCCTTCCBC
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEc-CCCcEEEeecceeeccccCCcccc
Confidence 999999999999899999999999999999999999998 99999999999998 67899999999998643 23356
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
+.+||+.|||||++. ..|+.++|||||||++|||++|.+||.+ .+..+++..|..+.. .++...++++++||.+||
T Consensus 501 ~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL 577 (674)
T 3pfq_A 501 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLM 577 (674)
T ss_dssp CCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHSSCC--CCCTTSCHHHHHHHHHHS
T ss_pred cccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHHc
Confidence 789999999999774 6799999999999999999999999987 677888888887643 355678899999999999
Q ss_pred C-CCCCCCCH-----HHHhcCccccccCCCCCCCCCCCCCcCCCCCc
Q 006277 250 V-PASQRLSA-----KELLMDPFLQVNGTTKNRPLPLPDIVLPRVGA 290 (652)
Q Consensus 250 ~-~P~~RpSa-----~elL~hpf~~~~~~~~~~~~~~p~~~lp~~~~ 290 (652)
. +|.+||++ +|+++||||+..+|.........+++.|....
T Consensus 578 ~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~ 624 (674)
T 3pfq_A 578 TKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG 624 (674)
T ss_dssp CSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG
T ss_pred cCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC
Confidence 8 89999997 99999999998776544333344455666543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=370.53 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=198.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.++.+|+.||+|++..... ....+.+.+|+.+|++|+||||+++++++.+.. .+|+||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~ 84 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLYDVIHTEN--KLTLVFEF 84 (317)
T ss_dssp ---------CEEEEEECSSSCCEEEEEEEECCST---TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT--EEEEEEEC
T ss_pred eeEECCCCCEEEEEEEECCCCcEEEEEEeecccc---cccHHHHHHHHHHHHhcCCCCcceEEEEEEECC--eEEEEEEe
Confidence 3577888889999999999999999999975532 234467889999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 93 FTSGSLRQYRKKH------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 93 ~~gGsL~~~i~~~------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
|. |+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..+..
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCSSCEETTS
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEc-CCCCEEECcCccceecCC
Confidence 97 5999988754 35999999999999999999999998 99999999999998 678999999999987653
Q ss_pred c--ccccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc--CCCC----------
Q 006277 167 A--NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GIKP---------- 230 (652)
Q Consensus 167 ~--~~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~--g~~p---------- 230 (652)
. .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.. .......+.. +..+
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN-DEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 3 2346689999999998743 58999999999999999999999998744 3443333322 1100
Q ss_pred --------------------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 231 --------------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 231 --------------------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.......++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence 00112467899999999998 89999999999999999854
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=380.40 Aligned_cols=247 Identities=23% Similarity=0.405 Sum_probs=211.8
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC--CCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK--HNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~--HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
..|+++..|+||+|.+.. |+.||+|++..... .....+++.+|+.+|+.|. ||||+++++++.... .+|+|||
T Consensus 62 ~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~--~~~lv~E 136 (390)
T 2zmd_A 62 KQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--YIYMVME 136 (390)
T ss_dssp EEEECCSSEEEEEEECTT-CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEEEEEE
T ss_pred EEEccCCCeEEEEEEcCC-CCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC--EEEEEEe
Confidence 567777779999999865 99999999986543 4567889999999999996 599999999887655 7999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
|.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|||+++.+....
T Consensus 137 -~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~--~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 137 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp -CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES--SSCEEECCCSSSCCC-------
T ss_pred -cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE--CCeEEEEecCccccccCCCccc
Confidence 668899999999999999999999999999999999998 99999999999996 4799999999998765432
Q ss_pred -cccccCCCCccCcccccc------------CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccC
Q 006277 169 -AKSVIGTPEFMAPELYDE------------NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 235 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl~~------------~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~ 235 (652)
....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||....+.......+..+.....++.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence 346789999999998743 6899999999999999999999999876666666666766655556667
Q ss_pred CCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 236 VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 236 ~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
..+.++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 778899999999998 89999999999999999743
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=366.41 Aligned_cols=252 Identities=27% Similarity=0.375 Sum_probs=215.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCH--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSP--EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~--e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
...|+++..|+||+|.++.+|+.||+|++......... ...+.+.+|+.++++++||||+++++++.+.. .+++||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 94 (321)
T 2a2a_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT--DVVLIL 94 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEEE
T ss_pred eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--EEEEEE
Confidence 35678888899999999999999999999865432211 13678899999999999999999999987654 899999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCC---cEEEeccCchhhhhcc
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG---EVKIGDLGLATIMEQA 167 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g---~VKL~DFGla~~l~~~ 167 (652)
|||.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.++. .+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~ 172 (321)
T 2a2a_A 95 ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172 (321)
T ss_dssp CCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCccceecCcc
Confidence 99999999999998889999999999999999999999998 999999999999984332 7999999999876543
Q ss_pred c-cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--CccccCCCChHHHH
Q 006277 168 N-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKS 243 (652)
Q Consensus 168 ~-~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~~kd 243 (652)
. .....||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .........+..+.. +.......++.+++
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (321)
T 2a2a_A 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEEFFSHTSELAKD 251 (321)
T ss_dssp CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTCCHHHHH
T ss_pred ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccccChhhhcccCHHHHH
Confidence 2 35678999999999774 5789999999999999999999999987 455666666666543 22333567889999
Q ss_pred HHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 244 FIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
||.+||. +|.+|||+.|+|+||||+.
T Consensus 252 li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 252 FIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp HHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred HHHHHcCCChhhCcCHHHHhcCccccC
Confidence 9999998 8999999999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=362.92 Aligned_cols=252 Identities=21% Similarity=0.330 Sum_probs=204.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.+..+|+.||+|++.... ......+.+.+|+.++++++||||+++++++.+.. .+++||||
T Consensus 8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 83 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR--RLHLVFEY 83 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecCC--eEEEEEEe
Confidence 468888889999999999999999999986543 34556788899999999999999999999998754 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
|.+++|..++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....... ..
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (311)
T 4agu_A 84 CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYYD 160 (311)
T ss_dssp CSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC-------
T ss_pred CCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEc-CCCCEEEeeCCCchhccCcccccC
Confidence 999999999988889999999999999999999999998 99999999999998 67899999999998765332 35
Q ss_pred cccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc--CC-----------------C
Q 006277 171 SVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GI-----------------K 229 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~--g~-----------------~ 229 (652)
..+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+............. .. .
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence 668999999999874 46899999999999999999999999885444433322111 00 0
Q ss_pred -C--cc------ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccccC
Q 006277 230 -P--AA------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 271 (652)
Q Consensus 230 -p--~~------l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~~ 271 (652)
+ .. .....++.+.+||.+||. +|.+|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 0 00 012467789999999998 899999999999999998543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=362.99 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=213.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.. .+|+||||
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 87 (304)
T 2jam_A 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP----AFRDSSLENEIAVLKKIKHENIVTLEDIYESTT--HYYLVMQL 87 (304)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEEECC
T ss_pred eeeccCCCCceEEEEEECCCCCEEEEEEEeccc----ccchHHHHHHHHHHHhCCCCCeeehhhhcccCC--EEEEEEEc
Confidence 467888888999999999999999999998543 233467889999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEc--CCCCcEEEeccCchhhhhccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGLATIMEQANAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~--~~~g~VKL~DFGla~~l~~~~~~ 170 (652)
+.+|+|.+++...+.+++..+..++.||+.||.|||++| |+||||||+|||+. ..++.+||+|||++.........
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (304)
T 2jam_A 88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165 (304)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTH
T ss_pred CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccc
Confidence 999999999988889999999999999999999999998 99999999999993 25678999999999876554455
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC--ccccCCCChHHHHHHHH
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AALSKVKDPEVKSFIEK 247 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p--~~l~~~~s~~~kdlI~k 247 (652)
..+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .....+...+..+..+ .......++++++||.+
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 244 (304)
T 2jam_A 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISESAKDFICH 244 (304)
T ss_dssp HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHH
T ss_pred cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHH
Confidence 668999999999875 5689999999999999999999999987 5666777777776532 23345678999999999
Q ss_pred hCC-CCCCCCCHHHHhcCcccccc
Q 006277 248 CLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
||. +|.+|||+.|+|+||||+..
T Consensus 245 ~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 245 LLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HcCCChhHCcCHHHHhcCccccCC
Confidence 998 89999999999999999743
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=356.14 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=213.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...++++..|+||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.. ..|+||||
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 86 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGN--IQYLFLEY 86 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC--EEEEEEEe
Confidence 3578888889999999999999999999975543 345678999999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc----c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----N 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~----~ 168 (652)
+.+|+|.+++.....+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++..+... .
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEc-cCCCEEEeeCCCccccCCCcchhc
Confidence 999999999988788999999999999999999999998 99999999999998 6689999999999866432 2
Q ss_pred cccccCCCCccCcccccc-C-CCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYDE-N-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~~-~-y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
.....||+.|+|||++.+ . ++.++|||||||++|+|++|..||.........+..+.............++.+++||.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHH
Confidence 345789999999998754 4 47889999999999999999999987655545555555544333333457889999999
Q ss_pred HhCC-CCCCCCCHHHHhcCcccccc
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+||. +|.+|||+.|+++||||+..
T Consensus 244 ~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 244 KILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHCCCCchhCCCHHHHhcCccccCh
Confidence 9998 89999999999999999743
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=372.42 Aligned_cols=247 Identities=29% Similarity=0.460 Sum_probs=211.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.+..+|+.||+|++..... ...+..+++.+|+.+|++++||||++++++|.+.. .+|+||||
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e~ 135 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAWLVMEY 135 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--eEEEEEec
Confidence 4578888889999999999999999999975432 23456788999999999999999999999998765 89999999
Q ss_pred CCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccc
Q 006277 93 FTSGSLRQYRK-KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 171 (652)
Q Consensus 93 ~~gGsL~~~i~-~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~ 171 (652)
|. |+|.+++. ..+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..... ...
T Consensus 136 ~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~--~~~ 209 (348)
T 1u5q_A 136 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANS 209 (348)
T ss_dssp CS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS--BCC
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEeeccCceecCC--CCc
Confidence 97 57877775 4568999999999999999999999998 99999999999998 678999999999987643 346
Q ss_pred ccCCCCccCcccc----ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHH
Q 006277 172 VIGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 172 ~vGTp~YmAPEvl----~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~k 247 (652)
.+||+.|+|||++ .+.|+.++|||||||++|+|++|.+||.+......++ .+..+..+.......++.+++||.+
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~ 288 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHWSEYFRNFVDS 288 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHSCCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 7899999999976 3579999999999999999999999998754444444 4444444544556678999999999
Q ss_pred hCC-CCCCCCCHHHHhcCccccc
Q 006277 248 CLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~~~ 269 (652)
||. +|.+|||+.++|+||||..
T Consensus 289 ~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 289 CLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HcccChhhCcCHHHHhhChhhhc
Confidence 998 8999999999999999964
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=371.52 Aligned_cols=247 Identities=23% Similarity=0.401 Sum_probs=208.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC--CCeeeeeeEEEeCCCCeEEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH--NNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~H--pnIVkl~~~~~d~~~~~~~LVm 90 (652)
...|++++.|+||+|.+ .+|+.||+|++..... .....+.+.+|+.+|+.|+| |||+++++++.+.. .+|+||
T Consensus 14 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~--~~~lv~ 88 (343)
T 3dbq_A 14 LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--YIYMVM 88 (343)
T ss_dssp EEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEEEEE
T ss_pred EEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc--chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC--EEEEEE
Confidence 35677777799999998 4699999999986542 45677899999999999976 99999999987654 899999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
| +.+|+|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ++.+||+|||++..+....
T Consensus 89 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~--~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp C-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECCCSSSCCC------
T ss_pred e-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE--CCcEEEeecccccccCccccc
Confidence 9 568899999999999999999999999999999999998 99999999999997 4789999999998765432
Q ss_pred --cccccCCCCccCccccc------------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc
Q 006277 169 --AKSVIGTPEFMAPELYD------------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS 234 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl~------------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 234 (652)
....+||+.|+|||++. ..|+.++|||||||++|+|++|..||....+.......+........++
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc
Confidence 34678999999999873 5688999999999999999999999987666656666666655555667
Q ss_pred CCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 235 KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 235 ~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
...++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 244 ~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 7778899999999998 8999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=364.32 Aligned_cols=253 Identities=26% Similarity=0.347 Sum_probs=202.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCC-HHHHHHHHHHHHHHHhC---CCCCeeeeeeEEEeCCCC---e
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQS-PEDLERLYSEVHLLKSL---KHNNIIRFYNSWIDDQNK---T 85 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s-~e~~~~l~~Ei~iLk~L---~HpnIVkl~~~~~d~~~~---~ 85 (652)
..+|++++.|+||+|.+..+|+.||+|++........ ......+.+|+.+++.+ +||||+++++++.+.... .
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~ 93 (308)
T 3g33_A 14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93 (308)
T ss_dssp EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence 3567777789999999999999999999986442111 11234566677777766 599999999998775432 5
Q ss_pred EEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 86 VNIITELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 86 ~~LVmEy~~gGsL~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
+++||||+. |+|.+++..... +++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||++..
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~ 169 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARI 169 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEEC-TTSCEEECSCSCTTT
T ss_pred EEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEEeeCccccc
Confidence 899999996 599999987754 999999999999999999999999 99999999999998 678999999999987
Q ss_pred hhccc-cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC--CCC-cc------
Q 006277 164 MEQAN-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IKP-AA------ 232 (652)
Q Consensus 164 l~~~~-~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g--~~p-~~------ 232 (652)
..... ....+||+.|+|||++ ...|+.++|||||||++|+|++|.+||.+... ......+... ..+ ..
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~ 248 (308)
T 3g33_A 170 YSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLGKIFDLIGLPPEDDWPRDVS 248 (308)
T ss_dssp STTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSCSSCS
T ss_pred cCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhhccchhh
Confidence 75443 4567899999999977 56799999999999999999999999987444 4333333321 111 11
Q ss_pred ----------------ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 233 ----------------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 233 ----------------l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 249 LPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred ccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 113467899999999998 89999999999999999854
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=367.02 Aligned_cols=247 Identities=24% Similarity=0.389 Sum_probs=204.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---------
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--------- 83 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~--------- 83 (652)
...|++++.|.||+|.++.+|+.||+|++.... .....+.+.+|+.+|++|+|||||+++++|.+...
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~ 87 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE 87 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence 467888888999999999999999999997543 24567889999999999999999999999876532
Q ss_pred ----------------------------------------------CeEEEEEecCCCCCHHHHHHhCCC---CCHHHHH
Q 006277 84 ----------------------------------------------KTVNIITELFTSGSLRQYRKKHKK---VDMKAVK 114 (652)
Q Consensus 84 ----------------------------------------------~~~~LVmEy~~gGsL~~~i~~~~~---lse~~i~ 114 (652)
..+++|||||.+|+|.+++..... .++..++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 167 (332)
T 3qd2_B 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL 167 (332)
T ss_dssp --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHH
T ss_pred hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHH
Confidence 248999999999999999987654 4566789
Q ss_pred HHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--------------ccccccCCCCccC
Q 006277 115 GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--------------NAKSVIGTPEFMA 180 (652)
Q Consensus 115 ~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--------------~~~~~vGTp~YmA 180 (652)
.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...... .....+||+.|+|
T Consensus 168 ~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHhCC--eeecCCCcccEEEe-CCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 99999999999999998 99999999999998 6689999999999876542 1234679999999
Q ss_pred ccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCH
Q 006277 181 PELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSA 258 (652)
Q Consensus 181 PEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa 258 (652)
||++. ..|+.++|||||||++|+|++|..|+. ........+..+..+... ...++++++||.+||. +|.+|||+
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rps~ 320 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---ERVRIITDVRNLKFPLLF-TQKYPQEHMMVQDMLSPSPTERPEA 320 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH---HHHHHHHHHHTTCCCHHH-HHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh---HHHHHHHHhhccCCCccc-ccCChhHHHHHHHHccCCCCcCCCH
Confidence 99774 579999999999999999999877753 234455555555444332 2345788999999998 89999999
Q ss_pred HHHhcCccccc
Q 006277 259 KELLMDPFLQV 269 (652)
Q Consensus 259 ~elL~hpf~~~ 269 (652)
.|+|+||||+.
T Consensus 321 ~~~l~~~~f~~ 331 (332)
T 3qd2_B 321 TDIIENAIFEN 331 (332)
T ss_dssp HHHHHSTTCCC
T ss_pred HHHhhchhhhc
Confidence 99999999973
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=397.86 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=217.6
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
....|+++..|.||+|.++.+|+.||+|++...... .....+.+.+|+.+|+.++||||++++++|.+.. .+|+|||
T Consensus 189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~l~lVmE 265 (543)
T 3c4z_A 189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT--DLCLVMT 265 (543)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEEEC
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh-hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC--EEEEEEE
Confidence 345688888899999999999999999999754321 1234578899999999999999999999997654 7999999
Q ss_pred cCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 92 LFTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 92 y~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
||.||+|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|++||+|||+++.+...
T Consensus 266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~-~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECCTT
T ss_pred eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEe-CCCCEEEeecceeeeccCC
Confidence 99999999998764 36999999999999999999999999 99999999999998 6789999999999876543
Q ss_pred c--cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCC---CHHHHHHHHhcCCCCccccCCCChHH
Q 006277 168 N--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECR---NSAQIYKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 168 ~--~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~---~~~~i~~~I~~g~~p~~l~~~~s~~~ 241 (652)
. ....+||+.|+|||++. ..|+.++|||||||++|||++|.+||.+.. ....++..+..+.. .++...++++
T Consensus 343 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--~~p~~~s~~~ 420 (543)
T 3c4z_A 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDKFSPAS 420 (543)
T ss_dssp CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--CCCcccCHHH
Confidence 3 34569999999999774 579999999999999999999999997643 45677777776542 3456678999
Q ss_pred HHHHHHhCC-CCCCCCC-----HHHHhcCccccccCCC
Q 006277 242 KSFIEKCLV-PASQRLS-----AKELLMDPFLQVNGTT 273 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpS-----a~elL~hpf~~~~~~~ 273 (652)
++||.+||. +|.+||+ +.++++||||+...|.
T Consensus 421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp HHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred HHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 999999998 8999995 5899999999976664
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=370.48 Aligned_cols=253 Identities=27% Similarity=0.364 Sum_probs=205.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQ-SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~-s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...|+++..|+||+|.+..+|+.||+|++....... ++...+++.+|+.+|+.++||||++++++|.+.. .+++|||
T Consensus 31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e 108 (345)
T 3hko_A 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ--YICLVME 108 (345)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEEEE
T ss_pred cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC--eEEEEEe
Confidence 467888888999999999999999999997643211 3456788999999999999999999999997654 8999999
Q ss_pred cCCCCCHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 006277 92 LFTSGSLRQYRKK----------------------------------------HKKVDMKAVKGWARQILSGLIYLHSHD 131 (652)
Q Consensus 92 y~~gGsL~~~i~~----------------------------------------~~~lse~~i~~i~~QIl~aL~yLHs~g 131 (652)
||.||+|.+++.. ...+++..++.++.||+.||.|||+++
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 188 (345)
T 3hko_A 109 LCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG 188 (345)
T ss_dssp CCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999998742 112467889999999999999999998
Q ss_pred CCeeeccCCcccEEEcCC-CCcEEEeccCchhhhhccc------cccccCCCCccCccccc---cCCCccccchhhHHHH
Q 006277 132 PPIIHRDLKCDNIFINGN-QGEVKIGDLGLATIMEQAN------AKSVIGTPEFMAPELYD---ENYNELADIYSFGMCM 201 (652)
Q Consensus 132 ~~IiHRDLKp~NILl~~~-~g~VKL~DFGla~~l~~~~------~~~~vGTp~YmAPEvl~---~~y~~~sDIWSlGvil 201 (652)
|+||||||+|||++.+ .+.+||+|||++..+.... .....||+.|+|||++. ..|+.++|||||||++
T Consensus 189 --ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il 266 (345)
T 3hko_A 189 --ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266 (345)
T ss_dssp --EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHH
T ss_pred --ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHH
Confidence 9999999999999832 2289999999998664321 34568999999999874 5689999999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHhcCCCCc--cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 202 LEMVTFEYPYSECRNSAQIYKKVSSGIKPA--ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 202 yeLltG~~Pf~~~~~~~~i~~~I~~g~~p~--~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
|+|++|..||.+... ......+..+.... ......++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 267 ~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 267 HLLLMGAVPFPGVND-ADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHSSCSSCCSSH-HHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHCCCCCCCCCh-HHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 999999999988544 44444454443322 2233478999999999998 89999999999999999753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=388.98 Aligned_cols=249 Identities=28% Similarity=0.379 Sum_probs=197.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC----CCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ----NKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~----~~~~~L 88 (652)
...||+++.|+||+|.+..+|+.||+|++.... ......+++.+|+.+|+.++|||||+++++|.... ...+|+
T Consensus 67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 144 (464)
T 3ttj_A 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144 (464)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEESGG--GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEECccc--cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEE
Confidence 356788888999999999999999999997542 24567889999999999999999999999986543 246899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
|||||.+ +|.+++. ..+++..++.+++||+.||.|||++| |+||||||+|||++ .++.+||+|||+++......
T Consensus 145 v~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~ 218 (464)
T 3ttj_A 145 VMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSF 218 (464)
T ss_dssp EEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCCC-----CC
T ss_pred EEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEe-CCCCEEEEEEEeeeecCCCc
Confidence 9999976 4666664 35999999999999999999999999 99999999999998 67899999999998776543
Q ss_pred -cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CCCCc--------------
Q 006277 169 -AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIKPA-------------- 231 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~~p~-------------- 231 (652)
....+||+.|+|||++ ...|+.++|||||||++|+|++|.+||.+.....++.+.+.. |..+.
T Consensus 219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~ 298 (464)
T 3ttj_A 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 298 (464)
T ss_dssp CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHH
T ss_pred ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHh
Confidence 4567999999999976 457999999999999999999999999885544443333221 11000
Q ss_pred ---------cccC---------------CCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 232 ---------ALSK---------------VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 232 ---------~l~~---------------~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.++. ..++++++||.+||+ ||.+|||+.|+|+||||+.
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 299 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp TTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 0000 014679999999998 9999999999999999973
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=393.03 Aligned_cols=247 Identities=25% Similarity=0.404 Sum_probs=215.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..|+++..|.||+|.+..+|+.||+|++...... ..+..+++.+|+.+|+.++||||+++++++.+.. .+|+|||||
T Consensus 22 ~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--~~~lv~E~~ 98 (476)
T 2y94_A 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS--DIFMVMEYV 98 (476)
T ss_dssp EEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEEEECC
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEEeCC
Confidence 4567777799999999999999999999754321 1234678999999999999999999999987654 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-ccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKSV 172 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~~~ 172 (652)
.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...... ...+.
T Consensus 99 ~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~-~~~~vkL~DFG~a~~~~~~~~~~~~ 175 (476)
T 2y94_A 99 SGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTS 175 (476)
T ss_dssp SSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEC-TTCCEEECCCSSCEECCTTCCBCCC
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEe-cCCCeEEEeccchhhcccccccccc
Confidence 99999999998889999999999999999999999998 99999999999998 6689999999999876543 34567
Q ss_pred cCCCCccCcccccc-CC-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 173 IGTPEFMAPELYDE-NY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 173 vGTp~YmAPEvl~~-~y-~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
+||+.|+|||++.+ .| +.++|||||||++|+|++|..||.+ .+...++..+..+... .+...++++++||.+||.
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~Li~~~L~ 252 (476)
T 2y94_A 176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFY--TPQYLNPSVISLLKHMLQ 252 (476)
T ss_dssp CSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC-SSSHHHHHHHHTTCCC--CCTTCCHHHHHHHHHHTC
T ss_pred CCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCcC--CCccCCHHHHHHHHHHcC
Confidence 89999999998755 34 6899999999999999999999987 5566777888777543 345678999999999998
Q ss_pred -CCCCCCCHHHHhcCccccc
Q 006277 251 -PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 251 -~P~~RpSa~elL~hpf~~~ 269 (652)
+|.+|||+.|+++||||+.
T Consensus 253 ~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 253 VDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp SSTTTSCCHHHHHTCHHHHT
T ss_pred CCchhCcCHHHHHhCHHhhh
Confidence 8999999999999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=386.21 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=206.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCC----CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQ----SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~----s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
...|++++.|+||+|.+..+|+.||+|++....... ..+....+.+|+.+|++|+||||+++++++... .+|+
T Consensus 140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~~l 216 (419)
T 3i6u_A 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE---DYYI 216 (419)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS---EEEE
T ss_pred EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC---ceEE
Confidence 356888888999999999999999999998654321 122344688999999999999999999987532 5899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC--CCcEEEeccCchhhhhc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~--~g~VKL~DFGla~~l~~ 166 (652)
|||||.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.. ++.+||+|||+++.+..
T Consensus 217 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~ 294 (419)
T 3i6u_A 217 VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294 (419)
T ss_dssp EEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-
T ss_pred EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecccceecCC
Confidence 9999999999999988889999999999999999999999998 9999999999999732 34699999999988754
Q ss_pred cc-cccccCCCCccCccccc----cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc--cccCCCCh
Q 006277 167 AN-AKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA--ALSKVKDP 239 (652)
Q Consensus 167 ~~-~~~~vGTp~YmAPEvl~----~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~--~l~~~~s~ 239 (652)
.. ....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||........+...+..+.... ......++
T Consensus 295 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 374 (419)
T 3i6u_A 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 374 (419)
T ss_dssp ----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCH
T ss_pred CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCH
Confidence 43 45678999999999873 4688999999999999999999999987665556666676665332 23345688
Q ss_pred HHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 240 EVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 240 ~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 375 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 375 KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 99999999998 89999999999999999753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=370.51 Aligned_cols=249 Identities=23% Similarity=0.427 Sum_probs=213.4
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCH----HHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSP----EDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~----e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~L 88 (652)
..|+.+..|.||+|.+..+|+.||+|++......... +..+.+.+|+.+++.+ +||||++++++|.... ..|+
T Consensus 100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--~~~l 177 (365)
T 2y7j_A 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS--FMFL 177 (365)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS--EEEE
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC--EEEE
Confidence 5677777899999999999999999998764322222 2356788999999999 8999999999987654 8999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 167 (652)
||||+.||+|.+++.....+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 178 v~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~-~~~~ikl~DfG~~~~~~~~~ 254 (365)
T 2y7j_A 178 VFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGE 254 (365)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCTTC
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEEecCcccccCCCc
Confidence 9999999999999998889999999999999999999999998 99999999999998 6789999999999876543
Q ss_pred ccccccCCCCccCccccc-------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccc--cCCCC
Q 006277 168 NAKSVIGTPEFMAPELYD-------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL--SKVKD 238 (652)
Q Consensus 168 ~~~~~vGTp~YmAPEvl~-------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l--~~~~s 238 (652)
.....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .........+..+...... ....+
T Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~ 333 (365)
T 2y7j_A 255 KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSPEWDDRS 333 (365)
T ss_dssp CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCHHHHSSSC
T ss_pred ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCCcccccCC
Confidence 345678999999999774 2588999999999999999999999987 4556666667666543222 24567
Q ss_pred hHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 239 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 239 ~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
+.+++||.+||. +|.+|||+.|+|+||||+
T Consensus 334 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 334 STVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 899999999997 899999999999999996
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=376.76 Aligned_cols=247 Identities=25% Similarity=0.326 Sum_probs=206.3
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
.|+++..|.||+|.+..+|+.||+|++.... ....+++.+|+.+|++|+||||++++++|.+.. .+++|||||.
T Consensus 96 ~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~E~~~ 169 (373)
T 2x4f_A 96 ILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLDHANLIQLYDAFESKN--DIVLVMEYVD 169 (373)
T ss_dssp ECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEEEECCT
T ss_pred EEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEEEEEeCCC
Confidence 4677777999999999999999999997542 356778999999999999999999999987654 7999999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEc-CCCCcEEEeccCchhhhhccc-ccc
Q 006277 95 SGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN-GNQGEVKIGDLGLATIMEQAN-AKS 171 (652)
Q Consensus 95 gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~-~~~g~VKL~DFGla~~l~~~~-~~~ 171 (652)
+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||+. ...+.+||+|||++..+.... ...
T Consensus 170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~ 247 (373)
T 2x4f_A 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247 (373)
T ss_dssp TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence 99999988654 46999999999999999999999998 99999999999984 255789999999998765433 355
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--CccccCCCChHHHHHHHHh
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~~kdlI~kc 248 (652)
.+||+.|+|||++. +.|+.++|||||||++|+|++|..||.+. +....+..+..... +.......++++++||.+|
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 326 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD-NDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTT
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHH
Confidence 68999999999775 56899999999999999999999999874 45555555555432 2223345789999999999
Q ss_pred CC-CCCCCCCHHHHhcCcccccc
Q 006277 249 LV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~~~~ 270 (652)
|. +|.+|||+.|+|+||||+..
T Consensus 327 L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 327 LIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp SCSSGGGSCCHHHHHHSHHHHCH
T ss_pred cCCChhhCCCHHHHhcCcCcCCC
Confidence 98 89999999999999999743
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=374.02 Aligned_cols=249 Identities=29% Similarity=0.386 Sum_probs=201.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC----CeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN----KTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~----~~~~LV 89 (652)
..++++..|+||+|.+..+|+.||+|++.... .+....+++.+|+++|+.++||||+++++++..... ..+|+|
T Consensus 31 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv 108 (367)
T 1cm8_A 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108 (367)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEE
Confidence 45666666899999999999999999986432 345677899999999999999999999999875432 357999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 169 (652)
|||+ +++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++..... .
T Consensus 109 ~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~-~ 182 (367)
T 1cm8_A 109 MPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQADSE-M 182 (367)
T ss_dssp EECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCSS-C
T ss_pred EecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEc-CCCCEEEEeeecccccccc-c
Confidence 9999 8899999876 57999999999999999999999999 99999999999998 6789999999999875432 4
Q ss_pred ccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CCCC----------------
Q 006277 170 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIKP---------------- 230 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~~p---------------- 230 (652)
...+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.....++...+.. |..+
T Consensus 183 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~ 262 (367)
T 1cm8_A 183 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 262 (367)
T ss_dssp CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHH
T ss_pred CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHH
Confidence 5678999999999774 47999999999999999999999999885444443332221 1111
Q ss_pred -----------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 231 -----------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 231 -----------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
..+....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 263 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 11223457899999999998 89999999999999999753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=367.04 Aligned_cols=244 Identities=23% Similarity=0.289 Sum_probs=203.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-----CCCeeeeeeEEEeCCCCeEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-----HNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-----HpnIVkl~~~~~d~~~~~~~ 87 (652)
..+|++++.|+||+|.+..+|+.||+|++.. .......+..|+.+++.+. ||||++++++|.... .++
T Consensus 40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~--~~~ 112 (360)
T 3llt_A 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD--HMC 112 (360)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT--EEE
T ss_pred EEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC--eeE
Confidence 4577888889999999999999999999863 2456677888999999996 999999999998765 899
Q ss_pred EEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC-----------------
Q 006277 88 IITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING----------------- 148 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~----------------- 148 (652)
+||||| +++|.+++...+ .+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 113 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 113 LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchhcccccc
Confidence 999999 999999998764 5999999999999999999999998 999999999999973
Q ss_pred -------CCCcEEEeccCchhhhhccccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHH
Q 006277 149 -------NQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI 220 (652)
Q Consensus 149 -------~~g~VKL~DFGla~~l~~~~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i 220 (652)
..+.+||+|||++..... .....+||+.|+|||++ ...|+.++|||||||++|+|++|.+||... +....
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~ 267 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH-EHMEH 267 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS-SHHHH
T ss_pred cccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC-cHHHH
Confidence 367899999999986543 34567899999999976 457999999999999999999999999874 33443
Q ss_pred HHHHhcCCCCc--------------------------------------------cccCCCChHHHHHHHHhCC-CCCCC
Q 006277 221 YKKVSSGIKPA--------------------------------------------ALSKVKDPEVKSFIEKCLV-PASQR 255 (652)
Q Consensus 221 ~~~I~~g~~p~--------------------------------------------~l~~~~s~~~kdlI~kcL~-~P~~R 255 (652)
...+.....+. .+....++.+.+||.+||. +|.+|
T Consensus 268 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 347 (360)
T 3llt_A 268 LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLR 347 (360)
T ss_dssp HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhC
Confidence 33333211110 0011234778899999998 89999
Q ss_pred CCHHHHhcCcccc
Q 006277 256 LSAKELLMDPFLQ 268 (652)
Q Consensus 256 pSa~elL~hpf~~ 268 (652)
||+.|+|+||||+
T Consensus 348 pta~elL~hp~f~ 360 (360)
T 3llt_A 348 PSPAELLKHKFLE 360 (360)
T ss_dssp CCHHHHTTSGGGC
T ss_pred CCHHHHhcCcccC
Confidence 9999999999995
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=365.25 Aligned_cols=254 Identities=22% Similarity=0.285 Sum_probs=209.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC--eEEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK--TVNIIT 90 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~--~~~LVm 90 (652)
...|++++.|+||+|.+..+|+.||+|++... ....+....++.+|+.++++++||||+++++++...... .+|+||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~ 95 (311)
T 3ork_A 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 95 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECTT-TTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEEccCCCEEEEEEEECCCCceEEEEEeCcc-ccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEE
Confidence 45788888899999999999999999998753 334567788999999999999999999999998765432 469999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
|||.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+....
T Consensus 96 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~ 172 (311)
T 3ork_A 96 EYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNS 172 (311)
T ss_dssp ECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTSCEEECCCSCC---------
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEc-CCCCEEEeeccCcccccccccc
Confidence 99999999999998889999999999999999999999998 99999999999998 56899999999998765321
Q ss_pred ---cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc-cccCCCChHHHH
Q 006277 169 ---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA-ALSKVKDPEVKS 243 (652)
Q Consensus 169 ---~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~-~l~~~~s~~~kd 243 (652)
....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.......+..+.....+. ......++++++
T Consensus 173 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 252 (311)
T 3ork_A 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 252 (311)
T ss_dssp ---------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHH
T ss_pred cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHH
Confidence 24567999999999774 5789999999999999999999999988555455555555544332 233457899999
Q ss_pred HHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 244 FIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
||.+||. +|.+||++.++|.|+|++..
T Consensus 253 li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 253 VVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 9999998 89999999999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=355.01 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=211.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCC--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQS--PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s--~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
...|+++..|+||+|.+..+|+.||+|++........ ....+.+.+|+.++++++||||+++++++.+.. .+++||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 87 (283)
T 3bhy_A 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT--DVVLIL 87 (283)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEEE
T ss_pred HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC--eEEEEE
Confidence 3678888889999999999999999999986543221 123678999999999999999999999987654 799999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCC----cEEEeccCchhhhhc
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG----EVKIGDLGLATIMEQ 166 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g----~VKL~DFGla~~l~~ 166 (652)
||+.+++|.+++...+.+++..+..++.||+.||.|||++| |+||||||+||+++. ++ .+||+|||++.....
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~-~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 88 ELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLD-KNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESC-SSSSSCCEEECCCTTCEECC-
T ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEec-CCCCCCceEEEecccceeccC
Confidence 99999999999998889999999999999999999999998 999999999999983 34 799999999987654
Q ss_pred c-ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--CccccCCCChHHH
Q 006277 167 A-NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVK 242 (652)
Q Consensus 167 ~-~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~~k 242 (652)
. ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .........+..... +.......++.++
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T 3bhy_A 165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFSNTSELAK 243 (283)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC-cchHHHHHHhHhcccCCcchhcccCCHHHH
Confidence 3 234568999999999875 5789999999999999999999999987 455566666665443 2233356788999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 243 SFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+||.+||. +|.+|||+.|+|+||||+..
T Consensus 244 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 244 DFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 99999998 89999999999999999753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=355.21 Aligned_cols=248 Identities=31% Similarity=0.473 Sum_probs=207.4
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCC
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~~ 94 (652)
.|+++..|+||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.. .+++||||+.
T Consensus 29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~ 102 (295)
T 2clq_A 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG--FIKIFMEQVP 102 (295)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEEEECCS
T ss_pred EEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC--cEEEEEEeCC
Confidence 6888999999999999999999999987543 345678999999999999999999999997654 8999999999
Q ss_pred CCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 95 SGSLRQYRKKHK---KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 95 gGsL~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
+|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++..++.+||+|||++...... ..
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~ 180 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCCcc
Confidence 999999998652 5679999999999999999999998 9999999999999865789999999999876532 23
Q ss_pred ccccCCCCccCcccccc---CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 170 KSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~---~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.....................++...++++++||.
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 260 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFIL 260 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHH
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHH
Confidence 46689999999998743 388999999999999999999999977555443333322222233455667899999999
Q ss_pred HhCC-CCCCCCCHHHHhcCcccccc
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+||. +|.+|||+.++|+||||+..
T Consensus 261 ~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 261 KCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HHccCChhhCCCHHHHhcChhhhhc
Confidence 9998 89999999999999999754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=374.33 Aligned_cols=254 Identities=20% Similarity=0.296 Sum_probs=211.2
Q ss_pred EEEEEEecCcEEEEEEEc---cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~---~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~L 88 (652)
...|++++.|+||+|.+. .+|+.||+|+++...........+.+.+|+++|+.+ +||||+++++++.+.. .+|+
T Consensus 59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~l 136 (355)
T 1vzo_A 59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET--KLHL 136 (355)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT--EEEE
T ss_pred EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc--eEEE
Confidence 356788888999999985 589999999987543322223455677899999999 7999999999987765 7999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 167 (652)
|||||.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 137 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~ 213 (355)
T 1vzo_A 137 ILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADE 213 (355)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEEECCGGG
T ss_pred EeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCcEEEeeCCCCeecccCC
Confidence 9999999999999998889999999999999999999999998 99999999999998 6789999999999865332
Q ss_pred --ccccccCCCCccCcccccc---CCCccccchhhHHHHHHHhhccCCCCCC---CCHHHHHHHHhcCCCCccccCCCCh
Q 006277 168 --NAKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSEC---RNSAQIYKKVSSGIKPAALSKVKDP 239 (652)
Q Consensus 168 --~~~~~vGTp~YmAPEvl~~---~y~~~sDIWSlGvilyeLltG~~Pf~~~---~~~~~i~~~I~~g~~p~~l~~~~s~ 239 (652)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||... .....+...+.... ..++...++
T Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 291 (355)
T 1vzo_A 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQEMSA 291 (355)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--CCCCTTSCH
T ss_pred CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC--CCCCcccCH
Confidence 2345789999999998753 4789999999999999999999999643 23455555555543 234556788
Q ss_pred HHHHHHHHhCC-CCCCCC-----CHHHHhcCccccccCCC
Q 006277 240 EVKSFIEKCLV-PASQRL-----SAKELLMDPFLQVNGTT 273 (652)
Q Consensus 240 ~~kdlI~kcL~-~P~~Rp-----Sa~elL~hpf~~~~~~~ 273 (652)
.+++||.+||. +|.+|| ++.|+++||||+...+.
T Consensus 292 ~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~ 331 (355)
T 1vzo_A 292 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 331 (355)
T ss_dssp HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence 99999999998 899999 99999999999876553
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=354.95 Aligned_cols=249 Identities=26% Similarity=0.371 Sum_probs=196.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.+..+|+.||+|++..... .......+.++...++.++||||+++++++.+.. .+++||||
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~--~~~lv~e~ 87 (290)
T 3fme_A 12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG--DVWICMEL 87 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEC---C--HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--SEEEEEEC
T ss_pred HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC--cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC--CEEEEEeh
Confidence 4678888889999999999999999999875421 2334445555666688889999999999998654 79999999
Q ss_pred CCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 93 FTSGSLRQYRK----KHKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 93 ~~gGsL~~~i~----~~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
+.+ +|.+++. ..+.+++..++.++.||+.||.|||++ | |+||||||+|||++ .++.+||+|||++......
T Consensus 88 ~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 88 MDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEEC-TTCCEEBCCC---------
T ss_pred hcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeecCCccccccc
Confidence 974 8877654 356899999999999999999999998 8 99999999999998 5689999999999877554
Q ss_pred c-cccccCCCCccCcccc-----ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHH
Q 006277 168 N-AKSVIGTPEFMAPELY-----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 168 ~-~~~~vGTp~YmAPEvl-----~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~ 241 (652)
. .....||+.|+|||++ ...|+.++|||||||++|+|++|..||............+.....+.......++++
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (290)
T 3fme_A 164 VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEF 243 (290)
T ss_dssp ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHH
T ss_pred ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHH
Confidence 3 3445899999999985 346889999999999999999999999876666555555555544444445678999
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 242 KSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
++||.+||. +|.+|||+.|+|+||||+.
T Consensus 244 ~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 244 VDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 999999998 8999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=353.94 Aligned_cols=249 Identities=29% Similarity=0.398 Sum_probs=216.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...+++++.|+||+|.+..+|+.||+|.+..... ......+++.+|+.+++.++||||+++++++.+.. .+++||||
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 96 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND--FVFVVLEL 96 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEEEEEC
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC--EEEEEEec
Confidence 4567788889999999999999999999975433 34567888999999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--ccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~ 170 (652)
+.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...... ...
T Consensus 97 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~ 173 (294)
T 2rku_A 97 CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKK 173 (294)
T ss_dssp CTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCSTTCCBC
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEc-CCCCEEEEeccCceecccCccccc
Confidence 999999999998889999999999999999999999998 99999999999998 6789999999999876432 234
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
...||+.|+|||++. ..++.++|||||||++|+|++|..||.. ......+..+..+.. .++...++.+++||.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l 250 (294)
T 2rku_A 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPKHINPVAASLIQKML 250 (294)
T ss_dssp CCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHHHHT
T ss_pred cccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhhccC--CCccccCHHHHHHHHHHc
Confidence 568999999999874 4688999999999999999999999987 455566666665532 345567899999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccc
Q 006277 250 V-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 250 ~-~P~~RpSa~elL~hpf~~~~ 270 (652)
. +|.+|||+.|+|+||||...
T Consensus 251 ~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 251 QTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp CSSGGGSCCGGGGGGSHHHHTS
T ss_pred ccChhhCcCHHHHhhChheecC
Confidence 8 89999999999999999753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=372.83 Aligned_cols=246 Identities=23% Similarity=0.302 Sum_probs=201.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC-----------
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD----------- 81 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~----------- 81 (652)
...|+++..|+||+|.+..+|+.||+|++..... ...+|+++|+.|+|||||+++++|...
T Consensus 12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp EEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--------hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 3578888889999999999999999999874432 123699999999999999999998653
Q ss_pred -------------------------CCCeEEEEEecCCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 006277 82 -------------------------QNKTVNIITELFTSGSLRQYR----KKHKKVDMKAVKGWARQILSGLIYLHSHDP 132 (652)
Q Consensus 82 -------------------------~~~~~~LVmEy~~gGsL~~~i----~~~~~lse~~i~~i~~QIl~aL~yLHs~g~ 132 (652)
.+.++++|||||.+ +|.+.+ ...+.+++..++.++.||+.||.|||++|
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g- 161 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG- 161 (383)
T ss_dssp --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT-
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc-
Confidence 23468999999975 766554 44678999999999999999999999998
Q ss_pred CeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-ccccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccC
Q 006277 133 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEY 209 (652)
Q Consensus 133 ~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~ 209 (652)
|+||||||+|||++..++.+||+|||+++.+... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+
T Consensus 162 -i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 162 -ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp -EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 9999999999999866789999999999876543 3456789999999997643 58999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhcCCCC--------------------------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHh
Q 006277 210 PYSECRNSAQIYKKVSSGIKP--------------------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELL 262 (652)
Q Consensus 210 Pf~~~~~~~~i~~~I~~g~~p--------------------------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL 262 (652)
||.+.....++...+.....| ..++...++++++||.+||. +|.+|||+.|+|
T Consensus 241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (383)
T 3eb0_A 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM 320 (383)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 998865555554444311110 01234467889999999998 899999999999
Q ss_pred cCccccc
Q 006277 263 MDPFLQV 269 (652)
Q Consensus 263 ~hpf~~~ 269 (652)
+||||+.
T Consensus 321 ~hp~f~~ 327 (383)
T 3eb0_A 321 AHPFFDH 327 (383)
T ss_dssp TSGGGHH
T ss_pred cCHHHHH
Confidence 9999974
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=377.43 Aligned_cols=246 Identities=20% Similarity=0.287 Sum_probs=197.5
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHH-hCCCCCeeeeeeEEEe--CCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLK-SLKHNNIIRFYNSWID--DQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk-~L~HpnIVkl~~~~~d--~~~~~~~LVm 90 (652)
..|+++..|+||+|.++.+|+.||+|++... ..+.+|+.++. .++||||++++++|.. .....+|+||
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~ 138 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEE
Confidence 3578888999999999999999999998621 35677888874 4589999999998865 2234799999
Q ss_pred ecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC--CCcEEEeccCchhhhhc
Q 006277 91 ELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~--~g~VKL~DFGla~~l~~ 166 (652)
|||.||+|.+++...+ .+++..++.|+.||+.||.|||++| |+||||||+|||++.. ++.+||+|||+++....
T Consensus 139 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 139 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp ECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred EeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 9999999999998754 5999999999999999999999998 9999999999999842 67899999999987654
Q ss_pred c-ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCH---HHHHHHHhcCCCC--ccccCCCCh
Q 006277 167 A-NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNS---AQIYKKVSSGIKP--AALSKVKDP 239 (652)
Q Consensus 167 ~-~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~---~~i~~~I~~g~~p--~~l~~~~s~ 239 (652)
. ...+.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.... ......+..+... .......++
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 296 (400)
T 1nxk_A 217 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 296 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCH
T ss_pred CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCH
Confidence 3 245678999999999874 57999999999999999999999999764322 1234445554432 222345789
Q ss_pred HHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 240 EVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 240 ~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
++++||.+||. +|.+|||+.|+|+||||...
T Consensus 297 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 297 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 99999999998 89999999999999999743
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=352.84 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=215.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...+++++.|+||+|.++.+|+.||+|.+..... +....+.+.+|+.++++++||||+++++++.+..+..+|+||||
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 88 (279)
T 2w5a_A 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88 (279)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeC
Confidence 4678888889999999999999999999986543 45677889999999999999999999999887666789999999
Q ss_pred CCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---CCeeeccCCcccEEEcCCCCcEEEeccCchhhhh
Q 006277 93 FTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYLHSHD---PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 93 ~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g---~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~ 165 (652)
+.+|+|.+++... ..+++..++.++.||+.||.|||+++ .+|+||||||+|||++ .++.+||+|||++....
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~-~~~~~kl~dfg~~~~~~ 167 (279)
T 2w5a_A 89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILN 167 (279)
T ss_dssp CTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC-SSSCEEECCCCHHHHC-
T ss_pred CCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc-CCCCEEEecCchheeec
Confidence 9999999998754 34999999999999999999999976 2499999999999998 67899999999998765
Q ss_pred ccc--cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 166 QAN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 166 ~~~--~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.. .....+...+..+..+ .++...+++++
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~ 245 (279)
T 2w5a_A 168 HDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRYSDELN 245 (279)
T ss_dssp --CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC-CCCTTSCHHHH
T ss_pred cccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc-cCHHHHHHHHhhcccc-cCCcccCHHHH
Confidence 432 24567999999999774 4689999999999999999999999987 4566777777776543 34556789999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 243 SFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+||.+||. +|.+|||+.|+|+|+|+...
T Consensus 246 ~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 246 EIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 99999998 89999999999999999743
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=352.19 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=213.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCC-C----HHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQ-S----PEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTV 86 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~-s----~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~ 86 (652)
...++++..|.||+|.++.+|+.||+|++....... . ....+.+.+|+.+++++. ||||+++++++.+.. .+
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--~~ 99 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT--FF 99 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS--EE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC--eE
Confidence 357788888999999999999999999997543211 1 234567889999999995 999999999987644 89
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 87 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..+..
T Consensus 100 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~ 176 (298)
T 1phk_A 100 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDP 176 (298)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCT
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEc-CCCcEEEecccchhhcCC
Confidence 999999999999999998889999999999999999999999998 99999999999998 678999999999987654
Q ss_pred c-ccccccCCCCccCccccc-------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcc--ccCC
Q 006277 167 A-NAKSVIGTPEFMAPELYD-------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA--LSKV 236 (652)
Q Consensus 167 ~-~~~~~vGTp~YmAPEvl~-------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~--l~~~ 236 (652)
. ......||+.|+|||++. ..++.++|||||||++|+|++|..||.. .........+..+..... ....
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T 1phk_A 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDD 255 (298)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHHHhcCCcccCcccccc
Confidence 3 245678999999999763 3588999999999999999999999987 455666666666543322 2245
Q ss_pred CChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 237 KDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 237 ~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 67899999999998 89999999999999999754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=365.08 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=208.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccC----CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVL----QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~----~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
...|++++.|+||+|.+..+|+.||+|++...... ........+.+|+.+|+.|+||||+++++++... .+|+
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~l 91 (322)
T 2ycf_A 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE---DYYI 91 (322)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS---SEEE
T ss_pred eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC---ceEE
Confidence 46788888899999999999999999998754321 1123345688999999999999999999988654 3899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC--CCcEEEeccCchhhhhc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~--~g~VKL~DFGla~~l~~ 166 (652)
||||+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ ++.+||+|||++.....
T Consensus 92 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 169 (322)
T 2ycf_A 92 VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169 (322)
T ss_dssp EEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCC
T ss_pred EEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCccceeccc
Confidence 9999999999999988889999999999999999999999998 9999999999999843 23599999999987654
Q ss_pred cc-cccccCCCCccCcccc----ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC--ccccCCCCh
Q 006277 167 AN-AKSVIGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AALSKVKDP 239 (652)
Q Consensus 167 ~~-~~~~vGTp~YmAPEvl----~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p--~~l~~~~s~ 239 (652)
.. .....||+.|+|||++ ...|+.++|||||||++|+|++|..||........+...+..+... .......++
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (322)
T 2ycf_A 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249 (322)
T ss_dssp CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCH
Confidence 32 3456799999999986 3568999999999999999999999998765554555666655432 223345688
Q ss_pred HHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 240 EVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 240 ~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 250 ~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred HHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 99999999998 89999999999999999753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=356.40 Aligned_cols=248 Identities=28% Similarity=0.432 Sum_probs=205.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...+++++.|+||+|.+..+|+.||+|++.... ....+++.+|+.+++.++||||+++++++.+.. .+++||||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 97 (302)
T 2j7t_A 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDG--KLWIMIEF 97 (302)
T ss_dssp EEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred cceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC--eEEEEEEe
Confidence 356777778999999999999999999986432 345778999999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
|.+|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...... ..
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~ 174 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKR 174 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTSCEEECCCHHHHHHHHHHHC-
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEC-CCCCEEEEECCCCcccccccccc
Confidence 999999998875 467999999999999999999999998 99999999999998 6689999999998755332 23
Q ss_pred ccccCCCCccCcccc------ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC-ccccCCCChHHH
Q 006277 170 KSVIGTPEFMAPELY------DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKVKDPEVK 242 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl------~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p-~~l~~~~s~~~k 242 (652)
....||+.|+|||++ ...++.++|||||||++|+|++|..||... +.......+..+..+ ...+...+..++
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDPPTLLTPSKWSVEFR 253 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHHHHHhccCCcccCCccccCHHHH
Confidence 456899999999976 356889999999999999999999999874 444444445444333 233456788999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 243 SFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+||.+||. +|.+|||+.++++||||+..
T Consensus 254 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 254 DFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp HHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred HHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 99999998 89999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=349.67 Aligned_cols=245 Identities=23% Similarity=0.322 Sum_probs=205.8
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
....++++..|+||+|.+..+|+.||+|++..... ......++.+|+.++..+ +||||+++++++.+.. .+++||
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~--~~~lv~ 90 (289)
T 1x8b_A 15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD--HMLIQN 90 (289)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT--EEEEEE
T ss_pred hhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC--eEEEEE
Confidence 34678888889999999999999999999875432 235667889999999999 9999999999997765 899999
Q ss_pred ecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC------------------
Q 006277 91 ELFTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING------------------ 148 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~------------------ 148 (652)
|||.+|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999998765 67999999999999999999999998 999999999999972
Q ss_pred CCCcEEEeccCchhhhhccccccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc
Q 006277 149 NQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS 226 (652)
Q Consensus 149 ~~g~VKL~DFGla~~l~~~~~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~ 226 (652)
....+||+|||++...... ....||+.|+|||++.+ .++.++|||||||++|+|++|.+|+... ..+..+..
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~~~ 242 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHEIRQ 242 (289)
T ss_dssp -CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHHHHHT
T ss_pred CceEEEEcccccccccCCc--cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHHHHHc
Confidence 2347999999999876543 34569999999998754 4568999999999999999999877542 23444555
Q ss_pred CCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 227 GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 227 g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+..+ .++...++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 243 ~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 243 GRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp TCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred CCCC-CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 5433 3456678999999999998 8999999999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=358.20 Aligned_cols=251 Identities=21% Similarity=0.387 Sum_probs=212.3
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..+++++.|.||+|.+..+|+.||+|++........+...+++.+|+++++.++||||+++++++.+.....+|+|||||
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (305)
T 2wtk_C 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC 90 (305)
T ss_dssp CEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECC
T ss_pred eEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhc
Confidence 57888889999999999999999999997654322234568899999999999999999999998766666899999999
Q ss_pred CCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc----
Q 006277 94 TSGSLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA---- 167 (652)
Q Consensus 94 ~gGsL~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~---- 167 (652)
.+| |.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 91 ~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~-~~~~~kl~dfg~~~~~~~~~~~~ 166 (305)
T 2wtk_C 91 VCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADD 166 (305)
T ss_dssp SEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCTTCSSC
T ss_pred cCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-CCCcEEeeccccccccCcccccc
Confidence 876 7777765 357999999999999999999999998 99999999999998 6789999999999876432
Q ss_pred ccccccCCCCccCcccccc---CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 168 NAKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 168 ~~~~~vGTp~YmAPEvl~~---~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+...++..+..+.. .++...++.+.+|
T Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~--~~~~~~~~~l~~l 243 (305)
T 2wtk_C 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSY--AIPGDCGPPLSDL 243 (305)
T ss_dssp EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCC--CCCSSSCHHHHHH
T ss_pred ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHHhcCCC--CCCCccCHHHHHH
Confidence 2345679999999998754 247899999999999999999999987 566777777777643 3455678999999
Q ss_pred HHHhCC-CCCCCCCHHHHhcCccccccC
Q 006277 245 IEKCLV-PASQRLSAKELLMDPFLQVNG 271 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~hpf~~~~~ 271 (652)
|.+||. +|.+|||+.|+++||||+...
T Consensus 244 i~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 244 LKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHccCChhhCCCHHHHhcCcccccCC
Confidence 999998 899999999999999998543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=366.66 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=197.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+|++++.|+||+|.+..+|+.||+|++..... ......+.+|+.+|+.++||||+++++++.+.. .+++||||
T Consensus 7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 81 (324)
T 3mtl_A 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK--SLTLVFEY 81 (324)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS--CEEEEEEC
T ss_pred EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC--EEEEEecc
Confidence 4688888899999999999999999999864331 122234567999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
|. |+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++...... ..
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEEC-TTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEEC-CCCCEEEccCcccccccCCcccc
Confidence 97 5899888765 45999999999999999999999999 99999999999998 6689999999999865433 23
Q ss_pred ccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc---CCCCccc-----------
Q 006277 170 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS---GIKPAAL----------- 233 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~---g~~p~~l----------- 233 (652)
...+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.. .......+.. ...+..+
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-VEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 4568999999999774 468999999999999999999999998844 3333333322 1111111
Q ss_pred --------------cCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccccCC
Q 006277 234 --------------SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGT 272 (652)
Q Consensus 234 --------------~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~~~ 272 (652)
....++++++||.+||. +|.+|||+.|+|+||||.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 12357889999999998 8999999999999999986543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=362.01 Aligned_cols=249 Identities=29% Similarity=0.398 Sum_probs=216.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|.||+|.+..+|+.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.. .+|+||||
T Consensus 46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 122 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND--FVFVVLEL 122 (335)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEEEECC
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--eEEEEEec
Confidence 3567888889999999999999999999975433 34677889999999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--ccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~ 170 (652)
|.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...... ...
T Consensus 123 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (335)
T 2owb_A 123 CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKK 199 (335)
T ss_dssp CTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECCSTTCCBC
T ss_pred CCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEc-CCCCEEEeeccCceecccCccccc
Confidence 999999999998889999999999999999999999998 99999999999998 6789999999999876432 235
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
...||+.|+|||++. ..++.++|||||||++|+|++|..||.. ......+..+..+.. .++...++.+++||.+||
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l 276 (335)
T 2owb_A 200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPKHINPVAASLIQKML 276 (335)
T ss_dssp CCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHHT
T ss_pred ccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHhcCCC--CCCccCCHHHHHHHHHHc
Confidence 578999999999874 5689999999999999999999999977 455556666665532 344567899999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccc
Q 006277 250 V-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 250 ~-~P~~RpSa~elL~hpf~~~~ 270 (652)
. +|.+|||+.|+|+||||...
T Consensus 277 ~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 277 QTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp CSSGGGSCCGGGGGGSHHHHTS
T ss_pred cCChhHCcCHHHHhcCccccCC
Confidence 8 89999999999999999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=354.65 Aligned_cols=249 Identities=27% Similarity=0.428 Sum_probs=188.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.+..+|+.||+|++...... ..+..+++.+|+.+++.++||||+++++++.+.. .+++||||
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 92 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN--YVYLVLEM 92 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS--EEEEEEEC
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC--eEEEEEec
Confidence 35788888899999999999999999998743221 1123578999999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
+.+++|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...... ..
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~ 169 (278)
T 3cok_A 93 CHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKH 169 (278)
T ss_dssp CTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEEC-TTCCEEECCCTTCEECC------
T ss_pred CCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEEeecceeeccCCCCcc
Confidence 9999999999876 67999999999999999999999998 99999999999998 6789999999999876432 23
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
....||+.|+|||++. ..++.++|||||||++|+|++|..||....... ....+... ....+...++++++||.+|
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~li~~~ 246 (278)
T 3cok_A 170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-TLNKVVLA--DYEMPSFLSIEAKDLIHQL 246 (278)
T ss_dssp ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSS--CCCCCTTSCHHHHHHHHHH
T ss_pred eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-HHHHHhhc--ccCCccccCHHHHHHHHHH
Confidence 4568999999999774 468899999999999999999999997644332 22222221 1234556789999999999
Q ss_pred CC-CCCCCCCHHHHhcCcccccc
Q 006277 249 LV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~~~~ 270 (652)
|. +|.+|||+.++|+||||...
T Consensus 247 l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 247 LRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp SCSSGGGSCCHHHHTTSTTTC--
T ss_pred cccCHhhCCCHHHHhcCccccCC
Confidence 98 89999999999999999743
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=354.84 Aligned_cols=250 Identities=30% Similarity=0.458 Sum_probs=216.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.+..+|+.||+|++..... .....+++.+|+.++++++||||+++++++.+.. .+++||||
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 102 (287)
T 2wei_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMKLFEILEDSS--SFYIVGEL 102 (287)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB--SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEEEECC
T ss_pred eEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC--eEEEEEEc
Confidence 4678888889999999999999999999975433 2345678999999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC--CCcEEEeccCchhhhhccc-c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~--~g~VKL~DFGla~~l~~~~-~ 169 (652)
+.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.. ++.+||+|||++....... .
T Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 103 YTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 999999999988889999999999999999999999998 9999999999999743 3479999999998765432 3
Q ss_pred ccccCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc--CCCChHHHHHHHH
Q 006277 170 KSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS--KVKDPEVKSFIEK 247 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~--~~~s~~~kdlI~k 247 (652)
....||+.|+|||++.+.++.++|||||||++|+|++|..||.+ .+...+...+..+..+...+ ...++++++||.+
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 259 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259 (287)
T ss_dssp SCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHH
T ss_pred ccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHH
Confidence 45578999999999988899999999999999999999999987 56667777777765443332 4568899999999
Q ss_pred hCC-CCCCCCCHHHHhcCccccc
Q 006277 248 CLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~~~ 269 (652)
||. +|.+|||+.|+|+||||+.
T Consensus 260 ~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 260 MLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HTCSSGGGSCCHHHHHHSHHHHH
T ss_pred HcccChhhCcCHHHHhcCHHHhc
Confidence 998 8999999999999999974
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=363.80 Aligned_cols=245 Identities=21% Similarity=0.319 Sum_probs=203.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...|+++..|+||+|.+..+|+.||+|++... ..+++.+|+.+|++|. ||||+++++++.+......++|||
T Consensus 41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 41 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSC-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeccc-------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 45788888899999999999999999998632 3467889999999996 999999999998866668999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-ccc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAK 170 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~ 170 (652)
|+.+++|.+++. .+++..++.++.||+.||.|||++| |+||||||+|||++.+++.+||+|||++...... ...
T Consensus 114 ~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~ 188 (330)
T 3nsz_A 114 HVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 188 (330)
T ss_dssp CCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred ccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccc
Confidence 999999999875 4899999999999999999999999 9999999999999855558999999999876543 345
Q ss_pred cccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-------------CCC------
Q 006277 171 SVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-------------GIK------ 229 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-------------g~~------ 229 (652)
..+||+.|+|||++. ..|+.++|||||||++|+|++|..||............+.. ...
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (330)
T 3nsz_A 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 268 (330)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence 678999999999774 46899999999999999999999999654443332222111 100
Q ss_pred ----------------CccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 230 ----------------PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 230 ----------------p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+.......++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 011122368899999999998 8999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=352.58 Aligned_cols=248 Identities=23% Similarity=0.388 Sum_probs=205.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...++++..|+||+|.+..+|+.||+|++..... ...+..+++.+|+.+++.++||||+++++++.+.. .+|+||||
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 92 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT--DFFMVMEY 92 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEEEEEC
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccc-cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC--eEEEEEec
Confidence 3567778889999999999999999999875322 11234678899999999999999999999987654 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-ccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKS 171 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~~~ 171 (652)
+.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....... ...
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~ 169 (276)
T 2h6d_A 93 VSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRT 169 (276)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEEC-TTSCEEECCCCGGGCCCC------
T ss_pred cCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEEC-CCCCEEEeecccccccCCCcceec
Confidence 999999999998889999999999999999999999998 99999999999998 66899999999998765432 345
Q ss_pred ccCCCCccCccccccC-C-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 172 VIGTPEFMAPELYDEN-Y-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 172 ~vGTp~YmAPEvl~~~-y-~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
..||+.|+|||++.+. + +.++||||||+++|+|++|..||.. .....++..+..+..+ ++...+..+++||.+||
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l 246 (276)
T 2h6d_A 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFY--IPEYLNRSVATLLMHML 246 (276)
T ss_dssp -------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHT
T ss_pred ccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCccc--CchhcCHHHHHHHHHHc
Confidence 6899999999988653 3 6899999999999999999999977 5666777777766432 34567889999999999
Q ss_pred C-CCCCCCCHHHHhcCccccc
Q 006277 250 V-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 250 ~-~P~~RpSa~elL~hpf~~~ 269 (652)
. +|.+|||+.++++||||+.
T Consensus 247 ~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 247 QVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp CSSGGGSCCHHHHHHSHHHHT
T ss_pred cCChhhCCCHHHHHhChhhcc
Confidence 8 8999999999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=363.67 Aligned_cols=252 Identities=21% Similarity=0.328 Sum_probs=209.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..|++++.|+||+|.+..+|+.||+|++..... .......+.+|+.+++.+ .||||++++++|.+.. .+++||||
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~--~~~lv~e~ 110 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS--EIILILEY 110 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEEEEEEC
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC--eEEEEEEe
Confidence 468888899999999999999999999875432 234567889999999999 5699999999987654 79999999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC--CCCcEEEeccCchhhhhccc
Q 006277 93 FTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~--~~g~VKL~DFGla~~l~~~~ 168 (652)
|.+|+|.+++... +.+++..++.++.||+.||+|||++| |+||||||+|||++. ..+.+||+|||++.......
T Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 188 (327)
T 3lm5_A 111 AAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188 (327)
T ss_dssp CTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc
Confidence 9999999988543 67999999999999999999999998 999999999999984 26799999999998765432
Q ss_pred -cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC--CCccccCCCChHHHHH
Q 006277 169 -AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDPEVKSF 244 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~--~p~~l~~~~s~~~kdl 244 (652)
....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ ......+..+.... .+.......++.+++|
T Consensus 189 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 267 (327)
T 3lm5_A 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG-EDNQETYLNISQVNVDYSEETFSSVSQLATDF 267 (327)
T ss_dssp -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCchHHHHHHHhcccccCchhhcccCHHHHHH
Confidence 35678999999999874 5789999999999999999999999987 44555555555433 2333345678899999
Q ss_pred HHHhCC-CCCCCCCHHHHhcCccccccCC
Q 006277 245 IEKCLV-PASQRLSAKELLMDPFLQVNGT 272 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~hpf~~~~~~ 272 (652)
|.+||. +|.+|||+.++|+||||+...+
T Consensus 268 i~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 268 IQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp HHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred HHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 999998 8999999999999999986544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=358.11 Aligned_cols=248 Identities=30% Similarity=0.477 Sum_probs=203.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+|++++.|+||+|.+ +|..||+|++..... ..+..+++.+|+.+|++++||||+++++++.+.. .+++||||
T Consensus 42 ~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~ 115 (309)
T 3p86_A 42 KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP--NLSIVTEY 115 (309)
T ss_dssp EEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--CCEEEEEC
T ss_pred eeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--ceEEEEec
Confidence 35788888899999976 689999999875432 4567788999999999999999999999986554 68999999
Q ss_pred CCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 93 FTSGSLRQYRKKHKK---VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~---lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
|.+|+|.+++...+. +++..++.++.||+.||+|||++|++|+||||||+|||++ .++.+||+|||++.......
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~~~~~ 194 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFL 194 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC-TTCCEEECCCC----------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe-CCCcEEECCCCCCcccccccc
Confidence 999999999987654 9999999999999999999999987899999999999998 67899999999998654432
Q ss_pred -cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 169 -AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .+..+....+.........+...++++++||.
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 273 (309)
T 3p86_A 195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273 (309)
T ss_dssp -------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHH
T ss_pred ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHH
Confidence 35678999999999874 5689999999999999999999999987 55666666665554555667778899999999
Q ss_pred HhCC-CCCCCCCHHHHhc--Ccccc
Q 006277 247 KCLV-PASQRLSAKELLM--DPFLQ 268 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~--hpf~~ 268 (652)
+||. +|.+|||+.++++ .++++
T Consensus 274 ~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 274 GCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHccCChhhCcCHHHHHHHHHHHHH
Confidence 9998 8999999999987 46664
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=358.25 Aligned_cols=248 Identities=27% Similarity=0.456 Sum_probs=204.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCC----CCeEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQ----NKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~----~~~~~ 87 (652)
...|++++.|+||+|.+..+|+.||+|++.... ...+.+.+|+.+++++ +||||+++++++.... ...+|
T Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred EEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 457788888999999999999999999987542 2346788999999999 8999999999998743 45899
Q ss_pred EEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh
Q 006277 88 IITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~ 165 (652)
+|||||.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEEECCCTTTC---
T ss_pred EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEc-CCCCEEEeeCcCceecC
Confidence 999999999999999875 57999999999999999999999998 99999999999998 67899999999998765
Q ss_pred cc--ccccccCCCCccCccccc------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCC
Q 006277 166 QA--NAKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK 237 (652)
Q Consensus 166 ~~--~~~~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 237 (652)
.. ......||+.|+|||++. ..|+.++|||||||++|+|++|..||.+. ........+.....+.......
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPAPRLKSKKW 259 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCSCS
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHhhcCccccCCcccc
Confidence 43 234568999999999873 46889999999999999999999999874 4444444455554444445667
Q ss_pred ChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 238 DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 238 s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 260 ~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 260 SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 8999999999997 8999999999999999974
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=362.37 Aligned_cols=248 Identities=20% Similarity=0.301 Sum_probs=205.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.+..+|+.||+|++...... ...+.+.+|+++|++++||||+++++++.+.....+++||||
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 35778888899999999999999999998754432 336677899999999999999999999987776689999999
Q ss_pred CCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEE----cCCCCcEEEeccCchhhhh
Q 006277 93 FTSGSLRQYRKKHKK---VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI----NGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~---lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl----~~~~g~VKL~DFGla~~l~ 165 (652)
|.+|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||+ + ..+.+||+|||++..+.
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLTDFGAARELE 167 (319)
T ss_dssp CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTT-SCEEEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCC-CCceEEEccCCCceecC
Confidence 999999999986543 999999999999999999999998 9999999999998 4 45679999999998765
Q ss_pred ccc-cccccCCCCccCccccc---------cCCCccccchhhHHHHHHHhhccCCCCCCCC---HHHHHHHHhcCCCCc-
Q 006277 166 QAN-AKSVIGTPEFMAPELYD---------ENYNELADIYSFGMCMLEMVTFEYPYSECRN---SAQIYKKVSSGIKPA- 231 (652)
Q Consensus 166 ~~~-~~~~vGTp~YmAPEvl~---------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~---~~~i~~~I~~g~~p~- 231 (652)
... ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||..... ...+...+..+..+.
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence 443 35678999999999773 5789999999999999999999999964322 234444444433211
Q ss_pred ----------------------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcc
Q 006277 232 ----------------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPF 266 (652)
Q Consensus 232 ----------------------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf 266 (652)
.+....++.+.+||.+||. ||.+|||+.|+|+||-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 1112234578999999998 8999999999999984
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=365.51 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=201.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC------CCeEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ------NKTVN 87 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~------~~~~~ 87 (652)
..|++++.|+||+|.+..+|+.||+|++..... .......+.+|+.+|+.++||||+++++++.+.. .+.+|
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 100 (351)
T 3mi9_A 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 100 (351)
T ss_dssp EECSSCSTTSEEEEEETTTCCEEEEEECCCSSC--SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEE
T ss_pred EEEecCCCcEEEEEEECCCCCEEEEEEEecccc--cccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEE
Confidence 456666668999999999999999999865543 2234557789999999999999999999987653 34789
Q ss_pred EEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 88 IITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
+|||||.+ +|...+... +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+..
T Consensus 101 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~~~~~ 176 (351)
T 3mi9_A 101 LVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSL 176 (351)
T ss_dssp EEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCC
T ss_pred EEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCCEEEccchhcccccc
Confidence 99999975 777766554 67999999999999999999999998 99999999999998 678999999999987642
Q ss_pred c------ccccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc---CCCCccccC
Q 006277 167 A------NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS---GIKPAALSK 235 (652)
Q Consensus 167 ~------~~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~---g~~p~~l~~ 235 (652)
. .....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.. .......+.. ...+..++.
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 255 (351)
T 3mi9_A 177 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-EQHQLALISQLCGSITPEVWPN 255 (351)
T ss_dssp CSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhhccc
Confidence 1 234568999999999774 358999999999999999999999998744 4433333332 222221211
Q ss_pred C---------------------------CChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 236 V---------------------------KDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 236 ~---------------------------~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
. .++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 1 26789999999998 89999999999999999743
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=364.78 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=203.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..|++++.|+||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.. .+|+||||+
T Consensus 31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~ 106 (331)
T 4aaa_A 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK--RWYLVFEFV 106 (331)
T ss_dssp EEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEECC
T ss_pred eEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC--EEEEEEecC
Confidence 45666666899999999999999999987543 24556778899999999999999999999987654 799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAKS 171 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~~ 171 (652)
.+++|..++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+... ....
T Consensus 107 ~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 183 (331)
T 4aaa_A 107 DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDD 183 (331)
T ss_dssp SEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCTTC------------
T ss_pred CcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEc-CCCcEEEEeCCCceeecCCccccCC
Confidence 99999998888889999999999999999999999998 99999999999998 6689999999999876543 2356
Q ss_pred ccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-C------------------CCC
Q 006277 172 VIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-G------------------IKP 230 (652)
Q Consensus 172 ~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g------------------~~p 230 (652)
.+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+...+.. + ...
T Consensus 184 ~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
T 4aaa_A 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263 (331)
T ss_dssp CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCC
T ss_pred CcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccC
Confidence 789999999998754 6899999999999999999999999885554444433321 0 000
Q ss_pred c---------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 231 A---------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 231 ~---------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
. ......++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0 0112357899999999998 89999999999999999854
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.12 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=205.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC---CCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ---NKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~---~~~~~LV 89 (652)
...|++++.|+||+|.+..+|+.||+|++... ......+++.+|+++|++++||||+++++++.... ...+|+|
T Consensus 32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCeEEEEEEeccc---cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence 45788888899999999999999999998743 23566788999999999999999999999886542 2468999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
|||+. |+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 109 ~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 109 QDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp EECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCGGGC
T ss_pred EcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEEC-CCCCEEEEeCcceEecCCCCC
Confidence 99996 599998875 46999999999999999999999999 99999999999998 67899999999998765432
Q ss_pred ----cccccCCCCccCcccc-c-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CCCC-----------
Q 006277 169 ----AKSVIGTPEFMAPELY-D-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIKP----------- 230 (652)
Q Consensus 169 ----~~~~vGTp~YmAPEvl-~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~~p----------- 230 (652)
....+||+.|+|||++ . ..|+.++|||||||++|+|++|.+||.+......+...+.. +..+
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 263 (364)
T 3qyz_A 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263 (364)
T ss_dssp BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 2456899999999976 3 35899999999999999999999999875544433322211 0000
Q ss_pred ----------------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 231 ----------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 231 ----------------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
..+....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 01123457899999999998 89999999999999999854
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=354.76 Aligned_cols=247 Identities=29% Similarity=0.498 Sum_probs=205.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.+..+|+.||+|++.... ..+++.+|+.+++.++||||+++++++.+.. .+|+||||
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 105 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT--DLWIVMEY 105 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--EEEEEeec
Confidence 346667777999999999999999999987532 3467889999999999999999999988754 79999999
Q ss_pred CCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c
Q 006277 93 FTSGSLRQYRK-KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 169 (652)
Q Consensus 93 ~~gGsL~~~i~-~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~ 169 (652)
+.+|+|.+++. ....+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||++....... .
T Consensus 106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 182 (314)
T 3com_A 106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKR 182 (314)
T ss_dssp CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECBTTBSCB
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEEC-CCCCEEEeecccchhhhhhcccc
Confidence 99999999987 4568999999999999999999999998 99999999999998 56899999999997765432 3
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
....||+.|+|||++. ..|+.++|||||||++|+|++|..||........++............+...++.+++||.+|
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 262 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQC 262 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHH
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHH
Confidence 4568999999999774 468999999999999999999999998744444333333332222233455688999999999
Q ss_pred CC-CCCCCCCHHHHhcCcccccc
Q 006277 249 LV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~~~~ 270 (652)
|. +|.+|||+.++|+||||+..
T Consensus 263 l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 263 LVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp TCSCTTTSCCHHHHTTSHHHHTC
T ss_pred ccCChhhCcCHHHHHhCHHHhcC
Confidence 98 89999999999999999754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=373.29 Aligned_cols=247 Identities=21% Similarity=0.257 Sum_probs=199.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC----CCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD----QNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~----~~~~~~L 88 (652)
...|+++..|+||+|.+..+|+.||+|++..... ...+|+++|+.|+|||||+++++|... ...++++
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 4567888889999999999999999999874322 234699999999999999999988643 2235789
Q ss_pred EEecCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhh
Q 006277 89 ITELFTSGSLRQYRK----KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 164 (652)
Q Consensus 89 VmEy~~gGsL~~~i~----~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l 164 (652)
||||+.+ +|.+++. ....+++..++.++.||+.||.|||++| |+||||||+|||++.+.+.+||+|||+++.+
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 9999976 5655443 3578999999999999999999999998 9999999999999966678999999999876
Q ss_pred hcc-ccccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC-----------
Q 006277 165 EQA-NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP----------- 230 (652)
Q Consensus 165 ~~~-~~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p----------- 230 (652)
... .....+||+.|+|||++.+ .|+.++|||||||++|||++|.+||.+.....++.+.+.....|
T Consensus 208 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~ 287 (420)
T 1j1b_A 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287 (420)
T ss_dssp CTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred ccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 443 3456789999999997743 69999999999999999999999998865555554443310000
Q ss_pred ---cc------------ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 231 ---AA------------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 231 ---~~------------l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.. +....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 00 123457899999999998 89999999999999999743
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=353.30 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=206.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.+..+|+.||+|.+..... ...+..+++.+|+.++++++||||+++++++.+.. .+|+||||
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~ 92 (294)
T 4eqm_A 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD--CYYLVMEY 92 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS--EEEEEEEC
T ss_pred EEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC--eEEEEEeC
Confidence 4678888889999999999999999999875433 34677889999999999999999999999887554 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---~ 169 (652)
|.||+|.+++...+++++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+.... .
T Consensus 93 ~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (294)
T 4eqm_A 93 IEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILID-SNKTLKIFDFGIAKALSETSLTQT 169 (294)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCSSSTTC--------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEEeCCCcccccccccccc
Confidence 999999999999899999999999999999999999998 99999999999998 66899999999998765432 3
Q ss_pred ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC--ccccCCCChHHHHHHH
Q 006277 170 KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AALSKVKDPEVKSFIE 246 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p--~~l~~~~s~~~kdlI~ 246 (652)
...+||+.|+|||++ ...++.++|||||||++|+|++|..||.+........+.+...... .......++.+.++|.
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 249 (294)
T 4eqm_A 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVIL 249 (294)
T ss_dssp -----CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHH
T ss_pred CccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHH
Confidence 456899999999977 4568999999999999999999999998854444444444443322 2234557889999999
Q ss_pred HhCC-CCCCCCCHHHHhcCcccc
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
+||. +|.+||+..+.+.+.|..
T Consensus 250 ~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 250 RATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHhcCCHhHccccHHHHHHHHHH
Confidence 9998 899999766667777654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=370.74 Aligned_cols=249 Identities=30% Similarity=0.378 Sum_probs=187.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC----CCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ----NKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~----~~~~~LV 89 (652)
..|+++..|+||+|.+..+|+.||+|++.... .+....+++.+|+.+|+.|+||||+++++++.... ...+|+|
T Consensus 35 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv 112 (367)
T 2fst_X 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112 (367)
T ss_dssp EECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred eEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEE
Confidence 45566666899999999999999999986432 34567789999999999999999999999986532 2468999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 169 (652)
|||+ +++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++..... .
T Consensus 113 ~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kL~DFG~a~~~~~~-~ 186 (367)
T 2fst_X 113 THLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTADE-M 186 (367)
T ss_dssp EECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECC------------
T ss_pred eccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEEC-CCCCEEEeecccccccccc-C
Confidence 9999 7899988865 67999999999999999999999998 99999999999998 6789999999999876533 3
Q ss_pred ccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CCC-----------------
Q 006277 170 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIK----------------- 229 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~~----------------- 229 (652)
...+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.....++...+.. |..
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~ 266 (367)
T 2fst_X 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266 (367)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHH
T ss_pred CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHH
Confidence 4578999999999774 47899999999999999999999999885444433322211 110
Q ss_pred -------Cc---cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 230 -------PA---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 230 -------p~---~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+. ......++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 267 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 00 0112357889999999998 89999999999999999753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=349.19 Aligned_cols=246 Identities=34% Similarity=0.474 Sum_probs=203.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC----------
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ---------- 82 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~---------- 82 (652)
...++++..|+||+|.+..+|+.||+|.+... ....+.+.+|+.+++.++||||++++++|.+..
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 46788888899999999999999999998642 456788999999999999999999999987632
Q ss_pred -CCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCc
Q 006277 83 -NKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160 (652)
Q Consensus 83 -~~~~~LVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGl 160 (652)
...+|+|||||.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~ 162 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVKIGDFGL 162 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCCCC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEc-CCCCEEEeeCcc
Confidence 357899999999999999998654 6889999999999999999999998 99999999999998 678999999999
Q ss_pred hhhhhcc----------------ccccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHH
Q 006277 161 ATIMEQA----------------NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 222 (652)
Q Consensus 161 a~~l~~~----------------~~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~ 222 (652)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|++ ||........+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 9765421 1245679999999998753 68999999999999999998 6654344555666
Q ss_pred HHhcCC--CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 223 KVSSGI--KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 223 ~I~~g~--~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.+.... .+..+....++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred hccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 665543 3444555667889999999998 8999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=363.09 Aligned_cols=251 Identities=21% Similarity=0.294 Sum_probs=201.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQS-PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s-~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...|++++.|+||+|.+..+|+.||+|++........ ......+.+|+.+++.++||||++++++|.+.. .+++|||
T Consensus 15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 92 (346)
T 1ua2_A 15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NISLVFD 92 (346)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCEEEEE
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC--ceEEEEE
Confidence 3678888889999999999999999999875432111 112357889999999999999999999986554 7899999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 92 LFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 92 y~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
|+.+ +|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..+....
T Consensus 93 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~ 168 (346)
T 1ua2_A 93 FMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRA 168 (346)
T ss_dssp CCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCC
T ss_pred cCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEc-CCCCEEEEecccceeccCCccc
Confidence 9976 888888765 46999999999999999999999999 99999999999998 67899999999998775432
Q ss_pred cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc--CCC-Cccc----------
Q 006277 169 AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GIK-PAAL---------- 233 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~--g~~-p~~l---------- 233 (652)
....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+... ...+..+.. +.. ...+
T Consensus 169 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T 1ua2_A 169 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQWPDMCSLPDYV 247 (346)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence 35678999999999874 3589999999999999999999999987544 333333332 111 1111
Q ss_pred -------------cCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 234 -------------SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 234 -------------~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 13456899999999998 89999999999999999753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=366.32 Aligned_cols=242 Identities=25% Similarity=0.365 Sum_probs=204.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCC----HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQS----PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s----~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
..|+++..|+||+|.++.+|+.||+|.+........ .....++.+|+.+|+.++||||++++++|.+.. .+++|
T Consensus 30 ~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~--~~~lv 107 (335)
T 3dls_A 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG--FFQLV 107 (335)
T ss_dssp EECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS--EEEEE
T ss_pred eEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC--EEEEE
Confidence 456666678999999999999999999986543221 123456788999999999999999999987654 89999
Q ss_pred EecCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 90 TELFTSG-SLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 90 mEy~~gG-sL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
|||+.+| +|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+....
T Consensus 108 ~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~ 184 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIA-EDFTIKLIDFGSAAYLERGK 184 (335)
T ss_dssp EECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECCTTC
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEc-CCCcEEEeecccceECCCCC
Confidence 9999777 99999999999999999999999999999999998 99999999999998 57899999999998765433
Q ss_pred -cccccCCCCccCcccccc-CC-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 169 -AKSVIGTPEFMAPELYDE-NY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl~~-~y-~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
....+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||..... .... ....+...++++++||
T Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~--~~~~~~~~~~~l~~li 255 (335)
T 3dls_A 185 LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------TVEA--AIHPPYLVSKELMSLV 255 (335)
T ss_dssp CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GTTT--CCCCSSCCCHHHHHHH
T ss_pred ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------HHhh--ccCCCcccCHHHHHHH
Confidence 356789999999998743 44 7899999999999999999999976221 1111 1223445789999999
Q ss_pred HHhCC-CCCCCCCHHHHhcCccccc
Q 006277 246 EKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.+||. +|.+|||+.++|+||||+.
T Consensus 256 ~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 256 SGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp HHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred HHHccCChhhCcCHHHHhcCccccC
Confidence 99998 8999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=365.83 Aligned_cols=248 Identities=29% Similarity=0.383 Sum_probs=194.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC----CeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN----KTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~----~~~~L 88 (652)
...|++++.|+||+|.+..+|+.||+|++.... ......+++.+|+.+++.++||||+++++++..... ..+|+
T Consensus 30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~l 107 (371)
T 2xrw_A 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 107 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred eeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEE
Confidence 356777888999999999999999999987542 345677889999999999999999999999865431 37899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
|||||.+ +|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.......
T Consensus 108 v~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 108 VMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSF 181 (371)
T ss_dssp EEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCCCC--------
T ss_pred EEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEEEeeccccccccc
Confidence 9999965 7888875 46999999999999999999999998 99999999999998 67899999999998765432
Q ss_pred -cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc--cc-----------
Q 006277 169 -AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA--AL----------- 233 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~--~l----------- 233 (652)
....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.. ....+..+....... .+
T Consensus 182 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 260 (371)
T 2xrw_A 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-HIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260 (371)
T ss_dssp --------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHC-CCCCCHHHHTTSCHHHHHH
T ss_pred ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 35678999999999774 579999999999999999999999998844 444444443321100 00
Q ss_pred ---------------------c------CCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 234 ---------------------S------KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 234 ---------------------~------~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+ ...++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0 0014678999999998 8999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=371.28 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=186.9
Q ss_pred EEEEecCcEEEEEEEc--cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 15 RLIQLVDTSGYKAFDE--VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 15 rL~~l~~gtVykA~d~--~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
+|+++..|+||+|.++ .+++.||+|++..... ...+.+|+.+|+.|+|||||+++++|.+.....+|+||||
T Consensus 28 ~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~ 101 (405)
T 3rgf_A 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 101 (405)
T ss_dssp CCC-----EEEEEEESSSSCCCCEEEEECSSSSC------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEEC
T ss_pred EeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeC
Confidence 5888888999999966 5799999999864322 2467889999999999999999999987777799999999
Q ss_pred CCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEc---CCCCcEEEeccCc
Q 006277 93 FTSGSLRQYRKKH---------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN---GNQGEVKIGDLGL 160 (652)
Q Consensus 93 ~~gGsL~~~i~~~---------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~---~~~g~VKL~DFGl 160 (652)
+. |+|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+|||+. ...+.+||+|||+
T Consensus 102 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 102 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp CS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred CC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 96 5888877532 24999999999999999999999999 99999999999994 2567999999999
Q ss_pred hhhhhcc-----ccccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCC---------HHHHHHHH
Q 006277 161 ATIMEQA-----NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRN---------SAQIYKKV 224 (652)
Q Consensus 161 a~~l~~~-----~~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~---------~~~i~~~I 224 (652)
+..+... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+... ..++...+
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~ 258 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence 9876542 2356789999999997753 589999999999999999999999975332 12222221
Q ss_pred hc-CCCC-cccc---------------------------------CCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 225 SS-GIKP-AALS---------------------------------KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 225 ~~-g~~p-~~l~---------------------------------~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
.. |..+ ..+. ...++.+++||.+||. +|.+|||+.|+|+||||+
T Consensus 259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~ 338 (405)
T 3rgf_A 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL 338 (405)
T ss_dssp HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhc
Confidence 11 1111 0110 1126789999999998 899999999999999997
Q ss_pred cc
Q 006277 269 VN 270 (652)
Q Consensus 269 ~~ 270 (652)
..
T Consensus 339 ~~ 340 (405)
T 3rgf_A 339 ED 340 (405)
T ss_dssp SS
T ss_pred cC
Confidence 54
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=350.14 Aligned_cols=247 Identities=29% Similarity=0.467 Sum_probs=213.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+|++++.|+||+|.+..+|+.||+|++..... ....+++.+|+.+++.++||||+++++++.+.. .+++||||
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 101 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT--KLWIIMEY 101 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--eEEEEEEe
Confidence 4578888889999999999999999999975543 345788999999999999999999999998754 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
+.+++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+.... ..
T Consensus 102 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 177 (303)
T 3a7i_A 102 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRN 177 (303)
T ss_dssp CTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECBTTBCCBC
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEEC-CCCCEEEeecccceecCccccccC
Confidence 999999999864 57999999999999999999999998 99999999999998 66899999999998765432 35
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
...||+.|+|||++. ..++.++|||||||++|+|++|..||.. .........+..+.. ..+....++.+++||.+||
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l 255 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACL 255 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCC-CCCCSSCCHHHHHHHHHHC
T ss_pred ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC-cCHHHHHHHhhcCCC-CCCccccCHHHHHHHHHHc
Confidence 678999999999774 5689999999999999999999999987 455555555555443 3455667899999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccc
Q 006277 250 V-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 250 ~-~P~~RpSa~elL~hpf~~~~ 270 (652)
. +|.+|||+.++|+||||...
T Consensus 256 ~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 256 NKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CSSGGGSCCHHHHTTCHHHHHH
T ss_pred CCChhhCcCHHHHhhChhhhcC
Confidence 7 89999999999999999743
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.69 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=200.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC------------
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD------------ 81 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~------------ 81 (652)
..|++++.|+||+|.+..+|+.||+|++... ++...+++.+|+.++++++||||+++++++...
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 92 (320)
T 2i6l_A 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92 (320)
T ss_dssp EECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence 4566666789999999999999999998743 357788999999999999999999999987432
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCch
Q 006277 82 QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 161 (652)
Q Consensus 82 ~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla 161 (652)
....+|+||||+. |+|.+++.. +++++..++.++.||+.||+|||++| |+||||||+|||++..++.+||+|||++
T Consensus 93 ~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~Dfg~~ 168 (320)
T 2i6l_A 93 ELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLA 168 (320)
T ss_dssp SCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEEccCccc
Confidence 2357999999997 699998864 67999999999999999999999998 9999999999999866779999999999
Q ss_pred hhhhcc-----ccccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC----
Q 006277 162 TIMEQA-----NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP---- 230 (652)
Q Consensus 162 ~~l~~~-----~~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p---- 230 (652)
...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.. ....+..+......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~ 247 (320)
T 2i6l_A 169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH-ELEQMQLILESIPVVHEE 247 (320)
T ss_dssp BCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHSCCCCHH
T ss_pred cccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCchh
Confidence 876432 234567899999999763 578999999999999999999999998744 33333333322110
Q ss_pred ------------------------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 231 ------------------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 231 ------------------------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.......++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 248 DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred hhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 01223468899999999998 89999999999999999754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=366.22 Aligned_cols=249 Identities=24% Similarity=0.293 Sum_probs=199.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC----CCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ----NKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~----~~~~~L 88 (652)
...|++++.|+||+|.+..++. ||+|++...... ..+|+++|+.|+||||++++++|.... ..++|+
T Consensus 45 ~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 45 CKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 4567888889999999987776 888888643322 236999999999999999999986543 224889
Q ss_pred EEecCCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh
Q 006277 89 ITELFTSGSLRQY---RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 89 VmEy~~gGsL~~~---i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~ 165 (652)
|||||.++.+... ....+.+++..++.|+.||+.||.|||++| |+||||||+|||++..++.+||+|||+++.+.
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 9999987544332 334578999999999999999999999998 99999999999998667899999999998764
Q ss_pred cc-ccccccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC-------------
Q 006277 166 QA-NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK------------- 229 (652)
Q Consensus 166 ~~-~~~~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~------------- 229 (652)
.. .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.....++...+.....
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 43 3456789999999997743 5999999999999999999999999886555555443331100
Q ss_pred ---------C----ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccccCC
Q 006277 230 ---------P----AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGT 272 (652)
Q Consensus 230 ---------p----~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~~~ 272 (652)
+ ..+....++++++||.+||+ +|.+|||+.|+|+||||+...+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 0 01223467899999999998 8999999999999999986443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=353.12 Aligned_cols=248 Identities=26% Similarity=0.452 Sum_probs=185.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..+++++.|+||+|.+..+|+.||+|++..... ....+++.+|+.++++++||||+++++++.+.. .+++||||+
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 95 (303)
T 2vwi_A 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD--ELWLVMKLL 95 (303)
T ss_dssp EECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSS--CEEEEEECC
T ss_pred heeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC--CcEEEehhc
Confidence 456666668999999999999999998865432 345678899999999999999999999988765 699999999
Q ss_pred CCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh
Q 006277 94 TSGSLRQYRKK--------HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 94 ~gGsL~~~i~~--------~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~ 165 (652)
.+|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..+.
T Consensus 96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIADFGVSAFLA 172 (303)
T ss_dssp TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEEECCCHHHHHCC
T ss_pred cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEc-CCCCEEEEeccchheec
Confidence 99999999874 456999999999999999999999998 99999999999998 67899999999998764
Q ss_pred cc-------ccccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC------
Q 006277 166 QA-------NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP------ 230 (652)
Q Consensus 166 ~~-------~~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p------ 230 (652)
.. ......||+.|+|||++. ..++.++|||||||++|+|++|..||............+......
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC---
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccc
Confidence 32 124568999999999875 468999999999999999999999998755544444433332211
Q ss_pred -ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 231 -AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 231 -~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.......++++++||.+||. +|.+|||+.++++||||+.
T Consensus 253 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp --CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 12234567899999999998 8999999999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=376.14 Aligned_cols=243 Identities=16% Similarity=0.151 Sum_probs=194.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHH---HHHHhCCCCCeeeee-------eEEEeCC
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEV---HLLKSLKHNNIIRFY-------NSWIDDQ 82 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei---~iLk~L~HpnIVkl~-------~~~~d~~ 82 (652)
...|+++..|+||+|.+..+|+.||+|++..... ......+.+.+|+ ++|++++|||||+++ +++.+.+
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 156 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC--CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccc-cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence 4677888889999999999999999999985433 2345678899999 555566899999998 6655442
Q ss_pred C----------C-----eEEEEEecCCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCCCeeeccCC
Q 006277 83 N----------K-----TVNIITELFTSGSLRQYRKKHKKVDM-------KAVKGWARQILSGLIYLHSHDPPIIHRDLK 140 (652)
Q Consensus 83 ~----------~-----~~~LVmEy~~gGsL~~~i~~~~~lse-------~~i~~i~~QIl~aL~yLHs~g~~IiHRDLK 140 (652)
. . ..|+||||| +|+|.+++...+.+++ ..+..|+.||+.||+|||++| |+|||||
T Consensus 157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDik 233 (377)
T 3byv_A 157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLR 233 (377)
T ss_dssp SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCC
T ss_pred CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCC
Confidence 1 0 278999999 6899999987666666 788889999999999999999 9999999
Q ss_pred cccEEEcCCCCcEEEeccCchhhhhccccccccCCCCccCcccccc------------CCCccccchhhHHHHHHHhhcc
Q 006277 141 CDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDE------------NYNELADIYSFGMCMLEMVTFE 208 (652)
Q Consensus 141 p~NILl~~~~g~VKL~DFGla~~l~~~~~~~~vGTp~YmAPEvl~~------------~y~~~sDIWSlGvilyeLltG~ 208 (652)
|+|||++ .+|.+||+|||+++.... .....+| +.|+|||++.+ .|+.++|||||||++|+|++|.
T Consensus 234 p~NIll~-~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~ 310 (377)
T 3byv_A 234 PVDIVLD-QRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310 (377)
T ss_dssp GGGEEEC-TTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred HHHEEEc-CCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCC
Confidence 9999998 668999999999986443 3456788 99999998743 5999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 209 YPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 209 ~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.||.+... ......+.. .....++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 311 ~Pf~~~~~-~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 311 LPITKDAA-LGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp CCC-------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred CCCccccc-ccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99976322 222222221 124567899999999998 8999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=354.92 Aligned_cols=251 Identities=25% Similarity=0.331 Sum_probs=203.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC---CCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ---NKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~---~~~~~LV 89 (652)
...|++++.|+||+|.+..+|+.||+|++... ..+....++.+|+.+++.++||||+++++++.... ...+|+|
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 35778888899999999999999999998633 24566788899999999999999999999875431 2479999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
|||+. |+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+....
T Consensus 93 ~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 93 QELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp ECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECC----
T ss_pred EeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-CCCcEEEEecccccccccccc
Confidence 99996 589998876 57999999999999999999999998 99999999999998 67899999999998664221
Q ss_pred -----------cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CCCC----
Q 006277 169 -----------AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIKP---- 230 (652)
Q Consensus 169 -----------~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~~p---- 230 (652)
....+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+......+...... +..+
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence 23458999999999763 56899999999999999999999999875433332221110 0000
Q ss_pred ------------------------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccccC
Q 006277 231 ------------------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 271 (652)
Q Consensus 231 ------------------------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~~ 271 (652)
.......++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 01123567899999999998 899999999999999998543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=357.88 Aligned_cols=251 Identities=21% Similarity=0.330 Sum_probs=211.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCH-------------HHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSP-------------EDLERLYSEVHLLKSLKHNNIIRFYNSWI 79 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~-------------e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 79 (652)
...++++..|+||+|.+ +|+.||+|++......... ...+.+.+|+.++++|+||||+++++++.
T Consensus 36 ~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 113 (348)
T 2pml_X 36 IRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT 113 (348)
T ss_dssp EEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEE
T ss_pred EEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 35667777799999998 9999999999754322110 11278999999999999999999999987
Q ss_pred eCCCCeEEEEEecCCCCCHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCcccEEEcCCC
Q 006277 80 DDQNKTVNIITELFTSGSLRQY------RKK--HKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQ 150 (652)
Q Consensus 80 d~~~~~~~LVmEy~~gGsL~~~------i~~--~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IiHRDLKp~NILl~~~~ 150 (652)
+.. .+|+||||+.+|+|.++ +.. .+.+++..++.++.||+.||.|||+ +| |+||||||+|||++ .+
T Consensus 114 ~~~--~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~~-~~ 188 (348)
T 2pml_X 114 NYD--EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMD-KN 188 (348)
T ss_dssp SSS--EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEEC-TT
T ss_pred eCC--eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEEc-CC
Confidence 654 89999999999999998 665 5789999999999999999999999 88 99999999999998 67
Q ss_pred CcEEEeccCchhhhhccccccccCCCCccCcccccc--CCCc-cccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC
Q 006277 151 GEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDE--NYNE-LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG 227 (652)
Q Consensus 151 g~VKL~DFGla~~l~~~~~~~~vGTp~YmAPEvl~~--~y~~-~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g 227 (652)
+.+||+|||++............||+.|+|||++.+ .|+. ++|||||||++|+|++|..||........+...+..+
T Consensus 189 ~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~ 268 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268 (348)
T ss_dssp SCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC
T ss_pred CcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc
Confidence 899999999998776555667789999999998854 4666 9999999999999999999998866657788888776
Q ss_pred CCCccc-----------------cCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 228 IKPAAL-----------------SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 228 ~~p~~l-----------------~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
...... ....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 269 NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 433221 14578899999999998 89999999999999999754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=367.41 Aligned_cols=245 Identities=25% Similarity=0.336 Sum_probs=200.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC------CCCCeeeeeeEEEeCCCCeE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL------KHNNIIRFYNSWIDDQNKTV 86 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L------~HpnIVkl~~~~~d~~~~~~ 86 (652)
...|+++..|+||+|.+..+|+.||+|++... ......+.+|+.+++.+ +|+||++++++|.... .+
T Consensus 102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~--~~ 174 (429)
T 3kvw_A 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN--HI 174 (429)
T ss_dssp EEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT--EE
T ss_pred EEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC--eE
Confidence 35788888899999999999999999998632 34567788899988887 5779999999987764 89
Q ss_pred EEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCc--EEEeccCchh
Q 006277 87 NIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE--VKIGDLGLAT 162 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~--VKL~DFGla~ 162 (652)
++||||+. |+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++ .++. +||+|||++.
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~-~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLK-QQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEES-STTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-cCCCcceEEeecccce
Confidence 99999995 69999988764 4999999999999999999999998 99999999999998 4555 9999999997
Q ss_pred hhhccccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CCCCc---------
Q 006277 163 IMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIKPA--------- 231 (652)
Q Consensus 163 ~l~~~~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~~p~--------- 231 (652)
.... ...+.+||+.|+|||++ ...|+.++|||||||++|+|++|.+||.+......+...+.. +..+.
T Consensus 251 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~ 329 (429)
T 3kvw_A 251 YEHQ-RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA 329 (429)
T ss_dssp ETTC-CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTH
T ss_pred ecCC-cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhh
Confidence 6543 34567899999999976 457999999999999999999999999885444433322211 11000
Q ss_pred ----------------------------------------------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 232 ----------------------------------------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 232 ----------------------------------------------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.+....++++++||.+||. +|.+|||+.|+|+|
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRH 409 (429)
T ss_dssp HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCC
Confidence 0112237889999999998 89999999999999
Q ss_pred ccccc
Q 006277 265 PFLQV 269 (652)
Q Consensus 265 pf~~~ 269 (652)
|||+.
T Consensus 410 pw~~~ 414 (429)
T 3kvw_A 410 PWLRR 414 (429)
T ss_dssp TTTC-
T ss_pred hhhcc
Confidence 99974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=360.19 Aligned_cols=248 Identities=27% Similarity=0.354 Sum_probs=199.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC----eEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK----TVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~----~~~L 88 (652)
...|++++.|+||+|.+..+|+.||+|++.... .......++.+|+.+++.++||||+++++++...... .+|+
T Consensus 47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 124 (371)
T 4exu_A 47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 124 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred EeEEecCCCeEEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEE
Confidence 356788888999999999999999999987432 3456678999999999999999999999998765421 2499
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
||||+. |+|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 125 v~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~~~- 197 (371)
T 4exu_A 125 VMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLARHADAE- 197 (371)
T ss_dssp EEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECSTTCC-------
T ss_pred EEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEEC-CCCCEEEEecCcccccccC-
Confidence 999997 68888763 45999999999999999999999998 99999999999998 6789999999999866433
Q ss_pred cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CCCCc--------------
Q 006277 169 AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIKPA-------------- 231 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~~p~-------------- 231 (652)
....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+......+...+.. +..+.
T Consensus 198 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 277 (371)
T 4exu_A 198 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 277 (371)
T ss_dssp --CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHH
T ss_pred cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhh
Confidence 45678999999999774 47899999999999999999999999874443333332221 11100
Q ss_pred -------------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 232 -------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 232 -------------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
......++.+++||.+||. +|.+|||+.|+|+||||+.
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 278 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp HHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 1123457899999999998 8999999999999999974
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=338.89 Aligned_cols=242 Identities=19% Similarity=0.282 Sum_probs=204.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...+++++.|+||+|.+. |..||+|++..... +....+++.+|+.++++++||||+++++++.+.....+++||||
T Consensus 15 ~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp EEEEEEETTEEEEEEEET--TEEEEEEEECCTTC--CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred HHHhcCCCcceEEEEEEC--CeeEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 468888888999999984 89999999876532 45677889999999999999999999999887655689999999
Q ss_pred CCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccc
Q 006277 93 FTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~ 170 (652)
+.+|+|.+++...+ .+++..++.++.||+.||.|||+++++|+||||||+|||++ .+|.++|+|||++.... ..
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~-~~~~~~l~~~~~~~~~~---~~ 166 (271)
T 3kmu_A 91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQ---SP 166 (271)
T ss_dssp CTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC-TTSCEEEEGGGSCCTTS---CT
T ss_pred cCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc-CCcceeEEeccceeeec---cc
Confidence 99999999998765 48999999999999999999999988899999999999998 67889999888875432 34
Q ss_pred cccCCCCccCcccccc-CC---CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 171 SVIGTPEFMAPELYDE-NY---NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~~-~y---~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
...||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.. .......+.........+...++++++||.
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 245 (271)
T 3kmu_A 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKVALEGLRPTIPPGISPHVSKLMK 245 (271)
T ss_dssp TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-HHHHHHHHHHSCCCCCCCTTCCHHHHHHHH
T ss_pred CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-hHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 5678999999998753 23 347999999999999999999998744 444444444443444566678899999999
Q ss_pred HhCC-CCCCCCCHHHHhc
Q 006277 247 KCLV-PASQRLSAKELLM 263 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~ 263 (652)
+||. +|.+|||+.++++
T Consensus 246 ~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 246 ICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 9998 8999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=349.05 Aligned_cols=247 Identities=24% Similarity=0.410 Sum_probs=206.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC--CCCeeeeeeEEEeCCCCeEEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK--HNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~--HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
...|+++..|+||+|.+. +|+.||+|++..... .....+++.+|+.++++++ ||||+++++++.+.. .+++||
T Consensus 33 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~--~~~lv~ 107 (313)
T 3cek_A 33 LKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--YIYMVM 107 (313)
T ss_dssp EEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS--EEEEEE
T ss_pred EEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEEEeecCC--EEEEEE
Confidence 346677777999999985 599999999976543 4567889999999999996 599999999887654 799999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
| +.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|||++..+....
T Consensus 108 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~--~~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 108 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp C-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECCCSSSCC-------
T ss_pred e-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE--CCeEEEeeccccccccCcccc
Confidence 9 568899999999999999999999999999999999998 99999999999997 3799999999998765432
Q ss_pred --cccccCCCCccCcccccc------------CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc
Q 006277 169 --AKSVIGTPEFMAPELYDE------------NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS 234 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl~~------------~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 234 (652)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||............+........++
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc
Confidence 245689999999998753 688999999999999999999999987666655555665555455566
Q ss_pred CCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 235 KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 235 ~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
...+.++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 263 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 6678899999999998 8999999999999999974
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=340.43 Aligned_cols=246 Identities=27% Similarity=0.368 Sum_probs=193.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...+++++.|+||+|.+. |..||+|++............+.+.+|+.+++.++||||+++++++.+.. .+++||||
T Consensus 12 ~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 87 (271)
T 3dtc_A 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP--NLCLVMEF 87 (271)
T ss_dssp EEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----CEEEEEC
T ss_pred eeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC--ceEEEEEc
Confidence 468899999999999974 89999999876543333345678999999999999999999999986554 78999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CeeeccCCcccEEEcC-------CCCcEEEeccCchhhh
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP-PIIHRDLKCDNIFING-------NQGEVKIGDLGLATIM 164 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~-~IiHRDLKp~NILl~~-------~~g~VKL~DFGla~~l 164 (652)
+.+|+|.+++. .+.+++..++.++.||+.||.|||++|. +|+||||||+|||++. .++.+||+|||++...
T Consensus 88 ~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~ 166 (271)
T 3dtc_A 88 ARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW 166 (271)
T ss_dssp CTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----
T ss_pred CCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccc
Confidence 99999999885 5689999999999999999999999873 3889999999999974 2678999999999887
Q ss_pred hccccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHH
Q 006277 165 EQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 243 (652)
Q Consensus 165 ~~~~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kd 243 (652)
.........||+.|+|||++. ..++.++|||||||++|+|++|..||.+. ........+.........+...++.+++
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (271)
T 3dtc_A 167 HRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGVAMNKLALPIPSTCPEPFAK 245 (271)
T ss_dssp ---------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS-CHHHHHHHHHTSCCCCCCCTTCCHHHHH
T ss_pred ccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHhhhcCCCCCCCCcccCHHHHH
Confidence 666556778999999999774 56899999999999999999999999874 4444444555555455566777899999
Q ss_pred HHHHhCC-CCCCCCCHHHHhcC
Q 006277 244 FIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~h 264 (652)
||.+||. +|.+|||+.|++++
T Consensus 246 li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 246 LMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCcccCcCHHHHHHH
Confidence 9999998 89999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=355.66 Aligned_cols=250 Identities=22% Similarity=0.240 Sum_probs=190.4
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC-----CCeEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ-----NKTVNI 88 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~-----~~~~~L 88 (652)
..|++++.|+||+|.+..+|+.||+|++..... ...+..+|++.++.++||||++++++|.... ..++++
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l 103 (360)
T 3e3p_A 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV 103 (360)
T ss_dssp ----------CEEEEETTTCCEEEEEEEECCTT-----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-----ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence 577888889999999999999999999865432 2345677888899999999999999987533 224889
Q ss_pred EEecCCCCCHHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 89 ITELFTSGSLRQY----RKKHKKVDMKAVKGWARQILSGLIYLH--SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 89 VmEy~~gGsL~~~----i~~~~~lse~~i~~i~~QIl~aL~yLH--s~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
|||||.++ |... ......+++..++.++.||+.||.||| ++| |+||||||+|||++..++.+||+|||++.
T Consensus 104 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 104 VMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred Eeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 99999875 4333 335678999999999999999999999 777 99999999999998557899999999998
Q ss_pred hhhccc-cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc--------
Q 006277 163 IMEQAN-AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA-------- 231 (652)
Q Consensus 163 ~l~~~~-~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~-------- 231 (652)
.+.... ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+......+...+.....+.
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcc
Confidence 775443 35678999999999773 3489999999999999999999999988444333333222100000
Q ss_pred ---------------------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccccC
Q 006277 232 ---------------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 271 (652)
Q Consensus 232 ---------------------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~~ 271 (652)
......++++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 0011145789999999998 899999999999999998543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=357.29 Aligned_cols=244 Identities=23% Similarity=0.337 Sum_probs=207.8
Q ss_pred EEEEEEecCcEEEEEE-----EccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeE
Q 006277 13 YLRLIQLVDTSGYKAF-----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTV 86 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~-----d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~ 86 (652)
...|++++.|.||+|. +..+|+.||+|++.... .....+++.+|+++|+++ +||||++++++|.+.. ..+
T Consensus 27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-~~~ 102 (359)
T 3vhe_A 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-GPL 102 (359)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-SCC
T ss_pred ceeecCCCCceEEEEEeccccccccceEEEEEEecCcC---CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC-Cce
Confidence 3577788889999999 66788999999986432 356678899999999999 8999999999987644 368
Q ss_pred EEEEecCCCCCHHHHHHhCCC-----------------------------------------------------------
Q 006277 87 NIITELFTSGSLRQYRKKHKK----------------------------------------------------------- 107 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~~~~----------------------------------------------------------- 107 (652)
++|||||.+|+|.+++.....
T Consensus 103 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (359)
T 3vhe_A 103 MVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182 (359)
T ss_dssp EEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------------
T ss_pred EEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccc
Confidence 999999999999999987543
Q ss_pred -------CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc----ccccccCCC
Q 006277 108 -------VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----NAKSVIGTP 176 (652)
Q Consensus 108 -------lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~----~~~~~vGTp 176 (652)
+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+... ......||+
T Consensus 183 ~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~ 259 (359)
T 3vhe_A 183 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259 (359)
T ss_dssp -CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred cchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCcEEEEeccceeeecccccchhccccCCCc
Confidence 899999999999999999999998 99999999999998 6789999999999866432 234567899
Q ss_pred CccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCC
Q 006277 177 EFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PAS 253 (652)
Q Consensus 177 ~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~ 253 (652)
.|+|||++ ...|+.++|||||||++|+|++ |..||.+......+...+..+.. ...+...++++.+||.+||. +|.
T Consensus 260 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~ 338 (359)
T 3vhe_A 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPS 338 (359)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred eeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHccCChh
Confidence 99999977 5679999999999999999998 99999886666777777766543 33456678999999999998 899
Q ss_pred CCCCHHHHhcC
Q 006277 254 QRLSAKELLMD 264 (652)
Q Consensus 254 ~RpSa~elL~h 264 (652)
+|||+.|+++|
T Consensus 339 ~Rps~~ell~~ 349 (359)
T 3vhe_A 339 QRPTFSELVEH 349 (359)
T ss_dssp GSCCHHHHHHH
T ss_pred hCCCHHHHHHH
Confidence 99999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=360.51 Aligned_cols=247 Identities=25% Similarity=0.332 Sum_probs=196.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC--------CCCeeeeeeEEEeC--C
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK--------HNNIIRFYNSWIDD--Q 82 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~--------HpnIVkl~~~~~d~--~ 82 (652)
...|++++.|+||+|.+..+|+.||+|++.. .....+++.+|+.+|+.+. ||||++++++|... .
T Consensus 42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~ 116 (397)
T 1wak_A 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116 (397)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred EEEeeecCCeeEEEEEecCCCeEEEEEEEec-----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence 3577888889999999999999999999863 2456788999999999995 78899999998732 3
Q ss_pred CCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCcccEEEcCCC---------
Q 006277 83 NKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQ--------- 150 (652)
Q Consensus 83 ~~~~~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~-g~~IiHRDLKp~NILl~~~~--------- 150 (652)
...+|+||||+ +|+|.+++... +.+++..++.++.||+.||.|||++ | |+||||||+|||++.++
T Consensus 117 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 117 GTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp EEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhhhhhhh
Confidence 44799999999 66777766554 5699999999999999999999998 8 99999999999998432
Q ss_pred ---------------------------------------CcEEEeccCchhhhhccccccccCCCCccCcccc-ccCCCc
Q 006277 151 ---------------------------------------GEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENYNE 190 (652)
Q Consensus 151 ---------------------------------------g~VKL~DFGla~~l~~~~~~~~vGTp~YmAPEvl-~~~y~~ 190 (652)
..+||+|||++...... ....+||+.|+|||++ ...|+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ 272 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVLIGSGYNT 272 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHHHTSCCCT
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChhhcCCCCCc
Confidence 27999999999876543 4556899999999977 456999
Q ss_pred cccchhhHHHHHHHhhccCCCCCCCC-----HHHHHHHHhc--CCCCc--------------------------------
Q 006277 191 LADIYSFGMCMLEMVTFEYPYSECRN-----SAQIYKKVSS--GIKPA-------------------------------- 231 (652)
Q Consensus 191 ~sDIWSlGvilyeLltG~~Pf~~~~~-----~~~i~~~I~~--g~~p~-------------------------------- 231 (652)
++|||||||++|+|++|.+||..... .......+.. +..|.
T Consensus 273 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (397)
T 1wak_A 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE 352 (397)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence 99999999999999999999975332 1111111111 11110
Q ss_pred ------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 232 ------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 232 ------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
.++...++.+++||.+||. +|.+|||+.|+|+||||+
T Consensus 353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0111223578899999998 899999999999999996
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=353.58 Aligned_cols=238 Identities=25% Similarity=0.373 Sum_probs=198.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
-..|++++.|+||+|.+..+|+.||+|.+.. .+.+..+.+.+|+++|++|+||||+++++++.+.. .+++||||
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~ 88 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK--RLNFITEY 88 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESC----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC--eeEEEEEe
Confidence 3567778889999999999999999998753 24677889999999999999999999999998764 79999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc--
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-- 169 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~-- 169 (652)
|.+|+|.+++.. .+.+++..+..++.||+.||+|||++| |+||||||+|||++ .++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEC-TTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEEC-CCCCEEEeecccceecccccccc
Confidence 999999999987 567999999999999999999999999 99999999999998 678999999999986543211
Q ss_pred --------------ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHH----HHHHHhcCCCC
Q 006277 170 --------------KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ----IYKKVSSGIKP 230 (652)
Q Consensus 170 --------------~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~----i~~~I~~g~~p 230 (652)
...+||+.|+|||++. ..|+.++|||||||++|+|++|..||........ .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~---- 241 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD---- 241 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH----
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc----
Confidence 2568999999999775 5689999999999999999999999865322110 0011111
Q ss_pred ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 231 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 231 ~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
...+...++.+.+||.+||. +|.+|||+.++++
T Consensus 242 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11234567889999999998 8999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=361.07 Aligned_cols=252 Identities=14% Similarity=0.115 Sum_probs=186.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC--CCCCeeeee-------eEEEeCCC
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL--KHNNIIRFY-------NSWIDDQN 83 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L--~HpnIVkl~-------~~~~d~~~ 83 (652)
...|++++.|+||+|.+..+|+.||+|++..... ......+.+.+|+.+++.| +||||++++ +++.....
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTS
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCC
Confidence 4567777789999999999999999999986543 2345677888886555555 699988765 44443322
Q ss_pred ---------------CeEEEEEecCCCCCHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCeeeccCCc
Q 006277 84 ---------------KTVNIITELFTSGSLRQYRKKH-KKVDMKAV------KGWARQILSGLIYLHSHDPPIIHRDLKC 141 (652)
Q Consensus 84 ---------------~~~~LVmEy~~gGsL~~~i~~~-~~lse~~i------~~i~~QIl~aL~yLHs~g~~IiHRDLKp 141 (652)
..+|+|||||. |+|.+++... ..+.+..+ ..++.||+.||+|||++| |+||||||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHrDikp 222 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTP 222 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEETTCSG
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccCcCCH
Confidence 35899999998 8999999864 34444455 567799999999999999 99999999
Q ss_pred ccEEEcCCCCcEEEeccCchhhhhccccccccCCCCccCccccc---cCCCccccchhhHHHHHHHhhccCCCCCCCCHH
Q 006277 142 DNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYSECRNSA 218 (652)
Q Consensus 142 ~NILl~~~~g~VKL~DFGla~~l~~~~~~~~vGTp~YmAPEvl~---~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~ 218 (652)
+|||++ .+|.+||+|||+++...... ....||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.....
T Consensus 223 ~NIll~-~~~~~kL~DFG~a~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 300 (371)
T 3q60_A 223 DNLFIM-PDGRLMLGDVSALWKVGTRG-PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300 (371)
T ss_dssp GGEEEC-TTSCEEECCGGGEEETTCEE-EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC
T ss_pred HHEEEC-CCCCEEEEecceeeecCCCc-cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc
Confidence 999998 67899999999998765432 2456679999999875 468999999999999999999999997742211
Q ss_pred -HHHHH---HhcCC--CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 219 -QIYKK---VSSGI--KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 219 -~i~~~---I~~g~--~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
..+.. ..... .........++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 00000 00111 1112224568999999999998 89999999999999999743
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.34 Aligned_cols=247 Identities=27% Similarity=0.360 Sum_probs=198.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC----CeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN----KTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~----~~~~L 88 (652)
...+++++.|+||+|.++.+|+.||+|++.... ......+++.+|+.+++.++||||+++++++.+... ..+|+
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 106 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 106 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEE
Confidence 356777778999999999999999999986432 345667889999999999999999999999876542 13699
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
||||+. |+|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 107 v~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~- 179 (353)
T 3coi_A 107 VMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLARHADAE- 179 (353)
T ss_dssp EEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTCCEEECSTTCTTC-----
T ss_pred Eecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeEC-CCCcEEEeecccccCCCCC-
Confidence 999997 58887764 36999999999999999999999998 99999999999998 6789999999999865432
Q ss_pred cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc--CCC---------------
Q 006277 169 AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GIK--------------- 229 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~--g~~--------------- 229 (652)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+...... ...+.. +..
T Consensus 180 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~ 258 (353)
T 3coi_A 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQKLNDKAAKS 258 (353)
T ss_dssp ----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence 34568999999999774 4689999999999999999999999987443333 322221 000
Q ss_pred ---------C---ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 230 ---------P---AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 230 ---------p---~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
. .......++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0 11223467899999999998 8999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=354.48 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=196.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeeccc-------CCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC---C
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDV-------LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD---Q 82 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~-------~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~---~ 82 (652)
...|+++..|+||+|.+.. |..||+|++..... .......+++.+|+.+|++++||||+++++++... .
T Consensus 27 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA 105 (362)
T ss_dssp EEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTT
T ss_pred eEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCC
Confidence 3678888899999999865 99999999865322 22344568999999999999999999999998653 3
Q ss_pred CCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCch
Q 006277 83 NKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 161 (652)
Q Consensus 83 ~~~~~LVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla 161 (652)
...+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++
T Consensus 106 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~ 181 (362)
T 3pg1_A 106 MHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLA-DNNDITICDFNLA 181 (362)
T ss_dssp CCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCTTC-
T ss_pred cceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEc-CCCCEEEEecCcc
Confidence 347899999997 5888887654 47999999999999999999999998 99999999999998 6789999999999
Q ss_pred hhhhccc-cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CCCC-------
Q 006277 162 TIMEQAN-AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIKP------- 230 (652)
Q Consensus 162 ~~l~~~~-~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~~p------- 230 (652)
....... ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+... ......+.. ...+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~ 260 (362)
T 3pg1_A 182 REDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF-YNQLNKIVEVVGTPKIEDVVM 260 (362)
T ss_dssp --------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCHHHHHH
T ss_pred cccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChHHhhh
Confidence 8654432 35578999999999774 4689999999999999999999999987443 333333321 0000
Q ss_pred ----------------------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 231 ----------------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 231 ----------------------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.......++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp TSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred ccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 01123457889999999998 89999999999999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=357.59 Aligned_cols=247 Identities=23% Similarity=0.307 Sum_probs=199.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CC-----CeeeeeeEEEeCCCCeE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HN-----NIIRFYNSWIDDQNKTV 86 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-Hp-----nIVkl~~~~~d~~~~~~ 86 (652)
...|+++..|+||+|.+..+|+.||+|++... ......+..|+.+++.+. |+ +|+++++++.... .+
T Consensus 59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~--~~ 131 (382)
T 2vx3_A 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN--HL 131 (382)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT--EE
T ss_pred EEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC--ce
Confidence 35788888899999999999999999998632 455677888999999884 55 4999999988764 89
Q ss_pred EEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC-CCCcEEEeccCchhh
Q 006277 87 NIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING-NQGEVKIGDLGLATI 163 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~-~~g~VKL~DFGla~~ 163 (652)
|+||||+. |+|.+++... +.+++..++.++.||+.||.|||++..+|+||||||+|||++. ..+.+||+|||++..
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 99999995 5999998876 4699999999999999999999965445999999999999962 467899999999987
Q ss_pred hhccccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc--CCCCccccC-----
Q 006277 164 MEQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GIKPAALSK----- 235 (652)
Q Consensus 164 l~~~~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~--g~~p~~l~~----- 235 (652)
.... ....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.... .....+.. +..+..+..
T Consensus 211 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~ 288 (382)
T 2vx3_A 211 LGQR-IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV-DQMNKIVEVLGIPPAHILDQAPKA 288 (382)
T ss_dssp TTCC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred cccc-cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhhHHH
Confidence 6532 45678999999999774 57999999999999999999999999874443 33333332 111100000
Q ss_pred ----------------------------C---------------------------CChHHHHHHHHhCC-CCCCCCCHH
Q 006277 236 ----------------------------V---------------------------KDPEVKSFIEKCLV-PASQRLSAK 259 (652)
Q Consensus 236 ----------------------------~---------------------------~s~~~kdlI~kcL~-~P~~RpSa~ 259 (652)
. .++++++||.+||. ||.+|||+.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~ 368 (382)
T 2vx3_A 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY 368 (382)
T ss_dssp HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHH
T ss_pred HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHH
Confidence 0 01378999999998 899999999
Q ss_pred HHhcCccccc
Q 006277 260 ELLMDPFLQV 269 (652)
Q Consensus 260 elL~hpf~~~ 269 (652)
|+|+||||+.
T Consensus 369 e~L~hp~f~~ 378 (382)
T 2vx3_A 369 YALQHSFFKK 378 (382)
T ss_dssp HHTTSGGGCC
T ss_pred HHhcCccccc
Confidence 9999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=344.73 Aligned_cols=252 Identities=27% Similarity=0.365 Sum_probs=202.3
Q ss_pred EEEEEEecCcEEEEEEEc-cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC---CCCCeeeeeeEEEe---CCCCe
Q 006277 13 YLRLIQLVDTSGYKAFDE-VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL---KHNNIIRFYNSWID---DQNKT 85 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~-~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L---~HpnIVkl~~~~~d---~~~~~ 85 (652)
...|+++..|+||+|.+. .+|+.||+|++...... ......+.+|+.+++.+ +||||+++++++.. .....
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 93 (326)
T 1blx_A 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT--TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred eeeecccccEEEEEEEecCCCCEEEEEEEeccCccc--ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCce
Confidence 467888888999999995 68999999999765421 11223455677777666 89999999998862 13347
Q ss_pred EEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 86 VNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 86 ~~LVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
+++||||+. |+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..
T Consensus 94 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 94 LTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARI 169 (326)
T ss_dssp EEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECSCCSCCC
T ss_pred EEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEc-CCCCEEEecCccccc
Confidence 999999997 69999998754 4999999999999999999999998 99999999999998 678999999999987
Q ss_pred hhcc-ccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC--CC----------
Q 006277 164 MEQA-NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IK---------- 229 (652)
Q Consensus 164 l~~~-~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g--~~---------- 229 (652)
.... ......||+.|+|||++ ...|+.++|||||||++|+|++|.+||.+..... ....+... ..
T Consensus 170 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 248 (326)
T 1blx_A 170 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDWPRDVA 248 (326)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCGGGSCTTCS
T ss_pred ccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCcccCccccc
Confidence 6543 24567899999999976 4578999999999999999999999998754433 33333321 00
Q ss_pred -------------CccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccccC
Q 006277 230 -------------PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 271 (652)
Q Consensus 230 -------------p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~~ 271 (652)
...+....++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 011224567899999999998 899999999999999997543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.18 Aligned_cols=245 Identities=21% Similarity=0.303 Sum_probs=199.7
Q ss_pred EEEEEEecCcEEEEEEE-ccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC------eeeeeeEEEeCCCCe
Q 006277 13 YLRLIQLVDTSGYKAFD-EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN------IIRFYNSWIDDQNKT 85 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d-~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hpn------IVkl~~~~~d~~~~~ 85 (652)
...|+++..|+||+|.+ ..+|+.||+|++... ....+.+.+|+++++.++|++ |+++++++.+.. .
T Consensus 19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~--~ 91 (339)
T 1z57_A 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG--H 91 (339)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT--E
T ss_pred EEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC--c
Confidence 45788888899999999 568999999998632 456778899999999997654 999999987665 8
Q ss_pred EEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC--------------
Q 006277 86 VNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN-------------- 149 (652)
Q Consensus 86 ~~LVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~-------------- 149 (652)
+++||||| +++|.+++...+ .+++..++.++.||+.||+|||++| |+||||||+|||++..
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCcccccc
Confidence 99999999 889999998775 6899999999999999999999998 9999999999999842
Q ss_pred ----CCcEEEeccCchhhhhccccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 006277 150 ----QGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 224 (652)
Q Consensus 150 ----~g~VKL~DFGla~~l~~~~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I 224 (652)
++.+||+|||++..... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||..... ......+
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~~ 246 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS-KEHLAMM 246 (339)
T ss_dssp EEESCCCEEECCCSSCEETTS-CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH-HHHHHHH
T ss_pred ccccCCCceEeeCcccccCcc-ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHH
Confidence 56799999999976543 245678999999999774 5799999999999999999999999987433 3322222
Q ss_pred hc--CCCCcc----------------------------------------ccCCCChHHHHHHHHhCC-CCCCCCCHHHH
Q 006277 225 SS--GIKPAA----------------------------------------LSKVKDPEVKSFIEKCLV-PASQRLSAKEL 261 (652)
Q Consensus 225 ~~--g~~p~~----------------------------------------l~~~~s~~~kdlI~kcL~-~P~~RpSa~el 261 (652)
.. +..|.. .....++++.+||.+||. +|.+|||+.|+
T Consensus 247 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 326 (339)
T 1z57_A 247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA 326 (339)
T ss_dssp HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence 11 111110 011124678999999998 89999999999
Q ss_pred hcCccccc
Q 006277 262 LMDPFLQV 269 (652)
Q Consensus 262 L~hpf~~~ 269 (652)
|+||||+.
T Consensus 327 l~hp~f~~ 334 (339)
T 1z57_A 327 LKHPFFDL 334 (339)
T ss_dssp TTSGGGGG
T ss_pred hcCHHHHH
Confidence 99999974
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=338.74 Aligned_cols=244 Identities=23% Similarity=0.352 Sum_probs=202.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHH---HHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDL---ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~---~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
..|++++.|+||+|.+..+|+.||+|++............ +++.+|+.++++++||||+++++++.+. .++||
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~~lv~ 100 (287)
T 4f0f_A 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP----PRMVM 100 (287)
T ss_dssp EECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT----TEEEE
T ss_pred hccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC----CeEEE
Confidence 4677777799999999999999999998765443332222 7899999999999999999999987543 27999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCc-----EEEeccCchhhh
Q 006277 91 ELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE-----VKIGDLGLATIM 164 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~-----VKL~DFGla~~l 164 (652)
||+.+|+|.+++... ..+++..++.++.||+.||.|||++|++|+||||||+|||++. ++. +||+|||++...
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~-~~~~~~~~~kl~Dfg~~~~~ 179 (287)
T 4f0f_A 101 EFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQS-LDENAPVCAKVADFGLSQQS 179 (287)
T ss_dssp ECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESC-CCTTCSCCEEECCCTTCBCC
T ss_pred EecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEec-cCCCCceeEEeCCCCccccc
Confidence 999999999888655 4799999999999999999999999877999999999999973 344 999999999754
Q ss_pred hccccccccCCCCccCccccc---cCCCccccchhhHHHHHHHhhccCCCCCCCCHH-HHHHHHhcCCCCccccCCCChH
Q 006277 165 EQANAKSVIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYSECRNSA-QIYKKVSSGIKPAALSKVKDPE 240 (652)
Q Consensus 165 ~~~~~~~~vGTp~YmAPEvl~---~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~-~i~~~I~~g~~p~~l~~~~s~~ 240 (652)
.. ......||+.|+|||++. ..|+.++|||||||++|+|++|..||....... .....+.....+...+...+++
T Consensus 180 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (287)
T 4f0f_A 180 VH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPR 258 (287)
T ss_dssp SS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred cc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHH
Confidence 33 235578999999999873 357899999999999999999999997754433 3344444444455566778899
Q ss_pred HHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 241 VKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 241 ~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
+++||.+||. +|.+|||+.++++
T Consensus 259 l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 259 LRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999998 8999999999985
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=358.11 Aligned_cols=241 Identities=27% Similarity=0.402 Sum_probs=204.6
Q ss_pred EEEEEecCcEEEEEEEc-------cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 006277 14 LRLIQLVDTSGYKAFDE-------VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 85 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~-------~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~ 85 (652)
..|++++.|+||+|.+. .++..||+|+++... .....+++.+|+.+|+.+ +||||+++++++.+.. .
T Consensus 87 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~--~ 161 (370)
T 2psq_A 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG--P 161 (370)
T ss_dssp EEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS--S
T ss_pred eEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC--C
Confidence 45666777999999975 467789999986432 356778999999999999 8999999999886544 7
Q ss_pred EEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC
Q 006277 86 VNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN 149 (652)
Q Consensus 86 ~~LVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~ 149 (652)
+|+|||||.+|+|.+++...+ .+++..+..++.||+.||.|||++| |+||||||+|||++ .
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~ 238 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVT-E 238 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-T
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEEEC-C
Confidence 999999999999999998754 4789999999999999999999998 99999999999998 6
Q ss_pred CCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHH
Q 006277 150 QGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKK 223 (652)
Q Consensus 150 ~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~ 223 (652)
+|.+||+|||+++.+.... .....||+.|+|||++ ...|+.++|||||||++|||++ |..||.+ ....+++..
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~-~~~~~~~~~ 317 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKL 317 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHH
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHH
Confidence 7899999999998665422 2345678999999976 5579999999999999999999 9999987 556667777
Q ss_pred HhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 224 VSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 224 I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
+..+..+ ..+...++++.+||.+||. +|.+|||+.|++++
T Consensus 318 ~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 318 LKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHTTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7776543 3455678899999999998 89999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=358.60 Aligned_cols=247 Identities=22% Similarity=0.309 Sum_probs=207.6
Q ss_pred EEEEEEecCcEEEEEE-----EccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 006277 13 YLRLIQLVDTSGYKAF-----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~-----d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~ 87 (652)
...|++++.|+||+|. +..+++.||+|++... .......++.+|+.++++++|||||++++++.+.. ..|
T Consensus 76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~ 150 (367)
T 3l9p_A 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL--PRF 150 (367)
T ss_dssp EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCE
T ss_pred eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc---cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--CCE
Confidence 3567777789999999 6678899999998632 23566778999999999999999999999986654 679
Q ss_pred EEEecCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC--CCCcEEEecc
Q 006277 88 IITELFTSGSLRQYRKKHK-------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDL 158 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~-------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~--~~g~VKL~DF 158 (652)
+|||||.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++. .+..+||+||
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEECCC
Confidence 9999999999999998653 5899999999999999999999999 999999999999983 2335999999
Q ss_pred Cchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCcc
Q 006277 159 GLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAA 232 (652)
Q Consensus 159 Gla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~ 232 (652)
|+++.+.... .....||+.|+|||++ ...|+.++|||||||++|+|++ |..||.. .....+...+..+..+ .
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~-~~~~~~~~~i~~~~~~-~ 306 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRM-D 306 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCC-C
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-C
Confidence 9998764322 3456789999999977 5679999999999999999998 9999987 5667777777776543 3
Q ss_pred ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 233 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 233 l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
.+...++.+.+||.+||. +|.+|||+.+++++.++.
T Consensus 307 ~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 307 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 345678899999999998 899999999999998875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.08 Aligned_cols=251 Identities=21% Similarity=0.283 Sum_probs=190.8
Q ss_pred EEEEEEecCcEEEEEEEccCCe---EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC----e
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGL---EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK----T 85 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~---~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~----~ 85 (652)
...+++++.|+||+|.+..++. .||+|++..... .....+++.+|+.++++++||||+++++++.+.... .
T Consensus 28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (323)
T 3qup_A 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPI 105 (323)
T ss_dssp EEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------C
T ss_pred eceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCc
Confidence 3578888889999999988876 899999875432 235678899999999999999999999998765421 2
Q ss_pred EEEEEecCCCCCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccC
Q 006277 86 VNIITELFTSGSLRQYRKKHK------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 159 (652)
Q Consensus 86 ~~LVmEy~~gGsL~~~i~~~~------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFG 159 (652)
.++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||
T Consensus 106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~-~~~~~kl~Dfg 182 (323)
T 3qup_A 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLA-EDMTVCVADFG 182 (323)
T ss_dssp EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCC
T ss_pred cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEc-CCCCEEEeecc
Confidence 489999999999999986543 6999999999999999999999998 99999999999998 66899999999
Q ss_pred chhhhhccc----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccc
Q 006277 160 LATIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAAL 233 (652)
Q Consensus 160 la~~l~~~~----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l 233 (652)
++....... .....||+.|+|||++. ..|+.++|||||||++|+|++ |.+||.+ .....++..+..+..+ ..
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~ 260 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG-IENAEIYNYLIGGNRL-KQ 260 (323)
T ss_dssp C-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CC
T ss_pred ccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccc-cChHHHHHHHhcCCCC-CC
Confidence 998764432 23456788999999774 568999999999999999999 8999987 4555666666665433 33
Q ss_pred cCCCChHHHHHHHHhCC-CCCCCCC-------HHHHhcCcccccc
Q 006277 234 SKVKDPEVKSFIEKCLV-PASQRLS-------AKELLMDPFLQVN 270 (652)
Q Consensus 234 ~~~~s~~~kdlI~kcL~-~P~~RpS-------a~elL~hpf~~~~ 270 (652)
+...++++++||.+||. +|.+||| .++++.|||+...
T Consensus 261 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 261 PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 45677899999999998 8999999 7888899999743
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=353.05 Aligned_cols=246 Identities=21% Similarity=0.309 Sum_probs=176.6
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC--CCCeEEEEEec
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD--QNKTVNIITEL 92 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~--~~~~~~LVmEy 92 (652)
.|++++.|+||+|.++.+|+.||+|++... .... .+....++.++||||++++++|... .+..+++||||
T Consensus 36 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 107 (336)
T 3fhr_A 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC 107 (336)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEec
Confidence 378888899999999999999999998632 2222 2233446777999999999998652 23468999999
Q ss_pred CCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC--CCcEEEeccCchhhhhccc
Q 006277 93 FTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~--~g~VKL~DFGla~~l~~~~ 168 (652)
|.||+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.. ++.+||+|||++.......
T Consensus 108 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~ 185 (336)
T 3fhr_A 108 MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185 (336)
T ss_dssp CTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccceeccccc
Confidence 99999999998764 6999999999999999999999998 9999999999999742 4569999999998776655
Q ss_pred cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHH---HHHHHhcCC--CCccccCCCChHHH
Q 006277 169 AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ---IYKKVSSGI--KPAALSKVKDPEVK 242 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~---i~~~I~~g~--~p~~l~~~~s~~~k 242 (652)
....+||+.|+|||++ ...|+.++|||||||++|+|++|..||........ ....+..+. .+.......+++++
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (336)
T 3fhr_A 186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAK 265 (336)
T ss_dssp ------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHH
T ss_pred cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHH
Confidence 6678899999999987 45689999999999999999999999976332211 122222222 12223345789999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 243 SFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+||.+||. +|.+|||+.|+|+||||+..
T Consensus 266 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 266 QLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred HHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 99999998 89999999999999999753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=344.01 Aligned_cols=241 Identities=25% Similarity=0.370 Sum_probs=205.4
Q ss_pred EEEEEecCcEEEEEEEc-----cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 14 LRLIQLVDTSGYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~-----~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
..|++++.|.||+|.+. .+|..||+|++... ......+++.+|+.+|+.|+||||+++++++.+.. .+++
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~l 103 (314)
T 2ivs_A 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN---ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG--PLLL 103 (314)
T ss_dssp EEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--SCEE
T ss_pred eeecccCCeeEEEEEEeccCcccCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC--ceEE
Confidence 56777778999999983 56699999998643 24677889999999999999999999999986544 7999
Q ss_pred EEecCCCCCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccE
Q 006277 89 ITELFTSGSLRQYRKKHKK------------------------VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~------------------------lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NI 144 (652)
|||||.+|+|.+++...+. +++..++.++.||+.||.|||++| |+||||||+||
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~NI 181 (314)
T 2ivs_A 104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNI 181 (314)
T ss_dssp EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGE
T ss_pred EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--CcccccchheE
Confidence 9999999999999987643 899999999999999999999998 99999999999
Q ss_pred EEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHH
Q 006277 145 FINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSA 218 (652)
Q Consensus 145 Ll~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~ 218 (652)
|++ .++.+||+|||++....... .....||+.|+|||++ ...|+.++|||||||++|+|++ |..||.+ ....
T Consensus 182 li~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~ 259 (314)
T 2ivs_A 182 LVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-IPPE 259 (314)
T ss_dssp EEE-TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCGG
T ss_pred EEc-CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC-CCHH
Confidence 998 67899999999998664322 2345678999999977 4568999999999999999999 9999987 4556
Q ss_pred HHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 219 QIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 219 ~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.++..+..+..+ ..+...++.+++||.+||. +|.+|||+.+++++
T Consensus 260 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 260 RLFNLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 677777766533 3455678999999999997 89999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=334.88 Aligned_cols=239 Identities=19% Similarity=0.371 Sum_probs=204.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...+++++.|+||+|.+. ++..||+|++..... ..+++.+|+.++++++||||+++++++.+.. .+++||||
T Consensus 15 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 86 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PICLVFEF 86 (269)
T ss_dssp EEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SEEEEEEC
T ss_pred eheecCCCccEEEEEEec-CCCeEEEEEeccccc-----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--ceEEEEEe
Confidence 467888888999999986 578899999874432 2457889999999999999999999986654 69999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
+.+|+|.+++... +.+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-GGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEc-CCCCEEecccccccccccccccc
Confidence 9999999999764 46899999999999999999999999 99999999999998 66899999999998764432
Q ss_pred cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
.....||+.|+|||++. ..|+.++|||||||++|+|++ |..||.. .....+...+..+..+ ..+...++.+.+||.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 241 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTHVYQIMN 241 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHHHHHHHH
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhcCccC-CCCCcCCHHHHHHHH
Confidence 34456788999999874 679999999999999999999 9999987 5667777777776433 344567899999999
Q ss_pred HhCC-CCCCCCCHHHHhcC
Q 006277 247 KCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~h 264 (652)
+||. +|.+|||+.++++|
T Consensus 242 ~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 242 HCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCCcccCcCHHHHHHH
Confidence 9998 89999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=342.34 Aligned_cols=248 Identities=24% Similarity=0.392 Sum_probs=191.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..|+++..|+||+|.+..+|+.||+|++..... .....+.+.++..+++.++||||+++++++.+.. .+++||||+
T Consensus 31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~--~~~lv~e~~ 106 (318)
T 2dyl_A 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT--DVFIAMELM 106 (318)
T ss_dssp EEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEEEEECCC
T ss_pred ceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC--cEEEEEecc
Confidence 455666668999999999999999999975432 1233444555566788889999999999987654 899999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-cc
Q 006277 94 TSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AK 170 (652)
Q Consensus 94 ~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~~ 170 (652)
++.+..+... .+.+++..++.++.||+.||.|||++ | |+||||||+|||++ .++.+||+|||++..+.... ..
T Consensus 107 -~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 182 (318)
T 2dyl_A 107 -GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKD 182 (318)
T ss_dssp -SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEEC-TTSCEEECCCTTC----------
T ss_pred -CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEEC-CCCCEEEEECCCchhccCCcccc
Confidence 6666666544 57899999999999999999999995 8 99999999999998 67899999999998765432 34
Q ss_pred cccCCCCccCccccc------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcc-ccCCCChHHHH
Q 006277 171 SVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA-LSKVKDPEVKS 243 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~-l~~~~s~~~kd 243 (652)
...||+.|+|||++. ..|+.++|||||||++|+|++|..||............+..+..+.. .....++++++
T Consensus 183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 262 (318)
T 2dyl_A 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQS 262 (318)
T ss_dssp ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHH
T ss_pred ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHH
Confidence 568999999999873 46889999999999999999999999886677677766666543322 22346899999
Q ss_pred HHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 244 FIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
||.+||. +|.+|||+.++|+||||+.
T Consensus 263 li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 263 FVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 9999998 8999999999999999974
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=345.47 Aligned_cols=242 Identities=19% Similarity=0.237 Sum_probs=206.8
Q ss_pred EEEEEEecCcEEEEEEEc-----cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 006277 13 YLRLIQLVDTSGYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~-----~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~ 87 (652)
...|++++.|.||+|.+. .+++.||+|++.... ..+..+++.+|+.+++.++||||+++++++.+.. .+|
T Consensus 52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~ 126 (343)
T 1luf_A 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK--PMC 126 (343)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SCE
T ss_pred eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC--ceE
Confidence 357888888999999998 466999999987432 3566788999999999999999999999886544 789
Q ss_pred EEEecCCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCccc
Q 006277 88 IITELFTSGSLRQYRKKH------------------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~------------------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~N 143 (652)
+|||||.+|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~N 204 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRN 204 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcce
Confidence 999999999999999874 57999999999999999999999998 9999999999
Q ss_pred EEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCH
Q 006277 144 IFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNS 217 (652)
Q Consensus 144 ILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~ 217 (652)
||++ .++.+||+|||++....... .....||+.|+|||++ ...|+.++|||||||++|+|++ |..||.+ ...
T Consensus 205 Il~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~ 282 (343)
T 1luf_A 205 CLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-MAH 282 (343)
T ss_dssp EEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCH
T ss_pred EEEC-CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC-CCh
Confidence 9998 67899999999998765432 2346789999999976 4579999999999999999999 9999987 566
Q ss_pred HHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 218 AQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 218 ~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
..+...+..+..+ ..+...++.+.+||.+||. +|.+|||+.+++++
T Consensus 283 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 283 EEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 6777777776543 3455678999999999998 89999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=347.80 Aligned_cols=248 Identities=23% Similarity=0.387 Sum_probs=182.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHH-HHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~-iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...|++++.|+||+|.++.+|+.||+|++.... ......++..|+. +++.++||||+++++++.+.. .+++|||
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~--~~~lv~e 101 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG--DCWICME 101 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS--EEEEEEC
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC--ceEEEEe
Confidence 346777778999999999999999999997542 2445556666666 777789999999999998654 8999999
Q ss_pred cCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh
Q 006277 92 LFTSGSLRQYRKK-----HKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 92 y~~gGsL~~~i~~-----~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~ 165 (652)
|+.+ +|.+++.. ...+++..+..++.|++.||.|||++ | |+||||||+|||++ .++.+||+|||++..+.
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLD-RSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEE-TTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEc-CCCCEEEccCCCceecc
Confidence 9975 88877663 57899999999999999999999998 8 99999999999998 67899999999998765
Q ss_pred ccc-cccccCCCCccCcccc-----ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc---cccCC
Q 006277 166 QAN-AKSVIGTPEFMAPELY-----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA---ALSKV 236 (652)
Q Consensus 166 ~~~-~~~~vGTp~YmAPEvl-----~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~---~l~~~ 236 (652)
... .....||+.|+|||++ ...|+.++|||||||++|+|++|..||.+..........+..+..+. .....
T Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3aln_A 178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE 257 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCC
T ss_pred cccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCccccc
Confidence 443 3345899999999987 34689999999999999999999999987443333333333332221 12235
Q ss_pred CChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 237 KDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 237 ~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.++.+++||.+||. +|.+|||+.++++||||..
T Consensus 258 ~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 258 FSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 68899999999998 8999999999999999974
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=347.26 Aligned_cols=242 Identities=21% Similarity=0.310 Sum_probs=203.3
Q ss_pred EEEEEEecCcEEEEEEEccCCe---EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGL---EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~---~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
...|++++.|+||+|.+..+|. .||+|.+.... .....+++.+|+.+|+.|+||||+++++++.+.. .+|+|
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 128 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR--LAMIV 128 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG--CCEEE
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--ccEEE
Confidence 3578888889999999986554 59999986432 3567788999999999999999999999986544 78999
Q ss_pred EecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 90 TELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
||||.+|+|.+++... +.+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+....
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEC-CCCCEEECCCCcccccccCc
Confidence 9999999999999765 57999999999999999999999998 99999999999998 67899999999998764322
Q ss_pred -----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHH
Q 006277 169 -----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 169 -----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~ 241 (652)
.....||+.|+|||++. ..|+.++|||||||++|+|++ |..||.+ .....+...+..+..+ ..+...++.+
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l 283 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNRDVISSVEEGYRL-PAPMGCPHAL 283 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHH
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCCC-CCCCCcCHHH
Confidence 22345688999999875 579999999999999999999 9999987 5666777777776433 3445678999
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 242 KSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.+||.+||. +|.+|||+.++++.
T Consensus 284 ~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 284 HQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999998 89999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=350.85 Aligned_cols=249 Identities=26% Similarity=0.341 Sum_probs=198.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-----------CCCeeeeeeEEEeC
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-----------HNNIIRFYNSWIDD 81 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-----------HpnIVkl~~~~~d~ 81 (652)
...|++++.|+||+|.+..+|+.||+|++.. .....+.+.+|+.+++++. ||||+++++++...
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred EEeeeecCCeEEEEEEecCCCcEEEEEEecC-----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 4577888889999999999999999999863 2345677889999999986 89999999998754
Q ss_pred C--CCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCcccEEEcC-----CCC
Q 006277 82 Q--NKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFING-----NQG 151 (652)
Q Consensus 82 ~--~~~~~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~-g~~IiHRDLKp~NILl~~-----~~g 151 (652)
. ...+++||||+ +++|.+++... +.+++..++.++.||+.||.|||++ | |+||||||+|||++. ..+
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCCCcCcc
Confidence 2 23789999999 89999999874 4599999999999999999999998 8 999999999999952 334
Q ss_pred cEEEeccCchhhhhccccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCC-----HHHHHHHHh
Q 006277 152 EVKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRN-----SAQIYKKVS 225 (652)
Q Consensus 152 ~VKL~DFGla~~l~~~~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~-----~~~i~~~I~ 225 (652)
.+||+|||++...... ....+||+.|+|||++ ...|+.++|||||||++|+|++|..||..... .......+.
T Consensus 176 ~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254 (373)
T ss_dssp EEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred eEEEcccccccccCCC-CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHH
Confidence 7999999999876543 3456899999999977 45689999999999999999999999975321 111111111
Q ss_pred c--CCCCc--------------------------------------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 226 S--GIKPA--------------------------------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 226 ~--g~~p~--------------------------------------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
. +..|. .++...++++++||.+||. +|.+|||+.|+|+|
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 1 11110 1112234688999999998 89999999999999
Q ss_pred cccccc
Q 006277 265 PFLQVN 270 (652)
Q Consensus 265 pf~~~~ 270 (652)
|||+..
T Consensus 335 p~f~~~ 340 (373)
T 1q8y_A 335 PWLKDT 340 (373)
T ss_dssp GGGTTC
T ss_pred hhhhcc
Confidence 999853
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=346.82 Aligned_cols=245 Identities=22% Similarity=0.298 Sum_probs=204.5
Q ss_pred EEEEEEecCcEEEEEEE-----ccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeE
Q 006277 13 YLRLIQLVDTSGYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTV 86 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d-----~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~ 86 (652)
...|++++.|+||+|.+ ..++..||+|++.... .....+++.+|+.+|++| +||||+++++++.+.. .+
T Consensus 50 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--~~ 124 (344)
T 1rjb_A 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG--PI 124 (344)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SC
T ss_pred eeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC--cc
Confidence 34677777899999997 3477899999987432 234567899999999999 9999999999987644 79
Q ss_pred EEEEecCCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCccc
Q 006277 87 NIITELFTSGSLRQYRKKHK-----------------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~~~-----------------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~N 143 (652)
++|||||.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~N 202 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARN 202 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhh
Confidence 99999999999999998653 3799999999999999999999998 9999999999
Q ss_pred EEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCH
Q 006277 144 IFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNS 217 (652)
Q Consensus 144 ILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~ 217 (652)
||++ .++.+||+|||++..+.... .....||+.|+|||++ .+.|+.++|||||||++|+|+| |..||.+....
T Consensus 203 Ill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 203 VLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp EEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred EEEc-CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 9998 67899999999998765432 2345678899999976 5679999999999999999998 99999886666
Q ss_pred HHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcc
Q 006277 218 AQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPF 266 (652)
Q Consensus 218 ~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf 266 (652)
......+..+.. ...+...++++.+||.+||. +|.+|||+.++++|..
T Consensus 282 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 282 ANFYKLIQNGFK-MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp HHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 666666666543 33455678999999999998 8999999999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.71 Aligned_cols=245 Identities=19% Similarity=0.199 Sum_probs=197.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...++++..|+||+|.+..+|+.||+|++.... ...+...+++.+|+.+++.++||||+++++++.+.. .+|+||||
T Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~ 115 (309)
T 2h34_A 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETL-SSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG--QLYVDMRL 115 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECGGGG-GGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred EEEEcCCCCeeEEEEEEcCCCeEEEEEecCccc-ccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC--eEEEEEEe
Confidence 356777778999999999999999999987432 234566788999999999999999999999987754 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---A 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---~ 169 (652)
+.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....... .
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 192 (309)
T 2h34_A 116 INGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVS-ADDFAYLVDFGIASATTDEKLTQL 192 (309)
T ss_dssp CCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSCCC------------
T ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEc-CCCCEEEecCccCccccccccccc
Confidence 999999999998889999999999999999999999998 99999999999998 56899999999998765432 2
Q ss_pred ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC-CccccCCCChHHHHHHHH
Q 006277 170 KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-PAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~-p~~l~~~~s~~~kdlI~k 247 (652)
....||+.|+|||++ ...++.++|||||||++|+|++|..||.. .....+...+..... +...+...++++++||.+
T Consensus 193 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 271 (309)
T 2h34_A 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIAR 271 (309)
T ss_dssp ----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS-CHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHH
T ss_pred cccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC-chHHHHHHHhccCCCCccccCCCCCHHHHHHHHH
Confidence 456899999999987 45689999999999999999999999987 344445455554432 334456678899999999
Q ss_pred hCC-CCCCCC-CHHHHhcC
Q 006277 248 CLV-PASQRL-SAKELLMD 264 (652)
Q Consensus 248 cL~-~P~~Rp-Sa~elL~h 264 (652)
||. +|.+|| +++++++.
T Consensus 272 ~l~~dP~~Rp~s~~~l~~~ 290 (309)
T 2h34_A 272 GMAKNPEDRYVTCGDLSAA 290 (309)
T ss_dssp HTCSSGGGSCSSHHHHHHH
T ss_pred hccCCHHHHHHhHHHHHHH
Confidence 998 899999 78887753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=335.78 Aligned_cols=245 Identities=30% Similarity=0.480 Sum_probs=197.3
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..|+++..|.||+|.+..+|+.||+|++..... ......+++.+|+.+++.++||||+++++++.+.. .+++||||+
T Consensus 38 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 114 (310)
T 2wqm_A 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELNIVLELA 114 (310)
T ss_dssp EEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEEEECC
T ss_pred EeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--cEEEEEecC
Confidence 567777779999999999999999999975433 34667888999999999999999999999998755 899999999
Q ss_pred CCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 94 TSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 94 ~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
.+|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.......
T Consensus 115 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~-~~~~~kl~Dfg~~~~~~~~~~ 191 (310)
T 2wqm_A 115 DAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTT 191 (310)
T ss_dssp CSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCC-----------
T ss_pred CCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEc-CCCCEEEEeccceeeecCCCc
Confidence 99999998864 467999999999999999999999998 99999999999998 67899999999998765432
Q ss_pred -cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCC-CHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 169 -AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECR-NSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~-~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
.....||+.|+|||++ ...++.++|||||||++|+|++|..||.+.. ....+...+..+..+.......++++++||
T Consensus 192 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 271 (310)
T 2wqm_A 192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 271 (310)
T ss_dssp -------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHH
T ss_pred cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHH
Confidence 3456899999999976 4578999999999999999999999997643 445666677766655544466789999999
Q ss_pred HHhCC-CCCCCCCHHHHhcC
Q 006277 246 EKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~h 264 (652)
.+||. +|.+|||+.+++++
T Consensus 272 ~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 272 NMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhhCCCHHHHHHH
Confidence 99998 89999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=343.46 Aligned_cols=253 Identities=23% Similarity=0.298 Sum_probs=206.3
Q ss_pred CCCcceeeee-eEEEEEEecCcEEEEEEEccCCeEE--EEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeE
Q 006277 2 VRQKWSLLIL-MYLRLIQLVDTSGYKAFDEVNGLEV--AWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNS 77 (652)
Q Consensus 2 ~~~~W~~~~~-~~~rL~~l~~gtVykA~d~~tG~~V--AiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~ 77 (652)
.||......+ ....|++++.|.||+|.+..+|..+ |+|.+... ......+++.+|+.+|+++ +||||++++++
T Consensus 18 ~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 94 (327)
T 1fvr_A 18 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGA 94 (327)
T ss_dssp CSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred ccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc---cchHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence 4554444333 2356777777999999999999866 88888632 2345667899999999999 99999999999
Q ss_pred EEeCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCc
Q 006277 78 WIDDQNKTVNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 141 (652)
Q Consensus 78 ~~d~~~~~~~LVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp 141 (652)
+.+.. .+|+|||||.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||
T Consensus 95 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp 170 (327)
T 1fvr_A 95 CEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAA 170 (327)
T ss_dssp EEETT--EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred eeeCC--ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCcc
Confidence 97765 8999999999999999998764 7999999999999999999999998 99999999
Q ss_pred ccEEEcCCCCcEEEeccCchhhhhccc-cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHH
Q 006277 142 DNIFINGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSA 218 (652)
Q Consensus 142 ~NILl~~~~g~VKL~DFGla~~l~~~~-~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~ 218 (652)
+|||++ .++.+||+|||++....... .....+|+.|+|||++. ..|+.++|||||||++|+|++ |..||.+ ....
T Consensus 171 ~NIl~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~ 248 (327)
T 1fvr_A 171 RNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCA 248 (327)
T ss_dssp GGEEEC-GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHH
T ss_pred ceEEEc-CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC-CcHH
Confidence 999998 67899999999997544332 23456789999999875 468999999999999999998 9999987 5667
Q ss_pred HHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 219 QIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 219 ~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.++..+..+..+ ..+...++.+++||.+||. +|.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 249 ELYEKLPQGYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHHGGGTCCC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 777777776433 3345567899999999998 89999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=346.37 Aligned_cols=245 Identities=22% Similarity=0.333 Sum_probs=201.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCH--HHHHHHHHHHHHHHhC----CCCCeeeeeeEEEeCCCCeE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSP--EDLERLYSEVHLLKSL----KHNNIIRFYNSWIDDQNKTV 86 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~--e~~~~l~~Ei~iLk~L----~HpnIVkl~~~~~d~~~~~~ 86 (652)
...|++++.|+||+|.+..+|+.||+|++......... ....++.+|+.+++++ +||||+++++++.+.. ..
T Consensus 36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~--~~ 113 (312)
T 2iwi_A 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQE--GF 113 (312)
T ss_dssp EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-------C
T ss_pred eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCC--eE
Confidence 46788888899999999999999999998755432111 2344567799999999 8999999999887654 68
Q ss_pred EEEEec-CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh
Q 006277 87 NIITEL-FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 87 ~LVmEy-~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~ 165 (652)
++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++..++.+||+|||++....
T Consensus 114 ~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~ 191 (312)
T 2iwi_A 114 MLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191 (312)
T ss_dssp EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECCCSSCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEEcchhhhcc
Confidence 999999 789999999998889999999999999999999999998 99999999999998667899999999998877
Q ss_pred ccccccccCCCCccCccccc-cCC-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHH
Q 006277 166 QANAKSVIGTPEFMAPELYD-ENY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 243 (652)
Q Consensus 166 ~~~~~~~vGTp~YmAPEvl~-~~y-~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kd 243 (652)
........||+.|+|||++. ..+ +.++|||||||++|+|++|..||... ..+ ... ...++...++.+++
T Consensus 192 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~----~~~--~~~~~~~~~~~~~~ 262 (312)
T 2iwi_A 192 DEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---QEI----LEA--ELHFPAHVSPDCCA 262 (312)
T ss_dssp SSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HHH----HHT--CCCCCTTSCHHHHH
T ss_pred cCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---HHH----hhh--ccCCcccCCHHHHH
Confidence 66666778999999999774 344 45899999999999999999999652 222 222 12344567899999
Q ss_pred HHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 244 FIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
||.+||. +|.+|||+.|+|+||||+..
T Consensus 263 li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 263 LIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred HHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 9999998 89999999999999999853
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=343.29 Aligned_cols=246 Identities=20% Similarity=0.302 Sum_probs=198.1
Q ss_pred EEEEEEecCcEEEEEEEccCC-eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC------eeeeeeEEEeCCCCe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNG-LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN------IIRFYNSWIDDQNKT 85 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG-~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hpn------IVkl~~~~~d~~~~~ 85 (652)
...|+++..|+||+|.+..+| +.||+|+++. .....+.+.+|+.+++.++|++ |+.+++++.... .
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~--~ 96 (355)
T 2eu9_A 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG--H 96 (355)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT--E
T ss_pred EEEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC--e
Confidence 457888888999999998887 7999999863 2456678889999999997766 999999887655 8
Q ss_pred EEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC---------------
Q 006277 86 VNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--------------- 148 (652)
Q Consensus 86 ~~LVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~--------------- 148 (652)
+++||||+ +++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccccccccc
Confidence 99999999 667777776653 7999999999999999999999998 999999999999931
Q ss_pred ---CCCcEEEeccCchhhhhccccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 006277 149 ---NQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 224 (652)
Q Consensus 149 ---~~g~VKL~DFGla~~l~~~~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I 224 (652)
..+.+||+|||++..... .....+||+.|+|||++ ...|+.++|||||||++|+|++|..||........+ ..+
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~ 251 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHE-HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL-VMM 251 (355)
T ss_dssp EEESCCCEEECCCTTCEETTS-CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHH
T ss_pred cccCCCcEEEeecCccccccc-cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHH
Confidence 467899999999976543 23567899999999977 557999999999999999999999999874433322 222
Q ss_pred hc--CCCCccc----------------------------------------cCCCChHHHHHHHHhCC-CCCCCCCHHHH
Q 006277 225 SS--GIKPAAL----------------------------------------SKVKDPEVKSFIEKCLV-PASQRLSAKEL 261 (652)
Q Consensus 225 ~~--g~~p~~l----------------------------------------~~~~s~~~kdlI~kcL~-~P~~RpSa~el 261 (652)
.. +..|..+ ....++++++||.+||. +|.+|||+.|+
T Consensus 252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 331 (355)
T 2eu9_A 252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA 331 (355)
T ss_dssp HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence 11 1111100 01113478899999998 89999999999
Q ss_pred hcCcccccc
Q 006277 262 LMDPFLQVN 270 (652)
Q Consensus 262 L~hpf~~~~ 270 (652)
|+||||+..
T Consensus 332 l~hp~f~~~ 340 (355)
T 2eu9_A 332 LLHPFFAGL 340 (355)
T ss_dssp TTSGGGGGC
T ss_pred hcChhhcCC
Confidence 999999853
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=351.36 Aligned_cols=251 Identities=27% Similarity=0.388 Sum_probs=211.9
Q ss_pred CcceeeeeeE---EEEEEecCcEEEEEEEcc-------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCee
Q 006277 4 QKWSLLILMY---LRLIQLVDTSGYKAFDEV-------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNII 72 (652)
Q Consensus 4 ~~W~~~~~~~---~rL~~l~~gtVykA~d~~-------tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIV 72 (652)
++|.+....| ..|++++.|+||+|.+.. .+..||+|++... .......++.+|+++++.+ +|||||
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv 138 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNII 138 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHHHHHHHHHHHHHhcCCchhh
Confidence 4566554333 567778889999999764 4468999998743 2456778999999999999 999999
Q ss_pred eeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 006277 73 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIH 136 (652)
Q Consensus 73 kl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiH 136 (652)
++++++.+.. .+++|||||.+|+|.+++...+ .+++..++.|+.||+.||.|||++| |+|
T Consensus 139 ~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH 214 (382)
T 3tt0_A 139 NLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIH 214 (382)
T ss_dssp CEEEEECSSS--SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred hheeeeccCC--ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--Eec
Confidence 9999886544 6899999999999999998764 4999999999999999999999998 999
Q ss_pred ccCCcccEEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCC
Q 006277 137 RDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYP 210 (652)
Q Consensus 137 RDLKp~NILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~P 210 (652)
|||||+|||++ .++.+||+|||++..+.... .....||+.|+|||++ ...++.++|||||||++|+|++ |..|
T Consensus 215 ~Dlkp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p 293 (382)
T 3tt0_A 215 RDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293 (382)
T ss_dssp SCCCGGGEEEC-TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCCcceEEEc-CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 99999999998 66899999999998765422 3445678999999976 5578999999999999999999 9999
Q ss_pred CCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 211 YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 211 f~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
|.+ ....++...+..+..+ ..+...++++++||.+||. +|.+|||+.|++++
T Consensus 294 ~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 294 YPG-VPVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp STT-CCHHHHHHHHHTTCCC-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC-CCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 987 5677788888776543 3445678999999999998 89999999999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=339.01 Aligned_cols=244 Identities=25% Similarity=0.388 Sum_probs=198.5
Q ss_pred EEEEEEecCcEEEEEE----EccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~----d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
..+|+++..|+||+|. +..+|+.||+|++... .....+++.+|+.+|++++||||+++++++.......+++
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 90 (295)
T 3ugc_A 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 90 (295)
T ss_dssp EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence 4678888889999998 6779999999998643 3567788999999999999999999999987655456899
Q ss_pred EEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 89 ITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
|||||.+|+|.+++...+ .+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 91 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp EEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCCSCC-----
T ss_pred EEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEc-CCCeEEEccCcccccccCC
Confidence 999999999999998764 5999999999999999999999998 99999999999998 6689999999999876543
Q ss_pred c-----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCH---------------HHHHHHHhc
Q 006277 168 N-----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNS---------------AQIYKKVSS 226 (652)
Q Consensus 168 ~-----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~---------------~~i~~~I~~ 226 (652)
. .....||+.|+|||++ ...|+.++|||||||++|+|++|..||...... ..+...+..
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 247 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc
Confidence 2 2345678889999977 467999999999999999999999998541100 022233333
Q ss_pred CCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 227 GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 227 g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
+. ....+...++++.+||.+||. +|.+|||+.|+++.
T Consensus 248 ~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 248 NG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp TC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cC-cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 33 223455678999999999998 89999999999853
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=345.71 Aligned_cols=241 Identities=25% Similarity=0.263 Sum_probs=193.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC--CCeEEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ--NKTVNIIT 90 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~--~~~~~LVm 90 (652)
...|++++.|+||+|.+. |+.||+|++... ........+|+.+|++++|||||++++++.+.. ...+++||
T Consensus 29 ~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 29 LEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ-----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEECSTTCEEEEEEET--TEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hheecccCceEEEEEEEC--CCEEEEEEeecC-----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 346666677999999875 899999998643 234455667999999999999999999998754 33589999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCeeeccCCcccEEEcCCCCcEEEeccCc
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH----------DPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~----------g~~IiHRDLKp~NILl~~~~g~VKL~DFGl 160 (652)
|||.+|+|.+++... .+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.+||+|||+
T Consensus 102 e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~-~~~~~kL~DFg~ 177 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLK-NNLTACIADFGL 177 (322)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEEC-TTCCEEECCCTT
T ss_pred ecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEEC-CCCeEEEccCCc
Confidence 999999999999764 599999999999999999999998 7 99999999999998 678999999999
Q ss_pred hhhhhccc----cccccCCCCccCcccccc------CCCccccchhhHHHHHHHhhccCCCCCCC---------------
Q 006277 161 ATIMEQAN----AKSVIGTPEFMAPELYDE------NYNELADIYSFGMCMLEMVTFEYPYSECR--------------- 215 (652)
Q Consensus 161 a~~l~~~~----~~~~vGTp~YmAPEvl~~------~y~~~sDIWSlGvilyeLltG~~Pf~~~~--------------- 215 (652)
++.+.... ....+||+.|+|||++.+ .++.++|||||||++|+|+||..||.+..
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 97764332 344689999999998754 46778999999999999999999996532
Q ss_pred CHHHHHHHHhcCCCCccccCC-----CChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 216 NSAQIYKKVSSGIKPAALSKV-----KDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 216 ~~~~i~~~I~~g~~p~~l~~~-----~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
....+...+........+... .++++.+||.+||. +|.+|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 233344444443332222221 12459999999998 89999999999863
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=330.07 Aligned_cols=239 Identities=20% Similarity=0.349 Sum_probs=202.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.+. ++..||+|++..... ..+++.+|++++++++||||+++++++.+.. .+++||||
T Consensus 13 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 84 (268)
T 3sxs_A 13 LKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY--PIYIVTEY 84 (268)
T ss_dssp EEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SEEEEEEC
T ss_pred eeeeccCCCceEEEEEec-CceeEEEEEeccCCC-----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--ceEEEEEc
Confidence 467888888999999775 678899999875432 2456889999999999999999999886544 79999999
Q ss_pred CCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
+.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVD-RDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEEC-TTCCEEECCTTCEEECCTTCEEE
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEEC-CCCCEEEccCccceecchhhhhc
Confidence 99999999988754 5999999999999999999999998 99999999999998 67899999999998765433
Q ss_pred cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
.....||+.|+|||++. ..|+.++|||||||++|+|++ |..||.. .........+..+.. ...+...++.+.+||.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~ 239 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL-YTNSEVVLKVSQGHR-LYRPHLASDTIYQIMY 239 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCC-CCCCTTSCHHHHHHHH
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc-cChHHHHHHHHcCCC-CCCCCcChHHHHHHHH
Confidence 23345677899999875 478999999999999999999 9999977 455566666666543 2334556889999999
Q ss_pred HhCC-CCCCCCCHHHHhcC
Q 006277 247 KCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~h 264 (652)
+||. +|.+|||+.+++++
T Consensus 240 ~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 240 SCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HTTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9998 89999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.59 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=204.7
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCC--HHHHHHHHHHHHHHHhCC--CCCeeeeeeEEEeCCCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQS--PEDLERLYSEVHLLKSLK--HNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s--~e~~~~l~~Ei~iLk~L~--HpnIVkl~~~~~d~~~~~~~LV 89 (652)
..|++++.|+||+|.+..+|+.||+|++........ ....+++.+|+.+++.+. ||||+++++++.+.. .+++|
T Consensus 49 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~--~~~lv 126 (320)
T 3a99_A 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD--SFVLI 126 (320)
T ss_dssp EECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS--EEEEE
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC--cEEEE
Confidence 456666678999999999999999999986543210 012356778999999996 599999999987654 79999
Q ss_pred EecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 90 TELFTS-GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 90 mEy~~g-GsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
||++.+ ++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+++.+||+|||++.......
T Consensus 127 ~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~ 204 (320)
T 3a99_A 127 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 204 (320)
T ss_dssp EECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC
T ss_pred EEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc
Confidence 999986 899999998889999999999999999999999998 99999999999998667899999999998877665
Q ss_pred cccccCCCCccCccccc-cC-CCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYD-EN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~-y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
.....||+.|+|||++. .. ++.++|||||||++|+|++|..||... .. +..+. ..++...++++++||.
T Consensus 205 ~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~---~~----~~~~~--~~~~~~~~~~~~~li~ 275 (320)
T 3a99_A 205 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---EE----IIRGQ--VFFRQRVSSECQHLIR 275 (320)
T ss_dssp BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HH----HHHCC--CCCSSCCCHHHHHHHH
T ss_pred ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh---hh----hhccc--ccccccCCHHHHHHHH
Confidence 66778999999999774 34 478899999999999999999999652 11 22222 2234567899999999
Q ss_pred HhCC-CCCCCCCHHHHhcCcccccc
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+||. +|.+|||+.++++||||+..
T Consensus 276 ~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 276 WCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp HHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHccCChhhCcCHHHHhcCHhhcCc
Confidence 9998 89999999999999999743
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=336.94 Aligned_cols=238 Identities=20% Similarity=0.287 Sum_probs=197.7
Q ss_pred EEEEEEecCcEEEEEEEccCC-------eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNG-------LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 85 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG-------~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 85 (652)
...|+++..|+||+|.+..+| ..||+|.+.... ....+++.+|+.++++++||||+++++++.+.. .
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 86 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD--E 86 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT--C
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC--C
Confidence 467888888999999999988 579999986432 356688999999999999999999999987654 6
Q ss_pred EEEEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCc--------EEEe
Q 006277 86 VNIITELFTSGSLRQYRKKHKK-VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE--------VKIG 156 (652)
Q Consensus 86 ~~LVmEy~~gGsL~~~i~~~~~-lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~--------VKL~ 156 (652)
.++|||||.+|+|.+++...+. +++..++.++.||+.||.|||++| |+||||||+|||++ .++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLI-REEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-ECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEe-cCCcccccccceeeec
Confidence 8999999999999999987754 999999999999999999999999 99999999999998 3444 9999
Q ss_pred ccCchhhhhccccccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc
Q 006277 157 DLGLATIMEQANAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS 234 (652)
Q Consensus 157 DFGla~~l~~~~~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 234 (652)
|||++...... ....||+.|+|||++. ..++.++|||||||++|+|++|..|+................ ...+
T Consensus 164 Dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~---~~~~ 238 (289)
T 4fvq_A 164 DPGISITVLPK--DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR---HQLP 238 (289)
T ss_dssp CCCSCTTTSCH--HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT---CCCC
T ss_pred cCcccccccCc--cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc---CCCC
Confidence 99998765432 3456799999999875 568999999999999999999655544445555554444432 2233
Q ss_pred CCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 235 KVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 235 ~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
...++++++||.+||. +|.+|||+.++++|
T Consensus 239 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 239 APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4456789999999998 89999999999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=338.86 Aligned_cols=242 Identities=22% Similarity=0.331 Sum_probs=205.8
Q ss_pred EEEEEecCcEEEEEEE-----ccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEE
Q 006277 14 LRLIQLVDTSGYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d-----~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~ 87 (652)
..|++++.|+||+|.+ ..+|+.||+|.+.... .....+.+.+|+.++++| +||||+++++++.+.. ..+
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--~~~ 103 (313)
T 1t46_A 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG--PTL 103 (313)
T ss_dssp EEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCE
T ss_pred HhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC--CcE
Confidence 4677777899999985 5688999999987432 345678899999999999 9999999999986654 689
Q ss_pred EEEecCCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC
Q 006277 88 IITELFTSGSLRQYRKKHK------------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN 149 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~------------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~ 149 (652)
+|||||.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~ 180 (313)
T 1t46_A 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT-H 180 (313)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-T
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEc-C
Confidence 9999999999999998764 4899999999999999999999998 99999999999998 6
Q ss_pred CCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHH
Q 006277 150 QGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKK 223 (652)
Q Consensus 150 ~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~ 223 (652)
++.+||+|||++....... .....||+.|+|||++ ...++.++|||||||++|+|++ |..||.+..........
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 260 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHH
Confidence 7899999999998765432 2345678899999976 5679999999999999999999 99999886666666666
Q ss_pred HhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 224 VSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 224 I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
+..+..+ ..+...++.+++||.+||. +|.+|||+.|++++
T Consensus 261 ~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 261 IKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccCCCC-CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 6665433 3345578899999999998 89999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.91 Aligned_cols=241 Identities=25% Similarity=0.404 Sum_probs=196.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEE----EEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEV----AWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~V----AiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
...|++++.|+||+|.+..+|..| |+|.+... ......+++.+|+.++++++||||+++++++.+. ..++
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 93 (327)
T 3poz_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---TVQL 93 (327)
T ss_dssp EEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---SEEE
T ss_pred ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc---cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---CeEE
Confidence 467888889999999999888776 55554322 1235567899999999999999999999998764 3789
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 89 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
|++|+.+|+|.+++... +.+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEEC-CCCCEEEccCcceeEccCC
Confidence 99999999999998874 57999999999999999999999998 99999999999998 6789999999999887543
Q ss_pred c----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHH
Q 006277 168 N----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 168 ~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~ 241 (652)
. .....||+.|+|||++ ...|+.++|||||||++|+|++ |..||.+ .....+...+..+... ..+...+..+
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 248 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICTIDV 248 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCTTBCHHH
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC-CCHHHHHHHHHcCCCC-CCCccCCHHH
Confidence 2 2345678899999976 5679999999999999999999 9999977 4555666666665433 3445577899
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 242 KSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.+||.+||. +|.+|||+.+++++
T Consensus 249 ~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 249 YMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999998 89999999999976
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=331.50 Aligned_cols=248 Identities=20% Similarity=0.345 Sum_probs=204.5
Q ss_pred CcceeeeeeE---EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 006277 4 QKWSLLILMY---LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 80 (652)
Q Consensus 4 ~~W~~~~~~~---~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 80 (652)
..|......| ..|++++.|+||+|.+. ++..||+|++..... ..+++.+|+++++.++||||+++++++.+
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-----CHHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 3455544333 45666666899999876 788999999874432 23568899999999999999999998865
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccC
Q 006277 81 DQNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 159 (652)
Q Consensus 81 ~~~~~~~LVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFG 159 (652)
.. .+++||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||
T Consensus 91 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg 165 (283)
T 3gen_A 91 QR--PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFG 165 (283)
T ss_dssp SS--SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTSCEEECSTT
T ss_pred CC--CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEc-CCCCEEEcccc
Confidence 44 79999999999999999986 467999999999999999999999998 99999999999998 67899999999
Q ss_pred chhhhhccc---cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCcccc
Q 006277 160 LATIMEQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALS 234 (652)
Q Consensus 160 la~~l~~~~---~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 234 (652)
++....... .....||+.|+|||++. ..|+.++|||||||++|+|++ |..||.. .........+..+..+ ..+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~ 243 (283)
T 3gen_A 166 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRP 243 (283)
T ss_dssp GGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCC
T ss_pred ccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cChhHHHHHHhcccCC-CCC
Confidence 998764432 23456788999999774 679999999999999999998 9999987 5566677777776433 334
Q ss_pred CCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 235 KVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 235 ~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
...++.+.+||.+||. +|.+|||+.++++|
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 5668899999999998 89999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.80 Aligned_cols=244 Identities=25% Similarity=0.393 Sum_probs=200.0
Q ss_pred EEEEEEecCcEEEEEE----EccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~----d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
...|++++.|.||+|. +..+|+.||+|++.... .....+++.+|+.+|+.++||||+++++++.+.....+++
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred hhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 4678888889999999 67899999999987543 2345678999999999999999999999998876567999
Q ss_pred EEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 89 ITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
||||+.+|+|.+++.. .+.+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 103 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEECCTT
T ss_pred EEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEc-CCCCEEECcccccccccCC
Confidence 9999999999999954 467999999999999999999999998 99999999999998 6689999999999876543
Q ss_pred c-----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCC--------------CCCHHHHHHHHhcC
Q 006277 168 N-----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSE--------------CRNSAQIYKKVSSG 227 (652)
Q Consensus 168 ~-----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~--------------~~~~~~i~~~I~~g 227 (652)
. .....||+.|+|||++ ...++.++|||||||++|+|++|..|+.. ......+...+..+
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence 2 3456789999999977 45688999999999999999999887532 12223344445444
Q ss_pred CCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 228 IKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 228 ~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
.. ...+...++.+.+||.+||. +|.+|||+.++++
T Consensus 260 ~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 260 KR-LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp CC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CC-CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 43 33455678999999999998 8999999999985
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=340.61 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=207.3
Q ss_pred EEEEEEecCcEEEEEEE-----ccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeE
Q 006277 13 YLRLIQLVDTSGYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTV 86 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d-----~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~ 86 (652)
...|++++.|+||+|.+ ..+|+.||+|++.... ......++.+|+.+++++ +||||+++++++.... ..+
T Consensus 32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-~~~ 107 (316)
T 2xir_A 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-GPL 107 (316)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-SCC
T ss_pred eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC-Cce
Confidence 35677777899999985 4678999999987432 355677899999999999 7999999999886543 468
Q ss_pred EEEEecCCCCCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCC
Q 006277 87 NIITELFTSGSLRQYRKKHKK----------------VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 150 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~~~~----------------lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~ 150 (652)
++|||||.+|+|.+++...+. +++..++.++.||+.||.|||++| |+||||||+|||++ .+
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~ 184 (316)
T 2xir_A 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EK 184 (316)
T ss_dssp EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GG
T ss_pred EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEEC-CC
Confidence 999999999999999987654 899999999999999999999998 99999999999998 67
Q ss_pred CcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHH
Q 006277 151 GEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKV 224 (652)
Q Consensus 151 g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I 224 (652)
+.+||+|||++..+.... .....||+.|+|||++ ...|+.++|||||||++|+|++ |..||.+......+...+
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 264 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHh
Confidence 899999999998764322 2346789999999977 5679999999999999999998 999998866666677777
Q ss_pred hcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 225 SSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 225 ~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
..+..+ ..+...++.+.++|.+||. +|.+|||+.++++|
T Consensus 265 ~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 265 KEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCccC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 666432 3455678999999999998 89999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=338.34 Aligned_cols=242 Identities=22% Similarity=0.314 Sum_probs=204.8
Q ss_pred EEEEEEecCcEEEEEEEc-----cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 006277 13 YLRLIQLVDTSGYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~-----~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~ 87 (652)
...|++++.|+||+|.+. .+++.||+|.+.... ......++.+|+.+++.++||||+++++++.+.. .++
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 104 (322)
T 1p4o_A 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ--PTL 104 (322)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS--SCE
T ss_pred eeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC--ccE
Confidence 356777777999999987 478999999986432 3456778999999999999999999999886544 789
Q ss_pred EEEecCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEec
Q 006277 88 IITELFTSGSLRQYRKKH----------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 157 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~----------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~D 157 (652)
+|||||.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~-~~~~~kl~D 181 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGD 181 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC-TTCCEEECC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEc-CCCeEEECc
Confidence 999999999999998753 45799999999999999999999998 99999999999998 678999999
Q ss_pred cCchhhhhccc----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCc
Q 006277 158 LGLATIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPA 231 (652)
Q Consensus 158 FGla~~l~~~~----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~ 231 (652)
||++....... .....||+.|+|||++. ..|+.++|||||||++|+|++ |..||.+ ....++...+..+..+
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~- 259 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVMEGGLL- 259 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHTTCCC-
T ss_pred CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc-CCHHHHHHHHHcCCcC-
Confidence 99998765432 23456789999999874 578999999999999999999 8999977 5666777777766533
Q ss_pred cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 232 ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 232 ~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
..+...++.+++||.+||. +|.+|||+.|+++|
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 3345678899999999998 89999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=357.31 Aligned_cols=246 Identities=20% Similarity=0.306 Sum_probs=202.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.+..+|+.||+|++..... ....+.+.+|+.+|++++||||+++++++.+.....+++||||
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 3578888889999999999999999999875433 2345677899999999999999999999987776689999999
Q ss_pred CCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEE----cCCCCcEEEeccCchhhhh
Q 006277 93 FTSGSLRQYRKKHKK---VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI----NGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~---lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl----~~~~g~VKL~DFGla~~l~ 165 (652)
|.+|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||+ + ..+.+||+|||+++.+.
T Consensus 91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLTDFGAARELE 167 (396)
T ss_dssp CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTT-SCEEEEECCGGGCEECC
T ss_pred CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCC-CceeEEEecCCCceEcc
Confidence 999999999876533 999999999999999999999998 9999999999998 4 45679999999998765
Q ss_pred ccc-cccccCCCCccCccccc---------cCCCccccchhhHHHHHHHhhccCCCCCC---CCHHHHHHHHhcCCCCcc
Q 006277 166 QAN-AKSVIGTPEFMAPELYD---------ENYNELADIYSFGMCMLEMVTFEYPYSEC---RNSAQIYKKVSSGIKPAA 232 (652)
Q Consensus 166 ~~~-~~~~vGTp~YmAPEvl~---------~~y~~~sDIWSlGvilyeLltG~~Pf~~~---~~~~~i~~~I~~g~~p~~ 232 (652)
... ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||... .....+...+..+..+..
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence 433 45678999999999874 46888999999999999999999999642 223444555555433211
Q ss_pred -----------------------ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 233 -----------------------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 233 -----------------------l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
+....++.+.+||.+||. +|.+|||+.|++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 112234578899999998 89999999998654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=339.76 Aligned_cols=245 Identities=19% Similarity=0.202 Sum_probs=197.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC--CCCeEEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD--QNKTVNIIT 90 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~--~~~~~~LVm 90 (652)
...|++++.|+||+|.+..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++... ....+++||
T Consensus 34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 35677777799999999999999999998753 356788899999999999999999999998743 234789999
Q ss_pred ecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 91 ELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 91 Ey~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
|||.+|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLG-DEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEESCE
T ss_pred EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEc-CCCCEEEEecCcchhccc
Confidence 99999999999876 467999999999999999999999998 99999999999998 678999999998875432
Q ss_pred cc-----------cccccCCCCccCcccccc----CCCccccchhhHHHHHHHhhccCCCCCCCC-HHHHHHHHhcCCCC
Q 006277 167 AN-----------AKSVIGTPEFMAPELYDE----NYNELADIYSFGMCMLEMVTFEYPYSECRN-SAQIYKKVSSGIKP 230 (652)
Q Consensus 167 ~~-----------~~~~vGTp~YmAPEvl~~----~y~~~sDIWSlGvilyeLltG~~Pf~~~~~-~~~i~~~I~~g~~p 230 (652)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+...+.... .
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~ 265 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL-S 265 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC---
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC-C
Confidence 11 124568999999998753 268899999999999999999999954111 111222233322 2
Q ss_pred ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCc
Q 006277 231 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDP 265 (652)
Q Consensus 231 ~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hp 265 (652)
.......++++++||.+||. +|.+|||+.+++++-
T Consensus 266 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 22334568899999999998 899999999999873
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=352.40 Aligned_cols=241 Identities=21% Similarity=0.301 Sum_probs=204.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
-..|+++..|+||+|.+..+|+.||+|.++.. ..++..+++.+|+++|++++||||+++++++.+.. .+|+||||
T Consensus 119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e~ 193 (377)
T 3cbl_A 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIYIVMEL 193 (377)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEECCTT---SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS--SCEEEEEC
T ss_pred eeEeccCCCCeEEEEEEecCCeEEEEEEcccc---CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC--CcEEEEEc
Confidence 45678888899999999999999999988632 23566778999999999999999999999886544 68999999
Q ss_pred CCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc--
Q 006277 93 FTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-- 169 (652)
Q Consensus 93 ~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~-- 169 (652)
|.+|+|.+++...+ .+++..+..++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+++.......
T Consensus 194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~-~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGCEECTTSEEEC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEc-CCCcEEECcCCCceecCCCceee
Confidence 99999999988654 6999999999999999999999999 99999999999998 678999999999986543321
Q ss_pred --ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 170 --KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 170 --~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
....+++.|+|||++. +.|+.++|||||||++|||++ |..||.+ ....++...+..+... ..+...++++.+||
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 348 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN-LSNQQTREFVEKGGRL-PCPELCPDAVFRLM 348 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHH
Confidence 2234577899999874 579999999999999999998 9999987 4556666677666533 34556788999999
Q ss_pred HHhCC-CCCCCCCHHHHhc
Q 006277 246 EKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~ 263 (652)
.+||. +|.+|||+.++++
T Consensus 349 ~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 349 EQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 99998 8999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.79 Aligned_cols=237 Identities=19% Similarity=0.191 Sum_probs=196.1
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..|++++.|+||+|.+..+|+.||+|++..... .+++.+|+.+++.| +||||+++++++.+.. ..++||||
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--~~~lv~e~ 86 (330)
T 2izr_A 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK--YNAMVLEL 86 (330)
T ss_dssp EECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT--EEEEEEEC
T ss_pred EEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC--ccEEEEEe
Confidence 567777779999999999999999999875432 23578899999999 9999999999988754 89999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCc-----EEEeccCchhhhhc
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE-----VKIGDLGLATIMEQ 166 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~-----VKL~DFGla~~l~~ 166 (652)
+ +|+|.+++... +.+++..++.++.||+.||+|||++| |+||||||+|||++ .++. +||+|||+++.+..
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~-~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIG-RPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-CGGGTCTTSEEECCCTTCEESBC
T ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeec-cCCCCCCceEEEEEcccceeeec
Confidence 9 99999999874 68999999999999999999999998 99999999999998 4455 99999999987643
Q ss_pred cc---------cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCC--CCHHHHHHHHhcCCCCc---
Q 006277 167 AN---------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSEC--RNSAQIYKKVSSGIKPA--- 231 (652)
Q Consensus 167 ~~---------~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~--~~~~~i~~~I~~g~~p~--- 231 (652)
.. ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+. ......+..+.....+.
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence 22 24678999999999774 56999999999999999999999999764 33445555554432111
Q ss_pred cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 232 ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 232 ~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
.+.... +++++||.+||. +|.+||++.++++
T Consensus 243 ~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 243 VLCENF-PEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHhccC-hHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 112223 499999999997 8999999988876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.88 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=209.3
Q ss_pred CCcceeeeeeEE---EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 006277 3 RQKWSLLILMYL---RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 79 (652)
Q Consensus 3 ~~~W~~~~~~~~---rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 79 (652)
+..|.+....|. +|++++.|+||+|.+..+|..||+|.+... ....+++.+|+.++++++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 79 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 456766655443 455555689999999999999999998643 345778999999999999999999999886
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEec
Q 006277 80 DDQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 157 (652)
Q Consensus 80 d~~~~~~~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~D 157 (652)
+.. .+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|
T Consensus 80 ~~~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~D 154 (288)
T 3kfa_A 80 REP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVAD 154 (288)
T ss_dssp SSS--SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEEC-GGGCEEECC
T ss_pred cCC--CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEc-CCCCEEEcc
Confidence 554 799999999999999999874 45999999999999999999999998 99999999999998 678999999
Q ss_pred cCchhhhhccc---cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCcc
Q 006277 158 LGLATIMEQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAA 232 (652)
Q Consensus 158 FGla~~l~~~~---~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~ 232 (652)
||++....... .....||+.|+|||++. ..++.++|||||||++|+|++ |.+||.. .+..++...+.....+ .
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~ 232 (288)
T 3kfa_A 155 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-E 232 (288)
T ss_dssp CCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-C
T ss_pred CccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhccCCC-C
Confidence 99998765432 23456788999999774 679999999999999999999 9999977 4556666666665433 3
Q ss_pred ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 233 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 233 l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.+...++.+++||.+||. +|.+|||+.++++.
T Consensus 233 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence 445678999999999998 89999999999863
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=331.98 Aligned_cols=241 Identities=24% Similarity=0.377 Sum_probs=192.2
Q ss_pred EEEEEEecCcEEEEEEEccC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~t---G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
...|++++.|+||+|.+..+ +..||+|.+... ......+++.+|+.++++++||||+++++++.+ ..+|+|
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~lv 93 (281)
T 1mp8_A 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWII 93 (281)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSCEEE
T ss_pred EeEeeecCCeeEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---CccEEE
Confidence 35677788899999999764 567999987532 245677889999999999999999999998732 358999
Q ss_pred EecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 90 TELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
|||+.+|+|.+++...+ .+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC-----------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEEC-CCCCEEECccccccccCccc
Confidence 99999999999998664 6999999999999999999999998 99999999999998 66899999999998775432
Q ss_pred ---cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHH
Q 006277 169 ---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 243 (652)
Q Consensus 169 ---~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kd 243 (652)
.....||+.|+|||++. ..|+.++|||||||++|+|++ |..||.+. ....+...+..+..+ ..+...++.+.+
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~-~~~~~~~~i~~~~~~-~~~~~~~~~l~~ 248 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENGERL-PMPPNCPPTLYS 248 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC-CHHHHHHHHHcCCCC-CCCCCCCHHHHH
Confidence 23456788999999874 578999999999999999996 99999874 445566666665432 345567899999
Q ss_pred HHHHhCC-CCCCCCCHHHHhcC
Q 006277 244 FIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~h 264 (652)
||.+||. +|.+|||+.+++++
T Consensus 249 li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 249 LMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999998 89999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=326.19 Aligned_cols=239 Identities=19% Similarity=0.377 Sum_probs=203.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...++++..|+||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.. .+++||||
T Consensus 13 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 84 (267)
T 3t9t_A 13 VQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PICLVTEF 84 (267)
T ss_dssp EEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SCEEEECC
T ss_pred eeEecCCCceeEEEEEec-CCCeEEEEEccccCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--CeEEEEeC
Confidence 456777888999999986 788999999875432 2367889999999999999999999886654 68999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
+.+|+|.+++... +.+++..+..++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-GGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEC-CCCCEEEcccccccccccccccc
Confidence 9999999999875 56899999999999999999999998 99999999999998 67899999999998764322
Q ss_pred cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
.....||+.|+|||++. ..++.++|||||||++|+|++ |.+||.. .....+...+..+..+ ..+...++.+++||.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~ 239 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTHVYQIMN 239 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHHHHHHHH
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC-CCHHHHHHHHhcCCcC-CCCccCcHHHHHHHH
Confidence 23456788999999875 678999999999999999999 8999987 5666777777776433 344567899999999
Q ss_pred HhCC-CCCCCCCHHHHhcC
Q 006277 247 KCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~h 264 (652)
+||. +|.+|||+.+++++
T Consensus 240 ~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 240 HCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHH
Confidence 9998 89999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.04 Aligned_cols=238 Identities=27% Similarity=0.428 Sum_probs=202.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe------------
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID------------ 80 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d------------ 80 (652)
...++++..|.||+|.+..+|+.||+|.+.... +.+.+|+++++.++||||++++++|.+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred eeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 356777778999999999999999999987532 356789999999999999999998864
Q ss_pred --CCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEe
Q 006277 81 --DQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 156 (652)
Q Consensus 81 --~~~~~~~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~ 156 (652)
.....+++|||||.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~ 164 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV-DTKQVKIG 164 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEEC
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEc-CCCCEEEC
Confidence 1234689999999999999999765 57999999999999999999999998 99999999999998 67899999
Q ss_pred ccCchhhhhccc-cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc
Q 006277 157 DLGLATIMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS 234 (652)
Q Consensus 157 DFGla~~l~~~~-~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 234 (652)
|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.. ....+..+..+.. +
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~~~~~~~----~ 237 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGII----S 237 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---HHHHHHHHHTTCC----C
T ss_pred cchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---HHHHHHHhhcccc----c
Confidence 999998765432 34568999999999874 5689999999999999999999998853 2344555555433 3
Q ss_pred CCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 235 KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 235 ~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
...++.+++||.+||. +|.+|||+.|+++|.+.-
T Consensus 238 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 4567899999999997 899999999999998864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=330.84 Aligned_cols=240 Identities=17% Similarity=0.170 Sum_probs=199.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...++++..|+||+|.+..+|+.||+|++.... ..+.+.+|+.+++.+ +|+||+++++++.+.. ..++|||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~--~~~lv~e 86 (298)
T 1csn_A 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL--HNVLVID 86 (298)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--EEEEEEE
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeccCC------ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc--eeEEEEE
Confidence 357888888999999999999999999986443 234578899999999 8999999999887654 8999999
Q ss_pred cCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCc-----EEEeccCchhhhh
Q 006277 92 LFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE-----VKIGDLGLATIME 165 (652)
Q Consensus 92 y~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~-----VKL~DFGla~~l~ 165 (652)
|+ +|+|.+++...+ ++++..++.++.||+.||.|||++| |+||||||+|||++ .++. +||+|||++....
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIG-RPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-CSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-cCCCCCCCeEEEEECccccccc
Confidence 99 999999998754 5999999999999999999999998 99999999999997 3344 9999999998765
Q ss_pred ccc---------cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCC--CHHHHHHHHhcCC---CC
Q 006277 166 QAN---------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECR--NSAQIYKKVSSGI---KP 230 (652)
Q Consensus 166 ~~~---------~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~--~~~~i~~~I~~g~---~p 230 (652)
... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.. ...+.+..+..+. ..
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 321 24568999999999874 568999999999999999999999997643 3445555444332 12
Q ss_pred ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 231 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 231 ~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
..+....++++++||.+||. +|.+||++.++++.
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 243 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 22334568899999999997 89999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=340.72 Aligned_cols=251 Identities=27% Similarity=0.394 Sum_probs=208.0
Q ss_pred Ccceeeeee---EEEEEEecCcEEEEEEEc-------cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCee
Q 006277 4 QKWSLLILM---YLRLIQLVDTSGYKAFDE-------VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNII 72 (652)
Q Consensus 4 ~~W~~~~~~---~~rL~~l~~gtVykA~d~-------~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIV 72 (652)
+.|.+.... -..|++++.|+||+|.+. .++..||+|++.... .....+++.+|+.+++.+ +||||+
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv 104 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNII 104 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEe
Confidence 455543332 346777777999999986 578899999986432 356778899999999999 999999
Q ss_pred eeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 006277 73 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIH 136 (652)
Q Consensus 73 kl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiH 136 (652)
++++++.+.. .+|+|||||.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+|
T Consensus 105 ~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH 180 (334)
T 2pvf_A 105 NLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIH 180 (334)
T ss_dssp CEEEEECSSS--CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred eEEEEEccCC--ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeC
Confidence 9999886544 7899999999999999998754 3899999999999999999999998 999
Q ss_pred ccCCcccEEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCC
Q 006277 137 RDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYP 210 (652)
Q Consensus 137 RDLKp~NILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~P 210 (652)
|||||+|||++ .++.+||+|||++....... .....||+.|+|||++ ...|+.++|||||||++|+|++ |..|
T Consensus 181 ~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 259 (334)
T 2pvf_A 181 RDLAARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259 (334)
T ss_dssp SCCSGGGEEEC-TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCccceEEEc-CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999998 67899999999998765422 2345678999999977 4568999999999999999999 9999
Q ss_pred CCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 211 YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 211 f~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
|.+ .....+...+..+..+ ..+...++++++||.+||. +|.+|||+.+++++
T Consensus 260 ~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 260 YPG-IPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp STT-CCHHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCc-CCHHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 987 5667777777776533 3445678999999999998 89999999999976
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=340.34 Aligned_cols=244 Identities=22% Similarity=0.339 Sum_probs=205.3
Q ss_pred EEEEEEecCcEEEEEE----EccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~----d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
...|+++..|+||+|. +..+|+.||+|++... .....+++.+|++++++++||||+++++++.......+++
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 4678888889999999 5789999999998743 3567788999999999999999999999998776678999
Q ss_pred EEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 89 ITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
|||||.+|+|.+++.. .+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCGGGCEECCTT
T ss_pred EEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEEC-CCCCEEEcccccceecccC
Confidence 9999999999999987 456999999999999999999999998 99999999999998 6789999999999876432
Q ss_pred c-----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCC--------------HHHHHHHHhcC
Q 006277 168 N-----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRN--------------SAQIYKKVSSG 227 (652)
Q Consensus 168 ~-----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~--------------~~~i~~~I~~g 227 (652)
. .....||+.|+|||++. ..|+.++|||||||++|+|++|..||..... ...+...+..+
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence 2 23457889999999774 5689999999999999999999999854221 12333444444
Q ss_pred CCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 228 IKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 228 ~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
. ....+...++.+++||.+||. +|.+|||+.+++++
T Consensus 261 ~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 261 Q-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 333456678999999999998 89999999999755
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=333.00 Aligned_cols=241 Identities=31% Similarity=0.446 Sum_probs=195.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+|++++.|+||+|.+.. .||+|+++... ......+.+.+|+.+|++++||||++++++.. . ..+++||||
T Consensus 29 ~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~--~~~~lv~e~ 100 (289)
T 3og7_A 29 GQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-A--PQLAIVTQW 100 (289)
T ss_dssp EEEEEECSSEEEEEEESSS---EEEEEEESCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S--SSCEEEEEC
T ss_pred eeEecCCCCeEEEEEEEcC---ceEEEEEeccC--CCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-C--CccEEEEEe
Confidence 3678888889999997643 59999987543 34677889999999999999999999999543 2 258999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc----
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA---- 167 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~---- 167 (652)
|.+++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTTEEEECCCC------------
T ss_pred cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEEC-CCCCEEEccceeccccccccccc
Confidence 9999999998644 57999999999999999999999998 99999999999998 5689999999999866432
Q ss_pred ccccccCCCCccCccccc----cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccc---cCCCChH
Q 006277 168 NAKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL---SKVKDPE 240 (652)
Q Consensus 168 ~~~~~vGTp~YmAPEvl~----~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l---~~~~s~~ 240 (652)
......||+.|+|||++. ..|+.++|||||||++|+|++|..||........+...+..+..+..+ ....++.
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHH
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHH
Confidence 234568999999999773 468889999999999999999999999878888888888776644433 3456789
Q ss_pred HHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 241 VKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 241 ~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
+++||.+||. +|.+|||+.++++.
T Consensus 258 l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 258 MKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHH
Confidence 9999999998 89999999999863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=340.32 Aligned_cols=247 Identities=22% Similarity=0.311 Sum_probs=204.3
Q ss_pred EEEEEEecCcEEEEEE-----EccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 006277 13 YLRLIQLVDTSGYKAF-----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~-----d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~ 87 (652)
...|++++.|+||+|. +..+|..||+|.+... .......++.+|+.++++++||||+++++++.+.. .+|
T Consensus 35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 109 (327)
T 2yfx_A 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL--PRF 109 (327)
T ss_dssp EEECC--CSSCEEEEEC--------CCEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCE
T ss_pred EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc---cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC--CcE
Confidence 3567777789999999 6678999999998632 23566778999999999999999999999987654 689
Q ss_pred EEEecCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC--CCCcEEEecc
Q 006277 88 IITELFTSGSLRQYRKKHK-------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDL 158 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~-------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~--~~g~VKL~DF 158 (652)
+|||||.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++. ..+.+||+||
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEECcc
Confidence 9999999999999998763 4899999999999999999999998 999999999999983 3346999999
Q ss_pred Cchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCcc
Q 006277 159 GLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAA 232 (652)
Q Consensus 159 Gla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~ 232 (652)
|++....... .....||+.|+|||++ ...|+.++|||||||++|+|+| |..||.. .....+...+..+..+ .
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~ 265 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRM-D 265 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCC-C
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-cCHHHHHHHHhcCCCC-C
Confidence 9998764332 2346789999999977 5678999999999999999998 9999977 5666777777776543 3
Q ss_pred ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 233 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 233 l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
.+...++.+.+||.+||. +|.+|||+.++++|.|+.
T Consensus 266 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 266 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 445678899999999998 899999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=331.76 Aligned_cols=239 Identities=19% Similarity=0.296 Sum_probs=201.5
Q ss_pred EEEEecCcEEEEEE--EccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 15 RLIQLVDTSGYKAF--DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 15 rL~~l~~gtVykA~--d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
.|++++.|+||+|. +..+++.||+|++.... ..+...+++.+|+.+++.++||||+++++++.. ..+++||||
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~ 98 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEM 98 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEEC
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC---CCcEEEEEe
Confidence 68888889999995 46678999999987543 234557889999999999999999999998832 368999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc----
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---- 168 (652)
+.+|+|.+++...+.+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 99 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (291)
T 1xbb_A 99 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYK 175 (291)
T ss_dssp CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCSEEE
T ss_pred CCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEe-CCCcEEEccCCcceeeccCCCccc
Confidence 999999999999889999999999999999999999998 99999999999998 66899999999998764322
Q ss_pred -cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHH
Q 006277 169 -AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI 245 (652)
.....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+ ....++...+..+..+ ..+...++.+++||
T Consensus 176 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 253 (291)
T 1xbb_A 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYDLM 253 (291)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHH
Confidence 12345778999999874 468999999999999999999 9999987 5666777777776543 34566789999999
Q ss_pred HHhCC-CCCCCCCHHHHhc
Q 006277 246 EKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 246 ~kcL~-~P~~RpSa~elL~ 263 (652)
.+||. +|.+|||+.++++
T Consensus 254 ~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 254 NLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHTCSSTTTSCCHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 99998 8999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=331.31 Aligned_cols=241 Identities=18% Similarity=0.310 Sum_probs=204.5
Q ss_pred EEEEecCcEEEEEEEc--cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 15 RLIQLVDTSGYKAFDE--VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 15 rL~~l~~gtVykA~d~--~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
.|+++..|+||+|.+. .+|..||+|++... ......+++.+|++++++|+||||+++++++.. ..+++||||
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~ 90 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEM 90 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEEC
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---CCcEEEEEe
Confidence 5777777999999864 57899999998754 245678899999999999999999999998843 258999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~ 167 (287)
T 1u59_A 91 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYY 167 (287)
T ss_dssp CTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEECTTCSCEE
T ss_pred CCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEc-CCCCEEECcccceeeeccCccee
Confidence 9999999998654 56999999999999999999999998 99999999999998 67899999999998764322
Q ss_pred --cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 169 --AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
.....||+.|+|||++. ..++.++|||||||++|+|++ |..||... ....+...+..+..+ ..+...++++++|
T Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~l~~l 245 (287)
T 1u59_A 168 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECPPECPPELYAL 245 (287)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHhcCCcC-CCCCCcCHHHHHH
Confidence 23446789999999874 578999999999999999998 99999874 455666777766533 3456678999999
Q ss_pred HHHhCC-CCCCCCCHHHHhcCcc
Q 006277 245 IEKCLV-PASQRLSAKELLMDPF 266 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~hpf 266 (652)
|.+||. +|.+||++.+++++.+
T Consensus 246 i~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 246 MSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHHHH
Confidence 999998 8999999999998864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=334.67 Aligned_cols=244 Identities=21% Similarity=0.319 Sum_probs=194.7
Q ss_pred EEEEEecCcEEEEEEEcc---CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC---eEE
Q 006277 14 LRLIQLVDTSGYKAFDEV---NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK---TVN 87 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~---tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~---~~~ 87 (652)
..+++++.|+||+|.+.. +++.||+|.+..... .....+++.+|+.++++++||||+++++++.+.... ..+
T Consensus 40 ~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEE
T ss_pred cceeecCCeEEEEEEEeccCCceeEEEEEEEecccc--chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccE
Confidence 457777789999998876 677999999875432 456778899999999999999999999998765432 469
Q ss_pred EEEecCCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCch
Q 006277 88 IITELFTSGSLRQYRKK------HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 161 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~------~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla 161 (652)
+||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~~~~kl~Dfg~~ 194 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLR-DDMTVCVADFGLS 194 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEEC-TTSCEEECSCSCC
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCcEEEeecCcc
Confidence 99999999999999853 356999999999999999999999998 99999999999998 6689999999999
Q ss_pred hhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccC
Q 006277 162 TIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSK 235 (652)
Q Consensus 162 ~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~ 235 (652)
..+.... .....|++.|+|||++ ...|+.++|||||||++|+|++ |.+||.+ .....++..+..+..+ ..+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 272 (313)
T 3brb_A 195 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG-VQNHEMYDYLLHGHRL-KQPE 272 (313)
T ss_dssp ----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCBT
T ss_pred eecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCcc-CCHHHHHHHHHcCCCC-CCCc
Confidence 8764432 2345678899999977 4568999999999999999999 8899977 4555666666666533 3445
Q ss_pred CCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 236 VKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 236 ~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
..++.+.+||.+||. +|.+|||+.+++.+
T Consensus 273 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 273 DCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 678899999999997 89999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=330.12 Aligned_cols=243 Identities=16% Similarity=0.240 Sum_probs=203.9
Q ss_pred EEEEEecCcEEEEEEEccCCe---EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGL---EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~---~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
..|++++.|+||+|.+..++. .||+|.+... ......+++.+|+.+++.++||||+++++++.+.. ...++||
T Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~v~ 102 (298)
T 3pls_A 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI---TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-GLPHVLL 102 (298)
T ss_dssp EEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCCEEEE
T ss_pred ceeccCCCceEEEEEEecCCCceeeeeeeecccc---ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-CCcEEEE
Confidence 578899999999999766544 8999987632 34567889999999999999999999999987654 3458999
Q ss_pred ecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--
Q 006277 91 ELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-- 167 (652)
Q Consensus 91 Ey~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 167 (652)
||+.+|+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+...
T Consensus 103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLD-ESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECCTTSSCTTTTGGG
T ss_pred ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCcEEeCcCCCcccccCCcc
Confidence 99999999999987 457899999999999999999999998 99999999999998 6789999999999865432
Q ss_pred ----ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 168 ----NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 168 ----~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
......||+.|+|||++. ..|+.++|||||||++|+|++|..||....+...+...+..+..+ ..+...++.++
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 258 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-PQPEYCPDSLY 258 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-CCCTTCCHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-CCCccchHHHH
Confidence 234567899999999875 478999999999999999999666655556667777777766533 34556788999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcC
Q 006277 243 SFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~h 264 (652)
+||.+||. +|.+|||+.++++.
T Consensus 259 ~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 259 QVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999998 89999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=336.65 Aligned_cols=243 Identities=26% Similarity=0.333 Sum_probs=182.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEe------CCCCe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWID------DQNKT 85 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d------~~~~~ 85 (652)
...|+++..|+||+|.+..+|+.||+|++... .....+.+.+|+.+++++. ||||+++++++.. .....
T Consensus 33 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred EEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 35666777799999999999999999998644 3566788999999999995 9999999998853 33446
Q ss_pred EEEEEecCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 86 VNIITELFTSGSLRQYRKK---HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 86 ~~LVmEy~~gGsL~~~i~~---~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
+++|||||. |+|.+++.. .+.+++..++.++.||+.||.|||++|++|+||||||+|||++ .++.+||+|||++.
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSAT 186 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC-TTSCEEBCCCTTCB
T ss_pred EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC-CCCCEEEecCccce
Confidence 899999995 699888765 5679999999999999999999999987799999999999998 67899999999998
Q ss_pred hhhccc--------------cccccCCCCccCcccc----ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 006277 163 IMEQAN--------------AKSVIGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 224 (652)
Q Consensus 163 ~l~~~~--------------~~~~vGTp~YmAPEvl----~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I 224 (652)
...... .....||+.|+|||++ ...++.++|||||||++|+|++|..||..... ..+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~---- 261 (337)
T 3ll6_A 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK-LRI---- 261 (337)
T ss_dssp CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH-HHh----
Confidence 764321 1245799999999987 34688999999999999999999999976332 222
Q ss_pred hcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcc
Q 006277 225 SSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPF 266 (652)
Q Consensus 225 ~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf 266 (652)
..+..........++.+++||.+||. +|.+|||+.|+++|-+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 22222223344556789999999998 8999999999999854
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=330.66 Aligned_cols=240 Identities=22% Similarity=0.378 Sum_probs=197.9
Q ss_pred EEEEEecCcEEEEEEEcc---CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEV---NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~---tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
..+++++.|+||+|.+.. ++..||+|.+.... .....+++.+|+.+++.++||||+++++++.+. ..|+||
T Consensus 18 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~v~ 91 (281)
T 3cc6_A 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE---PTWIIM 91 (281)
T ss_dssp EEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS---SCEEEE
T ss_pred EEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---CCEEEE
Confidence 567777779999999654 45679999887432 356778999999999999999999999987543 468999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 91 ELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
||+.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 92 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 92 ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVA-SPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp ECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-ETTEEEECCCCGGGCC-----
T ss_pred ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEC-CCCcEEeCccCCCcccccccc
Confidence 999999999999765 45999999999999999999999998 99999999999998 67899999999998765432
Q ss_pred --cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 169 --AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
.....||+.|+|||++. ..|+.++|||||||++|+|++ |..||... ........+..+..+ ..+...++.+.+|
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 246 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL-ENKDVIGVLEKGDRL-PKPDLCPPVLYTL 246 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CGGGHHHHHHHTCCC-CCCTTCCHHHHHH
T ss_pred cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC-ChHHHHHHHhcCCCC-CCCCCCCHHHHHH
Confidence 23456788999999874 578999999999999999998 99999763 334455555555432 3345678999999
Q ss_pred HHHhCC-CCCCCCCHHHHhcC
Q 006277 245 IEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~h 264 (652)
|.+||. +|.+|||+.+++++
T Consensus 247 i~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 247 MTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCCchhCcCHHHHHHH
Confidence 999998 89999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=343.51 Aligned_cols=241 Identities=21% Similarity=0.346 Sum_probs=198.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeE----EEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLE----VAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~----VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
...|++++.|+||+|.+..+|.. ||+|.+.... ......++.+|+.++++++||||+++++++.+ ..+++
T Consensus 18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~ 91 (325)
T 3kex_A 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS---GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---SSLQL 91 (325)
T ss_dssp EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT---SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---SSEEE
T ss_pred eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc---cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CccEE
Confidence 45778888899999999998887 5666554222 12334567889999999999999999998753 35899
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 89 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
||||+.+|+|.+++... +.+++..+..|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLK-SPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEES-SSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEEC-CCCeEEECCCCcccccCcc
Confidence 99999999999999875 57999999999999999999999999 99999999999998 6789999999999887543
Q ss_pred c----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHH
Q 006277 168 N----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 168 ~----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~ 241 (652)
. .....||+.|+|||++. +.|+.++|||||||++|+|++ |..||.+ .....+...+..+.. ...+...++++
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~ 246 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG-LRLAEVPDLLEKGER-LAQPQICTIDV 246 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCTTHHHHHHHTTCB-CCCCTTBCTTT
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccc-cCHHHHHHHHHcCCC-CCCCCcCcHHH
Confidence 2 24567888999999874 679999999999999999999 9999987 445556666666543 23445567889
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 242 KSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.+||.+||. +|.+|||+.+++++
T Consensus 247 ~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 247 YMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp THHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999998 89999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.54 Aligned_cols=243 Identities=23% Similarity=0.343 Sum_probs=204.5
Q ss_pred EEEEEEecCcEEEEEEEccCCe-----EEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGL-----EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTV 86 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~-----~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~ 86 (652)
...|++++.|+||+|.+..+|. .||+|.+.... ..+..+.+.+|+.+|+.| +||||+++++++.+.. .+
T Consensus 51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~ 125 (333)
T 2i1m_A 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG--PV 125 (333)
T ss_dssp EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SC
T ss_pred eeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC--ce
Confidence 3567777789999999987765 79999886432 356778899999999999 8999999999886544 79
Q ss_pred EEEEecCCCCCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCc
Q 006277 87 NIITELFTSGSLRQYRKKH--------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE 152 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~~--------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~ 152 (652)
++|||||.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++ .++.
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~ 202 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLT-NGHV 202 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEE-GGGE
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEEC-CCCe
Confidence 9999999999999998753 45899999999999999999999998 99999999999998 6789
Q ss_pred EEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhc
Q 006277 153 VKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSS 226 (652)
Q Consensus 153 VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~ 226 (652)
+||+|||++....... .....||+.|+|||++ ...|+.++|||||||++|+|++ |..||.+..........+..
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 282 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc
Confidence 9999999998764432 2345678899999976 5679999999999999999998 99999886666666666655
Q ss_pred CCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 227 GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 227 g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
+.. ...+...++.+.+||.+||. +|.+|||+.+++++
T Consensus 283 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 283 GYQ-MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp TCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 543 33455668899999999998 89999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=329.97 Aligned_cols=238 Identities=26% Similarity=0.378 Sum_probs=189.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHh--CCCCCeeeeeeEEEeC--CCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKS--LKHNNIIRFYNSWIDD--QNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~--L~HpnIVkl~~~~~d~--~~~~~~L 88 (652)
...|++++.|+||+|.+ +|+.||+|++.. .....+.+|.+++.. ++||||+++++++.+. ....+++
T Consensus 13 ~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-------~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 13 LECVGKGRYGEVWRGSW--QGENVAVKIFSS-------RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp EEEEEECSSEEEEEEEE--TTEEEEEEEECG-------GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeccCCCcEEEEEEE--CCEEEEEEEecc-------ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 46888888999999987 799999999863 234556667777777 7999999999987653 2346899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeeeccCCcccEEEcCCCCcEEEeccCc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH--------SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLH--------s~g~~IiHRDLKp~NILl~~~~g~VKL~DFGl 160 (652)
||||+.+|+|.++++ ...+++..+..++.||+.||.||| +++ |+||||||+|||++ .++.+||+|||+
T Consensus 84 v~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVK-KNGQCCIADLGL 159 (301)
T ss_dssp EECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEEC-TTSCEEECCCTT
T ss_pred ehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEc-CCCCEEEeeCCC
Confidence 999999999999995 457999999999999999999999 777 99999999999998 678999999999
Q ss_pred hhhhhccc------cccccCCCCccCcccccc-------CCCccccchhhHHHHHHHhhc----------cCCCCCCC--
Q 006277 161 ATIMEQAN------AKSVIGTPEFMAPELYDE-------NYNELADIYSFGMCMLEMVTF----------EYPYSECR-- 215 (652)
Q Consensus 161 a~~l~~~~------~~~~vGTp~YmAPEvl~~-------~y~~~sDIWSlGvilyeLltG----------~~Pf~~~~-- 215 (652)
+....... ....+||+.|+|||++.+ .++.++|||||||++|+|++| ..||....
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 97654322 234589999999998754 355789999999999999999 88886532
Q ss_pred --CHHHHHHHHhcCCCCcccc-----CCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 216 --NSAQIYKKVSSGIKPAALS-----KVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 216 --~~~~i~~~I~~g~~p~~l~-----~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
....+...+........++ ...++++.+||.+||. +|.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2233333333222222222 2234679999999998 8999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=335.39 Aligned_cols=244 Identities=23% Similarity=0.300 Sum_probs=199.8
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+|++++.|+||+|.+ +|..||+|++.........+..+++.+|+.+++.++||||+++++++.+.. .+++||||+
T Consensus 37 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 112 (307)
T 2nru_A 37 NKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD--DLCLVYVYM 112 (307)
T ss_dssp CEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECC
T ss_pred CccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC--ceEEEEEec
Confidence 5789999999999985 689999999875443344566788999999999999999999999886554 789999999
Q ss_pred CCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 94 TSGSLRQYRKK---HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 94 ~gGsL~~~i~~---~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
.+|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECCSCSSC
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEc-CCCcEEEeeccccccccccccc
Confidence 99999999874 356999999999999999999999998 99999999999998 67899999999987654321
Q ss_pred --cccccCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHH---HHHHHHhcCCC---------Ccccc
Q 006277 169 --AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSA---QIYKKVSSGIK---------PAALS 234 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~---~i~~~I~~g~~---------p~~l~ 234 (652)
.....||+.|+|||++.+.++.++|||||||++|+|++|.+||....... .+...+..... ....+
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD 269 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred ccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccc
Confidence 24568999999999998889999999999999999999999997643322 23333322211 01111
Q ss_pred CCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 235 KVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 235 ~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
...+..+.++|.+||. +|.+|||+.+++++
T Consensus 270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2234678999999998 89999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=338.46 Aligned_cols=244 Identities=24% Similarity=0.376 Sum_probs=195.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecc-cCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDD-VLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~-~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...|++++.|+||+|.+..+|+.||+|++.+.- ........+++.+|+.+++.++||||+++++++.+. ..++|++
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---~~~~v~~ 96 (327)
T 3lzb_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQ 96 (327)
T ss_dssp EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS---SEEEEEC
T ss_pred EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC---CceEEEE
Confidence 467888888999999999998876544332211 111234577899999999999999999999998764 3889999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--
Q 006277 92 LFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 168 (652)
Q Consensus 92 y~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 168 (652)
|+.+|+|.+++... +.+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+....
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kL~DfG~a~~~~~~~~~ 173 (327)
T 3lzb_A 97 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp CCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCTTC----------
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEc-CCCCEEEccCcceeEccCcccc
Confidence 99999999998874 57999999999999999999999998 99999999999998 67899999999998764332
Q ss_pred --cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 169 --AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
.....||+.|+|||++ ...|+.++|||||||++|+|++ |..||.+ .....+...+..+..+ ..+...++++.+|
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 251 (327)
T 3lzb_A 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICTIDVYMI 251 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCTTBCHHHHHH
T ss_pred ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCC-CCCccCCHHHHHH
Confidence 2345678899999976 5579999999999999999999 9999977 4555666666665433 3455678899999
Q ss_pred HHHhCC-CCCCCCCHHHHhcC
Q 006277 245 IEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~h 264 (652)
|.+||. +|.+|||+.|+++.
T Consensus 252 i~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 252 MRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHH
Confidence 999998 89999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=351.48 Aligned_cols=245 Identities=19% Similarity=0.352 Sum_probs=202.3
Q ss_pred Ccceeeee---eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 006277 4 QKWSLLIL---MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 80 (652)
Q Consensus 4 ~~W~~~~~---~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 80 (652)
..|..... ....|+++..|.||+|.+. |..||+|+++... ..+.+.+|+.+|++|+|||||++++++.+
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 257 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVE 257 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence 34544433 3457777778999999874 8899999987432 35678999999999999999999998876
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEecc
Q 006277 81 DQNKTVNIITELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 158 (652)
Q Consensus 81 ~~~~~~~LVmEy~~gGsL~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DF 158 (652)
.. ..+|+|||||.+|+|.+++...+. +++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+||
T Consensus 258 ~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~Df 333 (450)
T 1k9a_A 258 EK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDF 333 (450)
T ss_dssp TT-SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTSCEEECCC
T ss_pred CC-CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEC-CCCCEEEeeC
Confidence 54 369999999999999999987654 799999999999999999999999 99999999999998 6789999999
Q ss_pred CchhhhhccccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCC
Q 006277 159 GLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKV 236 (652)
Q Consensus 159 Gla~~l~~~~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~ 236 (652)
|+++..... .....+|+.|+|||++ ...|+.++|||||||++|||++ |..||.+. ...++...+..+..+ ..+..
T Consensus 334 G~a~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~-~~p~~ 410 (450)
T 1k9a_A 334 GLTKEASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKM-DAPDG 410 (450)
T ss_dssp TTCEECC-------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS-CTTTHHHHHHTTCCC-CCCTT
T ss_pred CCccccccc-ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCc
Confidence 999854432 2334778999999977 5679999999999999999998 99999874 445566777776543 34566
Q ss_pred CChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 237 KDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 237 ~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
.++++.+||.+||. +|.+|||+.+++.
T Consensus 411 ~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 411 CPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78999999999997 8999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=345.60 Aligned_cols=241 Identities=22% Similarity=0.338 Sum_probs=192.9
Q ss_pred EEEEEEecCcEEEEEEEc---cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~---~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
...|++++.|+||+|.+. .++..||+|+++... .....+++.+|+.+|++++||||+++++++.+.. .+++|
T Consensus 50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv 124 (373)
T 2qol_A 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK--PVMIV 124 (373)
T ss_dssp CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--SCEEE
T ss_pred eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--ceEEE
Confidence 367888999999999987 578889999986432 3567788999999999999999999999886543 78999
Q ss_pred EecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 90 TELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
||||.+|+|.+++...+ .+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEc-CCCCEEECcCccccccccCC
Confidence 99999999999998764 6999999999999999999999998 99999999999998 67899999999998775432
Q ss_pred -----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHH
Q 006277 169 -----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 169 -----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~ 241 (652)
.....+|+.|+|||++. +.|+.++|||||||++|||++ |..||.+ .....+...+..+... ..+...+..+
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l 279 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-MSNQDVIKAVDEGYRL-PPPMDCPAAL 279 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT-CCHHHHHHHHHTTEEC-CCCTTCBHHH
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCccccHHH
Confidence 12234578899999774 679999999999999999998 9999987 4566677777766432 2234567899
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhc
Q 006277 242 KSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
.+||.+||. +|.+||++.++++
T Consensus 280 ~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 280 YQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCcChhhCcCHHHHHH
Confidence 999999998 8999999999886
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=324.08 Aligned_cols=242 Identities=21% Similarity=0.205 Sum_probs=195.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.+..+|+.||+|++..... .+++.+|+.+++.++|++++..+..+... ....++||||
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~e~ 86 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVMEL 86 (296)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEEEEEC
T ss_pred EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCccccccCC-CCceEEEEEe
Confidence 3577888889999999999999999999875432 23588999999999998877777665443 3488999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEc--CCCCcEEEeccCchhhhhccc-
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~--~~~g~VKL~DFGla~~l~~~~- 168 (652)
+ +|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..++.+||+|||++.......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 9 9999999974 467999999999999999999999998 99999999999994 356789999999998765432
Q ss_pred --------cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCC--HHHHHHHHhcCC---CCcccc
Q 006277 169 --------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRN--SAQIYKKVSSGI---KPAALS 234 (652)
Q Consensus 169 --------~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~--~~~i~~~I~~g~---~p~~l~ 234 (652)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||.+... ..+.+..+.... ....+.
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 243 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHH
Confidence 24568999999999774 4789999999999999999999999976322 122333332211 112233
Q ss_pred CCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 235 KVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 235 ~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
...++++.+||.+||. +|.+|||+.++++.
T Consensus 244 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 5568899999999998 89999999998863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=326.47 Aligned_cols=236 Identities=19% Similarity=0.340 Sum_probs=191.6
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...+++++.|+||+|.+ +|..||+|++... ...+++.+|+.++++++||||+++++++.+.. ..+++||||
T Consensus 26 ~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~e~ 96 (278)
T 1byg_A 26 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEY 96 (278)
T ss_dssp EEEEEECSSCEEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEECC
T ss_pred EeEEecCCCceEEEEEE--cCCEEEEEEecch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-CceEEEEec
Confidence 45677777799999986 4899999998643 24578899999999999999999999876543 368999999
Q ss_pred CCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccc
Q 006277 93 FTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~ 170 (652)
+.+|+|.+++...+. +++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...... ..
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~-~~ 172 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST-QD 172 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEe-CCCcEEEeecccccccccc-cc
Confidence 999999999987643 899999999999999999999998 99999999999998 6789999999999865543 23
Q ss_pred cccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 171 SVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 171 ~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
...+|+.|+|||++ ...++.++|||||||++|+|++ |..||.. .+...+...+..+.. ...+...++.++++|.+|
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~ 250 (278)
T 1byg_A 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYK-MDAPDGCPPAVYEVMKNC 250 (278)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCC-CCCCTTCCHHHHHHHHHH
T ss_pred CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCC-CCCcccCCHHHHHHHHHH
Confidence 45689999999987 4578999999999999999998 9999977 455666667766643 334556789999999999
Q ss_pred CC-CCCCCCCHHHHhc
Q 006277 249 LV-PASQRLSAKELLM 263 (652)
Q Consensus 249 L~-~P~~RpSa~elL~ 263 (652)
|. +|.+|||+.++++
T Consensus 251 l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 251 WHLDAAMRPSFLQLRE 266 (278)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred hcCChhhCCCHHHHHH
Confidence 97 8999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=350.21 Aligned_cols=240 Identities=25% Similarity=0.316 Sum_probs=184.4
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..||++..|+||.+ +..+|+.||+|++... ..+.+.+|+++|+++ +|||||++++++.+.. .+|+||||
T Consensus 21 ~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~--~~~lv~E~ 90 (434)
T 2rio_A 21 KILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-------FCDIALMEIKLLTESDDHPNVIRYYCSETTDR--FLYIALEL 90 (434)
T ss_dssp EEEEECSTTCEEEE-EESSSSEEEEEEEEGG-------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS--EEEEEECC
T ss_pred CeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC--eEEEEEec
Confidence 45788888999875 5678999999998642 345678899999987 8999999999887654 89999999
Q ss_pred CCCCCHHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC------------CCCcE
Q 006277 93 FTSGSLRQYRKKHKKVD-------MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING------------NQGEV 153 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~ls-------e~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~------------~~g~V 153 (652)
|. |+|.+++...+... +..++.++.||+.||+|||++| |+||||||+|||++. ..+.+
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 95 69999998765433 2345789999999999999998 999999999999973 23489
Q ss_pred EEeccCchhhhhccc------cccccCCCCccCccccc--------cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHH
Q 006277 154 KIGDLGLATIMEQAN------AKSVIGTPEFMAPELYD--------ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSA 218 (652)
Q Consensus 154 KL~DFGla~~l~~~~------~~~~vGTp~YmAPEvl~--------~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~ 218 (652)
||+|||+++.+.... ....+||+.|+|||++. ..++.++|||||||++|+|+| |..||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999998765432 23568999999999874 458899999999999999999 999997644332
Q ss_pred HHHHHHhcCCCC-ccccC----CCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 219 QIYKKVSSGIKP-AALSK----VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 219 ~i~~~I~~g~~p-~~l~~----~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
..+..+... ..... ..++++++||.+||. +|.+|||+.++|+||||..
T Consensus 248 ---~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 248 ---SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp ---HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred ---HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 223333211 11111 234789999999998 8999999999999999963
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=323.57 Aligned_cols=245 Identities=23% Similarity=0.390 Sum_probs=203.5
Q ss_pred cceeeee---eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 006277 5 KWSLLIL---MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 81 (652)
Q Consensus 5 ~W~~~~~---~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 81 (652)
.|.+... ...+|++++.|+||+|.+. ++..||+|.+.... ...+.+.+|+++|+.++||||+++++++.+.
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-----ccHHHHHHHHHHHHhCCCcCcceEEEEEcCC
Confidence 4555433 3456777777999999975 67889999986432 2356788999999999999999999987532
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccC
Q 006277 82 QNKTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 159 (652)
Q Consensus 82 ~~~~~~LVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFG 159 (652)
.+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||
T Consensus 81 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg 154 (279)
T 1qpc_A 81 ---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFG 154 (279)
T ss_dssp ---SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCT
T ss_pred ---CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEc-CCCCEEECCCc
Confidence 5899999999999999987543 7999999999999999999999999 99999999999998 67899999999
Q ss_pred chhhhhccc---cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCcccc
Q 006277 160 LATIMEQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALS 234 (652)
Q Consensus 160 la~~l~~~~---~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 234 (652)
++....... .....||+.|+|||++. +.++.++|||||||++|+|++ |..||.+ .....+...+..+..+ ..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~ 232 (279)
T 1qpc_A 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLERGYRM-VRP 232 (279)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCC
T ss_pred ccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc-cCHHHHHHHHhcccCC-CCc
Confidence 998765432 23456788999999875 568999999999999999999 9999987 5566677777766433 344
Q ss_pred CCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 235 KVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 235 ~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
...++++.+||.+||. +|.+|||+.++++
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 5678999999999998 8999999999886
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=334.94 Aligned_cols=243 Identities=24% Similarity=0.360 Sum_probs=200.2
Q ss_pred EEEEEEecCcEEEEEE----EccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~----d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
..+|++++.|+||+|. +..+|+.||+|++... ..+...+++.+|+.+|+.++||||+++++++.+.....+++
T Consensus 36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 3678888889997764 5568999999998743 24567888999999999999999999999998876668999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
|||||.+|+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 113 v~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGCEECCTTC
T ss_pred EEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEc-CCCCEEECCccccccccccc
Confidence 99999999999998765 5999999999999999999999999 99999999999998 66899999999998765432
Q ss_pred -----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCH--------------HHHHHHHhcCC
Q 006277 169 -----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNS--------------AQIYKKVSSGI 228 (652)
Q Consensus 169 -----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~--------------~~i~~~I~~g~ 228 (652)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||...... ..+...+..+.
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence 23457889999999874 46889999999999999999999998652111 11223333333
Q ss_pred CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 229 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 229 ~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
....+...++++.+||.+||. +|.+|||+.|+++
T Consensus 269 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 269 -RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 334456678999999999998 8999999999984
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=332.60 Aligned_cols=241 Identities=22% Similarity=0.355 Sum_probs=197.5
Q ss_pred EEEEEecCcEEEEEEEccCC----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNG----LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG----~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
..|++++.|+||+|.+..++ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus 50 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 124 (333)
T 1mqb_A 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--KPMMII 124 (333)
T ss_dssp EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEEEE
T ss_pred cEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC--CCcEEE
Confidence 57888888999999987653 569999986432 356677899999999999999999999988654 379999
Q ss_pred EecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 90 TELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
||||.+|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 125 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 125 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC--------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEEC-CCCcEEECCCCcchhhcccc
Confidence 9999999999999765 67999999999999999999999998 99999999999998 67899999999998765432
Q ss_pred -----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHH
Q 006277 169 -----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 169 -----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~ 241 (652)
.....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+ .....+...+..+..+. .+...++.+
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l 279 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAINDGFRLP-TPMDCPSAI 279 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-CCTTCBHHH
T ss_pred ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHCCCcCC-CcccCCHHH
Confidence 12345688999999874 579999999999999999998 9999987 45667777777765332 344567899
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 242 KSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
++||.+||. +|.+||++.+++++
T Consensus 280 ~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 280 YQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999997 89999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.07 Aligned_cols=236 Identities=27% Similarity=0.405 Sum_probs=189.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|++++.|+||+|.+ .|+.||+|++.. ....+++.+|+++|++++||||+++++++.+ ..++||||
T Consensus 13 ~~~lg~G~~g~V~~~~~--~~~~vavK~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~lv~e~ 80 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKW--RAKDVAIKQIES------ESERKAFIVELRQLSRVNHPNIVKLYGACLN----PVCLVMEY 80 (307)
T ss_dssp EEEEECCSSSEEEEEEE--TTEEEEEEECSS------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TTEEEEEC
T ss_pred eeEeecCCCceEEEEEE--CCeeEEEEEecC------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CcEEEEEc
Confidence 35788888899999986 479999998752 2456789999999999999999999997642 37899999
Q ss_pred CCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 93 FTSGSLRQYRKKHK---KVDMKAVKGWARQILSGLIYLHS---HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 93 ~~gGsL~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs---~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
+.+|+|.+++.... .+++..+..|+.||+.||.|||+ +| |+||||||+|||++.+...+||+|||++.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999998765 37899999999999999999999 66 999999999999984433489999999986643
Q ss_pred cccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCC-HHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 167 ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRN-SAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 167 ~~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~-~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
. .....||+.|+|||++. ..|+.++|||||||++|+|++|..||..... ...+...+..+..+ ......++.+++|
T Consensus 159 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 236 (307)
T 2eva_A 159 H-MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPIESL 236 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-CCBTTCCHHHHHH
T ss_pred c-cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-CcccccCHHHHHH
Confidence 3 23457999999999875 4789999999999999999999999976433 33444455555433 3445678899999
Q ss_pred HHHhCC-CCCCCCCHHHHhcC
Q 006277 245 IEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~h 264 (652)
|.+||. +|.+|||+.+++++
T Consensus 237 i~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 237 MTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCChhhCcCHHHHHHH
Confidence 999998 89999999999974
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=364.05 Aligned_cols=240 Identities=19% Similarity=0.294 Sum_probs=203.5
Q ss_pred EEEEEecCcEEEEEEE--ccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 14 LRLIQLVDTSGYKAFD--EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d--~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
..|+++..|+||+|.+ +.+++.||+|+++... .+....+++.+|+++|++|+|||||++++++.+. .+++|||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~~lv~E 449 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVME 449 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG--GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEEEEEE
Confidence 3689999999999955 4578999999987542 2345678899999999999999999999988543 4899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
||.+|+|.+++...+.+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCTTHHHHTTC-----
T ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEe-CCCCEEEEEcCCccccccCcccc
Confidence 9999999999999899999999999999999999999999 99999999999998 67899999999998775432
Q ss_pred --cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 169 --AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
.....||+.|+|||++. ..|+.++|||||||++|||++ |..||.+ ....++...+..+..+ ..+...++++.+|
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l~~l 604 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYDL 604 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence 23345788999999874 579999999999999999998 9999987 5666777778777543 3455678999999
Q ss_pred HHHhCC-CCCCCCCHHHHhc
Q 006277 245 IEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~ 263 (652)
|.+||. +|.+||++.++++
T Consensus 605 i~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 605 MNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHH
Confidence 999998 8999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=354.93 Aligned_cols=241 Identities=27% Similarity=0.301 Sum_probs=185.5
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..|+++..|+|+. ....+|+.||+|++.... ...+.+|+++|+.+ +|||||++++++.+.. .+|+||||
T Consensus 30 ~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~--~~~lv~E~ 99 (432)
T 3p23_A 30 DVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC-------FSFADREVQLLRESDEHPNVIRYFCTEKDRQ--FQYIAIEL 99 (432)
T ss_dssp EEEEECGGGCEEE-EEESSSSEEEEEEECTTT-------EEECHHHHHHHHHSCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred CeeecCcCEEEEE-EEEeCCeEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC--EEEEEEEC
Confidence 4677777788653 446789999999986432 22356799999999 8999999999987655 89999999
Q ss_pred CCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC--C--CcEEEeccCchhhhhcc
Q 006277 93 FTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--Q--GEVKIGDLGLATIMEQA 167 (652)
Q Consensus 93 ~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~--~--g~VKL~DFGla~~l~~~ 167 (652)
|. |+|.+++.... .+.+..+..++.||+.||.|||++| |+||||||+|||++.. + ..+||+|||+++.+...
T Consensus 100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 96 59999988664 4666677899999999999999999 9999999999999521 2 25889999999876532
Q ss_pred -----ccccccCCCCccCccccc----cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCc--cccC
Q 006277 168 -----NAKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPA--ALSK 235 (652)
Q Consensus 168 -----~~~~~vGTp~YmAPEvl~----~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~--~l~~ 235 (652)
.....+||+.|+|||++. ..++.++|||||||++|+|++ |..||... ...+... +....... ....
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~-~~~~~~~-~~~~~~~~~~~~~~ 254 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS-LQRQANI-LLGACSLDCLHPEK 254 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST-TTHHHHH-HTTCCCCTTSCTTC
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh-hHHHHHH-HhccCCccccCccc
Confidence 234578999999999885 457789999999999999999 89999653 3333322 22221111 1112
Q ss_pred CCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 236 VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 236 ~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
..++.+++||.+||. +|.+|||+.++|+||||..
T Consensus 255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 235678999999998 8999999999999999974
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=355.07 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=207.4
Q ss_pred CcceeeeeeE---EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 006277 4 QKWSLLILMY---LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 80 (652)
Q Consensus 4 ~~W~~~~~~~---~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 80 (652)
..|......| .+|+++..|.||+|.++.+|..||+|.++... ...+.+.+|+.+|++|+|||||++++++.+
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 287 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-----cchHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 4566654444 34555556899999999999999999986432 236789999999999999999999998865
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEecc
Q 006277 81 DQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 158 (652)
Q Consensus 81 ~~~~~~~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DF 158 (652)
.. .+|+|||||.+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+||
T Consensus 288 ~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DF 362 (495)
T 1opk_A 288 EP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVG-ENHLVKVADF 362 (495)
T ss_dssp SS--SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGGCEEECCT
T ss_pred CC--cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEC-CCCcEEEeec
Confidence 54 789999999999999999864 45899999999999999999999999 99999999999998 6789999999
Q ss_pred Cchhhhhccc---cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccc
Q 006277 159 GLATIMEQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAAL 233 (652)
Q Consensus 159 Gla~~l~~~~---~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l 233 (652)
|+++.+.... .....+|+.|+|||++. +.|+.++|||||||++|||++ |..||.+ .+..+++..+..+... ..
T Consensus 363 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~ 440 (495)
T 1opk_A 363 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ER 440 (495)
T ss_dssp TCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CC
T ss_pred ccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CC
Confidence 9998765432 23345678999999874 579999999999999999999 9999987 4556677777766533 34
Q ss_pred cCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 234 SKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 234 ~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
+...++.+.+||.+||. +|.+|||+.++++
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 55678999999999998 8999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=327.87 Aligned_cols=243 Identities=25% Similarity=0.356 Sum_probs=194.0
Q ss_pred EEEEEecCcEEEEEEEcc-CC--eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEV-NG--LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~-tG--~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
..|+++..|+||+|.+.. ++ ..||+|++..... ..++..+++.+|++++++++||||+++++++.+. ..++||
T Consensus 24 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~v~ 99 (291)
T 1u46_A 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---PMKMVT 99 (291)
T ss_dssp EECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEEE
T ss_pred eeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---CceeeE
Confidence 456666668999998644 33 4799998875432 2346778999999999999999999999988654 388999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 91 ELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
||+.+|+|.+++... +.+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~ 176 (291)
T 1u46_A 100 ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDD 176 (291)
T ss_dssp ECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEECCC-CC
T ss_pred ecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEc-CCCCEEEcccccccccccccc
Confidence 999999999998764 57999999999999999999999998 99999999999998 66899999999998764322
Q ss_pred ----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 169 ----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 169 ----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
.....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+ .+..++...+.........+...+++++
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (291)
T 1u46_A 177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPEDCPQDIY 255 (291)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTTCCHHHH
T ss_pred chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc-CCHHHHHHHHHccCCCCCCCcCcCHHHH
Confidence 23456888999999874 568999999999999999999 9999987 4566676777665544455567789999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcC
Q 006277 243 SFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~h 264 (652)
++|.+||. +|.+|||+.+++++
T Consensus 256 ~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 256 NVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCcccCcCHHHHHHH
Confidence 99999998 89999999999973
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=325.18 Aligned_cols=243 Identities=21% Similarity=0.302 Sum_probs=198.0
Q ss_pred EEEEEEecCcEEEEEEEccC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~t---G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
...|++++.|+||+|.+..+ +..||+|.+.. .......+++.+|+.++++++||||+++++++.... ...++|
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~v 105 (298)
T 3f66_A 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPLVV 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEC-----CEEEEEEEETT---CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCCEEE
T ss_pred cceeeecCCceEEEEEEecCCCceeEEEEEeccc---CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC-CceEEE
Confidence 36788888899999997553 45688888763 234567889999999999999999999999876543 478999
Q ss_pred EecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 90 TELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+....
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSCGGGCCCSCGG
T ss_pred EeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEC-CCCCEEECcccccccccccc
Confidence 9999999999999764 56899999999999999999999998 99999999999998 67899999999998664322
Q ss_pred ------cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChH
Q 006277 169 ------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 240 (652)
Q Consensus 169 ------~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 240 (652)
.....||+.|+|||++ ...++.++|||||||++|+|++ |.+||.. .+...+...+..+..+ ..+...++.
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 260 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGRRL-LQPEYCPDP 260 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-SCTTTHHHHHHTTCCC-CCCTTCCHH
T ss_pred hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhcCCCC-CCCccCCHH
Confidence 2345678899999977 4578999999999999999999 5666655 4445555555555432 334556889
Q ss_pred HHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 241 VKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 241 ~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
+.+||.+||. +|.+|||+.++++.
T Consensus 261 l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 261 LYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999998 89999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=321.72 Aligned_cols=241 Identities=22% Similarity=0.213 Sum_probs=193.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|+||+|.+..+|+.||+|++..... ..++.+|+.+++.++|++++..+..+... ....++||||
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~e~ 86 (296)
T 4hgt_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVMEL 86 (296)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEEEEEC
T ss_pred eeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------chHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceEEEEEc
Confidence 3578888889999999999999999998765432 23578899999999998888777766543 3488999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEc--CCCCcEEEeccCchhhhhccc-
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~--~~~g~VKL~DFGla~~l~~~~- 168 (652)
+ +|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..++.+||+|||++.......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 9 9999999885 467999999999999999999999999 99999999999993 266889999999998765432
Q ss_pred --------cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCH--HHHHHHHhcCC---CCcccc
Q 006277 169 --------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNS--AQIYKKVSSGI---KPAALS 234 (652)
Q Consensus 169 --------~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~--~~i~~~I~~g~---~p~~l~ 234 (652)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.... .+.+..+.... ......
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 243 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhh
Confidence 23568999999999774 57899999999999999999999999763321 12222222211 111223
Q ss_pred CCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 235 KVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 235 ~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
...++++++||.+||. +|.+|||+.++++
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp TTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 4567899999999998 8999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=341.08 Aligned_cols=247 Identities=16% Similarity=0.156 Sum_probs=190.3
Q ss_pred EEEEEecCcEEEEEEEcc---CCeEEEEEEEeecccCCCH--H-----HHHHHHHHHHHHHhCCCCCeeeeeeEEEeC--
Q 006277 14 LRLIQLVDTSGYKAFDEV---NGLEVAWCQVRIDDVLQSP--E-----DLERLYSEVHLLKSLKHNNIIRFYNSWIDD-- 81 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~---tG~~VAiK~v~~~~~~~s~--e-----~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~-- 81 (652)
..|++++.|+||+|.+.. ++..||+|++......... . ....+.+|+.+++.++||||+++++++.+.
T Consensus 43 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~ 122 (345)
T 2v62_A 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFK 122 (345)
T ss_dssp EEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESS
T ss_pred eeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccC
Confidence 466777779999999988 8999999998754310000 0 112466789999999999999999998873
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCC--cEEEeccC
Q 006277 82 QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG--EVKIGDLG 159 (652)
Q Consensus 82 ~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g--~VKL~DFG 159 (652)
....+|+||||| +++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++ .+||+|||
T Consensus 123 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~~~kL~Dfg 198 (345)
T 2v62_A 123 GRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLG-YKNPDQVYLADYG 198 (345)
T ss_dssp SCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-SSSTTSEEECCCT
T ss_pred CCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEc-cCCCCcEEEEeCC
Confidence 245899999999 9999999988889999999999999999999999998 99999999999998 344 89999999
Q ss_pred chhhhhccc---------cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc---
Q 006277 160 LATIMEQAN---------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--- 226 (652)
Q Consensus 160 la~~l~~~~---------~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~--- 226 (652)
+++.+.... .....||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.............
T Consensus 199 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 278 (345)
T 2v62_A 199 LSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLL 278 (345)
T ss_dssp TCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHH
T ss_pred CceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhc
Confidence 998764321 14568999999999875 46899999999999999999999999653322222211111
Q ss_pred CCCCccc-----cCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 227 GIKPAAL-----SKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 227 g~~p~~l-----~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
...+..+ ....++++++||.+||. +|.+|||+.++++.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 279 DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1112111 11567899999999997 89999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=348.23 Aligned_cols=246 Identities=21% Similarity=0.374 Sum_probs=204.2
Q ss_pred Ccceeeee---eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 006277 4 QKWSLLIL---MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 80 (652)
Q Consensus 4 ~~W~~~~~---~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 80 (652)
..|.+... .-.+|+++..|+||+|.+. ++..||+|.++... ...+.+.+|+.+|++|+|||||++++++..
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~ 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC
Confidence 34555443 3356777777999999985 57889999987432 246789999999999999999999998742
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEecc
Q 006277 81 DQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 158 (652)
Q Consensus 81 ~~~~~~~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DF 158 (652)
..+|+|||||.+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+||
T Consensus 255 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DF 328 (454)
T 1qcf_A 255 ---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADF 328 (454)
T ss_dssp ---SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTCCEEECST
T ss_pred ---CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEC-CCCcEEEeeC
Confidence 3689999999999999999754 37899999999999999999999998 99999999999998 6789999999
Q ss_pred Cchhhhhccc---cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccc
Q 006277 159 GLATIMEQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAAL 233 (652)
Q Consensus 159 Gla~~l~~~~---~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l 233 (652)
|+++...... .....+|+.|+|||++. +.|+.++|||||||++|||+| |..||.+ ....++...+..+... ..
T Consensus 329 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~~ 406 (454)
T 1qcf_A 329 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-MSNPEVIRALERGYRM-PR 406 (454)
T ss_dssp TGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHHTCCC-CC
T ss_pred CCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CC
Confidence 9998764322 23445678999999874 679999999999999999999 9999987 4566677777776543 23
Q ss_pred cCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 234 SKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 234 ~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
+...++++.+||.+||. +|.+|||+.+++.
T Consensus 407 ~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 407 PENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 45678999999999998 8999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=336.37 Aligned_cols=244 Identities=22% Similarity=0.301 Sum_probs=192.4
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..|++++.|+||+|.+ .+|..||+|++..... .....++.+|+.+++.++||||+++++++.+.. ..++|||||
T Consensus 36 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~ 109 (326)
T 3uim_A 36 NILGRGGFGKVYKGRL-ADGTLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVYPYM 109 (326)
T ss_dssp TEEECCSSSEEEEECC-SSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS--CCEEEEECC
T ss_pred eeEecCCCcEEEEEEe-cCCCEEEEEEeccccC---chHHHHHHHHHHHHHhccCCCccceEEEEecCC--ceEEEEEec
Confidence 4788888999999985 4799999999875432 222336889999999999999999999987654 689999999
Q ss_pred CCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 94 TSGSLRQYRKKHK----KVDMKAVKGWARQILSGLIYLHSH---DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 94 ~gGsL~~~i~~~~----~lse~~i~~i~~QIl~aL~yLHs~---g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
.+|+|.+++.... .+++..+..++.||+.||.|||++ | |+||||||+|||++ .++.+||+|||++.....
T Consensus 110 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 186 (326)
T 3uim_A 110 ANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDFGLAKLMDY 186 (326)
T ss_dssp TTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEEC-TTCCEEECCCSSCEECCS
T ss_pred cCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEEC-CCCCEEeccCccccccCc
Confidence 9999999998653 499999999999999999999998 7 99999999999998 678999999999987643
Q ss_pred cc---cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCC----CCHHHHHHHHhcCCCCc-------
Q 006277 167 AN---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSEC----RNSAQIYKKVSSGIKPA------- 231 (652)
Q Consensus 167 ~~---~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~----~~~~~i~~~I~~g~~p~------- 231 (652)
.. .....||+.|+|||++ ...++.++|||||||++|+|++|..||... .........+.......
T Consensus 187 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (326)
T 3uim_A 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVD 266 (326)
T ss_dssp SSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSC
T ss_pred ccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcC
Confidence 22 3456799999999987 557899999999999999999999999521 11111111221111111
Q ss_pred -----cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcc
Q 006277 232 -----ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPF 266 (652)
Q Consensus 232 -----~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf 266 (652)
......++.+.+||.+||. +|.+|||+.|+++|-.
T Consensus 267 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 267 VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 1111123578999999998 8999999999998865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=327.39 Aligned_cols=239 Identities=25% Similarity=0.379 Sum_probs=187.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC--CCCCeeeeeeEEEeCCC--CeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL--KHNNIIRFYNSWIDDQN--KTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L--~HpnIVkl~~~~~d~~~--~~~~L 88 (652)
...|++++.|.||+|.+. |+.||+|++... ......+|.+++..+ +||||+++++++.+... ..+|+
T Consensus 42 ~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 42 VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-------EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp EEEEEEETTEEEEEEEET--TEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred EeEeecCCCeEEEEEEEC--CceEEEEEEecc-------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 468888899999999875 899999998632 234455566666655 99999999999887643 47999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCeeeccCCcccEEEcCCCCcEEEeccCc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH--------DPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~--------g~~IiHRDLKp~NILl~~~~g~VKL~DFGl 160 (652)
|||||.+|+|.++++.. .+++..++.++.||+.||.|||++ | |+||||||+|||++ .++.+||+|||+
T Consensus 113 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVK-KNGTCCIADLGL 188 (337)
T ss_dssp EECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEEC-TTSCEEECCCTT
T ss_pred EEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEEC-CCCCEEEEeCCC
Confidence 99999999999999764 799999999999999999999998 6 99999999999998 678999999999
Q ss_pred hhhhhccc------cccccCCCCccCcccccc-CCCc------cccchhhHHHHHHHhhc----------cCCCCCCC--
Q 006277 161 ATIMEQAN------AKSVIGTPEFMAPELYDE-NYNE------LADIYSFGMCMLEMVTF----------EYPYSECR-- 215 (652)
Q Consensus 161 a~~l~~~~------~~~~vGTp~YmAPEvl~~-~y~~------~sDIWSlGvilyeLltG----------~~Pf~~~~-- 215 (652)
+..+.... ....+||+.|+|||++.+ .+.. ++|||||||++|+|++| ..||....
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 268 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence 97664322 235689999999998754 3333 38999999999999999 77775432
Q ss_pred --CHHHHHHHHhcCCCCccccC-----CCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 216 --NSAQIYKKVSSGIKPAALSK-----VKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 216 --~~~~i~~~I~~g~~p~~l~~-----~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
........+........++. ..++++.+||.+||. +|.+|||+.++++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 22233333332222222221 234679999999998 89999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=328.83 Aligned_cols=245 Identities=24% Similarity=0.311 Sum_probs=185.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHH--HHhCCCCCeeeeeeEEEe---CCCCeEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHL--LKSLKHNNIIRFYNSWID---DQNKTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~i--Lk~L~HpnIVkl~~~~~d---~~~~~~~ 87 (652)
...|++++.|+||+|.+ +|+.||+|++... ....+..|..+ ++.++||||+++++.+.. .....++
T Consensus 18 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSL--DERPVAVKVFSFA-------NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp EEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred eeecccCCCeEEEEEEE--CCeEEEEEEeecc-------chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 45778888899999965 7899999998743 22334444444 555899999999986542 2334689
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCeeeccCCcccEEEcCCCCcEEEecc
Q 006277 88 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH---------DPPIIHRDLKCDNIFINGNQGEVKIGDL 158 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~---------g~~IiHRDLKp~NILl~~~~g~VKL~DF 158 (652)
+|||||.+|+|.+++... ..++..++.++.||+.||.|||++ | |+||||||+|||++ .++.+||+||
T Consensus 89 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~~kL~DF 164 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVK-NDGTCVISDF 164 (336)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEEC-TTSCEEECCC
T ss_pred EEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEc-CCCcEEEeec
Confidence 999999999999999765 458999999999999999999999 7 99999999999998 6689999999
Q ss_pred Cchhhhhcc----------ccccccCCCCccCcccccc--------CCCccccchhhHHHHHHHhhccCCCCCCCC----
Q 006277 159 GLATIMEQA----------NAKSVIGTPEFMAPELYDE--------NYNELADIYSFGMCMLEMVTFEYPYSECRN---- 216 (652)
Q Consensus 159 Gla~~l~~~----------~~~~~vGTp~YmAPEvl~~--------~y~~~sDIWSlGvilyeLltG~~Pf~~~~~---- 216 (652)
|++..+... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.....
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 999865421 1235689999999998754 467789999999999999999776533221
Q ss_pred -------------HHHHHHHHhcCCCCccccCC------CChHHHHHHHHhCC-CCCCCCCHHHHh------cCcccccc
Q 006277 217 -------------SAQIYKKVSSGIKPAALSKV------KDPEVKSFIEKCLV-PASQRLSAKELL------MDPFLQVN 270 (652)
Q Consensus 217 -------------~~~i~~~I~~g~~p~~l~~~------~s~~~kdlI~kcL~-~P~~RpSa~elL------~hpf~~~~ 270 (652)
...+...+........++.. .++.+++||.+||. +|.+|||+.|++ .++|-+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 12222223332222223322 23479999999998 899999999994 56787654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=325.85 Aligned_cols=225 Identities=21% Similarity=0.304 Sum_probs=181.8
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHH-HhCCCCCeeeeeeEEEe--CCCCeEEEEEe
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL-KSLKHNNIIRFYNSWID--DQNKTVNIITE 91 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iL-k~L~HpnIVkl~~~~~d--~~~~~~~LVmE 91 (652)
.|+++..|+||+|.+..+|+.||+|++... ..+.+|+.++ +.++||||++++++|.+ .....+++|||
T Consensus 25 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 95 (299)
T 3m2w_A 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95 (299)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred ccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence 478888899999999999999999998631 3567788888 56699999999999865 23347999999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC--CCcEEEeccCchhhhhcc
Q 006277 92 LFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 92 y~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~--~g~VKL~DFGla~~l~~~ 167 (652)
||.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.. ++.+||+|||++....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-- 171 (299)
T 3m2w_A 96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-- 171 (299)
T ss_dssp CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence 999999999998764 6999999999999999999999999 9999999999999843 6789999999885432
Q ss_pred ccccccCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc----CCC--CccccCCCChHH
Q 006277 168 NAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS----GIK--PAALSKVKDPEV 241 (652)
Q Consensus 168 ~~~~~vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~----g~~--p~~l~~~~s~~~ 241 (652)
...|+.++|||||||++|+|++|..||..... ......+.. +.. +.......++++
T Consensus 172 -----------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T 3m2w_A 172 -----------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKTRIRMGQYEFPNPEWSEVSEEV 233 (299)
T ss_dssp -----------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCCSSCHHHHTTSCHHH
T ss_pred -----------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc-hhhhHHHHHHHhhccccCCchhcccCCHHH
Confidence 24578899999999999999999999976322 221111111 111 111114568899
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 242 KSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
++||.+||. +|.+|||+.|+|+||||+..
T Consensus 234 ~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 234 KMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred HHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 999999998 89999999999999999754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=341.17 Aligned_cols=247 Identities=19% Similarity=0.206 Sum_probs=190.1
Q ss_pred EEEEEEecCcEEEEEEEccC-----CeEEEEEEEeecccCCCHHH--------HHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVN-----GLEVAWCQVRIDDVLQSPED--------LERLYSEVHLLKSLKHNNIIRFYNSWI 79 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~t-----G~~VAiK~v~~~~~~~s~e~--------~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 79 (652)
...|++++.|+||+|.+..+ ++.||+|++...... .... ...+..|+..++.++||||+++++++.
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 118 (364)
T 3op5_A 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGL 118 (364)
T ss_dssp EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH-HHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEE
T ss_pred EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh-HHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeee
Confidence 34667777799999999775 689999998743210 0000 112345666778889999999999987
Q ss_pred eCCC--CeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC-CCCcEEE
Q 006277 80 DDQN--KTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING-NQGEVKI 155 (652)
Q Consensus 80 d~~~--~~~~LVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~-~~g~VKL 155 (652)
...+ ..+|+||||| ||+|.+++... +.+++..++.|+.||+.||.|||++| |+||||||+|||++. .++.+||
T Consensus 119 ~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~~~~~~kl 195 (364)
T 3op5_A 119 HDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYL 195 (364)
T ss_dssp EEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESSCTTCEEE
T ss_pred eccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecCCCCeEEE
Confidence 6532 4689999999 99999999876 68999999999999999999999998 999999999999972 4579999
Q ss_pred eccCchhhhhccc---------cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHh
Q 006277 156 GDLGLATIMEQAN---------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS 225 (652)
Q Consensus 156 ~DFGla~~l~~~~---------~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~ 225 (652)
+|||+++.+.... ....+||+.|+|||++. ..|+.++|||||||++|+|+||..||.+............
T Consensus 196 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~ 275 (364)
T 3op5_A 196 VDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSK 275 (364)
T ss_dssp CCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHH
T ss_pred EECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHH
Confidence 9999998764322 13456999999999775 4699999999999999999999999986433333222221
Q ss_pred cCCC--Cc-----cc-cCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 226 SGIK--PA-----AL-SKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 226 ~g~~--p~-----~l-~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
.... .. .+ ....++++.+||..||. +|.+||++.++++
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 276 IRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1100 00 00 14457899999999997 8999999999885
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=335.27 Aligned_cols=238 Identities=16% Similarity=0.225 Sum_probs=192.8
Q ss_pred EEEEEEecCcEEEEEEEccC--------CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeee-----------
Q 006277 13 YLRLIQLVDTSGYKAFDEVN--------GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR----------- 73 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~t--------G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVk----------- 73 (652)
...|+++..|+||+|.+..+ |+.||+|.+... +++.+|+.++++++||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 35778888899999999984 899999998743 35788999999999999988
Q ss_pred ----eeeEEEeCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEc
Q 006277 74 ----FYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN 147 (652)
Q Consensus 74 ----l~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~ 147 (652)
+++++... ...+|+||||| +|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++
T Consensus 118 ~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 118 AIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVD 193 (352)
T ss_dssp SCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEEEE
T ss_pred CccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEc
Confidence 56666553 35899999999 99999999986 78999999999999999999999998 99999999999998
Q ss_pred CCCC--cEEEeccCchhhhhccc---------cccccCCCCccCcccccc-CCCccccchhhHHHHHHHhhccCCCCCCC
Q 006277 148 GNQG--EVKIGDLGLATIMEQAN---------AKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECR 215 (652)
Q Consensus 148 ~~~g--~VKL~DFGla~~l~~~~---------~~~~vGTp~YmAPEvl~~-~y~~~sDIWSlGvilyeLltG~~Pf~~~~ 215 (652)
.++ .+||+|||+++.+.... .....||+.|+|||++.+ .|+.++|||||||++|+|++|..||....
T Consensus 194 -~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 194 -PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp -TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred -CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 455 89999999998764322 134589999999998754 79999999999999999999999998754
Q ss_pred -CHHHHHHHHh---cCCCCcc----ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 216 -NSAQIYKKVS---SGIKPAA----LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 216 -~~~~i~~~I~---~g~~p~~----l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
....+..... ....+.. .....++++++||.+||. +|.+|||+.++++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp TCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 4444433332 1111110 112457999999999997 89999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=329.65 Aligned_cols=243 Identities=25% Similarity=0.387 Sum_probs=197.9
Q ss_pred EEEEEEecCcEEEEEE----EccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~----d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~L 88 (652)
...|++++.|.||+|. +..+|+.||+|++... ..+..+++.+|+.+++.++||||+++++++.......+++
T Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 121 (326)
T 2w1i_A 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121 (326)
T ss_dssp EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence 3567777789999998 5679999999998643 3467788999999999999999999999887665557899
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc
Q 006277 89 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 167 (652)
||||+.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 122 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 122 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp EECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEECCSS
T ss_pred EEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEc-CCCcEEEecCcchhhcccc
Confidence 99999999999999876 46999999999999999999999998 99999999999998 6789999999999876543
Q ss_pred c-----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCC---------------HHHHHHHHhc
Q 006277 168 N-----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRN---------------SAQIYKKVSS 226 (652)
Q Consensus 168 ~-----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~---------------~~~i~~~I~~ 226 (652)
. .....||+.|+|||++. ..++.++|||||||++|+|+||..||..... ...+...+..
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 278 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhc
Confidence 2 23456788899999774 5689999999999999999999998853210 0112233333
Q ss_pred CCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 227 GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 227 g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
+.. ...+...++++.+||.+||. +|.+|||+.++++
T Consensus 279 ~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 279 NGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp TCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 332 23455678999999999997 8999999999985
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=338.73 Aligned_cols=243 Identities=18% Similarity=0.168 Sum_probs=190.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccC----CCHHHHHHHHHHHHHHHhCC---------CCCeeeeeeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVL----QSPEDLERLYSEVHLLKSLK---------HNNIIRFYNSWI 79 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~----~s~e~~~~l~~Ei~iLk~L~---------HpnIVkl~~~~~ 79 (652)
..+|+++..|+||+|.+ +|+.||+|++...... ......+.+.+|+.+|+.|+ |||||++++.+.
T Consensus 25 ~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~ 102 (336)
T 2vuw_A 25 CEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHC 102 (336)
T ss_dssp CEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEE
T ss_pred eeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeE
Confidence 46899999999999998 7899999999876421 12234578889999999986 777777776654
Q ss_pred eC----------------------------CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hC
Q 006277 80 DD----------------------------QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH-SH 130 (652)
Q Consensus 80 d~----------------------------~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLH-s~ 130 (652)
.. ....+|+|||||.+|++.+.+.+ +.+++..++.+++||+.||+||| ++
T Consensus 103 ~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ 181 (336)
T 2vuw_A 103 VQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASL 181 (336)
T ss_dssp EESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 21 14589999999999977666643 67899999999999999999999 89
Q ss_pred CCCeeeccCCcccEEEcCCCC--------------------cEEEeccCchhhhhccccccccCCCCccCccccccCCCc
Q 006277 131 DPPIIHRDLKCDNIFINGNQG--------------------EVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNE 190 (652)
Q Consensus 131 g~~IiHRDLKp~NILl~~~~g--------------------~VKL~DFGla~~l~~~~~~~~vGTp~YmAPEvl~~~y~~ 190 (652)
| |+||||||+|||++ .+| .+||+|||+|+.... ...+||+.|||||++.+..+.
T Consensus 182 ~--ivHrDlKp~NILl~-~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~---~~~~gt~~y~aPE~~~g~~~~ 255 (336)
T 2vuw_A 182 R--FEHRDLHWGNVLLK-KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD---GIVVFCDVSMDEDLFTGDGDY 255 (336)
T ss_dssp C--CBCSCCCGGGEEEE-ECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET---TEEECCCCTTCSGGGCCCSSH
T ss_pred C--EeECCCCHHHEEEe-ccCCcceeeeccCccccccCCCceEEEeeccccEecCC---CcEEEeecccChhhhcCCCcc
Confidence 8 99999999999998 444 899999999987653 345899999999999877799
Q ss_pred cccchhhHHH-HHHHhhccCCCCCCCCHHHHHHHHhcCC-----CCccccCCCChHHHHHHHHhCCCCCCCCCHHHHh-c
Q 006277 191 LADIYSFGMC-MLEMVTFEYPYSECRNSAQIYKKVSSGI-----KPAALSKVKDPEVKSFIEKCLVPASQRLSAKELL-M 263 (652)
Q Consensus 191 ~sDIWSlGvi-lyeLltG~~Pf~~~~~~~~i~~~I~~g~-----~p~~l~~~~s~~~kdlI~kcL~~P~~RpSa~elL-~ 263 (652)
++||||||++ .+++++|..||.+......+...+.... .+.......++++++||.+||+.+ ||.|+| +
T Consensus 256 ~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----sa~e~l~~ 331 (336)
T 2vuw_A 256 QFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----SATDLLCQ 331 (336)
T ss_dssp HHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----SHHHHHHH
T ss_pred ceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----CHHHHHhc
Confidence 9999998777 7788999999965222123333433221 111222345789999999999732 999999 9
Q ss_pred Ccccc
Q 006277 264 DPFLQ 268 (652)
Q Consensus 264 hpf~~ 268 (652)
||||+
T Consensus 332 Hp~f~ 336 (336)
T 2vuw_A 332 HSLFK 336 (336)
T ss_dssp CGGGC
T ss_pred CCCcC
Confidence 99995
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=357.33 Aligned_cols=243 Identities=18% Similarity=0.320 Sum_probs=201.7
Q ss_pred EEEEecCcEEEEEEEcc--CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 15 RLIQLVDTSGYKAFDEV--NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~--tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
+|+++..|.||+|.+.. ++..||+|+++... .....+.+.+|+++|++|+|||||++++++.+. .+|+||||
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~lv~E~ 416 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALMLVMEM 416 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---SEEEEEEC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---CeEEEEEe
Confidence 68999999999998763 67789999987542 234578899999999999999999999998653 59999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
|.+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 417 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 417 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLV-NRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp CTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCSTTTTCC------
T ss_pred CCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEc-CCCcEEEeeccCcccccCCCcee
Confidence 9999999998754 46999999999999999999999998 99999999999998 67899999999998764321
Q ss_pred --cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 169 --AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
.....+|+.|+|||++. +.|+.++|||||||++|||++ |..||.+. ...++...+..+..+ ..+...++++.+|
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l~~l 571 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECPPECPPELYAL 571 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CSHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHHHHH
Confidence 12335678999999874 679999999999999999998 99999884 456677777777543 3455678999999
Q ss_pred HHHhCC-CCCCCCCHHHHh---cCcccc
Q 006277 245 IEKCLV-PASQRLSAKELL---MDPFLQ 268 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL---~hpf~~ 268 (652)
|.+||. +|.+||++.+++ ++.|+.
T Consensus 572 i~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 572 MSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp HHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 999998 899999999875 455554
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.45 Aligned_cols=243 Identities=21% Similarity=0.285 Sum_probs=193.8
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..+++++.|+||+|.+ .+|+.||+|++... .....+++.+|+.+++.++||||+++++++.+.. .+++|||||
T Consensus 45 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~ 117 (321)
T 2qkw_B 45 FLIGHGVFGKVYKGVL-RDGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN--EMILIYKYM 117 (321)
T ss_dssp CCSCBCSSSEEEEEEC-TTCCEEEEEECCSC----CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT--CCEEEEECC
T ss_pred ceeecCCCeeEEEEEE-CCCCEEEEEEeccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--eEEEEEEcC
Confidence 3577778899999996 47999999987643 2356788999999999999999999999886543 789999999
Q ss_pred CCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--
Q 006277 94 TSGSLRQYRKKHK----KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-- 167 (652)
Q Consensus 94 ~gGsL~~~i~~~~----~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 167 (652)
.+|+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~ 194 (321)
T 2qkw_B 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLD-ENFVPKITDFGISKKGTELDQ 194 (321)
T ss_dssp TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEEC-TTCCEEECCCTTCEECSSSSC
T ss_pred CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEEC-CCCCEEEeecccccccccccc
Confidence 9999999886543 5899999999999999999999998 99999999999998 6789999999999765322
Q ss_pred --ccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHH-----HH-HHHHhcCCCC--------
Q 006277 168 --NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSA-----QI-YKKVSSGIKP-------- 230 (652)
Q Consensus 168 --~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~-----~i-~~~I~~g~~p-------- 230 (652)
......||+.|+|||++ .+.|+.++|||||||++|+|++|..||....... .. ......+...
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (321)
T 2qkw_B 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA 274 (321)
T ss_dssp CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc
Confidence 12345789999999977 5679999999999999999999999997533211 11 1111111111
Q ss_pred ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcc
Q 006277 231 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPF 266 (652)
Q Consensus 231 ~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf 266 (652)
.......+..+.+||.+||. +|.+|||+.|++++..
T Consensus 275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11111224578999999998 8999999999998753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=337.42 Aligned_cols=234 Identities=19% Similarity=0.221 Sum_probs=183.6
Q ss_pred EEEEEEecCcEEEEE-----EEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC---CCCeeeeeeEEEeCCCC
Q 006277 13 YLRLIQLVDTSGYKA-----FDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK---HNNIIRFYNSWIDDQNK 84 (652)
Q Consensus 13 ~~rL~~l~~gtVykA-----~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~---HpnIVkl~~~~~d~~~~ 84 (652)
...|++++.|+||+| .+..+|+.||+|++... ....+..|+++++.++ |+||+++++++....
T Consensus 70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~-- 140 (365)
T 3e7e_A 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-------NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN-- 140 (365)
T ss_dssp EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-------CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS--
T ss_pred EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-------ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC--
Confidence 356888888999999 57889999999998632 2446777888888886 999999999987655
Q ss_pred eEEEEEecCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCC----------
Q 006277 85 TVNIITELFTSGSLRQYRKK-----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN---------- 149 (652)
Q Consensus 85 ~~~LVmEy~~gGsL~~~i~~-----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~---------- 149 (652)
..|+|||||.+|+|.+++.. .+.+++..++.|+.||+.||+|||++| |+||||||+|||++..
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC------
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCccccccc
Confidence 68999999999999999974 467999999999999999999999998 9999999999999731
Q ss_pred CCcEEEeccCchhhhhc----cccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 006277 150 QGEVKIGDLGLATIMEQ----ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 224 (652)
Q Consensus 150 ~g~VKL~DFGla~~l~~----~~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I 224 (652)
++.+||+|||+++.+.. ......+||+.|||||++. ..|+.++|||||||++|+|+||.+||.........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---- 294 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---- 294 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee----
Confidence 68999999999976542 2345678999999999874 46999999999999999999999999653221000
Q ss_pred hcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 225 SSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 225 ~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.....+ ....+..+.+++.+||. +|.+|++..+.|.+
T Consensus 295 ~~~~~~---~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 295 PEGLFR---RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp ECSCCT---TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred echhcc---ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 000000 11235689999999998 78888654444444
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=327.28 Aligned_cols=239 Identities=25% Similarity=0.360 Sum_probs=194.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHh--CCCCCeeeeeeEEEeCCC--CeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKS--LKHNNIIRFYNSWIDDQN--KTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~--L~HpnIVkl~~~~~d~~~--~~~~L 88 (652)
...|+++..|+||+|.+ +|+.||+|++.. .....+.+|+++++. ++||||+++++++.+... ..+++
T Consensus 47 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-------~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l 117 (342)
T 1b6c_B 47 QESIGKGRFGEVWRGKW--RGEEVAVKIFSS-------REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 117 (342)
T ss_dssp EEEEEEETTEEEEEEEE--TTEEEEEEEECG-------GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred EeeecCCCCcEEEEEEE--cCccEEEEEeCc-------hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence 35788888899999987 599999999863 234677889999988 799999999999876543 27999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeeeccCCcccEEEcCCCCcEEEeccCc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH--------SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 160 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLH--------s~g~~IiHRDLKp~NILl~~~~g~VKL~DFGl 160 (652)
||||+.+|+|.+++.+. .+++..++.++.||+.||.||| +++ |+||||||+|||++ .++.+||+|||+
T Consensus 118 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 118 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVK-KNGTCCIADLGL 193 (342)
T ss_dssp EECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEEC-TTSCEEECCCTT
T ss_pred EEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEEC-CCCCEEEEECCC
Confidence 99999999999999764 6999999999999999999999 777 99999999999998 678999999999
Q ss_pred hhhhhccc------cccccCCCCccCccccccC-------CCccccchhhHHHHHHHhhc----------cCCCCCCC--
Q 006277 161 ATIMEQAN------AKSVIGTPEFMAPELYDEN-------YNELADIYSFGMCMLEMVTF----------EYPYSECR-- 215 (652)
Q Consensus 161 a~~l~~~~------~~~~vGTp~YmAPEvl~~~-------y~~~sDIWSlGvilyeLltG----------~~Pf~~~~-- 215 (652)
+....... .....||+.|+|||++.+. ++.++|||||||++|+|++| ..||....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 97664432 2456899999999987543 34689999999999999999 78886532
Q ss_pred --CHHHHHHHHhcCCCCccccC-----CCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 216 --NSAQIYKKVSSGIKPAALSK-----VKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 216 --~~~~i~~~I~~g~~p~~l~~-----~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
....+...+........++. .....+.+||.+||. +|.+|||+.++++|
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 33455555544433322222 123578999999997 89999999999976
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.75 Aligned_cols=246 Identities=22% Similarity=0.354 Sum_probs=199.6
Q ss_pred Ccceeeee---eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 006277 4 QKWSLLIL---MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 80 (652)
Q Consensus 4 ~~W~~~~~---~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 80 (652)
..|..... .-.+|+++..|+||+|.+.. +..||+|.++.... ..+.+.+|+++|++|+||||+++++++.+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 45665443 34567777789999999865 56799999874331 24678999999999999999999998754
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEecc
Q 006277 81 DQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 158 (652)
Q Consensus 81 ~~~~~~~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DF 158 (652)
..+|+|||||.+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+||
T Consensus 251 ---~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~Df 324 (452)
T 1fmk_A 251 ---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADF 324 (452)
T ss_dssp ---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCC
T ss_pred ---CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEC-CCCCEEECCC
Confidence 3589999999999999998743 56999999999999999999999999 99999999999998 6789999999
Q ss_pred Cchhhhhccc---cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccc
Q 006277 159 GLATIMEQAN---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAAL 233 (652)
Q Consensus 159 Gla~~l~~~~---~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l 233 (652)
|+++...... .....||+.|+|||++ .+.|+.++|||||||++|||++ |..||.+ ....++...+..+..+ ..
T Consensus 325 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~~ 402 (452)
T 1fmk_A 325 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-PC 402 (452)
T ss_dssp CTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CC
T ss_pred ccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CC
Confidence 9998765432 2334578899999976 4679999999999999999999 9999987 5566777777776543 33
Q ss_pred cCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 234 SKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 234 ~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
+...++.+.+||.+||. +|.+|||+.+++.
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 45678899999999998 8999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=336.79 Aligned_cols=242 Identities=20% Similarity=0.295 Sum_probs=191.3
Q ss_pred EEEEEecCcEEEEEEEccC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~t---G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
..|+++..|+||+|.+..+ +..||+|.+... ......+++.+|+.+|++++||||+++++++.... ...++||
T Consensus 95 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~~lv~ 170 (373)
T 3c1x_A 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPLVVL 170 (373)
T ss_dssp EEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS-SCCEEEE
T ss_pred cEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-CCeEEEE
Confidence 4678888899999998654 356899987532 23567889999999999999999999999875443 3689999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 91 ELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
||+.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC-----------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEEC-CCCCEEEeecccccccccccc
Confidence 999999999999865 45899999999999999999999998 99999999999998 67899999999998764322
Q ss_pred -----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHH
Q 006277 169 -----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 169 -----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~ 241 (652)
.....||+.|+|||++ ...|+.++|||||||++|+|+| |.+||... +..++...+..+..+ ..+...++.+
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~-~~~~~~~~~~~~~~~-~~p~~~~~~l 325 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRL-LQPEYCPDPL 325 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CSSCHHHHHHTTCCC-CCCTTCCHHH
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHH
Confidence 2345678899999977 4679999999999999999999 67788763 344455556665433 3345678899
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 242 KSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.+||.+||. +|.+|||+.+++++
T Consensus 326 ~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 326 YEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999998 89999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.80 Aligned_cols=239 Identities=23% Similarity=0.367 Sum_probs=197.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..|++++.|+||+|.+.. .||+|++..... .....+++.+|+.++++++||||+++++++.+.. .+++||||+
T Consensus 39 ~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~iv~e~~ 111 (319)
T 2y4i_B 39 ELIGKGRFGQVYHGRWHG---EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP--HLAIITSLC 111 (319)
T ss_dssp CBCCCSSSSEEEEEEESS---SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS--CEEEECBCC
T ss_pred eEeccCCceEEEEEEEcC---eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC--ceEEEeecc
Confidence 355666668999998864 499999875432 2234566788999999999999999999988654 699999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-----
Q 006277 94 TSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----- 167 (652)
Q Consensus 94 ~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~----- 167 (652)
.+++|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|||++......
T Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~--~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 112 KGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp CSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCCSCCC----------
T ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe--CCCEEEeecCCcccccccccccc
Confidence 9999999998765 6999999999999999999999998 99999999999997 479999999998765321
Q ss_pred --ccccccCCCCccCcccccc----------CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccC
Q 006277 168 --NAKSVIGTPEFMAPELYDE----------NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 235 (652)
Q Consensus 168 --~~~~~vGTp~YmAPEvl~~----------~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~ 235 (652)
......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .....+...+..+..+.....
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~ 266 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLSQI 266 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHHHHHTTCCCCCCCS
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhccCCCCCCCcC
Confidence 1234579999999997742 478899999999999999999999987 566677777777766655555
Q ss_pred CCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 236 VKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 236 ~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
..+.++.+||.+||. +|.+|||+.++++.
T Consensus 267 ~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 267 GMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp SCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 678899999999998 89999999999863
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=345.67 Aligned_cols=248 Identities=21% Similarity=0.349 Sum_probs=205.4
Q ss_pred CCcceeeee---eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 006277 3 RQKWSLLIL---MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 79 (652)
Q Consensus 3 ~~~W~~~~~---~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 79 (652)
...|.+... ...+|+++..|.||+|.+.. +..||+|+++.... ..+.+.+|+++|++|+|||||++++++.
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~ 332 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVS 332 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345665543 34567777789999999865 56799999875432 2467899999999999999999999875
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEec
Q 006277 80 DDQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 157 (652)
Q Consensus 80 d~~~~~~~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~D 157 (652)
+ ..+|+|||||.+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|
T Consensus 333 ~---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~D 406 (535)
T 2h8h_A 333 E---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVAD 406 (535)
T ss_dssp S---SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECC
T ss_pred e---ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEc-CCCcEEEcc
Confidence 4 3689999999999999998743 56999999999999999999999999 99999999999998 678999999
Q ss_pred cCchhhhhccc---cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCcc
Q 006277 158 LGLATIMEQAN---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAA 232 (652)
Q Consensus 158 FGla~~l~~~~---~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~ 232 (652)
||+++.+.... .....+|+.|+|||++ .+.|+.++|||||||++|||++ |..||.+ ....++...+..+... .
T Consensus 407 FG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~ 484 (535)
T 2h8h_A 407 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-P 484 (535)
T ss_dssp TTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT-CCHHHHHHHHHTTCCC-C
T ss_pred cccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-C
Confidence 99998765322 2344578899999976 4679999999999999999999 9999987 4566777777776533 3
Q ss_pred ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 233 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 233 l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
.+...+..+.+||.+||. +|.+|||+.+|+..
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 345678899999999998 89999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=364.03 Aligned_cols=251 Identities=27% Similarity=0.348 Sum_probs=202.3
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe----CCCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID----DQNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d----~~~~~~~LV 89 (652)
.+|+.++.|+||+|.+..+|+.||+|++... ..+...+++.+|+.+|+.++||||+++++++.+ ..+...|+|
T Consensus 20 ~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~---~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LV 96 (676)
T 3qa8_A 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96 (676)
T ss_dssp CCCCBCSSSBCCCCCCTTTTCCEEECCCCSC---CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCE
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEE
Confidence 4778888899999999999999999988643 246778899999999999999999999998644 124578999
Q ss_pred EecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCC--cEEEeccCchhhh
Q 006277 90 TELFTSGSLRQYRKKHK---KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG--EVKIGDLGLATIM 164 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g--~VKL~DFGla~~l 164 (652)
||||.||+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.+++ .+||+|||++...
T Consensus 97 mEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~ 174 (676)
T 3qa8_A 97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174 (676)
T ss_dssp EECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBT
T ss_pred EEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEccccccccc
Confidence 99999999999998754 6999999999999999999999998 999999999999984322 3899999999877
Q ss_pred hccc-cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHh-------------cCC-
Q 006277 165 EQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS-------------SGI- 228 (652)
Q Consensus 165 ~~~~-~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~-------------~g~- 228 (652)
.... .....||+.|+|||++. ..|+.++|||||||++|+|++|..||.......++...+. .+.
T Consensus 175 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~ 254 (676)
T 3qa8_A 175 DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254 (676)
T ss_dssp TSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSC
T ss_pred ccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcccc
Confidence 6543 35678999999999875 5799999999999999999999999976433322111110 000
Q ss_pred -------CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 229 -------KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 229 -------~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.+..+....++.+.+||.+||. +|.+|||+.|+|.||||+.
T Consensus 255 ~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 255 KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred ccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 1112223356789999999998 8999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.43 Aligned_cols=242 Identities=17% Similarity=0.182 Sum_probs=184.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC-CCee--------------------
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH-NNII-------------------- 72 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~H-pnIV-------------------- 72 (652)
..|++++.|+||+|.+..+|+.||+|++..... ......+.+.+|+.+++.|.| +|+.
T Consensus 84 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred cccccCCCEEEEEEEecCCCCceEEEEEecCCC-ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 468888889999999999999999998874332 223457789999999999987 3211
Q ss_pred -eeeeEEEeCC---CCeEEEEEecCCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCc
Q 006277 73 -RFYNSWIDDQ---NKTVNIITELFTSGSLRQYRKK-------HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 141 (652)
Q Consensus 73 -kl~~~~~d~~---~~~~~LVmEy~~gGsL~~~i~~-------~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp 141 (652)
.+..++.... ...++++|+++ +|+|.+++.. .+.+++..+..++.||+.||+|||++| |+||||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iiHrDiKp 239 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRP 239 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCccc
Confidence 1111111111 22467888876 6799988851 235788899999999999999999999 99999999
Q ss_pred ccEEEcCCCCcEEEeccCchhhhhccccccccCCCCccCcccc----------cc-CCCccccchhhHHHHHHHhhccCC
Q 006277 142 DNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY----------DE-NYNELADIYSFGMCMLEMVTFEYP 210 (652)
Q Consensus 142 ~NILl~~~~g~VKL~DFGla~~l~~~~~~~~vGTp~YmAPEvl----------~~-~y~~~sDIWSlGvilyeLltG~~P 210 (652)
+|||++ .+|.+||+|||+++..... ....+| +.|+|||++ .. .|+.++|||||||++|+|++|..|
T Consensus 240 ~NILl~-~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P 316 (413)
T 3dzo_A 240 VDIVLD-QRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316 (413)
T ss_dssp GGEEEC-TTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred ceEEEe-cCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999998 6688999999998876544 456788 999999977 22 478899999999999999999999
Q ss_pred CCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 211 YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 211 f~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
|.... .......+... ....++.+++||.+||. +|.+||++.++|+||||+.
T Consensus 317 f~~~~-~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 317 NTDDA-ALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp CCTTG-GGSCSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCCcc-hhhhHHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 97633 22222222221 12457899999999998 8999999999999999974
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=335.73 Aligned_cols=239 Identities=20% Similarity=0.238 Sum_probs=193.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC-CeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN-NIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hp-nIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..|+++..|.||+|.+..+|+.||+|++...... .++.+|+.+++.|.|+ +|+.++.++.+. ...+|||||
T Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~~~--~~~~lvme~ 84 (483)
T 3sv0_A 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGVEG--DYNVLVMDL 84 (483)
T ss_dssp CCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEEET--TEEEEEEEC
T ss_pred EEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEeeC--CEEEEEEEC
Confidence 5688888899999999999999999988754432 3478899999999775 455555444433 488999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEc--CCCCcEEEeccCchhhhhccc-
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~--~~~g~VKL~DFGla~~l~~~~- 168 (652)
| +++|.+++.. .+.+++..++.|+.||+.||.|||++| |+||||||+||||+ ...+.+||+|||+++.+....
T Consensus 85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 9 9999999985 567999999999999999999999998 99999999999994 256899999999998765432
Q ss_pred --------cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCC--CHHHHHHHHhcCC---CCcccc
Q 006277 169 --------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECR--NSAQIYKKVSSGI---KPAALS 234 (652)
Q Consensus 169 --------~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~--~~~~i~~~I~~g~---~p~~l~ 234 (652)
....+||+.|+|||++ ...|+.++|||||||++|+|++|..||.+.. ...+.+..+.... ....+.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC 241 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh
Confidence 1267899999999976 4579999999999999999999999997643 2344444443322 112233
Q ss_pred CCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 235 KVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 235 ~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
...++++.+||.+||. +|.+||++.+|++
T Consensus 242 ~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 242 RGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp TTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 5567899999999997 8999999998764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=347.10 Aligned_cols=240 Identities=24% Similarity=0.380 Sum_probs=199.7
Q ss_pred EEEEEecCcEEEEEEEccC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~t---G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
..|++++.|+||+|.+..+ +..||+|.+... ......+++.+|+.+|++++||||+++++++.+ ..+|+||
T Consensus 396 ~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~~lv~ 469 (656)
T 2j0j_A 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWIIM 469 (656)
T ss_dssp EEEECCSSCCEEEEEECCSSSCCEEEEEEECSST---TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEE
T ss_pred eEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---CceEEEE
Confidence 4677788899999998653 577999987532 245667889999999999999999999998743 2589999
Q ss_pred ecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 91 ELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
|||.+|+|.+++...+ .+++..+..++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.......
T Consensus 470 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~-~~~~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 470 ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp ECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCCCCCSCCC---
T ss_pred EcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEe-CCCCEEEEecCCCeecCCCcc
Confidence 9999999999998654 6999999999999999999999998 99999999999998 67899999999998765432
Q ss_pred --cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 169 --AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
.....||+.|+|||++. ..|+.++|||||||++|||++ |..||.+ .....+...+..+..+ ..+...++.+.+|
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~l 624 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERL-PMPPNCPPTLYSL 624 (656)
T ss_dssp -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHHTCCC-CCCTTCCHHHHHH
T ss_pred eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCC-CCCccccHHHHHH
Confidence 23456788999999774 579999999999999999997 9999987 4566666777666533 3455678999999
Q ss_pred HHHhCC-CCCCCCCHHHHhcC
Q 006277 245 IEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~h 264 (652)
|.+||. +|.+|||+.++++.
T Consensus 625 i~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 625 MTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHH
Confidence 999998 89999999999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=352.33 Aligned_cols=236 Identities=20% Similarity=0.238 Sum_probs=194.5
Q ss_pred EEEEEEecCcEEEEEEEcc-CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---CeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEV-NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN---KTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~-tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~---~~~~L 88 (652)
...|++++.|+||+|.+.. +|+.||+|++... ...+....+.+|+++|++++|||||++++++.+... ..+||
T Consensus 85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence 3567888889999999987 8999999987642 245677889999999999999999999999876542 12799
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
|||||.|++|.+++.. .+++..++.|+.||+.||.|||++| |+||||||+|||++. +.+||+|||+++.....
T Consensus 162 v~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~--~~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 162 VMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTE--EQLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECS--SCEEECCCTTCEETTCC-
T ss_pred EEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeC--CcEEEEecccchhcccC-
Confidence 9999999999988754 7999999999999999999999999 999999999999984 48999999999876543
Q ss_pred cccccCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 169 AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
...+||+.|+|||++.+.++.++|||||||++|+|++|.+||.+... .+..........++.+.+||.+|
T Consensus 235 -~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~ 304 (681)
T 2pzi_A 235 -GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSYGRLLRRA 304 (681)
T ss_dssp -SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHHHHHHHHH
T ss_pred -CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHHHHHHhhh
Confidence 56789999999999887889999999999999999999998865211 01111001111357899999999
Q ss_pred CC-CCCCCCCHHHHhcCcccc
Q 006277 249 LV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~~ 268 (652)
|. +|.+||++.+.+.|+|+.
T Consensus 305 l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 305 IDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp TCSSGGGSCSSHHHHHHHHHH
T ss_pred ccCChhhCCCHHHHHHHHHHH
Confidence 98 899999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.54 Aligned_cols=218 Identities=14% Similarity=0.123 Sum_probs=177.5
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..|++++.|.||+|.+..+|+.||+|++.... ....+..+++.+|+.++++++||||+++++++.+.. .+|+|||||
T Consensus 37 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~ 113 (286)
T 3uqc_A 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQG-VLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA--GGLVVAEWI 113 (286)
T ss_dssp EEEEBSTTCEEEEEEETTTTEEEEEEESCTTC-CSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEEEECC
T ss_pred EEEcccCCeEEEEEEecCCCceEEEEEECccc-ccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC--cEEEEEEec
Confidence 56777777999999999999999999987443 334667789999999999999999999999998754 799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccccc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI 173 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~v 173 (652)
.|++|.++++. + .....+..|+.||+.||.|||++| |+||||||+|||++ .+|.+||+++
T Consensus 114 ~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~-~~g~~kl~~~--------------- 173 (286)
T 3uqc_A 114 RGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVS-IDGDVVLAYP--------------- 173 (286)
T ss_dssp CEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-TTSCEEECSC---------------
T ss_pred CCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEc-CCCCEEEEec---------------
Confidence 99999999854 3 466678999999999999999999 99999999999998 6789999744
Q ss_pred CCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHH---HHHHhcCCC-CccccCCCChHHHHHHHHhC
Q 006277 174 GTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI---YKKVSSGIK-PAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 174 GTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i---~~~I~~g~~-p~~l~~~~s~~~kdlI~kcL 249 (652)
.|++| ++.++|||||||++|+|+||..||.+......+ ++.+..... +.......++++++||.+||
T Consensus 174 ---~~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 244 (286)
T 3uqc_A 174 ---ATMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSV 244 (286)
T ss_dssp ---CCCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHH
T ss_pred ---cccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHc
Confidence 34443 789999999999999999999999874332211 011111111 11233557889999999999
Q ss_pred C-CCCCCCCHHHHhcC
Q 006277 250 V-PASQRLSAKELLMD 264 (652)
Q Consensus 250 ~-~P~~RpSa~elL~h 264 (652)
. +|.+| |+.|+++.
T Consensus 245 ~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 245 QGDGGIR-SASTLLNL 259 (286)
T ss_dssp CTTSSCC-CHHHHHHH
T ss_pred ccCCccC-CHHHHHHH
Confidence 8 89999 99999975
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-34 Score=322.67 Aligned_cols=188 Identities=13% Similarity=0.051 Sum_probs=138.2
Q ss_pred EEEecCcEEEEEEEccCCeEEEEEEEeecccCC------CHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEE
Q 006277 16 LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQ------SPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 16 L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~------s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~L 88 (652)
...+.++.+..+.....|+.||+|++.+.-... .....+++.+|+++|+++ .|+||++++++++++. .+||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~--~~yL 319 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ--SGWL 319 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS--EEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC--EEEE
Confidence 344555677788888899999999997643221 123456799999999999 7999999999998765 8999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 167 (652)
|||||+||+|.+++.+.+++++. .|++||+.||+|||++| ||||||||+|||++ .+|+|||+|||+|+.+...
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~-~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVD-ARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEEC-TTSCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEEC-CCCCEEEeecccCeeCCCCC
Confidence 99999999999999999999875 47899999999999999 99999999999998 6789999999999877543
Q ss_pred -ccccccCCCCccCccccccCCCccccchhhHHHHHHHhhccCCC
Q 006277 168 -NAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPY 211 (652)
Q Consensus 168 -~~~~~vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf 211 (652)
...+.+|||.|||||++.+.+...+|+||+|+++++|.++..|+
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH
T ss_pred ccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh
Confidence 34678999999999999998999999999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.7e-26 Score=256.44 Aligned_cols=180 Identities=18% Similarity=0.172 Sum_probs=145.8
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCH-----HHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSP-----EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~-----e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
.|+++..|+||+| ...+..+|+|....+.. ..+ ...+++.+|+++|++|+||||+++..++.+.. ..|||
T Consensus 343 ~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~~lV 417 (540)
T 3en9_A 343 LIGKGAEADIKRD--SYLDFDVIIKERVKKGY-RDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD--NKRIM 417 (540)
T ss_dssp -----CCEEEEEE--ECSSCEEEEEEECCCTT-SCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT--TTEEE
T ss_pred EEeeCCCEEEEEE--EECCCeEEEEEEecccc-cchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC--ccEEE
Confidence 6788888999999 56789999998765332 222 22567899999999999999995544445444 46999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
||||+||+|.+++.. +..|+.||+.||.|||+++ |+||||||+|||++. .+||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS---SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC---eEEEEECccCEECCCccc
Confidence 999999999999865 6789999999999999999 999999999999984 99999999998775421
Q ss_pred --------cccccCCCCccCccccc---cCCCccccchhhHHHHHHHhhccCCCC
Q 006277 169 --------AKSVIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYS 212 (652)
Q Consensus 169 --------~~~~vGTp~YmAPEvl~---~~y~~~sDIWSlGvilyeLltG~~Pf~ 212 (652)
..+.+||+.|||||++. ..|+..+|+||..+-.++.+.++.+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 24678999999999885 468899999999999999988888774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.9e-22 Score=204.57 Aligned_cols=143 Identities=13% Similarity=0.108 Sum_probs=113.7
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCC-----CH---------HHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQ-----SP---------EDLERLYSEVHLLKSLKHNNIIRFYNSWI 79 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~-----s~---------e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 79 (652)
..++++..|.||+|.+ .+|+.||+|.++...... .. ....++.+|+.+|+.|+ | +++++++.
T Consensus 96 ~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 96 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred CEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 6788888899999999 899999999986432110 00 24677899999999999 4 55555443
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccC
Q 006277 80 DDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 159 (652)
Q Consensus 80 d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFG 159 (652)
.. ..|+|||||.||+|.+ +. ......++.||+.||.|||++| |+||||||+|||++ +|.+||+|||
T Consensus 172 ~~---~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~--~~~vkl~DFG 237 (282)
T 1zar_A 172 WE---GNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS--EEGIWIIDFP 237 (282)
T ss_dssp EE---TTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE--TTEEEECCCT
T ss_pred cc---ceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE--CCcEEEEECC
Confidence 32 4699999999999987 31 2345679999999999999999 99999999999998 6899999999
Q ss_pred chhhhhccccccccCCCCccCccccc
Q 006277 160 LATIMEQANAKSVIGTPEFMAPELYD 185 (652)
Q Consensus 160 la~~l~~~~~~~~vGTp~YmAPEvl~ 185 (652)
++.. +..++|||++.
T Consensus 238 ~a~~-----------~~~~~a~e~l~ 252 (282)
T 1zar_A 238 QSVE-----------VGEEGWREILE 252 (282)
T ss_dssp TCEE-----------TTSTTHHHHHH
T ss_pred CCeE-----------CCCCCHHHHHH
Confidence 9863 55689999774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.7e-17 Score=169.32 Aligned_cols=137 Identities=17% Similarity=0.155 Sum_probs=104.8
Q ss_pred EEEEEecCcEEEEEEEccCCeE--EEEEEEeecccCCC--------------------HHHHHHHHHHHHHHHhCCCCCe
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLE--VAWCQVRIDDVLQS--------------------PEDLERLYSEVHLLKSLKHNNI 71 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~--VAiK~v~~~~~~~s--------------------~e~~~~l~~Ei~iLk~L~HpnI 71 (652)
..++++..|.||+|.+..+|+. ||+|+++....... ......+.+|+.+|+.|.|++|
T Consensus 53 ~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 132 (258)
T 1zth_A 53 GVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGV 132 (258)
T ss_dssp EEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5678888899999999889999 99998764321100 1123478899999999988864
Q ss_pred --eeeeeEEEeCCCCeEEEEEecCCC-C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeeeccCCccc
Q 006277 72 --IRFYNSWIDDQNKTVNIITELFTS-G----SLRQYRKKHKKVDMKAVKGWARQILSGLIYLH-SHDPPIIHRDLKCDN 143 (652)
Q Consensus 72 --Vkl~~~~~d~~~~~~~LVmEy~~g-G----sL~~~i~~~~~lse~~i~~i~~QIl~aL~yLH-s~g~~IiHRDLKp~N 143 (652)
+.++. .. ..+|||||+.+ | +|.++... .++..+..++.||+.||.||| ++| |+||||||+|
T Consensus 133 ~~p~~~~--~~----~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlkp~N 201 (258)
T 1zth_A 133 SVPQPYT--YM----KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVHADLSEYN 201 (258)
T ss_dssp CCCCEEE--EE----TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCSTTS
T ss_pred CCCeEEE--cC----CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHH
Confidence 44443 21 35899999942 3 77776432 335678899999999999999 888 9999999999
Q ss_pred EEEcCCCCcEEEeccCchhhh
Q 006277 144 IFINGNQGEVKIGDLGLATIM 164 (652)
Q Consensus 144 ILl~~~~g~VKL~DFGla~~l 164 (652)
||++. .++|+|||+|...
T Consensus 202 ILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 202 IMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp EEESS---SEEECCCTTCEET
T ss_pred EEEcC---cEEEEECcccccC
Confidence 99984 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.45 E-value=9.2e-14 Score=150.58 Aligned_cols=138 Identities=17% Similarity=0.140 Sum_probs=95.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeeccc-----------CCCH---H--HHH--HHHHHHHHHHhCCCCCeeee
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDV-----------LQSP---E--DLE--RLYSEVHLLKSLKHNNIIRF 74 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~-----------~~s~---e--~~~--~l~~Ei~iLk~L~HpnIVkl 74 (652)
-.+|+.++.+.||+|.+. +|+.||+|+++.... .... . ... ...+|...|.+|.+.++.-.
T Consensus 100 ~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp 178 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP 178 (397)
T ss_dssp EEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred cCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 356777778999999984 799999998764211 0000 0 011 12457777887755544322
Q ss_pred eeEEEeCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCC---
Q 006277 75 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG--- 151 (652)
Q Consensus 75 ~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g--- 151 (652)
.-+... . .+|||||+.|++|.++. ....+..++.||+.+|.|||.+| ||||||||.|||++ ++|
T Consensus 179 ~p~~~~-~---~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~-~dgd~~ 245 (397)
T 4gyi_A 179 EPIAQS-R---HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIR-EEKDAE 245 (397)
T ss_dssp CEEEEE-T---TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-EEECSS
T ss_pred eeeecc-C---ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEe-CCCCcc
Confidence 211121 2 37999999998886532 22345678899999999999998 99999999999998 333
Q ss_pred -------cEEEeccCchhhh
Q 006277 152 -------EVKIGDLGLATIM 164 (652)
Q Consensus 152 -------~VKL~DFGla~~l 164 (652)
.+.|+||+-+...
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 3889999966543
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.63 E-value=1.8e-11 Score=105.07 Aligned_cols=63 Identities=29% Similarity=0.390 Sum_probs=58.7
Q ss_pred cccceeeeeeecC---CCcee---eeecccccCCCCcCcchHHHHhccccCCcChHHHHHHHHHHHHHh
Q 006277 358 EYSVSLILRIADQ---SGRLR---NIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNL 420 (652)
Q Consensus 358 ~~~I~liLri~D~---~g~i~---~ieF~f~~d~Dta~~Va~EmV~~l~l~~~d~~~iA~~Id~~i~~l 420 (652)
...|+|+||+.|+ .|+.+ +|+|+|++++|||.+||+|||++++|.++|+..||+||+.-+..+
T Consensus 23 ~~~i~L~LRi~Dpkk~~gk~KeNeaIeF~Fdle~Dta~eVA~EMVe~~~l~e~D~~~VaklI~~~v~~~ 91 (98)
T 2lru_A 23 KIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLI 91 (98)
Confidence 4789999999997 48999 999999999999999999999999999999999999999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=7e-10 Score=111.78 Aligned_cols=128 Identities=15% Similarity=0.044 Sum_probs=95.6
Q ss_pred CcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHH
Q 006277 21 DTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLR 99 (652)
Q Consensus 21 ~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~ 99 (652)
++.||++.. .|..+++|....... ....++.+|+.+|+.| .+..+.++++++.+. +..|+||||++|.+|.
T Consensus 27 ~~~v~~~~~--~~~~~vlK~~~~~~~----~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 27 PAKVYKLVG--ENENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLMSEADGVLCS 98 (263)
T ss_dssp SSEEEEEEC--SSCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCSSEEHH
T ss_pred CCeEEEEEC--CCCcEEEEeCCcccC----CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC--CceEEEEEecCCeehh
Confidence 367999974 368899998764211 1123588899999999 467788898877654 4789999999999997
Q ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------------
Q 006277 100 QYRKKHKKVDMKAVKGWARQILSGLIYLHSHD------------------------------------------------ 131 (652)
Q Consensus 100 ~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g------------------------------------------------ 131 (652)
+.. .+......++.++..+|..||+..
T Consensus 99 ~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 173 (263)
T 3tm0_A 99 EEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF 173 (263)
T ss_dssp HHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHH
T ss_pred hcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHH
Confidence 652 122334578899999999999810
Q ss_pred ---------CCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 132 ---------PPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 132 ---------~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
+.++|+|++|.||+++ +++.+.|+||+.+.
T Consensus 174 l~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 174 LKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHCCCCCCEEEECSSCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred HHhcCCCCCceEECCCCCcCcEEEE-CCcEEEEEEchhcc
Confidence 2389999999999997 34456799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.88 E-value=3.2e-09 Score=105.68 Aligned_cols=122 Identities=13% Similarity=0.033 Sum_probs=88.0
Q ss_pred cEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC--eeeeeeEEEeCCCCeEEEEEecCCCCCHH
Q 006277 22 TSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN--IIRFYNSWIDDQNKTVNIITELFTSGSLR 99 (652)
Q Consensus 22 gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hpn--IVkl~~~~~d~~~~~~~LVmEy~~gGsL~ 99 (652)
+.||++. ..+|..|++|..... ....+.+|+.+++.|.+.+ +.+++.+..+. +..++||||++|.+|.
T Consensus 34 ~~v~~~~-~~~g~~~vlK~~~~~-------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 34 AAVFRLS-AQGRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CEEEEEE-CTTSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECCSSEETT
T ss_pred ceEEEEe-cCCCCeEEEEeCCcc-------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCEEEEEecCCcccC
Confidence 6899985 456788999986532 1245778999999995444 45688766543 3689999999998883
Q ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------------
Q 006277 100 QYRKKHKKVDMKAVKGWARQILSGLIYLHSHD------------------------------------------------ 131 (652)
Q Consensus 100 ~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g------------------------------------------------ 131 (652)
. ...+ ...++.++...|..||+..
T Consensus 104 --~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 --S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp --T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred --c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 1 1122 2356777888888888753
Q ss_pred --------CCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 132 --------PPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 132 --------~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
+.++|+|++|.||+++ .++.+.|+||+.+.
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVE-NGRFSGFIDCGRLG 213 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEE-CCcEEEEEcchhcc
Confidence 1299999999999997 44456799999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.81 E-value=8.7e-09 Score=109.03 Aligned_cols=144 Identities=13% Similarity=0.157 Sum_probs=100.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEe--ecccCCCHHHHHHHHHHHHHHHhCC--CCCeeeeeeEEEeCCC-CeEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVR--IDDVLQSPEDLERLYSEVHLLKSLK--HNNIIRFYNSWIDDQN-KTVN 87 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~--~~~~~~s~e~~~~l~~Ei~iLk~L~--HpnIVkl~~~~~d~~~-~~~~ 87 (652)
..++..+..+.||++... +..+++|... ..... .....+.+|+.+++.|. +..+++++.++.+... +..|
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~---~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL---PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC---CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 456666666789998753 4677788654 22211 12456788999999996 4567888886654321 3578
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------
Q 006277 88 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH------------------------------------- 130 (652)
Q Consensus 88 LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~------------------------------------- 130 (652)
+||||+.|..+.+. ....++......++.+++..|..||+.
T Consensus 118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999999877431 123577888899999999999999973
Q ss_pred -------------------CCCeeeccCCcccEEEcCCCCc-EEEeccCchhh
Q 006277 131 -------------------DPPIIHRDLKCDNIFINGNQGE-VKIGDLGLATI 163 (652)
Q Consensus 131 -------------------g~~IiHRDLKp~NILl~~~~g~-VKL~DFGla~~ 163 (652)
.+.++|+|++|+|||++.+++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 1349999999999999844333 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.74 E-value=1.3e-08 Score=105.39 Aligned_cols=193 Identities=17% Similarity=0.143 Sum_probs=122.3
Q ss_pred CCcceeeeeeEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCC--eeeeeeEEE
Q 006277 3 RQKWSLLILMYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNN--IIRFYNSWI 79 (652)
Q Consensus 3 ~~~W~~~~~~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~Hpn--IVkl~~~~~ 79 (652)
+|.|.... ...+..+....||++. ..+++|... ......++.+|+.+|+.| .+.. +.+++....
T Consensus 17 ~p~~~~~~--i~~~~~G~~n~v~~v~-----~~~vlR~~~------~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~ 83 (304)
T 3sg8_A 17 YPDFTINT--IEISGEGNDCIAYEIN-----RDFIFKFPK------HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGM 83 (304)
T ss_dssp CTTCCCCC--CCEEEECSSEEEEEST-----TSEEEEEES------SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECC
T ss_pred CCCcccee--eEecCCCCcceEEEEC-----CEEEEEecC------CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecC
Confidence 45565532 3346666667788763 357788643 234567899999999988 4433 334443221
Q ss_pred eCCC-CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------
Q 006277 80 DDQN-KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD--------------------------- 131 (652)
Q Consensus 80 d~~~-~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g--------------------------- 131 (652)
+... ...|+||++++|.+|..... ..++......++.|+...|..||+..
T Consensus 84 ~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (304)
T 3sg8_A 84 PSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLL 161 (304)
T ss_dssp CCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHh
Confidence 1111 23488999999988865332 35778888888899998888888621
Q ss_pred -----------------------------CCeeeccCCcccEEEcCC-CCcEEEeccCchhhhhccccccccCCCCc---
Q 006277 132 -----------------------------PPIIHRDLKCDNIFINGN-QGEVKIGDLGLATIMEQANAKSVIGTPEF--- 178 (652)
Q Consensus 132 -----------------------------~~IiHRDLKp~NILl~~~-~g~VKL~DFGla~~l~~~~~~~~vGTp~Y--- 178 (652)
+.++|+|++|.||+++.+ .+.+.|+||+.+..-.... .......+
T Consensus 162 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl~~~~~~~~~ 239 (304)
T 3sg8_A 162 SRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DFISLMEDDEE 239 (304)
T ss_dssp TTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HHHTTCCTTTS
T ss_pred cccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HHHHHHhhccc
Confidence 237999999999999843 4567899999875422110 00001111
Q ss_pred cCccccc---cCCC------------ccccchhhHHHHHHHhhccCCCC
Q 006277 179 MAPELYD---ENYN------------ELADIYSFGMCMLEMVTFEYPYS 212 (652)
Q Consensus 179 mAPEvl~---~~y~------------~~sDIWSlGvilyeLltG~~Pf~ 212 (652)
..|+.+. ..|. ...+.|++|.++|.+.+|..+|.
T Consensus 240 ~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 240 YGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 2333211 1121 22589999999999999998873
|
| >2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.58 E-value=5.1e-08 Score=82.88 Aligned_cols=59 Identities=25% Similarity=0.406 Sum_probs=57.1
Q ss_pred cceeeeeeecCCCceeeeecccccCCCCcCcchHHHHhccccCCcChHHHHHHHHHHHH
Q 006277 360 SVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLL 418 (652)
Q Consensus 360 ~I~liLri~D~~g~i~~ieF~f~~d~Dta~~Va~EmV~~l~l~~~d~~~iA~~Id~~i~ 418 (652)
+|+|+||++|.+.++++|.|.|..++||+..||+|||..+.++..|+..+|..++.+|.
T Consensus 2 pv~LvLRlRn~~rELnDIrFeF~~g~DTaegiA~ELv~AgLVDg~D~~vVAanL~klv~ 60 (96)
T 2v3s_A 2 PISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVE 60 (96)
T ss_dssp CEEEEEEEECTTSCEEEEEEEECTTTCCHHHHHHHHHHTTSSCGGGHHHHHHHHHHHHH
T ss_pred CeeEEEEeccccchhcceEEEeecCCCcHHHHHHHHHHCCCcccccHHHHHHHHHHHHh
Confidence 58999999999999999999999999999999999999999999999999999999986
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=6.1e-06 Score=83.03 Aligned_cols=135 Identities=14% Similarity=0.060 Sum_probs=94.0
Q ss_pred EEEEEecCc-EEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 14 LRLIQLVDT-SGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~g-tVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.++..+.++ +||+......|..+.+|.-. +.....+.+|..+|+.|. +--+.+++.++.+.+ ..|+|||
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~-------~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~--~~~lvme 100 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGK-------GSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD--DAWLLTT 100 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEE-------THHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT--EEEEEEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECC-------CCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECC--eEEEEEE
Confidence 444444333 79998887788889999755 234567888999999883 334667777766654 7899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD---------------------------------------- 131 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g---------------------------------------- 131 (652)
+++|.++.+..... ......++.++...|.-||...
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 99998887755432 1223345556666666666421
Q ss_pred ----------------CCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 132 ----------------PPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 132 ----------------~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
+.++|+|+.+.|||++ .++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~-~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD-EGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEE-CCeEEEEEECcccc
Confidence 1279999999999998 44556799998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=9.1e-06 Score=84.42 Aligned_cols=145 Identities=19% Similarity=0.089 Sum_probs=94.1
Q ss_pred CCcceeeeeeEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC---CeeeeeeEEE
Q 006277 3 RQKWSLLILMYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN---NIIRFYNSWI 79 (652)
Q Consensus 3 ~~~W~~~~~~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hp---nIVkl~~~~~ 79 (652)
+|.|... ....+..+....||+. |..+++|... .+....++.+|+.+|+.|.+. .+.+++.+..
T Consensus 16 ~p~~~~~--~v~~l~~G~~n~v~~v-----g~~~VlR~~~------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~ 82 (306)
T 3tdw_A 16 FPDISIQ--SVESLGEGFRNYAILV-----NGDWVFRFPK------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK 82 (306)
T ss_dssp CTTSCCS--CEEEEEECSSEEEEEE-----TTTEEEEEES------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE
T ss_pred CCCCCce--eeeecCCCcceeEEEE-----CCEEEEEecC------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc
Confidence 4444443 2345555555688887 5668888642 245567899999999999642 3455565544
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------
Q 006277 80 DDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD---------------------------- 131 (652)
Q Consensus 80 d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g---------------------------- 131 (652)
. ..+..++||++++|..|....- ..++......++.++...|..||+..
T Consensus 83 ~-~~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~ 159 (306)
T 3tdw_A 83 R-SDGNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQ 159 (306)
T ss_dssp C-TTSCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHH
T ss_pred c-CCCceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHh
Confidence 2 2346789999999988765321 23445555555555555555555432
Q ss_pred ------------------------------CCeeeccCCcccEEEcC--CCCc-EEEeccCchhh
Q 006277 132 ------------------------------PPIIHRDLKCDNIFING--NQGE-VKIGDLGLATI 163 (652)
Q Consensus 132 ------------------------------~~IiHRDLKp~NILl~~--~~g~-VKL~DFGla~~ 163 (652)
+.++|+|++|.||+++. .++. +.|+||+.+..
T Consensus 160 ~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 160 VFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp TGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred cccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 23699999999999984 1345 48999997653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00014 Score=77.81 Aligned_cols=79 Identities=10% Similarity=0.007 Sum_probs=47.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCH---HHHHHHHHHHHHHHhCCC--CC-eeeeeeEEEeCCCCeEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSP---EDLERLYSEVHLLKSLKH--NN-IIRFYNSWIDDQNKTVN 87 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~---e~~~~l~~Ei~iLk~L~H--pn-IVkl~~~~~d~~~~~~~ 87 (652)
..++.+..+.||++.+..+|..|++|+.........+ ...+++..|+++|+.+.. |. +.++|. .+.. ..+
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~--~d~~--~~~ 111 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTE--MAV 111 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETT--TTE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE--EcCC--ccE
Confidence 4555555679999987667889999986522110001 124567889999998832 43 445664 2443 357
Q ss_pred EEEecCCCC
Q 006277 88 IITELFTSG 96 (652)
Q Consensus 88 LVmEy~~gG 96 (652)
+|||++.|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999774
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.0013 Score=67.71 Aligned_cols=42 Identities=19% Similarity=0.222 Sum_probs=31.6
Q ss_pred HHHHHHHHHh-----------CCCCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 120 ILSGLIYLHS-----------HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 120 Il~aL~yLHs-----------~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
+..++.+|+. ..+.++|+|+++.|||++ .++.+.|+||+.+.
T Consensus 199 ~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~-~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLG-ENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEEC-GGGCEEECCCTTCE
T ss_pred HHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEe-CCCcEEEEehhhcc
Confidence 4456667763 224599999999999997 34689999999663
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00026 Score=74.26 Aligned_cols=75 Identities=5% Similarity=-0.119 Sum_probs=45.2
Q ss_pred CcEEEEEEEcc------CCeEEEEEEEeeccc--CCCHHHHHHHHHHHHHHHhCC-C--CCeeeeeeEEEeCC-CCeEEE
Q 006277 21 DTSGYKAFDEV------NGLEVAWCQVRIDDV--LQSPEDLERLYSEVHLLKSLK-H--NNIIRFYNSWIDDQ-NKTVNI 88 (652)
Q Consensus 21 ~gtVykA~d~~------tG~~VAiK~v~~~~~--~~s~e~~~~l~~Ei~iLk~L~-H--pnIVkl~~~~~d~~-~~~~~L 88 (652)
...+|+..... +|..+++|....... ... ...+.+|+.+|+.|. + ..+.+++.+..+.. .+..|+
T Consensus 34 ~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~ 110 (357)
T 3ats_A 34 SSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFF 110 (357)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEE
T ss_pred cceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceE
Confidence 35788775431 267788887543220 000 135677888888883 3 35677777553321 134689
Q ss_pred EEecCCCCCH
Q 006277 89 ITELFTSGSL 98 (652)
Q Consensus 89 VmEy~~gGsL 98 (652)
||||++|..+
T Consensus 111 v~e~l~G~~l 120 (357)
T 3ats_A 111 LMDYVEGVVP 120 (357)
T ss_dssp EEECCCCBCC
T ss_pred EEEecCCCCh
Confidence 9999988654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0054 Score=64.12 Aligned_cols=74 Identities=12% Similarity=-0.075 Sum_probs=52.7
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC---CCCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK---HNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~---HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
.++..+....+|+... ++..+++|.... .....+.+|...|+.|. ...+++++.+..+. +..++||
T Consensus 42 ~~l~gG~~n~~y~v~~--~~~~~vlK~~~~-------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvm 110 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND--EVQTVFVKINER-------SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLL 110 (312)
T ss_dssp EEECCSSSSEEEEEES--SSCEEEEEEEEG-------GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEE
T ss_pred EEeCCccceeeeEEEE--CCCeEEEEeCCc-------ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEE
Confidence 4454444478999864 567888887652 23567888999999883 35677888765443 4789999
Q ss_pred ecCCCCCH
Q 006277 91 ELFTSGSL 98 (652)
Q Consensus 91 Ey~~gGsL 98 (652)
||++|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0037 Score=67.37 Aligned_cols=30 Identities=17% Similarity=0.359 Sum_probs=24.9
Q ss_pred CCeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 132 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 132 ~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
+.++|+|++|.|||++. ++ +.++||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~-~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQ-DS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECS-SC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeC-CC-CEEEeCccccc
Confidence 34999999999999983 34 99999987753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0085 Score=59.70 Aligned_cols=120 Identities=16% Similarity=0.162 Sum_probs=79.5
Q ss_pred CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHH-HhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccccC
Q 006277 97 SLRQYRKKH-KKVDMKAVKGWARQILSGLIYL-HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG 174 (652)
Q Consensus 97 sL~~~i~~~-~~lse~~i~~i~~QIl~aL~yL-Hs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~vG 174 (652)
+|.+.++.. .+++|++++.++.|.+.+|.-+ +... -..+=+.|..|++. .+|.|-..+ +.+. ..
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~-~dG~V~f~~-~~s~----------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVW-RDGAVTLAP-AADD----------AG 99 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEE-TTSCEEECC-C---------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEe-cCCceeccc-cccc----------cc
Confidence 688887754 6899999999999999998766 2222 12334457899998 678887653 1111 11
Q ss_pred CCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC
Q 006277 175 TPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 250 (652)
Q Consensus 175 Tp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~ 250 (652)
...|.|||......+.+.=|||||+++|.-+-...|-. .....++.+..||..|..
T Consensus 100 ~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e~--------------------eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 100 EPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKEN--------------------EERELSPPLEQLIDHMAN 155 (229)
T ss_dssp -------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCTT--------------------EEECCCHHHHHHHHHHTT
T ss_pred ccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCcc--------------------cchhhCHHHHHHHHHHHh
Confidence 33567888775555678889999999999986554422 234567889999999874
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0035 Score=67.40 Aligned_cols=148 Identities=15% Similarity=0.174 Sum_probs=85.5
Q ss_pred Cccee---eeeeEEEEEEecCcEEEEEEEcc-------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCee
Q 006277 4 QKWSL---LILMYLRLIQLVDTSGYKAFDEV-------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNII 72 (652)
Q Consensus 4 ~~W~~---~~~~~~rL~~l~~gtVykA~d~~-------tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIV 72 (652)
+.|.. ....+.++..+....+|++.... ++..|.++..- ... .....+.+|.++++.|. +.-..
T Consensus 43 ~~W~~~~~~~l~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g--~~~---~~~~~~~rE~~vl~~L~~~gv~P 117 (379)
T 3feg_A 43 GAWRRVQPEELRVYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYG--AIL---QGVDSLVLESVMFAILAERSLGP 117 (379)
T ss_dssp GGGGGCCGGGCCCEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSC
T ss_pred CcCCCCCcCceEEEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECC--Ccc---chHHHHHHHHHHHHHHHhcCCCC
Confidence 45664 23355677667777899987642 35778888642 111 12445568999998883 33335
Q ss_pred eeeeEEEeCCCCeEEEEEecCCCCCHH-----------HH---HHh-C-------CCC--CHHHHHHHHHHHHH------
Q 006277 73 RFYNSWIDDQNKTVNIITELFTSGSLR-----------QY---RKK-H-------KKV--DMKAVKGWARQILS------ 122 (652)
Q Consensus 73 kl~~~~~d~~~~~~~LVmEy~~gGsL~-----------~~---i~~-~-------~~l--se~~i~~i~~QIl~------ 122 (652)
+++..+ .+ .+||||++|..|. .. +.+ | +.. -...+..|+.++..
T Consensus 118 ~ll~~~--~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~ 191 (379)
T 3feg_A 118 QLYGVF--PE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGL 191 (379)
T ss_dssp CEEEEE--TT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSC
T ss_pred eEEEEc--CC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCccc
Confidence 666543 32 2999999985432 11 111 1 111 24567777766532
Q ss_pred -------------HHHHH----HhCC--CCeeeccCCcccEEEcCC---CCcEEEeccCchh
Q 006277 123 -------------GLIYL----HSHD--PPIIHRDLKCDNIFINGN---QGEVKIGDLGLAT 162 (652)
Q Consensus 123 -------------aL~yL----Hs~g--~~IiHRDLKp~NILl~~~---~g~VKL~DFGla~ 162 (652)
.+.+| ...+ ..++|+|+.++||+++.+ .+.+.++||..+.
T Consensus 192 ~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 192 PEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp CSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred chhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 23333 2221 248999999999999844 3689999998775
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0078 Score=62.36 Aligned_cols=31 Identities=23% Similarity=0.345 Sum_probs=25.5
Q ss_pred CeeeccCCcccEEEcCC---CCcEEEeccCchhh
Q 006277 133 PIIHRDLKCDNIFINGN---QGEVKIGDLGLATI 163 (652)
Q Consensus 133 ~IiHRDLKp~NILl~~~---~g~VKL~DFGla~~ 163 (652)
.++|+|+.+.||+++.+ .+.+.|+||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 49999999999999842 25789999997753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0089 Score=61.16 Aligned_cols=71 Identities=10% Similarity=0.074 Sum_probs=40.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-IRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnI-Vkl~~~~~d~~~~~~~LVmE 91 (652)
+.++..+....+|++ ..+++|+..... .......+|+.+++.+...++ .+++. .+.. .-++|++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~-----~~~~~r~~E~~~l~~l~~~g~~P~~~~--~~~~--~~~~v~e 87 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT-----EEYINRANEAVAAREAAKAGVSPEVLH--VDPA--TGVMVTR 87 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC---------CCCHHHHHHHHHHHHHTTSSCCEEE--ECTT--TCCEEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc-----cceeCHHHHHHHHHHHHHcCCCCceEE--EECC--CCEEEEe
Confidence 467777777889998 347788765321 111122457777777732222 45554 3333 2368999
Q ss_pred cC-CCCCH
Q 006277 92 LF-TSGSL 98 (652)
Q Consensus 92 y~-~gGsL 98 (652)
|+ .|.+|
T Consensus 88 ~i~~g~~l 95 (301)
T 3dxq_A 88 YIAGAQTM 95 (301)
T ss_dssp CCTTCEEC
T ss_pred ecCCCccC
Confidence 99 66443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.22 E-value=0.0051 Score=66.95 Aligned_cols=73 Identities=11% Similarity=0.048 Sum_probs=46.4
Q ss_pred eEEEEEEecCcEEEEEEEcc-------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeEEEeCCC
Q 006277 12 MYLRLIQLVDTSGYKAFDEV-------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-IRFYNSWIDDQN 83 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~-------tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnI-Vkl~~~~~d~~~ 83 (652)
.+.++..+....+|++.... ++..|.+|+.... .. .+.+.+|..+++.|...++ .++++.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~---~~~li~E~~~l~~L~~~g~~P~l~~~~--~~- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET---ESHLVAESVIFTLLSERHLGPKLYGIF--SG- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT-
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe--CC-
Confidence 45566666667899997643 3578888876321 11 1345579999998843333 5666643 22
Q ss_pred CeEEEEEecCCCC
Q 006277 84 KTVNIITELFTSG 96 (652)
Q Consensus 84 ~~~~LVmEy~~gG 96 (652)
.+|++|++|.
T Consensus 148 ---g~v~e~l~G~ 157 (429)
T 1nw1_A 148 ---GRLEEYIPSR 157 (429)
T ss_dssp ---EEEECCCCEE
T ss_pred ---CEEEEEeCCc
Confidence 2899999863
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.10 E-value=0.019 Score=58.33 Aligned_cols=74 Identities=14% Similarity=-0.020 Sum_probs=49.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-C--CCeeeeeeEEEeCCCCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-H--NNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-H--pnIVkl~~~~~d~~~~~~~LV 89 (652)
..+++.+..+.||+... .+|+.|.+|+..... +.....+..|+..|+.|. . --+.+++. .+. -++|
T Consensus 20 v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~--~~~----~~lv 88 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA----PALDGLFRAEALGLDWLGRSFGSPVPQVAG--WDD----RTLA 88 (288)
T ss_dssp EEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC----CCCTTHHHHHHHHHHHHTCSTTCCSCCEEE--EET----TEEE
T ss_pred EEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC----cchhhHHHHHHHHHHHHHhhCCCCcceEEe--ccC----ceEE
Confidence 45677777789999974 579999999754222 112235678999999883 2 23455554 232 3789
Q ss_pred EecCCCCC
Q 006277 90 TELFTSGS 97 (652)
Q Consensus 90 mEy~~gGs 97 (652)
|||+.++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.90 E-value=0.021 Score=62.74 Aligned_cols=76 Identities=14% Similarity=0.034 Sum_probs=46.7
Q ss_pred eeEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeEEEeCCCCeEEEE
Q 006277 11 LMYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-IRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 11 ~~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnI-Vkl~~~~~d~~~~~~~LV 89 (652)
..+.++..+....+|++.....+..|++|+..... ...+. ..+|..+++.|...++ .++++.+ .. .+|
T Consensus 111 ~~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~----~~~id-R~~E~~vl~~L~~~gl~P~ll~~~--~~----G~v 179 (458)
T 2qg7_A 111 LEFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT----DEIIN-REREKKISCILYNKNIAKKIYVFF--TN----GRI 179 (458)
T ss_dssp EEEEEECC--CEEEEEEEETTTTEEEEEEEECC-C----CSCSC-HHHHHHHHHHHTTSSSBCCEEEEE--TT----EEE
T ss_pred eEEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh----hhhcC-HHHHHHHHHHHHhcCCCCCEEEEe--CC----eEE
Confidence 34566666666789999865546888888764211 01111 2579999999965444 5677654 22 259
Q ss_pred EecCCCCC
Q 006277 90 TELFTSGS 97 (652)
Q Consensus 90 mEy~~gGs 97 (652)
|||++|.+
T Consensus 180 ~e~I~G~~ 187 (458)
T 2qg7_A 180 EEFMDGYA 187 (458)
T ss_dssp EECCCSEE
T ss_pred EEeeCCcc
Confidence 99998743
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.82 E-value=0.037 Score=56.82 Aligned_cols=72 Identities=7% Similarity=-0.031 Sum_probs=42.6
Q ss_pred ecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC--CCeeeeeeE----EEeCCCCeEEEEEec
Q 006277 19 LVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH--NNIIRFYNS----WIDDQNKTVNIITEL 92 (652)
Q Consensus 19 l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~H--pnIVkl~~~----~~d~~~~~~~LVmEy 92 (652)
+....||++.. .+|..+++|....... ....+..|+.+++.|.. -.+++++.. +.. ..+..++||++
T Consensus 36 g~~n~~y~v~~-~~g~~~vlK~~~~~~~-----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~-~~g~~~~l~~~ 108 (328)
T 1zyl_A 36 SYENRVYQFQD-EDRRRFVVKFYRPERW-----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLN-HQGFYFAVFPS 108 (328)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTS-----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEE-ETTEEEEEEEC
T ss_pred CcccceEEEEc-CCCCEEEEEEcCCCCC-----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEE-ECCEEEEEEEe
Confidence 44568998753 3566789998752211 23456668888887732 224444432 011 12367899999
Q ss_pred CCCCC
Q 006277 93 FTSGS 97 (652)
Q Consensus 93 ~~gGs 97 (652)
++|..
T Consensus 109 i~G~~ 113 (328)
T 1zyl_A 109 VGGRQ 113 (328)
T ss_dssp CCCEE
T ss_pred cCCCC
Confidence 98743
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.68 E-value=0.014 Score=61.49 Aligned_cols=84 Identities=12% Similarity=0.145 Sum_probs=46.7
Q ss_pred CCcceee---eeeEEEEEEecCcEEEEEEEcc--------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC-
Q 006277 3 RQKWSLL---ILMYLRLIQLVDTSGYKAFDEV--------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN- 70 (652)
Q Consensus 3 ~~~W~~~---~~~~~rL~~l~~gtVykA~d~~--------tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hpn- 70 (652)
++.|... ...+.++..+....+|++.... .+..|++|+.... .........|..+++.|...+
T Consensus 25 ~~~w~~~~~~~~~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~-----~~~~~~~~~E~~~l~~L~~~g~ 99 (369)
T 3c5i_A 25 VPEWNHFTEDNLRVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH-----VDELYNTISEFEVYKTMSKYKI 99 (369)
T ss_dssp CGGGTTCCGGGEEEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT-----GGGTSCHHHHHHHHHHHHHTTS
T ss_pred CCCCCCCCcCceEEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC-----ccceecHHHHHHHHHHHHhcCC
Confidence 4567642 1245566666667899987643 1367888865421 111112357888888884333
Q ss_pred eeeeeeEEEeCCCCeEEEEEecCCCCC
Q 006277 71 IIRFYNSWIDDQNKTVNIITELFTSGS 97 (652)
Q Consensus 71 IVkl~~~~~d~~~~~~~LVmEy~~gGs 97 (652)
+.+++..+ .. ++||+|++|..
T Consensus 100 ~P~~~~~~--~~----~~v~e~i~G~~ 120 (369)
T 3c5i_A 100 APQLLNTF--NG----GRIEEWLYGDP 120 (369)
T ss_dssp SCCEEEEE--TT----EEEEECCCSEE
T ss_pred CCceEEec--CC----cEEEEEecCCc
Confidence 44666543 22 68999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.23 E-value=0.059 Score=55.13 Aligned_cols=138 Identities=16% Similarity=0.135 Sum_probs=70.3
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC--eeeeeeE-----EEeCCCCeEE
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN--IIRFYNS-----WIDDQNKTVN 87 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~Hpn--IVkl~~~-----~~d~~~~~~~ 87 (652)
.+..+....+|+.... .| .+++|..... ...+.+..|+.+++.|...+ +.+++.. +.. ..+..+
T Consensus 29 ~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~------~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~-~~g~~~ 99 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTT-KD-PLILTLYEKR------VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE-LSGRPA 99 (322)
T ss_dssp EECC---EEEEEEEES-SC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE-ETTEEE
T ss_pred ccCCCcccceEEEEeC-Cc-cEEEEEeCCC------CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEE-ECCEEE
Confidence 3333444678888642 34 6778877632 11234556788877773212 3333321 000 123678
Q ss_pred EEEecCCCCCHH-----HH---------HHh-CCCC--------CHHHHHHH---------------HHHHHHHHHHHHh
Q 006277 88 IITELFTSGSLR-----QY---------RKK-HKKV--------DMKAVKGW---------------ARQILSGLIYLHS 129 (652)
Q Consensus 88 LVmEy~~gGsL~-----~~---------i~~-~~~l--------se~~i~~i---------------~~QIl~aL~yLHs 129 (652)
++|+|++|..+. .+ +.. ...+ ........ ...+...+++|+.
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 999999886421 11 100 0011 11100000 0113344555553
Q ss_pred C-----CCCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 130 H-----DPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 130 ~-----g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
. .+.++|+|+.++|||+++ ++.+-|+||+.+.
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~-~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLG-DELSGLIDFYFAC 216 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred hCcccCCcccCCCCCCccCEEEeC-CceEEEecchhcc
Confidence 2 124999999999999983 3445799998664
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.48 E-value=0.13 Score=53.68 Aligned_cols=30 Identities=20% Similarity=0.401 Sum_probs=25.3
Q ss_pred CeeeccCCcccEEEcCCCCcEEEeccCchhh
Q 006277 133 PIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163 (652)
Q Consensus 133 ~IiHRDLKp~NILl~~~~g~VKL~DFGla~~ 163 (652)
.++|+|+.+.||+++ .++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~-~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVG-NEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEEC-GGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEe-CCCeEEEEECCCCee
Confidence 499999999999997 456799999986643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.24 E-value=0.23 Score=54.04 Aligned_cols=84 Identities=7% Similarity=0.019 Sum_probs=49.9
Q ss_pred CCccee---eeeeEEEEEEecCcEEEEEEEccC-------CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCe
Q 006277 3 RQKWSL---LILMYLRLIQLVDTSGYKAFDEVN-------GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNI 71 (652)
Q Consensus 3 ~~~W~~---~~~~~~rL~~l~~gtVykA~d~~t-------G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnI 71 (652)
+|.|.. ....+.++..+....+|+...... +..|++++..... +..-...+|.++++.|. +.-.
T Consensus 62 ~p~w~~~~~~~~~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-----~~~idR~~E~~~l~~L~~~gi~ 136 (424)
T 3mes_A 62 IPGWKEINESYIEVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-----GKFYDSKVELDVFRYLSNINIA 136 (424)
T ss_dssp STTCTTCCGGGEEEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC------CCCCHHHHHHHHHHHHHTTSS
T ss_pred cCccccCCCCceEEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-----chhcCHHHHHHHHHHHHhcCCC
Confidence 466763 223456666666678999886521 5778888753211 11112356888888883 3334
Q ss_pred eeeeeEEEeCCCCeEEEEEecCCCCC
Q 006277 72 IRFYNSWIDDQNKTVNIITELFTSGS 97 (652)
Q Consensus 72 Vkl~~~~~d~~~~~~~LVmEy~~gGs 97 (652)
.++++.+ .. ++||+|++|..
T Consensus 137 P~l~~~~--~~----~~I~efI~G~~ 156 (424)
T 3mes_A 137 PNIIADF--PE----GRIEEFIDGEP 156 (424)
T ss_dssp CCEEEEE--TT----EEEEECCCSEE
T ss_pred CCEEEEc--CC----CEEEEEeCCcc
Confidence 5566532 22 68999999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.24 E-value=1.2 Score=47.35 Aligned_cols=30 Identities=17% Similarity=0.303 Sum_probs=24.3
Q ss_pred eeeccCCcccEEEc-----CCCCcEEEeccCchhh
Q 006277 134 IIHRDLKCDNIFIN-----GNQGEVKIGDLGLATI 163 (652)
Q Consensus 134 IiHRDLKp~NILl~-----~~~g~VKL~DFGla~~ 163 (652)
++|+|+.+.|||+. ..++.+.++||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 57999999999994 2456799999987753
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=87.26 E-value=0.0099 Score=57.03 Aligned_cols=82 Identities=23% Similarity=0.275 Sum_probs=48.3
Q ss_pred chhhhcccCcceeccCCcCCcccceeeeeeec--CCCceeeeecc-------------------cccCCCCcCcchHHHH
Q 006277 338 IEVRRSKRGNFFLLKGESNDEYSVSLILRIAD--QSGRLRNIHFL-------------------FYLDSDTAFSVSSEMV 396 (652)
Q Consensus 338 i~~~~l~~~~~~~~~G~~~~~~~I~liLri~D--~~g~i~~ieF~-------------------f~~d~Dta~~Va~EmV 396 (652)
++.+++... +...|.......+..+++..| .+|.|.+-||. -.+|.|..|.|+.+++
T Consensus 74 Is~~El~~~--l~~~g~~~~~~~~~~l~~~~D~d~~g~I~~~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~Is~~El 151 (197)
T 3pm8_A 74 LSSQEILDG--LKKIGYQKIPPDIHQVLRDIDSNASGQIHYTDFLAATIDKQTYLKKEVCLIPFKFFDIDGNGKISVEEL 151 (197)
T ss_dssp ECHHHHHHH--HHHHC----CHHHHHHHHC-------CEEHHHHHHTTCCHHHHCSHHHHHHHHHHHCTTCSSEECHHHH
T ss_pred CCHHHHHHH--HHHhCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHhhhhHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 666666544 222366667778888999988 46799999997 3478999999999999
Q ss_pred hccccCCc-ChHHHHHHHHHHHHHhC
Q 006277 397 EQLELADQ-NVTFIAELIDLLLLNLI 421 (652)
Q Consensus 397 ~~l~l~~~-d~~~iA~~Id~~i~~l~ 421 (652)
..+.-.-. ......+.|+.++..+=
T Consensus 152 ~~~l~~~~~~~~~~~~~~~~l~~~~D 177 (197)
T 3pm8_A 152 KRIFGRDDIENPLIDKAIDSLLQEVD 177 (197)
T ss_dssp HHHHC----CCHHHHHHHHHHHHHHC
T ss_pred HHHHHhcccCCCCCHHHHHHHHHHHc
Confidence 98443320 22233344666666553
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 652 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-74 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-50 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-44 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-41 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-41 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-39 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-39 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-38 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-38 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-36 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-33 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-12 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (606), Expect = 3e-74
Identities = 132/247 (53%), Positives = 171/247 (69%), Gaps = 5/247 (2%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID--DQ 82
YK D +EVAWC + D + + +R E +LK L+H NI+RFY+SW
Sbjct: 26 YKGLDTETTVEVAWC--ELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83
Query: 83 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
K + ++TEL TSG+L+ Y K+ K + +K ++ W RQIL GL +LH+ PPIIHRDLKCD
Sbjct: 84 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 143
Query: 143 NIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCML 202
NIFI G G VKIGDLGLAT+ + AK+VIGTPEFMAPE+Y+E Y+E D+Y+FGMCML
Sbjct: 144 NIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCML 203
Query: 203 EMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKEL 261
EM T EYPYSEC+N+AQIY++V+SG+KPA+ KV PEVK IE C+ +R S K+L
Sbjct: 204 EMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
Query: 262 LMDPFLQ 268
L F Q
Sbjct: 264 LNHAFFQ 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 8e-56
Identities = 75/254 (29%), Positives = 125/254 (49%), Gaps = 16/254 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
K + +G + W ++ + + + + L SEV+LL+ LKH NI+R+Y+ ID N
Sbjct: 21 QKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78
Query: 85 TVNIITELFTSGSLRQYRKKHKK----VDMKAVKGWARQILSGLIYLHSH---DPPIIHR 137
T+ I+ E G L K K +D + V Q+ L H ++HR
Sbjct: 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 138
Query: 138 DLKCDNIFINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPE-LYDENYNELADI 194
DLK N+F++G VK+GD GLA I+ + + AK+ +GTP +M+PE + +YNE +DI
Sbjct: 139 DLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDI 197
Query: 195 YSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-AS 253
+S G + E+ P+ + ++ K+ G K + E+ I + L
Sbjct: 198 WSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKDY 255
Query: 254 QRLSAKELLMDPFL 267
R S +E+L +P +
Sbjct: 256 HRPSVEEILENPLI 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 5e-54
Identities = 60/248 (24%), Positives = 112/248 (45%), Gaps = 11/248 (4%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y A ++ + +A + L+ +L EV + L+H NI+R Y + D
Sbjct: 23 YLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR- 80
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
V +I E G++ + +K K D + + ++ + L Y HS +IHRD+K +N+
Sbjct: 81 -VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--RVIHRDIKPENL 137
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLE 203
+ GE+KI D G + + ++ GT +++ PE + ++E D++S G+ E
Sbjct: 138 LLGSA-GELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 196
Query: 204 MVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELL 262
+ + P+ E + YK++S + I + L SQR +E+L
Sbjct: 197 FLVGKPPF-EANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
Query: 263 MDPFLQVN 270
P++ N
Sbjct: 254 EHPWITAN 261
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (467), Expect = 1e-53
Identities = 72/268 (26%), Positives = 120/268 (44%), Gaps = 19/268 (7%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y A D N VA ++ QS E + + EV L+ L+H N I++ ++ +
Sbjct: 32 YFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT- 89
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
++ E + K + + L GL YLHSH +IHRD+K NI
Sbjct: 90 -AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNI 146
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY----DENYNELADIYSFGMC 200
++ G VK+GD G A+IM AN S +GTP +MAPE+ + Y+ D++S G+
Sbjct: 147 LLSEP-GLVKLGDFGSASIMAPAN--SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203
Query: 201 MLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAK 259
+E+ + P N+ ++ PA S ++F++ CL R +++
Sbjct: 204 CIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 262
Query: 260 ELLMDPFLQVNGTTKNRPLPLPDIVLPR 287
LL F+ + RP + ++ R
Sbjct: 263 VLLKHRFV-----LRERPPTVIMDLIQR 285
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 3e-52
Identities = 73/264 (27%), Positives = 122/264 (46%), Gaps = 19/264 (7%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKA ++ + A + +S E+LE E+ +L S H NI++ +++ + N
Sbjct: 29 YKAQNKETSVLAAAKVID----TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN- 83
Query: 85 TVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ I+ E G++ + + + ++ +Q L L YLH + IIHRDLK N
Sbjct: 84 -LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGN 140
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPELY------DENYNELADIY 195
I + G++K+ D G++ + + S IGTP +MAPE+ D Y+ AD++
Sbjct: 141 ILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 199
Query: 196 SFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQ 254
S G+ ++EM E P+ E + K S A K F++KCL
Sbjct: 200 SLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDA 259
Query: 255 RLSAKELLMDPFLQVNGTTKNRPL 278
R + +LL PF+ V+ R L
Sbjct: 260 RWTTSQLLQHPFVTVDSNKPIREL 283
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 5e-52
Identities = 65/287 (22%), Positives = 121/287 (42%), Gaps = 50/287 (17%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+K + +GL +A + ++ P ++ E+ +L I+ FY ++ D
Sbjct: 23 FKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE- 78
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
++I E GSL Q KK ++ + + + ++ GL YL I+HRD+K NI
Sbjct: 79 -ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNI 136
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLE 203
+N GE+K+ D G++ + + A S +GT +M+PE L +Y+ +DI+S G+ ++E
Sbjct: 137 LVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 195
Query: 204 MVTFEYPYS-----------------------------------------ECRNSAQIYK 222
M YP ++
Sbjct: 196 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLD 255
Query: 223 KVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 268
+ + P S V E + F+ KCL+ ++R K+L++ F++
Sbjct: 256 YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 9e-52
Identities = 73/250 (29%), Positives = 121/250 (48%), Gaps = 14/250 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y A D G EVA Q+ LQ E + +E+ +++ K+ NI+ + +S++
Sbjct: 37 YTAMDVATGQEVAIRQMN----LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE- 91
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ ++ E GSL + D + R+ L L +LHS+ +IHRD+K DNI
Sbjct: 92 -LWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNI 147
Query: 145 FINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCM 201
+ + G VK+ D G + EQ+ +++GTP +MAPE + + Y DI+S G+
Sbjct: 148 LLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 202 LEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKE 260
+EM+ E PY +Y ++G + + F+ +CL +R SAKE
Sbjct: 207 IEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKE 266
Query: 261 LLMDPFLQVN 270
LL FL++
Sbjct: 267 LLQHQFLKIA 276
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-50
Identities = 60/251 (23%), Positives = 111/251 (44%), Gaps = 15/251 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
A + V VA V + + PE++++ E+ + K L H N+++FY +
Sbjct: 22 QLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNI- 77
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ E + G L + + + + Q+++G++YLH I HRD+K +N+
Sbjct: 78 -QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENL 134
Query: 145 FINGNQGEVKIGDLGLATIM----EQANAKSVIGTPEFMAPELY--DENYNELADIYSFG 198
++ +KI D GLAT+ + + GT ++APEL E + E D++S G
Sbjct: 135 LLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 193
Query: 199 MCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLS 257
+ + M+ E P+ + +S Q Y K D + + K LV S R++
Sbjct: 194 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 253
Query: 258 AKELLMDPFLQ 268
++ D +
Sbjct: 254 IPDIKKDRWYN 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-49
Identities = 73/241 (30%), Positives = 120/241 (49%), Gaps = 21/241 (8%)
Query: 35 EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFT 94
+VA + + +P+ L+ +EV +L+ +H NI+ F Q + I+T+
Sbjct: 32 DVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ---LAIVTQWCE 86
Query: 95 SGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 153
SL + K +M + ARQ G+ YLH+ IIHRDLK +NIF++ + V
Sbjct: 87 GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK--SIIHRDLKSNNIFLHED-LTV 143
Query: 154 KIGDLGLATIMEQANA----KSVIGTPEFMAPELY----DENYNELADIYSFGMCMLEMV 205
KIGD GLAT+ + + + + G+ +MAPE+ Y+ +D+Y+FG+ + E++
Sbjct: 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 206 TFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD---PEVKSFIEKCLVP-ASQRLSAKEL 261
T + PYS N QI V G LSKV+ +K + +CL +R ++
Sbjct: 204 TGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263
Query: 262 L 262
L
Sbjct: 264 L 264
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 4e-47
Identities = 61/250 (24%), Positives = 118/250 (47%), Gaps = 15/250 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
A + E A + + + + E ++ L H ++ Y ++ DD+
Sbjct: 25 VLARELATSREYAIKILEKRH-IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK- 82
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ +G L +Y +K D + + +I+S L YLH IIHRDLK +NI
Sbjct: 83 -LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK--GIIHRDLKPENI 139
Query: 145 FINGNQGEVKIGDLGLATIM----EQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGM 199
+N + ++I D G A ++ +QA A S +GT ++++PE L +++ + +D+++ G
Sbjct: 140 LLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 198
Query: 200 CMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSA 258
+ ++V P+ N I++K+ + K P+ + +EK LV A++RL
Sbjct: 199 IIYQLVAGLPPF-RAGNEYLIFQKIIKL-EYDFPEKF-FPKARDLVEKLLVLDATKRLGC 255
Query: 259 KELLMDPFLQ 268
+E+ L+
Sbjct: 256 EEMEGYGPLK 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (422), Expect = 8e-47
Identities = 58/261 (22%), Positives = 108/261 (41%), Gaps = 14/261 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
++ ++ G + P D + +E+ ++ L H +I ++++ D
Sbjct: 46 HRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE- 100
Query: 85 TVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ +I E + G L + K+ V + RQ GL ++H H I+H D+K +N
Sbjct: 101 -MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPEN 157
Query: 144 IFINGNQ-GEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMC 200
I + VKI D GLAT + K T EF APE+ D E D+++ G+
Sbjct: 158 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 217
Query: 201 MLEMVTFEYPYSECRNSAQIYKKVSSGIK-PAALSKVKDPEVKSFIEKCLVP-ASQRLSA 258
+++ P++ + + + PE K FI+ L +RL+
Sbjct: 218 GYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 277
Query: 259 KELLMDPFLQVNGTTKNRPLP 279
+ L P+L+ + + +P
Sbjct: 278 HDALEHPWLKGDHSNLTSRIP 298
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (422), Expect = 9e-47
Identities = 60/271 (22%), Positives = 113/271 (41%), Gaps = 17/271 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
++ + G A V D E + E+ + L+H ++ ++++ DD
Sbjct: 43 HRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE- 97
Query: 85 TVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ +I E + G L + +H K+ + RQ+ GL ++H ++ +H DLK +N
Sbjct: 98 -MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPEN 154
Query: 144 IFINGNQ-GEVKIGDLGLATIM-EQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMC 200
I + E+K+ D GL + + + K GT EF APE + D++S G+
Sbjct: 155 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 214
Query: 201 MLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD--PEVKSFIEKCLVP-ASQRLS 257
+++ P+ N + + V S S + K FI K L+ + R++
Sbjct: 215 SYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 273
Query: 258 AKELLMDPFLQVNGTTKNRPLPLPDIVLPRV 288
+ L P+L G R +P ++
Sbjct: 274 IHQALEHPWLT-PGNAPGRDSQIPSSRYTKI 303
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (407), Expect = 3e-45
Identities = 49/263 (18%), Positives = 106/263 (40%), Gaps = 14/263 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
A D+ VA + + +E E+ +L +KH NI+ + + +
Sbjct: 26 ILAEDKRTQKLVAIKCIAKKALEGKEGSMEN---EIAVLHKIKHPNIVALDDIYESGGH- 81
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ +I +L + G L + + Q+L + YLH I+HRDLK +N+
Sbjct: 82 -LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL--GIVHRDLKPENL 138
Query: 145 FIN--GNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAP-ELYDENYNELADIYSFGMC 200
++ I D GL+ + + + + GTP ++AP L + Y++ D +S G+
Sbjct: 139 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 198
Query: 201 MLEMVTFEYPYSECRNSAQIYKKVSSGIK-PAALSKVKDPEVKSFIEKCLVP-ASQRLSA 258
++ P+ + ++ + + + + + K FI + +R +
Sbjct: 199 AYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTC 258
Query: 259 KELLMDPFLQVNGTTKNRPLPLP 281
++ L P++ T ++ +
Sbjct: 259 EQALQHPWIA-GDTALDKNIHQS 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-44
Identities = 53/251 (21%), Positives = 102/251 (40%), Gaps = 19/251 (7%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDV--LQSPEDLERLYSEVHLLKSLK--HNNIIRFYNSWID 80
Y + L VA V D + + R+ EV LLK + + +IR + W +
Sbjct: 21 YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD-WFE 79
Query: 81 DQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 140
+ V I+ L + + + + + + Q+L + + H+ ++HRD+K
Sbjct: 80 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC--GVLHRDIK 137
Query: 141 CDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY--DENYNELADIYSFG 198
+NI I+ N+GE+K+ D G +++ GT + PE + A ++S G
Sbjct: 138 DENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 197
Query: 199 MCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLS 257
+ + +MV + P+ + + E + I CL S R +
Sbjct: 198 ILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------SSECQHLIRWCLALRPSDRPT 248
Query: 258 AKELLMDPFLQ 268
+E+ P++Q
Sbjct: 249 FEEIQNHPWMQ 259
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (397), Expect = 4e-44
Identities = 59/261 (22%), Positives = 111/261 (42%), Gaps = 23/261 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVL-----QSPEDLERLYSEVHLLKSLK-HNNIIRFYNSW 78
+ + E A + + + E E EV +L+ + H NII+ +++
Sbjct: 20 RRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 79
Query: 79 IDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRD 138
+ ++ +L G L Y + + K + R +L + LH + I+HRD
Sbjct: 80 ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRD 135
Query: 139 LKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPELY-------DENYNE 190
LK +NI ++ + +K+ D G + ++ + V GTP ++APE+ Y +
Sbjct: 136 LKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 194
Query: 191 LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD--PEVKSFIEKC 248
D++S G+ M ++ P+ R + + + SG + D VK + +
Sbjct: 195 EVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRF 253
Query: 249 LVP-ASQRLSAKELLMDPFLQ 268
LV +R +A+E L PF Q
Sbjct: 254 LVVQPQKRYTAEEALAHPFFQ 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 8e-44
Identities = 48/251 (19%), Positives = 108/251 (43%), Gaps = 17/251 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
++ + + V++ D + E+ +L +H NI+ + S+ +
Sbjct: 22 HRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESMEE- 75
Query: 85 TVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ +I E + + + +++ + + + Q+ L +LHSH I H D++ +N
Sbjct: 76 -LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH--NIGHFDIRPEN 132
Query: 144 IFI-NGNQGEVKIGDLGLATIMEQA-NAKSVIGTPEFMAPELY-DENYNELADIYSFGMC 200
I +KI + G A ++ N + + PE+ APE++ + + D++S G
Sbjct: 133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
Query: 201 MLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD--PEVKSFIEKCLVP-ASQRLS 257
+ +++ P+ + QI + + + K+ E F+++ LV R++
Sbjct: 193 VYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT 251
Query: 258 AKELLMDPFLQ 268
A E L P+L+
Sbjct: 252 ASEALQHPWLK 262
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-43
Identities = 43/221 (19%), Positives = 95/221 (42%), Gaps = 10/221 (4%)
Query: 46 VLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY--RK 103
+++ + +E ++ L+H+N+++ ++++ + I+TE GSL Y +
Sbjct: 37 CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSR 95
Query: 104 KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 163
+ + ++ + + YL + +HRDL N+ ++ + K+ D GL
Sbjct: 96 GRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSED-NVAKVSDFGLTKE 152
Query: 164 MEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 222
+ ++ APE L ++ ++ +D++SFG+ + E+ +F +
Sbjct: 153 ASS-TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 211
Query: 223 KVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELL 262
+V G K A P V ++ C A+ R S +L
Sbjct: 212 RVEKGYKMDAPDGC-PPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-42
Identities = 63/294 (21%), Positives = 114/294 (38%), Gaps = 42/294 (14%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDL-ERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
YKA D+ VA ++++ ++ + + E+ LL+ L H NII +++ N
Sbjct: 15 YKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 74
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
++++ + + + + +K + L GL YLH H I+HRDLK +N
Sbjct: 75 --ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH--WILHRDLKPNN 130
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAKS--VIGTPEFMAPELY--DENYNELADIYSFGM 199
+ ++ N G +K+ D GLA N + T + APEL Y D+++ G
Sbjct: 131 LLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 189
Query: 200 CMLEMVTFEYPYSECRNSAQIYK-------------------------KVSSGIKPAALS 234
+ E++ + Q+ + K GI +
Sbjct: 190 ILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 249
Query: 235 KVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPR 287
++ I+ + R++A + L + NRP P P LPR
Sbjct: 250 SAAGDDLLDLIQGLFLFNPCARITATQALKMKYF------SNRPGPTPGCQLPR 297
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 4e-42
Identities = 65/253 (25%), Positives = 119/253 (47%), Gaps = 13/253 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQS--PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 82
K ++ GL+ A ++ S E + EV +LK ++H N+I + + +
Sbjct: 27 KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86
Query: 83 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+ V +I EL G L + + + + + + +QIL+G+ YLHS I H DLK +
Sbjct: 87 D--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPE 142
Query: 143 NIFI---NGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSF 197
NI + N + +KI D GLA ++ N K++ GTPEF+APE+ + E AD++S
Sbjct: 143 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 202
Query: 198 GMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-PAALSKVKDPEVKSFIEKCLVP-ASQR 255
G+ +++ P+ + + + K FI + LV +R
Sbjct: 203 GVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 262
Query: 256 LSAKELLMDPFLQ 268
++ ++ L P+++
Sbjct: 263 MTIQDSLQHPWIK 275
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 150 bits (379), Expect = 1e-41
Identities = 56/257 (21%), Positives = 101/257 (39%), Gaps = 13/257 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD--Q 82
+ A D +VA +R D + + P R E +L H I+ Y++ +
Sbjct: 24 HLARDLRLHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82
Query: 83 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
I+ E +LR + K L + H + IIHRD+K
Sbjct: 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN--GIIHRDVKPA 140
Query: 143 NIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPE-LYDENYNELADIYSF 197
NI I+ + I + N +VIGT ++++PE ++ + +D+YS
Sbjct: 141 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 200
Query: 198 GMCMLEMVTFEYPYSECRNSAQIYKKVSSG-IKPAALSKVKDPEVKSFIEKCLVP-ASQR 255
G + E++T E P++ + Y+ V I P+A + ++ + + K L R
Sbjct: 201 GCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 260
Query: 256 LSAKELLMDPFLQV-NG 271
+ ++V NG
Sbjct: 261 YQTAAEMRADLVRVHNG 277
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (377), Expect = 4e-41
Identities = 44/248 (17%), Positives = 90/248 (36%), Gaps = 16/248 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
++ G + ++ + + SE ++ H N+I
Sbjct: 43 CSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP- 101
Query: 85 TVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
V IITE +GSL + R+ + + + G R I +G+ YL +HRDL N
Sbjct: 102 -VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM--NYVHRDLAARN 158
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAKSV-------IGTPEFMAPE-LYDENYNELADIY 195
I +N N K+ D GL+ +E + + APE + + +D++
Sbjct: 159 ILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVW 217
Query: 196 SFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQ 254
S+G+ M E++++ + + + + + + C +
Sbjct: 218 SYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC-PSALHQLMLDCWQKDRNH 276
Query: 255 RLSAKELL 262
R +++
Sbjct: 277 RPKFGQIV 284
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 7e-41
Identities = 46/244 (18%), Positives = 95/244 (38%), Gaps = 18/244 (7%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+ + N +VA +R + E E ++ L H +++ Y ++
Sbjct: 22 HLGYWL-NKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP- 74
Query: 85 TVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ ++ E G L Y R + + + G + G+ YL +IHRDL N
Sbjct: 75 -ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARN 131
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAK---SVIGTPEFMAPE-LYDENYNELADIYSFGM 199
+ N +K+ D G+ + ++ +PE Y+ +D++SFG+
Sbjct: 132 CLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGV 190
Query: 200 CMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSA 258
M E+ + E R+++++ + +S+G + ++ V + C R +
Sbjct: 191 LMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVYQIMNHCWKERPEDRPAF 249
Query: 259 KELL 262
LL
Sbjct: 250 SRLL 253
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-40
Identities = 51/245 (20%), Positives = 99/245 (40%), Gaps = 20/245 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+ + +VA ++ Q + +E +L+K L+H ++R Y +
Sbjct: 30 WMGYYN-GHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-- 81
Query: 85 TVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+ IITE +GSL + K K+ + + A QI G+ ++ IHRDL+
Sbjct: 82 -IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--NYIHRDLRAA 138
Query: 143 NIFINGNQGEVKIGDLGLATIMEQANA---KSVIGTPEFMAP-ELYDENYNELADIYSFG 198
NI ++ + KI D GLA ++E + ++ AP + + +D++SFG
Sbjct: 139 NILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 197
Query: 199 MCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLS 257
+ + E+VT + ++ + + G + E+ + C R +
Sbjct: 198 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-PEELYQLMRLCWKERPEDRPT 256
Query: 258 AKELL 262
L
Sbjct: 257 FDYLR 261
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 43/255 (16%), Positives = 97/255 (38%), Gaps = 17/255 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
K + ++ + + + P + L +E ++++ L + I+R +
Sbjct: 24 KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE--- 80
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ ++ E+ G L +Y ++++ V K + Q+ G+ YL +HRDL N+
Sbjct: 81 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNV 138
Query: 145 FINGNQGEVKIGDLGLATIMEQAN-----AKSVIGTPEFMAPE-LYDENYNELADIYSFG 198
+ Q KI D GL+ + ++ APE + ++ +D++SFG
Sbjct: 139 LLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG 197
Query: 199 MCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLS 257
+ M E ++ +++ + G + + E+ + C R
Sbjct: 198 VLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYDLMNLCWTYDVENRPG 256
Query: 258 AKEL---LMDPFLQV 269
+ L + + V
Sbjct: 257 FAAVELRLRNYYYDV 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (371), Expect = 4e-40
Identities = 59/251 (23%), Positives = 118/251 (47%), Gaps = 17/251 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+ NG A ++ +++ + +E E +L + H IIR + ++ D Q
Sbjct: 21 HLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ- 78
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ +I + G L +K ++ K +A ++ L YLHS II+RDLK +NI
Sbjct: 79 -IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK--DIIYRDLKPENI 135
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLE 203
++ N G +KI D G A + ++ GTP+++APE + + YN+ D +SFG+ + E
Sbjct: 136 LLDKN-GHIKITDFGFAKYVPD-VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 193
Query: 204 MVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV------PASQRLS 257
M+ P+ + N+ + Y+K+ + + +VK + + + + +
Sbjct: 194 MLAGYTPFYD-SNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNG 250
Query: 258 AKELLMDPFLQ 268
+++ P+ +
Sbjct: 251 TEDVKNHPWFK 261
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-40
Identities = 53/246 (21%), Positives = 103/246 (41%), Gaps = 13/246 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
++ ++ S E+ E ++ H +I++ ++
Sbjct: 24 HQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-- 81
Query: 85 TVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
V II EL T G LR + + + +D+ ++ +A Q+ + L YL S +HRD+ N
Sbjct: 82 -VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--RFVHRDIAARN 138
Query: 144 IFINGNQGEVKIGDLGLATIMEQAN---AKSVIGTPEFMAPE-LYDENYNELADIYSFGM 199
+ ++ VK+GD GL+ ME + A ++MAPE + + +D++ FG+
Sbjct: 139 VLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 197
Query: 200 CMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSA 258
CM E++ + + + ++ +G + P + S + KC S+R
Sbjct: 198 CMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-PPTLYSLMTKCWAYDPSRRPRF 256
Query: 259 KELLMD 264
EL
Sbjct: 257 TELKAQ 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 60/250 (24%), Positives = 117/250 (46%), Gaps = 15/250 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL-KSLKHNNIIRFYNSWIDDQN 83
+ A + A ++ D V+ +D+E E +L + +H + + ++ +N
Sbjct: 19 FLAEFKKTNQFFAIKALKKD-VVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 77
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ + E G L + + K D+ +A +I+ GL +LHS I++RDLK DN
Sbjct: 78 --LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDN 133
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPE-LYDENYNELADIYSFGMC 200
I ++ + G +KI D G+ +AK + GTP+++APE L + YN D +SFG+
Sbjct: 134 ILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVL 192
Query: 201 MLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAK 259
+ EM+ + P+ ++ +++ + + + E K + K V +RL +
Sbjct: 193 LYEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKRLGVR 249
Query: 260 -ELLMDPFLQ 268
++ P +
Sbjct: 250 GDIRQHPLFR 259
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 55/253 (21%), Positives = 111/253 (43%), Gaps = 18/253 (7%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
++ G A +R + V+ + +++ +E +L++ +H + ++
Sbjct: 22 ILVREKATGRYYAMKILRKE-VIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR- 79
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ + E G L + + + + + + +I+S L YLHS +++RD+K +N+
Sbjct: 80 -LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--DVVYRDIKLENL 136
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKS--VIGTPEFMAPELY-DENYNELADIYSFGMCM 201
++ + G +KI D GL A GTPE++APE+ D +Y D + G+ M
Sbjct: 137 MLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195
Query: 202 LEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLS--- 257
EM+ P+ ++ ++++ + + PE KS + L QRL
Sbjct: 196 YEMMCGRLPF-YNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGP 252
Query: 258 --AKELLMDPFLQ 268
AKE++ F
Sbjct: 253 SDAKEVMEHRFFL 265
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 4e-39
Identities = 54/275 (19%), Positives = 107/275 (38%), Gaps = 28/275 (10%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNIIRFYNSWID--D 81
+ F++ + A ++ D + EV ++ + +I+R + + +
Sbjct: 29 LQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRASQCPHIVRIVDVYENLYA 79
Query: 82 QNKTVNIITELFTSGSLRQY--RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL 139
K + I+ E G L + + + + I + YLHS + I HRD+
Sbjct: 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDV 137
Query: 140 KCDNIFIN--GNQGEVKIGDLGLATIMEQANAK-SVIGTPEFMAPELY-DENYNELADIY 195
K +N+ +K+ D G A N+ + TP ++APE+ E Y++ D++
Sbjct: 138 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 197
Query: 196 SFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK------PAALSKVKDPEVKSFIEKCL 249
S G+ M ++ P+ + I + + I+ P EVK I L
Sbjct: 198 SLGVIMYILLCGYPPFYS-NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLL 256
Query: 250 VP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDI 283
+QR++ E + P++ + PL +
Sbjct: 257 KTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRV 291
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 6e-39
Identities = 57/248 (22%), Positives = 113/248 (45%), Gaps = 15/248 (6%)
Query: 25 YKAFDEVNGLEVAW-CQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
YK G +V ++ SP+ + + E +++ S+ + ++ R +
Sbjct: 26 YKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 83
Query: 84 KTVNIITELFTSGSLRQYRKKHKK-VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
TV +IT+L G L Y ++HK + + + W QI G+ YL ++HRDL
Sbjct: 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAAR 140
Query: 143 NIFINGNQGEVKIGDLGLATIM----EQANAKSVIGTPEFMAPE-LYDENYNELADIYSF 197
N+ + VKI D GLA ++ ++ +A+ ++MA E + Y +D++S+
Sbjct: 141 NVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 199
Query: 198 GMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRL 256
G+ + E++TF + +++I + G + +V + KC + A R
Sbjct: 200 GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRP 258
Query: 257 SAKELLMD 264
+EL+++
Sbjct: 259 KFRELIIE 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 8e-39
Identities = 41/248 (16%), Positives = 98/248 (39%), Gaps = 20/248 (8%)
Query: 25 YKAFDEV--NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 82
+ + ++VA +++ D E + E ++ L + I+R Q
Sbjct: 26 RQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC---Q 79
Query: 83 NKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 141
+ + ++ E+ G L ++ K +++ + V Q+ G+ YL +HRDL
Sbjct: 80 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--NFVHRDLAA 137
Query: 142 DNIFINGNQGEVKIGDLGLATIMEQANA-----KSVIGTPEFMAPE-LYDENYNELADIY 195
N+ + KI D GL+ + ++ + ++ APE + ++ +D++
Sbjct: 138 RNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 196
Query: 196 SFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQ 254
S+G+ M E +++ + ++ + G + + PE+ + + C +
Sbjct: 197 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-PPELYALMSDCWIYKWED 255
Query: 255 RLSAKELL 262
R +
Sbjct: 256 RPDFLTVE 263
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-38
Identities = 48/253 (18%), Positives = 100/253 (39%), Gaps = 22/253 (8%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+ VA ++ E E ++K L+H +++ Y ++
Sbjct: 34 WMGTWN-GTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-- 85
Query: 85 TVNIITELFTSGSLRQY--RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+ I+TE + GSL + + K + + + A QI SG+ Y+ +HRDL+
Sbjct: 86 -IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAA 142
Query: 143 NIFINGNQGEVKIGDLGLATIMEQANA---KSVIGTPEFMAPE-LYDENYNELADIYSFG 198
NI + N K+ D GLA ++E + ++ APE + +D++SFG
Sbjct: 143 NILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 201
Query: 199 MCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLS 257
+ + E+ T + ++ +V G + + + + +C +R +
Sbjct: 202 ILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-PESLHDLMCQCWRKEPEERPT 260
Query: 258 AKELL--MDPFLQ 268
+ L ++ +
Sbjct: 261 FEYLQAFLEDYFT 273
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-38
Identities = 61/249 (24%), Positives = 105/249 (42%), Gaps = 18/249 (7%)
Query: 25 YKAFDEV---NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 81
+ + + VA ++ DVL PE ++ EV+ + SL H N+IR Y +
Sbjct: 25 RRGEWDAPSGKTVSVAVKCLK-PDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 83
Query: 82 QNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 140
+ ++TEL GSL +KH+ + + +A Q+ G+ YL S IHRDL
Sbjct: 84 P---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK--RFIHRDLA 138
Query: 141 CDNIFINGNQGEVKIGDLGLATIMEQAN-----AKSVIGTPEFMAPE-LYDENYNELADI 194
N+ + VKIGD GL + Q + + + APE L ++ +D
Sbjct: 139 ARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 197
Query: 195 YSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-AS 253
+ FG+ + EM T+ N +QI K+ + + ++ + + +C
Sbjct: 198 WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPE 257
Query: 254 QRLSAKELL 262
R + L
Sbjct: 258 DRPTFVALR 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-38
Identities = 48/244 (19%), Positives = 98/244 (40%), Gaps = 18/244 (7%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+VA ++ + + + E ++ +L H +++ Y +
Sbjct: 21 KYGKWR-GQYDVAIKMIKEGSMSE-----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP- 73
Query: 85 TVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ IITE +G L Y R+ + + + + + + YL S +HRDL N
Sbjct: 74 -IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLAARN 130
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAKS---VIGTPEFMAPE-LYDENYNELADIYSFGM 199
+N G VK+ D GL+ + S + PE L ++ +DI++FG+
Sbjct: 131 CLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGV 189
Query: 200 CMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSA 258
M E+ + E +++ + ++ G++ + +V + + C A +R +
Sbjct: 190 LMWEIYSLGKMPYERFTNSETAEHIAQGLRL-YRPHLASEKVYTIMYSCWHEKADERPTF 248
Query: 259 KELL 262
K LL
Sbjct: 249 KILL 252
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-38
Identities = 50/247 (20%), Positives = 96/247 (38%), Gaps = 14/247 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y N + C V+ + + ++ + +E ++K H N++ + +
Sbjct: 44 YHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 103
Query: 85 TVNIITELFTSGSLRQYRK-KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ ++ G LR + + + +K + G+ Q+ G+ +HRDL N
Sbjct: 104 PL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK--FLASKKFVHRDLAARN 160
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAKS------VIGTPEFMAPE-LYDENYNELADIYS 196
++ VK+ D GLA M S ++MA E L + + +D++S
Sbjct: 161 CMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 219
Query: 197 FGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQR 255
FG+ + E++T P N+ I + G + + + KC P A R
Sbjct: 220 FGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC-PDPLYEVMLKCWHPKAEMR 278
Query: 256 LSAKELL 262
S EL+
Sbjct: 279 PSFSELV 285
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (352), Expect = 8e-38
Identities = 56/245 (22%), Positives = 100/245 (40%), Gaps = 18/245 (7%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y+ + L VA ++ D ++E E ++K +KH N+++ +
Sbjct: 34 YEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP- 87
Query: 85 TVNIITELFTSGSLRQY--RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
IITE T G+L Y ++V + A QI S + YL IHRDL
Sbjct: 88 -FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHRDLAAR 144
Query: 143 NIFINGNQGEVKIGDLGLATIMEQANAKSVIGT---PEFMAP-ELYDENYNELADIYSFG 198
N + N VK+ D GL+ +M + G ++ AP L ++ +D+++FG
Sbjct: 145 NCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 203
Query: 199 MCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLS 257
+ + E+ T+ + +Q+Y+ + + +V + C S R S
Sbjct: 204 VLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC-PEKVYELMRACWQWNPSDRPS 262
Query: 258 AKELL 262
E+
Sbjct: 263 FAEIH 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 141 bits (357), Expect = 1e-37
Identities = 54/254 (21%), Positives = 106/254 (41%), Gaps = 15/254 (5%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVL--QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 82
Y G A + + Q + L+ + I+ ++
Sbjct: 21 YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80
Query: 83 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
++ I +L G L + +H ++ +A +I+ GL ++H+ +++RDLK
Sbjct: 81 K--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPA 136
Query: 143 NIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDEN--YNELADIYSFGMC 200
NI ++ G V+I DLGLA + + +GT +MAPE+ + Y+ AD +S G
Sbjct: 137 NILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 195
Query: 201 MLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLS-- 257
+ +++ P+ + + + + L PE++S +E L ++RL
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCL 255
Query: 258 ---AKELLMDPFLQ 268
A+E+ PF +
Sbjct: 256 GRGAQEVKESPFFR 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-37
Identities = 60/299 (20%), Positives = 109/299 (36%), Gaps = 55/299 (18%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+KA G +VA +V +++ + E+ +L+ LKH N++ +
Sbjct: 27 FKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 84
Query: 85 ------TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRD 138
++ ++ + K + +K + +L+GL Y+H + I+HRD
Sbjct: 85 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN--KILHRD 142
Query: 139 LKCDNIFINGNQGEVKIGDLGLATIMEQANA------KSVIGTPEFMAPE--LYDENYNE 190
+K N+ I + G +K+ D GLA A + + T + PE L + +Y
Sbjct: 143 MKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP 201
Query: 191 LADIYSFGMCMLEMVTFEYPYSECRNSAQIY----------------------------- 221
D++ G M EM T Q+
Sbjct: 202 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 261
Query: 222 KKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLP 279
K +K + V+DP I+K LV +QR+ + + L F + P+P
Sbjct: 262 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW------SDPMP 314
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 58/258 (22%), Positives = 101/258 (39%), Gaps = 27/258 (10%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQN 83
KA + +GL + R+ + S +D E+ +L L H NII +
Sbjct: 27 LKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85
Query: 84 KTVNIITELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYL 127
+ + E G+L + +K + + + +A + G+ YL
Sbjct: 86 --LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143
Query: 128 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI-GTPEFMAPE-LYD 185
IHRDL NI + N KI D GL+ E K++ +MA E L
Sbjct: 144 SQK--QFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY 200
Query: 186 ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 245
Y +D++S+G+ + E+V+ A++Y+K+ G + D EV +
Sbjct: 201 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC-DDEVYDLM 259
Query: 246 EKCLVP-ASQRLSAKELL 262
+C +R S ++L
Sbjct: 260 RQCWREKPYERPSFAQIL 277
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-36
Identities = 67/293 (22%), Positives = 119/293 (40%), Gaps = 45/293 (15%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKA +++ G VA ++R+D ++ E+ LLK L H NI++ + +
Sbjct: 19 YKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK- 75
Query: 85 TVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+ ++ E + + + +K + Q+L GL + HSH ++HRDLK N
Sbjct: 76 -LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--RVLHRDLKPQN 132
Query: 144 IFINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPELY--DENYNELADIYSFGM 199
+ IN G +K+ D GLA + T + APE+ + Y+ DI+S G
Sbjct: 133 LLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 191
Query: 200 CMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--------------------------AAL 233
EMVT + Q+++ + P + +
Sbjct: 192 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKV 251
Query: 234 SKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVL 285
D + +S + + L ++R+SAK L PF ++ P+P + L
Sbjct: 252 VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF------QDVTKPVPHLRL 298
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-36
Identities = 54/271 (19%), Positives = 100/271 (36%), Gaps = 39/271 (14%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQ--SPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDD 81
A QV + + + + E L SE+ ++ L H NI+ +
Sbjct: 54 MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113
Query: 82 QNKTVNIITELFTSGSLRQYRKKHKK-----------------------VDMKAVKGWAR 118
+ +I E G L Y + ++ + + + +A
Sbjct: 114 GP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 171
Query: 119 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIG 174
Q+ G+ +L +HRDL N+ + VKI D GLA + + +
Sbjct: 172 QVAKGMEFLEFK--SCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARL 228
Query: 175 TPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAA 232
++MAPE L++ Y +D++S+G+ + E+ + PY A YK + +G K
Sbjct: 229 PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ 288
Query: 233 LSKVKDPEVKSFIEKCLVP-ASQRLSAKELL 262
E+ ++ C + +R S L
Sbjct: 289 PFYA-TEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-36
Identities = 58/294 (19%), Positives = 110/294 (37%), Gaps = 43/294 (14%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
A+D VN + VA ++ + +R E+ +L +H NII + +
Sbjct: 25 CSAYDNVNKVRVA---IKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81
Query: 85 T-VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
++ G+ K + + + + QIL GL Y+HS ++HRDLK N
Sbjct: 82 QMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA--NVLHRDLKPSN 139
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAK-----SVIGTPEFMAPELYDEN--YNELADIYS 196
+ +N ++KI D GLA + + + + T + APE+ + Y + DI+S
Sbjct: 140 LLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 198
Query: 197 FGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA------------------------ 232
G + EM++ + Q+ + P+
Sbjct: 199 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 258
Query: 233 ----LSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLP 281
L D + ++K L +R+ ++ L P+L+ + P+
Sbjct: 259 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 312
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-36
Identities = 47/247 (19%), Positives = 102/247 (41%), Gaps = 15/247 (6%)
Query: 25 YKAFDEVNGLEVAW-CQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
YK + + + ++ + + E ++ H+NIIR +
Sbjct: 24 YKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83
Query: 84 KTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+ IITE +G+L ++ R+K + + + G R I +G + + +HRDL
Sbjct: 84 --MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG--MKYLANMNYVHRDLAAR 139
Query: 143 NIFINGNQGEVKIGDLGLATIMEQANAKS-----VIGTPEFMAPE-LYDENYNELADIYS 196
NI +N N K+ D GL+ ++E + + APE + + +D++S
Sbjct: 140 NILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWS 198
Query: 197 FGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQR 255
FG+ M E++T+ ++ ++ K ++ G + + + +C ++R
Sbjct: 199 FGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC-PSAIYQLMMQCWQQERARR 257
Query: 256 LSAKELL 262
+++
Sbjct: 258 PKFADIV 264
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 134 bits (338), Expect = 6e-36
Identities = 62/275 (22%), Positives = 108/275 (39%), Gaps = 39/275 (14%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
YKA + G A ++R++ + E+ +LK LKH+NI++ Y+ +
Sbjct: 19 YKAQNN-YGETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR- 74
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ ++ E + ++ K + Q+L+G+ Y H ++HRDLK N+
Sbjct: 75 -LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--RVLHRDLKPQNL 131
Query: 145 FINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPELY--DENYNELADIYSFGMC 200
IN GE+KI D GLA K I T + AP++ + Y+ DI+S G
Sbjct: 132 LINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190
Query: 201 MLEMVTFEYPYSECRNSAQIYK--------------------------KVSSGIKPAALS 234
EMV + + Q+ + V + +
Sbjct: 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250
Query: 235 KVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 268
K D + K L +QR++AK+ L + +
Sbjct: 251 KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-35
Identities = 67/325 (20%), Positives = 122/325 (37%), Gaps = 51/325 (15%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR----FYNSWID 80
Y+A +G VA +V +D E+ +++ L H NI+R FY+S
Sbjct: 37 YQAKLCDSGELVAIKKVL--------QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEK 88
Query: 81 DQNKTVNIITELFTSG---SLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHR 137
+N++ + R Y + + + + VK + Q+ L Y+HS I HR
Sbjct: 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHR 146
Query: 138 DLKCDNIFINGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPELY--DENYNELADI 194
D+K N+ ++ + +K+ D G A + + S I + + APEL +Y D+
Sbjct: 147 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 206
Query: 195 YSFGMCMLEMVTFEYPYSECRNSAQIYKKVS----------------------SGIKPAA 232
+S G + E++ + + Q+ + + IK
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266
Query: 233 LSKVK----DPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIV-LP 286
+KV PE + + L + RL+ E F ++ + LP+ P
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD---ELRDPNVKLPNGRDTP 323
Query: 287 RVGAFGDRCLMSEGPASVRNKHPSM 311
+ F + L S P + P
Sbjct: 324 ALFNFTTQELSSNPPLATILIPPHA 348
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (335), Expect = 4e-35
Identities = 51/284 (17%), Positives = 111/284 (39%), Gaps = 52/284 (18%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQN 83
++A + N +V ++ P +++ E+ +L++L+ NII + D +
Sbjct: 52 FEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNIITLADIVKDPVS 104
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
+T ++ E + +Q ++ + ++ + +IL L Y HS I+HRD+K N
Sbjct: 105 RTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSM--GIMHRDVKPHN 159
Query: 144 IFINGNQGEVKIGDLGLATIMEQANAKS-VIGTPEFMAPELY--DENYNELADIYSFGMC 200
+ I+ ++++ D GLA + + + F PEL + Y+ D++S G
Sbjct: 160 VMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCM 219
Query: 201 MLEMVTFEYPYSECRNSAQIYKKVS----------------------------------- 225
+ M+ + P+ ++ +++
Sbjct: 220 LASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRW 279
Query: 226 SGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 268
+ + PE F++K L RL+A+E + P+
Sbjct: 280 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (336), Expect = 6e-35
Identities = 51/251 (20%), Positives = 109/251 (43%), Gaps = 17/251 (6%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+ +G A + + + +E +E +L+++ +++ S+ D+ N
Sbjct: 58 MLVKHKESGNHYAMKILDKQK-VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN- 115
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
+ ++ E G + + ++ + + +A QI+ YLHS D +I+RDLK +N+
Sbjct: 116 -LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENL 172
Query: 145 FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLE 203
I+ G +++ D G A ++ ++ GTPE +APE + + YN+ D ++ G+ + E
Sbjct: 173 LIDQQ-GYIQVTDFGFAKRVKG-RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 204 MVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV------PASQRLS 257
M P+ QIY+K+ SG ++K + L + +
Sbjct: 231 MAAGYPPF-FADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNG 287
Query: 258 AKELLMDPFLQ 268
++ +
Sbjct: 288 VNDIKNHKWFA 298
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-34
Identities = 68/277 (24%), Positives = 114/277 (41%), Gaps = 36/277 (12%)
Query: 25 YKAFD-EVNGLEVAWCQVRIDDVLQS-PEDLERLYSEVHLLKSLKHNNIIRFYNSWID-- 80
+KA D + G VA +VR+ + P R + + L++ +H N++R ++
Sbjct: 24 FKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83
Query: 81 -DQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRD 138
D+ + ++ E + V + +K Q+L GL +LHSH ++HRD
Sbjct: 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRD 141
Query: 139 LKCDNIFINGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LYDENYNELADIYS 196
LK NI + + G++K+ D GLA I A SV+ T + APE L +Y D++S
Sbjct: 142 LKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWS 200
Query: 197 FGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD------------------ 238
G EM + + + Q+ K + P +D
Sbjct: 201 VGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK 260
Query: 239 ------PEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 268
K + KCL ++R+SA L P+ Q
Sbjct: 261 FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-34
Identities = 58/260 (22%), Positives = 114/260 (43%), Gaps = 21/260 (8%)
Query: 24 GYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 83
K G A ++ ++Q + E +E +L+ ++ + + + +
Sbjct: 43 VRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102
Query: 84 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 143
K +++I + G L + + ++ V+ + +I+ L +LH II+RD+K +N
Sbjct: 103 K-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL--GIIYRDIKLEN 159
Query: 144 IFINGNQGEVKIGDLGLATI---MEQANAKSVIGTPEFMAPELY---DENYNELADIYSF 197
I ++ N G V + D GL+ E A GT E+MAP++ D +++ D +S
Sbjct: 160 ILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218
Query: 198 GMCMLEMVTFEYPY---SECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-AS 253
G+ M E++T P+ E + A+I +++ P + K I++ L+
Sbjct: 219 GVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDLIQRLLMKDPK 276
Query: 254 QRLS-----AKELLMDPFLQ 268
+RL A E+ F Q
Sbjct: 277 KRLGCGPRDADEIKEHLFFQ 296
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-34
Identities = 61/276 (22%), Positives = 108/276 (39%), Gaps = 39/276 (14%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
+KA + VA +VR+DD E+ LLK LKH NI+R ++ D+
Sbjct: 19 FKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL 76
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
++ E + + + +D + VK + Q+L GL + HS ++HRDLK N+
Sbjct: 77 --TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR--NVLHRDLKPQNL 132
Query: 145 FINGNQGEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPELY--DENYNELADIYSFGMC 200
IN N GE+K+ + GLA + + T + P++ + Y+ D++S G
Sbjct: 133 LINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191
Query: 201 MLEMVTFEYPYSECRNSAQIYKKVSSGI---------------------------KPAAL 233
E+ P + K++ + +
Sbjct: 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251
Query: 234 SKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 268
+ + ++ L QR+SA+E L P+
Sbjct: 252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (328), Expect = 2e-34
Identities = 51/267 (19%), Positives = 92/267 (34%), Gaps = 30/267 (11%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
Y D G EVA + +L+ E + K ++ I W +
Sbjct: 24 YLGTDIAAGEEVAIKLECVK------TKHPQLHIESKIYKMMQGGVGIPTIR-WCGAEGD 76
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
++ EL + +K +K V A Q++S + Y+HS + IHRD+K DN
Sbjct: 77 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNF 134
Query: 145 FI--NGNQGEVKIGDLGLATIMEQAN---------AKSVIGTPEFMAPELY-DENYNELA 192
+ V I D GLA A K++ GT + + + +
Sbjct: 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD 194
Query: 193 DIYSFGMCMLEMVT--FEYPYSECRNSAQIYKKVSSG---IKPAALSKVKDPEVKSFIEK 247
D+ S G ++ + + Q Y+++S L K E +++
Sbjct: 195 DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNF 254
Query: 248 CLVP-ASQRLSA---KELLMDPFLQVN 270
C + ++L + F +
Sbjct: 255 CRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 39/286 (13%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
A D G +VA ++ QS +R Y E+ LLK ++H N+I + + D+
Sbjct: 35 CSAVDGRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92
Query: 85 T--VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
+ + G+ KH+K+ ++ Q+L GL Y+H+ HRDLK
Sbjct: 93 DDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPG 150
Query: 143 NIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY--DENYNELADIYSFGMC 200
N+ +N + E+KI D GLA + + T + APE+ Y + DI+S G
Sbjct: 151 NLAVNED-CELKILDFGLARQADS-EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCI 208
Query: 201 MLEMVTFEYPYSECRNSAQIYKKVSSGIKP----------------------------AA 232
M EM+T + + + Q+ + + P A+
Sbjct: 209 MAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS 268
Query: 233 LSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRP 277
+ P + +EK LV A QR++A E L P+ + T++ P
Sbjct: 269 ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 314
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-33
Identities = 60/279 (21%), Positives = 100/279 (35%), Gaps = 50/279 (17%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN- 83
++ G EVA + E +E++ L+H NI+ F + D
Sbjct: 20 WRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 72
Query: 84 -KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS------HDPPIIH 136
+ ++++ GSL Y ++ +K A SGL +LH P I H
Sbjct: 73 WTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHMEIVGTQGKPAIAH 131
Query: 137 RDLKCDNIFINGNQGEVKIGDLGLATIMEQAN------AKSVIGTPEFMAPELYDEN--- 187
RDLK NI + N G I DLGLA + A +GT +MAPE+ D++
Sbjct: 132 RDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 188 ----YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG------IKPAALSKVK 237
+ ADIY+ G+ E+ + Y + ++ +
Sbjct: 191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 250
Query: 238 DP-------------EVKSFIEKCLVP-ASQRLSAKELL 262
P + + +C + RL+A +
Sbjct: 251 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 4e-33
Identities = 64/256 (25%), Positives = 111/256 (43%), Gaps = 32/256 (12%)
Query: 32 NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIIT 90
+VA ++ D + +DL L SE+ ++K + KH NII + D + +I
Sbjct: 44 RVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP--LYVIV 98
Query: 91 ELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPI 134
E + G+LR+Y + + ++ K + A Q+ G+ YL S
Sbjct: 99 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--KC 156
Query: 135 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ----ANAKSVIGTPEFMAPE-LYDENYN 189
IHRDL N+ + + +KI D GLA + + ++MAPE L+D Y
Sbjct: 157 IHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215
Query: 190 ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249
+D++SFG+ + E+ T +++K + G + S E+ + C
Sbjct: 216 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNC-TNELYMMMRDCW 274
Query: 250 VP-ASQRLSAKELLMD 264
SQR + K+L+ D
Sbjct: 275 HAVPSQRPTFKQLVED 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (319), Expect = 4e-33
Identities = 44/273 (16%), Positives = 91/273 (33%), Gaps = 44/273 (16%)
Query: 25 YKA-----FDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 79
++A VA ++ + S + E L+ + NI++
Sbjct: 30 FQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCA 86
Query: 80 DDQNKTVNIITELFTSGSLRQYRKKHKK------------------------VDMKAVKG 115
+ + ++ E G L ++ + +
Sbjct: 87 VGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 144
Query: 116 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK----S 171
ARQ+ +G+ YL +HRDL N + N VKI D GL+ + A+ +
Sbjct: 145 IARQVAAGMAYLSER--KFVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGN 201
Query: 172 VIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP 230
+M PE ++ Y +D++++G+ + E+ ++ ++ V G
Sbjct: 202 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL 261
Query: 231 AALSKVKDPEVKSFIEKCLVP-ASQRLSAKELL 262
A E+ + + C + R S +
Sbjct: 262 ACPENC-PLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 5e-33
Identities = 53/264 (20%), Positives = 106/264 (40%), Gaps = 35/264 (13%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQN 83
Y + VA V++ + E L SE+ +L L H NI+ +
Sbjct: 45 YGLIKSDAAMTVA---VKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101
Query: 84 KTVNIITELFTSGSLRQYRKKHK------------------KVDMKAVKGWARQILSGLI 125
+ITE G L + ++ + +D++ + ++ Q+ G+
Sbjct: 102 --TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159
Query: 126 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV----IGTPEFMAP 181
+L S + IHRDL NI + KI D GLA ++ + V ++MAP
Sbjct: 160 FLASKN--CIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216
Query: 182 E-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNS-AQIYKKVSSGIKPAALSKVKDP 239
E +++ Y +D++S+G+ + E+ + ++ YK + G + +
Sbjct: 217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHA-PA 275
Query: 240 EVKSFIEKCLVP-ASQRLSAKELL 262
E+ ++ C +R + K+++
Sbjct: 276 EMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 1e-32
Identities = 51/271 (18%), Positives = 103/271 (38%), Gaps = 36/271 (13%)
Query: 25 YKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 79
Y+ + VA ++ + S + +E ++K ++++R
Sbjct: 37 YEGVAKGVVKDEPETRVA---IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93
Query: 80 DDQNKTVNIITELFTSGSLRQYRKKHKKV----------DMKAVKGWARQILSGLIYLHS 129
Q +I EL T G L+ Y + + + + A +I G+ YL++
Sbjct: 94 QGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA 151
Query: 130 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK----SVIGTPEFMAPE-LY 184
+ +HRDL N + + VKIGD G+ + + + + +M+PE L
Sbjct: 152 N--KFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 208
Query: 185 DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244
D + +D++SFG+ + E+ T + ++ Q+ + V G +
Sbjct: 209 DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC-PDMLFEL 267
Query: 245 IEKCLVP-ASQRLSAKELL------MDPFLQ 268
+ C R S E++ M+P +
Sbjct: 268 MRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 5e-32
Identities = 56/276 (20%), Positives = 106/276 (38%), Gaps = 37/276 (13%)
Query: 25 YKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 79
+A VA V++ + + L SE+ +L + H+ +
Sbjct: 30 IEADAFGIDKTATCRTVA---VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86
Query: 80 DDQNKTVNIITELFTSGSLRQYRKKHKK----------------VDMKAVKGWARQILSG 123
+ +I E G+L Y + + + ++ + ++ Q+ G
Sbjct: 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 146
Query: 124 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM----EQANAKSVIGTPEFM 179
+ +L S IHRDL NI ++ VKI D GLA + + ++M
Sbjct: 147 MEFLASR--KCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 203
Query: 180 A-PELYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAALSKVK 237
A ++D Y +D++SFG+ + E+ + PY + + +++ G + A
Sbjct: 204 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT- 262
Query: 238 DPEVKSFIEKCLVP-ASQRLSAKELL--MDPFLQVN 270
PE+ + C SQR + EL+ + LQ N
Sbjct: 263 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-31
Identities = 74/290 (25%), Positives = 118/290 (40%), Gaps = 39/290 (13%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
AFD GL VA ++ QS +R Y E+ LLK +KH N+I + + ++
Sbjct: 35 CAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92
Query: 85 T--VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142
++ G+ K +K+ V+ QIL GL Y+HS D IIHRDLK
Sbjct: 93 EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPS 150
Query: 143 NIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY--DENYNELADIYSFGMC 200
N+ +N E+KI D GLA + + T + APE+ +YN+ DI+S G
Sbjct: 151 NLAVN-EDCELKILDFGLARHTDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 208
Query: 201 MLEMVTFEYPYSECRNSAQIYKKVSSGIKP----------------------------AA 232
M E++T + + Q+ + P A
Sbjct: 209 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN 268
Query: 233 LSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLP 281
+ +P +EK LV + +R++A + L + + P+ P
Sbjct: 269 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 9e-31
Identities = 70/305 (22%), Positives = 115/305 (37%), Gaps = 54/305 (17%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ-- 82
A+D V VA ++ Q+ +R Y E+ L+K + H NII N + +
Sbjct: 34 CAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91
Query: 83 --NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 140
+ V ++ EL + + + + D + + Q+L G+ +LHS IHRDLK
Sbjct: 92 EEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSAGI--IHRDLK 146
Query: 141 CDNIFINGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPE-LYDENYNELADIYSFG 198
NI + + +KI D GLA + + T + APE + Y E DI+S G
Sbjct: 147 PSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 205
Query: 199 MCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP---------------------------- 230
M EMV + + Q K + P
Sbjct: 206 CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP 265
Query: 231 -----------AALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPL 278
+ +K+K + + + K LV ++R+S + L P++ V
Sbjct: 266 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEA 325
Query: 279 PLPDI 283
P P I
Sbjct: 326 PPPQI 330
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 117 bits (294), Expect = 6e-30
Identities = 34/244 (13%), Positives = 84/244 (34%), Gaps = 28/244 (11%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84
++ + +N +VA ++ + L Y LL + ++ +
Sbjct: 22 FEGTNLLNNQQVA---IKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF----GQEGL 74
Query: 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 144
++ +L +K +K V A+Q+L+ + +H +++RD+K DN
Sbjct: 75 HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNF 132
Query: 145 FIN----GNQGEVKIGDLGLATIME---------QANAKSVIGTPEFMAPELY-DENYNE 190
I N + + D G+ K++ GT +M+ + +
Sbjct: 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR 192
Query: 191 LADIYSFGMCMLEMVT--FEYPYSECRNSAQIYKKVSSGIKPAALSKVKD---PEVKSFI 245
D+ + G + + + + + Q Y+++ + L ++ E ++
Sbjct: 193 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYM 252
Query: 246 EKCL 249
Sbjct: 253 HYAR 256
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 96.3 bits (238), Expect = 5e-22
Identities = 62/323 (19%), Positives = 116/323 (35%), Gaps = 73/323 (22%)
Query: 25 YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH-----------NNIIR 73
+ A D VN VA VR D V E E+ LL+ + N+I++
Sbjct: 30 WLAKDMVNNTHVAMKIVRGDKVYT-----EAAEDEIKLLQRVNDADNTKEDSMGANHILK 84
Query: 74 FYNSWIDDQNKTVNIITELFTSG---SLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH 130
+ + V+++ G + +H+ + + VK ++Q+L GL Y+H
Sbjct: 85 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH-R 143
Query: 131 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI----MEQANAKSVIGTPEFMAPE-LYD 185
IIH D+K +N+ + + + +A + + + I T E+ +PE L
Sbjct: 144 RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG 203
Query: 186 ENYNELADIYSFGMCMLEMVTFEYPYS--------------------------------- 212
+ ADI+S + E++T ++ +
Sbjct: 204 APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGK 263
Query: 213 ---ECRNSAQIYKKVSSG---------IKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAK 259
NS + + +S + SK + E+ F+ L +R A
Sbjct: 264 YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323
Query: 260 ELLMDPFLQVNGTTKNRPLPLPD 282
L+ P+L+ T + +PD
Sbjct: 324 GLVNHPWLK--DTLGMEEIRVPD 344
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 62.5 bits (151), Expect = 7e-12
Identities = 26/193 (13%), Positives = 58/193 (30%), Gaps = 32/193 (16%)
Query: 25 YKAFDEVNGLEVA--------------WCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 70
+ + E E + D+ S + +E L+ L+
Sbjct: 17 FNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA 75
Query: 71 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH 130
+ + Y ++ EL + L + R ++ IL + +
Sbjct: 76 VPKVY-----AWEGNA-VLMELIDAKELYRVRVENPD-------EVLDMILEEVAKFYHR 122
Query: 131 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNE 190
I+H DL N+ ++ + I D + + + + ++ + Y
Sbjct: 123 --GIVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYRT 178
Query: 191 LADIYSFGMCMLE 203
DI S +L+
Sbjct: 179 EKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 652 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.6 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.47 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.07 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.17 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.09 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 85.55 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-57 Score=468.61 Aligned_cols=252 Identities=52% Similarity=0.938 Sum_probs=232.6
Q ss_pred EEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC--CCCeEEEEEec
Q 006277 15 RLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD--QNKTVNIITEL 92 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~--~~~~~~LVmEy 92 (652)
.||+++.|+||+|.++.+|+.||+|.+..... .....+++.+|+++|++|+|||||++|++|.+. .+..+|+||||
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~ 93 (270)
T d1t4ha_ 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 93 (270)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred EEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeC
Confidence 57888889999999999999999999986543 456778899999999999999999999999763 34578999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
|++|+|.+++.+.+.+++..++.|++||+.||+|||+++++|+||||||+|||+++.++.+||+|||+|+........+.
T Consensus 94 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~~~ 173 (270)
T d1t4ha_ 94 MTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV 173 (270)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEES
T ss_pred CCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCccCCc
Confidence 99999999999999999999999999999999999999888999999999999986678999999999988766667788
Q ss_pred cCCCCccCccccccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-C
Q 006277 173 IGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-P 251 (652)
Q Consensus 173 vGTp~YmAPEvl~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~ 251 (652)
+|||.|||||++.+.|+.++|||||||++|+|++|..||.+..+..++++.+..+..+..++...++++++||.+||. +
T Consensus 174 ~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~d 253 (270)
T d1t4ha_ 174 IGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQN 253 (270)
T ss_dssp CSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSS
T ss_pred ccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCC
Confidence 999999999999999999999999999999999999999988889999999999988888888889999999999998 8
Q ss_pred CCCCCCHHHHhcCcccc
Q 006277 252 ASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 252 P~~RpSa~elL~hpf~~ 268 (652)
|.+|||+.|+|+||||+
T Consensus 254 p~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 254 KDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GGGSCCHHHHHTSGGGC
T ss_pred HhHCcCHHHHhCCcccC
Confidence 99999999999999996
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=452.32 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=226.9
Q ss_pred Ccceeeeee-EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 006277 4 QKWSLLILM-YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 82 (652)
Q Consensus 4 ~~W~~~~~~-~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 82 (652)
.+|+...+. ...||+++.|+||+|.++.+|+.||+|++...... .....+++.+|+++|++++|||||++|++|.+..
T Consensus 1 r~~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 1 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79 (263)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCcchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc-ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence 368777653 34578888899999999999999999999754321 1234678899999999999999999999998765
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 83 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 83 ~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
.+|+|||||.||+|.+++.+.+.+++..++.|++||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|+
T Consensus 80 --~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~~kl~DFG~a~ 154 (263)
T d2j4za1 80 --RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSV 154 (263)
T ss_dssp --EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCSCS
T ss_pred --EEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceec-CCCCEeecccceee
Confidence 79999999999999999999999999999999999999999999999 99999999999998 67899999999998
Q ss_pred hhhccccccccCCCCccCcccccc-CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHH
Q 006277 163 IMEQANAKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 163 ~l~~~~~~~~vGTp~YmAPEvl~~-~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~ 241 (652)
..........+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+ .+..+++..+..+.. .++...++++
T Consensus 155 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~ 231 (263)
T d2j4za1 155 HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGA 231 (263)
T ss_dssp CCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHH
T ss_pred ecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHH
Confidence 877666677899999999998854 689999999999999999999999977 677788888877653 3556788999
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 242 KSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
++||.+||. +|.+|||+.|+|+||||+.
T Consensus 232 ~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 232 RDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 999999998 8999999999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-55 Score=449.69 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=214.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...||++..|+||+|.++.+|+.||+|++..... .+..+++.+|+++|++|+|||||++|++|.+.. .+|+||||
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~--~~~ivmEy 84 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGN--IQYLFLEY 84 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc--eeEEEEec
Confidence 4688889999999999999999999999986543 344567899999999999999999999998765 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc----c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----N 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~----~ 168 (652)
|.||+|.+++.+.+.+++..++.+++||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|+.+... .
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEEC-CCCCEEEccchhheeeccCCcccc
Confidence 999999999988889999999999999999999999999 99999999999998 6689999999999877532 2
Q ss_pred cccccCCCCccCccccc-cCC-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYD-ENY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y-~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
..+.+|||.|||||++. ..| +.++|||||||++|+|+||.+||.........+..+.............++++++||.
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 241 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence 35679999999999874 444 6789999999999999999999987666666666666655444444567899999999
Q ss_pred HhCC-CCCCCCCHHHHhcCccccc
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+||. +|.+|||++|+|+||||+.
T Consensus 242 ~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 242 KILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHcCCChhHCcCHHHHhcCHhhCc
Confidence 9998 8999999999999999973
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-54 Score=447.72 Aligned_cols=247 Identities=28% Similarity=0.494 Sum_probs=217.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+||+|+.|+||+|.++.+|+.||+|++..... ...+.+.+|+++|++++|||||+++++|.+.. .+|+||||
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~ivmEy 98 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGD--ELWVVMEY 98 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEecccC----hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC--EEEEEEEe
Confidence 4678888889999999999999999999986542 23567899999999999999999999998765 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--ccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~ 170 (652)
|.||+|.+++.+ +.+++..++.|++||+.||.|||++| |+||||||+|||++ .+|++||+|||+|+.+... ...
T Consensus 99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSTTCCBC
T ss_pred cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEEC-CCCcEeeccchhheeecccccccc
Confidence 999999998765 47999999999999999999999999 99999999999998 6789999999999877543 346
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhC
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 249 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL 249 (652)
..+|||.|||||++. +.|+.++|||||||++|+|+||.+||.+......++..+..+..+...+...++++++||.+||
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 254 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHT
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHc
Confidence 678999999999875 4699999999999999999999999988666666666666665555566678899999999999
Q ss_pred C-CCCCCCCHHHHhcCccccc
Q 006277 250 V-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 250 ~-~P~~RpSa~elL~hpf~~~ 269 (652)
. +|.+|||+.|+|+||||+.
T Consensus 255 ~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 255 DMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp CSSTTTSCCHHHHTTCGGGGG
T ss_pred cCChhHCcCHHHHhcCHhhCC
Confidence 8 8999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-54 Score=440.66 Aligned_cols=250 Identities=29% Similarity=0.463 Sum_probs=207.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...||+++.|+||+|.++.+|+.||+|++..... ++...+.+.+|+++|++|+|||||++|++|.+..+..+|+||||
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy 86 (269)
T d2java1 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 86 (269)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEEC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEec
Confidence 4688899999999999999999999999976543 45677889999999999999999999999988766689999999
Q ss_pred CCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CCeeeccCCcccEEEcCCCCcEEEeccCchhhhh
Q 006277 93 FTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHD---PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 93 ~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g---~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~ 165 (652)
|+||+|.+++.+ .+.+++..++.|+.||+.||.|||+++ .+|+||||||+|||++ .+|.+||+|||+|+.+.
T Consensus 87 ~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 87 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILN 165 (269)
T ss_dssp CTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC-TTSCEEECCHHHHHHC-
T ss_pred CCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC-CCCcEEEeeccceeecc
Confidence 999999998864 467999999999999999999999864 2499999999999998 66899999999999876
Q ss_pred cc--ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 166 QA--NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 166 ~~--~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
.. ...+.+|||.|||||++. ..|+.++|||||||++|||+||.+||.+ .+..+++..+..+..+ .++...+++++
T Consensus 166 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~s~~l~ 243 (269)
T d2java1 166 HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRYSDELN 243 (269)
T ss_dssp ----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTTSCHHHH
T ss_pred cCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCHHHH
Confidence 43 245789999999999874 5799999999999999999999999987 6777888888887654 35566789999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcCccc
Q 006277 243 SFIEKCLV-PASQRLSAKELLMDPFL 267 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~hpf~ 267 (652)
+||.+||. +|.+|||+.|+|+|||+
T Consensus 244 ~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 244 EIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999998 89999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=450.09 Aligned_cols=250 Identities=26% Similarity=0.458 Sum_probs=211.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+||++..|+||+|.++.+|+.||+|+++... ++...+++.+|+.+|++|+|||||+++++|.+.. .+|+||||
T Consensus 11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~iVmEy 85 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISICMEH 85 (322)
T ss_dssp EEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS--EEEEEEEC
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEEEc
Confidence 467888888999999999999999999997542 3456788999999999999999999999998765 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 171 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~ 171 (652)
|.||+|.+++.+.+.+++..++.++.||+.||.|||+ +| |+||||||+|||++ .+|++||+|||+|+.+......+
T Consensus 86 ~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~~~~~ 162 (322)
T d1s9ja_ 86 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANS 162 (322)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHHHTC--
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeEC-CCCCEEEeeCCCccccCCCcccc
Confidence 9999999999999999999999999999999999997 57 99999999999998 67899999999999887777778
Q ss_pred ccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHH-------------------------------
Q 006277 172 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ------------------------------- 219 (652)
Q Consensus 172 ~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~------------------------------- 219 (652)
.+||+.|||||++. ..|+.++|||||||++|||++|+.||.+......
T Consensus 163 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242 (322)
T ss_dssp -CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------------
T ss_pred ccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccc
Confidence 89999999999874 5799999999999999999999999976433211
Q ss_pred ----------HHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 220 ----------IYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 220 ----------i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
....+.....+.......++++++||.+||+ ||.+||||+|+|+||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 1111112222222223467899999999998 89999999999999999853
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=440.81 Aligned_cols=248 Identities=28% Similarity=0.466 Sum_probs=214.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+||+++.|+||+|.++.+|+.||+|++.... .+..+++.+|+++|++|+|||||++|++|.+.. .+|+||||
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~lvmEy 90 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--NLWILIEF 90 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--eEEEEEec
Confidence 357888889999999999999999999987542 356778999999999999999999999998765 79999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
|.||+|.+++.+ .+.+++..++.+++||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+..... ..
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECHHHHHHH
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeEC-CCCCEEEEechhhhccCCCcccc
Confidence 999999999765 567999999999999999999999999 99999999999998 6789999999999866543 34
Q ss_pred ccccCCCCccCcccc------ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC-CccccCCCChHHH
Q 006277 170 KSVIGTPEFMAPELY------DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-PAALSKVKDPEVK 242 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl------~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~-p~~l~~~~s~~~k 242 (652)
.+.+|||.|||||++ ...|+.++|||||||++|+|+||.+||.+. +..+++..+..+.. ....+...+++++
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 246 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSRWSSNFK 246 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS-CGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence 578999999999976 245899999999999999999999999884 44555555555543 3344566789999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 243 SFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+||.+||+ +|.+|||+.|+|+||||+..
T Consensus 247 ~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 247 DFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999998 89999999999999999743
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=449.87 Aligned_cols=253 Identities=22% Similarity=0.366 Sum_probs=224.0
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
....||++..|.||+|.++.+|+.||+|++++.... ..+..+++.+|+.+|+.++|||||+++++|.+.. .+|+|||
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~iv~e 85 (337)
T d1o6la_ 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFVME 85 (337)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS--EEEEEEE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc-CHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc--cccccee
Confidence 346788888899999999999999999999854332 2345788999999999999999999999998765 8999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
||+||+|.+++.+.+.+++..++.+++||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|+..... ..
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~-~~g~vkl~DFG~a~~~~~~~~~~ 162 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTCCB
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEec-CCCCEEEeecccccccccCCccc
Confidence 9999999999999999999999999999999999999999 99999999999998 6789999999999876432 34
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
.+.+|||.|||||++. ..|+.++|||||||++|||++|.+||.+ .+..++++.+..+. ..++...++++++||.+|
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~~~ 239 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHH
T ss_pred ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC-cCHHHHHHHHhcCC--CCCCccCCHHHHHHHHhh
Confidence 6789999999999874 5799999999999999999999999987 67788888888765 345677899999999999
Q ss_pred CC-CCCCCCC-----HHHHhcCccccccCCC
Q 006277 249 LV-PASQRLS-----AKELLMDPFLQVNGTT 273 (652)
Q Consensus 249 L~-~P~~RpS-----a~elL~hpf~~~~~~~ 273 (652)
|+ +|.+|++ +.|+++||||+...|.
T Consensus 240 L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~ 270 (337)
T d1o6la_ 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ccCCchhhcccccccHHHHHcCcccccCCHH
Confidence 98 8999994 9999999999876553
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-53 Score=443.66 Aligned_cols=248 Identities=28% Similarity=0.424 Sum_probs=218.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+||+|+.|+||+|.++.+|+.||||++..... ...+..+++.+|+++|++|+|||||+++++|.+.. .+|+||||
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~~iv~E~ 96 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAWLVMEY 96 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC--EEEEEEEe
Confidence 4678888889999999999999999999985443 34566788999999999999999999999998765 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
|.+|+|..++..++++++..++.|++||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|..... ....
T Consensus 97 ~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~~Kl~DFG~a~~~~~--~~~~ 171 (309)
T d1u5ra_ 97 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANSF 171 (309)
T ss_dssp CSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS--BCCC
T ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEC-CCCCEEEeecccccccCC--CCcc
Confidence 999999888888889999999999999999999999999 99999999999998 678999999999987644 3567
Q ss_pred cCCCCccCccccc----cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 173 IGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 173 vGTp~YmAPEvl~----~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
+|||.|||||++. +.|+.++|||||||++|||++|.+||.+. +..+.+..+..+..+...+...++++++||.+|
T Consensus 172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~ 250 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250 (309)
T ss_dssp CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHH
T ss_pred ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence 8999999999873 35999999999999999999999999874 445555556666555555666789999999999
Q ss_pred CC-CCCCCCCHHHHhcCccccc
Q 006277 249 LV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 249 L~-~P~~RpSa~elL~hpf~~~ 269 (652)
|+ +|.+|||+.|+|+||||+.
T Consensus 251 L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 251 LQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp TCSSGGGSCCHHHHTTCHHHHS
T ss_pred CcCChhHCcCHHHHHhCHHhcC
Confidence 98 8999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=442.15 Aligned_cols=253 Identities=24% Similarity=0.367 Sum_probs=219.2
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...||+++.|+||+|.++.+|+.||+|++...... .....+.+.+|+++|++|+|||||++|++|.+.. .+|+||||
T Consensus 13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~ivmEy 89 (288)
T d1uu3a_ 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE--KLYFGLSY 89 (288)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS--EEEEEECC
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc-CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC--EEEEEEEc
Confidence 35778888899999999999999999999754321 2245678999999999999999999999998764 89999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc----c
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----N 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~----~ 168 (652)
|.||+|.+++...+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|+.+... .
T Consensus 90 ~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 90 AKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECC-------
T ss_pred cCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccC-CCceEEecccccceecccCCcccc
Confidence 999999999999999999999999999999999999999 99999999999998 6789999999999877532 2
Q ss_pred cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~k 247 (652)
..+.+||+.|||||++. ..|+.++|||||||++|+|++|.+||.+ .+..+++.++..+.. .++...++++++||.+
T Consensus 167 ~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~ 243 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEY--DFPEKFFPKARDLVEK 243 (288)
T ss_dssp ---CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCC--CCCTTCCHHHHHHHHT
T ss_pred cccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHcCCC--CCCccCCHHHHHHHHH
Confidence 35678999999999874 5799999999999999999999999987 677788888887643 3556778999999999
Q ss_pred hCC-CCCCCCCHHH------HhcCccccccCCCC
Q 006277 248 CLV-PASQRLSAKE------LLMDPFLQVNGTTK 274 (652)
Q Consensus 248 cL~-~P~~RpSa~e------lL~hpf~~~~~~~~ 274 (652)
||+ +|.+|||++| +++||||+..+|..
T Consensus 244 ~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~ 277 (288)
T d1uu3a_ 244 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 277 (288)
T ss_dssp TSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred HccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence 998 8999999987 58899998765543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-52 Score=439.66 Aligned_cols=248 Identities=20% Similarity=0.306 Sum_probs=199.5
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..||+|+.|+||+|.++.+|+.||+|++..... .....++.+|+.+|++|+|||||+++++|.+.. .+|+|||||
T Consensus 15 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lvmE~~ 89 (307)
T d1a06a_ 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL---EGKEGSMENEIAVLHKIKHPNIVALDDIYESGG--HLYLIMQLV 89 (307)
T ss_dssp EESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSS--EEEEEECCC
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEchHHh---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEEecc
Confidence 456666778999999999999999999986543 233467889999999999999999999998654 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC--CCCcEEEeccCchhhhhccc-cc
Q 006277 94 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLATIMEQAN-AK 170 (652)
Q Consensus 94 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~--~~g~VKL~DFGla~~l~~~~-~~ 170 (652)
.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||+.. .+|.+||+|||+|+...... ..
T Consensus 90 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 167 (307)
T d1a06a_ 90 SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 167 (307)
T ss_dssp CSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred CCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCCCeee
Confidence 99999999999999999999999999999999999999 999999999999963 46789999999998775443 46
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc--cccCCCChHHHHHHHH
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA--ALSKVKDPEVKSFIEK 247 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~--~l~~~~s~~~kdlI~k 247 (652)
+.+||+.|||||++. +.|+.++|||||||++|+|++|.+||.+ ....+++..+..+..+. ......++++++||.+
T Consensus 168 ~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 246 (307)
T d1a06a_ 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246 (307)
T ss_dssp -----CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred eeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHH
Confidence 788999999999875 4699999999999999999999999987 56677777887765432 3345678999999999
Q ss_pred hCC-CCCCCCCHHHHhcCccccc
Q 006277 248 CLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~~~ 269 (652)
||. +|.+|||+.|+|+||||+.
T Consensus 247 ~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 247 LMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HccCCHhHCcCHHHHhcCHhhCC
Confidence 998 8999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-52 Score=439.80 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=224.2
Q ss_pred ceeeee-eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 006277 6 WSLLIL-MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84 (652)
Q Consensus 6 W~~~~~-~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 84 (652)
|+...+ ....||+++.|+||+|.++.+|+.||+|+++..... .....+++.+|+.+|+.++|||||+++++|.+..
T Consensus 1 ~sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-- 77 (316)
T d1fota_ 1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-- 77 (316)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS--
T ss_pred CchhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC--
Confidence 344333 346788888899999999999999999999754321 2245678999999999999999999999998765
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhh
Q 006277 85 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 164 (652)
Q Consensus 85 ~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l 164 (652)
.+|+|||||.||+|..++...+.+++..++.|++||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|+..
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYV 154 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEEC
T ss_pred eeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEc-CCCCEEEecCccceEe
Confidence 89999999999999999999999999999999999999999999999 99999999999998 6789999999999876
Q ss_pred hccccccccCCCCccCcccccc-CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHH
Q 006277 165 EQANAKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 243 (652)
Q Consensus 165 ~~~~~~~~vGTp~YmAPEvl~~-~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kd 243 (652)
... ..+.+|||.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+..+++..+..+.. .++...++++++
T Consensus 155 ~~~-~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~ 230 (316)
T d1fota_ 155 PDV-TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKD 230 (316)
T ss_dssp SSC-BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHH
T ss_pred ccc-cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCCCCHHHHH
Confidence 543 456899999999998854 699999999999999999999999987 677778888877643 345667899999
Q ss_pred HHHHhCC-CCCCCC-----CHHHHhcCccccccCCC
Q 006277 244 FIEKCLV-PASQRL-----SAKELLMDPFLQVNGTT 273 (652)
Q Consensus 244 lI~kcL~-~P~~Rp-----Sa~elL~hpf~~~~~~~ 273 (652)
+|.+||. +|.+|+ |++++|+||||+...|.
T Consensus 231 li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 231 LLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp HHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred HHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 9999997 899996 99999999999876553
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-52 Score=429.89 Aligned_cols=253 Identities=26% Similarity=0.378 Sum_probs=219.5
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCC--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQS--PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s--~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
..||+|..|+||+|.++.+|+.||+|++.+...... ....+.+.+|+++|++|+|||||++|++|.+.. .+|+|||
T Consensus 16 ~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~iv~E 93 (293)
T d1jksa_ 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT--DVILILE 93 (293)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEEE
Confidence 568888889999999999999999999986544322 234678999999999999999999999998765 8999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCC---CcEEEeccCchhhhhccc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ---GEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~---g~VKL~DFGla~~l~~~~ 168 (652)
||+||+|.+++...+.+++..++.+++||+.||+|||+++ |+||||||+|||++..+ +.+||+|||+|..+....
T Consensus 94 ~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~ 171 (293)
T d1jksa_ 94 LVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171 (293)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC
T ss_pred cCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhhhcCCCc
Confidence 9999999999999899999999999999999999999999 99999999999998432 259999999998876543
Q ss_pred -cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--CccccCCCChHHHHH
Q 006277 169 -AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKSF 244 (652)
Q Consensus 169 -~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~~kdl 244 (652)
..+.+||+.|||||++. +.|+.++|||||||++|+|++|..||.+ .+..+.+..+..+.. +...+...++++++|
T Consensus 172 ~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 250 (293)
T d1jksa_ 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250 (293)
T ss_dssp BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHH
T ss_pred cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCchhcCCCCHHHHHH
Confidence 46679999999999885 4699999999999999999999999987 567777777777653 233445678999999
Q ss_pred HHHhCC-CCCCCCCHHHHhcCccccccC
Q 006277 245 IEKCLV-PASQRLSAKELLMDPFLQVNG 271 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~hpf~~~~~ 271 (652)
|.+||. +|.+|||++|+|+||||+...
T Consensus 251 i~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 251 IRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred HHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 999998 899999999999999998543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-52 Score=442.24 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=221.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...||++..|+||+|.++.+|+.||||++.+.... .....+++.+|+++|+.++|||||++|++|.+.. .+++||||
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~~v~e~ 122 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEY 122 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEEEEC
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHHcCCCcEeeccccccccc--cccccccc
Confidence 46788888899999999999999999999754332 2245678999999999999999999999998765 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccccc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 172 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~~ 172 (652)
|.||+|..++.+.+.+++..++.|+.||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|+.+... ..+.
T Consensus 123 ~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~~-~~~~ 198 (350)
T d1rdqe_ 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGR-TWTL 198 (350)
T ss_dssp CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC-BCCC
T ss_pred ccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccC-CCCCEEeeeceeeeecccc-cccc
Confidence 999999999999999999999999999999999999999 99999999999998 6789999999999877543 4567
Q ss_pred cCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-
Q 006277 173 IGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV- 250 (652)
Q Consensus 173 vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~- 250 (652)
+|||.|||||++. ..|+.++|||||||++|+|+||.+||.+ .+...++..+..+.. ..+...++++++||.+||.
T Consensus 199 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~ 275 (350)
T d1rdqe_ 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLLRNLLQV 275 (350)
T ss_dssp EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHHHHHSCS
T ss_pred cCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcCCC--CCCccCCHHHHHHHHHHhhh
Confidence 8999999999875 5699999999999999999999999987 677788888877653 3345678999999999998
Q ss_pred CCCCCC-----CHHHHhcCccccccCCC
Q 006277 251 PASQRL-----SAKELLMDPFLQVNGTT 273 (652)
Q Consensus 251 ~P~~Rp-----Sa~elL~hpf~~~~~~~ 273 (652)
||.+|+ |++++|+||||+...|.
T Consensus 276 dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 276 DLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred CHHhccccccccHHHHHcCccccCCCHH
Confidence 899885 99999999999876654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.2e-51 Score=437.89 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=218.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+||+|+.|+||+|.++.+|+.||+|++.... ....+.+.+|+.+|++|+|||||+++++|.+.. .+|+||||
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~ivmE~ 104 (350)
T d1koaa2 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN--EMVMIYEF 104 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECCCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT--EEEEEECC
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEcccc----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEEEc
Confidence 467899999999999999999999999987542 456788999999999999999999999998765 89999999
Q ss_pred CCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC-CCCcEEEeccCchhhhhccc-c
Q 006277 93 FTSGSLRQYRK-KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING-NQGEVKIGDLGLATIMEQAN-A 169 (652)
Q Consensus 93 ~~gGsL~~~i~-~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~-~~g~VKL~DFGla~~l~~~~-~ 169 (652)
|+||+|.+++. ..+++++..++.|++||+.||.|||++| |+||||||+|||++. .+|.+||+|||+++.+.... .
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 99999999985 4567999999999999999999999999 999999999999973 35789999999998876543 4
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--CccccCCCChHHHHHHH
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKSFIE 246 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~~kdlI~ 246 (652)
.+.+||+.|||||++. ..|+.++|||||||++|+|++|.+||.+ .+..+++..+..+.. +.......++++++||.
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 261 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHH
T ss_pred ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 5689999999999875 5699999999999999999999999987 566777777776543 23334557899999999
Q ss_pred HhCC-CCCCCCCHHHHhcCccccccC
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQVNG 271 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~~~~ 271 (652)
+||+ ||.+|||+.|+|+||||+...
T Consensus 262 ~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 262 KLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHccCChhHCcCHHHHhcCcccCCCC
Confidence 9998 899999999999999998543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.9e-51 Score=438.72 Aligned_cols=248 Identities=24% Similarity=0.337 Sum_probs=216.9
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..||+++.|+||+|.++.+|+.||+|++.... ....+.+.+|+.+|++|+|||||++|++|.+.. .+|||||||
T Consensus 35 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~~ivmE~~ 108 (352)
T d1koba_ 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY--EMVLILEFL 108 (352)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS--EEEEEEECC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEEEcC
Confidence 57888888999999999999999999987543 455678899999999999999999999998654 899999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC-CCCcEEEeccCchhhhhccc-cc
Q 006277 94 TSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING-NQGEVKIGDLGLATIMEQAN-AK 170 (652)
Q Consensus 94 ~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~-~~g~VKL~DFGla~~l~~~~-~~ 170 (652)
.||+|.+++...+ ++++..++.|++||+.||.|||++| |+||||||+|||++. .+|.+||+|||+|+.+.... ..
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 9999999876554 6999999999999999999999999 999999999999973 46899999999999876543 45
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--CccccCCCChHHHHHHHH
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~~kdlI~k 247 (652)
+.+||+.|||||++. ..|+.++|||||||++|+|+||.+||.+ .+...++..+..+.. +.......++++++||.+
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 265 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 265 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHT
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence 679999999999875 5699999999999999999999999987 556666677766543 333445678999999999
Q ss_pred hCC-CCCCCCCHHHHhcCcccccc
Q 006277 248 CLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
||+ +|.+|||+.|+|+||||+..
T Consensus 266 ~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 266 LLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp TSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HccCChhHCcCHHHHhcCHhhCCC
Confidence 998 89999999999999999854
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-51 Score=440.83 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=214.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccC--CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVL--QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~--~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
...||+|+.|+||+|.++.+|+.||+|++.+.... .......+...|+.+++.++|||||+++++|.+.. .+|+||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~--~~~ivm 86 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KLSFIL 86 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--EEEEEE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC--EEEEEE
Confidence 36788899999999999999999999999754321 11222334445578888889999999999998765 799999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccc
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 170 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~ 170 (652)
|||.||+|.+++.+++.+++..++.|++||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|+.+......
T Consensus 87 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~-~~g~iKl~DFGla~~~~~~~~~ 163 (364)
T d1omwa3 87 DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH 163 (364)
T ss_dssp CCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-SSSCEEECCCTTCEECSSSCCC
T ss_pred EecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEc-CCCcEEEeeeceeeecCCCccc
Confidence 99999999999999999999999999999999999999999 99999999999998 6789999999999988776677
Q ss_pred cccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCC--HHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 171 SVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRN--SAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~--~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
..+||+.|||||++. ..|+.++|||||||++|+|+||.+||.+... ...+.+.+.. .+..++...++++++||.
T Consensus 164 ~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~ 241 (364)
T d1omwa3 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLLE 241 (364)
T ss_dssp SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS--CCCCCCSSSCHHHHHHHH
T ss_pred ccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--CCCCCCCCCCHHHHHHHH
Confidence 889999999999874 3589999999999999999999999976432 2233333322 344456678899999999
Q ss_pred HhCC-CCCCCCC-----HHHHhcCccccccCCC
Q 006277 247 KCLV-PASQRLS-----AKELLMDPFLQVNGTT 273 (652)
Q Consensus 247 kcL~-~P~~RpS-----a~elL~hpf~~~~~~~ 273 (652)
+||+ +|.+||| |+|+|+||||+...|.
T Consensus 242 ~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~ 274 (364)
T d1omwa3 242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274 (364)
T ss_dssp HHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred HHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence 9998 8999999 8999999999876553
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=428.81 Aligned_cols=250 Identities=20% Similarity=0.280 Sum_probs=204.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCH-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSP-EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~-e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..||+|..|+||+|.++.+|+.||+|+++........ ...+++.+|+++|++++|||||+++++|.+.. .+|+||||
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~~ivmE~ 81 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NISLVFDF 81 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCEEEEEC
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC--ceeehhhh
Confidence 5689999999999999999999999999765432222 22457899999999999999999999997655 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
|.++++..+....+.+++..++.|++||+.||+|||++| |+||||||+|||++ .+|.+||+|||+++...... ..
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEec-CCCccccccCccccccCCCccccc
Confidence 999888877777788999999999999999999999999 99999999999998 67899999999998775532 35
Q ss_pred cccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC--CC-C---------------
Q 006277 171 SVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IK-P--------------- 230 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g--~~-p--------------- 230 (652)
+.+||+.|||||++. ..|+.++|||||||++|||+||.+||.+....+++ ..+.+. .. .
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l-~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL-TRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH-HHHHHhcCCCChhhccchhccchhhhh
Confidence 678999999999763 35899999999999999999999999875444443 333221 00 0
Q ss_pred --------ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 231 --------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 231 --------~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.......++++++||.+||+ ||.+||||.|+|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 00112457899999999998 8999999999999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=430.77 Aligned_cols=251 Identities=23% Similarity=0.379 Sum_probs=218.4
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHH-hCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLK-SLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk-~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...||+|..|+||+|.++.+|+.||+|++++..... .+..+.+..|+.++. .++|||||++|++|.+.. .+|+|||
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~--~~yivmE 83 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE--NLFFVME 83 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS--EEEEEEE
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC--ceeEEEe
Confidence 467888889999999999999999999998543221 234566777777765 689999999999998765 7999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
||+||+|.+++...+.+++..++.+++||+.||+|||++| |+||||||+|||++ ..|++||+|||+++..... ..
T Consensus 84 y~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCCB
T ss_pred ecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeec-CCCceeccccchhhhcccccccc
Confidence 9999999999999999999999999999999999999999 99999999999998 6789999999999876432 34
Q ss_pred ccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 170 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
...+||+.|||||++. +.|+.++|||||||++|+|++|..||.+ .+..+++..+..+. ..++...++++++||.+|
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHH
T ss_pred cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCccCCHHHHHHHHHh
Confidence 5678999999999774 5799999999999999999999999987 67778888887764 345667899999999999
Q ss_pred CC-CCCCCCCHH-HHhcCccccccCC
Q 006277 249 LV-PASQRLSAK-ELLMDPFLQVNGT 272 (652)
Q Consensus 249 L~-~P~~RpSa~-elL~hpf~~~~~~ 272 (652)
|. +|.+|||+. ++++||||+...+
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred cccCCCCCcCHHHHHHhCchhccCCH
Confidence 98 899999995 8999999986544
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5e-50 Score=414.03 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=217.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCC-----HHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQS-----PEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTV 86 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s-----~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~ 86 (652)
...||++..|+||+|.++.+|+.||+|++.+...... ....+++.+|+.+|++|+ |||||+++++|.+.. .+
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~--~~ 85 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT--FF 85 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS--EE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc--ce
Confidence 4678888899999999999999999999986543221 223467899999999996 999999999998654 89
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 87 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
|||||||+||+|.++++.++++++..++.|+.||+.||+|||++| |+||||||+|||++ .++.+||+|||+++.+..
T Consensus 86 ~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 86 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEc-CCCCeEEccchheeEccC
Confidence 999999999999999999999999999999999999999999999 99999999999998 678999999999988765
Q ss_pred c-ccccccCCCCccCccccc-------cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCC--CccccCC
Q 006277 167 A-NAKSVIGTPEFMAPELYD-------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKV 236 (652)
Q Consensus 167 ~-~~~~~vGTp~YmAPEvl~-------~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~ 236 (652)
. .....+||+.|+|||++. ..|+.++||||+||++|+|++|..||.+ .+....+..+..+.. +......
T Consensus 163 ~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 241 (277)
T d1phka_ 163 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDD 241 (277)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-CCHHHHHHHHHhCCCCCCCccccc
Confidence 4 345678999999999773 2478899999999999999999999987 566667777776643 2233346
Q ss_pred CChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 237 KDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 237 ~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.++++++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 242 ~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 78999999999998 8999999999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=424.36 Aligned_cols=246 Identities=20% Similarity=0.302 Sum_probs=215.6
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..||+|..|+||+|.++.+|+.||+|+++... .....+.+|+++|+.++|||||++|++|.+.. .+|+|||||
T Consensus 11 ~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~~lvmE~~ 83 (321)
T d1tkia_ 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESME--ELVMIFEFI 83 (321)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--EEEEEECCC
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEEEEEecC
Confidence 57888889999999999999999999997542 34567889999999999999999999998765 899999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC-CCCcEEEeccCchhhhhccc-cc
Q 006277 94 TSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING-NQGEVKIGDLGLATIMEQAN-AK 170 (652)
Q Consensus 94 ~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~-~~g~VKL~DFGla~~l~~~~-~~ 170 (652)
.||+|.+++..++ .+++..++.|++||+.||+|||++| |+||||||+|||++. ..+.+||+|||+++...... ..
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 9999999998765 7999999999999999999999999 999999999999973 34579999999998775433 45
Q ss_pred cccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC--ccccCCCChHHHHHHHH
Q 006277 171 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AALSKVKDPEVKSFIEK 247 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p--~~l~~~~s~~~kdlI~k 247 (652)
+.+|||.|+|||++. ..|+.++|||||||++|+|++|.+||.+ .+..+++..|..+... .......++++++||.+
T Consensus 162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 240 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHT
T ss_pred ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHH
Confidence 678999999999774 5699999999999999999999999987 5677788888776532 23334678999999999
Q ss_pred hCC-CCCCCCCHHHHhcCccccc
Q 006277 248 CLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~hpf~~~ 269 (652)
||+ +|.+|||+.|+|+||||+.
T Consensus 241 ~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 241 LLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp TSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HccCChhHCcCHHHHhcCHhhcc
Confidence 998 8999999999999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-50 Score=422.61 Aligned_cols=246 Identities=21% Similarity=0.295 Sum_probs=202.7
Q ss_pred EE-EEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeC--CCCeEEEE
Q 006277 14 LR-LIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDD--QNKTVNII 89 (652)
Q Consensus 14 ~r-L~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~--~~~~~~LV 89 (652)
.+ ||+|..|+||+|.+..+|+.||+|+++.. ..+.+|+.++.++ +|||||++|++|.+. .+..+|+|
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 45 78888899999999999999999998632 3567899987654 899999999999762 34579999
Q ss_pred EecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC--CCCcEEEeccCchhhhh
Q 006277 90 TELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLATIME 165 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~--~~g~VKL~DFGla~~l~ 165 (652)
||||+||+|.+++.++ .++++..++.|++||+.||+|||++| |+||||||+|||++. +.+.+||+|||+|+...
T Consensus 88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccceeeecc
Confidence 9999999999999875 36999999999999999999999999 999999999999984 34679999999998775
Q ss_pred cc-ccccccCCCCccCcccccc-CCCccccchhhHHHHHHHhhccCCCCCCCCHH---HHHHHHhcCCC--CccccCCCC
Q 006277 166 QA-NAKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSA---QIYKKVSSGIK--PAALSKVKD 238 (652)
Q Consensus 166 ~~-~~~~~vGTp~YmAPEvl~~-~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~---~i~~~I~~g~~--p~~l~~~~s 238 (652)
.. .....+|||.|||||++.+ .|+.++|||||||++|+|+||.+||.+..... .+...+..+.. |.......+
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 245 (335)
T d2ozaa1 166 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245 (335)
T ss_dssp CCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSC
T ss_pred CCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCC
Confidence 44 3467789999999998854 69999999999999999999999997743322 22233333321 222223468
Q ss_pred hHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 239 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 239 ~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
+++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 246 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 899999999998 89999999999999999743
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-50 Score=410.30 Aligned_cols=243 Identities=23% Similarity=0.319 Sum_probs=208.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCC--HHHHHHHHHHHHHHHhCC--CCCeeeeeeEEEeCCCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQS--PEDLERLYSEVHLLKSLK--HNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s--~e~~~~l~~Ei~iLk~L~--HpnIVkl~~~~~d~~~~~~~LV 89 (652)
..||+++.|+||+|.++.+|+.||+|++........ .....++.+|+.+|++++ |||||+++++|.+.. .+|+|
T Consensus 10 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~--~~~lv 87 (273)
T d1xwsa_ 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD--SFVLI 87 (273)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS--EEEEE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC--eEEEE
Confidence 578888889999999999999999999986443211 112345778999999996 899999999998765 79999
Q ss_pred EecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 90 TELFTS-GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 90 mEy~~g-GsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
|||+.+ +++.+++.+++.+++..++.|+.||+.||+|||++| |+||||||+|||++.+.+.+||+|||+|+......
T Consensus 88 ~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~ 165 (273)
T d1xwsa_ 88 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 165 (273)
T ss_dssp EECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC
T ss_pred EEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccceeccccc
Confidence 999976 688999998899999999999999999999999999 99999999999998667899999999998877666
Q ss_pred cccccCCCCccCccccc-cC-CCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYD-EN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 246 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~-y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~ 246 (652)
..+.+||+.|||||++. .. ++.++|||||||++|+|+||.+||... . .+..+. ..++...++++++||.
T Consensus 166 ~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~----~i~~~~--~~~~~~~s~~~~~li~ 236 (273)
T d1xwsa_ 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---E----EIIRGQ--VFFRQRVSSECQHLIR 236 (273)
T ss_dssp BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---H----HHHHCC--CCCSSCCCHHHHHHHH
T ss_pred ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---h----HHhhcc--cCCCCCCCHHHHHHHH
Confidence 67889999999999874 33 567899999999999999999999752 2 233332 2345667899999999
Q ss_pred HhCC-CCCCCCCHHHHhcCccccc
Q 006277 247 KCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 247 kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+||. +|.+|||++|+|+||||+.
T Consensus 237 ~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 237 WCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp HHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred HHccCCHhHCcCHHHHhcCHhhCC
Confidence 9998 8999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=405.90 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=203.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+||+|..|+||+|.+..+|+.||+|+++.... .....+++.+|+++|++++|||||++|++|.+.. .+|+||||
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~--~~~iv~e~ 82 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN--KLYLVFEF 82 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEecccccccc--ceeEEEee
Confidence 4688898899999999999999999999975432 2344678999999999999999999999998765 89999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc--cc
Q 006277 93 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NA 169 (652)
Q Consensus 93 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 169 (652)
|.++.+...... .+.+++..++.++.||+.||+|||++| ||||||||+|||++ .++.+||+|||+|+..... ..
T Consensus 83 ~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTHHHHHCCCSBCT
T ss_pred cCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeec-ccCcceeccCCcceeccCCcccc
Confidence 976544433333 457999999999999999999999999 99999999999998 6689999999999887543 24
Q ss_pred ccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCc----------------
Q 006277 170 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA---------------- 231 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~---------------- 231 (652)
...+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+......+++.+.....+.
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 5678999999999763 3468899999999999999999999988655555555443211000
Q ss_pred ----------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 232 ----------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 232 ----------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
......++++++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 0112346889999999998 8999999999999999974
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=403.27 Aligned_cols=245 Identities=19% Similarity=0.292 Sum_probs=208.3
Q ss_pred EEEEEecCcEEEEEEEc--cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 14 LRLIQLVDTSGYKAFDE--VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~--~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
.+||+++.|+||+|.+. .+++.||+|+++... .++...+++.+|+.+|++|+|||||++++++.++ ..++|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh--CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---CEEEEEE
Confidence 46999999999999864 467899999986432 2345678899999999999999999999988543 4789999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
||++|+|.+++.+.+.+++..+..|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+++.+....
T Consensus 88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~-~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCSEE
T ss_pred cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccc-ccCcccccchhhhhhcccccccc
Confidence 9999999999999999999999999999999999999998 99999999999998 67899999999998764322
Q ss_pred --cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 169 --AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
.....||+.|||||++ .+.|+.++|||||||++|||+| |.+||.+ .+..++...+..+..+ ..+...++++++|
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~~~~l 242 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYDL 242 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCHHHHHH
Confidence 2346799999999977 5679999999999999999998 8999987 5667888888887644 4556678999999
Q ss_pred HHHhCC-CCCCCCCHHHH---hcCcccc
Q 006277 245 IEKCLV-PASQRLSAKEL---LMDPFLQ 268 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~el---L~hpf~~ 268 (652)
|.+||. +|.+|||+.++ |+|+|+.
T Consensus 243 i~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 243 MNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 999998 89999999998 5677764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.1e-48 Score=399.95 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=206.0
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC--CeEEEEEe
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--KTVNIITE 91 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~--~~~~LVmE 91 (652)
..||+++.|+||+|.+..+|+.||+|+++.. ...+++..+++.+|+++|+.++|||||++++++.+... ..+|+|||
T Consensus 13 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE 91 (277)
T d1o6ya_ 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91 (277)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECST-TTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEchh-hccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEE
Confidence 5788888899999999999999999999754 34556778899999999999999999999999876543 46899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc----
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA---- 167 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~---- 167 (652)
||.||+|.+++...+.+++..++.|++||+.||+|||++| |+||||||+|||++ .++.++|+|||++......
T Consensus 92 ~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~-~~~~~~l~d~~~~~~~~~~~~~~ 168 (277)
T d1o6ya_ 92 YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSV 168 (277)
T ss_dssp CCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-TTSCEEECCCTTCEECC------
T ss_pred CCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccC-ccccceeehhhhhhhhccccccc
Confidence 9999999999999999999999999999999999999999 99999999999998 6789999999988765322
Q ss_pred -ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCC-ccccCCCChHHHHH
Q 006277 168 -NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKVKDPEVKSF 244 (652)
Q Consensus 168 -~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p-~~l~~~~s~~~kdl 244 (652)
...+.+||+.|||||++. +.|+.++|||||||++|+|+||.+||.+........+.+..+..+ .......++++++|
T Consensus 169 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 248 (277)
T d1o6ya_ 169 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 248 (277)
T ss_dssp ----------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHH
T ss_pred cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHH
Confidence 235678999999999875 469999999999999999999999998854445555555555433 23445678999999
Q ss_pred HHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 245 IEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
|.+||. +|.+||+..+.|.|+|++
T Consensus 249 i~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 249 VLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHccCCHhHCHhHHHHHHHHHHH
Confidence 999998 899999544445577765
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.5e-48 Score=399.38 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=204.6
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
...+||+|..|+||+|.++ +|+.||+|++..... +....+++.+|+.+|++++|||||++|++|.+.. .++++|+
T Consensus 6 ~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~i~~e 80 (286)
T d1ob3a_ 6 GLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RLVLVFE 80 (286)
T ss_dssp EEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CEEEEEE
T ss_pred eccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC--ceeEEEE
Confidence 3567888888999999985 889999999976532 2334678999999999999999999999998765 7999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--c
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 169 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~ 169 (652)
|+.++.+..+....+.+++..++.+++||+.||+|||+++ |+||||||+|||++ .++.+||+|||++....... .
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC-----
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEc-CCCCEEecccccceecccCcccc
Confidence 9998888888777889999999999999999999999998 99999999999998 67899999999998875432 3
Q ss_pred ccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CC------------------
Q 006277 170 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GI------------------ 228 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~------------------ 228 (652)
...+||+.|+|||++. ..|+.++|||||||++|||++|.+||.+.....++.+.... +.
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 5568999999999774 35799999999999999999999999875444444332210 00
Q ss_pred -------CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccc
Q 006277 229 -------KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 268 (652)
Q Consensus 229 -------~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~ 268 (652)
.........++.+++||.+||+ ||++||||.|+|+||||+
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 0011234467899999999998 899999999999999997
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=400.14 Aligned_cols=252 Identities=27% Similarity=0.364 Sum_probs=202.2
Q ss_pred EEEEEEecCcEEEEEEEccC-CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC---CCCCeeeeeeEEEeC---CCCe
Q 006277 13 YLRLIQLVDTSGYKAFDEVN-GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL---KHNNIIRFYNSWIDD---QNKT 85 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~t-G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L---~HpnIVkl~~~~~d~---~~~~ 85 (652)
..+||++..|+||+|.+..+ |+.||+|+++..... ......+.+|+.+|+.| +|||||+++++|... ....
T Consensus 12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~ 89 (305)
T d1blxa_ 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 89 (305)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT--TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc--chHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCce
Confidence 46888888999999999765 778999999765432 12233456777777666 899999999998643 2347
Q ss_pred EEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhh
Q 006277 86 VNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 164 (652)
Q Consensus 86 ~~LVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l 164 (652)
++++||||.+|.+...... ...+++..++.+++||+.||+|||+++ |+||||||+|||++ ..|.+||+|||+++..
T Consensus 90 ~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~-~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 90 LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECSCCSCCCC
T ss_pred EEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEc-CCCCeeecchhhhhhh
Confidence 8999999988877655443 457999999999999999999999999 99999999999998 6689999999999876
Q ss_pred hcc-ccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc--CC------------
Q 006277 165 EQA-NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GI------------ 228 (652)
Q Consensus 165 ~~~-~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~--g~------------ 228 (652)
... .....+||+.|||||++ ...|+.++|||||||++|||++|.+||.+... ......+.. +.
T Consensus 167 ~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~ 245 (305)
T d1blxa_ 167 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEEDWPRDVAL 245 (305)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCchhcccccccc
Confidence 543 34678999999999976 56799999999999999999999999987544 433333321 00
Q ss_pred -----------CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 229 -----------KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 229 -----------~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
....+....++.+++||.+||+ ||.+||||.|+|+||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 0112234467899999999998 89999999999999999854
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=399.34 Aligned_cols=240 Identities=30% Similarity=0.424 Sum_probs=203.5
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
.+||+++.|+||+|... ..||||+++.... +++..+.+.+|+.+|++++|||||++++++.+ ..+++|||||
T Consensus 14 ~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~lv~Ey~ 85 (276)
T d1uwha_ 14 QRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAIVTQWC 85 (276)
T ss_dssp SEEEECSSCEEEEEESS---SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEEECC
T ss_pred EEEeeCCCcEEEEEEEC---CEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEEEEEecC
Confidence 57899999999999643 4699999875432 35678899999999999999999999997532 2589999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc----c
Q 006277 94 TSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----N 168 (652)
Q Consensus 94 ~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~----~ 168 (652)
++|+|.+++... +.+++..+..++.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+..... .
T Consensus 86 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~-~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 86 EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp CEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTSSEEECCCCCSCC---------
T ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEc-CCCCEEEccccceeeccccCCccc
Confidence 999999999765 56999999999999999999999998 99999999999998 6789999999999876532 2
Q ss_pred cccccCCCCccCccccc----cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcc---ccCCCChHH
Q 006277 169 AKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA---LSKVKDPEV 241 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~----~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~---l~~~~s~~~ 241 (652)
..+..||+.|||||++. +.|+.++|||||||++|||+||..||.+..+..++...+..+..++. .+...++++
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l 242 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHH
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHH
Confidence 35678999999999873 35899999999999999999999999987788888888887765443 345578899
Q ss_pred HHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 242 KSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
++||.+||. +|.+|||+.|++++
T Consensus 243 ~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 243 KRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999997 89999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-48 Score=399.46 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=213.2
Q ss_pred CCcceeeeeeE---EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 006277 3 RQKWSLLILMY---LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 79 (652)
Q Consensus 3 ~~~W~~~~~~~---~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 79 (652)
+.+|......| .+||+++.|+||+|.++.+|+.||||+++... ...+++.+|+++|++|+|||||++|++|.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCCEecCCccEe
Confidence 45687765444 34556666899999999999999999986432 34567999999999999999999999987
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEec
Q 006277 80 DDQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 157 (652)
Q Consensus 80 d~~~~~~~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~D 157 (652)
+.. .+|+|||||.+|+|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+|||++ .++.+||+|
T Consensus 84 ~~~--~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~D 158 (287)
T d1opja_ 84 REP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVAD 158 (287)
T ss_dssp SSS--SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECC
T ss_pred eCC--eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEEC-CCCcEEEcc
Confidence 654 789999999999999998764 57899999999999999999999998 99999999999998 678999999
Q ss_pred cCchhhhhccc---cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccc
Q 006277 158 LGLATIMEQAN---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL 233 (652)
Q Consensus 158 FGla~~l~~~~---~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l 233 (652)
||+|+...... .....||+.|||||++ .+.|+.++|||||||++|||++|..||....+..++++.+..+..+ ..
T Consensus 159 FG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~-~~ 237 (287)
T d1opja_ 159 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-ER 237 (287)
T ss_dssp CCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-CC
T ss_pred ccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC-CC
Confidence 99999875433 2345689999999976 5689999999999999999999877776668888888888877544 44
Q ss_pred cCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 234 SKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 234 ~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
+...++++++||.+||. +|.+|||+.|+++
T Consensus 238 ~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 56678999999999998 8999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=396.59 Aligned_cols=243 Identities=18% Similarity=0.331 Sum_probs=209.0
Q ss_pred EEEEecCcEEEEEEEcc--CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 15 RLIQLVDTSGYKAFDEV--NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 15 rL~~l~~gtVykA~d~~--tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
+||+++.|+||+|.+.. ++..||||+++.. ..+...+++.+|+++|++|+|||||++|+++.++ .+|+||||
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~~lvmE~ 89 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALMLVMEM 89 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEEC
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChh---cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---eEEEEEEe
Confidence 58999999999998754 5678999998643 2466788999999999999999999999988643 48999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
|++|+|.+++... +.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 90 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 90 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp CTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEECTTCSCEE
T ss_pred CCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeec-cCCceeeccchhhhccccccccc
Confidence 9999999997654 57999999999999999999999998 99999999999998 67899999999998775432
Q ss_pred --cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHH
Q 006277 169 --AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 244 (652)
Q Consensus 169 --~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdl 244 (652)
.....||+.|||||++. +.|+.++|||||||++|||+| |..||.+. +..++...+..|..+ ..+...++++.+|
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l~~l 244 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECPPECPPELYAL 244 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHHHHH
Confidence 23567999999999874 679999999999999999998 89999874 456778888887654 3456678999999
Q ss_pred HHHhCC-CCCCCCCHHHH---hcCcccc
Q 006277 245 IEKCLV-PASQRLSAKEL---LMDPFLQ 268 (652)
Q Consensus 245 I~kcL~-~P~~RpSa~el---L~hpf~~ 268 (652)
|.+||. +|.+|||+.++ |+|+|+.
T Consensus 245 i~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 245 MSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 999998 89999998877 6788875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=404.47 Aligned_cols=252 Identities=22% Similarity=0.311 Sum_probs=208.9
Q ss_pred Ccceeeee---eEEEEEEecCcEEEEEEEccCC-----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeee
Q 006277 4 QKWSLLIL---MYLRLIQLVDTSGYKAFDEVNG-----LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRF 74 (652)
Q Consensus 4 ~~W~~~~~---~~~rL~~l~~gtVykA~d~~tG-----~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl 74 (652)
.+|..... .-..||+++.|+||+|.+..++ ..||+|.+.... .......+.+|+.+|+++ +|||||++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l 106 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNL 106 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence 35754432 3357888888999999987654 479999886432 234567889999999998 89999999
Q ss_pred eeEEEeCCCCeEEEEEecCCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 006277 75 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-----------------------KVDMKAVKGWARQILSGLIYLHSHD 131 (652)
Q Consensus 75 ~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~-----------------------~lse~~i~~i~~QIl~aL~yLHs~g 131 (652)
|++|.+.. .+|+|||||++|+|.+++..++ .+++..++.|+.||+.||+|||+++
T Consensus 107 ~~~~~~~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~ 184 (325)
T d1rjba_ 107 LGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 184 (325)
T ss_dssp EEEECSSS--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEeeCC--eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99987655 6999999999999999997643 4899999999999999999999998
Q ss_pred CCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh
Q 006277 132 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT 206 (652)
Q Consensus 132 ~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt 206 (652)
|+||||||+|||++ .++.+||+|||+|+...... ..+..||+.|||||++ .+.|+.++|||||||++|||+|
T Consensus 185 --IiHRDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt 261 (325)
T d1rjba_ 185 --CVHRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261 (325)
T ss_dssp --EEETTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred --eeeccCchhccccc-cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHh
Confidence 99999999999998 67899999999998765433 2456789999999976 5689999999999999999997
Q ss_pred -ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 207 -FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 207 -G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
|.+||.+......+.+.+..+.. ...+...++++++||.+||. +|.+|||++||++|
T Consensus 262 ~g~~Pf~~~~~~~~~~~~~~~~~~-~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 262 LGVNPYPGIPVDANFYKLIQNGFK-MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TSCCSSTTCCCSHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHhcCCC-CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 89999886666777777766654 34566778999999999998 89999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.8e-47 Score=400.04 Aligned_cols=246 Identities=21% Similarity=0.319 Sum_probs=205.1
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEe
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITE 91 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LVmE 91 (652)
..+||++..|+||+|.++.+|+.||+|+++.. ..+++.+|+++|++| .||||++++++|.......+++|||
T Consensus 40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSS-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEECHH-------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 45688888899999999999999999998632 246788999999999 4999999999998776678999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-ccc
Q 006277 92 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAK 170 (652)
Q Consensus 92 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~ 170 (652)
||.+|+|..+ .+.+++..++.+++||+.||.|||++| |+||||||+|||++.+++.+||+|||+|...... ...
T Consensus 113 ~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~ 187 (328)
T d3bqca1 113 HVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 187 (328)
T ss_dssp CCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCC
T ss_pred ecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccCCCccc
Confidence 9999998765 357999999999999999999999999 9999999999999866667999999999877654 356
Q ss_pred cccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-------------C-C------
Q 006277 171 SVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-------------G-I------ 228 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-------------g-~------ 228 (652)
..+||+.|+|||++. ..|+.++||||+||++|+|++|..||....+.......+.. . .
T Consensus 188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 267 (328)
T d3bqca1 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267 (328)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGG
T ss_pred ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCccc
Confidence 778999999999764 35899999999999999999999999775554433222211 0 0
Q ss_pred ---------------CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 229 ---------------KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 229 ---------------~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
.+.......++++++||++||+ +|.+||||+|+|+||||+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp GGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred chhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 0111123467899999999998 89999999999999999853
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=387.25 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=213.9
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+||+|+.|+||+|.++.+|+.||||+++.... ......++.+|+.+|+.++|||||+++++|.+.. .+++||++
T Consensus 7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~~iv~~~ 82 (292)
T d1unla_ 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLTLVFEF 82 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEEEEC
T ss_pred eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeecccccccc--ceeEEeee
Confidence 4688999999999999999999999999976542 3456789999999999999999999999998765 79999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc--cc
Q 006277 93 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--~~ 170 (652)
+.+++|..++..++.+++..++.+++|++.||+|||++| |+||||||+|||++ .++.+||+|||+++...... ..
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~-~~~~~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSCCSCCC
T ss_pred ccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccc-cCCceeeeecchhhcccCCCccce
Confidence 999999999999999999999999999999999999999 99999999999998 56799999999998775432 34
Q ss_pred cccCCCCccCcccccc--CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC--------------------
Q 006277 171 SVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI-------------------- 228 (652)
Q Consensus 171 ~~vGTp~YmAPEvl~~--~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~-------------------- 228 (652)
...+++.|+|||++.. .++.++|||||||++|||++|..||....+..+.+..+....
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 5578899999997643 478999999999999999999999876677776666554210
Q ss_pred -------CCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 229 -------KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 229 -------~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.........++++++||.+||+ ||.+||||+|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 1111223457899999999998 8999999999999999974
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=391.69 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=210.9
Q ss_pred cceeeee---eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 006277 5 KWSLLIL---MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 81 (652)
Q Consensus 5 ~W~~~~~---~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 81 (652)
.|..... ...+||+++.|+||+|.++ ++..||||+++... ...+.+.+|+.+|++|+|||||++++++.+.
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-----CCHHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence 4655332 3456888889999999975 68899999986432 2346789999999999999999999976432
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccC
Q 006277 82 QNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 159 (652)
Q Consensus 82 ~~~~~~LVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFG 159 (652)
.+|+|||||.+|+|.+++... .++++..+..++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||
T Consensus 81 ---~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFG 154 (272)
T d1qpca_ 81 ---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFG 154 (272)
T ss_dssp ---SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCT
T ss_pred ---CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeee-cccceeecccc
Confidence 479999999999999976543 36999999999999999999999998 99999999999998 67899999999
Q ss_pred chhhhhccc---cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccC
Q 006277 160 LATIMEQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 235 (652)
Q Consensus 160 la~~l~~~~---~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~ 235 (652)
+|+.+.... .....||+.|||||++. +.|+.++|||||||++|||+||..|+.......++...+..+..+. .+.
T Consensus 155 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~p~ 233 (272)
T d1qpca_ 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-RPD 233 (272)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCT
T ss_pred ceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-Ccc
Confidence 998875432 34568999999999874 5799999999999999999997666555577888888888876543 456
Q ss_pred CCChHHHHHHHHhCC-CCCCCCCHHHHhc--Ccccc
Q 006277 236 VKDPEVKSFIEKCLV-PASQRLSAKELLM--DPFLQ 268 (652)
Q Consensus 236 ~~s~~~kdlI~kcL~-~P~~RpSa~elL~--hpf~~ 268 (652)
..++++++||.+||. +|.+|||+.++++ |+||.
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 678999999999997 8999999999998 78874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-47 Score=401.27 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=200.3
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC----CCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD----QNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~----~~~~~~LV 89 (652)
..||+|+.|+||+|.++.+|+.||+|++...... ..+|+++|++|+|||||+++++|... ...++|||
T Consensus 26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred eEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 3488888899999999999999999999765432 23699999999999999999998653 23468999
Q ss_pred EecCCCCCHHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhc
Q 006277 90 TELFTSGSLRQ---YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 166 (652)
Q Consensus 90 mEy~~gGsL~~---~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~ 166 (652)
||||.+|.+.. +......+++..++.|++||+.||+|||++| |+||||||+|||++.+...+||+|||+++.+..
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 99998764333 3345668999999999999999999999999 999999999999986556899999999987754
Q ss_pred c-ccccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-C---------------
Q 006277 167 A-NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-G--------------- 227 (652)
Q Consensus 167 ~-~~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g--------------- 227 (652)
. ...+.+||+.|+|||++. ..|+.++|||||||++|||++|.+||.......++.+.+.. |
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence 3 346779999999999653 46899999999999999999999999875544444433221 0
Q ss_pred --CCC----c----cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 228 --IKP----A----ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 228 --~~p----~----~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
..+ . ......++++++||.+||. ||.+||||.|+|+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 000 0 1123467899999999998 89999999999999999743
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=387.15 Aligned_cols=240 Identities=18% Similarity=0.331 Sum_probs=196.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
..+||++..|+||+|.+. ++..||||+++... ...+++.+|++++++++|||||++++++.+.. .+++||||
T Consensus 10 ~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~--~~~lv~E~ 81 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PICLVFEF 81 (263)
T ss_dssp EEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEEC
T ss_pred EEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-----CcHHHHHHHHHHHHhcCCCCcccccceeccCC--ceEEEEEe
Confidence 467888889999999985 67889999986432 23467899999999999999999999987654 68999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 168 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 168 (652)
|.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEEC-GGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeec-CCCCeEecccchheeccCCCcee
Confidence 9999999998765 56899999999999999999999998 99999999999998 67899999999998775433
Q ss_pred cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHH
Q 006277 169 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~k 247 (652)
.....||+.|||||++. +.|+.++|||||||++|||+|+..|+....+..+++..+..+..+ ..+...++++.+||.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-CCccccCHHHHHHHHH
Confidence 23468999999999875 579999999999999999999654544447778888888887644 3456678999999999
Q ss_pred hCC-CCCCCCCHHHHhcC
Q 006277 248 CLV-PASQRLSAKELLMD 264 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~h 264 (652)
||. +|.+|||++|+++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 998 89999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.3e-47 Score=393.18 Aligned_cols=241 Identities=20% Similarity=0.311 Sum_probs=195.2
Q ss_pred EEEEEecCcEEEEEEEccCCe---EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGL---EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~---~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
..||+++.|+||+|.++.+|+ .||+|.+... .+....+++.+|+++|++|+|||||++|+++.+.. .+|+||
T Consensus 32 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--~~~iv~ 106 (299)
T d1jpaa_ 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST--PVMIIT 106 (299)
T ss_dssp EEEEECSSSEEEEEEECC---CCEEEEEEECCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--SCEEEE
T ss_pred eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC--EEEEEE
Confidence 468888889999999987765 5888876532 24567788999999999999999999999986554 799999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 91 ELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
|||.+|+|.+++... +.+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 107 Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp ECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC-----------
T ss_pred EecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEEC-CCCcEEECCcccceEccCCCC
Confidence 999999999988874 57999999999999999999999998 99999999999998 67899999999998775432
Q ss_pred ------cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChH
Q 006277 169 ------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 240 (652)
Q Consensus 169 ------~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 240 (652)
.....||+.|||||++ .+.|+.++|||||||++|||+| |.+||.+ ....++...+..+..+. .+...+++
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~ 261 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIEQDYRLP-PPMDCPSA 261 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-CCTTCCHH
T ss_pred cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccchHH
Confidence 1224689999999987 4679999999999999999998 8999987 56677888888776443 34567899
Q ss_pred HHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 241 VKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 241 ~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
+++||.+||. +|.+|||+.|++++
T Consensus 262 l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 262 LHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999997 89999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=405.34 Aligned_cols=270 Identities=20% Similarity=0.289 Sum_probs=218.9
Q ss_pred EEEEEEecCcEEEEEEEc---cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC-CCeeeeeeEEEeCCCCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH-NNIIRFYNSWIDDQNKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~---~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~H-pnIVkl~~~~~d~~~~~~~L 88 (652)
...||+|..|+||+|.+. .+|+.||+|+++......+....+++.+|+++|++++| |||+++++++.+.. .+++
T Consensus 29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~--~~~~ 106 (322)
T d1vzoa_ 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET--KLHL 106 (322)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT--EEEE
T ss_pred EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC--ceee
Confidence 467888888999999984 47999999999765543333456778899999999966 89999999998765 8999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcc-
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 167 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 167 (652)
|||||.+|+|.+++...+.+++..++.+++||+.||+|||++| |+||||||+|||++ .+|.+||+|||+++.+...
T Consensus 107 v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~vkL~DFG~a~~~~~~~ 183 (322)
T d1vzoa_ 107 ILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADE 183 (322)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEEECCGGG
T ss_pred eeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeec-CCCCEEEeeccchhhhcccc
Confidence 9999999999999999999999999999999999999999999 99999999999998 5689999999999876432
Q ss_pred --ccccccCCCCccCcccccc---CCCccccchhhHHHHHHHhhccCCCCCCC---CHHHHHHHHhcCCCCccccCCCCh
Q 006277 168 --NAKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECR---NSAQIYKKVSSGIKPAALSKVKDP 239 (652)
Q Consensus 168 --~~~~~vGTp~YmAPEvl~~---~y~~~sDIWSlGvilyeLltG~~Pf~~~~---~~~~i~~~I~~g~~p~~l~~~~s~ 239 (652)
...+..||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.. ....+.+....+. ...+...++
T Consensus 184 ~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~--~~~~~~~s~ 261 (322)
T d1vzoa_ 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQEMSA 261 (322)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--CCCCTTSCH
T ss_pred cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC--CCCcccCCH
Confidence 2456789999999997742 47889999999999999999999997643 3334444444433 334556889
Q ss_pred HHHHHHHHhCC-CCCCCC-----CHHHHhcCccccccCCCCCCCCCCCCCcCCCCC
Q 006277 240 EVKSFIEKCLV-PASQRL-----SAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVG 289 (652)
Q Consensus 240 ~~kdlI~kcL~-~P~~Rp-----Sa~elL~hpf~~~~~~~~~~~~~~p~~~lp~~~ 289 (652)
++++||.+||. +|.+|| ||+|+|+||||+...+........+++..|.+.
T Consensus 262 ~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~ 317 (322)
T d1vzoa_ 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIR 317 (322)
T ss_dssp HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred HHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCC
Confidence 99999999998 899999 589999999998755433222233444555543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=399.54 Aligned_cols=249 Identities=29% Similarity=0.384 Sum_probs=200.5
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC----CCeEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ----NKTVNI 88 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~----~~~~~L 88 (652)
...||+|+.|+||+|.++.+|+.||||+++... .+....+++.+|+++|++|+|||||+++++|.+.. ...+|+
T Consensus 23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 100 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 100 (346)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEchhh--cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEE
Confidence 355677777999999999999999999987432 35667889999999999999999999999987653 235799
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 89 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 89 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
||||| +++|..+++ ++++++..++.+++||+.||.|||++| |+||||||+|||++ .++.+||+|||+|+.....
T Consensus 101 v~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~-~~~~~kl~Dfg~a~~~~~~- 174 (346)
T d1cm8a_ 101 VMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQADSE- 174 (346)
T ss_dssp EEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCSS-
T ss_pred EEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcc-cccccccccccceeccCCc-
Confidence 99999 667877665 468999999999999999999999999 99999999999998 6789999999999876543
Q ss_pred cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc-CC-----------------
Q 006277 169 AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GI----------------- 228 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~-g~----------------- 228 (652)
....+||+.|+|||++. ..++.++||||+||++|+|++|.+||.+......+...... +.
T Consensus 175 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (346)
T d1cm8a_ 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254 (346)
T ss_dssp CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHH
T ss_pred cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhh
Confidence 45678999999999773 35789999999999999999999999875443333222111 00
Q ss_pred -------CC---ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 229 -------KP---AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 229 -------~p---~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
.. .......++++++||.+||. +|.+||||.|+|+||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 01 11223467899999999998 8999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-47 Score=394.86 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=201.9
Q ss_pred eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC------CCe
Q 006277 12 MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ------NKT 85 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~------~~~ 85 (652)
...+||+|..|+||+|.++.+|+.||||++..... ......++.+|+.+|++|+||||+++++++.... ...
T Consensus 14 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~ 91 (318)
T d3blha1 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91 (318)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCce
Confidence 34788888899999999999999999999876543 2345677889999999999999999999986532 236
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhh
Q 006277 86 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 165 (652)
Q Consensus 86 ~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~ 165 (652)
+|+|||||.++.+..+......+++..++.+++||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.+.
T Consensus 92 ~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~-~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFS 168 (318)
T ss_dssp EEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeec-CCCcEEeeecceeeecc
Confidence 8999999988877766666778999999999999999999999998 99999999999998 67899999999997664
Q ss_pred cc------ccccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc---CCCCcccc
Q 006277 166 QA------NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS---GIKPAALS 234 (652)
Q Consensus 166 ~~------~~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~---g~~p~~l~ 234 (652)
.. ...+.+||+.|+|||++. ..|+.++|||||||++|||++|.+||.+. +.......+.. ...+....
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC-CHHHHHHHHHHhcCCCChhhcc
Confidence 32 234568999999999763 46899999999999999999999999874 44333333322 11111110
Q ss_pred ---------------------------CCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 235 ---------------------------KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 235 ---------------------------~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
...++++++||.+||+ ||++||||+|+|+||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 1136788999999998 8999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=397.23 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=200.8
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---CeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN---KTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~---~~~~LV 89 (652)
...||++..|+||+|.++.+|+.||||++.... .....+++.+|+.+|++|+||||+++++++..... ..+|++
T Consensus 13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 367777888999999999999999999987433 35677899999999999999999999999865421 234555
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
+|+.||+|.+++..+ ++++..++.++.||+.||+|||++| ||||||||+|||++ ++|.+||+|||+++......
T Consensus 90 -~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~-~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 90 -THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp -EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCGGGC
T ss_pred -EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEEC-CCCCEEEcccCceeeccCCCc
Confidence 556699999999764 7999999999999999999999999 99999999999998 67899999999998764332
Q ss_pred ----cccccCCCCccCccccc--cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcC---------------
Q 006277 169 ----AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--------------- 227 (652)
Q Consensus 169 ----~~~~vGTp~YmAPEvl~--~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g--------------- 227 (652)
....+||+.|+|||++. ..|+.++||||+||++|+|++|.+||.+..........+...
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 35578999999999873 357899999999999999999999998754433333222110
Q ss_pred ----------CCCc---cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 228 ----------IKPA---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 228 ----------~~p~---~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
..+. ......++++++||.+||+ ||.+||||.|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0000 1123457899999999998 99999999999999999744
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=379.96 Aligned_cols=241 Identities=20% Similarity=0.321 Sum_probs=199.9
Q ss_pred EEEEEecCcEEEEEEEccCC----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNG----LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG----~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
..||+++.|+||+|.+..++ ..||||++... .+.....++.+|+++|++|+|||||++|+++.+.. .+++|
T Consensus 13 ~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~--~~~~v 87 (283)
T d1mqba_ 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK--PMMII 87 (283)
T ss_dssp EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SEEEE
T ss_pred eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc---cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC--ceEEE
Confidence 45888889999999987765 57999998643 23566778999999999999999999999987554 69999
Q ss_pred EecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 90 TELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
||||.+|+|.+++... +.+++..+..++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+++.+....
T Consensus 88 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 88 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC--------
T ss_pred EEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEEC-CCCeEEEcccchhhcccCCC
Confidence 9999999999987655 67999999999999999999999998 99999999999998 67899999999998775432
Q ss_pred -----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 169 -----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 169 -----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
.....||+.|||||++ .+.|+.++|||||||++|||++|..||....+..++++.+..+..+. .+...+++++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~ 243 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-TPMDCPSAIY 243 (283)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-CCTTCBHHHH
T ss_pred ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC-CchhhHHHHH
Confidence 2335789999999977 56799999999999999999997666666678888999998886543 4456788999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhc
Q 006277 243 SFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~ 263 (652)
+||.+||. +|.+|||+.|+++
T Consensus 244 ~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 244 QLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHCcCCHhHCcCHHHHHH
Confidence 99999997 8999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=380.96 Aligned_cols=241 Identities=24% Similarity=0.358 Sum_probs=195.6
Q ss_pred EEEEEEecCcEEEEEEEccC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~t---G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
...||+++.|+||+|.+..+ +..||+|.++.. ......+.+.+|+++|++++|||||++|+++.+ ..+|+|
T Consensus 12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~~iv 85 (273)
T d1mp8a_ 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWII 85 (273)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSCEEE
T ss_pred EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CeEEEE
Confidence 36788888899999998764 457888876432 245667889999999999999999999998843 268999
Q ss_pred EecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 90 TELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
||||.+|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||+|+.+....
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~-~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeec-CCCcEEEccchhheeccCCc
Confidence 999999999998765 457999999999999999999999998 99999999999998 67899999999998775432
Q ss_pred ---cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHH
Q 006277 169 ---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 243 (652)
Q Consensus 169 ---~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kd 243 (652)
.....||+.|+|||++ .+.|+.++|||||||++|||+| |.+||.+ .+..+++..+..+..+ ..+...++++++
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~~~ 240 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERL-PMPPNCPPTLYS 240 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHH
Confidence 3456789999999987 4689999999999999999998 8999977 5667788888887654 355667899999
Q ss_pred HHHHhCC-CCCCCCCHHHHhcC
Q 006277 244 FIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 244 lI~kcL~-~P~~RpSa~elL~h 264 (652)
||.+||. +|.+|||+.|+++|
T Consensus 241 li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 241 LMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999998 89999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-46 Score=378.47 Aligned_cols=238 Identities=20% Similarity=0.354 Sum_probs=207.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 93 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy~ 93 (652)
..||++..|+||+|.++ +++.||||+++.... ..+.+.+|+.++++++|||||++|+++.+.. .+++|||||
T Consensus 10 ~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~--~~~iv~Ey~ 81 (258)
T d1k2pa_ 10 KELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR--PIFIITEYM 81 (258)
T ss_dssp CCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS--SEEEEEECC
T ss_pred EEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC--ceEEEEEcc
Confidence 46888899999999984 889999999985432 3457899999999999999999999887654 799999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc---c
Q 006277 94 TSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---A 169 (652)
Q Consensus 94 ~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---~ 169 (652)
.+|+|.+++.. ...+++..++.++.||++||.|||++| |+||||||+|||++ +++.+||+|||+++.+.... .
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEc-CCCcEEECcchhheeccCCCceee
Confidence 99999999664 467999999999999999999999998 99999999999998 67899999999998765433 2
Q ss_pred ccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHH
Q 006277 170 KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 247 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~k 247 (652)
....||+.|||||++ ...|+.++|||||||++|||+| |..||.+ .+..++...+..+..+ ..+...++++++||.+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHH
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC-CCHHHHHHHHHhCCCC-CCcccccHHHHHHHHH
Confidence 346799999999987 4679999999999999999998 8999987 4677788888887644 4566788999999999
Q ss_pred hCC-CCCCCCCHHHHhcC
Q 006277 248 CLV-PASQRLSAKELLMD 264 (652)
Q Consensus 248 cL~-~P~~RpSa~elL~h 264 (652)
||+ +|.+|||+.++|+|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 998 89999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=393.86 Aligned_cols=250 Identities=29% Similarity=0.350 Sum_probs=199.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC---CCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ---NKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~---~~~~~LV 89 (652)
..+||+|+.|+||+|.++.+|+.||||++.... .+....+++.+|+++|++|+|||||+++++|.... ....++|
T Consensus 23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i 100 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 100 (348)
T ss_dssp EEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEE
Confidence 345566666899999999999999999987543 34567788999999999999999999999986432 2244666
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhcccc
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 169 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 169 (652)
|+||.||+|.+++.. +++++..++.+++||+.||+|||++| |+||||||+|||++ .+|.+|++|||++...... .
T Consensus 101 ~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~-~~~~~kl~dfg~a~~~~~~-~ 175 (348)
T d2gfsa1 101 VTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDE-M 175 (348)
T ss_dssp EEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCC----CCTGG-G
T ss_pred EEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccc-ccccccccccchhcccCcc-c
Confidence 777889999998854 57999999999999999999999999 99999999999998 6789999999999765433 4
Q ss_pred ccccCCCCccCccccc-c-CCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCC--CCc--------------
Q 006277 170 KSVIGTPEFMAPELYD-E-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPA-------------- 231 (652)
Q Consensus 170 ~~~vGTp~YmAPEvl~-~-~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~--~p~-------------- 231 (652)
.+..||+.|+|||++. . .++.++|||||||++|+|++|.+||.+. +.......+.... .+.
T Consensus 176 ~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (348)
T d2gfsa1 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-DHIDQLKLILRLVGTPGAELLKKISSESARNY 254 (348)
T ss_dssp SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCChHHhhhccchhhhhh
Confidence 5678999999999753 3 4689999999999999999999999874 3333333332210 000
Q ss_pred -------------cccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCcccccc
Q 006277 232 -------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 270 (652)
Q Consensus 232 -------------~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~~ 270 (652)
......++++++||.+||. ||.+||||.|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0113467899999999998 89999999999999999853
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=382.39 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=202.7
Q ss_pred Ccceeeee---eEEEEEEecCcEEEEEEEcc-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeee
Q 006277 4 QKWSLLIL---MYLRLIQLVDTSGYKAFDEV-----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRF 74 (652)
Q Consensus 4 ~~W~~~~~---~~~rL~~l~~gtVykA~d~~-----tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl 74 (652)
.+|.+... .-.+||+++.|.||+|.+.. +++.||+|+++... .....+.+.+|+.++.++ +|||||.+
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 35665332 34667888889999999754 56899999986432 345677888888888887 78999999
Q ss_pred eeEEEeCCCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeecc
Q 006277 75 YNSWIDDQNKTVNIITELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRD 138 (652)
Q Consensus 75 ~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRD 138 (652)
++++.... ..+++|||||++|+|.+++... ..+++..++.|+.||+.||.|||+++ |+|||
T Consensus 83 ~~~~~~~~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrD 159 (299)
T d1ywna1 83 LGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD 159 (299)
T ss_dssp EEEECSTT-SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred eeeeccCC-CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCc
Confidence 99876543 4789999999999999998754 24899999999999999999999998 99999
Q ss_pred CCcccEEEcCCCCcEEEeccCchhhhhcc----ccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhc-cCCCC
Q 006277 139 LKCDNIFINGNQGEVKIGDLGLATIMEQA----NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTF-EYPYS 212 (652)
Q Consensus 139 LKp~NILl~~~~g~VKL~DFGla~~l~~~----~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG-~~Pf~ 212 (652)
|||+|||++ .++.+||+|||+|+..... .....+||+.|||||++ .+.|+.++|||||||++|||+|| .+||.
T Consensus 160 lKp~NILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 160 LAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CCGGGEEEC-GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCccceeEC-CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 999999998 6789999999999876432 23457899999999977 56799999999999999999987 56888
Q ss_pred CCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 213 ECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 213 ~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
+......+...+..+..+ ..+...++++++||.+||. +|.+|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 239 GVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp TCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 766677777888877654 4556678999999999998 89999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=384.32 Aligned_cols=241 Identities=25% Similarity=0.397 Sum_probs=199.4
Q ss_pred EEEEEecCcEEEEEEEccCCe----EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGL----EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~----~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
..||+|+.|+||+|.+..+|+ .||+|.++.. .+.+..+++.+|+.+|++|+|||||++|+++.+. ..+++
T Consensus 15 ~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---~~~~v 88 (317)
T d1xkka_ 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---TVQLI 88 (317)
T ss_dssp EEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEE
T ss_pred eEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CeeEE
Confidence 578888889999999998887 4677766432 2345577899999999999999999999998754 47899
Q ss_pred EecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 90 TELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
|+||.+|+|.+++..+ ..+++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~-~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeC-CCCCeEeeccccceeccccc
Confidence 9999999999887764 67999999999999999999999998 99999999999998 67899999999999875432
Q ss_pred ----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 169 ----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 169 ----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
.....||+.|||||++ .+.|+.++|||||||++|||+| |.+||.+ .+..++...+..+..+ ..+...+++++
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~-~~p~~~~~~~~ 243 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICTIDVY 243 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCC-CCCTTBCHHHH
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCHHHH
Confidence 2345799999999976 5679999999999999999998 7888876 5666788888887654 34556789999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcCc
Q 006277 243 SFIEKCLV-PASQRLSAKELLMDP 265 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~hp 265 (652)
+||.+||. +|.+|||+.|++.|.
T Consensus 244 ~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 244 MIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhCCCChhhCcCHHHHHHHH
Confidence 99999998 899999999999884
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=377.77 Aligned_cols=253 Identities=20% Similarity=0.320 Sum_probs=206.1
Q ss_pred Ccceeeee---eEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 006277 4 QKWSLLIL---MYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 80 (652)
Q Consensus 4 ~~W~~~~~---~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 80 (652)
..|.+... ...+||+++.|+||+|.+..+ ..||+|++.... ...+.+.+|+++|++++|||||++|+++.+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-----CCHHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence 44666333 445677777899999998755 679999986432 234678999999999999999999998743
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEecc
Q 006277 81 DQNKTVNIITELFTSGSLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 158 (652)
Q Consensus 81 ~~~~~~~LVmEy~~gGsL~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DF 158 (652)
. .+++|||||.+|+|..++.. .+.+++..+..++.||+.||+|||++| |+||||||+||||+ .++.+||+||
T Consensus 84 ~---~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~-~~~~~kl~Df 157 (285)
T d1fmka3 84 E---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADF 157 (285)
T ss_dssp S---SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCC
T ss_pred C---CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEEC-CCCcEEEccc
Confidence 2 47999999999999988653 457999999999999999999999998 99999999999998 6789999999
Q ss_pred Cchhhhhccc---cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCcccc
Q 006277 159 GLATIMEQAN---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS 234 (652)
Q Consensus 159 Gla~~l~~~~---~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 234 (652)
|+++.+.... .....||+.|+|||++ .+.|+.++|||||||++|||+||..||.......+++..+..+..+. .+
T Consensus 158 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~ 236 (285)
T d1fmka3 158 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CP 236 (285)
T ss_dssp CTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CC
T ss_pred chhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CC
Confidence 9998765332 2446899999999977 56899999999999999999997777666678888888888876543 55
Q ss_pred CCCChHHHHHHHHhCC-CCCCCCCHHHHhc--Cccccc
Q 006277 235 KVKDPEVKSFIEKCLV-PASQRLSAKELLM--DPFLQV 269 (652)
Q Consensus 235 ~~~s~~~kdlI~kcL~-~P~~RpSa~elL~--hpf~~~ 269 (652)
...++++++||.+||. +|++|||+.+++. ++||..
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 6678999999999998 8999999999987 788853
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=390.72 Aligned_cols=247 Identities=27% Similarity=0.361 Sum_probs=190.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC----CCCeEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD----QNKTVNII 89 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~----~~~~~~LV 89 (652)
..||+|+.|+||+|.|+.+|+.||||++..... +.....++.+|+.+|++++|||||+++++|... ....+|+|
T Consensus 23 ~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv 100 (355)
T d2b1pa1 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 100 (355)
T ss_dssp EECSCC--CEEEEEEETTTTEEEEEEEEESTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEChhhc--CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEE
Confidence 356666668999999999999999999975432 466778999999999999999999999998654 23589999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 90 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
||||.++.+ +.+ .+.+++..++.+++||+.||.|||++| |+||||||+|||++ .++.+|++|||+++......
T Consensus 101 ~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~-~~~~~kl~df~~~~~~~~~~~ 174 (355)
T d2b1pa1 101 MELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFM 174 (355)
T ss_dssp EECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC---------
T ss_pred EeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccc-cccceeeechhhhhccccccc
Confidence 999976544 444 457999999999999999999999999 99999999999998 56899999999988776543
Q ss_pred cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhc---------------------
Q 006277 169 AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--------------------- 226 (652)
Q Consensus 169 ~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~--------------------- 226 (652)
....+||+.|+|||++ +..|+.++||||+||++|+|++|.+||.+... .....++..
T Consensus 175 ~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 253 (355)
T d2b1pa1 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253 (355)
T ss_dssp ------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHTTSCHHHHHHH
T ss_pred cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH-HHHHHHHHHhccCCCHHHHHHhhhhHHHHh
Confidence 4567899999999987 45799999999999999999999999987443 333222221
Q ss_pred -CCCCc-----------c-------ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCccccc
Q 006277 227 -GIKPA-----------A-------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 269 (652)
Q Consensus 227 -g~~p~-----------~-------l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hpf~~~ 269 (652)
+..+. . .....++++++||++||. +|++||||+|+|+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 00000 0 001135678999999998 9999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-44 Score=375.45 Aligned_cols=242 Identities=19% Similarity=0.260 Sum_probs=207.1
Q ss_pred eEEEEEEecCcEEEEEEEc-----cCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 006277 12 MYLRLIQLVDTSGYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 86 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~-----~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~ 86 (652)
...+||+++.|+||+|..+ .++..||||++... ...+..+++.+|+++|++++||||+++++++.+.. .+
T Consensus 17 ~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~ 91 (301)
T d1lufa_ 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK--PM 91 (301)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SC
T ss_pred EeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh---cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC--ce
Confidence 4578999999999999975 46789999998643 23566788999999999999999999999987654 79
Q ss_pred EEEEecCCCCCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcc
Q 006277 87 NIITELFTSGSLRQYRKKHK------------------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 142 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~~~------------------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~ 142 (652)
++|||||.+|+|.+++.... .+++..+..++.||+.||+|||+++ ||||||||+
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlKp~ 169 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATR 169 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEEccc
Confidence 99999999999999986532 4889999999999999999999998 999999999
Q ss_pred cEEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhcc-CCCCCCCC
Q 006277 143 NIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFE-YPYSECRN 216 (652)
Q Consensus 143 NILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~-~Pf~~~~~ 216 (652)
|||++ .++.+||+|||+|+.+.... ..+..||+.|||||++ ...|+.++|||||||++|||++|. +||.+ .+
T Consensus 170 NILld-~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~-~~ 247 (301)
T d1lufa_ 170 NCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-MA 247 (301)
T ss_dssp GEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SC
T ss_pred ceEEC-CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC-CC
Confidence 99998 67899999999998775432 2456889999999977 457999999999999999999996 56766 67
Q ss_pred HHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 217 SAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 217 ~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
..++...+..+..+ ..+...++++.+||.+||. +|.+|||+.|+++
T Consensus 248 ~~e~~~~v~~~~~~-~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCC-CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78888889888754 3456678999999999998 8999999999964
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-45 Score=372.49 Aligned_cols=237 Identities=19% Similarity=0.331 Sum_probs=196.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
...|+++..|.||+|.+ .|..||+|+++.. ...+.+.+|+++|++|+|||||++|+++.+.. ..+|+||||
T Consensus 12 ~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv~ey 82 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEY 82 (262)
T ss_dssp EEEEEECSSCEEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEECC
T ss_pred eEEEecCCCeEEEEEEE--CCeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-CcEEEEEec
Confidence 45688888899999987 5889999998643 24567899999999999999999999886543 358999999
Q ss_pred CCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccccc
Q 006277 93 FTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 170 (652)
Q Consensus 93 ~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~ 170 (652)
|++|+|.+++.+++ .+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++..... ..
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~s~~~~~~-~~ 158 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST-QD 158 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheec-CCCCEeecccccceecCCC-Cc
Confidence 99999999987653 5899999999999999999999998 99999999999998 6789999999999876543 34
Q ss_pred cccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHh
Q 006277 171 SVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 248 (652)
Q Consensus 171 ~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kc 248 (652)
...||+.|+|||++ ++.|+.++|||||||++|||+| |.+||.. .+..+++..+..+..+. .+...++++++||.+|
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~c 236 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMD-APDGCPPAVYEVMKNC 236 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCC-CCTTCCHHHHHHHHHH
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHH
Confidence 56789999999977 5689999999999999999998 6777766 57778888888876654 4566789999999999
Q ss_pred CC-CCCCCCCHHHHhcC
Q 006277 249 LV-PASQRLSAKELLMD 264 (652)
Q Consensus 249 L~-~P~~RpSa~elL~h 264 (652)
|. +|.+|||+.+++++
T Consensus 237 l~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 237 WHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cccCHhHCcCHHHHHHH
Confidence 98 89999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=375.37 Aligned_cols=242 Identities=24% Similarity=0.312 Sum_probs=202.7
Q ss_pred EEEEEEecCcEEEEEEEccCCeE--EEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLE--VAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~--VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
-..||++..|+||+|.++.+|.. ||||.+... ...+..+.+.+|+++|+++ +|||||++|+++.+.. .+|+|
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~--~~~iV 89 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLYLA 89 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--EEEEE
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc---cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC--eeEEE
Confidence 35788888899999999999985 566665422 2345677899999999999 7999999999998764 89999
Q ss_pred EecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcE
Q 006277 90 TELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 153 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~V 153 (652)
||||++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~-~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEc-CCCce
Confidence 9999999999998754 57999999999999999999999998 99999999999998 66899
Q ss_pred EEeccCchhhhhccc-cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccC-CCCCCCCHHHHHHHHhcCCCC
Q 006277 154 KIGDLGLATIMEQAN-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEY-PYSECRNSAQIYKKVSSGIKP 230 (652)
Q Consensus 154 KL~DFGla~~l~~~~-~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~-Pf~~~~~~~~i~~~I~~g~~p 230 (652)
||+|||+++...... .....||+.|+|||.+ .+.|+.++|||||||++|||++|.. ||.+ .+..+++..+.++..+
T Consensus 167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-~~~~~~~~~i~~~~~~ 245 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL 245 (309)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGGGTCCC
T ss_pred EEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhcCCC
Confidence 999999998765543 3456799999999977 5679999999999999999999764 5654 7888899999887654
Q ss_pred ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 231 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 231 ~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
. .+...++++++||.+||. +|++|||+.|+++|
T Consensus 246 ~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 246 E-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp C-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3 455678999999999998 89999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=372.30 Aligned_cols=242 Identities=25% Similarity=0.358 Sum_probs=193.0
Q ss_pred EEEEEEecCcEEEEEEEcc-C--CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEV-N--GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 89 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~-t--G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LV 89 (652)
..+||+++.|+||+|.... + +..||+|++..... ..++..+++.+|+.+|++|+|||||++|+++.+. .+++|
T Consensus 13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---~~~lv 88 (273)
T d1u46a_ 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---PMKMV 88 (273)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEE
T ss_pred EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---chhee
Confidence 3567888889999998654 3 35799999875433 3456778999999999999999999999988643 47899
Q ss_pred EecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc
Q 006277 90 TELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 168 (652)
Q Consensus 90 mEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 168 (652)
||||.+|+|.+++..+ +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~-~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEECCC-C
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccc-cccceeeccchhhhhcccCC
Confidence 9999999999876654 57999999999999999999999998 99999999999998 56899999999999774332
Q ss_pred -----cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHH
Q 006277 169 -----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 241 (652)
Q Consensus 169 -----~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~ 241 (652)
.....||+.|+|||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+.........+...++++
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 23457888999999774 568999999999999999998 8999987 566666677766544445556678999
Q ss_pred HHHHHHhCC-CCCCCCCHHHHh
Q 006277 242 KSFIEKCLV-PASQRLSAKELL 262 (652)
Q Consensus 242 kdlI~kcL~-~P~~RpSa~elL 262 (652)
++||.+||. +|.+|||+.|++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHH
Confidence 999999998 899999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=373.37 Aligned_cols=250 Identities=27% Similarity=0.378 Sum_probs=207.6
Q ss_pred Ccceeeeee---EEEEEEecCcEEEEEEEccCC-------eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCee
Q 006277 4 QKWSLLILM---YLRLIQLVDTSGYKAFDEVNG-------LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNII 72 (652)
Q Consensus 4 ~~W~~~~~~---~~rL~~l~~gtVykA~d~~tG-------~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIV 72 (652)
|+|...... ...||+++.|.||+|.+..++ ..||+|+++... .......+.+|+.++.++ +|||||
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv 82 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNII 82 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeEE
Confidence 678654433 345677777999999987654 579999886432 356678899999999998 899999
Q ss_pred eeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 006277 73 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIH 136 (652)
Q Consensus 73 kl~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiH 136 (652)
+++++|.+.. .+++|||||.+|+|.+++..+. .+++..++.|+.||+.||+|||+++ |+|
T Consensus 83 ~~~~~~~~~~--~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivH 158 (299)
T d1fgka_ 83 NLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIH 158 (299)
T ss_dssp CEEEEECSSS--SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ecccccccCC--eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEe
Confidence 9999987654 7999999999999999997553 5899999999999999999999999 999
Q ss_pred ccCCcccEEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCC
Q 006277 137 RDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYP 210 (652)
Q Consensus 137 RDLKp~NILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~P 210 (652)
|||||+|||++ .++.+||+|||+++...... .....||+.|+|||++ .+.|+.++|||||||++|||++ |.+|
T Consensus 159 rDiKp~NiLl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p 237 (299)
T d1fgka_ 159 RDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237 (299)
T ss_dssp SCCSGGGEEEC-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred eeecccceeec-CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCC
Confidence 99999999998 67899999999999876543 3446899999999976 5689999999999999999998 6888
Q ss_pred CCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 211 YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 211 f~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
|.+ .+..+++..+..+..+ ..+...++++++||.+||+ +|++|||+.|+++
T Consensus 238 ~~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 238 YPG-VPVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp STT-CCHHHHHHHHHTTCCC-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC-CCHHHHHHHHHcCCCC-CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 866 6778888888887654 4566778999999999998 8999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=370.95 Aligned_cols=243 Identities=20% Similarity=0.276 Sum_probs=204.5
Q ss_pred EEEEEecCcEEEEEEEccC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~t---G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~~LVm 90 (652)
..||+++.|+||+|.+..+ +..||||.++. ..+....+++.+|+++|++|+|||||++++++.+.. +.+++||
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv~ 108 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPLVVL 108 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-TEEEEEE
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECc---ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC-CceEEEE
Confidence 3689999999999998664 34799998863 235678899999999999999999999999987654 3799999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccCchhhhhccc-
Q 006277 91 ELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 168 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 168 (652)
|||.+|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~-~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSSGGGCCTTTTTC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeEC-CCCCEEEecccchhhcccccc
Confidence 999999999988754 46788999999999999999999998 99999999999998 67899999999998765432
Q ss_pred -----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHhcCCCCccccCCCChHHH
Q 006277 169 -----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 242 (652)
Q Consensus 169 -----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~k 242 (652)
.....||+.|+|||++ .+.|+.++|||||||++|||+||..||....+..++...+..|..+ ..+...++++.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~-~~p~~~~~~l~ 264 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-LQPEYCPDPLY 264 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC-CCCTTCCHHHH
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-CCcccCcHHHH
Confidence 2345799999999976 5689999999999999999999888887766777788888888654 34566789999
Q ss_pred HHHHHhCC-CCCCCCCHHHHhcC
Q 006277 243 SFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 243 dlI~kcL~-~P~~RpSa~elL~h 264 (652)
+||.+||. +|.+|||+.|+++|
T Consensus 265 ~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 265 EVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999998 89999999999988
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=368.24 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=209.4
Q ss_pred Ccceeeee---eEEEEEEecCcEEEEEEE-----ccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCeeee
Q 006277 4 QKWSLLIL---MYLRLIQLVDTSGYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRF 74 (652)
Q Consensus 4 ~~W~~~~~---~~~rL~~l~~gtVykA~d-----~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L-~HpnIVkl 74 (652)
++|..... .-.+||+++.|.||+|.+ ..+++.||+|+++... .......+.+|+.+++.| +|||||++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 35764322 234578888899999986 3578899999987543 356777899999999999 79999999
Q ss_pred eeEEEeCCCCeEEEEEecCCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 006277 75 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHK------------------KVDMKAVKGWARQILSGLIYLHSHDPPIIH 136 (652)
Q Consensus 75 ~~~~~d~~~~~~~LVmEy~~gGsL~~~i~~~~------------------~lse~~i~~i~~QIl~aL~yLHs~g~~IiH 136 (652)
|+++.+.. .+|+|||||.+|+|.+++.+.. .+++..+..|+.||+.||+|||+++ |+|
T Consensus 93 ~g~~~~~~--~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivH 168 (311)
T d1t46a_ 93 LGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIH 168 (311)
T ss_dssp EEEECSSS--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred EEEEeeCC--EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 99986654 6899999999999999987653 5899999999999999999999999 999
Q ss_pred ccCCcccEEEcCCCCcEEEeccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhh-ccCC
Q 006277 137 RDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYP 210 (652)
Q Consensus 137 RDLKp~NILl~~~~g~VKL~DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLlt-G~~P 210 (652)
|||||+|||++ ..+.+||+|||+++...... ....+||+.|+|||++ .+.|+.++|||||||++|||+| |.+|
T Consensus 169 rDLKp~NIl~~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~ 247 (311)
T d1t46a_ 169 RDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247 (311)
T ss_dssp SCCSGGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ccccccccccc-ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence 99999999998 67899999999998775432 2456899999999977 4678999999999999999998 6666
Q ss_pred CCCCCCHHHHHHHHhcCCCCccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 211 YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 211 f~~~~~~~~i~~~I~~g~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
|........+.+.+..+..+ ..+...++++++||.+||. +|.+|||+.|+|+
T Consensus 248 ~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 248 YPGMPVDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp STTCCSSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 76655656677777776544 3455678999999999998 8999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-43 Score=365.45 Aligned_cols=242 Identities=22% Similarity=0.325 Sum_probs=206.5
Q ss_pred eEEEEEEecCcEEEEEEEcc-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 006277 12 MYLRLIQLVDTSGYKAFDEV-----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 86 (652)
Q Consensus 12 ~~~rL~~l~~gtVykA~d~~-----tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~~ 86 (652)
...+||+++.|+||+|.+.. ++..||||+++.. ...+....+.+|++++++++|||||++++++.... .+
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~---~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~ 98 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ--PT 98 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS--SC
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc---cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC--ce
Confidence 45678888899999999863 4689999998633 24566778999999999999999999999886544 68
Q ss_pred EEEEecCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEe
Q 006277 87 NIITELFTSGSLRQYRKKH----------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 156 (652)
Q Consensus 87 ~LVmEy~~gGsL~~~i~~~----------~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~ 156 (652)
++|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld-~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC-TTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeec-CCceEEEe
Confidence 9999999999999987643 34789999999999999999999998 99999999999998 67899999
Q ss_pred ccCchhhhhccc----cccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhcc-CCCCCCCCHHHHHHHHhcCCCC
Q 006277 157 DLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFE-YPYSECRNSAQIYKKVSSGIKP 230 (652)
Q Consensus 157 DFGla~~l~~~~----~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~-~Pf~~~~~~~~i~~~I~~g~~p 230 (652)
|||+++.+.... ....+||+.|||||.+ .+.|+.++|||||||++|||+||. +||.+ .+..+++..+.++..+
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~~~~~i~~~~~~ 254 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVMEGGLL 254 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHTTCCC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhCCCC
Confidence 999998775432 3455789999999976 567999999999999999999985 66765 7778888888887654
Q ss_pred ccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 231 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 231 ~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
. .+...++.+.++|.+||+ +|.+|||+.++++
T Consensus 255 ~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 255 D-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3 455678999999999998 8999999999997
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-42 Score=354.48 Aligned_cols=250 Identities=21% Similarity=0.236 Sum_probs=193.4
Q ss_pred cceeeeeeEEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 006277 5 KWSLLILMYLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 84 (652)
Q Consensus 5 ~W~~~~~~~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 84 (652)
+|.+ ..+||++..|+||+|.+..+|+.||+|++..... .+++..|+++++.++|+|+|..+..+... +.
T Consensus 8 rY~l----~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~ 76 (299)
T d1ckia_ 8 RYRL----GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GD 76 (299)
T ss_dssp TEEE----EEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT------SCCHHHHHHHHHHSTTSTTCCCEEEEEEE-TT
T ss_pred EEEE----eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc------CHHHHHHHHHHHHccCCCcccEEEEEEec-CC
Confidence 4655 3688999999999999999999999999875432 23578899999999877766555444333 34
Q ss_pred eEEEEEecCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC--CCCcEEEeccCch
Q 006277 85 TVNIITELFTSGSLRQYRK-KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLA 161 (652)
Q Consensus 85 ~~~LVmEy~~gGsL~~~i~-~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~--~~g~VKL~DFGla 161 (652)
..++||||| +|+|..++. ..+.+++..+..++.||+.||+|||++| |+||||||+|||++. .+..+||+|||+|
T Consensus 77 ~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 77 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred EEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcc
Confidence 889999999 456655544 4568999999999999999999999999 999999999999863 3457999999999
Q ss_pred hhhhccc---------cccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCCCHHHH--HHHHhcC--
Q 006277 162 TIMEQAN---------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI--YKKVSSG-- 227 (652)
Q Consensus 162 ~~l~~~~---------~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~~~i--~~~I~~g-- 227 (652)
+.+.... ..+.+||+.|||||++. ..|+.++|||||||++|||+||..||......... +......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence 8775322 24568999999999775 46999999999999999999999999764433222 1111111
Q ss_pred -CCCccccCCCChHHHHHHHHhCC-CCCCCCCHH---HHhcCcccc
Q 006277 228 -IKPAALSKVKDPEVKSFIEKCLV-PASQRLSAK---ELLMDPFLQ 268 (652)
Q Consensus 228 -~~p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~---elL~hpf~~ 268 (652)
..........++++.+||.+||. +|.+||++. ++|+|+|.+
T Consensus 234 ~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 11223345678999999999997 899999976 567888764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-42 Score=356.56 Aligned_cols=243 Identities=24% Similarity=0.292 Sum_probs=187.0
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC--CeEEEEE
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--KTVNIIT 90 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~--~~~~LVm 90 (652)
..+||+++.|+||+|.. +|+.||+|++.... ........|+..++.++|||||++|+++.+... ..+|+||
T Consensus 8 ~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp EEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 46789999999999975 79999999986332 122222345566677899999999999987643 3689999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeeeccCCcccEEEcCCCCcEEEeccCchhhh
Q 006277 91 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH------DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 164 (652)
Q Consensus 91 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~------g~~IiHRDLKp~NILl~~~~g~VKL~DFGla~~l 164 (652)
|||.+|+|.+++++. .+++..+..++.|++.||+|||+. .++|+||||||+||||+ .++.+||+|||+++..
T Consensus 81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCCTTCEEE
T ss_pred ecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc-CCCCeEEEecCccccc
Confidence 999999999999865 699999999999999999999974 12499999999999998 6789999999999876
Q ss_pred hccc------cccccCCCCccCccccccC-------CCccccchhhHHHHHHHhhccCCCCCC--------------CCH
Q 006277 165 EQAN------AKSVIGTPEFMAPELYDEN-------YNELADIYSFGMCMLEMVTFEYPYSEC--------------RNS 217 (652)
Q Consensus 165 ~~~~------~~~~vGTp~YmAPEvl~~~-------y~~~sDIWSlGvilyeLltG~~Pf~~~--------------~~~ 217 (652)
.... ....+||+.|||||++.+. |+.++|||||||++|||+||..||... ...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 4322 3457899999999987542 677899999999999999998876321 123
Q ss_pred HHHHHHHhcCCCCccccCC-----CChHHHHHHHHhCC-CCCCCCCHHHHhcC
Q 006277 218 AQIYKKVSSGIKPAALSKV-----KDPEVKSFIEKCLV-PASQRLSAKELLMD 264 (652)
Q Consensus 218 ~~i~~~I~~g~~p~~l~~~-----~s~~~kdlI~kcL~-~P~~RpSa~elL~h 264 (652)
..+...+..+...+.++.. ....+.+|+.+||+ +|.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 3344444443322222221 12358899999998 89999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.4e-40 Score=339.77 Aligned_cols=239 Identities=17% Similarity=0.182 Sum_probs=195.2
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC-CCeeeeeeEEEeCCCCeEEEEEec
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH-NNIIRFYNSWIDDQNKTVNIITEL 92 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~H-pnIVkl~~~~~d~~~~~~~LVmEy 92 (652)
.+||+++.|+||+|.+..+|+.||+|++..... ...+.+|+++++.|.| +||+.+++++.+.. ..++||||
T Consensus 11 ~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~--~~~~vme~ 82 (293)
T d1csna_ 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL--HNVLVIDL 82 (293)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--EEEEEEEC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEeecCC--ccEEEEEe
Confidence 578999999999999999999999998864322 2357789999999965 89999999887654 89999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcC----CCCcEEEeccCchhhhhcc
Q 006277 93 FTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING----NQGEVKIGDLGLATIMEQA 167 (652)
Q Consensus 93 ~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~----~~g~VKL~DFGla~~l~~~ 167 (652)
| +|+|.+++... +.+++..+..++.|++.||+|||++| |+||||||+|||++. ..+.+||+|||+|+.+...
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 9 78999988765 47999999999999999999999999 999999999999963 3568999999999876432
Q ss_pred ---------ccccccCCCCccCccccc-cCCCccccchhhHHHHHHHhhccCCCCCCC--CHHHHHHHHhcCC---CCcc
Q 006277 168 ---------NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECR--NSAQIYKKVSSGI---KPAA 232 (652)
Q Consensus 168 ---------~~~~~vGTp~YmAPEvl~-~~y~~~sDIWSlGvilyeLltG~~Pf~~~~--~~~~i~~~I~~g~---~p~~ 232 (652)
...+.+|||.|||||++. ..|+.++|||||||++|||+||.+||.+.. .....+..+.... .+..
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence 134578999999999775 469999999999999999999999997533 3334444443321 2233
Q ss_pred ccCCCChHHHHHHHHhCC-CCCCCCCHHHHhc
Q 006277 233 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 263 (652)
Q Consensus 233 l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~ 263 (652)
+....++++.+|+..|+. +|.+||+...+.+
T Consensus 240 l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 445577899999999996 8999998776643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.2e-40 Score=345.46 Aligned_cols=249 Identities=25% Similarity=0.320 Sum_probs=190.3
Q ss_pred EEEEEEecCcEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-----------CCCeeeeeeEEEeC
Q 006277 13 YLRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-----------HNNIIRFYNSWIDD 81 (652)
Q Consensus 13 ~~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-----------HpnIVkl~~~~~d~ 81 (652)
...||++..|+||+|.++.+|+.||||+++.. ....+.+.+|+.+++.+. |+|||++++++...
T Consensus 18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 46788888899999999999999999998743 344567888999998885 57899999998766
Q ss_pred CCCeEEEEEecCCCCCH-HHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCcccEEEcCCC-----Cc
Q 006277 82 QNKTVNIITELFTSGSL-RQYR--KKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQ-----GE 152 (652)
Q Consensus 82 ~~~~~~LVmEy~~gGsL-~~~i--~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IiHRDLKp~NILl~~~~-----g~ 152 (652)
.....+++|.++..+.. .... .....+++..++.+++||+.||+|||+ +| |+||||||+|||++..+ ..
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccccce
Confidence 55577788877766543 2222 234679999999999999999999998 77 99999999999997332 14
Q ss_pred EEEeccCchhhhhccccccccCCCCccCcccc-ccCCCccccchhhHHHHHHHhhccCCCCCCCCH------HHHHHHHh
Q 006277 153 VKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNS------AQIYKKVS 225 (652)
Q Consensus 153 VKL~DFGla~~l~~~~~~~~vGTp~YmAPEvl-~~~y~~~sDIWSlGvilyeLltG~~Pf~~~~~~------~~i~~~I~ 225 (652)
+|++|||.+..... .....+||+.|+|||++ ...|+.++||||+||++++|++|..||...... ..+...+.
T Consensus 171 ~kl~dfg~s~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 171 IKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249 (362)
T ss_dssp EEECCCTTCEETTB-CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred eeEeeccccccccc-ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence 99999999986554 34667899999999976 567999999999999999999999999653211 11111110
Q ss_pred c-CCC--------------------------------------CccccCCCChHHHHHHHHhCC-CCCCCCCHHHHhcCc
Q 006277 226 S-GIK--------------------------------------PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDP 265 (652)
Q Consensus 226 ~-g~~--------------------------------------p~~l~~~~s~~~kdlI~kcL~-~P~~RpSa~elL~hp 265 (652)
. |.. ........++++++||.+||. ||.+||||+|+|+||
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp 329 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 329 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0 000 000111235689999999998 999999999999999
Q ss_pred cccc
Q 006277 266 FLQV 269 (652)
Q Consensus 266 f~~~ 269 (652)
||+.
T Consensus 330 ~f~~ 333 (362)
T d1q8ya_ 330 WLKD 333 (362)
T ss_dssp GGTT
T ss_pred ccCC
Confidence 9983
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=2.2e-22 Score=194.04 Aligned_cols=163 Identities=15% Similarity=0.148 Sum_probs=121.8
Q ss_pred EEEEEecCcEEEEEEEccCCeEEEEEEEeecccC----C----------CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 006277 14 LRLIQLVDTSGYKAFDEVNGLEVAWCQVRIDDVL----Q----------SPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 79 (652)
Q Consensus 14 ~rL~~l~~gtVykA~d~~tG~~VAiK~v~~~~~~----~----------s~e~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 79 (652)
.+||+++.|+||+|.+. +|++||+|+++..... . ..........|...+.++.|++++..+++.
T Consensus 6 ~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~- 83 (191)
T d1zara2 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE- 83 (191)
T ss_dssp EEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-
T ss_pred CEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-
Confidence 58999999999999985 7999999987532110 0 011234456789999999999999988742
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCcccEEEcCCCCcEEEeccC
Q 006277 80 DDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 159 (652)
Q Consensus 80 d~~~~~~~LVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IiHRDLKp~NILl~~~~g~VKL~DFG 159 (652)
. .+++|||+.++.+. .+++..+..++.||+.+|.|||++| |+||||||+|||++ + +.++|+|||
T Consensus 84 -~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~-~-~~~~liDFG 147 (191)
T d1zara2 84 -G----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWIIDFP 147 (191)
T ss_dssp -T----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEECCCT
T ss_pred -C----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeee-C-CCEEEEECC
Confidence 2 37999999886543 3556677889999999999999999 99999999999998 3 459999999
Q ss_pred chhhhhccccccccCCCCccC------ccccccCCCccccchhhHHH
Q 006277 160 LATIMEQANAKSVIGTPEFMA------PELYDENYNELADIYSFGMC 200 (652)
Q Consensus 160 la~~l~~~~~~~~vGTp~YmA------PEvl~~~y~~~sDIWSlGvi 200 (652)
+|.......... |.. .+.+.+.|+..+|+||+.--
T Consensus 148 ~a~~~~~~~~~~------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 148 QSVEVGEEGWRE------ILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp TCEETTSTTHHH------HHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred CcccCCCCCcHH------HHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 997665333211 111 12345779999999996543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.60 E-value=0.00013 Score=70.37 Aligned_cols=127 Identities=14% Similarity=0.040 Sum_probs=78.8
Q ss_pred cEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHH
Q 006277 22 TSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQ 100 (652)
Q Consensus 22 gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~~~LVmEy~~gGsL~~ 100 (652)
..||+.. ..+..+.+|....... .....+.+|...++.|. +--+.+++.+..+. +..++||++++|.++..
T Consensus 28 ~~v~rv~--~~~~~~vlk~~~~~~~----~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 28 AKVYKLV--GENENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLMSEADGVLCSE 99 (263)
T ss_dssp SEEEEEE--CSSCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCSSEEHHH
T ss_pred CcEEEEE--eCCCeEEEEEcCCCcc----cchhhHHHHHHHHHHHhccCCCCcEEEEEecC--CceEEEEEecccccccc
Confidence 4799874 4566677887653321 12335677888888773 43356666655444 47899999999988755
Q ss_pred HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------------
Q 006277 101 YRKKHKKVDMKAVKGWARQILSGLIYLHSHD------------------------------------------------- 131 (652)
Q Consensus 101 ~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g------------------------------------------------- 131 (652)
.... ......++.++...|..||+..
T Consensus 100 ~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 100 EYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp HTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred cccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 3211 1112223344444444444310
Q ss_pred --------CCeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 132 --------PPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 132 --------~~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
+.++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~-~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSG 212 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred HhcCCcCCcEEEEeeccCcceeec-CCceEEEeechhcc
Confidence 1279999999999998 44445699998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.47 E-value=0.00012 Score=76.40 Aligned_cols=72 Identities=15% Similarity=0.139 Sum_probs=43.5
Q ss_pred cEEEEEEEccCCeEEEEEEEeecc-cCC--CHHHHHHHHHHHHHHHhC-CC--CCeeeeeeEEEeCCCCeEEEEEecCCC
Q 006277 22 TSGYKAFDEVNGLEVAWCQVRIDD-VLQ--SPEDLERLYSEVHLLKSL-KH--NNIIRFYNSWIDDQNKTVNIITELFTS 95 (652)
Q Consensus 22 gtVykA~d~~tG~~VAiK~v~~~~-~~~--s~e~~~~l~~Ei~iLk~L-~H--pnIVkl~~~~~d~~~~~~~LVmEy~~g 95 (652)
..||++.+..+|+.|++|+-...- ... -+-...|...|...|+.+ .+ ..++++|. .+.. ..++|||++.+
T Consensus 40 N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~--~~~lvmE~L~~ 115 (392)
T d2pula1 40 NYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTE--MAVTVMEDLSH 115 (392)
T ss_dssp EEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETT--TTEEEECCCTT
T ss_pred EeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCC--CCEEEEeccCC
Confidence 689999888888999999864311 100 012345677898888877 33 34566665 3444 34789999977
Q ss_pred CC
Q 006277 96 GS 97 (652)
Q Consensus 96 Gs 97 (652)
..
T Consensus 116 ~~ 117 (392)
T d2pula1 116 LK 117 (392)
T ss_dssp SE
T ss_pred cc
Confidence 54
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.07 E-value=0.00039 Score=66.60 Aligned_cols=75 Identities=8% Similarity=-0.087 Sum_probs=47.9
Q ss_pred EEEEEecC-cEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC--CCeeeeeeEEEeCCCCeEEEEE
Q 006277 14 LRLIQLVD-TSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH--NNIIRFYNSWIDDQNKTVNIIT 90 (652)
Q Consensus 14 ~rL~~l~~-gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~H--pnIVkl~~~~~d~~~~~~~LVm 90 (652)
.++..+.. ..||+... ..|..+.+|...... ...+..|+..|+.|.. -.+.+++.+..+. +..++||
T Consensus 16 ~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~ 85 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLL 85 (255)
T ss_dssp EECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEE
T ss_pred EEcCCcccCCeEEEEEe-CCCCEEEEEeCCccC-------HhHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEE
Confidence 34444443 47898864 456678888755322 2346778888887732 3356677655443 4789999
Q ss_pred ecCCCCCH
Q 006277 91 ELFTSGSL 98 (652)
Q Consensus 91 Ey~~gGsL 98 (652)
++++|.++
T Consensus 86 ~~i~G~~~ 93 (255)
T d1nd4a_ 86 GEVPGQDL 93 (255)
T ss_dssp ECCSSEET
T ss_pred Eeeecccc
Confidence 99988654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.17 E-value=0.0039 Score=62.54 Aligned_cols=68 Identities=7% Similarity=0.020 Sum_probs=42.0
Q ss_pred cEEEEEEEccCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCe--eeeee----EEEeCCCCeEEEEEecCCC
Q 006277 22 TSGYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI--IRFYN----SWIDDQNKTVNIITELFTS 95 (652)
Q Consensus 22 gtVykA~d~~tG~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~HpnI--Vkl~~----~~~d~~~~~~~LVmEy~~g 95 (652)
..||++.. .+|..|++|+.+.... ..+.+..|...+..|...+| +.... .... ..+..+.+++++.|
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~-----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~-~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERW-----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLN-HQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTS-----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEE-ETTEEEEEEECCCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCC-----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeee-eeeEEEEEEeecCC
Confidence 68999975 5788999998763321 24557778888888842222 11111 1111 13468889999977
Q ss_pred C
Q 006277 96 G 96 (652)
Q Consensus 96 G 96 (652)
.
T Consensus 109 ~ 109 (325)
T d1zyla1 109 R 109 (325)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.09 E-value=0.0037 Score=64.39 Aligned_cols=83 Identities=12% Similarity=0.072 Sum_probs=49.2
Q ss_pred CCcceeee---eeEEEEEEecCcEEEEEEEccC-------CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCe
Q 006277 3 RQKWSLLI---LMYLRLIQLVDTSGYKAFDEVN-------GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNI 71 (652)
Q Consensus 3 ~~~W~~~~---~~~~rL~~l~~gtVykA~d~~t-------G~~VAiK~v~~~~~~~s~e~~~~l~~Ei~iLk~L~-HpnI 71 (652)
.+.|.... ..+.++..+..-.+|++..... +..|.+++.- .. . ... ...+|..+++.+. +.-.
T Consensus 34 ~~~W~~~~~~~l~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~--~--~~i-dr~~E~~i~~~ls~~gl~ 107 (395)
T d1nw1a_ 34 GGAWKTVPLEHLRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP--E--TES-HLVAESVIFTLLSERHLG 107 (395)
T ss_dssp CTHHHHCCGGGEEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC--C--CHH-HHHHHHHHHHHHHHTTSS
T ss_pred cccccCCCccceEEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc--c--hhh-HHHHHHHHHHHHHhCCCC
Confidence 35575533 2345555555568999886532 3456665543 11 1 122 3457999999884 4334
Q ss_pred eeeeeEEEeCCCCeEEEEEecCCCCC
Q 006277 72 IRFYNSWIDDQNKTVNIITELFTSGS 97 (652)
Q Consensus 72 Vkl~~~~~d~~~~~~~LVmEy~~gGs 97 (652)
.++|.++ .+ ++||||+.|..
T Consensus 108 Pkll~~~--~~----g~I~efi~g~~ 127 (395)
T d1nw1a_ 108 PKLYGIF--SG----GRLEEYIPSRP 127 (395)
T ss_dssp SCEEEEE--TT----EEEECCCCEEE
T ss_pred CeEEEEc--CC----ceEEEEecccc
Confidence 5777755 32 58999998753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=85.55 E-value=0.37 Score=46.68 Aligned_cols=29 Identities=34% Similarity=0.429 Sum_probs=23.9
Q ss_pred CeeeccCCcccEEEcCCCCcEEEeccCchh
Q 006277 133 PIIHRDLKCDNIFINGNQGEVKIGDLGLAT 162 (652)
Q Consensus 133 ~IiHRDLKp~NILl~~~~g~VKL~DFGla~ 162 (652)
++||+|+.++||++++ ++..-|+||+.+.
T Consensus 184 giIHgDl~~dNvl~~~-~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLG-DELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred ccccCCcchhhhhccc-ccceeEecccccc
Confidence 4999999999999984 4445799999764
|